PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Roberts, TL; Idris, A; Dunn, JA; Kelly, GM; Burnton, CM; Hodgson, S; Hardy, LL; Garceau, V; Sweet, MJ; Ross, IL; Hume, DA; Stacey, KJ				Roberts, Tara L.; Idris, Adi; Dunn, Jasmyn A.; Kelly, Greg M.; Burnton, Carol M.; Hodgson, Samantha; Hardy, Lani L.; Garceau, Valerie; Sweet, Matthew J.; Ross, Ian L.; Hume, David A.; Stacey, Katryn J.			HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA	SCIENCE			English	Article							CELL-DEATH; INTERFERON; GENE; RECOGNITION; SIGNALS; FAMILY	The mammalian innate immune system is activated by foreign nucleic acids. Detection of double- stranded DNA ( dsDNA) in the cytoplasm triggers characteristic antiviral responses and macrophage cell death. Cytoplasmic dsDNA rapidly activated caspase 3 and caspase 1 in bone marrow- derived macrophages. We identified the HIN- 200 family member and candidate lupus susceptibility factor, p202, as a dsDNA binding protein that bound stably and rapidly to transfected DNA. Knockdown studies showed p202 to be an inhibitor of DNA- induced caspase activation. Conversely, the related pyrin domain- containing HIN- 200 factor, AIM2 ( p210), was required for caspase activation by cytoplasmic dsDNA. This work indicates that HIN- 200 proteins can act as pattern recognition receptors mediating responses to cytoplasmic dsDNA.	[Roberts, Tara L.; Idris, Adi; Dunn, Jasmyn A.; Kelly, Greg M.; Burnton, Carol M.; Hodgson, Samantha; Hardy, Lani L.; Garceau, Valerie; Sweet, Matthew J.; Ross, Ian L.; Hume, David A.; Stacey, Katryn J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Roberts, Tara L.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Sweet, Matthew J.; Stacey, Katryn J.] Univ Queensland, Sch Chem & Biomol Sci, Brisbane, Qld 4072, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland	Stacey, KJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	k.stacey@imb.uq.edu.au	Roberts, Tara L/B-7278-2011; Hume, David A/C-7695-2013; Idris, Adi/N-3500-2016; Sweet, Matthew J/F-2229-2011; Ross, Ian/A-8622-2011	Roberts, Tara L/0000-0001-9266-0943; Idris, Adi/0000-0002-0562-1549; Sweet, Matthew J/0000-0002-0406-8139; Ross, Ian/0000-0002-2389-4292; Stacey, Katryn/0000-0002-3992-7802; Hume, David/0000-0002-2615-1478	National Health and Medical Research Council (NHMRC) of Australia [455920, 455882]; Cooperative Research Centre for Chronic Inflammatory Diseases; NHMRC Peter Doherty Fellowship; Australian Research Council Special Research Centre for Functional and Applied Genomics; Australian Cancer Research Foundation; Medical Research Council [G9900991B] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Chronic Inflammatory Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NHMRC Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Special Research Centre for Functional and Applied Genomics(Australian Research Council); Australian Cancer Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (grants 455920 and 455882), and by the Cooperative Research Centre for Chronic Inflammatory Diseases. T. L. R. is the recipient of an NHMRC Peter Doherty Fellowship. Mass spectrometry facilities are supported by the Australian Research Council Special Research Centre for Functional and Applied Genomics. Confocalmicroscopy was performed at the Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology funded by the Australian Cancer Research Foundation. R. Johnstone and C. Clarke provided materials and valuable advice on the HIN-200 family proteins. S. Akira provided TLR9<SUP>-/-</SUP> mice. The work presented here is related to International Patent Application PCT/AU2007/001330.	Asefa B, 2004, BLOOD CELL MOL DIS, V32, P155, DOI 10.1016/j.bcmd.2003.10.002; Choubey D, 2000, FEBS LETT, V474, P38, DOI 10.1016/S0014-5793(00)01571-4; Choubey D, 1996, BIOCHEM BIOPH RES CO, V221, P396, DOI 10.1006/bbrc.1996.0607; Haywood M, 2006, GENES IMMUN, V7, P250, DOI 10.1038/sj.gene.6364294; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Liu T, 2003, PROTEIN SCI, V12, P1872, DOI 10.1110/ps.0359603; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; STACEY KJ, 1993, IMMUNOL CELL BIOL, V71, P75, DOI 10.1038/icb.1993.8; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Van de Parre TJL, 2005, BIOCHEM BIOPH RES CO, V327, P356, DOI 10.1016/j.bbrc.2004.12.027; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	20	640	679	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1057	1060		10.1126/science.1169841	http://dx.doi.org/10.1126/science.1169841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19131592				2022-12-01	WOS:000263478400041
J	Scott, FL; Stec, B; Pop, C; Dobaczewska, MK; Lee, JJ; Monosov, E; Robinson, H; Salvesen, GS; Schwarzenbacher, R; Riedl, SJ				Scott, Fiona L.; Stec, Boguslaw; Pop, Cristina; Dobaczewska, Malgorzata K.; Lee, JeongEun J.; Monosov, Edward; Robinson, Howard; Salvesen, Guy S.; Schwarzenbacher, Robert; Riedl, Stefan J.			The Fas-FADD death domain complex structure unravels signalling by receptor clustering	NATURE			English	Article							CELL-DEATH; MUTATIONAL ANALYSIS; APOPTOSIS; CD95; ARCHITECTURE; INFLAMMATION; INTERFACES; SPOTS	The death inducing signalling complex ( DISC) formed by Fas receptor, FADD( Fas- associated death domain protein) and caspase 8 is a pivotal trigger of apoptosis(1-3). The Fas - FADD DISC represents a receptor platform, which once assembled initiates the induction of programmed cell death. A highly oligomeric network of homotypic protein interactions comprised of the death domains of Fas and FADD is at the centre of DISC formation(4,5). Thus, characterizing the mechanistic basis for the Fas - FADD interaction is crucial for understanding DISC signalling but has remained unclear largely because of a lack of structural data. We have successfully formed and isolated the human Fas - FADD death domain complex and report the 2.7 angstrom crystal structure. The complex shows a tetrameric arrangement of four FADD death domains bound to four Fas death domains. We show that an opening of the Fas death domain exposes the FADD binding site and simultaneously generates a Fas - Fas bridge. The result is a regulatory Fas - FADD complex bridge governed by weak protein - protein interactions revealing a model where the complex itself functions as a mechanistic switch. This switch prevents accidental DISC assembly, yet allows for highly processive DISC formation and clustering upon a sufficient stimulus. In addition to depicting a previously unknown mode of death domain interactions, these results further uncover a mechanism for receptor signalling solely by oligomerization and clustering events.	[Scott, Fiona L.; Stec, Boguslaw; Pop, Cristina; Dobaczewska, Malgorzata K.; Lee, JeongEun J.; Monosov, Edward; Salvesen, Guy S.; Riedl, Stefan J.] Burnham Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Sanford Burnham Prebys Medical Discovery Institute; United States Department of Energy (DOE); Brookhaven National Laboratory; Salzburg University	Riedl, SJ (corresponding author), Burnham Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA.	robert.schwarzenbacher@sbg.ac.at; sriedl@burnham.org		Stec, Boguslaw/0000-0002-8696-0349	cancer center grant [P30 CA030199]; Biological and Environmental Research DOE; National Center for Research Resources NIH; LLS scholarship;  [R01AA017238];  [PO1CA69381];  [MCEXT-033534]; NATIONAL CANCER INSTITUTE [P01CA069381, P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017238] Funding Source: NIH RePORTER	cancer center grant; Biological and Environmental Research DOE(United States Department of Energy (DOE)); National Center for Research Resources NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); LLS scholarship; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Snipas for protein sequencing and technical assistance, J. Reed for providing Fas cDNA and A. Bobkov for the AUC. This work was supported by a P30 CA030199 cancer center grant and R01AA017238 to S.J.R.; PO1CA69381 to G. S. S.; and MCEXT-033534 to R. S. Data measured at beamline X29 of the National Synchrotron Light Source were also supported by Biological and Environmental Research DOE, and National Center for Research Resources NIH. Earlier stages of the work were supported by a LLS scholarship to S.J.R. S.J.R. is currently a V Foundation scholar.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Ferguson BJ, 2007, CELL DEATH DIFFER, V14, P1717, DOI 10.1038/sj.cdd.4402191; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Festjens N, 2006, BIOL CHEM, V387, P1005, DOI 10.1515/BC.2006.124; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Huxford T, 2002, J MOL BIOL, V324, P587, DOI 10.1016/S0022-2836(02)01149-X; ITOH N, 1993, J BIOL CHEM, V268, P10932; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; O'Reilly LA, 2004, CELL DEATH DIFFER, V11, P724, DOI 10.1038/sj.cdd.4401408; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Werner MH, 2006, CELL CYCLE, V5, P2332, DOI 10.4161/cc.5.20.3385	30	262	274	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1019	1022		10.1038/nature07606	http://dx.doi.org/10.1038/nature07606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19118384	Green Accepted			2022-12-01	WOS:000263425400044
J	Cartwright, HN; Humphries, JA; Smith, LG				Cartwright, Heather N.; Humphries, John A.; Smith, Laurie G.			PAN1: A Receptor-Like Protein That Promotes Polarization of an Asymmetric Cell Division in Maize	SCIENCE			English	Article							STOMATAL DEVELOPMENT; KINASES; ARABIDOPSIS; MECHANISM; LEPRK2; PLANTS; LEAF	Polarization of cell division is essential for eukaryotic development, but little is known about how this is accomplished in plants. The formation of stomatal complexes in maize involves the polarization of asymmetric subsidiary mother cell ( SMC) divisions toward the adjacent guard mother cell ( GMC), apparently under the influence of a GMC- derived signal. We found that the maize pan1 gene promotes the premitotic polarization of SMCs and encodes a leucine- rich repeat receptor- like protein that becomes localized in SMCs at sites of GMC contact. PAN1 has an inactive kinase domain but is required for the accumulation of a membrane- associated phosphoprotein, suggesting a function for PAN1 in signal transduction. Our findings implicate PAN1 in the transmission of an extrinsic signal that polarizes asymmetric SMC divisions toward GMCs.	[Cartwright, Heather N.; Humphries, John A.; Smith, Laurie G.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Smith, LG (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lgsmith@ucsd.edu		Cartwright, Heather/0000-0001-6639-5808	NSF [IOB-0544226]	NSF(National Science Foundation (NSF))	We thank A. Wright and F. Delgado for help with experiments and J. Bolado, J. Chory, and R. Boston for reagents. This work was supported by NSF grant IOB-0544226. pan1 gene and PAN1 protein sequences are available at GenBank (accession number FJ231525).	Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Chevalier D, 2005, P NATL ACAD SCI USA, V102, P9074, DOI 10.1073/pnas.0503526102; CHO SO, 1990, PROTOPLASMA, V157, P154, DOI 10.1007/BF01322648; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Gallagher K, 2000, CURR BIOL, V10, P1229, DOI 10.1016/S0960-9822(00)00730-2; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Llompart B, 2003, J BIOL CHEM, V278, P48105, DOI 10.1074/jbc.M307482200; Muschietti J, 1998, PLANT CELL, V10, P319, DOI 10.1105/tpc.10.3.319; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Panteris E, 2006, CELL MOTIL CYTOSKEL, V63, P696, DOI 10.1002/cm.20155; Scheres B, 1999, ANNU REV PLANT PHYS, V50, P505, DOI 10.1146/annurev.arplant.50.1.505; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; STEBBINS GL, 1960, DEV BIOL, V2, P477, DOI 10.1016/0012-1606(60)90050-6; ten Hove CA, 2008, CURR OPIN PLANT BIOL, V11, P34, DOI 10.1016/j.pbi.2007.11.001; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104	18	91	100	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					649	651		10.1126/science.1161686	http://dx.doi.org/10.1126/science.1161686			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179535				2022-12-01	WOS:000262862800047
J	Islam, SM; Shinmyo, Y; Okafuji, T; Su, YH; Bin Naser, I; Ahmed, G; Zhang, SB; Chen, S; Ohta, K; Kiyonari, H; Abe, T; Tanaka, S; Nishinakamura, R; Terashima, T; Kitamura, T; Tanaka, H				Islam, Shahidul M.; Shinmyo, Yohei; Okafuji, Tatsuya; Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Chen, Sandy; Ohta, Kunimasa; Kiyonari, Hiroshi; Abe, Takaya; Tanaka, Satomi; Nishinakamura, Ryuichi; Terashima, Toshio; Kitamura, Toshio; Tanaka, Hideaki			Draxin, a Repulsive Guidance Protein for Spinal Cord and Forebrain Commissures	SCIENCE			English	Article							AXON GUIDANCE; CORPUS-CALLOSUM; CHEMOATTRACTANT; NETRIN-1; RYK	Axon guidance proteins are critical for the correct wiring of the nervous system during development. Several axon guidance cues and their family members have been well characterized. More unidentified axon guidance cues are assumed to participate in the formation of the extremely complex nervous system. We identified a secreted protein, draxin, that shares no homology with known guidance cues. Draxin inhibited or repelled neurite outgrowth from dorsal spinal cord and cortical explants in vitro. Ectopically expressed draxin inhibited growth or caused misrouting of chick spinal cord commissural axons in vivo. draxin knockout mice showed defasciculation of spinal cord commissural axons and absence of all forebrain commissures. Thus, draxin is a previously unknown chemorepulsive axon guidance molecule required for the development of spinal cord and forebrain commissures.	[Islam, Shahidul M.; Shinmyo, Yohei; Okafuji, Tatsuya; Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Chen, Sandy; Ohta, Kunimasa; Tanaka, Hideaki] Kumamoto Univ, Div Dev Neurobiol, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Islam, Shahidul M.; Shinmyo, Yohei; Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Tanaka, Hideaki] Kumamoto Univ, 21st Century COE Ctr Excellence, Cell Fate Regulat Res & Educ Unit, Kumamoto 8600811, Japan; [Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Nishinakamura, Ryuichi; Tanaka, Hideaki] Kumamoto Univ, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto 8600811, Japan; [Kiyonari, Hiroshi; Abe, Takaya] RIKEN Kobe, Chuo Ku, Lab Anim Resources & Genet Engn, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Tanaka, Satomi; Nishinakamura, Ryuichi] Kumamoto Univ, Div Integrat Cell Biol, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Terashima, Toshio] Kobe Univ, Grad Sch Med, Div Anat & Neurobiol, Kobe, Hyogo 6500017, Japan; [Kitamura, Toshio] Univ Tokyo, Minato Ku, Div Cellular Therapy, Inst Med Sci, Tokyo 1088639, Japan	Kumamoto University; Kumamoto University; Kumamoto University; RIKEN; Kumamoto University; Kobe University; University of Tokyo	Tanaka, H (corresponding author), Kumamoto Univ, Div Dev Neurobiol, Grad Sch Med Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hitanaka@kumamoto-u.ac.jp	Islam, Shahidul/N-5897-2013; Kiyonari, Hiroshi/N-7936-2015; Kitamura, Toshio/AAA-2071-2021; Ohta, Kunimasa/AAW-6993-2020	Ohta, Kunimasa/0000-0002-4564-9757	Ministry of Education, Science, Sports, and Culture of Japan (MEXT); (Cell Fate Regulation Research and Education Unit), MEXT, Japan	Ministry of Education, Science, Sports, and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); (Cell Fate Regulation Research and Education Unit), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank D. S. Campbell for careful reading of the manuscript, C. Krull for the pMES-internal ribosome entry site (IRES)-EGFP vector, J. G. Flanagan for APTag-2 vector, H. Fujisawa for helpful discussions, and the Developmental Studies Hybridoma Bank for antibodies. This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT), by the 21st Century COE Program and by the Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan.	Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shu TZ, 2003, J NEUROSCI, V23, P8176; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006	15	115	127	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					388	393		10.1126/science.1165187	http://dx.doi.org/10.1126/science.1165187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150847				2022-12-01	WOS:000262481400041
J	Sasaki, S; Mello, CC; Shimada, A; Nakatani, Y; Hashimoto, SI; Ogawa, M; Matsushima, K; Gu, SGP; Kasahara, M; Ahsan, B; Sasaki, A; Saito, T; Suzuki, Y; Sugano, S; Kohara, Y; Takeda, H; Fire, A; Morishita, S				Sasaki, Shin; Mello, Cecilia C.; Shimada, Atsuko; Nakatani, Yoichiro; Hashimoto, Shin-ichi; Ogawa, Masako; Matsushima, Kouji; Gu, Sam Guoping; Kasahara, Masahiro; Ahsan, Budrul; Sasaki, Atsushi; Saito, Taro; Suzuki, Yutaka; Sugano, Sumio; Kohara, Yuji; Takeda, Hiroyuki; Fire, Andrew; Morishita, Shinichi			Chromatin-Associated Periodicity in Genetic Variation Downstream of Transcriptional Start Sites	SCIENCE			English	Article							NUCLEOSOME POSITIONS; HIGH-RESOLUTION; HUMAN GENOME; DNA-REPAIR; EVOLUTION; YEAST; PROMOTERS; STRAND	Might DNA sequence variation reflect germline genetic activity and underlying chromatin structure? We investigated this question using medaka (Japanese killifish, Oryzias latipes), by comparing the genomic sequences of two strains (Hd-rR and HNI) and by mapping similar to 37.3 million nucleosome cores from Hd-rR blastulae and 11,654 representative transcription start sites from six embryonic stages. We observed a distinctive similar to 200-base pair (bp) periodic pattern of genetic variation downstream of transcription start sites; the rate of insertions and deletions longer than 1 bp peaked at positions of approximately +200, +400, and +600 bp, whereas the point mutation rate showed corresponding valleys. This similar to 200-bp periodicity was correlated with the chromatin structure, with nucleosome occupancy minimized at positions 0, +200, +400, and +600 bp. These data exemplify the potential for genetic activity (transcription) and chromatin structure to contribute to molding the DNA sequence on an evolutionary time scale.	[Mello, Cecilia C.; Gu, Sam Guoping; Fire, Andrew] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Mello, Cecilia C.; Gu, Sam Guoping; Fire, Andrew] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Sasaki, Shin; Nakatani, Yoichiro; Kasahara, Masahiro; Ahsan, Budrul; Sasaki, Atsushi; Saito, Taro; Morishita, Shinichi] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba 2770882, Japan; [Shimada, Atsuko; Takeda, Hiroyuki] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; [Hashimoto, Shin-ichi; Ogawa, Masako; Matsushima, Kouji] Univ Tokyo, Dept Mol Prevent Med, Sch Med, Tokyo 1130033, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 1088639, Japan; [Kohara, Yuji] Res Org Informat & Syst, Ctr Genet Resources Informat, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Morishita, Shinichi] Japan Sci & Technol Agcy, Tokyo 1028666, Japan	Stanford University; Stanford University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST)	Fire, A (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	afire@stanford.edu; moris@cb.k.u-tokyo.ac.jp	Pillay, Nischalan/F-9536-2012; TAKEDA, HIROYUKI/G-4950-2014	Nakatani, Yoichiro/0000-0001-7604-0242; Fire, Andrew/0000-0001-6217-8312; Morishita, Shinichi/0000-0002-6201-8885; Kasahara, Masahiro/0000-0001-8430-1414	Monbukagakusho; Japan Science and Technology Agency; NIH [T32 CA09151, R01 GM37706]; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037706] Funding Source: NIH RePORTER	Monbukagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas (C) from the Monbukagakusho: MEXT, by the Japan Science and Technology Agency, and by the NIH (T32 CA09151 to C. C. M.; R01 GM37706 to A. F.). Computational time was provided by the Human Genome Center and the Information Technology Center, the University of Tokyo. We thank A. Sidow, A. Valouev, S. Johnson, J. Ford, and J. Cai for specific advice over the course of this work, and our colleagues at each institution for their help and suggestions. All sequence data are deposited at NCBI Short Read Archive (accession number SRA002449).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Higasa K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-66; Hong YH, 1998, P NATL ACAD SCI USA, V95, P3679, DOI 10.1073/pnas.95.7.3679; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Polak P, 2008, GENOME RES, V18, P1216, DOI 10.1101/gr.076570.108; Prendergast JGD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-72; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Suter B, 1997, EMBO J, V16, P2150, DOI 10.1093/emboj/16.8.2150; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Tijsterman M, 1999, MOL CELL BIOL, V19, P934; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Washietl S, 2008, TRENDS GENET, V24, P583, DOI 10.1016/j.tig.2008.09.003; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391	23	100	102	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					401	404		10.1126/science.1163183	http://dx.doi.org/10.1126/science.1163183			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19074313	Green Accepted			2022-12-01	WOS:000262481400044
J	Landers, SH				Landers, Steven H.			The Other Medical Home	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Landers, Steven H.] Ctr Home Hlth Serv, Cleveland Clin Rehabil Inst, Independence, OH 44131 USA	Cleveland Clinic Foundation	Landers, SH (corresponding author), Ctr Home Hlth Serv, Cleveland Clin Rehabil Inst, 6801 Brecksville Rd, Independence, OH 44131 USA.	landers@ccf.org						Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Goldman DP, 2005, HLTH AFF MILLWOO S2, V24; Hackbarth G, 2008, NEW ENGL J MED, V359, P3, DOI 10.1056/NEJMp0803749; Johnson L.B., 1965, REMARKS PRESIDENT TR; Leff B, 2005, ANN INTERN MED, V143, P798, DOI 10.7326/0003-4819-143-11-200512060-00008; Leff B, 1996, J AM GERIATR SOC, V44, P603, DOI 10.1111/j.1532-5415.1996.tb01452.x; Levine SA, 2003, JAMA-J AM MED ASSOC, V290, P1203, DOI 10.1001/jama.290.9.1203; MEDALIE JH, 1978, FAMILY MED PRINCIPLE; Sands LP, 2006, J AM GERIATR SOC, V54, P339, DOI 10.1111/j.1532-5415.2005.00590.x; 2005, RAND HLTH WORKING PA	11	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					97	99		10.1001/jama.2008.917	http://dx.doi.org/10.1001/jama.2008.917			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	391FY	19126815				2022-12-01	WOS:000262220400026
J	Kim, S; Takahashi, H; Lin, WW; Descargues, P; Grivennikov, S; Kim, Y; Luo, JL; Karin, M				Kim, Sunhwa; Takahashi, Hiroyuki; Lin, Wan-Wan; Descargues, Pascal; Grivennikov, Sergei; Kim, Youngjun; Luo, Jun-Li; Karin, Michael			Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis	NATURE			English	Article							LEWIS-LUNG-CARCINOMA; CANCER METASTASIS; PROSTATE-CANCER; INNATE IMMUNITY; TUMOR-GROWTH; PROTEOGLYCAN; INFLAMMATION; MACROPHAGES; ANGIOGENESIS; HYALURONAN	Metastatic progression depends on genetic alterations intrinsic to cancer cells as well as the inflammatory microenvironment of advanced tumours(1,2). To understand how cancer cells affect the inflammatory microenvironment, we conducted a biochemical screen for macrophage- activating factors secreted by metastatic carcinomas. Here we show that, among the cell lines screened, Lewis lung carcinoma (LLC)(3) were the most potent macrophage activators leading to production of interleukin-6 (IL-6) and tumour-necrosis factor-alpha (TNF-alpha) through activation of the Toll-like receptor (TLR) family members(4) TLR2 and TLR6. Both TNF-alpha and TLR2 were found to be required for LLC metastasis. Biochemical purification of LLC- conditioned medium ( LCM) led to identification of the extracellular matrix proteoglycan versican, which is upregulated in many human tumours including lung cancer(5,6), as a macrophage activator that acts through TLR2 and its coreceptors TLR6 and CD14. By activating TLR2: TLR6 complexes and inducing TNF-alpha secretion by myeloid cells, versican strongly enhances LLC metastatic growth. These results explain how advanced cancer cells usurp components of the host innate immune system, including bone- marrow- derived myeloid progenitors(7), to generate an inflammatory microenvironment hospitable for metastatic growth.	[Kim, Sunhwa; Takahashi, Hiroyuki; Lin, Wan-Wan; Descargues, Pascal; Grivennikov, Sergei; Kim, Youngjun; Luo, Jun-Li; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Kim, Sunhwa; Takahashi, Hiroyuki; Lin, Wan-Wan; Descargues, Pascal; Grivennikov, Sergei; Kim, Youngjun; Luo, Jun-Li; Karin, Michael] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; [Lin, Wan-Wan] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan	University of California System; University of California San Diego; University of California System; University of California San Diego; National Taiwan University	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Grivennikov, Sergei/AAE-7365-2019	Grivennikov, Sergei/0000-0003-2987-0555; Lin, Wan Wan/0000-0002-3207-734X; Luo, Jun-Li/0000-0002-7625-4766	International Human Frontier Science Program Organization; National Cancer Institute-sponsored Cancer Therapeutic Training Program; Ruth L. Kirschstein National Research Service Award; California Institute of Regenerative Medicine; Japanese Respiratory Society; Life Science Research Foundation; IHFSPO; Crohn's and Colitis Foundation of America; National Institutes of Health; Littlefield-AACR; NATIONAL CANCER INSTITUTE [R01CA118165, T32CA121938, R01CA132586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006376] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); National Cancer Institute-sponsored Cancer Therapeutic Training Program; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Japanese Respiratory Society; Life Science Research Foundation; IHFSPO; Crohn's and Colitis Foundation of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Littlefield-AACR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	S.K. was supported by the International Human Frontier Science Program Organization (IHFSPO), the National Cancer Institute-sponsored Cancer Therapeutic Training Program and a Ruth L. Kirschstein National Research Service Award. Y.K., H.T., J.-L.L., P.D. and S.G. were supported by the California Institute of Regenerative Medicine, the Japanese Respiratory Society, the Life Science Research Foundation, IHFSPO and the Crohn's and Colitis Foundation of America, respectively. Work in the M. K. laboratory was supported by grants from the National Institutes of Health and a Littlefield-AACR grant in Metastatic Colon Cancer Research. M. K. is an American Cancer Society Research Professor. We thank S. Akira and B. Beutler for TLR and adaptor protein deficient mice, D. Zimmermann for human versican construct, R. Hoffman for DsRed-LLC cells and K. Takenaga for LLC-P29 cells. We also thank R. Gallo and K. Yamasaki for the hyaluronan- inhibiting peptides and advice, J. Varner for analysing cell migration and Santa Cruz Biotechnology for gifts of antibodies.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bas S, 2008, J IMMUNOL, V180, P1158, DOI 10.4049/jimmunol.180.2.1158; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Eckmann L, 1996, J IMMUNOL, V156, P2894; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Isogai Z, 1996, CANCER RES, V56, P3902; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; NAKANISHI H, 1992, BIOCHEM J, V288, P215, DOI 10.1042/bj2880215; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Pirinen R, 2005, HUM PATHOL, V36, P44, DOI 10.1016/j.humpath.2004.10.010; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Urosevic M, 2004, BLOOD, V103, P1796, DOI 10.1182/blood-2003-10-3372; WEISS L, 1987, INT J CANCER, V40, P570, DOI 10.1002/ijc.2910400423; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	27	823	879	0	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					102	U108		10.1038/nature07623	http://dx.doi.org/10.1038/nature07623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122641	Green Accepted			2022-12-01	WOS:000262104900039
J	Watts, G				Watts, Geoff			Google watches over flu	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						GINSBERG J, 2008, NATURE          1119; *HLTH PROT AG, SOURC UK FLU DAT	2	7	9	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 31	2008	337								a3076	10.1136/bmj.a3076	http://dx.doi.org/10.1136/bmj.a3076			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401MZ	19118085				2022-12-01	WOS:000262946300002
J	James, AB; Monreal, JA; Nimmo, GA; Kelly, CL; Herzyk, P; Jenkins, GI; Nimmo, HG				James, Allan B.; Monreal, Jose A.; Nimmo, Gillian A.; Kelly, Ciaran L.; Herzyk, Pawel; Jenkins, Gareth I.; Nimmo, Hugh G.			The Circadian Clock in Arabidopsis Roots Is a Simplified Slave Version of the Clock in Shoots	SCIENCE			English	Article							GENE-EXPRESSION; MOLECULAR-BASES; FEEDBACK LOOP; RHYTHMS; PATHWAYS; LIVER; PRR7; CCA1; LHY	The circadian oscillator in eukaryotes consists of several interlocking feedback loops through which the expression of clock genes is controlled. It is generally assumed that all plant cells contain essentially identical and cell- autonomous multiloop clocks. Here, we show that the circadian clock in the roots of mature Arabidopsis plants differs markedly from that in the shoots and that the root clock is synchronized by a photosynthesis- related signal from the shoot. Two of the feedback loops of the plant circadian clock are disengaged in roots, because two key clock components, the transcription factors CCA1 and LHY, are able to inhibit gene expression in shoots but not in roots. Thus, the plant clock is organ- specific but not organ- autonomous.	[James, Allan B.; Monreal, Jose A.; Nimmo, Gillian A.; Kelly, Ciaran L.; Jenkins, Gareth I.; Nimmo, Hugh G.] Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow G12 8QQ, Lanark, Scotland; [Herzyk, Pawel] Univ Glasgow, Fac Biomed & Life Sci, Div Integrated Biol, Glasgow G12 8QQ, Lanark, Scotland; [Herzyk, Pawel] Univ Glasgow, Fac Biomed & Life Sci, Sir Henry Wellcome Funct Genom Facil, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Nimmo, HG (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow G12 8QQ, Lanark, Scotland.	h.g.nimmo@bio.gla.ac.uk	Jenkins, Gareth I/B-4785-2010; Kelly, Ciarán/AAR-2404-2021; Monreal, Jose Antonio/K-2210-2014	Kelly, Ciarán/0000-0002-2263-5176; Monreal, Jose Antonio/0000-0002-0186-5634; James, Allan/0000-0003-4472-7095; Nimmo, Hugh/0000-0003-1389-7147	Leverhulme Trust; Spanish Ministry of Education and Science	Leverhulme Trust(Leverhulme Trust); Spanish Ministry of Education and Science(Spanish Government)	We thank A. Millar (Edinburgh), S.A. Kay (San Diego), and C.R. McClung (Dartmouth) for Arabidopsis lines; I. Carr, (Warwick) and E. M. Tobin (Los Angeles) for the LHY- and CCA1-specific antisera, respectively; K. Edwards (Advanced Technologies, Cambridge) for advice on COSOPT; and J. Galbraith (Faculty of Biomedical and Life Sciences, University of Glasgow) for microarray experiments. The work was supported by the Leverhulme Trust. J.A.M. holds a fellowship from the Spanish Ministry of Education and Science.	Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Aschoff J., 1981, HDB BEHAVIOURAL NEUR, V4, P81; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Michael TP, 2002, PLANT PHYSIOL, V130, P627, DOI 10.1104/pp.004929; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Straume M, 2004, METHOD ENZYMOL, V383, P149; Sullivan S, 2004, PLANT PHYSIOL, V135, P2078, DOI 10.1104/pp.104.042762; Thain SC, 2000, CURR BIOL, V10, P951, DOI 10.1016/S0960-9822(00)00630-8; Thain SC, 2002, PLANT PHYSIOL, V130, P102, DOI 10.1104/pp.005405; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101	28	177	193	4	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1832	1835		10.1126/science.1161403	http://dx.doi.org/10.1126/science.1161403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095940				2022-12-01	WOS:000261799400051
J	Mendenhall, GS				Mendenhall, G. Stuart			Death and Taxes	ANNALS OF INTERNAL MEDICINE			English	Article							POSTPONEMENT; OCCASIONS	Tax incentives can provide a large financial impetus to change behavior. Current U. S. law establishes a substantial discontinuity in the amount of estate tax that many patients will have to pay in 2010: During this year only, the tax rate drops to zero. This article discusses concerns regarding the sharp change in tax rate and the incentives it creates for persons who are nearing the end of life and provides estimates of the number of people affected by this issue.	Univ Pittsburgh, Med Ctr, Cardiovasc Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mendenhall, GS (corresponding author), Univ Pittsburgh, Med Ctr, Cardiovasc Inst, Scaife Hall S-553,200 Lothrop St, Pittsburgh, PA 15213 USA.	gsmenden@post.harvard.edu						*CBO CTR BUDG POL, 2006, STAT EST TAX 2006; *CDC NAT CTR HLTH, 2007, BIRTHS MARR DIV DEAT; Clotfelter CT., 1990, W3273 NBER; PHILLIPS DP, 1988, LANCET, V2, P728; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; *US CENS BUR, 2006, S1101 US CENS BUR AM; Young DC, 2004, JAMA-J AM MED ASSOC, V292, P3012, DOI 10.1001/jama.292.24.3012; [No title captured]	9	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					822	824		10.7326/0003-4819-149-11-200812020-00010	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	19047030				2022-12-01	WOS:000261645300007
J	Vale, RD				Vale, Ronald D.			Microscopes for Fluorimeters: The Era of Single Molecule Measurements	CELL			English	Article							LOCALIZATION MICROSCOPY; DYNAMIC INSTABILITY; RNA-POLYMERASE; LIVING CELLS; PROTEIN; MICROTUBULES; F-1-ATPASE; COMPLEXES; FILAMENT; MOVEMENT	As transforming as the first atomic resolution view of myoglobin in the late 1950s, scientists can now use a suite of single molecule technologies to watch protein macromolecular machines executing their functions "in real time." This Essay highlights applications and challenges of single molecule studies in structural biology, cell biology, and biotechnology.	[Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	vale@cmp.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM038499-17, R01 GM038499] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Greenleaf WJ, 2006, SCIENCE, V313, P801, DOI 10.1126/science.1130105; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	33	17	19	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 28	2008	135	5					779	785		10.1016/j.cell.2008.11.009	http://dx.doi.org/10.1016/j.cell.2008.11.009			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041739	Bronze, Green Accepted			2022-12-01	WOS:000261183900006
J	Hagerman, RJ; Hagerman, PJ				Hagerman, Randi J.; Hagerman, Paul J.			Testing for Fragile X Gene Mutations Throughout the Life Span	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TREMOR/ATAXIA-SYNDROME; PREMUTATION; FXTAS		[Hagerman, Randi J.] Univ Calif Davis, Sch Med, MIND Inst, Davis, CA 95616 USA; [Hagerman, Randi J.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Hagerman, Paul J.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hagerman, RJ (corresponding author), Univ Calif Davis Hlth Syst, 2825 50th St, Sacramento, CA 95817 USA.	randi.hagerman@ucdmc.ucdavis.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274, R01HD036071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RL1AG032119, RL1AG032115] Funding Source: NIH RePORTER; NIA NIH HHS [RL1 AG032115-01, RL1 AG032115, AG032119, RL1 AG032119, AG032115, RL1 AG032119-01] Funding Source: Medline; NICHD NIH HHS [HD02274, HD036071, P30 HD002274, R01 HD036071-10, P30 HD002274-36S1, R01 HD036071] Funding Source: Medline; NIDCR NIH HHS [DE19583, UL1 DE019583, UL1 DE019583-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bailey DB, 2003, PEDIATRICS, V111, P407, DOI 10.1542/peds.111.2.407; Bear MF, 2005, GENES BRAIN BEHAV, V4, P393, DOI 10.1111/j.1601-183X.2005.00135.x; Coffey SM, 2008, AM J MED GENET A, V146A, P1009, DOI 10.1002/ajmg.a.32060; Farzin F, 2006, J DEV BEHAV PEDIATR, V27, pS137, DOI 10.1097/00004703-200604002-00012; Greco CM, 2007, J UROLOGY, V177, P1434, DOI 10.1016/j.juro.2006.11.097; Hagerman RJ, 2008, CLIN INTERV AGING, V3, P251, DOI 10.2147/CIA.S1794; HAGERMAN RJ, IN PRESS PEDIATRICS; Hall DA, 2005, NEUROLOGY, V65, P299, DOI 10.1212/01.wnl.0000168900.86323.9c; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Loesch DZ, 2007, NEUROSCI BIOBEHAV R, V31, P315, DOI 10.1016/j.neubiorev.2006.09.007; ROBERTS JE, AM J MED GENET B, DOI DOI 10.1002/AIMG.B.30786; Song FJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073	15	26	26	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2419	2421		10.1001/jama.2008.684	http://dx.doi.org/10.1001/jama.2008.684			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033593	Green Accepted			2022-12-01	WOS:000261150800025
J	Werdin, F; Tenenhaus, M; Rennekampff, HO				Werdin, Frank; Tenenhaus, Mayer; Rennekampff, Hans-Oliver			Chronic wound care	LANCET			English	Editorial Material							PERIPHERAL ARTERIAL-DISEASE; THERAPY		[Werdin, Frank] Univ Tubingen, Dept Plast Hand & Reconstruct Surg, Burn Ctr, D-72076 Tubingen, Germany; [Tenenhaus, Mayer] Univ Calif San Diego, Sch Med, Div Plast Surg, San Diego, CA 92103 USA; [Rennekampff, Hans-Oliver] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany	Eberhard Karls University of Tubingen; University of California System; University of California San Diego; Hannover Medical School	Werdin, F (corresponding author), Univ Tubingen, Dept Plast Hand & Reconstruct Surg, Burn Ctr, D-72076 Tubingen, Germany.	fwerdin@gmx.de						Ayello EA, 2004, NURSING, V34, P26; Chaby G, 2007, ARCH DERMATOL, V143, P1297, DOI 10.1001/archderm.143.10.1297; Dissemond J., 2007, HAUTARZT, V12, P1; Gohel MS, 2007, BMJ-BRIT MED J, V335, P83, DOI 10.1136/bmj.39216.542442.BE; Hiatt WR, 2002, J VASC SURG, V36, P1283, DOI 10.1067/mva.2002.129654; JULL A, 2007, COCHRANE DB SYST REV, V1; McInnes E, 1998, Nurs Stand, V13, P61; MIELL JM, 1999, WOUND REPAIR REGEN, V7, P335; Norman PE, 2004, MED J AUSTRALIA, V181, P150, DOI 10.5694/j.1326-5377.2004.tb06206.x; Padberg FT, 2004, J VASC SURG, V39, P79, DOI 10.1016/j.jvs.2003.09.036; Press E, 2010, CLIN PRACTICE GUIDEL; Royal College of Nursing (RCN), 2006, CLIN PRACTICE GUIDEL; Steed DL, 2004, AM J SURG, V187, p71S, DOI 10.1016/S0002-9610(03)00307-6; Vaneau M, 2007, ARCH DERMATOL, V143, P1291, DOI 10.1001/archderm.143.10.1291; Wraight PR, 2005, DIABETIC MED, V22, P127, DOI 10.1111/j.1464-5491.2004.01363.x	15	71	79	1	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1860	1862		10.1016/S0140-6736(08)61793-6	http://dx.doi.org/10.1016/S0140-6736(08)61793-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19041788				2022-12-01	WOS:000261388700006
J	Scheibert, J; Leurent, S; Prevost, A; Debregeas, G				Scheibert, J.; Leurent, S.; Prevost, A.; Debregeas, G.			The Role of Fingerprints in the Coding of Tactile Information Probed with a Biomimetic Sensor	SCIENCE			English	Article							TEXTURE; FINE; SKIN; DISCRIMINATION; PERCEPTION; RESOLUTION; MECHANICS; FILTER	In humans, the tactile perception of fine textures (spatial scale <200 micrometers) is mediated by skin vibrations generated as the finger scans the surface. To establish the relationship between texture characteristics and subcutaneous vibrations, a biomimetic tactile sensor has been designed whose dimensions match those of the fingertip. When the sensor surface is patterned with parallel ridges mimicking the fingerprints, the spectrum of vibrations elicited by randomly textured substrates is dominated by one frequency set by the ratio of the scanning speed to the interridge distance. For human touch, this frequency falls within the optimal range of sensitivity of Pacinian afferents, which mediate the coding of fine textures. Thus, fingerprints may perform spectral selection and amplification of tactile information that facilitate its processing by specific mechanoreceptors.	[Debregeas, G.] Univ Paris 06, Ecole Normale Super, Lab Phys Stat, CNRS,UMR 8550, F-75231 Paris 05, France; Univ Paris 07, F-75231 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Debregeas, G (corresponding author), Univ Paris 06, Ecole Normale Super, Lab Phys Stat, CNRS,UMR 8550, 24 Rue Lhomond, F-75231 Paris 05, France.	georges.debregeas@lps.ens.fr	Scheibert, Julien/C-5892-2009	Scheibert, Julien/0000-0002-9600-3796; Prevost, Alexis Michel/0000-0002-4588-3316; Debregeas, Georges/0000-0003-3698-4497; LEURENT, Sebastien/0000-0003-3847-8352	CNRS; EU-NEST; MONAT [contract 21, number 29000]	CNRS(Centre National de la Recherche Scientifique (CNRS)); EU-NEST(European Commission); MONAT	This project was supported primarily by CNRS basic funding and in part by the EU-NEST (New and Emerging Science and Technology) program, MONAT (Measurement of Naturalness) project (contract 21, number 29000). We are grateful to D. Chatenay and L. Bourdieu for fruitful discussions and careful reading of the manuscript.	Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P842, DOI 10.3758/BF03193537; Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; CARTMILL M, 1979, AM J PHYS ANTHROPOL, V50, P497, DOI 10.1002/ajpa.1330500402; CAUNA N, 1954, ANAT RECORD, V119, P449, DOI 10.1002/ar.1091190405; Crowder R, 2006, SCIENCE, V312, P1478, DOI 10.1126/science.1129110; Dandekar K, 2003, J BIOMECH ENG-T ASME, V125, P682, DOI 10.1115/1.1613673; DARIANSMITH I, 1984, HDB PHYSL NERVOUS SY, V3, pCH17; FEARING RS, 1985, INT J ROBOT RES, V4, P40, DOI 10.1177/027836498500400304; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; HOWE RD, 1993, IEEE T ROBOTIC AUTOM, V9, P140, DOI 10.1109/70.238278; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; Johnson KL, 1987, CONTACT MECH, DOI 10.1201/b17110-2; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177, DOI 10.1152/jn.1981.46.6.1177; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Katz, 1989, THE WORLD OF TOUCH; Lederman S.J., 2006, HUMAN HAND FUNCTION; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; Maheshwari V, 2006, SCIENCE, V312, P1501, DOI 10.1126/science.1126216; MAKOUS JC, 1995, J NEUROSCI, V15, P2808; Rieke F., 1999, SPIKES EXPLORING NEU; Scheibert J, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/34003; SRINIVASAN MA, 1990, J NEUROPHYSIOL, V63, P1323, DOI 10.1152/jn.1990.63.6.1323; Wang Q, 2007, J BIOMECH, V40, P851, DOI 10.1016/j.jbiomech.2006.03.004; WIENER N, 1958, NONLINEAR PROBLEMS R	26	251	263	13	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1503	1506		10.1126/science.1166467	http://dx.doi.org/10.1126/science.1166467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19179493	Green Submitted			2022-12-01	WOS:000264101700048
J	Liu, D; Vader, G; Vromans, MJM; Lampson, MA; Lens, SMA				Liu, Dan; Vader, Gerben; Vromans, Martijn J. M.; Lampson, Michael A.; Lens, Susanne M. A.			Sensing Chromosome Bi-Orientation by Spatial Separation of Aurora B Kinase from Kinetochore Substrates	SCIENCE			English	Article							MICROTUBULE ATTACHMENT; CLEAVAGE FURROW; CELL-DIVISION; SPINDLE; ANAPHASE; COMPLEX; LOCALIZATION; CYTOKINESIS; MECHANISMS; CHECKPOINT	Successful cell division requires that chromosomes attach to opposite poles of the mitotic spindle (bi-orientation). Aurora B kinase regulates chromosome-spindle attachments by phosphorylating kinetochore substrates that bind microtubules. Centromere tension stabilizes bi-oriented attachments, but how physical forces are translated into signaling at individual centromeres is unknown. Using fluorescence resonance energy transfer-based biosensors to measure localized phosphorylation dynamics in living cells, we found that phosphorylation of an Aurora B substrate at the kinetochore depended on its distance from the kinase at the inner centromere. Furthermore, repositioning Aurora B closer to the kinetochore prevented stabilization of bi-oriented attachments and activated the spindle checkpoint. Thus, centromere tension can be sensed by increased spatial separation of Aurora B from kinetochore substrates, which reduces phosphorylation and stabilizes kinetochore microtubules.	[Liu, Dan; Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Vader, Gerben; Vromans, Martijn J. M.; Lens, Susanne M. A.] Univ Med Ctr, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands	University of Pennsylvania; Utrecht University; Utrecht University Medical Center	Lampson, MA (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	lampson@sas.upenn.edu	Liu, Dan/G-9006-2018	Liu, Dan/0000-0003-4017-3136; Vader, Gerben/0000-0001-5729-0991	American Cancer Society [IRG-78-002-30]; National Institutes of Health [GM083988]; Searle Scholars Program; Penn Genome Frontiers Institute; Netherlands Organization for Scientific Research [Vidi 917.66.332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083988] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Penn Genome Frontiers Institute; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. M. Kapoor (Rockefeller University) and R. H. Medema (University Medical Center, Utrecht) for their support during the initiation of these studies. We also thank B. E. Black, G. Kops, and R. H. Medema for critical reading of the manuscript and helpful comments and K. V. Le and T. Chiang for assistance with preparing reagents. This work was supported by grants from the American Cancer Society (IRG-78-002-30, M.A.L.), the National Institutes of Health (GM083988, M.A.L.), the Searle Scholars Program (M.A.L.), the Penn Genome Frontiers Institute (M.A.L.), and the Netherlands Organization for Scientific Research (Vidi 917.66.332, S.M.A.L.).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Eckley DM, 1997, J CELL BIOL, V136, P1169, DOI 10.1083/jcb.136.6.1169; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; PLUTA AF, 1992, J CELL BIOL, V116, P1081, DOI 10.1083/jcb.116.5.1081; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	21	405	409	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1350	1353		10.1126/science.1167000	http://dx.doi.org/10.1126/science.1167000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19150808	Green Accepted			2022-12-01	WOS:000263876700044
J	Lancrin, C; Sroczynska, P; Stephenson, C; Allen, T; Kouskoff, V; Lacaud, G				Lancrin, Christophe; Sroczynska, Patrycja; Stephenson, Catherine; Allen, Terry; Kouskoff, Valerie; Lacaud, Georges			The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage	NATURE			English	Article							EMBRYONIC STEM-CELL; DEFINITIVE HEMATOPOIESIS; MOUSE EMBRYO; YOLK-SAC; COMMON PRECURSOR; TYROSINE KINASE; IN-VITRO; EXPRESSION; HEMANGIOBLAST; COMMITMENT	It has been proposed that during embryonic development haematopoietic cells arise from a mesodermal progenitor with both endothelial and haematopoietic potential called the haemangioblast(1,2). A conflicting theory instead associates the first haematopoietic cells with a phenotypically differentiated endothelial cell that has haematopoietic potential ( that is, a haemogenic endothelium) (3-5). Support for the haemangioblast concept was initially provided by the identification during mouse embryonic stem cell differentiation of a clonal precursor, the blast colony- forming cell (BL-CFC), which gives rise to blast colonies with both endothelial and haematopoietic components(6,7). Although recent studies have now provided evidence for the presence of this bipotential precursor in vivo(8,9), the precise mechanism for generation of haematopoietic cells from the haemangioblast still remains completely unknown. Here we demonstrate that the haemangioblast generates haematopoietic cells through the formation of a haemogenic endothelium intermediate, providing the first direct link between these two precursor populations. The cell population containing the haemogenic endothelium is transiently generated during BL-CFC development. This cell population is also present in gastrulating mouse embryos and generates haematopoietic cells on further culture. At the molecular level, we demonstrate that the transcription factor Tal1 ( also known as Scl; ref. 10) is indispensable for the establishment of this haemogenic endothelium population whereas the core binding factor Runx1 ( also known as AML1; ref. 11) is critical for generation of definitive haematopoietic cells from haemogenic endothelium. Together our results merge the two a priori conflicting theories on the origin of haematopoietic development into a single linear developmental process.	[Lancrin, Christophe; Sroczynska, Patrycja; Stephenson, Catherine; Lacaud, Georges] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Stem Cell Biol Grp, Manchester M20 4BX, Lancs, England; [Allen, Terry] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Struct Cell Biol Grp, Manchester M20 4BX, Lancs, England; [Kouskoff, Valerie] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Stem Cell Haematopoiesis Grp, Manchester M20 4BX, Lancs, England	Paterson Institute for Cancer Research; University of Manchester; Paterson Institute for Cancer Research; University of Manchester; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester	Lacaud, G (corresponding author), Univ Manchester, Paterson Inst Canc Res, Canc Res UK Stem Cell Biol Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	glacaud@picr.man.ac.uk	lacaud, Georges/ABH-5215-2020; Lancrin, Christophe/AAG-8169-2019	Lancrin, Christophe/0000-0003-0028-7374; Lacaud, Georges/0000-0002-5630-2417	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank K. Labib, C. Miller and T. Somervaille for critical reading of the manuscript, J. Barry and M. Hughes for cell sorting, S. Bagley for help with the time-lapse photography, G. Ashton for help with preparation of sections, and L. Gautreau for advice with the OP9 cultures. Cancer Research UK supported this work.	Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Choi K, 1998, DEVELOPMENT, V125, P725; D'Souza SL, 2005, BLOOD, V105, P3862, DOI 10.1182/blood-2004-09-3611; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Faloon P, 2000, DEVELOPMENT, V127, P1931; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; Hirai H, 2003, BLOOD, V101, P886, DOI 10.1182/blood-2002-02-0655; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li WM, 2005, STEM CELLS DEV, V14, P44, DOI 10.1089/scd.2005.14.44; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mukouyama Y, 2000, DEV BIOL, V220, P27, DOI 10.1006/dbio.2000.9617; MURRAY PDF, 1932, P R SOC LOND, V11, P497; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Palis J, 1999, DEVELOPMENT, V126, P5073; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Sabin F, 1920, CONTRIB EMBRYOL, V9, P213; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; YOUNG PE, 1995, BLOOD, V85, P96, DOI 10.1182/blood.V85.1.96.bloodjournal85196	30	461	482	4	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					892	895		10.1038/nature07679	http://dx.doi.org/10.1038/nature07679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19182774	Green Accepted			2022-12-01	WOS:000263266700047
J	Hamdan, FF; Gauthier, J; Spiegelman, D; Noreau, A; Yang, Y; Pellerin, S; Dobrzeniecka, S; Cote, M; Perreault-Linck, E; Carmant, L; D'Anjou, G; Fombonne, E; Addington, AM; Rapoport, JL; Delisi, LE; Krebs, MO; Mouaffak, F; Joober, R; Mottron, L; Drapeau, P; Marineau, C; Lafreniere, RG; Lacaille, JC; Rouleau, GA; Michaud, JL				Hamdan, Fadi F.; Gauthier, Julie; Spiegelman, Dan; Noreau, Anne; Yang, Yan; Pellerin, Stephanie; Dobrzeniecka, Sylvia; Cote, Melanie; Perreault-Linck, Elizabeth; Carmant, Lionel; D'Anjou, Guy; Fombonne, Eric; Addington, Anjene M.; Rapoport, Judith L.; Delisi, Lynn E.; Krebs, Marie-Odile; Mouaffak, Faycal; Joober, Ridha; Mottron, Laurent; Drapeau, Pierre; Marineau, Claude; Lafreniere, Ronald G.; Lacaille, Jean Claude; Rouleau, Guy A.; Michaud, Jacques L.		Synapse Dis Grp	Mutations in SYNGAP1 in Autosomal nonsyndromic Mental Retardation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYNAPTIC PLASTICITY; NMDA RECEPTORS; PROTEIN; TRAFFICKING; COMPLEXES; GENETICS; DEFECT	Although autosomal forms of nonsyndromic mental retardation account for the majority of cases of mental retardation, the genes that are involved remain largely unknown. We sequenced the autosomal gene SYNGAP1, which encodes a ras GTPAse-activating protein that is critical for cognition and synapse function, in 94 patients with nonsyndromic mental retardation. We identified de novo truncating mutations (K138X, R579X, and L813RfsX22) in three of these patients. In contrast, we observed no de novo or truncating mutations in SYNGAP1 in samples from 142 subjects with autism spectrum disorders, 143 subjects with schizophrenia, and 190 control subjects. These results indicate that SYNGAP1 disruption is a cause of autosomal dominant nonsyndromic mental retardation.	[Hamdan, Fadi F.; Pellerin, Stephanie; Carmant, Lionel; D'Anjou, Guy; Michaud, Jacques L.] CHU St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Gauthier, Julie; Spiegelman, Dan; Noreau, Anne; Yang, Yan; Dobrzeniecka, Sylvia; Cote, Melanie; Marineau, Claude; Lafreniere, Ronald G.; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neurom, Ctr Hosp, Res Ctr, Montreal, PQ, Canada; [Gauthier, Julie; Spiegelman, Dan; Noreau, Anne; Yang, Yan; Dobrzeniecka, Sylvia; Cote, Melanie; Marineau, Claude; Lafreniere, Ronald G.; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neurom, Dept Med, Montreal, PQ, Canada; [Drapeau, Pierre] Univ Montreal, Ctr Excellence Neurom, Grp Rech Syst Nerveux Cent, Dept Pathol & Cell Biol, Montreal, PQ, Canada; [Lacaille, Jean Claude] Univ Montreal, Ctr Excellence Neurom, Dept Physiol, Montreal, PQ, Canada; [Perreault-Linck, Elizabeth; Mottron, Laurent] Univ Montreal, Ctr Excellence Neurom, Ctr Rech Fernand Seguin, Hop Riviere Prairies, Montreal, PQ, Canada; [Fombonne, Eric] Montreal Childrens Hosp, Dept Psychiat, Montreal, PQ H3H 1P3, Canada; [Joober, Ridha] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Addington, Anjene M.; Rapoport, Judith L.] NIMH, Child Psychiat Branch, Bethesda, MD 20892 USA; [Delisi, Lynn E.] Nathan S Kline Inst Psychiat Res, Ctr Adv Brain Imaging, Orangeburg, NY 10962 USA; [Krebs, Marie-Odile; Mouaffak, Faycal] Univ Paris 05, INSERM, Unite 894, Paris, France; [Krebs, Marie-Odile; Mouaffak, Faycal] Hop St Anne, F-75674 Paris, France	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Nathan Kline Institute for Psychiatric Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Michaud, JL (corresponding author), CHU St Justine, Res Ctr, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	michaud@recherche-ste-justine.qc.ca	Fombonne, Eric/M-4893-2018; Krebs, Marie-Odile/O-2104-2017	Fombonne, Eric/0000-0002-8605-3538; Krebs, Marie-Odile/0000-0002-4715-9890; Mottron, Laurent/0000-0001-5668-5422; spiegelman, dan/0000-0003-4971-8868; MOUAFFAK, Faycal/0000-0002-6277-5755; Addington, Anjene/0000-0001-7770-299X	Canadian Institute of Health Research; Fonds de la Recherche en Sant; Genome Canada; Genome Quebec; Universite de Montreal; Clinical Investigatorship Award; CIHR (Institute of Genetics); Fondation Pierre Deniker; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002581] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sant; Genome Canada(Genome Canada); Genome Quebec; Universite de Montreal; Clinical Investigatorship Award; CIHR (Institute of Genetics)(Canadian Institutes of Health Research (CIHR)); Fondation Pierre Deniker; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the Canadian Institute of Health Research (CIHR) (to Drs. Lacaille, Rouleau, and Michaud), from Fonds de la Recherche en Sant, (to Dr. Michaud), and from Genome Canada and Genome Quebec and cofunding by Universite de Montreal for the Synapse to Diseases project (to Drs. Drapeau and Rouleau). Dr. Michaud is the recipient of a Clinical Investigatorship Award of the CIHR (Institute of Genetics). The schizophrenia series was collected partly through the Collaborative Network for Family Study in Psychiatry, which is supported by the Fondation Pierre Deniker.; No potential conflict of interest relevant to this article was reported.; We thank the patients and their parents for participating in this study; the members of the Synapse to Disease Group, including Edouard Henrion and Ousmane Diallo of the bioinformatics division and Sandra Laurent, Frederic Kuku, Joannie Duguay, Laurie Destroismaisons, Karine Lachapelle, Philippe Jolivet, Pascale Thibodeau, and Annie Raymond of the genetic screening division; Annie Levert and Judith St.-Onge for performing DNA extraction and paternity testing, respectively; and Pierre Lepage, Sebastien Brunet, and Hao Fan Yam of McGill University and Genome Quebec Innovation Centre sequencing group and Louis Letourneau and Louis Dumond Joseph of the bioinformatics group.	Angehagen M, 2005, J NEUROCHEM, V94, P1124, DOI 10.1111/j.1471-4159.2005.03259.x; Basel-Vanagaite L, 2007, CLIN GENET, V72, P167, DOI 10.1111/j.1399-0004.2007.00881.x; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Du J, 2004, J NEUROSCI, V24, P6578, DOI 10.1523/JNEUROSCI.1258-04.2004; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Li WD, 2001, J BIOL CHEM, V276, P21417, DOI 10.1074/jbc.M010744200; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756	24	208	227	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					599	605		10.1056/NEJMoa0805392	http://dx.doi.org/10.1056/NEJMoa0805392			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402QS	19196676	Green Accepted			2022-12-01	WOS:000263028800006
J	Ludwig, DS; Pollack, HA				Ludwig, David S.; Pollack, Harold A.			Obesity and the Economy From Crisis to Opportunity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONSEQUENCES		[Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Pollack, Harold A.] Univ Chicago, Ctr Hlth Adm Studies, Chicago, IL 60637 USA	Harvard University; Boston Children's Hospital; University of Chicago	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu	Pollack, Harold A/A-1166-2007	Ludwig, David/0000-0003-3307-8544				*BUR LAB STAT, JUN 2008 CPI DET REP; Caroli M, 2004, INT J OBESITY, V28, pS104, DOI 10.1038/sj.ijo.0802802; Economos CD, 2007, OBESITY, V15, P1325, DOI 10.1038/oby.2007.155; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1808, DOI 10.1001/jama.300.15.1808; Marniemi J, 2002, J INTERN MED, V251, P35, DOI 10.1046/j.1365-2796.2002.00921.x; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Rose D, 1999, J NUTR, V129, p517S, DOI 10.1093/jn/129.2.517S; Roux L, 2006, OBESITY, V14, P1093, DOI 10.1038/oby.2006.125; SHAND D, STANDARD POORS; Wang LY, 2003, OBES RES, V11, P1313, DOI 10.1038/oby.2003.178	14	78	78	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					533	535		10.1001/jama.2009.52	http://dx.doi.org/10.1001/jama.2009.52			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402CS	19190318				2022-12-01	WOS:000262992400024
J	Venteicher, AS; Abreu, EB; Meng, ZJ; McCann, KE; Terns, RM; Veenstra, TD; Terns, MP; Artandi, SE				Venteicher, Andrew S.; Abreu, Eladio B.; Meng, Zhaojing; McCann, Kelly E.; Terns, Rebecca M.; Veenstra, Timothy D.; Terns, Michael P.; Artandi, Steven E.			A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis	SCIENCE			English	Article							SMALL NUCLEOLAR RNPS; DYSKERATOSIS-CONGENITA; RNA; ACCUMULATION; HOMOLOG; BODIES; PURIFICATION; RECRUITMENT; BIOGENESIS; SHARE	Telomerase is a ribonucleoprotein ( RNP) complex that synthesizes telomere repeats in tissue progenitor cells and cancer cells. Active human telomerase consists of at least three principal subunits, including the telomerase reverse transcriptase, the telomerase RNA ( TERC), and dyskerin. Here, we identify a holoenzyme subunit, TCAB1 ( telomerase Cajal body protein 1), that is notably enriched in Cajal bodies, nuclear sites of RNP processing that are important for telomerase function. TCAB1 associates with active telomerase enzyme, established telomerase components, and small Cajal body RNAs that are involved in modifying splicing RNAs. Depletion of TCAB1 by using RNA interference prevents TERC from associating with Cajal bodies, disrupts telomerase- telomere association, and abrogates telomere synthesis by telomerase. Thus, TCAB1 controls telomerase trafficking and is required for telomere synthesis in human cancer cells.	[Venteicher, Andrew S.; McCann, Kelly E.; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Sch Med, Program Biophys, Stanford, CA 94305 USA; [Abreu, Eladio B.; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Abreu, Eladio B.; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Meng, Zhaojing; Veenstra, Timothy D.] NCI, Lab Proteom & Analyt Technol, Adv Technol Program, Sci Applicat Int Corp, Frederick, MD 21702 USA; [McCann, Kelly E.; Artandi, Steven E.] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Terns, Michael/N-6435-2016; Venteicher, Andrew/AAN-5666-2021	Venteicher, Andrew/0000-0003-0643-0493	Medical Scientist Training Program [GM07365]; NCI [CA104676, NO1-CO-12400, CA111691, CA125453]; Leukemia and Lymphoma Society Specialized Centers of Research [7007-09]; NATIONAL CANCER INSTITUTE [R01CA125453, R01CA104676, R01CA111691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER	Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society Specialized Centers of Research(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Medical Scientist Training Program grant GM07365 (A.S.V.) and NCI grant CA104676 (M.P.T. and R.M.T.), with a Supplement to Promote Diversity in Health- Related Research (E.B.A.). This project has been funded in part with federal funds from the NCI under contract NO1-CO-12400 (T.D.V.). This work was supported by NCI grants CA111691 and CA125453 (S.E.A.) and by Leukemia and Lymphoma Society Specialized Centers of Research grant 7007-09 (S.E.A.).	Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Dragon F, 2000, MOL CELL BIOL, V20, P3037, DOI 10.1128/MCB.20.9.3037-3048.2000; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Hoareau-Aveilla C, 2006, RNA, V12, P832, DOI 10.1261/rna.2344106; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; MEIER UT, 1994, J CELL BIOL, V127, P1505, DOI 10.1083/jcb.127.6.1505; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Reichenbach P, 2003, CURR BIOL, V13, P568, DOI 10.1016/S0960-9822(03)00173-8; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	23	373	395	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					644	648		10.1126/science.1165357	http://dx.doi.org/10.1126/science.1165357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179534	Green Accepted			2022-12-01	WOS:000262862800046
J	Arias, CA; Murray, BE				Arias, Cesar A.; Murray, Barbara E.			Antibiotic-Resistant Bugs in the 21st Century -- A Clinical Super-Challenge.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Arias, Cesar A.; Murray, Barbara E.] Univ Texas Houston, Sch Med, Dept Internal Med, Houston, TX 77025 USA; [Arias, Cesar A.] Univ El Bosque, Mol Genet & Antimicrobial Resistance Unit, Bogota, Colombia; [Murray, Barbara E.] Univ Texas Houston, Sch Med, Div Infect Dis, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Universidad El Bosque; University of Texas System; University of Texas Health Science Center Houston	Arias, CA (corresponding author), Univ Texas Houston, Sch Med, Dept Internal Med, Houston, TX 77025 USA.							Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; LAX E, 2004, MOLD FLOREYS COAT ST; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Schwartz BS, 2008, ANN PHARMACOTHER, V42, P289, DOI 10.1345/aph.1K548	5	732	820	6	189	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					439	443		10.1056/NEJMp0804651	http://dx.doi.org/10.1056/NEJMp0804651			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179312				2022-12-01	WOS:000262812400002
J	Brandt, F; Etchells, SA; Ortiz, JO; Elcock, AH; Hartl, FU; Baumeister, W				Brandt, Florian; Etchells, Stephanie A.; Ortiz, Julio O.; Elcock, Adrian H.; Hartl, F. Ulrich; Baumeister, Wolfgang			The Native 3D Organization of Bacterial Polysomes	CELL			English	Article							COLI 70S RIBOSOME; TRIGGER FACTOR; NASCENT CHAIN; ESCHERICHIA-COLI; MESSENGER-RNA; ELECTRON TOMOGRAPHY; ANGSTROM RESOLUTION; INITIATION-FACTORS; PROTEIN-SYNTHESIS; BINDING-PROTEIN	Recent advances have led to insights into the structure of the bacterial ribosome, but little is known about the 3D organization of ribosomes in the context of translating polysomes. We employed cryoelectron tomography and a template-matching approach to map 70S ribosomes in vitrified bacterial translation extracts and in lysates of active E. coli spheroplasts. In these preparations, polysomal arrangements were observed in which neighboring ribosomes are densely packed and exhibit preferred orientations. Analysis of characteristic examples of polysomes reveals a staggered or pseudohelical organization of ribosomes along the mRNA trace, with the transcript being sequestered on the inside, the tRNA entrance sites being accessible, and the polypeptide exit sites facing the cytosol. Modeling of elongating nascent polypeptide chains suggests that this arrangement maximizes the distance between nascent chains on adjacent ribosomes, thereby reducing the probability of intermolecular interactions that would give rise to aggregation and limit productive folding.	[Brandt, Florian; Etchells, Stephanie A.; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Brandt, Florian; Ortiz, Julio O.; Baumeister, Wolfgang] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Hartl, F. Ulrich; Baumeister, Wolfgang] Univ Munich, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Elcock, Adrian H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Max Planck Society; Max Planck Society; University of Munich; University of Iowa	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; baumeist@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Elcock, Adrian H./F-4799-2010	Ortiz, Julio/0000-0001-7470-5546; Elcock, Adrian/0000-0003-2820-1376	European Union; Deutsche Forschungsgemeinschaft [FOR 967]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank S. K. Lakshmipathy for providing the pBAD Luc-SecM-GFP construct. This work was supported by Framework 7 Program of the European Union, by "Fondation Fourmentin Guilbert,'' and by the Deutsche Forschungsgemeinschaft (FOR 967).	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Antoun A, 2006, EMBO J, V25, P2539, DOI 10.1038/sj.emboj.7601140; Arnold TE, 1998, RNA, V4, P319; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; Bashan A, 2005, BIOCHEM SOC T, V33, P488, DOI 10.1042/BST0330488; Bohm J, 2000, P NATL ACAD SCI USA, V97, P14245, DOI 10.1073/pnas.230282097; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Elcock AH, 2006, PLOS COMPUT BIOL, V2, P824, DOI 10.1371/journal.pcbi.0020098; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; Evans MS, 2005, PROTEIN PEPTIDE LETT, V12, P189, DOI 10.2174/0929866053005908; Forster F, 2008, J STRUCT BIOL, V161, P276, DOI 10.1016/j.jsb.2007.07.006; Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299; FRIEDBERG I, 1975, FEBS LETT, V56, P108, DOI 10.1016/0014-5793(75)80121-9; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hsu STD, 2007, P NATL ACAD SCI USA, V104, P16516, DOI 10.1073/pnas.0704664104; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; KIHO Y, 1964, P NATL ACAD SCI USA, V51, P111, DOI 10.1073/pnas.51.1.111; Kopeina GS, 2008, NUCLEIC ACIDS RES, V36, P2476, DOI 10.1093/nar/gkm1177; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Madin K, 2004, FEBS LETT, V562, P155, DOI 10.1016/S0014-5793(04)00221-2; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Ortiz JO, 2006, J STRUCT BIOL, V156, P334, DOI 10.1016/j.jsb.2006.04.014; RICH A, 1963, SCI AM, V209, P44, DOI 10.1038/scientificamerican1263-44; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; SLAYTER H, 1968, J CELL BIOL, V37, P583, DOI 10.1083/jcb.37.2.583; Spirin AS, 2004, TRENDS BIOTECHNOL, V22, P538, DOI 10.1016/j.tibtech.2004.08.012; STAEHELIN T, 1963, NATURE, V199, P865, DOI 10.1038/199865a0; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vanzi F, 2005, BIOPHYS J, V89, P1909, DOI 10.1529/biophysj.104.056283; WARNER JR, 1962, SCIENCE, V138, P1399, DOI 10.1126/science.138.3548.1399; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOOLHEAD CA, 2004, NATURE, V444, P391	44	182	186	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					261	271		10.1016/j.cell.2008.11.016	http://dx.doi.org/10.1016/j.cell.2008.11.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167328	Bronze			2022-12-01	WOS:000262648800015
J	Lyle, K; Kumar, P; Wittmann, T				Lyle, Karen; Kumar, Praveen; Wittmann, Torsten			SnapShot: Microtubule Regulators I	CELL			English	Editorial Material							NUCLEATION; ARRAYS		[Lyle, Karen; Kumar, Praveen; Wittmann, Torsten] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lyle, K (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.		Wittmann, Torsten/F-9833-2013	Wittmann, Torsten/0000-0001-9134-691X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079139] Funding Source: NIH RePORTER; NIDCR NIH HHS [T32 DE007306, 5T32DE007306] Funding Source: Medline; NIGMS NIH HHS [R01 GM079139, R01GM079139] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baas PW, 2005, TRENDS CELL BIOL, V15, P518, DOI 10.1016/j.tcb.2005.08.004; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Ehrhardt DW, 2008, CURR OPIN CELL BIOL, V20, P107, DOI 10.1016/j.ceb.2007.12.004; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Manning J, 2007, INT J BIOCHEM CELL B, V39, P7, DOI 10.1016/j.biocel.2006.08.012; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wordeman L, 2005, CURR OPIN CELL BIOL, V17, P82, DOI 10.1016/j.ceb.2004.12.003	8	10	10	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					379	U189	380.e1	10.1016/j.cell.2009.01.010	http://dx.doi.org/10.1016/j.cell.2009.01.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167337	Bronze, Green Accepted			2022-12-01	WOS:000262648800025
J	Battisti, DS; Naylor, RL				Battisti, David. S.; Naylor, Rosamond L.			Historical Warnings of Future Food Insecurity with Unprecedented Seasonal Heat	SCIENCE			English	Article							YIELDS	Higher growing season temperatures can have dramatic impacts on agricultural productivity, farm incomes, and food security. We used observational data and output from 23 global climate models to show a high probability (> 90%) that growing season temperatures in the tropics and subtropics by the end of the 21st century will exceed the most extreme seasonal temperatures recorded from 1900 to 2006. In temperate regions, the hottest seasons on record will represent the future norm in many locations. We used historical examples to illustrate the magnitude of damage to food systems caused by extreme seasonal heat and show that these short- run events could become long-term trends without sufficient investments in adaptation.	[Battisti, David. S.] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Naylor, Rosamond L.] Stanford Univ, Program Food Secur & Environm, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; Stanford University	Battisti, DS (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	battisti@washington.edu; roz@stanford.edu	Battisti, David S/A-3340-2013	Battisti, David S/0000-0003-4871-1293	NSF [SES 0433679]; Tamaki Foundation	NSF(National Science Foundation (NSF)); Tamaki Foundation	This work was made possible by grants from the NSF (grant SES 0433679) and the Tamaki Foundation. We thank M. Baker, M. Burke, W. Falcon, D. Kennedy, S.-H. Kim, D. Lobell, R. Nicholas, K. Niemer Johnson, K. Rennert, and D. Vimont for comments and/or assistance on the draft.	Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; DEBONO A, 2004, ENV ALERT B IMPACTS; Dronin N.M., 2005, CLIMATE DEPENDENCE F; EASTERLING W, 2007, CLIMATE CHANGE 2007, P976; HATHAWAY DE, 1974, BROOKINGS PAPERS EC, V1, P63; *INT FIN STAT DAT, 2008, US GULF PORTS WHEAT; IPCC, 2007, 4 ASS REP SYNTH; JAYNE T, 2008, TRANSFORMATION AGRIF; KANDJI ST, 2006, CLIMATE CHANGE VARIA; LARSEN J, 2006, EARTH POLICY I; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; NAYLOR R, 2008, BOSTON REV, V33, P13; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; PIRARD A, 2005, EUROSURVEILLANCE, V10, P554; Schlenker W, 2006, REV AGR ECON, V28, P391, DOI 10.1111/j.1467-9353.2006.00304.x; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; World Bank, 2007, WORLD DEV REPORT 200; World Bank, 2007, AFR DEV IND 2007	19	943	980	15	383	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					240	244		10.1126/science.1164363	http://dx.doi.org/10.1126/science.1164363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131626				2022-12-01	WOS:000262290600035
J	Colantonio, JR; Vermot, J; Wu, D; Langenbacher, AD; Fraser, S; Chen, JN; Hill, KL				Colantonio, Jessica R.; Vermot, Julien; Wu, David; Langenbacher, Adam D.; Fraser, Scott; Chen, Jau-Nian; Hill, Kent L.			The dynein regulatory complex is required for ciliary motility and otolith biogenesis in the inner ear	NATURE			English	Article							TRYPANOSOMA-BRUCEI; ZEBRAFISH; CHLAMYDOMONAS; PROTEIN; MUTATIONS; GAS11; COMPONENTS; MECHANISM; HOMOLOG; ARMS	In teleosts, proper balance and hearing depend on mechanical sensors in the inner ear. These sensors include actin- based microvilli and microtubule- based cilia that extend from the surface of sensory hair cells and attach to biomineralized 'ear stones' ( or otoliths)(1). Otolith number, size and placement are under strict developmental control, but the mechanisms that ensure otolith assembly atop specific cells of the sensory epithelium are unclear. Here we demonstrate that cilia motility is required for normal otolith assembly and localization. Using in vivo video microscopy, we show that motile tether cilia at opposite poles of the otic vesicle create fluid vortices that attract otolith precursor particles, thereby biasing an otherwise random distribution to direct localized otolith seeding on tether cilia. Independent knockdown of subunits for the dynein regulatory complex and outer- arm dynein disrupt cilia motility, leading to defective otolith biogenesis. These results demonstrate a requirement for the dynein regulatory complex in vertebrates and show that cilia- driven flow is a key epigenetic factor in controlling otolith biomineralization.	[Colantonio, Jessica R.; Hill, Kent L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Langenbacher, Adam D.; Chen, Jau-Nian] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Chen, Jau-Nian; Hill, Kent L.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Vermot, Julien; Wu, David; Fraser, Scott] CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; California Institute of Technology	Hill, KL (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	kenthill@mednet.ucla.edu	Fraser, Scott/Y-3406-2019; Vermot, Julien/I-6568-2016; Chen, Jau-Nian/AAM-7808-2020	Fraser, Scott/0000-0002-5377-0223; , Julien/0000-0002-8924-732X; Wu, David/0000-0003-3162-3238; Chen, Jau-Nian/0000-0001-8807-3607	Human Frontier Science Program; NIH Medical Scientist Training Program at UCLA/Caltech; NIH RSDA [M07185]; Warsaw Fellowship; NSF; NIH [R01 HL081799, R01AI52348]; Beckman Young Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052348] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); NIH Medical Scientist Training Program at UCLA/Caltech(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH RSDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Warsaw Fellowship; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Young Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to R. Crosbie for discussions and encouragement throughout the course of the project. We thank I. Drummond and C. Nguyen for discussions and comments on the work. We are grateful to L. Trinh, O. Bricaud and A. Collazo for sharing reagents and for providing probes, as well as to all the members of the Fraser laboratory for discussions, in particular M. Liebling and W. Supatto for sharing Matlab scripts and comments. We are grateful to Z.P. Kabututu for performing the lrrc50 reverse transcriptase PCR experiments. J.V. was supported by a fellowship from the Human Frontier Science Program, D.W. was supported by the NIH Medical Scientist Training Program at UCLA/ Caltech. J. R. C. was supported by NIH RSDA training grant no. M07185 and a Warsaw Fellowship from the MIMG Department at UCLA. A. D. L is supported by an NSF fellowship. This work was supported by NIH grant R01 HL081799 ( J. C.), NIH grant R01AI52348 and Beckman Young Investigator Award ( K. L. H.).	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bekker JM, 2007, CELL MOTIL CYTOSKEL, V64, P461, DOI 10.1002/cm.20196; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Bok J, 2007, DEV BIOL, V311, P69, DOI 10.1016/j.ydbio.2007.08.013; Chen JN, 1996, DEVELOPMENT, V122, P3809; Colantonio JR, 2006, TRAFFIC, V7, P538, DOI 10.1111/j.1600-0854.2006.00411.x; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Hill KL, 2000, J BIOL CHEM, V275, P39369, DOI 10.1074/jbc.M006907200; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Hughes I, 2006, BRAIN RES, V1091, P58, DOI 10.1016/j.brainres.2006.01.074; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Leger S, 2002, MECH DEVELOP, V119, P91, DOI 10.1016/S0925-4773(02)00343-X; Mowbray C, 2001, MECH DEVELOP, V108, P179, DOI 10.1016/S0925-4773(01)00479-8; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Shastry Barkur S., 2000, Microbial and Comparative Genomics, V5, P61, DOI 10.1089/10906590050179747; Sollner C., 2004, BIOMINERALIZATION PR, P229; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; van Rooijen E, 2008, J AM SOC NEPHROL, V19, P1128, DOI 10.1681/ASN.2007080917; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitmore SA, 1998, GENOMICS, V52, P325, DOI 10.1006/geno.1998.5457; Yeh SD, 2002, J BIOL CHEM, V277, P6311, DOI 10.1074/jbc.M106941200	34	93	95	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					205	U102		10.1038/nature07520	http://dx.doi.org/10.1038/nature07520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19043402	Green Accepted			2022-12-01	WOS:000262360200035
J	Mayor, S				Mayor, Susan			Unravelling the secrets of ageing	BRITISH MEDICAL JOURNAL			English	Editorial Material							LEUKOCYTE TELOMERE LENGTH; DISEASE; CANCER					susanmayor@mac.com						ABRAHAM A, 2004, SCI AGING KNOW ENV, V51, P43; ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Guralnih JM, 2008, ARCH INTERN MED, V168, P131, DOI 10.1001/archinternmed.2007.11; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Poonepalli A, 2008, GENE CHROMOSOME CANC, V47, P1098, DOI 10.1002/gcc.20608; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011	9	2	2	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 8	2009	338								a3024	10.1136/bmj.a3024	http://dx.doi.org/10.1136/bmj.a3024			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PQ	19131385				2022-12-01	WOS:000263165900006
J	Baxter, NN; Goldwasser, MA; Paszat, LF; Saskin, R; Urbach, DR; Rabeneck, L				Baxter, Nancy N.; Goldwasser, Meredith A.; Paszat, Lawrence F.; Saskin, Refik; Urbach, David R.; Rabeneck, Linda			Association of Colonoscopy and Death From Colorectal Cancer	ANNALS OF INTERNAL MEDICINE			English	Article							NEGATIVE SCREENING COLONOSCOPY; POPULATION-BASED ANALYSIS; COLON-CANCER; UNITED-STATES; RISK; ENDOSCOPY; PATTERNS; SIGMOIDOSCOPY; SURVEILLANCE; PROTECTION	Background: Colonoscopy is advocated for screening and prevention of colorectal cancer (CRC), but randomized trials supporting the benefit of this practice are not available. Objective: To evaluate the association between colonoscopy and CRC deaths. Design: Population-based, case -control study. Setting: Ontario, Canada. Patients: Persons age 52 to 90 years who received a CRC diagnosis from January 1996 to December 2001 and died of CRC by December 2003. Five controls matched by age, sex, geographic location, and socioeconomic status were randomly selected for each case patient. Measurements: Administrative claims data were used to detect exposure to any colonoscopy and complete colonoscopy (to the cecum) from January 1992 to an index date 6 months before diagnosis in each case patient and the same assigned date in matched controls. Exposures in case patients and controls were compared by using conditional logistic regression to control for comorbid conditions. Secondary analyses were done to see whether associations differed by site of primary CRC, age, or sex. Results: 10 292 case patients and 51 460 controls were identified; 719 case patients (7.0%) and 5031 controls (9.8%) had undergone colonoscopy. Compared with controls, case patients were less likely to have undergone any attempted colonoscopy (adjusted conditional odds ratio [OR], 0.69 [95% CI, 0.63 to 0.74; P < 0.001]) or complete colonoscopy (adjusted conditional OR, 0.63 [CI, 0.57 to 0.69; P < 0.001]). Complete colonoscopy was strongly associated with fewer deaths from left-sided CRC (adjusted conditional OR, 0.33 [CI, 0.28 to 0.39]) but not from right-sided CRC (adjusted conditional OR, 0.99 [CI, 0.86 to 1.14]). Limitation: Screening could not be differentiated from diagnostic procedures. Conclusion: In usual practice, colonoscopy is associated with fewer deaths from CRC. This association is primarily limited to deaths from cancer developing in the left side of the colon.	[Baxter, Nancy N.] Univ Toronto, St Michaels Hosp, Div Gen Surg, Toronto, ON M5B 1W8, Canada; [Goldwasser, Meredith A.; Paszat, Lawrence F.; Saskin, Refik] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Urbach, David R.] Univ Toronto, Toronto, ON M5G 2C4, Canada; [Rabeneck, Linda] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Baxter, NN (corresponding author), Univ Toronto, St Michaels Hosp, Div Gen Surg, 30 Bond St 16CC-40, Toronto, ON M5B 1W8, Canada.	baxtern@smh.toronto.on.ca	Baxter, Nancy N/E-7020-2015	Baxter, Nancy N/0000-0003-4793-4620	Canadian Institutes of Health Research; American Society of Clinical Oncology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Society of Clinical Oncology	Canadian Institutes of Health Research and American Society of Clinical Oncology.	*AM COLL GASTR, COL CANC YOU CAN PRE; American Cancer Society, 2008, CANC FACTS FIG 2008; Azzoni C, 2007, INT J COLORECTAL DIS, V22, P115, DOI 10.1007/s00384-006-0093-x; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Bowles CJA, 2004, GUT, V53, P277, DOI 10.1136/gut.2003.016436; Brenner H, 2006, GUT, V55, P1145, DOI [10.1136/gut.2005.087130, 10.1136/gut.2005087130]; Bressler B, 2004, GASTROENTEROLOGY, V127, P452, DOI 10.1053/j.gastro.2004.05.032; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; *COL CANC PREV PRO, 2006, COL CANC SCREEN TIP; Cremers MI, 2006, DIGEST LIVER DIS, V38, P912, DOI 10.1016/j.dld.2006.04.011; Dafnis G, 2000, SCAND J GASTROENTERO, V35, P765, DOI 10.1080/003655200750023462; Detsky AS, 2001, NEW ENGL J MED, V345, P607, DOI 10.1056/NEJM200108233450809; Farrar WD, 2006, CLIN GASTROENTEROL H, V4, P1259, DOI 10.1016/j.cgh.2006.07.012; Fasoli R, 2002, DIGEST LIVER DIS, V34, P833, DOI 10.1016/S1590-8658(02)80252-3; Gervaz P, 2004, J SURG ONCOL, V88, P261, DOI 10.1002/jso.20156; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Hodgson DC, 2001, JNCI-J NATL CANCER I, V93, P501, DOI 10.1093/jnci/93.7.501; Hosokawa O, 2003, ENDOSCOPY, V35, P506; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Lieberman DA, 2000, GASTROENTEROLOGY, V118, P619, DOI 10.1016/S0016-5085(00)70269-1; MORRISON AS, 1982, AM J EPIDEMIOL, V115, P6; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; *NEW YORK CIT DEP, 2005, GET CHECK; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; O'Brien MJ, 2004, CLIN GASTROENTEROL H, V2, P905, DOI 10.1016/S1542-3565(04)00392-1; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Rabeneck L, 2004, AM J GASTROENTEROL, V99, P1141, DOI 10.1111/j.1572-0241.2004.30623.x; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; ROBLES SC, 1988, J CLIN EPIDEMIOL, V41, P495, DOI 10.1016/0895-4356(88)90052-2; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Singh G, 2007, GASTROENTEROLOGY, V132, pA81; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Singh SM, 2004, CAN MED ASSOC J, V171, P461, DOI 10.1503/cmaj.1031921; Sonnenberg A, 2008, GASTROINTEST ENDOSC, V67, P489, DOI 10.1016/j.gie.2007.08.041; Sugai T, 2006, J MOL DIAGN, V8, P193, DOI 10.2353/jmoldx.2006.050052; Taylor C, 2007, CAN J GASTROENTEROL, V21, P805, DOI 10.1155/2007/230420; Vinden CM., 2004, ICES RES ATLAS USE L; Watanabe T, 2006, CANCER RES, V66, P9804, DOI 10.1158/0008-5472.CAN-06-1163	46	987	1005	0	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2009	150	1					1	W1		10.7326/0003-4819-150-1-200901060-00306	http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397IC	19075198				2022-12-01	WOS:000262655100001
J	Sun, S; Kondabagil, K; Draper, B; Alam, TI; Bowman, VD; Zhang, Z; Hegde, S; Fokine, A; Rossmann, MG; Rao, VB				Sun, Siyang; Kondabagil, Kiran; Draper, Bonnie; Alam, Tanfis I.; Bowman, Valorie D.; Zhang, Zhihong; Hegde, Shylaja; Fokine, Andrei; Rossmann, Michael G.; Rao, Venigalla B.			The Structure of the Phage T4 DNA Packaging Motor Suggests a Mechanism Dependent on Electrostatic Forces	CELL			English	Article							ATPASE ACTIVITY; PORTAL PROTEIN; REVEALS; RECONSTRUCTION; VISUALIZATION; ORGANIZATION; GENERATION; MICROSCOPY; RESOLUTION; EVOLUTION	Viral genomes are packaged into "procapsids'' by powerful molecular motors. We report the crystal structure of the DNA packaging motor protein, gene product 17 (gp17), in bacteriophage T4. The structure consists of an N-terminal ATPase domain, which provides energy for compacting DNA, and a C-terminal nuclease domain, which terminates packaging. We show that another function of the C-terminal domain is to translocate the genome into the procapsid. The two domains are in close contact in the crystal structure, representing a "tensed state.'' A cryo-electron microscopy reconstruction of the T4 procapsid complexed with gp17 shows that the packaging motor is a pentamer and that the domains within each monomer are spatially separated, representing a "relaxed state.'' These structures suggest a mechanism, supported by mutational and other data, in which electrostatic forces drive the DNA packaging by alternating between tensed and relaxed states. Similar mechanisms may occur in other molecular motors.	[Sun, Siyang; Bowman, Valorie D.; Fokine, Andrei; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kondabagil, Kiran; Draper, Bonnie; Alam, Tanfis I.; Zhang, Zhihong; Hegde, Shylaja; Rao, Venigalla B.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Catholic University of America	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	mr@purdue.edu; rao@cua.edu	Fokine, Andrei/A-1330-2013	Rao, Venigalla/0000-0002-0777-6587	U. S. Department of Energy; National Institutes of Health; National Science Foundation [MCB-443899, MCB-423528]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102725] Funding Source: NIH RePORTER	U. S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Petr Leiman, Ping Zhang, Ye Xiang, Paul Chipman, and especially Victor Kostyuchenko for helpful advice on cryo-EM reconstruction. We also thank Anastasia Aksyuk, Petr Leiman, and William Cramer for discussions on the mechanisms of ATP-driven motors. We are grateful to David Stuart, Marc Morais, Petr Leiman, and Bentley Fane for reading and commenting on the manuscript. We thank Sheryl Kelly and Cheryl Towell for help in the preparation of the manuscript. We also thank the staff of the Advanced Photon Source, The General Medicine and Cancer Institutes sector for their help in X-ray diffraction data collection, whose facilities are supported by the U. S. Department of Energy and the National Institutes of Health. This work was supported by National Science Foundation grants to M. G. R (MCB-443899) and V. B. R (MCB-423528).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; Baumann RG, 2006, MOL MICROBIOL, V61, P16, DOI 10.1111/j.1365-2958.2006.05203.x; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BHATTACHARYYA SP, 1993, VIROLOGY, V196, P34, DOI 10.1006/viro.1993.1452; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hendrix RW, 1998, CELL, V94, P147, DOI 10.1016/S0092-8674(00)81413-0; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Kanamaru S, 2004, J BIOL CHEM, V279, P40795, DOI 10.1074/jbc.M403647200; Kondabagil KR, 2006, J MOL BIOL, V363, P786, DOI 10.1016/j.jmb.2006.08.054; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Morais MC, 2001, J STRUCT BIOL, V135, P38, DOI 10.1006/jsbi.2001.4379; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Oliveira L, 2006, J BIOL CHEM, V281, P21914, DOI 10.1074/jbc.M603314200; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RAO VB, 1985, J MOL BIOL, V185, P565, DOI 10.1016/0022-2836(85)90072-5; Rao VB, 2001, J MOL BIOL, V314, P401, DOI 10.1006/jmbi.2001.5169; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Rentas FJ, 2003, J MOL BIOL, V334, P37, DOI 10.1016/j.jmb.2003.09.028; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; STREISIN.G, 1967, P NATL ACAD SCI USA, V57, P292, DOI 10.1073/pnas.57.2.292; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510	52	180	187	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1251	1262		10.1016/j.cell.2008.11.015	http://dx.doi.org/10.1016/j.cell.2008.11.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109896	Bronze			2022-12-01	WOS:000261989800016
J	Trivedi, AN; Swaminathan, S; Mor, V				Trivedi, Amal N.; Swaminathan, Shailender; Mor, Vincent			Insurance Parity and the Use of Outpatient Mental Health Care Following a Psychiatric Hospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGED CARE; FEDERAL-EMPLOYEES; SUBSTANCE-ABUSE; SERVICES; QUALITY; LEGISLATION; COVERAGE; BENEFITS; TRENDS; READMISSION	Context Mental health services are typically subject to higher cost sharing than other health services. In 2008, the US Congress enacted legislation requiring parity in insurance coverage for mental health services in group health plans and Medicare Part B. Objective To determine the relationship between mental health insurance parity and the use of timely follow- up care after a psychiatric hospitalization. Design, Setting, and Population We reviewed cost- sharing requirements for outpatient mental health and general medical services for 302 Medicare health plans from 2001 to 2006. Among 43 892 enrollees in 173 health plans who were hospitalized for a mental illness, we determined the relation between parity in cost sharing and receipt of timely outpatient mental health care after discharge using cross- sectional analyses of all Medicare plans and longitudinal analyses of 10 plans that discontinued parity compared with 10 matched control plans that maintained parity. Main Outcome Measures Outpatient mental health visits within 7 and 30 days following a discharge for a psychiatric hospitalization. Results More than three- quarters of Medicare plans, representing 79% of Medicare enrollees, required greater cost sharing for mental health care compared with primary or specialty care. The adjusted rate of follow- up within 30 days after a psychiatric hospitalization was 10.9 percentage points greater ( 95% confidence interval [CI], 4.6- 17.3; P <. 001) in plans with equivalent cost sharing for mental health and primary care compared with plans with mental health cost sharing greater than primary and specialty care cost sharing. The association of parity with follow- up care was increased for enrollees from areas of low income and less education. Rates of follow- up visits within 30 days decreased by 7.7 percentage points ( 95% CI, - 12.9 to - 2.4; P=. 004) in plans that discontinued parity and increased by 7.5 percentage points ( 95% CI, 2.012.9; P=. 008) among control plans that maintained parity ( adjusted difference in difference, 14.2 percentage points; 95% CI, 4.5- 23.9; P=. 007). Conclusion Medicare enrollees in health plans with insurance parity for mental health and primary care have markedly higher use of clinically appropriate mental health services following a psychiatric hospitalization.	[Trivedi, Amal N.; Swaminathan, Shailender; Mor, Vincent] Brown Univ, Dept Community Hlth, Warren Alpert Med Sch, Providence, RI 02912 USA; [Trivedi, Amal N.] Providence VA Med Ctr, Res Enhancement Award Program, Providence, RI USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Trivedi, AN (corresponding author), Brown Univ, Dept Community Hlth, Warren Alpert Med Sch, Box G-S121, Providence, RI 02912 USA.	amal_trivedi@brown.edu			Health Policy Scholars Award; Agency for Healthcare Research and Quality [T32 HS000011]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000011] Funding Source: NIH RePORTER	Health Policy Scholars Award; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by a Health Policy Scholars Award to Dr Trivedi from the Pfizer Foundation. Dr Swaminathan was supported by a postdoctoral training grant (T32 HS000011) from the Agency for Healthcare Research and Quality, of which Dr Mor is principal investigator.	*AG HEALTHC RES QU, 2004, 2004 NAT HEALTHC QUA; [Anonymous], 2001, INTERSTUDY COMPETITI; Bao YH, 2004, HEALTH SERV RES, V39, P1361, DOI 10.1111/j.1475-6773.2004.00294.x; Barry CL, 2003, HEALTH AFFAIR, V22, P127, DOI 10.1377/hlthaff.22.5.127; Buchmueller TC, 2007, HEALTH AFFAIR, V26, pW483, DOI 10.1377/hlthaff.26.4.w483; Busch AB, 2006, MED CARE, V44, P506, DOI 10.1097/01.mlr.0000215890.30756.b2; DORWART RA, 1994, AM J PUBLIC HEALTH, V84, P1229, DOI 10.2105/AJPH.84.8.1229; Druss BG, 2002, AM J PSYCHIAT, V159, P860, DOI 10.1176/appi.ajp.159.5.860; FRANK R, 1999, 7052 NAT BUR EC RES; Frank RG, 2001, NEW ENGL J MED, V345, P1701, DOI 10.1056/NEJM200112063452311; Glied SA, 2006, BETTER BUT NOT WELL; Glied SA, 2008, NEW ENGL J MED, V359, P113, DOI 10.1056/NEJMp0804447; Goldman HH, 2006, NEW ENGL J MED, V354, P1378, DOI 10.1056/NEJMsa053737; Harman JS, 2003, J BEHAV HEALTH SER R, V30, P332, DOI 10.1007/BF02287321; Harris KM, 2006, MED CARE, V44, P499, DOI 10.1097/01.mlr.0000215813.16211.00; *HLTH CAR FIN ADM, 301998 HEDIS HLTH CA; Hodgkin D, 2003, MED CARE RES REV, V60, P101, DOI 10.1177/1077558702250248; KEELER E B, 1985, Journal of the American Medical Association, V254, P1926, DOI 10.1001/jama.254.14.1926; KEELER EB, 1988, J HEALTH ECON, V7, P369, DOI 10.1016/0167-6296(88)90021-5; Kerry SM, 1998, BRIT MED J, V316, P549, DOI 10.1136/bmj.316.7130.549; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Klinkenberg WD, 1996, PSYCHIATR SERV, V47, P487; LURIE N, 1989, AM J PUBLIC HEALTH, V79, P640, DOI 10.2105/AJPH.79.5.640; MANNING WG, 1986, J HUM RESOUR, V21, P293, DOI 10.2307/145965; MECHANIC D, 1993, MILBANK Q, V71, P349, DOI 10.2307/3350406; Mechanic D, 2003, PSYCHIAT SERV, V54, P1227, DOI 10.1176/appi.ps.54.9.1227; MECHANIC D, 1995, MILBANK Q, V73, P19, DOI 10.2307/3350312; Nelson EA, 2000, PSYCHIAT SERV, V51, P885, DOI 10.1176/appi.ps.51.7.885; Pacula RL, 2000, HEALTH SERV RES, V35, P263; Patel KK, 2006, HEALTH AFFAIR, V25, P681, DOI 10.1377/hlthaff.25.3.681; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; Regier DA, 2008, HEALTH AFFAIR, V27, pW70, DOI 10.1377/hlthaff.27.1.w70; ROSENFIELD S, 1986, J APPL BEHAV SCI, V22, P411, DOI 10.1177/002188638602200405; Sakauye K, 2005, PSYCHIAT SERV, V56, P795; SCHOENBAUM SC, 1995, PSYCHIATR SERV, V46, P943; SOLOMON P, 1986, HOSP COMMUNITY PSYCH, V37, P708; Sturm R, 1997, JAMA-J AM MED ASSOC, V278, P1533, DOI 10.1001/jama.278.18.1533; Sturm R, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.5.182; Sturm Roland, 2000, J Ment Health Policy Econ, V3, P209; Trivedi AN, 2008, NEW ENGL J MED, V358, P375, DOI 10.1056/NEJMsa070929; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; WINSTON A, 1977, HOSP COMMUNITY PSYCH, V28, P118; Zuvekas Samuel H., 1998, J Ment Health Policy Econ, V1, P135, DOI 10.1002/(SICI)1099-176X(1998100)1:3<135::AID-MHP17>3.0.CO;2-S	43	31	31	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2879	2885						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386ZG	19109116	Green Accepted, Bronze			2022-12-01	WOS:000261920900021
J	Griffith, EM; Paytan, A; Caldeira, K; Bullen, TD; Thomas, E				Griffith, Elizabeth M.; Paytan, Adina; Caldeira, Ken; Bullen, Thomas D.; Thomas, Ellen			A Dynamic Marine Calcium Cycle During the Past 28 Million Years	SCIENCE			English	Article							SEAWATER CHEMISTRY; CHEMICAL EVOLUTION; ISOTOPE RECORD; FRACTIONATION; MONITOR	Multiple lines of evidence have shown that the isotopic composition and concentration of calcium in seawater have changed over the past 28 million years. A high- resolution, continuous seawater calcium isotope ratio curve from marine ( pelagic) barite reveals distinct features in the evolution of the seawater calcium isotopic ratio suggesting changes in seawater calcium concentrations. The most pronounced increase in the delta Ca-44/40 value of seawater (of 0.3 per mil) occurred over roughly 4 million years following a period of low values around 13 million years ago. The major change in marine calcium corresponds to a climatic transition and global change in the carbon cycle and suggests a reorganization of the global biogeochemical system.	[Griffith, Elizabeth M.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Griffith, Elizabeth M.; Paytan, Adina] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Caldeira, Ken] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Bullen, Thomas D.] US Geol Survey, Div Water Resources, Branch Reg Res, Menlo Pk, CA 94025 USA; [Thomas, Ellen] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Thomas, Ellen] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA	Stanford University; University of California System; University of California Santa Cruz; Carnegie Institution for Science; United States Department of the Interior; United States Geological Survey; Yale University; Wesleyan University	Griffith, EM (corresponding author), Stanford Univ, Dept Geol & Environm Sci, Bldg 320,Room 118, Stanford, CA 94305 USA.	egriffith@ucsc.edu	Caldeira, Ken/E-7914-2011; Thomas, Ellen/E-5573-2011	Caldeira, Ken/0000-0002-4591-643X; Thomas, Ellen/0000-0002-7141-9904; Griffith, Elizabeth/0000-0002-7919-4551	NSF CAREER [OCE-0449732]; National Defense Science and Engineering Graduate Fellowship; NSF Graduate Research Fellowship	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Defense Science and Engineering Graduate Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF))	Samples provided by the Integrated Ocean Drilling Program. We thank A. Eisenhauer, J. Fitzpatrick, W. A. Griffith, R. Jones, and G. Li for analytical assistance. Supported by NSF CAREER Grant OCE-0449732 (A.P.) and by a National Defense Science and Engineering Graduate Fellowship and an NSF Graduate Research Fellowship (E.M.G.).	Amini M, 2008, GEOCHIM COSMOCHIM AC, V72, P4107, DOI 10.1016/j.gca.2008.05.055; Budyko MI, 1987, HIST EARTHS ATMOSPHE; Conrad CP, 2007, GEOLOGY, V35, P29, DOI 10.1130/G22759A.1; De La Rocha CL, 2000, SCIENCE, V289, P1176, DOI 10.1126/science.289.5482.1176; Dickson JAD, 2002, SCIENCE, V298, P1222, DOI 10.1126/science.1075882; Fantle MS, 2005, EARTH PLANET SC LETT, V237, P102, DOI 10.1016/j.epsl.2005.06.024; Farkas J, 2007, GEOCHIM COSMOCHIM AC, V71, P5117, DOI 10.1016/j.gca.2007.09.004; Griffith EM, 2008, GEOCHIM COSMOCHIM AC, V72, P5641, DOI 10.1016/j.gca.2008.08.010; Gussone N, 2005, GEOCHIM COSMOCHIM AC, V69, P4485, DOI 10.1016/j.gca.2005.06.003; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; Hathorne EC, 2006, EARTH PLANET SC LETT, V246, P393, DOI 10.1016/j.epsl.2006.04.020; HEUSER A, 2005, PALEOCEANOGRAPHY, V20, DOI DOI 10.1029/2004PA01048; HODELL DA, 1989, EARTH PLANET SC LETT, V92, P165, DOI 10.1016/0012-821X(89)90044-7; Holbourn A, 2005, NATURE, V438, P483, DOI 10.1038/nature04123; Holland HD, 2005, AM J SCI, V305, P220, DOI 10.2475/ajs.305.3.220; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Lyle M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000777; Paytan A, 2004, SCIENCE, V304, P1663, DOI 10.1126/science.1095258; PAYTAN A, 1993, NATURE, V366, P445, DOI 10.1038/366445a0; Ridgwell AJ, 2003, SCIENCE, V302, P859, DOI 10.1126/science.1088342; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Schmitt AD, 2003, EARTH PLANET SC LETT, V213, P503, DOI 10.1016/S0012-821X(03)00341-8; Sime NG, 2007, GEOCHIM COSMOCHIM AC, V71, P3979, DOI 10.1016/j.gca.2007.06.009; Skulan J, 1997, GEOCHIM COSMOCHIM AC, V61, P2505, DOI 10.1016/S0016-7037(97)00047-1; Turchyn AV, 2004, SCIENCE, V303, P2004, DOI 10.1126/science.1092296; Urey H., 1952, PLANETS THEIR ORIGIN; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhu P, 1998, GEOCHIM COSMOCHIM AC, V62, P1691, DOI 10.1016/S0016-7037(98)00110-0	30	70	74	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1671	1674		10.1126/science.1163614	http://dx.doi.org/10.1126/science.1163614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074345				2022-12-01	WOS:000261608300039
J	Robbiani, DF; Bothmer, A; Callen, E; Reina-San-Martin, B; Dorsett, Y; Difilippantonio, S; Bolland, DJ; Chen, HT; Corcoran, AE; Nussenzweig, A; Nussenzweig, MC				Robbiani, Davide F.; Bothmer, Anne; Callen, Elsa; Reina-San-Martin, Bernardo; Dorsett, Yair; Difilippantonio, Simone; Bolland, Daniel J.; Chen, Hua Tang; Corcoran, Anne E.; Nussenzweig, Andre; Nussenzweig, Michel C.			AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations	CELL			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE AID; HEAVY-CHAIN LOCUS; CENTER B-CELLS; SOMATIC HYPERMUTATION; BURKITT-LYMPHOMA; IN-VIVO; ANTIBODY DIVERSIFICATION; MURINE PLASMACYTOMAS	Chromosomal translocation requires formation of paired double-strand DNA breaks (DSBs) on heterologous chromosomes. One of the most well characterized oncogenic translocations juxtaposes c-myc and the immunoglobulin heavy-chain locus (IgH) and is found in Burkitt's lymphomas in humans and plasmacytomas in mice. DNA breaks in IgH leading to c-myc/IgH translocations are created by activation-induced cytidine deaminase ( AID) during antibody class switch recombination or somatic hypermutation. However, the source of DNA breaks at c-myc is not known. Here, we provide evidence for the c-myc promoter region being required in targeting AID-mediated DNA damage to produce DSBs in c-myc that lead to c-myc/IgH translocations in primary B lymphocytes. Thus, in addition to producing somatic mutations and DNA breaks in antibody genes, AID is also responsible for the DNA lesions in oncogenes that are required for their translocation.	[Robbiani, Davide F.; Bothmer, Anne; Reina-San-Martin, Bernardo; Dorsett, Yair; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Callen, Elsa; Difilippantonio, Simone; Chen, Hua Tang; Nussenzweig, Andre] NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA; [Bolland, Daniel J.; Corcoran, Anne E.] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu	Bolland, Daniel/AAE-5185-2020; Reina-San-Martin, Bernardo/I-9484-2016; Nussenzweig, Michel/AAE-7292-2019; Robbiani, Davide F./AAF-7662-2019	Bolland, Daniel/0000-0003-3674-9913; Reina-San-Martin, Bernardo/0000-0003-2083-6166; Robbiani, Davide F./0000-0001-7379-3484	NIH; National Cancer Institute; Center for Cancer Research; Leukemia and Lymphoma Society; Howard Hughes Medical Institute Investigator; BBSRC [BB/F012217/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F012217/1, BBS/E/B/0000C163] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute Investigator(Howard Hughes Medical Institute); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All members of the Nussenzweig lab for discussions. Dr. Barry Stoddard ( Fred Hutchinson Cancer Research Center, Seattle) for suggestions on catalytically inactive I-SceI*. The Rockefeller University Gene Targeting Facility, Klara Velinzon, and Tamara Shengelia for FACSorting, Matthias Muellenbeck and Nancy Wong for technical assistance, and David Bosque and Tom Eisenreich for help in managing the mouse colonies. The work was supported in part by NIH grants to M. C. N. The A. N. lab was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. D. F. R. is a Fellow of the Leukemia and Lymphoma Society, and M. C. N. is a Howard Hughes Medical Institute Investigator.	ADAMS JM, 1982, P NATL ACAD SCI-BIOL, V79, P6966, DOI 10.1073/pnas.79.22.6966; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; BOLES TC, 1987, BIOCHEMISTRY-US, V26, P367, DOI 10.1021/bi00376a006; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Chakalova L, 2004, METHOD ENZYMOL, V375, P479; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; CORY S, 1983, EMBO J, V2, P213, DOI 10.1002/j.1460-2075.1983.tb01407.x; CREWS S, 1982, SCIENCE, V218, P1319, DOI 10.1126/science.7146913; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Egli D, 2004, GENOME RES, V14, P1382, DOI 10.1101/gr.2279804; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; Franco S, 2006, DNA REPAIR, V5, P1030, DOI 10.1016/j.dnarep.2006.05.024; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Gribnau J, 1998, EMBO J, V17, P6020, DOI 10.1093/emboj/17.20.6020; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; HAMLYN PH, 1983, NATURE, V304, P135, DOI 10.1038/304135a0; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Jankovic M, 2007, NAT IMMUNOL, V8, P801, DOI 10.1038/ni1498; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Parada LA, 2004, EXP CELL RES, V296, P64, DOI 10.1016/j.yexcr.2004.03.013; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reddy MC, 2005, RADIAT RES, V164, P345, DOI 10.1667/RR3419.1; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; SPENCER CA, 1991, ADV CANCER RES, V56, P1; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1	77	321	330	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1028	1038		10.1016/j.cell.2008.09.062	http://dx.doi.org/10.1016/j.cell.2008.09.062			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070574	Green Accepted, Bronze			2022-12-01	WOS:000261642800019
J	Steinbrook, R				Steinbrook, Robert			Physician-Assisted Death - From Oregon to Washington State.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						GANZINI L, 2008, BMJ-BRIT MED J, V337, P973; Ganzini L, 2008, J GEN INTERN MED, V23, P154, DOI 10.1007/s11606-007-0476-x; Quill TE, 2007, NEW ENGL J MED, V356, P1911, DOI 10.1056/NEJMp078061; *TASK FORC IMPR CA, OR DEATH DIGN ACT GU	4	21	23	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2513	2515		10.1056/NEJMp0809394	http://dx.doi.org/10.1056/NEJMp0809394			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	381KG	19073972				2022-12-01	WOS:000261534200001
J	Christakis, NA				Christakis, Nicholas A.			This allergies hysteria is just nuts	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Christakis, Nicholas A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Mt Auburn Hosp, Cambridge, MA 02138 USA	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009						0	14	14	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 10	2008	337								a2880	10.1136/bmj.a2880	http://dx.doi.org/10.1136/bmj.a2880			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CA	19073662				2022-12-01	WOS:000262776800007
J	Avierinos, JF; Inamo, J; Grigioni, F; Gersh, B; Shub, C; Enriquez-Sarano, M				Avierinos, Jean-Francois; Inamo, Jocelyn; Grigioni, Francesco; Gersh, Bernard; Shub, Clarence; Enriquez-Sarano, Maurice			Sex Differences in Morphology and Outcomes of Mitral Valve Prolapse	ANNALS OF INTERNAL MEDICINE			English	Article							POPULATION-BASED SAMPLE; TERM-FOLLOW-UP; DOPPLER-ECHOCARDIOGRAPHY; AORTIC REGURGITATION; NATURAL-HISTORY; REFERRAL BIAS; PREVALENCE; DIAGNOSIS; DISEASE; EPIDEMIOLOGY	Background: Mitral valve prolapse is more common in women than in men, but men more often have surgery for severe regurgitation. Objective: To compare morphology and outcomes of mitral valve prolapse in men and women. Design: Retrospective cohort study. Setting: The Mayo Clinic, Rochester, Minnesota. Patients: 4461 women and 3768 men who received a diagnosis of mitral valve prolapse by echocardiography from 1989 to 1998 ( 896 Olmsted County residents and 7333 referred patients). Measurements: Mitral prolapse characteristics ( localization, leaflet thickening or flail, regurgitation), ventricular and atrial characteristics, cardiac surgery, and mortality. Results: Compared with men, women had less posterior prolapse (22% vs. 31%), less flail (2% vs. 8%), more leaflet thickening (32% vs. 28%), and less frequent severe regurgitation (10% vs. 23%) ( P < 0.001 for all comparisons). Regardless of the severity of regurgitation, left ventricular and atrial diameters were smaller in women than in men but were larger in women after normalization to body surface area. Among patients with severe regurgitation, women were less likely than men to undergo cardiac valve surgery (52% vs. 60%; adjusted risk ratio, 0.79 [95% CI, 0.74 to 0.84]). At 15 years, women with no or mild mitral regurgitation had better odds of survival than men (87% vs. 77%; adjusted risk ratio, 0.82 [CI, 0.76 to 0.89]), but those with severe regurgitation had worse survival than men ( 60% vs. 68%; adjusted risk ratio, 1.13 [CI, 1.01 to 1.26]). The survival rate 10 years after surgery was similar in women and men (77% vs. 79%; P = 0.14). Observations in Olmsted County patients and referred patients were similar. Limitation: Diagnoses were based on echocardiography, and clinical data at initial diagnosis, reason for index echocardiography, and cause of all deaths were lacking. Conclusion: Morphology and severity of mitral valve prolapse differ according to sex. Among patients with severe regurgitation, women have higher mortality and lower surgery rates than men.	[Enriquez-Sarano, Maurice] Mayo Clin, Rochester, MN 55905 USA; Hop Enfants La Timone, Marseille, France; Osped Univ Bologna, Bologna, Italy	Mayo Clinic; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Bologna	Enriquez-Sarano, M (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	sarano.maurice@mayo.edu	Grigioni, Francesco/AAL-3603-2020; INAMO, Jocelyn/AGZ-1674-2022	Avierinos, Jean Francois/0000-0002-3775-8371; GRIGIONI, FRANCESCO/0000-0002-4767-7073	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR030582-43, R01 AR030582] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Avierinos JF, 2003, STROKE, V34, P1339, DOI 10.1161/01.STR.0000072274.12041.FF; Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Devereux R B, 1989, Cardiovasc Clin, V19, P243; Devereux RB, 2001, AM J MED, V111, P679, DOI 10.1016/S0002-9343(01)00981-0; Dujardin KS, 1999, CIRCULATION, V99, P1851, DOI 10.1161/01.CIR.99.14.1851; DUREN DR, 1988, J AM COLL CARDIOL, V11, P42; Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536, DOI 10.1016/0735-1097(94)90151-1; Flack JM, 1999, AM HEART J, V138, P486, DOI 10.1016/S0002-8703(99)70151-1; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4; GUTMAN J, 1983, AM J CARDIOL, V51, P336, DOI 10.1016/S0002-9149(83)80061-7; Iung B, 2002, EUR HEART J, V23, P1253, DOI 10.1053/euhj.2002.3320; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Klodas E, 1996, CIRCULATION, V94, P2472, DOI 10.1161/01.CIR.94.10.2472; Kokmen E, 1996, J CLIN EPIDEMIOL, V49, P79, DOI 10.1016/0895-4356(95)00031-3; LEVINE RA, 1988, J AM COLL CARDIOL, V11, P1010, DOI 10.1016/S0735-1097(98)90059-6; LEVINE RA, 1987, CIRCULATION, V75, P756, DOI 10.1161/01.CIR.75.4.756; LEVY D, 1987, AM HEART J, V113, P1281, DOI 10.1016/0002-8703(87)90956-2; Ling LH, 1996, NEW ENGL J MED, V335, P1417, DOI 10.1056/NEJM199611073351902; MACMAHON SW, 1987, AM J CARDIOL, V59, P105, DOI 10.1016/S0002-9149(87)80080-2; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MELTON LJ, 1985, MAYO CLIN PROC, V60, P880, DOI 10.1016/S0025-6196(12)64794-6; MINTZ GS, 1980, AM J CARDIOL, V45, P253, DOI 10.1016/0002-9149(80)90643-8; Mitts WR, 2004, AM HEART J, V148, P144, DOI 10.1016/j.ahj.2004.01.021; Mohty D, 2001, CIRCULATION, V104, pI1; NISHIMURA RA, 1985, MAYO CLIN PROC, V60, P321, DOI 10.1016/S0025-6196(12)60540-0; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; SALIVE ME, 1994, MAYO CLIN PROC, V69, P808, DOI 10.1016/S0025-6196(12)61105-7; Singh RG, 2000, AM J CARDIOL, V85, P193, DOI 10.1016/S0002-9149(99)00645-1; Tribouilloy CM, 1999, CIRCULATION, V99, P400, DOI 10.1161/01.CIR.99.3.400; Trochu JN, 2000, J AM COLL CARDIOL, V35, P1890, DOI 10.1016/S0735-1097(00)00617-3; WISENBAUGH T, 1994, CIRCULATION, V89, P191, DOI 10.1161/01.CIR.89.1.191; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	37	95	97	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					787	W164		10.7326/0003-4819-149-11-200812020-00003	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	19047025	Green Accepted			2022-12-01	WOS:000261645300002
J	Imai, J; Katagiri, H; Yamada, T; Ishigaki, Y; Suzuki, T; Kudo, H; Uno, K; Hasegawa, Y; Gao, JH; Kaneko, K; Ishihara, H; Niijima, A; Nakazato, M; Asano, T; Minokoshi, Y; Oka, Y				Imai, Junta; Katagiri, Hideki; Yamada, Tetsuya; Ishigaki, Yasushi; Suzuki, Toshinobu; Kudo, Hirohito; Uno, Kenji; Hasegawa, Yutaka; Gao, Junhong; Kaneko, Keizo; Ishihara, Hisamitsu; Niijima, Akira; Nakazato, Masamitsu; Asano, Tomoichiro; Minokoshi, Yasuhiko; Oka, Yoshitomo			Regulation of Pancreatic beta Cell Mass by Neuronal Signals from the Liver	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-HOMEOSTASIS; METABOLIC SYNDROME; INSULIN; GENE; PROLIFERATION; SENSITIVITY; DYSFUNCTION; DISRUPTION; OBESITY	Metabolic regulation in mammals requires communication between multiple organs and tissues. The rise in the incidence of obesity and associated metabolic disorders, including type 2 diabetes, has renewed interest in interorgan communication. We used mouse models to explore the mechanism whereby obesity enhances pancreatic beta cell mass, pathophysiological compensation for insulin resistance. We found that hepatic activation of extracellular regulated kinase (ERK) signaling induced pancreatic b cell proliferation through a neuronal- mediated relay of metabolic signals. This metabolic relay from the liver to the pancreas is involved in obesity- induced islet expansion. In mouse models of insulin- deficient diabetes, liver- selective activation of ERK signaling increased b cell mass and normalized serum glucose levels. Thus, interorgan metabolic relay systems may serve as valuable targets in regenerative treatments for diabetes.	[Katagiri, Hideki; Suzuki, Toshinobu; Kudo, Hirohito; Uno, Kenji; Gao, Junhong; Kaneko, Keizo] Tohoku Univ, Grad Sch Med, Div Adv Therapeut Metab Dis, Ctr Translat & Adv Anim Res, Sendai, Miyagi 9808575, Japan; [Imai, Junta; Yamada, Tetsuya; Ishigaki, Yasushi; Suzuki, Toshinobu; Kudo, Hirohito; Hasegawa, Yutaka; Kaneko, Keizo; Ishihara, Hisamitsu; Oka, Yoshitomo] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Sendai, Miyagi 9808575, Japan; [Niijima, Akira] Niigata Univ, Sch Med, Niigata 9518150, Japan; [Nakazato, Masamitsu] Miyazaki Univ, Miyazaki Med Coll, Dept Internal Med 3, Miyazaki 8891692, Japan; [Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Hiroshima, Japan; [Minokoshi, Yasuhiko] Natl Inst Physiol Sci, Div Endocrinol & Metab, Dept Dev Physiol, Okazaki, Aichi 444, Japan	Tohoku University; Tohoku University; Niigata University; University of Miyazaki; Hiroshima University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Katagiri, H (corresponding author), Tohoku Univ, Grad Sch Med, Div Adv Therapeut Metab Dis, Ctr Translat & Adv Anim Res, Sendai, Miyagi 9808575, Japan.	katagiri@mail.tains.tohoku.ac.jp		Minokoshi, Yasuhiko/0000-0002-7119-4805	21st Center of Excellence (COE); Global-COE; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	21st Center of Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global-COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We thank M. Yokoyama for the generous gift of recombinant adenoviruses. This work was supported by Grants-in Aid (H.K., Y.O., and J.I.); the 21st Center of Excellence (COE) (H.K.) and Global-COE (Y.O.) programs from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a Grant-in Aid (Y.O.) from the Ministry of Health, Labor and Welfare of Japan. Tohoku University, J.I., H.K., and Y.O have applied for patents related to this work in the United States and Japan.	Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Edvell A, 1998, AM J PHYSIOL-ENDOC M, V274, pE1034, DOI 10.1152/ajpendo.1998.274.6.E1034; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Katagiri H, 2007, CIRC RES, V101, P27, DOI 10.1161/CIRCRESAHA.107.151621; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kiba T, 1996, GASTROENTEROLOGY, V110, P885, DOI 10.1053/gast.1996.v110.pm8608899; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001; Yang J, 2001, CANCER RES, V61, P4010	24	158	162	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1250	1254		10.1126/science.1163971	http://dx.doi.org/10.1126/science.1163971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023081				2022-12-01	WOS:000261033400043
J	Murayama, M; Perez-Garci, E; Nevian, T; Bock, T; Senn, W; Larkum, ME				Murayama, Masanori; Perez-Garci, Enrique; Nevian, Thomas; Bock, Tobias; Senn, Walter; Larkum, Matthew E.			Dendritic encoding of sensory stimuli controlled by deep cortical interneurons	NATURE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; PRIMARY SOMATOSENSORY CORTEX; DISTAL APICAL DENDRITES; MOUSE SMI CORTEX; ACTION-POTENTIALS; IN-VIVO; LAYER-I; PROJECTION NEURONS; CELLS; RAT	The computational power of single neurons is greatly enhanced by active dendritic conductances(1) that have a large influence on their spike activity(2-4). In cortical output neurons such as the large pyramidal cells of layer 5 (L5), activation of apical dendritic calcium channels leads to plateau potentials that increase the gain of the input/output function(5) and switch the cell to burst-firing mode(6-9). The apical dendrites are innervated by local excitatory and inhibitory inputs as well as thalamic(10-13) and corticocortical projections(14-16), which makes it a formidable task to predict how these inputs influence active dendritic properties in vivo. Here we investigate activity in populations of L5 pyramidal dendrites of the somatosensory cortex in awake and anaesthetized rats following sensory stimulation using a new fibre-optic method(17) for recording dendritic calcium changes. We show that the strength of sensory stimulation is encoded in the combined dendritic calcium response of a local population of L5 pyramidal cells in a graded manner. The slope of the stimulus-response function was under the control of a particular subset of inhibitory neurons activated by synaptic inputs predominantly in L5. Recordings from single apical tuft dendrites in vitro showed that activity in L5 pyramidal neurons disynaptically coupled via interneurons directly blocks the initiation of dendritic calcium spikes in neighbouring pyramidal neurons. The results constitute a functional description of a cortical microcircuit in awake animals that relies on the active properties of L5 pyramidal dendrites and their very high sensitivity to inhibition. The microcircuit is organized so that local populations of apical dendrites can adaptively encode bottom-up sensory stimuli linearly across their full dynamic range.	[Murayama, Masanori; Perez-Garci, Enrique; Nevian, Thomas; Bock, Tobias; Senn, Walter; Larkum, Matthew E.] Univ Bern, Inst Physiol, CH-3012 Bern, Switzerland	University of Bern	Larkum, ME (corresponding author), Univ Bern, Inst Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	larkum@pyl.unibe.ch	Murayama, Masanori/G-5457-2015; Senn, Walter/D-6308-2014; Murayama, Masanori/AHA-9840-2022; Murayama, Masanori/B-4319-2009	Murayama, Masanori/0000-0001-7623-010X; Senn, Walter/0000-0003-3622-0497; Larkum, Matthew/0000-0001-9799-2656; Nevian, Thomas/0000-0001-9804-608X; Bock, Tobias/0000-0002-7734-1183	Swiss National Science Foundation [PP00A-102721/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank K. Martin, H.-R. Luscher and Y. Kudo for their comments on the manuscript, O. Gschwend for support in the laboratory, D. Morris for software development, D. Limoges and J. Burkhalter for their expert technical support and K. Fischer for Neurolucida reconstructions of the biocytin-filled neurons. We also thank Sumitomo Electric Industries for their generous donation of the optical fibre. This work was supported by the Swiss National Science Foundation (grant no. PP00A-102721/1).	Budd JML, 1998, P ROY SOC B-BIOL SCI, V265, P1037, DOI 10.1098/rspb.1998.0396; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; ELHANANY E, 1990, J COMP NEUROL, V291, P43, DOI 10.1002/cne.902910105; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; HERSCH SM, 1981, NEUROSCI LETT, V24, P207, DOI 10.1016/0304-3940(81)90157-9; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Murayama M, 2007, J NEUROPHYSIOL, V98, P1791, DOI 10.1152/jn.00082.2007; Oda S, 2004, NEUROSCI LETT, V367, P394, DOI 10.1016/j.neulet.2004.06.042; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Tan ZJ, 2008, P NATL ACAD SCI USA, V105, P2187, DOI 10.1073/pnas.0710628105; WHITE EL, 1982, J NEUROCYTOL, V11, P137, DOI 10.1007/BF01258009; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Zhu YH, 2004, J NEUROSCI, V24, P1272, DOI 10.1523/JNEUROSCI.4805-03.2004	26	258	262	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1137	U95		10.1038/nature07663	http://dx.doi.org/10.1038/nature07663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19151696				2022-12-01	WOS:000263680100042
J	Grande, C; Patel, NH				Grande, Cristina; Patel, Nipam H.			Nodal signalling is involved in left-right asymmetry in snails	NATURE			English	Article							SEA-URCHIN EMBRYO; CONSERVED ROLE; EXPRESSION; DEUTEROSTOMES; ESTABLISHMENT; INHERITANCE; EVOLUTION; INVERSUS; LIMNAEA; AXES	Many animals display specific internal or external features with left right asymmetry. In vertebrates, the molecular pathway that leads to this asymmetry uses the signalling molecule Nodal, a member of the transforming growth factor-beta superfamily(1), which is expressed in the left lateral plate mesoderm(2), and loss of nodal function produces a randomization of the left - right asymmetry of visceral organs(3,4). Orthologues of nodal have also been described in other deuterostomes, including ascidians and sea urchins(5,6), but no nodal orthologue has been reported in the other two main clades of Bilateria: Ecdysozoa ( including flies and nematodes) and Lophotrochozoa ( including snails and annelids). Here we report the first evidence for a nodal orthologue in a non- deuterostome group. We isolated nodal and Pitx ( one of the targets of Nodal signalling) in two species of snails and found that the side of the embryo that expresses nodal and Pitx is related to body chirality: both genes are expressed on the right side of the embryo in the dextral ( right- handed) species Lottia gigantea and on the left side in the sinistral ( left- handed) species Biomphalaria glabrata. We pharmacologically inhibited the Nodal pathway and found that nodal acts upstream of Pitx, and that some treated animals developed with a loss of shell chirality. These results indicate that the involvement of the Nodal pathway in left - right asymmetry might have been an ancestral feature of the Bilateria.	[Grande, Cristina; Patel, Nipam H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Grande, Cristina; Patel, Nipam H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Grande, Cristina; Patel, Nipam H.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Patel, NH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	nipam@uclink.berkeley.edu	; Grande Pardo, Maria Cristina/N-8956-2015	Patel, Nipam/0000-0003-4328-654X; Grande Pardo, Maria Cristina/0000-0002-5659-8967	Ministerio de Educacion y Ciencia (Spain); Center for Integrative Genomics	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Center for Integrative Genomics	We thank E. Begovic, E.E. Gonzales and I. Martinez-Solano for help collecting and fertilizing L. gigantea. A. Almeida helped with the drug experiments. D. R. Lindberg provided the Busycon pulleyi specimen. The NIAID Schistosomiasis Resource Center provided adults of B. glabrata. We thank M. Levine, D. R. Lindberg, P. Liu, M. Modrell, S. Nichols, M. Protas and J.Rehm for comments on the manuscript, and I. Hariharan for suggesting the experiments with rapamycin. C.G. was sponsored by a postdoctoral fellowship of the Ministerio de Educacion y Ciencia (Spain) and the Center for Integrative Genomics. N.H.P. is an Investigator of the Howard Hughes Medical Institute.	Boycott AE, 1923, P R SOC LOND B-CONTA, V95, P207, DOI 10.1098/rspb.1923.0033; CAMEY T, 1970, Netherlands Journal of Zoology, V20, P93; Christiaen L, 2007, SEMIN CELL DEV BIOL, V18, P502, DOI 10.1016/j.semcdb.2007.06.002; Dictus WJAG, 1997, MECH DEVELOP, V62, P213, DOI 10.1016/S0925-4773(97)00666-7; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; Duboc V, 2008, J EXP ZOOL PART B, V310B, P41, DOI 10.1002/jez.b.21121; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Gould MC, 2001, J EXP ZOOL, V290, P411, DOI 10.1002/jez.1082; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hibino T, 2006, DEV GROWTH DIFFER, V48, P587, DOI 10.1111/j.1440-169x.2006.00892.x; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Lartillot N, 2002, DEVELOPMENT, V129, P1411; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Morokuma J, 2002, DEV GENES EVOL, V212, P439, DOI 10.1007/s00427-002-0242-3; Nederbragt AJ, 2002, NATURE, V417, P811, DOI 10.1038/417811b; Nogi T, 2005, LATERALITY, V10, P193, DOI 10.1080/1357650054200001440; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Oviedo NJ, 2007, CELL, V129, P645, DOI 10.1016/j.cell.2007.05.005; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; Ponder WF, 1997, ZOOL J LINN SOC-LOND, V119, P83, DOI 10.1111/j.1096-3642.1997.tb00137.x; Price AL, 2008, J EXP ZOOL PART B, V310B, P24, DOI 10.1002/jez.b.21135; Schilthuizen M, 2005, NATURWISSENSCHAFTEN, V92, P504, DOI 10.1007/s00114-05-0045-2; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; VandenBiggelaar J, 1996, NETH J ZOOL, V46, P8	28	191	193	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1007	1011		10.1038/nature07603	http://dx.doi.org/10.1038/nature07603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19098895	Green Submitted, Green Accepted			2022-12-01	WOS:000263425400041
J	Xu, ZY; Wei, W; Gagneur, J; Perocchi, F; Clauder-Munster, S; Camblong, J; Guffanti, E; Stutz, F; Huber, W; Steinmetz, LM				Xu, Zhenyu; Wei, Wu; Gagneur, Julien; Perocchi, Fabiana; Clauder-Muenster, Sandra; Camblong, Jurgi; Guffanti, Elisa; Stutz, Francoise; Huber, Wolfgang; Steinmetz, Lars M.			Bidirectional promoters generate pervasive transcription in yeast	NATURE			English	Article							GENOME-WIDE TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; ANTISENSE TRANSCRIPTION; TILING ARRAYS; IDENTIFICATION; RESOLUTION; NUCLEOSOMES; POLYMERASE; LANDSCAPE; MAP	Genome- wide pervasive transcription has been reported in many eukaryotic organisms(1-7), revealing a highly interleaved transcriptome organization that involves hundreds of previously unknown non- codingRNAs(8). These recently identified transcripts either exist stably in cells ( stable unannotated transcripts, SUTs) or are rapidly degraded by the RNA surveillance pathway ( cryptic unstable transcripts, CUTs). One characteristic of pervasive transcription is the extensive overlap of SUTs and CUTs with previously annotated features, which prompts questions regarding how these transcripts are generated, and whether they exert function(9). Single- gene studies have shown that transcription of SUTs and CUTs can be functional, through mechanisms involving the generated RNAs10,11 or their generation itself(12-14). So far, a complete transcriptome architecture including SUTs and CUTs has not been described in any organism. Knowledge about the position and genome- wide arrangement of these transcripts will be instrumental in understanding their function(8,15). Here we provide a comprehensive analysis of these transcripts in the context of multiple conditions, a mutant of the exosome machinery and different strain backgrounds of Saccharomyces cerevisiae. We show that both SUTs and CUTs display distinct patterns of distribution at specific locations. Most of the newly identified transcripts initiate from nucleosome- free regions ( NFRs) associated with the promoters of other transcripts ( mostly protein- coding genes), or from NFRs at the 3 ' ends of protein- coding genes. Likewise, about half of all coding transcripts initiate from NFRs associated with promoters of other transcripts. These data change our view of how a genome is transcribed, indicating that bidirectionality is an inherent feature of promoters. Such an arrangement of divergent and overlapping transcripts may provide a mechanism for local spreading of regulatory signals - that is, coupling the transcriptional regulation of neighbouring genes by means of transcriptional interference or histone modification.	[Xu, Zhenyu; Wei, Wu; Gagneur, Julien; Perocchi, Fabiana; Clauder-Muenster, Sandra; Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Camblong, Jurgi] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Guffanti, Elisa; Stutz, Francoise] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Huber, Wolfgang] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England	European Molecular Biology Laboratory (EMBL); University of Oxford; University of Geneva; European Molecular Biology Laboratory (EMBL)	Steinmetz, LM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de	Wei, Wu/AAC-8285-2020; Stutz, Françoise C/N-4329-2017	Wei, Wu/0000-0001-5643-8739; perocchi, fabiana/0000-0002-1102-6500; Gagneur, Julien/0000-0002-8924-8365; Clauder-Muenster, Sandra/0000-0002-9530-2938; Steinmetz, Lars/0000-0002-3962-2865; Huber, Wolfgang/0000-0002-0474-2218	National Institutes of Health; Deutsche Forschungsgemeinschaft; SystemsX fellowship; Roche fellowship; SNF; NCCR Frontiers in Genetics; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SystemsX fellowship; Roche fellowship; SNF; NCCR Frontiers in Genetics(Swiss National Science Foundation (SNSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Akhtar, A. Ladurner, S. Blandin, R. Aiyar, E. Mancera and E. Fritsch for comments on the manuscript, J. Toedling for discussion and for the template of the website, C. Girardot for data submission to ArrayExpress, N. Proudfoot for access to experimental equipment, and the contributors to the Bioconductor (www.bioconductor.org) and R (http://www.r-project.org) projects for their software. This work was supported by grants to L.M.S. from the National Institutes of Health and Deutsche Forschungsgemeinschaft, by a SystemsX fellowship to E.G., by a Roche fellowship to J.C. and by grants to F.S. from SNF and NCCR Frontiers in Genetics.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Hermsen R, 2008, TRENDS GENET, V24, P216, DOI 10.1016/j.tig.2008.02.004; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	30	666	679	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1033	U7		10.1038/nature07728	http://dx.doi.org/10.1038/nature07728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19169243	Green Accepted			2022-12-01	WOS:000263425400047
J	McKay, CP				McKay, Christopher P.			PLANETARY SCIENCE Biologically Reversible Exploration	SCIENCE			English	Editorial Material							MARS; EARTH		[McKay, Christopher P.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	McKay, CP (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	christopher.mckay@nasa.gov						Barengoltz J, 2005, AEROSP CONF PROC, P253; Boston P J, 2003, Gravit Space Biol Bull, V16, P121; *COSPAR, 2003, COSPAR INF B, V156, P24; Kminek G, 2003, RADIAT RES, V159, P722, DOI 10.1667/0033-7587(2003)159[0722:RLFTVO]2.0.CO;2; Marinova MM, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002306; McKay C.P., 2001, PLANET REP, V21, P4; MCKAY CP, 1991, NATURE, V352, P489, DOI 10.1038/352489a0; McKay CP, 2004, PLOS BIOL, V2, P1260, DOI 10.1371/journal.pbio.0020302; *NAT RES COUNC, 2006, PREV FORW CONT MARS, P362; Schuerger AC, 2003, ICARUS, V165, P253, DOI 10.1016/S0019-1035(03)00200-8; Sleep NH, 1998, J GEOPHYS RES-PLANET, V103, P28529, DOI 10.1029/98JE01809; Weiss BP, 2000, SCIENCE, V290, P791, DOI 10.1126/science.290.5492.791	12	16	18	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					718	718		10.1126/science.1167987	http://dx.doi.org/10.1126/science.1167987			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197043	Green Submitted			2022-12-01	WOS:000263066800024
J	Drazen, JM; Desai, NR; Green, P				Drazen, Jeffrey M.; Desai, Nihar R.; Green, Philip			Fighting On.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Desai, Nihar R.; Green, Philip] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital			Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890					0	9	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					444	445		10.1056/NEJMp0809496	http://dx.doi.org/10.1056/NEJMp0809496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179313				2022-12-01	WOS:000262812400003
J	Marchetti, A; Parker, MS; Moccia, LP; Lin, EO; Arrieta, AL; Ribalet, F; Murphy, MEP; Maldonado, MT; Armbrust, EV				Marchetti, Adrian; Parker, Micaela S.; Moccia, Lauren P.; Lin, Ellen O.; Arrieta, Angele L.; Ribalet, Francois; Murphy, Michael E. P.; Maldonado, Maria T.; Armbrust, E. Virginia			Ferritin is used for iron storage in bloom-forming marine pennate diatoms	NATURE			English	Article							SOUTHERN-OCEAN; PHYTOPLANKTON; GROWTH; REQUIREMENTS; HYDROLYSIS; LIMITATION; CHEMISTRY; EVOLUTION; OXIDATION; PACIFIC	Primary productivity in 30 - 40% of the world's oceans is limited by availability of the micronutrient iron(1,2). Regions with chronically low iron concentrations are sporadically pulsed with new iron inputs by way of dust(3) or lateral advection from continental margins(4). Addition of iron to surface waters in these areas induces massive phytoplankton blooms dominated primarily by pennate diatoms(5,6). Here we provide evidence that the bloom- forming pennate diatoms Pseudo- nitzschia and Fragilariopsis use the iron- concentrating protein, ferritin, to safely store iron. Ferritin has not been reported previously in any member of the Stramenopiles, a diverse eukaryotic lineage that includes unicellular algae, macroalgae and plant parasites. Phylogenetic analyses suggest that ferritin may have arisen in this small subset of diatoms through a lateral gene transfer. The crystal structure and functional assays of recombinant ferritin derived from Pseudo- nitzschia multiseries reveal a maxi- ferritin that exhibits ferroxidase activity and binds iron. The protein is predicted to be targeted to the chloroplast to control the distribution and storage of iron for proper functioning of the photosynthetic machinery. Abundance of Pseudo- nitzschia ferritin transcripts is regulated by iron nutritional status, and is closely tied to the loss and recovery of photosynthetic competence. Enhanced iron storage with ferritin allows the oceanic diatom Pseudo- nitzschia granii to undergo several more cell divisions in the absence of iron than the comparably sized, oceanic centric diatom Thalassiosira oceanica. Ferritin in pennate diatoms probably contributes to their success in chronically low- iron regions that receive intermittent iron inputs, and provides an explanation for the importance of these organisms in regulating oceanic CO2 over geological timescales(7,8).	[Marchetti, Adrian; Parker, Micaela S.; Lin, Ellen O.; Ribalet, Francois; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Moccia, Lauren P.; Maldonado, Maria T.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; [Arrieta, Angele L.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of Washington; University of Washington Seattle; University of British Columbia; University of British Columbia	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Box 357940, Seattle, WA 98195 USA.	armbrust@ocean.washington.edu	Murphy, Michael/R-6805-2017; Maldonado, Maria T/N-2877-2017; ribalet, francois/C-2626-2011	Murphy, Michael/0000-0003-2589-0014; Maldonado, Maria T/0000-0001-8134-9375; ribalet, francois/0000-0002-7431-0234; Marchetti, Adrian/0000-0003-4608-4775; Parker, Micaela/0000-0003-1007-4612	Gordon and Betty Moore Foundation Marine Microbiology Investigator Award; National Science Foundation; National Institute of Environmental Health Sciences; National Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health; National Center for Research Resources; Biomedical Technology Program; National Institute of General Medical Sciences	Gordon and Betty Moore Foundation Marine Microbiology Investigator Award; National Science Foundation(National Science Foundation (NSF)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. S. Bates for providing P. multiseries CLN-47 and CLN-17 isolates used in this study, and T. Rynearson for sea water from OSP in which P. granii (UWOSP36) was isolated. We are grateful to K.R. Boissonneault for providing P. multiseries actin sequences, R. Marohl and I. Oleinkov for assistance with culture maintenance and sample analyses, and W.C. Lee for assistance with X-ray diffraction data collection. This study was supported by a Gordon and Betty Moore Foundation Marine Microbiology Investigator Award, National Science Foundation grants and a National Institute of Environmental Health Sciences grant to E.V.A.; a National Sciences and Engineering Research Council of Canada grant to M.T.M.; and a Canadian Institutes of Health Research grant to M.E.P.M. Portions of this research were carried out at the Canadian Light Source (CLS) and the Stanford Synchrotron Radiation Laboratory (SSRL). SSRL is a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences.	Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BI X, 1991, J BIOL CHEM, V266, P19965; Bou-Abdallah F, 2002, J BIOL CHEM, V277, P37064, DOI 10.1074/jbc.M205712200; Bowie AR, 2001, DEEP-SEA RES PT II, V48, P2703, DOI 10.1016/S0967-0645(01)00015-7; Cortese G, 2007, EARTH PLANET SC LETT, V257, P526, DOI 10.1016/j.epsl.2007.03.021; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; Katsuki K, 2005, DEEP-SEA RES PT II, V52, P2110, DOI 10.1016/j.dsr2.2005.07.001; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Lam PJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033294; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Marchetti A, 2006, DEEP-SEA RES PT II, V53, P2095, DOI 10.1016/j.dsr2.2006.05.038; Marchetti A, 2006, LIMNOL OCEANOGR, V51, P2092, DOI 10.4319/lo.2006.51.5.2092; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; SUNDA WG, 1991, NATURE, V351, P55, DOI 10.1038/351055a0; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Yang XK, 2000, BIOCHEM J, V349, P783, DOI 10.1042/bj3490783; 2006, PHAEODACTYLUM TRICOR	26	234	242	5	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					467	470		10.1038/nature07539	http://dx.doi.org/10.1038/nature07539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19037243				2022-12-01	WOS:000262519200044
J	Simon, T; Verstuyft, C; Mary-Krause, M; Quteineh, L; Drouet, E; Meneveau, N; Steg, PG; Ferrieres, J; Danchin, N; Becquemont, L				Simon, Tabassome; Verstuyft, Celine; Mary-Krause, Murielle; Quteineh, Lina; Drouet, Elodie; Meneveau, Nicolas; Steg, P. Gabriel; Ferrieres, Jean; Danchin, Nicolas; Becquemont, Laurent		French Registry Acute ST-Elevation	Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; OF-FUNCTION POLYMORPHISM; SEQUENCE VARIATIONS; P-GLYCOPROTEIN; DUODENAL ENTEROCYTES; DRUG RESPONSE; ST-ELEVATION; MDR1 GENE; ASPIRIN	Background: Pharmacogenetic determinants of the response of patients to clopidogrel contribute to variability in the biologic antiplatelet activity of the drug. The effect of these determinants on clinical outcomes after an acute myocardial infarction is unknown. Methods: We consecutively enrolled 2208 patients presenting with an acute myocardial infarction in a nationwide French registry and receiving clopidogrel therapy. We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up. Results: Death occurred in 225 patients, and nonfatal myocardial infarction or stroke in 94 patients, during the follow-up period. None of the selected single-nucleotide polymorphisms (SNPs) in CYP3A5, P2RY12, or ITGB3 were associated with a risk of an adverse outcome. Patients with two variant alleles of ABCB1 (TT at nucleotide 3435) had a higher rate of cardiovascular events at 1 year than those with the ABCB1 wild-type genotype (CC at nucleotide 3435) (15.5% vs. 10.7%; adjusted hazard ratio, 1.72; 95% confidence interval [CI], 1.20 to 2.47). Patients carrying any two CYP2C19 loss-of-function alleles (*2, *3, *4, or *5), had a higher event rate than patients with none (21.5% vs. 13.3%; adjusted hazard ratio, 1.98; 95% CI, 1.10 to 3.58). Among the 1535 patients who underwent percutaneous coronary intervention during hospitalization, the rate of cardiovascular events among patients with two CYP2C19 loss-of-function alleles was 3.58 times the rate among those with none (95% CI, 1.71 to 7.51). Conclusions: Among patients with an acute myocardial infarction who were receiving clopidogrel, those carrying CYP2C19 loss-of-function alleles had a higher rate of subsequent cardiovascular events than those who were not. This effect was particularly marked among the patients undergoing percutaneous coronary intervention. (ClinicalTrials.gov number, NCT00673036.) N Engl J Med 2009;360:363-75.	[Simon, Tabassome; Quteineh, Lina; Drouet, Elodie] Univ Paris 06, Dept Pharmacol, F-75012 Paris, France; [Simon, Tabassome; Quteineh, Lina; Drouet, Elodie] Hop St Antoine, AP HP, F-75571 Paris, France; [Verstuyft, Celine; Becquemont, Laurent] Univ Paris 11, AP HP, Hop Bicetre, Paris, France; [Steg, P. Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Steg, P. Gabriel] INSERM, Unite 698, Paris, France; [Steg, P. Gabriel] Univ Paris 07, Paris, France; [Danchin, Nicolas] Univ Paris 05, AP HP, Hop Europeen Georges Pompidou, Paris, France; [Meneveau, Nicolas] Ctr Hosp Univ Besancon, F-25030 Besancon, France; [Ferrieres, Jean] Fac Med Toulouse, INSERM, Unite 558, F-31073 Toulouse, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Simon, T (corresponding author), Univ Paris 06, Dept Pharmacol, 27 Rue Chaligny, F-75012 Paris, France.	tabassome.simon@sat.aphp.fr	verstuyft, celine/AAU-3343-2021; Danchin, Nicolas/AAN-8291-2020; STEG, Philippe Gabriel/Z-1567-2019; Ferrieres, Jean/S-7993-2016	verstuyft, celine/0000-0002-8534-224X; STEG, Philippe Gabriel/0000-0001-6896-2941; Ferrieres, Jean/0000-0001-6144-1297; SIMON, Tabassome/0000-0002-4550-0450	Pfizer; Servier; French Caisse Nationale d'Assurance Maladie; Bayer Schering; Pfizer and Eli Lilly; Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Endotis; GlaxoSmithKline; MedtronicMerck Sharp Dohme; Nycomed; Sanofi-Aventis; Medicines Company	Pfizer(Pfizer); Servier(Servier); French Caisse Nationale d'Assurance Maladie; Bayer Schering(Bayer AG); Pfizer and Eli Lilly; Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Endotis; GlaxoSmithKline(GlaxoSmithKline); MedtronicMerck Sharp Dohme; Nycomed; Sanofi-Aventis(Sanofi-Aventis); Medicines Company	Supported by unrestricted grants from Pfizer and Servier for FAST-MI, a registry of the French Society of Cardiology, and a research grant from the French Caisse Nationale d'Assurance Maladie.; Dr. Simon reports receiving consulting fees from Bayer Schering, Pfizer and Eli Lilly, lecture fees from Bayer-Schering, and grant support from Pfizer and Servier; Dr. Steg, consulting fees from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Endotis, GlaxoSmithKline, Medtronic, Merck Sharp & Dohme, Nycomed, Sanofi-Aventis, Servier, and the Medicines Company, lecture fees from Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic, Nycomed, Sanofi-Aventis, Servier, and the Medicines Company, and grant support from Sanofi-Aventis; Dr. Danchin, consulting fees from Servier, Sanofi- Aventis, Eli Lilly, and AstraZeneca, lecture fees from Servier, Sanofi- Aventis, and Bristol-Myers Squibb, and grant support from Pfizer and Servier; and Dr. Becquemont, consulting fees from Sanofi- Aventis, Pfizer, and Servier and lecture fees from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.; We thank the physicians who cared for the patients at the participating institutions, E. Martin and F. Rousseau (IntegraGene, Paris), the International Clinical Trials Association Contract Research Organization (Fontaine-les-Dijon, France), Liliane Dubert (Department of Pharmacology, Universit, Pierre et Marie Curie [UPMC] Paris 06), the Clinical Research Assistant team of Unit, de Recherche Clinique de l'Est Parisien (Assistance Publique-Hopitaux de Paris and UPMC Paris 06), and Benoit Pace and Genevieve Mulak (French Society of Cardiology) for their assistance in designing the electronic case-record form and data management during the follow-up period.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Anderson SD, 2008, CIRCULATION, V117, pE174, DOI 10.1161/CIRCULATIONAHA.107.737551; Angiolillo DJ, 2004, BLOOD COAGUL FIBRIN, V15, P89, DOI 10.1097/00001721-200401000-00014; Angiolillo DJ, 2007, THROMB HAEMOSTASIS, V98, P707, DOI 10.1160/TH07-08-0518; Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; Antman EM, 2008, J AM COLL CARDIOL, V51, P977, DOI 10.1016/j.jacc.2008.01.007; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI 10.1016/j.jacc.2007.10.001; Bonello L, 2008, J AM COLL CARDIOL, V51, P1404, DOI 10.1016/j.jacc.2007.12.044; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Cambou JP, 2007, ARCH MAL COEUR VAISS, V100, P524; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Clarke TA, 2003, DRUG METAB DISPOS, V31, P53, DOI 10.1124/dmd.31.1.53; Cuisset T, 2007, THROMB RES, V120, P893, DOI 10.1016/j.thromres.2007.01.012; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; Fontana P, 2008, THROMB RES, V121, P463, DOI 10.1016/j.thromres.2007.06.012; Gerloff T, 2002, BRIT J CLIN PHARMACO, V54, P610, DOI 10.1046/j.1365-2125.2002.01691.x; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Giusti B, 2007, PHARMACOGENET GENOM, V17, P1057, DOI 10.1097/FPC.0b013e3282f1b2be; Gurbel PA, 2007, J AM COLL CARDIOL, V50, P1822, DOI 10.1016/j.jacc.2007.07.051; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Lev EI, 2007, THROMB RES, V119, P355, DOI 10.1016/j.thromres.2006.02.006; Marzolini C, 2004, CLIN PHARMACOL THER, V75, P13, DOI 10.1016/j.clpt.2003.09.012; Mehta RH, 2006, ARCH INTERN MED, V166, P2027, DOI 10.1001/archinte.166.18.2027; Moriya Y, 2002, BIOL PHARM BULL, V25, P1356, DOI 10.1248/bpb.25.1356; Nakamura T, 2002, CLIN PHARMACOL THER, V71, P297, DOI 10.1067/mcp.2002.122055; Philippi A, 2005, MOL PSYCHIATR, V10, P950, DOI 10.1038/sj.mp.4001704; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Schaeffeler E, 2001, LANCET, V358, P383, DOI 10.1016/S0140-6736(01)05579-9; Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002; Smith SMG, 2006, PLATELETS, V17, P250, DOI 10.1080/09537100500475844; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Suh JW, 2006, CAN MED ASSOC J, V175, P64, DOI 10.1503/cmaj.060701; Taubert D, 2006, CLIN PHARMACOL THER, V80, P486, DOI 10.1016/j.clpt.2006.07.007; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Wang TH, 2006, EUR HEART J, V27, P647, DOI 10.1093/eurheartj/ehi684; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; [No title captured]	42	1333	1453	2	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					363	375		10.1056/NEJMoa0808227	http://dx.doi.org/10.1056/NEJMoa0808227			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395JH	19106083				2022-12-01	WOS:000262519900008
J	Ray, WA; Chung, CP; Murray, KT; Hall, K; Stein, CM				Ray, Wayne A.; Chung, Cecilia P.; Murray, Katherine T.; Hall, Kathi; Stein, C. Michael			Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TORSADE-DE-POINTES; INTERVAL ABNORMALITIES; QT INTERVAL; MECHANISM; THERAPY; PROLONGATION; PATIENT	Background Users of typical antipsychotic drugs have an increased risk of serious ventricular arrhythmias and sudden cardiac death. However, less is known regarding the cardiac safety of the atypical antipsychotic drugs, which have largely replaced the older agents in clinical practice. Methods We calculated the adjusted incidence of sudden cardiac death among current users of antipsychotic drugs in a retrospective cohort study of Medicaid enrollees in Tennessee. The primary analysis included 44,218 and 46,089 baseline users of single typical and atypical drugs, respectively, and 186,600 matched nonusers of antipsychotic drugs. To assess residual confounding related to factors associated with the use of antipsychotic drugs, we performed a secondary analysis of users of antipsychotic drugs who had no baseline diagnosis of schizophrenia or related psychoses and with whom nonusers were matched according to propensity score ( i. e., the predicted probability that they would be users of antipsychotic drugs). Results Current users of typical and of atypical antipsychotic drugs had higher rates of sudden cardiac death than did nonusers of antipsychotic drugs, with adjusted incidence-rate ratios of 1.99 ( 95% confidence interval [ CI], 1.68 to 2.34) and 2.26 ( 95% CI, 1.88 to 2.72), respectively. The incidence- rate ratio for users of atypical antipsychotic drugs as compared with users of typical antipsychotic drugs was 1.14 ( 95% CI, 0.93 to 1.39). Former users of antipsychotic drugs had no significantly increased risk ( incidence-rate ratio, 1.13; 95% CI, 0.98 to 1.30). For both classes of drugs, the risk for current users increased significantly with an increasing dose. Among users of typical antipsychotic drugs, the incidence- rate ratios increased from 1.31 ( 95% CI, 0.97 to 1.77) for those taking low doses to 2.42 ( 95% CI, 1.91 to 3.06) for those taking high doses ( P< 0.001). Among users of atypical agents, the incidence- rate ratios increased from 1.59 ( 95% CI, 1.03 to 2.46) for those taking low doses to 2.86 ( 95% CI, 2.25 to 3.65) for those taking high doses ( P = 0.01). The findings were similar in the cohort that was matched for propensity score. Conclusions Current users of typical and of atypical antipsychotic drugs had a similar, dose- related increased risk of sudden cardiac death.	[Ray, Wayne A.; Hall, Kathi] Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA; [Chung, Cecilia P.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Div Rheumatol, Nashville, TN 37212 USA; [Murray, Katherine T.] Vanderbilt Univ, Sch Med, Div Cardiol, Nashville, TN 37212 USA; [Murray, Katherine T.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Ray, Wayne A.] Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ray, WA (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Village Vanderbilt,Suite 2600,1501 21st Ave S, Nashville, TN 37212 USA.	cindy.naron@vanderbilt.edu	Chung, Cecilia P/ABE-2177-2021	Chung, Cecilia P/0000-0001-5908-9423	National Heart, Lung, and Blood Institute [HL081707]; Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics [HS1-0384]; Pfizer; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081707] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics; Pfizer(Pfizer); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (HL081707) and the Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics (cooperative agreement, HS1-0384).; Dr. Ray reports receiving research support from Pfizer and consulting fees from plaintiffs' attorneys in litigation involving rofecoxib and zoledronic acid and from insurance companies regarding rofecoxib and hormone- replacement therapy; and Dr. Stein, consulting fees from insurance companies regarding antipsychotic drugs. No other potential conflict of interest relevant to this article was reported.; We thank the staff of the Tennessee Bureau of TennCare and the Department of Health, who gave us access to the study data.	Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; *AM MED ASS, 1995, DRUG EV ANN 1995; Aparasu Rajender R, 2005, Ann Clin Psychiatry, V17, P147, DOI 10.1080/10401230591002084; Arbogast PG, 2008, EPIDEMIOLOGY, V19, P30, DOI 10.1097/EDE.0b013e31815be000; Buckley NA, 2000, DRUG SAFETY, V23, P215, DOI 10.2165/00002018-200023030-00004; Darpo B, 2001, EUR HEART J SUPPL, V3, pK70, DOI 10.1016/S1520-765X(01)90009-4; Flockhart DA, 2000, J CLIN PSYCHOPHARM, V20, P317, DOI 10.1097/00004714-200006000-00005; Glassman AH, 2005, J CLIN PSYCHIAT, V66, P5; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Haddad PM, 2002, DRUGS, V62, P1649, DOI 10.2165/00003495-200262110-00006; Harrigan EP, 2004, J CLIN PSYCHOPHARM, V24, P62, DOI 10.1097/01.jcp.0000104913.75206.62; Heinrich TW, 2006, PSYCHOSOMATICS, V47, P264, DOI 10.1176/appi.psy.47.3.264; Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; Kleinbaum D.G., 1982, EPIDEMIOLOGIC RES PR, P1; Kongsamut S, 2002, EUR J PHARMACOL, V450, P37, DOI 10.1016/S0014-2999(02)02074-5; LANDRY JA, 1988, GERONTOLOGIST, V28, P672, DOI 10.1093/geront/28.5.672; LIBERATORE MA, 1984, J CLIN PSYCHOPHARM, V4, P143; Liberthson RR, 1996, NEW ENGL J MED, V334, P1039, DOI 10.1056/NEJM199604183341607; MARCUS FI, 1988, AM J CARDIOL, V61, P8, DOI 10.1016/0002-9149(88)91295-7; Ray WA, 2004, CLIN PHARMACOL THER, V75, P234, DOI 10.1016/j.clpt.2003.09.019; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ray WA, 2003, NEW ENGL J MED, V349, P1592, DOI 10.1056/NEJMp038145; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Reilly JG, 2002, BRIT J PSYCHIAT, V180, P515, DOI 10.1192/bjp.180.6.515; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; SISCOVICK DS, 1994, NEW ENGL J MED, V330, P1852, DOI 10.1056/NEJM199406303302603; STRAUS SM, 2004, ARCH INTERN MED, V164, P1839; Straus SMJM, 2004, ARCH INTERN MED, V164, P1293, DOI 10.1001/archinte.164.12.1293; Tei Y, 2004, PSYCHOSOMATICS, V45, P450, DOI 10.1176/appi.psy.45.5.450; THOMAS SHL, 1994, ADVERSE DRUG REACT T, V13, P77; Vieweg WVR, 2005, ACTA PSYCHIAT SCAND, V112, P318, DOI 10.1111/j.1600-0447.2005.00592.x; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Zarate CA, 2001, ARCH GEN PSYCHIAT, V58, P1168, DOI 10.1001/archpsyc.58.12.1168	39	797	827	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					225	235		10.1056/NEJMoa0806994	http://dx.doi.org/10.1056/NEJMoa0806994			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144938	Green Accepted			2022-12-01	WOS:000262434500005
J	Lipworth, BJ; Williamson, PA				Lipworth, Brian J.; Williamson, Peter A.			beta blockers for asthma: a double-edged sword	LANCET			English	Editorial Material							INHALED CORTICOSTEROIDS; METAANALYSIS; BLOCKADE; MODEL		[Lipworth, Brian J.; Williamson, Peter A.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland	University of Dundee	Lipworth, BJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland.	b.j.lipworth@googlemail.com						Callaerts-Vegh Z, 2004, P NATL ACAD SCI USA, V101, P4948, DOI 10.1073/pnas.0400452101; Currie GP, 2003, QJM-INT J MED, V96, P435, DOI 10.1093/qjmed/hcg071; Currie GP, 2003, ANN ALLERG ASTHMA IM, V90, P194, DOI 10.1016/S1081-1206(10)62140-0; Hanania NA, 2008, PULM PHARMACOL THER, V21, P134, DOI 10.1016/j.pupt.2007.07.002; IND PW, 1989, AM REV RESPIR DIS, V139, P1390, DOI 10.1164/ajrccm/139.6.1390; Lin R, 2008, PULM PHARMACOL THER, V21, P115, DOI 10.1016/j.pupt.2007.06.003; LIPWORTH BJ, 1991, EUR J CLIN PHARMACOL, V40, P467, DOI 10.1007/BF00315224; Lipworth BJ, 2007, TRENDS PHARMACOL SCI, V28, P257, DOI 10.1016/j.tips.2007.04.003; Nguyen LP, 2008, AM J RESP CELL MOL, V38, P256, DOI 10.1165/rcmb.2007-0279RC; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Salpeter SR, 2002, ANN INTERN MED, V137, P715, DOI 10.7326/0003-4819-137-9-200211050-00035; WHEELDON NM, 1994, BRIT J CLIN PHARMACO, V38, P103, DOI 10.1111/j.1365-2125.1994.tb04332.x	12	18	22	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					104	105		10.1016/S0140-6736(09)60018-0	http://dx.doi.org/10.1016/S0140-6736(09)60018-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135598				2022-12-01	WOS:000262340900008
J	Yang, Q; She, H; Gearing, M; Colla, E; Lee, M; Shacka, JJ; Mao, ZX				Yang, Qian; She, Hua; Gearing, Marla; Colla, Emanuela; Lee, Michael; Shacka, John J.; Mao, Zixu			Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy	SCIENCE			English	Article							MYOCYTE ENHANCER FACTOR-2; TRANSCRIPTION FACTOR MEF2; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; PROTEIN-DEGRADATION; CELL-DEATH; NEURODEGENERATION	Chaperone- mediated autophagy controls the degradation of selective cytosolic proteins and may protect neurons against degeneration. In a neuronal cell line, we found that chaperone- mediated autophagy regulated the activity of myocyte enhancer factor 2D ( MEF2D), a transcription factor required for neuronal survival. MEF2D was observed to continuously shuttle to the cytoplasm, interact with the chaperone Hsc70, and undergo degradation. Inhibition of chaperone- mediated autophagy caused accumulation of inactive MEF2D in the cytoplasm. MEF2D levels were increased in the brains of alpha-synuclein transgenic mice and patients with Parkinson's disease. Wild-type alpha-synuclein and a Parkinson's disease- associated mutant disrupted the MEF2D-Hsc70 binding and led to neuronal death. Thus, chaperone- mediated autophagy modulates the neuronal survival machinery, and dysregulation of this pathway is associated with Parkinson's disease.	[Yang, Qian; She, Hua; Mao, Zixu] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Gearing, Marla; Mao, Zixu] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Colla, Emanuela; Lee, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Shacka, John J.] Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA	Emory University; Emory University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham	Mao, ZX (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	zmao@pharm.emory.edu	Colla, Emanuela/H-2483-2013; Lee, Michael K/D-9491-2013	Colla, Emanuela/0000-0002-4755-7450; Lee, Michael K/0000-0001-5865-9682	NIH [NS048254, AG023695, NS038065]; Emory; UAB Alzheimer's Disease Research Center; Robert Woodruff Health Sciences Center Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057098, R56NS038065, R01NS038065, P30NS047466, P30NS055077, R01NS048254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688, R01AG023695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory; UAB Alzheimer's Disease Research Center; Robert Woodruff Health Sciences Center Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Rees and D. Cooper at Emory Neuroscience NINDS Core Facility (NS055077) and UAB Neuroscience Core Facility (NS47466 and NS57098) for assistance in imaging and immunohistochemistry analysis, and J. Blum and A. M. Cuervo for Hsc70 and Lamp2a constructs. Supported by NIH grants NS048254 (Z.M.), AG023695 (Z.M.), and NS038065 (M.L.) and by Emory and UAB Alzheimer's Disease Research Center pilot grants (Z.M. and J.J.S.) and the Robert Woodruff Health Sciences Center Fund (Z.M.).	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bandhyopadhyay U, 2007, EXP GERONTOL, V42, P120, DOI 10.1016/j.exger.2006.05.019; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Chun HS, 2001, J NEUROCHEM, V76, P1010, DOI 10.1046/j.1471-4159.2001.00096.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gonzalez P, 2007, NEUROSCI LETT, V411, P47, DOI 10.1016/j.neulet.2006.09.055; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200	25	243	254	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					124	127		10.1126/science.1166088	http://dx.doi.org/10.1126/science.1166088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119233	Green Accepted			2022-12-01	WOS:000262104100056
J	Varricchio, DJ; Moore, JR; Erickson, GM; Norell, MA; Jackson, FD; Borkowski, JJ				Varricchio, David J.; Moore, Jason R.; Erickson, Gregory M.; Norell, Mark A.; Jackson, Frankie D.; Borkowski, John J.			Avian Paternal Care Had Dinosaur Origin	SCIENCE			English	Article							PARENTAL-CARE; SEXUAL-MATURITY; EVOLUTION; BIRDS; CLUTCHES; EGGS	The repeated discovery of adult dinosaurs in close association with egg clutches leads to speculation over the type and extent of care exhibited by these extinct animals for their eggs and young. To assess parental care in Cretaceous troodontid and oviraptorid dinosaurs, we examined clutch volume and the bone histology of brooding adults. In comparison to four archosaur care regressions, the relatively large clutch volumes of Troodon, Oviraptor, and Citipati scale most closely with a bird- paternal care model. Clutch- associated adults lack the maternal and reproductively associated histologic features common to extant archosaurs. Large clutch volumes and a suite of reproductive features shared only with birds favor paternal care, possibly within a polygamous mating system. Paternal care in both troodontids and oviraptorids indicates that this care system evolved before the emergence of birds and represents birds' ancestral condition. In extant birds and over most adult sizes, paternal and biparental care correspond to the largest and smallest relative clutch volumes, respectively.	[Varricchio, David J.; Jackson, Frankie D.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Moore, Jason R.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; [Erickson, Gregory M.] Florida State Univ, Dept Sci Biol, Tallahassee, FL 32306 USA; [Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Borkowski, John J.] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Texas A&M University System; Texas A&M University College Station; State University System of Florida; Florida State University; American Museum of Natural History (AMNH); Montana State University System; Montana State University Bozeman	Varricchio, DJ (corresponding author), Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA.	djv@montana.edu			NSF [EAR-0418649, DBI-446224]	NSF(National Science Foundation (NSF))	We thank J. Horner, A. Chinsamy-Turan, L. Hall, H. Akashi, J. Rotella, and P.T. Varricchio Sr. Supported by NSF grants EAR-0418649 and DBI-446224 (G.M.E.).	BRANCH W R, 1975, Journal of Herpetology, V9, P243, DOI 10.2307/1563048; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Clutton-Brock TH., 1991, EVOLUTION PARENTAL C, DOI [10.1515/9780691206981, DOI 10.1515/9780691206981, DOI 10.104641420-9101.1992.5040719.X]; Davies S.J.J.F., 2002, RATITES TINAMOUS; Elzanowski A., 1985, ACT 18 C INT ORN, V1, P178; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Ligon JD., 1999, EVOLUTION AVIAN BREE; Lourdais O, 2007, J COMP PHYSIOL B, V177, P569, DOI 10.1007/s00360-007-0155-6; Mateus I, 1997, CR ACAD SCI II A, V325, P71, DOI 10.1016/S1251-8050(97)83275-2; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Pahl R, 1997, P ROY SOC B-BIOL SCI, V264, P239, DOI 10.1098/rspb.1997.0034; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Shine R, 1988, BIOL REPTILIA, V16, P276; Simkiss K., 1967, CALCIUM REPROD PHYSL; SOMMA LA, 1990, SMITHSONIAN HERPETOL; Tullberg BS, 2002, PHILOS T R SOC B, V357, P251, DOI 10.1098/rstb.2001.0932; van Mierop L.H.S., 1976, Journal Herpet, V10, P333; VANRHIJN J, 1984, NETH J ZOOL, V34, P103, DOI 10.1163/002829684X00092; Varricchio DJ, 2004, J VERTEBR PALEONTOL, V24, P931, DOI 10.1671/0272-4634(2004)024[0931:APAOPD]2.0.CO;2; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Varricchio DJ, 2004, LIFE O PAST, P215; Vehrencamp SL, 2000, BEHAV ECOL, V11, P334, DOI 10.1093/beheco/11.3.334; WESOLOWSKI T, 1994, AM NAT, V143, P39, DOI 10.1086/285595; WINK CS, 1986, J MORPHOL, V189, P183, DOI 10.1002/jmor.1051890208; [No title captured]	28	94	97	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1826	1828		10.1126/science.1163245	http://dx.doi.org/10.1126/science.1163245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095938				2022-12-01	WOS:000261799400049
J	Goswami, D; Gowrishankar, K; Bilgrami, S; Ghosh, S; Raghupathy, R; Chadda, R; Vishwakarma, R; Rao, M; Mayor, S				Goswami, Debanjan; Gowrishankar, Kripa; Bilgrami, Sameera; Ghosh, Subhasri; Raghupathy, Riya; Chadda, Rahul; Vishwakarma, Ram; Rao, Madan; Mayor, Satyajit			Nanoclusters of GPI-Anchored Proteins Are Formed by Cortical Actin-Driven Activity	CELL			English	Article							LIPID RAFTS; PLASMA-MEMBRANE; CELL; CHOLESTEROL; ACTIVATION; ORGANIZATION; MICROSCOPY; CDC42	Several cell-surface lipid-tethered proteins exhibit a concentration-independent, cholesterol-sensitive organization of nanoscale clusters and monomers. To understand the mechanism of formation of these clusters, we investigate the spatial distribution and steady-state dynamics of fluorescently tagged GPI-anchored protein nanoclusters using high-spatial and temporal resolution FRET microscopy. These studies reveal a nonrandom spatial distribution of nanoclusters, concentrated in optically resolvable domains. Monitoring the dynamics of recovery of fluorescence intensity and anisotropy, we find that nanoclusters are immobile, and the dynamics of inter-conversion between nanoclusters and monomers, over a range of temperatures, is spatially heterogeneous and non-Arrhenius, with a sharp crossover coinciding with a reduction in the activity of cortical actin. Cholesterol depletion perturbs cortical actin and the spatial scale and interconversion dynamics of nanoclusters. Direct perturbations of cortical actin activity also affect the construction, dynamics, and spatial organization of nanoclusters. These results suggest a unique mechanism of complexation of cell-surface molecules regulated by cortical actin activity.	[Goswami, Debanjan; Bilgrami, Sameera; Ghosh, Subhasri; Raghupathy, Riya; Chadda, Rahul; Rao, Madan; Mayor, Satyajit] Nat Ctr Biol Sci TIFR, Bangalore 560065, Karnataka, India; [Gowrishankar, Kripa; Rao, Madan] Raman Res Inst, Bangalore 560080, Karnataka, India; [Vishwakarma, Ram] Natl Inst Immunol, New Delhi 110067, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Department of Science & Technology (India); Raman Research Institute (RRI); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Rao, M (corresponding author), Nat Ctr Biol Sci TIFR, Bellary Rd, Bangalore 560065, Karnataka, India.	madan@ncbs.res.in; mayor@ncbs.res.in	Chadda, Rahul/AAM-2085-2020; Rao, Madan/E-2927-2012	Ghosh, Subhasri/0000-0002-3907-6366	Central Imaging and Flow Facility at NCBS; HFSP [RGP 0050/ 2005)/DST(SR/S5/NM-36/2005)]	Central Imaging and Flow Facility at NCBS; HFSP(Human Frontier Science Program)	We thank M. Thattai, G. V. Shivashankar, and S. Ramaswamy for a critical reading, N. Periasami ( DCS, TIFR, Mumbai) for the help with time-resolved anistropy analysis, and H. Krishnamurthy and the Central Imaging and Flow Facility at NCBS for their help and support. S. M. acknowledges DST for J C Bose fellowship. S. M. and M. R. acknowledge grants from HFSP(RGP 0050/ 2005)/DST(SR/S5/NM-36/2005)/DBT/Wellcome Trust ( NLO-056727/Z/99/B)and HFSP( RGP26/2007)/IFCPAR, respectively.	[Anonymous], 1995, PRINCIPLES CONDENSED, DOI DOI 10.1017/CBO9780511813467; Becker W., 2005, ADV TIME CORRELATED, DOI [10.1007/3-540-28882-1, DOI 10.1007/3-540-28882-1]; Bretscher A, 1997, J CELL SCI, V110, P3011; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hatwalne Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118101; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; ISRAELACHVILI JN, 1992, INTERMOLOLECULAR SUR; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Keller H, 2002, EXP CELL RES, V277, P161, DOI 10.1006/excr.2002.5552; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Niggli V, 2005, ANNU REV CELL DEV BI, V21, P57, DOI 10.1146/annurev.cellbio.21.021704.102317; PETERS R, 1981, P NATL ACAD SCI-BIOL, V78, P962, DOI 10.1073/pnas.78.2.962; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Ramaswamy S, 2001, CR ACAD SCI IV-PHYS, V2, P817, DOI 10.1016/S1296-2147(01)01226-4; Ramaswamy S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/423; Rao M, 2005, BBA-MOL CELL RES, V1746, P221, DOI 10.1016/j.bbamcr.2005.08.002; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SHEETZ MP, 1984, J CELL BIOL, V99, P1867, DOI 10.1083/jcb.99.5.1867; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563	36	354	354	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1085	1097		10.1016/j.cell.2008.11.032	http://dx.doi.org/10.1016/j.cell.2008.11.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070578	Bronze			2022-12-01	WOS:000261642800024
J	Roberts, I				Roberts, Ian			Corporate capture and Coca-Cola	LANCET			English	Editorial Material									[Roberts, Ian] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Ian.Roberts@lshtm.ac.uk						GARCIA P, 2008, COMMUNICATION   1006; KER K, 2003, COCHRANE DB SYST REV, V3; Millstone E, 2008, LANCET, V372, P94, DOI 10.1016/S0140-6736(08)61012-0; PRATS J, 2008, COMMUNICATION   1007; Roberts I, 2007, J ROY SOC MED, V100, P360, DOI 10.1258/jrsm.100.8.360; Yach D, 2008, PUBLIC HEALTH NUTR, V11, P109, DOI 10.1017/S1368980007001619	6	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 6	2008	372	9654					1934	1935		10.1016/S0140-6736(08)61825-5	http://dx.doi.org/10.1016/S0140-6736(08)61825-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	19059037				2022-12-01	WOS:000261471600007
J	Thompson, RJ; Jackson, MF; Olah, ME; Rungta, RL; Hines, DJ; Beazely, MA; MacDonald, JF; MacVicar, BA				Thompson, Roger J.; Jackson, Michael F.; Olah, Michelle E.; Rungta, Ravi L.; Hines, Dustin J.; Beazely, Michael A.; MacDonald, John F.; MacVicar, Brian A.			Activation of Pannexin-1 Hemichannels Augments Aberrant Bursting in the Hippocampus	SCIENCE			English	Article							EPILEPTIFORM ACTIVITY; ENTORHINAL CORTEX; P2X(7) RECEPTOR; IN-VIVO; NEURONS; GAP; SLICES; ATP	Pannexin- 1 ( Px1) is expressed at postsynaptic sites in pyramidal neurons, suggesting that these hemichannels contribute to dendritic signals associated with synaptic function. We found that, in pyramidal neurons, N- methyl- D- aspartate receptor ( NMDAR) activation induced a secondary prolonged current and dye flux that were blocked with a specific inhibitory peptide against Px1 hemichannels; knockdown of Px1 by RNA interference blocked the current in cultured neurons. Enhancing endogenous NMDAR activation in brain slices by removing external magnesium ions (Mg2+) triggered epileptiform activity, which had decreased spike amplitude and prolonged interburst interval during application of the Px1 hemichannel blocking peptide. We conclude that Px1 hemichannel opening is triggered by NMDAR stimulation and can contribute to epileptiform seizure activity.	[Thompson, Roger J.; Rungta, Ravi L.; Hines, Dustin J.; MacVicar, Brian A.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Thompson, Roger J.; Rungta, Ravi L.; Hines, Dustin J.; MacVicar, Brian A.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Jackson, Michael F.; Olah, Michelle E.; Beazely, Michael A.; MacDonald, John F.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada	University of British Columbia; University of British Columbia; Western University (University of Western Ontario)	Thompson, RJ (corresponding author), Univ Calgary, Dept Cell Biol & Anat, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	rj.thompson@ucalgary.ca; bmacvicar@brain.ubc.ca	MacVicar, Brian/AAI-7729-2020; Thompson, Roger/A-3029-2012; MacVicar, Brian/P-1553-2015; Jackson, Mike/H-5573-2012; Thompson, Roger/L-3930-2016; Hines, Dustin/AAC-6394-2021	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Jackson, Mike/0000-0002-4730-201X; Thompson, Roger/0000-0002-7019-7246; Beazely, Michael/0000-0002-8722-460X; Rungta, Ravi/0000-0003-3505-2743	Heart and Stroke Foundation of British Columbia; Canadian Institutes of Health Research; Canadian Stroke Network	Heart and Stroke Foundation of British Columbia; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Stroke Network	This work was supported by grants to B. A. M. from the Heart and Stroke Foundation of British Columbia, to B.A.M. or J.F.M. (15514) from the Canadian Institutes of Health Research, and by a grant from the Canadian Stroke Network to B.A.M., J.F.M., and R.J.T. B.A.M. holds a Canada Research Chair (Tier 1) in Neuroscience. The authors kindly acknowledge Y.T. Wang for critical reading of the manuscript and S. Panuela and D. Laird for generously providing the anti-Px1 antibody.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bennett MVL, 2006, BRAIN CELL BIOL, V35, P5, DOI 10.1007/s11068-006-9004-x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chen QX, 1997, J NEUROSCI, V17, P4032; Connor JA, 2000, J NEUROPHYSIOL, V83, P90, DOI 10.1152/jn.2000.83.1.90; DREIER JP, 1990, NEUROSCI LETT, V119, P68, DOI 10.1016/0304-3940(90)90757-Z; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Jagt TAV, 2008, J NEUROSCI, V28, P5029, DOI 10.1523/JNEUROSCI.5069-07.2008; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061	18	261	264	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1555	1559		10.1126/science.1165209	http://dx.doi.org/10.1126/science.1165209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056988				2022-12-01	WOS:000261377400052
J	Price, TAR; Hodgson, DJ; Lewis, Z; Hurst, GDD; Wedell, N				Price, T. A. R.; Hodgson, D. J.; Lewis, Z.; Hurst, G. D. D.; Wedell, N.			Selfish Genetic Elements Promote Polyandry in a Fly	SCIENCE			English	Article							SPERM COMPETITIVE ABILITY; SEX-RATIO; MEIOTIC DRIVE; DROSOPHILA-PSEUDOOBSCURA; FEMALES; SELECTION; CHROMOSOME; STERILITY; INSECT; COMMON	It is unknown why females mate with multiple males when mating is frequently costly and a single copulation often provides enough sperm to fertilize all a female's eggs. One possibility is that remating increases the fitness of offspring, because fertilization success is biased toward the sperm of high- fitness males. We show that female Drosophila pseudoobscura evolved increased remating rates when exposed to the risk of mating with males carrying a deleterious sex ratio- distorting gene that also reduces sperm competitive ability. Because selfish genetic elements that reduce sperm competitive ability are generally associated with low genetic fitness, they may represent a common driver of the evolution of polyandry.	[Price, T. A. R.; Hodgson, D. J.; Wedell, N.] Univ Exeter, Sch Biosci, Penryn TR10 9EZ, England; [Lewis, Z.] Okayama Univ, Grad Sch Environm Sci, Okayama 7008530, Japan; [Hurst, G. D. D.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	University of Exeter; Okayama University; University of Liverpool	Wedell, N (corresponding author), Univ Exeter, Sch Biosci, Cornwall Campus, Penryn TR10 9EZ, England.	n.wedell@exeter.ac.uk	Hurst, Gregory D D/C-2723-2008; Lewis, Zenobia/T-2928-2019	Hurst, Gregory D D/0000-0002-7163-7784; Price, Thomas/0000-0002-4394-6301; Lewis, Zenobia/0000-0001-9464-7638	Funded by a Natural Environment Research Council; Natural Environment Research Council [NER/A/S/2003/00536/2] Funding Source: researchfish	Funded by a Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Isofemale lines were collected with assistance from T. Markow. We thank J. Blount, F. E. Champion de Crespigny, D. J. Hosken, and T. Tregenza for discussion. Funded by a Natural Environment Research Council grant (N.W. and G.H.).	[Anonymous], 1998, SPERM COMPETITION SE; Arnqvist Goran, 2005, pUnpaginated; BEUKEBOOM LW, 1994, EVOL ECOL, V8, P1, DOI 10.1007/BF01237662; BRYANT SH, 1982, EVOLUTION, V36, P27, DOI 10.1111/j.1558-5646.1982.tb05006.x; Burt A., 2006, GENES CONFLICT; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; de Crespigny FEC, 2006, P ROY SOC B-BIOL SCI, V273, P1455, DOI 10.1098/rspb.2006.3478; HAIG D, 1995, J EVOLUTION BIOL, V8, P265, DOI 10.1046/j.1420-9101.1995.8030265.x; Hosken DJ, 2003, P ROY SOC B-BIOL SCI, V270, P1933, DOI 10.1098/rspb.2003.2443; HURST LD, 1991, GENETICS, V128, P841; Jaenike J, 1996, AM NAT, V148, P237, DOI 10.1086/285923; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jiggins FM, 1999, AM NAT, V154, P481, DOI 10.1086/303251; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; POLICANSKY D, 1978, EVOLUTION, V32, P922, DOI 10.1111/j.1558-5646.1978.tb04647.x; Powell J.R., 1997, PROGR PROSPECTS EVOL; Price TAR, 2008, EVOLUTION, V62, P1644, DOI 10.1111/j.1558-5646.2008.00386.x; Price TAR, 2008, GENETICA, V132, P295, DOI 10.1007/s10709-007-9173-2; Rajendra TK, 2001, J GENET, V80, P97, DOI 10.1007/BF02728335; Rice WR, 2005, EVOLUTION, V59, P682; Simmons L.W., 2001, MG BEH ECOL; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010	26	82	83	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1241	1243		10.1126/science.1163766	http://dx.doi.org/10.1126/science.1163766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023079				2022-12-01	WOS:000261033400040
J	Hammarlund, M; Nix, P; Hauth, L; Jorgensen, EM; Bastiani, M				Hammarlund, Marc; Nix, Paola; Hauth, Linda; Jorgensen, Erik M.; Bastiani, Michael			Axon Regeneration Requires a Conserved MAP Kinase Pathway	SCIENCE			English	Article							ZIPPER-BEARING KINASE; GROWTH; OUTGROWTH; SYNAPTOGENESIS; NERVE; RPM-1; STAGE; GENE; CAMP	Regeneration of injured neurons can restore function, but most neurons regenerate poorly or not at all. The failure to regenerate in some cases is due to a lack of activation of cell- intrinsic regeneration pathways. These pathways might be targeted for the development of therapies that can restore neuron function after injury or disease. Here, we show that the DLK- 1 mitogen-activated protein ( MAP) kinase pathway is essential for regeneration in Caenorhabditis elegans motor neurons. Loss of this pathway eliminates regeneration, whereas activating it improves regeneration. Further, these proteins also regulate the later step of growth cone migration. We conclude that after axon injury, activation of this MAP kinase cascade is required to switch the mature neuron from an aplastic state to a state capable of growth.	[Hammarlund, Marc; Nix, Paola; Hauth, Linda; Jorgensen, Erik M.; Bastiani, Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Hammarlund, Marc; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Bastiani, M (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	bastiani@bioscience.utah.edu		Nix, Paul/0000-0002-7284-710X	Craig H. Neilsen Foundation; McKnight Endowment Fund for Neuroscience; NIH [1R21NS060275, NS034307]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034307, R01NS034307, R21NS060275] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0950955] Funding Source: National Science Foundation	Craig H. Neilsen Foundation; McKnight Endowment Fund for Neuroscience; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is dedicated to the memory of Craig H. Neilsen. We thank C.- B. Chen, D. Gard, W. Davis, J. White, and K. Schuske for helpful discussions. Supported by the Craig H. Neilsen Foundation, the McKnight Endowment Fund for Neuroscience, and NIH 1R21NS060275 to M. B. and NIH NS034307 to E. M.	Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Daviau A, 2006, J BIOL CHEM, V281, P31467, DOI 10.1074/jbc.M607612200; Erez H, 2007, J CELL BIOL, V176, P497, DOI 10.1083/jcb.200607098; Ewbank Jonathan J, 2006, WormBook, P1; Gabel CV, 2008, DEVELOPMENT, V135, P1129, DOI 10.1242/dev.013995; Gitler D, 2002, J NEUROBIOL, V52, P267, DOI 10.1002/neu.10084; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Reynolds AJ, 2001, NEUROSCIENCE, V105, P761, DOI 10.1016/S0306-4522(01)00235-4; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sung YJ, 2001, J NEUROBIOL, V47, P67, DOI 10.1002/neu.1016; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Wu Z, 2007, P NATL ACAD SCI USA, V104, P15132, DOI 10.1073/pnas.0707001104; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Zrouri H, 2004, EUR J NEUROSCI, V20, P1811, DOI 10.1111/j.1460-9568.2004.03641.x	31	307	319	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					802	806		10.1126/science.1165527	http://dx.doi.org/10.1126/science.1165527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19164707	Green Accepted			2022-12-01	WOS:000263066800053
J	Cardone, G; Purdy, JG; Cheng, NQ; Craven, RC; Steven, AC				Cardone, Giovanni; Purdy, John G.; Cheng, Naiqian; Craven, Rebecca C.; Steven, Alasdair C.			Visualization of a missing link in retrovirus capsid assembly	NATURE			English	Article							ROUS-SARCOMA-VIRUS; AMINO-TERMINAL DOMAIN; 3-DIMENSIONAL STRUCTURE; DIMERIZATION DOMAIN; CA PROTEIN; HIV-1 CORE; RESOLUTION; RECONSTRUCTIONS; ORGANIZATION; MODELS	For a retrovirus such as HIV to be infectious, a properly formed capsid is needed; however, unusually among viruses, retrovirus capsids are highly variable in structure. According to the fullerene conjecture, they are composed of hexamers and pentamers of capsid protein (CA), with the shape of a capsid varying according to how the twelve pentamers are distributed and its size depending on the number of hexamers. Hexamers have been studied in planar and tubular arrays, but the predicted pentamers have not been observed. Here we report cryo- electron microscopic analyses of two in- vitro- assembled capsids of Rous sarcoma virus. Both are icosahedrally symmetric: one is composed of 12 pentamers, and the other of 12 pentamers and 20 hexamers. Fitting of atomic models of the two CA domains into the reconstructions shows three distinct inter- subunit interactions. These observations substantiate the fullerene conjecture, show how pentamers are accommodated at vertices, support the inference that nucleation is a crucial morphologic determinant, and imply that electrostatic interactions govern the differential assembly of pentamers and hexamers.	[Cardone, Giovanni; Cheng, Naiqian; Steven, Alasdair C.] NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Purdy, John G.; Craven, Rebecca C.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Steven, AC (corresponding author), NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA.	rcc6@psu.edu; stevena@mail.nih.gov		Cardone, Giovanni/0000-0003-4712-1451; Purdy, John/0000-0001-7460-7567	Intramural Research Program of NIAMS; IATAP Program; NIH [CA100322]; Pennsylvania Department of Health; Penn State Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA100322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041166, ZIAAR027002] Funding Source: NIH RePORTER	Intramural Research Program of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); IATAP Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Penn State Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Flanagan for advice on protein purification and analytic methods and access to equipment, R. Meyers for assistance in electron microscopy at the Penn State College of Medicine and B. Heymann for advice on data analysis. This work was supported by the Intramural Research Program of NIAMS and the IATAP Program (A.C.S.), and funding from NIH grant CA100322, the Pennsylvania Department of Health and the Penn State Cancer Institute (R.C.C.).	Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Butan C, 2008, J MOL BIOL, V376, P1168, DOI 10.1016/j.jmb.2007.12.003; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cantele F, 2003, J STRUCT BIOL, V141, P84, DOI 10.1016/S1047-8477(02)00577-4; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; Cheng N, 2002, J VIROL, V76, P7855, DOI 10.1128/JVI.76.15.7855-7859.2002; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 2003, EMBO J, V22, P2886, DOI 10.1093/emboj/cdg276; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Heymann JB, 2008, COMPUT MATH METHOD M, V9, P197, DOI 10.1080/17486700802168106; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Kingston RL, 2001, J STRUCT BIOL, V136, P67, DOI 10.1006/jsbi.2001.4423; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Lokhandwala PM, 2008, VIROLOGY, V376, P191, DOI 10.1016/j.virol.2008.03.001; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mayo K, 2003, J MOL BIOL, V325, P225, DOI 10.1016/S0022-2836(02)01176-2; Mayo K, 2002, J MOL BIOL, V316, P667, DOI 10.1006/jmbi.2001.5354; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purdy JG, 2008, J VIROL, V82, P5951, DOI 10.1128/JVI.00214-08; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Vogt V. M., 1997, P27; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yeager M, 1998, P NATL ACAD SCI USA, V95, P7299, DOI 10.1073/pnas.95.13.7299	43	81	81	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					694	U3		10.1038/nature07724	http://dx.doi.org/10.1038/nature07724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19194444	Green Accepted			2022-12-01	WOS:000263064700034
J	Cummings, JH; Mann, JI; Nishida, C; Vorster, HH				Cummings, J. H.; Mann, J. I.; Nishida, C.; Vorster, H. H.			Dietary fibre: an agreed definition	LANCET			English	Editorial Material									[Cummings, J. H.] Univ Dundee, Ninewells Hosp, Dundee DD1 4HN, Scotland; [Mann, J. I.] Univ Otago, Edgar Natl Ctr Diabet Res, Dunedin, New Zealand; [Nishida, C.] WHO, Dept Nutr Hlth Dev, CH-1211 Geneva, Switzerland; [Vorster, H. H.] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa	University of Dundee; University of Otago; World Health Organization; North West University - South Africa	Cummings, JH (corresponding author), Univ Dundee, Ninewells Hosp, Dundee DD1 4HN, Scotland.	j.h.cummings@dundee.ac.uk	Cummings, John/AAC-2007-2019					Cummings JH, 2007, EUR J CLIN NUTR, V61, pS5, DOI 10.1038/sj.ejcn.1602936; *FOOD STAND AG, 2002, MCC WIDD COMP FOODS; IOM, 2005, DIET REF INT EN CARB; Mann J, 2007, EUR J CLIN NUTR, V61, pS132, DOI 10.1038/sj.ejcn.1602943; *UN FAO, 1998, 66 UN FAO	5	64	70	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2009	373	9661					365	366		10.1016/S0140-6736(09)60117-3	http://dx.doi.org/10.1016/S0140-6736(09)60117-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401BC	19186261				2022-12-01	WOS:000262912100010
J	Ohtsuki, H; Iwasa, Y; Nowak, MA				Ohtsuki, Hisashi; Iwasa, Yoh; Nowak, Martin A.			Indirect reciprocity provides only a narrow margin of efficiency for costly punishment	NATURE			English	Article							SOCIAL NORMS; ALTRUISTIC PUNISHMENT; COOPERATION; EVOLUTION; REPUTATION; HUMANS; RULES	Indirect reciprocity(1-5) is a key mechanism for the evolution of human cooperation. Our behaviour towards other people depends not only on what they have done to us but also on what they have done to others. Indirect reciprocity works through reputation(5-17). The standard model of indirect reciprocity offers a binary choice: people can either cooperate or defect. Cooperation implies a cost for the donor and a benefit for the recipient. Defection has no cost and yields no benefit. Currently there is considerable interest in studying the effect of costly (or altruistic) punishment on human behaviour(18-25). Punishment implies a cost for the punished person. Costly punishment means that the punisher also pays a cost. It has been suggested that costly punishment between individuals can promote cooperation. Here we study the role of costly punishment in an explicit model of indirect reciprocity. We analyse all social norms, which depend on the action of the donor and the reputation of the recipient. We allow errors in assigning reputation and study gossip as a mechanism for establishing coherence. We characterize all strategies that allow the evolutionary stability of cooperation. Some of those strategies use costly punishment; others do not. We find that punishment strategies typically reduce the average payoff of the population. Consequently, there is only a small parameter region where costly punishment leads to an efficient equilibrium. In most cases the population does better by not using costly punishment. The efficient strategy for indirect reciprocity is to withhold help for defectors rather than punishing them.	[Ohtsuki, Hisashi] Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo 1528552, Japan; [Ohtsuki, Hisashi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Iwasa, Yoh] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Dept Organism & Evolut Biol, Dept Math, Cambridge, MA 02138 USA	Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Kyushu University; Harvard University	Ohtsuki, H (corresponding author), Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo 1528552, Japan.	ohtsuki.h.aa@m.titech.ac.jp	Nowak, Martin A/A-6977-2008; Iwasa, Yoh/G-5368-2010	Iwasa, Yoh/0000-0003-0691-1852	John Templeton Foundation; Japan Society for the Promotion of Science; NSF/NIH joint program in mathematical biology; NIH [R01GM078986]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	John Templeton Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NSF/NIH joint program in mathematical biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support from the John Templeton Foundation, the Japan Society for the Promotion of Science, the NSF/NIH joint program in mathematical biology (NIH grant R01GM078986) and J. Epstein is gratefully acknowledged.	Alexander RD, 1987, BIOL MORAL SYSTEMS; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bolton GE, 2005, J PUBLIC ECON, V89, P1457, DOI 10.1016/j.jpubeco.2004.03.008; Brandt H, 2005, P NATL ACAD SCI USA, V102, P2666, DOI 10.1073/pnas.0407370102; Brandt H, 2004, J THEOR BIOL, V231, P475, DOI 10.1016/j.jtbi.2004.06.032; Chalub FACC, 2006, J THEOR BIOL, V241, P233, DOI 10.1016/j.jtbi.2005.11.028; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Colman A.M., 1995, GAME THEORY ITS APPL; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Dufwenberg M., 2001, HOMO OECON, V43, P19; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fishman MA, 2003, J THEOR BIOL, V225, P285, DOI 10.1016/S0022-5193(03)00246-7; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; KANDORI M, 1992, REV ECON STUD, V59, P63, DOI 10.2307/2297925; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; OKUNOFUJIWARA M, 1995, GAME ECON BEHAV, V9, P79, DOI 10.1006/game.1995.1006; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Rutte C, 2008, BEHAV ECOL SOCIOBIOL, V62, P499, DOI 10.1007/s00265-007-0474-3; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Sugden R., 1986, EC RIGHTS COOPERATIO; Suzuki S, 2005, P ROY SOC B-BIOL SCI, V272, P1373, DOI 10.1098/rspb.2005.3072; Takahashi N, 2006, J THEOR BIOL, V243, P418, DOI 10.1016/j.jtbi.2006.05.014; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; YAMAGISHI T, 1988, SOC PSYCHOL QUART, V51, P32, DOI 10.2307/2786982	30	225	230	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 1	2009	457	7225					79	82		10.1038/nature07601	http://dx.doi.org/10.1038/nature07601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122640	Green Accepted			2022-12-01	WOS:000262104900034
J	Smyth, DJ; Plagnol, V; Walker, NM; Cooper, JD; Downes, K; Yang, JHM; Howson, JMM; Stevens, H; McManus, R; Wijmenga, C; Heap, GA; Dubois, PC; Clayton, DG; Hunt, KA; van Heel, DA; Todd, JA				Smyth, Deborah J.; Plagnol, Vincent; Walker, Neil M.; Cooper, Jason D.; Downes, Kate; Yang, Jennie H. M.; Howson, Joanna M. M.; Stevens, Helen; McManus, Ross; Wijmenga, Cisca; Heap, Graham A.; Dubois, Patrick C.; Clayton, David G.; Hunt, Karen A.; van Heel, David A.; Todd, John A.			Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTESTINAL MICROBIOTA; RISK VARIANTS; CHEMOKINE; SUSCEPTIBILITY; ASSOCIATION; POLYMORPHISMS; PREVALENCE; MULTIPLE; CHILDREN; LOCUS	Background: Two inflammatory disorders, type 1 diabetes and celiac disease, cosegregate in populations, suggesting a common genetic origin. Since both diseases are associated with the HLA class II genes on chromosome 6p21, we tested whether non-HLA loci are shared. Methods: We evaluated the association between type 1 diabetes and eight loci related to the risk of celiac disease by genotyping and statistical analyses of DNA samples from 8064 patients with type 1 diabetes, 9339 control subjects, and 2828 families providing 3064 parent-child trios (consisting of an affected child and both biologic parents). We also investigated 18 loci associated with type 1 diabetes in 2560 patients with celiac disease and 9339 control subjects. Results: Three celiac disease loci - RGS1 on chromosome 1q31, IL18RAP on chromosome 2q12, and TAGAP on chromosome 6q25 - were associated with type 1 diabetes (P<1.00 x 10(-4)). The 32-bp insertion-deletion variant on chromosome 3p21 was newly identified as a type 1 diabetes locus (P=1.81 x 10(-8)) and was also associated with celiac disease, along with PTPN2 on chromosome 18p11 and CTLA4 on chromosome 2q33, bringing the total number of loci with evidence of a shared association to seven, including SH2B3 on chromosome 12q24. The effects of the IL18RAP and TAGAP alleles confer protection in type 1 diabetes and susceptibility in celiac disease. Loci with distinct effects in the two diseases included INS on chromosome 11p15, IL2RA on chromosome 10p15, and PTPN22 on chromosome 1p13 in type 1 diabetes and IL12A on 3q25 and LPP on 3q28 in celiac disease. Conclusions: A genetic susceptibility to both type 1 diabetes and celiac disease shares common alleles. These data suggest that common biologic mechanisms, such as autoimmunity-related tissue damage and intolerance to dietary antigens, may be etiologic features of both diseases.	[Smyth, Deborah J.; Plagnol, Vincent; Walker, Neil M.; Cooper, Jason D.; Downes, Kate; Yang, Jennie H. M.; Howson, Joanna M. M.; Stevens, Helen; Clayton, David G.; Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res,Dept Med Genet, Juvenile Diabet Res Fdn Wellcome Trust Diabet & I, Cambridge CB2 0XY, England; [McManus, Ross] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Heap, Graham A.; Dubois, Patrick C.; Hunt, Karen A.; van Heel, David A.] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Trinity College Dublin; University of Groningen; University of Groningen; University of London; Queen Mary University London	Todd, JA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res,Dept Med Genet, Juvenile Diabet Res Fdn Wellcome Trust Diabet & I, Cambridge CB2 0XY, England.	john.todd@cimr.cam.ac.uk	Plagnol, Vincent/A-5667-2011; Wijmenga, Cisca/AAE-7719-2019; Todd, John A/A-3542-2010; Wijmenga, Cisca/D-2173-2009; McManus, Ross/AAE-9236-2020	Wijmenga, Cisca/0000-0002-5635-1614; Todd, John A/0000-0003-2740-8148; Walker, Neil/0000-0001-9796-7688; Howson, Joanna/0000-0001-7618-0050; smyth, deborah/0000-0002-6330-2669; van Heel, David/0000-0002-0637-2265; Plagnol, Vincent/0000-0002-5597-9215; Heap, Graham/0000-0003-4131-6792; McManus, Ross/0000-0002-0529-9617	Juvenile Diabetes Research Foundation International; Wellcome Trust; National Institute for Health Research's Cambridge Biomedical Research Centre; Celiac UK; Celiac Disease Consortium; European Union; Netherlands Organization for Scientific Research; Science Foundation Ireland; Irish Health Research Board; Hitachi Europe; NexPep; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0700545, G0000934] Funding Source: researchfish; MRC [G0700545, G0000934] Funding Source: UKRI	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research's Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Celiac UK; Celiac Disease Consortium; European Union(European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Health Research Board; Hitachi Europe; NexPep; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by Juvenile Diabetes Research Foundation International, the Wellcome Trust, the National Institute for Health Research's Cambridge Biomedical Research Centre, Celiac UK, the Celiac Disease Consortium (an innovative cluster approved by the Netherlands Genomics Initiative and partly funded by the Dutch Government), the European Union, the Netherlands Organization for Scientific Research, the Science Foundation Ireland, and the Irish Health Research Board.; Dr. McManus reports receiving grant support from Hitachi Europe; and Dr. van Heel, having an equity interest in and receiving consulting fees from NexPep. No other potential conflict of interest relevant to this article was reported.; We thank all the patients and control subjects for their participation in the study; the Avon Longitudinal Study of Parents and Children Laboratory in Bristol and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan, and P. Burton for preparing and providing the control DNA samples; the Human Biological Data Interchange and Diabetes UK for data on multiplex families; the Norwegian Study Group for Childhood Diabetes for the collection of the Norwegian families, especially D. Undlien and K. Ronningen; D. Savage, C. Patterson, D. Carson, and P. Maxwell for the Northern Irish samples; J. Tuomilehto, L. Kinnunen, E. TuomilehtoWolf, V. Harjutsalo, and T. Valle of Genetics of Type 1 Diabetes in Finland for the Finnish family samples; C. Guja and C. IonescuTirgoviste for the Romanian family samples; the Irish Blood Transfusion Service - Trinity College Dublin Biobank for DNA from Irish control subjects; the Barts and the London Genome Centre for genotyping support; J. Swift, R. Crimmins, P. Kumar, D. P. Jewell, L. Dinesen, S. P. L. Travis, K. Moriarty, P. Howdle, D. S. Sanders, G. K. T. Holmes, S. Sleet, and Celiac UK for the collection of British celiac samples; A. Monsuur, C. J. Mulder, M. L. Mearin, and W. H. M. Verbeek, for the recruitment of patients; G. Meijer and J. Meijer for their review of histologic analyses; K. Duran for DNA extraction; H. van Someren and F. Mulder for clinical database management; L. Franke, A. Zhernakova, M. Plateel, and the genotyping facilities at University Medical Center Groningen and University Medical Center Utrecht in the Netherlands for their technical assistance; F. M. Stevens, C. O'Morain, N. P. Kennedy, M. Abuzakouk, R. McLoughlin, K. Brophy, C. Feighery, J. McPartlin, D. Kelleher, A. W. Ryan, and G. Turner for sample collection and genotyping; and L. Wicker for comments on the manuscript.	Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Barrett R, 2008, J MOTOR BEHAV, V40, P62, DOI 10.3200/JMBR.40.1.62-70; Buhler MM, 2002, AUTOIMMUNITY, V35, P457, DOI 10.1080/0891693021000041088; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; COOPER JD, 2008, NAT GENET       1102; Frisk G, 2008, MED HYPOTHESES, V70, P1207, DOI 10.1016/j.mehy.2007.05.058; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; HAFLER JP, 2008, GENES IMMUN     1030; Hanifi-Moghaddam P, 2006, DIABETIC MED, V23, P156, DOI 10.1111/j.1464-5491.2005.01743.x; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Kalev I, 2003, J DIABETES COMPLICAT, V17, P387, DOI 10.1016/S1056-8727(02)00242-8; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Lohi S, 2007, ALIMENT PHARM THERAP, V26, P1217, DOI 10.1111/j.1365-2036.2007.03502.x; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; Meagher C, 2007, DIABETES, V56, P809, DOI 10.2337/db06-0619; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Prahalad S, 2006, GENES IMMUN, V7, P264, DOI 10.1038/sj.gene.6364298; Rioux JD, 2004, AM J MED GENET A, V130A, P345, DOI 10.1002/ajmg.a.30072; Santin I, 2008, TISSUE ANTIGENS, V71, P247, DOI 10.1111/j.1399-0039.2007.01002.x; Szalai C, 1999, PEDIATR RES, V46, P82, DOI 10.1203/00006450-199907000-00014; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weber F, 2008, GENES IMMUN, V9, P259, DOI 10.1038/gene.2008.14; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang B, 2004, CYTOKINE, V26, P114, DOI 10.1016/j.cyto.2004.01.005	35	519	534	3	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2767	2777		10.1056/NEJMoa0807917	http://dx.doi.org/10.1056/NEJMoa0807917			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19073967	Green Accepted			2022-12-01	WOS:000261950800004
J	Colmone, A; Amorim, M; Pontier, AL; Wang, S; Jablonski, E; Sipkins, DA				Colmone, Angela; Amorim, Maria; Pontier, Andrea L.; Wang, Sheng; Jablonski, Elizabeth; Sipkins, Dorothy A.			Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells	SCIENCE			English	Article							STEM-CELLS; C-KIT; MOBILIZATION; ENGRAFTMENT; DIFFERENTIATION; REPOPULATION; EXPRESSION; REGULATOR; DISEASE; CXCR4	The host tissue microenvironment influences malignant cell proliferation and metastasis, but little is known about how tumor- induced changes in the microenvironment affect benign cellular ecosystems. Applying dynamic in vivo imaging to a mouse model, we show that leukemic cell growth disrupts normal hematopoietic progenitor cell ( HPC) bone marrow niches and creates abnormal microenvironments that sequester transplanted human CD34(+) (HPC- enriched) cells. CD34(+) cells in leukemic mice declined in number over time and failed to mobilize into the peripheral circulation in response to cytokine stimulation. Neutralization of stem cell factor ( SCF) secreted by leukemic cells inhibited CD34(+) cell migration into malignant niches, normalized CD34(+) cell numbers, and restored CD34(+) cell mobilization in leukemic mice. These data suggest that the tumor microenvironment causes HPC dysfunction by usurping normal HPC niches and that therapeutic inhibition of HPC interaction with tumor niches may help maintain normal progenitor cell function in the setting of malignancy.	[Colmone, Angela; Amorim, Maria; Pontier, Andrea L.; Wang, Sheng; Jablonski, Elizabeth; Sipkins, Dorothy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Sipkins, DA (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave,MC 2115, Chicago, IL 60637 USA.	dsipkins@medicine.bsd.uchicago.edu	wang, sheng/B-1969-2010; Colmone, Angela/GXA-0568-2022; de Amorim, Maria Galli/K-8259-2016	de Amorim, Maria Galli/0000-0002-1910-8770	Illinois Regenerative Medicine Institute; NIH K08 award [5K08CA112126-02]; NIH Director's DP2 award [1DP2OD002160-01]; NATIONAL CANCER INSTITUTE [K08CA112126] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002160] Funding Source: NIH RePORTER	Illinois Regenerative Medicine Institute; NIH K08 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's DP2 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Chenn, K. Cohen, L. Godley, and R. Salgia for critical discussions and reading of the manuscript; A. Chenn for assistance with retroviral cell transduction; A. Wickrema for help with CD34+ purification; V. Bindokas for imaging expertise; and S. Gurbuxani for assistance with histopathology interpretation. Supported by a grant from the Illinois Regenerative Medicine Institute ( IRMI), an NIH ( National Cancer Institute) K08 award (5K08CA112126-02), and an NIH Director's DP2 award ( 1DP2OD002160-01). A patent application related to this work has been filed by the University of Chicago.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Bellone G, 2006, INT J ONCOL, V29, P851; BENSINGER W, 1995, J CLIN ONCOL, V13, P2547, DOI 10.1200/JCO.1995.13.10.2547; Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Calandra G, 2008, BONE MARROW TRANSPL, V41, P331, DOI 10.1038/sj.bmt.1705908; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Driessen RL, 2003, EXP HEMATOL, V31, P1284, DOI 10.1016/j.exphem.2003.08.015; Giehl A, 2007, J CUTAN PATHOL, V34, P7, DOI 10.1111/j.1600-0560.2006.00569.x; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Naveiras O, 2006, CELL MOL LIFE SCI, V63, P760, DOI 10.1007/s00018-005-5469-5; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Okumura N, 1996, BLOOD, V87, P4100, DOI 10.1182/blood.V87.10.4100.bloodjournal87104100; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Sharma S, 2006, STEM CELLS DEV, V15, P755, DOI 10.1089/scd.2006.15.755; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Tao M, 2000, CYTOKINE, V12, P699, DOI 10.1006/cyto.2000.0666; Theou-Anton N, 2006, BRIT J CANCER, V94, P1180, DOI 10.1038/sj.bjc.6603063; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zheng R, 2004, LEUKEMIA RES, V28, P121, DOI 10.1016/S0145-2126(03)00184-X	26	446	473	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1861	1865		10.1126/science.1164390	http://dx.doi.org/10.1126/science.1164390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095944				2022-12-01	WOS:000261799400060
J	Karkazis, K; Feder, EK				Karkazis, Katrina; Feder, Ellen K.			Naming the problem: disorders and their meanings	LANCET			English	Editorial Material									[Karkazis, Katrina] Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA; [Feder, Ellen K.] American Univ, Dept Philosophy & Relig, Washington, DC 20016 USA	Stanford University; American University	Karkazis, K (corresponding author), Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA.	karkazis@stanford.edu	Karkazis, Katrina/AAE-7276-2019	Karkazis, Katrina/0000-0001-9103-2881; Feder, Ellen K./0000-0002-8014-2804				Aronowitz Robert, 1998, MAKING SENSE ILLNESS; Frank AW., 2013, WOUNDED STORYTELLER; Karkazis K., 2008, FIXING SEX INTERSEX; Kleinman A., 1988, ILLNESS NARRATIVES S; Rosenberg Charles, 1992, FRAMING DIS STUDIES; Sontag, 1978, ILLNESS METAPHOR, P64	6	16	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2016	2017		10.1016/S0140-6736(08)61858-9	http://dx.doi.org/10.1016/S0140-6736(08)61858-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19090028				2022-12-01	WOS:000261746900012
J	Klareskog, L; Catrina, AI; Paget, S				Klareskog, Lars; Catrina, Anca Irinel; Paget, Stephen			Rheumatoid arthritis	LANCET			English	Review							CYCLIC CITRULLINATED PEPTIDE; ANTITUMOR NECROSIS FACTOR; COLLEGE-OF-RHEUMATOLOGY; HLA-DRB1 SHARED EPITOPE; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; CIGARETTE-SMOKING; RISK-FACTORS; RADIOLOGICAL PROGRESSION; CARDIOVASCULAR-DISEASE	Rheumatoid arthritis is a systemic, inflammatory, autoimmune disorder. Enhanced understanding of molecular pathogenesis has enabled development of innovative biological agents that target specific parts of the immune system. These treatments have changed the course and face of rheumatoid arthritis and outcomes for patients and society New knowledge has emerged of how environmental factors interact with susceptibility genes and the immune system in the pathogenesis of a major subset of rheumatoid arthritis. Research undertaken on the longitudinal disease process and molecular pathology of joint inflammation has led to new therapeutic strategies that promote early use of disease-modifying drugs with tight disease control and distinct and quantifiable treatment goals. Today, such approaches can halt most cases of joint destruction but not all instances of joint inflammation and comorbidity Understanding the cause and pathogenesis of different rheumatoid arthritis subsets will lead not only to individualised treatments during early phases of the illness but also, possibly, to disease prevention.	[Paget, Stephen] Hosp Special Surg, Div Rheumatol, New York, NY 10021 USA; [Klareskog, Lars; Catrina, Anca Irinel] Karolinska Inst, Rheumatol Unit, Dept Med, Stockholm, Sweden; [Klareskog, Lars; Catrina, Anca Irinel] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Paget, S (corresponding author), Hosp Special Surg, Div Rheumatol, 535 E 70th St, New York, NY 10021 USA.	pagets@hss.edu		Klareskog, Lars/0000-0001-9601-6186	EU FP6 programme Autocure; Rheuminations; James and Linda Gosden Robinson Foundation	EU FP6 programme Autocure(European Commission); Rheuminations; James and Linda Gosden Robinson Foundation	For work that led to this Seminar, we acknowledge funding from the EU FP6 programme Autocure (to LK) and from Rheuminations and the James and Linda Gosden Robinson Foundation (to SP). We thank our colleagues for discussions and advice that led to the ideas described in this Seminar.	AHO K, 1993, ANN RHEUM DIS, V52, P897, DOI 10.1136/ard.52.12.897-b; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Askling J, 2005, ANN RHEUM DIS, V64, P1421, DOI 10.1136/ard.2004.033993; Askling J, 2008, CURR OPIN RHEUMATOL, V20, P334, DOI 10.1097/BOR.0b013e3282f7c706; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Bongartz T, 2007, RHEUMATOLOGY, V46, P70, DOI 10.1093/rheumatology/kel202; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Boonen A, 2005, RHEUM DIS CLIN N AM, V31, P681, DOI 10.1016/j.rdc.2005.07.004; BRENNAN FM, 1989, LANCET, V2, P244; BRENNAN FM, 1989, J AUTOIMMUN, V2, P177, DOI 10.1016/0896-8411(89)90129-7; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Bukhari M, 2002, ARTHRITIS RHEUM-US, V46, P906, DOI 10.1002/art.10167; Burger D, 2006, BEST PRACT RES CL RH, V20, P879, DOI 10.1016/j.berh.2006.06.004; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CAPLAN A, 1959, P ROY SOC MED, V52, P1111, DOI 10.1177/003591575905201225; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; Combe B, 2007, BEST PRACT RES CL RH, V21, P27, DOI 10.1016/j.berh.2006.08.011; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; DING B, ARTHRITIS R IN PRESS; Dougados M, 2005, J RHEUMATOL, V32, P1; Edwards JCW, 1999, IMMUNOLOGY, V97, P188; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Ek M, 2001, NATURE, V410, P430, DOI 10.1038/35068632; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; Erickson Alan R, 2007, Curr Rheumatol Rep, V9, P416, DOI 10.1007/s11926-007-0066-2; Farragher TM, 2008, ARTHRITIS RHEUM-US, V58, P359, DOI 10.1002/art.23149; Feitsma AL, 2007, P NATL ACAD SCI USA, V104, P19966, DOI 10.1073/pnas.0710260104; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Freeston JE, 2007, ANN RHEUM DIS, V66, P1538, DOI 10.1136/ard.2007.074708; Furst DE, 2007, ANN RHEUM DIS, V66, P2, DOI 10.1136/ard.2007.081430; Genovese MC, 2008, ANN RHEUM DIS, V67, P547, DOI 10.1136/ard.2007.074773; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Horwood NJ, 1999, BIOCHEM BIOPH RES CO, V265, P144, DOI 10.1006/bbrc.1999.1623; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Jacobsson LTH, 2003, BRIT MED J, V326, P1068, DOI 10.1136/bmj.326.7398.1068; Jarrett SJ, 2006, ARTHRITIS RHEUM-US, V54, P1410, DOI 10.1002/art.21824; Jonsson IM, 2007, P NATL ACAD SCI USA, V104, P258, DOI 10.1073/pnas.0608620104; Kallberg H, 2009, ANN RHEUM DIS, V68, P222, DOI 10.1136/ard.2007.086314; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Karlson EW, 1999, ARTHRITIS RHEUM-US, V42, P910, DOI 10.1002/1529-0131(199905)42:5<910::AID-ANR9>3.3.CO;2-4; Karlson EW, 2004, ARTHRITIS RHEUM-US, V50, P3458, DOI 10.1002/art.20621; Keystone E, 2007, ARTHRITIS RHEUM-US, V56, P3896, DOI 10.1002/art.23059; KLARESKOG L, 1982, P NATL ACAD SCI-BIOL, V79, P3632, DOI 10.1073/pnas.79.11.3632; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; KLOCKARS M, 1987, BMJ-BRIT MED J, V294, P997, DOI 10.1136/bmj.294.6578.997; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Kremer JM, 2008, CURR OPIN RHEUMATOL, V20, P123, DOI 10.1097/BOR.0b013e3282f50eb1; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Laiho K, 1999, CLIN RHEUMATOL, V18, P122, DOI 10.1007/s100670050068; Landewe RBM, 2002, ARTHRITIS RHEUM-US, V46, P347, DOI 10.1002/art.10083; Landewe R, 2006, ARTHRITIS RHEUM-US, V54, P3119, DOI 10.1002/art.22143; Lange F, 2005, ANN RHEUM DIS, V64, P599, DOI 10.1136/ard.2004.026120; Lee AT, 2005, GENES IMMUN, V6, P129, DOI 10.1038/sj.gene.6364159; Lee HS, 2008, MOL MED, V14, P293, DOI 10.2119/2007-00123.Lee; Lee HS, 2007, ARTHRITIS RHEUM-US, V56, P1745, DOI 10.1002/art.22703; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Lofdahl JM, 2006, CLIN EXP IMMUNOL, V145, P428, DOI 10.1111/j.1365-2249.2006.03154.x; Lorentzen JC, 2007, ARTHRITIS RHEUM-US, V56, P2620, DOI 10.1002/art.22813; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Makrygiannakis D, 2008, ANN RHEUM DIS, V67, P1488, DOI 10.1136/ard.2007.075192; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Michaud K, 2007, BEST PRACT RES CL RH, V21, P885, DOI 10.1016/j.berh.2007.06.002; Montesinos MC, 2007, ARTHRITIS RHEUM-US, V56, P1440, DOI 10.1002/art.22643; Moreland LW, 2006, ARTHRIT RHEUM-ARTHR, V55, P287, DOI 10.1002/art.21838; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; *NAT I HLTH CLIN E, 2008, AB TREATM RHEUM ARTH, V141; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; Oliver JE, 2006, SCAND J RHEUMATOL, V35, P169, DOI 10.1080/03009740600718080; Olsson AR, 2004, OCCUP ENVIRON MED, V61, P233, DOI 10.1136/oem.2003.007971; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Pedersen M, 2007, ARTHRITIS RHEUM-US, V56, P1446, DOI 10.1002/art.22597; Pedersen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2022; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; PINCUS T, 1986, J RHEUMATOL, V13, P841; Plant MJ, 1998, J RHEUMATOL, V25, P417; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rengel Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2304; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Roman MJ, 2005, HYPERTENSION, V46, P194, DOI 10.1161/01.HYP.0000168055.89955.db; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schepp PP, 2007, ADV ENG MATER, V9, P1; Sigurdsson S, 2007, ARTHRITIS RHEUM-US, V56, P2202, DOI 10.1002/art.22704; Silman AJ, 1996, ARTHRITIS RHEUM, V39, P732, DOI 10.1002/art.1780390504; Smolen JS, 2007, ANN RHEUM DIS, V66, P143, DOI 10.1136/ard.2006.061002; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; SPITZ P W, 1987, Clinical Rheumatology, V6, P105, DOI 10.1007/BF02203393; STASTNY P, 1976, J CLIN INVEST, V57, P1148, DOI 10.1172/JCI108382; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Svensson B, 2005, ARTHRITIS RHEUM-US, V52, P3360, DOI 10.1002/art.21298; Sverdrup B, 2005, ARTHRITIS RES THER, V7, pR1296, DOI 10.1186/ar1824; Symmons DPM, 1997, ARTHRITIS RHEUM, V40, P1955, DOI 10.1002/art.1780401106; Szkudlarek M, 2004, ARTHRITIS RHEUM-US, V50, P2103, DOI 10.1002/art.20333; Teng YKO, 2007, ARTHRITIS RHEUM-US, V56, P3909, DOI 10.1002/art.22967; Ulfgren AK, 2000, ANN RHEUM DIS, V59, P439, DOI 10.1136/ard.59.6.439; van der Helm-van Mil AHM, 2005, ARTHRITIS RHEUM-US, V52, P2637, DOI 10.1002/art.21272; van der Helm-van Mil AHM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2384; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; VANBOXEL JA, 1975, NEW ENGL J MED, V293, P517, DOI 10.1056/NEJM197509112931101; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Verpoort KN, 2005, ARTHRITIS RHEUM, V52, P3058, DOI 10.1002/art.21302; VESSEY MP, 1987, CONTRACEPTION, V35, P457, DOI 10.1016/0010-7824(87)90082-5; Vossenaar ER, 2004, ARTHRITIS RHEUM-US, V50, P3485, DOI 10.1002/art.20584; Wallberg-Jonsson S, 1999, J RHEUMATOL, V26, P2562; Watts RA, 2004, RHEUMATOLOGY, V43, P920, DOI 10.1093/rheumatology/keh210; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wessels JAM, 2008, RHEUMATOLOGY, V47, P249, DOI 10.1093/rheumatology/kem279; Wijbrandts CA, 2008, ANN RHEUM DIS, V67, P1139, DOI 10.1136/ard.2007.080440; Zendman AJW, 2006, RHEUMATOLOGY, V45, P20, DOI 10.1093/rheumatology/kei111; Zhang HG, 2002, J IMMUNOL, V168, P4164, DOI 10.4049/jimmunol.168.8.4164	135	655	711	1	132	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2009	373	9664					659	672		10.1016/S0140-6736(09)60008-8	http://dx.doi.org/10.1016/S0140-6736(09)60008-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19157532				2022-12-01	WOS:000263563500031
J	Hill, AVS; Shirley, M; Greenwood, BM				Hill, Adrian V. S.; Shirley, Martin; Greenwood, Brian M.			Jenner reborn: a new vaccine institute	LANCET			English	Editorial Material									[Hill, Adrian V. S.] Univ Oxford, Jenner Inst Labs, Oxford OX3 78DQ, England; [Shirley, Martin] Inst Food Res, Inst Anim Hlth, Compton Lab, Newbury RG16 0NN, Berks, England; [Greenwood, Brian M.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Quadram Institute; University of London; London School of Hygiene & Tropical Medicine	Hill, AVS (corresponding author), Univ Oxford, Jenner Inst Labs, Oxford OX3 78DQ, England.	adrian.hill@ndm.ox.ac.uk			Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Brookes RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002921; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Fowler VL, 2008, VACCINE, V26, P1982, DOI 10.1016/j.vaccine.2008.02.012; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Nossal GJV, 2004, NAT IMMUNOL, V5, P457, DOI 10.1038/ni0504-457; POLLARD AJ, NAT REV IMM IN PRESS; Snape MD, 2008, JAMA-J AM MED ASSOC, V299, P173, DOI 10.1001/jama.2007.29-c; WILKINSON E, 2008, BBC NEWS        0905	11	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 7	2009	373	9662					445	446		10.1016/S0140-6736(09)60150-1	http://dx.doi.org/10.1016/S0140-6736(09)60150-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19200904				2022-12-01	WOS:000263132800010
J	Hishida, T; Kubota, Y; Carr, AM; Iwasaki, H				Hishida, Takashi; Kubota, Yoshino; Carr, Antony M.; Iwasaki, Hiroshi			RAD6-RAD18-RAD5-pathway-dependent tolerance to chronic low-dose ultraviolet light	NATURE			English	Article							DNA-DAMAGE TOLERANCE; NUCLEOTIDE EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; BUDDING YEAST; REPLICATION; CHECKPOINT; PROTEIN; MECHANISMS; UBIQUITIN	In nature, organisms are exposed to chronic low- dose ultraviolet light ( CLUV) as opposed to the acute high doses common to laboratory experiments. Analysis of the cellular response to acute high-dose exposure has delineated the importance of direct DNA repair by the nucleotide excision repair pathway(1) and for checkpoint-induced cell cycle arrest in promoting cell survival(2). Here we examine the response of yeast cells to CLUV and identify a key role for the RAD6-RAD18-RAD5 error- free postreplication repair (RAD6 error-free PRR) pathway(3,4) in promoting cell growth and survival. We show that loss of the RAD6 error- free PRR pathway results in DNA-damage-checkpoint- induced G2 arrest in CLUV-exposed cells, whereas wild-type and nucleotide-excision-repair-deficient cells are largely unaffected. Cell cycle arrest in the absence of the RAD6 error- free PRR pathway was not caused by a repair defect or by the accumulation of ultraviolet-induced photoproducts. Notably, we observed increased replication protein A (RPA) and Rad52 - yellow fluorescent protein foci(5) in the CLUV- exposed rad18 Delta cells and demonstrated that Rad52- mediated homologous recombination is required for the viability of the rad18 Delta cells after release from CLUV- induced G2 arrest. These and other data presented suggest that, in response to environmental levels of ultraviolet exposure, the RAD6 error- free PRR pathway promotes replication of damaged templates without the generation of extensive single- stranded DNA regions. Thus, the error- free PRR pathway is specifically important during chronic low- dose ultraviolet exposure to prevent counter- productive DNA checkpoint activation and allow cells to proliferate normally.	[Hishida, Takashi; Kubota, Yoshino] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Carr, Antony M.] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Iwasaki, Hiroshi] Yokohama City Univ, Int Grad Sch Arts & Sci, Kanagawa 2300045, Japan	Osaka University; University of Sussex; Yokohama City University	Hishida, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hishida@biken.osaka-u.ac.jp	Iwasaki, Hiroshi/Y-7946-2018	Iwasaki, Hiroshi/0000-0002-0153-6873; Carr, Antony Michael/0000-0002-2028-2389; Hishida, Takashi/0000-0002-9752-6599	Sumitomo foundation; Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; MRC (UK) [G0600233]; MRC [G0600233] Funding Source: UKRI; Medical Research Council [G0600233, G0300662B] Funding Source: researchfish	Sumitomo foundation; Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Rothstein and H. Araki for strains; T. Matsunaga for anti- thymine dimer monoclonal antibody (designated TDM2 antibody); and T. Ohya for technical assistance. This work was supported by the Sumitomo foundation, by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the MRC (UK) grant G0600233.	Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Callegari AJ, 2006, P NATL ACAD SCI USA, V103, P15877, DOI 10.1073/pnas.0607343103; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Gangavarapu V, 2007, MOL CELL BIOL, V27, P7758, DOI 10.1128/MCB.01331-07; Giavara S, 2005, CURR BIOL, V15, P68, DOI 10.1016/j.cub.2004.12.065; HARM W, 1969, RADIAT RES, V40, P63, DOI 10.2307/3572983; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hishida T, 2002, EMBO J, V21, P2019, DOI 10.1093/emboj/21.8.2019; Hishida T, 2006, MOL CELL BIOL, V26, P5509, DOI 10.1128/MCB.00307-06; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Paciotti V, 2000, GENE DEV, V14, P2046; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Schepers A, 2001, J MOL BIOL, V308, P597, DOI 10.1006/jmbi.2001.4637; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	34	64	66	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					612	U124		10.1038/nature07580	http://dx.doi.org/10.1038/nature07580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19079240				2022-12-01	WOS:000262852200048
J	Sridharan, R; Tchieu, J; Mason, MJ; Yachechko, R; Kuoy, E; Horvath, S; Zhou, Q; Plath, K				Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Horvath, Steve; Zhou, Qing; Plath, Kathrin			Role of the Murine Reprogramming Factors in the Induction of Pluripotency	CELL			English	Article							STEM-CELLS; TRANSCRIPTIONAL NETWORK; MOUSE; FIBROBLASTS; MYC; GENERATION; EXPRESSION; CIRCUITRY	Induced pluripotent stem (iPS) cells can be obtained from fibroblasts upon expression of Oct4, Sox2, Klf4, and c-Myc. To understand how these factors induce pluripotency, we carried out genome-wide analyses of their promoter binding and expression in iPS and partially reprogrammed cells. We find that target genes of the four factors strongly overlap in iPS and embryonic stem (ES) cells. In partially reprogrammed cells, many genes co-occupied by c-Myc and any of the other three factors already show an ES cell-like binding and expression pattern. In contrast, genes that are specifically co-bound by Oct4, Sox2, and Klf4 in ES cells and encode pluripotency regulators severely lack binding and transcriptional activation. Among the four factors, c-Myc promotes the most ES cell-like transcription pattern when expressed individually in fibroblasts. These data uncover temporal and separable contributions of the four factors during the reprogramming process and indicate that ectopic c-Myc predominantly acts before pluripotency regulators are activated.	[Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Horvath, Steve; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Plath, Kathrin] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Tchieu, Jason; Plath, Kathrin] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Plath, Kathrin] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Mason, Mike J.; Zhou, Qing] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu	Tchieu, Jason/AAG-1551-2020	Tchieu, Jason/0000-0002-9793-9836; Kuoy, Edward/0000-0003-4721-1254; Plath, Kathrin/0000-0001-7796-3372; Mason, Michael/0000-0002-5652-7739	California Institute of Regenerative Medicine (CIRM); NSF [DMS-0805491]; Kimmel Scholar Foundations; NIH Director's Young Innovator Award; CIRM Young Investigator Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); Kimmel Scholar Foundations; NIH Director's Young Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM Young Investigator Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Stephen Smale, Siavash Kurdistani, Bernadett Papp, Lars Dreier, Mark Chin, Bill Lowry, and Konrad Hochedlinger for critical reading of the manuscript. R. S. is supported by a training grant from the California Institute of Regenerative Medicine (CIRM), Q. Z. by a NSF grant (DMS-0805491), and K. P. by the V and Kimmel Scholar Foundations, the NIH Director's Young Innovator Award, and a CIRM Young Investigator Award.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	27	501	531	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					364	377		10.1016/j.cell.2009.01.001	http://dx.doi.org/10.1016/j.cell.2009.01.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167336	Green Accepted, Bronze			2022-12-01	WOS:000262648800023
J	Grewal, J; McCully, RB; Kane, GC; Lam, C; Pellikka, PA				Grewal, Jasmine; McCully, Robert B.; Kane, Garvan C.; Lam, Carolyn; Pellikka, Patricia A.			Left Ventricular Function and Exercise Capacity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIASTOLIC DYSFUNCTION; CARDIAC-FUNCTION; HEART-FAILURE; AGE; MEN; ECHOCARDIOGRAPHY; PERFORMANCE; TOLERANCE; GENDER; WOMEN	Context Limited information exists regarding the role of left ventricular function in predicting exercise capacity and impact on age- and sex- related differences. Objectives To determine the impact of measures of cardiac function assessed by echocardiography on exercise capacity and to determine if these associations are modified by sex or advancing age. Design Cross- sectional study of patients undergoing exercise echocardiography with routine measurements of left ventricular systolic and diastolic function by 2- dimensional and Doppler techniques. Analyses were conducted to determine the strongest correlates of exercise capacity and the age and sex interactions of these variables with exercise capacity. Setting Large tertiary referral center in Rochester, Minnesota, in 2006. Participants Patients undergoing exercise echocardiography using the Bruce protocol ( N= 2867). Patients with echocardiographic evidence of exercise- induced ischemia, ejection fractions lower than 50%, or significant valvular heart disease were excluded. Main Outcome Measure Exercise capacity in metabolic equivalents ( METs). Results Diastolic dysfunction was strongly and inversely associated with exercise capacity. Compared with normal function, after multivariate adjustment, those with moderate/ severe resting diastolic dysfunction (- 1.30 METs; 95% confidence interval [ CI], - 1.52 to - 0.99; P <. 001) and mild resting diastolic dysfunction (- 0.70 METs; 95% CI, - 0.88 to - 0.46; P <. 001) had substantially lower exercise capacity. Variation of left ventricular systolic function within the normal range was not associated with exercise capacity. Left ventricular filling pressures measured by resting E/ e' of 15 or greater (- 0.41 METs; 95% CI, - 0.70 to - 0.11; P=. 007) or postexercise E/ e' of 15 or greater (- 0.41 METs; 95% CI, - 0.71 to - 0.11; P=. 007) were similarly associated with a reduction in exercise capacity, each in separate multivariate analyses. Individuals with impaired relaxation ( mild dysfunction) or resting E/e' of 15 or greater had a progressive increase in the magnitude of reduction in exercise capacity with advancing age ( P <. 001 and P=. 02, respectively). Other independent correlates of exercise capacity were age ( unstandardized beta coefficient, - 0.85 METs; 95% CI, - 0.92 to - 0.77, per 10- year increment; P <. 001), female sex (- 1.98 METs; 95% CI, - 2.15 to - 1.84; P <. 001), and body mass index greater than 30 (- 1.24 METs; 95% CI, - 1.41 to - 1.10; P <. 001). Conclusion In this large cross- sectional study of those referred for exercise echocardiography and not limited by ischemia, abnormalities of left ventricular diastolic function were independently associated with exercise capacity.	[Grewal, Jasmine; McCully, Robert B.; Kane, Garvan C.; Lam, Carolyn; Pellikka, Patricia A.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Pellikka, PA (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	pellikka.patricia@mayo.edu	Pellikka, Patricia A/N-5387-2014; Lam, Carolyn SP/ABD-6810-2021	Pellikka, Patricia A/0000-0001-6800-3521; Lam, Carolyn SP/0000-0003-1903-0018	National Center for Research Resources [1 UL1 RR024150]; National Institutes of Health; NIH Roadmap for Medical Research; Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by grant No. 1 UL1 RR024150 (for biostatistical analysis) from the National Center for Research Resources, a component of the National Institutes of Health (NIH); the NIH Roadmap for Medical Research; and the Mayo Foundation (data management).	BRANDAO MUP, 1993, J APPL PHYSIOL, V75, P1989, DOI 10.1152/jappl.1993.75.5.1989; Brassard P, 2007, MED SCI SPORT EXER, V39, P1896, DOI 10.1249/mss.0b013e318145b642; Burgess MI, 2006, J AM COLL CARDIOL, V47, P1891, DOI 10.1016/j.jacc.2006.02.042; BUSKIRK ER, 1987, FASEB J, V46, P1824; COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71; ELLSTAD MH, 1996, STRESS TESTING PRINC, P75; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1; Gilman G, 2007, J AM SOC ECHOCARDIOG, V20, P199, DOI 10.1016/j.echo.2006.08.005; Ha JW, 2003, AM J CARDIOL, V91, P114, DOI 10.1016/S0002-9149(02)03016-3; HIGGINBOTHAM MB, 1983, AM J CARDIOL, V51, P52, DOI 10.1016/S0002-9149(83)80010-1; HIGGINBOTHAM MB, 1986, AM J CARDIOL, V57, P1374, DOI 10.1016/0002-9149(86)90221-3; HOSSACK KF, 1982, J APPL PHYSIOL, V53, P799, DOI 10.1152/jappl.1982.53.4.799; JULIUS S, 1967, CIRCULATION, V36, P222, DOI 10.1161/01.CIR.36.2.222; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEVY WC, 1993, CIRCULATION, V88, P116, DOI 10.1161/01.CIR.88.1.116; Little WC, 2006, AM J CARDIOL, V98, P383, DOI 10.1016/j.amjcard.2006.01.106; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Okura H, 2000, AM HEART J, V139, P716, DOI 10.1016/S0002-8703(00)90054-1; OLDERSHAW PJ, 1983, BRIT HEART J, V49, P568; Ommen SR, 2000, CIRCULATION, V102, P1788; PAINTAL AS, 1969, J PHYSIOL-LONDON, V203, P511, DOI 10.1113/jphysiol.1969.sp008877; Proctor DN, 1998, J APPL PHYSIOL, V84, P599, DOI 10.1152/jappl.1998.84.2.599; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; ROBERTS AM, 1986, CIRC RES, V58, P512, DOI 10.1161/01.RES.58.4.512; Shubair Mamdouh M, 2004, J Cardiopulm Rehabil, V24, P405, DOI 10.1097/00008483-200411000-00008; Skaluba SJ, 2004, CIRCULATION, V109, P972, DOI 10.1161/01.CIR.0000117405.74491.D2; Smart N, 2007, AM HEART J, V153, P530, DOI 10.1016/j.ahj.2007.01.004; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; VANOVERSCHELDE JLJ, 1993, J APPL PHYSIOL, V74, P2225, DOI 10.1152/jappl.1993.74.5.2225; Warner JG, 1999, J AM COLL CARDIOL, V33, P1567, DOI 10.1016/S0735-1097(99)00048-0; Weiss EP, 2006, J APPL PHYSIOL, V101, P938, DOI 10.1152/japplphysiol.01398.2005; Woo JS, 2006, J AM COLL CARDIOL, V47, P1049, DOI 10.1016/j.jacc.2005.09.066	36	174	178	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					286	294		10.1001/jama.2008.1022	http://dx.doi.org/10.1001/jama.2008.1022			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395IV	19155455	Green Accepted, Bronze			2022-12-01	WOS:000262518700019
J	Tanaka, H; Kato, K; Yamashita, E; Sumizawa, T; Zhou, Y; Yao, M; Iwasaki, K; Yoshimura, M; Tsukihara, T				Tanaka, Hideaki; Kato, Koji; Yamashita, Eiki; Sumizawa, Tomoyuki; Zhou, Yong; Yao, Min; Iwasaki, Kenji; Yoshimura, Masato; Tsukihara, Tomitake			The Structure of Rat Liver Vault at 3.5 Angstrom Resolution	SCIENCE			English	Article							RIBONUCLEOPROTEIN-PARTICLES; PROTEIN; CELLS; RESISTANCE; DOMAIN; RNA; ASSOCIATION; POLYMERASE; STOMATIN; SYMMETRY	Vaults are among the largest cytoplasmic ribonucleoprotein particles and are found in numerous eukaryotic species. Roles in multidrug resistance and innate immunity have been suggested, but the cellular function remains unclear. We have determined the x-ray structure of rat liver vault at 3.5 angstrom resolution and show that the cage structure consists of a dimer of half-vaults, with each half-vault comprising 39 identical major vault protein (MVP) chains. Each MVP monomer folds into 12 domains: nine structural repeat domains, a shoulder domain, a cap-helix domain, and a cap-ring domain. Interactions between the 42-turn-long cap-helix domains are key to stabilizing the particle. The shoulder domain is structurally similar to a core domain of stomatin, a lipid-raft component in erythrocytes and epithelial cells.	[Tanaka, Hideaki; Kato, Koji; Yamashita, Eiki; Iwasaki, Kenji; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Sumizawa, Tomoyuki] Univ Occupat & Environm Hlth, Fukuoka, Japan; [Zhou, Yong; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; [Iwasaki, Kenji] RIKEN, Harima Inst, Biomultisome Res Team, Struct Physiol Res Grp, Mikazuki, Hyogo 6795148, Japan; [Yoshimura, Masato] Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan; [Tsukihara, Tomitake] Univ Hyogo, Dept Life Sci, Akoh, Hyogo 6781297, Japan	Osaka University; University of Occupational & Environmental Health - Japan; Hokkaido University; RIKEN; National Synchrotron Radiation Research Center; University of Hyogo	Tsukihara, T (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsuki@protein.osaka-u.ac.jp	Yamashita, Eiki/V-6758-2019; Kato, Koji/H-8502-2017; yao, min/F-5287-2011; Tanaka, Hideaki/AGY-8426-2022	Yamashita, Eiki/0000-0002-4278-0039; Kato, Koji/0000-0001-9846-5903; yao, min/0000-0003-1687-5904; Yoshimura, Masato/0000-0002-7466-2192	Ministry of Education, Culture, Sports, Science, and Technology of Japan [10188101, 10179101, A-041, 19770082, 16048216, 20051001]; Japan Space Forum	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum	We thank T. Tomizaki for help in the diffraction data collection on X10SA (PX II) at the Swiss Light Source (Villigen, Switzerland). This work was supported in part by a Grant-in-Aid for Scientific Research in a Priority Area ( 10188101 and 10179101) and the Global Center of Excellence (GCOE) program (A-041) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. T.) and by a Ground-Based Research Announcement for Space Utilization provided by the Japan Space Forum (T. T.). This work was also supported in part by a Grant-in-Aid for Young Scientists (B) 19770082 (H. T.) and Grant-in-Aids for Scientific Research in a Priority Area 16048216 ( H. T.) and 20051001 (M. Y.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Coordinates and structure factors have been deposited with the PDB under accession codes 2ZUO, 2ZV4, and 2ZV5. The three entries were made because the number of coordinates exceeded the limits of a PDB file. A PDB formatted file that contains whole coordinates and structure factors is available from www.protein.osaka-u.ac.jp/crystallograpy/mvp/.	Anderson DH, 2007, PLOS BIOL, V5, P2661, DOI 10.1371/journal.pbio.0050318; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHUGANI DC, 1993, J CELL SCI, V106, P23; Gopinath SCB, 2005, NUCLEIC ACIDS RES, V33, P4874, DOI 10.1093/nar/gki809; Hamill DR, 1997, DEV BIOL, V190, P117, DOI 10.1006/dbio.1997.8676; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kato K, 2008, ACTA CRYSTALLOGR D, V64, P525, DOI 10.1107/S0907444908004277; KEDERSHA NL, 1991, J CELL BIOL, V112, P225, DOI 10.1083/jcb.112.2.225; KEDERSHA NL, 1990, J CELL BIOL, V110, P895, DOI 10.1083/jcb.110.4.895; KICKHOEFER VA, 1993, J BIOL CHEM, V268, P7868; Kickhoefer VA, 1999, J BIOL CHEM, V274, P32712, DOI 10.1074/jbc.274.46.32712; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kickhoefer VA, 2001, J CELL BIOL, V152, P157, DOI 10.1083/jcb.152.1.157; Kim E, 2006, FEBS J, V273, P793, DOI 10.1111/j.1742-4658.2006.05112.x; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Kong LB, 2000, RNA, V6, P890, DOI 10.1017/S1355838200000157; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Kozlov G, 2006, J MOL BIOL, V356, P444, DOI 10.1016/j.jmb.2005.11.064; Mikyas Y, 2004, J MOL BIOL, V344, P91, DOI 10.1016/j.jmb.2004.09.021; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Scheffer GL, 2000, CURR OPIN ONCOL, V12, P550, DOI 10.1097/00001622-200011000-00007; SCHEFFER GL, 1995, NAT MED, V1, P578, DOI 10.1038/nm0695-578; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; Stephen AG, 2001, J BIOL CHEM, V276, P23217, DOI 10.1074/jbc.C100226200; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Yokoyama H, 2008, J MOL BIOL, V376, P868, DOI 10.1016/j.jmb.2007.12.024; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	30	101	110	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					384	388		10.1126/science.1164975	http://dx.doi.org/10.1126/science.1164975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150846				2022-12-01	WOS:000262481400040
J	Hsu, HE; Shutt, KA; Moore, MR; Beall, BW; Bennett, NM; Craig, AS; Farley, MM; Jorgensen, JH; Lexau, CA; Petit, S; Reingold, A; Schaffner, W; Thomas, A; Whitney, CG; Harrison, LH				Hsu, Heather E.; Shutt, Kathleen A.; Moore, Matthew R.; Beall, Bernard W.; Bennett, Nancy M.; Craig, Allen S.; Farley, Monica M.; Jorgensen, James H.; Lexau, Catherine A.; Petit, Susan; Reingold, Arthur; Schaffner, William; Thomas, Ann; Whitney, Cynthia G.; Harrison, Lee H.			Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STREPTOCOCCUS-PNEUMONIAE; BACTERIAL-MENINGITIS; UNITED-STATES; DISEASE; ERA; CHILDHOOD; SEROTYPES; CARRIAGE; ADULTS	Background Invasive pneumococcal disease declined among children and adults after the introduction of the pediatric heptavalent pneumococcal conjugate vaccine ( PCV7) in 2000, but its effect on pneumococcal meningitis is unclear. Methods We examined trends in pneumococcal meningitis from 1998 through 2005 using active, population- based surveillance data from eight sites in the United States. Isolates were grouped into PCV7 serotypes ( 4, 6B, 9V, 14, 18C, 19F, and 23F), PCV7- related serotypes ( 6A, 9A, 9L, 9N, 18A, 18B, 18F, 19B, 19C, 23A, and 23B), and non- PCV7 serotypes ( all others). Changes in the incidence of pneumococcal meningitis were assessed against baseline values from 1998- 1999. Results We identified 1379 cases of pneumococcal meningitis. The incidence declined from 1.13 cases to 0.79 case per 100,000 persons between 1998- 1999 and 2004- 2005 ( a 30.1% decline, P< 0.001). Among persons younger than 2 years of age and those 65 years of age or older, the incidence decreased during the study period by 64.0% and 54.0%, respectively ( P< 0.001 for both groups). Rates of PCV7- serotype meningitis declined from 0.66 case to 0.18 case ( a 73.3% decline, P< 0.001) among patients of all ages. Although rates of PCV7- related- serotype disease decreased by 32.1% ( P = 0.08), rates of non- PCV7- serotype disease increased from 0.32 to 0.51 ( an increase of 60.5%, P< 0.001). The percentages of cases from non- PCV7 serotypes 19A, 22F, and 35B each increased significantly during the study period. On average, 27.8% of isolates were nonsusceptible to penicillin, but fewer isolates were nonsusceptible to chloramphenicol ( 5.7%), meropenem ( 16.6%), and cefotaxime ( 11.8%). The proportion of penicillin-nonsusceptible isolates decreased between 1998 and 2003 ( from 32.0% to 19.4%, P = 0.01) but increased between 2003 and 2005 ( from 19.4% to 30.1%, P = 0.03). Conclusions Rates of pneumococcal meningitis have decreased among children and adults since PCV7 was introduced. Although the overall effect of the vaccine remains substantial, a recent increase in meningitis caused by non- PCV7 serotypes, including strains nonsusceptible to antibiotics, is a concern.	[Hsu, Heather E.; Shutt, Kathleen A.; Harrison, Lee H.] Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15261 USA; [Moore, Matthew R.; Beall, Bernard W.; Whitney, Cynthia G.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Farley, Monica M.] Emory Univ, Vet Affairs Med Ctr, Atlanta, GA 30322 USA; [Bennett, Nancy M.] Univ Rochester, Rochester, NY USA; [Craig, Allen S.] Tennessee Dept Hlth, Nashville, TN USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Jorgensen, James H.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Lexau, Catherine A.] Minnesota Dept Hlth, St Paul, MN USA; [Petit, Susan] Connecticut Dept Publ Hlth, Hartford, CT USA; [Reingold, Arthur] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Thomas, Ann] Oregon State Publ Hlth Div, Portland, OR USA; [Harrison, Lee H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Rochester; Tennessee Department Health; Vanderbilt University; University of Texas System; University of Texas Health San Antonio; Minnesota Department of Health (MHD); University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Harrison, LH (corresponding author), Univ Pittsburgh, Infect Dis Epidemiol Res Unit, 521 Parran Hall,130 Desoto St, Pittsburgh, PA 15261 USA.	lharriso@edc.pitt.edu		Hsu, Heather/0000-0002-5863-1804; Shutt, Kathleen/0000-0003-3376-6152	National Institute of Allergy and Infectious Diseases [K24 AI052788]; Sanofi-Pasteur; AstraZeneca; Wyeth; BD Diagnostics; bioMerieux; Astellis; Siemens MicroScan; Accelr8 Technology; Arpida; Johnson Johnson; Cubist; Merck; Pfizer; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI052788] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sanofi-Pasteur; AstraZeneca(AstraZeneca); Wyeth(Wyeth); BD Diagnostics; bioMerieux; Astellis; Siemens MicroScan; Accelr8 Technology; Arpida; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Cubist; Merck(Merck & Company); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the CDC and a career development award from the National Institute of Allergy and Infectious Diseases (K24 AI052788, to Dr. Harrison). Ms. Shutt reports receiving grant support from Sanofi-Pasteur and AstraZeneca; Dr. Bennett, honoraria and travel expenses from Wyeth for an advisory board meeting on an experimental pneumococcal vaccine and from Merck for participation on an advisory board on herpes zoster vaccine; Dr. Farley, travel expenses for lectures from Wyeth; Dr. Jorgensen, consulting, lecture, or advisory fees from BD Diagnostics, bioMerieux, Astellis, Siemens MicroScan, and Accelr8 Technology and grant support from bioMerieux, Arpida, Johnson & Johnson, Cubist, Merck, and Pfizer; Dr. Schaffner, honoraria from Wyeth for an advisory board meeting about an experimental vaccine and from Merck for participation on a data and safety monitoring board for experimental vaccines and advisory-board meetings on adult immunization and pneumococcal vaccine; and Dr. Harrison, consulting fees and honoraria from Wyeth, Merck, Sanofi-Pasteur, and GlaxoSmithKline and grant support from Sanofi-Pasteur. No other potential conflict of interest relevant to this article was reported.; We thank the personnel in the Active Bacterial Core surveillance sites of the Emerging Infections Program, especially Wendy Baughman and Paul Malpiedi of the Georgia Emerging Infections Program; Rosemary Hollick and Kim Holmes of the Johns Hopkins Bloomberg School of Public Health; Brenda G. Barnes of the Department of Preventive Medicine, Vanderbilt School of Medicine; Lori Triden, Ruth Lynfield, and Richard Danila of the Clinical Microbiology Section, Minnesota Public Health Laboratory; James L. Hadler and Zack Fraser of the Connecticut Department of Public Health; Karen Stefonek of the Oregon Public Health Division; Shelley M. Zansky of the Emerging Infections Program, New York State Department of Health; Glenda L. Smith of the Emerging Infections Program, Rochester, NY; and Susan Brooks and Pamala Daily of the California Emerging Infections Program, Oakland, CA; and also Delois Jackson and her team in the CDC Strep Laboratory for serotyping and data on minimal inhibitory concentrations; M. Leticia McElmeel, Letitia Fulcher, and Christa Trippy for assistance with the antimicrobial susceptibility testing; and Tamara Pilishvili and Elizabeth Zell for assistance with data management and programming.	Abramson JS, 2000, PEDIATRICS, V106, P362; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P893; Bingen E, 2008, EUR J CLIN MICROBIOL, V27, P191, DOI 10.1007/s10096-007-0417-y; Black S, 2007, PEDIATR INFECT DIS J, V26, P771, DOI 10.1097/INF.0b013e318124a494; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; *CDCP, 2007, ACT BACT COR SURV OV; *CDCP, 2007, METH SURV POP ACT BA; *CDCP, 2006, ABCS REP EM INF PROG; *CLIN LAB STAND I, 2007, M100S17 NCCLS, P126; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Dery Mark Alain, 2007, Curr Infect Dis Rep, V9, P301, DOI 10.1007/s11908-007-0047-7; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kyaw MH, 2006, NEW ENGL J MED, V355, P638; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Musher DM, 2006, NEW ENGL J MED, V354, P1522, DOI 10.1056/NEJMe068038; *NAT CTR HLTH STAT, 2007, DAT FIL DOC; *NAT CTR IMM RESP, 2007, IMM COV US COV IND V; Neuman HB, 2001, CLIN PEDIATR, V40, P595, DOI 10.1177/000992280104001102; *NIH, 2007, STUD EV 13 VAL PNEUM; *NIH, 2006, SAF IMM STUD 10 VAL; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Temime L, 2005, EPIDEMIOL INFECT, V133, P493, DOI 10.1017/S0950268804003565; THIGPEN MC, 2005, 43 ANN M INF DIS SOC; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Yu XH, 1999, J INFECT DIS, V180, P1569, DOI 10.1086/315096	35	328	354	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					244	256		10.1056/NEJMoa0800836	http://dx.doi.org/10.1056/NEJMoa0800836			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144940	Green Accepted			2022-12-01	WOS:000262434500007
J	Gray, A; Read, S; McGale, P; Darby, S				Gray, Alastair; Read, Simon; McGale, Paul; Darby, Sarah			Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLLABORATIVE ANALYSIS; RESIDENTIAL RADON; INDIVIDUAL DATA; REMEDIATION; HOMES	Objective To determine the number of deaths from lung cancer related to radon in the home and to explore the cost effectiveness of alternative policies to control indoor radon and their potential to reduce lung cancer mortality. Design Cost effectiveness analysis. Setting United Kingdom. Data sources Epidemiological data on risks from indoor radon and from smoking, vital statistics on deaths from lung cancer, survey information on effectiveness and costs of radon prevention and remediation. Main outcome measures Estimated number of deaths from lung cancer related to indoor radon, lifetime risks of death from lung cancer before and after various potential interventions to control radon, the cost per quality adjusted life year ( QALY) gained from different policies for control of radon, and the potential of those policies to reduce lung cancer mortality. Results The mean radon concentration in UK homes is 21 becquerels per cubic metre (Bq/m(3)). Each year around 1100 deaths from lung cancer ( 3.3% of all deaths from lung cancer) are related to radon in the home. Over 85% of these arise from radon concentrations below 100 Bq/m(3) and most are caused jointly by radon and active smoking. Current policy requiring basic measures to prevent radon in new homes in selected areas is highly cost effective, and such measures would remain cost effective if extended to the entire UK, with a cost per QALY gained of 11 400 ((euro) 12 200; $ 16 913). Current policy identifying and remediating existing homes with high radon levels is, however, neither cost effective ( cost per QALY gained 36 800) nor effective in reducing lung cancer mortality. Conclusions Policies requiring basic preventive measures against radon in all new homes throughout the UK would be cost effective and could complement existing policies to reduce smoking. Policies involving remedial work on existing homes with high radon levels cannot prevent most radon related deaths, as these are caused by moderate exposure in many homes. These conclusions are likely to apply to most developed countries, many with higher mean radon concentrations than the UK.	[Gray, Alastair] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England; [Read, Simon; McGale, Paul; Darby, Sarah] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Read, Simon; McGale, Paul; Darby, Sarah] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England	University of Oxford; University of Oxford; University of Oxford	Gray, A (corresponding author), Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England.	alastair.gray@dphpc.ox.ac.uk			Cancer Research UK [C500/A10573, A10293]; Medical Research Council [E270/4]; European Commission [516483 (FI6R)]; National Institute for Health Research; Medical Research Council [MC_U137686857] Funding Source: researchfish; MRC [MC_U137686857] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancer Research UK [grant Nos C500/A10573, A10293], the Medical Research Council [grant No E270/4], the European Commission sixth framework programme ( project: alpha risk grant No 516483 (FI6R)), and the National Institute for Health Research. The funders had no role in the design of the study, carrying out the analysis, or the decision to submit for publication.	AKERBLOM G, 1999, 9918 SWED RAD PROT I; [Anonymous], 2005, METHODS EC EVALUATIO; Bradley EJ, 1996, NRPBM707; Cancer Research UK, 2008, CANC STAT; Chilton S., 2004, VALUATION HLTH BENEF; *COMM BIOL EFF ION, 1999, HLTH EFF EXP IND RAD; Coskeran T, 2005, HEALTH POLICY, V71, P43, DOI 10.1016/j.healthpol.2004.05.003; Darby S, 2006, SCAND J WORK ENV HEA, V32, P1; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; *DEP HLTH, 2004, POL APPR HLTH GUID D; *DEP TRANSP, 2007, 1 DEP TRANSP; Department of the Environment Transport and the Regions, 2000, DETRRAS00004; Ford ES, 1999, AM J PUBLIC HEALTH, V89, P351, DOI 10.2105/AJPH.89.3.351; Gold MR., 1996, COST EFFECTIVENESS H; *HLTH PROT AG, HPA ADV RAD PROT MEA; HUNTER N, 2005, 7 INT S NAT RAD ENV, P438; *IND ADV GROUP ION, 2009, RAD PUBL HL IN PRESS; Kennedy CA, 1999, BRIT J CANCER, V81, P1243, DOI 10.1038/sj.bjc.6690836; LOMAS PR, 1994, RADIAT PROT DOSIM, V56, P323; Naismith SP, 1998, HEALTH PHYS, V75, P410, DOI 10.1097/00004032-199810000-00008; *NAT I HLTH CLIN E, 2005, GUID NICE; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; *OFF NAT STAT, 2006, LIV BRIT 2004 GEN HO; *PARL OFF SCI TECH, RED RAD RISKS HOM; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Stigum H, 2003, HEALTH PHYS, V84, P227, DOI 10.1097/00004032-200302000-00011; Thun MJ, 2006, JNCI-J NATL CANCER I, V98, P691, DOI 10.1093/jnci/djj187; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, UNSCEAR 2006 REP GEN, V1; UNSCEAR, 2000, SOURC EFF ION RAD; *WHO, WHO IND AIR QUAL GUI; Wrixon AD, 1988, NRPBR190	31	102	102	2	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2009	338								a3110	10.1136/bmj.a3110	http://dx.doi.org/10.1136/bmj.a3110			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PN	19129153	Green Published, hybrid			2022-12-01	WOS:000263165600003
J	Granich, RM; Gilks, CF; Dye, C; De Cock, KM; Williams, BG				Granich, Reuben M.; Gilks, Charles F.; Dye, Christopher; De Cock, Kevin M.; Williams, Brian G.			Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model	LANCET			English	Article							PREVENTION INTERVENTIONS; MALE CIRCUMCISION; PUBLIC-HEALTH; INFECTION; IMPACT; RISK; MORTALITY; COUNTRIES; EPIDEMIC; BEHAVIOR	Background Roughly 3 million people worldwide were receiving antiretroviral therapy (ART) at the end of 2007, but an estimated 6.7 million were still in need of treatment and a further 2.7 million became infected with HIV in 2007. Prevention efforts might reduce HIV incidence but are unlikely to eliminate this disease. We investigated a theoretical strategy of universal voluntary HIV testing and immediate treatment with ART, and examined the conditions under which the HIV epidemic could be driven towards elimination. Methods We used mathematical models to explore the effect on the case reproduction number (stochastic model) and long-term dynamics of the HIV epidemic (deterministic transmission model) of testing all people in our test-case community (aged 15 years and older) for HIV every year and starting people on ART immediately after they are diagnosed HIV positive. We used data from South Africa as the test case for a generalised epidemic, and assumed that all HIV transmission was heterosexual. Findings The studied strategy could greatly accelerate the transition from the present endemic phase, in which most adults living with HIV are not receiving ART, to an elimination phase, in which most are on ART, within 5 years. it could reduce HIV incidence and mortality to less than one case per 1000 people per year by 2016, or within 10 years of full implementation of the strategy, and reduce the prevalence of HIV to less than 1% within 50 years. We estimate that in 2032, the yearly cost of the present strategy and the theoretical strategy would both be US$1.7 billion; however, after this time, the cost of the present strategy would continue to increase whereas that of the theoretical strategy would decrease. Interpretation Universal voluntary HIV testing and immediate ART, combined with present prevention approaches, could have a major effect on severe genralised HIV/AIDS epidemics. This approach merits further mathematical modelling, research, and broad consultation. Funding None.	[Granich, Reuben M.; Gilks, Charles F.; De Cock, Kevin M.] WHO, Antiretroviral Treatment & HIV Care Unit, Dept HIV AIDS, CH-1211 Geneva 27, Switzerland; [Dye, Christopher; Williams, Brian G.] WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland	World Health Organization; World Health Organization	Granich, RM (corresponding author), WHO, Antiretroviral Treatment & HIV Care Unit, Dept HIV AIDS, Ave Appia 20, CH-1211 Geneva 27, Switzerland.	granichr@who.int	Dye, Christopher/AIC-4659-2022; Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123; Williams, Brian/0000-0002-3174-4876; Dye, Christopher/0000-0002-2957-1793				Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bennett DE, 2008, ANTIVIR THER, V13, P25; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; CASCADE Collaboration, 2000, LANCET, V355, P1158, DOI 10.1016/S0140-6736(00)02069-9; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P592; *CLINT FDN, 2008, ANT ARV PRIC LIST; Cohen J, 2008, SCIENCE, V321, P512, DOI 10.1126/science.321.5888.512; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; DESJARLAIS DC, 1995, JAMA-J AM MED ASSOC, V274, P1226, DOI 10.1001/jama.274.15.1226; DESROSIERS R, 2008, 15 C RETR OPP INF CR; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Ghys PD, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000299404.99033.bf; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Hallett TB, 2008, INT J EPIDEMIOL, V37, P77, DOI 10.1093/ije/dym232; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI55, DOI 10.1136/sti.2006.023663; Hirsch MS, 2008, J INFECT DIS, V197, pS252, DOI 10.1086/533416; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; Horton R, 2008, LANCET, V372, P421, DOI 10.1016/S0140-6736(08)60882-X; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Kilby JM, 2008, AIDS, V22, P957, DOI 10.1097/QAD.0b013e3282fbd1da; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; *MED SANS FRONT, 2007, UNT WEB ARV PRIC RED; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; NASH D, 2008, 15 C RETR OPP INF CR; *PEPFAR, 2007, POW PARTN PRES EM PL; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Plate DK, 2007, AIDS RES HUM RETROV, V23, P1491, DOI 10.1089/aid.2007.0020; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Shisana O., 2005, S AFRICAN NATL HIV P; *UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNAIDS, 2008, EX SUMM 2008 REP GLO; UNAIDS, 2007, FIN RES REQ ACH UN A; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weiss RA, 2008, CLIN EXP IMMUNOL, V152, P201, DOI 10.1111/j.1365-2249.2008.03645.x; WHO / UNAIDS, 2008, UN ACC SCAL UP PRIOR; Williams BG, 2000, S AFR J SCI, V96, P305; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; Williams BG, 2006, J INFECT DIS, V194, P1450, DOI 10.1086/508206; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2007, ESSENTIAL PREVENTION; Wright RJ, 2004, AM J PREV MED, V27, P42, DOI 10.1016/j.amepre.2004.03.004; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; 2008, NATL HIV SYPHILIS AN; 2008, S AFR J HIV MED, V29, P18	55	1417	1446	1	160	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					48	57		10.1016/S0140-6736(08)61697-9	http://dx.doi.org/10.1016/S0140-6736(08)61697-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19038438				2022-12-01	WOS:000262183800031
J	McMeniman, CJ; Lane, RV; Cass, BN; Fong, AWC; Sidhu, M; Wang, YF; O'Neill, SL				McMeniman, Conor J.; Lane, Roxanna V.; Cass, Bodil N.; Fong, Amy W. C.; Sidhu, Manpreet; Wang, Yu-Feng; O'Neill, Scott L.			Stable Introduction of a Life-Shortening Wolbachia Infection into the Mosquito Aedes aegypti	SCIENCE			English	Article							CYTOPLASMIC INCOMPATIBILITY; VIRULENT WOLBACHIA; TRANSMISSION; DROSOPHILA; AGE; TEMPERATURE; STRAIN	Most pathogens require a relatively long period of development in their mosquito vector before they can be transmitted to a new human host; hence, only older insects are of epidemiological importance. The successful transfer of a life- shortening strain of the inherited bacterial symbiont, Wolbachia, into the major mosquito vector of dengue, Aedes aegypti, halved adult life span under laboratory conditions. The association is stable, and the Wolbachia strain is maternally inherited at high frequency. It is capable of inducing complete cytoplasmic incompatibility, which should facilitate its invasion into natural field populations and its persistence over time. Our data suggest that targeting mosquito age with inherited Wolbachia infections may be a viable strategy to reduce the transmission of pathogens such as dengue viruses.	[McMeniman, Conor J.; Lane, Roxanna V.; Cass, Bodil N.; Fong, Amy W. C.; Sidhu, Manpreet; Wang, Yu-Feng; O'Neill, Scott L.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; [Wang, Yu-Feng] Cent China Normal Univ, Coll Life Sci, Wuhan 430079, Peoples R China	University of Queensland; Central China Normal University	O'Neill, SL (corresponding author), Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia.	scott.oneill@uq.edu.au	O'Neill, Scott/R-9560-2019; wang, yufeng/E-5122-2010; O'Neill, Scott L/B-3568-2009	O'Neill, Scott/0000-0002-4131-3615; O'Neill, Scott L/0000-0002-4131-3615; McMeniman, Conor/0000-0001-8502-8712	Foundation for the NIH; Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation	Foundation for the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank S. Dobson, Z. Xi, and Y. Fu for their advice on microinjection of mosquito eggs; C. Williams and S. Ritchie for supplying the JCU mosquito strain; and E. McGraw and members of the O'Neill laboratory for helpful comments. This research was supported by a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation.	Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Rasgon JL, 2003, J MED ENTOMOL, V40, P125, DOI 10.1603/0022-2585-40.2.125; Reynolds KT, 2003, GENETICS, V164, P1027; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Warrell DA., 2002, ESSENTIAL MALARIOLOG; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607	25	640	676	3	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					141	144		10.1126/science.1165326	http://dx.doi.org/10.1126/science.1165326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119237				2022-12-01	WOS:000262104100061
J	Stiglitz, JE				Stiglitz, Joseph E.			Trade agreements and health in developing countries	LANCET			English	Editorial Material									[Stiglitz, Joseph E.] Columbia Univ, New York, NY 10027 USA	Columbia University	Stiglitz, JE (corresponding author), Columbia Univ, New York, NY 10027 USA.	jes322@columbia.edu						*EUR COMM, BIL TRAD REL, P2; Matthijs G, 2004, BRIT MED J, V329, P1358, DOI 10.1136/bmj.329.7479.1358; *MED SANS FRONT, 2006, PEOPL NOT GETT TREAT, P2; *OFF US TRAD REPR, TRAD AGR, P2; Smith RD, 2009, LANCET, V373, P684, DOI 10.1016/S0140-6736(08)61779-1; Smith RD, 2009, LANCET, V373, P768, DOI 10.1016/S0140-6736(08)61780-8; SOEKIRMAN KD, 2008, ASIA PACIFIC J CLI S, V10, P557; STIGLITZ JE, 2006, MAKING GLOBALIZATION, P2; *UN DEV PROGR, 2003, MAK GLOB TRAD WORK P, P2; 2007, MED NEWS TODAY  0207, P2	10	28	28	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					363	365		10.1016/S0140-6736(08)61772-9	http://dx.doi.org/10.1016/S0140-6736(08)61772-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401BC	19167055	Green Published			2022-12-01	WOS:000262912100009
J	King, CR; Knutson, KL; Rathouz, PJ; Sidney, S; Liu, K; Lauderdale, DS				King, Christopher Ryan; Knutson, Kristen L.; Rathouz, Paul J.; Sidney, Steve; Liu, Kiang; Lauderdale, Diane S.			Short Sleep Duration and Incident Coronary Artery Calcification	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTOR; COMPUTED-TOMOGRAPHY; APNEA-HYPOPNEA; CALCIUM; ATHEROSCLEROSIS; ASSOCIATION; PROGRESSION; ACTIGRAPHY; ADULTS; HYPERTENSION	Context Coronary artery calcification is a subclinical predictor of coronary heart disease. Recent studies have found that sleep duration is correlated with established risk factors for calcification including glucose regulation, blood pressure, sex, age, education, and body mass index. Objective To determine whether objective and subjective measures of sleep duration and quality are associated with incidence of calcification over 5 years and whether calcification risk factors mediate the association. Design, Setting, and Participants Observational cohort of home monitoring in a healthy middle- aged population of 495 participants from the Coronary Artery Risk Development in Young Adults ( CARDIA) cohort Chicago site ( black and white men and women aged 35- 47 years at year 15 of the study in 2000- 2001 with follow- up data at year 20 in 2005- 2006). Potential confounders ( age, sex, race, education, apnea risk, smoking status) and mediators ( lipids, blood pressure, body mass index, diabetes, inflammatory markers, alcohol consumption, depression, hostility, selfreported medical conditions) were measured at both baseline and follow- up. Sleep metrics ( wrist actigraphy measured duration and fragmentation, daytime sleepiness, overall quality, self- reported duration) were examined for association with incident calcification. Participants had no detectable calcification at baseline. Main Outcome Measure Coronary artery calcification was measured by computed tomography in 2000- 2001 and 2005- 2006 and incidence of new calcification over that time was the primary outcome. Results Five- year calcification incidence was 12.3% ( n= 61). Longer measured sleep duration was significantly associated with reduced calcification incidence ( adjusted odds ratio, 0.67 per hour [ 95% confidence interval, 0.49- 0.91 per hour]; P=. 01). No potential mediators appreciably altered the magnitude or significance of sleep ( adjusted odds ratio estimates ranged from 0.64 to 0.68 per sleep hour; maximum P=. 02). Alternative sleep metrics were not significantly associated with calcification. Conclusion Longer measured sleep is associated with lower calcification incidence independent of examined potential mediators and confounders.	[King, Christopher Ryan; Knutson, Kristen L.; Rathouz, Paul J.; Lauderdale, Diane S.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Sidney, Steve] Kaiser Permanente, Oakland, CA USA; [Liu, Kiang] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA	University of Chicago; Kaiser Permanente; Northwestern University	Lauderdale, DS (corresponding author), Univ Chicago, Dept Hlth Studies, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	lauderdale@uchicago.edu		Knutson, Kristen/0000-0002-2751-6168; King, Christopher/0000-0002-4574-8616	National Institute on Aging [AG 11412]; Medical Scientist National Research Service Award [T 32 GM07281]; US Public Health Service [NO1-HC-48047, NO1-HC-48048, NO1-HC48049, NO1-HC-48050]; National Heart, Lung, and Blood Institute [NO1-HC-95095]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048049, N01HC048048, N01HC048047, N01HC048050, N01HC095095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048049, R29HL048048, R01HL048050, R01HL048048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Scientist National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research for this study was supported by grant AG 11412 from the National Institute on Aging and the Medical Scientist National Research Service Award T 32 GM07281. The Coronary Artery Risk Development in Young Adults (CARDIA) study is supported by US Public Health Service contracts NO1-HC-48047, NO1-HC-48048, NO1-HC48049, NO1-HC-48050, and NO1-HC-95095 from the National Heart, Lung, and Blood Institute.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; EVANS PD, 1987, J BEHAV MED, V10, P311, DOI 10.1007/BF00846544; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289; Garcia-Diaz E, 2007, CHEST, V131, P725, DOI 10.1378/chest.06-1604; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Hann D, 1999, J PSYCHOSOM RES, V46, P437, DOI 10.1016/S0022-3999(99)00004-5; Hastings PC, 2006, EUR RESPIR J, V27, P748, DOI 10.1183/09031936.06.00063005; Hedner J, 2004, SLEEP, V27, P1560, DOI 10.1093/sleep/27.8.1560; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; JeanLouis G, 1997, PERCEPT MOTOR SKILL, V85, P207, DOI 10.2466/pms.1997.85.1.207; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jung HH, 2005, AM J KIDNEY DIS, V45, P875, DOI 10.1053/j.ajkd.2005.01.006; Knutson KL, 2007, SLEEP, V30, P793, DOI 10.1093/sleep/30.6.793; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Knutson KL, 2006, SLEEP, V29, P878, DOI 10.1093/sleep/29.7.878; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Leproult R, 1997, SLEEP, V20, P865; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Matthews K, 2006, PSYCHOSOM MED, V68, P657, DOI 10.1097/01.psy.0000244071.42939.0e; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; PATEL SR, INT J OBES IN PRESS; Reiner AP, 2006, J THROMB HAEMOST, V4, P1279, DOI 10.1111/j.1538-7836.2006.01907.x; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Silva GE, 2007, J CLIN SLEEP MED, V3, P622; Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; STAESSEN J, 1992, AM J HYPERTENS, V5, P386, DOI 10.1093/ajh/5.6.386; Tryon WW, 2004, SLEEP, V27, P158, DOI 10.1093/sleep/27.1.158; van den Berg JF, 2008, INT J OBESITY, V32, P1083, DOI 10.1038/ijo.2008.57; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P1793, DOI 10.1001/jama.295.15.1793; Yoon HC, 2002, RADIOLOGY, V224, P236, DOI 10.1148/radiol.2241011191; Zisapel N, 2007, CELL MOL LIFE SCI, V64, P1174, DOI 10.1007/s00018-007-6529-9; Zou D, 2006, SLEEP, V29, P367, DOI 10.1093/sleep/29.3.367	48	235	241	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2859	2866						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109114	Green Accepted			2022-12-01	WOS:000261920900019
J	Chan, CE; Odde, DJ				Chan, Clarence E.; Odde, David J.			Traction Dynamics of Filopodia on Compliant Substrates	SCIENCE			English	Article							FOCAL ADHESIONS; GROWTH; ACTIN; FORCE; CELLS	Cells sense the environment's mechanical stiffness to control their own shape, migration, and fate. To better understand stiffness sensing, we constructed a stochastic model of the "motor-clutch" force transmission system, where molecular clutches link F-actin to the substrate and mechanically resist myosin- driven F- actin retrograde flow. The model predicts two distinct regimes: ( i) "frictional slippage," with fast retrograde flow and low traction forces on stiff substrates and ( ii) oscillatory "load-and-fail" dynamics, with slower retrograde flow and higher traction forces on soft substrates. We experimentally confirmed these model predictions in embryonic chick forebrain neurons by measuring the nanoscale dynamics of single- growth- cone filopodia. Furthermore, we experimentally observed a model- predicted switch in F- actin dynamics around an elastic modulus of 1 kilopascal. Thus, a motor- clutch system inherently senses and responds to the mechanical stiffness of the local environment.	[Chan, Clarence E.; Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Odde, DJ (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	oddex002@umn.edu	Ladoux, Benoit/A-9879-2013; Odde, David/H-4925-2011; Odde, David/AAY-1720-2020	Odde, David/0000-0001-7731-2799	Institute for Engineering in Medicine at the University of Minnesota; NSF [MCB-0615568]; National Institute of General Medical Sciences [R01-GM-76177]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076177] Funding Source: NIH RePORTER	Institute for Engineering in Medicine at the University of Minnesota(University of Minnesota System); NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Institute for Engineering in Medicine at the University of Minnesota, NSF (grant MCB-0615568), and the National Institute of General Medical Sciences (grant R01-GM-76177). We thank P. Letourneau, D. Bray, and E. Tuzel for stimulating discussions; N. Simha for helpful discussions on gel mechanics; N. Koyano for assistance with in ovo electroporation; and members of the Odde Lab, D. Seetapun, A. Bicek, M. Gardner, and T. Dahl for technical assistance.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fass JN, 2003, BIOPHYS J, V85, P623, DOI 10.1016/S0006-3495(03)74506-8; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Howard J., 2002, APPL MECH REV, V55, pB39; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	19	543	562	10	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1687	1691		10.1126/science.1163595	http://dx.doi.org/10.1126/science.1163595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074349				2022-12-01	WOS:000261608300044
J	Sabio, G; Das, M; Mora, A; Zhang, ZY; Jun, JY; Ko, HJ; Barrett, T; Kim, JK; Davis, RJ				Sabio, Guadalupe; Das, Madhumita; Mora, Alfonso; Zhang, Zhiyou; Jun, John Y.; Ko, Hwi Jin; Barrett, Tamera; Kim, Jason K.; Davis, Roger J.			A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; IN-VIVO; INTERLEUKIN-6 DOES/DOES; GLUCOSE-HOMEOSTASIS; BENEFICIAL ROLE; OBESITY; SOCS-3; MICE; INFLAMMATION; HEPATOCYTES	A high-fat diet causes activation of the regulatory protein c-Jun NH(2)-terminal kinase 1 (JNK1) and triggers development of insulin resistance. JNK1 is therefore a potential target for therapeutic treatment of metabolic syndrome. We explored the mechanism of JNK1 signaling by engineering mice in which the Jnk1 gene was ablated selectively in adipose tissue. JNK1 deficiency in adipose tissue suppressed high- fat diet- induced insulin resistance in the liver. JNK1- dependent secretion of the inflammatory cytokine interleukin- 6 by adipose tissue caused increased expression of liver SOCS3, a protein that induces hepatic insulin resistance. Thus, JNK1 activation in adipose tissue can cause insulin resistance in the liver.	[Sabio, Guadalupe; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Sabio, Guadalupe; Das, Madhumita; Mora, Alfonso; Barrett, Tamera; Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Jun, John Y.] Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	roger.davis@umassmed.edu	Mora, Alfonso/D-2759-2017; Sabio, Guadalupe/H-9733-2015	Mora, Alfonso/0000-0002-6397-4836; Sabio, Guadalupe/0000-0002-2822-0625; Kim, Jason/0000-0002-7185-042X; Davis, Roger/0000-0002-0130-1652	NIH; American Diabetes Association [1-04-RA-47]; Pennsylvania State Department of Health; Core facilities at the University of Massachusetts; National Institute of Diabetes and Digestive and Kidney Diseases; Diabetes and Endocrinology Research Center [DK52530]; NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052530, R01DK080756] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Pennsylvania State Department of Health; Core facilities at the University of Massachusetts; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes and Endocrinology Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank V. Benoit, J. Cavanagh- Kyros, K. Gemme, N. Kennedy, J. Liu, and J. Reilly for expert assistance. These studies were supported by grants from NIH (to R.J.D.), the American Diabetes Association (1-04-RA-47 to J.K.K.), and the Pennsylvania State Department of Health (to J.K.K.). Core facilities at the University of Massachusetts used by these studies were supported by the National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes and Endocrinology Research Center (DK52530). R.J.D. is an Investigator of the Howard Hughes Medical Institute.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Mauvais-Jarvis F, 2002, CLIN ENDOCRINOL, V57, P1, DOI 10.1046/j.1365-2265.2002.01563.x; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Mooney RA, 2007, J APPL PHYSIOL, V102, P816, DOI 10.1152/japplphysiol.01208a.2006; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Pedersen BK, 2001, CURR OPIN HEMATOL, V8, P137, DOI 10.1097/00062752-200105000-00002; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001	26	433	450	3	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1539	1543		10.1126/science.1160794	http://dx.doi.org/10.1126/science.1160794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056984	Green Accepted			2022-12-01	WOS:000261377400048
J	Windsor, JS				Windsor, Jeremy S.			Voices in the air	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Windsor, Jeremy S.] UCL, Inst Human Hlth & Performance, London N19 5LW, England	University of London; University College London	Windsor, JS (corresponding author), UCL, Inst Human Hlth & Performance, London N19 5LW, England.	jswindsor@doctors.org.uk						BONINGTON C, 1997, EVEREST HARD WAY, P186; HABELER P, 1979, EVEREST IMPOSSIBLE V, P167; POTTERFIELD P, 2004, MOUNTAINEERS ANTHOLO, P52; VENABLES S, 2000, EVEREST ALONE AUMMIT, P184	4	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 5	2008	337								a2667	10.1136/bmj.a2667	http://dx.doi.org/10.1136/bmj.a2667			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NY	19060106				2022-12-01	WOS:000261891100005
J	Morgan, DO				Morgan, David O.			SnapShot: Cell-Cycle Regulators II	CELL			English	Editorial Material							MACHINE		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.			Morgan, David/0000-0001-8753-4416				Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Morgan DO., 2007, CELL CYCLE PRINCIPLE; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606	5	5	5	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 28	2008	135	5					974	U14		10.1016/j.cell.2008.10.040	http://dx.doi.org/10.1016/j.cell.2008.10.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041757	Bronze			2022-12-01	WOS:000261183900026
J	Grabowski, GA				Grabowski, Gregory A.			Lysosomal storage disease 1 - Phenotype, diagnosis, and treatment of Gaucher's disease	LANCET			English	Review							ENZYME REPLACEMENT THERAPY; UNFOLDED PROTEIN RESPONSE; MACROPHAGE-TARGETED GLUCOCEREBROSIDASE; ACID BETA-GLUCOSIDASE; PARKINSONS-DISEASE; N-BUTYLDEOXYNOJIRIMYCIN; ENDOPLASMIC-RETICULUM; GENE-THERAPY; GLUCOSYLCERAMIDE SYNTHASE; CHITOTRIOSIDASE ACTIVITY	Gaucher's disease continues to be a model for applications of molecular medicine to clinical delineation, diagnosis, and treatment. Analyses of several thousand affected individuals have broadened the range of the pan-ethnic disease variants, provided initial genotype and phenotype correlations, and established the effectiveness of enzyme therapy. Large numbers of affected individuals worldwide have provided insight into the effect of disease variation related to ethnic origin, prognosis, and outcome. The ability to safely and effectively use enzyme therapy to inhibit or reverse visceral-disease progression and involvement has provided impetus for design of new enzyme therapies, and creation of substrate depletion and pharmacological chaperone strategies. Such innovations could provide interventions that are effective for neuronopathic variants and, potentially, could be more cost effective than other treatments. These developments are novel, clinically important, advancements for patients with other lysosomal storage diseases and genetic diseases.	[Grabowski, Gregory A.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Grabowski, GA (corresponding author), Childrens Hosp Res Fdn, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	greg.grabowski@cchmc.org			NIDDK NIH HHS [DK36729] Funding Source: Medline; NINDS NIH HHS [NS36681, NS45911] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036681, U01NS045911] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE A, 1992, EUR J BIOCHEM, V210, P765, DOI 10.1111/j.1432-1033.1992.tb17479.x; ABRAHAMOV A, 1995, LANCET, V346, P1000, DOI 10.1016/S0140-6736(95)91688-1; Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Beutler E, 2000, BLOOD CELL MOL DIS, V26, P303, DOI 10.1006/bcmd.2000.0311; BEUTLER E, 1993, BRIT J HAEMATOL, V85, P401, DOI 10.1111/j.1365-2141.1993.tb03185.x; Beutler E, 2005, BLOOD CELL MOL DIS, V35, P355, DOI 10.1016/j.bcmd.2005.07.005; BEUTLER E, 1993, AM J HUM GENET, V52, P85; BEUTLER E, 1991, BLOOD, V78, P1183; Beutler E, 2000, ACTA HAEMATOL-BASEL, V104, P103, DOI 10.1159/000039760; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Bieberich E, 1999, J NEUROCHEM, V72, P1040, DOI 10.1046/j.1471-4159.1999.0721040.x; Bonetta L, 2002, NAT MED, V8, P1189, DOI 10.1038/nm1102-1189; Boven LA, 2004, AM J CLIN PATHOL, V122, P359, DOI 10.1309/BG5VA8JRDQH1M7HN; Brady RO, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.6.e11; Brinkman J, 2005, J INHERIT METAB DIS, V28, P13, DOI 10.1007/s10545-005-4416-9; Clark LN, 2005, MOVEMENT DISORD, V20, P100, DOI 10.1002/mds.20320; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Cox TM, 2003, J INHERIT METAB DIS, V26, P513, DOI 10.1023/A:1025902113005; Czartoryska B, 1998, CLIN BIOCHEM, V31, P417, DOI 10.1016/S0009-9120(98)00030-7; de Fost M, 2006, BLOOD, V108, P830, DOI 10.1182/blood-2005-12-5072; DESNICK RJ, 1982, GAUCHER DIS CENTURY; Eblan MJ, 2005, NEW ENGL J MED, V352, P728; Elstein D, 2004, J INHERIT METAB DIS, V27, P757, DOI 10.1023/B:BOLI.0000045756.54006.17; Enquist IB, 2006, P NATL ACAD SCI USA, V103, P13819, DOI 10.1073/pnas.0606016103; ERIKSON A, 1990, ACTA PAEDIATR SCAND, V79, P680, DOI 10.1111/j.1651-2227.1990.tb11535.x; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Filocamo M, 2000, BLOOD CELL MOL DIS, V26, P611, DOI 10.1006/bcmd.2000.0341; Frederickson DS, 1972, METABOLIC BASIS INHE, P730; Fredman P, 1998, J INHERIT METAB DIS, V21, P472, DOI 10.1023/A:1005454602454; FUTERMAN T, 2006, GAUCHER DIS; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gaucher PCE, 1882, THESIS PARIS; Ginzburg L, 2004, SEMIN CELL DEV BIOL, V15, P417, DOI 10.1016/j.semcdb.2004.03.003; Giraldo P, 2006, HAEMATOLOGICA, V91, P703; Goker-Alpan O, 2006, NEUROLOGY, V67, P908, DOI 10.1212/01.wnl.0000230215.41296.18; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grabowski GA, 1997, BAILLIERE CLIN HAEM, V10, P635, DOI 10.1016/S0950-3536(97)80032-7; Grabowski GA, 2003, ANNU REV GENOM HUM G, V4, P403, DOI 10.1146/annurev.genom.4.070802.110415; Grabowski GA, 1997, GENET TEST, V1, P5, DOI 10.1089/gte.1997.1.5; GRABOWSKI GA, 2006, AM J HUM GENET, P427; GRABOWSKI GA, 2006, GAUCHER DIS, P49; Grabowski GA, 2006, METABOLIC MOL BASES; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; HOLLAK CEM, 1995, LANCET, V345, P1474, DOI 10.1016/S0140-6736(95)91037-9; Hruska KS, 2006, GAUCHER DIS, P13; JONSSON LMV, 1987, EUR J BIOCHEM, V164, P171, DOI 10.1111/j.1432-1033.1987.tb11008.x; Kaplan P, 2006, ARCH PEDIAT ADOL MED, V160, P603, DOI 10.1001/archpedi.160.6.603; Kelly JW, 2005, NEW ENGL J MED, V352, P722, DOI 10.1056/NEJMcibr044231; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Luberto C, 2002, NEUROCHEM RES, V27, P609, DOI 10.1023/A:1020267831851; Marshall E, 2003, SCIENCE, V299, P320, DOI 10.1126/science.299.5605.320; MCEACHERN K, 2006, AM J HUM GENET, P424; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; McEachern KA, 2006, J GENE MED, V8, P719, DOI 10.1002/jgm.901; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Mignot C, 2003, AM J MED GENET A, V120A, P338, DOI 10.1002/ajmg.a.20117; Moran MT, 2000, BLOOD, V96, P1969, DOI 10.1182/blood.V96.5.1969.h8001969_1969_1978; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; OHASHI T, 1991, J BIOL CHEM, V266, P3661; Orvisky E, 2000, PEDIATR RES, V48, P233, DOI 10.1203/00006450-200008000-00018; Pastores GM, 2005, CLIN THER, V27, P1215, DOI 10.1016/j.clinthera.2005.08.004; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2004.07.009; Pastores GM, 2003, J INHERIT METAB DIS, V26, P641, DOI 10.1023/B:BOLI.0000005623.60471.51; PASTORES GM, 1993, BLOOD, V82, P408; PATTERSON MC, 1993, NEUROLOGY, V43, P1993, DOI 10.1212/WNL.43.10.1993; Platt FM, 2001, J INHERIT METAB DIS, V24, P275, DOI 10.1023/A:1010335505357; POLLACK A, 2003, NY TIMES, pA17; Pollack Andrew, 2003, N Y Times Web, pA17; Rappeport J M, 1986, Birth Defects Orig Artic Ser, V22, P101; RICHARDS SM, 1993, BLOOD, V82, P1402; RINGDEN O, 1988, TRANSPLANTATION, V46, P66, DOI 10.1097/00007890-198807000-00011; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Rosenberg M, 1999, BLOOD, V93, P2081, DOI 10.1182/blood.V93.6.2081.406k07_2081_2088; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Sato C, 2005, MOVEMENT DISORD, V20, P367, DOI 10.1002/mds.20319; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shayman JA, 2003, GLYCOCONJUGATE J, V20, P25, DOI 10.1023/B:GLYC.0000016739.32089.55; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; SHUKLA GS, 1991, J NEUROCHEM, V56, P2125, DOI 10.1111/j.1471-4159.1991.tb03475.x; Sidransky E, 2005, MOL GENET METAB, V84, P302, DOI 10.1016/j.ymgme.2004.11.007; Sidransky E, 2004, MOL GENET METAB, V83, P6, DOI 10.1016/j.ymgme.2004.08.015; Sobreira E, 2007, MOL GENET METAB, V90, P81, DOI 10.1016/j.ymgme.2006.08.009; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Stone DL, 1999, EUR J HUM GENET, V7, P505, DOI 10.1038/sj.ejhg.5200315; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Tylki-Szymanska A, 2006, GENET MED, V8, P8, DOI 10.1097/01.gim.0000196443.42899.25; Weinreb NJ, 2004, SEMIN HEMATOL, V41, P15, DOI 10.1053/j.seminhematol.2004.07.010; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wenstrup RJ, 2007, J BONE MINER RES, V22, P119, DOI 10.1359/JBMR.061004; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; XU YH, 2005, AM J HUM GENET, V207, P1413; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhao HQ, 2003, BLOOD CELL MOL DIS, V30, P90, DOI 10.1016/S1079-9796(03)00012-3; Zimmer KP, 1999, J PATHOL, V188, P407; ZIMRAN A, 2006, AM J HUM GENET, P428	105	356	408	2	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1263	1271		10.1016/S0140-6736(08)61522-6	http://dx.doi.org/10.1016/S0140-6736(08)61522-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357YB	19094956				2022-12-01	WOS:000259882000032
J	Yuan, PW; Bartlam, M; Lou, ZY; Chen, SD; Zhou, J; He, XJ; Lv, ZY; Ge, RW; Li, XM; Deng, T; Fodor, E; Rao, ZH; Liu, YF				Yuan, Puwei; Bartlam, Mark; Lou, Zhiyong; Chen, Shoudeng; Zhou, Jie; He, Xiaojing; Lv, Zongyang; Ge, Ruowen; Li, Xuemei; Deng, Tao; Fodor, Ervin; Rao, Zihe; Liu, Yingfang			Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site	NATURE			English	Article							RNA-POLYMERASE; PA SUBUNIT; A VIRUS; TERMINAL REGION; CAP-BINDING; REPLICATION; PROTEIN; PB2; IDENTIFICATION; RESIDUES	The heterotrimeric influenza virus polymerase, containing the PA, PB1 and PB2 proteins, catalyses viral RNA replication and transcription in the nucleus of infected cells. PB1 holds the polymerase active site(1) and reportedly harbours endonuclease activity(2), whereas PB2 is responsible for cap binding(2-4). The PA amino terminus is understood to be the major functional part of the PA protein and has been implicated in several roles, including endonuclease(5) and protease activities(6) as well as viral RNA/complementary RNA promoter binding(7). Here we report the 2.2 angstrom (angstrom) crystal structure of the N-terminal 197 residues of PA, termed PA(N), from an avian influenza H5N1 virus. The PA(N) structure has an alpha/beta architecture and reveals a bound magnesium ion coordinated by a motif similar to the (P) DXN(D/E) XK motif characteristic of many endonucleases. Structural comparisons and mutagenesis analysis of the motif identified in PA(N) provide further evidence that PA(N) holds an endonuclease active site. Furthermore, functional analysis with in vivo ribonucleoprotein reconstitution and direct in vitro endonuclease assays strongly suggest that PA(N) holds the endonuclease active site and has critical roles in endonuclease activity of the influenza virus polymerase, rather than PB1. The high conservation of this endonuclease active site among influenza strains indicates that PA(N) is an important target for the design of new anti-influenza therapeutics.	[Yuan, Puwei; Chen, Shoudeng; Zhou, Jie; He, Xiaojing; Lv, Zongyang; Li, Xuemei; Rao, Zihe; Liu, Yingfang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Bartlam, Mark; Deng, Tao; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Bartlam, Mark; Deng, Tao; Rao, Zihe] Nankai Univ, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Lou, Zhiyong; Li, Xuemei; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Deng, Tao; Fodor, Ervin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University; Nankai University; Tsinghua University; National University of Singapore; University of Oxford	Rao, ZH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	raozh@xtal.tsinghua.edu.cn; liuy@ibp.ac.cn	Ge, Ruowen/D-8352-2012; HE, XIAOJING/A-6040-2013; chen, shoudeng/AAX-8738-2021; Lv, Zongyang/M-9307-2018; Rao, Zihe/HCH-6944-2022; chen, shoudeng/G-3556-2012	Ge, Ruowen/0000-0002-0750-7336; chen, shoudeng/0000-0002-7634-2141; Lv, Zongyang/0000-0002-8862-113X; Bartlam, Mark/0000-0001-5173-5080; Fodor, Ervin/0000-0003-3249-196X	National Natural Science Foundation of China [30599432, 30221003, 30721003]; Ministry of Science and Technology International Cooperation [2006DFB32420]; Ministry of Science and Technology 863 Project [2006AA02A314, 2006AA02A322]; Ministry of Science and Technology 973 Project [2006CB504300, 2007CB914300]; Medical Research Council [G0700848]; MRC [G0700848] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology International Cooperation; Ministry of Science and Technology 863 Project(National High Technology Research and Development Program of China); Ministry of Science and Technology 973 Project(National Basic Research Program of China); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank H. Chen and K. Yu for providing the A/goose/Guangdong/1/96 influenza PA gene, R. Zhang and A. Joachimiak for assistance with data collection, and G. G. Brownlee for providing materials and for valuable advice. This work was supported by the National Natural Science Foundation of China (grant numbers 30599432, 30221003 and 30721003), the Ministry of Science and Technology International Cooperation Project (2006DFB32420), the Ministry of Science and Technology 863 Project (2006AA02A314 and 2006AA02A322), the Ministry of Science and Technology 973 Project (2006CB504300 and 2007CB914300) and the Medical Research Council (G0700848).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blok V, 1996, J GEN VIROL, V77, P1025, DOI 10.1099/0022-1317-77-5-1025; BROWNLEE GG, 1995, NUCLEIC ACIDS RES, V23, P2641, DOI 10.1093/nar/23.14.2641; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Guu TSY, 2008, VIROLOGY, V379, P135, DOI 10.1016/j.virol.2008.06.022; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Huarte M, 2003, J VIROL, V77, P6007, DOI 10.1128/JVI.77.10.6007-6013.2003; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Lukacs CM, 2000, NAT STRUCT BIOL, V7, P134; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Naffakh N, 2001, VIROLOGY, V285, P244, DOI 10.1006/viro.2001.0956; NEWMAN M, 1994, NATURE, V368, P660, DOI 10.1038/368660a0; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; NIETO A, 1992, VIRUS RES, V24, P65, DOI 10.1016/0168-1702(92)90031-4; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perales B, 2000, J VIROL, V74, P1307, DOI 10.1128/JVI.74.3.1307-1312.2000; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHI LC, 1995, VIROLOGY, V208, P38, DOI 10.1006/viro.1995.1127; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	35	385	417	3	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					909	U12		10.1038/nature07720	http://dx.doi.org/10.1038/nature07720			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19194458				2022-12-01	WOS:000265182500047
J	Mehta, R; Zhu, R				Mehta, Ravi; Zhu, Rui (Juliet)			Blue or Red? Exploring the Effect of Color on Cognitive Task Performances	SCIENCE			English	Article							REGULATORY FOCUS; CUES; PREVENTION; PROMOTION	Existing research reports inconsistent findings with regard to the effect of color on cognitive task performances. Some research suggests that blue or green leads to better performances than red; other studies record the opposite. Current work reconciles this discrepancy. We demonstrate that red (versus blue) color induces primarily an avoidance (versus approach) motivation (study 1, n = 69) and that red enhances performance on a detail-oriented task, whereas blue enhances performance on a creative task (studies 2 and 3, n = 208 and 118). Further, we replicate these results in the domains of product design (study 4, n = 42) and persuasive message evaluation (study 5, n = 161) and show that these effects occur outside of individuals' consciousness (study 6, n = 68). We also provide process evidence suggesting that the activation of alternative motivations mediates the effect of color on cognitive task performances.	[Mehta, Ravi; Zhu, Rui (Juliet)] Univ British Columbia, Sauder Sch Business, Vancouver, BC V6T 1Z2, Canada	University of British Columbia	Zhu, R (corresponding author), Univ British Columbia, Sauder Sch Business, 2053 Main Mall, Vancouver, BC V6T 1Z2, Canada.	juliet.zhu@sauder.ubc.ca			Social Sciences and Humanities Research Council	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work benefited from financial support from the Social Sciences and Humanities Research Council to R.J.Z. We thank J. Meyers-Levy and K. D. Vohs for very helpful comments on earlier drafts of this paper. Research assistance from P. Behmardi, S. Ho, and S. Park is greatly appreciated.	Aslam M.M., 2006, J MARK COMMUN, V12, P15, DOI [DOI 10.1080/13527260500247827, 10.1080/13527260500247827]; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BRAUN CC, 1995, ERGONOMICS, V38, P2207, DOI 10.1080/00140139508925263; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; Crowe E, 1997, ORGAN BEHAV HUM DEC, V69, P117, DOI 10.1006/obhd.1996.2675; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Elliot AJ, 2007, J EXP PSYCHOL GEN, V136, P154, DOI 10.1037/0096-3445.136.1.154; Friedman RS, 2005, J PERS SOC PSYCHOL, V88, P263, DOI 10.1037/0022-3514.88.2.263; Friedman RS, 2002, J EXP SOC PSYCHOL, V38, P41, DOI 10.1006/jesp.2001.1488; Friedman RS, 2001, J PERS SOC PSYCHOL, V81, P1001, DOI 10.1037/0022-3514.81.6.1001; Griskevicius V, 2006, J PERS SOC PSYCHOL, V91, P63, DOI 10.1037/0022-3514.91.1.63; Higgins ET, 1998, ADV EXP SOC PSYCHOL, V30, P1, DOI 10.1016/S0065-2601(08)60381-0; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Higgins ET, 2003, J PERS SOC PSYCHOL, V84, P1140, DOI 10.1037/0022-3514.84.6.1140; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Koch S, 2008, COGNITION, V109, P133, DOI 10.1016/j.cognition.2008.07.014; KWALLEK N, 1990, APPL ERGON, V21, P275, DOI 10.1016/0003-6870(90)90197-6; Moreau CP, 2005, J CONSUM RES, V32, P13, DOI 10.1086/429597; Naz K., 2004, COLL STUDENT J, V38, P396; Schwarz N., 1990, FEELINGS INFORM INFO, DOI DOI 10.2307/2072281; Soldat AS, 1997, SOC COGNITION, V15, P55, DOI 10.1521/soco.1997.15.1.55; Stone NJ, 2003, J ENVIRON PSYCHOL, V23, P63, DOI 10.1016/S0272-4944(02)00107-X; THOMPSON E, 1992, BEHAV BRAIN SCI, V15, P1, DOI 10.1017/S0140525X00067248; Williams DJ, 2007, THEOR ISS ERGON SCI, V8, P1, DOI 10.1080/14639220500484419; Zhu R, 2007, J CONSUM RES, V34, P89, DOI 10.1086/513049	25	393	408	7	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1226	1229		10.1126/science.1169144	http://dx.doi.org/10.1126/science.1169144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19197022				2022-12-01	WOS:000263687600042
J	Eggeling, C; Ringemann, C; Medda, R; Schwarzmann, G; Sandhoff, K; Polyakova, S; Belov, VN; Hein, B; von Middendorff, C; Schonle, A; Hell, SW				Eggeling, Christian; Ringemann, Christian; Medda, Rebecca; Schwarzmann, Guenter; Sandhoff, Konrad; Polyakova, Svetlana; Belov, Vladimir N.; Hein, Birka; von Middendorff, Claas; Schoenle, Andreas; Hell, Stefan W.			Direct observation of the nanoscale dynamics of membrane lipids in a living cell	NATURE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CULTURED-CELLS; RAFTS; MICROSCOPY; DIFFUSION; ORGANIZATION; RESOLUTION; GLUCOSYLCERAMIDE; MICRODOMAINS; DEPLETION	Cholesterol-mediated lipid interactions are thought to have a functional role in many membrane-associated processes such as signalling events(1-5). Although several experiments indicate their existence, lipid nanodomains ('rafts') remain controversial owing to the lack of suitable detection techniques in living cells(4,6-9). The controversy is reflected in their putative size of 5-200 nm, spanning the range between the extent of a protein complex and the resolution limit of optical microscopy. Here we demonstrate the ability of stimulated emission depletion (STED) far-field fluorescence nanoscopy(10) to detect single diffusing (lipid) molecules in nanosized areas in the plasma membrane of living cells. Tuning of the probed area to spot sizes similar to 70-fold below the diffraction barrier reveals that unlike phosphoglycerolipids, sphingolipids and glycosylphosphatidylinositol-anchored proteins are transiently (similar to 10-20 ms) trapped in cholesterol-mediated molecular complexes dwelling within <20-nm diameter areas. The non-invasive optical recording of molecular time traces and fluctuation data in tunable nanoscale domains is a powerful new approach to study the dynamics of biomolecules in living cells.	[Eggeling, Christian; Ringemann, Christian; Medda, Rebecca; Polyakova, Svetlana; Belov, Vladimir N.; Hein, Birka; von Middendorff, Claas; Schoenle, Andreas; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; [Schwarzmann, Guenter; Sandhoff, Konrad] Univ Bonn, LIMES Membrane Biol & Lipid Biochem Unit, D-53121 Bonn, Germany	Max Planck Society; University of Bonn	Eggeling, C (corresponding author), Max Planck Inst Biophys Chem, Dept Nanobiophoton, Fassberg 11, D-37077 Gottingen, Germany.	ceggeli@gwdg.de; shell@gwdg.de	Polyakova, Svetlana M./U-4325-2018	Polyakova, Svetlana M./0000-0002-2971-5267; Belov, Vladimir N/0000-0002-7741-4653				BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; FAHEY PF, 1977, SCIENCE, V195, P305, DOI 10.1126/science.831279; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fielding C. J, 2006, LIPID RAFTS CAVEOLAE; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Keller J, 2007, OPT EXPRESS, V15, P3361, DOI 10.1364/OE.15.003361; Lommerse PHM, 2004, BBA-BIOMEMBRANES, V1664, P119, DOI 10.1016/j.bbamem.2004.05.005; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; OSBORN M, 1977, P NATL ACAD SCI USA, V74, P2490, DOI 10.1073/pnas.74.6.2490; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; SCHWARZMANN G, 1995, J BIOL CHEM, V270, P21271, DOI 10.1074/jbc.270.36.21271; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Wawrezinieck L, 2005, BIOPHYS J, V89, P4029, DOI 10.1529/biophysj.105.067959; Wenger J, 2007, BIOPHYS J, V92, P913, DOI 10.1529/biophysj.106.096586; Willig KI, 2006, NAT METHODS, V3, P721, DOI 10.1038/NMETH922; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; YECHIEL E, 1987, J CELL BIOL, V105, P755, DOI 10.1083/jcb.105.2.755; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	32	1102	1117	16	744	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1159	U121		10.1038/nature07596	http://dx.doi.org/10.1038/nature07596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19098897	Green Published			2022-12-01	WOS:000263680100047
J	Ma, DK; Jang, MH; Guo, JU; Kitabatake, Y; Chang, ML; Pow-Anpongkul, N; Flavell, RA; Lu, B; Ming, GL; Song, H				Ma, Dengke K.; Jang, Mi-Hyeon; Guo, Junjie U.; Kitabatake, Yasuji; Chang, Min-lin; Pow-Anpongkul, Nattapol; Flavell, Richard A.; Lu, Binfeng; Ming, Guo-li; Song, Hongjun			Neuronal Activity-Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis	SCIENCE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; MOUSE; TRANSCRIPTION; METHYLATION; MECHANISMS; PLASTICITY; SIGNALS; PROTEIN; CORTEX	The mammalian brain exhibits diverse types of neural plasticity, including activity- dependent neurogenesis in the adult hippocampus. How transient activation of mature neurons leads to long-lasting modulation of adult neurogenesis is unknown. Here we identify Gadd45b as a neural activity- induced immediate early gene in mature hippocampal neurons. Mice with Gadd45b deletion exhibit specific deficits in neural activity- induced proliferation of neural progenitors and dendritic growth of newborn neurons in the adult hippocampus. Mechanistically, Gadd45b is required for activity- induced DNA demethylation of specific promoters and expression of corresponding genes critical for adult neurogenesis, including brain- derived neurotrophic factor and fibroblast growth factor. Thus, Gadd45b links neuronal circuit activity to epigenetic DNA modification and expression of secreted factors in mature neurons for extrinsic modulation of neurogenesis in the adult brain.	[Ma, Dengke K.; Jang, Mi-Hyeon; Guo, Junjie U.; Kitabatake, Yasuji; Chang, Min-lin; Pow-Anpongkul, Nattapol; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Jang, Mi-Hyeon; Kitabatake, Yasuji; Chang, Min-lin; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Lu, Binfeng] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ma, DK (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, 733 N Broadway, Baltimore, MD 21205 USA.	dma2@jhmi.edu; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013	Kitabatake, Yasuji/0000-0002-2907-9512; Ming, Guo-li/0000-0002-2517-6075	NIH; McKnight; NARSAD; March of Dimes; Johns Hopkins Brain Science Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight; NARSAD(NARSAD); March of Dimes(March of Dimes); Johns Hopkins Brain Science Institute(Johns Hopkins University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Ginty, S. Synder, and members of Ming and Song laboratories for help and critical comments and L. Liu and Y. Cai for technical support. This work was supported by NIH, McKnight, and NARSAD (to H.S.) and by NIH, March of Dimes, and Johns Hopkins Brain Science Institute (to G-L.M.). R.A.F. is an investigator with the Howard Hughes Medical Institute.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Alam KY, 1996, J BIOL CHEM, V271, P30263, DOI 10.1074/jbc.271.47.30263; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Kempermann G, 2000, Prog Brain Res, V127, P35; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; MING GL, 2005, BIOL PSYCHIAT, V47, P223; Ploski JE, 2006, J NEUROCHEM, V99, P1122, DOI 10.1111/j.1471-4159.2006.04156.x; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Zhang YX, 2001, BBA-GENE STRUCT EXPR, V1521, P45, DOI 10.1016/S0167-4781(01)00282-2	28	698	721	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1074	1077		10.1126/science.1166859	http://dx.doi.org/10.1126/science.1166859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19119186	Green Accepted			2022-12-01	WOS:000263478400046
J	Wilczek, AM; Roe, JL; Knapp, MC; Cooper, MD; Lopez-Gallego, C; Martin, LJ; Muir, CD; Sim, S; Walker, A; Anderson, J; Egan, JF; Moyers, BT; Petipas, R; Giakountis, A; Charbit, E; Coupland, G; Welch, SM; Schmitt, J				Wilczek, Amity M.; Roe, Judith L.; Knapp, Mary C.; Cooper, Martha D.; Lopez-Gallego, Cristina; Martin, Laura J.; Muir, Christopher D.; Sim, Sheina; Walker, Alexis; Anderson, Jillian; Egan, J. Franklin; Moyers, Brook T.; Petipas, Renee; Giakountis, Antonis; Charbit, Erika; Coupland, George; Welch, Stephen M.; Schmitt, Johanna			Effects of Genetic Perturbation on Seasonal Life History Plasticity	SCIENCE			English	Article							FLOWERING TIME CONTROL; LOCUS-C ACTIVITY; ARABIDOPSIS-THALIANA; VERNALIZATION; PHOTOPERIOD; PHENOTYPE; PLANTS; TEMPERATURE; CONSTANS; GIGANTEA	Like many species, the model plant Arabidopsis thaliana exhibits multiple different life histories in natural environments. We grew mutants impaired in different signaling pathways in field experiments across the species' native European range in order to dissect the mechanisms underlying this variation. Unexpectedly, mutational loss at loci implicated in the cold requirement for flowering had little effect on life history except in late- summer cohorts. A genetically informed photothermal model of progression toward flowering explained most of the observed variation and predicted an abrupt transition from autumn flowering to spring flowering in late- summer germinants. Environmental signals control the timing of this transition, creating a critical window of acute sensitivity to genetic and climatic change that may be common for seasonally regulated life history traits.	[Wilczek, Amity M.; Cooper, Martha D.; Lopez-Gallego, Cristina; Martin, Laura J.; Muir, Christopher D.; Walker, Alexis; Anderson, Jillian; Egan, J. Franklin; Moyers, Brook T.; Petipas, Renee; Schmitt, Johanna] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Roe, Judith L.; Knapp, Mary C.; Sim, Sheina; Charbit, Erika; Welch, Stephen M.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Giakountis, Antonis; Coupland, George] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Brown University; Kansas State University; Max Planck Society	Schmitt, J (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	johanna_schmitt@brown.edu	Moyers, Brook T./E-1516-2012; Coupland, George/AAP-8609-2020; Lopez-Gallego, Cristina/F-5034-2015; Muir, Christopher/V-4461-2017	Moyers, Brook T./0000-0003-0340-9488; Coupland, George/0000-0001-6988-4172; Muir, Christopher/0000-0003-2555-3878; Lopez-Gallego, Cristina/0000-0002-5872-6053; Petipas, Renee/0000-0002-8712-8183; Giakountis, Antonis/0000-0001-8648-9908	NSF Frontiers in Integrative Biological Research [EF- 0425759]; Alexander von Humboldt Research Award	NSF Frontiers in Integrative Biological Research(National Science Foundation (NSF)); Alexander von Humboldt Research Award(Alexander von Humboldt Foundation)	We thank M. Blazquez, C. Dean, M. Hoffmann, M. Koornneef, H. Kuittinen, and O. Savolainen for hosting these experiments at the European field sites; L. Albertson, L. Burghardt, C. Cooper, M.F. Cooper, Josephs, A. Lockwood, S. Myllyla, C. Oakley, R. Palmer, S. Rudder, and E. vonWettberg for assistance with planting and censusing; B. Robertson, M. Gosling, C. Lister, F. Eikelmann, G. Leuffen, W. Schuchert, T. Kauppila, and H. Eissner for technical and field assistance; R. Griffin, J. Kreikemeier, and G. Ragusa for assistance with the chamber experiment; A. Heim for contributions to the processing of temperature data; R. Amasino and J. Martinez- Zapater for sharing lines; S. Ruzsa of the Purugganan lab, who bulked lines for the experiments; and R. Amasino and C. Dean for manuscript comments. Supported by NSF Frontiers in Integrative Biological Research program grant EF- 0425759 and an Alexander von Humboldt Research Award.	Ausin I, 2005, INT J DEV BIOL, V49, P689, DOI 10.1387/ijdb.052022ia; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; BURGHARDT LT, 2008, 19 INT C AR RES MONT; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; De Melo-Abreu JP, 2004, AGR FOREST METEOROL, V125, P117, DOI 10.1016/j.agrformet.2004.02.009; Dennis ES, 2007, CURR OPIN PLANT BIOL, V10, P520, DOI 10.1016/j.pbi.2007.06.009; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/B03-141, 10.1139/b03-141]; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; LAIBACH F, 1965, ARABIDOPSIS INFORMAT; LEE I, 1995, PLANT PHYSIOL, V108, P157, DOI 10.1104/pp.108.1.157; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; McMaster GS, 2008, ANN BOT-LONDON, V102, P561, DOI 10.1093/aob/mcn115; Michaels SD, 2003, P NATL ACAD SCI USA, V100, P10102, DOI 10.1073/pnas.1531467100; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Schmitz RJ, 2007, BBA-GENE STRUCT EXPR, V1769, P269, DOI 10.1016/j.bbaexp.2007.02.003; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; THOMPSON L, 1994, J ECOL, V82, P63, DOI 10.2307/2261386; Welch SM, 2005, AUST J AGR RES, V56, P919, DOI 10.1071/AR05155; Welch SM, 2003, AGRON J, V95, P71, DOI 10.2134/agronj2003.0071; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403	28	287	292	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					930	934		10.1126/science.1165826	http://dx.doi.org/10.1126/science.1165826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19150810				2022-12-01	WOS:000263295400041
J	McNab, F; Varrone, A; Farde, L; Jucaite, A; Bystritsky, P; Forssberg, H; Klingberg, T				McNab, Fiona; Varrone, Andrea; Farde, Lars; Jucaite, Aurelija; Bystritsky, Paulina; Forssberg, Hans; Klingberg, Torkel			Changes in Cortical Dopamine D1 Receptor Binding Associated with Cognitive Training	SCIENCE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; WORKING-MEMORY; PREFRONTAL CORTEX; MODULATION; DEPLETION; CHILDREN	Working memory is a key function for human cognition, dependent on adequate dopamine neurotransmission. Here we show that the training of working memory, which improves working memory capacity, is associated with changes in the density of cortical dopamine D1 receptors. Fourteen hours of training over 5 weeks was associated with changes in both prefrontal and parietal D1 binding potential. This plasticity of the dopamine D1 receptor system demonstrates a reciprocal interplay between mental activity and brain biochemistry in vivo.	[McNab, Fiona; Bystritsky, Paulina; Forssberg, Hans; Klingberg, Torkel] Karolinska Inst, Neuropediat Unit, Dept Woman & Child Hlth, Stockholm Brain Inst, Stockholm, Sweden; [Varrone, Andrea; Farde, Lars; Jucaite, Aurelija] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm Brain Inst, Stockholm, Sweden; [Farde, Lars; Jucaite, Aurelija] AstraZeneca Res & Dev, Sodertalje, Sweden	Karolinska Institutet; Karolinska Institutet; AstraZeneca	Klingberg, T (corresponding author), Karolinska Inst, Neuropediat Unit, Dept Woman & Child Hlth, Stockholm Brain Inst, Stockholm, Sweden.	torkel.klingberg@ki.se	Forssberg, Hans/A-2944-2009	Forssberg, Hans/0000-0003-2069-6618; Klingberg, Torkel/0000-0002-3175-2171	Swedish Foundation for Strategic Research; Swedish Research Council; VINNOVA ( the Swedish Governmental Agency for Innovation Systems); Knut and Alice Wallenberg Foundation	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA ( the Swedish Governmental Agency for Innovation Systems)(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	The authors thank C. Halldin, K. Kolaas, G. Lei, J. Macoveanu, and members of the Karolinska Institutet PET center for assistance in the PET measurements. This work was supported by the Swedish Foundation for Strategic Research, Swedish Research Council, VINNOVA (the Swedish Governmental Agency for Innovation Systems), and Knut and Alice Wallenberg Foundation.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Cai JX, 1997, J PHARMACOL EXP THER, V283, P183; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Guo NN, 2003, NEUROPSYCHOPHARMACOL, V28, P1703, DOI 10.1038/sj.npp.1300224; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Laruelle M, 1998, Q J NUCL MED, V42, P211; Lidow MS, 1998, TRENDS PHARMACOL SCI, V19, P136, DOI 10.1016/S0165-6147(98)01186-9; Muller U, 1998, J NEUROSCI, V18, P2720; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Postle BR, 1999, J COGNITIVE NEUROSCI, V11, P585, DOI 10.1162/089892999563652; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; Soiza-Reilly M, 2004, BRAIN RES, V1004, P217, DOI 10.1016/j.brainres.2004.01.050; Suss HM, 2002, INTELLIGENCE, V30, P261, DOI 10.1016/S0160-2896(01)00100-3; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	27	363	384	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					800	802		10.1126/science.1166102	http://dx.doi.org/10.1126/science.1166102			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197069				2022-12-01	WOS:000263066800052
J	Rowland, JM; Emlen, DJ				Rowland, J. Mark; Emlen, Douglas J.			Two Thresholds, Three Male Forms Result in Facultative Male Trimorphism in Beetles	SCIENCE			English	Article							HORN LENGTH DIMORPHISM; SEXUAL-DIMORPHISM; SCARAB BEETLE; BODY-SIZE; EVOLUTION; COLEOPTERA; TACTICS; MODELS	Male animals of many species deploy conditional reproductive strategies that contain distinct alternative phenotypes. Such facultatively expressed male tactics are assumed to be due to a single developmental threshold mechanism switching between the expression of two alternative phenotypes. However, we discovered a clade of dung beetles that commonly expresses two threshold mechanisms, resulting in three alternative phenotypes (male trimorphism). Once recognized, we found trimorphism in other beetle families that involves different types of male weapons. Evidence that insects assumed to be dimorphic can express three facultative male forms suggests that we need to adjust how we think about animal mating systems and the evolution of conditional strategies.	[Rowland, J. Mark] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Emlen, Douglas J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of New Mexico; University of Montana System; University of Montana	Rowland, JM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rowland@unm.edu			NSF [IOS-0642409]	NSF(National Science Foundation (NSF))	We thank S. Spector, T. Larsen, A. Solis, T. Gardner, J. Louzada, P. Skelley, D. Almquist, C. Gillett, D. Edmonds, D. Lewis, L. Herman, T. Fincher, M. Barclay, C. O'Brien, J. Prena, F. Genier, G. and J. Lewallern, R. Veal, D. Heinicke, and B. Raber for providing critical samples; assistance of the Scarabaeine Research Network; K. Bright, W. Eberhard, E. Greene, A. Kodric- Brown, T. Maginnis, E. McCullough, C. Qualls, and two anonymous reviewers for ideas and comments on the manuscript; J. Driver and the University of Montana Electron Microscopy facility for the weevil images; and the NSF (IOS-0642409) (to D.J.E.) for funding.	Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; EBERHARD WG, 1991, EVOLUTION, V45, P18, DOI 10.2307/2409478; Eberhard WG, 2000, P ROY SOC B-BIOL SCI, V267, P1129, DOI 10.1098/rspb.2000.1118; Emlen DJ, 2006, HEREDITY, V97, P179, DOI 10.1038/sj.hdy.6800868; Emlen DJ, 2005, AM NAT, V166, pS42, DOI 10.1086/444599; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; EMLEN DJ, 1994, P ROY SOC B-BIOL SCI, V256, P131, DOI 10.1098/rspb.1994.0060; HAZEL WN, 1990, P ROY SOC B-BIOL SCI, V242, P181, DOI 10.1098/rspb.1990.0122; HUNT J, 2001, P ROY SOC LOND B BIO, V26, P2409; Iguchi Y, 1998, ANN ENTOMOL SOC AM, V91, P845, DOI 10.1093/aesa/91.6.845; Iguchi Yutaka, 2000, Kogane, V1, P21; Jukema J, 2006, BIOL LETTERS, V2, P161, DOI 10.1098/rsbl.2005.0416; Karino K, 2004, ECOL RES, V19, P663, DOI 10.1111/j.1440-1703.2004.00681.x; Kelly CD, 2008, BEHAV ECOL, V19, P1018, DOI 10.1093/beheco/arn058; Kotiaho JS, 2001, BEHAV ECOL, V12, P553, DOI 10.1093/beheco/12.5.553; Maddison D. R., 2000, MACCLADE 4 0 ANAL PH; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; Moczek AP, 2002, EVOL DEV, V4, P252, DOI 10.1046/j.1525-142X.2002.02014.x; Moczek AP, 2006, AM NAT, V168, P711, DOI 10.1086/509051; Moczek AP, 2006, DEV GENES EVOL, V216, P655, DOI 10.1007/s00427-006-0087-2; Moore JC, 2004, BEHAV ECOL, V15, P735, DOI 10.1093/beheco/arh069; OLIVEIRA RF, 2008, ALTERNATIVE REPROD T, P507; Plaistow SJ, 2004, BEHAV ECOL, V15, P534, DOI 10.1093/beheco/arh029; Price DL, 2007, INSECT SYST EVOL, V38, P1, DOI 10.1163/187631207788784058; RASMUSSEN JL, 1994, J INSECT BEHAV, V7, P67, DOI 10.1007/BF01989828; Rowland JM, 2005, EVOL ECOL RES, V7, P421; RYAN MJ, 1992, AM NAT, V139, P21, DOI 10.1086/285311; SHUSTER SM, 1989, EVOLUTION, V43, P1683, DOI 10.1111/j.1558-5646.1989.tb02618.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Sinervo A, 2001, J HERED, V92, P198, DOI 10.1093/jhered/92.2.198; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2007, AM NAT, V170, P663, DOI 10.1086/522092; Tomkins JL, 2005, AM NAT, V165, P389, DOI 10.1086/427732; West-Eberhard Mary Jane, 2003, pi	34	59	62	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					773	776		10.1126/science.1167345	http://dx.doi.org/10.1126/science.1167345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197062				2022-12-01	WOS:000263066800044
J	Lu, BX; Su, YH; Das, S; Wang, HK; Wang, Y; Liu, J; Ren, DJ				Lu, Boxun; Su, Yanhua; Das, Sudipto; Wang, Haikun; Wang, Yan; Liu, Jin; Ren, Dejian			Peptide neurotransmitters activate a cation channel complex of NALCN and UNC-80	NATURE			English	Article							LOCUS-CERULEUS NEURONS; SUBSTANCE-P; TRP CHANNELS; SYMPATHETIC NEURONS; DOPAMINE NEURONS; RAT; EXCITATION; RECEPTORS; PROTEIN; TRANSMITTERS	Several neurotransmitters act through G- protein- coupled receptors to evoke a 'slow' excitation of neurons(1,2). These include peptides, such as substance P and neurotensin, as well as acetylcholine and noradrenaline. Unlike the fast ( approximately millisecond) ionotropic actions of small- molecule neurotransmitters, the slow excitation is not well understood at themolecular level, but can be mainly attributed to suppressing K+ currents and/or activating a nonselective cation channel(3-9). The molecular identity of this cation channel has yet to be determined; similarly, how the channel is activated and its relative contribution to neuronal excitability induced by the neuropeptides are unknown. Here we show that, in the mouse hippocampal and ventral tegmental area neurons, substance P and neurotensin activate a channel complex containing NALCN and a large previously unknown protein UNC-80. The activation by substance P through TACR1 (a G- protein- coupled receptor for substance P) occurs by means of a unique mechanism: it does not require G- protein activation but is dependent on Src family kinases. These findings identify NALCN as the cation channel activated by substance P receptor, and suggest that UNC- 80 and Src family kinases, rather than a G protein, are involved in the coupling from receptor to channel.	[Lu, Boxun; Su, Yanhua; Das, Sudipto; Wang, Haikun; Wang, Yan; Liu, Jin; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ren, DJ (corresponding author), Univ Penn, Dept Biol, 415 S University Ave, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu		wang, hai kun/0000-0002-4714-4672	American Heart Association; NIH; University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055293] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Clapham, C. Deutsch, I. Medina, B. Novarro, M. Schmidt and H. Xu for critically reading earlier versions of the manuscript, J. Xia for help with experiments, H. Yu and L. Yue for cDNA constructs, and Sanofi- Aventis for the gift of SR48692. This work was supported, in part, by funding from American Heart Association, the NIH and the University of Pennsylvania Research Foundation.	Aosaki T, 1996, J NEUROSCI, V16, P5141; BLEY KR, 1990, NEURON, V4, P379, DOI 10.1016/0896-6273(90)90050-P; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Davis MJ, 2001, AM J PHYSIOL-HEART C, V281, pH1835, DOI 10.1152/ajpheart.2001.281.5.H1835; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Farkas RH, 1996, J NEUROPHYSIOL, V76, P1968, DOI 10.1152/jn.1996.76.3.1968; GRACE AA, 1989, J NEUROSCI, V9, P3463; Heuss C, 1999, NAT NEUROSCI, V2, P1070, DOI 10.1038/15996; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; HILLE B, 2001, CHANNELS EXCITABLE M, P201; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; INOUE K, 1995, J NEUROPHYSIOL, V73, P736, DOI 10.1152/jn.1995.73.2.736; JAN YN, 1980, P NATL ACAD SCI-BIOL, V77, P5008, DOI 10.1073/pnas.77.8.5008; JONES SW, 1985, J PHYSIOL-LONDON, V366, P63, DOI 10.1113/jphysiol.1985.sp015785; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; KANDEL E, 2000, PRINCIPLES NEURAL SC, P229; KUBA K, 1978, PROG NEUROBIOL, V11, P77, DOI 10.1016/0301-0082(78)90010-2; KUFFLER SW, 1983, J PHYSIOL-LONDON, V341, P257, DOI 10.1113/jphysiol.1983.sp014805; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; MASUKO S, 1992, NEUROSCIENCE, V49, P347, DOI 10.1016/0306-4522(92)90101-7; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Oh EJ, 2003, J NEUROPHYSIOL, V90, P2069, DOI 10.1152/jn.00026.2003; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; Pena F, 2004, J NEUROSCI, V24, P7549, DOI 10.1523/JNEUROSCI.1871-04.2004; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SHEN KZ, 1992, NEUROSCIENCE, V50, P345, DOI 10.1016/0306-4522(92)90428-5; SHEN KZ, 1993, J PHYSIOL-LONDON, V462, P483, DOI 10.1113/jphysiol.1993.sp019565; SHEN KZ, 1992, J PHYSIOL-LONDON, V455, P471, DOI 10.1113/jphysiol.1992.sp019312; STANFIELD PR, 1985, NATURE, V315, P498, DOI 10.1038/315498a0; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	33	113	117	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					741	U10		10.1038/nature07579	http://dx.doi.org/10.1038/nature07579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19092807	Green Accepted			2022-12-01	WOS:000263064700045
J	Winkelmayer, WC; Liu, J; Brookhart, MA				Winkelmayer, Wolfgang C.; Liu, Jun; Brookhart, M. Alan			Altitude and All-Cause Mortality in Incident Dialysis Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-DISEASE; HIF-1	Context Patients undergoing dialysis at higher altitude receive lower erythropoietin doses, yet achieve higher hemoglobin concentrations. Increased iron availability caused by activation of hypoxia- induced factors at higher altitude may explain this finding. Hypoxia- induced factors are also involved in other pathways that may affect morbidity and mortality. Objective To study whether mortality differed by altitude in patients initiating dialysis. Design, Setting, and Participants Retrospective cohort of patients initiating dialysis in the United States between 1995 and 2004. Patients were stratified by the average elevation of their residential zip code. Covariates included age, sex, race, Medicaid coverage, dialysis modality, comorbidities, and reported laboratory measurements. We constructed proportional hazards models of all- cause mortality, stratifying by year, and censoring patients at 5 years from first dialysis, at the end of the database ( December 31, 2004), or loss to follow- up. We also compared age- and sex- adjusted standardized mortality rates of US patients receiving dialysis with the general population. Main Outcome Measure Mortality from any cause. Results A total of 804 812 patients initiated dialysis and were followed up for a median of 1.78 years. Crude mortality rates per 1000 person- years were 220.1 at an altitude lower than 76 m ( <250 ft), 221.2 from 76 through 609 m ( 250- 1999 ft), 214.6 from 610 through 1218 m ( 2000- 3999 ft), 184.9 from 1219 through 1828 m ( 4000 to 5999 ft), and 177.2 at an altitude higher than 1828 m ( > 6000 ft). After multivariable adjustment, compared with patients living at an altitude of lower than 76 m, the relative mortality rates were 0.97 ( 95% confidence interval [ CI], 0.96- 0.98) for those living from 76 through 609 m; 0.93 ( 95% CI, 0.91- 0.95), from 610 through 1218 m; 0.88 ( 95% CI, 0.84- 0.91), from 1219 through 1828 m, and 0.85 ( 95% CI, 0.79-0.92) higher than 1828 m. Age- and sex- standardized mortality decreased more with altitude in patients receiving dialysis than in the general population. Conclusions Altitude was inversely associated with all- cause mortality among US patients receiving dialysis.	[Winkelmayer, Wolfgang C.; Liu, Jun; Brookhart, M. Alan] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA 02120 USA; [Winkelmayer, Wolfgang C.; Liu, Jun; Brookhart, M. Alan] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Winkelmayer, Wolfgang C.] Brigham & Womens Hosp, Div Renal, Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Winkelmayer, WC (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Ste 3-030, Boston, MA 02120 USA.	wwinkelmayer@partners.org			American Heart Association [0535232N]; National Institute on Aging [AG-027400]; NATIONAL INSTITUTE ON AGING [K25AG027400] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Winkelmayer is supported by Scientist Development Grant 0535232N from the American Heart Association. Dr Brookhart is supported by career development award AG-027400 from the National Institute on Aging.	Baibas N, 2005, J EPIDEMIOL COMMUN H, V59, P274, DOI 10.1136/jech.2004.025510; Brookhart MA, 2008, J AM SOC NEPHROL, V19, P1389, DOI 10.1681/ASN.2007111181; BUECHLEY RW, 1979, AM J EPIDEMIOL, V109, P663, DOI 10.1093/oxfordjournals.aje.a112729; *CDC WONDER, COMPR MORT FIL 1999; Dawn B, 2005, AM J PHYSIOL-HEART C, V289, pH522, DOI 10.1152/ajpheart.00274.2005; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Maxwell P, 2003, J AM SOC NEPHROL, V14, P2712, DOI 10.1097/01.ASN.0000092792.97122.E0; MORTIMER EA, 1977, NEW ENGL J MED, V296, P581, DOI 10.1056/NEJM197703172961101; REGENSTEINER JG, 1985, JAMA-J AM MED ASSOC, V253, P3124, DOI 10.1001/jama.253.21.3124; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; WEINBERG CR, 1987, RADIAT RES, V112, P381, DOI 10.2307/3577265	11	47	49	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					508	512		10.1001/jama.2009.84	http://dx.doi.org/10.1001/jama.2009.84			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402CS	19190315	Bronze			2022-12-01	WOS:000262992400020
J	Junker, JP; Ziegler, F; Rief, M				Junker, Jan Philipp; Ziegler, Fabian; Rief, Matthias			Ligand-Dependent Equilibrium Fluctuations of Single Calmodulin Molecules	SCIENCE			English	Article							FORCE SPECTROSCOPY; MECHANICAL STABILITY; APO-CALMODULIN; PROTEIN; BINDING; KINETICS; ADHESION; AFFINITY	Single- molecule force spectroscopy allows superb mechanical control of protein conformation. We used a custom- built low- drift atomic force microscope to observe mechanically induced conformational equilibrium fluctuations of single molecules of the eukaryotic calcium- dependent signal transducer calmodulin ( CaM). From this data, the ligand dependence of the full energy landscape can be reconstructed. We find that calcium ions affect the folding kinetics of the individual CaM domains, whereas target peptides stabilize the already folded structure. Single- molecule data of full length CaM reveal that a wasp venom peptide binds noncooperatively to CaM with 2: 1 stoichiometry, whereas a target enzyme peptide binds cooperatively with 1: 1 stoichiometry. If mechanical load is applied directly to the target peptide, real- time binding/ unbinding transitions can be observed.	[Rief, Matthias] Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Junker, Jan Philipp; Ziegler, Fabian; Rief, Matthias] Tech Univ Munich, Phys Dept E22, D-85748 Munich, Germany	University of Munich; Technical University of Munich	Rief, M (corresponding author), Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany.	mrief@ph.tum.de	Junker, Jan Philipp/A-9754-2010	Junker, Jan Philipp/0000-0002-2826-8290	Deutsche Forschungsgemeinschaft [RI 990/3-1]; International Graduate School "Materials Science of Complex Interfaces	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School "Materials Science of Complex Interfaces	We thank P. M. Bayley for inspiring discussions and A. Bausch, H. Gaub, M. Bertz, and M. Schlierf for helpful comments on the manuscript. This work was supported by Deutsche Forschungsgemeinschaft grant RI 990/3-1. J.P.J. was supported by the International Graduate School "Materials Science of Complex Interfaces."	Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Best RB, 2008, J AM CHEM SOC, V130, P3706, DOI 10.1021/ja0762691; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao Y, 2008, P NATL ACAD SCI USA, V105, P11152, DOI 10.1073/pnas.0803446105; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; LINSE S, 1986, FEBS LETT, V199, P28, DOI 10.1016/0014-5793(86)81217-0; MALENCIK DA, 1983, BIOCHEM BIOPH RES CO, V114, P50, DOI 10.1016/0006-291X(83)91592-9; Masino L, 2000, PROTEIN SCI, V9, P1519, DOI 10.1110/ps.9.8.1519; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Munoz V, 2007, ANNU REV BIOPH BIOM, V36, P395, DOI 10.1146/annurev.biophys.36.040306.132608; Ng SP, 2007, P NATL ACAD SCI USA, V104, P9633, DOI 10.1073/pnas.0609901104; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Rabl CR, 2002, BIOPHYS CHEM, V101, P553, DOI 10.1016/S0301-4622(02)00150-3; Schlierf M, 2007, BIOPHYS J, V93, P3989, DOI 10.1529/biophysj.107.114397; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	26	169	172	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					633	637		10.1126/science.1166191	http://dx.doi.org/10.1126/science.1166191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179531				2022-12-01	WOS:000262862800043
J	Kim, AH; Puram, SV; Bilimoria, PM; Ikeuchi, Y; Keough, S; Wong, M; Rowitch, D; Bonni, A				Kim, Albert H.; Puram, Sidharth V.; Bilimoria, Parizad M.; Ikeuchi, Yoshiho; Keough, Samantha; Wong, Michael; Rowitch, David; Bonni, Azad			A Centrosomal Cdc20-APC Pathway Controls Dendrite Morphogenesis in Postmitotic Neurons	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; MAMMALIAN BRAIN; AXONAL GROWTH; UBIQUITINATION; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; DEGRADATION; MECHANISMS; COMPONENTS	The ubiquitin ligase anaphase-promoting complex (APC) recruits the coactivator Cdc20 to drive mitosis in cycling cells. However, the nonmitotic functions of Cdc20-APC have remained unexplored. We report that Cdc20-APC plays an essential role in dendrite morphogenesis in postmitotic neurons. Knockdown of Cdc20 in cerebellar slices and in postnatal rats in vivo profoundly impairs the formation of granule neuron dendrite arbors in the cerebellar cortex. Remarkably, Cdc20 is enriched at the centrosome in neurons, and the centrosomal localization is critical for Cdc20-dependent dendrite development. We also find that the centrosome-associated protein histone deacetylase 6 (HDAC6) promotes the poly-ubiquitination of Cdc20, stimulates the activity of centrosomal Cdc20-APC, and drives the differentiation of dendrites. These findings define a postmitotic function for Cdc20-APC in the morphogenesis of dendrites in the mammalian brain. The identification of a centrosomal Cdc20-APC ubiquitin signaling pathway holds important implications for diverse biological processes, including neuronal connectivity and plasticity.	[Kim, Albert H.; Puram, Sidharth V.; Bilimoria, Parizad M.; Ikeuchi, Yoshiho; Keough, Samantha; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Puram, Sidharth V.; Bonni, Azad] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Bilimoria, Parizad M.; Bonni, Azad] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Kim, Albert H.] Childrens Hosp, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Wong, Michael; Rowitch, David] Univ Calif San Francisco, Howard Hughes Med Inst, Inst Regenerat Med, San Francisco, CA 94143 USA; [Rowitch, David] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Rowitch, David] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Ikeuchi, Yoshiho/N-1057-2019; ikeuchi, yoshiho/C-1713-2014	ikeuchi, yoshiho/0000-0002-2829-3840; Puram, Sidharth/0000-0003-3543-889X; Rowitch, David/0000-0002-0079-0060	National Institutes of Health [NS051255, NS41021]; National Research Service; National Cancer Institute; Brain Science Foundation; Albert J Ryan Foundation; Human Frontier Science Program Long-Term Fellowship; NATIONAL CANCER INSTITUTE [F32CA124028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021, R01NS051255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brain Science Foundation; Albert J Ryan Foundation; Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grants NS051255 and NS41021 (A. B.), a Ruth L. Kirschstein National Research Service Award research fellowship, the National Cancer Institute, and Brain Science Foundation grant (A. H. K.), the Albert J Ryan Foundation (P. B.), and a Human Frontier Science Program Long-Term Fellowship (Y.I.). We thank members of the Bonni laboratory for helpful discussions and critical reading of the manuscript.	ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; Becker EBE, 2005, SEMIN CELL DEV BIOL, V16, P439, DOI 10.1016/j.semcdb.2005.02.006; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gillingham AK, 2000, EMBO REP, V1, P524; GOSLIN K, 1998, RAT HIPPOCAMPAL NEUR; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; Hasskarl J, 2004, ONCOGENE, V23, P1930, DOI 10.1038/sj.onc.1207310; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2003, J NEUROSCI, V23, P1649; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pietromonaco SF, 1996, BLOOD CELL MOL DIS, V22, P225, DOI 10.1006/bcmd.1996.0103; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	32	150	152	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					322	336		10.1016/j.cell.2008.11.050	http://dx.doi.org/10.1016/j.cell.2008.11.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167333	Green Accepted, Bronze			2022-12-01	WOS:000262648800020
J	White, DB; Katz, MH; Luce, JM; Lo, B				White, Douglas B.; Katz, Mitchell H.; Luce, John M.; Lo, Bernard			Who Should Receive Life Support During a Public Health Emergency? Using Ethical Principles to Improve Allocation Decisions	ANNALS OF INTERNAL MEDICINE			English	Article							FAIR PROCESS; PANDEMIC INFLUENZA; CRITICALLY-ILL; CRITICAL-CARE; TRIAGE	A public health emergency, such as an influenza pandemic, will lead to shortages of mechanical ventilators, critical care beds, and other potentially life-saving treatments. Difficult decisions about who will and will not receive these scarce resources will have to be made. Existing recommendations reflect a narrow utilitarian perspective, in which allocation decisions are based primarily on patients' chances of survival to hospital discharge. Certain patient groups, such as the elderly and those with functional impairment, are denied access to potentially life-saving treatments on the basis of additional allocation criteria. We analyze the ethical principles that could guide allocation and propose an allocation strategy that incorporates and balances multiple morally relevant considerations, including saving the most lives, maximizing the number of "life-years" saved, and prioritizing patients who have had the least chance to live through life's stages. We also argue that these principles are relevant to all patients and therefore should be applied to all patients, rather than selectively to the elderly, those with functional impairment, and those with certain chronic conditions. We discuss strategies to engage the public in setting the priorities that will guide allocation of scarce life-sustaining treatments during a public health emergency.	[White, Douglas B.] Univ Calif San Francisco, Program Med Eth, Sch Med, San Francisco, CA 94143 USA; San Francisco Dept Publ Hlth, San Francisco, CA USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; San Francisco Department of Public Health; San Francisco General Hospital Medical Center	White, DB (corresponding author), Univ Calif San Francisco, Program Med Eth, Sch Med, 521 Parnassus Ave,Suite C-126,Box 0903, San Francisco, CA 94143 USA.	dwhite@medicine.ucsf.edu			National Center for Research Resources [KL2 RR024130]; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG032875] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By grant KL2 RR024130 from the National Center for Research Resources, a component of the NIH and NIH Roadmap for Medical Research and by the Greenwall Foundation.	Agency for Healthc.Res.Quality (AHRQ), 2005, AHRQ PUBL, V05-P022; Barnato AE, 2004, CRIT CARE CLIN, V20, P345, DOI 10.1016/j.ccc.2004.03.002; Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Burkle FM, 2002, EMERG MED CLIN N AM, V20, P409, DOI 10.1016/S0733-8627(01)00008-6; Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x; Childress JF, 2003, TRIAGE RESPONSE BIOT; Childress JF., 1970, SOUNDINGS, V53, P339; Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Daniels N, 2005, LANCET, V366, P169, DOI 10.1016/S0140-6736(05)66518-X; Daniels N, 1997, PHILOS PUBLIC AFF, V26, P303, DOI 10.1111/j.1088-4963.1997.tb00082.x; Danis M, 1997, CRIT CARE MED, V25, P887; *DEP HLTH HUM SERV, 2007, DRAFT GUID IN PRESS; Devereaux AV, 2008, CHEST, V133, p51S, DOI 10.1378/chest.07-2693; Egan TM, 2005, CHEST, V128, P407, DOI 10.1378/chest.128.1.407; Emanuel EJ, 2006, SCIENCE, V312, P854, DOI 10.1126/science.1125347; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Gostin L, 2006, JAMA-J AM MED ASSOC, V295, P1700, DOI 10.1001/jama.295.14.1700; Gostin LO, 2006, JAMA-J AM MED ASSOC, V295, P554, DOI 10.1001/jama.295.5.554; Gostin LO, 2002, JAMA-J AM MED ASSOC, V288, P622, DOI 10.1001/jama.288.5.622; Harris J, 1985, VALUE LIFE; Hick JL, 2006, ACAD EMERG MED, V13, P223, DOI [10.1111/j.1553-2712.2006.tb01677.x, 10.1197/j.aem.2005.07.037]; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; LEVINSKY NG, 1984, NEW ENGL J MED, V311, P1573, DOI 10.1056/NEJM198412133112412; Neuberger J, 1998, BMJ-BRIT MED J, V317, P172, DOI 10.1136/bmj.317.7152.172; Pesik N, 2001, ANN EMERG MED, V37, P642, DOI 10.1067/mem.2001.114316; PHILLIPS SJ, 2006, AHRQ PUBLICATION; Powell T, 2008, DISASTER MED PUBLIC, V2, P20, DOI 10.1097/DMP.0b013e3181620794; *PUBL ENG PIL PROJ, 2005, CIT VOIC PAND FLU CH; Ramsey Paul., 1970, PATIENT PERSON EXPLO; Repine TB, 2005, MIL MED, V170, P505, DOI 10.7205/MILMED.170.6.505; RESCHER N, 1969, ETHICS, V79, P173, DOI 10.1086/291723; Rubinson L, 2005, CRIT CARE MED, V33, P2393, DOI 10.1097/01.CCM.0000173411.06574.D5; SANDERS D, 1968, UCLA LAW REV, V15, P357; Shortt SED, 1999, CAN MED ASSOC J, V161, P823; TANNER L, 2008, WASHINGTON POST 0505; Toner E, 2006, BIOSECUR BIOTERROR, V4, P207, DOI 10.1089/bsp.2006.4.207; vandenBos K, 1997, J PERS SOC PSYCHOL, V72, P1034, DOI 10.1037/0022-3514.72.5.1034; Veatch RM, 1997, KENNEDY INST ETHIC J, V7, P391, DOI 10.1353/ken.1997.0041; Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B	41	183	195	1	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					132	U94		10.7326/0003-4819-150-2-200901200-00011	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397ID	19153413	Green Accepted			2022-12-01	WOS:000262655200008
J	Geuking, MB; Weber, J; Dewannieux, M; Gorelik, E; Heidmann, T; Hengartner, H; Zinkernagel, RM; Hangartner, L				Geuking, Markus B.; Weber, Jacqueline; Dewannieux, Marie; Gorelik, Elieser; Heidmann, Thierry; Hengartner, Hans; Zinkernagel, Rolf M.; Hangartner, Lars			Recombination of Retrotransposon and Exogenous RNA Virus Results in Nonretroviral cDNA Integration	SCIENCE			English	Article							GENE-EXPRESSION; GERM-LINE; CELLS; ACTIVATION; GENOME; IDENTIFICATION; SEQUENCES; ONCOGENE; LEUKEMIA; ELEMENTS	Retroviruses have the potential to acquire host cell-derived genetic material during reverse transcription and can integrate into the genomes of larger, more complex DNA viruses. In contrast, RNA viruses were believed not to integrate into the host's genome under any circumstances. We found that illegitimate recombination between an exogenous nonretroviral RNA virus, lymphocytic choriomeningitis virus, and the endogenous intracisternal A-type particle (IAP) retrotransposon occurred and led to reverse transcription of exogenous viral RNA. The resulting complementary DNA was integrated into the host's genome with an IAP element. Thus, RNA viruses should be closely scrutinized for any capacity to interact with endogenous retroviral elements before their approval for therapeutic use in humans.	[Geuking, Markus B.; Weber, Jacqueline; Hengartner, Hans; Zinkernagel, Rolf M.; Hangartner, Lars] Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Dewannieux, Marie; Heidmann, Thierry] Inst Gustave Roussy, CNRS, Unite Mixte Rech 8122, Unite Retrovirus Endogenes & Elements Retroides E, F-94805 Villejuif, France; [Dewannieux, Marie; Heidmann, Thierry] Univ Paris 11, F-91405 Orsay, France; [Gorelik, Elieser] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15232 USA	University of Zurich; University Zurich Hospital; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Geuking, MB (corresponding author), McMaster Univ, Dept Med, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	geuking@mcmaster.ca; rolf.zinkernagel@usz.ch; hangartner.lars@virology.uzh.ch	Hangartner, Lars/AAS-1320-2021; Hangartner, Lars/H-3503-2011	Hangartner, Lars/0000-0002-3165-2058; Dewannieux, Marie/0000-0003-3918-2414	Swiss National Science Foundation; Canton of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Zurich	We are very grateful to K. K. Lueders for providing plasmids and critically reading the manuscript. We thank A. Macpherson, K. McCoy, and D. Burton for their support. We would also like to thank K. McCoy for critically reading the manuscript and for helpful comments. This study was supported by the Swiss National Science Foundation and the Canton of Zurich. M. B. G. planned and performed the experiments and wrote the paper together with L. H.; J. W. performed experiments; M. D., E. G., and T. H. provided reagents, cell lines, or plasmids; H. H. and R. M. Z. were involved in the planning and discussions of experiments, helped to write the paper, and provided the infrastructure used for this study; and L. H. initiated and supervised the study, planned and conducted experiments, and wrote the paper together with M. B. G. Sequences depicted in Fig. 1 are available from GenBank under accession numbers FJ460582 (MC57.18) and FJ460583 (MC57.23).	Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Braun E, 2000, VIROLOGY, V277, P136, DOI 10.1006/viro.2000.0568; CANAANI E, 1983, P NATL ACAD SCI-BIOL, V80, P7118, DOI 10.1073/pnas.80.23.7118; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Dupressoir A, 1996, MOL CELL BIOL, V16, P4495; Ishihara H, 2004, J RADIAT RES, V45, P25, DOI 10.1269/jrr.45.25; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; KUFF EL, 1983, NATURE, V302, P547, DOI 10.1038/302547a0; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; KUFF EL, 1985, MOL CELL BIOL, V5, P474, DOI 10.1128/MCB.5.3.474; Lehmann- Grube F, 1971, VIROLOGY MONOGRAPHS; LESLIE KB, 1991, MOL CELL BIOL, V11, P5562, DOI 10.1128/MCB.11.11.5562; Li MF, 1996, J GEN VIROL, V77, P2757, DOI 10.1099/0022-1317-77-11-2757; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; ONO M, 1983, NUCLEIC ACIDS RES, V11, P7169, DOI 10.1093/nar/11.20.7169; Recher M, 2007, NAT MED, V13, P1316, DOI 10.1038/nm1670; Wang XY, 1997, CYTOKINES CELL MOL T, V3, P3	19	105	112	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2009	323	5912					393	396		10.1126/science.1167375	http://dx.doi.org/10.1126/science.1167375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150848				2022-12-01	WOS:000262481400042
J	Boulton, AJM; Jeffcoate, WJ; Jones, TLZ; Ulbrecht, JS				Boulton, Andrew J. M.; Jeffcoate, William J.; Jones, Teresa L. Z.; Ulbrecht, Jon S.			International collaborative research on Charcot's disease	LANCET			English	Editorial Material									[Jeffcoate, William J.] Nottingham Univ Hosp Trust, Foot Ulcer Trials Unit, Dept Diabet & Endocrinol, Nottingham NG5 1PB, England; [Boulton, Andrew J. M.] Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England; [Jones, Teresa L. Z.] NIDDK, DEM, NIH, Bethesda, MD USA; [Ulbrecht, Jon S.] Penn State Univ, Penn State Inst Diabet & Obes, University Pk, PA 16802 USA	Nottingham University Hospital NHS Trust; University of Nottingham; University of Manchester; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park	Jeffcoate, WJ (corresponding author), Nottingham Univ Hosp Trust, Foot Ulcer Trials Unit, Dept Diabet & Endocrinol, City Hosp Campus, Nottingham NG5 1PB, England.	william.jeffcoate@tiscali.co.uk						Jeffcoate WJ, 2005, LANCET, V366, P2058, DOI 10.1016/S0140-6736(05)67029-8	1	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2009	373	9658					105	106		10.1016/S0140-6736(09)60019-2	http://dx.doi.org/10.1016/S0140-6736(09)60019-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135599				2022-12-01	WOS:000262340900009
J	Davis, JM; Ramakrishnan, L				Davis, J. Muse; Ramakrishnan, Lalita			The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection	CELL			English	Article							MYCOBACTERIUM-MARINUM INFECTION; HUMAN MACROPHAGES; CELL-DEATH; CALMETTE-GUERIN; IN-VIVO; APOPTOSIS; IMMUNITY; ZEBRAFISH; PATHOGENESIS; VIRULENCE	Granulomas, organized aggregates of immune cells, form in response to persistent stimuli and are hallmarks of tuberculosis. Tuberculous granulomas have long been considered host-protective structures formed to contain infection. However, work in zebrafish infected with Mycobacterium marinum suggests that granulomas contribute to early bacterial growth. Here we use quantitative intravital microscopy to reveal distinct steps of granuloma formation and assess their consequence for infection. Intracellular mycobacteria use the ESX-1/RD1 virulence locus to induce recruitment of new macrophages to, and their rapid movement within, nascent granulomas. This motility enables multiple arriving macrophages to efficiently find and phagocytose infected macrophages undergoing apoptosis, leading to rapid, iterative expansion of infected macrophages and thereby bacterial numbers. The primary granuloma then seeds secondary granulomas via egress of infected macrophages. Our direct observations provide insight into how pathogenic mycobacteria exploit the granuloma during the innate immune phase for local expansion and systemic dissemination.	[Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Davis, J. Muse] Emory Univ, Immunol & Mol Pathogenesis Grad Program, Atlanta, GA 30322 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	lalitar@u.washington.edu		Davis, J. Muse/0000-0001-9959-6921; Ramakrishnan, Lalita/0000-0003-0692-5533	NIH [RO1 AI54503, RO1 AI36396]; Burroughs Wellcome Foundation; American Society for Engineering Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054503, R01AI054503, R01AI036396] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); American Society for Engineering Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Troll for mathematical modelling, K. Winglee for data analysis, G. MacDonald, G. Davis, and F. Peri for technical advice, O. Humbert for initial observations, and B. Cormack, P. Edelstein, K. Urdahl, J. Egen, E. Brown, D. Tobin, H. Clay, H. Volkman, R. Lesley, and C. Cosma for discussion and critical comments. J. M. D. is grateful to R. Ahmed and to the late H. K. Ziegler for guidance. This work was supported by NIH RO1 grants AI54503 and AI36396 and the Burroughs Wellcome Foundation (L.R.) and an American Society for Engineering Education predoctoral fellowship (J.M.D.).	ADAMS DO, 1976, AM J PATHOL, V84, P164; ADAMS DO, 1975, AM J PATHOL, V80, P101; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Andersen P, 1997, SCAND J IMMUNOL, V45, P115, DOI 10.1046/j.1365-3083.1997.d01-380.x; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; BALASUBRAMANIAN V, 1994, TUBERCLE LUNG DIS, V75, P168, DOI 10.1016/0962-8479(94)90002-7; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chan K, 2002, P NATL ACAD SCI USA, V99, P3920, DOI 10.1073/pnas.002024599; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Cosma C. L., 2006, CURRENT PROTOCOLS MI, DOI 10.1002/; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; CREE IA, 1987, J CLIN PATHOL, V40, P1314, DOI 10.1136/jcp.40.11.1314; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Dannenberg AM, 2003, TUBERCULOSIS, V83, P251, DOI 10.1016/S1472-9792(03)00048-9; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Ernst JD, 2007, J CLIN INVEST, V117, P1738, DOI 10.1172/JCI31810; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kahnert A, 2007, J INFECT DIS, V195, P46, DOI 10.1086/508894; KAUFMANN SHE, 1994, IMMUNOBIOLOGY, V191, P509, DOI 10.1016/S0171-2985(11)80457-2; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lesley R, 2008, CURR OPIN MICROBIOL, V11, P277, DOI 10.1016/j.mib.2008.05.013; Miller EA, 2008, IMMUNITY, V29, P175, DOI 10.1016/j.immuni.2008.07.003; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Oddo M, 1998, J IMMUNOL, V160, P5448; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Peters W, 2003, MICROBES INFECT, V5, P151, DOI 10.1016/S1286-4579(02)00082-5; Rich AR, 1946, PATHOGENESIS TUBERCU; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Sherman DR, 2004, J INFECT DIS, V190, P123, DOI 10.1086/421472; Stamm LA, 2004, MICROBES INFECT, V6, P1418, DOI 10.1016/j.micinf.2004.10.003; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; STANLEY SA, 2003, SCIENCE, V296, P1873; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Webb SE, 1996, J CELL SCI, V109, P793; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	62	582	606	2	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					37	49		10.1016/j.cell.2008.11.014	http://dx.doi.org/10.1016/j.cell.2008.11.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135887	Green Accepted, Bronze			2022-12-01	WOS:000262318400013
J	Narbonne, P; Roy, R				Narbonne, Patrick; Roy, Richard			Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival	NATURE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; C-ELEGANS; LIFE-SPAN; SIGNALING PATHWAY; GENE-EXPRESSION; TISSUE; RESTRICTION; METABOLISM; HYPODERMIS; LONGEVITY	Many organisms can enter a dormant state or diapause to survive harsh environmental conditions for extended durations. When Caenorhabditis elegans larvae enter dauer they arrest feeding but remain active and motile, yet become stress- resistant, extremely long- lived and non- ageing(1). Entry into dauer is associated with a reduction in insulin- like signalling, the accumulation of nutritive resources and a concomitant global change in metabolism(2-5), yet the precise molecular and physiological processes that enable long- term survival in the absence of caloric intake remain largely unknown. We show here that C. elegans larvae that lack LKB1/ AMPK (AMP-activated protein kinase) signalling enter dauer normally, but then rapidly consume their stored energy and prematurely expire following vital organ failure. We found that this signalling pathway acts in adipose- like tissues to downregulate triglyceride hydrolysis so that these lipid reserves are rationed to last the entire duration of the arrest. Indeed, the downregulation of adipose triglyceride lipase (ATGL-1) activity suppresses both the rapid depletion of stored lipids and reduced life span of AMPK mutant dauers, while AMPK directly phosphorylates ATGL-1. Finally, we show that the slow release of energy during dauer is critical for appropriate long- term osmoregulation, which fails as triglyceride resources become depleted. These mechanisms may be essential for survival through diapause, hibernation, or long- term fasting in diverse organisms and may also underlie AMPK- dependent life span extension.	[Narbonne, Patrick; Roy, Richard] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Roy, R (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	richard.roy@mcgill.ca			Canadian Cancer Society; Canadian Institutes of Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank A. Fire, O. Hobert, I. Greenwald, D. Baillie, K. Nehrke, J. McGhee, M. Han, S. Li, E. Colella, M. Hebeisen, J. Ouellet, A. Shingina, M. Maduro, F. Solari, E. Greer, J. Lapointe, W. Yang and S. Hekimi for reagents, strains, constructs, help, advice and support. Some of the strains that were used in this analysis came from the Caenorhabditis Genetic Center (CGC), the C. elegans Gene Knockout Consortium, the Japan National Bioresource Project, and the Genome BC C. elegans Gene Expression Consortium. This work was supported by research grants from the Canadian Cancer Society and the Canadian Institutes of Health Research (CIHR) to R.R. P.N. is a recipient of an NSERC studentship. R. R. is a CIHR New Investigator.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fukushige T, 1999, P NATL ACAD SCI USA, V96, P11883, DOI 10.1073/pnas.96.21.11883; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Huang P, 2004, DEVELOPMENT, V131, P2595, DOI 10.1242/dev.01135; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; MADURO M, 1995, GENETICS, V141, P977; Masse I, 2005, DEV BIOL, V286, P91, DOI 10.1016/j.ydbio.2005.07.010; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Myers TR, 2005, DEV CELL, V8, P117, DOI 10.1016/j.devcel.2004.11.015; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; OKKEMA PG, 1993, GENETICS, V135, P385; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sherman T, 2005, AM J PHYSIOL-CELL PH, V289, pC341, DOI 10.1152/ajpcell.00071.2005; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	30	231	247	5	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					210	U108		10.1038/nature07536	http://dx.doi.org/10.1038/nature07536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19052547				2022-12-01	WOS:000262360200036
J	Grossman, D				Grossman, Daniel			Should the contraceptive pill be available without prescription? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							ORAL-CONTRACEPTIVES; HORMONAL CONTRACEPTION; NATIONAL-SURVEY; UNITED-STATES; WOMENS; ACCESS; MEXICO; GUIDELINES; ATTITUDES; FAILURE		[Grossman, Daniel] Ibis Reprod Hlth, San Francisco, CA USA; [Grossman, Daniel] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Grossman, D (corresponding author), Ibis Reprod Hlth, San Francisco, CA USA.	DGrossman@ibisreproductivehealth.org	Potter, Joseph E/A-3122-2008					Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Editorial, 2008, LANCET, V371, P275; Foster DG, 2006, OBSTET GYNECOL, V108, P1107, DOI 10.1097/01.AOG.0000239122.98508.39; Gardner JS, 2008, J AM PHARM ASSOC, V48, P212, DOI 10.1331/JAPhA.2008.07138; Gianfrancesco F., 2002, DRUG BENEFIT TRENDS, V14, P13; Gianfrancesco F, 2002, DRUG BENEFIT TRENDS, V14, P44; Glasier A, 2008, J FAM PLAN REPROD H, V34, P213, DOI 10.1783/147118908786000497; Grossman D, 2006, AM J PUBLIC HEALTH, V96, P791, DOI 10.2105/AJPH.2004.040774; Grossman D, 2008, OBSTET GYNECOL, V112, P572, DOI 10.1097/AOG.0b013e31818345f0; Kost K, 2008, CONTRACEPTION, V77, P10, DOI 10.1016/j.contraception.2007.09.013; Landau SC, 2006, CONTRACEPTION, V74, P463, DOI 10.1016/j.contraception.2006.07.006; Moos MK, 2003, CONTRACEPTION, V67, P115, DOI 10.1016/S0010-7824(02)00472-9; *NAT I REPR HLTH, EXP MED COV EC STAT; *POP REF BUR, FAM PLANN WORLDW 200; Schwingl PJ, 1999, AM J OBSTET GYNECOL, V180, P241, DOI 10.1016/S0002-9378(99)70182-1; Shah MA, 2001, INT J GYNECOL OBSTET, V73, P243, DOI 10.1016/S0020-7292(01)00375-7; Shotorbani S, 2006, CONTRACEPTION, V73, P501, DOI 10.1016/j.contraception.2005.12.001; Smith JD, 2005, J MIDWIFERY WOM HEAL, V50, P380, DOI 10.1016/j.jmwh.2005.01.011; Stewart FH, 2001, JAMA-J AM MED ASSOC, V285, P2232, DOI 10.1001/jama.285.17.2232; Tatum C, 2005, CONTRACEPTION, V71, P208, DOI 10.1016/j.contraception.2004.08.018; Trussell J, 2004, CONTRACEPTION, V70, P89, DOI 10.1016/j.contraception.2004.03.009; WHO, 2004, MED EL CRIT CONTR US, V3; Yeatman SE, 2006, STUD FAMILY PLANN, V37, P197, DOI 10.1111/j.1728-4465.2006.00098.x; ZAVALA AS, 1987, STUD FAMILY PLANN, V18, P284, DOI 10.2307/1966857	24	7	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 23	2008	337								a3044	10.1136/bmj.a3044	http://dx.doi.org/10.1136/bmj.a3044			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394EL	19106138				2022-12-01	WOS:000262428400003
J	Ehlmann, BL; Mustard, JF; Murchie, SL; Poulet, F; Bishop, JL; Brown, AJ; Calvin, WM; Clark, RN; Des Marais, DJ; Milliken, RE; Roach, LH; Roush, TL; Swayze, GA; Wray, JJ				Ehlmann, Bethany L.; Mustard, John F.; Murchie, Scott L.; Poulet, Francois; Bishop, Janice L.; Brown, Adrian J.; Calvin, Wendy M.; Clark, Roger N.; Des Marais, David J.; Milliken, Ralph E.; Roach, Leah H.; Roush, Ted L.; Swayze, Gregg A.; Wray, James J.			Orbital Identification of Carbonate-Bearing Rocks on Mars	SCIENCE			English	Article							MINERALS; CLIMATE; TEMPERATURE; PRODUCTS; SULFATES; OLIVINE; SYSTEM; MODEL	Geochemical models for Mars predict carbonate formation during aqueous alteration. Carbonate- bearing rocks had not previously been detected on Mars' surface, but Mars Reconnaissance Orbiter mapping reveals a regional rock layer with near- infrared spectral characteristics that are consistent with the presence of magnesium carbonate in the Nili Fossae region. The carbonate is closely associated with both phyllosilicate- bearing and olivine- rich rock units and probably formed during the Noachian or early Hesperian era from the alteration of olivine by either hydrothermal fluids or near- surface water. The presence of carbonate as well as accompanying clays suggests that waters were neutral to alkaline at the time of its formation and that acidic weathering, proposed to be characteristic of Hesperian Mars, did not destroy these carbonates and thus did not dominate all aqueous environments.	[Ehlmann, Bethany L.; Mustard, John F.; Roach, Leah H.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Murchie, Scott L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Poulet, Francois] Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; [Bishop, Janice L.; Brown, Adrian J.] SETI Inst, Mountain View, CA 94043 USA; [Bishop, Janice L.; Brown, Adrian J.; Des Marais, David J.; Roush, Ted L.] NASA, Ames Res Ctr, Mountain View, CA 94043 USA; [Calvin, Wendy M.] Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA; [Clark, Roger N.; Swayze, Gregg A.] US Geol Survey, Lakewood, CO 80225 USA; [Milliken, Ralph E.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Wray, James J.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	Brown University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University	Ehlmann, BL (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.		Murchie, Scott L/E-8030-2015; Brown, Adrian Jon/AAC-5047-2022; Wray, James J/B-8457-2008	Murchie, Scott L/0000-0002-1616-8751; Wray, James J/0000-0001-5559-2179; Bishop, Janice/0000-0002-6681-9954; Calvin, Wendy/0000-0002-6097-9586	NASA/Keck Reflectance Experiment Laboratory (RELAB) spectral database	NASA/Keck Reflectance Experiment Laboratory (RELAB) spectral database(National Aeronautics & Space Administration (NASA))	We thank R. Arvidson, R. Morris, N. Mangold, A. Baldridge, J.-P. Bibring, D. Jouglet, A. Fraeman, S. Wiseman, A. McEwen, G. Marzo, P. McGuire, and M. Wyatt for thoughtful discussions during manuscript preparation and E. Cloutis and others who have made quality spectral libraries available and contributed to the building of the NASA/Keck Reflectance Experiment Laboratory (RELAB) spectral database. We are grateful for the ongoing efforts of the MRO science and engineering teams, in particular the CRISM team, which enable these discoveries.	Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; BLANEY DL, 1989, J GEOPHYS RES-SOLID, V94, P10159, DOI 10.1029/JB094iB08p10159; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Bullock MA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030688; Burns R. G., 1993, MINERALOGICAL APPL C; CALVIN WM, 1994, J GEOPHYS RES-PLANET, V99, P14659, DOI 10.1029/94JE01090; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; Chevrier V, 2007, NATURE, V448, P60, DOI 10.1038/nature05961; CHRISTENSEN PR, 2003, 6 INT C MARS LUN PLA; Clark R.N., 2007, USGS DIGITAL DATA SE, V231; CLOUTIS EA, 2000, LUNAR PLANET SCI C, V31; Ehlmann BL, 2008, NAT GEOSCI, V1, P355, DOI 10.1038/ngeo207; EHLMANN BL, 2007, 7 INT C MARS LUN PLA; Fairen AG, 2004, NATURE, V431, P423, DOI 10.1038/nature02911; GAFFEY SJ, 1987, J GEOPHYS RES-SOLID, V92, P1429, DOI 10.1029/JB092iB02p01429; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; Greeley R., 1987, GEOLOGICAL MAP E EQU; Hanchen M, 2008, CHEM ENG SCI, V63, P1012, DOI 10.1016/j.ces.2007.09.052; Halevy I, 2007, SCIENCE, V318, P1903, DOI 10.1126/science.1147039; Hamilton VE, 2005, GEOLOGY, V33, P433, DOI 10.1130/G21258.1; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Hunt G. R., 1971, Modern Geology, V2, P23; Hurowitz JA, 2007, EARTH PLANET SC LETT, V260, P432, DOI 10.1016/j.epsl.2007.05.043; JOUGLET D, 2007, 7 INT C MARS LUN PLA; JULL AJT, 1988, SCIENCE, V242, P417, DOI 10.1126/science.242.4877.417; Koeppen WC, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002984; Konigsberger E, 1999, GEOCHIM COSMOCHIM AC, V63, P3105, DOI 10.1016/S0016-7037(99)00238-0; Lellouch E, 2000, PLANET SPACE SCI, V48, P1393, DOI 10.1016/S0032-0633(00)00118-5; Mangold N, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002835; Melezhik VA, 2001, SEDIMENTOLOGY, V48, P379, DOI 10.1046/j.1365-3091.2001.00369.x; Mukhin LM, 1996, NATURE, V379, P141, DOI 10.1038/379141a0; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Mustard JF, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002834; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; Parente M., 2008, LUNAR PLANET SCI C, VXXXIX; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; Poulet F, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002840; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Poulet F., 2007, 7 INT C MARS LUN PLA; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Tornabene LL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002988; Tosca NJ, 2008, SCIENCE, V320, P1204, DOI 10.1126/science.1155432; Wagner C, 1996, ICARUS, V123, P256, DOI 10.1006/icar.1996.0156	45	470	477	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1828	1832		10.1126/science.1164759	http://dx.doi.org/10.1126/science.1164759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095939				2022-12-01	WOS:000261799400050
J	Gebauer, D; Volkel, A; Colfen, H				Gebauer, Denis; Voelkel, Antje; Coelfen, Helmut			Stable Prenucleation Calcium Carbonate Clusters	SCIENCE			English	Article							BIOMINERALIZATION; NUCLEATION	Calcium carbonate forms scales, geological deposits, biominerals, and ocean sediments. Huge amounts of carbon dioxide are retained as carbonate ions, and calcium ions represent a major contribution to water hardness. Despite its relevance, little is known about the precipitation mechanism of calcium carbonate, and specified complex crystal structures challenge the classical view on nucleation considering the formation of metastable ion clusters. We demonstrate that dissolved calcium carbonate in fact contains stable prenucleation ion clusters forming even in undersaturated solution. The cluster formation can be characterized by means of equilibrium thermodynamics, applying a multiple- binding model, which allows for structural preformation. Stable clusters are the relevant species in calcium carbonate nucleation. Such mechanisms may also be important for the crystallization of other minerals.	[Gebauer, Denis; Voelkel, Antje; Coelfen, Helmut] Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	Max Planck Society	Colfen, H (corresponding author), Max Planck Inst Colloids & Interfaces, Res Campus Golm,Muhlenberg 1, D-14424 Potsdam, Germany.	coelfen@mpikg.mpg.de	Gebauer, Denis/H-2408-2011	Gebauer, Denis/0000-0003-1612-051X	German Science Foundation [1117]; Max Planck Society	German Science Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	Financial support by the German Science Foundation priority program 1117 "Principles of Biomineralization" and the Max Planck Society are gratefully acknowledged. We thank M. Antonietti (MPI) and P. Bowen (Ecole Polytechnique Federale de Lausanne, Switzerland) for valuable discussions on the manuscript, A. Verch (MPI) for experimental assistance, and O. Paris and I. Zenke (both MPI) for SAXS analysis. D. G. thanks T. Ketterer and J. Thomas of Deutsche Metrohm for technical assistance.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Becker R, 1935, ANN PHYS-BERLIN, V24, P719; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; Casey WH, 2003, REV GEOPHYS, V41, DOI 10.1029/2002RG000118; De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057; Faatz M, 2004, ADV MATER, V16, P996, DOI 10.1002/adma.200306565; Furrer G, 2002, SCIENCE, V297, P2245, DOI 10.1126/science.1076505; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Hasse B, 2000, CHEM-EUR J, V6, P3679, DOI 10.1002/1521-3765(20001016)6:20<3679::AID-CHEM3679>3.0.CO;2-#; Horn D, 2001, ANGEW CHEM INT EDIT, V40, P4331; Izmailov AF, 1999, J CRYST GROWTH, V196, P234, DOI 10.1016/S0022-0248(98)00830-6; Knezic D, 2004, J PHYS CHEM B, V108, P10672, DOI 10.1021/jp049586s; Lam RSK, 2007, CRYSTENGCOMM, V9, P1226, DOI 10.1039/b710895h; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; LARSON MA, 1991, ADVANCES IN INDUSTRIAL CRYSTALLIZATION, P20; LARSON MA, 1986, CHEM ENG SCI, V41, P1285, DOI 10.1016/0009-2509(86)87101-9; Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Perry CC, 2003, REV MINERAL GEOCHEM, V54, P291, DOI 10.2113/0540291; Politi Y, 2006, ADV FUNCT MATER, V16, P1289, DOI 10.1002/adfm.200600134; Quigley D., 2008, J CHEM PHYS, V128, P4; Rieger J, 2007, FARADAY DISCUSS, V136, P265, DOI 10.1039/b701450c; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sinn CG, 2004, MACROMOLECULES, V37, P3444, DOI 10.1021/ma030550s; Volmer M, 1939, KINETIK PHASENBILDUN; Xu AW, 2007, J MATER CHEM, V17, P415, DOI 10.1039/b611918m; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124	27	1101	1118	39	709	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1819	1822		10.1126/science.1164271	http://dx.doi.org/10.1126/science.1164271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095936	Green Submitted			2022-12-01	WOS:000261799400047
J	Seila, AC; Calabrese, JM; Levine, SS; Yeo, GW; Rahl, PB; Flynn, RA; Young, RA; Sharp, PA				Seila, Amy C.; Calabrese, J. Mauro; Levine, Stuart S.; Yeo, Gene W.; Rahl, Peter B.; Flynn, Ryan A.; Young, Richard A.; Sharp, Phillip A.			Divergent Transcription from Active Promoters	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; GENE-EXPRESSION; GENOME; POLYCOMB	Transcription initiation by RNA polymerase II ( RNAPII) is thought to occur unidirectionally from most genes. Here, we present evidence of widespread divergent transcription at protein- encoding gene promoters. Transcription start site- associated RNAs ( TSSa- RNAs) nonrandomly flank active promoters, with peaks of antisense and sense short RNAs at 250 nucleotides upstream and 50 nucleotides downstream of TSSs, respectively. Northern analysis shows that TSSa- RNAs are subsets of an RNA population 20 to 90 nucleotides in length. Promoter- associated RNAPII and H3K4- trimethylated histones, transcription initiation hallmarks, colocalize at sense and antisense TSSa- RNA positions; however, H3K79- dimethylated histones, characteristic of elongating RNAPII, are only present downstream of TSSs. These results suggest that divergent transcription over short distances is common for active promoters and may help promoter regions maintain a state poised for subsequent regulation.	[Seila, Amy C.; Calabrese, J. Mauro; Flynn, Ryan A.; Sharp, Phillip A.] MIT, Robert Koch Inst, Cambridge, MA 02139 USA; [Calabrese, J. Mauro; Young, Richard A.; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Levine, Stuart S.; Rahl, Peter B.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Yeo, Gene W.] Crick Jacobs Ctr Theoret & Computat Biol, Salk Inst, La Jolla, CA 92037 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Salk Institute	Sharp, PA (corresponding author), MIT, Robert Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu	Young, Richard A/F-6495-2012; Yeo, Gene/AAE-7676-2019	Young, Richard A/0000-0001-8855-8647; Yeo, Gene/0000-0002-0799-6037; Flynn, Ryan/0000-0001-5013-0442; Levine, Stuart/0000-0001-7363-562X	NIH [5-F32-HD051190, RO1-GM34277, HG002668]; Crick-Jacobs Center for Computational Biology; NCI Cancer Center Support (core) [PO1- CA42063, P30- CA14051]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD051190] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA042063, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crick-Jacobs Center for Computational Biology; NCI Cancer Center Support (core)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Zheng, C. Whittaker, S. Hoersch, and A.F. Seila. A.C.S. was supported by NIH postdoctoral fellowship 5-F32-HD051190 and G.W.Y. by the Crick-Jacobs Center for Computational Biology. This work was supported by NIH grants RO1-GM34277 and HG002668, NCI grant PO1- CA42063, and the NCI Cancer Center Support (core) grant P30- CA14051. The data discussed in this publication have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus under accession numbers GSE13483 and GSE12680.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Kays AR, 2000, CHEM BIOL, V7, P601, DOI 10.1016/S1074-5521(00)00009-0; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; XIAO H, 1994, NUCLEIC ACIDS RES, V22, P1966, DOI 10.1093/nar/22.11.1966	16	658	684	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1849	1851		10.1126/science.1162253	http://dx.doi.org/10.1126/science.1162253			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056940	Green Accepted			2022-12-01	WOS:000261799400056
J	Box, JA; Bunch, JT; Tang, W; Baumann, P				Box, Jessica A.; Bunch, Jeremy T.; Tang, Wen; Baumann, Peter			Spliceosomal cleavage generates the 3 ' end of telomerase RNA	NATURE			English	Article							PRE-MESSENGER-RNA; FISSION YEAST TELOMERASE; SMALL NUCLEOLAR RNAS; SCHIZOSACCHAROMYCES-POMBE; DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; MUTATIONAL ANALYSIS; CATALYTIC SUBUNIT; APLASTIC-ANEMIA; U1 SNRNA	Telomeres cap the ends of chromosomes and provide a means to complete replication. The DNA portion of telomeres is synthesized by the enzyme telomerase using part of an RNA subunit as a template for reverse transcription. How the mature 39 end of telomerase RNA is generated has so far remained elusive. Here we show that in Schizosaccharomyces pombe telomerase RNA transcripts must be processed to generate functional telomerase. Characterization of the maturation pathway uncovered an unexpected role for the spliceosome, which normally catalyses splicing of pre- messenger RNA. The first spliceosomal cleavage reaction generates the mature 39 end of telomerase RNA ( TER1, the functional RNA encoded by the ter1(+) gene), releasing the active form of the RNA without exon ligation. Blocking the first step or permitting completion of splicing generates inactive forms of TER1 and causes progressive telomere shortening. We establish that 39 end processing of TER1 is critical for telomerase function and describe a previously unknown mechanism for RNA maturation that uses the ability of the spliceosome to mediate site- specific cleavage.	[Box, Jessica A.; Bunch, Jeremy T.; Tang, Wen; Baumann, Peter] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Tang, Wen; Baumann, Peter] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Baumann, P (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	peb@stowers-institute.org		Baumann, Peter/0000-0003-4892-1485	Stowers Institute for Medical Research; Pew Scholars; Biomedical Sciences Award	Stowers Institute for Medical Research; Pew Scholars; Biomedical Sciences Award	The authors thank H. Yang and the other members of the Baumann laboratory for help and discussions, Y. Tzfati and L. Tomaska for sharing results before publication, and A. Berglund, M. Blanchette, R. Conaway and T. Cech for discussions and comments on the manuscript. We also thank the Molecular Biology Core Facility for site- directed mutagenesis and sequencing, M. Gogol and R. Voelker for computational analysis, and D. Baumann and R. Helston for proofreading of the manuscript. This work was funded by the Stowers Institute for Medical Research and a Pew Scholars in the Biomedical Sciences Award to P. B.	Alvarez CJ, 1996, RNA, V2, P404; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Box JA, 2008, J BIOL CHEM, V283, P24224, DOI 10.1074/jbc.M802043200; Bunch JT, 2005, MOL CELL BIOL, V25, P5567, DOI 10.1128/mcb.25.13.5567-5578.2005; Burge C.B., 1999, RNA WORLD, V37, P525; Chapon C, 1997, RNA, V3, P1337; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; DOMDEY H, 1984, CELL, V39, P611, DOI 10.1016/0092-8674(84)90468-9; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Li SG, 2005, J BIOL CHEM, V280, P16446, DOI 10.1074/jbc.M500326200; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Romfo CM, 1997, NUCLEIC ACIDS RES, V25, P4658, DOI 10.1093/nar/25.22.4658; SERAPHIN B, 1989, GENE, V82, P145, DOI 10.1016/0378-1119(89)90039-5; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; SILICIANO PG, 1988, GENE DEV, V2, P1258, DOI 10.1101/gad.2.10.1258; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; ZHANG MQ, 1994, NUCLEIC ACIDS RES, V22, P1750, DOI 10.1093/nar/22.9.1750; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	34	76	78	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					910	U71		10.1038/nature07584	http://dx.doi.org/10.1038/nature07584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19052544				2022-12-01	WOS:000261768300036
J	Lebreton, A; Tomecki, R; Dziembowski, A; Seraphin, B				Lebreton, Alice; Tomecki, Rafal; Dziembowski, Andrzej; Seraphin, Bertrand			Endonucleolytic RNA cleavage by a eukaryotic exosome	NATURE			English	Article							MESSENGER-RNA; QUALITY-CONTROL; YEAST EXOSOME; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; ESCHERICHIA-COLI; COMPLEX; DEGRADATION; NUCLEASE; SUBUNIT	The exosome is a major eukaryotic nuclease located in both the nucleus and the cytoplasm that contributes to the processing, quality control and/ or turnover of a large number of cellular RNAs(1-6). This large macromolecular assembly has been described as a 3 '-> 5 ' exonuclease(1) and shown to contain a nine- subunit ring structure evolutionarily related to archaeal exosome- like complexes and bacterial polynucleotide phosphorylases. Recent results have shown that, unlike its prokaryotic counterparts, the yeast and human ring structures are catalytically inactive. In contrast, the exonucleolytic activity of the yeast exosome core was shown to be mediated by the RNB domain of the eukaryote- specific Dis3 subunit(7-9). Here we show, using in vitro assays, that yeast Dis3 has an additional endoribonuclease activity mediated by the PIN domain located at the amino terminus of this multidomain protein. Simultaneous inactivation of the endonucleolytic and exonucleolytic activities of the exosome core generates a synthetic growth phenotype in vivo, supporting a physiological function for the PIN domain. This activity is responsible for the cleavage of some natural exosome substrates, independently of exonucleolytic degradation. In contrast with current models, our results show that eukaryotic exosome cores have both endonucleolytic and exonucleolytic activities, mediated by two distinct domains of the Dis3 subunit. The mode of action of eukaryotic exosome cores in RNA processing and degradation should be reconsidered, taking into account the cooperation between its multiple ribonucleolytic activities.	[Tomecki, Rafal; Dziembowski, Andrzej] Warsaw Univ, Dept Genet & Biotechnol, Fac Biol, PL-02106 Warsaw, Poland; [Tomecki, Rafal; Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Lebreton, Alice; Seraphin, Bertrand] CNRS, Ctr Genet Mol, UPR 2167, F-91198 Gif Sur Yvette, France; [Lebreton, Alice; Seraphin, Bertrand] Univ Paris 11, F-91405 Orsay, France; [Lebreton, Alice; Seraphin, Bertrand] Univ Paris 06, F-75005 Paris, France	University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Dziembowski, A (corresponding author), Warsaw Univ, Dept Genet & Biotechnol, Fac Biol, PL-02106 Warsaw, Poland.	andrzejd@ibb.waw.pl; seraphin@cgm.cnrs-gif.fr	Lebreton, Alice/M-8764-2015; Tomecki, Rafal/Y-8438-2019	Lebreton, Alice/0000-0002-6643-902X; Tomecki, Rafał/0000-0003-2880-0555; Tomecki, Rafal/0000-0003-2473-5004; Dziembowski, Andrzej/0000-0001-8492-7572; Seraphin, Bertrand/0000-0002-5168-1921	La Ligue contre le Cancer (Equipe Labellisee 2008); Agence Nationale de la Recherche project CUTs; CNRS; ESF RNA Quality program (project EUxosome); FP6 EU; Foundation for Polish Science; Faculty of Biology, University of Warsaw	La Ligue contre le Cancer (Equipe Labellisee 2008); Agence Nationale de la Recherche project CUTs(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); ESF RNA Quality program (project EUxosome); FP6 EU(European Commission); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Faculty of Biology, University of Warsaw	We thank E. Conti and J. Basquin for providing the Dis3 PIN domain expression construct and 6xHis- SUMO protease, and E. Conti, E. Lorentzen, J. Kufel and members of our groups for insightful discussions. This work was supported by La Ligue contre le Cancer (Equipe Labellisee 2008), Agence Nationale de la Recherche project CUTs, CNRS, ESF RNA Quality program (project EUxosome) and the FP6 EU grant 3D repertoire, and an EMBO installation grant. R. T. is the recipient of the Stipend for Young Researchers from the Foundation for Polish Science and was supported through a Faculty of Biology, University of Warsaw intramural grant.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; EBERLE AB, NATURE STRU IN PRESS; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; LIU Q, 2003, CELL, V127, P1223; Liu QS, 2007, CELL, V131, P188, DOI 10.1016/j.cell.2007.09.019; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; MANDL CW, 1991, BIOTECHNIQUES, V10, P484; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; SCHAEFFER D, NATURE STRU IN PRESS; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	29	245	248	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					993	U87		10.1038/nature07480	http://dx.doi.org/10.1038/nature07480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19060886	Green Submitted			2022-12-01	WOS:000261768300055
J	Wilson, A; Laurenti, E; Oser, G; van der Wath, RC; Blanco-Bose, W; Jaworski, M; Offner, S; Dunant, CF; Eshkind, L; Bockamp, E; Lio, P; MacDonald, HR; Trumpp, A				Wilson, Anne; Laurenti, Elisa; Oser, Gabriela; van der Wath, Richard C.; Blanco-Bose, William; Jaworski, Maike; Offner, Sandra; Dunant, Cyrille F.; Eshkind, Leonid; Bockamp, Ernesto; Lio, Pietro; MacDonald, H. Robson; Trumpp, Andreas			Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair	CELL			English	Article							OSTEOBLASTIC NICHE; PROGENITOR CELLS; MOUSE MODEL; IN-VITRO; MARROW; CYCLE; LONG; CANCER; PROLIFERATION; QUIESCENCE	Bone marrow hematopoietic stem cells (HSCs) are crucial to maintain lifelong production of all blood cells. Although HSCs divide infrequently, it is thought that the entire HSC pool turns over every few weeks, suggesting that HSCs regularly enter and exit cell cycle. Here, we combine flow cytometry with label-retaining assays (BrdU and histone H2B-GFP) to identify a population of dormant mouse HSCs (d-HSCs) within the lin(-)Sca1(+)cKit(+)CD150(+)CD48(-)CD34(-) population. Computational modeling suggests that d-HSCs divide about every 145 days, or five times per lifetime. d-HSCs harbor the vast majority of multilineage long-term self-renewal activity. While they form a silent reservoir of the most potent HSCs during homeostasis, they are efficiently activated to self-renew in response to bone marrow injury or G-CSF stimulation. After re-establishment of homeostasis, activated HSCs return to dormancy, suggesting that HSCs are not stochastically entering the cell cycle but reversibly switch from dormancy to self-renewal under conditions of hematopoietic stress.	[Laurenti, Elisa; Oser, Gabriela; Blanco-Bose, William; Jaworski, Maike; Offner, Sandra; Trumpp, Andreas] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Trumpp, Andreas] Deutsch Krebsforschungszentrum, Div Cell Biol, ZMBH Alliance, D-69120 Heidelberg, Germany; [Wilson, Anne; MacDonald, H. Robson] Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; [van der Wath, Richard C.; Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB3 0FD, England; [Eshkind, Leonid; Bockamp, Ernesto] Johannes Gutenberg Univ Mainz, Lab Mol Mouse Genet, Inst Toxicol, D-55113 Mainz, Germany; [Dunant, Cyrille F.] LMC IMX, CH-1015 Lausanne, Switzerland; [Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Helmholtz Association; German Cancer Research Center (DKFZ); Ludwig Institute for Cancer Research; University of Lausanne; University of Cambridge; Johannes Gutenberg University of Mainz	Trumpp, A (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, CH-1015 Lausanne, Switzerland.	a.trumpp@dkfz.de	Trumpp, Andreas/Z-2141-2019; P. Lió, Pietro Lio/AAV-3358-2021; Wilson, Anne/A-7131-2011	Trumpp, Andreas/0000-0002-6212-3466; P. Lió, Pietro Lio/0000-0002-0540-5053; Laurenti, Elisa/0000-0002-9917-9092; Dunant, Cyrille/0000-0001-5176-4439; Bockamp, Ernesto/0000-0002-6181-1734	Swiss National Science Foundation; Swiss Cancer League; EU-FP6 program "INTACT"; EU-FP7 progam "Eurosystem."; Bradlow Foundation; St. Johns College Cambridge	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; EU-FP6 program "INTACT"(European Commission); EU-FP7 progam "Eurosystem."(European Commission); Bradlow Foundation; St. Johns College Cambridge	We thank Dr. Christelle Adolphe for the initial breeding of the Scl-tTA; H2B-GFP mice; Christelle Dubey and Catherine Fumey for animal husbandry and genetic screening; Armin Ehninger for help with RT-PCR analysis; Joanna Roberts and Steven Merlin for FACS sorting; and the MIM facility for help with histology. This work was supported in part by grants to A. T. from the Swiss National Science Foundation, the Swiss Cancer League, the EU-FP6 program "INTACT" and the EU-FP7 progam "Eurosystem." R.C.v.d.W. would like to thank the Bradlow Foundation and St. Johns College Cambridge for financial support. The authors declare no financial conflict of interest.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Furness SGB, 2006, IMMUNOL RES, V34, P13, DOI 10.1385/IR:34:1:13; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bockamp E, 2006, BLOOD, V108, P1533, DOI 10.1182/blood-2005-12-012104; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Bradford GB, 1997, EXP HEMATOL, V25, P445; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Caldwell MA, 2005, EUR J NEUROSCI, V22, P2965, DOI 10.1111/j.1460-9568.2005.04504.x; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Challen GA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002357; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; Colucci F, 1999, J IMMUNOL, V162, P2761; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; GRAF T, 2007, NATURE REV IMMUNOLOG; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jorgensen HG, 2006, CLIN CANCER RES, V12, P626, DOI 10.1158/1078-0432.CCR-05-0429; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; LERNER C, 1990, EXP HEMATOL, V18, P114; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Matsuoka S, 2001, BLOOD, V97, P419, DOI 10.1182/blood.V97.2.419; MITCHELL JB, 1983, INT J RADIAT ONCOL, V9, P457, DOI 10.1016/0360-3016(83)90061-5; MORSTYN G, 1985, EXP HEMATOL, V13, P289; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Punzel M, 2001, ANN NY ACAD SCI, V938, P72; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Quesenberry PJ, 2006, CURR OPIN HEMATOL, V13, P216, DOI 10.1097/01.moh.0000231417.08031.ac; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Siegl-Cachedenier I, 2007, GENE DEV, V21, P2234, DOI 10.1101/gad.430107; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; Suda T, 2005, CORNEA, V24, pS12, DOI 10.1097/01.ico.0000178742.98716.65; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van der Wath RC, 2008, LECT N BIOINFORMAT, V5307, P387, DOI 10.1007/978-3-540-88562-7_26; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	67	1298	1339	1	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1118	1129		10.1016/j.cell.2008.10.048	http://dx.doi.org/10.1016/j.cell.2008.10.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19062086	Bronze			2022-12-01	WOS:000261642800027
J	Granick, S; Bae, SC				Granick, Steve; Bae, Sung Chul			CHEMISTRY A Curious Antipathy for Water	SCIENCE			English	Editorial Material							HYDROPHOBICITY; TRANSPORT		[Granick, Steve; Bae, Sung Chul] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Granick, Steve; Bae, Sung Chul] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Granick, Steve; Bae, Sung Chul] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Granick, S (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.	sgranick@uiuc.edu	Bae, Sung C/A-3423-2008	Bae, Sung C/0000-0002-9765-6801				Ben-Amotz D, 2006, J PHYS CHEM B, V110, P19839, DOI 10.1021/jp061824r; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Janecek J, 2007, LANGMUIR, V23, P8417, DOI 10.1021/la700561q; Kalra A, 2004, J PHYS CHEM B, V108, P544, DOI 10.1021/jp035828x; Kalra A, 2003, P NATL ACAD SCI USA, V100, P10175, DOI 10.1073/pnas.1633354100; Kashimoto K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076102; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Maibaum L, 2003, J PHYS CHEM B, V107, P1189, DOI 10.1021/jp0267196; Mezger M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2931574; Poynor A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.039602; Poynor A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266101; Sovago M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.173901; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; Wang HJ, 2008, SCIENCE, V322, P80, DOI 10.1126/science.1162412; Zhang XY, 2002, SCIENCE, V295, P663, DOI 10.1126/science.1066854	16	92	92	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1477	1478		10.1126/science.1167219	http://dx.doi.org/10.1126/science.1167219			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056964				2022-12-01	WOS:000261377400027
J	Trost, BM; Dong, GB				Trost, Barry M.; Dong, Guangbin			Total synthesis of bryostatin 16 using atom-economical and chemoselective approaches	NATURE			English	Article							ANALOGS; ALCOHOLS; ESTERS	Of the concepts used to improve the efficiency of organic syntheses, two have been especially effective: atom economy(1) ( the use of routes in which most of the atoms present in the reactants also end up in the product) and chemoselectivity(2) ( the use of reactions that take place only at desired positions in a molecule). Synthesis of complex natural products is the most demanding arena in which to explore such principles. The bryostatin family of compounds are especially interesting targets, because they combine structural complexity with promising biological activity(3-7). Furthermore, synthetic routes to some bryostatins have already been reported(9-12), providing a benchmark against which new syntheses can be measured. Here we report a concise total synthesis of bryostatin 16 ( 1), a parent structure from which almost all other bryostatins could in principle be accessed. Application of atom-economical and chemoselective reactions currently under development provides ready access to polyhydropyran motifs in the molecule, which are common structural features of many other natural products. The most notable transformations are two transition-metal- catalysed reactions. The first is a palladium- catalysed reaction of two different alkynes to form a large ring. The product of this step is then converted into a dihydropyran ( the 'C ring' of bryostatins) in the second key reaction, which is catalysed by a gold compound. Analogues of bryostatin that do not exist in nature could be readily made by following this route, which might allow the biological activity of bryostatins to be fine- tuned.	[Trost, Barry M.; Dong, Guangbin] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Trost, BM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	bmtrost@stanford.edu			National Institutes of Health [GM 13598]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013598, R37GM013598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the National Institutes of Health (GM 13598) for their support of our programs. G. D. is a Stanford Graduate Fellow. We thank H. Yang for discussions and for help characterizing compound 21, and we additionally thank him and C. S. Brindle for providing synthetic intermediates. Palladium and ruthenium salts were supplied by Johnson Matthey. We acknowledge S. R. Lynch for his help with two-dimensional nuclear magnetic resonance analysis. We also thank the Wender group's assistance with reverse-phase high-performance liquid chromatography.	Ball M, 2006, TETRAHEDRON LETT, V47, P2223, DOI 10.1016/j.tetlet.2006.01.097; BROWN HC, 1983, J AM CHEM SOC, V105, P2092, DOI 10.1021/ja00345a085; Corey EJ, 1998, ANGEW CHEM INT EDIT, V37, P1987, DOI 10.1002/(SICI)1521-3773(19980817)37:15<1986::AID-ANIE1986>3.0.CO;2-Z; DELLAQUILA ML, 1988, CANCER RES, V48, P3702; DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027; Dowlati A, 2003, CLIN CANCER RES, V9, P5929; Evans DA, 1999, J AM CHEM SOC, V121, P7540, DOI 10.1021/ja990860j; Hale KJ, 2002, NAT PROD REP, V19, P413, DOI 10.1039/b009211h; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; INANAGA J, 1979, B CHEM SOC JPN, V52, P1989, DOI 10.1246/bcsj.52.1989; KAGEYAMA M, 1990, J AM CHEM SOC, V112, P7407, DOI 10.1021/ja00176a058; Keck GE, 2008, J AM CHEM SOC, V130, P6660, DOI 10.1021/ja8022169; Lin MJ, 2003, J AM CHEM SOC, V125, P13042, DOI 10.1021/ja037410i; Liu YH, 2005, ORG LETT, V7, P5409, DOI 10.1021/ol052160r; Manaviazar S, 2006, ORG LETT, V8, P4477, DOI 10.1021/ol061626i; Newman DJ, 2004, J NAT PROD, V67, P1216, DOI 10.1021/np040031y; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P1378, DOI 10.1002/anie.200462207; Ohmori K, 2000, ANGEW CHEM INT EDIT, V39, P2290; Pettit GR, 1996, J NAT PROD, V59, P286, DOI 10.1021/np960100b; PETTIT GR, 1991, CAN J CHEM, V69, P856, DOI 10.1139/v91-126; Roth GJ, 2004, SYNTHESIS-STUTTGART, P59, DOI 10.1055/s-2003-44346; SCHAUFELBERGER DE, 1991, J NAT PROD, V54, P1265, DOI 10.1021/np50077a004; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Trost BM, 2007, J AM CHEM SOC, V129, P2206, DOI 10.1021/ja067305j; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Trost BM, 2005, ORG LETT, V7, P4761, DOI 10.1021/ol0520065; TROST BM, 1989, J AM CHEM SOC, V111, P8745, DOI 10.1021/ja00205a041; TROST BM, 1983, SCIENCE, V219, P245, DOI 10.1126/science.219.4582.245; Wender PA, 2008, ORG LETT, V10, P3331, DOI 10.1021/ol801235h; Wender PA, 2008, J AM CHEM SOC, V130, P6658, DOI 10.1021/ja8015632	30	198	200	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					485	488		10.1038/nature07543	http://dx.doi.org/10.1038/nature07543			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	376FW	19037312	Green Accepted			2022-12-01	WOS:000261170500034
J	Smith, RD; Correa, C; Oh, C				Smith, Richard D.; Correa, Carlos; Oh, Cecilia			Trade and Health 5 Trade, TRIPS, and pharmaceuticals	LANCET			English	Article							AFFORDABILITY; ACCESS; DRUGS	The World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) set global minimum standards for the protection of intellectual property, substantially increasing and expanding intellectual-property rights, and generated clear gains for the pharmaceutical industry and the developed world. The question of whether TRIPS generates gains for developing countries, in the form of increased exports, is addressed in this paper through consideration of the importance of pharmaceuticals in health-care trade, outlining the essential requirements, implications, and issues related to TRIPS, and TRIPS-plus, in which increased restrictions are imposed as part of bilateral free-trade agreements. TRIPS has not generated substantial gains for developing countries, but has further increased pharmaceutical trade in developed countries. The unequal trade between developed and developing countries (ie, exporting and importing high-value patented drugs, respectively) raises the issue of access to medicines, which is exacerbated by TRIPS-plus provisions, although many countries have not even enacted provision for TRIPS flexibilities. Therefore this paper focuses on options that are available to the health community for negotiation to their advantage under TRIPS, and within the presence of TRIPS-plus.	[Smith, Richard D.] Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Correa, Carlos] Univ Buenos Aires, Ctr Interdisciplinary Studies Ind Property & Econ, Buenos Aires, DF, Argentina; [Oh, Cecilia] UNDP Reg Ctr, Colombo, Sri Lanka	University of London; London School of Hygiene & Tropical Medicine; University of Buenos Aires	Smith, RD (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Dept Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	Richard.Smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559				ABBOTT F, 2007, WORLD TRADE ORG ACCE; *AGCM, 2007, DEC A364 MERCK PRINC; ANDO G, 2006, PHARM MARKET MALAYSI; *ASEAN SECR, 2005, REG REP ASEAN ROCK F; Azmi IM, 2001, J WORLD INTELLECTUAL, V4, P947; Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; BASU S, 2003, ZNET GLOBAL EC  0529; BLOUIN C, 2007, WHO SEARO M TRAD HLT; *BURR LIF SCI MED, 2007, BURR Q IND LIF SCI; Commission on Intellectual Property Rights, INT INT PROP RIGHTS; Correa CM, 2006, B WORLD HEALTH ORGAN, V84, P399, DOI 10.2471/BLT.05.023432; DEEPTI R, 2007, CHEM WEEK, P169; Dzung N.N, 2007, CHICAGO KENT J INTEL, V6, P138; Endeshaw A, 2005, J WORLD INTELLECT PR, V8, P211, DOI 10.1111/j.1747-1796.2005.tb00247.x; *FED TRAD COMM, 2002, GEN DRUG ENTR PRIOR; *GLOB TRAD INF SER, UK CUST EXC; Haakonsson SJ, 2007, DEV POLICY REV, V25, P71, DOI 10.1111/j.1467-7679.2007.00360.x; *KEI, 2007, KEI RES NOT 2007 REC; Kerry VB, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-3; Kinnon CM, 1998, WORLD HEALTH FORUM, V19, P397; KRAUS L, 2004, VANDERBILT J TRANSNA, V37, pL527; MILSTIEN J, B WHO, V84, P360; *MIN INT TRAD IND, 3 IND MAST 1996 2020; *MITI, 2007, IND PROF CHEM MAL TR; MUSUNGU SF, 2004, S PERSPECTIVES R APR; *MYLPO, 2008, CALC PAT STAT INT PR; Oh C., 2006, International Journal of Intellectual Property Management, V1, P22, DOI 10.1504/IJIPM.2006.011020; Oxfam International, 2007, ALL COSTS NO BEN TRI; *PIR1BO, 2007, 200711 PIR1BO; Priapantja Priapantja, 2000, ASEAN WORKSH TRIPS A; Schaffer Gregory C., 2003, DEFENDING INTERESTS; Smith R., 2003, GLOBAL PUBLIC GOODS; Smith RD, 2004, B WORLD HEALTH ORGAN, V82, P385; SMITH RD, 2009, LANCET          0122; Steinbrook R, 2007, NEW ENGL J MED, V357, P1996, DOI 10.1056/NEJMp0706918; *UNCTAD, 2005, W MACK PROD VIEW PHA; USTR (Office of the United States Trade Representative), 2007, SPEC 301 REP; *WHO, 2006, COMM INT PROP INN PU; WILBULPROPRASER.S, 2001, WORKSH DIFF PRIC FIN	39	94	94	2	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					684	691		10.1016/S0140-6736(08)61779-1	http://dx.doi.org/10.1016/S0140-6736(08)61779-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19167054	Green Submitted			2022-12-01	WOS:000263563500033
J	Doil, C; Mailand, N; Bekker-Jensen, S; Menard, P; Larsen, DH; Pepperkok, R; Ellenberg, J; Panier, S; Durocher, D; Bartek, J; Lukas, J; Lukas, C				Doil, Carsten; Mailand, Niels; Bekker-Jensen, Simon; Menard, Patrice; Larsen, Dorthe Helena; Pepperkok, Rainer; Ellenberg, Jan; Panier, Stephanie; Durocher, Daniel; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia			RNF168 Binds and Amplifies Ubiquitin Conjugates on Damaged Chromosomes to Allow Accumulation of Repair Proteins	CELL			English	Article							DNA; H2AX; CHECKPOINT; COMPLEX; BRCA1; PHOSPHORYLATION; UBIQUITYLATION; ORGANIZATION; ACETYLATION; RECOGNITION	DNA double-strand breaks (DSBs) not only interrupt the genetic information, but also disrupt the chromatin structure, and both impairments require repair mechanisms to ensure genome integrity. We showed previously that RNF8-mediated chromatin ubiquitylation protects genome integrity by promoting the accumulation of repair factors at DSBs. Here, we provide evidence that, while RNF8 is necessary to trigger the DSB-associated ubiquitylations, it is not sufficient to sustain conjugated ubiquitin in this compartment. We identified RNF168 as a novel chromatin-associated ubiquitin ligase with an ability to bind ubiquitin. We show that RNF168 interacts with ubiquitylated H2A, assembles at DSBs in an RNF8-dependent manner, and, by targeting H2A and H2AX, amplifies local concentration of lysine 63-linked ubiquitin conjugates to the threshold required for retention of 53BP1 and BRCA1. Thus, RNF168 defines a new pathway involving sequential ubiquitylations on damaged chromosomes and uncovers a functional cooperation between E3 ligases in genome maintenance.	[Doil, Carsten; Mailand, Niels; Bekker-Jensen, Simon; Menard, Patrice; Larsen, Dorthe Helena; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; [Doil, Carsten; Mailand, Niels; Bekker-Jensen, Simon; Menard, Patrice; Larsen, Dorthe Helena; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia] Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Pepperkok, Rainer] European Mol Biol Lab, Cell Biol Biophys Units, D-69117 Heidelberg, Germany; [Ellenberg, Jan] European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany; [Panier, Stephanie; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Danish Cancer Society; Danish Cancer Society; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Lukas, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jil@cancer.dk	Larsen, Dorthe Helena/E-9771-2010; Bartek, Jiri/G-5870-2014; Ellenberg, Jan/I-4688-2014; Panier, Stephanie/GVT-6365-2022; Durocher, Daniel/A-7733-2010; Larsen, Dorthe Helena/Z-6206-2019	Larsen, Dorthe Helena/0000-0002-8280-1252; Ellenberg, Jan/0000-0001-5909-701X; Durocher, Daniel/0000-0003-3863-8635; Larsen, Dorthe Helena/0000-0002-8280-1252; Pepperkok, Rainer/0000-0002-9762-3583; Menard, Patrice/0000-0001-8844-3727; Lukas, Claudia/0000-0001-7169-6883; Lukas, Jiri/0000-0001-9087-506X; Bekker-Jensen, Simon/0000-0002-7308-4597	Danish Cancer Society; Danish National Research Foundation; European Commission Integrated Projects "DNA Repair'' and "GENICA,'' Lundbeck Foundation [R13-A1287]; Danish Research Council; John and Birthe Meyer Foundation; German Federal Ministry of Education and Research ( BMBF); National Genome Research Network [01GR0403]; European Commission Integrated Project Mitocheck [FP6-503464]	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); European Commission Integrated Projects "DNA Repair'' and "GENICA,'' Lundbeck Foundation(European CommissionEuropean Commission Joint Research Centre); Danish Research Council(Det Frie Forskningsrad (DFF)); John and Birthe Meyer Foundation; German Federal Ministry of Education and Research ( BMBF)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network; European Commission Integrated Project Mitocheck(European CommissionEuropean Commission Joint Research Centre)	We thank Junjie Chen, Stephen Jackson, Thanos Halazonetis, Ze'ev Ronai, Kim Newton, and Vishva M. Dixit for reagents; Mark R. Payne for help with statistical analysis; and Holger Erfle and Beate Neumann for assistance with the siRNA screen. This work was supported by the Danish Cancer Society, Danish National Research Foundation, European Commission Integrated Projects "DNA Repair'' and "GENICA,'' Lundbeck Foundation (R13-A1287), Danish Research Council, and the John and Birthe Meyer Foundation. J.E. and R. P. acknowledge support from the German Federal Ministry of Education and Research ( BMBF) grant within the National Genome Research Network (NGFN-1, SMP-RNAi, 01GR0403) and the European Commission Integrated Project Mitocheck (FP6-503464).	Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924	35	664	693	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					435	446		10.1016/j.cell.2008.12.041	http://dx.doi.org/10.1016/j.cell.2008.12.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203579	Bronze			2022-12-01	WOS:000263120600014
J	Anderson, LL; Mao, XR; Scott, BA; Crowder, CM				Anderson, Lori L.; Mao, Xianrong; Scott, Barbara A.; Crowder, C. Michael			Survival from Hypoxia in C-elegans by Inactivation of Aminoacyl-tRNA Synthetases	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; LIFE-SPAN; TRANSLATION; INHIBITION; PATHWAYS; COMPLEX; BRAIN; DEATH	Hypoxia is important in a wide range of biological processes, such as animal hibernation and cell survival, and is particularly relevant in many diseases. The sensitivity of cells and organisms to hypoxic injury varies widely, but the molecular basis for this variation is incompletely understood. Using forward genetic screens in Caenorhabditis elegans, we isolated a hypoxia- resistant reduction- of- function mutant of rrt- 1 that encodes an arginyl- transfer RNA ( tRNA) synthetase, an enzyme essential for protein translation. Knockdown of rrt- 1, and of most other genes encoding aminoacyl- tRNA synthetases, rescued animals from hypoxia- induced death, and the level of hypoxia resistance was inversely correlated with translation rate. The unfolded protein response was induced by hypoxia and was required for the hypoxia resistance of the reduction- of- function mutant of rrt- 1. Thus, translational suppression produces hypoxia resistance, in part by reducing unfolded protein toxicity.	[Anderson, Lori L.; Mao, Xianrong; Scott, Barbara A.; Crowder, C. Michael] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Crowder, C. Michael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Crowder, CM (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	crowderm@morpheus.wustl.edu			National Institute of Neurological Disorders and Stroke; Neuroscience of Brain Disorders Award; McKnight Endowment Fund for Neuroscience; American Heart Association Established Investigator Award; NIH National Center for Research Resources; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045905] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Neuroscience of Brain Disorders Award; McKnight Endowment Fund for Neuroscience; American Heart Association Established Investigator Award(American Heart Association); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Mabon for early efforts on screen design, L. Metz for technical help, and M. Hansen for advice and strains. Supported by the National Institute of Neurological Disorders and Stroke, a Neuroscience of Brain Disorders Award from the McKnight Endowment Fund for Neuroscience, and an American Heart Association Established Investigator Award. Some of the strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources.	Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Dasgupta N, 2007, CURR BIOL, V17, P1954, DOI 10.1016/j.cub.2007.10.017; DeGracia DJ, 2002, J CEREBR BLOOD F MET, V22, P127, DOI 10.1097/00004647-200202000-00001; DeGracia DJ, 2007, J CEREBR BLOOD F MET, V27, P875, DOI 10.1038/sj.jcbfm.9600388; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Koumenis C, 2007, METHOD ENZYMOL, V435, P275, DOI 10.1016/S0076-6879(07)35014-3; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; LANDES C, 1995, BIOCHIMIE, V77, P194, DOI 10.1016/0300-9084(96)88125-9; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Paschen W, 2007, CURR PHARM DESIGN, V13, P1887; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	25	75	82	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					630	633		10.1126/science.1166175	http://dx.doi.org/10.1126/science.1166175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179530	Green Accepted			2022-12-01	WOS:000262862800042
J	Das, J; Ho, M; Zikherman, J; Govern, C; Yang, M; Weiss, A; Chakraborty, AK; Roose, JP				Das, Jayajit; Ho, Mary; Zikherman, Julie; Govern, Christopher; Yang, Ming; Weiss, Arthur; Chakraborty, Arup K.; Roose, Jeroen P.			Digital Signaling and Hysteresis Characterize Ras Activation in Lymphoid Cells	CELL			English	Article							NUCLEOTIDE EXCHANGE FACTOR; T-CELLS; POSITIVE FEEDBACK; DENDRITIC CELLS; SOS; SEVENLESS; GENE; TRANSDUCTION; REQUIREMENT; LYMPHOCYTES	Activation of Ras proteins underlies functional decisions in diverse cell types. Two molecules, RasGRP and SOS, catalyze Ras activation in lymphocytes. Binding of active Ras to SOS' allosteric pocket markedly increases SOS' activity establishing a positive feedback loop for SOS-mediated Ras activation. Integrating in silico and in vitro studies, we demonstrate that digital signaling in lymphocytes (cells are "on'' or "off'') is predicated upon feedback regulation of SOS. SOS' feedback loop leads to hysteresis in the dose-response curve, which can enable a capacity to sustain Ras activation as stimuli are withdrawn and exhibit "memory'' of past encounters with antigen. Ras activation via RasGRP alone is analog (graded increase in amplitude with stimulus). We describe how complementary analog (RasGRP) and digital (SOS) pathways act on Ras to efficiently convert analog input to digital output. Numerous predictions regarding the impact of our findings on lymphocyte function and development are noted.	[Zikherman, Julie; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Ho, Mary; Roose, Jeroen P.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Das, Jayajit; Govern, Christopher; Yang, Ming; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, Div Rheumatol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu; arupc@mit.edu; jeroen.roose@ucsf.edu	Das, Jayajit/E-2951-2011; Das, Jayajit/AAD-8502-2022	Das, Jayajit/0000-0001-9649-4698; Zikherman, Julie/0000-0002-0873-192X; Roose, Jeroen/0000-0003-4746-2811	NIH Director's Pioneer [1PO1/AI071195/01]; Rosalind Russell Medical Research Center for Arthritis; NCI [K01CA113367]; Arthritis Foundation; Sandler Foundation; NATIONAL CANCER INSTITUTE [K01CA113367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI071195] Funding Source: NIH RePORTER	NIH Director's Pioneer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosalind Russell Medical Research Center for Arthritis; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Arthritis Foundation; Sandler Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Kurosaki for DT40 lines and Dr. Dafna Bar-sagi for the H-RasG59E38 plasmid. We are grateful to Dr. DeFranco and members of the Weiss, Chakraborty, and Roose labs for critical reading of the manuscript. We apologize to colleagues we could not cite due to space constraints. Financial support: NIH Director's Pioneer Award and 1PO1/AI071195/01 (A. K. C.), the Howard Hughes Medical Institute as well as the Rosalind Russell Medical Research Center for Arthritis (A. W.), and the NCI (K01CA113367), Arthritis Foundation, and Sandler Foundation (J.P.R.).	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BORTZ AB, 1975, J COMPUT PHYS, V17, P10, DOI 10.1016/0021-9991(75)90060-1; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 2000, BLOOD, V95, P3199; Elf J., 2004, Systems Biology, V1, P230, DOI 10.1049/sb:20045021; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Gilbert JJ, 1996, J IMMUNOL, V156, P2054; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Prasad A, 2009, P NATL ACAD SCI USA, V106, P528, DOI 10.1073/pnas.0805981105; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Ruiz S, 2007, MOL CELL BIOL, V27, P8127, DOI 10.1128/MCB.00912-07; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; van Kampen N. G., 1992, STOCHASTIC PROCESSES; Wang DZM, 1997, GENE DEV, V11, P309, DOI 10.1101/gad.11.3.309; WEISS A, 1987, J IMMUNOL, V138, P2169	39	281	285	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					337	351		10.1016/j.cell.2008.11.051	http://dx.doi.org/10.1016/j.cell.2008.11.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167334	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000262648800021
J	Sumara, G; Formentini, I; Collins, S; Sumara, I; Windak, R; Bodenmiller, B; Ramracheya, R; Caille, D; Jiang, HP; Platt, KA; Meda, P; Aebersold, R; Rorsman, P; Ricci, R				Sumara, Grzegorz; Formentini, Ivan; Collins, Stephan; Sumara, Izabela; Windak, Renata; Bodenmiller, Bernd; Ramracheya, Reshma; Caille, Dorothee; Jiang, Huiping; Platt, Kenneth A.; Meda, Paolo; Aebersold, Rudolf; Rorsman, Patrik; Ricci, Romeo			Regulation of PKD by the MAPK p38 delta in Insulin Secretion and Glucose Homeostasis	CELL			English	Article							PROTEIN-KINASE-D; BETA-CELL; NEUROTENSIN SECRETION; TRANSPORT CARRIERS; DIABETES-MELLITUS; SKELETAL-MUSCLE; P38 MAPK; P38-ALPHA; MECHANISMS; RESISTANCE	Dysfunction and loss of insulin-producing pancreatic beta cells represent hallmarks of diabetes mellitus. Here, we show that mice lacking the mitogen-activated protein kinase (MAPK) p38 delta display improved glucose tolerance due to enhanced insulin secretion from pancreatic beta cells. Deletion of p38 delta results in pronounced activation of protein kinase D (PKD), the latter of which we have identified as a pivotal regulator of stimulated insulin exocytosis. p38 delta catalyzes an inhibitory phosphorylation of PKD1, thereby attenuating stimulated insulin secretion. In addition, p38 delta null mice are protected against high-fat-feeding induced insulin resistance and oxidative stress-mediated b cell failure. Inhibition of PKD1 reverses enhanced insulin secretion from p38 delta-deficient islets and glucose tolerance in p38 delta null mice as well as their susceptibility to oxidative stress. In conclusion, the p38 delta-PKD pathway integrates regulation of the insulin secretory capacity and survival of pancreatic b cells, pointing to a pivotal role for this pathway in the development of overt diabetes mellitus.	[Sumara, Grzegorz; Formentini, Ivan; Windak, Renata; Ricci, Romeo] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Collins, Stephan; Ramracheya, Reshma; Rorsman, Patrik] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Sumara, Izabela] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Bodenmiller, Bernd; Aebersold, Rudolf] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Bodenmiller, Bernd; Aebersold, Rudolf] Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland; [Caille, Dorothee; Meda, Paolo] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Jiang, Huiping] Boehringer Ingelheim Pharmaceut Inc, Dept Biotherapeut & Integrat Biol, Ridgefield, CT 06877 USA; [Platt, Kenneth A.] Lexicon Pharmaceut, The Woodlands, TX 77381 USA; [Aebersold, Rudolf] Inst Syst Physiol, Seattle, WA 98103 USA; [Aebersold, Rudolf; Ricci, Romeo] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Geneva; Boehringer Ingelheim; Lexicon Pharmaceuticals	Ricci, R (corresponding author), ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland.	romeo.ricci@cell.biol.ethz.ch	Ricci, Romeo/K-3009-2013; Rorsman, Patrik/A-4331-2016; collins, stephan c/P-4409-2016	Ricci, Romeo/0000-0002-9766-4369; Rorsman, Patrik/0000-0001-7578-0767; collins, stephan c/0000-0002-1533-3380; Sumara, Izabela/0000-0002-5968-3358; Sumara, Grzegorz/0000-0003-1502-6265; Ramracheya, Reshma/0000-0001-6117-1936	Boehringer Ingelheim Pharmeaceuticals, Inc; Ridgefield, CT; Forschungskredit 2003 of the University of Zurich; Swiss National Science Foundation (SNF) [PP00A114856]; Roche Research Foundation; Bonizzi-Theler Foundation; ETHZ; Boehringer Ingelheim Fonds; Swiss National Science Foundation [310000-122430]; Juvenile Diabetes Research Foundation [1-2007-158]; Novo Nordisk; SNF [31000-10767]; Competence Center for Systems Physiology and Metabolic Diseases, Zurich; Wellcome Trust; European Union (Eurodia);  [337-2004];  [FP-7 BETAIMAGE 222980]	Boehringer Ingelheim Pharmeaceuticals, Inc(Boehringer Ingelheim); Ridgefield, CT; Forschungskredit 2003 of the University of Zurich; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Roche Research Foundation; Bonizzi-Theler Foundation; ETHZ(ETH Zurich); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Novo Nordisk(Novo Nordisk); SNF; Competence Center for Systems Physiology and Metabolic Diseases, Zurich; Wellcome Trust(Wellcome TrustEuropean Commission); European Union (Eurodia)(European Commission); ; 	We are grateful to Boehringer Ingelheim Pharmeaceuticals, Inc., Ridgefield, CT, for their generous financial support. We also would like to thank Markus Stoffel and Arne Ittner for numerous fruitful scientific discussions; Olga Herdzina for careful reading; Ana Cuenda for providing us with an antibody against p38d; David Engelberg for providing us with plasmids to express constitutive active p38d; Angelika Hausser and Vivek Malhotra for providing us with PKD plasmids; and Mary McFarland and Lynn Pantages-Torok for organizing mouse shipments. G. S. was supported by the Forschungskredit 2003 of the University of Zurich, the Swiss National Science Foundation (SNF) (PP00A114856), and the Roche Research Foundation (337-2004). I. F. was supported by the Bonizzi-Theler Foundation. I. S. is a senior research associate in the M. Peter laboratory, and her work was supported by grants from the SNF and the ETHZ to M. Peter. B. B. is the recipient of a fellowship by the Boehringer Ingelheim Fonds. The Meda team is supported by grants from the Swiss National Science Foundation (310000-122430), the Juvenile Diabetes Research Foundation (1-2007-158), the European Union (FP-7 BETAIMAGE 222980), and Novo Nordisk. The R. A. team is supported by the SNF (31000-10767) and by the Competence Center for Systems Physiology and Metabolic Diseases, Zurich. Work in Oxford was funded by the Wellcome Trust and the European Union (Eurodia).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Aston-Mourney K, 2008, DIABETOLOGIA, V51, P540, DOI 10.1007/s00125-008-0930-2; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Feijoo C, 2005, J CELL SCI, V118, P397, DOI 10.1242/jcs.01655; Fridlyand LE, 2006, CURR DIABETES REV, V2, P241, DOI 10.2174/157339906776818541; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Haxhinasto SA, 2003, J IMMUNOL, V171, P4655, DOI 10.4049/jimmunol.171.9.4655; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Koistinen HA, 2003, DIABETOLOGIA, V46, P1324, DOI 10.1007/s00125-003-1196-3; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Li J, 2004, J BIOL CHEM, V279, P28466, DOI 10.1074/jbc.M314307200; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Makeeva N, 2006, BIOCHEM J, V393, P129, DOI 10.1042/BJ20050814; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; PETERRIESCH B, 1988, J CLIN INVEST, V81, P1154, DOI 10.1172/JCI113430; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Thore S, 2007, DIABETES, V56, P818, DOI 10.2337/db06-0843; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vertommen D, 2000, J BIOL CHEM, V275, P19567, DOI 10.1074/jbc.M001357200; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; WIEDENKELLER DE, 1983, ENDOCRINOLOGY, V113, P2311, DOI 10.1210/endo-113-6-2311; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200	46	177	190	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					235	248		10.1016/j.cell.2008.11.018	http://dx.doi.org/10.1016/j.cell.2008.11.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19135240	Green Published, hybrid			2022-12-01	WOS:000262648800013
J	Phadnis, N; Orr, HA				Phadnis, Nitin; Orr, H. Allen			A Single Gene Causes Both Male Sterility and Segregation Distortion in Drosophila Hybrids	SCIENCE			English	Article							MEIOTIC-DRIVE; SEX-RATIO; UNISEXUAL STERILITY; PSEUDOOBSCURA; EVOLUTION; BOGOTA; INVIABILITY; EXPLANATION; DIVERGENCE; LOCUS	A central goal of evolutionary biology is to identify the genes and evolutionary forces that cause speciation, the emergence of reproductive isolation between populations. Despite the identification of several genes that cause hybrid sterility or inviability-many of which have evolved rapidly under positive Darwinian selection-little is known about the ecological or genomic forces that drive the evolution of postzygotic isolation. Here, we show that the same gene, Overdrive, causes both male sterility and segregation distortion in F-1 hybrids between the Bogota and U. S. subspecies of Drosophila pseudoobscura. This segregation distorter gene is essential for hybrid sterility, a strong reproductive barrier between these young taxa. Our results suggest that genetic conflict may be an important evolutionary force in speciation.	[Phadnis, Nitin; Orr, H. Allen] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Phadnis, N (corresponding author), Univ Rochester, Dept Biol, 601 Elmwood Ave, Rochester, NY 14627 USA.	pdns@mail.rochester.edu			NIH [GM51932]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051932, R29GM051932] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Aquadro, J. Fry, R. Glor, H. Malik, D. Presgraves, Y. Tao, and the Orr lab for discussions; D. Lambert for advice on molecular techniques; H. Malik and N. Elde for help with PAML; and S. Schaeffer for fly stocks. Financial support was provided by NIH (GM51932). All sequences are available at GenBank (accession numbers FJ349335 to FJ349342 and FJ418600 to FJ418631). The authors declare no conflict of interest.	Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; CHARLESWORTH B, 1993, GENETICS, V133, P421; Coyne J.A., 2004, SPECIATION; COYNE JA, 1993, EVOLUTION, V47, P685, DOI 10.1111/j.1558-5646.1993.tb02123.x; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hall DW, 2004, EVOLUTION, V58, P925; HARTL DL, 1975, THEOR POPUL BIOL, V7, P168, DOI 10.1016/0040-5809(75)90012-X; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; HURST LD, 1991, GENETICS, V128, P841; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Merrill C, 1999, SCIENCE, V283, P1742, DOI 10.1126/science.283.5408.1742; Montchamp-Moreau C, 2006, GENETICS, V174, P1365, DOI 10.1534/genetics.105.051755; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; Orr HA, 2001, GENETICS, V158, P1089; PRAKASH S, 1972, GENETICS, V72, P143; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; SCHAEFFER SW, 1991, P NATL ACAD SCI USA, V88, P6097, DOI 10.1073/pnas.88.14.6097; TAJIMA F, 1989, GENETICS, V123, P585; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; Tao Y, 2007, PLOS BIOL, V5, P2576, DOI 10.1371/journal.pbio.0050293; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; WITTBRODT J, 1992, EMBO J, V11, P4239, DOI 10.1002/j.1460-2075.1992.tb05518.x	27	247	251	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					376	379		10.1126/science.1163934	http://dx.doi.org/10.1126/science.1163934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19074311	Green Accepted			2022-12-01	WOS:000262481400037
J	Attia, J; Ioannidis, JPA; Thakkinstian, A; McEvoy, M; Scott, RJ; Minelli, C; Thompson, J; Infante-Rivard, C; Guyatt, G				Attia, John; Ioannidis, John P. A.; Thakkinstian, Ammarin; McEvoy, Mark; Scott, Rodney J.; Minelli, Cosetta; Thompson, John; Infante-Rivard, Claire; Guyatt, Gordon			How to Use an Article About Genetic Association B: Are the Results of the Study Valid?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HARDY-WEINBERG EQUILIBRIUM; GENOME-WIDE ASSOCIATION; FALSE DISCOVERY RATE; GENOTYPING ERRORS; POPULATION STRATIFICATION; EMPIRICAL-EVALUATION; MEDICAL LITERATURE; ALZHEIMER-DISEASE; METAANALYSIS; REPLICATION	In the first article of this series, we reviewed the basic genetics concepts necessary to understand genetic association studies. In this second article, we enumerate the major issues in judging the validity of these studies, framed as critical appraisal questions. Was the disease phenotype properly defined and accurately recorded by someone blind to the genetic information? Have any potential differences between disease and nondisease groups, particularly ethnicity, been properly addressed? In genetic studies, one potential cause of spurious associations is differences between cases and controls in ethnicity, a situation termed population stratification. Was measurement of the genetic variants unbiased and accurate? Methods for determining DNA sequence variation are not perfect and may have some measurement error. Do the genotype proportions observe Hardy- Weinberg equilibrium? This simple mathematic rule about the distribution of genetic groups may be one way to check for errors in reading DNA information. Have the investigators adjusted their inferences for multiple comparisons? Given the thousands of genetic markers tested in genome- wide association studies, the potential for false- positive and false-negative results is much higher than in traditional medical studies, and it is particularly important to look for replication of results.	[Attia, John] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2308, Australia; [Attia, John] John Hunter Hosp, Hunter Med Res Inst, Newcastle, NSW, Australia; [Attia, John] John Hunter Hosp, Dept Gen Med, Newcastle, NSW, Australia; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Ctr Genet Epidemiol & Modeling, Tufts Med Ctr,Dept Med, Boston, MA 02111 USA; [Thakkinstian, Ammarin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Clin Epidemiol Unit, Bangkok 10400, Thailand; [McEvoy, Mark] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2308, Australia; [Scott, Rodney J.] John Hunter Hosp, Hunter Area Pathol Serv, Div Genet, New Lambton, Australia; [Scott, Rodney J.] Univ Newcastle, Hunter Med Res Inst, Fac Hlth, Ctr Informat Based Med, Newcastle, NSW 2308, Australia; [Minelli, Cosetta] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Thompson, John] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Infante-Rivard, Claire] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; John Hunter Hospital; University of Ioannina; Tufts Medical Center; Tufts University; Mahidol University; University of Newcastle; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; Imperial College London; University of Leicester; McGill University; McMaster University	Attia, J (corresponding author), Univ Newcastle, Royal Newcastle Hosp, Ctr Clin Epidemiol & Biostat, Level 3,David Maddison Bldg, Newcastle, NSW 2300, Australia.	john.attia@newcastle.edu.au	Attia, John R/F-5376-2013; Scott, Rodney J/B-2827-2013; Thakkinstian, Ammarin/J-4788-2019; Ioannidis, John P. A./G-9836-2011	Attia, John R/0000-0001-9800-1308; Scott, Rodney J/0000-0001-7724-3404; McEvoy, Mark/0000-0002-5505-5557				Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P74, DOI 10.1001/jama.2008.901; Barnholtz-Sloan JS, 2008, CANCER EPIDEM BIOMAR, V17, P471, DOI 10.1158/1055-9965.EPI-07-0491; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Contopoulos-Ioannidis DG, 2006, PHARMACOGENET GENOM, V16, P705, DOI 10.1097/01.fpc.0000236332.11304.8f; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Cox DG, 2006, HUM HERED, V61, P10, DOI 10.1159/000091787; Evangelou E, 2006, PLOS GENET, V2, P1147, DOI 10.1371/journal.pgen.0020123; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; *HUM GEN EP NETW, NAV HUM GEN EP; Ioannidis JPA, 2008, AM J MED GENET B, V147B, P964, DOI 10.1002/ajmg.b.30721; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Khoury MJ, 1998, AM J EPIDEMIOL, V148, P1; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; Leal SM, 2005, GENET EPIDEMIOL, V29, P204, DOI 10.1002/gepi.20086; LEVINE M, 1994, JAMA-J AM MED ASSOC, V271, P1615, DOI 10.1001/jama.271.20.1615; Levine M, 2008, USERS GUIDES MED LIT; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; LITTLE J, 2008, HUGENET HUGHE REV HD; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Montoya-Delgado LE, 2001, GENETICS, V158, P875; Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Province MA, 2001, ADV GENET, V42, P499, DOI 10.1016/S0065-2660(01)42039-6; Randolph A, 2008, USERS GUIDES MED LIT; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rubinsztein DC, 1999, DEMENT GERIATR COGN, V10, P199, DOI 10.1159/000017120; Sabatti Chiara, 2007, Methods Mol Biol, V376, P195; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Slooter AJC, 2004, NEUROLOGY, V62, P1196, DOI 10.1212/01.WNL.0000118302.66674.E1; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; *TUFTS U COMP MOL, SIMPL CALC DET WHETH; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; WACHOLDER S, ASSESSING PROBABILIT; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	59	121	125	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					191	197		10.1001/jama.2008.946	http://dx.doi.org/10.1001/jama.2008.946			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141767				2022-12-01	WOS:000262405500021
J	Chen, B; Cepko, CL				Chen, Bo; Cepko, Constance L.			HDAC4 Regulates Neuronal Survival in Normal and Diseased Retinas	SCIENCE			English	Article							CONTROLS CHONDROCYTE HYPERTROPHY; MEF2 TRANSCRIPTION FACTOR; CELL-DEATH; INTRACELLULAR TRAFFICKING; RETINITIS-PIGMENTOSA; BETA-SUBUNIT; MOUSE; PHOSPHODIESTERASE; DIFFERENTIATION; DEGENERATION	Histone deacetylase 4 ( HDAC4) shuttles between the nucleus and cytoplasm and serves as a nuclear co- repressor that regulates bone and muscle development. We report that HDAC4 regulates the survival of retinal neurons in the mouse in normal and pathological conditions. Reduction in HDAC4 expression during normal retinal development led to apoptosis of rod photoreceptors and bipolar ( BP) interneurons, whereas overexpression reduced naturally occurring cell death of the BP cells. HDAC4 overexpression in a mouse model of retinal degeneration prolonged photoreceptor survival. The survival effect was due to the activity of HDAC4 in the cytoplasm and relied at least partly on the activity of hypoxia- inducible factor 1 alpha (HIF1 alpha). These data provide evidence that HDAC4 plays an important role in promoting the survival of retinal neurons.	[Chen, Bo; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Chen, Bo; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Chen, Bo; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Chen, B (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	bochen@genetics.med.harvard.edu; cepko@genetics.med.harvard.edu			NIH [EYO 14466]; Foundation for Retinal Research; Merck; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY014466] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Retinal Research; Merck(Merck & Company); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J.R. Lu for providing HDAC4, HDAC5, and HDAC6 expression constructs; T.P. Yao for providing HDAC4-3SA mutant; X.J. Yang for providing HDAC4-L175A mutant; G.L. Semenza for providing dnHIF1 alpha constructs and K.W. Kim for providing HIF1 alpha and HIF1 alpha K532R constructs; and T. Matsuda for assistance with various techniques. Supported by NIH grant EYO 14466, the Foundation for Retinal Research, a gift from Merck, and the Howard Hughes Medical Institute (HHMI). C.L.C. is an Investigator of HHMI and B.C. is a postdoctoral fellow of HHMI. C.L.C. and B.C. have filed a U.S. patent application, 61/088,455, based on the work in this paper.	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bolger TA, 2007, J BIOL CHEM, V282, P29186, DOI 10.1074/jbc.M704182200; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Voyvodic JT, 1995, EUR J NEUROSCI, V7, P2469, DOI 10.1111/j.1460-9568.1995.tb01045.x; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	22	157	180	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					256	259		10.1126/science.1166226	http://dx.doi.org/10.1126/science.1166226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131628	Green Accepted			2022-12-01	WOS:000262290600039
J	Baid, SK; Lai, EW; Wesley, RA; Ling, A; Timmers, HJLM; Adams, KT; Kozupa, A; Pacak, K				Baid, Smita K.; Lai, Edwin W.; Wesley, Robert A.; Ling, Alex; Timmers, Henri J. L. M.; Adams, Karen T.; Kozupa, Anna; Pacak, Karel			Brief Communication: Radiographic Contrast Infusion and Catecholamine Release in Patients With Pheochromocytoma	ANNALS OF INTERNAL MEDICINE			English	Article								Background: Contrast-enhanced computed tomography (CT) is useful for localizing pheochromocytoma. However, in patients with suspected pheochromocytoma, CT is often canceled or not performed because of the strong belief that intravenous contrast may induce hypertensive crisis. Objective: To examine whether intravenous low-osmolar contrast administration during CT induces catecholamine release that increases blood pressure or heart rate. Design: Prospective study. Setting: Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland. Participants: 22 patients with pheochromocytoma (15 nonadrenal and 7 adrenal) and 8 unmatched control participants without pheochromocytoma. Measurements: Plasma catecholamine levels, blood pressure, and heart rate. Results: Plasma catecholamine levels within and between groups did not significantly differ before and after intravenous administration of low-osmolar CT contrast. Patients with pheochromocytoma experienced a clinically and statistically significant increase in diastolic blood pressure that was not accompanied by corresponding increases in plasma catecholamine levels. The difference became non -statistically significant after adjustment for use of alpha-and beta-blockers. Limitation: The study lacked a placebo group, and the sample was relatively small. Conclusion: Intravenous low-osmolar contrast-enhanced CT can safely be used in patients with pheochromocytoma who are not receiving alpha-or beta-blockers.	[Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Dev, Adult Endocrinol Program, Sect Med Neuroendocrinol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pacak, K (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Dev, Adult Endocrinol Program, Sect Med Neuroendocrinol, NIH, Bldg 10,CRC,Room 1E-1-3140,10 Ctr Dr,MSC-1109, Bethesda, MD 20892 USA.	karel@mail.nih.gov	Timmers, Henri JLM/A-4641-2010		Eunice Kennedy Shriver National Institute of Child Health and Development; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Eunice Kennedy Shriver National Institute of Child Health and Development, National Institutes of Health.	Aspelin P, 2006, EUR RADIOL, V16, P1041, DOI 10.1007/s00330-005-0081-5; EISENHOFER G, 1986, CLIN CHEM, V32, P2030; Ilias I, 2004, J CLIN ENDOCR METAB, V89, P479, DOI 10.1210/jc.2003-031091; Mukherjee JJ, 1997, RADIOLOGY, V202, P227, DOI 10.1148/radiology.202.1.8988215; ROSSI P, 1968, J AMER MED ASSOC, V205, P547, DOI 10.1001/jama.205.8.547	5	20	21	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2009	150	1					27	W6		10.7326/0003-4819-150-1-200901060-00006	http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397IC	19124817	Green Accepted			2022-12-01	WOS:000262655100004
J	Bradshaw, N; Neher, SB; Booth, DS; Walter, P				Bradshaw, Niels; Neher, Saskia B.; Booth, David S.; Walter, Peter			Signal Sequences Activate the Catalytic Switch of SRP RNA	SCIENCE			English	Article							RECOGNITION PARTICLE; CONFORMATIONAL-CHANGES; PROTEIN TRANSLOCATION; CRYSTAL-STRUCTURE; 4.5S RNA; RECEPTOR; BINDING; PEPTIDES; RIBONUCLEOPROTEIN; SUBUNIT	The signal recognition particle ( SRP) recognizes polypeptide chains bearing a signal sequence as they emerge from the ribosome, and then binds its membrane- associated receptor ( SR), thereby delivering the ribosome- nascent chain complex to the endoplasmic reticulum in eukaryotic cells and the plasma membrane in prokaryotic cells. SRP RNA catalytically accelerates the interaction of SRP and SR, which stimulates their guanosine triphosphatase ( GTPase) activities, leading to dissociation of the complex. We found that although the catalytic activity of SRP RNA appeared to be constitutive, SRP RNA accelerated complex formation only when SRP was bound to a signal sequence. This crucial control step was obscured because a detergent commonly included in the reaction buffer acted as a signal peptide mimic. Thus, SRP RNA is a molecular switch that renders the SRP- SR GTPase engine responsive to signal peptide recruitment, coupling GTP hydrolysis to productive protein targeting.	[Bradshaw, Niels; Neher, Saskia B.; Booth, David S.; Walter, Peter] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Bradshaw, Niels; Neher, Saskia B.; Booth, David S.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Walter, P (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.	pwalter@biochem.ucsf.edu	Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Bradshaw, Niels/0000-0002-6845-4717; Booth, David/0000-0002-4724-4702; Neher, Saskia/0000-0003-4165-6674	NIH [ROI GM32384]; NSF; Jane Coffin Childs Memorial Fund; National Institute of General Medical Sciences [R25 GM56847]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847, R01GM032384] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Weissman, C. Gross, P. Egea, C. Gallagher, A. Korennykh, A. Acevedo, W. Weare, and J. Kardon for assistance and comments. Supported by NIH grant ROI GM32384 (P.W.), an NSF predoctoral fellowship (N.B.), the Jane Coffin Childs Memorial Fund (S.B.N.), and National Institute of General Medical Sciences fellowship R25 GM56847 (D.S.B.). P.W. is an Investigator of the Howard Hughes Medical Institute.	Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Bradshaw N, 2007, MOL BIOL CELL, V18, P2728, DOI 10.1091/mbc.e07-02-0117; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; Neher SB, 2008, NAT STRUCT MOL BIOL, V15, P916, DOI 10.1038/nsmb.1467; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Swain JF, 2001, J BIOL CHEM, V276, P12222, DOI 10.1074/jbc.M011128200; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	19	67	67	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					127	130		10.1126/science.1165971	http://dx.doi.org/10.1126/science.1165971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119234	Green Accepted			2022-12-01	WOS:000262104100057
J	Smith, M				Smith, Malcolm			Year of astronomy: Time to turn off the lights	NATURE			English	Editorial Material							POLLUTION; NIGHT		[Smith, Malcolm] Cerro Tololo Interamer Observ, La Serena, Chile	National Optical Astronomy Observatory	Smith, M (corresponding author), Cerro Tololo Interamer Observ, Casilla 603, La Serena, Chile.	msmith@ctio.noao.edu						Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; DEDA P, 2007, STARLIGHT COMMON HER, P177; Isobe S, 2000, ASTROPHYS SPACE SCI, V273, P289, DOI 10.1023/A:1002719404278; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.1890/1540-9295(2004)002[0191:ELP]2.0.CO;2; Marin C., 2007, STARLIGHT COMMON HER; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Rich C., 2006, ECOLOGICAL CONSEQUEN; UNFPA, 2007, STATE WORLD POPULATI	8	38	39	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 1	2009	457	7225					27	27		10.1038/457027a	http://dx.doi.org/10.1038/457027a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122621				2022-12-01	WOS:000262104900015
J	Xie, YC; Yin, T; Wiegraebe, W; He, XC; Miller, D; Stark, D; Perko, K; Alexander, R; Schwartz, J; Grindley, JC; Park, J; Haug, JS; Wunderlich, JP; Li, H; Zhang, S; Johnson, T; Feldman, RA; Li, LH				Xie, Yucai; Yin, Tong; Wiegraebe, Winfried; He, Xi C.; Miller, Diana; Stark, Danny; Perko, Katherine; Alexander, Richard; Schwartz, Joel; Grindley, Justin C.; Park, Jungeun; Haug, Jeff S.; Wunderlich, Joshua P.; Li, Hua; Zhang, Simon; Johnson, Teri; Feldman, Ricardo A.; Li, Linheng			Detection of functional haematopoietic stem cell niche using real-time imaging	NATURE			English	Article							BONE-MARROW; PROGENITOR CELLS; IN-VIVO; N-CADHERIN; DIFFERENTIATION; MOBILIZATION; IDENTIFICATION; MICROSCOPY; RECEPTOR; LINEAGE	Haematopoietic stem cell (HSC) niches, although proposed decades ago(1), have only recently been identified as separate osteoblastic and vascular microenvironments(2-6). Their interrelationships and interactions with HSCs in vivo remain largely unknown. Here we report the use of a newly developed ex vivo real- time imaging technology and immunoassaying to trace the homing of purified green-fluorescent-protein- expressing (GFP(+)) HSCs. We found that transplanted HSCs tended to home to the endosteum (an inner bone surface) in irradiated mice, but were randomly distributed and unstable in non- irradiated mice. Moreover, GFP(+) HSCs were more frequently detected in the trabecular bone area compared with compact bone area, and this was validated by live imaging bioluminescence driven by the stem- cell- leukaemia ( Scl) promoter enhancer(7). HSCs home to bone marrow through the vascular system. We found that the endosteum is well vascularized and that vasculature is frequently localized near N-cadherin(+) pre-osteoblastic cells, a known niche component. By monitoring individual HSC behaviour using real- time imaging, we found that a portion of the homed HSCs underwent active division in the irradiated mice, coinciding with their expansion as measured by flow assay. Thus, in contrast to central marrow, the endosteum formed a special zone, which normally maintains HSCs but promotes their expansion in response to bone marrow damage.	[Miller, Diana; Feldman, Ricardo A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Miller, Diana; Feldman, Ricardo A.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Xie, Yucai; Yin, Tong; Wiegraebe, Winfried; He, Xi C.; Stark, Danny; Perko, Katherine; Alexander, Richard; Schwartz, Joel; Grindley, Justin C.; Park, Jungeun; Haug, Jeff S.; Wunderlich, Joshua P.; Li, Hua; Zhang, Simon; Johnson, Teri; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Xie, Yucai] Shanghai Jiao Tong Univ, Sch Med, Dept Cardiol, Shanghai Rui Jin Hosp, Shanghai 200025, Peoples R China; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Stowers Institute for Medical Research; Shanghai Jiao Tong University; University of Kansas; University of Kansas Medical Center	Feldman, RA (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	rfeldman@umaryland.edu; lil@stowers-institute.org		Feldman, Ricardo A./0000-0001-6090-0439; Li, Linheng/0000-0001-9963-430X	DOD [W81XWH-04-1-0801]; DRIF Award; University of Maryland; Stowers Institute for Medical Research	DOD(United States Department of Defense); DRIF Award; University of Maryland; Stowers Institute for Medical Research	We appreciate scientific support from R. Krumlauf, W. Neaves and encouragement from G. Luand W. Shen. We are grateful to D. Scadden and P. Kulesa for discussion. We thank D. Rowe for providing the Col2.3-GFP line. We thank R. Yu, L. Ma, Q. Qiu and W. Wang for technological advice, M. Hembree, A. Box, H. Marshall, E. Rendenbaugh, C. Cooper and M. Smith for technical support, S. Beckham for histology assistance, J. Perry and J. Ross for comments, and K. Tannen for proofreading. R.A.F. was supported by DOD grant W81XWH-04-1-0801 and by a DRIF Award from the University of Maryland. L.L. is supported by Stowers Institute for Medical Research.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen CZ, 2002, P NATL ACAD SCI USA, V99, P15468, DOI 10.1073/pnas.202614899; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Juopperi TA, 2007, EXP HEMATOL, V35, P335, DOI 10.1016/j.exphem.2006.09.014; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Murphy GJ, 2003, J BIOL CHEM, V278, P43556, DOI 10.1074/jbc.M302717200; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Osawa M, 1996, J IMMUNOL, V156, P3207; Sausville J, 2008, CLIN CANCER RES, V14, P3948, DOI 10.1158/1078-0432.CCR-07-5152; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	30	419	436	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					97	U102		10.1038/nature07639	http://dx.doi.org/10.1038/nature07639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19052548				2022-12-01	WOS:000262104900038
J	Yang, AHJ; Moore, SD; Schmidt, BS; Klug, M; Lipson, M; Erickson, D				Yang, Allen H. J.; Moore, Sean D.; Schmidt, Bradley S.; Klug, Matthew; Lipson, Michal; Erickson, David			Optical manipulation of nanoparticles and biomolecules in sub-wavelength slot waveguides	NATURE			English	Article							DNA-MOLECULES; MICROPARTICLES; PARTICLES; CELLS; TWEEZERS; PARALLEL; FORCES; LIGHT	The ability to manipulate nanoscopic matter precisely is critical for the development of active nanosystems. Optical tweezers(1-4) are excellent tools for transporting particles ranging in size fromseveral micrometres to a few hundred nanometres. Manipulation of dielectric objects with much smaller diameters, however, requires stronger optical confinement and higher intensities than can be provided by these diffraction- limited(5) systems. Here we present an approach to optofluidic transport that overcomes these limitations, using sub-wavelength liquid- core slot waveguides(6). The technique simultaneously makes use of near- field optical forces to confine matter inside the waveguide and scattering/ adsorption forces to transport it. The ability of the slot waveguide to condense the accessible electromagnetic energy to scales as small as 60 nm allows us also to overcome the fundamental diffraction problem. We apply the approach here to the trapping and transport of 75- nm dielectric nanoparticles and lambda-DNA molecules. Because trapping occurs along a line, rather than at a point as with traditional point traps(7,8), the method provides the ability to handle extended biomolecules directly. We also carry out a detailed numerical analysis that relates the near- field optical forces to release kinetics. We believe that the architecture demonstrated here will help to bridge the gap between optical manipulation and nanofluidics.	[Moore, Sean D.; Klug, Matthew; Erickson, David] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Yang, Allen H. J.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Schmidt, Bradley S.; Lipson, Michal] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Erickson, D (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	de54@cornell.edu	Han, Kyuhee/B-6201-2009; Yang, Allen/A-7155-2008; Erickson, David/A-3319-2009; Abrams, William R/A-5782-2008	Yang, Allen/0000-0003-3733-4066; Erickson, David/0000-0002-1624-9711; 	US National Science Foundation NIRT [0708599]	US National Science Foundation NIRT(National Science Foundation (NSF))	We thank A. Stroock for discussions, and A. Nitkowski and S. Manipatruni for technical support. This work was done in part at the Cornell NanoScale Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by the US National Science Foundation. This work was funded by the US National Science Foundation NIRT: Active Nanophotofluidic Systems for Single Molecule/Particle Analysis (award number 0708599).	Almeida VR, 2004, OPT LETT, V29, P1209, DOI 10.1364/OL.29.001209; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Born M., 2003, PRINCIPLES OPTICS; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Chiou PY, 2005, NATURE, V436, P370, DOI [10.1038/nature03831, 10.1038/nature0383l]; Chiu DT, 1996, J AM CHEM SOC, V118, P6512, DOI 10.1021/ja960978p; Cizmar T, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035105; Dholakia K, 2008, STRUCTURED LIGHT AND ITS APPLICATIONS: AN INTRODUCTION TO PHASE-STRUCTURED BEAMS AND NANOSCALE OPTICAL FORCES, P107, DOI 10.1016/B978-0-12-374027-4.00005-0; Gaugiran S, 2007, OPT EXPRESS, V15, P8146, DOI 10.1364/OE.15.008146; Gaugiran S, 2005, OPT EXPRESS, V13, P6956, DOI 10.1364/OPEX.13.006956; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Grigorenko AN, 2008, NAT PHOTONICS, V2, P365, DOI 10.1038/nphoton.2008.78; Grujic K, 2005, OPT EXPRESS, V13, P1, DOI 10.1364/OPEX.13.000001; Hart SJ, 2006, ANAL CHEM, V78, P3221, DOI 10.1021/ac052221z; Hirano K, 2008, ANAL CHEM, V80, P5197, DOI 10.1021/ac8003538; Liu GL, 2006, NAT MATER, V5, P27, DOI 10.1038/nmat1528; MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144; Marchington RF, 2008, OPT EXPRESS, V16, P3712, DOI 10.1364/OE.16.003712; Monat C, 2007, NAT PHOTONICS, V1, P106, DOI 10.1038/nphoton.2006.96; Neale SL, 2005, NAT MATER, V4, P530, DOI 10.1038/nmat1411; Ng LN, 2002, OPT COMMUN, V208, P117, DOI 10.1016/S0030-4018(02)01590-0; Ng LN, 2000, J LIGHTWAVE TECHNOL, V18, P388, DOI 10.1109/50.827512; Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060; Righini M, 2007, NAT PHYS, V3, P477, DOI 10.1038/nphys624; Schmidt BS, 2007, OPT EXPRESS, V15, P14322, DOI 10.1364/OE.15.014322; Sinclair G, 2004, OPT EXPRESS, V12, P5475, DOI 10.1364/OPEX.12.005475; SVOBODA K, 1994, OPT LETT, V19, P930, DOI 10.1364/OL.19.000930; Wang MM, 2005, NAT BIOTECHNOL, V23, P83, DOI 10.1038/nbt1050; Woolley AT, 2000, NAT BIOTECHNOL, V18, P760, DOI 10.1038/77760; Yang AHJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/04/045704	30	631	645	6	386	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					71	75		10.1038/nature07593	http://dx.doi.org/10.1038/nature07593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122638				2022-12-01	WOS:000262104900032
J	Petticrew, M				Petticrew, Mark			Billy Bunter and the obesogenic environment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Petticrew, Mark] Univ London London Sch Hyg & Trop Med, Publ & Environm Hlth Res Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Petticrew, M (corresponding author), Univ London London Sch Hyg & Trop Med, Publ & Environm Hlth Res Unit, Keppel St, London WC1E 7HT, England.	mark.petticrew@lshtm.ac.uk	Petticrew, Mark/AAY-6274-2021					BUNTER B, 1976, VALIANT ANN, P20; BUTCHER JS, 1965, GREYFRIARS SCH PROSP, P6; Carnell S, 2008, INT J OBESITY, V32, P1468, DOI 10.1038/ijo.2008.127; Chang PC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-193; Department of Health, 2008, HLTH WEIGHT HLTH LIV; Department of Health Social Security, 1980, WORK GROUP IN HLTH I; Gustafsson U, 2002, SOC POLICY ADMIN, V36, P685, DOI 10.1111/1467-9515.00311; Halford JCG, 2007, APPETITE, V49, P263, DOI 10.1016/j.appet.2006.12.003; Hyde R, 2008, LANCET, V371, P2160, DOI 10.1016/S0140-6736(08)60936-8; Macdonald L, 2007, APPETITE, V49, P251, DOI 10.1016/j.appet.2006.11.004; Miller SA, 2008, INT J PEDIATR OBES, V3, P168, DOI 10.1080/17477160801915935; Moore L, 2008, J EPIDEMIOL COMMUN H, V62, P926, DOI 10.1136/jech.2007.070953; RICHARDS H, 1949, B BUNTER CLIFF HOUSE; School Food Trust, 2008, NEW RES REV SCAL JUN; Schwartz J, 2006, J AM DIET ASSOC, V106, P1412, DOI 10.1016/j.jada.2006.06.006; West P, 2007, TOB CONTROL, V16, P329, DOI 10.1136/tc.2006.018721; WILLIAMS C, 2008, GROCER          0112, P31; 2008, LEATHERMEAD MAT 0223	18	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2008	337								a2877	10.1136/bmj.a2877	http://dx.doi.org/10.1136/bmj.a2877			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SV	19088137	Green Accepted			2022-12-01	WOS:000262184900004
J	Lim, SS; Stein, DB; Charrow, A; Murray, CJL				Lim, Stephen S.; Stein, David B.; Charrow, Alexandra; Murray, Christopher J. L.			Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage	LANCET			English	Article							VACCINATION COVERAGE; MOTHERS REPORTS; DATA QUALITY; CHILDREN; SEROEPIDEMIOLOGY; PREVALENCE; ACCURACY; VALIDITY; ANTIBODY; MEASLES	Background Substantial resources have been invested in increasing childhood immunisation coverage through global initiatives such as the Universal Childhood Immunisation (UCI) campaign and the Global Alliance on Vaccines and Immunisations (GAVI). There are longstanding concerns that target-oriented and performance-oriented initiatives such as UCI and GAVI's immunisation services support (ISS) might encourage over-reporting. We estimated the coverage of three doses of diphtheria, tetanus, and pertussis vaccine (DTP3) based on surveys using all available data. Methods We estimated DTP3 coverage by analysing unit record data from surveys and supplemented this with reported coverage from other surveys and administrative data. We used bidirectional distance-dependent regression to estimate trends in survey-based coverage in 193 countries during 1986-2006. We used standard time-series cross-sectional analysis to investigate any association in the difference between countries' official reports and survey-based coverage as the dependent variable and the presence of GAVI ISS as the independent variable, controlling for country and time effects. Findings Crude coverage of DTP3 based on surveys increased from 59% (95% uncertainty interval 51-65) in 1986 to 65% (60-68) in 1990, 70% (65-74) in 2000, and 74% (70-77) in 2006. There were substantial differences between officially reported and survey-based coverage during VCI. GAVI ISS significantly increased the difference between officially reported coverage and survey coverage. Up to 2006, in 51 countries receiving GAVI ISS payments, 7.4 million (5.7 million to 9.2 million) additional children were immunised with DTP3 based on surveys compared with officially reported estimates of 13.9 million. On the basis of the number of additional children immunised from surveys at a rate of US$20 each, GAVI ISS payments are estimated at $150 million (115 million to 184 million) compared with actual disbursements of $290 million. Interpretation Survey-based DTP3 immunisation coverage has improved more gradually and not to the level suggested by countries' official reports or WHO and UNICEF estimates. There is an urgent need for independent and contestable monitoring of health indicators in an era of global initiatives that are target-oriented and disburse funds based on performance. Funding Bill & Melinda Gates Foundation.	[Lim, Stephen S.; Stein, David B.; Charrow, Alexandra; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@u.washington.edu	Lim, Stephen S/B-4055-2012	Stein, David/0000-0003-3743-1595	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill & Melinda Gates Foundation. We thank Abdallah Bchir and Nina Schwalbe for helpful comments on drafts; Stanislava Nikolova for help with editing; Catherine Claiborne for help with editing and programme assistance; and Jennifer Berthiaume for assistance with data collation.	Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Beck N., 1996, POLIT ANAL, V6, P1, DOI 10.1093/pan/6.1.1; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Brogan Donna, 1994, Annals of Epidemiology, V4, P302, DOI 10.1016/1047-2797(94)90086-8; Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9; Cutts FT, 2000, TROP MED INT HEALTH, V5, P157, DOI 10.1046/j.1365-3156.2000.00536.x; Gabutti G, 2002, EPIDEMIOL INFECT, V129, P543, DOI 10.1017/S0950268802007677; GAREABALLAH ET, 1989, B WORLD HEALTH ORGAN, V67, P669; *GAVI, IMM SERV SUPP ISS; *GAVI UNICEF, 2000, VACC IMM PROD GUID C; George K, 1990, Indian J Pediatr, V57, P588, DOI 10.1007/BF02726779; Gidding HF, 2005, AUST NZ J PUBL HEAL, V29, P48, DOI 10.1111/j.1467-842X.2005.tb00748.x; Hardon A, 2005, SOC SCI MED, V60, P345, DOI 10.1016/j.socscimed.2004.05.008; HONAKER J, 2008, WHAT DO MISSING VALU; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Jolly Richard., 2004, J HUMAN DEV, V5, P69, DOI DOI 10.1080/14649880310001660210; Katz J, 1997, INT J EPIDEMIOL, V26, P1041, DOI 10.1093/ije/26.5.1041; Keele L, 2006, POLIT ANAL, V14, P186, DOI 10.1093/pan/mpj006; KEJA K, 1988, World Health Statistics Quarterly, V41, P59; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Langsten R, 1998, SOC SCI MED, V46, P1205, DOI 10.1016/S0277-9536(97)10049-1; LE T, 1997, DHS ANAL REPORTS, V3; Lin L., 2000, BIOMETRICS, V56, P324, DOI [DOI 10.1111/J.0006-341X.2000.00324.X, 10.1111/j.0006-341X.2000.00324.x]; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Little RJ., 2019, STAT ANAL MISSING DA, VVolume 793; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lu CL, 2006, LANCET, V368, P1088, DOI 10.1016/S0140-6736(06)69337-9; Mavimbe JC, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-108; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; Milligan P, 2004, INT J EPIDEMIOL, V33, P469, DOI 10.1093/ije/dyh096; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJL, 2003, LANCET, V362, P1022, DOI 10.1016/S0140-6736(03)14411-X; Nigatu W, 2008, VACCINE, V26, P4769, DOI 10.1016/j.vaccine.2008.07.005; NIKOLETTI S, 1994, EPIDEMIOL INFECT, V112, P161, DOI 10.1017/S0950268800057526; OHUMA EO, 2008, EPIDEMIOL INFECT, V10, P1; Onta SR, 1998, HEALTH POLICY PLANN, V13, P131, DOI 10.1093/heapol/13.2.131; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Ramakrishnan R, 1999, Indian Pediatr, V36, P881; Ren R., 2006, DHS WORKING PAPERS, V30; Ringler M, 2003, EUR J EPIDEMIOL, V18, P161, DOI 10.1023/A:1023038705835; Ronveaux O, 2005, B WORLD HEALTH ORGAN, V83, P503; Rubin D.B., 2004, MULTIPLE IMPUTATION; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Shinall MC, 2007, PEDIATRICS, V120, pe783, DOI 10.1542/peds.2007-0052; Starling M., 2002, NEW PRODUCTS OLD SYS; Suarez L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e3; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; UN, 2007, WORLD POP PROSP; *UNICEF WHO, 2007, IMM SUMM 2007; VALADEZ JJ, 1992, AM J PUBLIC HEALTH, V82, P120, DOI 10.2105/AJPH.82.1.120; Vancelik S, 2007, INDIAN J MED RES, V126, P528; *WHO UNICEF, 1980, COUNTR REP WHO UNICE; *WHO UNICEF, WHO UNICEF JOINT REP; *WHO UNICEF, 1980, WHO UNICEF REV NAT I; 2005, GLOBAL BURDEN DIS ST	60	189	191	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2008	372	9655					2031	2046		10.1016/S0140-6736(08)61869-3	http://dx.doi.org/10.1016/S0140-6736(08)61869-3			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	384LS	19070738				2022-12-01	WOS:000261746900024
J	Faure-Andre, G; Vargas, P; Yuseff, MI; Heuze, M; Diaz, J; Lankar, D; Steri, V; Manry, J; Hugues, S; Vascotto, F; Boulanger, J; Raposo, G; Bono, MR; Rosemblatt, M; Piel, M; Lennon-Dumenil, AM				Faure-Andre, Gabrielle; Vargas, Pablo; Yuseff, Maria-Isabel; Heuze, Melina; Diaz, Jheimmy; Lankar, Danielle; Steri, Veronica; Manry, Jeremy; Hugues, Stephanie; Vascotto, Fulvia; Boulanger, Jerome; Raposo, Graca; Bono, Maria-Rosa; Rosemblatt, Mario; Piel, Matthieu; Lennon-Dumenil, Ana-Maria			Regulation of Dendritic Cell Migration by CD74, the MHC Class II-Associated Invariant Chain	SCIENCE			English	Article							CATHEPSIN-S; ANTIGEN PRESENTATION; MYOSIN-IIA; NK CELLS; STIMULATION; TRAFFICKING; DEGRADATION; COMPLEX; CD44	Dendritic cells ( DCs) sample peripheral tissues of the body in search of antigens to present to T cells. This requires two processes, antigen processing and cell motility, originally thought to occur independently. We found that the major histocompatibility complex II- associated invariant chain (li or CD74), a known regulator of antigen processing, negatively regulates DC motility in vivo. By using microfabricated channels to mimic the confined environment of peripheral tissues, we found that wild- type DCs alternate between high and low motility, whereas li-deficient cells moved in a faster and more uniform manner. The regulation of cell motility by li depended on the actin- based motor protein myosin II. Coupling antigen processing and cell motility may enable DCs to more efficiently detect and process antigens within a defined space.	[Boulanger, Jerome; Raposo, Graca; Piel, Matthieu] Inst Curie, CNRS, UMR144, F-75005 Paris, France; [Bono, Maria-Rosa; Rosemblatt, Mario] Fdn Ciencia Vida, Santiago, Chile; [Bono, Maria-Rosa; Rosemblatt, Mario] Inst Milenio Biol Fundamental & Aplicada, Santiago, Chile; [Rosemblatt, Mario] Univ Andres Bello, Fac Ciencias Salud, Santiago, Chile; [Faure-Andre, Gabrielle; Vargas, Pablo; Yuseff, Maria-Isabel; Heuze, Melina; Diaz, Jheimmy; Lankar, Danielle; Steri, Veronica; Manry, Jeremy; Hugues, Stephanie; Vascotto, Fulvia; Lennon-Dumenil, Ana-Maria] Inst Curie, INSERM, U653, F-75005 Paris, France; [Vargas, Pablo; Bono, Maria-Rosa; Rosemblatt, Mario] Univ Chile, Dept Biol, Fac Ciencias, Santiago 3425, Chile	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; Universidad Andres Bello; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universidad de Chile	Piel, M (corresponding author), Inst Curie, CNRS, UMR144, 12 Rue Lhomond, F-75005 Paris, France.	mpiel@curie.fr; amlennon@curie.fr	Vargas, Pablo/L-9858-2017; Diaz, Jheimmy/AAF-6886-2019; Lennon-Dumenil, Ana-Maria/I-6716-2016; Bono, Maria/G-7461-2014	Vargas, Pablo/0000-0002-6475-494X; Boulanger, Jerome/0000-0003-0237-3743; hugues, stephanie/0000-0002-1031-5909; Raposo, graca/0000-0001-9590-1298; Manry, Jeremy/0000-0001-5998-2051; Vascotto, Fulvia/0000-0002-9839-3484; Heuze, Melina/0000-0002-4271-2706	Ministere Francais de la Recherche; Association pour la Recherche contre le Cancer; ECOS-Comision Nacional de Investigacion Cientifica y Technologica; Gobierno de Chile [CO3S01]; Institut Curie and Inserm; ARC, Fondecyt (Chile) [1060834, 1060253]; Agence Nationale pour la Recherche [ANR-06-PCVI-0010]; Human Frontiers Science Program [RGY53/2007]	Ministere Francais de la Recherche(Ministry of Research, France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ECOS-Comision Nacional de Investigacion Cientifica y Technologica; Gobierno de Chile; Institut Curie and Inserm; ARC, Fondecyt (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Human Frontiers Science Program(Human Frontier Science Program)	The authors thank T. Makushok for setting up the cell migration microchannel system; A. Azicune for cell micropatterning techniques; W. Faigle and D. Lowe for proteomics analysis; C. Recchi for help with gelatin-FITC degradation experiments; H. Overkleeft for synthesizing the LHVS; J. Roger for providing magnetic nanoparticles; M. Leberre, D. Baigl, and Y. Chen for help with microfabrication; and S. Amigorena, M. Sixt, P. Benaroch, V. Soumelis, C. Hivroz, and I. Fernandez for advice on the manuscript. A.-M. L.-D. thanks Y. Bellaiche for help with manuscript redaction. G.F.-A. was supported by a fellowship from the Ministere Francais de la Recherche and, together with M. H., from the Association pour la Recherche contre le Cancer (ARC). P.V. and M.- I.Y. benefited from ECOS-Comision Nacional de Investigacion Cientifica y Technologica, Gobierno de Chile fellowship (CO3S01), Institut Curie and Inserm fellowships, respectively. V.S. was part of the Leonardo Da Vinci project (Unipharma-Graduates, Sapienza University of Rome). This work was funded in part by grants from the ARC, Fondecyt (Chile) to M.- R.B. (1060834) and M. R. ( 1060253); Agence Nationale pour la Recherche (ANR-06-PCVI-0010) and Human Frontiers Science Program (RGY53/2007) to M.P.	Andzelm MM, 2007, J EXP MED, V204, P2285, DOI 10.1084/jem.20071143; Boes M, 2005, EUR J IMMUNOL, V35, P2552, DOI 10.1002/eji.200526323; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chao SH, 2007, LAB CHIP, V7, P641, DOI 10.1039/b618269k; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; FINK J, 2008, LAB CHIP, V453, P51; Fink J, 2007, LAB CHIP, V7, P672, DOI 10.1039/b618545b; Irimia D, 2007, LAB CHIP, V7, P1783, DOI 10.1039/b710524j; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153	22	207	215	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1705	1710		10.1126/science.1159894	http://dx.doi.org/10.1126/science.1159894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074353				2022-12-01	WOS:000261608300049
J	Roehr, B				Roehr, Bob			The invisible epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEN; SEX					BobRoehr@aol.com						amfAR, 2008, MSM HIV ROAD UN ACC; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Centers for Disease Control and Prevention, EST NEW HIV INF US; Epstein H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2638; Ottoson Daniel, 2008, STATE SPONSORED HOMO; Roehr Bob, 2008, BMJ, V337, pa1182, DOI 10.1136/bmj.a1182	7	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2008	337								a2566	10.1136/bmj.a2566	http://dx.doi.org/10.1136/bmj.a2566			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QA	19033333				2022-12-01	WOS:000261827500016
J	Mumma, MJ; Villanueva, GL; Novak, RE; Hewagama, T; Bonev, BP; DiSanti, MA; Mandell, AM; Smith, MD				Mumma, Michael J.; Villanueva, Geronimo L.; Novak, Robert E.; Hewagama, Tilak; Bonev, Boncho P.; DiSanti, Michael A.; Mandell, Avi M.; Smith, Michael D.			Strong Release of Methane on Mars in Northern Summer 2003	SCIENCE			English	Article							MARTIAN DUST DEVILS; MU-M; OXIDANT ENHANCEMENT; ATMOSPHERE; ORIGIN; LIFE; SPECTRUM; SEARCH; STORMS; MODEL	Living systems produce more than 90% of Earth's atmospheric methane; the balance is of geochemical origin. On Mars, methane could be a signature of either origin. Using high- dispersion infrared spectrometers at three ground- based telescopes, we measured methane and water vapor simultaneously on Mars over several longitude intervals in northern early and late summer in 2003 and near the vernal equinox in 2006. When present, methane occurred in extended plumes, and the maxima of latitudinal profiles imply that the methane was released from discrete regions. In northern midsummer, the principal plume contained similar to 19,000 metric tons of methane, and the estimated source strength (>= 0.6 kilogram per second) was comparable to that of the massive hydrocarbon seep at Coal Oil Point in Santa Barbara, California.	[Mumma, Michael J.; Villanueva, Geronimo L.; Hewagama, Tilak; Bonev, Boncho P.; DiSanti, Michael A.; Mandell, Avi M.; Smith, Michael D.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Villanueva, Geronimo L.; Bonev, Boncho P.] Univ Amer, Dept Phys, Washington, DC 20008 USA; [Novak, Robert E.] Iona Coll, Dept Phys, New Rochelle, NY 10801 USA; [Hewagama, Tilak] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Iona College; University System of Maryland; University of Maryland College Park	Mumma, MJ (corresponding author), NASA, Goddard Space Flight Ctr, Mailstop 690-3, Greenbelt, MD 20771 USA.	michael.j.mumma@nasa.gov	Hewagama, T/C-8488-2012; Mandell, Avi M/F-9361-2012; Smith, Michael/C-8875-2012; mumma, michael j/I-2764-2013	Mandell, Avi M/0000-0002-8119-3355; mumma, michael j/0000-0003-4627-750X	NASA the Planetary Astronomy Program [RTOP 344-32-07]; Astrobiology Institute [RTOP 344-53-51]; NSF Research at Undergraduate Institutions Program [AST-0505765]	NASA the Planetary Astronomy Program(National Aeronautics & Space Administration (NASA)); Astrobiology Institute; NSF Research at Undergraduate Institutions Program(National Science Foundation (NSF))	We thank T. C. Onstott and L. M. Pratt for helpful comments and two anonymous referees for their comments and suggestions. This work was supported by NASA [the Planetary Astronomy Program (RTOP 344-32-07 to M.J.M), Astrobiology Institute (RTOP 344-53-51, to M.J.M), and Postdoctoral Program (G.L.V.)] by NSF (Research at Undergraduate Institutions Program AST-0505765 to R.E.N.). We thank the director and staff of NASA's InfraRed Telescope Facility (operated for NASA by the University of Hawaii) for exceptional support throughout our long Mars observing program. Data were also obtained at the W. M. Keck Observatory, operated as a scientific partnership by CalTech, the University of California Los Angeles, and NASA.	Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Atreya SK, 2006, ASTROBIOLOGY, V6, P439, DOI 10.1089/ast.2006.6.439; Baratoux D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002890; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Delory GT, 2006, ASTROBIOLOGY, V6, P451, DOI 10.1089/ast.2006.6.451; Encrenaz T, 2008, ICARUS, V195, P547, DOI 10.1016/j.icarus.2008.01.022; Farrell WM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027210; Formisano V, 2005, PLANET SPACE SCI, V53, P1043, DOI 10.1016/j.pss.2005.03.009; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Geminale A, 2008, PLANET SPACE SCI, V56, P1194, DOI 10.1016/j.pss.2008.03.004; HECHT MH, 2008, EOS S, V89; Hiesinger H, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002143; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; KOUNAVES SP, 2008, EOS S, V89; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Krasnopolsky VA, 2006, ICARUS, V180, P359, DOI 10.1016/j.icarus.2005.10.015; Krasnopolsky VA, 1997, J GEOPHYS RES-PLANET, V102, P6525, DOI 10.1029/96JE03766; Krasnopolsky VA, 2007, ICARUS, V190, P93, DOI 10.1016/j.icarus.2007.02.014; Lellouch E, 2000, PLANET SPACE SCI, V48, P1393, DOI 10.1016/S0032-0633(00)00118-5; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Lyons JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022161; MAGUIRE WC, 1977, ICARUS, V32, P85, DOI 10.1016/0019-1035(77)90051-3; Mau S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031344; Max MD, 2000, J GEOPHYS RES-PLANET, V105, P4165, DOI 10.1029/1999JE001119; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; MUMMA M. J., 2003, B AM ASTRON SOC, V35, P937; Mumma M.J., 2004, AM ASTRON SOC DPS ME, V36, P1127; MUMMA MJ, 2008, B AM ASTRON SOC, V40, P396; MUMMA MJ, 2007, B AM ASTRON SOC, V39, P471; MUMMA MJ, 2005, B AM ASTRON SOC, V37, P669; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; NAIR H, 1994, ICARUS, V111, P124, DOI 10.1006/icar.1994.1137; Onstott TC, 2006, GEOMICROBIOL J, V23, P369, DOI 10.1080/01490450600875688; Onstott TC, 2006, ASTROBIOLOGY, V6, P377, DOI 10.1089/ast.2006.6.377; Oze C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022691; Pellenbarg RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001901; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Summers ME, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015377; Villanueva GL, 2008, ICARUS, V195, P34, DOI 10.1016/j.icarus.2007.11.014; Wille C, 2008, GLOBAL CHANGE BIOL, V14, P1395, DOI 10.1111/j.1365-2486.2008.01586.x; Wong AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002003	42	421	433	3	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1041	1045		10.1126/science.1165243	http://dx.doi.org/10.1126/science.1165243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19150811				2022-12-01	WOS:000263478400036
J	Chen, MJ; Yokomizo, T; Zeigler, BM; Dzierzak, E; Speck, NA				Chen, Michael J.; Yokomizo, Tomomasa; Zeigler, Brandon M.; Dzierzak, Elaine; Speck, Nancy A.			Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter	NATURE			English	Article							STEM-CELLS; MOUSE EMBRYO; ADULT HEMATOPOIESIS; FETAL LIVER; MURINE ALLANTOIS; VE-CADHERIN; EXPRESSION; VASCULOGENESIS; CIRCULATION; COMPARTMENT	Haematopoietic stem cells ( HSCs) are the founder cells of the adult haematopoietic system, and thus knowledge of the molecular program directing their generation during development is important for regenerative haematopoietic strategies. Runx1 is a pivotal transcription factor required for HSC generation in the vascular regions of the mouse conceptus - the aorta, vitelline and umbilical arteries, yolk sac and placenta(1,2). It is thought that HSCs emerge from vascular endothelial cells through the formation of intra-arterial clusters(3) and that Runx1 functions during the transition from 'haemogenic endothelium' to HSCs4,5. Here we show by conditional deletion that Runx1 activity in vascular- endothelial- cadherin-positive endothelial cells is indeed essential for intra-arterial cluster, haematopoietic progenitor and HSC formation in mice. In contrast, Runx1 is not required in cells expressing Vav1, one of the first pan- haematopoietic genes expressed in HSCs. Collectively these data show that Runx1 function is essential in endothelial cells for haematopoietic progenitor and HSC formation from the vasculature, but its requirement ends once or before Vav is expressed.	[Chen, Michael J.; Zeigler, Brandon M.; Speck, Nancy A.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Chen, Michael J.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Yokomizo, Tomomasa; Dzierzak, Elaine] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands	Dartmouth College; Dartmouth College; Erasmus University Rotterdam; Erasmus MC	Speck, NA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	nancyas@exchange.upenn.edu		Zeigler, Brandon/0000-0002-1258-7780	Norris Cotton Cancer Center [NIH CA23108]; Abramson Family Cancer Research Institute;  [R01HL091724];  [R01DK54077];  [T32 AI-07519]; NATIONAL CANCER INSTITUTE [R01CA058343, P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054077, R37DK054077] Funding Source: NIH RePORTER	Norris Cotton Cancer Center; Abramson Family Cancer Research Institute; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank G. Ward for his assistance with flow, K. Downs for technical advice, T. Graf for the Vav-Cre mice, and P. Huber for the Cdh5 sequences. This work was supported by R01HL091724 (N.A.S.), R01DK54077 (E.D.) and T32 AI-07519 (B.M.Z.). Core services were supported in part by the Norris Cotton Cancer Center (NIH CA23108) and the Abramson Family Cancer Research Institute.	Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Downs KM, 2004, DEVELOPMENT, V131, P37, DOI 10.1242/dev.00906; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Gory S, 1999, BLOOD, V93, P184, DOI 10.1182/blood.V93.1.184.401a20_184_192; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Inman KE, 2006, DEVELOPMENT, V133, P2947, DOI 10.1242/dev.02454; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kim I, 2005, BLOOD, V106, P903, DOI 10.1182/blood-2004-12-4960; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Ogilvy S, 1999, BLOOD, V94, P1855; Okada H, 1998, ONCOGENE, V17, P2287, DOI 10.1038/sj.onc.1202151; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Yokomizo T, 2007, EMBO J, V26, P184, DOI 10.1038/sj.emboj.7601480; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596	31	680	704	5	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					887	891		10.1038/nature07619	http://dx.doi.org/10.1038/nature07619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19129762	Green Accepted			2022-12-01	WOS:000263266700046
J	Forbes, AA; Powell, THQ; Stelinski, LL; Smith, JJ; Feder, JL				Forbes, Andrew A.; Powell, Thomas H. Q.; Stelinski, Lukasz L.; Smith, James J.; Feder, Jeffrey L.			Sequential Sympatric Speciation Across Trophic Levels	SCIENCE			English	Article							RHAGOLETIS-POMONELLA DIPTERA; APPLE MAGGOT FLY; HOST RACES; MATING BEHAVIOR; TEPHRITIDAE; DIVERSITY	A major cause for biodiversity may be biodiversity itself. As new species form, they may create new niches for others to exploit, potentially catalyzing a chain reaction of speciation events across trophic levels. We tested for such sequential radiation in the Rhagoletis pomonella ( Diptera: Tephritidae) complex, a model for sympatric speciation via host plant shifting. We report that the parasitic wasp Diachasma alloeum ( Hymenoptera: Braconidae) has formed new incipient species as a result of specializing on diversifying fly hosts, including the recently derived apple- infesting race of R. pomonella. Furthermore, we show that traits that differentially adapt R. pomonella flies to their host plants have also quickly evolved and serve as ecological barriers to reproduction, isolating the wasps. Speciation therefore cascades as the effects of new niche construction move across trophic levels.	[Forbes, Andrew A.; Powell, Thomas H. Q.; Feder, Jeffrey L.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Stelinski, Lukasz L.] Univ Florida, Ctr Agr Res & Educ, Dept Entomol & Nematol, Lake Alfred, FL 33850 USA; [Smith, James J.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Smith, James J.] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA	University of Notre Dame; State University System of Florida; University of Florida; Michigan State University; Michigan State University	Forbes, AA (corresponding author), Univ Calif Davis, Dept Entomol, 1 Shields Ave, Davis, CA 95616 USA.	aaforbes@ucdavis.edu	Powell, Thomas/B-8575-2013	Powell, Thomas/0000-0002-4780-5215; Forbes, Andrew/0000-0001-8332-6652	NSF; American Museum of Natural History Theodore Roosevelt Fund Grant; Wissenschaftskolleg zu Berlin	NSF(National Science Foundation (NSF)); American Museum of Natural History Theodore Roosevelt Fund Grant; Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF))	We thank M. Aluja, S. H. Berlocher, H. R. Dambroski, F. Footman, T. M. Forbes, E. Luecke, A. P. Michel, M. A. F. Noor, J. Rull, D. Schwarz, S. Velez, F. Wang, and R. A. Wharton for their technical, physical, intellectual, and moral support. Funded by a NSF doctoral dissertation improvement grant to A. A. F. and J. L. F., an American Museum of Natural History Theodore Roosevelt Fund Grant to A. A. F., and support to J. L. F. from the Wissenschaftskolleg zu Berlin. GenBank accession numbers for the mtDNA COI sequences are EU881512 to EU881682.	Abrahamson WG, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P188; Berlocher SH, 1999, HEREDITY, V83, P652, DOI 10.1038/sj.hdy.6885910; Berlocher SH, 2000, EVOLUTION, V54, P543, DOI 10.1111/j.0014-3820.2000.tb00057.x; Butterfield NJ, 2001, ECOLOGY CAMBRIAN REG; Coyne J.A., 2004, SPECIATION; Dilcher D, 2000, P NATL ACAD SCI USA, V97, P7030, DOI 10.1073/pnas.97.13.7030; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Erwin DH, 2005, SCIENCE, V308, P1752, DOI 10.1126/science.1113416; Feder Jeffrey L., 1998, P408; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; FEDER JL, 1995, ECOLOGY, V76, P801, DOI 10.2307/1939346; FEDER JL, 1988, NATURE, V336, P61, DOI 10.1038/336061a0; FEDER JL, 1998, ENDLESS FORMS SPECIE; LaSalle J., 1991, Redia, V74, P315; Linn C, 2003, P NATL ACAD SCI USA, V100, P11490, DOI 10.1073/pnas.1635049100; MCPHERON BA, 1988, NATURE, V336, P64, DOI 10.1038/336064a0; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Price P.W., 1980, EVOLUTIONARY BIOL PA; PROKOPY RJ, 1971, CAN ENTOMOL, V103, P1405, DOI 10.4039/Ent1031405-10; PROKOPY RJ, 1972, CAN ENTOMOL, V104, P97, DOI 10.4039/Ent10497-1; Smith JJ, 1997, MOL PHYLOGENET EVOL, V7, P33, DOI 10.1006/mpev.1996.0374; Strong D.R., 1984, INSECTS PLANTS COMMU; TURLINGS TCJ, 1993, INSECT LEARNING ECOL, P398; Wharton R.A., 1978, Journal of the Washington Academy of Sciences, V68, P147	24	131	135	0	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					776	779		10.1126/science.1166981	http://dx.doi.org/10.1126/science.1166981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197063				2022-12-01	WOS:000263066800045
J	Marenzi, G; Assanelli, E; Campodonico, J; Lauri, G; Marana, I; De Metrio, M; Moltrasio, M; Grazi, M; Rubino, M; Veglia, F; Fabbiocchi, F; Bartorelli, AL				Marenzi, Giancarlo; Assanelli, Emilio; Campodonico, Jeness; Lauri, Gianfranco; Marana, Ivana; De Metrio, Monica; Moltrasio, Marco; Grazi, Marco; Rubino, Mara; Veglia, Fabrizio; Fabbiocchi, Franco; Bartorelli, Antonio L.			Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PRIMARY ANGIOPLASTY; RENAL DYSFUNCTION; CREATININE CLEARANCE; N-ACETYLCYSTEINE; PREDICTION; INSUFFICIENCY; FAILURE; IMPACT; MEDIA	Background: Contrast-induced nephropathy (CIN) frequently occurs in patients with acute ST-segment elevation myocardial infarction (STEMI) who are undergoing primary percutaneous coronary intervention, and CIN is associated with a more complicated clinical course and increased mortality. Objective: To investigate the association between absolute and weight- and creatinine-adjusted contrast volume, CIN incidence, and clinical outcome in the era of mechanical reperfusion of STEMI. Design: Prospective, observational study. Setting: A university cardiology center in Milan, Italy. Patients: 561 consecutive patients with STEMI who were undergoing primary percutaneous coronary intervention. Measurements: For each patient, the maximum contrast dose was calculated, according to the formula (5 X body weight [kg])/serum creatinine, and the contrast ratio, defined as the ratio between the contrast volume administered and the maximum dose calculated, was assessed. An increase in serum creatinine of more than 25% from baseline was defined as CIN. Results: 115 (20.5%) patients developed CIN. In-hospital mortality was higher among patients with CIN than those without CIN (21.4% vs. 0.9%; P < 0.001). The maximum contrast dose was exceeded in 130 (23%) patients. Patients who received more than the maximum contrast dose (contrast ratio >1) had a more complicated in-hospital clinical course and higher mortality rate (13% vs. 2.8%; P < 0.001) than did patients with a contrast ratio less than 1. Development of CIN was associated with both contrast volume and contrast ratio. Limitation: The association between contrast volume and outcomes was observed in a single center and could be due to comorbid conditions, disease severity, or an unknown factor. Conclusion: During primary percutaneous coronary intervention for STEMI, higher contrast volume is associated with higher rates of CIN and mortality; however, further study is needed to determine whether limiting contrast volume would improve patient outcome.	[Marenzi, Giancarlo; Assanelli, Emilio; Campodonico, Jeness; Lauri, Gianfranco; Marana, Ivana; De Metrio, Monica; Moltrasio, Marco; Grazi, Marco; Rubino, Mara; Veglia, Fabrizio; Fabbiocchi, Franco; Bartorelli, Antonio L.] Univ Milan, Ctr Cardiol Monzino, I-20138 Milan, Italy	IRCCS Centro Cardiologico Monzino; University of Milan	Marenzi, G (corresponding author), Univ Milan, Ctr Cardiol Monzino, Via Parea 4, I-20138 Milan, Italy.	giancarlo.marenzi@ccfm.it	Bartorelli, Antonio Luca/ABG-9593-2020; campodonico, jeness/AAC-2284-2022; Grazi, Marco/ABH-5946-2020; Veglia, Fabrizio/K-1958-2016; De Metrio, Monica/ABH-6561-2020; Assanelli, Emilio/ABH-4902-2020; Rubino, Mara/K-1537-2016; Bartorelli, Antonio/K-3955-2018	Grazi, Marco/0000-0003-1518-3199; Veglia, Fabrizio/0000-0002-9378-8874; Rubino, Mara/0000-0001-7820-9814; De Metrio, Monica/0000-0002-1955-747X; Marenzi, Giancarlo/0000-0003-4410-4461	Centro Cardiologico Monzino; Institute of Cardiology, University of Milan	Centro Cardiologico Monzino; Institute of Cardiology, University of Milan	Centro Cardiologico Monzino, Institute of Cardiology, University of Milan.	Addala S, 2004, AM J CARDIOL, V93, P629, DOI 10.1016/j.amjcard.2003.11.036; Baumgart D, 1997, CATHETER CARDIO DIAG, V40, P241; BOURDILLON PD, 1985, J AM COLL CARDIOL, V6, P845, DOI 10.1016/S0735-1097(85)80493-9; Brodie BR, 1996, J AM COLL CARDIOL, V28, P319, DOI 10.1016/0735-1097(96)00152-0; CIGARROA RG, 1989, AM J MED, V86, P649, DOI 10.1016/0002-9343(89)90437-3; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; CRUZ C, 1986, RADIOLOGY, V158, P109, DOI 10.1148/radiology.158.1.3079623; De Luca G, 2004, CIRCULATION, V109, P2737, DOI 10.1161/01.CIR.0000131765.73959.87; DeGeare VS, 2000, AM J CARDIOL, V86, P30, DOI 10.1016/S0002-9149(00)00824-9; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Freeman RV, 2002, AM J CARDIOL, V90, P1068, DOI 10.1016/S0002-9149(02)02771-6; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Heggunje PS, 2004, J AM COLL CARDIOL, V44, P1400, DOI 10.1016/j.jacc.2004.06.065; Jaumdally RJ, 2007, J THROMB THROMBOLYS, V23, P189, DOI 10.1007/s11239-006-9048-x; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; Laskey WK, 2007, J AM COLL CARDIOL, V50, P584, DOI 10.1016/j.jacc.2007.03.058; MANSKE CL, 1990, AM J MED, V89, P615, DOI 10.1016/0002-9343(90)90180-L; Marenzi G, 2004, J AM COLL CARDIOL, V44, P1780, DOI 10.1016/j.jacc.2004.07.043; Marenzi G, 2007, AM HEART J, V153, P755, DOI 10.1016/j.ahj.2007.02.018; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; MASON RA, 1985, JAMA-J AM MED ASSOC, V253, P1001, DOI 10.1001/jama.253.7.1001; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; MILLER DL, 1988, RADIOLOGY, V167, P607, DOI 10.1148/radiology.167.3.3363118; Moscucci M, 2005, J AM COLL CARDIOL, V46, P625, DOI 10.1016/j.jacc.2005.05.048; Nyman U, 2008, ACTA RADIOL, V49, P658, DOI 10.1080/02841850802050762; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Pradhan J, 2007, CORONARY ARTERY DIS, V18, P275, DOI 10.1097/MCA.0b013e328056dd46; Recio-Mayoral A, 2007, J AM COLL CARDIOL, V49, P1283, DOI 10.1016/j.jacc.2006.11.034; Sadeghi HM, 2003, CIRCULATION, V108, P2769, DOI 10.1161/01.CIR.0000103623.63687.21; Solomon R, 2006, KIDNEY INT, V69, pS46, DOI 10.1038/sj.ki.5000374; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; TALIERCIO CP, 1986, ANN INTERN MED, V104, P501, DOI 10.7326/0003-4819-104-4-501; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Vlietstra RE, 1996, AM HEART J, V132, P1049, DOI 10.1016/S0002-8703(96)90021-6	38	251	271	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2009	150	3					170	+		10.7326/0003-4819-150-3-200902030-00006	http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402RA	19189906				2022-12-01	WOS:000263029600003
J	Van Raamsdonk, CD; Bezrookove, V; Green, G; Bauer, J; Gaugler, L; O'Brien, JM; Simpson, EM; Barsh, GS; Bastian, BC				Van Raamsdonk, Catherine D.; Bezrookove, Vladimir; Green, Gary; Bauer, Juergen; Gaugler, Lona; O'Brien, Joan M.; Simpson, Elizabeth M.; Barsh, Gregory S.; Bastian, Boris C.			Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi	NATURE			English	Article							KINASE-C; BRAF; MELANOCYTES; PATHWAY; CELLS	BRAF and NRAS are common targets for somatic mutations in benign and malignant neoplasms that arise from melanocytes situated in epithelial structures, and lead to constitutive activation of the mitogen- activated protein ( MAP) kinase pathway(1,2). However, BRAF and NRAS mutations are absent in a number of other melanocytic neoplasms in which the equivalent oncogenic events are currently unknown(3). Here we report frequent somatic mutations in the heterotrimeric G protein alpha-subunit, GNAQ, in blue naevi (83%) and ocular melanoma of the uvea ( 46%). The mutations occur exclusively in codon 209 in the Ras- like domain and result in constitutive activation, turning GNAQ into a dominant acting oncogene. Our results demonstrate an alternative route to MAP kinase activation in melanocytic neoplasia, providing new opportunities for therapeutic intervention.	[Bezrookove, Vladimir; Green, Gary; Bauer, Juergen; Gaugler, Lona; Bastian, Boris C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Bezrookove, Vladimir; Green, Gary; Bauer, Juergen; Gaugler, Lona; O'Brien, Joan M.; Bastian, Boris C.] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [O'Brien, Joan M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Bauer, Juergen] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Simpson, Elizabeth M.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Simpson, Elizabeth M.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of British Columbia; University of British Columbia; Stanford University	Bastian, BC (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.	bastian@cc.ucsf.edu	Van Raamsdonk, Catherine D./B-6207-2017; Simpson, Elizabeth/H-1183-2012; Bauer, Jurgen/B-4656-2008	Van Raamsdonk, Catherine D./0000-0002-4309-3513; Bauer, Jurgen/0000-0001-8789-1536; Simpson, Elizabeth/0000-0002-0654-4303; Bastian, Boris/0000-0003-1836-6062	National Cancer Institute [P01 CA025874 Project 2]; Melanoma Research Alliance, the Canadian Institutes of Health Research [MOP-79511]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA025874, R01CA131524] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melanoma Research Alliance, the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Harbour for providing additional DNA samples from uveal melanomas and P. Viciana-Rodriguez and A. Balmain for providing advice. hTERT/CDK4<SUP>R24C</SUP>/p53<SUP>DD</SUP> melanocytes were a gift from D. Fisher, Dana Farber Cancer Institute<SUP>13</SUP>, normal human melanocytes from foreskin were a gift from M. Herlyn, and OMM1.3 and Mel202 cells were originally from B. Ksander. The melan-a cells were a gift from D. Bennett, St George's University, London23. This work was supported by grants from the National Cancer Institute (P01 CA025874 Project 2 to B.C.B.) the Melanoma Research Alliance, the Canadian Institutes of Health Research (MOP-79511 to C.D.V.R.), and the National Institutes of Health (G.S.B.).	BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; HORSMAN DE, 1993, CANCER, V71, P811, DOI 10.1002/1097-0142(19930201)71:3<811::AID-CNCR2820710325>3.0.CO;2-F; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Marin YE, 2006, CELL SIGNAL, V18, P1279, DOI 10.1016/j.cellsig.2005.10.012; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; Mizushima J, 1998, BRIT J DERMATOL, V139, P349; POLLOCK PM, 2002, NAT GENET, V25, P25; Saldanha G, 2004, INT J CANCER, V111, P705, DOI 10.1002/ijc.20325; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Singh AD, 1998, OPHTHALMOLOGY, V105, P195, DOI 10.1016/S0161-6420(98)92205-9; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Zembowicz A, 2004, HISTOPATHOLOGY, V45, P433, DOI 10.1111/j.1365-2559.2004.01975.x; Zuidervaart W, 2005, BRIT J CANCER, V92, P2032, DOI 10.1038/sj.bjc.6602598	23	1041	1061	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					599	U108		10.1038/nature07586	http://dx.doi.org/10.1038/nature07586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19078957	Green Accepted, Green Submitted			2022-12-01	WOS:000262852200045
J	Giraudo, CG; Garcia-Diaz, A; Eng, WS; Chen, YH; Hendrickson, WA; Melia, TJ; Rothman, JE				Giraudo, Claudio G.; Garcia-Diaz, Alejandro; Eng, William S.; Chen, Yuhang; Hendrickson, Wayne A.; Melia, Thomas J.; Rothman, James E.			Alternative Zippering as an On-Off Switch for SNARE-Mediated Fusion	SCIENCE			English	Article							SYNAPTIC VESICLE CYCLE; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; DISTINCT DOMAINS; SYNAPTOTAGMIN-I; CA2+ SENSOR; COMPLEX; EXOCYTOSIS	Membrane fusion between vesicles and target membranes involves the zippering of a four- helix bundle generated by constituent helices derived from target- and vesicle- soluble N-ethylmaleimide- sensitive factor attachment protein receptors (SNAREs). In neurons, the protein complexin clamps otherwise spontaneous fusion by SNARE proteins, allowing neurotransmitters and other mediators to be secreted when and where they are needed as this clamp is released. The membrane- proximal accessory helix of complexin is necessary for clamping, but its mechanism of action is unknown. Here, we present experiments using a reconstituted fusion system that suggest a simple model in which the complexin accessory helix forms an alternative four- helix bundle with the target- SNARE near the membrane, preventing the vesicle- SNARE from completing its zippering.	[Giraudo, Claudio G.; Garcia-Diaz, Alejandro; Eng, William S.; Melia, Thomas J.; Rothman, James E.] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Eng, William S.; Chen, Yuhang; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Eng, William S.; Chen, Yuhang; Hendrickson, Wayne A.] Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Giraudo, CG (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	claudio.giraudo@yale.edu; james.rothman@yale.edu			NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071458] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH grant to J.E.R.	Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Giraudo CG, 2008, J BIOL CHEM, V283, P21211, DOI 10.1074/jbc.M803478200; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; JONES A, 2008, O VERSION 12 0; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292	23	121	121	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					512	516		10.1126/science.1166500	http://dx.doi.org/10.1126/science.1166500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164750	Green Accepted			2022-12-01	WOS:000262587900045
J	Kawahara, A; Nishi, T; Hisano, Y; Fukui, H; Yamaguchi, A; Mochizuki, N				Kawahara, Atsuo; Nishi, Tsuyoshi; Hisano, Yu; Fukui, Hajime; Yamaguchi, Akihito; Mochizuki, Naoki			The Sphingolipid Transporter Spns2 Functions in Migration of Zebrafish Myocardial Precursors	SCIENCE			English	Article							AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; SPHINGOSINE 1-PHOSPHATE; ENDODERM FORMATION; HEART DEVELOPMENT; SPHINGOSINE-1-PHOSPHATE; GENETICS; PROTEIN; CASANOVA; MUTATION; SLC11A3	Sphingosine-1-phosphate ( S1P) is a secreted lipid mediator that functions in vascular development; however, it remains unclear how S1P secretion is regulated during embryogenesis. We identified a zebrafish mutant, ko157, that displays cardia bifida ( two hearts) resembling that in the S1P receptor- 2 mutant. A migration defect of myocardial precursors in the ko157 mutant is due to a mutation in a multipass transmembrane protein, Spns2, and can be rescued by S1P injection. We show that the export of S1P from cells requires Spns2. spns2 is expressed in the extraembryonic tissue yolk syncytial layer ( YSL), and the introduction of spns2 mRNA in the YSL restored the cardiac defect in the ko157 mutant. Thus, Spns2 in the YSL functions as a S1P transporter in S1P secretion, thereby regulating myocardial precursor migration.	[Kawahara, Atsuo; Fukui, Hajime; Mochizuki, Naoki] Natl Cardiovasc Ctr Hosp & Res Inst, Dept Struct Anal, Osaka 5658565, Japan; [Kawahara, Atsuo] Kyoto Univ, Fac Med, HMRO, Sakyo Ku, Kyoto 6068501, Japan; [Nishi, Tsuyoshi; Hisano, Yu; Yamaguchi, Akihito] Osaka Univ, Dept Cell Membrane Biol, Inst Sci & Ind Res, Osaka 5670047, Japan; [Nishi, Tsuyoshi; Hisano, Yu; Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	National Cerebral & Cardiovascular Center - Japan; Kyoto University; Osaka University; Osaka University	Kawahara, A (corresponding author), Natl Cardiovasc Ctr Hosp & Res Inst, Dept Struct Anal, Fujishirodai 5-7-1, Osaka 5658565, Japan.	atsuo@ri.ncvc.go.jp	Fukui, Hajime/AAG-2004-2020	Fukui, Hajime/0000-0002-7652-2222	Ministry of Education, Culture, Sports, Science and Technology of Japan; National BioResource Project of Japan; Japan Society for the Promotion of Science; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Ministry of Health, Labor and Welfare of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National BioResource Project of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank M. Sone and M. Minamimoto for technical assistance; S. Endo and R. Hanaoka for the mutagenesis screening; T. Kitaguchi for the establishment of cmlc2: mRFP; M. Masuda, Y. Igarashi, A. Kihara, S. Mitsutake, K. Shioya, I. B. Dawid, and Y. Kaziro for support and suggestions; M. Hibi, J. S. Gutkind, and M. Tsang for critical reading and valuable suggestions; D. Y. Stainier for discussions and sharing of unpublished data; and H. Okamoto, K. Kawakami, Y. Kikuchi, H. Yanagisawa, D. Yamamoto, R. Y. Tsien, and H.- J. Tsai for fish and reagents. Supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the National BioResource Project of Japan; the Japan Society for the Promotion of Science; the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; the Ministry of Health, Labor and Welfare of Japan; and the Takeda Science Foundation. The sequences of zebrafish spns2, human Spns2, and mouse Spns2 have been deposited in the DNA Data Bank of Japan [accession numbers: AB441164 (zebrafish), AB441165 (human), AB441166 (mouse)]. The authors are filing a patent based on the results reported in this paper.	Chen JN, 2000, TRENDS GENET, V16, P383, DOI 10.1016/S0168-9525(00)02075-8; Dickmeis T, 2001, GENE DEV, V15, P1487, DOI 10.1101/gad.196901; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Matsui Takaaki, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS77, DOI 10.1038/ncpcardio0764; Milstien S, 2006, CANCER CELL, V9, P148, DOI 10.1016/j.ccr.2006.02.025; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI13468; Nakano Y, 2001, MOL CELL BIOL, V21, P3775, DOI 10.1128/MCB.21.11.3775-3788.2001; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; Sakaguchi T, 2006, DEVELOPMENT, V133, P4063, DOI 10.1242/dev.02581; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schoenebeck JJ, 2007, SEMIN CELL DEV BIOL, V18, P27, DOI 10.1016/j.semcdb.2006.12.010; Sekiguchi M, 2008, J IMMUNOL, V180, P1921, DOI 10.4049/jimmunol.180.3.1921; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Young RM, 2002, DEV DYNAM, V223, P298, DOI 10.1002/dvdy.10060	25	292	303	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					524	527		10.1126/science.1167449	http://dx.doi.org/10.1126/science.1167449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19074308				2022-12-01	WOS:000262587900048
J	O'Gorman, CM; Fuller, HT; Dyer, PS				O'Gorman, Celine M.; Fuller, Hubert T.; Dyer, Paul S.			Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus	NATURE			English	Article							POLYMORPHIC DNA MARKERS; MATING-TYPE; SEQUENCE; SYSTEMS; HETEROTHALLISM; TELEOMORPH; BIOLOGY	Aspergillus fumigatus is a saprotrophic fungus whose spores are ubiquitous in the atmosphere(1). It is also an opportunistic human pathogen in immunocompromised individuals, causing potentially lethal invasive infections(2,3), and is associated with severe asthma and sinusitis(4). The species is only known to reproduce by asexual means(5), but there has been accumulating evidence for recombination and gene flow from population genetic studies(5-8), genome analysis(9,10), the presence of mating- type genes(8,10) and expression of sex- related genes(8) in the fungus. Here we show that A. fumigatus possesses a fully functional sexual reproductive cycle that leads to the production of cleistothecia and ascospores, and the teleomorph Neosartorya fumigata is described. The species has a heterothallic breeding system; isolates of complementary mating types are required for sex to occur. We demonstrate increased genotypic variation resulting from recombination between mating type and DNA fingerprint markers in ascospore progeny from an Irish environmental subpopulation. The ability of A. fumigatus to engage in sexual reproduction is highly significant in understanding the biology and evolution of the species. The presence of a sexual cycle provides an invaluable tool for classical genetic analyses and will facilitate research into the genetic basis of pathogenicity and fungicide resistance in A. fumigatus, with the aim of improving methods for the control of aspergillosis. These results also yield insights into the potential for sexual reproduction in other supposedly 'asexual' fungi.	[O'Gorman, Celine M.; Fuller, Hubert T.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland; [O'Gorman, Celine M.; Dyer, Paul S.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	University College Dublin; University of Nottingham	O'Gorman, CM (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland.	celine.ogorman@ucd.ie; paul.dyer@nottingham.ac.uk	O'Gorman, Celine M/E-7732-2010	O'Gorman, Celine M/0000-0001-9618-8981; Dyer, Paul/0000-0003-0237-026X	IRCSET Postgraduate Research Scholarship; EC Marie Curie Training Fellowship; British Mycological Society	IRCSET Postgraduate Research Scholarship(Irish Research Council for Science, Engineering and Technology); EC Marie Curie Training Fellowship(European Commission); British Mycological Society	We thank S. A. Balajee for access to unpublished data, C. Duggan for assistance with the Latin diagnosis, and C.O'Connell for taking the scanning electron micrographs. This work was supported by an IRCSET Postgraduate Research Scholarship, an EC Marie Curie Training Fellowship and a grant from the British Mycological Society to C.O'G.	Anderson M.J., 2003, GENOMICS PLANTS FUNG, P1; Anderson MJ, 1996, J CLIN MICROBIOL, V34, P87, DOI 10.1128/JCM.34.1.87-93.1996; AUFAUVREBROWN A, 1992, J CLIN MICROBIOL, V30, P2991, DOI 10.1128/JCM.30.11.2991-2993.1992; Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Debuchy R, 2006, MYCOTA, VI, P293, DOI DOI 10.1007/3-540-28135-5_15; Dyer Paul S., 2007, P123; DYER PS, 1992, BIOL REV, V67, P421, DOI 10.1111/j.1469-185X.1992.tb01189.x; Dyer PS, 2005, MED MYCOL, V43, pS7, DOI 10.1080/13693780400029015; DYER PS, 1993, PHYSIOL MOL PLANT P, V43, P403, DOI 10.1006/pmpp.1993.1068; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fisher R.A., 1938, SANKHYA, V4, P14; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Honegger R, 2004, MYCOL RES, V108, P480, DOI 10.1017/s0953756204009682; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Kema GHJ, 1996, CURR GENET, V30, P251, DOI 10.1007/s002940050129; Klich MA., 2002, IDENTIFICATION COMMO, V2002, P1; KORNERUP A., 1967, Methuen handbook of colour.; KWONCHUN.KJ, 1974, MYCOLOGIA, V66, P628, DOI 10.2307/3758166; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; LIN DM, 1995, J CLIN MICROBIOL, V33, P1596, DOI 10.1128/JCM.33.6.1596-1601.1995; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Lucas JA, 2000, ADV BOT RES, V33, P225, DOI 10.1016/S0065-2296(00)33044-0; Magee PT, 2004, CURR OPIN MICROBIOL, V7, P661, DOI 10.1016/j.mib.2004.10.003; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; MULLINS J, 1976, CLIN ALLERGY, V6, P209, DOI 10.1111/j.1365-2222.1976.tb01899.x; Murtagh GJ, 1999, LICHENOLOGIST, V31, P257; Murtagh GJ, 2000, NATURE, V404, P564, DOI 10.1038/35007142; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Gorman CM, 2008, ATMOS ENVIRON, V42, P4355, DOI 10.1016/j.atmosenv.2008.01.009; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Pavlicek A, 1999, FOLIA BIOL-PRAGUE, V45, P97; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Pyrzak W, 2008, EUKARYOT CELL, V7, P1029, DOI 10.1128/EC.00380-07; Robert V, 2007, CBS YEASTS DATABASE; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; Samson RA, 2007, STUD MYCOL, P147, DOI 10.3114/sim.2007.59.14; Seymour FA, 2005, FUNGAL GENET BIOL, V42, P554, DOI 10.1016/j.fgb.2005.03.006; TAKADA M, 1985, MYCOTAXON, V24, P395; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varga J, 2003, INFECT GENET EVOL, V3, P3, DOI 10.1016/S1567-1348(02)00156-9; Ware SB, 2007, FUNGAL GENET BIOL, V44, P389, DOI 10.1016/j.fgb.2006.12.005; Weising K., 1995, DNA FINGERPRINTING P	47	337	356	1	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					471	U5		10.1038/nature07528	http://dx.doi.org/10.1038/nature07528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19043401				2022-12-01	WOS:000262519200045
J	Steig, EJ; Schneider, DP; Rutherford, SD; Mann, ME; Comiso, JC; Shindell, DT				Steig, Eric J.; Schneider, David P.; Rutherford, Scott D.; Mann, Michael E.; Comiso, Josefino C.; Shindell, Drew T.			Warming of the Antarctic ice-sheet surface since the 1957 International Geophysical Year	NATURE			English	Article							SOUTHERN-HEMISPHERE CLIMATE; IN-SITU; VARIABILITY; TRENDS; TEMPERATURES; SIMULATION; LENGTH; SEASON	Assessments of Antarctic temperature change have emphasized the contrast between strong warming of the Antarctic Peninsula and slight cooling of the Antarctic continental interior in recent decades(1). This pattern of temperature change has been attributed to the increased strength of the circumpolar westerlies, largely in response to changes in stratospheric ozone(2). This picture, however, is substantially incomplete owing to the sparseness and short duration of the observations. Here we show that significant warming extends well beyond the Antarctic Peninsula to cover most of West Antarctica, an area of warming much larger than previously reported. West Antarctic warming exceeds 0.1 degrees C per decade over the past 50 years, and is strongest in winter and spring. Although this is partly offset by autumn cooling in East Antarctica, the continent- wide average near- surface temperature trend is positive. Simulations using a general circulation model reproduce the essential features of the spatial pattern and the long- term trend, and we suggest that neither can be attributed directly to increases in the strength of the westerlies. Instead, regional changes in atmospheric circulation and associated changes in sea surface temperature and sea ice are required to explain the enhanced warming in West Antarctica.	[Steig, Eric J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Steig, Eric J.] Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; [Schneider, David P.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Rutherford, Scott D.] Roger Williams Univ, Dept Environm Sci, Bristol, RI 02809 USA; [Mann, Michael E.] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; [Mann, Michael E.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Comiso, Josefino C.] NASA, Goddard Space Flight Ctr, NASA Lab Hydrospher & Biospher Sci, Greenbelt, MD 20771 USA; [Shindell, Drew T.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Shindell, Drew T.] Columbia Univ, Ctr Climate Syst Res, New York, NY 10025 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Center Atmospheric Research (NCAR) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University	Steig, EJ (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	steig@ess.washington.edu	Steig, Eric J/G-9088-2015; Schneider, David/E-2726-2010; Shindell, Drew/D-4636-2012; Mann, Michael E/B-8472-2017	Steig, Eric J/0000-0002-8191-5549; Schneider, David/0000-0001-5308-1834; Shindell, Drew/0000-0003-1552-4715; Mann, Michael E/0000-0003-3067-296X	US National Science Foundation [OPP-0440414, OPP-0126161, OPP-0125670]; US ITASE	US National Science Foundation(National Science Foundation (NSF)); US ITASE	E.J.S. and D.P.S. were supported by the US National Science Foundation, grant numbers OPP-0440414 and OPP-0126161, as part of the US ITASE programme. M.E.M. was supported by the US National Science Foundation, grant number OPP-0125670. We thank D. Winebrenner, A. Monaghan, D. Bromwich, J. Turner, P. Mayewski, T. Scambos, E. Bard and O. Bellier.	Bromwich DH, 2004, J CLIMATE, V17, P4603, DOI 10.1175/3241.1; Bromwich DH, 2008, EOS; Chapman WL, 2007, J CLIMATE, V20, P4096, DOI 10.1175/JCLI4236.1; Comiso JC, 2000, J CLIMATE, V13, P1674, DOI 10.1175/1520-0442(2000)013<1674:VATIAS>2.0.CO;2; CONOLLEY WM, 2007, GEOPHYS RES LETT, V34, DOI DOI 10.1029/2007GL031648; Doran PT, 2002, NATURE, V415, P517, DOI 10.1038/nature710; Fierro RD, 1997, SIAM J SCI COMPUT, V18, P1223, DOI 10.1137/S1064827594263837; Gillett NP, 2003, SCIENCE, V302, P273, DOI 10.1126/science.1087440; Hansen J, 2007, CLIM DYNAM, V29, P661, DOI 10.1007/s00382-007-0255-8; Holland MM, 2006, CLIM DYNAM, V26, P229, DOI 10.1007/s00382-005-0087-3; Johanson CM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029108; Jones PD, 2003, J CLIMATE, V16, P206, DOI 10.1175/1520-0442(2003)016<0206:HALSSA>2.0.CO;2; Keeley SPE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031238; Kwok R, 2002, J CLIMATE, V15, P487, DOI 10.1175/1520-0442(2002)015<0487:SOCASI>2.0.CO;2; Mann ME, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008272; Miller RL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006323; Monaghan AJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009094; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rutherford S, 2005, J CLIMATE, V18, P2308, DOI 10.1175/JCLI3351.1; Schneider DP, 2008, P NATL ACAD SCI USA, V105, P12154, DOI 10.1073/pnas.0803627105; Schneider DP, 2004, J CLIMATE, V17, P1569, DOI 10.1175/1520-0442(2004)017<1569:RCVIAF>2.0.CO;2; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Shindell DT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020724; Shuman CA, 2001, J CLIMATE, V14, P1977, DOI 10.1175/1520-0442(2001)014<1977:DLCIWA>2.0.CO;2; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Turner J, 2006, SCIENCE, V311, P1914, DOI 10.1126/science.1121652; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991	30	492	516	6	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					459	462		10.1038/nature07669	http://dx.doi.org/10.1038/nature07669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158794	Green Published			2022-12-01	WOS:000262519200042
J	Li, S; Makovets, S; Matsuguchi, T; Blethrow, JD; Shokat, KM; Blackburn, EH				Li, Shang; Makovets, Svetlana; Matsuguchi, Tetsuya; Blethrow, Justin D.; Shokat, Kevan M.; Blackburn, Elizabeth H.			Cdk1-Dependent Phosphorylation of Cdc13 Coordinates Telomere Elongation during Cell-Cycle Progression	CELL			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERES; DEPENDENT KINASE CDK1; DNA-BINDING PROTEIN; LENGTH REGULATION; YEAST TELOMERES; END PROTECTION; IN-VIVO; REPLICATION; EST1P; MEC1	Elongation of telomeres by telomerase replenishes the loss of terminal telomeric DNA repeats during each cell cycle. In budding yeast, Cdc13 plays an essential role in telomere length homeostasis, partly through its interactions with both the telomerase complex and the competing Stn1-Ten1 complex. Previous studies in yeast have shown that telomere elongation by telomerase is cell cycle dependent, but the mechanism underlying this dependence is unclear. In S. cerevisiae, a single cyclin-dependent kinase Cdk1 (Cdc28) coordinates the serial events required for the cell division cycle, but no Cdk1 substrate has been identified among telomerase and telomere-associated factors. Here we show that Cdk1-dependent phosphorylation of Cdc13 is essential for efficient recruitment of the yeast telomerase complex to telomeres by favoring the interaction of Cdc13 with Est1 rather than the competing Stn1-Ten1 complex. These results provide a direct mechanistic link between coordination of telomere elongation and cell-cycle progression in vivo.	[Li, Shang; Makovets, Svetlana; Matsuguchi, Tetsuya; Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Blethrow, Justin D.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blackburn, EH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Box 2200, San Francisco, CA 94143 USA.	elizabeth.blackburn@ucsf.edu		Matsuguchi, Tetsuya/0000-0003-2018-4575; Makovets, Svetlana/0000-0002-0226-2093; LI, SHANG/0000-0002-6226-3362	NIH; UC BREP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC BREP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bradley Stohr, Jennifer Fung, Jeff Seidel, and Tanya Williams for critical reading of the manuscript. This work was supported by grants from the NIH to E.H.B. and K.M.S. J.D.B. was supported by a UC BREP great fellowship.	Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bourns BD, 1998, MOL CELL BIOL, V18, P5600, DOI 10.1128/MCB.18.9.5600; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Chan SWL, 2001, CURR BIOL, V11, P1240, DOI 10.1016/S0960-9822(01)00391-8; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Chen JL, 2004, TRENDS BIOCHEM SCI, V29, P183, DOI 10.1016/j.tibs.2004.02.003; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Dahlseid JN, 2003, EUKARYOT CELL, V2, P134, DOI 10.1128/EC.2.1.134-142.2003; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Frank CJ, 2006, MOL CELL, V24, P423, DOI 10.1016/j.molcel.2006.10.020; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Goudsouzian LK, 2006, MOL CELL, V24, P603, DOI 10.1016/j.molcel.2006.10.005; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Hirano Y, 2007, MOL BIOL CELL, V18, P2026, DOI 10.1091/mbc.E06-12-1074; Hsu CL, 2004, NUCLEIC ACIDS RES, V32, P511, DOI 10.1093/nar/gkh203; Hughes TR, 2000, P NATL ACAD SCI USA, V97, P6457, DOI 10.1073/pnas.97.12.6457; Laroche T, 2000, J STRUCT BIOL, V129, P159, DOI 10.1006/jsbi.2000.4240; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lendvay TS, 1996, GENETICS, V144, P1399; Levy DL, 2004, MOL CELL BIOL, V24, P10857, DOI 10.1128/MCB.24.24.10857-10867.2004; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Osterhage JL, 2006, NAT STRUCT MOL BIOL, V13, P720, DOI 10.1038/nsmb1125; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Petreaca RC, 2007, GENETICS, V177, P1459, DOI 10.1534/genetics.107.078840; Petreaca RC, 2006, NAT CELL BIOL, V8, P748, DOI 10.1038/ncb1430; Puglisi A, 2008, EMBO J, V27, P2328, DOI 10.1038/emboj.2008.158; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vodenicharov MD, 2006, MOL CELL, V24, P127, DOI 10.1016/j.molcel.2006.07.035; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; WRIGHT JH, 1995, NUCLEIC ACIDS RES, V23, P1454, DOI 10.1093/nar/23.9.1454; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141	52	102	103	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					50	61		10.1016/j.cell.2008.11.027	http://dx.doi.org/10.1016/j.cell.2008.11.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135888	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000262318400014
J	Bednarek, P; Pislewska-Bednarek, M; Svatos, A; Schneider, B; Doubsky, J; Mansurova, M; Humphry, M; Consonni, C; Panstruga, R; Sanchez-Vallet, A; Molina, A; Schulze-Lefert, P				Bednarek, Pawel; Pislewska-Bednarek, Mariola; Svatos, Ales; Schneider, Bernd; Doubsky, Jan; Mansurova, Madina; Humphry, Matt; Consonni, Chiara; Panstruga, Ralph; Sanchez-Vallet, Andrea; Molina, Antonio; Schulze-Lefert, Paul			A Glucosinolate Metabolism Pathway in Living Plant Cells Mediates Broad-Spectrum Antifungal Defense	SCIENCE			English	Article							GLUTATHIONE-DEFICIENT MUTANT; ARABIDOPSIS-THALIANA; SECONDARY METABOLISM; DISEASE RESISTANCE; NONHOST RESISTANCE; BIOSYNTHESIS; MYROSINASE; CAMALEXIN; DATABASE; ENZYME	Selection pressure exerted by insects and microorganisms shapes the diversity of plant secondary metabolites. We identified a metabolic pathway for glucosinolates, known insect deterrents, that differs from the pathway activated by chewing insects. This pathway is active in living plant cells, may contribute to glucosinolate turnover, and has been recruited for broad- spectrum antifungal defense responses. The Arabidopsis CYP81F2 gene encodes a P450 monooxygenase that is essential for the pathogen- induced accumulation of 4- methoxyindol- 3- ylmethylglucosinolate, which in turn is activated by the atypical PEN2 myrosinase ( a type of beta-thioglucoside glucohydrolase) for antifungal defense. We propose that reiterated enzymatic cycles, controlling the generation of toxic molecules and their detoxification, enable the recruitment of glucosinolates in defense responses.	[Bednarek, Pawel; Pislewska-Bednarek, Mariola; Humphry, Matt; Consonni, Chiara; Panstruga, Ralph; Schulze-Lefert, Paul] Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Svatos, Ales; Schneider, Bernd; Doubsky, Jan; Mansurova, Madina] Max Planck Inst Chem Ecol, D-07745 Jena, Germany; [Sanchez-Vallet, Andrea; Molina, Antonio] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, E-28223 Madrid, Spain	Max Planck Society; Max Planck Society; Universidad Politecnica de Madrid	Bednarek, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, Carl Von Linne Weg 10, D-50829 Cologne, Germany.	bednarek@mpiz-koeln.mpg.de; schlef@mpiz-koeln.mpg.de	Schulze-Lefert, Paul/B-6707-2011; Svatos, Ales/A-3305-2014; Bednarek, Pawel/D-2561-2009; Humphry, Matthew/A-8136-2008; Sánchez-vallet, Andrea/B-6128-2019; Humphry, Matt/E-8072-2010; Bruening, Stefan/B-8505-2011; Molina, Antonio/G-9789-2015; Panstruga, Ralph/F-3340-2011; Schneider, Bernd/A-3287-2014; Mansurova, Madina/F-7118-2015	Svatos, Ales/0000-0003-1032-7288; Bednarek, Pawel/0000-0002-3064-7775; Sánchez-vallet, Andrea/0000-0002-3668-9503; Molina, Antonio/0000-0003-3137-7938; Panstruga, Ralph/0000-0002-3756-8957; Schneider, Bernd/0000-0003-4788-1565; Mansurova, Madina/0000-0001-6284-8283; Pislewska-Bednarek, Mariola/0000-0001-9241-3328	Max Planck Chemical Genomics Center; Spanish Ministerio de Educacion y Ciencia [BIO200600488]	Max Planck Chemical Genomics Center; Spanish Ministerio de Educacion y Ciencia(Spanish Government)	We thank J. Meier for the TGG4 antiserum and S. Rosahl and L. Westphal for pen2 pad3 seeds. Partially supported by the Max Planck Chemical Genomics Center, Spanish Ministerio de Educacion y Ciencia (MEC; grant BIO200600488) and a Ph. D. fellowship (A.S.-V.).	Andreasson E, 2001, PLANT PHYSIOL, V127, P1750, DOI 10.1104/pp.010334; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bednarek P, 2005, PLANT PHYSIOL, V138, P1058, DOI 10.1104/pp.104.057794; Bones AM, 2006, PHYTOCHEMISTRY, V67, P1053, DOI 10.1016/j.phytochem.2006.02.024; BRUSEWITZ G, 1977, BIOCHEM J, V162, P99; Burmeister WP, 1997, STRUCTURE, V5, P663, DOI 10.1016/S0969-2126(97)00221-9; Burow M, 2008, PHYTOCHEMISTRY, V69, P663, DOI 10.1016/j.phytochem.2007.08.027; Cejpek K, 2001, ROY SOC CH, P480; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Dixon DP, 1998, CURR OPIN PLANT BIOL, V1, P258, DOI 10.1016/S1369-5266(98)80114-3; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; MONDE K, 1994, J AM CHEM SOC, V116, P6650, DOI 10.1021/ja00094a021; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Nagano AJ, 2008, PLANT CELL PHYSIOL, V49, P969, DOI 10.1093/pcp/pcn075; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Pedras MSC, 2008, ORG BIOMOL CHEM, V6, P51, DOI 10.1039/B714743K; Pedras MSC, 2007, NAT PROD COMMUN, V2, P319; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Sherameti I, 2008, PLANT J, V54, P428, DOI 10.1111/j.1365-313X.2008.03424.x; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; TSUJI J, 1992, PLANT PHYSIOL, V98, P1304, DOI 10.1104/pp.98.4.1304; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; ZHANG YS, 1995, BIOCHEM BIOPH RES CO, V206, P748, DOI 10.1006/bbrc.1995.1106; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	39	694	727	8	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					101	106		10.1126/science.1163732	http://dx.doi.org/10.1126/science.1163732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19095900				2022-12-01	WOS:000262104100049
J	Greenfield, JR; Miller, JW; Keogh, JM; Henning, E; Satterwhite, JH; Cameron, GS; Astruc, B; Mayer, JP; Brage, S; See, TC; Lomas, DJ; O'Rahilly, S; Farooqi, IS				Greenfield, Jerry R.; Miller, Jeffrey W.; Keogh, Julia M.; Henning, Elana; Satterwhite, Julie H.; Cameron, Gregory S.; Astruc, Beatrice; Mayer, John P.; Brage, Soren; See, Teik Choon; Lomas, David J.; O'Rahilly, Stephen; Farooqi, I. Sadaf			Modulation of Blood Pressure by Central Melanocortinergic Pathways	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; OBESITY; HYPERTENSION; PREVALENCE; ACTIVATION; MUTATIONS; WEIGHT; LEPTIN; RECEPTORS; MICE	Background Weight gain and weight loss are associated with changes in blood pressure through unknown mechanisms. Central melanocortinergic signaling is implicated in the control of energy balance and blood pressure in rodents, but there is no information regarding such an association with blood pressure in humans. Methods We assessed blood pressure, heart rate, and urinary catecholamines in overweight or obese subjects with a loss-of-function mutation in MC4R, the gene encoding the melanocortin 4 receptor, and in equally overweight control subjects. We also examined the effects of an MC4R agonist administered for 7 days in 28 overweight or obese volunteers. Results The prevalence of hypertension was markedly lower in the MC4R- deficient subjects than in the control subjects ( 24% vs. 53%, P = 0.009). After the exclusion of subjects taking antihypertensive medications, blood- pressure levels were significantly lower in MC4R- deficient subjects than in control subjects, with mean (+/-SE) systolic blood pressures of 123+/-14 mm Hg and 131+/-12 mm Hg, respectively ( P = 0.02), and mean diastolic blood pressures of 73+/-10 mm Hg and 79+/-7 mm Hg, respectively ( P = 0.03). As compared with control subjects, MC4R- deficient subjects had a lower increase in heart rate on waking ( P = 0.007), a lower heart rate during euglycemic hyperinsulinemia ( P< 0.001), and lower 24- hour urinary norepinephrine excretion ( P = 0.04). The maximum tolerated daily dose of 1.0 mg of the MC4R agonist led to significant increases of 9.3+/-1.9 mm Hg in systolic blood pressure and of 6.6+/-1.1 mm Hg in diastolic blood pressure ( P< 0.001 for both comparisons) at 24 hours, as compared with placebo. Differences in blood pressure were not explained by changes in insulin levels; there were no significant adverse events. Conclusions Results of our genetic and pharmacologic studies implicate melanocortinergic signaling in the control of human blood pressure through an insulin- independent mechanism.	[Greenfield, Jerry R.; Keogh, Julia M.; Henning, Elana; O'Rahilly, Stephen; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Cambridge, England; [Brage, Soren] Addenbrookes Hosp, Med Res Council Epidemiol Unit, Cambridge, England; [See, Teik Choon; Lomas, David J.] Addenbrookes Hosp, Inst Metab Sci, Cambridge, England; [See, Teik Choon; Lomas, David J.] Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; [Miller, Jeffrey W.; Satterwhite, Julie H.; Cameron, Gregory S.; Mayer, John P.] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Astruc, Beatrice] Biotrial, Rennes, France	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Eli Lilly	Farooqi, IS (corresponding author), Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Hills Rd,Box 289, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk	Farooqi, Ismaa Sadaf/AAZ-3046-2020; Brage, Soren/C-6415-2013; O'Rahilly, Stephen/ABF-6509-2020	Brage, Soren/0000-0002-1265-7355; O'Rahilly, Stephen/0000-0003-2199-4449; LOMAS, David/0000-0003-2904-8617; Farooqi, Sadaf/0000-0001-7609-3504	National Health and Medical Research Council of Australia; Royal Australasian College of Physicians; St. Vincent's Clinic Foundation, Sydney; Wellcome Trust and the Cambridge Biomedical Research Centre of the National Institute for Health Research; Medical Research Council; Eli Lilly; Medical Research Council [MC_U106179473, G9824984] Funding Source: researchfish; MRC [G9824984, MC_U106179473] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Australasian College of Physicians(General Electric); St. Vincent's Clinic Foundation, Sydney; Wellcome Trust and the Cambridge Biomedical Research Centre of the National Institute for Health Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Eli Lilly(Eli Lilly); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the National Health and Medical Research Council of Australia, the Royal Australasian College of Physicians, and St. Vincent's Clinic Foundation, Sydney (to Dr. Greenfield); from the Wellcome Trust and the Cambridge Biomedical Research Centre of the National Institute for Health Research (to Drs. O'Rahilly and Farooqi); and from the Medical Research Council (to Drs. O'Rahilly, Brage, and Farooqi); and by Eli Lilly for the pharmacologic studies.; Drs. Miller, Satterwhite, Cameron, and Mayer report being employed by Eli Lilly and having an equity interest in the company; and Dr. O'Rahilly, receiving consulting fees from Eli Lilly. No other potential conflict of interest relevant to this article was reported.	Alharbi KK, 2007, HUM MUTAT, V28, P294, DOI 10.1002/humu.20404; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; DUSTAN HP, 1979, CIRCULATION, V60, P1566, DOI 10.1161/01.CIR.60.7.1566; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; Hall J E, 2000, Curr Hypertens Rep, V2, P139, DOI 10.1007/s11906-000-0073-4; HALL JE, 1994, AM J HYPERTENS, V7, P772, DOI 10.1093/ajh/7.8.772; Hall JE, 2000, BRAZ J MED BIOL RES, V33, P605, DOI 10.1590/S0100-879X2000000600001; Halli RW, 1997, ANQ-Q J SHORT ART N, V10, P55; Haynes WG, 1997, HYPERTENSION, V30, P619, DOI 10.1161/01.HYP.30.3.619; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KASSAB S, 1995, HYPERTENSION, V25, P893, DOI 10.1161/01.HYP.25.4.893; Kuo JJ, 2004, HYPERTENSION, V43, P370, DOI 10.1161/01.HYP.0000111836.54204.93; Kuo JJ, 2003, HYPERTENSION, V41, P768, DOI 10.1161/01.HYP.0000048194.97428.1A; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; Mertens IL, 2000, OBES RES, V8, P270, DOI 10.1038/oby.2000.32; Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa; ROCCHINI AP, 1989, HYPERTENSION, V13, P922, DOI 10.1161/01.HYP.13.6.922; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Song CK, 2005, AM J PHYSIOL-REG I, V289, pR1467, DOI 10.1152/ajpregu.00348.2005; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Vaz M, 1997, CIRCULATION, V96, P3423	28	345	355	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					44	52		10.1056/NEJMoa0803085	http://dx.doi.org/10.1056/NEJMoa0803085			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19092146	Bronze			2022-12-01	WOS:000262096800006
J	Xiao, A; Li, HT; Shechter, D; Ahn, SH; Fabrizio, LA; Erdjument-Bromage, H; Ishibe-Murakami, S; Wang, B; Tempst, P; Hofmann, K; Patel, DJ; Elledge, SJ; Allis, CD				Xiao, Andrew; Li, Haitao; Shechter, David; Ahn, Sung Hee; Fabrizio, Laura A.; Erdjument-Bromage, Hediye; Ishibe-Murakami, Satoko; Wang, Bin; Tempst, Paul; Hofmann, Kay; Patel, Dinshaw J.; Elledge, Stephen J.; Allis, C. David			WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity	NATURE			English	Article							DOUBLE-STRAND BREAKS; MASS-SPECTROMETRY; GENOMIC STABILITY; HISTONE H2AX; CHROMATIN; MDC1; COMPLEX; ISWI; ATM; PHOSPHORYLATION	DNA double- stranded breaks present a serious challenge for eukaryotic cells. The inability to repair breaks leads to genomic instability, carcinogenesis and cell death. During the double- strand break response, mammalian chromatin undergoes reorganization demarcated by H2A.X Ser 139 phosphorylation (gamma-H2A.X). However, the regulation of gamma-H2A.X phosphorylation and its precise role in chromatin remodelling during the repair process remain unclear. Here we report a new regulatory mechanism mediated by WSTF ( Williams - Beuren syndrome transcription factor, also known as BAZ1B) - a component of the WICH complex (WSTF-ISWI ATP- dependent chromatin- remodelling complex). We show that WSTF has intrinsic tyrosine kinase activity by means of a domain that shares no sequence homology to any known kinase fold. We show that WSTF phosphorylates Tyr 142 of H2A.X, and that WSTF activity has an important role in regulating several events that are critical for the DNA damage response. Our work demonstrates a new mechanism that regulates the DNA damage response and expands our knowledge of domains that contain intrinsic tyrosine kinase activity.	[Xiao, Andrew; Shechter, David; Ahn, Sung Hee; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA; [Li, Haitao; Ishibe-Murakami, Satoko; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Fabrizio, Laura A.; Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Wang, Bin; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; [Hofmann, Kay] Miltenyi Biotec GmbH, D-50829 Cologne, Germany	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Miltenyi Biotec	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA.	alliscd@rockefeller.edu	Hofmann, Kay/D-6714-2011; Li, Haitao/B-2668-2012; Shechter, David/B-4660-2008	Hofmann, Kay/0000-0002-2289-9083; Li, Haitao/0000-0001-6741-293X; Shechter, David/0000-0001-9388-6004; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987	Susan G. Komen Breast Cancer Foundation; Abby Rockefeller Mauze Trust; Starr Foundation; The Dewitt Wallace and Maloris Foundations; The Irma T. Hirschl Trust; NCI Cancer Center Support Grant [P30 CA08748]; National Institutes of Health; The Rockefeller University; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922, F32GM075486] Funding Source: NIH RePORTER	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Abby Rockefeller Mauze Trust; Starr Foundation; The Dewitt Wallace and Maloris Foundations; The Irma T. Hirschl Trust; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Rockefeller University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Nussenzweig for H2A.X<SUP>-/-</SUP> MEF cells, P. Varga-Weisz for WSTF constructs and antibodies, W. Herr for pBABE-puro vectors, J. Kim and R. Roeder for anti- BAF53 antibodies, D. Reinberg for anti- SNF2H antibodies, Z. Lou for anti- Mdc1 antibodies and Mdc1<SUP>-/-</SUP> MEF cells, L. Liang and Q. Li for their assistance in recombinant protein expression and purification, C. H. McDonald, R. G. Cook and The Rockefeller University Proteomic Core facility for H2A.X peptides. Wewould also like to thank theMillipore antibody development scientists for collaborating with us on the generation of H2A.X Tyr 142( ph) antibodies, catalogue number 07-1590. This study was supported by the following sources: Susan G. Komen Breast Cancer Foundation (A.X.), Abby Rockefeller Mauze Trust and Starr Foundation (H.L. and D.J.P.), The Dewitt Wallace and Maloris Foundations (H.L. and D.J.P.), The Irma T. Hirschl Trust (D.S.), NCI Cancer Center Support Grant P30 CA08748 (L.A.F., H.E.-B. and P.T.), research grants from National Institutes of Health to S.J.E., S.H.A. and C.D.A., and The Rockefeller University (C.D.A.). S.J.E. is an Investigator with the Howard Hughes Medical Institute. We are grateful to E. Bernstein and E. Duncan for critical reading of the manuscript.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; BELLARD M, 1989, METHOD ENZYMOL, V170, P317; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Dellaire G, 2007, CELL CYCLE, V6, P1864, DOI 10.4161/cc.6.15.4560; DIMITROV S, 1994, J CELL BIOL, V126, P591, DOI 10.1083/jcb.126.3.591; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KLEINSCHMIDT JA, 1991, EMBO J, V10, P3043, DOI 10.1002/j.1460-2075.1991.tb07855.x; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; LENNOX RW, 1989, METHOD ENZYMOL, V170, P532; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Pear Warren S., 1997, P41; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Sambrook JF., 2001, MOL CLONING LAB MANU; Steger DJ, 1998, P NATL ACAD SCI USA, V95, P12924, DOI 10.1073/pnas.95.22.12924; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	48	298	310	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					57	U57		10.1038/nature07668	http://dx.doi.org/10.1038/nature07668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19092802	Green Accepted			2022-12-01	WOS:000262104900029
J	Li, P; Tong, C; Mehrian-Shai, R; Jia, L; Wu, N; Yan, Y; Maxson, RE; Schulze, EN; Song, H; Hsieh, CL; Pera, MF; Ying, QL				Li, Ping; Tong, Chang; Mehrian-Shai, Ruty; Jia, Li; Wu, Nancy; Yan, Youzhen; Maxson, Robert E.; Schulze, Eric N.; Song, Houyan; Hsieh, Chih-Lin; Pera, Martin F.; Ying, Qi-Long			Germline Competent Embryonic Stem Cells Derived from Rat Blastocysts	CELL			English	Article							MOUSE EMBRYOS; SELF-RENEWAL; LINE TRANSMISSION; EGG-CYLINDERS; ES CELLS; GENE; PLURIPOTENT; DIFFERENTIATION; GENOME; GROWTH	Rats have important advantages over mice as an experimental system for physiological and pharmacological investigations. The lack of rat embryonic stem (ES) cells has restricted the availability of transgenic technologies to create genetic models in this species. Here, we show that rat ES cells can be efficiently derived, propagated, and genetically manipulated in the presence of small molecules that specifically inhibit GSK3, MEK, and FGF receptor tyrosine kinases. These rat ES cells express pluripotency markers and retain the capacity to differentiate into derivatives of all three germ layers. Most importantly, they can produce high rates of chimerism when reintroduced into early stage embryos and can transmit through the germline. Establishment of authentic rat ES cells will make possible sophisticated genetic manipulation to create models for the study of human diseases.	[Li, Ping; Tong, Chang; Schulze, Eric N.; Pera, Martin F.; Ying, Qi-Long] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Mehrian-Shai, Ruty; Maxson, Robert E.; Hsieh, Chih-Lin] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Mehrian-Shai, Ruty] Univ So Calif, Keck Sch Med, Custom Microarray Core Facil, Inst Med Genet, Los Angeles, CA 90033 USA; [Wu, Nancy; Yan, Youzhen; Maxson, Robert E.] Univ So Calif, Keck Sch Med, Knockout Core Facil, Norris Canc Ctr Transgen, Los Angeles, CA 90033 USA; [Pera, Martin F.; Ying, Qi-Long] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Jia, Li; Hsieh, Chih-Lin] Univ So Calif, Keck Sch Med, Norris Canc Ctr, Dept Urol, Los Angeles, CA 90033 USA; [Li, Ping; Song, Houyan] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 20032, Peoples R China	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Fudan University	Ying, QL (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	qying@keck.usc.edu	PERA, MARTIN/A-9812-2012; li, jia/GVT-7587-2022; Jia, li/GPW-8015-2022; Mehrian-Shai, Ruty/AAF-8008-2019	PERA, MARTIN/0000-0001-6239-0428; 	USC Startup fund; California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) [RS1-00327-1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016320] Funding Source: NIH RePORTER	USC Startup fund; California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Jing Du, Yu Su, Robin Wesselschmidt, Hongjun Zhang, and Shelley Hough for technical assistance; Gerald Chester for ordering animals; Ramiro Montano, Gloria Martinez, and colleagues for rat husbandry; and Dr. Wange Lu for sharing research materials. This work was supported by USC Startup fund (Q.-L.Y.) and in part by California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) grants RS1-00327-1 (Q.-L.Y.).	Behringer R., 2003, MANIPULATING MOUSE E; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brenin D, 1997, TRANSPLANT P, V29, P1761, DOI 10.1016/S0041-1345(97)00046-8; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chan EM, 2008, CLONING STEM CELLS, V10, P107, DOI 10.1089/clo.2007.0064; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; DAMJANOV I, 1977, J NATL CANCER I, V58, P1523, DOI 10.1093/jnci/58.5.1523; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Demers SP, 2007, CLONING STEM CELLS, V9, P512, DOI 10.1089/clo.2007.0029; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P303; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Hohenstein KA, 2008, STEM CELLS, V26, P1436, DOI 10.1634/stemcells.2007-0857; HSIEH CL, 1997, CELL BIOL LAB HDB, P391; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jia L, 2006, MOL CELL BIOL, V26, P7331, DOI 10.1128/MCB.00581-06; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kuramoto T, 2001, MAMM GENOME, V12, P469, DOI 10.1007/s003350020010; Liu X, 1997, DEV DYNAM, V209, P85; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nichols J, 1998, REPROD FERT DEVELOP, V10, P517, DOI 10.1071/RD98075; Nichols Jennifer, 2006, V329, P91; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ostertag EM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S16; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; SOLTER D, 1970, NATURE, V227, P503, DOI 10.1038/227503a0; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	49	492	570	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1299	1310		10.1016/j.cell.2008.12.006	http://dx.doi.org/10.1016/j.cell.2008.12.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109898	Bronze, Green Accepted			2022-12-01	WOS:000261989800020
J	Pucadyil, TJ; Schmid, SL				Pucadyil, Thomas J.; Schmid, Sandra L.			Real-Time Visualization of Dynamin-Catalyzed Membrane Fission and Vesicle Release	CELL			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; COPII VESICLE; MECHANOCHEMICAL ENZYME; BILAYER CURVATURE; GTPASE ACTIVITY; INVAGINATION; CONSTRICTION; DEFORMATION; ENDOCYTOSIS; PROTEINS	The GTPase dynamin assembles at the necks of budded vesicles in vivo and functions in membrane fission. We have developed fluid supported bilayers with excess membrane reservoir, (SUPER) templates, to assay vesicle formation and membrane fission. Consistent with previous studies, in the absence of GTP, dynamin assembles in spirals, forming long membrane tubules. GTP addition triggers disassembly, but not membrane fission, arguing against models in which fission is mediated by concerted and global GTP-driven conformational changes. In contrast, under physiological conditions in the constant presence of GTP, dynamin mediates membrane fission. Under these conditions, fluorescently labeled dynamin cooperatively organizes into self-limited assemblies that continuously cycle at the membrane and drive vesicle release. When visualized at the necks of emergent vesicles, self-limited dynamin assemblies display intensity fluctuations and persist for variable time periods before fission. Thus, self-limited assemblies of dynamin generated in the constant presence of GTP catalyze membrane fission.	[Pucadyil, Thomas J.; Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schmid, SL (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	slschmid@scripps.edu	Taylor, Graham/A-4027-2012; Pucadyil, Thomas/AAJ-3974-2020	Pucadyil, Thomas/0000-0002-2907-9889; Schmid, Sandra/0000-0002-1690-7024	National Institutes of Health [R01.GM042455, R37.MH61345]; The Leukemia and Lymphoma Society; The Scripps Research Institute [19489]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH061345, R01MH061345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); The Scripps Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge Malcolm R. Wood for help with electron microscopy, Vadim Frolov for help with the membrane tether-pulling experiments, and Sharmistha Acharya and Marilyn Leonard for technical assistance. We thank William Balch, Vadim Frolov, Shanti Kalipatnapu, Allen Liu, Rajesh Ramachandran, and Joshua Zimmerberg for discussions and critical comments on the manuscript. This work is supported by grants from the National Institutes of Health to S.L.S (R01.GM042455 and R37.MH61345). T.J.P. is a fellow of The Leukemia and Lymphoma Society. This is The Scripps Research Institute manuscript number 19489.	Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Baksh MM, 2004, NATURE, V427, P139, DOI 10.1038/nature02209; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Galneder R, 2001, BIOPHYS J, V80, P2298, DOI 10.1016/S0006-3495(01)76201-7; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miwako I, 2005, METHOD ENZYMOL, V404, P503, DOI 10.1016/S0076-6879(05)04044-9; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	34	202	204	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1263	1275		10.1016/j.cell.2008.11.020	http://dx.doi.org/10.1016/j.cell.2008.11.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19084268	Bronze, Green Accepted			2022-12-01	WOS:000261989800017
J	Solstad, T; Boccara, CN; Kropff, E; Moser, MB; Moser, EI				Solstad, Trygve; Boccara, Charlotte N.; Kropff, Emilio; Moser, May-Britt; Moser, Edvard I.			Representation of Geometric Borders in the Entorhinal Cortex	SCIENCE			English	Article							SPATIAL REPRESENTATION; PARIETAL CORTEX; PLACE CELLS; HIPPOCAMPUS; DIRECTION; MEMORY; MAP	We report the existence of an entorhinal cell type that fires when an animal is close to the borders of the proximal environment. The orientation- specific edge- apposing activity of these " border cells" is maintained when the environment is stretched and during testing in enclosures of different size and shape in different rooms. Border cells are relatively sparse, making up less than 10% of the local cell population, but can be found in all layers of the medial entorhinal cortex as well as the adjacent parasubiculum, often intermingled with head- direction cells and grid cells. Border cells may be instrumental in planning trajectories and anchoring grid fields and place fields to a geometric reference frame.	[Solstad, Trygve; Boccara, Charlotte N.; Kropff, Emilio; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway; [Solstad, Trygve; Boccara, Charlotte N.; Kropff, Emilio; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol & Memory, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Boccara, Claude/0000-0002-9603-0700; Kropff, Emilio/0000-0001-5996-8436	Kavli Foundation; Norwegian Research Council; European Commission Framework 7 project (SPACEBRAIN)	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); European Commission Framework 7 project (SPACEBRAIN)(European Commission)	We thank N. Burgess and a number of other colleagues for helpful discussion and suggestions; M.P. Witter for advice about electrode location; M. Fyhn for donating an implanted animal; and A.M. Amundsgard, E. Sjulstad, I.M.F. Hammer, K. Haugen, K. Jenssen, R. Skjerpeng, H. Waade, and T.A smul for technical assistance. The work was supported by the Kavli Foundation, the Centre of Excellence scheme of the Norwegian Research Council, and a European Commission Framework 7 project (SPACEBRAIN).	Barry C, 2006, REV NEUROSCIENCE, V17, P71; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1990, J NEUROSCI, V10, P420; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Yoganarasimha D, 2006, J NEUROSCI, V26, P622, DOI 10.1523/JNEUROSCI.3885-05.2006	19	634	649	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1865	1868		10.1126/science.1166466	http://dx.doi.org/10.1126/science.1166466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095945				2022-12-01	WOS:000261799400061
J	De Val, S; Chi, NC; Meadows, SM; Minovitsky, S; Anderson, JP; Harris, IS; Ehlers, ML; Agarwal, P; Visel, A; Xu, SM; Pennacchio, LA; Dubchak, I; Krieg, PA; Stainier, DYR; Black, BL				De Val, Sarah; Chi, Neil C.; Meadows, Stryder M.; Minovitsky, Simon; Anderson, Joshua P.; Harris, Ian S.; Ehlers, Melissa L.; Agarwal, Pooja; Visel, Axel; Xu, Shan-Mei; Pennacchio, Len A.; Dubchak, Inna; Krieg, Paul A.; Stainier, Didier Y. R.; Black, Brian L.			Combinatorial Regulation of Endothelial Gene Expression by Ets and Forkhead Transcription Factors	CELL			English	Article							PROMOTER; VASCULOGENESIS; SEQUENCE; ENHANCER; FAMILY; ANGIOGENESIS; CANCER; MEF2C; SCL	Vascular development begins when mesodermal cells differentiate into endothelial cells, which then form primitive vessels. It has been hypothesized that endothelial-specific gene expression may be regulated combinatorially, but the transcriptional mechanisms governing specificity in vascular gene expression remain incompletely understood. Here, we identify a 44 bp transcriptional enhancer that is sufficient to direct expression specifically and exclusively to the developing vascular endothelium. This enhancer is regulated by a composite cis-acting element, the FOX:ETS motif, which is bound and synergistically activated by Forkhead and Ets transcription factors. We demonstrate that coexpression of the Forkhead protein FoxC2 and the Ets protein Etv2 induces ectopic expression of vascular genes in Xenopus embryos, and that combinatorial knockdown of the orthologous genes in zebrafish embryos disrupts vascular development. Finally, we show that FOX: ETS motifs are present in many known endothelial-specific enhancers and that this motif is an efficient predictor of endothelial enhancers in the human genome.	[De Val, Sarah; Chi, Neil C.; Anderson, Joshua P.; Harris, Ian S.; Ehlers, Melissa L.; Agarwal, Pooja; Xu, Shan-Mei; Stainier, Didier Y. R.; Black, Brian L.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Chi, Neil C.; Stainier, Didier Y. R.; Black, Brian L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Meadows, Stryder M.; Krieg, Paul A.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Minovitsky, Simon; Visel, Axel; Pennacchio, Len A.; Dubchak, Inna] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Arizona; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Black, BL (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	brian.black@ucsf.edu	Visel, Axel/A-9398-2009	Visel, Axel/0000-0002-4130-7784; Pennacchio, Len/0000-0002-8748-3732; Stainier, Didier/0000-0002-0382-0026; Black, Brian/0000-0002-6664-8913	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064658, K08HL089330, P01HL089707, R01HL054737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052130] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL089707, R01 HL064658, R01 HL054737, P01 HL089707-01A1, HL54737, K08 HL089330, HL64658, R01 HL064658-08] Funding Source: Medline; NIAMS NIH HHS [R01 AR052130-04, R01 AR052130] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cleaver O, 1997, DEV DYNAM, V210, P66, DOI 10.1002/(SICI)1097-0177(199709)210:1<66::AID-AJA7>3.3.CO;2-S; De Val S, 2004, DEV BIOL, V275, P424, DOI 10.1016/j.ydbio.2004.08.016; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Goh PP, 2007, CURR CANCER DRUG TAR, V7, P743, DOI 10.2174/156800907783220462; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; Lin Q, 1998, DEVELOPMENT, V125, P4565; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Maroulakou IG, 2000, ONCOGENE, V19, P6432, DOI 10.1038/sj.onc.1204039; Patan S, 2004, CANC TREAT, V117, P3; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; Sato Y, 2001, CELL STRUCT FUNCT, V26, P19, DOI 10.1247/csf.26.19; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Stacker SA, 2002, FASEB J, V16, P922, DOI 10.1096/fj.01-0945rev; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Topczewska JM, 2001, MECH DEVELOP, V100, P343, DOI 10.1016/S0925-4773(00)00534-7; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wu J, 2005, MOL CELL BIOL, V25, P1458, DOI 10.1128/MCB.25.4.1458-1474.2005	35	233	239	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1053	1064		10.1016/j.cell.2008.10.049	http://dx.doi.org/10.1016/j.cell.2008.10.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070576	Green Accepted, Bronze			2022-12-01	WOS:000261642800021
J	Kennedy, S				Kennedy, Shaun			EPIDEMIOLOGY Why Can't We Test Our Way to Absolute Food Safety?	SCIENCE			English	Editorial Material									[Kennedy, Shaun] Univ Minnesota, Natl Ctr Food Protect & Def, Dept Homeland Secur, Ctr Excellence & Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Kennedy, S (corresponding author), Univ Minnesota, Natl Ctr Food Protect & Def, Dept Homeland Secur, Ctr Excellence & Vet Populat Med, St Paul, MN 55108 USA.	kenne108@umn.edu						Danzig R., 2003, CATASTROPHIC BIOTERR; Ferreira JL, 2004, J FOOD PROTECT, V67, P203, DOI 10.4315/0362-028X-67.1.203; *INT COMM MICR SPE, 1986, MICR FOODS, V2; International Commission on Microbiological Specifications for Foods, 2002, MICR FOODS; KENNEDY SP, 2007, FOOD MICROBIOLOGY FU, V3, pCH5	5	16	18	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1641	1643		10.1126/science.1163867	http://dx.doi.org/10.1126/science.1163867			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074334				2022-12-01	WOS:000261608300028
J	Omran, H; Kobayashi, D; Olbrich, H; Tsukahara, T; Loges, NT; Hagiwara, H; Zhang, Q; Leblond, G; O'Toole, E; Hara, C; Mizuno, H; Kawano, H; Fliegauf, M; Yagi, T; Koshida, S; Miyawaki, A; Zentgraf, H; Seithe, H; Reinhardt, R; Watanabe, Y; Kamiya, R; Mitchell, DR; Takeda, H				Omran, Heymut; Kobayashi, Daisuke; Olbrich, Heike; Tsukahara, Tatsuya; Loges, Niki T.; Hagiwara, Haruo; Zhang, Qi; Leblond, Gerard; O'Toole, Eileen; Hara, Chikako; Mizuno, Hideaki; Kawano, Hiroyuki; Fliegauf, Manfred; Yagi, Toshiki; Koshida, Sumito; Miyawaki, Atsushi; Zentgraf, Hanswalter; Seithe, Horst; Reinhardt, Richard; Watanabe, Yoshinori; Kamiya, Ritsu; Mitchell, David R.; Takeda, Hiroyuki			Ktu/PF13 is required for cytoplasmic pre-assembly of axonemal dyneins	NATURE			English	Article							PRIMARY CILIARY DYSKINESIA; CHLAMYDOMONAS-REINHARDTII; KUPFFERS VESICLE; FLUID-FLOW; ARM DYNEIN; MUTATIONS; MEDAKA; PROTEIN; CHAIN; MUTANT	Cilia and flagella are highly conserved organelles that have diverse roles in cell motility and sensing extracellular signals. Motility defects in cilia and flagella often result in primary ciliary dyskinesia. However, the mechanisms underlying cilia formation and function, and in particular the cytoplasmic assembly of dyneins that power ciliary motility, are only poorly understood. Here we report a new gene, kintoun ( ktu), involved in this cytoplasmic process. This gene was first identified in a medaka mutant, and found to be mutated in primary ciliary dyskinesia patients from two affected families as well as in the pf13 mutant of Chlamydomonas. In the absence of Ktu/ PF13, both outer and inner dynein arms are missing or defective in the axoneme, leading to a loss of motility. Biochemical and immunohistochemical studies show that Ktu/ PF13 is one of the long- sought proteins involved in pre- assembly of dynein arm complexes in the cytoplasm before intraflagellar transport loads them for the ciliary compartment.	[Omran, Heymut; Olbrich, Heike; Loges, Niki T.; Fliegauf, Manfred] Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Kobayashi, Daisuke; Yagi, Toshiki; Koshida, Sumito; Kamiya, Ritsu; Takeda, Hiroyuki] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; [Tsukahara, Tatsuya; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Grad Sch Sci, Tokyo 1130033, Japan; [Tsukahara, Tatsuya; Watanabe, Yoshinori] Univ Tokyo, Grad Program Biophys & Biochem, Grad Sch Sci, Tokyo 1130033, Japan; [Hagiwara, Haruo] Gunma Univ, Grad Sch Med, Dept Anat & Cell Biol, Gunma 3718511, Japan; [Zhang, Qi; Leblond, Gerard; Mitchell, David R.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA; [O'Toole, Eileen] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Hara, Chikako; Mizuno, Hideaki; Kawano, Hiroyuki; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan; [Zentgraf, Hanswalter] German Canc Res Ctr, Dept Tumor Virol, D-69120 Heidelberg, Germany; [Seithe, Horst] Klinikum Nurnberg Sud, Klin Kinder & Jugendliche, D-90471 Nurnberg, Germany; [Reinhardt, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Freiburg; University of Tokyo; University of Tokyo; University of Tokyo; Gunma University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Colorado System; University of Colorado Boulder; RIKEN; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Omran, H (corresponding author), Univ Hosp Freiburg, Dept Pediat & Adolescent Med, Mathildenstr 1, D-79106 Freiburg, Germany.	heymut.omran@uniklinik-freiburg.de; MitchelD@upstate.edu; htakeda@biol.s.u-tokyo.ac.jp	Mizuno, Hideaki/AAH-5737-2021; Miyawaki, Atsushi/K-3569-2014; TAKEDA, HIROYUKI/G-4950-2014; Kobayashi, Daisuke/AAQ-8465-2021; Tsukahara, Tatsuya/AAO-1707-2021	Mizuno, Hideaki/0000-0002-6983-5255; Miyawaki, Atsushi/0000-0002-2329-3235; Tsukahara, Tatsuya/0000-0002-6928-8562; Reinhardt, Richard/0000-0001-9376-2132; Omran, Heymut/0000-0003-0282-6765; Kobayashi, Daisuke/0000-0001-9755-6168; Watanabe, Yoshinori/0000-0002-5488-4812; Yagi, Toshiki/0000-0002-1379-460X; Mitchell, David/0000-0003-2821-7511	NIG Cooperative Research Program; Grants-in-Aid for Scientific Research Priority Area Genome Science and Scientific Research (A and B); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms); Ministry of Education, Culture, Sports, Science and Technology ( MEXT) of Japan; Yamada Science Foundation; Bio-Design Project of the Ministry of Agriculture, Forestry and Fisheries of Japan; University of Tokyo; MEXT, Japan; ' Deutsche Forschungsgemeinschaft' [DFG Om 6/4, GRK1104]; BIOSS; NIH [GM44228]; German Ministry of Science and Education ( BMBF) [NGFN-2:01GR0414-PDN-S02T17]; 'Primare Ciliaere Dyskinesie and Kartagener Syndrom e. V.';  [SFB592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044228] Funding Source: NIH RePORTER	NIG Cooperative Research Program; Grants-in-Aid for Scientific Research Priority Area Genome Science and Scientific Research (A and B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology ( MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; Bio-Design Project of the Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); University of Tokyo; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ' Deutsche Forschungsgemeinschaft'(German Research Foundation (DFG)); BIOSS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Science and Education ( BMBF)(Federal Ministry of Education & Research (BMBF)); 'Primare Ciliaere Dyskinesie and Kartagener Syndrom e. V.'; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Lo and D. Morris- Rosendahl for critical reading of this manuscript. We are grateful to M. Sugimoto, A. Ito-Igarashi, K. Nakaguchi, S. Minami, Y. H. Park, Y. Mochizuki, Y. Ozawa, K. Ohki, T. Obata, A. Heer and C. Reinhardt for excellent fish care and/or experimental assistance. We also thank A. Shimada and D. Nihei for their help in medaka experiments, J. Freshour and M. Nakatsugawa for help with Chlamydomonas, and S. King, H. Qin, W. Sale and D. Stern for antibodies. Our mutant screening was carried out mainly at the National Institute of Genetics (NIG), supported by NIG Cooperative Research Program (2002-2006). This work was supported in part by Grants-in-Aid for Scientific Research Priority Area Genome Science and Scientific Research (A and B), Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Yamada Science Foundation, and a Bio-Design Project of the Ministry of Agriculture, Forestry and Fisheries of Japan. D. K. was a research fellow supported by the 21th century COE program of the University of Tokyo, MEXT, Japan. This work was supported by grants to H. Omran from the ' Deutsche Forschungsgemeinschaft' DFG Om 6/4, GRK1104, BIOSS and the SFB592, and to D. R. M. from the NIH, GM44228. We would like to acknowledge the sequencing activities by K. Borzym and the Seq-Team at PI- MG, which was supported by the German Ministry of Science and Education ( BMBF) by grant NGFN-2:01GR0414-PDN-S02T17 to R. R. We are grateful for the support by the 'Primare Ciliaere Dyskinesie and Kartagener Syndrom e. V.'.	Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Ahmed NT, 2005, MOL BIOL CELL, V16, P5004, DOI 10.1091/mbc.E05-07-0627; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; CHEN XM, 1995, PLANT CELL, V7, P1295; DiBella LM, 2005, MOL BIOL CELL, V16, P5661, DOI 10.1091/mbc.E05-08-0732; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P647, DOI 10.1016/j.mod.2004.04.016; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; HAGIWARA H, 1990, Japanese Journal of Clinical Electron Microscopy, V23, P493; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hojo M, 2007, DEV GROWTH DIFFER, V49, P395, DOI 10.1111/j.1440-169x.2007.00937.x; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; HUANG B, 1979, J BIOL CHEM, V254, P3091; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; Kamiya R, 2002, INT REV CYTOL, V219, P115; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KING SM, 1985, P NATL ACAD SCI USA, V82, P4717, DOI 10.1073/pnas.82.14.4717; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; LEDIZET M, 1995, MOL BIOL CELL, V6, P697, DOI 10.1091/mbc.6.6.697; MASTRONARDE DN, 1992, J CELL BIOL, V118, P1145, DOI 10.1083/jcb.118.5.1145; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; MITCHELL DR, 1986, CELL MOTIL CYTOSKEL, V6, P510, DOI 10.1002/cm.970060510; Mitchell DR, 1999, J CELL BIOL, V144, P293, DOI 10.1083/jcb.144.2.293; Mochizuki E, 2005, KIDNEY INT, V68, P23, DOI 10.1111/j.1523-1755.2005.00378.x; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; TAM LW, 1993, GENETICS, V135, P375; VANDORP DB, 1992, HUM GENET, V88, P331, DOI 10.1007/BF00197269; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yagi T, 2005, J BIOL CHEM, V280, P41412, DOI 10.1074/jbc.M509072200; Yamamoto R, 2006, FEBS LETT, V580, P6357, DOI 10.1016/j.febslet.2006.10.047; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335; Yokoi H, 2007, DEV BIOL, V304, P326, DOI 10.1016/j.ydbio.2006.12.043; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	47	261	273	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					611	U54		10.1038/nature07471	http://dx.doi.org/10.1038/nature07471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052621	Green Accepted			2022-12-01	WOS:000261340000034
J	Brennecke, J; Malone, CD; Aravin, AA; Sachidanandam, R; Stark, A; Hannon, GJ				Brennecke, Julius; Malone, Colin D.; Aravin, Alexei A.; Sachidanandam, Ravi; Stark, Alexander; Hannon, Gregory J.			An Epigenetic Role for Maternally Inherited piRNAs in Transposon Silencing	SCIENCE			English	Article							R-HYBRID DYSGENESIS; MENDELIAN FEMALE STERILITY; DROSOPHILA-MELANOGASTER; I-ELEMENTS; MOLECULAR-BASIS; TRANSGENES; RETROTRANSPOSITION; IDENTIFICATION; REPRESSION; REACTIVITY	In plants and mammals, small RNAs indirectly mediate epigenetic inheritance by specifying cytosine methylation. We found that small RNAs themselves serve as vectors for epigenetic information. Crosses between Drosophila strains that differ in the presence of a particular transposon can produce sterile progeny, a phenomenon called hybrid dysgenesis. This phenotype manifests itself only if the transposon is paternally inherited, suggesting maternal transmission of a factor that maintains fertility. In both P- and I- element- mediated hybrid dysgenesis models, daughters show a markedly different content of Piwi- interacting RNAs ( piRNAs) targeting each element, depending on their parents of origin. Such differences persist from fertilization through adulthood. This indicates that maternally deposited piRNAs are important for mounting an effective silencing response and that a lack of maternal piRNA inheritance underlies hybrid dysgenesis.	[Brennecke, Julius; Malone, Colin D.; Aravin, Alexei A.; Sachidanandam, Ravi; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Stark, Alexander] MIT, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander] Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Brennecke, Julius/T-5883-2019; Brennecke, Julius/C-1626-2015; Stark, Alexander/D-1473-2012; Hannon, Gregory/AAB-3568-2019; sachidanandam, ravi/Q-6916-2019	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814; Stark, Alexander/0000-0003-2611-0841; sachidanandam, ravi/0000-0001-9844-4459	The Ernst Schering Foundation; Beckman fellow of the Watson School of Biological Sciences; NSF Graduate Research Fellowship; Human Frontier Science Program fellowship; NIH; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	The Ernst Schering Foundation; Beckman fellow of the Watson School of Biological Sciences; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Human Frontier Science Program fellowship(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Rooks and D. McCombie (CSHL) for help with deep sequencing, S. Jensen and S. Ronsseray for fly stocks and helpful discussions, and D. Finnegan for the I- element ORF-1 antibody. J.B. is supported by a fellowship from The Ernst Schering Foundation, C.D.M. is a Beckman fellow of the Watson School of Biological Sciences and is supported by an NSF Graduate Research Fellowship, and A.S. is supported by a Human Frontier Science Program fellowship. This work was supported by grants from NIH to G.J.H. and A.A.A. and a kind gift from K.W. Davis (to G.J.H.). Small RNA libraries are deposited at Gene Expression Omnibus ( accession no. GSE13081, data sets GSM327620 to GSM327634).	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BUCHETON A, 1978, HEREDITY, V41, P357, DOI 10.1038/hdy.1978.106; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; Castro JP, 2004, GENETICA, V121, P107, DOI 10.1023/B:GENE.0000040382.48039.a2; Chambeyron S, 2005, CYTOGENET GENOME RES, V110, P215, DOI 10.1159/000084955; CROZATIER M, 1988, NUCLEIC ACIDS RES, V16, P9199, DOI 10.1093/nar/16.19.9199; Dimitri P, 2005, CYTOGENET GENOME RES, V110, P160, DOI 10.1159/000084948; Dramard X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000304; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; JENSEN S, 1995, MOL GEN GENET, V248, P381, DOI 10.1007/BF02191637; Jensen S, 2002, GENETICS, V162, P1197; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; KIDWELL MG, 1977, GENETICS, V86, P813; KIDWELL MG, 1983, P NATL ACAD SCI-BIOL, V80, P1655, DOI 10.1073/pnas.80.6.1655; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Malinsky S, 2000, GENETICS, V156, P1147; Marin L, 2000, GENETICS, V155, P1841; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; PELISSON A, 1981, MOL GEN GENET, V183, P123, DOI 10.1007/BF00270149; PICARD G, 1976, GENETICS, V83, P107; Picard G, 1971, DIS, V46, P54; RONSSERAY S, 1991, GENETICS, V129, P501; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; Seleme MD, 1999, GENETICS, V151, P761; VAURY C, 1990, J MOL EVOL, V31, P424, DOI 10.1007/BF02106056	28	535	554	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1387	1392		10.1126/science.1165171	http://dx.doi.org/10.1126/science.1165171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039138	Green Accepted			2022-12-01	WOS:000261170600041
J	Wilusz, JE; Freier, SM; Spector, DL				Wilusz, Jeremy E.; Freier, Susan M.; Spector, David L.			3 ' End Processing of a Long Nuclear-Retained Noncoding RNA Yields a tRNA-like Cytoplasmic RNA	CELL			English	Article							POLY(A)-LIMITING ELEMENT; MICRORNAS; MECHANISM; SEQUENCE; PROTEIN; IDENTIFICATION; TRANSCRIPTS; INHIBITOR; GENOME; TFEB	MALAT1 is a long noncoding RNA known to be misregulated in many human cancers. We have identified a highly conserved small RNA of 61 nucleotides originating from the MALAT1 locus that is broadly expressed in human tissues. Although the long MALAT1 transcript localizes to nuclear speckles, the small RNA is found exclusively in the cytoplasm. RNase P cleaves the nascent MALAT1 transcript downstream of a genomically encoded poly(A)-rich tract to simultaneously generate the 30 end of the mature MALAT1 transcript and the 50 end of the small RNA. Enzymes involved in tRNA biogenesis then further process the small RNA, consistent with its adoption of a tRNA-like structure. Our findings reveal a 30 end processing mechanism by which a single gene locus can yield both a stable nuclear-retained noncoding RNA with a short poly(A) tail-like moiety and a small tRNA-like cytoplasmic RNA.	[Wilusz, Jeremy E.; Spector, David L.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Freier, Susan M.] ISIS Pharmaceut, Carlsbad, CA 92008 USA	Cold Spring Harbor Laboratory; Isis Pharmaceuticals Inc	Spector, DL (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	spector@cshl.edu	Wilusz, Jeremy/AAG-4628-2020	Wilusz, Jeremy/0000-0001-6929-8755	Beckman Graduate Studentship; National Institutes of Health; National Institute of General Medical Sciences [42694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694] Funding Source: NIH RePORTER	Beckman Graduate Studentship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank Tom Gingeras, Greg Hannon, Adrian Krainer, Kannanganattu Prasanth, Hongjae Sunwoo, Oliver Tam, Jeff Wilusz, Carol Wilusz, Zhenyu Xuan, and members of the Spector laboratory for many helpful discussions. We would also like to thank Chris Black and Frank Bennett for help and discussions regarding the antisense oligonucleotides, Josh Nichols and Walt Lima for performing the sucrose gradients, Sidney Altman and Masayuki Nashimoto for providing tRNA processing reagents, and Philip Leder for providing the EpH4-EV and EpH4-A6 cell lines. We thank Delphine Bernard and Alain Bessis for bringing MALAT1 to our attention. J. E. W. is supported by a Beckman Graduate Studentship at the Watson School of Biological Sciences. The work was supported by a grant to D. L. S. from the National Institutes of Health, National Institute of General Medical Sciences (42694).	Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Braidotti G, 2004, COLD SPRING HARB SYM, V69, P55, DOI 10.1101/sqb.2004.69.55; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Choi YH, 2003, P NATL ACAD SCI USA, V100, P7033, DOI 10.1073/pnas.1232347100; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Deng XX, 2006, TRENDS BIOCHEM SCI, V31, P526, DOI 10.1016/j.tibs.2006.07.007; Dinger ME, 2008, J MOL ENDOCRINOL, V40, P151, DOI 10.1677/JME-07-0160; Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X; Fechter P, 2001, CELL MOL LIFE SCI, V58, P1547, DOI 10.1007/PL00000795; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Giege R, 1998, CURR OPIN STRUC BIOL, V8, P286, DOI 10.1016/S0959-440X(98)80060-2; Gopalan V, 2002, J BIOL CHEM, V277, P6759, DOI 10.1074/jbc.R100067200; Gu HD, 1999, P NATL ACAD SCI USA, V96, P8943, DOI 10.1073/pnas.96.16.8943; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jacobson MR, 1997, J CELL SCI, V110, P829; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Masui O, 2006, COLD SPRING HARB SYM, V71, P419, DOI 10.1101/sqb.2006.71.058; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Peng J, 2005, RNA, V11, P958, DOI 10.1261/rna.2020805; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Rajaram V, 2007, GENE CHROMOSOME CANC, V46, P508, DOI 10.1002/gcc.20437; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Szymanski M, 2005, BBA-REV CANCER, V1756, P65, DOI 10.1016/j.bbcan.2005.07.005; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	486	527	2	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					919	932		10.1016/j.cell.2008.10.012	http://dx.doi.org/10.1016/j.cell.2008.10.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041754	Green Accepted, Bronze			2022-12-01	WOS:000261183900022
J	Haine, ER; Moret, Y; Siva-Jothy, MT; Rolff, J				Haine, Eleanor R.; Moret, Yannick; Siva-Jothy, Michael T.; Rolff, Jens			Antimicrobial Defense and Persistent Infection in Insects	SCIENCE			English	Article							INNATE IMMUNITY; DROSOPHILA-MELANOGASTER; TENEBRIO-MOLITOR; HOST-DEFENSE; RESISTANCE; PEPTIDES; SYSTEM	During 400 million years of existence, insects have rarely succumbed to the evolution of microbial resistance against their potent antimicrobial immune defenses. We found that microbial clearance after infection is extremely fast and that induced antimicrobial activity starts to increase only when most of the bacteria (99.5%) have been removed. Our experiments showed that those bacteria that survived exposure to the insect's constitutive immune response were subsequently more resistant to it. These results imply that induced antimicrobial compounds function primarily to protect the insect against the bacteria that persist within their body, rather than to clear microbial infections. These findings suggest that understanding of the management of antimicrobial peptides in natural systems might inform medical treatment strategies that avoid the risk of drug resistance.	[Haine, Eleanor R.; Siva-Jothy, Michael T.; Rolff, Jens] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Moret, Yannick] Univ Bourgogne 1, CNRS, UMR Biogeosci 5561, F-21000 Dijon, France	University of Sheffield; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Rolff, J (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	jor@sheffield.ac.uk	Moret, Yannick/I-9282-2012	Haine Bennett, Eleanor/0000-0001-8777-4532; Rolff, Jens/0000-0002-1529-5409	Leverhulme Trust; The Wellcome Trust	Leverhulme Trust(Leverhulme Trust); The Wellcome Trust(Wellcome TrustEuropean Commission)	We thank R. Clare, A. Dobson, S. Webster, and A. Williams for laboratory assistance. P. Brakefield, S. Foster, and M. Osborn made valuable comments that improved the manuscript. This research was funded by The Leverhulme Trust, and E. R. H. was also supported by The Wellcome Trust.	BULET P, 1992, EUR J BIOCHEM, V209, P977, DOI 10.1111/j.1432-1033.1992.tb17371.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; DUNN PE, 1986, ANNU REV ENTOMOL, V31, P321, DOI 10.1146/annurev.en.31.010186.001541; Garcia-Lara J, 2005, FEMS IMMUNOL MED MIC, V43, P311, DOI 10.1016/j.femsim.2004.11.003; Haine ER, 2008, J INSECT PHYSIOL, V54, P1090, DOI 10.1016/j.jinsphys.2008.04.013; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lavine MD, 2005, INSECT BIOCHEM MOLEC, V35, P1335, DOI 10.1016/j.ibmb.2005.08.005; Lazzaro BP, 2008, CURR OPIN MICROBIOL, V11, P284, DOI 10.1016/j.mib.2008.05.001; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Needham AJ, 2004, MICROBIOL-SGM, V150, P2347, DOI 10.1099/mic.0.27116-0; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Poulsen M, 2002, BEHAV ECOL SOCIOBIOL, V52, P151, DOI 10.1007/s00265-002-0489-8; Sadd BM, 2006, P ROY SOC B-BIOL SCI, V273, P2571, DOI 10.1098/rspb.2006.3574; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	23	238	246	3	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1257	1259		10.1126/science.1165265	http://dx.doi.org/10.1126/science.1165265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023083				2022-12-01	WOS:000261033400045
J	Stenman, JM; Rajagopal, J; Carroll, TJ; Ishibashi, M; McMahon, J; McMahon, AP				Stenman, Jan M.; Rajagopal, Jay; Carroll, Thomas J.; Ishibashi, Makoto; McMahon, Jill; McMahon, Andrew P.			Canonical Wnt Signaling Regulates Organ-Specific Assembly and Differentiation of CNS Vasculature	SCIENCE			English	Article							BETA-CATENIN GENE; ENDOTHELIAL-CELLS; MOUSE DEVELOPMENT; RECEPTOR GENE; EXPRESSION; PROLIFERATION; ANGIOGENESIS; INACTIVATION; DISRUPTION; PATHWAY	Every organ depends on blood vessels for oxygen and nutrients, but the vasculature associated with individual organs can be structurally and molecularly diverse. The central nervous system (CNS) vasculature consists of a tightly sealed endothelium that forms the blood- brain barrier, whereas blood vessels of other organs are more porous. Wnt7a and Wnt7b encode two Wnt ligands produced by the neuroepithelium of the developing CNS coincident with vascular invasion. Using genetic mouse models, we found that these ligands directly target the vascular endothelium and that the CNS uses the canonical Wnt signaling pathway to promote formation and CNS- specific differentiation of the organ's vasculature.	[Stenman, Jan M.; Rajagopal, Jay; Carroll, Thomas J.; Ishibashi, Makoto; McMahon, Jill; McMahon, Andrew P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Rajagopal, Jay] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA; [McMahon, Andrew P.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University	McMahon, AP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	mcmahon@mcb.harvard.edu	McMahon, Andrew P/ABE-7520-2020		Wenner-Gren Foundations (Sweden); National Heart, Lung, and Blood Institute [HL076393]; NIH [DK054364]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054364, R01DK054364] Funding Source: NIH RePORTER	Wenner-Gren Foundations (Sweden); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. D'Amore for helpful discussions. Supported by a Wenner-Gren Foundations (Sweden) postdoctoral fellowship (J.M.S.), National Heart, Lung, and Blood Institute grant HL076393 (J.R.), and NIH grant DK054364 (A.P.M.). The authors have a patent pending on the basis of the results reported in this paper. A.P.M. has been a paid consultant for Merck, Genentech, and Wythe in the past 3 years.	Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Brault V, 2001, DEVELOPMENT, V128, P1253; Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Engelhardt B, 2003, CELL TISSUE RES, V314, P119, DOI 10.1007/s00441-003-0751-z; Goodwin AM, 2007, GROWTH FACTORS, V25, P25, DOI 10.1080/08977190701272933; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Parr BA, 2001, DEV BIOL, V237, P324, DOI 10.1006/dbio.2001.0373; PARR BA, 1993, DEVELOPMENT, V119, P247; Shu WG, 2002, DEVELOPMENT, V129, P4831; Smith, 2006, DEATHS PRELIMINARY D; Suburo A. M., 2006, V176, P71; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Venkiteswaran K, 2002, AM J PHYSIOL-CELL PH, V283, pC811, DOI 10.1152/ajpcell.00417.2001; Wright M, 1999, BIOCHEM BIOPH RES CO, V263, P384, DOI 10.1006/bbrc.1999.1344; Yano H, 2000, NEUROL RES, V22, P650; Yano H, 2000, NEUROL RES, V22, P527	27	425	432	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1247	1250		10.1126/science.1164594	http://dx.doi.org/10.1126/science.1164594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023080				2022-12-01	WOS:000261033400042
J	Xiang, S; Cooper-Morgan, A; Jiao, XF; Kiledjian, M; Manley, JL; Tong, L				Xiang, Song; Cooper-Morgan, Amalene; Jiao, Xinfu; Kiledjian, Megerditch; Manley, James L.; Tong, Liang			Structure and function of the 5 '-> 3 ' exoribonuclease Rat1 and its activating partner Rai1	NATURE			English	Article							RNA-POLYMERASE-II; MESSENGER-RNA; TRANSCRIPTION TERMINATION; SACCHAROMYCES-CEREVISIAE; MACROMOLECULAR STRUCTURES; PIN DOMAINS; PROTEIN; EXONUCLEASE; TURNOVER; NUCLEAR	The 5'-> 3' exoribonucleases (XRNs) comprise a large family of conserved enzymes in eukaryotes with crucial functions in RNA metabolism and RNA interference(1-5). XRN2, or Rat1 in yeast(6), functions primarily in the nucleus and also has an important role in transcription termination by RNA polymerase II (refs 7-14). Rat1 exoribonuclease activity is stimulated by the protein Rai1 (refs 15, 16). Here we report the crystal structure at 2.2 angstrom resolution of Schizosaccharomyces pombe Rat1 in complex with Rai1, as well as the structures of Rai1 and its murine homologue Dom3Z alone at 2.0 angstrom resolution. The structures reveal the molecular mechanism for the activation of Rat1 by Rai1 and for the exclusive exoribonuclease activity of Rat1. Biochemical studies confirm these observations, and show that Rai1 allows Rat1 to degrade RNAs with stable secondary structure more effectively. There are large differences in the active site landscape of Rat1 compared to related and PIN (PilT N terminus) domain-containing nucleases(17-20). Unexpectedly, we identified a large pocket in Rai1 and Dom3Z that contains highly conserved residues, including three acidic side chains that coordinate a divalent cation. Mutagenesis and biochemical studies demonstrate that Rai1 possesses pyrophosphohydrolase activity towards 5' triphosphorylated RNA. Such an activity is important for messenger RNA degradation in bacteria(21), but this is, to our knowledge, the first demonstration of this activity in eukaryotes and suggests that Rai1/Dom3Z may have additional important functions in RNA metabolism.	[Xiang, Song; Cooper-Morgan, Amalene; Manley, James L.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Jiao, Xinfu; Kiledjian, Megerditch] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Columbia University; Rutgers State University New Brunswick	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Xiang, Song/AAF-6422-2019	Xiang, Song/0000-0001-9314-4684; Manley, James/0000-0002-8341-1459; Tong, Liang/0000-0002-0563-6468	NIH [GM077175, GM28983, GM67005]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067005, R01GM028983, R01GM077175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Abramowitz and J. Schwanof for setting up the X4A and X4C beamlines and H. Robinson for setting up the X29A beamline at the NSLS, and S. Jia for providing the S. pombe genome. This research is supported in part by grants from the NIH to L. T. (GM077175), J. L. M. (GM28983) and M. K. (GM67005).	AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; DeLano WL., 2002, PYMOL USERS MANUAL D; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Jiao XF, 2006, MOL CELL, V24, P713, DOI 10.1016/j.molcel.2006.10.013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; LAMZIN VS, 2001, CRYSTALLOGRAPHY BIOL, VF, P720; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Luo WF, 2004, CELL, V119, P911, DOI 10.1016/j.cell.2004.11.041; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page AM, 1998, NUCLEIC ACIDS RES, V26, P3707, DOI 10.1093/nar/26.16.3707; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Piccirillo C, 2003, RNA, V9, P1138, DOI 10.1261/rna.5690503; Poole TL, 1997, BIOCHEM BIOPH RES CO, V235, P799, DOI 10.1006/bbrc.1997.6877; Shobuike T, 2001, NUCLEIC ACIDS RES, V29, P1326, DOI 10.1093/nar/29.6.1326; Solinger JA, 1999, MOL CELL BIOL, V19, P5930; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; West S, 2008, NUCLEIC ACIDS RES, V36, P905, DOI 10.1093/nar/gkm1112; Westmont K, 2004, URBAN AFF REV, V39, P522, DOI 10.1177/1078087404394009; Xue Y, 2000, MOL CELL BIOL, V20, P4006, DOI 10.1128/MCB.20.11.4006-4015.2000; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	42	143	147	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					784	U130		10.1038/nature07731	http://dx.doi.org/10.1038/nature07731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19194460	Green Accepted			2022-12-01	WOS:000265193600046
J	Guan, N; Fan, QF; Ding, J; Zhao, YM; Lu, JQ; Ai, Y; Xu, GB; Zhu, SN; Yao, C; Jiang, LN; Miao, J; Zhang, H; Zhao, D; Liu, XY; Yao, Y				Guan, Na; Fan, Qingfeng; Ding, Jie; Zhao, Yiming; Lu, Jingqiao; Ai, Yi; Xu, Guobin; Zhu, Sainan; Yao, Chen; Jiang, Lina; Miao, Jing; Zhang, Han; Zhao, Dan; Liu, Xiaoyu; Yao, Yong			Melamine-Contaminated Powdered Formula and Urolithiasis in Young Children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: A recent epidemic of melamine contamination of baby formula in China has been associated with the development of urinary tract stones, though the clinical manifestations and predisposing factors are incompletely delineated. Methods: We administered a questionnaire to the parents of children 36 months of age or younger who were being screened for a history of exposure to melamine and symptoms of, and possible predisposing factors for, urinary tract stones. In addition, we performed urinalysis, renal-function and liver-function tests, urinary tests for biochemical markers and the calcium:creatinine ratio, and ultrasonography. Powdered-milk infant formulas were classified as having a high melamine content (>500 ppm), a moderate melamine content (<150 ppm), or no melamine (0 ppm); no formulas contained between 150 and 500 ppm of melamine. Results: Contaminated formula was ingested by 421 of 589 children. Fifty had urinary stones, including 8 who had not received melamine-contaminated formula; 112 were suspected to have stones; and 427 had no stones. Among children with stones, 5.9% had hematuria and 2.9% had leukocyturia, percentages that did not differ significantly from those among children who were suspected to have stones or those who did not have stones. Serum creatinine, urea nitrogen, and alanine aminotransferase levels were normal in the 22 children with stones who were tested. Four of the 41 children (9.8%) who had stones and in whom urinary markers of glomerular function were measured had evidence of abnormalities; none had tubular dysfunction. Children exposed to high-melamine formula were 7.0 times as likely to have stones as those exposed to no-melamine formula. Preterm infants were 4.5 times as likely to have stones as term infants. Conclusions: Prematurity and exposure to melamine-contaminated formula were associated with urinary stones. Affected children lacked typical signs and symptoms of urolithiasis. N Engl J Med 2009;360:1067-74.	[Guan, Na; Fan, Qingfeng; Ding, Jie; Ai, Yi; Xu, Guobin; Zhu, Sainan; Yao, Chen; Jiang, Lina; Miao, Jing; Zhang, Han; Zhao, Dan; Liu, Xiaoyu; Yao, Yong] Peking Univ, Hosp 1, Beijing 100034, Peoples R China; [Zhao, Yiming; Lu, Jingqiao] Peking Univ, Hosp 3, Res Ctr Clin Epidemiol, Beijing 100034, Peoples R China	Peking University; Peking University	Ding, J (corresponding author), Peking Univ, Hosp 1, 1 Xi An Men Da Jie, Beijing 100034, Peoples R China.	djnc_5855@126.com	Fan, Qingfeng/F-4778-2012	Fan, Qingfeng/0000-0002-7100-7766; Miao, Jing/0000-0003-0642-9740	National Key Technology Research and Development Program of China	National Key Technology Research and Development Program of China(National Key Technology R&D Program)	Supported by a grant from the National Key Technology Research and Development Program of China.	Chertow GM, 1996, JAMA-J AM MED ASSOC, V276, P1732, DOI 10.1001/jama.276.21.1732; COWARD RJ, 2004, ARCH DIS CHILD, V89, P797; Coward RJM, 2003, ARCH DIS CHILD, V88, P962, DOI 10.1136/adc.88.11.962; GILSANZ V, 1985, RADIOLOGY, V154, P107, DOI 10.1148/radiology.154.1.3964925; Sun Ning, 2008, Zhonghua Er Ke Za Zhi, V46, P810; Thompson ME, 2008, VET PATHOL, V45, P417, DOI 10.1354/vp.45-3-417	6	203	233	0	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1067	1074		10.1056/NEJMoa0809550	http://dx.doi.org/10.1056/NEJMoa0809550			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19196669				2022-12-01	WOS:000264051000004
J	Nozawa, K; O'Donoghue, P; Gundllapalli, S; Araiso, Y; Ishitani, R; Umehara, T; Soll, D; Nureki, O				Nozawa, Kayo; O'Donoghue, Patrick; Gundllapalli, Sarath; Araiso, Yuhei; Ishitani, Ryuichiro; Umehara, Takuya; Soell, Dieter; Nureki, Osamu			Pyrrolysyl-tRNA synthetase-tRNA(Pyl) structure reveals the molecular basis of orthogonality	NATURE			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; ESCHERICHIA-COLI; GENETIC-CODE; IN-VITRO; SYNTHETASES; RECOGNITION; TRNA(PHE); PROTEINS; ARCHAEA	Pyrrolysine (Pyl), the 22nd natural amino acid, is genetically encoded by UAG and inserted into proteins by the unique suppressor tRNA(Pyl) (ref.1). The Methanosarcinaceae produce Pyl and express Pyl-containing methyltransferases that allow growth on methylamines(2). Homologous methyltransferases and the Pyl biosynthetic and coding machinery are also found in two bacterial species(1,3). Pyl coding is maintained by pyrrolysyl-tRNA synthetase (PylRS), which catalyses the formation of Pyl-tRNA(Pyl) (refs 4, 5). Pyl is not a recent addition to the genetic code. PylRS was already present in the last universal common ancestor(6); it then persisted in organisms that utilize methylamines as energy sources. Recent protein engineering efforts added non-canonical amino acids to the genetic code(7,8). This technology relies on the directed evolution of an 'orthogonal' tRNA synthetase-tRNA pair in which an engineered aminoacyl-tRNA synthetase (aaRS) specifically and exclusively acylates the orthogonal tRNA with a non-canonical amino acid. For Pyl the natural evolutionary process developed such a system some 3 billion years ago. When transformed into Escherichia coli, Methanosarcina barkeri PylRS and tRNA(Pyl) function as an orthogonal pair in vivo(5,9). Here we show that Desulfitobacterium hafniense PylRS-tRNA(Pyl) is an orthogonal pair in vitro and in vivo, and present the crystal structure of this orthogonal pair. The ancient emergence of PylRS tRNA(Pyl) allowed the evolution of unique structural features in both the protein and the tRNA. These structural elements manifest an intricate, specialized aaRS-tRNA interaction surface that is highly distinct from those observed in any other known aaRS-tRNA complex; it is this general property that underlies the molecular basis of orthogonality.	[O'Donoghue, Patrick; Gundllapalli, Sarath; Umehara, Takuya; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Nozawa, Kayo; Araiso, Yuhei; Nureki, Osamu] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Minato Ku, Tokyo 1088639, Japan	Yale University; Yale University; Tokyo Institute of Technology; University of Tokyo	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu; nureki@ims.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014	Nozawa, Kayo/0000-0001-6677-7195; O'Donoghue, Patrick/0000-0002-9500-8640	National Science Foundation; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology; Mitsubishi Foundation; Kurata Memorial Hitachi Science and Technology Foundation; National Institute of General Medical Sciences; Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Kurata Memorial Hitachi Science and Technology Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline staff at BL41XU of SPring-8 (Harima, Japan) and NW12 of PF-AR (Tsukuba, Japan) for technical help during data collection. P.O. holds a National Science Foundation postdoctoral fellowship in Biological Informatics. This work was supported by grants from the Japan Science and Technology Agency (to O.N.), from the National Project on Protein Structural and Functional Analyses of the Ministry of Education, Culture, Sports, Science and Technology (to O.N.), from the Ministry of Education, Culture, Sports, Science and Technology (to R.I. and O.N.), from the Mitsubishi Foundation (to O.N.), from the Kurata Memorial Hitachi Science and Technology Foundation (to O.N.), from the National Institute of General Medical Sciences (to D. S.), from the Department of Energy (to D. S.), and from the National Science Foundation (to D. S.).	Ambrogelly A, 2007, P NATL ACAD SCI USA, V104, P3141, DOI 10.1073/pnas.0611634104; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Briand C, 2000, J MOL BIOL, V299, P1051, DOI 10.1006/jmbi.2000.3819; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Herring S, 2007, FEBS LETT, V581, P3197, DOI 10.1016/j.febslet.2007.06.004; Herring S, 2007, NUCLEIC ACIDS RES, V35, P1270, DOI 10.1093/nar/gkl1151; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Krzycki JA, 2005, CURR OPIN MICROBIOL, V8, P706, DOI 10.1016/j.mib.2005.10.009; Lee MM, 2008, BIOCHEM BIOPH RES CO, V374, P470, DOI 10.1016/j.bbrc.2008.07.074; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Moor N, 2006, BIOCHEMISTRY-US, V45, P10572, DOI 10.1021/bi060491l; MURGOLA EJ, 1985, ANNU REV GENET, V19, P57, DOI 10.1146/annurev.genet.19.1.57; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Theobald-Dietrich A, 2004, NUCLEIC ACIDS RES, V32, P1091, DOI 10.1093/nar/gkh266; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vasil'eva IA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P247, DOI 10.1134/S0006297907030029; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Yanagisawa T, 2008, J MOL BIOL, V378, P634, DOI 10.1016/j.jmb.2008.02.045; YANOFSKY C, 1972, J BIOL CHEM, V247, P4494; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, P4952, DOI 10.1093/nar/gkm514	35	129	139	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1163	U127		10.1038/nature07611	http://dx.doi.org/10.1038/nature07611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19118381	Green Accepted			2022-12-01	WOS:000263680100048
J	Ploss, A; Evans, MJ; Gaysinskaya, VA; Panis, M; You, HN; de Jong, YP; Rice, CM				Ploss, Alexander; Evans, Matthew J.; Gaysinskaya, Valeriya A.; Panis, Maryline; You, Hana; de Jong, Ype P.; Rice, Charles M.			Human occludin is a hepatitis C virus entry factor required for infection of mouse cells	NATURE			English	Article							EPITHELIAL TIGHT JUNCTIONS; COXSACKIEVIRUS ENTRY; REPLICATION; CD81; GLYCOPROTEINS; PROTEINS; CULTURE	Hepatitis C virus ( HCV) is a leading cause of liver disease worldwide. The development of much needed specific antiviral therapies and an effective vaccine has been hampered by the lack of a convenient small animal model. The determinants restricting HCV tropism to human and chimpanzee hosts are unknown. Replication of the viral RNA has been demonstrated in mouse cells(1,2), but these cells are not infectable with either lentiviral particles bearing HCV glycoproteins (HCVpp)(3) or HCV produced in cell culture ( HCVcc) ( A. P., M. E. and C. M. R., unpublished observations), suggesting that there is a block at the level of entry. Here we show, using an iterative complementary DNA library screening approach, that human occludin ( OCLN) is an essential HCV cell entry factor that is able to render murine cells infectable with HCVpp. Similarly, OCLN is required for the HCV- susceptibility of human cells, because its overexpression in uninfectable cells specifically enhanced HCVpp uptake, whereas its silencing in permissive cells impaired both HCVpp and HCVcc infection. In addition to OCLN, HCVpp infection of murine cells required expression of the previously identified HCV entry factors CD81 ( ref. 4), scavenger receptor class B type I ( SR- BI, also known as SCARB1) 5 and claudin- 1 (CLDN1)(6). Although the mouse versions of SR- BI and CLDN1 function at least as well as the human proteins in promoting HCV entry, both OCLN and CD81 must be of human origin to allow efficient infection. The species- specific determinants of OCLN were mapped to its second extracellular loop. The identification of OCLN as a new HCV entry factor further highlights the importance of the tight junction complex in the viral entry process, and provides an important advance towards efforts to develop small animal models for HCV.	[Ploss, Alexander; Evans, Matthew J.; Gaysinskaya, Valeriya A.; Panis, Maryline; You, Hana; de Jong, Ype P.; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA; [de Jong, Ype P.] Mt Sinai Sch Med, Div Gastroenterol, New York, NY 10029 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA.	ricec@rockefeller.edu	Ploss, Alexander/ABG-2330-2020	Ploss, Alexander/0000-0001-9322-7252; Evans, Matthew/0000-0002-4991-3877	Greenberg Medical Research Institute; Ellison Medical Foundation; Starr Foundation; Ronald A. Shellow Memorial Fund; Richard Salomon Family Foundation; Foundation for the National Institutes of Health; Grand Challenges in Global Health initiative; National Institutes of Health; Ellison Medical Foundation Senior Scholar in Global Infectious Diseases; Kimberly Lawrence-Netter Cancer Research Discovery Fund Award Postdoctoral Fellowships; Charles H. Revson Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072613] Funding Source: NIH RePORTER	Greenberg Medical Research Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Starr Foundation; Ronald A. Shellow Memorial Fund; Richard Salomon Family Foundation; Foundation for the National Institutes of Health; Grand Challenges in Global Health initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation Senior Scholar in Global Infectious Diseases(Lawrence Ellison Foundation); Kimberly Lawrence-Netter Cancer Research Discovery Fund Award Postdoctoral Fellowships; Charles H. Revson Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Bowman, K. Mu, M. Hunter, J. Tassello and M. Holz for excellent technical assistance, J. L. Law and N. Shohdy for advice on siRNA experiments, T. von Hahn and A. J. Syder for helpful discussions and C. Murray for editing the manuscript. S. Mazel, C. Bare and X. Fan provided outstanding technical support. This work was supported by the Greenberg Medical Research Institute, the Ellison Medical Foundation, the Starr Foundation, the Ronald A. Shellow Memorial Fund, the Richard Salomon Family Foundation and funded in part by a Grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative (to C.M.R.), and the National Institutes of Health (to M.J.E. and C.M.R.). C.M.R. is an Ellison Medical Foundation Senior Scholar in Global Infectious Diseases. A.P. and M.J.E. were supported by Kimberly Lawrence-Netter Cancer Research Discovery Fund Award Postdoctoral Fellowships. M.J.E. was also supported by the Charles H. Revson Postdoctoral Fellowship. We would like to thank P.D. Bieniasz and T. Hatziioannou for providing reagents, including the LMN8 retroviral plasmid, and expertise necessary for the cDNA library construction and screening. R. Tsien provided the mCherry fluorescent protein encoding plasmid, A. Miyawaki the Venus/YFP plasmid and D. W. Piston the Cerulean/CFP plasmid. Constructs expressing HCV glycoproteins of diverse genotypes and the JFH-1 subgenomic replicon cDNA were provided by J. Bukh and T. Wakita, respectively.	Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	19	691	737	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					882	886		10.1038/nature07684	http://dx.doi.org/10.1038/nature07684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19182773	Green Accepted			2022-12-01	WOS:000263266700045
J	Heuer, D; Lipinski, AR; Machuy, N; Karlas, A; Wehrens, A; Siedler, F; Brinkmann, V; Meyer, TF				Heuer, Dagmar; Lipinski, Anette Rejman; Machuy, Nikolaus; Karlas, Alexander; Wehrens, Andrea; Siedler, Frank; Brinkmann, Volker; Meyer, Thomas F.			Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction	NATURE			English	Article							HOST-CELL; ENDOPLASMIC-RETICULUM; TRACHOMATIS INCLUSION; APOPTOSIS; APPARATUS; SPHINGOLIPIDS; INHERITANCE; INHIBITION; PNEUMONIAE; ACTIVATION	The obligate intracellular bacterium Chlamydia trachomatis survives and replicates within a membrane- bound vacuole, termed the inclusion, which intercepts host exocytic pathways to obtain nutrients(1-3). Like many other intracellular pathogens, C. trachomatis has a marked requirement for host cell lipids, such as sphingolipids and cholesterol, produced in the endoplasmic reticulum and the Golgi apparatus(4-6). However, the mechanisms by which intracellular pathogens acquire host cell lipids are not well understood(1-3). In particular, no host cell protein responsible for transporting Golgi-derived lipids to the chlamydial inclusions has yet been identified. Here we show that Chlamydia infection in human epithelial cells induces Golgi fragmentation to generate Golgi ministacks surrounding the bacterial inclusion. Ministack formation is triggered by the proteolytic cleavage of the Golgimatrix protein golgin-84. Inhibition of golgin-84 truncation prevents Golgi fragmentation, causing a block in lipid acquisition and maturation of C. trachomatis. Golgi fragmentation by means of RNA- interference- mediated knockdown of distinct Golgi matrix proteins before infection enhances bacterial maturation. Our data functionally connect bacteria- induced golgin-84 cleavage, Golgi ministack formation, lipid acquisition and intracellular pathogen growth. We show that C. trachomatis subverts the structure and function of an entire host cell organelle for its own advantage.	[Heuer, Dagmar; Lipinski, Anette Rejman; Machuy, Nikolaus; Karlas, Alexander; Wehrens, Andrea; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Brinkmann, Volker] Max Planck Inst Infect Biol, Microscopy Core Facil, D-10117 Berlin, Germany; [Siedler, Frank] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Meyer, TF (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Charitepl 1, D-10117 Berlin, Germany.	meyer@mpiib-berlin.mpg.de	Meyer, Thomas F. F/J-2485-2013; Brinkmann, Volker/A-6015-2009	Meyer, Thomas F. F/0000-0002-6120-8679; Karlas, Alexander/0000-0002-2187-2057	Senate of Berlin; BMBF	Senate of Berlin; BMBF(Federal Ministry of Education & Research (BMBF))	The authors would like to thank A. Greiser, C. Goosmann, B. Laube, M. Wicht and E. Ziska for technical support; M.A. De Matteis for the gift of the GFP-GM130 fusion plasmid; H. P. Hauri for the provision of the anti-GPP130 antibody and helpful discussions; and K. Astrahantseff, S. and J. Heuer, T. Wolff and L. Ogilvie for critically reading the manuscript and helpful suggestions. This work was financially supported by the Senate of Berlin and the BMBF through the RiNA Network.	Altan-Bonnet N, 2006, MOL BIOL CELL, V17, P990, DOI 10.1091/mbc.E05-02-0155; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Heuer D, 2003, CELL MICROBIOL, V5, P315, DOI 10.1046/j.1462-5822.2003.00278.x; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Hood JL, 2004, J BIOL CHEM, V279, P43126, DOI 10.1074/jbc.M408100200; Lowe M, 2004, J CELL SCI, V117, P1139, DOI 10.1242/jcs.00950; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Machuy N, 2005, MOL CELL PROTEOMICS, V4, P44, DOI 10.1074/mcp.M400089-MCP200; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Suzuki K, 1998, FEBS LETT, V433, P1, DOI 10.1016/S0014-5793(98)00856-4; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997	25	205	217	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					731	U8		10.1038/nature07578	http://dx.doi.org/10.1038/nature07578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19060882				2022-12-01	WOS:000263064700043
J	Ruiz-Canada, C; Kelleher, DJ; Gilmore, R				Ruiz-Canada, Catalina; Kelleher, Daniel J.; Gilmore, Reid			Cotranslational and Posttranslational N-Glycosylation of Polypeptides by Distinct Mammalian OST Isoforms	CELL			English	Article							DIPEPTIDYL PEPTIDASE-I; ENDOPLASMIC-RETICULUM; RIBOPHORIN-I; LINKED GLYCOSYLATION; OLIGOSACCHARYLTRANSFERASE COMPLEX; TRYPANOSOMA-BRUCEI; CATHEPSIN-C; PROTEIN; MEMBRANE; SUBUNIT	Asparagine-linked glycosylation of polypeptides in the lumen of the endoplasmic reticulum is catalyzed by the hetero-oligomeric oligosaccharyltransferase (OST). OST isoforms with different catalytic subunits (STT3A versus STT3B) and distinct enzymatic properties are coexpressed in mammalian cells. Using siRNA to achieve isoform-specific knockdowns, we show that the OST isoforms cooperate and act sequentially to mediate protein N-glycosylation. The STT3A OST isoform is primarily responsible for cotranslational glycosylation of the nascent polypeptide as it enters the lumen of the endoplasmic reticulum. The STT3B isoform is required for efficient cotranslational glycosylation of an acceptor site adjacent to the N-terminal signal sequence of a secreted protein. Unlike STT3A, STT3B efficiently mediates posttranslational glycosylation of a carboxyl-terminal glycosylation site in an unfolded protein. These distinct and complementary roles for the OST isoforms allow sequential scanning of polypeptides for acceptor sites to insure the maximal efficiency of N-glycosylation.	[Ruiz-Canada, Catalina; Kelleher, Daniel J.; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Gilmore, R (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	reid.gilmore@umassmed.edu			Public Health Services [GM 43768]; Ministerio de Educacion y Ciencia, Spain; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043768] Funding Source: NIH RePORTER	Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); Ministerio de Educacion y Ciencia, Spain(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Katherine High for providing the plasmid for FVII and Professor Konrad Sandhoff for the SAP D antisera. We also thank members of the Gilmore laboratory for helpful discussions. This work was supported by Public Health Services grant GM 43768 (R. G.) and a fellowship from the Ministerio de Educacion y Ciencia, Spain (C. R.-C.).	Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; ALLEN S, 1995, J BIOL CHEM, V270, P4797, DOI 10.1074/jbc.270.9.4797; Ben-Dor S, 2004, GLYCOBIOLOGY, V14, P95, DOI 10.1093/glycob/cwh004; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Chen XM, 2001, J BIOL CHEM, V276, P2411, DOI 10.1074/jbc.M007723200; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; Duvet S, 2002, GLYCOBIOLOGY, V12, P95, DOI 10.1093/glycob/12.2.95; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Guth S, 2004, EUR J BIOCHEM, V271, P3200, DOI 10.1111/j.1432-1033.2004.04252.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Horn M, 2002, PROTEIN SCI, V11, P933, DOI 10.1110/ps.2910102; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Kolhekar AS, 1998, J BIOL CHEM, V273, P23012, DOI 10.1074/jbc.273.36.23012; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; KRETZ KA, 1990, P NATL ACAD SCI USA, V87, P2541, DOI 10.1073/pnas.87.7.2541; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; NILSSON I, 1993, J BIOL CHEM, V268, P5798; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P4862; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; Sanjay A, 1998, J BIOL CHEM, V273, P26094, DOI 10.1074/jbc.273.40.26094; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Wrobe D, 2000, J INHERIT METAB DIS, V23, P63, DOI 10.1023/A:1005603014401; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; YU Y, 1990, J CELL BIOL, V111, P1335, DOI 10.1083/jcb.111.4.1335; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	45	249	259	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					272	283		10.1016/j.cell.2008.11.047	http://dx.doi.org/10.1016/j.cell.2008.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167329	Bronze, Green Accepted			2022-12-01	WOS:000262648800016
J	Wu, JI; Lessard, J; Crabtree, GR				Wu, Jiang I.; Lessard, Julie; Crabtree, Gerald R.			Understanding the Words of Chromatin Regulation	CELL			English	Article							REMODELING COMPLEX; POLYCOMB GROUP; HISTONE H3; BRG1; ISWI; EXPRESSION; SUBUNIT; DISRUPTION; PROTEINS; GENES	Recent studies indicate that chromatin regulatory complexes produce biological specificity in the way that letters produce meanings by combinations into words. Combinatorial assembly of chromatin regulatory complexes may be critical for maximizing the information content provided by arrays of histone modifications.	[Wu, Jiang I.; Lessard, Julie; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94062 USA; [Wu, Jiang I.; Lessard, Julie; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94062 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94062 USA.	crabtree@stanford.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI060037, R01 AI060037-04, R01 AI060037-02, R01 AI060037-03, R01 AI060037-05, R01 AI060037-01] Funding Source: Medline; NICHD NIH HHS [R01 HD055391] Funding Source: Medline; NINDS NIH HHS [R01 NS046789-06, R01 NS046789-03, R01 NS046789-04, R01 NS046789-01, R01 NS046789-02, R01 NS046789-05, R01 NS046789] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akasaka T, 1996, DEVELOPMENT, V122, P1513; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Carrera I, 2008, MOL CELL BIOL, V28, P5238, DOI 10.1128/MCB.00747-08; Chalkley GE, 2008, MOL CELL BIOL, V28, P2920, DOI 10.1128/MCB.02217-07; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; NEIGEBORN L, 1984, GENETICS, V108, P845; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wong AKC, 2000, CANCER RES, V60, P6171; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	58	270	276	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					200	206		10.1016/j.cell.2009.01.009	http://dx.doi.org/10.1016/j.cell.2009.01.009			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167321	Green Accepted, Bronze			2022-12-01	WOS:000262648800007
J	Dupont, S; Mamidi, A; Cordenonsi, M; Montagner, M; Zacchigna, L; Adorno, M; Martello, G; Stinchfield, MJ; Soligo, S; Morsut, L; Inui, M; Moro, S; Modena, N; Argenton, F; Newfeld, SJ; Piccolo, S				Dupont, Sirio; Mamidi, Anant; Cordenonsi, Michelangelo; Montagner, Marco; Zacchigna, Luca; Adorno, Maddalena; Martello, Graziano; Stinchfield, Michael J.; Soligo, Sandra; Morsut, Leonardo; Inui, Masafumi; Moro, Stefano; Modena, Nicola; Argenton, Francesco; Newfeld, Stuart J.; Piccolo, Stefano			FAM/USP9x, a Deubiquitinating Enzyme Essential for TGF beta Signaling, Controls Smad4 Monoubiquitination	CELL			English	Article							GROWTH-FACTOR-BETA; FAT-FACETS GENE; UBIQUITIN LIGASE; TUMOR-CELLS; INDUCTION; CANCER; PHOSPHORYLATION; PATHWAYS; RECEPTOR; P53	The assembly of the Smad complex is critical for TGF beta signaling, yet the mechanisms that inactivate or empower nuclear Smad complexes are less understood. By means of siRNA screen we identified FAM (USP9x), a deubiquitinase acting as essential and evolutionarily conserved component in TGFb and bone morphogenetic protein signaling. Smad4 is monoubiquitinated in lysine 519 in vivo, a modification that inhibits Smad4 by impeding association with phospho-Smad2. FAM reverts this negative modification, re-empowering Smad4 function. FAM opposes the activity of Ectodermin/Tif1 gamma (Ecto), a nuclear factor for which we now clarify a prominent role as Smad4 monoubiquitin ligase. Our study points to Smad4 monoubiquitination and deubiquitination as a way for cells to set their TGF beta responsiveness: loss of FAM disables Smad4-dependent responses in several model systems, with Ecto being epistatic to FAM. This defines a regulative ubiquitination step controlling Smads that is parallel to those impinging on R-Smad phosphorylation.	[Dupont, Sirio; Mamidi, Anant; Cordenonsi, Michelangelo; Montagner, Marco; Zacchigna, Luca; Adorno, Maddalena; Martello, Graziano; Soligo, Sandra; Morsut, Leonardo; Inui, Masafumi; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35131 Padua, Italy; [Stinchfield, Michael J.; Newfeld, Stuart J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Modena, Nicola; Argenton, Francesco] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Moro, Stefano] Univ Padua, Dept Pharmaceut Sci, Mol Modeling Sect, I-35131 Padua, Italy	University of Padua; Arizona State University; Arizona State University-Tempe; University of Padua; University of Padua	Piccolo, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35131 Padua, Italy.	piccolo@civ.bio.unipd.it	Inui, Masafumi/GWZ-2521-2022; Montagner, Marco/AAY-3236-2020; Argenton, Francesco/AAS-8494-2021; Moro, Stefano/A-2979-2012; Dupont, Sirio/AAP-8133-2021; Martello, Graziano/AAM-3325-2021; Stinchfield, Michael/AAW-8983-2020; Cordenonsi, Michelangelo/K-7692-2016	Inui, Masafumi/0000-0003-4720-007X; Montagner, Marco/0000-0003-3080-2138; Argenton, Francesco/0000-0002-0803-8236; Moro, Stefano/0000-0002-7514-3802; Cordenonsi, Michelangelo/0000-0002-8253-5724; Mamidi, Anant/0000-0001-7953-7991; Martello, Graziano/0000-0001-5520-085X; Dupont, Sirio/0000-0002-6869-1966; PICCOLO, STEFANO/0000-0002-2037-0004	TELETHON-Italy [GGP07218]; Cariparo Foundation Excellence Grant, ASI; Swissbridge; AIRC; Marie Curie Epiplast Carcinoma RTN; NIH [CA095875]; SFAz [CAA0285-08]; EU [LSH-CT-2003-503496]; NATIONAL CANCER INSTITUTE [R01CA095875] Funding Source: NIH RePORTER	TELETHON-Italy(Fondazione Telethon); Cariparo Foundation Excellence Grant, ASI(Agenzia Spaziale Italiana (ASI)); Swissbridge; AIRC(Fondazione AIRC per la ricerca sul cancro); Marie Curie Epiplast Carcinoma RTN(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SFAz; EU(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to Caroline Hill for thoughtful discussions. We are grateful to S. Wood, K. Kaibuchi, F. Francis, A. Moustakas, P. Ten Dijke, C. Hill, M. Brattain, J. Massague, and C. Chang for gifts of reagents and Angela Bachi for comments. A special thanks to Anna Cabrelle for technical assistance with the FACS. Thanks to Oliver Wessely and Giorgio Bressan for reading the manuscript. We are also grateful to Chemical Computing Group and in particular to Dr. Andrea Bortolato for his assistance in molecular modeling. This work is supported by TELETHON-Italy (GGP07218), Cariparo Foundation Excellence Grant, ASI, and Swissbridge grants (to S. P.), and by an AIRC grant (to S. D.). A. M. is recipient of a Marie Curie Epiplast Carcinoma RTN network fellowship. S.J.N. is supported by the NIH (grant CA095875) and SFAz (grant CAA0285-08); F. A. is supported by EU grant LSH-CT-2003-503496.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)02130-4; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; De Bosscher K, 2004, BIOCHEM J, V379, P209, DOI 10.1042/BJ20031886; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Heldin CH, 2006, DEV CELL, V10, P685, DOI 10.1016/j.devcel.2006.05.006; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hudson JB, 1998, DEVELOPMENT, V125, P1407; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; KONIKOFF EC, 2008, J MOL EVOL IN PRESS, DOI DOI 10.1007/S00239-008-9159-4; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Marquez RM, 2001, GENETICS, V157, P1639; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pinho S, 2007, DIFFERENTIATION, V75, P957, DOI 10.1111/j.1432-0436.2007.00185.x; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Wang J, 2004, J BIOL CHEM, V279, P40237, DOI 10.1074/jbc.M401665200; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Zhou SB, 1998, P NATL ACAD SCI USA, V95, P2412, DOI 10.1073/pnas.95.5.2412	36	386	397	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					123	135		10.1016/j.cell.2008.10.051	http://dx.doi.org/10.1016/j.cell.2008.10.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135894	Bronze			2022-12-01	WOS:000262318400020
J	Mayo, MJ				Mayo, Merrilea J.			Video Games: A Route to Large-Scale STEM Education?	SCIENCE			English	Editorial Material									[Mayo, Merrilea J.] Ewing Marion Kauffman Fdn, Kansas City, MO 64110 USA		Mayo, MJ (corresponding author), Ewing Marion Kauffman Fdn, 4801 Rockhill Rd, Kansas City, MO 64110 USA.	mmayo@kauffman.org						Barab S, 2005, ETR&D-EDUC TECH RES, V53, P86, DOI 10.1007/BF02504859; Barab S, 2007, SCI EDUC, V91, P750, DOI 10.1002/sce.20217; Begg M., 2005, INNOVATE J ONLINE ED, V1; Bloom B.S., 1956, HDB 1 COGNITIVE DOMA; BOWER J, 2008, GRANTM ED ANN M BALT; Bransford JD., 2000, PEOPLE LEARN BRAIN M; COLLER BD, 2006, SER GAM SUMM WASH DC; Druckman DE, 1994, LEARNING REMEMBERING; Gee JP, 2003, WHAT VIDEO GAMES HAVE TO TEACH US ABOUT LEARNING AND LITERACY, P1; GRAESSER AC, 1994, AM EDUC RES J, V31, P104, DOI 10.3102/00028312031001104; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Hays R., 2005, 2005004 NAV AIR WARF; Hewitt Nancy M., 1997, TALKING LEAVING; Hutchison D, 2007, BRIT J EDUC TECHNOL, V38, P977, DOI 10.1111/j.1467-8535.2006.00686.x; JOHNSON DW, 1981, PSYCHOL BULL, V89, P47, DOI 10.1037/0033-2909.89.1.47; Kebritchi M., 2008, THESIS U CENTRAL FLO; KEBRITCHI M, EFFECTS MODERN MATH; Ketelhut D. J., 2006, 2006 AERA ANN M SAN; Kukich K, 2000, COMPARING VALIDITY A; McClean P, 2001, SELECTED PAPERS FROM THE 12TH INTERNATIONAL CONFERENCE ON COLLEGE TEACHING AND LEARNING, P111; *NAT SCI BOARD, 2008, NSF SCI ENG IND 2008; Oblinger D. G., 2004, J INTERACTIVE MEDIA, V8; Peck AC, 2000, HUM FACTORS, V42, P379, DOI 10.1518/001872000779698150; Ryan RM, 2006, MOTIV EMOTION, V30, P347, DOI 10.1007/s11031-006-9051-8; Sax L.J., 2001, AM FRESHMAN NATL NOR; Squire K, 2004, ICLS2004: INTERNATIONAL CONFERENCE OF THE LEARNING SCIENCES, PROCEEDINGS, P513; Vogel J. J., 2006, Journal of Educational Computing Research, V34, P229, DOI 10.2190/FLHV-K4WA-WPVQ-H0YM; Willinsky J, 2009, SCIENCE, V323, P39, DOI 10.1126/science.1167970	28	182	187	10	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					79	82		10.1126/science.1166900	http://dx.doi.org/10.1126/science.1166900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	389OL	19119223				2022-12-01	WOS:000262104100043
J	Dwyer, DJ; Kohanski, MA; Collins, JJ				Dwyer, Daniel J.; Kohanski, Michael A.; Collins, James J.			Networking Opportunities for Bacteria	CELL			English	Editorial Material							TRANSCRIPTIONAL REGULATION; ESCHERICHIA-COLI; CELL-CYCLE; CIRCUIT; MOTIFS	In this post-genomic era, our capacity to explore biological networks and predict network architectures has been greatly expanded, accelerating interest in systems biology. Here, we highlight recent systems biology studies in prokaryotes, consider the challenges ahead, and suggest opportunities for future studies in bacterial models.	[Dwyer, Daniel J.; Kohanski, Michael A.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Ctr BioDynam, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Dwyer, Daniel J.; Kohanski, Michael A.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Ctr BioDynam, Dept Biomed Engn, Boston, MA 02215 USA; [Kohanski, Michael A.; Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University; Howard Hughes Medical Institute; Boston University; Howard Hughes Medical Institute; Boston University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Ctr BioDynam, Ctr Adv Biotechnol, Boston, MA 02215 USA.	jcollins@engc.bu.edu			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIH HHS [DP1 OD003644, DP1 OD003644-02] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedberg E.C., 2006, DNA REPAIR MUTAGENES; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Shapiro L, 1997, SCIENCE, V276, P712, DOI 10.1126/science.276.5313.712; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018	15	15	16	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1153	1156		10.1016/j.cell.2008.12.016	http://dx.doi.org/10.1016/j.cell.2008.12.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109881	Green Accepted, Bronze			2022-12-01	WOS:000261989800001
J	Hitomi, JI; Christofferson, DE; Ng, A; Yao, JH; Degterev, A; Xavier, RJ; Yuan, JY				Hitomi, Junichi; Christofferson, Dana E.; Ng, Aylwin; Yao, Jianhua; Degterev, Alexei; Xavier, Ramnik J.; Yuan, Junying			Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death Pathway	CELL			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; NEGATIVE REGULATOR; L929 CELLS; APOPTOSIS; PROTEIN; DATABASE; DOMAIN; RIP1; CYLD	Stimulation of death receptors by agonists such as FasL and TNF alpha activates apoptotic cell death in apoptotic-competent conditions or a type of necrotic cell death dependent on RIP1 kinase, termed necroptosis, in apoptotic-deficient conditions. In a genomewide siRNA screen for regulators of necroptosis, we identify a set of 432 genes that regulate necroptosis, a subset of 32 genes that act downstream and/or as regulators of RIP1 kinase, 32 genes required for death-receptor-mediated apoptosis, and 7 genes involved in both necroptosis and apoptosis. We show that the expression of subsets of the 432 genes is enriched in the immune and nervous systems, and cellular sensitivity to necroptosis is regulated by an extensive signaling network mediating innate immunity. Interestingly, Bmf, a BH3-only Bcl-2 family member, is required for death-receptor-induced necroptosis. Our study defines a cellular signaling network that regulates necroptosis and the molecular bifurcation that controls apoptosis and necroptosis.	[Hitomi, Junichi; Christofferson, Dana E.; Yao, Jianhua; Degterev, Alexei; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	Ng, Aylwin/AAQ-6478-2020		National Institute of Health [DP1OD000580]; National Institute on Aging [R37 AG012859-14]; National Institute on Neurological Disorders and Stroke [U01NS050560]; NIH Director's Pioneer Award; National Institute of Allergy and Infectious Diseases [AI062773, DK43351]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation; Japan Society for Promotion of Science; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS050560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012859, R37AG012859] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000580] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dodzie Sogah, Marta Lipinski, and Caroline Yi for helpful comments on this manuscript. We are grateful for the support of Caroline Shamu, Stewart Rudnicki, Sean Johnston, and David Wrobel at the ICCB Longwood Facility during screening. We thank S. C. Sun (University of Texas, M. D. Anderson Cancer Center) and J. Blenis (Harvard Medical School) for CYLD antibody and FADD def Jurkat cells, respectively. This work was supported in part by grants from the National Institute of Health (DP1OD000580), the National Institute on Aging (R37 AG012859-14), the National Institute on Neurological Disorders and Stroke (U01NS050560), NIH Director's Pioneer Award (to J.Y.), and the National Institute of Allergy and Infectious Diseases (AI062773) and DK43351 (to R. J. X.). J. H. was supported in part by fellowships from the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Uehara Memorial Foundation, and the Japan Society for Promotion of Science. A.N. is a recipient of a Fellowship Award from the Crohn's and Colitis Foundation of America.	Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Fiers W., 1995, Journal of Inflammation, V47, P67; Fukushima K, 2004, ARCH BIOCHEM BIOPHYS, V426, P298, DOI 10.1016/j.abb.2004.02.028; Grimm S, 1996, P NATL ACAD SCI USA, V93, P10923, DOI 10.1073/pnas.93.20.10923; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hijikata A, 2007, BIOINFORMATICS, V23, P2934, DOI 10.1093/bioinformatics/btm430; Hildt E, 1999, J EXP MED, V189, P1707, DOI 10.1084/jem.189.11.1707; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Holmes SE, 2001, NAT GENET, V29, P377, DOI 10.1038/ng760; Horan K, 2008, PLANT PHYSIOL, V147, P41, DOI 10.1104/pp.108.117366; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Kalai M, 2002, CELL DEATH DIFFER, V9, P981, DOI 10.1038/sj.cdd.4401051; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kim JW, 2000, J CELL SCI, V113, P955; Kurth I, 2006, BIOCHEM J, V393, P277, DOI 10.1042/BJ20051094; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Simonson SJS, 2007, DEV CELL, V13, P601, DOI 10.1016/j.devcel.2007.10.009; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu XS, 2007, J NEUROCHEM, V103, P2004, DOI 10.1111/j.1471-4159.2007.04884.x; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	49	741	780	4	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1311	1323		10.1016/j.cell.2008.10.044	http://dx.doi.org/10.1016/j.cell.2008.10.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109899	Bronze, Green Accepted			2022-12-01	WOS:000261989800021
J	Zalts, R; Hayek, T				Zalts, Ronen; Hayek, Tony			Postpartum Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zalts, Ronen; Hayek, Tony] Rambam Med Ctr, IL-31096 Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology	Zalts, R (corresponding author), Rambam Med Ctr, IL-31096 Haifa, Israel.	r_zalts@rambam.health.gov.il							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2706	2706		10.1056/NEJMicm065130	http://dx.doi.org/10.1056/NEJMicm065130			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092155				2022-12-01	WOS:000261757300010
J	Schroder, FH; Roach, M; Scardino, P				Schroder, Fritz H.; Roach, Mack, III; Scardino, Peter			Management of Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; NOMOGRAM; BRACHYTHERAPY; SURVIVAL; THERAPY; MEN		[Schroder, Fritz H.] Erasmus Univ, Med Ctr, Dept Urol, Rotterdam, Netherlands; [Roach, Mack, III] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Scardino, Peter] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA	Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center	Schroder, FH (corresponding author), Erasmus Univ, Med Ctr, Dept Urol, Rotterdam, Netherlands.							Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Albertsen PC, 2007, J UROLOGY, V177, P932, DOI 10.1016/j.juro.2006.10.051; Arlen PM, 2008, J UROLOGY, V179, P2181, DOI 10.1016/j.juro.2008.01.099; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Karakiewicz PI, 1998, UROLOGY, V52, P1041, DOI 10.1016/S0090-4295(98)00350-1; Kattan MW, 2003, J UROLOGY, V170, P1792, DOI 10.1097/01.ju.0000091806.70171.41; Klotz L, 2007, NAT CLIN PRACT ONCOL, V4, P692, DOI 10.1038/ncponc0966; Liauw SL, 2006, INT J RADIAT ONCOL, V66, P669, DOI 10.1016/j.ijrobp.2006.05.016; Merrick GS, 2004, UROLOGY, V64, P754, DOI 10.1016/j.urology.2004.04.054; Moon K, 2006, CANCER-AM CANCER SOC, V107, P991, DOI 10.1002/cncr.22083; Parker C, 2004, LANCET ONCOL, V5, P101, DOI 10.1016/S1470-2045(04)01384-1; Pickett B, 2006, INT J RADIAT ONCOL, V65, P65, DOI 10.1016/j.ijrobp.2005.11.037; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683	17	17	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2605	2609						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073981				2022-12-01	WOS:000261534200016
J	Jeziorski, A; Yan, ND; Paterson, AM; DeSellas, AM; Turner, MA; Jeffries, DS; Keller, B; Weeber, RC; McNicol, DK; Palmer, ME; McIver, K; Arseneau, K; Ginn, BK; Cumming, BF; Smol, JP				Jeziorski, Adam; Yan, Norman D.; Paterson, Andrew M.; DeSellas, Anna M.; Turner, Michael A.; Jeffries, Dean S.; Keller, Bill; Weeber, Russ C.; McNicol, Don K.; Palmer, Michelle E.; McIver, Kyle; Arseneau, Kristina; Ginn, Brian K.; Cumming, Brian F.; Smol, John P.			The Widespread Threat of Calcium Decline in Fresh Waters	SCIENCE			English	Article							SOUTH-CENTRAL ONTARIO; CRUSTACEAN ZOOPLANKTON; FORESTED CATCHMENTS; UNITED-STATES; NEW-YORK; LAKES; ACIDIFICATION; CANADA; ASSEMBLAGES; DEPOSITION	Calcium concentrations are now commonly declining in softwater boreal lakes. Although the mechanisms leading to these declines are generally well known, the consequences for the aquatic biota have not yet been reported. By examining crustacean zooplankton remains preserved in lake sediment cores, we document near extirpations of calcium- rich Daphnia species, which are keystone herbivores in pelagic food webs, concurrent with declining lake- water calcium. A large proportion ( 62%, 47 to 81% by region) of the Canadian Shield lakes we examined has a calcium concentration approaching or below the threshold at which laboratory Daphnia populations suffer reduced survival and fecundity. The ecological impacts of environmental calcium loss are likely to be both widespread and pronounced.	[Jeziorski, Adam; DeSellas, Anna M.; McIver, Kyle; Arseneau, Kristina; Ginn, Brian K.; Cumming, Brian F.; Smol, John P.] Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; [Yan, Norman D.; Palmer, Michelle E.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Yan, Norman D.; Paterson, Andrew M.; DeSellas, Anna M.] Ontario Minist Environm, Dorset Environm Sci Ctr, Dorset, ON P0A 1E0, Canada; [Turner, Michael A.] Fisheries & Oceans Canada, Expt Lakes Area, Winnipeg, MB R3T 2N6, Canada; [Jeffries, Dean S.] Environm Canada, Natl Water Res Inst, Burlington, ON L7R 4A6, Canada; [Keller, Bill] Laurentian Univ, Ontario Minist Environm, Cooperat Freshwater Ecol Unit, Sudbury, ON P3E 2C6, Canada; [Weeber, Russ C.; McNicol, Don K.] Environm Canada, Canadian Wildlife Serv, Ottawa, ON K1A 0H3, Canada	Queens University - Canada; York University - Canada; Fisheries & Oceans Canada; Environment & Climate Change Canada; National Water Research Institute; Laurentian University; Environment & Climate Change Canada; Canadian Wildlife Service	Smol, JP (corresponding author), Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada.	smolj@queensu.ca	Keller, Wendel/G-1533-2012; Yan, Norman/H-5235-2013; Jeziorski, Adam/AAJ-6982-2020; Smol, John P/A-8838-2015	Jeziorski, Adam/0000-0001-7701-7247; Smol, John/0000-0002-2499-6696; Yan, Norman/0000-0003-4870-6865	Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of the Environment; Environment Canada; Fisheries and Oceans Canada; School of Environmental Systems Engineering; University of Western Australia	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of the Environment; Environment Canada(CGIAR); Fisheries and Oceans Canada; School of Environmental Systems Engineering; University of Western Australia	This work was primarily supported by grants from the Natural Sciences and Engineering Research Council of Canada, as well as funding from the Ontario Ministry of the Environment, Environment Canada, and Fisheries and Oceans Canada. We thank the latter three agencies for the data used to develop Fig. 4. N. D. Y. thanks the School of Environmental Systems Engineering from the University of Western Australia for their support. We would also like to thank D. Schindler and S. Watmough for their valuable comments on this manuscript.	Ashforth D, 2008, LIMNOL OCEANOGR, V53, P420, DOI 10.4319/lo.2008.53.2.0420; Battarbee Richard W., 1999, P85; CHAN C, 2004, THESIS QUEENS U; CHARLES DF, 1987, BIOGEOCHEMISTRY, V3, P267, DOI 10.1007/BF02185196; Clair T.A., 2001, 16 ENV CAN; Cyr H, 1999, OECOLOGIA, V118, P306, DOI 10.1007/s004420050731; DeSellas AM, 2008, HYDROBIOLOGIA, V600, P105, DOI 10.1007/s10750-007-9180-4; Driscoll CT, 2003, ENVIRON SCI TECHNOL, V37, P2036, DOI 10.1021/es020924h; Ginn BK, 2007, CAN J FISH AQUAT SCI, V64, P1043, DOI 10.1139/F07-078; GLIWICZ ZM, 1990, NATURE, V343, P638, DOI 10.1038/343638a0; Hall RI, 1996, CAN J FISH AQUAT SCI, V53, P1, DOI 10.1139/cjfas-53-1-1; HAVENS KE, 1993, ENVIRON SCI TECHNOL, V27, P1621, DOI 10.1021/es00045a019; Houle D, 2006, CAN J FISH AQUAT SCI, V63, P471, DOI 10.1139/f06-007; Huntington TG, 2000, SOIL SCI SOC AM J, V64, P1845, DOI 10.2136/sssaj2000.6451845x; JEFFRIES DS, 2004, 2004 CANADIAN ACID D, pCH6; Jeziorski A, 2006, CAN J FISH AQUAT SCI, V63, P1007, DOI 10.1139/F06-019; Keller W, 2001, CAN J FISH AQUAT SCI, V58, P2011, DOI 10.1139/cjfas-58-10-2011; KIRCHNER JW, 1995, ENVIRON SCI TECHNOL, V29, P1953, DOI 10.1021/es00008a012; Korhola A, 2001, TRACKING ENV CHANGE, P5, DOI DOI 10.1007/0-306-47671-1_2; LEIBOLD MA, 1989, AM NAT, V134, P922, DOI 10.1086/285022; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; MacRae PSD, 2001, CAN J FISH AQUAT SCI, V58, P342, DOI 10.1139/cjfas-58-2-342; Norton S.A., 2003, TREATISE GEOCHEMISTR, V9, P367, DOI [10.1016/B0-08-043751-6/09052-6, DOI 10.1016/B0-08-043751-6/09052-6]; Skjelkvale BL, 2005, ENVIRON POLLUT, V137, P165, DOI 10.1016/j.envpol.2004.12.023; Smol J., 2009, POLLUTION LAKES RIVE; Stoddard JL, 1999, NATURE, V401, P575, DOI 10.1038/44114; Watmough SA, 2005, ENVIRON MONIT ASSESS, V109, P1, DOI 10.1007/s10661-005-4336-z; Watmough SA, 2003, CAN J FISH AQUAT SCI, V60, P1095, DOI [10.1139/f03-093, 10.1139/F03-093]; Watmough SA, 2008, CAN J FISH AQUAT SCI, V65, P821, DOI 10.1139/F07-196; YARI ND, 2008, CAN J FISH AQUAT SCI, V65, P862	30	236	247	5	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1374	1377		10.1126/science.1164949	http://dx.doi.org/10.1126/science.1164949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039134				2022-12-01	WOS:000261170600037
J	Hovhannisyan, Z; Weiss, A; Martin, A; Wiesner, M; Tollefsen, S; Yoshida, K; Ciszewski, C; Curran, SA; Murray, JA; David, CS; Sollid, LM; Koning, F; Teyton, L; Jabri, B				Hovhannisyan, Zaruhi; Weiss, Angela; Martin, Alexandra; Wiesner, Martina; Tollefsen, Stig; Yoshida, Kenji; Ciszewski, Cezary; Curran, Shane A.; Murray, Joseph A.; David, Chella S.; Sollid, Ludvig M.; Koning, Frits; Teyton, Luc; Jabri, Bana			The role of HLA-DQ8 beta 57 polymorphism in the anti-gluten T-cell response in coeliac disease	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II MOLECULES; SMALL-INTESTINAL MUCOSA; GLIADIN; SUSCEPTIBILITY; RECOGNITION; REPERTOIRE; PEPTIDES; MOUSE; GENE	Major histocompatibility complex ( MHC) class II alleles HLA-DQ8 and the mouse homologue I-A(g7) lacking a canonical aspartic acid residue at position beta 57 are associated with coeliac disease(1,2) and type I diabetes(3,4). However, the role of this single polymorphism in disease initiation and progression remains poorly understood. The lack of Asp 57 creates a positively charged P9 pocket, which confers a preference for negatively charged peptides. Gluten lacks such peptides, but tissue transglutaminase ( TG2) introduces negatively charged residues at defined positions into gluten T- cell epitopes by deamidating specific glutamine residues(5,6) on the basis of their spacing to proline residues(7). The commonly accepted model, proposing that HLA-DQ8 simply favours binding of negatively charged peptides, does not take into account the fact that TG2 requires inflammation for activation(8) and that T- cell responses against native gluten peptides are found(9,10), particularly in children(11). Here we show that beta 57 polymorphism promotes the recruitment of T- cell receptors bearing a negative signature charge in the complementary determining region 3 beta (CDR3 beta) during the response against native gluten peptides presented by HLA-DQ8 in coeliac disease. These T cells showed a crossreactive and heteroclitic ( stronger) response to deamidated gluten peptides. Furthermore, gluten peptide deamidation extended the T- cell- receptor repertoire by relieving the requirement for a charged residue in CDR3 beta. Thus, the lack of a negative charge at position beta 57 in MHC class II was met by negatively charged residues in the T- cell receptor or in the peptide, the combination of which might explain the role of HLA-DQ8 in amplifying the T- cell response against dietary gluten.	[Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Weiss, Angela] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Wiesner, Martina; Koning, Frits] Leiden Univ, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands; [Tollefsen, Stig; Sollid, Ludvig M.] Natl Hosp Norway, Ctr Immune Regulat, Inst Immunol, N-0027 Oslo, Norway; [Yoshida, Kenji; Teyton, Luc] Scripps Res Inst, La Jolla, CA 92037 USA; [Murray, Joseph A.; David, Chella S.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, Inst Immunol, N-0027 Oslo, Norway	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Princeton University; Leiden University; Leiden University - Excl LUMC; University of Oslo; National Hospital Norway; Scripps Research Institute; Mayo Clinic; University of Oslo	Jabri, B (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu	Sollid, Ludvig/N-9691-2015	Sollid, Ludvig/0000-0001-8860-704X; murray, joseph/0000-0003-1941-9090; Koning, Frits/0000-0002-4007-5715	Digestive Disease Research Core Center of the University of Chicago [DK42086]; NIH [DK67180, DK55037]; Celiac Disease Consortium; EU MC-RTN [512385]; Research Council of Norway; University of Oslo; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055037, R01DK067180, P30DK042086] Funding Source: NIH RePORTER	Digestive Disease Research Core Center of the University of Chicago(University of Chicago); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Celiac Disease Consortium; EU MC-RTN; Research Council of Norway(Research Council of Norway); University of Oslo; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Sadegh-Nasseri for advice and discussion, and A. Bendelac and M. Mush for critical reading of the manuscript. This work was supported by the Digestive Disease Research Core Center of the University of Chicago (DK42086), NIH DK67180, DK55037, the Celiac Disease Consortium (F.K.), EU MC-RTN 512385 (M.W.), the Research Council of Norway (L.S.) and the University of Oslo (S.T.).	ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; Arden Bernhard, 1995, Immunogenetics, V42, P501; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; Bankovich AJ, 2004, MOL IMMUNOL, V40, P1033, DOI 10.1016/j.molimm.2003.11.016; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; BLANK U, 1993, EUR J IMMUNOL, V23, P3057, DOI 10.1002/eji.1830231203; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Chao CC, 1999, P NATL ACAD SCI USA, V96, P9299, DOI 10.1073/pnas.96.16.9299; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Jabri B, 2006, NAT CLIN PRACT GASTR, V3, P516, DOI 10.1038/ncpgasthep0582; LUNDIN KEA, 1994, HUM IMMUNOL, V41, P285, DOI 10.1016/0198-8859(94)90047-7; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Moustakas AK, 2000, INT IMMUNOL, V12, P1157, DOI 10.1093/intimm/12.8.1157; PLOSKI R, 1993, TISSUE ANTIGENS, V41, P173, DOI 10.1111/j.1399-0039.1993.tb01998.x; Quinn A, 2006, INT IMMUNOL, V18, P967, DOI 10.1093/intimm/dxl033; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; SOLINGER AM, 1979, J EXP MED, V150, P830, DOI 10.1084/jem.150.4.830; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; SPURKLAND A, 1992, HUM IMMUNOL, V35, P188, DOI 10.1016/0198-8859(92)90104-U; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, J IMMUNOL, V161, P1585; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; Yang Y, 1996, IMMUNITY, V4, P189, DOI 10.1016/S1074-7613(00)80683-4; Yu B, 2000, EUR J IMMUNOL, V30, P2497, DOI 10.1002/1521-4141(200009)30:9<2497::AID-IMMU2497>3.0.CO;2-J	30	69	78	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					534	538		10.1038/nature07524	http://dx.doi.org/10.1038/nature07524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037317	Green Accepted			2022-12-01	WOS:000261170500045
J	Li, C; Wu, XC; Rieppel, O; Wang, LT; Zhao, LJ				Li, Chun; Wu, Xiao-Chun; Rieppel, Olivier; Wang, Li-Ting; Zhao, Li-Jun			An ancestral turtle from the Late Triassic of southwestern China	NATURE			English	Article							CHELYDRA-SERPENTINA REPTILIA; ORIGIN; SHELL; HISTOLOGY; EVOLUTION; GUIZHOU; OSTEODERMS; AREA	The origin of the turtle body plan remains one of the great mysteries of reptile evolution. The anatomy of turtles is highly derived, which renders it difficult to establish the relationships of turtles with other groups of reptiles. The oldest known turtle, Proganochelys from the Late Triassic period of Germany(1), has a fully formed shell and offers no clue as to its origin. Here we describe a new 220- million- year- old turtle from China, somewhat older than Proganochelys, that documents an intermediate step in the evolution of the shell and associated structures. A ventral plastron is fully developed, but the dorsal carapace consists of neural plates only. The dorsal ribs are expanded, and osteoderms are absent. The new species shows that the plastron evolved before the carapace and that the first step of carapace formation is the ossification of the neural plates coupled with a broadening of the ribs. This corresponds to early embryonic stages of carapace formation in extant turtles, and shows that the turtle shell is not derived from a fusion of osteoderms. Phylogenetic analysis places the new species basal to all known turtles, fossil and extant. The marine deposits that yielded the fossils indicate that this primitive turtle inhabited marginal areas of the sea or river deltas.	[Li, Chun] Chinese Acad Sci, Lab Evolut Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Wu, Xiao-Chun] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Rieppel, Olivier] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; [Wang, Li-Ting] Geol Survey Guizhou Prov, Guiyang 550005, Peoples R China; [Zhao, Li-Jun] Zhejiang Museum Nat Hist, Hangzhou 310012, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Field Museum of Natural History (Chicago)	Li, C (corresponding author), Chinese Acad Sci, Lab Evolut Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	lichun@ivpp.ac.cn; xcwu@mus-nature.ca			Major Basic Research Projects [2006CB806400]; Ministry of Science and Technology of China; National Natural Science Foundation [40772015, 40121202]; Chinese Academy of Sciences; Canadian Museum of Nature [RS 34]; CAS/SAFEA International Partnership Program for Creative Research Teams	Major Basic Research Projects; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Canadian Museum of Nature; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	We thank Z. Tang for his help in collecting the specimens; J. Ding and H. Zhou for preparing the specimens; and W. Gao for taking the photos. C.L. and L.-T. W. were supported by the Major Basic Research Projects (2006CB806400) of the Ministry of Science and Technology of China, the National Natural Science Foundation (40772015, 40121202) of China (NNSFC) and a special grant for fossil excavation and preparation of the Chinese Academy of Sciences. X.-C.W. was supported by grants from the Canadian Museum of Nature (RS 34), NNSFC 40772015 and the CAS/SAFEA International Partnership Program for Creative Research Teams. O. R. was supported by a stipend from M. Tang.	GAFFNEY ES, 1990, B AM MUS NAT HIST, P5; Gilbert Scott F., 2008, P1; Gilbert SF, 2001, EVOL DEV, V3, P47, DOI 10.1046/j.1525-142x.2001.003002047.x; Jiang DY, 2005, ACTA GEOL SIN-ENGL, V79, P729; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2003, P ROY SOC LOND B BIO, V271, P1, DOI DOI 10.1098/RSPB.2003.2523); LEE MSY, 1993, SCIENCE, V261, P1716, DOI 10.1126/science.261.5129.1716; Lee MSY, 1996, NATURE, V379, P812, DOI 10.1038/379812a0; LERVRATCALVIAC V, 1986, AM J ANAT, V176, P437; Main RP, 2005, PALEOBIOLOGY, V31, P291, DOI 10.1666/0094-8373(2005)031[0291:TEAFOT]2.0.CO;2; MOSS ML, 1969, ACTA ANAT, V73, P510; Procter JB, 1922, P ZOOL SOC LOND, V1922, P483; REISZ RR, 1991, NATURE, V349, P324, DOI 10.1038/349324a0; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; Rieppel O, 1996, NATURE, V384, P453, DOI 10.1038/384453a0; RIEPPEL O, 1993, J ZOOL, V231, P487, DOI 10.1111/j.1469-7998.1993.tb01933.x; Scheyer TM, 2004, J VERTEBR PALEONTOL, V24, P874, DOI 10.1671/0272-4634(2004)024[0874:HOAOIF]2.0.CO;2; Scheyer TM, 2008, J MORPHOL, V269, P1008, DOI 10.1002/jmor.10637; Scheyer TM, 2007, P ROY SOC B-BIOL SCI, V274, P1885, DOI 10.1098/rspb.2007.0499; Sheil CA, 2005, J ZOOL, V265, P235, DOI 10.1017/S0952836904006296; Sheil CA, 2003, J MORPHOL, V256, P42, DOI 10.1002/jmor.10074; Versluys J., 1914, Palaeontologische Zeitschrift, V1; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; Wang LT, 2001, ACTA GEOL SIN-ENGL, V75, P349; Wang XF, 2008, PALAEONTOLOGY, V51, P27, DOI 10.1111/j.1475-4983.2007.00735.x; Wang XF, 2006, LETHAIA, V39, P187, DOI 10.1080/00241160600715321; Weber A, 1945, MON PSYCHIATR NEUROL, V111, P144; YNTEMA CL, 1968, J MORPHOL, V125, P219, DOI 10.1002/jmor.1051250207; Zangerl R, 1939, J MORPHOL, V65, P383, DOI 10.1002/jmor.1050650302; ZYLBERBERG L, 1985, J MORPHOL, V186, P327, DOI 10.1002/jmor.1051860309	30	243	259	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					497	501		10.1038/nature07533	http://dx.doi.org/10.1038/nature07533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037315				2022-12-01	WOS:000261170500037
J	Lameire, N; Van Biesen, W; Vanholder, R				Lameire, Norbert; Van Biesen, Wim; Vanholder, Raymond			Acute kidney injury	LANCET			English	Editorial Material							RENAL REPLACEMENT THERAPY; INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; SODIUM-BICARBONATE; SEPTIC SHOCK; PREVENTION; MANAGEMENT; SEPSIS; AKI		[Lameire, Norbert; Van Biesen, Wim; Vanholder, Raymond] Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital	Lameire, N (corresponding author), Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium.	norbert.lameire@ugent.be						Adolph E, 2008, CORONARY ARTERY DIS, V19, P413, DOI 10.1097/MCA.0b013e3283021ac6; Annane D, 2007, LANCET, V370, P676, DOI 10.1016/S0140-6736(07)61344-0; Bouchard J, 2008, ADV CHRONIC KIDNEY D, V15, P235, DOI 10.1053/j.ackd.2008.04.004; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Kellum JA, 2008, NEPHROL DIAL TRANSPL, V23, P1471, DOI 10.1093/ndt/gfn012; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Maioli M, 2008, J AM COLL CARDIOL, V52, P599, DOI 10.1016/j.jacc.2008.05.026; Murray PT, 2008, CLIN J AM SOC NEPHRO, V3, P864, DOI 10.2215/CJN.04851107; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Perel P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub3; Preiser JC, 2007, INTENS CARE MED, V33, P570, DOI 10.1007/s00134-006-0485-y; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Sakr Y, 2006, CRIT CARE MED, V34, P589, DOI 10.1097/01.CCM.0000201896.45809.E3; Seabra VF, 2008, AM J KIDNEY DIS, V52, P272, DOI 10.1053/j.ajkd.2008.02.371; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Thomas G, 2007, NEPHROL DIAL TRANSPL, V22, P2849, DOI 10.1093/ndt/gfm401; Tolwani AJ, 2008, J AM SOC NEPHROL, V19, P1233, DOI 10.1681/ASN.2007111173; Treggiari MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6807; Tumlin J, 2008, J AM SOC NEPHROL, V19, P1034, DOI 10.1681/ASN.2007080895; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615	22	85	88	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1863	1865		10.1016/S0140-6736(08)61794-8	http://dx.doi.org/10.1016/S0140-6736(08)61794-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19041789				2022-12-01	WOS:000261388700007
J	Diehn, M; Cho, RW; Lobo, NA; Kalisky, T; Dorie, MJ; Kulp, AN; Qian, DL; Lam, JS; Ailles, LE; Wong, MZ; Joshua, B; Kaplan, MJ; Wapnir, I; Dirbas, FM; Somlo, G; Garberoglio, C; Paz, B; Shen, J; Lau, SK; Quake, SR; Brown, JM; Weissman, IL; Clarke, MF				Diehn, Maximilian; Cho, Robert W.; Lobo, Neethan A.; Kalisky, Tomer; Dorie, Mary Jo; Kulp, Angela N.; Qian, Dalong; Lam, Jessica S.; Ailles, Laurie E.; Wong, Manzhi; Joshua, Benzion; Kaplan, Michael J.; Wapnir, Irene; Dirbas, Frederick M.; Somlo, George; Garberoglio, Carlos; Paz, Benjamin; Shen, Jeannie; Lau, Sean K.; Quake, Stephen R.; Brown, J. Martin; Weissman, Irving L.; Clarke, Michael F.			Association of reactive oxygen species levels and radioresistance in cancer stem cells	NATURE			English	Article							OXIDATIVE STRESS; IONIZING-RADIATION; MAMMARY-GLAND; SELF-RENEWAL; PROGENITORS; DIFFERENTIATION; IDENTIFICATION; GLUTATHIONE; ENRICHMENT; BIOLOGY	The metabolism of oxygen, although central to life, produces reactive oxygen species (ROS) that have been implicated in processes as diverse as cancer, cardiovascular disease and ageing. It has recently been shown that central nervous system stem cells(1,2) and haematopoietic stem cells and early progenitors(3-6) contain lower levels of ROS than their more mature progeny, and that these differences are critical for maintaining stem cell function. We proposed that epithelial tissue stem cells and their cancer stem cell (CSC) counterparts may also share this property. Here we show that normal mammary epithelial stem cells contain lower concentrations of ROS than their more mature progeny cells. Notably, subsets of CSCs in some human and murine breast tumours contain lower ROS levels than corresponding non-tumorigenic cells (NTCs). Consistent with ROS being critical mediators of ionizing-radiation-induced cell killing(7,8), CSCs in these tumours develop less DNA damage and are preferentially spared after irradiation compared to NTCs. Lower ROS levels in CSCs are associated with increased expression of free radical scavenging systems. Pharmacological depletion of ROS scavengers in CSCs markedly decreases their clonogenicity and results in radiosensitization. These results indicate that, similar to normal tissue stem cells, subsets of CSCs in some tumours contain lower ROS levels and enhanced ROS defences compared to their non-tumorigenic progeny, which may contribute to tumour radioresistance.	[Diehn, Maximilian; Cho, Robert W.; Lobo, Neethan A.; Kulp, Angela N.; Qian, Dalong; Lam, Jessica S.; Ailles, Laurie E.; Wong, Manzhi; Weissman, Irving L.; Clarke, Michael F.] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Diehn, Maximilian; Dorie, Mary Jo; Brown, J. Martin] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Cho, Robert W.] Stanford Univ, Sch Med, Dept Pediat, Div Stem Cell Transplantat, Stanford, CA 94305 USA; [Joshua, Benzion; Kaplan, Michael J.] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Wapnir, Irene; Dirbas, Frederick M.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Clarke, Michael F.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Kalisky, Tomer; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kalisky, Tomer; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Somlo, George] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Garberoglio, Carlos; Paz, Benjamin; Shen, Jeannie] City Hope Natl Med Ctr, Dept Surg, Duarte, CA 91010 USA; [Lau, Sean K.] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; City of Hope; City of Hope; City of Hope	Clarke, MF (corresponding author), Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	mfclarke@stanford.edu		Bowman, Angela/0000-0003-0980-8586; Diehn, Maximilian/0000-0003-2032-0581	National Institutes of Health; Virginia and D. K. Ludwig Foundation; Breast Cancer Research Foundation; Machiah foundation; American Society for Therapeutic Radiology and Oncology; Radiological Society of North America; Leonard B. Holman Research Pathway fellowship; NATIONAL CANCER INSTITUTE [U54CA126524, R01CA100225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and D. K. Ludwig Foundation; Breast Cancer Research Foundation; Machiah foundation; American Society for Therapeutic Radiology and Oncology; Radiological Society of North America; Leonard B. Holman Research Pathway fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Spitz for helpful discussions and D. Menke, D. Rossi, and J. Seita for technical assistance. This work was supported by grants from the National Institutes of Health (M. F. C., G. S. and I. L. W.), the Virginia and D. K. Ludwig Foundation (M. F. C. and I. L. W.), the Breast Cancer Research Foundation (M. F. C.), the Machiah foundation (T. K.), the American Society for Therapeutic Radiology and Oncology (M. D.), and the Radiological Society of North America (M. D.). M. D. is a recipient of the Leonard B. Holman Research Pathway fellowship.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bailey HH, 1998, CHEM-BIOL INTERACT, V112, P239, DOI 10.1016/S0009-2797(97)00164-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Cohen-Jonathan E, 1999, CURR OPIN CHEM BIOL, V3, P77, DOI 10.1016/S1367-5931(99)80014-3; Dorie Mary Jo, 1999, Neoplasia (New York), V1, P461, DOI 10.1038/sj.neo.7900060; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; HAHN SM, 1994, CANCER RES, V54, pS2006; Hosokawa K, 2007, BIOCHEM BIOPH RES CO, V363, P578, DOI 10.1016/j.bbrc.2007.09.014; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; POWELL S, 1990, RADIOTHER ONCOL, V19, P95, DOI 10.1016/0167-8140(90)90123-E; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; WARD JF, 1985, RADIAT RES, V104, pS103, DOI 10.2307/3576637; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103	31	1752	1826	18	467	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					780	U123		10.1038/nature07733	http://dx.doi.org/10.1038/nature07733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19194462	Green Accepted			2022-12-01	WOS:000265193600045
J	Du, LQ; Ali, GS; Simons, KA; Hou, JG; Yang, TB; Reddy, ASN; Poovaiah, BW				Du, Liqun; Ali, Gul S.; Simons, Kayla A.; Hou, Jingguo; Yang, Tianbao; Reddy, A. S. N.; Poovaiah, B. W.			Ca2+/calmodulin regulates salicylic-acid-mediated plant immunity	NATURE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; CALMODULIN-BINDING PROTEIN; DISEASE-RESISTANCE; TRANSCRIPTIONAL REGULATION; HYPERSENSITIVE RESPONSE; ARABIDOPSIS-THALIANA; SIGNALING PATHWAYS; CELL-DEATH; DEFENSE; FAMILY	Intracellular calcium transients during plant-pathogen interactions are necessary early events leading to local and systemic acquired resistance(1). Salicylic acid, a critical messenger, is also required for both of these responses(2,3), but whether and how salicylic acid level is regulated by Ca2+ signalling during plant-pathogen interaction is unclear. Here we report a mechanism connecting Ca2+ signal to salicylic-acid-mediated immune response through calmodulin, AtSR1 (also known as CAMTA3), a Ca2+/calmodulin-binding transcription factor, and EDS1, an established regulator of salicylic acid level. Constitutive disease resistance and elevated levels of salicylic acid in loss-of-function alleles of Arabidopsis AtSR1 suggest that AtSR1 is a negative regulator of plant immunity. This was confirmed by epistasis analysis with mutants of compromised salicylic acid accumulation and disease resistance. We show that AtSR1 interacts with the promoter of EDS1 and represses its expression. Furthermore, Ca2+/calmodulin-binding to AtSR1 is required for suppression of plant defence, indicating a direct role for Ca2+/calmodulin in regulating the function of AtSR1. These results reveal a previously unknown regulatory mechanism linking Ca2+ signalling to salicylic acid level.	[Du, Liqun; Simons, Kayla A.; Yang, Tianbao; Poovaiah, B. W.] Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA; [Du, Liqun; Simons, Kayla A.; Yang, Tianbao; Poovaiah, B. W.] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Hou, Jingguo] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Ali, Gul S.; Reddy, A. S. N.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Ali, Gul S.; Reddy, A. S. N.] Colorado State Univ, Program Mol Plant Biol, Ft Collins, CO 80523 USA	Washington State University; Washington State University; Washington State University; Colorado State University; Colorado State University	Poovaiah, BW (corresponding author), Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA.	poovaiah@wsu.edu			United States Department of Agriculture [2002-00741, 2005-01107, 2008-01034]; National Science Foundation [MCB-0424898, MCB-0424895, DBI 0743097, IOS-0642146]; Colorado Sate University Academic Enrichment Program [180470]; Office of Naval Research [N0014-08-1-0470]; Washington State University Agricultural Research Center	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Colorado Sate University Academic Enrichment Program; Office of Naval Research(Office of Naval Research); Washington State University Agricultural Research Center	Constructs and transgenic lines produced in this research are available on request. This research was supported by United States Department of Agriculture grants 2002-00741, 2005-01107 and 2008-01034, National Science Foundation grants MCB-0424898, MCB-0424895, DBI 0743097 and IOS-0642146, Colorado Sate University Academic Enrichment Program grant 180470, Office of Naval Research N0014-08-1-0470 and the Washington State University Agricultural Research Center. We also thank I. Day for her comments on the manuscript and A. Mochel for her help in preparing the manuscript.	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Chen KG, 2003, PLANT MOL BIOL, V53, P61, DOI 10.1023/B:PLAN.0000009265.72567.58; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Du LQ, 2005, NATURE, V437, P741, DOI 10.1038/nature03973; Du LQ, 2004, PLANT MOL BIOL, V54, P549, DOI 10.1023/B:PLAN.0000038269.98972.bb; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Han JH, 2006, CELL, V127, P847, DOI 10.1016/j.cell.2006.09.030; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Hernandez JM, 2007, P NATL ACAD SCI USA, V104, P17222, DOI 10.1073/pnas.0705629104; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mauch F, 2001, PLANT J, V25, P67, DOI 10.1046/j.1365-313x.2001.00940.x; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Reddy ASN, 2000, BIOCHEM BIOPH RES CO, V279, P762, DOI 10.1006/bbrc.2000.4032; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; TIMMERMANS MCP, 1990, J BIOTECHNOL, V14, P333, DOI 10.1016/0168-1656(90)90117-T; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xing DH, 2006, PLANT SCI, V171, P251, DOI 10.1016/j.plantsci.2006.03.022; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Yang TB, 2000, J BIOL CHEM, V275, P38467, DOI 10.1074/jbc.M003566200; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819	40	364	413	8	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					1154	U116		10.1038/nature07612	http://dx.doi.org/10.1038/nature07612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19122675				2022-12-01	WOS:000263680100046
J	Salomon, R; Webster, RG				Salomon, Rachelle; Webster, Robert G.			The Influenza Virus Enigma	CELL			English	Review							A H5N1 VIRUSES; PANDEMIC INFLUENZA; INTERSPECIES TRANSMISSION; CYTOKINE RESPONSES; HIGH VIRULENCE; PROTECTS MICE; HEMAGGLUTININ; RESISTANT; INFECTION; COMPLEX	Both seasonal and pandemic influenza continue to challenge both scientists and clinicians. Drug-resistant H1N1 influenza viruses have dominated the 2009 flu season, and the H5N1 avian influenza virus continues to kill both people and poultry in Eurasia. Here, we discuss the pathogenesis and transmissibility of influenza viruses and we emphasize the need to find better predictors of both seasonal and potentially pandemic influenza.	[Salomon, Rachelle; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Webster, RG (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA.	robert.webster@stjude.org			NIAID NIH HHS [HHSN266200700005C] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belser JA, 2007, J INFECT DIS, V196, P1493, DOI 10.1086/522609; Budd A, 2007, ANTIMICROB AGENTS CH, V51, P2965, DOI 10.1128/AAC.00219-07; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Fedson DS, 2006, CLIN INFECT DIS, V43, P199, DOI 10.1086/505116; Fouchier RAM, 2003, VACCINE, V21, P1754, DOI 10.1016/S0264-410X(03)00067-7; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Ito T, 2000, MICROBIOL IMMUNOL, V44, P423, DOI 10.1111/j.1348-0421.2000.tb02516.x; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; LACKENBY A, 2008, EUROSURVEILLANCE, V13; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; LUDWIG S, 1995, VIROLOGY, V212, P555, DOI 10.1006/viro.1995.1513; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wang J, 2008, J VIROL, V82, P3405, DOI 10.1128/JVI.02468-07; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Watanabe T, 2008, J VIROL, V82, P2486, DOI 10.1128/JVI.01899-07; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	70	166	181	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					402	410		10.1016/j.cell.2009.01.029	http://dx.doi.org/10.1016/j.cell.2009.01.029			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203576	Bronze, Green Accepted			2022-12-01	WOS:000263120600011
J	Alio, AP; Nana, PN; Salihu, HM				Alio, Amina P.; Nana, Philip N.; Salihu, Hamisu M.			Spousal violence and potentially preventable single and recurrent spontaneous fetal loss in an African setting: cross-sectional study	LANCET			English	Article							INTIMATE PARTNER VIOLENCE; DOMESTIC VIOLENCE; WOMEN; OUTCOMES; MISCARRIAGE; PREVALENCE; STILLBIRTH; PREGNANCY; HEALTH; ABUSE	Background Spousal violence is a global issue, with ramifications for the reproductive health of women. We aimed to investigate the effect of physical, sexual, and emotional violence on potentially preventable single and recurrent spontaneous fetal loss. Methods We analysed data from the Cameroon Demographic Health Survey. In the violence module of this survey, women were questioned about their experience of physical, emotional, and sexual violence inflicted by their spouses. Respondents were also asked about any stillbirths and spontaneous abortions. We measured risk for single and recurrent fetal loss with odds ratios, with adjustment for intracluster correlations as appropriate. We also estimated the proportion of preventable excess fetal loss at various levels of violence reduction. Findings 2562 women responded to the violence module. Those exposed to spousal violence (n=1307) were 50% more likely to experience at least one episode of fetal loss compared with women not exposed to abuse (odds ratio 1.5; 95% CI 1. 3-1 . 8). Recurrent fetal mortality was associated with all forms of spousal violence, but emotional violence had the strongest association (1 . 7; 1 . 2-2.3). If the prevalence of spousal abuse could be reduced to 50%, 25%, or entirely eliminated, preventable excess recurrent fetal demise would be 17%, 25%, and 33%, respectively. Interpretation Spousal violence increases the likelihood of single and repeated fetal loss. A large proportion of risk for recurrent fetal mortality is attributable to spousal violence and, therefore, is potentially preventable. Our findings support the idea of routine prenatal screening for spousal violence in the African setting, a region with the highest rate of fetal death in the world. Funding None.	[Alio, Amina P.] Univ S Florida, Dept Community & Family Hlth, Tampa, FL 33612 USA; [Salihu, Hamisu M.] Univ S Florida, Dept Epidemiol & Biostat, Tampa, FL 33612 USA; [Salihu, Hamisu M.] Univ S Florida, Dept Obstet & Gynecol, Tampa, FL 33612 USA; [Nana, Philip N.] Univ Yaounde, Dept Obstet & Gynecol, Yaounde, Cameroon	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Yaounde I	Alio, AP (corresponding author), Univ S Florida, Dept Community & Family Hlth, 13201 Bruce B Downs Blvd,MDC 56, Tampa, FL 33612 USA.	aalio@health.usf.edu						ADJETEY FNA, 1995, RIGHTS WOM NAT INT L, P26; Bowman CG, 2003, INT J LAW PSYCHIAT, V26, P473, DOI 10.1016/S0160-2527(03)00082-7; Boy A, 2004, INT J FERTIL WOMEN M, V49, P159; Clayton D., 1993, STAT MODELS EPIDEMIO; Curry MA, 1998, OBSTET GYNECOL, V92, P530, DOI 10.1016/S0029-7844(98)00258-0; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Hadi A, 2000, J INTERPERS VIOLENCE, V15, P787, DOI 10.1177/088626000015008001; *INS ORC MACR, 2004, ENQ DEM SANT CAM 200; Janssen PA, 2003, AM J OBSTET GYNECOL, V188, P1341, DOI 10.1067/mob.2003.274; JOHNSON MP, 1995, J MARRIAGE FAM, V57, P283, DOI 10.2307/353683; Jones RF, 1997, INT J GYNECOL OBSTET, V58, P43, DOI 10.1016/S0020-7292(97)02863-4; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Morland LA, 2008, J INTERPERS VIOLENCE, V23, P652, DOI 10.1177/0886260507313533; PEARCE TO, 1995, CONCEIVING NEW WORLD, P195; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; RUBIN DB, 1996, J AM STAT ASSOC, V91, P473, DOI DOI 10.2307/2291635; Salihu HM, 2003, OBSTET GYNECOL, V102, P679, DOI 10.1016/S0029-7844(03)00768-3; Schroth HA, 2005, INT J CONFL MANAGE, V16, P102, DOI 10.1108/eb022925; Silverman JG, 2007, BJOG-INT J OBSTET GY, V114, P1246, DOI 10.1111/j.1471-0528.2007.01481.x; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Szklo M, 2007, EPIDEMIOLOGY BASICS; WALKER A, 2002, PSYCHOL SEXUAL HLTH; Watts C, 2004, INT FAM PLAN PERSPEC, V30, P207, DOI 10.1363/3020704; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; *WHO DEP RHR, 2000, MON EV REPR HLTH IND; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; [No title captured]	30	52	52	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2009	373	9660					318	324		10.1016/S0140-6736(09)60096-9	http://dx.doi.org/10.1016/S0140-6736(09)60096-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19167571				2022-12-01	WOS:000262728100027
J	Lee, SSJ; Mudaliar, A				Lee, Sandra Soo-Jin; Mudaliar, Ashwin			MEDICINE Racing Forward: The Genomics and Personalized Medicine Act	SCIENCE			English	Editorial Material							RACE; GENETICS		[Lee, Sandra Soo-Jin; Mudaliar, Ashwin] Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA	Stanford University	Lee, SSJ (corresponding author), Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA.	sandra.lee@stanford.edu		Lee, Sandra Soo-Jin/0000-0002-2312-9814	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389, K01HG002883] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003389, K01 HG002883, K01 HG002883-05] Funding Source: Medline; NHLBI NIH HHS [K01 HL72465] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; *KAIS FAM FDN, 2008, TOD TOP HLTH DISP RA; Lee SSJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-404; Lee SSJ, 2005, AM J PUBLIC HEALTH, V95, P2133, DOI 10.2105/AJPH.2005.068676; *PHARM RES MAN ASS, 2007, MED DEV MAJ DIS AFF; Rotimi CN, 2004, NAT GENET, V36, pS43, DOI 10.1038/ng1439; Royal CDM, 2004, NAT GENET, V36, pS5, DOI 10.1038/ng1454; Yancy CW, 2008, CURR HYPERTENS REP, V10, P276, DOI 10.1007/s11906-008-0052-8	8	23	25	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2009	323	5912					342	342		10.1126/science.1165768	http://dx.doi.org/10.1126/science.1165768			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150830	Green Accepted			2022-12-01	WOS:000262481400022
J	Hamdan, SM; Loparo, JJ; Takahashi, M; Richardson, CC; van Oijen, AM				Hamdan, Samir M.; Loparo, Joseph J.; Takahashi, Masateru; Richardson, Charles C.; van Oijen, Antoine M.			Dynamics of DNA replication loops reveal temporal control of lagging-strand synthesis	NATURE			English	Article							OKAZAKI FRAGMENT SYNTHESIS; BACTERIOPHAGE T7; SINGLE-MOLECULE; POLYMERASE; FORK; PRIMASE; PROCESSIVITY; PROTEINS; DISSOCIATION; EXTENSION	In all organisms, the protein machinery responsible for the replication of DNA, the replisome, is faced with a directionality problem. The antiparallel nature of duplex DNA permits the leading- strand polymerase to advance in a continuous fashion, but forces the lagging- strand polymerase to synthesize in the opposite direction. By extending RNA primers, the lagging- strand polymerase restarts at short intervals and produces Okazaki fragments(1,2).At least in prokaryotic systems, this directionality problem is solved by the formation of a loop in the lagging strand of the replication fork to reorient the lagging- strand DNA polymerase so that it advances in parallel with the leading- strand polymerase. The replication loop grows and shrinks during each cycle of Okazaki fragment synthesis(3). Here we use single- molecule techniques to visualize, in real time, the formation and release of replication loops by individual replisomes of bacteriophage T7 supporting coordinated DNA replication. Analysis of the distributions of loop sizes and lag times between loops reveals that initiation of primer synthesis and the completion of an Okazaki fragment each serve as a trigger for loop release. The presence of two triggers may represent a fail-safe mechanism ensuring the timely reset of the replisome after the synthesis of every Okazaki fragment.	[Hamdan, Samir M.; Loparo, Joseph J.; Takahashi, Masateru; Richardson, Charles C.; van Oijen, Antoine M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	van Oijen, AM (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	antoine_van_oijen@hms.harvard.edu	van Oijen, Antoine/I-3167-2014	van Oijen, Antoine/0000-0002-1794-5161; Hamdan, Samir/0000-0001-5192-1852	National Institutes of Health [GM-077248, GM-54397]; National Science Foundation [CAREER 0543784]; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077248, R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.-B. Lee for technical advice and S. Moskowitz for illustrations. This work was supported by the National Institutes of Health (grants GM-077248 to A.M.v.O. and GM-54397 to C.C.R.) and the National Science Foundation (CAREER grant 0543784 to A.M.v.O.). J.J.L. acknowledges the Jane Coffin Childs Memorial Fund for a postdoctoral fellowship.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Carver TE, 1997, BIOCHEMISTRY-US, V36, P14409, DOI 10.1021/bi971423p; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; De Saro FJL, 2003, P NATL ACAD SCI USA, V100, P14689, DOI 10.1073/pnas.2435454100; Frick DN, 1999, J BIOL CHEM, V274, P35899, DOI 10.1074/jbc.274.50.35899; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hyland EM, 2003, J BIOL CHEM, V278, P7247, DOI 10.1074/jbc.M210605200; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kusakabe T, 1997, J BIOL CHEM, V272, P12446, DOI 10.1074/jbc.272.19.12446; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; TABOR S, 1987, J BIOL CHEM, V262, P16212; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; WU CA, 1992, J BIOL CHEM, V267, P4074; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029	27	116	116	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					336	U9		10.1038/nature07512	http://dx.doi.org/10.1038/nature07512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19029884	Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000262440900044
J	Ainsworth, S; Jones, W				Ainsworth, Sean; Jones, Wendy			It sticks in our throats too	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ainsworth, Sean] Forth Pk Hosp, Kirkcaldy, Fife, Scotland; [Jones, Wendy] Breastfeeding Network, Paisley, Renfrew, Scotland		Ainsworth, S (corresponding author), Forth Pk Hosp, Kirkcaldy, Fife, Scotland.	sean.ainsworth@nhs.net						*DEP HLTH, NURS PRESCR FAQ; DEVRIES TW, 2006, NED TIDSCHR GENEESKD, V148, P1598; HEY E, 2007, NEONATAL FORMULARY, P158; Hoppe JE, 1997, PEDIATR INFECT DIS J, V16, P288, DOI 10.1097/00006454-199703000-00007; *JANSS CIL, DAKT OR GEL; *MED HEALTHC PROD, OUR MISS VAL	6	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 5	2009	338								a3178	10.1136/bmj.a3178	http://dx.doi.org/10.1136/bmj.a3178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PM	19124549				2022-12-01	WOS:000263165500004
J	Sheather, J				Sheather, Julian			Landscape and health	LANCET			English	Editorial Material									[Sheather, Julian] British Med Assoc, London WC1H 9JP, England		Sheather, J (corresponding author), British Med Assoc, London WC1H 9JP, England.	JSheather@bma.org.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 3	2009	373	9657					22	23		10.1016/S0140-6736(08)61943-1	http://dx.doi.org/10.1016/S0140-6736(08)61943-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SK	19125445	Green Submitted			2022-12-01	WOS:000262183800014
J	Whitney, HM; Kolle, M; Andrew, P; Chittka, L; Steiner, U; Glover, BJ				Whitney, Heather M.; Kolle, Mathias; Andrew, Piers; Chittka, Lars; Steiner, Ullrich; Glover, Beverley J.			Floral Iridescence, Produced by Diffractive Optics, Acts As a Cue for Animal Pollinators	SCIENCE			English	Article							ULTRAVIOLET SIGNAL; COLIAS-EURYTHEME; FLOWER COLOR; CELL-SHAPE; BUMBLEBEES; LIGHT; FLUORESCENCE; PREFERENCES; ANTIRRHINUM; BUTTERFLIES	Iridescence, the change in hue of a surface with varying observation angles, is used by insects, birds, fish, and reptiles for species recognition and mate selection. We identified iridescence in flowers of Hibiscus trionum and Tulipa species and demonstrated that iridescence is generated through diffraction gratings that might be widespread among flowering plants. Although iridescence might be expected to increase attractiveness, it might also compromise target identification because the object's appearance will vary depending on the viewer's perspective. We found that bumblebees (Bombus terrestris) learn to disentangle flower iridescence from color and correctly identify iridescent flowers despite their continuously changing appearance. This ability is retained in the absence of cues from polarized light or ultraviolet reflectance associated with diffraction gratings.	[Kolle, Mathias; Steiner, Ullrich] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Whitney, Heather M.; Glover, Beverley J.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Kolle, Mathias; Andrew, Piers; Steiner, Ullrich] Univ Cambridge, Nanosci Ctr, Cambridge CB3 0HE, England; [Chittka, Lars] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of Cambridge; University of Cambridge; University of Cambridge; University of London; Queen Mary University London	Steiner, U (corresponding author), Univ Cambridge, Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England.	u.steiner@phy.cam.ac.uk; bjg26@cam.ac.uk	Chittka, Lars/C-3110-2012; Kolle, Mathias/E-3313-2013; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Steiner, Ullrich/K-4777-2013; Andrew, Piers/F-8188-2013	Chittka, Lars/0000-0001-8153-1732; Kolle, Mathias/0000-0001-7395-8824; Steiner, Ullrich/0000-0001-5936-339X; Andrew, Piers/0000-0001-5601-5322	Natural Environment Research Council [NE/C000552/1]; Engineering and Physical Sciences Research Council [EP/D040884/1]; European RTN-6 Network Patterns; Cambridge University Research Exchange; German Academic Exchange Service DAAD; EPSRC [EP/D040884/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European RTN-6 Network Patterns; Cambridge University Research Exchange(University of Cambridge); German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Rands, P. Rudall, R. Bateman, P. Cicuta, and J. Baumberg for discussions and Syngenta for bees. Funded by Natural Environment Research Council grant NE/C000552/1, Engineering and Physical Sciences Research Council grant EP/D040884/1, the European RTN-6 Network Patterns, the Cambridge University Research Exchange, and German Academic Exchange Service DAAD.	CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; DAUMER K, 1958, Z VERGL PHYSIOL, V41, P49; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Gandia-Herrero F, 2005, NATURE, V437, P334, DOI 10.1038/437334a; Gorton HL, 1996, PLANT PHYSIOL, V112, P879, DOI 10.1104/pp.112.3.879; GREEN PB, 1990, PROTOPLASMA, V158, P33, DOI 10.1007/BF01323271; HEBANT C, 1984, AM J BOT, V71, P216, DOI 10.2307/2443748; Heuschen B, 2005, PLANT SYST EVOL, V252, P121, DOI 10.1007/s00606-004-0249-5; JOKIEL PL, 1984, LIMNOL OCEANOGR, V29, P192, DOI 10.4319/lo.1984.29.1.0192; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; Kemp DJ, 2007, P R SOC B, V274, P1043, DOI 10.1098/rspb.2006.0043; KETTLER JE, 1991, AM J PHYS, V59, P367, DOI 10.1119/1.16553; Kevan P. G., 1998, COLOR VISION PERSPEC, P163; KEVAN PG, 1976, SCIENCE, V194, P341, DOI 10.1126/science.194.4262.341; KEVAN PG, 1985, P NATL ACAD SCI USA, V82, P4750, DOI 10.1073/pnas.82.14.4750; Kevan PG, 2001, J EXP BIOL, V204, P2571; Morehouse NI, 2007, P ROY SOC B-BIOL SCI, V274, P359, DOI 10.1098/rspb.2006.3730; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Palmer C., 2014, DIFFRACTION GRATING; Parker AR, 2000, J OPT A-PURE APPL OP, V2, pR15, DOI 10.1088/1464-4258/2/6/201; Parker AR, 2003, J OPT A-PURE APPL OP, V5, pS111, DOI 10.1088/1464-4258/5/4/364; Prum RO, 2006, BIRD COLORATION, V1, P295; Rutowski RL, 2005, P ROY SOC B-BIOL SCI, V272, P2329, DOI 10.1098/rspb.2005.3216; Rutowski RL, 2007, BIOL J LINN SOC, V90, P349, DOI 10.1111/j.1095-8312.2007.00749.x; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Skorupski P, 2007, J COMP PHYSIOL A, V193, P485, DOI 10.1007/s00359-006-0206-6; Sweeney A, 2003, NATURE, V423, P31, DOI 10.1038/423031a; THORP RW, 1975, SCIENCE, V189, P476, DOI 10.1126/science.189.4201.476; VOGELMANN TC, 1993, ANNU REV PLANT PHYS, V44, P231, DOI 10.1146/annurev.pp.44.060193.001311; Whitney HM, 2008, NATURWISSENSCHAFTEN, V95, P845, DOI 10.1007/s00114-008-0393-9	30	262	276	10	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					130	133		10.1126/science.1166256	http://dx.doi.org/10.1126/science.1166256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119235				2022-12-01	WOS:000262104100058
J	Clare, DK; Bakkes, PJ; van Heerikhuizen, H; van der Vies, SM; Saibil, HR				Clare, D. K.; Bakkes, P. J.; van Heerikhuizen, H.; van der Vies, S. M.; Saibil, H. R.			Chaperonin complex with a newly folded protein encapsulated in the folding chamber	NATURE			English	Article							GROEL-GROES; ELECTRON-MICROSCOPY; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CENTRAL CAVITY; HEAD PROTEIN; BINDING; CAGE; ATP	A subset of essential cellular proteins requires the assistance of chaperonins (in Escherichia coli, GroEL and GroES), double-ring complexes in which the two rings act alternately to bind, encapsulate and fold a wide range of nascent or stress- denatured proteins(1-5). This process starts by the trapping of a substrate protein on hydrophobic surfaces in the central cavity of a GroEL ring(6-10). Then, binding of ATP and co- chaperonin GroES to that ring ejects the non- native protein from its binding sites, through forced unfolding or other major conformational changes, and encloses it in a hydrophilic chamber for folding(11-15). ATP hydrolysis and subsequent ATP binding to the opposite ring trigger dissociation of the chamber and release of the substrate protein(3). The bacteriophage T4 requires its own version of GroES, gp31, which forms a taller folding chamber, to fold the major viral capsid protein gp23 ( refs 16-20). Polypeptides are known to fold inside the chaperonin complex, but the conformation of an encapsulated protein has not previously been visualized. Here we present structures of gp23-chaperonin complexes, showing both the initial captured state and the final, close-to-native state with gp23 encapsulated in the folding chamber. Although the chamber is expanded, it is still barely large enough to contain the elongated gp23 monomer, explaining why the GroEL-GroES complex is not able to fold gp23 and showing how the chaperonin structure distorts to enclose a large, physiological substrate protein.	[Clare, D. K.; Saibil, H. R.] Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; [Clare, D. K.; Saibil, H. R.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Bakkes, P. J.; van Heerikhuizen, H.; van der Vies, S. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands	University of London; Birkbeck University London; University of London; Birkbeck University London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Saibil, HR (corresponding author), Univ London Birkbeck Coll, Dept Crystallog, Malet St, London WC1E 7HX, England.	vdvies@vumc.nl; h.saibil@mail.cryst.bbk.ac.uk		Clare, daniel/0000-0002-3372-8378; Bakkes, Patrick/0000-0003-1876-7384	Wellcome Trust programme; EU 3D EM Network of Excellence; 3D Repertoire	Wellcome Trust programme(Wellcome Trust); EU 3D EM Network of Excellence(European Commission); 3D Repertoire	We thank R. Westlake, D. Houldershaw and L. Wang for computing and EM support. This work was carried out at the School of Crystallography, Birkbeck College, and was supported by a Wellcome Trust programme grant, EU 3D EM Network of Excellence and 3D Repertoire grants.	Bakkes PJ, 2005, P NATL ACAD SCI USA, V102, P8144, DOI 10.1073/pnas.0500048102; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Clare DK, 2006, J MOL BIOL, V358, P905, DOI 10.1016/j.jmb.2006.02.033; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Elad N, 2008, J STRUCT BIOL, V162, P108, DOI 10.1016/j.jsb.2007.11.007; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Falke S, 2005, J MOL BIOL, V348, P219, DOI 10.1016/j.jmb.2005.02.027; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; LIN ZL, 1995, J BIOL CHEM, V270, P1011, DOI 10.1074/jbc.270.3.1011; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Motojima F, 2004, P NATL ACAD SCI USA, V101, P15005, DOI 10.1073/pnas.0406132101; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Snyder L, 2005, J MOL BIOL, V345, P375, DOI 10.1016/j.jmb.2004.10.052; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; van Duijn E, 2006, J AM CHEM SOC, V128, P4694, DOI 10.1021/ja056756l; van Duijn E, 2005, NAT METHODS, V2, P371, DOI 10.1038/nmeth753; Van Duijn E, 2007, PROTEIN SCI, V16, P956, DOI 10.1110/ps.062713607; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	36	76	77	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					107	U113		10.1038/nature07479	http://dx.doi.org/10.1038/nature07479			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122642	Green Accepted			2022-12-01	WOS:000262104900040
J	Falit, BP; Gross, CP				Falit, Benjamin P.; Gross, Cary P.			Access to Experimental Drugs for Terminally Ill Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Falit, Benjamin P.; Gross, Cary P.] Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, New Haven, CT 06520 USA; [Gross, Cary P.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA	Yale University; Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	cary.gross@yale.edu						DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Jacobson PD, 2007, JAMA-J AM MED ASSOC, V297, P205, DOI 10.1001/jama.297.2.205; Krohmal BJ, 2007, ARCH INTERN MED, V167, P433, DOI 10.1001/archinte.167.5.433; STGEORGE D, 2004, WASH POST       0118, pW10; 2006, FED REG, V71, P75147	5	21	21	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2008	300	23					2793	2795		10.1001/jama.2008.828	http://dx.doi.org/10.1001/jama.2008.828			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384FJ	19088356				2022-12-01	WOS:000261730400025
J	Clubb, R; Rowcliffe, M; Lee, P; Mar, KU; Moss, C; Mason, GJ				Clubb, Ros; Rowcliffe, Marcus; Lee, Phyllis; Mar, Khyne U.; Moss, Cynthia; Mason, Georgia J.			Compromised Survivorship in Zoo Elephants	SCIENCE			English	Article									[Mason, Georgia J.] Univ Guelph, Dept Anim Sci, Guelph, ON N1G 2M7, Canada; [Clubb, Ros] RSPCA, Southwater RH13 9RS, W Sussex, England; [Rowcliffe, Marcus; Mar, Khyne U.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Lee, Phyllis] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Lee, Phyllis; Moss, Cynthia] Amboseli Trust Elephants, Nairobi, Kenya; [Mar, Khyne U.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Guelph; Zoological Society of London; University of Stirling; University of Sheffield	Mason, GJ (corresponding author), Univ Guelph, Dept Anim Sci, Guelph, ON N1G 2M7, Canada.	gmason@uoguelph.ca	U Mar, Khyne/AAO-8806-2021; Rowcliffe, Marcus/G-3713-2018; Yon, Lisa K/G-4453-2011	Rowcliffe, Marcus/0000-0002-4286-6887; Yon, Lisa K/0000-0002-9765-3192; Lee, Phyllis/0000-0002-4296-3513	Natural Science and Engineering Research Council; Amboseli Elephant Trust; Prospect Burma Foundation; Charles Wallace Burma Trust; Three Oaks Foundation; Whitney- Laing Foundation ( Rufford Small Grants); Toyota Foundation, Fantham Memorial Research Scholarship; University College London	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Amboseli Elephant Trust; Prospect Burma Foundation; Charles Wallace Burma Trust; Three Oaks Foundation; Whitney- Laing Foundation ( Rufford Small Grants); Toyota Foundation, Fantham Memorial Research Scholarship; University College London(General Electric)	J. M. thanks the Natural Science and Engineering Research Council for funding; R. C. and G. J. M. thank R. Ripley for statistical advice; P. L. and C. M. thank many conservation nongovernmental organizations and private donors for supporting the Amboseli Elephant Trust; K. U. M. thanks colleagues at M. T. E. for data compilation and comments. G. J. M. is a visiting professor at The Royal Veterinary College, London, UK. K. U. M. has received funding from Prospect Burma Foundation, Charles Wallace Burma Trust, Three Oaks Foundation, Whitney- Laing Foundation ( Rufford Small Grants), Toyota Foundation, Fantham Memorial Research Scholarship, and University College London. K. U. M. has been a paid consultant for Woburn Safari Park, UK. G. J. M. has been a paid consultant to Disney's Animal Kingdom, USA.	Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; *EUR EL GROUP, 2002, EL ZOOS SAF EUR; Hutchins M, 2006, ZOO BIOL, V25, P219, DOI 10.1002/zoo.20102	4	108	110	6	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1649	1649		10.1126/science.1164298	http://dx.doi.org/10.1126/science.1164298			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074339	Green Submitted, Green Accepted			2022-12-01	WOS:000261608300033
J	Nordborg, M; Weigel, D				Nordborg, Magnus; Weigel, Detlef			Next-generation genetics in plants	NATURE			English	Article							QUANTITATIVE TRAIT LOCUS; GENOME-WIDE ASSOCIATION; ARABIDOPSIS-THALIANA; FLOWERING TIME; COMPLEX TRAITS; STRUCTURAL VARIATION; HAPLOTYPE MAP; MAIZE; DISEQUILIBRIUM; RECOMBINATION	Natural variation presents one of the fundamental challenges of modern biology. Soon, the genome sequences of thousands of individuals will be known for each of several species. But how does the genotypic variation that will be observed among these individuals translate into phenotypic variation? Plants are in many ways ideal for addressing this question, and resources that are unmatched, except in humans, have now been developed.	[Nordborg, Magnus] Univ So Calif, Los Angeles, CA 90089 USA; [Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	University of Southern California; Max Planck Society	Nordborg, M (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	magnus@usc.edu; weigel@weigelworld.org	Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Nordborg, Magnus/0000-0001-7178-9748	National Science Foundation; National Institutes of Health; German Research Foundation; German Federal Ministry of Education and Research; European Union's Sixth Framework Programme; Human Frontier Science Program; Max Planck Society	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union's Sixth Framework Programme; Human Frontier Science Program(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Studies of natural genetic variation are supported by the National Science Foundation and the National Institutes of Health (M.N.), and by the German Research Foundation, the German Federal Ministry of Education and Research, the European Union's Sixth Framework Programme, the Human Frontier Science Program and the Max Planck Society (D.W.).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; East EM, 1910, AM NAT, V44, P65, DOI 10.1086/279117; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Macquet A, 2007, PLANT CELL, V19, P3990, DOI 10.1105/tpc.107.050179; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mouchel CF, 2004, GENE DEV, V18, P700, DOI 10.1101/gad.1187704; Nilsson-Ehle H, 1909, LUNDS U AARSKR, V5, P1; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Sax K, 1923, GENETICS, V8, P552; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; YU J, 2006, NAT GENET, V38, P303; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	35	290	306	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					720	723		10.1038/nature07629	http://dx.doi.org/10.1038/nature07629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079047				2022-12-01	WOS:000261559900034
J	Cohen, AA; Geva-Zatorsky, N; Eden, E; Frenkel-Morgenstern, M; Issaeva, I; Sigal, A; Milo, R; Cohen-Saidon, C; Liron, Y; Kam, Z; Cohen, L; Danon, T; Perzov, N; Alon, U				Cohen, A. A.; Geva-Zatorsky, N.; Eden, E.; Frenkel-Morgenstern, M.; Issaeva, I.; Sigal, A.; Milo, R.; Cohen-Saidon, C.; Liron, Y.; Kam, Z.; Cohen, L.; Danon, T.; Perzov, N.; Alon, U.			Dynamic Proteomics of Individual Cancer Cells in Response to a Drug	SCIENCE			English	Article							PROTEIN EXPRESSION; INDUCED APOPTOSIS; GENE-EXPRESSION; SYSTEMS BIOLOGY; TOPOISOMERASE-I; GLOBAL ANALYSIS; BUDDING YEAST; SINGLE-CELL; NOISE; DNA	Why do seemingly identical cells respond differently to a drug? To address this, we studied the dynamics and variability of the protein response of human cancer cells to a chemotherapy drug, camptothecin. We present a dynamic- proteomics approach that measures the levels and locations of nearly 1000 different endogenously tagged proteins in individual living cells at high temporal resolution. All cells show rapid translocation of proteins specific to the drug mechanism, including the drug target ( topoisomerase- 1), and slower, wide- ranging temporal waves of protein degradation and accumulation. However, the cells differ in the behavior of a subset of proteins. We identify proteins whose dynamics differ widely between cells, in a way that corresponds to the outcomes- cell death or survival. This opens the way to understanding molecular responses to drugs in individual cells.	[Cohen, A. A.; Geva-Zatorsky, N.; Eden, E.; Frenkel-Morgenstern, M.; Issaeva, I.; Cohen-Saidon, C.; Liron, Y.; Kam, Z.; Cohen, L.; Danon, T.; Perzov, N.; Alon, U.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Sigal, A.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Milo, R.] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; California Institute of Technology; Weizmann Institute of Science	Issaeva, I (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	ariel.cohen@weizmann.ac.il	Geva-Zatorsky, Naama/AAP-9176-2021; Sigal, Alex/GWC-7488-2022	Geva-Zatorsky, Naama/0000-0002-7303-854X; Sigal, Alex/0000-0001-8571-2004; Milo, Ron/0000-0003-1641-2299; Frenkel-Morgenstern, Milana/0000-0002-0329-4599	Kahn Family Foundation; Israel Science Foundation; Yeshaya Horowitz Association; Center for Complexity Science	Kahn Family Foundation; Israel Science Foundation(Israel Science Foundation); Yeshaya Horowitz Association; Center for Complexity Science	We thank the Kahn Family Foundation and the Israel Science Foundation for support. We thank E. Zalckvar, J. Bar, I. Glinert, T. Shlapok, and members of the Alon laboratory for discussions. The work of M.F.-M. and E.E. is supported by the Yeshaya Horowitz Association through the Center for Complexity Science.	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Clyne PJ, 2003, GENETICS, V165, P1433; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Eggert US, 2006, CURR OPIN CHEM BIOL, V10, P232, DOI 10.1016/j.cbpa.2006.04.010; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jarvik JW, 1996, BIOTECHNIQUES, V20, P896; Jarvik JW, 2002, BIOTECHNIQUES, V33, P852, DOI 10.2144/02334rr02; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; MULLER MT, 1985, EMBO J, V4, P1237, DOI 10.1002/j.1460-2075.1985.tb03766.x; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Trinkle-Mulcahy L, 2007, SCIENCE, V318, P1402, DOI 10.1126/science.1142033; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Yang L, 2007, ONCOGENE, V26, P6082, DOI 10.1038/sj.onc.1210427; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	34	436	447	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1511	1516		10.1126/science.1160165	http://dx.doi.org/10.1126/science.1160165			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19023046	Green Accepted			2022-12-01	WOS:000261377400041
J	Raoult, D				Raoult, Didier			Creationism-remember the principle of falsifiability	LANCET			English	Editorial Material									[Raoult, Didier] Univ Aix Marseille 2, Fac Med, Marseille 05, France	UDICE-French Research Universities; Aix-Marseille Universite; Universite de Franche-Comte	Raoult, D (corresponding author), Univ Aix Marseille 2, Fac Med, Marseille 05, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Darwin C.R., 1877, DIFFERENT FORMS FLOW; Dawkins R., 1976, SELFISH GENE; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Kuhn Thomas S., 1962, STRUCTURE SCI REVOLU, V1st; Popper K, 2002, LOGIC SCI DISCOVERY, V2; Trivers R. L., 2006, GENES CONFLICT	6	3	4	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2095	2096		10.1016/S0140-6736(08)61904-2	http://dx.doi.org/10.1016/S0140-6736(08)61904-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386PB	19101368				2022-12-01	WOS:000261894000008
J	Yadav, VK; Ryu, JH; Suda, N; Tanaka, KF; Gingrich, JA; Schuetz, GN; Glorieux, FH; Chiang, CY; Zajac, JD; Insogna, KL; Mann, JJ; Hen, R; Ducy, P; Karsenty, G				Yadav, Vijay K.; Ryu, Je-Hwang; Suda, Nina; Tanaka, Kenji F.; Gingrich, Jay A.; Schuetz, Guenther; Glorieux, Francis H.; Chiang, Cherie Y.; Zajac, Jeffrey D.; Insogna, Karl L.; Mann, J. John; Hen, Rene; Ducy, Patricia; Karsenty, Gerard			Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum	CELL			English	Article							BETA-CATENIN; RECEPTOR; MASS; PROTEINS; MUTATION; MICE	Loss- and gain-of-function mutations in the broadly expressed gene Lrp5 affect bone formation, causing osteoporosis and high bone mass, respectively. Although Lrp5 is viewed as a Wnt coreceptor, osteoblast-specific disruption of beta-Catenin does not affect bone formation. Instead, we show here that Lrp5 inhibits expression of Tph1, the rate-limiting biosynthetic enzyme for serotonin in enterochromaffin cells of the duodenum. Accordingly, decreasing serotonin blood levels normalizes bone formation and bone mass in Lrp5-deficient mice, and gut-but not osteoblast-specific Lrp5 inactivation decreases bone formation in a beta-Catenin-independent manner. Moreover, gut-specific activation of Lrp5, or inactivation of Tph1, increases bone mass and prevents ovariectomy-induced bone loss. Serotonin acts on osteoblasts through the Htr1b receptor and CREB to inhibit their proliferation. By identifying duodenum-derived serotonin as a hormone inhibiting bone formation in an Lrp5-dependent manner, this study broadens our understanding of bone remodeling and suggests potential therapies to increase bone mass.	[Ducy, Patricia] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Yadav, Vijay K.; Ryu, Je-Hwang; Suda, Nina; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Tanaka, Kenji F.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Tanaka, Kenji F.; Mann, J. John; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Gingrich, Jay A.] Columbia Univ, Dept Psychiat Dev Psychobiol, New York, NY 10032 USA; [Schuetz, Guenther] German Canc Res Ctr, Dept Mol Biol Cell, D-69120 Heidelberg, Germany; [Glorieux, Francis H.] McGill Univ, Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada; [Chiang, Cherie Y.; Zajac, Jeffrey D.] Univ Melbourne, Dept Med, Heidelberg, Vic 3010, Australia; [Insogna, Karl L.] Yale Sch Med, Dept Internal Med, New Haven, CT 06519 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Helmholtz Association; German Cancer Research Center (DKFZ); McGill University; University of Melbourne; Yale University	Karsenty, G (corresponding author), Columbia Univ, Dept Pathol, New York, NY 10032 USA.	pd2193@columbia.edu; gk2172@columbia.edu	Zajac, Jeffrey/ABC-3767-2021; Chiang, Cherie/AAR-3793-2021; yadav, VIJAY k/Q-2540-2016	Zajac, Jeffrey/0000-0003-3933-5708; yadav, VIJAY k/0000-0003-2345-2846; Tanaka, Kenji/0000-0003-2511-0057; Insogna, Karl/0000-0001-6973-5679	March of Dimes Foundation; National Institutes of Health; Shriners of North America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067936] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners of North America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. J. P. Bilezikian, S. Cremers, D. A. Mackey, M. Zacharin, R. Lang, S. Rao, H. Schubert, and J. Tosi for patient samples and eye analysis; G. Ren and Yung-yu Huang for superb technical assistance; and Dr. M. Gershon for his critical reading of this manuscript. This work was supported by grants from the March of Dimes Foundation and the National Institutes of Health (to G. K.) and by the Shriners of North America (F. H. G.).	Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Basselin M, 2005, NEUROPSYCHOPHARMACOL, V30, P461, DOI 10.1038/sj.npp.1300611; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Collet C, 2008, FASEB J, V22, P418, DOI 10.1096/fj.07-9209com; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FU L, 2007, GASTROENTEROLOGY, V132, P397; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; HEATH MJS, 1995, CURR BIOL, V5, P997, DOI 10.1016/S0960-9822(95)00199-0; Hediger ML, 2008, J AUTISM DEV DISORD, V38, P848, DOI 10.1007/s10803-007-0453-6; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kubera M, 2000, NEUROPSYCHOPHARMACOL, V23, P89, DOI 10.1016/S0893-133X(99)00150-5; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; MANN JJ, 1992, ARCH GEN PSYCHIAT, V49, P442; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; RAND M, 1951, NATURE, V168, P385, DOI 10.1038/168385b0; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	37	599	659	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					825	837		10.1016/j.cell.2008.09.059	http://dx.doi.org/10.1016/j.cell.2008.09.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041748	Green Accepted, Bronze			2022-12-01	WOS:000261183900015
J	Hernandez, AF; Shea, AM; Milano, CA; Rogers, JG; Hammill, BG; O'Connor, CM; Schulman, KA; Peterson, ED; Curtis, LH				Hernandez, Adrian F.; Shea, Alisa M.; Milano, Carmelo A.; Rogers, Joseph G.; Hammill, Bradley G.; O'Connor, Christopher M.; Schulman, Kevin A.; Peterson, Eric D.; Curtis, Lesley H.			Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICAL CIRCULATORY SUPPORT; CHRONIC HEART-FAILURE; TRANSPLANTATION; IMPLANTATION; UPDATE; DESTINATION; MANAGEMENT; COMMITTEE; ACCURACY; ICD-9-CM	Context In 2003, Medicare expanded coverage of ventricular assist devices as destination, or permanent, therapy for end- stage heart failure. Little is known about the long- term outcomes and costs associated with these devices. Objective To examine the acute and long- term outcomes of Medicare beneficiaries receiving ventricular assist devices alone or after open- heart surgery. Design, Setting, and Patients Analysis of inpatient claims from the Centers for Medicare & Medicaid Services for the period 2000 through 2006. Patients were Medicare fee- for- service beneficiaries who received a ventricular assist device between February 2000 and June 2006 alone as primary therapy ( primary device group; n= 1476) or after cardiotomy in the previous 30 days ( postcardiotomy group; n= 1467). Main Outcome Measures Cumulative incidence of device replacement, device removal, heart transplantation, readmission, and death, accounting for censoring and competing risks. Patients were followed up for at least 6 months and factors independently associated with long- term survival were identified. Medicare payments were used to calculate total inpatient costs and costs per day outside the hospital. Results Overall 1- year survival was 51.6% ( n= 669) in the primary device group and 30.8% ( n= 424) in the postcardiotomy group. Among primary device patients, 815 ( 55.2%) were discharged alive with a device. Of those, 450 (55.6%) were readmitted within 6 months and 504 (73.2%) were alive at 1 year. Of the 493 (33.6%) postcardiotomy patients discharged alive with a device, 237 (48.3%) were readmitted within 6 months and 355 (76.6%) were alive at 1 year. Mean 1- year Medicare payments for inpatient care for patients in the 2000- 2005 cohorts were $178714 (SD, $142549) in the primary device group and $ 111769 ( SD, $ 95413) in the postcardiotomy group. Conclusions Among Medicare beneficiaries receiving a ventricular assist device, early mortality, morbidity, and costs remain high. Improving patient selection and reducing perioperative mortality are critical for improving overall outcomes.	[Hernandez, Adrian F.; Shea, Alisa M.; Rogers, Joseph G.; Hammill, Bradley G.; O'Connor, Christopher M.; Schulman, Kevin A.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; [Hernandez, Adrian F.; Rogers, Joseph G.; O'Connor, Christopher M.; Schulman, Kevin A.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; [Milano, Carmelo A.] Duke Univ, Sch Med, Dept Surg, Durham, NC 27715 USA	Duke University; Duke University; Duke University	Hernandez, AF (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Hernandez, Adrian F/A-7818-2016; Peterson, Eric David/ABF-5033-2021	Hernandez, Adrian F/0000-0003-3387-9616; 	National Institute on Aging [1R01AG026038-01A1]; Agency for Healthcare Research and Quality [1U18HS016964-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026038] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by grants 1R01AG026038-01A1 from the National Institute on Aging and 1U18HS016964-01 from the Agency for Healthcare Research and Quality.	Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; *CTR MED MED SERV, DEC MEM VENTR ASS DE; CURTIS LH, IN PRESS ARCH INTERN; Esmore D, 2007, EUR J CARDIO-THORAC, V32, P735, DOI 10.1016/j.ejcts.2007.07.028; Felker GM, 2008, J CARD FAIL, V14, P368, DOI 10.1016/j.cardfail.2008.01.009; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Goldstein DJ, 2003, CIRCULATION, V108, P272, DOI 10.1161/01.cir.0000087387.02218.7e; Helman DN, 1999, ANN THORAC SURG, V68, P1187, DOI 10.1016/S0003-4975(99)00911-X; Hernandez AF, 2007, CIRCULATION, V116, P606, DOI 10.1161/CIRCULATIONAHA.106.666289; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kherani AR, 2003, J THORAC CARDIOV SUR, V126, P1634, DOI 10.1016/S0022-5223(03)00727-X; Kirklin JK, 2008, CIRC-HEART FAIL, V1, P200, DOI 10.1161/CIRCHEARTFAILURE.108.782599; Lietz K, 2007, CIRCULATION, V116, P497, DOI 10.1161/CIRCULATIONAHA.107.691972; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Long James W, 2005, Congest Heart Fail, V11, P133, DOI 10.1111/j.1527-5299.2005.04540.x; Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758; *NAT HEART LUNG BL, CLIN US VENTR ASS DE; *NAT HEART LUNG BL, NEXT GEN VENTR ASS D; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rogers JG, 2007, J AM COLL CARDIOL, V50, P741, DOI 10.1016/j.jacc.2007.03.063; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Russo MJ, 2008, J CARD FAIL, V14, P651, DOI 10.1016/j.cardfail.2008.06.005; Showstack J, 1999, JAMA-J AM MED ASSOC, V281, P1381, DOI 10.1001/jama.281.15.1381; Stevenson LW, 2005, CIRCULATION, V112, pE111, DOI 10.1161/CIRCULATIONAHA.104.506451; Stevenson LW, 2004, CIRCULATION, V110, P975, DOI 10.1161/01.CIR.0000139862.48167.23; Tunis SR, 2004, NEW ENGL J MED, V350, P2196, DOI 10.1056/NEJMe048091	30	66	66	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2398	2406		10.1001/jama.2008.716	http://dx.doi.org/10.1001/jama.2008.716			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033590	Green Accepted, Bronze			2022-12-01	WOS:000261150800022
J	Epstein, H				Epstein, Helen			AIDS and the irrational	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONCURRENT SEXUAL PARTNERSHIPS; HIV-INFECTION; TRANSMITTED INFECTIONS; AFRICAN-AMERICANS; YOUNG MEN; BEHAVIOR; RISK; PREVENTION; SPREAD; COMMUNITIES					helenepstein@yahoo.com						Adimora AA, 2004, ANN EPIDEMIOL, V14, P155, DOI 10.1016/S1047-2797(03)00129-7; Adimora AA, 2003, JAIDS-J ACQ IMM DEF, V34, P423, DOI 10.1097/00126334-200312010-00010; ANKRAH M, 1993, AIDS UGANDA ANAL SOC; Baeten JM, 2005, J INFECT DIS, V191, P546, DOI 10.1086/427656; BARTON T, 1997, EPIDEMICS BEHA UNPUB; BECKER MH, 1988, AM J PUBLIC HEALTH, V78, P394, DOI 10.2105/AJPH.78.4.394; BOGART L, 2005, J ACQ IMMUN DEF SYND, V38, P2; CARAEL M, 2001, AFRICAN J REPROD HLT, V5, P83, DOI DOI 10.2307/3583201; Carael M., 1995, SEXUAL BEHAV AIDS DE; Carter MW, 2007, AIDS BEHAV, V11, P822, DOI 10.1007/s10461-006-9203-6; Christakis NA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1675; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Colvin M, 1998, INT J STD AIDS, V9, P548, DOI 10.1258/0956462981922683; Drumright LN, 2004, SEX TRANSM DIS, V31, P437, DOI 10.1097/01.olq.0000129949.30114.37; England R, 2008, BRIT MED J, V336, P1072, DOI 10.1136/bmj.39569.497708.94; EPSTEIN H, 2004, DISCOVER         FEB; EPSTEIN H, 2005, AIDSLINK         SEP, P93; Epstein Helen, 2008, INVISIBLE CURE AFRIC; *FAM HLTH INT, 2002, SWAZ BEH SURV SURV; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; GILGEN D, 2000, NATURAL HIST HIV AID; Gray RH, 2008, LANCET, V371, P2064, DOI 10.1016/S0140-6736(08)60896-X; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Halperin DT, 2007, S AFR J HIV MED, P19; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; HEATON L, 2006, 16 INT AIDS C 13 18; Helleringer S, 2007, AIDS, V21, P2323, DOI 10.1097/QAD.0b013e328285df98; HUDSON CP, 1993, INT J STD AIDS, V4, P249, DOI 10.1177/095646249300400501; HUDSON CP, 1994, AIDS, V8, P1739, DOI 10.1097/00002030-199412000-00021; Hudson CP, 1996, INT J STD AIDS, V7, P236, DOI 10.1258/0956462961917906; HUDSON CP, 1993, AIDS, V7, P286, DOI 10.1097/00002030-199302000-00024; Human Rights Watch, 2007, HIDD MEAL MEAL GEND; KALEEBA N, 2002, WE MISS YOU ALL AIDS; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; MAH T, 2008, 225 CTR SOC SCI RES; MAH T, 2008, AIDS BEHAV      0722; MAJIRIOGHENE B, 2008, NIGERIANS AM    1013; Matovu JKB, 2007, AIDS BEHAV, V11, P71, DOI 10.1007/s10461-006-9170-y; Mattson CL, 2007, SEX TRANSM DIS, V34, P731, DOI 10.1097/01.olq.0000261335.42480.89; MEYERSON B, TCM EXPOSURE HIV REL; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2001, SEX TRANSM DIS, V28, P504, DOI 10.1097/00007435-200109000-00005; MORRIS M, 2007, SEXUALLY TRANSMITTED; Moszynski P, 2007, BRIT MED J, V334, P712, DOI 10.1136/bmj.39171.431736.DB; MUSINGUZI J, 1996, RESULTS POPULATION B; MUSSA A, 2001, THESIS U WASHINGTON; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; OBBO C, 1993, SOC SCI MED, V36, P949, DOI 10.1016/0277-9536(93)90086-J; Parker W, 2007, CONCURRENT SEXUAL PA; PARKER W, 2007, NAMIBIA MIDTERM HOUS; Peltzer K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-255; PIOT P, 1994, HIV EPIDEMIOLOGY, P77; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; *POP COUNC, 2006, AD GIRLS SOC SUPP LI; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Roehr B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2566; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; *SO AFR DEV COMM, 2006, REP EXP THINK TANK M; STANDING H, 1989, SEXUAL BEHAV AIDS SU; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; SULLIVAN J, 2006, AIDS; TALLE A, 1995, YOUNG PEOPLE RISK FI; Tuffs A, 2007, BRIT MED J, V334, P712, DOI 10.1136/bmj.39170.736412.DB; *UG MIN HLTH, 1995, UG DEM HLTH SURV 199; UNAIDS, 2001, HIV PREV NEEDS SUCC; *UNAIDS, 2006, REP GLOB AIDS EP 200, P127; *UNAIDS, 2008, REP GLOB AIDS EP 200, P36; Voeten HACM, 2004, SEX TRANSM DIS, V31, P481, DOI 10.1097/01.olq.0000135989.14131.9d; WATTS CH, 1992, MATH BIOSCI, V108, P89, DOI 10.1016/0025-5564(92)90006-I; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; *WORLD BANK, 2003, ED HIV AIDS SOUR HIV	73	16	16	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2008	337								a2638	10.1136/bmj.a2638	http://dx.doi.org/10.1136/bmj.a2638			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QA	19033334				2022-12-01	WOS:000261827500017
J	Walker, AS; Spiegelhalter, D; Crook, DW; Wyllie, D; Morris, J; Peto, TEA				Walker, A. Sarah; Spiegelhalter, David; Crook, Derrick W.; Wyllie, David; Morris, James; Peto, Tim E. A.			Fairness of financial penalties to improve control of Clostridium difficile	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE; STRAIN; REGRESSION; INFECTION; EPIDEMIC; QUALITY; DISEASE; PAY		[Walker, A. Sarah; Crook, Derrick W.; Morris, James; Peto, Tim E. A.] John Radcliffe Hosp, Natl Inst Hlth Res, Oxford Biomed Res Ctr Programme, Oxford OX3 9DU, England; [Walker, A. Sarah] MRC, Clin Trials Unit, London NW1 2DA, England; [Spiegelhalter, David] MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 0SR, England; [Spiegelhalter, David] Ctr Math Sci, Stat Lab, Cambridge CB3 0WB, England; [Wyllie, David] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England	University of Oxford; Medical Research Council Clinical Trials Unit; MRC Biostatistics Unit; University of Cambridge; University of Cambridge; University of Oxford	Walker, AS (corresponding author), John Radcliffe Hosp, Natl Inst Hlth Res, Oxford Biomed Res Ctr Programme, Oxford OX3 9DU, England.	asw@ctu.mrc.ac.uk	Walker, Sarah/HDM-8717-2022	peto, tim/0000-0003-3477-8307	Medical Research Council [MC_U105260557] Funding Source: Medline; MRC [MC_U105260557] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Duckett SJ, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-72; Fowler S, 2007, J ANTIMICROB CHEMOTH, V59, P990, DOI 10.1093/jac/dkm014; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; *HEALTHC COMM, STAT BAND NAT TARG I; HEALY MJR, 1978, ANN HUM BIOL, V5, P277, DOI 10.1080/03014467800002891; *HLTH PROT AG, CLOSTR DIFF; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Morton V, 2003, BRIT MED J, V326, P1083, DOI 10.1136/bmj.326.7398.1083; Morton V, 2005, J EVAL CLIN PRACT, V11, P59, DOI 10.1111/j.1365-2753.2004.00505.x; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; *UK DEP HLTH, NAT TARG RED CLOSTR; Valiquette L, 2007, CLIN INFECT DIS, V45, pS112, DOI 10.1086/519258	15	4	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2008	337								a2097	10.1136/bmj.a2097	http://dx.doi.org/10.1136/bmj.a2097			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HS	19022838				2022-12-01	WOS:000262654100001
J	Anderson, TM; vonHoldt, BM; Candille, SI; Musiani, M; Greco, C; Stahler, DR; Smith, DW; Padhukasahasram, B; Randi, E; Leonard, JA; Bustamante, CD; Ostrander, EA; Tang, H; Wayne, RK; Barsh, GS				Anderson, Tovi M.; vonHoldt, Bridgett M.; Candille, Sophie I.; Musiani, Marco; Greco, Claudia; Stahler, Daniel R.; Smith, Douglas W.; Padhukasahasram, Badri; Randi, Ettore; Leonard, Jennifer A.; Bustamante, Carlos D.; Ostrander, Elaine A.; Tang, Hua; Wayne, Robert K.; Barsh, Gregory S.			Molecular and Evolutionary History of Melanism in North American Gray Wolves	SCIENCE			English	Article							COAT COLOR; GENETIC-BASIS; DIFFERENTIATION; INTROGRESSION; PATTERNS; SEQUENCE; GENOME; BLACK; WOLF; WILD	Morphological diversity within closely related species is an essential aspect of evolution and adaptation. Mutations in the Melanocortin 1 receptor (Mc1r) gene contribute to pigmentary diversity in natural populations of fish, birds, and many mammals. However, melanism in the gray wolf, Canis lupus, is caused by a different melanocortin pathway component, the K locus, that encodes a beta-defensin protein that acts as an alternative ligand for Mc1r. We show that the melanistic K locus mutation in North American wolves derives from past hybridization with domestic dogs, has risen to high frequency in forested habitats, and exhibits a molecular signature of positive selection. The same mutation also causes melanism in the coyote, Canis latrans, and in Italian gray wolves, and hence our results demonstrate how traits selected in domesticated species can influence the morphological diversity of their wild relatives.	[Anderson, Tovi M.; Candille, Sophie I.; Tang, Hua; Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Anderson, Tovi M.; Candille, Sophie I.; Tang, Hua; Barsh, Gregory S.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [vonHoldt, Bridgett M.; Stahler, Daniel R.; Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 91302 USA; [Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Greco, Claudia; Randi, Ettore] Ist Nazl Fauna Selvat, I-40064 Ozzano Dell Emilia, BO, Italy; [Stahler, Daniel R.; Smith, Douglas W.] Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Natl Pk, WY 82190 USA; [Padhukasahasram, Badri; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Leonard, Jennifer A.] Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden; [Ostrander, Elaine A.] NHGRI, Bethesda, MD 20892 USA	Stanford University; Stanford University; University of California System; University of California Los Angeles; University of Calgary; Italian Institute for Environmental Protection & Research (ISPRA); United States Department of the Interior; Cornell University; Uppsala University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Barsh, GS (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	gbarsh@stanford.edu	Musiani, Marco/ABB-9387-2021; Greco, Claudia/ABA-6030-2020; Leonard, Jennifer/A-7894-2010	Musiani, Marco/0000-0002-6097-5841; Bustamante, Carlos D./0000-0002-4187-7920; Leonard, Jennifer/0000-0003-0291-7819; Greco, Claudia/0000-0002-8678-0890; Ostrander, Elaine/0000-0001-6075-9738	NIH; NSF; Swedish Research Council; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325, T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK068384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068882] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from NIH (G.S.B.), NSF (R.K.W., D.R.S., and D.W.S.), and the Swedish Research Council (J. A.L.). We are grateful to H. Chen and S. Schmutz for advice, to H. Manuel for technical assistance, and to members of the U.S. Department of Agriculture Wildlife Services and private citizens for assistance with sample collection. Sequences generated in this study are deposited in GenBank under accession numbers FJ609634 to FJ609641.	Andersson L, 2003, ANN NY ACAD SCI, V994, P313, DOI 10.1111/j.1749-6632.2003.tb03195.x; Bangs EE, 1996, WILDLIFE SOC B, V24, P402; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Gipson PS, 2002, WILDLIFE SOC B, V30, P821; Halbert ND, 2007, J HERED, V98, P1, DOI 10.1093/jhered/esl051; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; JOLICOEUR P, 1959, EVOLUTION, V13, P283, DOI 10.2307/2406106; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Klungland H, 2003, ANN NY ACAD SCI, V994, P331, DOI 10.1111/j.1749-6632.2003.tb03197.x; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; Leonard JA, 2008, BIOL LETTERS, V4, P95, DOI 10.1098/rsbl.2007.0354; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Majerus M.E.N., 1998, MELANISM EVOLUTION A; Mech L.D., 1998, WOLVES DENALI; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Peterson RO, 1984, WILDLIFE MONOGR, P3; Randi E, 2002, CONSERV GENET, V3, P31; ROY MS, 1994, MOL BIOL EVOL, V11, P553; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Tang H, 2002, GENETICS, V161, P447; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Woolley SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001913	29	292	306	1	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1339	1343		10.1126/science.1165448	http://dx.doi.org/10.1126/science.1165448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19197024	Green Accepted			2022-12-01	WOS:000263876700041
J	Jackson, M				Jackson, Mark			Dust	LANCET			English	Editorial Material												m.a.jackson@exeter.ac.uk							0	0	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 7	2009	373	9662					453	453		10.1016/S0140-6736(09)60156-2	http://dx.doi.org/10.1016/S0140-6736(09)60156-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404EF	19200905				2022-12-01	WOS:000263132800014
J	Stewart, GS; Panier, S; Townsend, K; Al-Hakim, AK; Kolas, NK; Miller, ES; Nakada, S; Ylanko, J; Olivarius, S; Mendez, M; Oldreive, C; Wildenhain, J; Tagliaferro, A; Pelletier, L; Taubenheim, N; Durandy, A; Byrd, PJ; Stankovic, T; Taylor, AMR; Durocher, D				Stewart, Grant S.; Panier, Stephanie; Townsend, Kelly; Al-Hakim, Abdallah K.; Kolas, Nadine K.; Miller, Edward S.; Nakada, Shinichiro; Ylanko, Jarkko; Olivarius, Signe; Mendez, Megan; Oldreive, Ceri; Wildenhain, Jan; Tagliaferro, Andrea; Pelletier, Laurence; Taubenheim, Nadine; Durandy, Anne; Byrd, Philip J.; Stankovic, Tatjana; Taylor, A. Malcolm R.; Durocher, Daniel			The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage	CELL			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; 53BP1; GENE; ATM; REPAIR; MDC1; PATHWAY	The biological response to DNA double-strand breaks acts to preserve genome integrity. Individuals bearing inactivating mutations in components of this response exhibit clinical symptoms that include cellular radiosensitivity, immunodeficiency, and cancer predisposition. The archetype for such disorders is Ataxia-Telangiectasia caused by biallelic mutation in ATM, a central component of the DNA damage response. Here, we report that the ubiquitin ligase RNF168 is mutated in the RIDDLE syndrome, a recently discovered immuno-deficiency and radiosensitivity disorder. We show that RNF168 is recruited to sites of DNA damage by binding toubiquitylated histone H2A. RNF168 acts with UBC13 to amplify the RNF8-dependent histone ubiquitylation by targeting H2A-type histones and by promoting the formation of lysine 63-linked ubiquitin conjugates. These RNF168-dependent chromatin modifications orchestrate the accumulation of 53BP1 and BRCA1 to DNA lesions, and their loss is the likely cause of the cellular and developmental phenotypes associated with RIDDLE syndrome.	[Stewart, Grant S.; Townsend, Kelly; Miller, Edward S.; Oldreive, Ceri; Byrd, Philip J.; Stankovic, Tatjana; Taylor, A. Malcolm R.] Univ Birmingham, Canc Res UK, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; [Panier, Stephanie; Al-Hakim, Abdallah K.; Kolas, Nadine K.; Nakada, Shinichiro; Ylanko, Jarkko; Olivarius, Signe; Mendez, Megan; Wildenhain, Jan; Tagliaferro, Andrea; Pelletier, Laurence; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Panier, Stephanie; Ylanko, Jarkko; Pelletier, Laurence; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Taubenheim, Nadine; Durandy, Anne] Hop Necker Enfants Malad, INSERM, U768, F-75015 Paris, France	Cancer Research UK; University of Birmingham; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Stewart, GS (corresponding author), Univ Birmingham, Canc Res UK, Inst Canc Studies, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	g.s.stewart@bham.ac.uk; durocher@lunenfeld.ca	Wildenhain, Jan/Q-6596-2019; OsakaU/AAY-3661-2020; Durocher, Daniel/A-7733-2010; Pelletier, Laurence/F-8858-2013; Panier, Stephanie/GVT-6365-2022; Durandy, Anne/H-7475-2017; Wildenhain, Jan/E-5597-2011	Wildenhain, Jan/0000-0002-5461-3828; Durocher, Daniel/0000-0003-3863-8635; Durandy, Anne/0000-0001-7706-8466; Wildenhain, Jan/0000-0002-5461-3828; Nakada, Shinichiro/0000-0001-9297-1565; Stewart, Grant/0000-0002-0960-3241; Stankovic, Tatjana/0000-0002-3780-274X				Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Callen E, 2007, ONCOGENE, V26, P7759, DOI 10.1038/sj.onc.1210873; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	33	562	589	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					420	434		10.1016/j.cell.2008.12.042	http://dx.doi.org/10.1016/j.cell.2008.12.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203578	Bronze			2022-12-01	WOS:000263120600013
J	Kao, SC; Wu, H; Xie, JM; Chang, CP; Ranish, JA; Graef, IA; Crabtree, GR				Kao, Shih-Chu; Wu, Hai; Xie, Jianming; Chang, Ching-Pin; Ranish, Jeffrey A.; Graef, Isabella A.; Crabtree, Gerald R.			Calcineurin/NFAT Signaling Is Required for Neuregulin-Regulated Schwann Cell Differentiation	SCIENCE			English	Article							TRANSCRIPTION FACTOR SOX10; PERIPHERAL NERVOUS-SYSTEM; HEART DEVELOPMENT; AXONAL REGULATION; NUCLEAR FACTOR; MYELINATION; SURVIVAL; PROLIFERATION; NERVES; OCT-6	Schwann cells develop from multipotent neural crest cells and form myelin sheaths around axons that allow rapid transmission of action potentials. Neuregulin signaling through the ErbB receptor regulates Schwann cell development; however, the downstream pathways are not fully defined. We find that mice lacking calcineurin B1 in the neural crest have defects in Schwann cell differentiation and myelination. Neuregulin addition to Schwann cell precursors initiates an increase in cytoplasmic Ca2+, which activates calcineurin and the downstream transcription factors NFATc3 and c4. Purification of NFAT protein complexes shows that Sox10 is an NFAT nuclear partner and synergizes with NFATc4 to activate Krox20, which regulates genes necessary for myelination. Our studies demonstrate that calcineurin and NFAT are essential for neuregulin and ErbB signaling, neural crest diversification, and differentiation of Schwann cells.	[Kao, Shih-Chu; Wu, Hai; Chang, Ching-Pin; Graef, Isabella A.; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Kao, Shih-Chu; Wu, Hai; Chang, Ching-Pin; Graef, Isabella A.; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Kao, Shih-Chu; Wu, Hai; Xie, Jianming; Chang, Ching-Pin; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ranish, Jeffrey A.] Inst Syst Biol, Seattle, WA 98103 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Institute for Systems Biology (ISB)	Graef, IA (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	igraef@stanford.edu; crabtree@stanford.edu	Xie, Jianming/AAC-6359-2019; Xie, Jianming/G-6567-2012	Xie, Jianming/0000-0003-4112-650X; Kao, Shih-chu/0000-0002-6294-5494	NIH [NS046789, HD55391, AI60037]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS046789, R21NS061702, R01NS046789] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B.A. Borres for insightful comments; K.J. Liu, Q. Lin, and J. Perrino for technical assistance; and J. I. Wu for critically reading this manuscript. G.R.C is an Investigator of HHMI. These studies were supported by grants from NIH (NS046789, HD55391, and AI60037) to G. R. C.	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Friedrich RP, 2005, MOL CELL BIOL, V25, P1821, DOI 10.1128/MCB.25.5.1821-1829.2005; Ghislain J, 2002, DEVELOPMENT, V129, P155; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Paratore C, 2001, DEVELOPMENT, V128, P3949; Parkinson DB, 2002, MOL CELL NEUROSCI, V20, P154, DOI 10.1006/mcne.2002.1109; Rahmatullah M, 1998, MOL CELL BIOL, V18, P6245, DOI 10.1128/MCB.18.11.6245; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Srinivasan R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-117; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wu H, 2007, J BIOL CHEM, V282, P30673, DOI 10.1074/jbc.M703622200; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006	29	161	166	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					651	654		10.1126/science.1166562	http://dx.doi.org/10.1126/science.1166562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179536	Green Accepted			2022-12-01	WOS:000262862800048
J	Lavik, G; Stuhrmann, T; Bruchert, V; Van der Plas, A; Mohrholz, V; Lam, P; Mussmann, M; Fuchs, BM; Amann, R; Lass, U; Kuypers, MMM				Lavik, Gaute; Stuehrmann, Torben; Bruechert, Volker; Van der Plas, Anja; Mohrholz, Volker; Lam, Phyllis; Mussmann, Marc; Fuchs, Bernhard M.; Amann, Rudolf; Lass, Ulrich; Kuypers, Marcel M. M.			Detoxification of sulphidic African shelf waters by blooming chemolithotrophs	NATURE			English	Article							SULFIDE; BACTERIA; IDENTIFICATION; HYPOXIA; GAS; PHYTOPLANKTON; COMMUNITIES; REDUCTION; OXIDATION; SEDIMENT	Coastal waters support similar to 90 per cent of global fisheries and are therefore an important food reserve for our planet(1). Eutrophication of these waters, due to human activity, leads to severe oxygen depletion and the episodic occurrence of hydrogen sulphide toxic to multi- cellular life - with disastrous consequences for coastal ecosytems(2-5). Here we show that an area of similar to 7,000 km(2) of African shelf, covered by sulphidic water, was detoxified by blooming bacteria that oxidized the biologically harmful sulphide to environmentally harmless colloidal sulphur and sulphate. Combined chemical analyses, stoichiometric modelling, isotopic incubations, comparative 16S ribosomal RNA, functional gene sequence analyses and fluorescence in situ hybridization indicate that the detoxification proceeded by chemolithotrophic oxidation of sulphide with nitrate and was mainly catalysed by two discrete populations of gamma- and epsilon-proteobacteria. Chemolithotrophic bacteria, accounting for similar to 20 per cent of the bacterioplankton in sulphidic waters, created a buffer zone between the toxic sulphidic subsurface waters and the oxic surface waters, where fish and other nekton live. This is the first time that large- scale detoxification of sulphidic waters by chemolithotrophs has been observed in an open- ocean system. The data suggest that sulphide can be completely consumed by bacteria in the subsurface waters and, thus, can be overlooked by remote sensing or monitoring of shallow coastal waters. Consequently, sulphidic bottom waters on continental shelves may be more common than previously believed, and could therefore have an important but as yet neglected effect on benthic communities.	[Lavik, Gaute; Stuehrmann, Torben; Bruechert, Volker; Lam, Phyllis; Fuchs, Bernhard M.; Amann, Rudolf; Kuypers, Marcel M. M.] Max Planck Inst Microbiol, D-28359 Bremen, Germany; [Van der Plas, Anja] Minist Fisheries & Marine Resources, Natl Marine Informat & Res Ctr, Swakopmund, Namibia; [Mohrholz, Volker; Lass, Ulrich] Balt Sea Res Inst Warnemunde, D-18119 Rostock, Germany; [Mussmann, Marc] Univ Vienna, Dept Microbial Ecol, Vienna Ecol Ctr, A-1090 Vienna, Austria	Max Planck Society; University of Vienna	Kuypers, MMM (corresponding author), Max Planck Inst Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	mkuypers@mpi-bremen.de	Lam, Phyllis/D-9574-2011; Lavik, Gaute/F-6578-2013; Mussmann, Marc/AAA-6108-2021; Mussmann, Marc/A-8649-2017; Amann, Rudolf I/C-6534-2014	Lam, Phyllis/0000-0003-2067-171X; Mussmann, Marc/0000-0003-3102-8703; Amann, Rudolf I/0000-0002-0846-7372; , Marc/0000-0003-2785-2521; Fuchs, Bernhard/0000-0001-9828-1290; Mohrholz, Volker/0000-0003-0778-9182; Bruchert, Volker/0000-0002-8956-3840	MPG; BMBF programme Geotechnologien; NAMIBGAS; DFG; BENEFIT; Namibian Ministry of Fisheries and Natural Resources	MPG(Max Planck Society); BMBF programme Geotechnologien(Federal Ministry of Education & Research (BMBF)); NAMIBGAS; DFG(German Research Foundation (DFG)); BENEFIT; Namibian Ministry of Fisheries and Natural Resources	We thank B. Barker Jorgensen, F. Inagaki, C. Hubert, T. Ferdelman and G. Collins for discussions; the Namibian authorities for access to their national waters; the crew of RV Alexander von Humboldt for assistance onboard; S. Kruger for operating the pump-CTD and oceanographic equipment; T. Heene for assistance with the collection of oceanographic data and generating oceanographic plots; and G. Klockgether, J. Sawicka, J. Wulf, S. Lenk, D. Franzke and K. Nkandi for assistance with the analysis. The investigations were supported by the MPG, the BMBF programme Geotechnologien and the project NAMIBGAS, the DFG, BENEFIT and the Namibian Ministry of Fisheries and Natural Resources.	Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Cardoso RB, 2006, BIOTECHNOL BIOENG, V95, P1148, DOI 10.1002/bit.21084; Blazejak A, 2006, APPL ENVIRON MICROB, V72, P5527, DOI 10.1128/AEM.02441-05; Bruchert V, 2006, NATO SCI S SS IV EAR, V64, P161; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Copenhagen, 1953, INVESTIGATIONAL REPO, V14, P1; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Emeis KC, 2004, CONT SHELF RES, V24, P627, DOI 10.1016/j.csr.2004.01.007; Fennel K, 2003, LIMNOL OCEANOGR, V48, P1521, DOI 10.4319/lo.2003.48.4.1521; Gevertz D, 2000, APPL ENVIRON MICROB, V66, P2491, DOI 10.1128/AEM.66.6.2491-2501.2000; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Hansen JW, 2000, MAR ECOL PROG SER, V208, P273, DOI 10.3354/meps208273; Hart T. J., 1960, Discovery Reports, V31, P123; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Kirchman DL, 2001, AQUAT MICROB ECOL, V26, P13, DOI 10.3354/ame026013; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; Malakoff D, 1998, SCIENCE, V281, P190, DOI 10.1126/science.281.5374.190; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Ohde T, 2007, CONT SHELF RES, V27, P744, DOI 10.1016/j.csr.2006.11.016; Paerl HW, 2003, ENVIRON MICROBIOL, V5, P1025, DOI 10.1046/j.1462-2920.2003.00504.x; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Peek AS, 1998, P NATL ACAD SCI USA, V95, P9962, DOI 10.1073/pnas.95.17.9962; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Rabalais NN, 2002, BIOSCIENCE, V52, P129, DOI 10.1641/0006-3568(2002)052[0129:BSIPGO]2.0.CO;2; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; VETTER RD, 1985, MAR BIOL, V88, P33, DOI 10.1007/BF00393041; Weeks SJ, 2002, NATURE, V415, P493, DOI 10.1038/415493b; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	40	236	241	4	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					581	U86		10.1038/nature07588	http://dx.doi.org/10.1038/nature07588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19078958				2022-12-01	WOS:000262852200041
J	Kohyama, M; Ise, W; Edelson, BT; Wilker, PR; Hildner, K; Mejia, C; Frazier, WA; Murphy, TL; Murphy, KM				Kohyama, Masako; Ise, Wataru; Edelson, Brian T.; Wilker, Peter R.; Hildner, Kai; Mejia, Carlo; Frazier, William A.; Murphy, Theresa L.; Murphy, Kenneth M.			Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis	NATURE			English	Article							ETS PROTEIN; IN-VIVO; B-CELLS; EXPRESSION; GENE; HEMOCHROMATOSIS; MICE; HETEROGENEITY; RECOGNITION; RECEPTORS	Tissue macrophages comprise a heterogeneous group of cell types differing in location, surface markers and function(1). Red pulp macrophages are a distinct splenic subset involved in removing senescent red blood cells(2). Transcription factors such as PU.1 ( also known as Sfpi1) and C/EBPa (Cebpa) have general roles in myelomonocytic development(3,4), but the transcriptional basis for producing tissue macrophage subsets remains unknown. Here we show that Spi-C ( encoded by Spic), a PU.1- related transcription factor, selectively controls the development of red pulp macrophages. Spi-C is highly expressed in red pulp macrophages, but not monocytes, dendritic cells or other tissue macrophages. Spic(-/-) mice have a cell- autonomous defect in the development of red pulp macrophages that is corrected by retroviral Spi- C expression in bone marrow cells, but have normal monocyte and other macrophage subsets. Red pulp macrophages highly express genes involved in capturing circulating haemoglobin and in iron regulation. Spic(-/-) mice show ormal trapping of red blood cells in the spleen, but fail to phagocytose these red blood cells efficiently, and develop an iron overload localized selectively to splenic red pulp. Thus, Spi- C controls development of red pulp macrophages required for red blood cell recycling and iron homeostasis.	[Kohyama, Masako; Ise, Wataru; Edelson, Brian T.; Wilker, Peter R.; Hildner, Kai; Mejia, Carlo; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kohyama, Masako; Ise, Wataru; Hildner, Kai; Mejia, Carlo; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Frazier, William A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	murphy@wustl.edu		Edelson, Brian/0000-0003-2856-7650	Howard Hughes Medical Institute; Burroughs Wellcome Fund Career Award for Medical Scientists	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund)	This work was supported by the Howard Hughes Medical Institute (K.M.M.), and the Burroughs Wellcome Fund Career Award for Medical Scientists (B.T.E.).	Bemark M, 1999, J BIOL CHEM, V274, P10259, DOI 10.1074/jbc.274.15.10259; Biggs TE, 2001, EUR J IMMUNOL, V31, P2060, DOI 10.1002/1521-4141(200107)31:7<2060::AID-IMMU2060>3.0.CO;2-L; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; Carlsson R, 2002, GENE, V299, P271, DOI 10.1016/S0378-1119(02)01078-8; Carlsson R, 2006, BIOCHEM BIOPH RES CO, V344, P1155, DOI 10.1016/j.bbrc.2006.04.026; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fleming RE, 2002, P NATL ACAD SCI USA, V99, P10653, DOI 10.1073/pnas.162360699; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hashimoto S, 1999, INT IMMUNOL, V11, P1423, DOI 10.1093/intimm/11.9.1423; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Leon B, 2004, BLOOD, V103, P2668, DOI 10.1182/blood-2003-01-0286; Lloberas J, 1999, IMMUNOL TODAY, V20, P184, DOI 10.1016/S0167-5699(99)01442-5; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Schweitzer BL, 2006, J IMMUNOL, V177, P2195, DOI 10.4049/jimmunol.177.4.2195; Stoermann B, 2007, EUR J IMMUNOL, V37, P1613, DOI 10.1002/eji.200636640; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; Torrance JD., 1980, METHODS HEMATOL, V1, P90; Ulyanova T, 2005, BLOOD, V106, P86, DOI 10.1182/blood-2004-09-3417; Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Zhou XY, 1998, GASTROENTEROLOGY, V114, pA1372, DOI 10.1016/S0016-5085(98)85570-4	30	289	298	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					318	321		10.1038/nature07472	http://dx.doi.org/10.1038/nature07472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19037245	Green Accepted			2022-12-01	WOS:000262440900040
J	Ni, ZF; Kim, ED; Ha, MS; Lackey, E; Liu, JX; Zhang, YR; Sun, QX; Chen, ZJ				Ni, Zhongfu; Kim, Eun-Deok; Ha, Misook; Lackey, Erika; Liu, Jianxin; Zhang, Yirong; Sun, Qixin; Chen, Z. Jeffrey			Altered circadian rhythms regulate growth vigour in hybrids and allopolyploids	NATURE			English	Article							GENE-EXPRESSION; ARABIDOPSIS ALLOTETRAPLOIDS; STARCH DEGRADATION; FLOWERING-TIME; CLOCK; THALIANA; MUTANT; PLANTS; CCA1; TRANSCRIPTION	Segregating hybrids and stable allopolyploids display morphological vigour(1-3), and Arabidopsis allotetraploids are larger than the parents Arabidopsis thaliana and Arabidopsis arenosa(1,4)- the mechanisms for this are unknown. Circadian clocks mediate metabolic pathways and increase fitness in animals and plants(5-8). Here we report that epigenetic modifications of the circadian clock genes CIRCADIAN CLOCK ASSOCIATED 1 (CCA1) and LATE ELONGATED HYPOCOTYL (LHY)(9-11) and their reciprocal regulators TIMING OF CAB EXPRESSION 1 ( TOC1) and GIGANTEA (GI)(10,12,13) mediate expression changes in downstream genes and pathways. During the day, epigenetic repression of CCA1 and LHY induced the expression of TOC1, GI and downstream genes containing evening elements(14) in chlorophyll and starch metabolic pathways in allotetraploids and F-1 hybrids, which produced more chlorophyll and starch than the parents in the same environment. Mutations in cca1 and cca1 lhy and the daily repression of cca1 by RNA interference (RNAi) in TOC1:: cca1(RNAi) transgenic plants increased the expression of downstream genes and increased chlorophyll and starch content, whereas constitutively expressing CCA1 or ectopically expressing TOC1:: CCA1 had the opposite effect. The causal effects of CCA1 on output traits suggest that hybrids and allopolyploids gain advantages from the control of circadian- mediated physiological and metabolic pathways, leading to growth vigour and increased biomass.	[Ni, Zhongfu; Kim, Eun-Deok; Ha, Misook; Lackey, Erika; Liu, Jianxin; Zhang, Yirong; Chen, Z. Jeffrey] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Ha, Misook; Chen, Z. Jeffrey] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ha, Misook; Chen, Z. Jeffrey] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Chen, Z. Jeffrey] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Sun, Qixin] China Agr Univ, Dept Genet & Plant Breeding, Beijing 100094, Peoples R China	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; China Agricultural University	Chen, ZJ (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, 1 University Stn,A-4800, Austin, TX 78712 USA.	zjchen@mail.utexas.edu		KIM, EUN-DEOK/0000-0002-0593-4553	National Science Foundation Plant Genome Research Program [DBI0733857, DBI0624077]; National Institutes of Health [GM067015]; National Basic Research Program of China [2007CB109000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067015] Funding Source: NIH RePORTER	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to E. Tobin for her gifts of the CCA1-overexpression (CCA1-OX) line and antibodies against CCA1. We thank H.Y. Chen for advice on recombinant CCA1 production, D. W. Ng for western blot analysis, T. Juenger for insightful discussions on life history traits in Arabidopsis, and D.Y. Chen and E. Huq for careful readings of the manuscript. The work was supported by the grants from the National Science Foundation Plant Genome Research Program (DBI0733857 and DBI0624077) and the National Institutes of Health (GM067015; Z.J.C.) and National Basic Research Program of China (2007CB109000; Q.S.).	Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; EIMERT K, 1995, PLANT CELL, V7, P1703, DOI 10.1105/tpc.7.10.1703; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lee HS, 2004, PLANT BIOTECHNOL J, V2, P45, DOI 10.1046/j.1467-7652.2003.00048.x; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lloyd JR, 2005, TRENDS PLANT SCI, V10, P130, DOI 10.1016/j.tplants.2005.01.001; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Reinbothe S, 1996, PLANT CELL, V8, P763, DOI 10.1105/tpc.8.5.763; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Sperling U, 1997, PLANT J, V12, P649, DOI 10.1046/j.1365-313X.1997.00649.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Tian L, 2005, GENETICS, V169, P337, DOI 10.1534/genetics.104.033142; Wang JL, 2006, GENETICS, V173, P965, DOI 10.1534/genetics.106.056580; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907	42	466	517	6	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					327	U7		10.1038/nature07523	http://dx.doi.org/10.1038/nature07523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19029881	Green Accepted			2022-12-01	WOS:000262440900042
J	Buszczak, M; Paterno, S; Spradling, AC				Buszczak, Michael; Paterno, Shelley; Spradling, Allan C.			Drosophila Stem Cells Share a Common Requirement for the Histone H2B Ubiquitin Protease Scrawny	SCIENCE			English	Article							RNA-POLYMERASE-II; METHYLATION; OVARY; MAINTENANCE; CHROMATIN; DIVISION; COMPASS; COMPLEX; MIDGUT; GENES	Stem cells within diverse tissues share the need for a chromatin configuration that promotes self- renewal, yet few chromatin proteins are known to regulate multiple types of stem cells. We describe a Drosophila gene, scrawny ( scny), encoding a ubiquitin- specific protease, which is required in germline, epithelial, and intestinal stem cells. Like its yeast relative UBP10, Scrawny deubiquitylates histone H2B and functions in gene silencing. Consistent with previous studies of this conserved pathway of chromatin regulation, scny mutant cells have elevated levels of ubiquitinylated H2B and trimethylated H3K4. Our findings suggest that inhibiting H2B ubiquitylation through scny represents a common mechanism within stem cells that is used to repress the premature expression of key differentiation genes, including Notch target genes.	[Buszczak, Michael; Paterno, Shelley; Spradling, Allan C.] Carnegie Inst, Dept Embryol, Howard Hughes Med Res Labs, Baltimore, MD 21218 USA	Carnegie Institution for Science	Spradling, AC (corresponding author), Carnegie Inst, Dept Embryol, Howard Hughes Med Res Labs, Baltimore, MD 21218 USA.	spradling@ciwemb.edu		Buszczak, Michael/0000-0001-6361-3654	Howard Hughes Medical Institute; American Cancer Society Fellowship [PF-04-022-01-CSM]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society Fellowship(American Cancer Society)	This work was supported by the Howard Hughes Medical Institute. M. B. was supported in part by American Cancer Society Fellowship PF-04-022-01-CSM. We thank D. McKearin, M. Oren, and the Bloomington Stock Center for reagents; B. Ohlstein for helpful advice and for assisting with the initial characterization of the scny midgut phenotype; and T. Nystul for critical reading of the manuscript.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Bray S, 2005, DEV CELL, V8, P279, DOI 10.1016/j.devcel.2004.11.020; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Li Jianduan, 2008, Int J Med Sci, V5, P133; Lin HF, 1997, DEVELOPMENT, V124, P2463; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tenney K, 2006, P NATL ACAD SCI USA, V103, P11970, DOI 10.1073/pnas.0603620103; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	22	93	100	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					248	251		10.1126/science.1165678	http://dx.doi.org/10.1126/science.1165678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19039105	Green Accepted			2022-12-01	WOS:000262290600037
J	Gertz, J; Siggia, ED; Cohen, BA				Gertz, Jason; Siggia, Eric D.; Cohen, Barak A.			Analysis of combinatorial cis-regulation in synthetic and genomic promoters	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PATTERNS; ASSOCIATIONS; SEQUENCE; NETWORK; MODELS	Transcription factor binding sites are being discovered at a rapid pace(1,2). It is now necessary to turn attention towards understanding how these sites work in combination to influence gene expression. Quantitative models that accurately predict gene expression from promoter sequence(3-5) will be a crucial part of solving this problem. Here we present such a model, based on the analysis of synthetic promoter libraries in yeast ( Saccharomyces cerevisiae). Thermodynamic models based only on the equilibrium binding of transcription factors to DNA and to each other captured a large fraction of the variation in expression in every library. Thermodynamic analysis of these libraries uncovered several phenomena in our system, including cooperativity and the effects of weak binding sites. When applied to the S. cerevisiae genome, a model of repression by Mig1 ( which was trained on synthetic promoters) predicts a number of Mig1- regulated genes that lack significant Mig1- binding sites in their promoters. The success of the thermodynamic approach suggests that the information encoded by combinations of cis- regulatory sites is interpreted primarily through simple protein - DNA and protein - protein interactions, with complicated biochemical reactions - such as nucleosome modifications - being downstream events. Quantitative analyses of synthetic promoter libraries will be an important tool in unravelling the rules underlying combinatorial cis- regulation.	[Gertz, Jason; Cohen, Barak A.] Washington Univ, Sch Med, Ctr Genome Sci, Dept Genet, St Louis, MO 63108 USA; [Siggia, Eric D.] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Washington University (WUSTL); Rockefeller University	Cohen, BA (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, Dept Genet, 4444 Forest Park Ave, St Louis, MO 63108 USA.	cohen@genetics.wustl.edu		Gertz, Jason/0000-0001-7568-6789	NIH [R01 GM078222]; NSF [DMR0129848, DGE-0202737]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Mitra, G. Stormo, M. Johnston, K. Varley, S. Doniger and members of the Cohen laboratory for discussions and suggestions, and J. Sabina for technical help with LacZ experiments. B.A.C. and J.G. were supported by the NIH (R01 GM078222) and E.D.S. was supported by the NSF (DMR0129848). J.G. was also supported by an NSF Graduate Research Fellowship (DGE-0202737).	Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Brachmann CB, 1998, YEAST, V14, P115; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; GISH W, 1995, WU BLAST; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Ligr M, 2006, GENETICS, V172, P2113, DOI 10.1534/genetics.105.052688; Lutfiyya LL, 1998, GENETICS, V150, P1377; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ptashne M., 2002, GENES SIGNALS; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	26	215	219	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					215	U113		10.1038/nature07521	http://dx.doi.org/10.1038/nature07521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19029883	Green Accepted			2022-12-01	WOS:000262360200037
J	Chen, J; Novick, RP				Chen, John; Novick, Richard P.			Phage-Mediated Intergeneric Transfer of Toxin Genes	SCIENCE			English	Article							PANTON-VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS-AUREUS; PATHOGENICITY ISLAND; BACTERIOPHAGE THERAPY; BOVINE MASTITIS; SHOCK; EVOLUTION; VIRULENCE	Because bacteriophages generally parasitize only closely related bacteria, it is assumed that phage- mediated genetic exchange occurs primarily within species. Here we report that staphylococcal pathogenenicity islands, containing superantigen genes, and other mobile elements transferred to Listeria monocytogenes at the same high frequencies as they transfer within Staphylococcus aureus. Several staphylococcal phages transduced L. monocytogenes but could not form plaques. In an experiment modeling phage therapy for bovine mastitis, we observed pathogenicity island transfer between S. aureus and L. monocytogenes in raw milk. Thus, phages may participate in a far more expansive network of genetic information exchange among bacteria of different species than originally thought, with important implications for the evolution of human pathogens.	[Chen, John; Novick, Richard P.] NYU, Med Ctr, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Novick, RP (corresponding author), NYU, Med Ctr, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA.	novick@saturn.med.nyu.edu		Chen, John/0000-0002-2318-1823; Novick, richard/0000-0003-4418-7893	Kimmel Center for Biology and Medicine; New York University Medical Center	Kimmel Center for Biology and Medicine; New York University Medical Center	We thank D. Portnoy, R. Calendar, M. Bowden, and M. Wiedmann for gifts of strains and for helpful discussions. The expert technical assistance of A. Subedi is gratefully acknowledged. This work was supported by grants-in-aid from the Kimmel Center for Biology and Medicine, from New York University Medical Center, and by personal funds (R.P.N.).	Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Brabban AD, 2005, FOODBORNE PATHOG DIS, V2, P287, DOI 10.1089/fpd.2005.2.287; CHEETHAM BF, 1995, MOL MICROBIOL, V18, P201, DOI 10.1111/j.1365-2958.1995.mmi_18020201.x; Fitzgerald JR, 2001, J BACTERIOL, V183, P63, DOI 10.1128/JB.183.1.63-70.2001; Garcia P, 2007, INT DAIRY J, V17, P1232, DOI 10.1016/j.idairyj.2007.03.014; Gill JJ, 2006, ANTIMICROB AGENTS CH, V50, P2912, DOI 10.1128/AAC.01630-05; Jensen NE, 1996, INT J FOOD MICROBIOL, V32, P209, DOI 10.1016/0168-1605(96)01105-1; KENNY K, 1993, J CLIN MICROBIOL, V31, P706, DOI 10.1128/JCM.31.3.706-707.1993; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Maiques E, 2007, J BACTERIOL, V189, P5608, DOI 10.1128/JB.00619-07; MAZODIER P, 1991, ANNU REV GENET, V25, P147, DOI 10.1146/annurev.ge.25.120191.001051; MILES H, 1992, J DAIRY SCI, V75, P596, DOI 10.3168/jds.S0022-0302(92)77797-2; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick Richard P, 2007, Chem Immunol Allergy, V93, P42, DOI 10.1159/000100857; O'Flaherty S, 2005, LETT APPL MICROBIOL, V41, P482, DOI 10.1111/j.1472-765X.2005.01781.x; Ruzin A, 2001, MOL MICROBIOL, V41, P365, DOI 10.1046/j.1365-2958.2001.02488.x; SHIMADA K, 1972, J MOL BIOL, V63, P483, DOI 10.1016/0022-2836(72)90443-3; Stephenson J, 2007, JAMA-J AM MED ASSOC, V298, P1388, DOI 10.1001/jama.298.12.1388; Stone R, 2002, SCIENCE, V298, P728, DOI 10.1126/science.298.5594.728; Subedi A, 2007, MICROBIOL-SGM, V153, P3235, DOI 10.1099/mic.0.2007/006932-0; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; WATTS JL, 1988, VET MICROBIOL, V16, P41, DOI 10.1016/0378-1135(88)90126-5	24	211	224	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					139	141		10.1126/science.1164783	http://dx.doi.org/10.1126/science.1164783			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119236				2022-12-01	WOS:000262104100060
J	Freudiger, CW; Min, W; Saar, BG; Lu, S; Holtom, GR; He, CW; Tsai, JC; Kang, JX; Xie, XS				Freudiger, Christian W.; Min, Wei; Saar, Brian G.; Lu, Sijia; Holtom, Gary R.; He, Chengwei; Tsai, Jason C.; Kang, Jing X.; Xie, X. Sunney			Label-Free Biomedical Imaging with High Sensitivity by Stimulated Raman Scattering Microscopy	SCIENCE			English	Article							IN-VIVO; CARS-MICROSCOPY; SPECTROSCOPY	Label- free chemical contrast is highly desirable in biomedical imaging. Spontaneous Raman microscopy provides specific vibrational signatures of chemical bonds, but is often hindered by low sensitivity. Here we report a three- dimensional multiphoton vibrational imaging technique based on stimulated Raman scattering ( SRS). The sensitivity of SRS imaging is significantly greater than that of spontaneous Raman microscopy, which is achieved by implementing high- frequency ( megahertz) phase- sensitive detection. SRS microscopy has a major advantage over previous coherent Raman techniques in that it offers background- free and readily interpretable chemical contrast. We show a variety of biomedical applications, such as differentiating distributions of omega- 3 fatty acids and saturated lipids in living cells, imaging of brain and skin tissues based on intrinsic lipid contrast, and monitoring drug delivery through the epidermis.	[Freudiger, Christian W.; Min, Wei; Saar, Brian G.; Lu, Sijia; Holtom, Gary R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Freudiger, Christian W.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [He, Chengwei; Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [He, Chengwei; Kang, Jing X.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Tsai, Jason C.] Pfizer Global Med, New York, NY 10017 USA	Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pfizer	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Wei, Min/GSI-8510-2022	He, Chengwei/0000-0003-4701-2984	Boehringer Ingelheim Fonds for a Ph.D. Fellowship; Army Research Office for a National Defense Science and Engineering Graduate Fellowship; NIH [CA113605]; U. S. Department of Energy's Basic Energy Sciences [DE-FG02-07ER15875]; NSF [DBI-0649892]; NIH Director's Pioneer Award; Melinda Gates Foundation Gates Foundation; Pfizer Global Medical; NATIONAL CANCER INSTITUTE [R01CA113605] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds for a Ph.D. Fellowship(Boehringer Ingelheim); Army Research Office for a National Defense Science and Engineering Graduate Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Energy's Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melinda Gates Foundation Gates Foundation(Bill & Melinda Gates Foundation); Pfizer Global Medical; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Ackermann and S. Zhang for advice on skin imaging; S. Kesari, X. Xu and the MCB Harvard Mouse Facilities for providing mouse tissue; J. Grice and M. Roberts for the loan of a sonicator; and G. Young, X. Xu, M. Ruckel, and P. Sims for helpful discussions. C.W.F. and B.G.S. thank Boehringer Ingelheim Fonds for a Ph.D. Fellowship and the Army Research Office for a National Defense Science and Engineering Graduate Fellowship, respectively. J.X.K. acknowledges support from the NIH (grant CA113605). The Xie Group is grateful to the U. S. Department of Energy's Basic Energy Sciences program (DE-FG02-07ER15875) for supporting high-sensitivity Raman detection. The instrumentation development was supported by NSF (grant DBI-0649892), NIH Director's Pioneer Award (to X.S.X.), the Bill & Melinda Gates Foundation Gates Foundation, and Pfizer Global Medical. Harvard University has filed a patent application based on this work.	BLOEMBERGEN N, 1967, AM J PHYS, V35, P989, DOI 10.1119/1.1973774; Boyd RW., 2003, NONLINEAR OPTICS; Caspers PJ, 2002, PHARMACEUT RES, V19, P1577, DOI 10.1023/A:1020481305420; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Einstein A, 1917, PHYS Z, V18, P121; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P27; Fu D, 2007, OPT LETT, V32, P2641, DOI 10.1364/OL.32.002641; Fu Y, 2006, OPT EXPRESS, V14, P3942, DOI 10.1364/OE.14.003942; Ganikhanov F, 2006, OPT LETT, V31, P1872, DOI 10.1364/OL.31.001872; Heinrich C, 2008, OPT EXPRESS, V16, P2699, DOI 10.1364/OE.16.002699; Kang JX, 2005, J MEMBRANE BIOL, V206, P165, DOI 10.1007/s00232-005-0790-3; Kukura P, 2004, J PHYS CHEM A, V108, P5921, DOI 10.1021/jp0482971; Kukura P, 2007, ANNU REV PHYS CHEM, V58, P461, DOI 10.1146/annurev.physchem.58.032806.104456; Levenson M. D., 1988, INTRO NONLINEAR LASE; LEVINE BF, 1979, IEEE J QUANTUM ELECT, V15, P1418, DOI 10.1109/JQE.1979.1069939; OWYOUNG A, 1977, OPT COMMUN, V22, P323, DOI 10.1016/S0030-4018(97)90020-1; Ploetz E, 2007, APPL PHYS B-LASERS O, V87, P389, DOI 10.1007/s00340-007-2630-x; Potma EO, 2000, J OPT SOC AM B, V17, P1678, DOI 10.1364/JOSAB.17.001678; Raman CV, 1928, NATURE, V121, P711, DOI 10.1038/121711a0; Shen Y. R, 2003, PRINCIPLE NONLINEAR; Turrell G., 1996, RAMAN MICROSCOPY DEV; Van De Kerkhof PCM, 2006, J DERMATOL TREAT, V17, P198, DOI 10.1080/09546630600830596; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; WOODBURY EJ, 1962, P IRE, V50, P2367; Ye J, 1998, J OPT SOC AM B, V15, P6, DOI 10.1364/JOSAB.15.000006; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	27	1480	1526	34	698	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1857	1861		10.1126/science.1165758	http://dx.doi.org/10.1126/science.1165758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095943	Green Accepted, Green Submitted			2022-12-01	WOS:000261799400059
J	Carter, AP; Garbarino, JE; Wilson-Kubalek, EM; Shipley, WE; Cho, C; Milligan, RA; Vale, RD; Gibbons, IR				Carter, Andrew P.; Garbarino, Joan E.; Wilson-Kubalek, Elizabeth M.; Shipley, Wesley E.; Cho, Carol; Milligan, Ronald A.; Vale, Ronald D.; Gibbons, I. R.			Structure and Functional Role of Dynein's Microtubule-Binding Domain	SCIENCE			English	Article							CYTOPLASMIC DYNEIN; MOTOR PROTEINS; TRANSPORT; RESOLUTION; MUTATIONS; MOTIONS; SITE	Dynein motors move various cargos along microtubules within the cytoplasm and power the beating of cilia and flagella. An unusual feature of dynein is that its microtubule- binding domain ( MTBD) is separated from its ring- shaped AAA+ adenosine triphosphatase ( ATPase) domain by a 15- nanometer coiled- coil stalk. We report the crystal structure of the mouse cytoplasmic dynein MTBD and a portion of the coiled coil, which supports a mechanism by which the ATPase domain and MTBD may communicate through a shift in the heptad registry of the coiled coil. Surprisingly, functional data suggest that the MTBD, and not the ATPase domain, is the main determinant of the direction of dynein motility.	[Carter, Andrew P.; Cho, Carol; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Carter, Andrew P.; Cho, Carol; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Garbarino, Joan E.; Shipley, Wesley E.; Gibbons, I. R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wilson-Kubalek, Elizabeth M.; Milligan, Ronald A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Scripps Research Institute	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu		Carter, Andrew/0000-0001-7292-5430; Cho, Carol/0000-0003-4070-6561	Jane Coffin Childs Foundation; NIH [GM52468-14, P01-AR42895, GM30401-29]; Agouron Institute; Leukemia and Lymphoma Society; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052468, R01GM097312, R01GM030401, R37GM030401, R37GM052468] Funding Source: NIH RePORTER	Jane Coffin Childs Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agouron Institute(Pfizer); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Welburn and E. Nogales for advice and equipment; M. Kikkawa for sending his group's electron density map; and N. Bradshaw, J. Kardon, K. Aathavan, A. Dose, A. Gennerich, A. Roll- Mecak, and S. Reck- Peterson for critically reading the manuscript. Supported by the Jane Coffin Childs Foundation (A.P.C.); NIH grants GM52468-14 (R.A.M.), P01-AR42895 (R.D.V.) and GM30401-29 (I.R.G.)]; the Agouron Institute (A.P.C.); the Leukemia and Lymphoma Society (A.P.C.); and the Howard Hughes Medical Institute. Crystallography data were collected at beamline 8.3.1 of the Advanced Light Source at Lawrence Berkeley National Laboratory. The atomic coordinates and structure factors have been deposited in the Protein Data Bank (code 3ERR). Cryo-EM data were collected in part at the National Resource for Automated Molecular Microscopy at the Scripps Research Institute (NIH P41 RR-17573). Maps were deposited at the EMDataBank (EMD-1581).	Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GIBBONS IR, 1995, CELL MOTIL CYTOSKEL, V32, P136, DOI 10.1002/cm.970320214; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Oda T, 2007, J CELL BIOL, V177, P243, DOI 10.1083/jcb.200609038; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zuccarello D, 2008, HUM REPROD, V23, P1957, DOI 10.1093/humrep/den193	24	181	183	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1691	1695		10.1126/science.1164424	http://dx.doi.org/10.1126/science.1164424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074350	Green Accepted			2022-12-01	WOS:000261608300045
J	Katikireddi, SV; Cloud, GC				Katikireddi, Srinivasa Vittal; Cloud, Geoffrey Christopher			Planning a patient's discharge from hospital	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSPECTIVE AUDIT; MEDICAL PATIENTS; READMISSION; CARE; RISK		[Katikireddi, Srinivasa Vittal] NHS Lothian, Edinburgh EH8 9RS, Midlothian, Scotland; [Cloud, Geoffrey Christopher] Univ London St Georges Hosp, Dept Clin Neurosci, London SW17 0QT, England	St Georges University London	Katikireddi, SV (corresponding author), NHS Lothian, Edinburgh EH8 9RS, Midlothian, Scotland.	vkatikireddi@yahoo.co.uk		Katikireddi, Srinivasa/0000-0001-6593-9092; Cloud, Geoffrey/0000-0002-8365-6907				Abramson J S, 1993, Health Soc Work, V18, P57; BOULT C, 1993, J AM GERIATR SOC, V41, P811, DOI 10.1111/j.1532-5415.1993.tb06175.x; Brown A, 1999, J SOC ADMIN PHARM, V16, P199; *CAR ENGL, 2002, HOSP DISCH PRACT BRI; Carers UK, 2007, REAL CHANG NOT SHORT; Chu LW, 1999, GERONTOLOGY, V45, P220, DOI 10.1159/000022091; Dawson R, 1998, ANN ROY COLL SURG, V80, P229; *DEP HLTH, 2007, NAT FRAM NHS CONT HE; *DEP HLTH, 2003, DISCH HOSP PATHW PRO; Kwok T, 1999, J ROY COLL PHYS LOND, V33, P153; Macaulay EM, 1996, BRIT J SURG, V83, P788, DOI 10.1002/bjs.1800830619; Melis RJF, 2004, BRIT MED J, V329, P360, DOI 10.1136/bmj.329.7462.360; Nazareth I, 2001, AGE AGEING, V30, P33, DOI 10.1093/ageing/30.1.33; SACHS SB, 2000, NURS PRACT FORUM, V11, P65; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; *SIGN, 2003, 65 SIGN; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206	17	12	13	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 12	2008	337								a2694	10.1136/bmj.a2694	http://dx.doi.org/10.1136/bmj.a2694			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CC	19074562				2022-12-01	WOS:000262777000002
J	Zhang, XQ; Chen, SH; Yoo, S; Chakrabarti, S; Zhang, T; Ke, T; Oberti, C; Yong, SL; Fang, F; Li, L; de la Fuente, R; Wang, LJ; Chen, QY; Wang, QK				Zhang, Xianqin; Chen, Shenghan; Yoo, Shin; Chakrabarti, Susmita; Zhang, Teng; Ke, Tie; Oberti, Carlos; Yong, Sandro L.; Fang, Fang; Li, Lin; de la Fuente, Roberto; Wang, Lejin; Chen, Qiuyun; Wang, Qing Kenneth			Mutation in Nuclear Pore Component NUP155 Leads to Atrial Fibrillation and Early Sudden Cardiac Death	CELL			English	Article							NATRIURETIC-PEPTIDE; COMPLEX PROTEIN; SCN5A MUTATION; MESSENGER-RNA; HEAT-SHOCK; GENE; ASSOCIATION; ENVELOPE; GENOME; HEAT-SHOCK-PROTEIN-70	Atrial fibrillation (AF) is the most common form of sustained clinical arrhythmia. We previously mapped an AF locus to chromosome 5p13 in an AF family with sudden death in early childhood. Here we show that the specific AF gene underlying this linkage is NUP155, which encodes a member of the nucleoporins, the components of the nuclear pore complex (NPC). We have identified a homozygous mutation, R391H, in NUP155 that cosegregates with AF, affects nuclear localization of NUP155, and reduces nuclear envelope permeability. Homozygous NUP155(-/-) knockout mice die before E8.5, but heterozygous NUP155(+/-) mice show the AF phenotype. The R391H mutation and reduction of NUP155 are associated with inhibition of both export of Hsp70 mRNA and nuclear import of Hsp70 protein. These human and mouse studies indicate that loss of NUP155 function causes AF by altering mRNA and protein transport and link the NPC to cardiovascular disease.	[Zhang, Xianqin; Chen, Shenghan; Yoo, Shin; Chakrabarti, Susmita; Zhang, Teng; Ke, Tie; Oberti, Carlos; Yong, Sandro L.; Fang, Fang; Li, Lin; Wang, Lejin; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Lerner Coll Med,Ctr Cardiovasc Genet, Cleveland Clin,Lerner Res Inst,Dept Mol Cardiol, Dept Mol Med,Taussig Canc Ctr,Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Zhang, Xianqin; Ke, Tie; Wang, Lejin; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Zhang, Xianqin; Ke, Tie; Wang, Lejin; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China; [Oberti, Carlos; de la Fuente, Roberto] Osped Italiano Umberto I, Dept Cardiol, Montevideo 11600, Uruguay; [Fang, Fang; Wang, Qing Kenneth] Cleveland State Univ, Dept Chem, Cleveland, OH 44107 USA	Case Western Reserve University; Cleveland Clinic Foundation; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University System of Ohio; Cleveland State University	Wang, QK (corresponding author), Case Western Reserve Univ, Lerner Coll Med,Ctr Cardiovasc Genet, Cleveland Clin,Lerner Res Inst,Dept Mol Cardiol, Dept Mol Med,Taussig Canc Ctr,Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wangq2@ccf.org	zhang, xianqin/GYE-0638-2022; Chakrabarti, Susmita/CAH-2331-2022; Ke, Tie/AIC-5771-2022	Chakrabarti, Susmita/0000-0003-1197-2780; Ke, Tie/0000-0002-8888-8424				Afzal AR, 2008, CARDIOLOGY, V110, P45, DOI 10.1159/000109406; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Chou CC, 2008, CONTEMP CARDIOL, P101, DOI 10.1007/978-1-59745-163-5_8; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Ehrlich JR, 2008, CONTEMP CARDIOL, P37, DOI 10.1007/978-1-59745-163-5_4; Franz C, 2005, EMBO J, V24, P3519, DOI 10.1038/sj.emboj.7600825; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grote P, 2006, NAT PROTOC, V1, P3034, DOI 10.1038/nprot.2006.460; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Hoelz A, 2004, NATURE, V432, P815, DOI 10.1038/432815a; Kampinga HH, 2007, CELL STRESS CHAPERON, V12, P97, DOI 10.1379/CSC-285.1; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Kim YK, 2006, CIRCULATION, V113, P2589, DOI 10.1161/CIRCULATIONAHA.105.598409; Knight BP, 2003, PACE, V26, P1620, DOI 10.1046/j.1460-9592.2003.t01-1-00241.x; Laramie JM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-17; Mandal K, 2005, ANN THORAC SURG, V79, P865, DOI 10.1016/j.athoracsur.2004.08.018; Nattel S, 1999, CARDIOVASC RES, V42, P298, DOI 10.1016/S0008-6363(99)00022-X; Oberti C, 2004, CIRCULATION, V110, P3753, DOI 10.1161/01.CIR.0000150333.87176.C7; Peters NS, 2002, LANCET, V359, P593, DOI 10.1016/S0140-6736(02)07748-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RADU A, 1993, J CELL BIOL, V121, P1, DOI 10.1083/jcb.121.1.1; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Rose RA, 2004, AM J PHYSIOL-HEART C, V286, pH1970, DOI 10.1152/ajpheart.00893.2003; Savelieva I, 2004, EUROPACE, V5, pS5, DOI 10.1016/j.eupc.2004.07.003; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; St Rammos K, 2002, CARDIOVASC SURG, V10, P228; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Van Wagoner DR, 2000, J MOL CELL CARDIOL, V32, P1101, DOI 10.1006/jmcc.2000.1147; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang QK, 2008, CONTEMP CARDIOL, P133, DOI 10.1007/978-1-59745-163-5_10; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yong SRL, 2007, BIOCHEM BIOPH RES CO, V352, P378, DOI 10.1016/j.bbrc.2006.11.019; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373; Zhang T, 2007, BIOCHEM BIOPH RES CO, V355, P444, DOI 10.1016/j.bbrc.2007.01.170; Zhang XQ, 2002, GENE, V288, P9, DOI 10.1016/S0378-1119(02)00470-5; Zhang XQ, 1999, GENOMICS, V57, P144, DOI 10.1006/geno.1999.5741	45	203	213	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1017	1027		10.1016/j.cell.2008.10.022	http://dx.doi.org/10.1016/j.cell.2008.10.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070573	Bronze			2022-12-01	WOS:000261642800018
J	Donnelly, P				Donnelly, Peter			Progress and challenges in genome-wide association studies in humans	NATURE			English	Article							SUSCEPTIBILITY LOCI; PROSTATE-CANCER; BREAST-CANCER; VARIANTS; DISEASE; RISK; REPLICATION; HEIGHT	After more than a decade of hope and hype, researchers are finally making inroads into understanding the genetic basis of many common human diseases. The use of genome- wide association studies has broken the logjam, enabling genetic variants at specific loci to be associated with particular diseases. Genetic association data are now providing new routes to understanding the aetiology of disease, as well as new footholds on the long and difficult path to better treatment and disease prevention.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	peter.donnelly@well.ox.ac.uk		Donnelly, Peter/0000-0001-9495-3408				Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; ORAHILLY SP, 1986, LANCET, V2, P360; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	20	251	262	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					728	731		10.1038/nature07631	http://dx.doi.org/10.1038/nature07631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079049				2022-12-01	WOS:000261559900036
J	Gsponer, J; Futschik, ME; Teichmann, SA; Babu, MM				Gsponer, Jorg; Futschik, Matthias E.; Teichmann, Sarah A.; Babu, M. Madan			Tight Regulation of Unstructured Proteins: From Transcript Synthesis to Protein Degradation	SCIENCE			English	Article							INTRINSIC DISORDER; ALPHA-SYNUCLEIN; METABOLISM; P27(KIP1); BINDING; CANCER; P27	Altered abundance of several intrinsically unstructured proteins ( IUPs) has been associated with perturbed cellular signaling that may lead to pathological conditions such as cancer. Therefore, it is important to understand how cells precisely regulate the availability of IUPs. We observed that regulation of transcript clearance, proteolytic degradation, and translational rate contribute to controlling the abundance of IUPs, some of which are present in low amounts and for short periods of time. Abundant phosphorylation and low stochasticity in transcription and translation indicate that the availability of IUPs can be finely tuned. Fidelity in signaling may require that most IUPs be available in appropriate amounts and not present longer than needed.	[Gsponer, Jorg; Futschik, Matthias E.; Teichmann, Sarah A.; Babu, M. Madan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Futschik, Matthias E.] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Futschik, Matthias E.] Univ Algarve, Inst Biotechnol & Bioengn, Ctr Mol & Struct Biomed, P-8005139 Faro, Portugal	MRC Laboratory Molecular Biology; Humboldt University of Berlin; Universidade do Algarve	Gsponer, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	jgsponer@mrc-lmb.cam.ac.uk; madanm@mrc-lmb.cam.ac.uk	Futschik, Matthias/AAK-8837-2020; Mohan, Babu P./I-7362-2019	Futschik, Matthias/0000-0002-6245-8071; Teichmann, Sarah/0000-0002-6294-6366	Royal Society; MRC Special Training Fellowship; Medical Research Council [MC_U105161047, MC_U105185859, G0600158] Funding Source: researchfish; MRC [G0600158, MC_U105185859, MC_U105161047] Funding Source: UKRI	Royal Society(Royal Society of London); MRC Special Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge MRC for funding and thank the two anonymous referees, the editor, A. Bertolotti, A. Tzakos, A. Wuster, C. Brockmann, C. Chothia, D. Finley, D. Rubinsztein, E. Levy, H. McMahon, I. Schafer, J. Bui, K. Weber, M. Goedert, R. Janky, S. Michnick, and S. Sarkar for providing helpful comments. We apologize for, because of lack of space, not citing the work that describes the datasets and other references. Many can be found in the SOM. M.M.B. acknowledges Darwin College and Schlumberger Ltd, and M.M.B. and M.E.F. acknowledge the Royal Society for support. J.G. is funded by an MRC Special Training Fellowship in computational biology.	Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Mathes E, 2008, EMBO J, V27, P1421, DOI 10.1038/emboj.2008.91; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sunde M, 2004, CANCER RES, V64, P2766, DOI 10.1158/0008-5472.CAN-03-2093; Tambyrajah WS, 2007, ARCH BIOCHEM BIOPHYS, V466, P186, DOI 10.1016/j.abb.2007.07.019; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	29	346	347	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1365	1368		10.1126/science.1163581	http://dx.doi.org/10.1126/science.1163581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039133	Green Submitted, Green Accepted			2022-12-01	WOS:000261170600035
J	Zhao, C; Chen, A; Jamieson, CH; Fereshteh, M; Abrahamsson, A; Blum, J; Kwon, HY; Kim, J; Chute, JP; Rizzieri, D; Munchhof, M; VanArsdale, T; Beachy, PA; Reya, T				Zhao, Chen; Chen, Alan; Jamieson, Catriona H.; Fereshteh, Mark; Abrahamsson, Annelie; Blum, Jordan; Kwon, Hyog Young; Kim, Jynho; Chute, John P.; Rizzieri, David; Munchhof, Michael; VanArsdale, Todd; Beachy, Philip A.; Reya, Tannishtha			Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; SONIC HEDGEHOG; RESISTANCE; GENE; PROLIFERATION; PROGENITORS; MECHANISMS; PATHWAYS; THERAPY	Although the role of Hedgehog (Hh) signalling in embryonic pattern formation is well established(1), its functions in adult tissue renewal and maintenance remain unclear, and the relationship of these functions to cancer development has not been determined. Here we show that the loss of Smoothened (Smo), an essential component of the Hh pathway(2), impairs haematopoietic stem cell renewal and decreases induction of chronic myelogenous leukaemia (CML) by the BCR-ABL1 oncoprotein(3). Loss of Smo causes depletion of CML stem cells-the cells that propagate the leukaemia-whereas constitutively active Smo augments CML stem cell number and accelerates disease. As a possible mechanism for Smo action, we show that the cell fate determinant Numb, which depletes CML stem cells, is increased in the absence of Smo activity. Furthermore, pharmacological inhibition of Hh signalling impairs not only the propagation of CML driven by wild-type BCR-ABL1, but also the growth of imatinib-resistant mouse and human CML. These data indicate that Hh pathway activity is required for maintenance of normal and neoplastic stem cells of the haematopoietic system and raise the possibility that the drug resistance and disease recurrence associated with imatinib treatment of CML4,5 might be avoided by targeting this essential stem cell maintenance pathway.	[Zhao, Chen; Chen, Alan; Fereshteh, Mark; Blum, Jordan; Kwon, Hyog Young; Reya, Tannishtha] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Chute, John P.; Rizzieri, David] Duke Univ, Med Ctr, Dept Med, Div Cellular Therapy, Durham, NC 27710 USA; [Jamieson, Catriona H.; Abrahamsson, Annelie] Moores UCSD Canc Ctr Jolla, Stem Cell Res Program, Dept Med, La Jolla, CA 92093 USA; [Kim, Jynho; Beachy, Philip A.] Stanford Univ, Med Ctr, Howard Hughes Med Inst, Dept Dev Biol,Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Munchhof, Michael] Pfizer Labs, Div Med Chem, Groton, CT 06340 USA; [VanArsdale, Todd] Pfizer Labs, Div Oncol, La Jolla, CA 92121 USA	Duke University; Duke University; Howard Hughes Medical Institute; Stanford University; Pfizer; Pfizer	Reya, T (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	t.reya@duke.edu	Kwon, Hyog/T-7915-2019	Kwon, Hyog/0000-0003-1663-5118	CRI; EMF; Leukemia and Lymphoma Society; Duke Molecular Cancer Biology Training; California Institute of Regenerative Medicine; National Institutes of Health [DK63031, DK072234, AI067798]; Lisa Stafford Memorial Prize; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072234, R01DK063031] Funding Source: NIH RePORTER	CRI; EMF; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Duke Molecular Cancer Biology Training; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lisa Stafford Memorial Prize; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We wish to thank R. Wechsler-Reya for critical advice, D. Kioussis for Vav-Cre transgenic mice, A. M. Pendergast, A. Means and B. Hogan for review of the manuscript, S. Li for advice on mouse CML experiments, G. Daley, M. Azam and S. Li for the T315I BCR-ABL1 construct, B. Harvat for cell sorting, and J. Harris, B. Zimdahl, N. D'Amato and S. Honeycutt for experimental help. T. R. is a recipient of a CRI Investigator Award, an EMF New Scholar award and a Leukemia and Lymphoma Society Scholar Award, M. F. is supported by the Duke Molecular Cancer Biology Training grant and C. H. J. is funded by the California Institute of Regenerative Medicine and a sponsored research agreement with Pfizer. This work was also supported by National Institutes of Health grants DK63031, DK072234, AI067798 and the Lisa Stafford Memorial Prize to T. R.	Adams JM, 2007, SCIENCE, V318, DOI 10.1126/science.1149672; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; Long FX, 2001, DEVELOPMENT, V128, P5099; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	30	678	726	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					776	U117		10.1038/nature07737	http://dx.doi.org/10.1038/nature07737			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19169242	Green Accepted			2022-12-01	WOS:000265193600044
J	Kafri, R; Springer, M; Pilpel, Y				Kafri, Ran; Springer, Michael; Pilpel, Yitzhak			Genetic Redundancy: New Tricks for Old Genes	CELL			English	Editorial Material							DUPLICATED GENES; YEAST; EVOLUTION; GENOME	Many crucial components of signal transduction, developmental, and metabolic pathways have functionally redundant copies. Further, these redundancies show surprising evolutionary stability over prolonged time scales. We propose that redundancies are not just archeological leftovers of ancient gene duplications, but rather that synergy arising from feedback between redundant copies may serve as an information processing element that facilitates signal transduction and the control of gene expression.	[Kafri, Ran; Springer, Michael] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Harvard University; Harvard Medical School; Weizmann Institute of Science	Kafri, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	ran_kafri@hms.harvard.edu; pilpel@weizmann.ac.il						Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Kafri R, 2008, P NATL ACAD SCI USA, V105, P1243, DOI 10.1073/pnas.0711043105; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kirschner M, 2005, PLAUSIBILITY LIFE RE; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; TISCHLER J, 2006, MOL BIOL EVOL, V20, P772	15	125	126	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 6	2009	136	3					389	392		10.1016/j.cell.2009.01.027	http://dx.doi.org/10.1016/j.cell.2009.01.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203571	Bronze			2022-12-01	WOS:000263120600006
J	Wegrzyn, J; Potla, R; Chwae, YJ; Sepuri, NBV; Zhang, QF; Koeck, T; Derecka, M; Szczepanek, K; Szelag, M; Gornicka, A; Moh, A; Moghaddas, S; Chen, Q; Bobbili, S; Cichy, J; Dulak, J; Baker, DP; Wolfman, A; Stuehr, D; Hassan, MO; Fu, XY; Avadhani, N; Drake, JI; Fawcett, P; Lesnefsky, EJ; Larner, AC				Wegrzyn, Joanna; Potla, Ramesh; Chwae, Yong-Joon; Sepuri, Naresh B. V.; Zhang, Qifang; Koeck, Thomas; Derecka, Marta; Szczepanek, Karol; Szelag, Magdalena; Gornicka, Agnieszka; Moh, Akira; Moghaddas, Shadi; Chen, Qun; Bobbili, Santha; Cichy, Joanna; Dulak, Jozef; Baker, Darren P.; Wolfman, Alan; Stuehr, Dennis; Hassan, Medhat O.; Fu, Xin-Yuan; Avadhani, Narayan; Drake, Jennifer I.; Fawcett, Paul; Lesnefsky, Edward J.; Larner, Andrew C.			Function of Mitochondrial Stat3 in Cellular Respiration	SCIENCE			English	Article							REGULATORY GENE-PRODUCT; INTERFERON-BETA; COMPLEX-I; GRIM-19; SUBUNIT; PROTEIN; DOMAIN; NADH	Cytokines such as interleukin- 6 induce tyrosine and serine phosphorylation of Stat3 that results in activation of Stat3- responsive genes. We provide evidence that Stat3 is present in the mitochondria of cultured cells and primary tissues, including the liver and heart. In Stat3(-/-) cells, the activities of complexes I and II of the electron transport chain ( ETC) were significantly decreased. We identified Stat3 mutants that selectively restored the protein's function as a transcription factor or its functions within the ETC. In mice that do not express Stat3 in the heart, there were also selective defects in the activities of complexes I and II of the ETC. These data indicate that Stat3 is required for optimal function of the ETC, which may allow it to orchestrate responses to cellular homeostasis.	[Wegrzyn, Joanna; Chwae, Yong-Joon; Zhang, Qifang; Derecka, Marta; Szczepanek, Karol; Szelag, Magdalena; Gornicka, Agnieszka; Bobbili, Santha; Fawcett, Paul] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Wegrzyn, Joanna; Chwae, Yong-Joon; Zhang, Qifang; Derecka, Marta; Szczepanek, Karol; Szelag, Magdalena; Gornicka, Agnieszka; Bobbili, Santha; Fawcett, Paul] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Wegrzyn, Joanna; Szelag, Magdalena; Dulak, Jozef] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Potla, Ramesh; Stuehr, Dennis] Cleveland State Univ, Dept Biol, Cleveland, OH 44114 USA; [Sepuri, Naresh B. V.] Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India; [Koeck, Thomas; Stuehr, Dennis] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Derecka, Marta; Szczepanek, Karol; Cichy, Joanna] Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Gornicka, Agnieszka] Jagiellonian Univ, Dept Cell Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Moh, Akira; Fu, Xin-Yuan] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Moghaddas, Shadi; Chen, Qun; Lesnefsky, Edward J.] Case Western Reserve Univ, Div Cardiol, Dept Med, Cleveland, OH 44106 USA; [Baker, Darren P.] Biogenldec, Cambridge, MA 02142 USA; [Wolfman, Alan] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Hassan, Medhat O.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Pathol & Lab Med Serv, Cleveland, OH 44106 USA; [Avadhani, Narayan] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Drake, Jennifer I.; Fawcett, Paul] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Med Serv, Cleveland, OH 44106 USA	Virginia Commonwealth University; Virginia Commonwealth University; Jagiellonian University; University System of Ohio; Cleveland State University; University of Hyderabad; Cleveland Clinic Foundation; Jagiellonian University; Jagiellonian University; Indiana University System; Indiana University-Purdue University Indianapolis; Case Western Reserve University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Pennsylvania; Virginia Commonwealth University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Larner, AC (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	alarner@vcu.edu	zhang, qifang/H-5691-2013; Sepuri, Naresh/AAF-2704-2020; zhang, qifang/F-9857-2013	Cichy, Joanna/0000-0002-0552-8344; Derecka, Marta/0000-0001-6265-9781	NIH [CA098924, PO1AG15885]; Office of Research and Development; Medical Research Service Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA098924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development; Medical Research Service Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants CA098924 (A.C.L.) and PO1AG15885 and the Office of Research and Development, Medical Research Service Department of Veterans Affairs (E.J.L.). We thank I. Scheffler for his many suggestions. DHQ was a kind gift from C. Hoppel. This manuscript is dedicated to Joseph Larner in honor of 60 years of scientific achievement and enthusiasm.	Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Gamero AM, 2006, J BIOL CHEM, V281, P16238, DOI 10.1074/jbc.M509516200; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3	14	681	700	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					793	797		10.1126/science.1164551	http://dx.doi.org/10.1126/science.1164551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19131594	Green Accepted, Green Submitted			2022-12-01	WOS:000263066800050
J	Honjoh, S; Yamamoto, T; Uno, M; Nishida, E				Honjoh, Sakiko; Yamamoto, Takuya; Uno, Masaharu; Nishida, Eisuke			Signalling through RHEB-1 mediates intermittent fasting-induced longevity in C-elegans	NATURE			English	Article							LIFE-SPAN EXTENSION; RESTRICTION-INDUCED LONGEVITY; MESSENGER-RNA TRANSLATION; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; TOR; DAF-16; DEPRIVATION; INHIBITION; RESISTANCE	Dietary restriction is the most effective and reproducible intervention to extend lifespan in divergent species(1). In mammals, two regimens of dietary restriction, intermittent fasting ( IF) and chronic caloric restriction, have proven to extend lifespan and reduce the incidence of age- related disorders(2). An important characteristic of IF is that it can increase lifespan even when there is little or no overall decrease in calorie intake(2). The molecular mechanisms underlying IF- induced longevity, however, remain largely unknown. Here we establish an IF regimen that effectively extends the lifespan of Caenorhabditis elegans, and show that the low molecular weight GTPase RHEB- 1 has a dual role in lifespan regulation; RHEB- 1 is required for the IF- induced longevity, whereas inhibition of RHEB- 1 mimics the caloric- restriction effects. RHEB- 1 exerts its effects in part by the insulin/ insulin growth factor ( IGF)- like signalling effector DAF- 16 in IF. Our analyses demonstrate that most fasting- induced upregulated genes require RHEB- 1 function for their induction, and that RHEB- 1 and TOR signalling are required for the fasting- induced downregulation of an insulin- like peptide, INS- 7. These findings identify the essential role of signalling by RHEB- 1 in IF- induced longevity and gene expression changes, and suggest a molecular link between the IF- induced longevity and the insulin/ IGF- like signalling pathway.	[Honjoh, Sakiko; Yamamoto, Takuya; Uno, Masaharu; Nishida, Eisuke] Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nishida, E (corresponding author), Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	L50174@sakura.kudpc.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017	Yamamoto, Takuya/0000-0002-0022-3947; Uno, Masaharu/0000-0001-7770-3941	Ministry of Education, Culture, Sports, Science and Technology of Japan; NIH National Center for Research Resources	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank members of our laboratory for technical comments and helpful discussion. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E.N.). Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Anson RM, 2005, AGE, V27, P17, DOI 10.1007/s11357-005-3286-2; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BRENNER S, 1974, GENETICS, V77, P71; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Malone EA, 1996, GENETICS, V143, P1193; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Weinkove D, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-1	33	171	179	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					726	U6		10.1038/nature07583	http://dx.doi.org/10.1038/nature07583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19079239				2022-12-01	WOS:000263064700042
J	Taylor, AF; Tinsley, MR; Wang, F; Huang, ZY; Showalter, K				Taylor, Annette F.; Tinsley, Mark R.; Wang, Fang; Huang, Zhaoyang; Showalter, Kenneth			Dynamical Quorum Sensing and Synchronization in Large Populations of Chemical Oscillators	SCIENCE			English	Article							EMERGING COHERENCE; FISCHERI; WAVES; CELLS	Populations of certain unicellular organisms, such as suspensions of yeast in nutrient solutions, undergo transitions to coordinated activity with increasing cell density. The collective behavior is believed to arise through communication by chemical signaling via the extracellular solution. We studied large, heterogeneous populations of discrete chemical oscillators (similar to 100,000) with well- defined kinetics to characterize two different types of density- dependent transitions to synchronized oscillatory behavior. For different chemical exchange rates between the oscillators and the surrounding solution, increasing oscillator density led to ( i) the gradual synchronization of oscillatory activity, or ( ii) the sudden "switching on" of synchronized oscillatory activity. We analyze the roles of oscillator density and exchange rate of signaling species in these transitions with a mathematical model of the interacting chemical oscillators.	[Tinsley, Mark R.; Wang, Fang; Huang, Zhaoyang; Showalter, Kenneth] W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA; [Taylor, Annette F.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	West Virginia University; University of Leeds	Showalter, K (corresponding author), W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA.	kshowalt@wvu.edu	Showalter, Kenneth/P-3460-2015; taylor, annette/Z-1062-2018	Showalter, Kenneth/0000-0003-3443-9911; taylor, annette/0000-0003-0071-8306	UK Engineering and Physical Sciences Research Council [GR/T11036/01]; NSF [CHE-0809058]; Engineering and Physical Sciences Research Council [GR/T11036/01] Funding Source: researchfish; Division Of Chemistry [0809058] Funding Source: National Science Foundation	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NSF(National Science Foundation (NSF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by UK Engineering and Physical Sciences Research Council grant GR/T11036/01 (A.F.T.) and by NSF grant CHE-0809058. We dedicate this paper to the memory of Anatol M. Zhabotinsky, a pioneer of modern research in oscillations and pattern formation in chemical systems.	ALDRIDGE J, 1976, NATURE, V259, P670, DOI 10.1038/259670a0; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Dano S, 1999, NATURE, V402, P320, DOI 10.1038/46329; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; ENGEBRECHT J, 1983, CELL, V32, P773, DOI 10.1016/0092-8674(83)90063-6; ERMENTROUT GB, 1990, PHYSICA D, V41, P219, DOI 10.1016/0167-2789(90)90124-8; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; GERISCH G, 1974, P NATL ACAD SCI USA, V71, P2118, DOI 10.1073/pnas.71.5.2118; Greenberg EP, 1997, ASM NEWS, V63, P371; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; MASELKO J, 1989, J PHYS CHEM-US, V93, P2774, DOI 10.1021/j100344a016; MASELKO J, 1989, NATURE, V339, P609, DOI 10.1038/339609a0; Patriquin GM, 2008, J BACTERIOL, V190, P662, DOI 10.1128/JB.01473-07; SHINOMOTO S, 1986, PROG THEOR PHYS, V75, P1105, DOI 10.1143/PTP.75.1105; Toth R, 2006, J PHYS CHEM B, V110, P10170, DOI 10.1021/jp060732z; Winfree AT, 2002, SCIENCE, V298, P2336, DOI 10.1126/science.1072560; Yoshikawa K, 1998, J PHYS CHEM A, V102, P7649, DOI 10.1021/jp982136d; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0; ZHABOTINSKY AM, 1993, J PHYS CHEM-US, V97, P7578, DOI 10.1021/j100131a030	20	311	315	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					614	617		10.1126/science.1166253	http://dx.doi.org/10.1126/science.1166253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179525				2022-12-01	WOS:000262862800037
J	Barker, N; Ridgway, RA; van Es, JH; van de Wetering, M; Begthel, H; van den Born, M; Danenberg, E; Clarke, AR; Sansom, OJ; Clevers, H				Barker, Nick; Ridgway, Rachel A.; van Es, Johan H.; van de Wetering, Marc; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; Clarke, Alan R.; Sansom, Owen J.; Clevers, Hans			Crypt stem cells as the cells-of-origin of intestinal cancer	NATURE			English	Article							MOUSE SMALL INTESTINE; BETA-CATENIN; COLORECTAL-CANCER; PANETH CELLS; IN-VIVO; GENE; APC; DIFFERENTIATION; EPITHELIUM; COLON	Intestinal cancer is initiated by Wnt- pathway- activating mutations in genes such as adenomatous polyposis coli ( APC). As in most cancers, the cell of origin has remained elusive. In a previously established Lgr5 ( leucine- rich- repeat containing G- protein-coupled receptor 5) knockin mouse model, a tamoxifen- inducible Cre recombinase is expressed in long- lived intestinal stem cells(1). Here we show that deletion of Apc in these stem cells leads to their transformation within days. Transformed stem cells remain located at crypt bottoms, while fuelling a growing microadenoma. These microadenomas show unimpeded growth and develop into macroscopic adenomas within 3-5 weeks. The distribution of Lgr5(+) cells within stem- cell- derived adenomas indicates that a stem cell/ progenitor cell hierarchy is maintained in early neoplastic lesions. When Apc is deleted in short- lived transit- amplifying cells using a different cre mouse, the growth of the induced microadenomas rapidly stalls. Even after 30 weeks, large adenomas are very rare in these mice. We conclude that stem- cell- specific loss of Apc results in progressively growing neoplasia.	[Barker, Nick; van Es, Johan H.; van de Wetering, Marc; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Ridgway, Rachel A.; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Clarke, Alan R.] Cardiff Sch Biosci, Cardiff CF10 3US, Wales	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Beatson Institute; Cardiff University	Clevers, H (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@niob.knaw.nl	van+Es, Johan/ABD-5411-2021; Barker, Nick/AAS-2774-2020; Barker, Nick/AAE-9833-2021; clarke, alan r/P-2820-2014; Barker, Nick/A-5535-2011; Clarke, Alan R/A-6256-2008	Barker, Nick/0000-0003-3566-4475; Danenberg, Esther/0000-0002-1799-4457; Sansom, Owen J./0000-0001-9540-3010; Clarke, Alan/0000-0002-4281-426X	Cancer Research UK; KWF program [PF-HUBR-2007-3956]; MRC [G0301154] Funding Source: UKRI; Medical Research Council [G0301154] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); KWF program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Cozijnsen, J. Korving, C. Nixon, M. Macdonald and B. Doyle for technical help. O.J.S. is funded by Cancer Research UK. N. B. and H. C. are supported by KWF program grant PF-HUBR-2007-3956.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P65, DOI 10.1002/aja.1001600106; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; POTTEN CS, 1975, B CANCER, V62, P419; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039	30	1523	1566	5	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					608	U119		10.1038/nature07602	http://dx.doi.org/10.1038/nature07602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19092804				2022-12-01	WOS:000262852200047
J	Gotzsche, PC; Hartling, OJ; Nielsen, M; Brodersen, J; Jorgensen, KJ				Gotzsche, Peter C.; Hartling, Ole J.; Nielsen, Margrethe; Brodersen, John; Jorgensen, Karsten Juhl			Breast screening: the facts-or maybe not	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; WOMEN		[Gotzsche, Peter C.; Nielsen, Margrethe; Jorgensen, Karsten Juhl] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Hartling, Ole J.] Dept Nucl Med, Vejle Sygehus, Denmark; [Brodersen, John] Univ Copenhagen, Dept Gen Practice, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Gotzsche, PC (corresponding author), Rigshosp, Nord Cochrane Ctr, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	pcg@cochrane.dk		Jorgensen, Karsten/0000-0001-8554-0388; Brodersen, John Brandt/0000-0001-9369-3376	KraeftFonden	KraeftFonden	Production and distribution of our leaflet in Denmark was funded by KraeftFonden.	Barton MB, 2001, J GEN INTERN MED, V16, P150, DOI 10.1046/j.1525-1497.2001.00329.x; Brodersen J., 2006, MEASURING PSYCHOSOCI; Brodersen J, 2007, VALUE HEALTH, V10, P294, DOI 10.1111/j.1524-4733.2007.00184.x; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; *DEP HLTH, 2006, NHS CANC SCREEN PROG; Domenighetti G, 2003, INT J EPIDEMIOL, V32, P816, DOI 10.1093/ije/dyg257; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; General Medical Council, 2008, CONS PAT DOCT MAK DE; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Hofvind S, 2004, CANCER-AM CANCER SOC, V101, P1501, DOI 10.1002/cncr.20528; Jorgensen KJ, 2006, BMJ-BRIT MED J, V332, P538, DOI 10.1136/bmj.332.7540.538; JORGENSEN KJ, BMJ IN PRESS; Perry N., 2006, EUROPEAN GUIDELINES; Raffle AE, 2007, SCREENING EVIDENCE P; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Thornton H, 2003, BMJ-BRIT MED J, V327, P101, DOI 10.1136/bmj.327.7406.101; Vainio H, 2002, IARC HDB CANC PREVEN, V7; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	18	76	77	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2009	338								b86	10.1136/bmj.b86	http://dx.doi.org/10.1136/bmj.b86			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EL	19174442				2022-12-01	WOS:000263205400003
J	Elde, NC; Child, SJ; Geballe, AP; Malik, HS				Elde, Nels C.; Child, Stephanie J.; Geballe, Adam P.; Malik, Harmit S.			Protein kinase R reveals an evolutionary model for defeating viral mimicry	NATURE			English	Article							POSITIVE SELECTION; SUBSTRATE RECOGNITION; MOLECULAR MIMICRY; ANTIVIRAL PROTEIN; CRYSTAL-STRUCTURE; PKR; YEAST; BACTERIAL; RNA; K3L	Distinguishing self from non- self is a fundamental biological challenge. Many pathogens exploit the challenge of self discrimination by employing mimicry to subvert key cellular processes including the cell cycle, apoptosis and cytoskeletal dynamics(1-5). Other mimics interfere with immunity(6,7). Poxviruses encode K3L, a mimic of eIF2 alpha, which is the substrate of protein kinase R ( PKR), an important component of innate immunity in vertebrates(8,9). The PKR - K3L interaction exemplifies the conundrum imposed by viral mimicry. To be effective, PKR must recognize a conserved substrate (eIF2 alpha) while avoiding rapidly evolving substrate mimics such as K3L. Using the PKR - K3L system and a combination of phylogenetic and functional analyses, we uncover evolutionary strategies by which host proteins can overcome mimicry. We find that PKR has evolved under intense episodes of positive selection in primates. The ability of PKR to evade viral mimics is partly due to positive selection at sites most intimately involved in eIF2 alpha recognition. We also find that adaptive changes on multiple surfaces of PKR produce combinations of substitutions that increase the odds of defeating mimicry. Thus, although it can seem that pathogens gain insurmountable advantages by mimicking cellular components, host factors such as PKR can compete in molecular 'arms races' with mimics because of evolutionary flexibility at protein interaction interfaces challenged by mimicry.	[Elde, Nels C.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Child, Stephanie J.; Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Geballe, Adam P.] Univ Washington, Dept Med, Seattle, WA 98115 USA; [Geballe, Adam P.] Univ Washington, Dept Microbiol, Seattle, WA 98115 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Malik, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	hsmalik@fhcrc.org	Malik, Harmit S/I-5591-2019; Malik, Harmit S/E-8519-2012	Malik, Harmit S/0000-0001-6005-0016; Child, Stephanie/0000-0002-1987-9540	NIH [AI026672]; Searle Scholar; Burroughs Wellcome Investigator Award; Ellison Medical Foundation Fellow of the Life Sciences Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI026672, R01AI026672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar; Burroughs Wellcome Investigator Award(Burroughs Wellcome Fund); Ellison Medical Foundation Fellow of the Life Sciences Research Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Dever for yeast strains and advice; J. Tartaglia and B. Jacobs for valuable reagents; and S. Biggins and S. Furuyama for yeast expression plasmids and advice, and M. Emerman, S. Henikoff, S. Biggins, A. Turkewitz, D. Gottschling, D. Koshland, E. Smith, J. Kerns, S. Sawyer and D. Vermaak for comments and suggestions. We are supported by NIH grant AI026672 (A.P.G.) and a Searle Scholar and Burroughs Wellcome Investigator Award (H.S.M.). N.C.E. is an Ellison Medical Foundation Fellow of the Life Sciences Research Foundation.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Babkin IV, 2006, MOL BIOL+, V40, P20; BEATTIE E, 1991, VIROLOGY, V183, P419, DOI 10.1016/0042-6822(91)90158-8; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; DeLano WL, 2004, PYMOL USERS MANUAL; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Earl PL, 2001, CURR PROTOCOLS PROTE, DOI [10.1002/0471140864.ps0512s13, DOI 10.1002/0471140864.PS0512S13]; Essbauer S, 2001, VIRUS GENES, V23, P347, DOI 10.1023/A:1012533625571; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Sawyer SL, 2006, P NATL ACAD SCI USA, V103, P17614, DOI 10.1073/pnas.0605468103; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; TARTAGLIA J, 1992, AIDS RES HUM RETROV, V8, P1445, DOI 10.1089/aid.1992.8.1445; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	39	171	175	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					485	U8		10.1038/nature07529	http://dx.doi.org/10.1038/nature07529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19043403	Green Accepted			2022-12-01	WOS:000262519200048
J	Martin, AC; Kaschube, M; Wieschaus, EF				Martin, Adam C.; Kaschube, Matthias; Wieschaus, Eric F.			Pulsed contractions of an actin-myosin network drive apical constriction	NATURE			English	Article							CELL-SHAPE CHANGES; DROSOPHILA GASTRULATION; FOLDED-GASTRULATION; ADHERENS JUNCTIONS; MORPHOGENESIS; MICROFILAMENTS; LOCALIZATION; MICROTUBULES; NEURULATION; MECHANISM	Apical constriction facilitates epithelial sheet bending and invagination during morphogenesis(1,2). Apical constriction is conventionally thought to be driven by the continuous purse- string- like contraction of a circumferential actin and non- muscle myosin- II ( myosin) belt underlying adherens junctions(3-7). However, it is unclear whether other force- generating mechanisms can drive this process. Here we show, with the use of real- time imaging and quantitative image analysis of Drosophila gastrulation, that the apical constriction of ventral furrow cells is pulsed. Repeated constrictions, which are asynchronous between neighbouring cells, are interrupted by pauses in which the constricted state of the cell apex is maintained. In contrast to the purse- string model, constriction pulses are powered by actin - myosin network contractions that occur at the medial apical cortex and pull discrete adherens junction sites inwards. The transcription factors Twist and Snail differentially regulate pulsed constriction. Expression of snail initiates actin - myosin network contractions, whereas expression of twist stabilizes the constricted state of the cell apex. Our results suggest a new model for apical constriction in which a cortical actin - myosin cytoskeleton functions as a developmentally controlled subcellular ratchet to reduce apical area incrementally.	[Martin, Adam C.; Wieschaus, Eric F.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Martin, Adam C.; Wieschaus, Eric F.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kaschube, Matthias] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Kaschube, Matthias] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; Princeton University; Princeton University	Wieschaus, EF (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	efw@princeton.edu			American Cancer Society [PF-06-143-01-DDC]; National Institutes of Health/National Institute of General Medical Sciences [P50 GM071508]; National Institute of Child Health and Human Development [5R37HD15587]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD015587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kiehart and R. Karess for providing flies; J. Goodhouse for assisting with microscopy; and S. De Renzis, X. Lu, T. Schupbach, A. Sokac, F. Ulrich and Y.-C. Wang for helpful comments on the manuscript. This work is supported by grant PF-06-143-01-DDC from the American Cancer Society to A. C. M., National Institutes of Health/National Institute of General Medical Sciences grant P50 GM071508 to M. K., and by National Institute of Child Health and Human Development grant 5R37HD15587 to E.F. W.E.F.W. is an investigator of the Howard Hughes Medical Institute.	Alberts B., 2008, MOL BIOL CELL; Arziman Z, 2005, NUCLEIC ACIDS RES, V33, pW582, DOI 10.1093/nar/gki468; BAKER PC, 1967, DEV BIOL, V15, P432, DOI 10.1016/0012-1606(67)90036-X; BURNSIDE B, 1971, DEV BIOL, V26, P416, DOI 10.1016/0012-1606(71)90073-X; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Fox DT, 2007, DEVELOPMENT, V134, P567, DOI 10.1242/dev.02748; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; IP YT, 1994, EMBO J, V13, P5826, DOI 10.1002/j.1460-2075.1994.tb06926.x; KARFUNKEL P, 1972, J EXP ZOOL, V181, P289, DOI 10.1002/jez.1401810302; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; Oda H, 2001, J CELL SCI, V114, P493; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Seher TC, 2007, MECH DEVELOP, V124, P167, DOI 10.1016/j.mod.2006.12.004; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; SWEETON D, 1991, DEVELOPMENT, V112, P775; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; YOUNG PE, 1991, DEVELOPMENT, V111, P1	29	776	784	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					495	U11		10.1038/nature07522	http://dx.doi.org/10.1038/nature07522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19029882	Green Accepted			2022-12-01	WOS:000262519200050
J	Sirotin, YB; Das, A				Sirotin, Yevgeniy B.; Das, Aniruddha			Anticipatory haemodynamic signals in sensory cortex not predicted by local neuronal activity	NATURE			English	Article							INTRINSIC SIGNAL; BOLD FMRI; SPECTROSCOPY; STIMULATION; SPIKES; MAPS; V1	Haemodynamic signals underlying functional brain imaging ( for example, functional magnetic resonance imaging ( fMRI)) are assumed to reflect metabolic demand generated by local neuronal activity, with equal increases in haemodynamic signal implying equal increases in the underlying neuronal activity(1-6). Few studies have compared neuronal and haemodynamic signals in alert animals(7,8) to test for this assumed correspondence. Here we present evidence that brings this assumption into question. Using a dual-wavelength optical imaging technique(9) that independently measures cerebral blood volume and oxygenation, continuously, in alert behaving monkeys, we find two distinct components to the haemodynamic signal in the alert animals' primary visual cortex (V1). One component is reliably predictable from neuronal responses generated by visual input. The other component - of almost comparable strength - is a hither to unknown signal that entrains to task structure independently of visual input or of standard neural predictors of haemodynamics. This latter component shows predictive timing, with increases of cerebral blood volume in anticipation of trial onsets even in darkness. This trial- locked haemodynamic signal could be due to an accompanying V1 arterial pumping mechanism, closely matched in time, with peaks of arterial dilation entrained to predicted trial onsets. These findings ( tested in two animals) challenge the current understanding of the link between brain haemodynamics and local neuronal activity. They also suggest the existence of a novel preparatory mechanism in the brain that brings additional arterial blood to cortex in anticipation of expected tasks.	[Sirotin, Yevgeniy B.; Das, Aniruddha] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, WM Keck Ctr Brain Plastic & Cognit, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, Mahoney Ctr Brain & Behav, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Das, Aniruddha] New York State Psychiat Inst & Hosp, Unit 87, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Das, A (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	ad2069@columbia.edu		Sirotin, Yevgeniy/0000-0001-7058-0424	Keck foundation; National Institutes of Health; Klingenstein Foundation; Gatsby Initiative in Brain Circuitry; Dana Foundation; National Research Service Award; NATIONAL EYE INSTITUTE [R01EY013759] Funding Source: NIH RePORTER	Keck foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); Gatsby Initiative in Brain Circuitry; Dana Foundation; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank: K. Korinek for designing and fabricating much of the dual- wavelength optical imaging hardware; P. P. Mitra for the suggestion of making continuous recordings and the use of the Chronux analysis software; E. M. C. Hillman for insights into brain haemodynamic mechanisms; C. Ma, G. Cantone, J. Ordinario, E. Glushenkova, W. Zhang, and M. Bucklin for help with recordings; E. Seidemann and R. Siegel for technical help during our initial setup; C. D. Gilbert and members of the Mahoney Center and the Center for Theoretical Neuroscience at Columbia University for comments on the manuscript. The work was supported by the Keck foundation, grants from the National Institutes of Health, the Klingenstein Foundation, the Gatsby Initiative in Brain Circuitry and the Dana Foundation to A. D. and a National Research Service Award to Y. B. S.	Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Berwick J, 2002, J CEREBR BLOOD F MET, V22, P670, DOI 10.1097/00004647-200206000-00005; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lucas BD, 1981, P 7 INT JOINT C ART, P674, DOI DOI 10.5555/1623264.1623280; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; MATSUDA K, 2000, SOC NEUR ABSTR, V26; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; PRAHL S, 2007, TABULATED MOLAR EXTI; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; Ugurbil K, 2003, TRENDS NEUROSCI, V26, P108, DOI 10.1016/S0166-2236(02)00039-5; VANDERMOLEN MW, 1989, PSYCHOPHYSIOLOGY, V26, P70; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555	30	293	293	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					475	U6		10.1038/nature07664	http://dx.doi.org/10.1038/nature07664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158795	Green Accepted			2022-12-01	WOS:000262519200046
J	Woo, JS; Lim, JH; Shin, HC; Suh, MK; Ku, B; Lee, KH; Joo, K; Robinson, H; Lee, J; Park, SY; Ha, NC; Oh, BH				Woo, Jae-Sung; Lim, Jae-Hong; Shin, Ho-Chul; Suh, Min-Kang; Ku, Bonsu; Lee, Kwang-Hoon; Joo, Keehyoung; Robinson, Howard; Lee, Jooyoung; Park, Sam-Yong; Ha, Nam-Chul; Oh, Byung-Ha			Structural Studies of a Bacterial Condensin Complex Reveal ATP-Dependent Disruption of Intersubunit Interactions	CELL			English	Article							ESCHERICHIA-COLI; CHROMOSOME CONDENSATION; BACILLUS-SUBTILIS; SMC PROTEINS; CELL-CYCLE; MITOTIC CHROMOSOME; MUKB; DNA; LOCALIZATION; SEGREGATION	Condensins are key mediators of chromosome condensation across organisms. Like other condensins, the bacterial MukBEF condensin complex consists of an SMC family protein dimer containing two ATPase head domains, MukB, and two interacting subunits, MukE and MukF. We report complete structural views of the intersubunit interactions of this condensin along with ensuing studies that reveal a role for the ATPase activity of MukB. MukE and MukF together form an elongated dimeric frame, and MukF's C-terminal winged-helix domains (C-WHDs) bind MukB heads to constitute closed ring-like structures. Surprisingly, one of the two bound C-WHDs is forced to detach upon ATP-mediated engagement of MukB heads. This detachment reaction depends on the linker segment preceding the C-WHD, and mutations on the linker restrict cell growth. Thus ATP-dependent transient disruption of the MukB-MukF interaction, which creates openings in condensin ring structures, is likely to be a critical feature of the functional mechanism of condensins.	[Woo, Jae-Sung; Lim, Jae-Hong; Shin, Ho-Chul; Suh, Min-Kang; Ku, Bonsu; Lee, Kwang-Hoon; Oh, Byung-Ha] Pohang Univ Sci & Technol, Ctr Biomol Recognit, Pohang 790784, South Korea; [Woo, Jae-Sung; Lim, Jae-Hong; Shin, Ho-Chul; Suh, Min-Kang; Ku, Bonsu; Lee, Kwang-Hoon; Oh, Byung-Ha] Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang 790784, South Korea; [Joo, Keehyoung; Lee, Jooyoung] Korea Inst Adv Study, Sch Computat Sci, Seoul 130722, South Korea; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Park, Sam-Yong] Yokohama City Univ, Prot Design Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ha, Nam-Chul] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Korea Institute for Advanced Study (KIAS); United States Department of Energy (DOE); Brookhaven National Laboratory; Yokohama City University; Pusan National University	Oh, BH (corresponding author), Pohang Univ Sci & Technol, Ctr Biomol Recognit, Pohang 790784, South Korea.	bhoh@postech.ac.kr	Woo, Jae-Sung/T-2343-2019; Woo, Jae-Sung/J-4531-2017; Oh, Byung-Ha/C-2061-2011	Woo, Jae-Sung/0000-0001-9163-3433; Woo, Jae-Sung/0000-0001-9163-3433; Ku, Bonsu/0000-0003-1784-8975; Shin, Ho-chul/0000-0001-5500-3901	Creative Research Initiatives (Center for Biomolecular Interaction) of MOST/KOSEF; Core Research Program of POSTECH; Brain Korea 21 Project; NIH institute; National Center for Research Resources	Creative Research Initiatives (Center for Biomolecular Interaction) of MOST/KOSEF(Korea Science and Engineering Foundation); Core Research Program of POSTECH; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NIH institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Creative Research Initiatives (Center for Biomolecular Interaction) of MOST/KOSEF and partly by Core Research Program of POSTECH. J.-H.L., M.-K.S., H.-C.S., B.K. and K.-H.L. were supported by the Brain Korea 21 Project. This study made use of the beamline 4A at the Pohang Accelerator Laboratory in Korea, the beamline BL-5A at Photon Factory in Japan and the Brookhaven National Laboratory/Biology beamline X29 at the National Synchrotron Light Source in USA. The BNL Biology/PX Mail-in program is supported by the NIH institute, National Center for Research Resources.	Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; Cui YB, 2008, NAT STRUCT MOL BIOL, V15, P411, DOI 10.1038/nsmb.1410; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Fennell-Fezzie R, 2005, EMBO J, V24, P1921, DOI 10.1038/sj.emboj.7600680; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hudson DF, 2008, MOL BIOL CELL, V19, P3070, DOI 10.1091/mbc.E08-01-0057; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Mascarenhas J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-28; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; Matoba K, 2005, BIOCHEM BIOPH RES CO, V333, P694, DOI 10.1016/j.bbrc.2005.05.163; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Strunnikov AV, 2006, PLASMID, V55, P135, DOI 10.1016/j.plasmid.2005.08.004; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873	29	119	121	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					85	96		10.1016/j.cell.2008.10.050	http://dx.doi.org/10.1016/j.cell.2008.10.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135891	Bronze, Green Submitted			2022-12-01	WOS:000262318400017
J	Clay, NK; Adio, AM; Denoux, C; Jander, G; Ausubel, FM				Clay, Nicole K.; Adio, Adewale M.; Denoux, Carine; Jander, Georg; Ausubel, Frederick M.			Glucosinolate Metabolites Required for an Arabidopsis Innate Immune Response	SCIENCE			English	Article							GLUTATHIONE-DEFICIENT MUTANT; METAL-BINDING PEPTIDES; NONHOST RESISTANCE; DISEASE RESISTANCE; ABC TRANSPORTER; ABSCISIC-ACID; ETHYLENE; THALIANA; DEFENSE; IDENTIFICATION	The perception of pathogen or microbe- associated molecular pattern molecules by plants triggers a basal defense response analogous to animal innate immunity and is defined partly by the deposition of the glucan polymer callose at the cell wall at the site of pathogen contact. Transcriptional and metabolic profiling in Arabidopsis mutants, coupled with the monitoring of pathogen- triggered callose deposition, have identified major roles in pathogen response for the plant hormone ethylene and the secondary metabolite 4- methoxy- indol- 3- ylmethylglucosinolate. Two genes, PEN2 and PEN3, are also necessary for resistance to pathogens and are required for both callose deposition and glucosinolate activation, suggesting that the pathogen- triggered callose response is required for resistance to microbial pathogens. Our study shows that well-studied plant metabolites, previously identified as important in avoiding damage by herbivores, are also required as a component of the plant defense response against microbial pathogens.	[Clay, Nicole K.; Denoux, Carine; Ausubel, Frederick M.] Harvard Univ, Sch Med, Dept Genet, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Clay, Nicole K.; Denoux, Carine; Ausubel, Frederick M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Clay, Nicole K.; Denoux, Carine; Ausubel, Frederick M.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Adio, Adewale M.; Jander, Georg] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Cornell University; Boyce Thompson Institute for Plant Research	Ausubel, FM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Massachusetts Gen Hosp, Boston, MA 02114 USA.	ausubel@molbio.mgh.harvard.edu	Bruening, Stefan/B-8505-2011; Jander, Georg/E-7101-2012		NIH National Research Service Award-Kirschstein Postdoctoral Fellowship [R37-GM48707]; NSF [IOS-0718733, DBI-0500550, MCB-0519898]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI066817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048707] Funding Source: NIH RePORTER	NIH National Research Service Award-Kirschstein Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Abel for ugt74B1-2; J.L. Celenza for atr1-3, atr4-1/cyp83B1, cyp79B2 cyp79B3, and trp3-1; C.S. Cobbett for cad1-3/pcs1 and cad2-1/gsh1; P.L. Conklin for vtc1-1 and vtc2-1; R. Blum for pcs1-1, pcs2-1, and pcs1-1 pcs2-1; S. C. Somerville for pcs1-2; and Arabidopsis Biological Resource Center for insertion lines. Ph. D. stipend support to N.K.C. comes from NIH National Research Service Award-Kirschstein Postdoctoral Fellowship. Support to A.M.A. and G.J. comes from NSF grants IOS-0718733 and DBI-0500550. Support to F.M.A. comes from NSF grant MCB-0519898 and NIH grant R37-GM48707.	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Beaudoin N, 2000, PLANT CELL, V12, P1103, DOI 10.1105/tpc.12.7.1103; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Burmeister WP, 2000, J BIOL CHEM, V275, P39385, DOI 10.1074/jbc.M006796200; Cazale AC, 2001, FEBS LETT, V507, P215, DOI 10.1016/S0014-5793(01)02976-3; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Conklin PL, 2000, GENETICS, V154, P847; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Ghassemian M, 2000, PLANT CELL, V12, P1117, DOI 10.1105/tpc.12.7.1117; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; HAUGHN GW, 1991, PLANT PHYSIOL, V97, P217, DOI 10.1104/pp.97.1.217; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; HOWDEN R, 1992, PLANT PHYSIOL, V100, P100, DOI 10.1104/pp.100.1.100; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Kim JH, 2004, PLANT MOL BIOL, V54, P671, DOI 10.1023/B:PLAN.0000040897.49151.98; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; NIYOGI KK, 1992, PLANT CELL, V4, P721, DOI 10.1105/tpc.4.6.721; Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Pedras MSC, 2007, CHEM COMMUN, P368, DOI 10.1039/b615424g; Radwanski ER, 1996, MOL GEN GENET, V253, P353; Rea PA, 1998, ANNU REV PLANT PHYS, V49, P727, DOI 10.1146/annurev.arplant.49.1.727; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; SONGNUAN W, 2008, BIOL PLANT MICROBE I, V6; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; 2007, PLOS GENET, V3, P1687	59	759	796	10	282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					95	101		10.1126/science.1164627	http://dx.doi.org/10.1126/science.1164627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19095898	Green Accepted			2022-12-01	WOS:000262104100048
J	Ayalon, G; Davis, JQ; Scotland, PB; Bennett, V				Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann			An Ankyrin-Based Mechanism for Functional Organization of Dystrophin and Dystroglycan	CELL			English	Article							BRONCHIAL EPITHELIAL-CELLS; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; GLYCOPROTEIN COMPLEX; NEUROMUSCULAR SYNAPSE; BETA-DYSTROGLYCAN; LATERAL MEMBRANE; SPECTRIN; SARCOLEMMA; DYNACTIN	beta-dystroglycan (DG) and the dystrophin- glycoprotein complex (DGC) are localized at costameres and neuromuscular junctions in the sarcolemma of skeletal muscle. We present evidence for an ankyrin-based mechanism for sarcolemmal localization of dystrophin and beta-DG. Dystrophin binds ankyrin-B and ankyrin-G, while beta-DG binds ankyrin-G. Dystrophin and beta-DG require ankyrin- G for retention at costameres but not delivery to the sarcolemma. Dystrophin and beta-DG remain intracellular in ankyrin- B-depleted muscle, where beta-DG accumulates in a juxta-TGN compartment. The neuromuscular junction requires ankyrin- B for localization of dystrophin/utrophin and beta-DG and for maintenance of its postnatal morphology. A Becker muscular dystrophy mutation reduces ankyrin binding and impairs sarcolemmal localization of dystrophin-Dp71. Ankyrin-B also binds to dynactin-4, a dynactin subunit. Dynactin-4 and a subset of microtubules disappear from sarcolemmal sites in ankyrin-B-depleted muscle. Ankyrin-B thus is an adaptor required for sarcolemmal localization of dystrophin, as well as dynactin-4.	[Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	v.bennett@cellbio.duke.edu			Muscular Dystrophy Association	Muscular Dystrophy Association(Muscular Dystrophy Association)	We thank K. Kizhatil for the plasmid-siRNA constructs, K. P. Campbell for his gift of beta-DG antibody, and L. Davis, J. Hostettler, and J. Hoffman for technical assistance. We also acknowledge P. Mohler and K. Abdi for performing the yeast two-hybrid screen that revealed ankB binding by dyn4/p62. This study was funded in part by the Muscular Dystrophy Association. Author contributions: G.A.: Figures 1-7, Figures S1-S5; J.Q.D.: Figures 5 and 6, Figure S3; P.B.S.: Figure 5; G.A. and V.B. wrote the paper.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; BENNETT V, 1981, P NATL ACAD SCI-BIOL, V78, P7550, DOI 10.1073/pnas.78.12.7550; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Bloch RJ, 2004, J MUSCLE RES CELL M, V25, P590; BOUDRIAU S, 1993, J HISTOCHEM CYTOCHEM, V41, P1013, DOI 10.1177/41.7.8515044; Brancaccio A, 2005, NEUROMUSCULAR DISORD, V15, P825, DOI 10.1016/j.nmd.2005.08.003; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.3.CO;2-K; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; COX GA, 1994, NAT GENET, V8, P333, DOI 10.1038/ng1294-333; CRAIG SW, 1983, CELL MOTIL CYTOSKEL, V3, P449, DOI 10.1002/cm.970030513; Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; DAVIS JQ, 1984, J BIOL CHEM, V259, P3550; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Hopitzan AA, 2005, EXP CELL RES, V309, P86, DOI 10.1016/j.yexcr.2005.04.013; JOE V, 2003, BIOESSAYS, V25, P25; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Koch I, 2008, NEURON, V58, P210, DOI 10.1016/j.neuron.2008.03.019; Kordeli E, 1998, J CELL SCI, V111, P2197; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Moorthy S, 2000, J CELL BIOL, V149, P915, DOI 10.1083/jcb.149.4.915; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; NELSON WJ, 1984, P NATL ACAD SCI-BIOL, V81, P3292, DOI 10.1073/pnas.81.11.3292; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Percival JM, 2007, TRAFFIC, V8, P1424, DOI 10.1111/j.1600-0854.2007.00622.x; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Roma J, 2004, ACTA NEUROPATHOL, V108, P443, DOI 10.1007/s00401-004-0908-1; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; SCHROER TA, 2004, J CELL BIOL, V143, P1305; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; VYBIRAL T, 1992, CELL MOTIL CYTOSKEL, V21, P293, DOI 10.1002/cm.970210405; Williams MW, 2001, J CELL SCI, V114, P751; WINDHOLZ M, 1983, MERCK INDEX, P206	52	102	109	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1189	1200		10.1016/j.cell.2008.10.018	http://dx.doi.org/10.1016/j.cell.2008.10.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109891	Bronze			2022-12-01	WOS:000261989800011
J	Kang, RJ; Wan, JM; Arstikaitis, P; Takahashi, H; Huang, K; Bailey, AO; Thompson, JX; Roth, AF; Drisdel, RC; Mastro, R; Green, WN; Yates, JR; Davis, NG; El-Husseini, A				Kang, Rujun; Wan, Junmei; Arstikaitis, Pamela; Takahashi, Hideto; Huang, Kun; Bailey, Aaron O.; Thompson, James X.; Roth, Amy F.; Drisdel, Renaldo C.; Mastro, Ryan; Green, William N.; Yates, John R., III; Davis, Nicholas G.; El-Husseini, Alaa			Neural palmitoyl-proteomics reveals dynamic synaptic palmitoylation	NATURE			English	Article							DENDRITIC SPINE DEVELOPMENT; RHO-FAMILY GTPASES; PROTEIN PALMITOYLATION; NEURONAL EXCITABILITY; MORPHOGENESIS; CDC42; SYNAPSES; TRAFFICKING; PLASTICITY; STABILITY	Palmitoylation regulates diverse aspects of neuronal protein trafficking and function. Here a global characterization of rat neural palmitoyl- proteomes identifies most of the known neural palmitoyl proteins - 68 in total, plus more than 200 new palmitoyl- protein candidates, with further testing confirming palmitoylation for 21 of these candidates. The new palmitoyl proteins include neurotransmitter receptors, transporters, adhesion molecules, scaffolding proteins, as well as SNAREs and other vesicular trafficking proteins. Of particular interest is the finding of palmitoylation for a brain- specific Cdc42 splice variant. The palmitoylated Cdc42 isoform ( Cdc42- palm) differs from the canonical, prenylated form ( Cdc42- prenyl), both with regard to localization and function: Cdc42- palm concentrates in dendritic spines and has a special role in inducing these post- synaptic structures. Furthermore, assessing palmitoylation dynamics in drug- induced activity models identifies rapidly induced changes for Cdc42 as well as for other synaptic palmitoyl proteins, suggesting that palmitoylation may participate broadly in the activity- driven changes that shape synapse morphology and function.	[Wan, Junmei; Roth, Amy F.; Davis, Nicholas G.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Kang, Rujun; Arstikaitis, Pamela; Takahashi, Hideto; Huang, Kun; El-Husseini, Alaa] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Bailey, Aaron O.; Thompson, James X.; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA; [Drisdel, Renaldo C.; Mastro, Ryan; Green, William N.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Wayne State University; University of British Columbia; Scripps Research Institute; University of Chicago	Davis, NG (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	rkang@interchange.ubc.ca; ndavis@med.wayne.edu	Bailey, Aaron/ABB-8522-2021; Takahashi, Hideto/T-2650-2018	Bailey, Aaron/0000-0001-8063-3032; Takahashi, Hideto/0000-0002-6473-5060	Canadian Institutes for Health Research [A.E.H-20R90479, A.E.H-20R91909]; Michael Smith foundation for Health Research [A.E.-H., 20R52464]; EJLB Foundation and Neuroscience Canada [A.E.-H., 20R61933]; National Institutes of Health [GM65525, RR011823, NS043782, DA13602, DA019695]; Peter F. McManus Trust; Uehara Memorial Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS043782, R01NS043782, R01NS032693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA019695, R01DA013602] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith foundation for Health Research(Michael Smith Foundation for Health Research); EJLB Foundation and Neuroscience Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peter F. McManus Trust; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This paper is dedicated to the memory of our friend and colleague, Alaa El-Husseini, whose ideas about palmitoylation and plasticity inspired this work (deceased 23 Dec 2007). We thank J. Levinson, M.-F. Lise, C. Jiang and E. Yu for technical assistance. This work was supported by grants to A.E.-H. from the Canadian Institutes for Health Research (CIHR) (A.E.-H., 20R90479 and 20R91909), the Michael Smith foundation for Health Research (A.E.-H., 20R52464), the EJLB Foundation and Neuroscience Canada (A.E.-H., 20R61933), as well as from grants from the National Institutes of Health to N.G.D. (GM65525), J.R.Y. (RR011823) and W.N.G.(NS043782, DA13602 and DA019695), and the Peter F. McManus Trust. H. T. was supported by a research fellowship from the Uehara Memorial Foundation. We thank L. Raymond, Y.T. Wang, K. Gerrow, R. Hines, M. Prior and I. Papanayotou for comments on manuscript.	Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fannjiang Y, 2003, DEV CELL, V4, P575, DOI 10.1016/S1534-5807(03)00091-1; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Halpain S, 1998, J NEUROSCI, V18, P9835; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hering H, 2003, J NEUROSCI, V23, P3262; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Marks PW, 1996, GENOMICS, V38, P13, DOI 10.1006/geno.1996.0586; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MOLLNER S, 1995, FEBS LETT, V371, P241, DOI 10.1016/0014-5793(95)00864-6; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Negishi M, 2005, NEUROSCIENTIST, V11, P187, DOI 10.1177/1073858404268768; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Node-Langlois R, 2006, J CELL SCI, V119, P4986, DOI 10.1242/jcs.03273; RESH MD, 2006, SCI STKE, DOI DOI 10.1126/STKE.3592006RE14; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Scott EK, 2003, J NEUROSCI, V23, P3118; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wilson AL, 1998, BIOCHEM J, V333, P497, DOI 10.1042/bj3330497	32	405	409	3	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					904	909		10.1038/nature07605	http://dx.doi.org/10.1038/nature07605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092927	Green Accepted			2022-12-01	WOS:000261768300035
J	Gillum, MP; Zhang, D; Zhang, XM; Erion, DM; Jamison, RA; Choi, C; Dong, J; Shanabrough, M; Duenas, HR; Frederick, DW; Hsiao, JJ; Horvath, TL; Lo, CM; Tso, P; Cline, GW; Shulman, GI				Gillum, Matthew P.; Zhang, Dongyan; Zhang, Xian-Man; Erion, Derek M.; Jamison, Rachel A.; Choi, Cheolsoo; Dong, Jianying; Shanabrough, Marya; Duenas, Hillary R.; Frederick, David W.; Hsiao, Jennifer J.; Horvath, Tamas L.; Lo, Chun Min; Tso, Pat; Cline, Gary W.; Shulman, Gerald I.			N-acylphosphatidylethanolamine, a Gut-Derived Circulating Factor Induced by Fat Ingestion, Inhibits Food Intake	CELL			English	Article							NERVOUS-SYSTEM CONTROL; ENERGY-INTAKE; DIETARY-FAT; BODY-WEIGHT; RECEPTOR; OLEOYLETHANOLAMIDE; BRAIN; ACTIVATION; GLUCOSE	N-acylphosphatidylethanolamines (NAPEs) are a relatively abundant group of plasma lipids of unknown physiological significance. Here, we show that NAPEs are secreted into circulation from the small intestine in response to ingested fat and that systemic administration of the most abundant circulating NAPE, at physiologic doses, decreases food intake in rats without causing conditioned taste aversion. Furthermore, C-14-radiolabeled NAPE enters the brain and is particularly concentrated in the hypothalamus, and intracerebroventricular infusions of nanomolar amounts of NAPE reduce food intake, collectively suggesting that its effects may be mediated through direct interactions with the central nervous system. Finally, chronic NAPE infusion results in a reduction of both food intake and body weight, suggesting that NAPE and long-acting NAPE analogs may be novel therapeutic targets for the treatment of obesity.	[Gillum, Matthew P.; Zhang, Dongyan; Erion, Derek M.; Jamison, Rachel A.; Dong, Jianying; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Gillum, Matthew P.; Zhang, Xian-Man; Erion, Derek M.; Jamison, Rachel A.; Choi, Cheolsoo; Frederick, David W.; Hsiao, Jennifer J.; Cline, Gary W.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Gillum, Matthew P.; Erion, Derek M.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Shanabrough, Marya; Duenas, Hillary R.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT 06520 USA; [Lo, Chun Min; Tso, Pat] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45627 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; University System of Ohio; University of Cincinnati	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Perry, Rachel/0000-0003-0748-8064; Gillum, Matthew/0000-0003-4893-012X	United States Public Health Service [R01 DK-40936, P30 DK-45735, U24 DK-76169]; Endocrine Society Research; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, P30DK045735, R01DK049230, U24DK076169, U24DK059635, R24DK085638] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Endocrine Society Research; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank Drs. James Pickel and George Kunos for kindly providing us with the CB1<SUP>-/-</SUP> mice and Maya Kotas for incisive commentary. This work was supported by grants from the United States Public Health Service (R01 DK-40936, P30 DK-45735, and U24 DK-76169), an Endocrine Society Research Fellowship (M. P. G.), and a Distinguished Clinical ScientistAward (G. I. S.) from the American Diabetes Association.	Abizaid A, 2006, NEURON, V51, P691, DOI 10.1016/j.neuron.2006.08.025; Carter RJ, 1999, J NEUROSCI, V19, P3248; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Donahoo W, 2008, OBESITY, V16, P64, DOI 10.1038/oby.2007.31; Emond M, 2001, PHYSIOL BEHAV, V72, P123, DOI 10.1016/S0031-9384(00)00393-0; Fry M, 2007, PHYSIOL BEHAV, V91, P413, DOI 10.1016/j.physbeh.2007.04.003; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Halford JCG, 1998, PHARMACOL BIOCHEM BE, V61, P159, DOI 10.1016/S0091-3057(98)00032-X; Holder JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE105, DOI 10.1152/ajpendo.00446.2003; Holder JL, 2000, HUM MOL GENET, V9, P101; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kobelt P, 2005, AM J PHYSIOL-REG I, V288, pR751, DOI 10.1152/ajpregu.00094.2004; Little TJ, 2007, AM J CLIN NUTR, V86, P531, DOI 10.1093/ajcn/86.3.531; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; MISELIS RR, 1975, AM J PHYSIOL, V229, P1438, DOI 10.1152/ajplegacy.1975.229.5.1438; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Petersen G, 2006, BBA-MOL CELL BIOL L, V1761, P143, DOI 10.1016/j.bbalip.2005.12.011; Riley Anthony L, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0806es29; Rowland NE, 1997, REGUL PEPTIDES, V71, P171, DOI 10.1016/S0167-0115(97)01034-3; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Wolfgang MJ, 2007, P NATL ACAD SCI USA, V104, P19285, DOI 10.1073/pnas.0709778104	33	114	118	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					813	824		10.1016/j.cell.2008.10.043	http://dx.doi.org/10.1016/j.cell.2008.10.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041747	Bronze, Green Accepted			2022-12-01	WOS:000261183900014
J	Rancati, G; Pavelka, N; Fleharty, B; Noll, A; Trimble, R; Walton, K; Perera, A; Staehling-Hampton, K; Seidel, CW; Li, R				Rancati, Giulia; Pavelka, Norman; Fleharty, Brian; Noll, Aaron; Trimble, Rhonda; Walton, Kendra; Perera, Anoja; Staehling-Hampton, Karen; Seidel, Chris W.; Li, Rong			Aneuploidy Underlies Rapid Adaptive Evolution of Yeast Cells Deprived of a Conserved Cytokinesis Motor	CELL			English	Article							HSP90 MOLECULAR CHAPERONE; WHOLE-GENOME DUPLICATION; LARGE POPULATIONS; BUDDING YEAST; GENE; PROTEIN; ORGANIZATION; PERSPECTIVE; POLYPLOIDY; RING	The ability to evolve is a fundamental feature of biological systems, but the mechanisms underlying this capacity and the evolutionary dynamics of conserved core processes remain elusive. We show that yeast cells deleted of MYO1, encoding the only myosin II normally required for cytokinesis, rapidly evolved divergent pathways to restore growth and cytokinesis. The evolved cytokinesis phenotypes correlated with specific changes in the transcriptome. Polyploidy and aneuploidy were common genetic alterations in the best evolved strains, and aneuploidy could account for gene expression changes due directly to altered chromosome stoichiometry as well as to downstream effects. The phenotypic effect of aneuploidy could be recapitulated with increased copy numbers of specific regulatory genes in myo1 Delta cells. These results demonstrate the evolvability of even a well-conserved process and suggest that changes in chromosome stoichiometry provide a source of heritable variation driving the emergence of adaptive phenotypes when the cell division machinery is strongly perturbed.	[Rancati, Giulia; Pavelka, Norman; Fleharty, Brian; Noll, Aaron; Trimble, Rhonda; Walton, Kendra; Perera, Anoja; Staehling-Hampton, Karen; Seidel, Chris W.; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Rong] Univ Kansas, Med Ctr, Dept Phys, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers-institute.org	Pavelka, Norman/G-4577-2018	Pavelka, Norman/0000-0003-4542-9970; Rancati, Giulia/0000-0003-0835-0139	NIH [GM058864]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Authors thank W. Bosl, O. Rando, and B. Rubinstein for stimulating discussions, J. Haug and J. Wunderlich for technical assistance with flow cytometry, F. Guo for technical assistance with electron microscopy, K. Zueckert-Gaudenz and A. Peak for suggestions and assistance in the preparation of genomic DNA samples and in microarray hybridizations, G. Hattem for help with bioinformatics analysis, A. Paulson for assistance in microarray data submission to public repositories, P. Baumann and X. Wang for suggestions and assistance with pulsed-field gel electrophoresis, G. Chen for help with strain construction, T. Nichols and M. Toth for media preparation and laboratory management, J. Rine for plasmids, and A. Murray, B. Slaughter, and S. Wai for critical reading of the manuscript. This paper is dedicated to the memory of Karen A. Pavelka. This work was supported by NIH GM058864 to R. L.	ADAMS AEM, 1991, METHOD ENZYMOL, V194, P729; Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Buscemi G, 2000, J CELL SCI, V113, P1199; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Carter AJR, 2002, P ROY SOC B-BIOL SCI, V269, P953, DOI 10.1098/rspb.2002.1968; Darwin C., 1859, ORIGIN SPECIES MEANS; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; GILLESPIE JH, 1984, SCIENCE, V224, P732, DOI 10.1126/science.224.4650.732; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kanada M, 2005, MOL BIOL CELL, V16, P3865, DOI 10.1091/mbc.E05-03-0233; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; MURRAY AW, 1986, CELL, V45, P529, DOI 10.1016/0092-8674(86)90284-9; Nagasaki A, 2002, J CELL SCI, V115, P2241; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Oeffinger M, 2003, EMBO J, V22, P6573, DOI 10.1093/emboj/cdg616; Ohta T, 2002, P NATL ACAD SCI USA, V99, P16134, DOI 10.1073/pnas.252626899; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schmidt M, 2002, J CELL SCI, V115, P293; Shafaatian R, 1996, MOL GEN GENET, V252, P101, DOI 10.1007/BF02173210; Sherman R., 1974, METHODS YEAST GENETI; Spence JM, 2006, CHROMOSOMA, V115, P60, DOI 10.1007/s00412-005-0032-6; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Tolliday N, 2003, MOL BIOL CELL, V14, P798, DOI 10.1091/mbc.E02-09-0558; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; WAGNER A, 2005, ROBUSTNESS EVOLVABIL, V1; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Weinreich DM, 2005, EVOLUTION, V59, P1175; Whistler JL, 1997, J BIOL CHEM, V272, P18790, DOI 10.1074/jbc.272.30.18790; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	48	232	235	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					879	893		10.1016/j.cell.2008.09.039	http://dx.doi.org/10.1016/j.cell.2008.09.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041751	Green Accepted, Bronze			2022-12-01	WOS:000261183900019
J	Quigley, DA; To, MD; Perez-Losada, J; Pelorosso, FG; Mao, JH; Nagase, H; Ginzinger, DG; Balmain, A				Quigley, David A.; To, Minh D.; Perez-Losada, Jesus; Pelorosso, Facundo G.; Mao, Jian-Hua; Nagase, Hiroki; Ginzinger, David G.; Balmain, Allan			Genetic architecture of mouse skin inflammation and tumour susceptibility	NATURE			English	Article							ATOPIC-DERMATITIS; LINKAGE ANALYSIS; INNATE IMMUNITY; STEM-CELLS; DISEASE; CANCER; IDENTIFICATION; EXPRESSION; PSORIASIS; NETWORKS	Germline polymorphisms in model organisms and humans influence susceptibility to complex trait diseases such as inflammation and cancer(1-4). Mice of the Mus spretus species are resistant to tumour development, and crosses between M. spretus and susceptible Mus musculus strains have been used to map locations of genetic variants that contribute to skin cancer susceptibility(4-6). We have integrated germline polymorphisms with gene expression in normal skin from a M. musculus 3 M. spretus backcross to generate a network view of the gene expression architecture of mouse skin. Here we demonstrate how this approach identifies expression motifs that contribute to tissue organization and biological functions related to inflammation, haematopoiesis, cell cycle control and tumour susceptibility. Motifs associated with inflammation, epidermal barrier function and proliferation are differentially regulated in backcross mice susceptible or resistant to tumour development. The intestinal stem cell marker Lgr5 is identified as a candidate master regulator of the hair follicle, and the vitamin D receptor (Vdr) is linked to coordinated control of epidermal barrier function, inflammation and tumour susceptibility.	[Quigley, David A.; To, Minh D.; Pelorosso, Facundo G.; Mao, Jian-Hua; Ginzinger, David G.; Balmain, Allan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [To, Minh D.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94115 USA; [Perez-Losada, Jesus] Univ Salamanca, Fac Med, Dept Med, Salamanca 37007, Spain; [Mao, Jian-Hua] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Nagase, Hiroki] Nihon Univ, Adv Res Inst Sci & Humanities, Tokyo, Japan; [Nagase, Hiroki] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Salamanca; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Nihon University; Roswell Park Cancer Institute	Balmain, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA.	abalmain@cc.ucsf.edu	Mao, Jian-Hua/EIZ-8595-2022; 2009, Secribsal/A-1266-2012; Pérez-Losada, Jesús/A-5883-2019	Mao, Jian-Hua/0000-0001-9320-6021; Pérez-Losada, Jesús/0000-0003-2400-624X	National Cancer Institute; Barbara Bass Bakar Chair of Cancer Genetics; Sandler Foundation; Spanish 'Ministerio de Educacion y Ciencia'; European Community; Fondo de Investigaciones Sanitarias; Junta de Castilla y Leon; NATIONAL CANCER INSTITUTE [U01CA084244, U01CA141455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR050440] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barbara Bass Bakar Chair of Cancer Genetics; Sandler Foundation; Spanish 'Ministerio de Educacion y Ciencia'(Spanish Government); European Community(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Junta de Castilla y Leon(Junta de Castilla y Leon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to R. Del Rosario for technical assistance with mouse breeding. We thank G. Hirst, R. Akhurst and H. Quigley for their comments. This work was supported by the National Cancer Institute. A. B. acknowledges support from the Barbara Bass Bakar Chair of Cancer Genetics. M. D. T. was supported in part by a Sandler Foundation postdoctoral research fellowship. J. P.-L. is an investigator of the 'Programa Ramon y Cajal' from the Spanish 'Ministerio de Educacion y Ciencia' partially supported by the European Community; his research is partially funded by the 'Fondo de Investigaciones Sanitarias' and Junta de Castilla y Leon.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bikle DD, 2002, J INVEST DERMATOL, V119, P1109, DOI 10.1046/j.1523-1747.2002.19508.x; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chen L, 2006, GENETICS, V173, P2371, DOI 10.1534/genetics.105.052506; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Giovannucci E, 2008, ADV EXP MED BIOL, V624, P31, DOI 10.1007/978-0-387-77574-6_3; Hoffjan S, 2007, BRIT J DERMATOL, V157, P441, DOI 10.1111/j.1365-2133.2007.07999.x; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahieu T, 2006, P NATL ACAD SCI USA, V103, P2292, DOI 10.1073/pnas.0510874103; Manenti G, 1996, NAT GENET, V12, P455, DOI 10.1038/ng0496-455; Murphy JE, 2003, J IMMUNOL, V170, P5697, DOI 10.4049/jimmunol.170.11.5697; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VIAJE A, 1977, CANCER RES, V37, P1530; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Zinser GM, 2002, CARCINOGENESIS, V23, P2103, DOI 10.1093/carcin/23.12.2103	29	100	101	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					505	508		10.1038/nature07683	http://dx.doi.org/10.1038/nature07683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19136944	Green Accepted, Green Submitted			2022-12-01	WOS:000264532400044
J	Teixeira, FK; Heredia, F; Sarazin, A; Roudier, F; Boccara, M; Ciaudo, C; Cruaud, C; Poulain, J; Berdasco, M; Fraga, MF; Voinnet, O; Wincker, P; Esteller, M; Colot, V				Teixeira, Felipe Karam; Heredia, Fabiana; Sarazin, Alexis; Roudier, Francois; Boccara, Martine; Ciaudo, Constance; Cruaud, Corinne; Poulain, Julie; Berdasco, Maria; Fraga, Mario F.; Voinnet, Olivier; Wincker, Patrick; Esteller, Manel; Colot, Vincent			A Role for RNAi in the Selective Correction of DNA Methylation Defects	SCIENCE			English	Article							EPIGENETIC INHERITANCE; ARABIDOPSIS; EPIGENOME; IV	DNA methylation is essential for silencing transposable elements and some genes in higher eukaryotes, which suggests that this modification must be tightly controlled. However, accidental changes in DNA methylation can be transmitted through mitosis (as in cancer) or meiosis, leading to epiallelic variation. We demonstrated the existence of an efficient mechanism that protects against transgenerational loss of DNA methylation in Arabidopsis. Remethylation is specific to the subset of heavily methylated repeats that are targeted by the RNA interference (RNAi) machinery. This process does not spread into flanking regions, is usually progressive over several generations, and faithfully restores wild-type methylation over target sequences in an RNAi-dependent manner. Our findings suggest an important role for RNAi in protecting genomes against long-term epigenetic defects.	[Teixeira, Felipe Karam; Heredia, Fabiana; Roudier, Francois; Boccara, Martine; Colot, Vincent] Univ Evry Val Essonne, Inst Natl Rech Agron UMR 1165, CNRS, UMR 8114,Unite Rech Genom Vegetale, F-91057 Evry, France; [Teixeira, Felipe Karam; Sarazin, Alexis; Roudier, Francois; Boccara, Martine; Colot, Vincent] Ecole Normale Super, CNRS, Dept Biol, UMR 8186, F-75230 Paris 05, France; [Ciaudo, Constance; Voinnet, Olivier] CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, F-67084 Strasbourg, France; [Ciaudo, Constance] Inst Curie, CNRS, UMR 218, F-75248 Paris 05, France; [Cruaud, Corinne; Poulain, Julie; Wincker, Patrick] CEA, Inst Genom, F-91057 Evry, France; [Berdasco, Maria; Fraga, Mario F.; Esteller, Manel] Ctr Nacl Invest Oncol, Lab Epigenet Canc, Madrid 28029, Spain	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Colot, V (corresponding author), Univ Evry Val Essonne, Inst Natl Rech Agron UMR 1165, CNRS, UMR 8114,Unite Rech Genom Vegetale, F-91057 Evry, France.	colot@biologie.ens.fr	Ciaudo, Constance/A-2014-2012; Esteller, Manel/L-5956-2014; Fraga, Mario F/H-7824-2017; Herédia, Fabiana/J-3999-2013	Ciaudo, Constance/0000-0002-0857-4506; Esteller, Manel/0000-0003-4490-6093; Fraga, Mario F/0000-0001-8450-2603; Herédia, Fabiana/0000-0002-6390-7545; Poulain, Julie/0000-0002-8744-3116; Sarazin, Alexis/0000-0002-1869-5192; Cruaud, Corinne/0000-0002-4752-7278; Heredia, Fabiana/0000-0003-0057-7654; Karam Teixeira, Felipe/0000-0001-7651-1657; Voinnet, Olivier/0000-0001-6982-9544	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil [Ph.D. studentship]; Network of Excellence (NoE) [postdoctoral fellowships]; Fondation pour la Recherche Medicale [postdoctoral fellowships]; Agence Nationale de la Recherche Programme Blanc (PolIV); Genoplante (EPIVAR); Genoscope; CNRS (PIME)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Network of Excellence (NoE); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche Programme Blanc (PolIV)(French National Research Agency (ANR)); Genoplante (EPIVAR); Genoscope; CNRS (PIME)(Centre National de la Recherche Scientifique (CNRS))	We thank P. Audigier for plant care, A. Bulski for DNA samples, R. Martienssen for sharing unpublished observations, and E. Heard for critical reading of the manuscript. F.K.T. was supported by a Ph.D. studentship (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil) and F.H. and C.C. by postdoctoral fellowships [Network of Excellence (NoE) "The Epigenome" and Fondation pour la Recherche Medicale, respectively]. Grant support was from Agence Nationale de la Recherche Programme Blanc (PolIV), NoE "The Epigenome," Genoplante (EPIVAR), Genoscope, and CNRS (PIME). The Gene Expression Omnibus accession number for sRNA sequences is GSE13419.	Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; Flintoft L, 2009, NAT REV GENET, V10, DOI 10.1038/nrg2565; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; KAKUTANI T, 1995, NUCLEIC ACIDS RES, V23, P130, DOI 10.1093/nar/23.1.130; Kakutani T, 1999, GENETICS, V151, P831; Kankel MW, 2003, GENETICS, V163, P1109; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	23	273	285	4	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1600	1604		10.1126/science.1165313	http://dx.doi.org/10.1126/science.1165313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19179494				2022-12-01	WOS:000264342300037
J	Bidere, N; Ngo, VN; Lee, J; Collins, C; Zheng, LX; Wan, FY; Davis, RE; Lenz, G; Anderson, DE; Arnoult, D; Vazquez, A; Sakai, K; Zhang, J; Meng, ZJ; Veenstra, TD; Staudt, LM; Lenardo, MJ				Bidere, Nicolas; Ngo, Vu N.; Lee, Jeansun; Collins, Cailin; Zheng, Lixin; Wan, Fengyi; Davis, R. Eric; Lenz, Georg; Anderson, D. Eric; Arnoult, Damien; Vazquez, Aime; Sakai, Keiko; Zhang, Jun; Meng, Zhaojing; Veenstra, Timothy D.; Staudt, Louis M.; Lenardo, Michael J.			Casein kinase 1 alpha governs antigen-receptor-induced NF-kappa B activation and human lymphoma cell survival	NATURE			English	Article							T-CELL; CARMA1; REQUIREMENT; PHOSPHORYLATION; BETA; WNT; UBIQUITINATION; PROLIFERATION; ADDICTION; REGULATOR	The transcription factor NF-kappa B is required for lymphocyte activation and proliferation as well as the survival of certain lymphoma types(1,2). Antigen receptor stimulation assembles an NF-kappa B activating platform containing the scaffold protein CARMA1 (also called CARD11), the adaptor BCL10 and the paracaspase MALT1 (the CBM complex), linked to the inhibitor of NF-kappa B kinase complex(3-12), but signal transduction is not fully understood(1). We conducted parallel screens involving a mass spectrometry analysis of CARMA1 binding partners and an RNA interference screen for growth inhibition of the CBM-dependent 'activated B-cell-like' (ABC) subtype of diffuse large B-cell lymphoma (DLBCL)(12). Here we report that both screens identified casein kinase 1 alpha (CK1 alpha) as a bifunctional regulator of NF-kappa B. CK1 alpha dynamically associates with the CBM complex on T-cell-receptor (TCR) engagement to participate in cytokine production and lymphocyte proliferation. However, CK1 alpha kinase activity has a contrasting role by subsequently promoting the phosphorylation and inactivation of CARMA1. CK1 alpha has thus a dual 'gating' function which first promotes and then terminates receptor-induced NF-kappa B. ABCDLBCL cells required CK1 alpha for constitutive NF-kappa B activity, indicating that CK1 alpha functions as a conditionally essential malignancy gene-a member of a new class of potential cancer therapeutic targets.	[Bidere, Nicolas; Lee, Jeansun; Zheng, Lixin; Wan, Fengyi; Sakai, Keiko; Zhang, Jun; Lenardo, Michael J.] NIAID, Mol Dev Sect, Immunol Lab, Bethesda, MD 20892 USA; [Ngo, Vu N.; Collins, Cailin; Davis, R. Eric; Lenz, Georg; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Anderson, D. Eric] NIDDK, Proteom & Mass Spectrometry Facil, NIH, Bethesda, MD 20892 USA; [Arnoult, Damien; Vazquez, Aime] Univ Paris Sud, Hop Paul Brousse, INSERM, U542, F-94800 Villejuif, France; [Meng, Zhaojing; Veenstra, Timothy D.] NCI, LPAT, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lenardo, MJ (corresponding author), NIAID, Mol Dev Sect, Immunol Lab, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov; lenardo@nih.gov	sakai, Keiko/F-5807-2013; Bidère, Nicolas/K-8887-2015; Lenz, Georg/I-6844-2012; Staudt, Louis/AAC-5324-2019; Arnoult, Damien/R-2032-2018	Bidère, Nicolas/0000-0001-9177-0008; Ngo, Vu/0000-0002-9501-6990	Intramural Research Program of the NIH; NIAID; NCI; NIDDK; Agence Nationale de la Recherche (ANR); NATIONAL CANCER INSTITUTE [ZIABC011007, Z01BC011007, ZIABC011008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000565, Z01AI000565] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the NIH, NIAID, NCI, NIDDK and by the Agence Nationale de la Recherche (ANR). We thank M.-T. Auffredou for technical assistance; X. Lin and J. Gavard for reagents; R. Germain, R. Schwartz, U. Siebenlist, P. Schwartzberg, J. Bosco de Oliveira, L. Yu, D. Baltimore, P. Sharp, H. Varmus and A. Snow for discussions and comments; and S. Porcella and the DNA sequencing core facility of the Rocky Mountain Laboratories, NIAID.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; HACKER H, 2006, SCI STKE, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027	31	110	124	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					92	U7		10.1038/nature07613	http://dx.doi.org/10.1038/nature07613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19118383	Green Accepted			2022-12-01	WOS:000263836000039
J	Sureshkumar, S; Todesco, M; Schneeberger, K; Harilal, R; Balasubramanian, S; Weigel, D				Sureshkumar, Sridevi; Todesco, Marco; Schneeberger, Korbinian; Harilal, Ramya; Balasubramanian, Sureshkumar; Weigel, Detlef			A Genetic Defect Caused by a Triplet Repeat Expansion in Arabidopsis thaliana	SCIENCE			English	Article							FRIEDREICH ATAXIA; SOMATIC INSTABILITY; EPIGENETIC CHANGES; IN-VIVO; TRANSCRIPTION; SEQUENCE; MECHANISMS; DELETION; BRAIN	Variation in the length of simple DNA triplet repeats has been linked to phenotypic variability in microbes and to several human disorders. Population- level forces driving triplet repeat contraction and expansion in multicellular organisms are, however, not well understood. We have identified a triplet repeat- associated genetic defect in an Arabidopsis thaliana variety collected from the wild. The Bur- 0 strain carries a dramatically expanded TTC/ GAA repeat in the intron of the ISOPROPYL MALATE ISOMERASE LARGE SUB UNIT1 ( IIL1; At4g13430) gene. The repeat expansion causes an environment-dependent reduction in IIL1 activity and severely impairs growth of this strain, whereas contraction of the expanded repeat can reverse the detrimental phenotype. The Bur- 0 IIL1 defect thus presents a genetically tractable model for triplet repeat expansions and their variability in natural populations.	[Sureshkumar, Sridevi; Todesco, Marco; Schneeberger, Korbinian; Harilal, Ramya; Balasubramanian, Sureshkumar; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Sureshkumar, Sridevi; Balasubramanian, Sureshkumar] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia	Max Planck Society; University of Queensland	Balasubramanian, S (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	mb.suresh@uq.edu.au; weigel@weigelworld.org	Balasubramanian, Sureshkumar/AAS-6919-2020; Todesco, Marco/HCH-3494-2022; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Schneeberger, Korbinian/U-6329-2019; Weigel, Detlef/GSJ-0799-2022	Balasubramanian, Sureshkumar/0000-0002-1057-2606; Weigel, Detlef/0000-0002-2114-7963; Schneeberger, Korbinian/0000-0002-5512-0443; Weigel, Detlef/0000-0002-2114-7963; Todesco, Marco/0000-0002-6227-4096	EMBO (European Molecular Biology Organization) Long-Term Fellowship; Marie Curie Research Training Network SY-STEM; European Research Area-Plant Genomics (ERA-PG) Deutsche Forschungsgemeinschaft ARelatives Consortium; European Union Sixth Framework Programme for Research and Technological Development Integrated Project [EU FP6 IP, LSHG-CT-2006-037704]; Leibniz Award; Max Planck Society	EMBO (European Molecular Biology Organization) Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Research Training Network SY-STEM(European Commission); European Research Area-Plant Genomics (ERA-PG) Deutsche Forschungsgemeinschaft ARelatives Consortium(German Research Foundation (DFG)); European Union Sixth Framework Programme for Research and Technological Development Integrated Project(European Commission); Leibniz Award; Max Planck Society(Max Planck SocietyFoundation CELLEX)	We are very grateful to T. Knill and S. Binder for sharing unpublished information. We acknowledge experimental support from our colleagues at the Max Planck Institute and University of Queensland. We also thank them as well as J. Carrington and D. Tautz for critical reading of the manuscript, and the European Arabidopsis Stock Centre and the French National Institute for Agricultural Research (INRA) at Versailles for seeds. Supported by an EMBO (European Molecular Biology Organization) Long-Term Fellowship (S.B.), Marie Curie Research Training Network SY-STEM, European Research Area-Plant Genomics (ERA-PG) Deutsche Forschungsgemeinschaft ARelatives Consortium, European Union Sixth Framework Programme for Research and Technological Development Integrated Project (EU FP6 IP) Agronomics (LSHG-CT-2006-037704), a Leibniz Award (DFG), and the Max Planck Society (D.W.). GenBank accession numbers are FJ665284 to FJ665378.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Baralle M, 2008, AM J HUM GENET, V83, P77, DOI 10.1016/j.ajhg.2008.06.018; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; Frisch R, 2001, MOL GENET METAB, V74, P281, DOI 10.1006/mgme.2001.3229; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Hashem VI, 2004, NUCLEIC ACIDS RES, V32, P6334, DOI 10.1093/nar/gkh976; Hashem VI, 2002, MUTAT RES-FUND MOL M, V508, P107, DOI 10.1016/S0027-5107(02)00190-2; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; KNILL T, COMMUNICATION; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Levdansky E, 2007, EUKARYOT CELL, V6, P1380, DOI 10.1128/EC.00229-06; Michael TP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000795; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sharma R, 2002, HUM MOL GENET, V11, P2175, DOI 10.1093/hmg/11.18.2175; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	26	55	57	7	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1060	1063		10.1126/science.1164014	http://dx.doi.org/10.1126/science.1164014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19150812				2022-12-01	WOS:000263478400042
J	Oshima, S; Turer, EE; Callahan, JA; Chai, S; Advincula, R; Barrera, J; Shifrin, N; Lee, B; Yen, B; Woo, T; Malynn, BA; Ma, A				Oshima, Shigeru; Turer, Emre E.; Callahan, Joseph A.; Chai, Sophia; Advincula, Rommel; Barrera, Julio; Shifrin, Nataliya; Lee, Bettina; Yen, Benjamin; Woo, Tammy; Malynn, Barbara A.; Ma, Averil			ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development	NATURE			English	Article							NF-KAPPA-B; ZINC-FINGER PROTEIN; JNK ACTIVATION; MICE; A20; INDUCTION; LETHALITY; APOPTOSIS; RESPONSES; REQUIRES	Proteins that directly regulate tumour necrosis factor receptor ( TNFR) signalling have critical roles in regulating cellular activation and survival. ABIN-1 (A20 binding and inhibitor of NF-kappa B) is a novel protein that is thought to inhibit NF-kappa B signalling(1,2). Here we show that mice deficient for ABIN-1 die during embryogenesis with fetal liver apoptosis, anaemia and hypoplasia. ABIN-1 deficient cells are hypersensitive to tumour necrosis factor (TNF)induced programmed cell death, and TNF deficiency rescues ABIN-1 deficient embryos. ABIN-1 inhibits caspase 8 recruitment to FADD (Fas-associated death domain-containing protein) in TNF-induced signalling complexes, preventing caspase 8 cleavage and programmed cell death. Moreover, ABIN-1 directly binds polyubiquitin chains and this ubiquitin sensing activity is required for ABIN-1's anti-apoptotic activity. These studies provide insights into how ubiquitination and ubiquitin sensing proteins regulate cellular and organismal survival.	[Oshima, Shigeru; Turer, Emre E.; Callahan, Joseph A.; Chai, Sophia; Advincula, Rommel; Barrera, Julio; Shifrin, Nataliya; Lee, Bettina; Yen, Benjamin; Woo, Tammy; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, 513 Parnassus Ave,S-1057, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu	Oshima, Shigeru/C-9865-2015	Oshima, Shigeru/0000-0003-1186-9177	NIH; UCSF Liver Center Pathology and Flow Cytometry Facilities; UCSF Transgenic and Targeted Mutagenesis Core Facility; Crohn's and Colitis Foundation of America; NSF fellowship; Rainin Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Liver Center Pathology and Flow Cytometry Facilities; UCSF Transgenic and Targeted Mutagenesis Core Facility; Crohn's and Colitis Foundation of America; NSF fellowship(National Science Foundation (NSF)); Rainin Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH (A.M.), UCSF Liver Center Pathology and Flow Cytometry Facilities, UCSF Transgenic and Targeted Mutagenesis Core Facility, a fellowship from the Crohn's and Colitis Foundation of America (S.O.), a pre-doctoral NSF fellowship (J.A.C.) and the Rainin Foundation.	Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee JC, 2003, IMMUNOL REV, V193, P39, DOI 10.1034/j.1600-065X.2003.00043.x; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; VAN AD, 1996, SCIENCE, V274, P787; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wullaert A, 2005, HEPATOLOGY, V42, P381, DOI 10.1002/hep.20785	24	127	133	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					906	909		10.1038/nature07575	http://dx.doi.org/10.1038/nature07575			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19060883	Green Accepted			2022-12-01	WOS:000263266700050
J	Songkhla, MN				Songkhla, Mongkol Na			Health before profits? Learning from Thailand's experience	LANCET			English	Editorial Material											Songkhla, MN (corresponding author), Ladprao 15, Bangkok 10900, Thailand.	mongkol@health.moph.go.th						ABBOTT F, 2007, ACCESS ESSENTIAL MED; Fidler DP, 2009, LANCET, V373, P325, DOI 10.1016/S0140-6736(08)61775-4; FINK C, 2003, IMPLEMENTING DOHA MA; Gerhardsen Tove, 2007, INTELLECTUAL PR 0216; Lee K, 2009, LANCET, V373, P416, DOI 10.1016/S0140-6736(08)61776-6; Tantivess S, 2008, INTRO GOVT USE PATEN; Tantivess S, 2008, HEALTH POLICY PLANN, V23, P328, DOI 10.1093/heapol/czn023; VELASQUEZ G, 2008, IMPROVING ACCESS MED; *WORLD TRAD ORG, 2001, MIN DECL WT MIN 01 D; World Trade Organization, UR ROUND AGR TRIPS 2	10	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					441	442		10.1016/S0140-6736(08)61737-7	http://dx.doi.org/10.1016/S0140-6736(08)61737-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19167059	Green Submitted			2022-12-01	WOS:000263132800008
J	Weinmann, L; Hock, J; Ivacevic, T; Ohrt, T; Mutze, J; Schwille, P; Kremmer, E; Benes, V; Urlaub, H; Meister, G				Weinmann, Lasse; Hoeck, Julia; Ivacevic, Tomi; Ohrt, Thomas; Muetze, Joerg; Schwille, Petra; Kremmer, Elisabeth; Benes, Vladimir; Urlaub, Henning; Meister, Gunter			Importin 8 Is a Gene Silencing Factor that Targets Argonaute Proteins to Distinct mRNAs	CELL			English	Article							MICRORNA-DEPENDENT LOCALIZATION; HUMAN-CELLS; TRANSLATION INITIATION; CAENORHABDITIS-ELEGANS; PASSENGER-STRAND; MAMMALIAN-CELLS; PIWI PROTEINS; IN-VITRO; MIRNAS; COMPLEXES	Small regulatory RNAs including small interfering RNAs (siRNAs) and microRNAs ( miRNAs) guide Argonaute ( Ago) proteins to specific target RNAs leading to mRNA destabilization or translational repression. Here, we report the identification of Importin 8 (Imp8) as a component of miRNA-guided regulatory pathways. We show that Imp8 interacts with Ago proteins and localizes to cytoplasmic processing bodies ( P bodies), structures involved in RNA metabolism. Furthermore, we detect Ago2 in the nucleus of HeLa cells, and knockdown of Imp8 reduces the nuclear Ago2 pool. Using immunoprecipitations of Ago2-associated mRNAs followed by microarray analysis, we further demonstrate that Imp8 is required for the recruitment of Ago protein complexes to a large set of Ago2-associated target mRNAs, allowing for efficient and specific gene silencing. Therefore, we provide evidence that Imp8 is required for cytoplasmic miRNA-guided gene silencing and affects nuclear localization of Ago proteins.	[Weinmann, Lasse; Hoeck, Julia; Meister, Gunter] Max Planck Inst Biochem, Lab RNA Biol, D-82152 Martinsried, Germany; [Weinmann, Lasse; Hoeck, Julia; Meister, Gunter] Max Planck Inst Biochem, Ctr Integrated Prot Sci Munich, D-82152 Martinsried, Germany; [Ohrt, Thomas; Muetze, Joerg; Schwille, Petra] Tech Univ Dresden, BIOTEC, D-01307 Dresden, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, D-81377 Munich, Germany; [Ivacevic, Tomi; Benes, Vladimir] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spect Grp, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; European Molecular Biology Laboratory (EMBL); Max Planck Society	Meister, G (corresponding author), Max Planck Inst Biochem, Lab RNA Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	meister@biochem.mpg.de	Weinmann, Lasse/B-9839-2008; Schwille, Petra/A-4983-2010	Benes, Vladimir/0000-0002-0352-2547	Max Planck Society; Deutsche Forschungsgemeinschaft [Me2064/2-1]; European Union [LSHG-CT-2006-037900]; Deutsche Volkswagenstiftung [I/79308]; Boehringer Ingelheim Fonds	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Deutsche Volkswagenstiftung(Volkswagen); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank Keiichi Ozono for pGEX-Imp4, Erich Nigg for pcDNA3.1- RanWT, - RanQ69L, and - RanT24N, Olaf Stemmann for pCS2, Simone Heubes for recombinant RanWT and RanQ69L, and Susanna Nagel for technical advice. Further, we thank Dirk Go " rlich, Witold Filipowicz, Michael Doyle, Laura Riolobos, Thomas Gu " ttler, Sabine Ru " del, Michaela Beitzinger, and Christine Ender for helpful discussions, Thomas Tuschl and Tobias Walther for critical reading of the manuscript, Sabine Rottmu " ller and Bernd Haas for technical assistance, and Stefan Jentsch for support. Our research is funded by the Max Planck Society. This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG, Me2064/2-1), the European Union (LSHG-CT-2006-037900), and the Max Planck Society. T. O. is funded by Deutsche Volkswagenstiftung I/79308. L. W. received a fellowship from the Boehringer Ingelheim Fonds.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	53	239	255	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					496	507		10.1016/j.cell.2008.12.023	http://dx.doi.org/10.1016/j.cell.2008.12.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19167051	Bronze			2022-12-01	WOS:000263120600019
J	Bikard, D; Patel, D; Le Mette, C; Giorgi, V; Camilleri, C; Bennett, MJ; Loudet, O				Bikard, David; Patel, Dhaval; Le Mette, Claire; Giorgi, Veronica; Camilleri, Christine; Bennett, Malcolm J.; Loudet, Olivier			Divergent Evolution of Duplicate Genes Leads to Genetic Incompatibilities Within A-thaliana	SCIENCE			English	Article							INBRED LINE POPULATIONS; ARABIDOPSIS-THALIANA; SPECIATION; DROSOPHILA; CONSEQUENCES; LOCI; REVEALS; MODEL	Genetic incompatibilities resulting from interactions between two loci represent a potential source of postzygotic barriers and may be an important factor in evolution when they impair the outcome of interspecific crosses. We show that, in crosses between strains of the plant Arabidopsis thaliana, loci interact epistatically, controlling a recessive embryo lethality. This interaction is explained by divergent evolution occurring among paralogs of an essential duplicate gene, for which the functional copy is not located at the same locus in different accessions. These paralogs demonstrate genetic heterogeneity in their respective evolutionary trajectories, which results in widespread incompatibility among strains. Our data suggest that these passive mechanisms, gene duplication and extinction, could represent an important source of genetic incompatibilities across all taxa.	[Bikard, David; Le Mette, Claire; Giorgi, Veronica; Camilleri, Christine; Loudet, Olivier] INRA, SGAP UR254, F-78026 Versailles, France; [Patel, Dhaval; Bennett, Malcolm J.] Univ Nottingham, Sch Biosci, Ctr Plant Integrat Biol, Div Plant Sci, Loughborough LE12 5RD, Leics, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Nottingham	Loudet, O (corresponding author), INRA, SGAP UR254, F-78026 Versailles, France.	loudet@versailles.inra.fr	Giorgi, Veronica/GQA-4191-2022; Bikard, David/L-2971-2015; Bennett, Malcolm/G-4004-2010; Bikard, David/AAZ-3752-2021; Loudet, Olivier/CAF-7559-2022; Patel, Dhaval/D-2745-2013; Loudet, Olivier/K-8266-2012	Giorgi, Veronica/0000-0002-8917-3949; Bikard, David/0000-0002-5729-1211; Bennett, Malcolm/0000-0003-0475-390X; Bikard, David/0000-0002-5729-1211; Loudet, Olivier/0000-0003-3717-0137	INRA-Departement de Genetique et d'Amelioration des Plantes Innovative Project; University of Nottingham; Biotechnology and Biological Sciences Research Council/Engineering; Physical Sciences Research Council Centres for Integrative Systems Biology	INRA-Departement de Genetique et d'Amelioration des Plantes Innovative Project; University of Nottingham; Biotechnology and Biological Sciences Research Council/Engineering(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Physical Sciences Research Council Centres for Integrative Systems Biology	We thank K. Bomblies and D. Weigel for providing F2 seeds for specific test crosses (Bay-0 x Cvi and Tsu-0 x Cvi), X. Mo for hpa1 seeds, and R. Mercier and F. Roux for discussion and critical reading of the manuscript. Funded partly by an INRA-Departement de Genetique et d'Amelioration des Plantes Innovative Project grant to C.C. and O.L. Funding by the University of Nottingham to D.P. and the Biotechnology and Biological Sciences Research Council/Engineering and Physical Sciences Research Council Centres for Integrative Systems Biology program to M.J.B. Sequences have been deposited in GenBank under accessions FJ436446 and FJ436447.	Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2007, CURR OPIN GENET DEV, V17, P500, DOI 10.1016/j.gde.2007.09.006; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Coyne J.A., 2004, SPECIATION; Dobzhansky T, 1937, GENETICS ORIGIN SPEC; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Kopp A, 2005, GENETICA, V125, P55, DOI 10.1007/s10709-005-4787-8; Loudet O, 2005, THEOR APPL GENET, V110, P742, DOI 10.1007/s00122-004-1900-9; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, AM NAT, V156, P590, DOI 10.1086/316992; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mallet J, 2006, TRENDS ECOL EVOL, V21, P386, DOI 10.1016/j.tree.2006.05.004; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Mo XR, 2006, PLANT PHYSIOL, V141, P1425, DOI 10.1104/pp.106.084178; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Muralla R, 2007, PLANT PHYSIOL, V144, P890, DOI 10.1104/pp.107.096511; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Orr HA, 2007, J HERED, V98, P103, DOI 10.1093/jhered/esl060; Orr HA, 2004, CURR OPIN GENET DEV, V14, P675, DOI 10.1016/j.gde.2004.08.009; Orr HA, 2001, EVOLUTION, V55, P1085; Ostrowski MF, 2006, MOL ECOL, V15, P1507, DOI 10.1111/j.1365-294X.2006.02865.x; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Staal J, 2006, PLANT J, V46, P218, DOI 10.1111/j.1365-313X.2006.02688.x; Torjek O, 2006, THEOR APPL GENET, V113, P1551, DOI 10.1007/s00122-006-0402-3; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; WERTH CR, 1991, AM NAT, V137, P515, DOI 10.1086/285180	33	198	201	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					623	626		10.1126/science.1165917	http://dx.doi.org/10.1126/science.1165917			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179528				2022-12-01	WOS:000262862800040
J	Westall, F				Westall, Frances			GEOCHEMISTRY Life on an Anaerobic Planet	SCIENCE			English	Editorial Material							CARBON ISOTOPES; MICROBIAL MATS		[Westall, Frances] CNRS, Ctr Biophys Mol, F-45071 Orleans 2, France; [Westall, Frances] Univ Orleans, F-45071 Orleans 2, France	Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Westall, F (corresponding author), CNRS, Ctr Biophys Mol, Rue Charles Sadron, F-45071 Orleans 2, France.	Frances.Westall@cnrs-orleans.fr						Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Derenne S, 2008, EARTH PLANET SC LETT, V272, P476, DOI 10.1016/j.epsl.2008.05.014; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Gerdes G., 1987, Lecture Notes in Earth Sciences, V9, P1; LOWE DR, 1994, GEOLOGY, V22, P387, DOI 10.1130/0091-7613(1994)022<0387:AOODSO>2.3.CO;2; Mcloughlin N, 2008, GEOBIOLOGY, V6, P95, DOI 10.1111/j.1472-4669.2007.00141.x; Noffke N, 2006, GEOLOGY, V34, P253, DOI 10.1130/G22246.1; NOFFKE N, 2008, EARTH IN PRESS  0910, DOI DOI 10.1016/J.EARSCIREV.2008.08.002; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Schidlowski M, 2001, PRECAMBRIAN RES, V106, P117, DOI 10.1016/S0301-9268(00)00128-5; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Ueno Y, 2004, GEOCHIM COSMOCHIM AC, V68, P573, DOI 10.1016/S0016-7037(03)00462-9; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; Walsh MM, 1999, GEOL S AM S, V329, P115, DOI 10.1130/0-8137-2329-9.115; Westall F, 2006, GEOL SOC AM SPEC PAP, P105; Westall F, 2006, GEOPHYS MONOGR SER, V164, P283; Westall F, 2006, PHILOS T R SOC B, V361, P1857, DOI 10.1098/rstb.2006.1896	20	10	10	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					471	472		10.1126/science.1167220	http://dx.doi.org/10.1126/science.1167220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164738				2022-12-01	WOS:000262587900031
J	Singh, SK; Piscitelli, CL; Yamashita, A; Gouaux, E				Singh, Satinder K.; Piscitelli, Chayne L.; Yamashita, Atsuko; Gouaux, Eric			A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation	SCIENCE			English	Article							DEPENDENT NEUROTRANSMITTER TRANSPORTERS; HUMAN SEROTONIN TRANSPORTERS; TRANSMEMBRANE DOMAIN-I; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; GABA TRANSPORTER; BINDING-SITE; MECHANISM; ANTIDEPRESSANTS; DEFICIENCY	Secondary transporters are workhorses of cellular membranes, catalyzing the movement of small molecules and ions across the bilayer and coupling substrate passage to ion gradients. However, the conformational changes that accompany substrate transport, the mechanism by which a substrate moves through the transporter, and principles of competitive inhibition remain unclear. We used crystallographic and functional studies on the leucine transporter ( LeuT), a model for neurotransmitter sodium symporters, to show that various amino acid substrates induce the same occluded conformational state and that a competitive inhibitor, tryptophan ( Trp), traps LeuT in an open- to- out conformation. In the Trp complex, the extracellular gate residues arginine 30 and aspartic acid 404 define a second weak binding site for substrates or inhibitors as they permeate from the extracellular solution to the primary substrate site, which demonstrates how residues that participate in gating also mediate permeation.	[Singh, Satinder K.; Piscitelli, Chayne L.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA; [Piscitelli, Chayne L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Yamashita, Atsuko] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Columbia University	Singh, SK (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.		Yamashita, Atsuko/H-5566-2017; Gouaux, Eric/Y-4370-2019	Yamashita, Atsuko/0000-0002-8001-4642; Gouaux, Eric/0000-0002-8549-2360	NIH/National Institute of Neurological Disorders and Stroke National Research Service Award; NIH/National Institute of Mental Health K99/R00 Pathway to Independence Award; NIH Multidisciplinary Training in Neuroendocrinology; NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH083050, R01MH070039] Funding Source: NIH RePORTER	NIH/National Institute of Neurological Disorders and Stroke National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/National Institute of Mental Health K99/R00 Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Multidisciplinary Training in Neuroendocrinology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to the staff of National Synchrotron Light Source beamline X29A and Advanced Light Source beamlines 8.2.1 and 8.2.2 for assistance with data collection. S. K. S. was supported by an individual NIH/National Institute of Neurological Disorders and Stroke National Research Service Award postdoctoral fellowship and a NIH/National Institute of Mental Health K99/R00 Pathway to Independence Award. C. L. P. was supported by an institutional NIH Multidisciplinary Training in Neuroendocrinology grant. A. Y. was on leave from the Laboratory for Structural Biochemistry, RIKEN Harima Institute at SPring-8, Japan. This work was supported by NIH (E.G.). E.G. is an investigator with the Howard Hughes Medical Institute. Coordinates and structure factors of the LeuT complexes have been deposited in the Protein Data Bank with the following accession codes: glycine (3F4J), alanine (3F48), 30 mM Leu (3F3E), methionine (3F3D), selenomethionine (3F4I), 4-fluorophenylalanine (3F3C) and Trp (3F3A).	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Apparsundaram S, 2008, J PHARMACOL EXP THER, V327, P982, DOI 10.1124/jpet.108.142315; BARKER EL, 2000, PSYCHOPHARMACOLOGY 4, P321; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; KIMELBERG HK, 1983, J NEUROCHEM, V40, P1265, DOI 10.1111/j.1471-4159.1983.tb13565.x; Krogsgaard-Larsen P, 2000, CURR PHARM DESIGN, V6, P1193, DOI 10.2174/1381612003399608; Masson J, 1999, PHARMACOL REV, V51, P439; Ozaki N, 2003, MOL PSYCHIATR, V8, P933, DOI 10.1038/sj.mp.4001365; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Warskulat U, 2004, J INVEST DERMATOL, V123, P516, DOI 10.1111/j.0022-202X.2004.23313.x; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	36	337	339	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1655	1661		10.1126/science.1166777	http://dx.doi.org/10.1126/science.1166777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074341	Green Accepted			2022-12-01	WOS:000261608300035
J	Gervas, J; Starfield, B; Heath, I				Gervas, Juan; Starfield, Barbara; Heath, Iona			Is clinical prevention better than cure?	LANCET			English	Editorial Material							HEALTH; CARE		[Gervas, Juan] Equipo CESCA, Med Canencia Sierra Garganta Montes & El Cuadron, Madrid, Spain; [Starfield, Barbara] Johns Hopkins Univ, Baltimore, MD USA; [Heath, Iona] Royal Coll Gen Practitioners, London, England	Novartis; Johns Hopkins University	Gervas, J (corresponding author), Equipo CESCA, Med Canencia Sierra Garganta Montes & El Cuadron, Madrid, Spain.	jgervasc@meditex.es						BARSKY AJ, 1988, NEW ENGL J MED, V318, P414, DOI 10.1056/NEJM198802183180705; Bentzen N, 2003, WONCA DICT GEN FAMIL; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Canadian Health Services Research Foundation, 2004, J Health Serv Res Policy, V9, P191; COCHRANE A L, 1955, R Soc Health J, V75, P584; Fleetcroft Robert, 2006, J Health Serv Res Policy, V11, P27, DOI 10.1258/135581906775094316; Fugelli P, 2006, PATIENT EDUC COUNS, V60, P267, DOI 10.1016/j.pec.2005.11.002; GERVAS J, 2002, EUR J GEN PRACT, V8, P47; Gervas Juan, 2006, Gac Sanit, V20 Suppl 1, P127, DOI 10.1157/13086036; Gray JAM, 1999, LANCET, V354, P1550, DOI 10.1016/S0140-6736(98)08482-7; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Heath I, 2007, BRIT MED J, V334, P19, DOI 10.1136/bmj.39066.541678.B7; HOLTZMAN NA, 1979, INT J HEALTH SERV, V9, P25, DOI 10.2190/9PJP-8R5C-JKJP-LK7A; Ilich I., 1976, MED NEMESIS EXPROPRI; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Moynihan R, 2002, BMJ-BRIT MED J, V324, P859, DOI 10.1136/bmj.324.7342.859; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Richens J, 2000, LANCET, V355, P400, DOI 10.1016/S0140-6736(99)09109-6; Starfield B, 2001, BRIT J GEN PRACT, V51, P303; Steinberg EP, 2005, HEALTH AFFAIR, V24, P80, DOI 10.1377/hlthaff.24.1.80; StewartBrown S, 1997, BRIT MED J, V314, P533, DOI 10.1136/bmj.314.7080.533; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101	22	52	56	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1997	1999		10.1016/S0140-6736(08)61843-7	http://dx.doi.org/10.1016/S0140-6736(08)61843-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	380NE	19059049				2022-12-01	WOS:000261471600026
J	Katz, IT; Wright, AA				Katz, Ingrid T.; Wright, Alexi A.			Circumcision - A Surgical Strategy for HIV Prevention in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEN						Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007433-19, T32 AI007433] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2006, PLOS MED, V3, P705, DOI 10.1371/journal.pmed.0030226; Bailey RC, 2008, B WORLD HEALTH ORGAN, V86, P669, DOI 10.2471/BLT.08.051482; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; WAWER M, 2008, 15 C RETR OPP INF BO	6	17	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2412	2415		10.1056/NEJMp0805791	http://dx.doi.org/10.1056/NEJMp0805791			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	378MT	19052123	Green Accepted			2022-12-01	WOS:000261325900002
J	Gostin, LO; Hankins, CA				Gostin, Lawrence O.; Hankins, Catherine A.			Male Circumcision as an HIV Prevention Strategy in Sub-Saharan Africa Sociolegal Barriers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTION; PARTNERS; HEALTH; RISK		[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Hankins, Catherine A.] Joint United Nations Programme HIV AIDS UNAIDS, Dept Evidence Monitoring & Policy, Geneva, Switzerland	Georgetown University; UNAIDS	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Hankins, Catherine/0000-0002-1642-8592				Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002679; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Gostin LO, 2008, JAMA-J AM MED ASSOC, V300, P2046, DOI 10.1001/jama.2008.588; Gostin LO, 2006, JAMA-J AM MED ASSOC, V296, P2023, DOI 10.1001/jama.296.16.2023; Hankins C, 2007, REPROD HEALTH MATTER, V15, P62, DOI 10.1016/S0968-8080(07)29311-5; Kigozi G, 2008, PLOS MED, V5, P911, DOI 10.1371/journal.pmed.0050116; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; SERWADDA D, 2008, 15 C RETR OPP INF FE; *UN EC SOC COUNC, 2000, 122004 UN EC UN COMM; UNAIDS, 2007, MAL CIRC GLOB TRENDS; *UNAIDS, 2007, SAF VOL INF MAL CIRC; *UNAIDS, 2008, LEG REG SELF ASS TOO; WHO/UNAIDS, 2007, NEW DAT MAL CIRC HIV	15	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2539	2541		10.1001/jama.2008.752	http://dx.doi.org/10.1001/jama.2008.752			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050196				2022-12-01	WOS:000261286200022
J	Machin, S; Pekkarinen, T				Machin, Stephen; Pekkarinen, Tuomas			ASSESSMENT Global Sex Differences in Test Score Variability	SCIENCE			English	Editorial Material							GENDER; PERFORMANCE; HYPOTHESIS; DIVERSITY; MATH		[Pekkarinen, Tuomas] Helsinki Sch Econ, Dept Econ, Helsinki 00101, Finland; [Pekkarinen, Tuomas] Govt Inst Econ Res VATT, Helsinki 00101, Finland; [Pekkarinen, Tuomas] Abo Akad Univ, Dept Econ & Stat, SF-20500 Turku, Finland; [Machin, Stephen] UCL, Dept Econ, London WC1E 6BT, England	Aalto University; VATT Institute for Economic Research; Abo Akademi University; University of London; University College London	Pekkarinen, T (corresponding author), Helsinki Sch Econ, Dept Econ, Helsinki 00101, Finland.	tuomas.pekkarinen@hse.fi			Economic and Social Research Council [RES-107-28-1001] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], PIRLS 2001 USER GUID; Arulampalam W, 2007, IND LABOR RELAT REV, V60, P163, DOI 10.1177/001979390706000201; Bayard K, 2003, J LABOR ECON, V21, P887, DOI 10.1086/377026; Ellis H., 1894, MAN WOMAN STUDY SECO; FEINGOLD A, 1992, REV ED RE, V59, P185; Galton F., 1869, HEREDITARY GENIUS; Guiso L, 2008, SCIENCE, V320, P1164, DOI 10.1126/science.1154094; Hausmann R., 2006, GLOBAL GENDER GAP RE; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Hyde JS, 2008, SCIENCE, V321, P494, DOI 10.1126/science.1160364; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; JENSEN AR, 1971, INTELLIGENCE GENETIC; Kimura Doreen, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P67; Leuven E, 2004, ECON J, V114, P466, DOI 10.1111/j.1468-0297.2004.00217.x; Maccoby E.E., 1974, PSYCHOL SEX DIFFEREN; Machin S, 2005, OXFORD REV ECON POL, V21, P357, DOI 10.1093/oxrep/gri021; MARTIN MO, 2005, TIMMS 2003 USER GUID; McGrayne S., 2001, NOBEL PRIZE WOMEN SC, Vsecond edition).; Muller CB, 2005, SCIENCE, V307, P1043; NODDINGS N, 1992, REV EDUC RES, V62, P85, DOI 10.3102/00346543062001085; *PISA, 2003, 2003 ASS FRAM MATH R	21	106	108	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1331	1332		10.1126/science.1162573	http://dx.doi.org/10.1126/science.1162573			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	376FX	19039123				2022-12-01	WOS:000261170600021
J	Meng, W; Mushika, Y; Ichii, T; Takeichi, M				Meng, Wenxiang; Mushika, Yoshimi; Ichii, Tetsuo; Takeichi, Masatoshi			Anchorage of Microtubule Minus Ends to Adherens Junctions Regulates Epithelial Cell-Cell Contacts	CELL			English	Article							TRACKING PROTEINS; CADHERIN FUNCTION; N-CADHERIN; CATENIN; COMPLEX; DYNAMICS; KINESIN; BINDING; LOCALIZATION; P120-CATENIN	Epithelial cells contain noncentrosomal microtubules (MTs), whose minus ends are oriented apically. In contrast with the well-known interactions of the minus ends with the centrosome, little is known about the termination site of the noncentrosomal minus ends. Here we show that a population of MT minus ends is anchored at the zonula adherens (ZA), the apical-most part of the cadherin-based adherens junction, via a protein that we have termed Nezha. We initially identified PLEKHA7 as a ZA component and subsequently detected Nezha as a partner for PLEKHA7. Nezha bound MTs at their minus ends and tethered them to the ZA. Furthermore, we found that a minus end-directed motor, KIFC3, was concentrated at the ZA in a PLEKHA7/Nezha/MT-dependent manner; and depletion of any of these proteins resulted in disorganization of the ZA. We propose that the PLEKHA7/Nezha/MT complex regulates the ZA integrity by recruiting KIFC3 to this junctional site.	[Meng, Wenxiang; Mushika, Yoshimi; Ichii, Tetsuo; Takeichi, Masatoshi] RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Mushika, Yoshimi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; Kyoto University	Takeichi, M (corresponding author), RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; Meng, Wenxiang/0000-0003-0060-0535	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y. Mimori-Kiyosue for advice, N. Hirokawa for KIFC3 antibody and cDNA, and K. Shinmyozu for mass spectrometric analysis. We are also grateful to C. Yoshii, H. Abe-Ishigami, and M. Nomura-Harata for their technical support, as well as other members of our laboratory for discussion. This work was supported by a grant from the program Grants-in-Aid for Specially Promoted Research of the Ministry of Education, Science, Sports, and Culture of Japan.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Chartier NT, 2007, CANCER RES, V67, P9781, DOI 10.1158/0008-5472.CAN-07-0233; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Ichii T, 2007, GENES CELLS, V12, P827, DOI 10.1111/j.1365-2443.2007.01095.x; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Kaufmann U, 1999, J CELL SCI, V112, P55; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liu H, 2007, CELL STRUCT FUNCT, V32, P127, DOI 10.1247/csf.07023; Maekawa S, 2001, J BIOCHEM-TOKYO, V129, P691, DOI 10.1093/oxfordjournals.jbchem.a002908; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mogensen MM, 2000, J CELL SCI, V113, P3013; MOGENSEN MM, 1987, J CELL SCI, V88, P95; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; SHIRAYOSHI Y, 1986, CELL STRUCT FUNCT, V11, P245, DOI 10.1247/csf.11.245; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SU LK, 1995, CANCER RES, V55, P2972; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Troxell ML, 1999, AM J PHYSIOL-CELL PH, V276, pC404, DOI 10.1152/ajpcell.1999.276.2.C404; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; Vogelmann R, 2005, MOL BIOL CELL, V16, P701, DOI 10.1091/mbc.E04-09-0827; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yang ZH, 1997, GENOMICS, V45, P123, DOI 10.1006/geno.1997.4901; Yvon AMC, 1997, J CELL SCI, V110, P2391	40	299	313	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					948	959		10.1016/j.cell.2008.09.040	http://dx.doi.org/10.1016/j.cell.2008.09.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041755	Bronze			2022-12-01	WOS:000261183900024
J	Merksamer, PI; Trusina, A; Papa, FR				Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.			Real-Time Redox Measurements during Endoplasmic Reticulum Stress Reveal Interlinked Protein Folding Functions	CELL			English	Article							ER-ASSOCIATED DEGRADATION; UNFOLDED-PROTEIN; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; DISULFIDE-ISOMERASE; MISFOLDED PROTEINS; LUMINAL DOMAIN; MEMBRANE; PATHWAY; KINASE	Disruption of protein folding in the endoplasmic reticulum (ER) causes unfolded proteins to accumulate, triggering the unfolded protein response (UPR). UPR outputs in turn decrease ER unfolded proteins to close a negative feedback loop. However, because it is infeasible to directly measure the concentration of unfolded proteins in vivo, cells are generically described as experiencing "ER stress'' whenever the UPR is active. Because ER redox potential is optimized for oxidative protein folding, we reasoned that measureable redox changes should accompany unfolded protein accumulation. To test this concept, we employed fluorescent protein reporters to dynamically measure ER redox status and UPR activity in single cells. Using these tools, we show that diverse stressors, both experimental and physiological, compromise ER protein oxidation when UPR-imposed homeostatic control is lost. Using genetic analysis we uncovered redox heterogeneities in isogenic cell populations, and revealed functional interlinks between ER protein folding, modification, and quality control systems.	[Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	frpapa@medicine.ucsf.edu	trusina, ala/H-7312-2012; Trusina, Ala/N-5030-2019; Trusina, Ala/L-6069-2013	Trusina, Ala/0000-0003-1945-454X; Trusina, Ala/0000-0003-1945-454X; Papa, Feroz/0000-0002-3684-9108	NIH Director's New Innovator [DP2OD001925]; Burroughs Wellcome Fund Career Award in Biomedical Sciences; Culpeper Scholarship from the Partnership for Cures; Sandler Foundation; Hillblom Foundation; National Science Foundation Predoctoral; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	NIH Director's New Innovator(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award in Biomedical Sciences(Burroughs Wellcome Fund); Culpeper Scholarship from the Partnership for Cures; Sandler Foundation; Hillblom Foundation; National Science Foundation Predoctoral(National Science Foundation (NSF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. James Remington for providing the roGFP2 construct; Victor Chubukov for assistance with automated flow cytometry and for data analysis software; Maya Schuldiner, Martin Jonikas, Erin Quan, Davis Ng, Chao Zhang, and Antony Cooper for reagents; and Kurt Thorn for imaging assistance. We thank Mark Hochstrasser, Scott Oakes, Chris Patil, Jonathan Weissman, and members of the Papa lab for comments on the manuscript. Microscopy images were collected at the Nikon Imaging Center at UCSF/QB3. F. R. P. is funded through an NIH Director's New Innovator Award (DP2OD001925), a Burroughs Wellcome Fund Career Award in Biomedical Sciences, a Culpeper Scholarship from the Partnership for Cures, and startup awards from the Sandler Foundation and the Hillblom Foundation. P. I. M. is supported through a National Science Foundation Predoctoral Fellowship.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Chin CS, 2008, PLOS BIOL, V6, P1343, DOI 10.1371/journal.pbio.0060146; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	41	224	228	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					933	947		10.1016/j.cell.2008.10.011	http://dx.doi.org/10.1016/j.cell.2008.10.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19026441	Green Accepted, Bronze			2022-12-01	WOS:000261183900023
J	Luan, B; Zhao, J; Wu, HY; Duan, BY; Shu, GW; Wang, XY; Li, DS; Jia, WP; Kang, JH; Pei, G				Luan, Bing; Zhao, Jian; Wu, Haiya; Duan, Baoyu; Shu, Guangwen; Wang, Xiaoying; Li, Dangsheng; Jia, Weiping; Kang, Jiuhong; Pei, Gang			Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance	NATURE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; ACTIVATION; PROTEIN; KINASE; AKT; SRC; OBESITY; PHOSPHORYLATION; TRANSDUCTION; PATHWAYS	Insulin resistance, a hallmark of type 2 diabetes, is a defect of insulin in stimulating insulin receptor signalling(1,2), which has become one of the most serious public health threats. Upon stimulation by insulin, insulin receptor recruits and phosphorylates insulin receptor substrate proteins(3), leading to activation of the phosphatidylinositol-3-OH kinase (PI(3) K)-Akt pathway. Activated Akt phosphorylates downstream kinases and transcription factors, thus mediating most of the metabolic actions of insulin(4-6). beta-arrestins mediate biological functions of G-protein-coupled receptors by linking activated receptors with distinct sets of accessory and effecter proteins, thereby determining the specificity, efficiency and capacity of signals(7-11). Here we show that in diabetic mouse models, beta-arrestin-2 is severely downregulated. Knockdown of beta-arrestin-2 exacerbates insulin resistance, whereas administration of beta-arrestin-2 restores insulin sensitivity in mice. Further investigation reveals that insulin stimulates the formation of a new beta-arrestin-2 signal complex, in which beta-arrestin-2 scaffolds Akt and Src to insulin receptor. Loss or dysfunction of beta-arrestin-2 results in deficiency of this signal complex and disturbance of insulin signalling in vivo, thereby contributing to the development of insulin resistance and progression of type 2 diabetes. Our findings provide new insight into the molecular pathogenesis of insulin resistance, and implicate new preventive and therapeutic strategies against insulin resistance and type 2 diabetes.	[Luan, Bing; Zhao, Jian; Duan, Baoyu; Shu, Guangwen; Kang, Jiuhong; Pei, Gang] Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Luan, Bing; Zhao, Jian; Duan, Baoyu; Shu, Guangwen; Kang, Jiuhong; Pei, Gang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Li, Dangsheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China; [Wu, Haiya; Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai, Peoples R China; [Wu, Haiya; Jia, Weiping] Shanghai Diabet Inst, Shanghai, Peoples R China; [Wu, Haiya; Jia, Weiping] Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China; [Wang, Xiaoying] Fudan Univ, Affiliated Zhongshan Hosp, Shanghai 200032, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences; Shanghai Jiao Tong University; Fudan University; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn	Zhao, Jian/E-2008-2019; Luan, Bing/B-5521-2014	Zhao, Jian/0000-0002-8862-0591; Kang, Jiuhong/0000-0001-7538-1889; Luan, Bing/0000-0002-0409-2964	Ministry of Science and Technology [2005CB522406, 2006CB943900, 2007CB947904, 2007CB947100, 2007CB948000, 2009CB941100]; National Natural Science Foundation of China [30621091, 30625014, 30623003, 30871285, 90713047]; Shanghai Municipal Commission for Science and Technology [07PJ14099, 06DZ22032]; Chinese Academy of Sciences [KSCX2-YW-R-56, 2007KIP204]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Chinese Academy of Sciences(Chinese Academy of Sciences)	We are grateful to R. J. Lefkowitz for providing us with beta-arr2-KO mice. We thank J.-L. Guan for discussions and comments on the manuscripts. We thank all members of the laboratory for sharing reagents and advice. This research was supported by the Ministry of Science and Technology (2005CB522406, 2006CB943900, 2007CB947904, 2007CB947100, 2007CB948000 and 2009CB941100), National Natural Science Foundation of China (30621091, 30625014, 30623003, 30871285 and 90713047), Shanghai Municipal Commission for Science and Technology (07PJ14099 and 06DZ22032), Chinese Academy of Sciences (KSCX2-YW-R-56 and 2007KIP204).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Craxton A, 1999, J BIOL CHEM, V274, P30644, DOI 10.1074/jbc.274.43.30644; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Haluzik MM, 2006, ENDOCRINOLOGY, V147, P4517, DOI 10.1210/en.2005-1624; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Luan B, 2005, EMBO J, V24, P4237, DOI 10.1038/sj.emboj.7600882; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Shen HQ, 1999, METABOLISM, V48, P965, DOI 10.1016/S0026-0495(99)90191-9; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	26	180	201	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1146	U105		10.1038/nature07617	http://dx.doi.org/10.1038/nature07617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19122674				2022-12-01	WOS:000263680100044
J	Blow, N				Blow, Nathan			Glycobiology: A spoonful of sugar	NATURE			English	Editorial Material																		Campbell MP, 2008, BIOINFORMATICS, V24, P1214, DOI 10.1093/bioinformatics/btn090; Hwang GM, 2008, IEEE SENS J, V8, P2074, DOI 10.1109/JSEN.2008.2007663; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Wang CC, 2007, NATURE, V446, P896, DOI 10.1038/nature05730	4	43	46	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 29	2009	457	7229					617	622		10.1038/457617a	http://dx.doi.org/10.1038/457617a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177129				2022-12-01	WOS:000262852200049
J	Sun, JC; Beilke, JN; Lanier, LL				Sun, Joseph C.; Beilke, Joshua N.; Lanier, Lewis L.			Adaptive immune features of natural killer cells	NATURE			English	Article							CD8(+) T-CELLS; MURINE CYTOMEGALOVIRUS; ACTIVATION RECEPTOR; VIRAL-INFECTION; NK CELLS; IN-VIVO; MEMORY; EFFECTOR; RECOGNITION; ANTIGEN	In an adaptive immune response, naive T cells proliferate during infection and generate long- lived memory cells that undergo secondary expansion after a repeat encounter with the same pathogen. Although natural killer (NK) cells have traditionally been classified as cells of the innate immune system, they share many similarities with cytotoxic T lymphocytes. We use a mouse model of cytomegalovirus infection to show that, like T cells, NK cells bearing the virus-specific Ly49H receptor proliferate 100-fold in the spleen and 1,000- fold in the liver after infection. After a contraction phase, Ly49H- positive NK cells reside in lymphoid and non- lymphoid organs for several months. These self- renewing 'memory' NK cells rapidly degranulate and produce cytokines on reactivation. Adoptive transfer of these NK cells into naive animals followed by viral challenge results in a robust secondary expansion and protective immunity. These findings reveal properties of NK cells that were previously attributed only to cells of the adaptive immune system.	[Sun, Joseph C.; Beilke, Joshua N.; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Sun, Joseph C.; Beilke, Joshua N.; Lanier, Lewis L.] Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lewis.lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	National Institutes of Health [AI068129]; Irvington Institute for Immunological Research; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute for Immunological Research; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Lanier laboratory for comments and discussions, and R. Locksley and W. Seaman for critical reading of this manuscript. The work was supported by National Institutes of Health grant AI068129. J.C.S. is supported by the Irvington Institute for Immunological Research. J.N.B. is supported by the Juvenile Diabetes Research Foundation. L.L.L. is an American Cancer Society Research Professor.	Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Badovinac VP, 2003, J IMMUNOL, V170, P4933, DOI 10.4049/jimmunol.170.10.4933; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; BUKOWSKI JF, 1985, J EXP MED, V161, P40, DOI 10.1084/jem.161.1.40; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Lanier LL, 2007, EUR J IMMUNOL, V37, P1424, DOI 10.1002/eji.200737418; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lefrancois L, 2002, CURR OPIN IMMUNOL, V14, P503, DOI 10.1016/S0952-7915(02)00360-6; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; Vidal SM, 2006, CURR TOP MICROBIOL, V298, P183; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	36	1053	1105	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					557	561		10.1038/nature07665	http://dx.doi.org/10.1038/nature07665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19136945	Green Accepted			2022-12-01	WOS:000262852200035
J	Mega, JL; Close, SL; Wiviott, SD; Shen, L; Hockett, RD; Brandt, JT; Walker, JR; Antman, EM; Macias, W; Braunwald, E; Sabatine, MS				Mega, Jessica L.; Close, Sandra L.; Wiviott, Stephen D.; Shen, Lei; Hockett, Richard D.; Brandt, John T.; Walker, Joseph R.; Antman, Elliott M.; Macias, William; Braunwald, Eugene; Sabatine, Marc S.			Cytochrome P-450 Polymorphisms and Response to Clopidogrel.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PLATELET INHIBITION; INDIVIDUAL RESPONSIVENESS; ATHEROTHROMBOTIC EVENTS; STENT THROMBOSIS; INCREASED RISK; PRASUGREL; PHARMACOKINETICS; PHARMACODYNAMICS; VARIABILITY	Background: Clopidogrel requires transformation into an active metabolite by cytochrome P-450 (CYP) enzymes for its antiplatelet effect. The genes encoding CYP enzymes are polymorphic, with common alleles conferring reduced function. Methods: We tested the association between functional genetic variants in CYP genes, plasma concentrations of active drug metabolite, and platelet inhibition in response to clopidogrel in 162 healthy subjects. We then examined the association between these genetic variants and cardiovascular outcomes in a separate cohort of 1477 subjects with acute coronary syndromes who were treated with clopidogrel in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction (TRITON-TIMI) 38. Results: In healthy subjects who were treated with clopidogrel, carriers of at least one CYP2C19 reduced-function allele (approximately 30% of the study population) had a relative reduction of 32.4% in plasma exposure to the active metabolite of clopidogrel, as compared with noncarriers (P<0.001). Carriers also had an absolute reduction in maximal platelet aggregation in response to clopidogrel that was 9 percentage points less than that seen in noncarriers (P<0.001). Among clopidogrel-treated subjects in TRITON-TIMI 38, carriers had a relative increase of 53% in the composite primary efficacy outcome of the risk of death from cardiovascular causes, myocardial infarction, or stroke, as compared with noncarriers (12.1% vs. 8.0%; hazard ratio for carriers, 1.53; 95% confidence interval [CI], 1.07 to 2.19; P=0.01) and an increase by a factor of 3 in the risk of stent thrombosis (2.6% vs. 0.8%; hazard ratio, 3.09; 95% CI, 1.19 to 8.00; P=0.02). Conclusions: Among persons treated with clopidogrel, carriers of a reduced-function CYP2C19 allele had significantly lower levels of the active metabolite of clopidogrel, diminished platelet inhibition, and a higher rate of major adverse cardiovascular events, including stent thrombosis, than did noncarriers. N Engl J Med 2009;360:354-62.	[Mega, Jessica L.; Wiviott, Stephen D.; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.] Brigham & Womens Hosp, Div Cardiovasc, Thrombolysis Myocardial Infarct Study Grp, Dept Med, Boston, MA 02115 USA; [Mega, Jessica L.; Wiviott, Stephen D.; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Close, Sandra L.; Shen, Lei; Hockett, Richard D.; Brandt, John T.; Macias, William] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Walker, Joseph R.] Daiichi Sankyo Pharma Dev, Edison, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Eli Lilly; Daiichi Sankyo Company Limited	Mega, JL (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, Thrombolysis Myocardial Infarct Study Grp, Dept Med, 350 Longwood Ave, Boston, MA 02115 USA.	jmega@partners.org; msabatine@partners.org	Sabatine, Marc/AAJ-6751-2020	Sabatine, Marc/0000-0002-0691-3359	Daiichi Sankyo; Eli Lilly; Sanofi-Aventis; Schering-Plough; AstraZeneca; Bristol-Myers Squibb	Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Sanofi-Aventis(Sanofi-Aventis); Schering-Plough(Merck & CompanySchering Plough Corporation); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb)	Supported by research grants from Daiichi Sankyo and Eli Lilly.; The TIMI Study Group reports receiving grant support from Daiichi Sankyo, Eli Lilly, Sanofi-Aventis, and Schering-Plough. In addition, Dr. Mega reports receiving grant support from Schering-Plough; Dr. Wiviott, grant support from Daiichi Sankyo, Eli Lilly, and Sanofi-Aventis, consulting fees from AstraZeneca and Sanofi-Aventis, and lecture fees from Daiichi-Sankyo, Eli Lilly, and AstraZeneca; Dr. Antman, grant support from Daiichi Sankyo and Eli Lilly, consulting fees from Sanofi- Aventis, and lecture fees from Eli Lilly and Sanofi-Aventis; Dr. Braunwald, grant support from Daiichi Sankyo, Eli Lilly, SanofiAventis, and Schering- Plough, consulting fees from Daiichi Sankyo, Eli Lilly, and Schering- Plough, and lecture fees from Eli Lilly and Schering-Plough; and Dr. Sabatine, grant support from Sanofi- Aventis and Schering-Plough, consulting fees from AstraZeneca, Bristol-Myers Squibb, and Sanofi- Aventis, and lecture fees from Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, and Sanofi-Aventis. Dr. Walker reports being an employee of Daiichi Sankyo and having an equity interest or stock options in the company; and Drs. Close, Shen, Hockett, Brandt, and Macias, being employees of Eli Lilly and having an equity interest or stock options in the company. No other potential conflict of interest relevant to this article was reported.	Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; *BLUE CROSS BLUE S, 2004, SPEC REP GEN CYT P45; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Daly TM, 2007, CLIN CHEM, V53, P1222, DOI 10.1373/clinchem.2007.086348; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Dumaual C, 2007, PHARMACOGENOMICS, V8, P293, DOI 10.2217/14622416.8.3.293; Farid NA, 2007, CLIN PHARMACOL THER, V81, P735, DOI 10.1038/sj.clpt.6100139; Farid NA, 2007, RAPID COMMUN MASS SP, V21, P169, DOI 10.1002/rcm.2813; Farid NA, 2008, PHARMACOTHERAPY, V28, P1483, DOI 10.1592/phco.28.12.1483; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; *KAR I, HUM CYT P450 CYP ALL; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Kurihara A., 2005, DRUG METAB REV S2, V37, P99; LI YG, 2008, AM J CARDIOL S, V102, P76; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; O'Donoghue M, 2006, CIRCULATION, V114, pE600, DOI 10.1161/CIRCULATIONAHA.106.643171; Payne CD, 2008, PLATELETS, V19, P275, DOI 10.1080/09537100801891640; Payne CD, 2007, J CARDIOVASC PHARM, V50, P555, DOI 10.1097/FJC.0b013e3181492209; Rehmel JLF, 2006, DRUG METAB DISPOS, V34, P600, DOI 10.1124/dmd.105.007989; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Small DS, 2008, CURR MED RES OPIN, V24, P2251, DOI 10.1185/03007990802205985; SMALL DS, 2008, CLIN PHARM THER S1, V83, pS56; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Suh JW, 2006, CAN MED ASSOC J, V175, P64, DOI 10.1503/cmaj.060701; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2006, AM HEART J, V152, P627, DOI 10.1016/j.ahj.2006.04.012; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2001, N ENGL J MED, V345, P1506; 2001, N ENGL J MED, V345, P1716	38	1817	1958	6	152	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					354	362		10.1056/NEJMoa0809171	http://dx.doi.org/10.1056/NEJMoa0809171			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395JH	19106084				2022-12-01	WOS:000262519900007
J	Allison, DB; Mattes, RD				Allison, David B.; Mattes, Richard D.			Nutritively Sweetened Beverage Consumption and Obesity The Need for Solid Evidence on a Fluid Issue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTING CHILDHOOD OBESITY; WEIGHT; CHILDREN; YOUNG; FOOD		[Allison, David B.] Univ Alabama, Sect Stat Genet, Dept Biostat, Birmingham, AL 35294 USA; [Allison, David B.] Univ Alabama, Clin Nutr Res Ctr, Birmingham, AL 35294 USA; [Mattes, Richard D.] Purdue Univ, Dept Foods & Nutr, W Lafayette, IN 47907 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Allison, DB (corresponding author), Univ Alabama, Sect Stat Genet, Dept Biostat, Ryals Publ Hlth Bldg,Ste 414,1665 Univ Blvd, Birmingham, AL 35294 USA.	dallison@uab.edu		Allison, David/0000-0003-3566-9399	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079913, P30DK056336] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK079913, P30 DK056336, P30DK056336, R01 DK079913-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albala C, 2008, AM J CLIN NUTR, V88, P605, DOI 10.1093/ajcn/88.3.605; Almiron-Roig E, 2004, PHYSIOL BEHAV, V82, P671, DOI 10.1016/j.physbeh.2004.06.003; [Anonymous], 1931, BIOMETRIKA, V23, P398; Belpoggi F, 2006, ANN NY ACAD SCI, V1076, P736, DOI 10.1196/annals.1371.078; BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; James J, 2007, BMJ-BRIT MED J, V335, P762, DOI 10.1136/bmj.39342.571806.55; Mourao DM, 2007, INT J OBESITY, V31, P1688, DOI 10.1038/sj.ijo.0803667; NAGOURNEY E, 2006, NY TIMES        0307; Newby PK, 2004, J AM DIET ASSOC, V104, P1086, DOI 10.1016/j.jada.2004.04.020; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sichieri R, 2009, PUBLIC HEALTH NUTR, V12, P197, DOI 10.1017/S1368980008002644; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782	14	48	49	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					318	320		10.1001/jama.2008.974	http://dx.doi.org/10.1001/jama.2008.974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395IV	19155459	Green Accepted			2022-12-01	WOS:000262518700023
J	Malizia, BA; Hacker, MR; Penzias, AS				Malizia, Beth A.; Hacker, Michele R.; Penzias, Alan S.			Cumulative Live-Birth Rates after In Vitro Fertilization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; ONGOING PREGNANCY; SPERM INJECTION; AGE; IVF; PROBABILITY; CONCEPTION; CYCLES; NUMBER; DIAGNOSIS	BACKGROUND Outcomes of in vitro fertilization ( IVF) treatment are traditionally reported as pregnancies per IVF cycle. However, a couple's primary concern is the chance of a live birth over an entire treatment course. METHODS We estimated cumulative live- birth rates among patients undergoing their first fresh-embryo, nondonor IVF cycle between 2000 and 2005 at one large center. Couples were followed until either discontinuation of treatment or delivery of a live- born infant. Analyses were stratified according to maternal age and performed with the use of both optimistic and conservative methods. Optimistic methods assumed that patients who did not return for subsequent IVF cycles would have the same chance of a pregnancy resulting in a live birth as patients who continued treatment; conservative methods assumed no live births among patients who did not return. RESULTS Among 6164 patients undergoing 14,248 cycles, the cumulative live- birth rate after 6 cycles was 72% ( 95% confidence interval [ CI], 70 to 74) with the optimistic analysis and 51% ( 95% CI, 49 to 52) with the conservative analysis. Among patients who were younger than 35 years of age, the corresponding rates after six cycles were 86% ( 95% CI, 83 to 88) and 65% ( 95% CI, 64 to 67). Among patients who were 40 years of age or older, the corresponding rates were 42% ( 95% CI, 37 to 47) and 23% ( 95% CI, 21 to 25). The cumulative live- birth rate decreased with increasing age, and the age-stratified curves (< 35 vs. = 40 years) were significantly different from one another ( P< 0.001). CONCLUSIONS Our results indicate that IVF may largely overcome infertility in younger women, but it does not reverse the age- dependent decline in fertility.	[Malizia, Beth A.; Penzias, Alan S.] Boston IVF, Waltham, MA 02451 USA; [Malizia, Beth A.; Hacker, Michele R.; Penzias, Alan S.] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Boston, MA 02215 USA; [Malizia, Beth A.; Hacker, Michele R.; Penzias, Alan S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Penzias, AS (corresponding author), Boston IVF, 130 2nd Ave, Waltham, MA 02451 USA.	apenzias@bidmc.harvard.edu	Hacker, Michele/ABC-5031-2021	Hacker, Michele/0000-0003-0217-9991; Penzias, Alan/0000-0002-7160-494X	Ferring Pharmaceuticals; EMD Serono; Organon; Repromedix	Ferring Pharmaceuticals(Ferring Pharmaceuticals); EMD Serono; Organon; Repromedix	Dr. Malizia reports receiving an educational grant from Ferring Pharmaceuticals for work unrelated to this study, and Dr. Penzias, receiving consulting and lecture fees and grant support (to Boston IVF) from Ferring Pharmaceuticals and grant support (to Boston IVF) from EMD Serono, Organon, and Repromedix. No other potential conflict of interest relevant to this article was reported. We thank Benjamin B. Taylor, M.D., M.P.H., for his assistance with revisions of an earlier version of the manuscript, Emily B. Levitan, Sc.D., for her statistical review, and the many nurses, assistants, scientists, and physicians at Boston IVF for their care of the patients in this study.	*AM SOC REPR MED S, 2007, 2005 ASS REPR TECHN; Andersen AN, 2008, HUM REPROD, V23, P756, DOI 10.1093/humrep/den014; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; Dickey RP, 2002, FERTIL STERIL, V78, P1088, DOI 10.1016/S0015-0282(02)04212-7; EATON JL, 2008, FERTIL STERIL   0426; Elizur SE, 2006, GYNECOL ENDOCRINOL, V22, P25, DOI 10.1080/09513590500453916; Engmann L, 1999, BRIT J OBSTET GYNAEC, V106, P165, DOI 10.1111/j.1471-0528.1999.tb08217.x; Fukuda J, 2001, ACTA OBSTET GYN SCAN, V80, P71, DOI 10.1080/791201838; Gnoth C, 2003, HUM REPROD, V18, P1959, DOI 10.1093/humrep/deg366; GUTTMACHER AF, 1956, JAMA-J AM MED ASSOC, V161, P855, DOI 10.1001/jama.1956.02970090081016; GUZICK DS, 1986, FERTIL STERIL, V46, P663; HULL MGR, 1992, BRIT MED J, V304, P1465, DOI 10.1136/bmj.304.6840.1465; Jain T, 2005, FERTIL STERIL, V84, P221, DOI 10.1016/j.fertnstert.2005.01.118; Jain T, 2002, NEW ENGL J MED, V347, P661, DOI 10.1056/NEJMsa013491; Klipstein S, 2005, FERTIL STERIL, V84, P435, DOI 10.1016/j.fertnstert.2005.02.020; Land JA, 1997, FERTIL STERIL, V68, P278, DOI 10.1016/S0015-0282(97)81515-4; Lintsen AME, 2007, HUM REPROD, V22, P2455, DOI 10.1093/humrep/dem183; Olivius K, 2002, FERTIL STERIL, V77, P505, DOI 10.1016/S0015-0282(01)03217-4; Pandian Z, 2005, HUM REPROD, V20, P2681, DOI 10.1093/humrep/dei153; Seif MM, 2006, COCHRANE DB SYST REV, V1; Stem JE, 2007, FERTIL STERIL, V88, P275, DOI 10.1016/j.fertnstert.2006.09.016; Stolwijk AM, 2000, HUM REPROD, V15, P203, DOI 10.1093/humrep/15.1.203; TAN SL, 1992, LANCET, V339, P1390, DOI 10.1016/0140-6736(92)91205-M; TAN SL, 1994, AM J OBSTET GYNECOL, V171, P513, DOI 10.1016/0002-9378(94)90291-7; TIETZE C, 1957, FERTIL STERIL, V8, P89; van Disseldorp J, 2007, REPROD BIOMED ONLINE, V14, P455, DOI 10.1016/S1472-6483(10)60893-0; Witsenburg C, 2005, FERTIL STERIL, V84, P99, DOI 10.1016/j.fertnstert.2005.02.013; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8; 2006, FERTIL STERIL S, V86, pS51	29	282	299	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					236	243		10.1056/NEJMoa0803072	http://dx.doi.org/10.1056/NEJMoa0803072			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144939				2022-12-01	WOS:000262434500006
J	Raftery, J				Raftery, James			NICE and the challenge of cancer drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-EXCELLENCE; NATIONAL-INSTITUTE		[Raftery, James] Univ Southampton, Southampton SO16 7PX, Hants, England	University of Southampton	Raftery, J (corresponding author), Univ Southampton, Southampton SO16 7PX, Hants, England.	j.p.raftery@soton.ac.uk						Miners AH, 2005, BMJ-BRIT MED J, V330, P65, DOI 10.1136/bmj.38285.482350.82; NICE, 2008, APPR LIF EXT END LIF; ODOWD A, 2008, BRIT MED J, V336, pA444; Raftery JP, 2008, MED J AUSTRALIA, V188, P26, DOI 10.5694/j.1326-5377.2008.tb01500.x; Richards M, 2008, IMPROVING ACCESS MED; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; Thompson Coon J, 2008, BEVACIZUMAB SORAFENI	7	34	34	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 13	2009	338								b67	10.1136/bmj.b67	http://dx.doi.org/10.1136/bmj.b67			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404ZY	19141502				2022-12-01	WOS:000263192900001
J	Acosta, IF; Laparra, H; Romero, SP; Schmelz, E; Hamberg, M; Mottinger, JP; Moreno, MA; Dellaporta, SL				Acosta, Ivan F.; Laparra, Helene; Romero, Sandra P.; Schmelz, Eric; Hamberg, Mats; Mottinger, John P.; Moreno, Maria A.; Dellaporta, Stephen L.			tasselseed1 Is a Lipoxygenase Affecting Jasmonic Acid Signaling in Sex Determination of Maize	SCIENCE			English	Article							ZEA-MAYS; ANTHER DEHISCENCE; ARCHITECTURE; ARABIDOPSIS; PLANTS; GENE; INFLORESCENCES; BIOSYNTHESIS; GRASSES; ENCODES	Sex determination in maize is controlled by a developmental cascade leading to the formation of unisexual florets derived from an initially bisexual floral meristem. Abortion of pistil primordia in staminate florets is controlled by a tasselseed- mediated cell death process. We positionally cloned and characterized the function of the sex determination gene tasselseed1 ( ts1). The TS1 protein encodes a plastid- targeted lipoxygenase with predicted 13- lipoxygenase specificity, which suggests that TS1 may be involved in the biosynthesis of the plant hormone jasmonic acid. In the absence of a functional ts1 gene, lipoxygenase activity was missing and endogenous jasmonic acid concentrations were reduced in developing inflorescences. Application of jasmonic acid to developing inflorescences rescued stamen development in mutant ts1 and ts2 inflorescences, revealing a role for jasmonic acid in male flower development in maize.	[Acosta, Ivan F.; Laparra, Helene; Romero, Sandra P.; Moreno, Maria A.; Dellaporta, Stephen L.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Schmelz, Eric] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, S-17177 Stockholm, Sweden; [Mottinger, John P.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA	Yale University; United States Department of Agriculture (USDA); Karolinska Institutet; University of Rhode Island	Dellaporta, SL (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	stephen.dellaporta@yale.edu	Acosta, Ivan/Q-2274-2018	Acosta, Ivan/0000-0001-7080-3384; Hamberg, Mats/0000-0002-8910-7810; Schmelz, Eric/0000-0002-2837-734X	NIH [R01 GM38148]; USDA [99-35301-8048]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Hake, P. Chomet, and B. Lowe for providing ts1 mutant alleles; A. Signorovitch and R. Rosengarten for help with phylogenetic analyses; E. Bortiri, C. Whipple, P. Bommet, and D. Jackson for advice on in situ hybridizations; I. Hwang for the pRbcSnt: GFP construct; and R. Tsien for the mCherry gene. Supported by NIH grant R01 GM38148 (S.L.D.) and USDA grant 99-35301-8048 (J.P.M.). Sequences obtained in this study were deposited in GenBank (accession numbers FJ360855 and FJ360856).	Ainsworth C, 1998, CURR TOP DEV BIOL, V38, P167; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bonnett OT, 1940, J AGRIC RES, V60, P0025; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Calderon-Urrea A, 1999, DEVELOPMENT, V126, P435; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; DELLAPORTA SL, 1994, SCIENCE, V266, P1501, DOI 10.1126/science.7985019; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emerson RA, 1920, J HERED, V11, P65, DOI 10.1093/oxfordjournals.jhered.a101971; Engelberth J, 2007, MOL PLANT MICROBE IN, V20, P707, DOI 10.1094/MPMI-20-6-0707; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Gaut BS, 2001, GENOME RES, V11, P55, DOI 10.1101/gr.160601; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; Hornung E, 1999, P NATL ACAD SCI USA, V96, P4192, DOI 10.1073/pnas.96.7.4192; Irish EE, 1996, BIOESSAYS, V18, P363, DOI 10.1002/bies.950180506; IRISH EE, 1993, AM J BOT, V80, P292, DOI 10.2307/2445352; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Kiesselbach T.A., 1949, STRUCTURE REPROD COR; Kim JC, 2007, GENETICS, V177, P2547, DOI 10.1534/genetics.107.082446; Lee KH, 2002, MOL CELLS, V14, P388; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; NICKERSON NORTON H., 1955, ANN MISSOURI BOT GARDEN, V42, P195, DOI 10.2307/2394655; Salse J, 2004, PLANT J, V38, P396, DOI 10.1111/j.1365-313X.2004.02058.x; Sanders PM, 2005, SEX PLANT REPROD, V17, P219, DOI 10.1007/s00497-004-0231-y; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; SHIBATA D, 1995, J LIPID MEDIAT CELL, V12, P213, DOI 10.1016/0929-7855(95)00020-Q; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; WEILER EW, 1993, PHYTOCHEMISTRY, V32, P591, DOI 10.1016/S0031-9422(00)95142-2; Wu XQ, 2007, FEBS J, V274, P1172, DOI 10.1111/j.1742-4658.2007.05642.x; Yamasaki S, 2005, VITAM HORM, V72, P79, DOI 10.1016/S0083-6729(05)72003-3	34	194	223	10	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					262	265		10.1126/science.1164645	http://dx.doi.org/10.1126/science.1164645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131630				2022-12-01	WOS:000262290600041
J	Klein, J				Klein, Jacob			CHEMISTRY Repair or Replacement-A Joint Perspective	SCIENCE			English	Editorial Material							MATERIALS SCIENCE; LUBRICATION; CARTILAGE; BIOMATERIALS; POLYMER		[Klein, Jacob] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Klein, J (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	jacob.klein@weizmann.ac.il						Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Briscoe WH, 2006, NATURE, V444, P191, DOI 10.1038/nature05196; Byrne JA, 2008, HUM MOL GENET, V17, pR37, DOI 10.1093/hmg/ddn053; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Chen FH, 2008, CURR RHEUMATOL REV, V4, P161, DOI 10.2174/157339708785133550; Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005; Gourdon D, 2008, LANGMUIR, V24, P1534, DOI 10.1021/la702259c; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Klein J, 2006, P I MECH ENG J-J ENG, V220, P691, DOI 10.1243/13506501JET143; Lee S, 2008, SCIENCE, V319, P575, DOI 10.1126/science.1153273; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; McCutchen C. W., 1962, WEAR, V5, P1, DOI [DOI 10.1016/0043-1648(62)90176-X, 10.1016/0043-1648(62)90176-X]; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890; 2008, ROYAL SOC CHEM C CHE	18	167	175	7	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					47	48		10.1126/science.1166753	http://dx.doi.org/10.1126/science.1166753			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119205				2022-12-01	WOS:000262104100029
J	Ingelfinger, JR				Ingelfinger, Julie R.			Melamine and the Global Implications of Food Contamination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Brown CA, 2007, J VET DIAGN INVEST, V19, P525, DOI 10.1177/104063870701900510; Chen K., 2007, PUBLIC HLTH SECURITY, P169; *FOOD DRUG ADM, 2008, MEL CONT CHIN; HAUGE MD, 1992, INVEST NEW DRUG, V10, P299, DOI 10.1007/BF00944184; TURNIPSEED S, 2008, LAB INFORMATION B, V4421	5	251	256	3	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2745	2748		10.1056/NEJMp0808410	http://dx.doi.org/10.1056/NEJMp0808410			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109571				2022-12-01	WOS:000261950800001
J	Sankaran, VG; Menne, TF; Xu, J; Akie, TE; Lettre, G; Van Handel, B; Mikkola, HKA; Hirschhorn, JN; Cantor, AB; Orkin, SH				Sankaran, Vijay G.; Menne, Tobias F.; Xu, Jian; Akie, Thomas E.; Lettre, Guillaume; Van Handel, Ben; Mikkola, Hanna K. A.; Hirschhorn, Joel N.; Cantor, Alan B.; Orkin, Stuart H.			Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; LOCUS-CONTROL REGION; ZINC-FINGER PROTEIN; BETA-THALASSEMIA; COMPLEX; DIFFERENTIATION; VARIANTS; RECRUITS; DISEASE; LINEAGE	Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the beta-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high- HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full- length forms of BCL11A is developmentally restricted to adult erythroid cells. Down- regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the beta- globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in beta- hemoglobin disorders.	[Sankaran, Vijay G.; Menne, Tobias F.; Xu, Jian; Akie, Thomas E.; Cantor, Alan B.; Orkin, Stuart H.] Harvard Univ, Sch Med, Div Hematol Oncol, Childrens Hosp Boston,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Sankaran, Vijay G.; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Lettre, Guillaume; Hirschhorn, Joel N.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lettre, Guillaume; Hirschhorn, Joel N.] Childrens Hosp, Div Genet Endocrinol, Boston, MA 02115 USA; [Lettre, Guillaume; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Van Handel, Ben; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of California System; University of California Los Angeles; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Div Hematol Oncol, Childrens Hosp Boston,Harvard Stem Cell Inst, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu		Cantor, Alan/0000-0002-5136-028X	National Heart, Lung, and Blood Institute; NIH [HL32262-26, HL32259-27]; Center of Excellence in Molecular Hematology Award from the National Institute of Digestive and Kidney Diseases; Howard Hughes Medical Institute; Leukaemia Research and Kay Kendall Leukaemia Funds; Medical Scientist Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, R01HL032259] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Molecular Hematology Award from the National Institute of Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Leukaemia Research and Kay Kendall Leukaemia Funds; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Snow, P. Tucker, G. Ippolito, B. Lee, M. Leid, T. Nakamura, D. Altshuler, E. Choy, and S. Bonakdar for providing reagents and suggestions. We are grateful to D. Nathan and A. Michelson for critical comments; D. Shao, N. Yudanin, and A. Soriano for experimental assistance; and C. Chen and V. Sankaran for assistance with data analysis. This work was supported by grants from the National Heart, Lung, and Blood Institute, NIH (HL32262-26 and HL32259-27), a Center of Excellence in Molecular Hematology Award from the National Institute of Digestive and Kidney Diseases, NIH, and the Howard Hughes Medical Institute. T. F. M. was supported by the Leukaemia Research and Kay Kendall Leukaemia Funds. V. G. S. was supported by a Medical Scientist Training Program grant from the NIH. Array datasets are deposited at Gene Expression Omnibus (accession no. GSE 13285). A patent application related to this work was filed, and V.G.S. and S.H.O. are inventors on this patent.	Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; GARLICK RL, 1981, J BIOL CHEM, V256, P1727; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; NAKAYASU H, 1991, P NATL ACAD SCI USA, V88, P10312, DOI 10.1073/pnas.88.22.10312; Navas PA, 1998, MOL CELL BIOL, V18, P4188, DOI 10.1128/MCB.18.7.4188; PAPAYANNOPOULOU T, 1986, CELL, V46, P469, DOI 10.1016/0092-8674(86)90667-7; PESCHLE C, 1985, NATURE, V313, P235, DOI 10.1038/313235a0; Quek L, 2007, BRIT J HAEMATOL, V136, P353, DOI 10.1111/j.1365-2141.2006.06408.x; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105	26	597	646	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1839	1842		10.1126/science.1165409	http://dx.doi.org/10.1126/science.1165409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056937				2022-12-01	WOS:000261799400053
J	Alenghat, T; Meyers, K; Mullican, SE; Leitner, K; Adeniji-Adele, A; Avila, J; Bucan, M; Ahima, RS; Kaestner, KH; Lazar, MA				Alenghat, Theresa; Meyers, Katherine; Mullican, Shannon E.; Leitner, Kirstin; Adeniji-Adele, Adetoun; Avila, Jacqueline; Bucan, Maja; Ahima, Rexford S.; Kaestner, Klaus H.; Lazar, Mitchell A.			Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology	NATURE			English	Article							REV-ERB-ALPHA; THYROID-HORMONE RECEPTOR; GENE-EXPRESSION; GLUCOSE-HOMEOSTASIS; CLOCK; TRANSCRIPTION; REPRESSION; PROMOTER; DELETION; ELEMENTS	Rhythmic changes in histone acetylation at circadian clock genes suggest that temporal modulation of gene expression is regulated by chromatin modifications(1-3). Furthermore, recent studies demonstrate a critical relationship between circadian and metabolic physiology(4-7). The nuclear receptor corepressor 1 (Ncor1) functions as an activating subunit for the chromatin modifying enzyme histone deacetylase 3 (Hdac3)(8). Lack of Ncor1 is incompatible with life, and hence it is unknown whether Ncor1, and particularly its regulation of Hdac3, is critical for adult mammalian physiology(9). Here we show that specific, genetic disruption of the Ncor1-Hdac3 interaction in mice causes aberrant regulation of clock genes and results in abnormal circadian behaviour. These mice are also leaner and more insulin- sensitive owing to increased energy expenditure. Unexpectedly, loss of a functional Ncor1-Hdac3 complex in vivo does not lead to sustained increases in known catabolic genes, but instead significantly alters the oscillatory patterns of several metabolic genes, demonstrating that circadian regulation of metabolism is critical for normal energy balance. These findings indicate that activation of Hdac3 by Ncor1 is a nodal point in the epigenetic regulation of circadian and metabolic physiology.	[Alenghat, Theresa; Meyers, Katherine; Mullican, Shannon E.; Leitner, Kirstin; Avila, Jacqueline; Ahima, Rexford S.; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; [Alenghat, Theresa; Meyers, Katherine; Mullican, Shannon E.; Leitner, Kirstin; Avila, Jacqueline; Ahima, Rexford S.; Kaestner, Klaus H.; Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Adeniji-Adele, Adetoun; Bucan, Maja; Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Ahima, Rexford/W-1394-2019; Lazar, Mitchell A/AAF-3738-2019		National Institutes of Health [DK43806]; National Research Training Grant in Developmental Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK043806, R01DK043806, P01DK049210, P30DK050306, P30DK019525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Training Grant in Developmental Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W. Pear for providing EIIa-CreC57BL/6 mice, G. Barnes and J. Rusche for providing MS-275, P. White and J. Tobias for bioinformatics assistance, and L. Yin, S.-H. You, M. Qatanani and other members of the Lazar laboratory for helpful discussions. We also thank J. Richa and The Transgenic Mouse Core, H. Collins and the Radioimmunoassay/Biomarkers Core, R. Dhir and the Metabolic Phenotyping Core of the Penn Diabetes and Endocrinology Research Center (DK19525), H. Fu and the Mouse Embryonic Stem Cell Core (DK49210) and the Morphology Core of the Center for Molecular Studies in Digestive and Liver Disease (DK50306 and DK49210) for consultation and services. This work was supported by National Institutes of Health grant DK43806 (to M.A.L.), and T.A. was supported by a National Research Training Grant in Developmental Biology.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Ishizuka T, 2005, MOL ENDOCRINOL, V19, P1443, DOI 10.1210/me.2005-0009; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kapfhamer D, 2002, NAT GENET, V32, P290, DOI 10.1038/ng991; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; LEONE TC, 1995, J BIOL CHEM, V270, P16308, DOI 10.1074/jbc.270.27.16308; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qi Y, 2006, DIABETES, V55, P3083, DOI 10.2337/db05-0615; Ramsey KM, 2007, ANNU REV NUTR, V27, P219, DOI 10.1146/annurev.nutr.27.061406.093546; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schultz TF, 2003, SCIENCE, V301, P326, DOI 10.1126/science.1085935; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200	34	199	212	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					997	U88		10.1038/nature07541	http://dx.doi.org/10.1038/nature07541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19037247	Green Accepted			2022-12-01	WOS:000261768300056
J	Deutman, ABC; Monnereau, C; Elemans, JAAW; Ercolani, G; Nolte, RJM; Rowan, AE				Deutman, Alexander B. C.; Monnereau, Cyrille; Elemans, Johannes A. A. W.; Ercolani, Gianfranco; Nolte, Roeland J. M.; Rowan, Alan E.			Mechanism of Threading a Polymer Through a Macrocyclic Ring	SCIENCE			English	Article							PROTEIN TRANSLOCATION; MOLECULAR SHUTTLE; ROTAXANE; THERMODYNAMICS; MEMBRANES; MACHINES; KINETICS	The translocation of biopolymers through pores and channels plays a fundamental role in numerous biological processes. We describe here the mechanism of the threading of a series of polymer chains through a synthetic macrocycle, which mimics these natural processes. The threading of polymers involves a kinetically favorable "entron" effect, which is associated with the initial filling of the cavity by the end of the polymer. A preassociation between the outside of the macrocycle and the polymer induces a process in which the polymer end loops back into the cavity of the macrocycle. This looping mechanism results in accelerated threading rates and unidirectional motion and is reminiscent of the protein translocation through membrane pores.	[Deutman, Alexander B. C.; Monnereau, Cyrille; Elemans, Johannes A. A. W.; Nolte, Roeland J. M.; Rowan, Alan E.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; [Ercolani, Gianfranco] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy	Radboud University Nijmegen; University of Rome Tor Vergata	Nolte, RJM (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	r.nolte@science.ru.nl; a.rowan@science.ru.nl	Nolte, Roeland/C-9930-2013; Ercolani, Gianfranco/AAH-2449-2019; Rowan, Alan E/F-9702-2015; Elemans, Johannes/D-4334-2012	Nolte, Roeland/0000-0002-5612-7815; Ercolani, Gianfranco/0000-0003-2437-3429; Rowan, Alan E/0000-0003-0728-3851; Elemans, Johannes/0000-0003-3825-7218	National Research School Combination Catalysis Controlled by Chemical Design; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni; Vidi and Vici; Koninklijke Nederlandse Akademie van Wetenschappen; Nanoned	National Research School Combination Catalysis Controlled by Chemical Design; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni(Netherlands Organization for Scientific Research (NWO)); Vidi and Vici; Koninklijke Nederlandse Akademie van Wetenschappen; Nanoned	This research was supported by a National Research School Combination Catalysis Controlled by Chemical Design grant, Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni, Vidi and Vici grants (J.A.A.W.E. and A.E.R.), a Koninklijke Nederlandse Akademie van Wetenschappen grant (R.J.M.N.), and a Nanoned grant (A.E.R. and R.J.M.N.).	Badjic JD, 2004, SCIENCE, V303, P1845, DOI 10.1126/science.1094791; BISSELL RA, 1994, NATURE, V369, P133, DOI 10.1038/369133a0; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Brouwer AM, 2001, SCIENCE, V291, P2124, DOI 10.1126/science.1057886; Browne WR, 2006, NAT NANOTECHNOL, V1, P25, DOI 10.1038/nnano.2006.45; Coumans RGE, 2006, P NATL ACAD SCI USA, V103, P19647, DOI 10.1073/pnas.0603036103; Galli C, 2000, EUR J ORG CHEM, V2000, P3117; HAMMETT LP, 1970, PHYS ORGANIC CHEM, P112; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; Herrmann W, 1997, MACROMOLECULES, V30, P4966, DOI 10.1021/ma961373g; Jimenez MC, 2000, ANGEW CHEM INT EDIT, V39, P3284, DOI 10.1002/1521-3773(20000915)39:18<3284::AID-ANIE3284>3.0.CO;2-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kay ER, 2006, NATURE, V440, P286, DOI 10.1038/440286a; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; Kolomeisky AB, 2008, BIOPHYS J, V94, P1547, DOI 10.1529/biophysj.107.122770; Liu Y, 2005, J AM CHEM SOC, V127, P9745, DOI 10.1021/ja051088p; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Mandolini L., 1986, ADV PHYS ORG CHEM, V22, P1; Meller A, 2001, PHYS REV LETT, V86, P3435, DOI 10.1103/PhysRevLett.86.3435; Ramos PH, 2007, J AM CHEM SOC, V129, P5699, DOI 10.1021/ja068714i; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Slonkina E, 2003, J CHEM PHYS, V118, P7112, DOI 10.1063/1.1560932; Thordarson P, 2003, NATURE, V424, P915, DOI 10.1038/nature01925; Thordarson P, 2003, J AM CHEM SOC, V125, P1186, DOI 10.1021/ja028463n; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752	25	84	87	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1668	1671		10.1126/science.1164647	http://dx.doi.org/10.1126/science.1164647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074344				2022-12-01	WOS:000261608300038
J	Lovell, JF; Billen, LP; Bindner, S; Shamas-Din, A; Fradin, C; Leber, B; Andrews, DW				Lovell, Jonathan F.; Billen, Lieven P.; Bindner, Scott; Shamas-Din, Aisha; Fradin, Cecile; Leber, Brian; Andrews, David W.			Membrane Binding by tBid Initiates an Ordered Series of Events Culminating in Membrane Permeabilization by Bax	CELL			English	Article							MITOCHONDRIAL-MEMBRANE; BCL-2 FAMILY; CONFORMATIONAL-CHANGE; APOPTOSIS; DEATH; DOMAIN; IDENTIFICATION; INDUCTION; MEMBERS	In normal circumstances, the Bcl-2 family dutifully governs when cells die. However, the rules of engagement between the pro- and antiapoptotic family members are still contested, and how Bax is transformed from a cytosolic monomer to an outer mitochondrial membrane-permeabilizing oligomer is unclear. With fluorescence techniques and an in vitro system, the combination of tBid and Bax produced dramatic membrane permeabilization. The membrane is not a passive partner in this process beause membranes are required for the protein-protein interactions to occur. Simultaneous measurements of these interactions revealed an ordered series of steps required for outer membrane permeabilization: ( 1) tBid rapidly binds to membranes, where ( 2) tBid interacts with Bax, causing ( 3) Bax insertion into membranes and ( 4) oligomerization, culminating in ( 5) membrane permeabilization. Bcl-XL prevents membrane- bound tBid from binding Bax. Bad releases tBid from Bcl-XL, restoring both tBid binding to Bax and membrane permeabilization.	[Lovell, Jonathan F.; Billen, Lieven P.; Bindner, Scott; Shamas-Din, Aisha; Fradin, Cecile; Leber, Brian; Andrews, David W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Fradin, Cecile] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8N 3Z5, Canada; [Leber, Brian] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University	Andrews, DW (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	andrewsd@mcmaster.ca	Fradin, Cécile/D-9302-2011	Fradin, Cécile/0000-0001-8329-4953; Lovell, Jonathan/0000-0002-9052-884X; Andrews, David/0000-0002-9266-7157; Leber, Brian/0000-0001-5502-1480	Canadian Institute of Health Research (CIHR) [FRN12517]; Tier I Canada Research Chair in Membrane Biogenesis	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier I Canada Research Chair in Membrane Biogenesis(Canada Research Chairs)	This work was supported by grant FRN12517 from the Canadian Institute of Health Research (CIHR) to D. W. A. and B. L. and a Tier I Canada Research Chair in Membrane Biogenesis to D. W. A. L. P. B. is recipient of a CIHR Canada Graduate Scholarship.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Basanez G, 2008, PLOS BIOL, V6, P1148, DOI 10.1371/journal.pbio.0060154; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Henderson MPA, 2007, METHODS, V41, P427, DOI 10.1016/j.ymeth.2006.07.004; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim M, 2005, BIOCHEM BIOPH RES CO, V338, P1834, DOI 10.1016/j.bbrc.2005.10.155; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	25	447	455	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1074	1084		10.1016/j.cell.2008.11.010	http://dx.doi.org/10.1016/j.cell.2008.11.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19062087	Bronze			2022-12-01	WOS:000261642800023
J	Yu, RC; Pesce, CG; Colman-Lerner, A; Lok, L; Pincus, D; Serra, E; Holl, M; Benjamin, K; Gordon, A; Brent, R				Yu, Richard C.; Pesce, C. Gustavo; Colman-Lerner, Alejandro; Lok, Larry; Pincus, David; Serra, Eduard; Holl, Mark; Benjamin, Kirsten; Gordon, Andrew; Brent, Roger			Negative feedback that improves information transmission in yeast signalling	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; INVASIVE GROWTH; MATING PATHWAY; PROTEIN-KINASE; STE5 SCAFFOLD; GENE NETWORKS; PHEROMONE; RECEPTOR; BINDING; TRANSDUCTION	Haploid Saccharomyces cerevisiae yeast cells use a prototypic cell signalling system to transmit information about the extracellular concentration of mating pheromone secreted by potential mating partners. The ability of cells to respond distinguishably to different pheromone concentrations depends on how much information about pheromone concentration the system can transmit. Here we show that the mitogen- activated protein kinase Fus3 mediates fast- acting negative feedback that adjusts the dose response of the downstream system response to match the dose response of receptor- ligand binding. This ` dose - response alignment', defined by a linear relationship between receptor occupancy and downstream response, can improve the fidelity of information transmission by making downstream responses corresponding to different receptor occupancies more distinguishable and reducing amplification of stochastic noise during signal transmission. We also show that one target of the feedback is a previously uncharacterized signal- promoting function of the regulator of G- protein signalling protein Sst2. Our work suggests that negative feedback is a general mechanism used in signalling systems to align dose responses and thereby increase the fidelity of information transmission.	[Yu, Richard C.; Pesce, C. Gustavo; Colman-Lerner, Alejandro; Lok, Larry; Pincus, David; Serra, Eduard; Benjamin, Kirsten; Gordon, Andrew; Brent, Roger] Inst Mol Sci, Berkeley, CA 94704 USA; [Holl, Mark] Univ Washington, Microscale Life Sci Ctr, Seattle, WA 98195 USA	The Molecular Sciences Institute; University of Washington; University of Washington Seattle	Yu, RC (corresponding author), Inst Mol Sci, 2168 Shattuck Ave, Berkeley, CA 94704 USA.	ryu@molsci.org; brent@molsci.org	Serra, Eduard/K-1332-2013; Colman-Lerner, Alejandro/ABC-3808-2020	Serra, Eduard/0000-0003-2895-9857; Colman-Lerner, Alejandro/0000-0002-2557-8883; Benjamin, Kirsten/0000-0003-4267-1972	Alpha Project at the Center for Quantitative Genome Function; NIH Center of Excellence in Genomic Science [P50 HG02370]; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097479] Funding Source: NIH RePORTER	Alpha Project at the Center for Quantitative Genome Function; NIH Center of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Abola, S. Andrews, A. Arkin, M. Bowen, L. Buck, C. Denby, A. Gann, D. Meldrum, T. Mitchison, C. Pabo, M. Ptashne, M. Reese, O. Resnekov, C. Ryan, M. Snyder, T. Thomson, A. E. Tsong and M. Wilson for discussions and/or comments on the manuscript, and O. Resnekov for help in articulating the requirements for fluidic induction devices. Work, including that of M. H. at the University of Washington, was supported by the Alpha Project at the Center for Quantitative Genome Function, an NIH Center of Excellence in Genomic Science under grant P50 HG02370 from the National Human Genome Research Institute to R. B.	AMIR SM, 1973, J BIOL CHEM, V248, P4092; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Ausubel M., 1989, MOL REPROD DEV, V1, P146, DOI [10.1002/mrd.1080010210, DOI 10.1002/MRD.1080010210]; Bajaj A, 2004, BIOCHEMISTRY-US, V43, P13564, DOI 10.1021/bi0494018; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Black H., 1934, ELECTRON ENG, V53, P114; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BLOOM E, 1980, J STEROID BIOCHEM, V12, P175, DOI 10.1016/0022-4731(80)90267-8; BRUN R, 1989, PAW PHYS ANAL WORKST; Budas GR, 2007, PHARMACOL RES, V55, P523, DOI 10.1016/j.phrs.2007.04.005; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; CUATRECASAS P, 1971, P NATL ACAD SCI USA, V68, P1264, DOI 10.1073/pnas.68.6.1264; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guthrie C., 1991, METHODS ENZYMOLOGY G; HEXIMER SP, 2007, SCI STKE, pPE2; JACKSON CL, 1990, CELL, V63, P1039, DOI 10.1016/0092-8674(90)90507-B; JENNESS DD, 1986, MOL CELL BIOL, V6, P318, DOI 10.1128/MCB.6.1.318; KASAI M, 1971, J MEMBRANE BIOL, V6, P58, DOI 10.1007/BF01874114; KNAUER DJ, 1984, J BIOL CHEM, V259, P5623; LIN SY, 1970, AM J PHYSIOL, V218, P1319, DOI 10.1152/ajplegacy.1970.218.5.1319; Lindsley CW, 2008, CURR CANCER DRUG TAR, V8, P7, DOI 10.2174/156800908783497096; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rousseau G G, 1979, Monogr Endocrinol, V12, P49; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Schrick K, 1997, GENETICS, V147, P19; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; SHANNON CE, 1948, BELL SYST TECH J, V27, P423; Shao DY, 2006, BIOPHYS J, V91, P3986, DOI 10.1529/biophysj.106.081661; SIMONS SS, 1992, MOL ENDOCRINOL, V6, P995, DOI 10.1210/me.6.7.995; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100	47	160	162	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					755	761		10.1038/nature07513	http://dx.doi.org/10.1038/nature07513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079053	Green Accepted			2022-12-01	WOS:000261559900041
J	Mold, JE; Michaelsson, J; Burt, TD; Muench, MO; Beckerman, KP; Busch, MP; Lee, TH; Nixon, DF; McCune, JM				Mold, Jeff E.; Michaelsson, Jakob; Burt, Trevor D.; Muench, Marcus O.; Beckerman, Karen P.; Busch, Michael P.; Lee, Tzong-Hae; Nixon, Douglas F.; McCune, Joseph M.			Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero	SCIENCE			English	Article							MEDIATED LYMPHOLYSIS; HLA ANTIGENS; MICROCHIMERISM; LYMPHOCYTES; RESPONSES; TOLERANCE; ONTOGENY; BLOOD; TIME	As the immune system develops, T cells are selected or regulated to become tolerant of self antigens and reactive against foreign antigens. In mice, the induction of such tolerance is thought to be attributable to the deletion of self- reactive cells. Here, we show that the human fetal immune system takes advantage of an additional mechanism: the generation of regulatory T cells ( T-regs) that suppress fetal immune responses. We find that substantial numbers of maternal cells cross the placenta to reside in fetal lymph nodes, inducing the development of CD4+CD25(high)FoxP3+ T-regs that suppress fetal antimaternal immunity and persist at least until early adulthood. These findings reveal a form of antigen- specific tolerance in humans, induced in utero and probably active in regulating immune responses after birth.	[Mold, Jeff E.; Burt, Trevor D.; Nixon, Douglas F.; McCune, Joseph M.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA; [Mold, Jeff E.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Michaelsson, Jakob] Karolinska Univ Hosp, Karolinska Inst, Ctr Infect Med, Dept Med, S-14186 Huddinge, Sweden; [Burt, Trevor D.] Univ Calif San Francisco, Dept Pediat, Div Neonatol, San Francisco, CA 94143 USA; [Muench, Marcus O.; Busch, Michael P.; Lee, Tzong-Hae] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94118 USA; [Muench, Marcus O.; Busch, Michael P.; Lee, Tzong-Hae] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94118 USA; [Beckerman, Karen P.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Karolinska Institutet; Karolinska University Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McCune, JM (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA.	mike.mccune@ucsf.edu	Muench, Marcus O./C-5025-2009; Nixon, Douglas/AAU-5734-2020	Muench, Marcus O./0000-0001-8946-6605; Nixon, Douglas/0000-0002-2801-1786; Burt, Trevor/0000-0001-7933-529X; Mold, Jeffrey/0000-0003-2195-2978	NIH [OD000329, AI40312, AI68498]; AIDS Biology Program of the AIDS Research Institute at UCSF; Swedish Research Council; National Institute of Child Health and Development [HD00850]; American Academy of Pediatrics; American Pediatric Society; Broad Medical Research Program of The Eli and Edythe L. Broad Foundation; National Blood Foundation; Blood Systems, Inc; UCSF Clinical and Translational Institute Clinical Research Center [RR024131]; Elizabeth Glaser Pediatric AIDS Foundation [PG-50804]; National Heart Lung and Blood Institute [HL083388]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040312, R01AI068498, R37AI040312] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS Biology Program of the AIDS Research Institute at UCSF; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Academy of Pediatrics; American Pediatric Society; Broad Medical Research Program of The Eli and Edythe L. Broad Foundation; National Blood Foundation; Blood Systems, Inc; UCSF Clinical and Translational Institute Clinical Research Center; Elizabeth Glaser Pediatric AIDS Foundation; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the families who donated blood for the studies shown in Fig. 3. We also thank B. Kanwar, D. Favre, E. Trachtenberg, R. Derynck, and S. Fisher for technical assistance and valuable discussions. Support for this work was provided by grants from NIH to J. M. M (OD000329 and AI40312) and D. F. N. (AI68498) and from the AIDS Biology Program of the AIDS Research Institute at UCSF. J. M. is supported by the Swedish Research Council. T. D. B. is a National Institute of Child Health and Development fellow (HD00850) and was also funded by the American Academy of Pediatrics and the American Pediatric Society. M.O.M. was supported by grants from the Broad Medical Research Program of The Eli and Edythe L. Broad Foundation, National Blood Foundation, and Blood Systems, Inc. K.P.B. was supported by grants from the UCSF Clinical and Translational Institute Clinical Research Center (RR024131) and the Elizabeth Glaser Pediatric AIDS Foundation (PG-50804). M.P.B. and T.-H.L. were both supported by grants from the National Heart Lung and Blood Institute (HL083388). J. M. M. is a recipient of the NIH Director's Pioneer Award Program.	Adams KM, 2004, JAMA-J AM MED ASSOC, V291, P1127, DOI 10.1001/jama.291.9.1127; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; FRIEDBER.SH, 1974, J IMMUNOL, V113, P1477; GITLIN D, 1964, J CLIN INVEST, V43, P1938, DOI 10.1172/JCI105068; GRANBERG C, 1980, CELL IMMUNOL, V51, P13, DOI 10.1016/0008-8749(80)90233-6; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jonsson AM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.047; Lee TH, 2006, TRANSFUSION, V46, P1870, DOI 10.1111/j.1537-2995.2006.00992.x; Loubiere LS, 2006, LAB INVEST, V86, P1185, DOI 10.1038/labinvest.3700471; Marchant A, 2003, J CLIN INVEST, V111, P1747, DOI 10.1172/JCI200317470; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Muller SM, 2001, BLOOD, V98, P1847, DOI 10.1182/blood.V98.6.1847; Rastogi D, 2007, J CLIN INVEST, V117, P1637, DOI 10.1172/JCI29466; RAYFIELD LS, 1980, CLIN EXP IMMUNOL, V42, P561; REMINGTON JS, 2006, INFECT DIS FETUS NEW, P11; SILVERSTEIN AM, 1964, SCIENCE, V144, P1423, DOI 10.1126/science.144.3625.1423; Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; West LJ, 2002, HUM EXP TOXICOL, V21, P499, DOI 10.1191/0960327102ht288oa	24	548	559	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1562	1565		10.1126/science.1164511	http://dx.doi.org/10.1126/science.1164511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056990	Green Accepted			2022-12-01	WOS:000261377400054
J	de Brito, OM; Scorrano, L				de Brito, Olga Martins; Scorrano, Luca			Mitofusin 2 tethers endoplasmic reticulum to mitochondria	NATURE			English	Article							MAMMALIAN-CELLS; CA2+; APOPTOSIS; FUSION; DETERMINANTS; OSCILLATIONS; MICRODOMAINS; MUSCLE; BAX; ER	Juxtaposition between endoplasmic reticulum ( ER) and mitochondria is a common structural feature, providing the physical basis for intercommunication during Ca(2+) signalling; yet, the molecular mechanisms controlling this interaction are unknown. Here we show that mitofusin 2, a mitochondrial dynamin- related protein mutated in the inherited motor neuropathy Charcot - Marie - Tooth type IIa, is enriched at the ER - mitochondria interface. Ablation or silencing of mitofusin 2 in mouse embryonic fibroblasts and HeLa cells disrupts ER morphology and loosens ER - mitochondria interactions, thereby reducing the efficiency of mitochondrial Ca(2+) uptake in response to stimuli that generate inositol-1,4,5-trisphosphate. An in vitro assay as well as genetic and biochemical evidences support a model in which mitofusin 2 on the ER bridges the two organelles by engaging in homotypic and heterotypic complexes with mitofusin 1 or 2 on the surface of mitochondria. Thus, mitofusin 2 tethers ER to mitochondria, a juxtaposition required for efficient mitochondrial Ca(2+) uptake.	[de Brito, Olga Martins; Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, I-35129 Padua, Italy; [Scorrano, Luca] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Geneva	Scorrano, L (corresponding author), Venetian Inst Mol Med, Dulbecco Telethon Inst, Via Orus 2, I-35129 Padua, Italy.	lscorrano@dti.telethon.it	Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019	Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928	Telethon Italy; Compagnia di San Paolo Italy; United Mitochondrial Disease Foundation USA; Muscular Distrophy Association USA; Swiss National Science Foundation [3100A0-118171]	Telethon Italy(Fondazione Telethon); Compagnia di San Paolo Italy(Compagnia di San Paolo); United Mitochondrial Disease Foundation USA; Muscular Distrophy Association USA(Muscular Dystrophy Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	O.M.d.B. received a 'Bolsa de Doutoramento' of FCT Portugal. L. S. is senior scientist of the Dulbecco-Telethon Institute and EMBO YIP. This work was supported by Telethon Italy, Compagnia di San Paolo Italy, United Mitochondrial Disease Foundation USA, Muscular Distrophy Association USA and Swiss National Science Foundation 3100A0-118171.	Annis MG, 2001, ONCOGENE, V20, P1939, DOI 10.1038/sj.onc.1204288; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Mironov SL, 2006, J CELL SCI, V119, P4926, DOI 10.1242/jcs.03254; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rojo M, 2002, J CELL SCI, V115, P1663; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; SOLTYS BJ, 1992, BIOCHEM CELL BIOL, V70, P1174, DOI 10.1139/o92-163; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	35	1648	1663	4	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					605	U47		10.1038/nature07534	http://dx.doi.org/10.1038/nature07534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052620				2022-12-01	WOS:000261340000033
J	Arroll, B; Fernando, A; Falloon, K				Arroll, Bruce; Fernando, Antonio, III; Falloon, Karen			10-Minute Consultation Sleep disorder (insomnia)	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Arroll, Bruce; Fernando, Antonio, III; Falloon, Karen] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand	University of Auckland	Arroll, B (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Private Bag 92019, Auckland 1, New Zealand.	b.arroll@auckland.ac.nz						Holbrook AM, 2004, BRIT MED J, V329, P1198, DOI 10.1136/bmj.329.7476.1198; Smith MT, 2002, AM J PSYCHIAT, V159, P5, DOI 10.1176/appi.ajp.159.1.5	2	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 28	2008	337								a1245	10.1136/bmj.a1245	http://dx.doi.org/10.1136/bmj.a1245			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QD	19042934				2022-12-01	WOS:000261827800001
J	van Leeuwen, JFN; Froyd, CA; van der Knaap, WO; Coffey, EE; Tye, A; Willis, KJ				van Leeuwen, Jacqueline F. N.; Froyd, Cynthia A.; van der Knaap, W. O.; Coffey, Emily E.; Tye, Alan; Willis, Katherine J.			Fossil Pollen as a Guide to Conservation in the Galapagos	SCIENCE			English	Article									[Froyd, Cynthia A.; Coffey, Emily E.; Willis, Katherine J.] Univ Oxford, Ctr Environm, Long Term Ecol Lab, Oxford OX1 3QY, England; [van Leeuwen, Jacqueline F. N.; van der Knaap, W. O.] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [van Leeuwen, Jacqueline F. N.; van der Knaap, W. O.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3013 Bern, Switzerland; [Tye, Alan] Charles Darwin Res Stn, Galapagos, Ecuador; [Willis, Katherine J.] Univ Bergen, Dept Biol, N-5007 Bergen, Norway	University of Oxford; University of Bern; University of Bern; University of Bergen	Froyd, CA (corresponding author), Univ Oxford, Ctr Environm, Long Term Ecol Lab, S Parks Rd, Oxford OX1 3QY, England.	cynthia.froyd@ouce.ox.ac.uk	Froyd, Cynthia/A-8488-2012	Froyd, Cynthia/0000-0001-5291-9156; Willis, Katherine/0000-0002-6763-2489	UK Natural Environment Research Council [NE/C510667/1]; National Geographic Society; Swiss Association of Friends of the Galapagos Islands; European Commission [017008-2]; Natural Environment Research Council [NE/C510667/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Geographic Society(National Geographic Society); Swiss Association of Friends of the Galapagos Islands; European Commission(European CommissionEuropean Commission Joint Research Centre); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank I. Robertson for helpful comments on the manuscript, the Galapagos National Park Service, and I. Flett and P.Q. Dresser for radiocarbon dates. This research was supported by the UK Natural Environment Research Council (grant NE/C510667/1 awarded to K.J.W. and C.A.F.), the National Geographic Society and the Swiss Association of Friends of the Galapagos Islands (W.O.v.d.K.), and European Commission grant 017008-2.	LAWESSON JE, 1987, REPORTS BOT I U AARH, V16, P1; Magee J, 2001, SCIENCE, V294, P1279; Porter D. M., 1983, PATTERNS EVOLUTION G, P33; SUGGS RC, 1967, Z ETHNOL, V92, P239	4	74	77	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1206	1206		10.1126/science.1163454	http://dx.doi.org/10.1126/science.1163454			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023075				2022-12-01	WOS:000261033400030
J	Zehn, D; Lee, SY; Bevan, MJ				Zehn, Dietmar; Lee, Sarah Y.; Bevan, Michael J.			Complete but curtailed T-cell response to very low-affinity antigen	NATURE			English	Article							LISTERIA-MONOCYTOGENES; PRECURSOR FREQUENCY; MEMORY; EFFECTOR; INFECTION; SELECTION; DIFFERENTIATION; RECOGNITION; ACTIVATION; EXPRESSION	After an infection, T cells that carry the CD8 marker are activated and undergo a characteristic kinetic sequence of rapid expansion, subsequent contraction and formation of memory cells(1-3). The pool of naive T-cell clones is diverse and contains cells bearing T-cell antigen receptors (TCRs) that differ in their affinity for the same antigen(4,5). How these differences in affinity affect the function and the response kinetics of individual T-cell clones was previously unknown. Here we show that during the in vivo response to microbial infection, even very weak TCR-ligand interactions are sufficient to activate naive T cells, induce rapid initial proliferation and generate effector and memory cells. The strength of the TCR ligand interaction critically affects when expansion stops, when the cells exit lymphoid organs and when contraction begins; that is, strongly stimulated T cells contract and exit lymphoid organs later than weakly stimulated cells. Our data challenge the prevailing view that strong TCR ligation is a prerequisite for CD8(+) T-cell activation. Instead, very weak interactions are sufficient for activation, but strong TCR ligation is required to sustain T-cell expansion. We propose that in response to microbial challenge, T-cell clones with a broad range of avidities for foreign ligands are initially recruited, and that the pool of T cells subsequently matures in affinity owing to the more prolonged expansion of high-affinity T-cell clones.	[Zehn, Dietmar; Lee, Sarah Y.; Bevan, Michael J.] Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Immunol, Box 357370, Seattle, WA 98195 USA.	mbevan@u.washington.edu			National Institutes of Health; Howard Hughes Medical Institute; Juvenile Diabetes Research Foundation; German Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Gallegos for advice in making the recombinant Listeria, and X.- C. Pan, B. Dere, B. Paul and K. Rider for technical support. Financial support was received from the National Institutes of Health and the Howard Hughes Medical Institute ( M. J. B.), and from the Juvenile Diabetes Research Foundation and the German Research Foundation ( D. Z.).	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Gronski MA, 2004, NAT MED, V10, P1234, DOI 10.1038/nm1114; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Xiao ZG, 2007, J EXP MED, V204, P2667, DOI 10.1084/jem.20062376	26	458	463	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					211	214		10.1038/nature07657	http://dx.doi.org/10.1038/nature07657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19182777	Green Accepted			2022-12-01	WOS:000264059700045
J	Mullighan, CG; Su, XP; Zhang, JH; Radtke, I; Phillips, LAA; Miller, CB; Ma, J; Liu, W; Cheng, C; Schulman, BA; Harvey, RC; Chen, I; Clifford, RJ; Carroll, WL; Reaman, G; Bowman, WP; Devidas, M; Gerhard, DS; Yang, WJ; Relling, MV; Shurtleff, SA; Campana, D; Borowitz, MJ; Pui, C; Smith, M; Hunger, SP; Willman, CL; Downing, JR				Mullighan, Charles G.; Su, Xiaoping; Zhang, Jinghui; Radtke, Ina; Phillips, Letha A. A.; Miller, Christopher B.; Ma, Jing; Liu, Wei; Cheng, Cheng; Schulman, Brenda A.; Harvey, Richard C.; Chen, I-Ming; Clifford, Robert J.; Carroll, William L.; Reaman, Gregory; Bowman, W. Paul; Devidas, Meenakshi; Gerhard, Daniela S.; Yang, Wenjian; Relling, Mary V.; Shurtleff, Sheila A.; Campana, Dario; Borowitz, Michael J.; Pui, Ching-Hon; Smith, Malcolm; Hunger, Stephen P.; Willman, Cheryl L.; Downing, James R.		Childrens Oncology Grp	Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; TOTAL THERAPY; IKAROS GENE; CHILDHOOD; CHILDREN; EXPRESSION; TRANSCRIPTION	Background: Despite best current therapy, up to 20% of pediatric patients with acute lymphoblastic leukemia (ALL) have a relapse. Recent genomewide analyses have identified a high frequency of DNA copy-number abnormalities in ALL, but the prognostic implications of these abnormalities have not been defined. Methods: We studied a cohort of 221 children with high-risk B-cell-progenitor ALL with the use of single-nucleotide-polymorphism microarrays, transcriptional profiling, and resequencing of samples obtained at diagnosis. Children with known very-high-risk ALL subtypes (i.e., BCR-ABL1-positive ALL, hypodiploid ALL, and ALL in infants) were excluded from this cohort. A copy-number abnormality was identified as a predictor of poor outcome, and it was then tested in an independent validation cohort of 258 patients with B-cell-progenitor ALL. Results: More than 50 recurring copy-number abnormalities were identified, most commonly involving genes that encode regulators of B-cell development (in 66.8% of patients in the original cohort); PAX5 was involved in 31.7% and IKZF1 in 28.6% of patients. Using copy-number abnormalities, we identified a predictor of poor outcome that was validated in the independent validation cohort. This predictor was strongly associated with alteration of IKZF1, a gene that encodes the lymphoid transcription factor IKAROS. The gene-expression signature of the group of patients with a poor outcome revealed increased expression of hematopoietic stem-cell genes and reduced expression of B-cell-lineage genes, and it was similar to the signature of BCR-ABL1-positive ALL, another high-risk subtype of ALL with a high frequency of IKZF1 deletion. Conclusions: Genetic alteration of IKZF1 is associated with a very poor outcome in B-cell-progenitor ALL. N Engl J Med 2009;360:470-80.	[Mullighan, Charles G.; Su, Xiaoping; Radtke, Ina; Phillips, Letha A. A.; Miller, Christopher B.; Shurtleff, Sheila A.; Campana, Dario; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Liu, Wei; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Yang, Wenjian; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Campana, Dario; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Zhang, Jinghui] NCI, Ctr Biomed Informat & Informat Technol, NIH, Bethesda, MD 20892 USA; [Clifford, Robert J.] NCI, Lab Populat Genet, NIH, Bethesda, MD 20892 USA; [Gerhard, Daniela S.] NCI, Off Canc Genom, NIH, Bethesda, MD 20892 USA; [Smith, Malcolm] NCI, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA; [Schulman, Brenda A.] Johns Hopkins Med Inst, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Borowitz, Michael J.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Harvey, Richard C.; Chen, I-Ming; Willman, Cheryl L.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Carroll, William L.] NYU, Inst Canc, New York, NY USA; [Reaman, Gregory] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Bowman, W. Paul] Cook Childrens Med Ctr, Dept Hematol & Oncol, Ft Worth, TX USA; [Devidas, Meenakshi] Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA; [Devidas, Meenakshi] Childrens Oncol Grp, Gainesville, FL USA; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Aurora, CO USA; [Hunger, Stephen P.] Childrens Hosp, Aurora, CO USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of New Mexico; New York University; Children's National Health System; Cook Children's Medical Center; State University System of Florida; University of Florida; Children's Oncology Group (COG); University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Downing, JR (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 262 Danny Thomas Pl,MS 271, Memphis, TN 38105 USA.	james.downing@stjude.org	Zhang, Jing/GWZ-7332-2022; Mullighan, Charles/H-3253-2011; Devidas, Meenakshi/H-1170-2019; Downing, James R./N-8102-2018; Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018; Cheng, Cheng/N-8075-2018	Mullighan, Charles/0000-0002-1871-1850; Devidas, Meenakshi/0000-0002-1099-3478; Pui, Ching-Hon/0000-0003-0303-5658; Harvey, Richard/0000-0002-4904-9767; Clifford, Robert/0000-0001-8888-897X	Children's Oncology Group Chair's Award [CA098543]; Strategic Partnering to Evaluate Cancer Signatures Program [CA114762]; National Cancer Institute; National Institute of General Medical Sciences Pharmacogenetics Research Network and Database [U01 GM61393, U01GM61374]; Cancer Center [21765]; National Institutes of Health [R01 CA86011, N01-C0-12400]; Leukemia and Lymphoma Society Specialized Center of Research [7388-06]; CureSearch National Childhood Cancer Foundation; National Health and Medical Research Council (Australia); Australia) C. J. Martin Traveling Fellowship; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NCI; Becton Dickinson Biosciences; Xanthus Pharmaceuticals; NATIONAL CANCER INSTITUTE [ZIACP010141, U01CA157937, U01CA114762, ZIHBC010470, U10CA098413, U10CA098543, R01CA086011, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM061374] Funding Source: NIH RePORTER	Children's Oncology Group Chair's Award; Strategic Partnering to Evaluate Cancer Signatures Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences Pharmacogenetics Research Network and Database(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Specialized Center of Research(Leukemia and Lymphoma Society); CureSearch National Childhood Cancer Foundation; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australia) C. J. Martin Traveling Fellowship; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Becton Dickinson Biosciences; Xanthus Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by funds provided as a supplement to the Children's Oncology Group Chair's Award (CA098543, to Dr. Hunger); a Strategic Partnering to Evaluate Cancer Signatures Program award (CA114762, to Drs. Carroll, Chen, Harvey, and Willman) from the National Cancer Institute ( NCI); grants from the National Institute of General Medical Sciences Pharmacogenetics Research Network and Database (U01 GM61393 and U01GM61374, to Dr. Relling), a Cancer Center core grant (21765, to Drs. Downing, Mullighan, and Pui), and a grant R01 CA86011, to Dr. Borowitz) from the National Institutes of Health ( NIH); a Leukemia and Lymphoma Society Specialized Center of Research grant (7388-06, to Dr. Willman); a grant from CureSearch National Childhood Cancer Foundation; a National Health and Medical Research Council (Australia) C. J. Martin Traveling Fellowship ( to Dr. Mullighan); and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. The sequencing was supported by funds from the NCI and NIH to Agencourt Bioscience under contract N01-C0-12400.; Dr. Cheng reports serving on the advisory board for Enzon Pharmaceuticals; Dr. Borowitz, receiving consulting fees and grant support from Becton Dickinson Biosciences; Dr. Reaman, serving on the advisory board for Enzon Pharmaceuticals; Dr. Willman, receiving grant support from Xanthus Pharmaceuticals; and Drs. Downing and Mullighan, being co-inventors on a pending patent application concerning tests for IKZF1 mutations that was filed by St. Jude Children's Research Hospital, which has not entered into any licenses related to this application. No other potential conflict of interest relevant to this article was reported.; We thank Zhongling Cai and Claire Boltz for technical assistance and Stephen Smale for helpful discussions.	Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Buhl AM, 2000, IMMUNOL REV, V176, P141; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Coustan-Smith E, 2000, BLOOD, V96, P2691, DOI 10.1182/blood.V96.8.2691; Coustan-Smith E, 1998, LANCET, V351, P550, DOI 10.1016/S0140-6736(97)10295-1; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Georgantas RW, 2004, CANCER RES, V64, P4434, DOI 10.1158/0008-5472.CAN-03-3247; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Kishi S, 2003, J CLIN ONCOL, V21, P3084, DOI 10.1200/JCO.2003.07.056; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; Mirebeau D, 2006, HAEMATOL-HEMATOL J, V91, P881; Moreno TMC, 2002, LEUKEMIA, V16, P2037, DOI 10.1038/sj.leu.2402697; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pui CH, 2006, ANN HEMATOL, V85, P88; Pui CH, 2000, LEUKEMIA, V14, P2286, DOI 10.1038/sj.leu.2401938; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Rivera GK, 2005, CANCER-AM CANCER SOC, V103, P368, DOI 10.1002/cncr.20743; Shuster J, 1999, CANC RES THER CONTRO, V9, P101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Tonnelle C, 2001, BLOOD, V98, P2673, DOI 10.1182/blood.V98.9.2673; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1	34	948	1003	2	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					470	480		10.1056/NEJMoa0808253	http://dx.doi.org/10.1056/NEJMoa0808253			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19129520	Green Accepted			2022-12-01	WOS:000262812400006
J	Ping, PP				Ping, Peipei			Getting to the Heart of Proteomics.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ping, Peipei] Univ Calif Los Angeles, David Geffen Sch Med, NHLBI, Program Project Myocardial Ischemia Injury & Prot, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ping, PP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, NHLBI, Program Project Myocardial Ischemia Injury & Prot, Los Angeles, CA 90095 USA.			Ping, Peipei/0000-0003-3583-3881	NHLBI NIH HHS [R37 HL063901, P01 HL080111-04, P01 HL080111, R01 HL101228] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063901, R01HL101228, P01HL080111] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Ping PP, 1997, CIRC RES, V81, P404, DOI 10.1161/01.RES.81.3.404; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; YTREHUS K, 1994, AM J PHYSIOL, V266, pH1145, DOI 10.1152/ajpheart.1994.266.3.H1145	5	22	22	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					532	534		10.1056/NEJMcibr0808487	http://dx.doi.org/10.1056/NEJMcibr0808487			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179323	Green Accepted			2022-12-01	WOS:000262812400018
J	Yang, JJ; Cheng, C; Yang, WJ; Pei, DQ; Cao, XY; Fan, YP; Pounds, SB; Neale, G; Trevino, LR; French, D; Campana, D; Downing, JR; Evans, WE; Pui, CH; Devidas, M; Bowman, WP; Camitta, BM; Willman, CL; Davies, SM; Borowitz, MJ; Carroll, WL; Hunger, SP; Relling, MV				Yang, Jun J.; Cheng, Cheng; Yang, Wenjian; Pei, Deqing; Cao, Xueyuan; Fan, Yiping; Pounds, Stanley B.; Neale, Geoffrey; Trevino, Lisa R.; French, Deborah; Campana, Dario; Downing, James R.; Evans, William E.; Pui, Ching-Hon; Devidas, Meenakshi; Bowman, W. P.; Camitta, Bruce M.; Willman, Cheryl L.; Davies, Stella M.; Borowitz, Michael J.; Carroll, William L.; Hunger, Stephen P.; Relling, Mary V.			Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic Leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMAL RESIDUAL DISEASE; CHILDRENS ONCOLOGY GROUP; CORONARY-ARTERY-DISEASE; P-GLYCOPROTEIN; RISK; METHOTREXATE; EXPRESSION; INTERLEUKIN-15; POLYMORPHISMS; IDENTIFICATION	Context Pediatric acute lymphoblastic leukemia ( ALL) is the prototype for a drug-responsive malignancy. Although cure rates exceed 80%, considerable unexplained interindividual variability exists in treatment response. Objectives To assess the contribution of inherited genetic variation to therapy response and to identify germline single- nucleotide polymorphisms ( SNPs) associated with risk of minimal residual disease ( MRD) after remission induction chemotherapy. Design, Setting, and Patients Genome- wide interrogation of 476 796 germline SNPs to identify genotypes that were associated with MRD in 2 independent cohorts of children with newly diagnosed ALL: 318 patients in St Jude Total Therapy protocols XIIIB and XV and 169 patients in Children's Oncology Group trial P9906. Patients were enrolled between 1994 and 2006 and last follow- up was in 2006. Main Outcome Measures Minimal residual disease at the end of induction therapy, measured by flow cytometry. Results There were 102 SNPs associated with MRD in both cohorts ( median odds ratio, 2.18; P <=. 0125), including 5 SNPs in the interleukin 15 ( IL15) gene. Of these 102 SNPs, 21 were also associated with hematologic relapse ( P <. 05). Of 102 SNPs, 21 were also associated with antileukemic drug disposition, generally linking MRD eradication with greater drug exposure. In total, 63 of 102 SNPs were associated with early response, relapse, or drug disposition. Conclusion Host genetic variations are associated with treatment response for childhood ALL, with polymorphisms related to leukemia cell biology and host drug disposition associated with lower risk of residual disease.	[Yang, Jun J.; Cheng, Cheng; Yang, Wenjian; Pei, Deqing; Cao, Xueyuan; Fan, Yiping; Pounds, Stanley B.; Neale, Geoffrey; Trevino, Lisa R.; French, Deborah; Campana, Dario; Downing, James R.; Evans, William E.; Pui, Ching-Hon; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Devidas, Meenakshi] Univ Florida, Gainesville, FL USA; [Bowman, W. P.] Cook Childrens Med Ctr, Ft Worth, TX USA; [Camitta, Bruce M.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Willman, Cheryl L.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Davies, Stella M.] Cincinnati Childrens Hosp & Med Ctr, Cincinnati, OH USA; [Borowitz, Michael J.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Carroll, William L.] NYU Med Ctr, New York, NY 10016 USA; [Hunger, Stephen P.] Childrens Hosp, Aurora, CO USA; [Hunger, Stephen P.] Univ Colorado, Ctr Canc, Aurora, CO USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; State University System of Florida; University of Florida; Cook Children's Medical Center; Medical College of Wisconsin; University of New Mexico; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Medicine; New York University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Relling, MV (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas Pl,MS313, Memphis, TN 38105 USA.	mary.relling@stjude.org	Pui, Ching-Hon/N-8076-2018; Devidas, Meenakshi/H-1170-2019; Cheng, Cheng/N-8075-2018; Yang, Jun/B-6976-2008; Pounds, Stanley B/N-2480-2018; Yang, Jun J./ABG-5646-2020; Relling, Mary/N-5032-2018; Evans, William E./C-2069-2012; Downing, James R./N-8102-2018	Pui, Ching-Hon/0000-0003-0303-5658; Devidas, Meenakshi/0000-0002-1099-3478; Yang, Jun/0000-0002-0770-9659; Pounds, Stanley B/0000-0002-9167-2114; Yang, Jun J./0000-0002-0770-9659; Evans, William E./0000-0002-9333-5322; 	National Institutes of Health [CA 093552-02, CA 51001, CA 78224, CA 21765, CA R3736401, CA 60419, CA 086011, CA 98543, CA 29139]; National Institute of General Medical Sciences; Pharmacogenetics Research Network and Database [U01 GM61393, U01 GM61374]; NATIONAL CANCER INSTITUTE [U10CA098543, R01CA086011, R01CA093552, R01CA051001, R29CA051001, R37CA036401, R01CA078224, R01CA060419, P30CA021765, U10CA098413, U10CA029139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374, U01GM061393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pharmacogenetics Research Network and Database(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants CA 093552-02, CA 51001, CA 78224, CA 21765, CA R3736401, CA 60419, CA 086011, CA 98543, CA 29139, and National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) Pharmacogenetics Research Network and Database grants U01 GM61393 and U01 GM61374 (http://www.pharmgkb.org) from the National Cancer Institute and NIGMS; by the American Lebanese Syrian Associated Charities; and by CureSearch.	Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Bleyer WA, 1997, J PEDIAT HEMATOL ONC, V19, P530, DOI 10.1097/00043426-199711000-00008; Borowitz MJ, 2003, LEUKEMIA, V17, P1566, DOI 10.1038/sj.leu.2403001; Bostrom BC, 2003, J PEDIAT HEMATOL ONC, V25, P114, DOI 10.1097/00043426-200302000-00006; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cario G, 2007, J CLIN ONCOL, V25, P4813, DOI 10.1200/JCO.2007.11.8166; Carroll WL, 2006, PEDIATR BLOOD CANCER, V46, P570, DOI 10.1002/pbc.20722; Carroll WL, 2003, JAMA-J AM MED ASSOC, V290, P2061, DOI 10.1001/jama.290.15.2061; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; Cheng C, 2004, STAT APPL GENET MOL, V3, P36; CONTER V, 1995, J CLIN ONCOL, V13, P2497, DOI 10.1200/JCO.1995.13.10.2497; Coustan-Smith E, 2000, BLOOD, V96, P2691, DOI 10.1182/blood.V96.8.2691; Coustan-Smith E, 1998, LANCET, V351, P550, DOI 10.1016/S0140-6736(97)10295-1; Davies SM, 2008, BLOOD, V111, P2984, DOI 10.1182/blood-2007-09-114082; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fleury Isabelle, 2004, Am J Pharmacogenomics, V4, P331, DOI 10.2165/00129785-200404050-00006; Flohr T, 2008, LEUKEMIA, V22, P771, DOI 10.1038/leu.2008.5; Holleman A, 2006, BLOOD, V107, P769, DOI 10.1182/blood-2005-07-2930; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Kadan-Lottick NS, 2003, JAMA-J AM MED ASSOC, V290, P2008, DOI 10.1001/jama.290.15.2008; Kager L, 2005, J CLIN INVEST, V115, P110, DOI 10.1172/JCI200522477; Kishi S, 2004, BLOOD, V103, P67, DOI 10.1182/blood-2003-06-2105; Kishi S, 2007, BLOOD, V109, P4151, DOI 10.1182/blood-2006-10-054528; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LEU BL, 1995, CANCER CHEMOTH PHARM, V35, P432, DOI 10.1007/s002800050258; LEWIS AD, 1992, CANCER RES, V52, P4379; Lugthart S, 2005, CANCER CELL, V7, P375, DOI 10.1016/j.ccr.2005.03.002; Malo N, 2008, AM J HUM GENET, V82, P375, DOI 10.1016/j.ajhg.2007.10.012; Masson E, 1996, J CLIN INVEST, V97, P73, DOI 10.1172/JCI118409; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Plasschaert SLA, 2004, CLIN PHARMACOL THER, V76, P220, DOI 10.1016/j.clpt.2004.05.007; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pui C.-H., 2004, Annals of Hematology, V83, pS124; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Relling MV, 1999, BLOOD, V93, P2817; RELLING MV, 1994, MOL PHARMACOL, V45, P352; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rocha JCC, 2005, BLOOD, V105, P4752, DOI 10.1182/blood-2004-11-4544; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schmidt S, 2006, BLOOD, V107, P2061, DOI 10.1182/blood-2005-07-2853; Schultz KR, 2007, BLOOD, V109, P926, DOI 10.1182/blood-2006-01-024729; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Sorich MJ, 2008, PLOS MED, V5, P646, DOI 10.1371/journal.pmed.0050083; Stanulla M, 2005, JAMA-J AM MED ASSOC, V293, P1485, DOI 10.1001/jama.293.12.1485; Szczepanski T, 2001, LANCET ONCOL, V2, P409, DOI 10.1016/S1470-2045(00)00418-6; Tinhofer I, 2000, BLOOD, V95, P610, DOI 10.1182/blood.V95.2.610; Tissing WJE, 2007, BLOOD, V109, P3929, DOI 10.1182/blood-2006-11-056366; Valdes AM, 2008, AM J HUM GENET, V82, P1231, DOI 10.1016/j.ajhg.2008.04.006; van Asperen J, 2000, DRUG METAB DISPOS, V28, P264; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6; Villikka K, 1999, CLIN PHARMACOL THER, V66, P589, DOI 10.1016/S0009-9236(99)90067-X; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yates CR, 2003, PHARM RES-DORDR, V20, P1794, DOI 10.1023/B:PHAM.0000003377.39548.f6; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang XJ, 2007, J INVEST DERMATOL, V127, P2544, DOI 10.1038/sj.jid.5700896; Zhou JB, 2007, BLOOD, V110, P1607, DOI 10.1182/blood-2006-09-045369	65	171	177	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2009	301	4					393	403		10.1001/jama.2009.7	http://dx.doi.org/10.1001/jama.2009.7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CE	19176441	Green Accepted			2022-12-01	WOS:000262777200019
J	D'Angelo, MA; Raices, M; Panowski, SH; Hetzer, MW				D'Angelo, Maximiliano A.; Raices, Marcela; Panowski, Siler H.; Hetzer, Martin W.			Age-Dependent Deterioration of Nuclear Pore Complexes Causes a Loss of Nuclear Integrity in Postmitotic Cells	CELL			English	Article							OXIDATIVE STRESS RESISTANCE; CAENORHABDITIS-ELEGANS; C-ELEGANS; GERM-LINE; ENVELOPE; DISEASE; PROTEIN; CYCLE; ORGANIZATION; LONGEVITY	In dividing cells, nuclear pore complexes (NPCs) disassemble during mitosis and reassemble into the newly forming nuclei. However, the fate of nuclear pores in postmitotic cells is unknown. Here, we show that NPCs, unlike other nuclear structures, do not turn over in differentiated cells. While a subset of NPC components, like Nup153 and Nup50, are continuously exchanged, scaffold nucleoporins, like the Nup107/160 complex, are extremely long-lived and remain incorporated in the nuclear membrane during the entire cellular life span. Besides the lack of nucleoporin expression and NPC turnover, we discovered an age-related deterioration of NPCs, leading to an increase in nuclear permeability and the leaking of cytoplasmic proteins into the nucleus. Our finding that nuclear "leakiness'' is dramatically accelerated during aging and that a subset of nucleoporins is oxidatively damaged in old cells suggests that the accumulation of damage at the NPC might be a crucial aging event.	[D'Angelo, Maximiliano A.; Raices, Marcela; Panowski, Siler H.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		D'Angelo, Maximiliano/0000-0001-7025-0142	NIH [R01 GM057438 .]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057438] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Dillin, P. Askjaer, B. Burke, J. Ellenberg, R. Foisner, M. Hengartner, Y. Gruenbaum, U. Kutay, and E. Schirmer for reagents; M. Downes for mammalian Q-PCR assays; J. Jepsen for isolation of rat brains; and the Hetzer lab, C. Hetzer-Egger, T. Hunter, W. Eckhart, F. Gage, and S. Pfaff for critical discussion and reading of the manuscript. This work was funded by the NIH R01 GM057438 grant.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; D'Angelo MA, 2006, CELL MOL LIFE SCI, V63, P316, DOI 10.1007/s00018-005-5361-3; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Danielson SR, 2008, FREE RADICAL BIO MED, V44, P1787, DOI 10.1016/j.freeradbiomed.2008.03.005; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI [10.1073/pnas.0506955102, 10.1073/pnas.0506755102]; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim Y, 2007, AGING CELL, V6, P489, DOI 10.1111/j.1474-9726.2007.00302.x; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Lenart P, 2006, METHODS, V38, P17, DOI 10.1016/j.ymeth.2005.07.010; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; LOVTRUPREIN H, 1966, J CELL BIOL, V30, P405, DOI 10.1083/jcb.30.2.405; MAUL GG, 1972, J CELL BIOL, V55, P433, DOI 10.1083/jcb.55.2.433; Oeda T, 2001, HUM MOL GENET, V10, P2013, DOI 10.1093/hmg/10.19.2013; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Woulfe JM, 2007, NEUROPATH APPL NEURO, V33, P2, DOI 10.1111/j.1365-2990.2006.00819.x; Zhu X, 2007, CELL MOL LIFE SCI, V64, P2202, DOI 10.1007/s00018-007-7218-4	44	361	367	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					284	295		10.1016/j.cell.2008.11.037	http://dx.doi.org/10.1016/j.cell.2008.11.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167330	Green Accepted, Bronze			2022-12-01	WOS:000262648800017
J	Graham, SM; English, M				Graham, Stephen M.; English, Mike			Non-typhoidal salmonellae: a management challenge for children with community-acquired invasive disease in tropical African countries	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; MALAWIAN CHILDREN; SEVERE PNEUMONIA; BACTEREMIA; INFECTIONS; MENINGITIS; RESISTANCE; ETIOLOGY; MALARIA; GAMBIA		[Graham, Stephen M.] Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Dept Paediat, Parkville, Vic 3052, Australia; [Graham, Stephen M.] Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [English, Mike] Ctr Geog Med Res, Kenya Med Res Inst, Nairobi, Kenya	Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Kenya Medical Research Institute	Graham, SM (corresponding author), Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Dept Paediat, Parkville, Vic 3052, Australia.	steve.graham@rch.org.au		English, Michael/0000-0002-7427-0826; Graham, Stephen/0000-0003-3525-2294	Wellcome Trust [074124/Z/04/Z, 097170, 076827] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Asghar R, 2008, BMJ-BRIT MED J, V336, P80, DOI 10.1136/bmj.39421.435949.BE; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Bahwere P, 2004, PEDIATR INFECT DIS J, V23, P739, DOI 10.1097/01.inf.0000135663.17018.51; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Cardoso MRA, 2008, ARCH DIS CHILD, V93, P221, DOI 10.1136/adc.2006.111625; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Falade AG, 1997, ANN TROP PAEDIATR, V17, P315, DOI 10.1080/02724936.1997.11747904; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Graham SM, 2002, CURR OPIN INFECT DIS, V15, P507, DOI 10.1097/00001432-200210000-00009; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; KABRA SK, 2006, COCHRANE DB SYST REV, V3, P4874; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086; World Health Organization, 2005, POCK HOSP CAR CHILDR	23	38	39	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2009	373	9659					267	269		10.1016/S0140-6736(09)60073-8	http://dx.doi.org/10.1016/S0140-6736(09)60073-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150705	Green Accepted			2022-12-01	WOS:000262537500029
J	Tigges, M; Marquez-Lago, TT; Stelling, J; Fussenegger, M				Tigges, Marcel; Marquez-Lago, Tatiana T.; Stelling, Joerg; Fussenegger, Martin			A tunable synthetic mammalian oscillator	NATURE			English	Article							CIRCADIAN GENE-EXPRESSION; CLOCK	Autonomous and self- sustained oscillator circuits mediating the periodic induction of specific target genes are minimal genetic time- keeping devices found in the central and peripheral circadian clocks(1,2). They have attracted significant attention because of their intriguing dynamics and their importance in controlling critical repair(3), metabolic(4) and signalling pathways(5). The precise molecular mechanism and expression dynamics of this mammalian circadian clock are still not fully understood. Here we describe a synthetic mammalian oscillator based on an auto- regulated sense - antisense transcription control circuit encoding a positive and a time- delayed negative feedback loop, enabling autonomous, self- sustained and tunable oscillatory gene expression. After detailed systems design with experimental analyses and mathematical modelling, we monitored oscillating concentrations of green fluorescent protein with tunable frequency and amplitude by time- lapse microscopy in real time in individual Chinese hamster ovary cells. The synthetic mammalian clock may provide an insight into the dynamics of natural periodic processes and foster advances in the design of prosthetic networks in future gene and cell therapies.	[Tigges, Marcel; Marquez-Lago, Tatiana T.; Stelling, Joerg; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Marquez-Lago, Tatiana T.; Stelling, Joerg] ETH, Inst Computat Sci, CH-8092 Zurich, Switzerland; [Marquez-Lago, Tatiana T.; Stelling, Joerg] ETH, Swiss Inst Bioinformat, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	joerg.stelling@bsse.ethz.ch; fussenegger@bsse.ethz.ch	Stelling, Joerg/F-7499-2010	Stelling, Joerg/0000-0002-1145-891X	Swiss National Science Foundation; EC Framework 6 (COBIOS)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC Framework 6 (COBIOS)(European Commission)	We thank H. Meyer for providing pcDNA3.1-Ub<SUP>V76</SUP>-GFP; and B. Kramer, M. Gitzinger, D. Greber and W. Weber for conceptual input and/or critical comments on the manuscript. This work was supported by the Swiss National Science Foundation and the EC Framework 6 (COBIOS).	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Chilov D, 2004, BIOTECHNOL BIOENG, V87, P234, DOI 10.1002/bit.20143; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Crosthwaite SK, 2004, FEBS LETT, V567, P49, DOI 10.1016/j.febslet.2004.04.073; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P1203, DOI 10.1038/81208; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; Fux C, 2001, Nucleic Acids Res, V29, pE19, DOI 10.1093/nar/29.4.e19; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kramer Beat P., 2005, V308, P123; LAHAV G, 2004, SCI STKE, pPE55, DOI DOI 10.1126/STKE.2642004PE55; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Moser S, 2001, J GENE MED, V3, P529, DOI 10.1002/jgm.219; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reppert SM, 1997, CELL, V89, P487, DOI 10.1016/S0092-8674(00)80229-9; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rossmanith W, 2002, DNA CELL BIOL, V21, P847, DOI 10.1089/104454902320908496; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Wu YH, 2006, FASEB J, V20, P1874, DOI 10.1096/fj.05-4446fje	29	420	448	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					309	312		10.1038/nature07616	http://dx.doi.org/10.1038/nature07616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19148099				2022-12-01	WOS:000262440900038
J	Walsh, S; Fan, SL				Walsh, Stephen; Fan, Stanley L.			Visualising rhabdomyolysis	LANCET			English	Editorial Material									[Walsh, Stephen] UCL, Royal Free & Univ Coll Med Sch, Ctr Neprhol, London, England; [Fan, Stanley L.] Barts & London Hosp NHS Trust, Dept Renal Med & Transplantat, London, England	University of London; University College London; Barts Health NHS Trust	Walsh, S (corresponding author), Royal Free Hosp, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	stephen.walsh@ucl.ac.uk	Walsh, Stephen Benedict/AAB-9930-2020; Fan, Stanley/ABA-1363-2020	Fan, Stanley/0000-0002-7323-1489; Walsh, Stephen/0000-0002-8693-1353					0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					154	154		10.1016/S0140-6736(09)60039-8	http://dx.doi.org/10.1016/S0140-6736(09)60039-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135612				2022-12-01	WOS:000262340900030
J	Scrima, A; Konickova, R; Czyzewski, BK; Kawasaki, Y; Jeffrey, PD; Groisman, R; Nakatani, Y; Iwai, S; Pavletich, NP; Thoma, NH				Scrima, Andrea; Konickova, Renata; Czyzewski, Bryan K.; Kawasaki, Yusuke; Jeffrey, Philip D.; Groisman, Regina; Nakatani, Yoshihiro; Iwai, Shigenori; Pavletich, Nikola P.; Thomae, Nicolas H.			Structural Basis of UV DNA-Damage Recognition by the DDB1-DDB2 Complex	CELL			English	Article							PIGMENTOSUM GROUP-E; GROUP-E CELLS; XERODERMA-PIGMENTOSUM; UBIQUITIN LIGASE; BINDING-PROTEIN; PYRIMIDINE DIMERS; DIFFRACTION DATA; REPAIR; DDB2; P48	Ultraviolet (UV) light-induced pyrimidine photodimers are repaired by the nucleotide excision repair pathway. Photolesions have biophysical parameters closely resembling undamaged DNA, impeding discovery through damage surveillance proteins. The DDB1-DDB2 complex serves in the initial detection of UV lesions in vivo. Here we present the structures of the DDB1-DDB2 complex alone and bound to DNA containing either a 6-4 pyrimidine-pyrimidone photodimer (6-4PP) lesion or an abasic site. The structure shows that the lesion is held exclusively by the WD40 domain of DDB2. A DDB2 hairpin inserts into the minor groove, extrudes the photodimer into a binding pocket, and kinks the duplex by similar to 40 degrees. The tightly localized probing of the photolesions, combined with proofreading in the photodimer pocket, enables DDB2 to detect lesions refractory to detection by other damage surveillance proteins. The structure provides insights into damage recognition in chromatin and suggests a mechanism by which the DDB1-associated CUL4 ubiquitin ligase targets proteins surrounding the site of damage.	[Czyzewski, Bryan K.; Jeffrey, Philip D.; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Scrima, Andrea; Konickova, Renata; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Kawasaki, Yusuke; Iwai, Shigenori] Osaka Univ, Grad Sch Engn Sci, Osaka 5608531, Japan; [Groisman, Regina] Univ Paris Sud, Inst Andre Lwoff, CNRS, FRE 2944, F-94801 Villejuif, France; [Nakatani, Yoshihiro] Dana Farber Canc Inst, Boston, MA 02115 USA; [Nakatani, Yoshihiro] Harvard Univ, Sch Med, Boston, MA 02115 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Friedrich Miescher Institute for Biomedical Research; Osaka University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.	pavletin@mskcc.org; nicolas.thoma@fmi.ch		Groisman, Sonia/0000-0003-1153-3841; Jeffrey, Philip/0000-0002-4351-5341; Groisman, Regina/0000-0003-3990-7622	Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland; Human Frontier Science Program (HFSP); Swiss National Fond [31-120205]; Novartis Research Foundation; European Molecular Biology Organization (EMBO)	Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland; Human Frontier Science Program (HFSP)(Human Frontier Science Program); Swiss National Fond(Swiss National Science Foundation (SNSF)); Novartis Research Foundation; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	We thank Norman Kairies for crystallographic support. We would like to thank Fritz Thoma, Hanspeter Naegeli, and Susan Gasser for discussions relating to DNA repair in the context of chromatin. We thank Hans Widmer for help and support. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland. Y.N. and S.I. acknowledge funding from the Human Frontier Science Program (HFSP). Funding in the laboratory of N.H.T. is provided by the Swiss National Fond (SNF;#31-120205) and the Novartis Research Foundation. A. S. gratefully acknowledges funding from the European Molecular Biology Organization (EMBO).	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barsky D, 2000, NUCLEIC ACIDS RES, V28, P2613, DOI 10.1093/nar/28.13.2613; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELDBERG RS, 1976, BIOCHEMISTRY-US, V15, P2402, DOI 10.1021/bi00656a024; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Friedberg E.C., 2006, DNA REPAIR MUTAGENES; Fugmann SD, 2001, MOL CELL, V8, P899, DOI 10.1016/S1097-2765(01)00352-5; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; Gelasco A, 1998, BIOCHEMISTRY-US, V37, P9230, DOI 10.1021/bi973176v; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Iwai S, 1996, J AM CHEM SOC, V118, P7642, DOI 10.1021/ja9603158; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Lukin M, 2006, CHEM REV, V106, P607, DOI 10.1021/cr0404646; Maillard O, 2007, TRENDS BIOCHEM SCI, V32, P494, DOI 10.1016/j.tibs.2007.08.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichols AF, 2000, J BIOL CHEM, V275, P21422, DOI 10.1074/jbc.M000960200; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; O'Neil LL, 2007, J PHYS CHEM B, V111, P11843, DOI 10.1021/jp074043e; Otrin VR, 1998, MOL CELL BIOL, V18, P3182, DOI 10.1128/MCB.18.6.3182; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Rapic-Otrin V, 2003, HUM MOL GENET, V12, P1507, DOI 10.1093/hmg/ddg174; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; TAKAO M, 1993, NUCLEIC ACIDS RES, V21, P4111, DOI 10.1093/nar/21.17.4111; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Wittschieben BO, 2003, DNA REPAIR, V2, P1065, DOI 10.1016/S1568-7864(03)00113-7; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yasuda G, 2007, MOL CELL BIOL, V27, P6606, DOI 10.1128/MCB.02166-06; Yasuda T, 2005, DNA REPAIR, V4, P389, DOI 10.1016/j.dnarep.2004.10.008	59	294	302	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1213	1223		10.1016/j.cell.2008.10.045	http://dx.doi.org/10.1016/j.cell.2008.10.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109893	Green Accepted, Bronze			2022-12-01	WOS:000261989800013
J	Heimberg, H				Heimberg, Harry			Boosting Beta-Cell Numbers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Heimberg, Harry] Vrije Univ Brussels, Ctr Diabet Res, Brussels, Belgium; [Heimberg, Harry] Juvenile Diabet Res Fdn Ctr Beta Cell Therapy Dia, Brussels, Belgium	Vrije Universiteit Brussel	Heimberg, H (corresponding author), Vrije Univ Brussels, Ctr Diabet Res, Brussels, Belgium.			Heimberg, Harry/0000-0003-1954-7375				Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2723	2724		10.1056/NEJMcibr0807675	http://dx.doi.org/10.1056/NEJMcibr0807675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19092158	Green Published			2022-12-01	WOS:000261757300014
J	Kelly, BT; McCoy, AJ; Spate, K; Miller, SE; Evans, PR; Honing, S; Owen, DJ				Kelly, Bernard T.; McCoy, Airlie J.; Spaete, Kira; Miller, Sharon E.; Evans, Philip R.; Hoening, Stefan; Owen, David J.			A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex	NATURE			English	Article							SORTING-SIGNAL RECOGNITION; CLATHRIN-COATED VESICLES; DI-LEUCINE MOTIF; ADAPTER; PHOSPHORYLATION; SUBUNIT; PROTEIN; CLUSTER; SOFTWARE; RECEPTOR	Most transmembrane proteins are selected as transport- vesicle cargo through the recognition of short, linear amino- acid motifs in their cytoplasmic portions by vesicle coat proteins. For clathrin-coated vesicles, the motifs are recognized by clathrin adaptors. The AP2 adaptor complex (subunits alpha, beta 2, mu 2 and sigma 2) recognizes both major endocytic motifs: Yxx Phi motifs(1) ( where Phi can be F, I, L, Mor V) and [ED] xxxL[ LI] acidic dileucine motifs. Here we describe the binding of AP2 to the endocytic dileucine motif from CD4 ( ref. 2). The major recognition events are the two leucine residues binding in hydrophobic pockets on sigma 2. The hydrophilic residue four residues upstream from the first leucine sits on a positively charged patch made from residues on the sigma 2 and a subunits. Mutations in key residues inhibit the binding of AP2 to 'acidic dileucine' motifs displayed in liposomes containing phosphatidylinositol-4,5-bisphosphate,but do not affect binding to Yxx Phi motifs through mu 2. In the 'inactive' AP2 core structure(3) both motif- binding sites are blocked by different parts of the beta 2 subunit. To allow a dileucine motif to bind, the beta 2 amino terminus is displaced and becomes disordered; however, in this structure the Yxx Phi-binding site on mu 2 remains blocked.	[Kelly, Bernard T.; McCoy, Airlie J.; Miller, Sharon E.; Owen, David J.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Kelly, Bernard T.; McCoy, Airlie J.; Miller, Sharon E.; Owen, David J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0XY, England; [Spaete, Kira; Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Spaete, Kira; Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Evans, Philip R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cologne; University of Cologne; MRC Laboratory Molecular Biology	Owen, DJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	djo30@cam.ac.uk			Wellcome Trust Senior Research Fellowship; Deutsche Forschungsgemeinschaft [SFB635, SFB670]; Medical Research Council [MC_U105178845] Funding Source: researchfish; MRC [MC_U105178845] Funding Source: UKRI	Wellcome Trust Senior Research Fellowship(Wellcome Trust); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the protein crystallography beamline staff at Diamond, especially E. Duke, K. McAuley and R. Flaig, for their support and assistance. D.J. O., B.T.K. and S.E.M. are funded by a Wellcome Trust Senior Research Fellowship to D.J.O.S.H. and K.S. are supported by grants from the Deutsche Forschungsgemeinschaft (SFB635 and SFB670).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; DORAY B, IDENTIFICAT IN PRESS; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Huang FT, 2003, J BIOL CHEM, V278, P43411, DOI 10.1074/jbc.M306072200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a	27	223	230	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					976	U81		10.1038/nature07422	http://dx.doi.org/10.1038/nature07422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19140243	Green Submitted, Green Accepted			2022-12-01	WOS:000261768300051
J	Sarewitz, D; Nelson, R				Sarewitz, Daniel; Nelson, Richard			Three rules for technological fixes	NATURE			English	Editorial Material							CAPTURE; ENERGY		[Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA; [Nelson, Richard] Columbia Univ, New York, NY 10027 USA	Arizona State University; Arizona State University-Tempe; Columbia University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA.	daniel.sarewitz@asu.edu; rrn2@columbia.edu						Baciocchi R, 2006, CHEM ENG PROCESS, V45, P1047, DOI 10.1016/j.cep.2006.03.015; Foray D., 2003, LONDON REV ED, V1, P7, DOI DOI 10.1080/14748460306689; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Keith DW, 2006, CLIMATIC CHANGE, V74, P17, DOI 10.1007/s10584-005-9026-x; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; MURNANE R, 2004, EC INNOVATION NEW TE, V16, P307; National Research Council, 2003, STRATEGIC ED RES PAR; Prins G, 2007, NATURE, V449, P973, DOI 10.1038/449973a; Sarewitz D, 2008, CONTROVERSIES IN SCIENCE & TECHNOLOGY, VOL 2, P329; Stolaroff J.K., 2006, THESIS CARNEGIE MELL	10	62	62	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					871	872		10.1038/456871a	http://dx.doi.org/10.1038/456871a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	384TY	19092910	Bronze			2022-12-01	WOS:000261768300015
J	Anbar, AD				Anbar, Ariel D.			OCEANS Elements and Evolution	SCIENCE			English	Editorial Material							CHEMISTRY; STOICHIOMETRY; OXYGENATION; COEVOLUTION; CYCLES		[Anbar, Ariel D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Anbar, AD (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	anbar@asu.edu						Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Arnold GL, 2004, SCIENCE, V304, P87, DOI 10.1126/science.1091785; Baudouin-Cornu P, 2001, SCIENCE, V293, P297, DOI 10.1126/science.1061052; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Buesseler KO, 2008, SCIENCE, V319, P162, DOI 10.1126/science.1154305; Buick R, 2007, GEOBIOLOGY, V5, P97, DOI 10.1111/j.1472-4669.2007.00110.x; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Elser J, 2006, AM NAT, V168, pS25, DOI 10.1086/509048; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Konhauser KO, 2007, SCIENCE, V315, P1234, DOI 10.1126/science.1136328; Lyons TW, 2008, SCIENCE, V321, P923, DOI 10.1126/science.1162870; Morel FMM, 2008, GEOBIOLOGY, V6, P318, DOI 10.1111/j.1472-4669.2008.00144.x; PECOITS E, 2008, ASTROBIOLOGY, V8, P412; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Williams RJP, 2003, J THEOR BIOL, V220, P323, DOI 10.1006/jtbi.2003.3152; WOLFESIMON F, INT J ASTRO IN PRESS; Zerkle AL, 2005, AM J SCI, V305, P467, DOI 10.2475/ajs.305.6-8.467; ZERKLE AL, 2006, GEOBIOLOGY, V4, P285	26	212	225	8	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1481	1483		10.1126/science.1163100	http://dx.doi.org/10.1126/science.1163100			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056967				2022-12-01	WOS:000261377400030
J	Das, P; Samarasekera, U				Das, Pam; Samarasekera, Udani			What next for UNAIDS?	LANCET			English	News Item																			0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2099	2102		10.1016/S0140-6736(08)61908-X	http://dx.doi.org/10.1016/S0140-6736(08)61908-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386PB	19112650	Bronze			2022-12-01	WOS:000261894000012
J	Doria, A; Wojcik, J; Xu, R; Gervino, EV; Hauser, TH; Johnstone, MT; Nolan, D; Hu, FB; Warram, JH				Doria, Alessandro; Wojcik, Joanna; Xu, Rui; Gervino, Ernest V.; Hauser, Thomas H.; Johnstone, Michael T.; Nolan, David; Hu, Frank B.; Warram, James H.			Interaction Between Poor Glycemic Control and 9p21 Locus on Risk of Coronary Artery Disease in Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ADIPONECTIN GENE; META-ANALYSIS; INSULIN; EPIDEMIOLOGY; POLYMORPHISM; MELLITUS; SUSCEPTIBILITY	Context A common allele on chromosome 9p21 has been repeatedly associated with increased risk of coronary artery disease ( CAD) in the general population. However, the magnitude of this effect in the population with diabetes has not been well characterized. Objective To examine the association of the 9p21 variant with CAD in individuals with type 2 diabetes and evaluate its interaction with poor glycemic control. Design, Setting, and Participants ( 1) Case- control study of 734 type 2 diabetes patients ( 322 with angiographically diagnosed CAD and 412 with no evidence of CAD) who were recruited between 2001 and 2006 at the Joslin Clinic, Beth Israel Deaconess Medical Center; and ( 2) independent cohort study of 475 type 2 diabetes patients from the Joslin Clinic whose survival status was monitored from their recruitment between 1993 and 1996 until December 31, 2004. Participants for both studies were genotyped for a representative single- nucleotide polymorphism at 9p21 ( rs2383206) and characterized for their long- term glycemic control by averaging multiple hemoglobin A(1c) ( HbA(1c)) measurements taken in the years before study entry. Main Outcome Measures For the case- control study, association between single-nucleotide polymorphism rs2383206 and CAD defined as angiographically documented stenosis greater than 50% in a major coronary artery or a main branch thereof was assessed and for the cohort study, cumulative 10- year mortality was documented. Results Individuals who were homozygous for the risk allele were significantly more frequent among case than control participants ( 42.3% vs 28.9P=. 0002). This association was unaffected by adjustment for cardiovascular risk factors, but the effect of the risk genotype was significantly magnified ( adjusted P for interaction=. 048) in the presence of poor glycemic control ( worst tertile of the distribution of HbA(1c) at examination). Relative to the CAD risk for patients with neither a 9p21 risk allele nor poor glycemic control, the CAD odds for participants having 2 risk alleles but not poor glycemic control were increased 2- fold ( odds ratio [ OR], 1.99; 95% confidence interval [ CI], 1.17- 3.41), whereas the odds for study participants with the same genotype and with poor glycemic control were increased 4- fold ( OR, 4.27; 95% CI, 2.26- 8.01). The interaction was stronger ( adjusted P=. 005) when a measure of long- term glycemic control ( 7- year average rather than most recent HbA(1c)) was used with ORs of 7.83 ( 95% CI, 3.49- 17.6) for participants having 2 risk alleles and a history of poor glycemia and 1.54 ( 95% CI, 0.72- 3.30) for participants with the same genotype but without this exposure. A similar interaction between 9p21 variant and poor glycemic control was observed with respect to cumulative 10- year mortality in the cohort study ( 43.6% in patients with 2 risk alleles and poor glycemic control, 23.1% in individuals with only the 2 risk alleles, 30.0% in individuals with only poor glycemic control, and 31.6% in individuals with neither factor, P for interaction, =. 036). Conclusion In this study population, the CAD risk associated with the 9p21 variant was increased in the presence of poor glycemic control in type 2 diabetes.	[Doria, Alessandro; Wojcik, Joanna; Xu, Rui; Nolan, David; Warram, James H.] Joslin Diabet Ctr, Div Res, Sect Genet & Epidemiol, Boston, MA 02215 USA; [Doria, Alessandro; Wojcik, Joanna; Xu, Rui; Gervino, Ernest V.; Hauser, Thomas H.; Hu, Frank B.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gervino, Ernest V.; Hauser, Thomas H.] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; [Johnstone, Michael T.] Caritas St Elizabeth Med Ctr, Boston, MA USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Doria, Alessandro; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; St. Elizabeth's Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Doria, A (corresponding author), Joslin Diabet Ctr, Div Res, Sect Genet & Epidemiol, 1 Joslin Pl, Boston, MA 02215 USA.	alessandro.doria@joslin.harvard.edu	Doria, Alessandro/H-9157-2018	Doria, Alessandro/0000-0002-3830-4304; Wojcik-Odyniec, Joanna/0000-0002-8495-4316	National Institutes of Health [HL73168, HL71981]; Genetics Core of the Diabetes and Endocrinology Research Center at the Joslin Diabetes Center [DK36836]; Donald W. Reynolds Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168, R01HL071981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics Core of the Diabetes and Endocrinology Research Center at the Joslin Diabetes Center; Donald W. Reynolds Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants HL73168, HL71981, and DK36836 (Genetics Core of the Diabetes and Endocrinology Research Center at the Joslin Diabetes Center), and a grant from the Donald W. Reynolds Foundation. Role of the Sponsors: None of the funding agencies had any role in the design and conduct of the study, in the collection, management, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	ABBOTT RD, 1990, AM J MED, V88, P376, DOI 10.1016/0002-9343(90)90492-V; Arnett DK, 2007, CIRCULATION, V115, P2878, DOI 10.1161/CIRCULATIONAHA.107.183679; Bacci S, 2005, DIABETES, V54, P3021, DOI 10.2337/diabetes.54.10.3021; Bacci S, 2004, DIABETES CARE, V27, P2015, DOI 10.2337/diacare.27.8.2015; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Boonyasrisawat W, 2007, DIABETES, V56, P499, DOI 10.2337/db06-0946; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DETRANO R, 1989, PROG CARDIOVASC DIS, V32, P173, DOI 10.1016/0033-0620(89)90025-X; Folsom AR, 1999, DIABETES CARE, V22, P1077, DOI 10.2337/diacare.22.7.1077; Freire MBS, 1998, HYPERTENSION, V31, P896, DOI 10.1161/01.HYP.31.4.896; Gavin JR, 1997, DIABETES CARE, V20, P1183; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Haffner SM, 1999, DIABETES CARE, V22, pC54; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; KAMB A, 1994, SCIENCE, V264, P440; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; Lacquemant C, 2004, DIABETIC MED, V21, P776, DOI 10.1111/j.1464-5491.2004.01224.x; Lange LA, 2002, STROKE, V33, P1876, DOI 10.1161/01.STR.0000019909.71547.AA; Libby P, 2002, CIRCULATION, V106, P2760, DOI 10.1161/01.CIR.0000037282.92395.AE; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Qi L, 2005, DIABETES, V54, P1607, DOI 10.2337/diabetes.54.5.1607; Rask-Madsen C, 2005, ARTERIOSCL THROM VAS, V25, P487, DOI 10.1161/01.ATV.0000155325.41507.e0; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SHEA S, 1984, J AM COLL CARDIOL, V4, P793, DOI 10.1016/S0735-1097(84)80408-8; Soccio T, 2006, DIABETES, V55, P2763, DOI 10.2337/db06-0613; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wackers FJT, 2004, DIABETES CARE, V27, P1954, DOI 10.2337/diacare.27.8.1954; Wagenknecht LE, 2001, DIABETES, V50, P861, DOI 10.2337/diabetes.50.4.861; Warram JH, 1997, ENDOCRIN METAB CLIN, V26, P165, DOI 10.1016/S0889-8529(05)70239-5; Wild SH, 1999, DIABETES-METAB RES, V15, P197, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<197::AID-DMRR28>3.0.CO;2-F; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	40	95	97	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2389	2397		10.1001/jama.2008.649	http://dx.doi.org/10.1001/jama.2008.649			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033589	Green Accepted, Bronze			2022-12-01	WOS:000261150800021
J	Chan, FKL				Chan, Francis K. L.			Proton-pump inhibitors in peptic ulcer disease	LANCET			English	Editorial Material							INDUCED GASTROINTESTINAL TOXICITY; COST-EFFECTIVENESS; DOUBLE-BLIND; HIGH-RISK; OMEPRAZOLE; ENDOSCOPY; PREVENTION; STRATEGIES; CELECOXIB		[Chan, Francis K. L.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Chan, Francis K. L.] Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Chan, FKL (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China.	fklchan@cuhk.edu.hk	Chan, Francis K. L./F-4851-2010	Chan, Francis K. L./0000-0001-7388-2436				Al-Sabah S, 2008, CLIN GASTROENTEROL H, V6, P418, DOI 10.1016/j.cgh.2007.12.037; Barkun A, 2003, ANN INTERN MED, V139, P843, DOI 10.7326/0003-4819-139-10-200311180-00012; Brown TJ, 2006, HEALTH TECHNOL ASSES, V10, P1; CHAN FK, AM J GASTRO IN PRESS; Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Chan FKL, 2002, NEW ENGL J MED, V347, P2104, DOI 10.1056/NEJMoa021907; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Dorward S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005415.pub2; Elliott RA, 2006, RHEUMATOLOGY, V45, P606, DOI 10.1093/rheumatology/kei241; Lau JY, 2007, NEW ENGL J MED, V356, P1631, DOI 10.1056/NEJMoa065703; Lau JYW, 2000, NEW ENGL J MED, V343, P310, DOI 10.1056/NEJM200008033430501; Leontiadis GI, 2007, HEALTH TECHNOL ASSES, V11, P1; Leontiadis GI, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002094.pub3; Rostom A, 2002, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD002296, 10.1002/14651858.CD002296]; Rostom A, 2007, CLIN GASTROENTEROL H, V5, P818, DOI 10.1016/j.cgh.2007.03.011; Tsoi KKF, 2008, GASTROINTEST ENDOSC, V67, P1056, DOI 10.1016/j.gie.2007.11.056	16	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1198	1200		10.1016/S0140-6736(08)61497-X	http://dx.doi.org/10.1016/S0140-6736(08)61497-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357YB	19094939				2022-12-01	WOS:000259882000006
J	Barbero, F; Thomas, JA; Bonelli, S; Balletto, E; Schonrogge, K				Barbero, Francesca; Thomas, Jeremy A.; Bonelli, Simona; Balletto, Emilio; Schonrogge, Karsten			Queen Ants Make Distinctive Sounds That Are Mimicked by a Butterfly Social Parasite	SCIENCE			English	Article							MACULINEA-REBELI; STRIDULATORY ORGAN; HOST-SPECIFICITY; HYMENOPTERA; SIGNALS; COMMUNICATION; CATERPILLARS; ECOLOGY	Ants dominate terrestrial ecosystems through living in complex societies whose organization is maintained via sophisticated communication systems. The role of acoustics in information exchange may be underestimated. We show that Myrmica schencki queens generate distinctive sounds that elicit increased benevolent responses from workers, reinforcing their supreme social status. Although fiercely defended by workers, ant societies are infiltrated by specialist insects that exploit their resources. Sounds produced by pupae and larvae of the parasitic butterfly Maculinea rebeli mimic those of queen ants more closely than those of workers, enabling them to achieve high status within ant societies. We conclude that acoustical mimicry provides another route for infiltration for similar to 10,000 species of social parasites that cheat ant societies.	[Barbero, Francesca; Thomas, Jeremy A.] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Barbero, Francesca; Bonelli, Simona; Balletto, Emilio] Univ Turin, Dipartimento Biol Anim, Uomo Lab Zool, I-10123 Turin, Italy; [Thomas, Jeremy A.; Schonrogge, Karsten] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	UK Centre for Ecology & Hydrology (UKCEH); University of Turin; University of Oxford	Thomas, JA (corresponding author), Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England.	jeremy.thomas@zoo.ox.ac.uk	Thomas, Jeremy/A-9619-2013; Barbero, Francesca/J-3555-2016; Schonrogge, Karsten/M-9935-2019	Barbero, Francesca/0000-0003-2667-0435; Schonrogge, Karsten/0000-0003-0122-6493; Bonelli, Simona/0000-0001-5185-8136; BALLETTO, Emilio/0000-0003-1168-2791	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; DEVRIES PJ, 1993, BIOL J LINN SOC, V49, P229, DOI 10.1111/j.1095-8312.1993.tb00902.x; Downey J.C., 1973, Bulletin Allyn Mus, VNo. 14, P1; Elmes GW, 2004, ENTOMOL EXP APPL, V110, P53, DOI 10.1111/j.0013-8703.2004.00121.x; Fiedler K, 1996, EXPERIENTIA, V52, P14, DOI 10.1007/BF01922410; Grasso DA, 1998, ITAL J ZOOL, V65, P167, DOI 10.1080/11250009809386741; Hickling R, 2000, J ACOUST SOC AM, V108, P1920, DOI 10.1121/1.1290515; HILL CJ, 1993, J AUST ENTOMOL SOC, V32, P283; Holldobler B, 1999, J COMP PHYSIOL A, V184, P129, DOI 10.1007/s003590050313; Holldobler B., 1990, pi; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; MARKL H, 1968, Z VERGL PHYSIOL, V60, P103, DOI 10.1007/BF00878447; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; MARKL H, 1978, BEHAV ECOL SOCIOBIOL, V4, P183, DOI 10.1007/BF00354979; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Roces F, 2001, J ACOUST SOC AM, V109, P3080, DOI 10.1121/1.1370085; Ruiz E, 2006, ANN SOC ENTOMOL FR, V42, P99, DOI 10.1080/00379271.2006.10697454; Schonrogge K, 2004, J CHEM ECOL, V30, P91, DOI 10.1023/B:JOEC.0000013184.18176.a9; Schurian Klaus G., 1994, Nachrichten des Entomologischen Vereins Apollo, V14, P339; Scott-Phillips TC, 2008, J EVOLUTION BIOL, V21, P387, DOI 10.1111/j.1420-9101.2007.01497.x; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; Thomas JA, 1998, P ROY SOC B-BIOL SCI, V265, P1895, DOI 10.1098/rspb.1998.0517; Thomas Jeremy A., 2005, P479, DOI 10.1079/9780851998121.0479; Travassos MA, 2000, ANIM BEHAV, V60, P13, DOI 10.1006/anbe.1999.1364	25	125	131	0	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					782	785		10.1126/science.1163583	http://dx.doi.org/10.1126/science.1163583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197065				2022-12-01	WOS:000263066800047
J	Aragon, T; van Anken, E; Pincus, D; Serafimova, IM; Korennykh, AV; Rubio, CA; Walter, P				Aragon, Tomas; van Anken, Eelco; Pincus, David; Serafimova, Iana M.; Korennykh, Alexei V.; Rubio, Claudia A.; Walter, Peter			Messenger RNA targeting to endoplasmic reticulum stress signalling sites	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; TRANSLATION; YEAST; KINASE; LOCALIZATION; DEGRADATION; EXPRESSION; MECHANISM; TRANSPORT	Deficiencies in the protein- folding capacity of the endoplasmic reticulum (ER) in all eukaryotic cells lead to ER stress and trigger the unfolded protein response (UPR)(1-3). ER stress is sensed by Ire1, a transmembrane kinase/ endoribonuclease, which initiates the non- conventional splicing of the messenger RNA encoding a key transcription activator, Hac1 in yeast or XBP1 in metazoans. In the absence of ER stress, ribosomes are stalled on unspliced HAC1 mRNA. The translational control is imposed by a base- pairing interaction between the HAC1 intron and the HAC1 5' untranslated region(4). After excision of the intron, transfer RNA ligase joins the severed exons(5,6), lifting the translational block and allowing synthesis of Hac1 from the spliced HAC1 mRNA to ensue(4). Hac1 in turn drives the UPR gene expression program comprising 7-8% of the yeast genome(7) to counteract ER stress. Here we show that, on activation, Ire1 molecules cluster in the ER membrane into discrete foci of higher- order oligomers, to which unspliced HAC1 mRNA is recruited by means of a conserved bipartite targeting element contained in the 3' untranslated region. Disruption of either Ire1 clustering or HAC1 mRNA recruitment impairs UPR signalling. The HAC1 3' untranslated region element is sufficient to target other mRNAs to Ire1 foci, as long as their translation is repressed. Translational repression afforded by the intron fulfils this requirement for HAC1 mRNA. Recruitment of mRNA to signalling centres provides a new paradigm for the control of eukaryotic gene expression.	[Aragon, Tomas; van Anken, Eelco; Pincus, David; Serafimova, Iana M.; Korennykh, Alexei V.; Rubio, Claudia A.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Aragon, Tomas; van Anken, Eelco; Pincus, David; Serafimova, Iana M.; Korennykh, Alexei V.; Rubio, Claudia A.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Aragon, T (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	Tomas.Aragon@ucsf.edu	van Anken, Eelco/AAN-9015-2020; Aragon, Tomas/ABH-4616-2020; Longo, Kenneth A/A-5631-2010	Aragon, Tomas/0000-0002-1700-2729; van Anken, Eelco/0000-0001-9529-2701	Basque Foundation for Science; Howard Hughes Medical Institute; Netherlands Organization for Scientific Research (NWO); National Science Foundation; President's Dissertation Year Fellowship; Jane Childs Memorial Fund for Medical Research	Basque Foundation for Science; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); President's Dissertation Year Fellowship; Jane Childs Memorial Fund for Medical Research	We thank M. Jonikas and B. Kornmann for their help with the MatLab scripts; R. Parker for the pPS2037 and pRP1187 plasmids; K. Thorn for the pKT127 plasmid and for his assistance with microscopy at the Nikon Imaging Center at UCSF; and C. Guthrie, R. Andino, J. Gross and members of the Walter laboratory for discussion and comments on the manuscript. T. A. was supported by the Basque Foundation for Science and the Howard Hughes Medical Institute; E. v. A. by the Netherlands Organization for Scientific Research (NWO); D. P. and C. A. R. by the National Science Foundation; C.A.R. by the President's Dissertation Year Fellowship; and A.V.K. by the Jane Childs Memorial Fund for Medical Research. P. W. is an Investigator of the Howard Hughes Medical Institute.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Choi SB, 2000, NATURE, V407, P765, DOI 10.1038/35037633; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Guthrie C., 2002, GUIDE YEAST GENETICS; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; MADDOCK JR, 1993, SCIENCE, V259, P1717; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pollock R, 1999, METHOD ENZYMOL, V306, P263; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIKORSKI RS, 1989, GENETICS, V122, P19; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P269, DOI 10.1080/10409230500315352	33	229	248	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 5	2009	457	7230					736	U9		10.1038/nature07641	http://dx.doi.org/10.1038/nature07641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19079237	Green Submitted, Green Accepted			2022-12-01	WOS:000263064700044
J	Kleinman, A				Kleinman, Arthur			Caregiving: the odyssey of becoming more human	LANCET			English	Editorial Material									[Kleinman, Arthur] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University	Kleinman, A (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	kleinman@wjh.harvard.edu						Abel E. K., 2000, HEARTS WISDOM AM WOM; Alterra Aaron, 1999, CAREGIVER LIFE ALZHE; Kleinman Arthur, 2006, WHAT REALLY MATTERS; Reiff David, 2008, SWIMMING SEA DEATH S; Tronto J., 1993, MORAL BOUNDARIES POL	5	92	94	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 24	2009	373	9660					292	293		10.1016/S0140-6736(09)60087-8	http://dx.doi.org/10.1016/S0140-6736(09)60087-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19177629	Green Submitted			2022-12-01	WOS:000262728100014
J	Barr, AJ; Ugochukwu, E; Lee, WH; King, ONF; Filippakopoulos, P; Alfano, I; Savitsky, P; Burgess-Brown, NA; Muller, S; Knapp, S				Barr, Alastair J.; Ugochukwu, Emilie; Lee, Wen Hwa; King, Oliver N. F.; Filippakopoulos, Panagis; Alfano, Ivan; Savitsky, Pavel; Burgess-Brown, Nicola A.; Mueller, Susanne; Knapp, Stefan			Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome	CELL			English	Article							RECEPTOR-TYPE-Z; CRYSTAL-STRUCTURE; RPTP-ALPHA; SUBSTRATE-SPECIFICITY; DIFFRACTION DATA; PTP-SIGMA; 1B; INHIBITOR; MECHANISM; GROWTH	Protein tyrosine phosphatases (PTPs) play a critical role in regulating cellular functions by selectively dephosphorylating their substrates. Here we present 22 human PTP crystal structures that, together with prior structural knowledge, enable a comprehensive analysis of the classical PTP family. Despite their largely conserved fold, surface properties of PTPs are strikingly diverse. A potential secondary substrate-binding pocket is frequently found in phosphatases, and this has implications for both substrate recognition and development of selective inhibitors. Structural comparison identified four diverse catalytic loop (WPD) conformations and suggested a mechanism for loop closure. Enzymatic assays revealed vast differences in PTP catalytic activity and identified PTPD1, PTPD2, and HDPTP as catalytically inert protein phosphatases. We propose a "head-totoe'' dimerization model for RPTP gamma/zeta that is distinct from the "inhibitory wedge'' model and that provides a molecular basis for inhibitory regulation. This phosphatome resource gives an expanded insight into intrafamily PTP diversity, catalytic activity, substrate recognition, and autoregulatory self-association.	[Barr, Alastair J.; Ugochukwu, Emilie; Lee, Wen Hwa; King, Oliver N. F.; Filippakopoulos, Panagis; Alfano, Ivan; Savitsky, Pavel; Burgess-Brown, Nicola A.; Mueller, Susanne; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England	University of Oxford; University of Oxford	Barr, AJ (corresponding author), Univ Oxford, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.	alastair.barr@sgc.ox.ac.uk; stefan.knapp@sgc.ox.ac.uk	Lee, Wen Hwa/GZA-8183-2022; Knapp, Stefan/AAG-2347-2019; Lee, Wen Hwa/G-1250-2013	Lee, Wen Hwa/0000-0002-4098-5225; Knapp, Stefan/0000-0001-5995-6494; Lee, Wen Hwa/0000-0002-4098-5225; Barr, Alastair/0000-0001-7738-8419; King, Oliver/0000-0002-6152-7207; Filippakopoulos, Panagis/0000-0002-1515-1317; Savitsky, Pavel/0000-0001-8584-7750; Muller-Knapp, Susanne/0000-0003-2402-4157	Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation, Genome Canada; Glaxo Smith Kline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada(Genome CanadaCanada Foundation for Innovation); Glaxo Smith Kline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	We gratefully acknowledge all our colleagues at the SGC, in particular J. Elkins, C. Johansson, E. Salah, J. Eswaran, and T. Keates. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, Glaxo Smith Kline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Barrett AC, 2006, EXP CLIN PSYCHOPHARM, V14, P1, DOI 10.1037/1064-1297.14.1.1; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanchetot C, 2002, EMBO J, V21, P493, DOI 10.1093/emboj/21.4.493; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2006, BIOCHEM J, V395, P483, DOI 10.1042/BJ20051931; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Groen A, 2008, FEBS J, V275, P2597, DOI 10.1111/j.1742-4658.2008.06407.x; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Jui HY, 2000, J BIOL CHEM, V275, P41124, DOI 10.1074/jbc.M007772200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lee S, 2007, MOL CELL BIOL, V27, P1795, DOI 10.1128/MCB.00535-06; Leslie AGW, 1992, RECENT CHANGES MOSFL; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; Nakamura M, 2003, CANCER RES, V63, P737; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Ogata M, 1999, J BIOL CHEM, V274, P12905, DOI 10.1074/jbc.274.18.12905; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Pedersen AK, 2004, ACTA CRYSTALLOGR D, V60, P1527, DOI 10.1107/S0907444904015094; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Peters GH, 2000, J BIOL CHEM, V275, P18201, DOI 10.1074/jbc.M910273199; Puius YA, 1997, P NATL ACAD SCI USA, V94, P13420, DOI 10.1073/pnas.94.25.13420; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Siu R, 2007, MOL CELL BIOL, V27, P208, DOI 10.1128/MCB.00707-06; Sonnenburg ED, 2003, BIOCHEMISTRY-US, V42, P7904, DOI 10.1021/bi0340503; Tautz L, 2006, EXPERT OPIN THER TAR, V10, P157, DOI 10.1517/14728222.10.1.157; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Villa F, 2005, J BIOL CHEM, V280, P8180, DOI 10.1074/jbc.M412211200; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wallace MJ, 1998, MOL CELL BIOL, V18, P2608, DOI 10.1128/MCB.18.5.2608; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	55	342	365	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 23	2009	136	2					352	363		10.1016/j.cell.2008.11.038	http://dx.doi.org/10.1016/j.cell.2008.11.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167335	Green Published, Green Accepted, hybrid			2022-12-01	WOS:000262648800022
J	van Mantgem, PJ; Stephenson, NL; Byrne, JC; Daniels, LD; Franklin, JF; Fule, PZ; Harmon, ME; Larson, AJ; Smith, JM; Taylor, AH; Veblen, TT				van Mantgem, Phillip J.; Stephenson, Nathan L.; Byrne, John C.; Daniels, Lori D.; Franklin, Jerry F.; Fule, Peter Z.; Harmon, Mark E.; Larson, Andrew J.; Smith, Jeremy M.; Taylor, Alan H.; Veblen, Thomas T.			Widespread Increase of Tree Mortality Rates in the Western United States	SCIENCE			English	Article							CLIMATE-CHANGE; NORTH-AMERICA; LONG-TERM; FOREST; DROUGHT; GROWTH; DISTURBANCES; RESTORATION; DYNAMICS; FIRE	Persistent changes in tree mortality rates can alter forest structure, composition, and ecosystem services such as carbon sequestration. Our analyses of longitudinal data from unmanaged old forests in the western United States showed that background ( noncatastrophic) mortality rates have increased rapidly in recent decades, with doubling periods ranging from 17 to 29 years among regions. Increases were also pervasive across elevations, tree sizes, dominant genera, and past fire histories. Forest density and basal area declined slightly, which suggests that increasing mortality was not caused by endogenous increases in competition. Because mortality increased in small trees, the overall increase in mortality rates cannot be attributed solely to aging of large trees. Regional warming and consequent increases in water deficits are likely contributors to the increases in tree mortality rates.	[van Mantgem, Phillip J.; Stephenson, Nathan L.] Western Ecol Res Ctr, US Geol Survey, Three Rivers, CA 93271 USA; [Byrne, John C.] USDA Forest Serv, Rocky Mt Res Stn, Moscow, ID 83843 USA; [Daniels, Lori D.] Univ British Columbia, Dept Geog, Vancouver, BC V6T 1Z2, Canada; [Franklin, Jerry F.; Larson, Andrew J.] Univ Washington, Coll Forest Resources, Seattle, WA 98195 USA; [Fule, Peter Z.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Fule, Peter Z.] No Arizona Univ, Ecol Restorat Inst, Flagstaff, AZ 86011 USA; [Harmon, Mark E.] Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; [Smith, Jeremy M.; Veblen, Thomas T.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [Taylor, Alan H.] Penn State Univ, Dept Geog, University Pk, PA 16802 USA	United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service; University of British Columbia; University of Washington; University of Washington Seattle; Northern Arizona University; Northern Arizona University; Oregon State University; University of Colorado System; University of Colorado Boulder; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	van Mantgem, PJ (corresponding author), Western Ecol Res Ctr, US Geol Survey, Arcata, CA 95521 USA.	pvanmantgem@usgs.gov; nstephenson@usgs.gov	Noojipady, Praveen/B-2511-2010; Veblen, Thomas T./U-6461-2018	Daniels, Lori/0000-0002-5015-8311	NSF's Long-term Studies Program [DEB-0218088]; Wind River Canopy Crane Program [PNW 08-DG- 11261952488]; USDA Forest Service's Pacific Northwest; Pacific Southwest; Rocky Mountain research stations; McIntire-Stennis Cooperative Forestry Program; NSF [DEB-0743498, BCS-0825823]; Natural Science and Engineering Research Council of Canada; U.S. National Park Service; U.S. Geological Survey	NSF's Long-term Studies Program(National Science Foundation (NSF)); Wind River Canopy Crane Program; USDA Forest Service's Pacific Northwest(United States Department of Agriculture (USDA)United States Forest Service); Pacific Southwest; Rocky Mountain research stations; McIntire-Stennis Cooperative Forestry Program; NSF(National Science Foundation (NSF)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. National Park Service; U.S. Geological Survey(United States Geological Survey)	We thank the many people involved in establishing and maintaining the permanent forest plots; C. Allen, A. Das, J. Halofsky, J. Hicke, J. Lutz, and four anonymous reviewers for helpful comments on the manuscript; and J. Yee for essential statistical advice. The forest plots were funded by NSF's Long- term Studies Program (DEB- 0218088); the Wind River Canopy Crane Program through cooperative agreement PNW 08-DG- 11261952488 with the USDA Forest Service Pacific Northwest Research Station; various awards through the USDA Forest Service's Pacific Northwest, Pacific Southwest, and Rocky Mountain research stations and the McIntire-Stennis Cooperative Forestry Program; NSF awards DEB- 0743498 and BCS- 0825823; the Natural Science and Engineering Research Council of Canada; various awards through the U.S. National Park Service and U.S. Geological Survey (USGS). This work is a contribution of the Western Mountain Initiative (a USGS global change research project) and the Cordillera Forest Dynamics Network (CORFOR).	Bigler C, 2007, OIKOS, V116, P1983, DOI 10.1111/j.2007.0030-1299.16034.x; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brown RT, 2004, CONSERV BIOL, V18, P903, DOI 10.1111/j.1523-1739.2004.521_1.x; Diaz HF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GLO31253; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Fellows AW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033965; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Hicke JA, 2007, ECOL APPL, V17, P2387, DOI 10.1890/06-1951.1; Jump AS, 2006, GLOBAL CHANGE BIOL, V12, P2163, DOI 10.1111/j.1365-2486.2006.01250.x; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Kobe RK, 1996, ECOL MONOGR, V66, P181, DOI 10.2307/2963474; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; McDonald G.I., 2001, WHITEBARK PINE COMMU, P193; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; North M, 2007, CAN J FOREST RES, V37, P331, DOI 10.1139/X06-236; Oliver C., 1990, FOREST STAND DYNAMIC; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834	24	1189	1230	23	562	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					521	524		10.1126/science.1165000	http://dx.doi.org/10.1126/science.1165000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164752				2022-12-01	WOS:000262587900047
J	Farquhar, C				Farquhar, Cynthia			Do uterine fibroids cause infertility and should they be removed to increase fertility?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Farquhar, Cynthia] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand	University of Auckland	Farquhar, C (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand.	c.farquhar@auckland.ac.nz		Farquhar, Cynthia/0000-0002-3685-3553				[Anonymous], 2004, FERT ASS TREATM PEOP; Bajekal N, 2000, HUM REPROD UPDATE, V6, P614, DOI 10.1093/humupd/6.6.614; Bradford Hill A., 1991, BRADFORD HILLS PRINC; Bulletti C, 1999, J AM ASSOC GYN LAP, V6, P441, DOI 10.1016/S1074-3804(99)80008-5; BUTTRAM VC, 1981, FERTIL STERIL, V36, P433; Casini ML, 2006, GYNECOL ENDOCRINOL, V22, P106, DOI 10.1080/09513590600604673; DANGELO AG, 2006, COCHRANE DB SYST REV; Donnez J, 2002, HUM REPROD, V17, P1424, DOI 10.1093/humrep/17.6.1424; Gupta JK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005073.pub2; PRITTS EA, 2008, FERTIL STERIL   0311; VERKAUF BS, 1992, FERTIL STERIL, V58, P1	11	11	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 16	2009	338								b126	10.1136/bmj.b126	http://dx.doi.org/10.1136/bmj.b126			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AE	19151067				2022-12-01	WOS:000263193500003
J	Aron, D; Pogach, L				Aron, David; Pogach, Leonard			Transparency Standards for Diabetes Performance Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TARGETS		[Aron, David] Louis Stokes Cleveland VA Med Ctr, Educ Off 14W, Cleveland, OH 44106 USA; [Aron, David] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Pogach, Leonard] New Jersey Vet Hlth Adm Healthcare Syst, E Orange, NJ USA; [Pogach, Leonard] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; New Jersey Department of Health & Senior Services; US Department of Veterans Affairs; Veterans Health Administration (VHA); Rutgers State University New Brunswick; Rutgers State University Medical Center	Aron, D (corresponding author), Louis Stokes Cleveland VA Med Ctr, Educ Off 14W, 10701 E Blvd, Cleveland, OH 44106 USA.	david.aron@va.gov						*AG HEALTHC RES QU, ASS QUAL CAR DIAB; Baumann MH, 2007, CHEST, V132, P1015, DOI 10.1378/chest.07-1271; *BRIDG EXC, DIAB CAR LINK; *BURS, NAT DIAB CALL ACT BL; Coyne DW, 2007, CLIN J AM SOC NEPHRO, V2, P3, DOI 10.2215/CJN.02170606; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hayward RA, 2007, AM J MANAG CARE, V13, P126; *NAT COMM QUAL ASS, QUAL MATT; *NAT QUAL FOR, NAT VOL CONS STAND 2; National Committee for Quality Assurance, 2008, HEDIS, V2; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Rose Johnie, 2008, Qual Manag Health Care, V17, P27, DOI 10.1097/01.QMH.0000308635.59108.29; SMITH PC, 2008, HLTH POLICY, V41, P37; WORKING GROUP, 1998, REP WORK GROUP TRANS	15	19	19	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					210	212		10.1001/jama.2008.930	http://dx.doi.org/10.1001/jama.2008.930			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141769				2022-12-01	WOS:000262405500023
J	Hirsch, IB				Hirsch, Irl B.			Sliding Scale Insulin-Time to Stop Sliding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIABETES-MELLITUS; HOSPITALIZED-PATIENTS; GLYCEMIC CONTROL; MANAGEMENT; THERAPY; HYPERGLYCEMIA; INPATIENTS; OUTCOMES; GLUCOSE		[Hirsch, Irl B.] Univ Washington, Sch Med, Diabet Care Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hirsch, IB (corresponding author), UWMC Roosevelt, 4225 Roosevelt Way NE,Ste 101, Seattle, WA 98105 USA.	ihirsch@u.washington.edu						Becker T, 2007, DIABETES RES CLIN PR, V78, P392, DOI 10.1016/j.diabres.2007.05.003; Bolli Geremia B, 2003, Pediatr Endocrinol Rev, V1, P9; Braithwaite SS, 2008, CURR OPIN ENDOCRINOL, V15, P159, DOI 10.1097/MED.0b013e3282f827e7; Browning LA, 2004, AM J HEALTH-SYST PH, V61, P1611, DOI 10.1093/ajhp/61.15.1611; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254; FORMAN BH, 1974, PEDIATRICS, V53, P257; Joslin EP, 1934, DIABETIC MANUAL MUTU, P108; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Mooradian AD, 2006, ANN INTERN MED, V145, P125, DOI 10.7326/0003-4819-145-2-200607180-00010; Queale WS, 1997, ARCH INTERN MED, V157, P545, DOI 10.1001/archinte.157.5.545; ROBBINS L, 1963, Med Rec Ann, V56, P201; Trence DL, 2003, J CLIN ENDOCR METAB, V88, P2430, DOI 10.1210/jc.2003-030347; Umpierrez GE, 2007, DIABETES CARE, V30, P2181, DOI 10.2337/dc07-0295	15	77	83	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					213	214		10.1001/jama.2008.943	http://dx.doi.org/10.1001/jama.2008.943			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141770				2022-12-01	WOS:000262405500024
J	Chuang, JS; Rivoire, O; Leibler, S				Chuang, John S.; Rivoire, Olivier; Leibler, Stanislas			Simpson's Paradox in a Synthetic Microbial System	SCIENCE			English	Article							BACTERIAL-POPULATIONS; COOPERATION; COMMUNICATION; EVOLUTION; BEHAVIOR; COMPETITION	The maintenance of "public" or "common good" producers is a major question in the evolution of cooperation. Because nonproducers benefit from the shared resource without bearing its cost of production, they may proliferate faster than producers. We established a synthetic microbial system consisting of two Escherichia coli strains of common- good producers and nonproducers. Depending on the population structure, which was varied by forming groups with different initial compositions, an apparently paradoxical situation could be attained in which nonproducers grew faster within each group, yet producers increased overall. We show that a simple way to generate the variance required for this effect is through stochastic fluctuations via population bottlenecks. The synthetic approach described here thus provides a way to study generic mechanisms of natural selection.	[Chuang, John S.; Rivoire, Olivier; Leibler, Stanislas] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA; [Chuang, John S.; Rivoire, Olivier; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Chuang, JS (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10065 USA.	chuangj@rockefeller.edu			NIH fellowship; Human Frontier Science Program	NIH fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program)	We are grateful to C. Bargmann, C. Guet, L. Keller, E. Kussell, R. Losick, and A. Murray for comments on the manuscript and members of our laboratory for advice and discussion. We also thank the Yale Coli Genetic Stock Center and the National BioResource Project (NIG, Japan) for strains and the Rockefeller Flow Cytometry Resource Center for help. J.S.C. was partly supported by a NIH fellowship and O.R. by a Human Frontier Science Program fellowship.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; BICKEL PJ, 1975, SCIENCE, V187, P398, DOI 10.1126/science.187.4175.398; BLYTH CR, 1972, J AM STAT ASSOC, V67, P364, DOI 10.2307/2284382; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Brockhurst MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000634; Chin JW, 2006, NAT CHEM BIOL, V2, P304, DOI 10.1038/nchembio789; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dunny GM, 2008, BIOESSAYS, V30, P296, DOI 10.1002/bies.20740; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Frank SA., 1998, FDN SOCIAL EVOLUTION, DOI [10.1515/9780691206820, DOI 10.1515/9780691206820]; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Haldane JBS., 1932, CAUSES EVOLUTION; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1975, ASA STUDIES, V4, P133; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Keller L, 1999, LEVELS SELECTION EVO; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Sober E., 1998, OTHERS EVOLUTION PSY; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104	28	192	199	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					272	275		10.1126/science.1166739	http://dx.doi.org/10.1126/science.1166739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131632				2022-12-01	WOS:000262290600044
J	Sharma, J; Chhabra, R; Cheng, A; Brownell, J; Liu, Y; Yan, H				Sharma, Jaswinder; Chhabra, Rahul; Cheng, Anchi; Brownell, Jonathan; Liu, Yan; Yan, Hao			Control of Self-Assembly of DNA Tubules Through Integration of Gold Nanoparticles	SCIENCE			English	Article							CONDUCTIVE NANOWIRES; ARRAYS; NANOSTRUCTURES; TEMPLATES; NANOTUBES; SURFACE; CRYSTALLIZATION; ORGANIZATION; TILES	The assembly of nanoparticles into three- dimensional ( 3D) architectures could allow for greater control of the interactions between these particles or with molecules. DNA tubes are known to form through either self- association of multi- helix DNA bundle structures or closing up of 2D DNA tile lattices. By the attachment of single- stranded DNA to gold nanoparticles, nanotubes of various 3D architectures can form, ranging in shape from stacked rings to single spirals, double spirals, and nested spirals. The nanoparticles are active elements that control the preference for specific tube conformations through size- dependent steric repulsion effects. For example, we can control the tube assembly to favor stacked- ring structures using 10- nanometer gold nanoparticles. Electron tomography revealed a left- handed chirality in the spiral tubes, double- wall tube features, and conformational transitions between tubes.	[Sharma, Jaswinder; Chhabra, Rahul; Liu, Yan; Yan, Hao] Arizona State Univ, Ctr Single Mol Biophys, Biodesign Inst, Tempe, AZ 85287 USA; [Sharma, Jaswinder; Chhabra, Rahul; Liu, Yan; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Cheng, Anchi; Brownell, Jonathan] Scripps Res Inst, La Jolla, CA 92037 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Scripps Research Institute	Liu, Y (corresponding author), Arizona State Univ, Ctr Single Mol Biophys, Biodesign Inst, Tempe, AZ 85287 USA.	yan_liu@asu.edu; hao.yan@asu.edu	Liu, Yan/K-1999-2014	Liu, Yan/0000-0003-0906-2606	National Science Foundation (NSF); Army Research Office ( ARO); Air Force Office of Scientific Research; Office of Naval Research; NSF; Alfred P. Sloan Fellowship; NIH [P41 RR000592, P41 RR-01081]; Technology and Research Institute Funds funds from Arizona State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, P41RR001081, P41RR000592] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Army Research Office ( ARO); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Technology and Research Institute Funds funds from Arizona State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank for financial support the National Science Foundation (NSF) and Army Research Office (ARO) (to Y.L.), the Air Force Office of Scientific Research, Office of Naval Research, NSF, Alfred P. Sloan Fellowship, ARO, and NIH (to H.Y.), and Technology and Research Institute Funds funds from Arizona State University (to H.Y. and Y.L.). Some of the work presented here was conducted at the National Resource for Automated Molecular Microscopy, which is supported by NIH though the National Center for Research Resources' P41 program (RR17573). We thank C. Potter and B. Carragher for helpful discussion and technical advice on the electron tomography work. IMOD software (Boulder Laboratory for 3D Electron Microscopy of Cells, Boulder, CO) used for tomographic reconstruction is supported by NIH grant P41 RR000592. 3D graphic images were produced using the University of California, San Francisco ( UCSF) Chimera package from the Resource for Biocomputing, Visualization, and Informatics at UCSF ( supported by NIH grant P41 RR-01081). We thank M. Palmer for technical assistance. We acknowledge the use of the EM facility in the School of Life Sciences at Arizona State University. We thank C. Lin for assistance in schematic figure drawings and Y. Ke for assistance in creating movies from the tomography reconstructions. We thank C. Flores for help proofreading the manuscript.	Aldaye FA, 2006, ANGEW CHEM INT EDIT, V45, P2204, DOI 10.1002/anie.200502481; Aldaye FA, 2007, J AM CHEM SOC, V129, P4130, DOI 10.1021/ja070017i; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Deng Z., 2005, ANGEW CHEM, V117, P3648; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Fu AH, 2004, J AM CHEM SOC, V126, P10832, DOI 10.1021/ja046747x; Ke YG, 2006, J AM CHEM SOC, V128, P4414, DOI 10.1021/ja058145z; Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+; Lee JH, 2007, ANGEW CHEM INT EDIT, V46, P9006, DOI 10.1002/anie.200702569; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; Liu FR, 1999, J AM CHEM SOC, V121, P917, DOI 10.1021/ja982824a; Liu HP, 2006, ANGEW CHEM INT EDIT, V45, P1942, DOI 10.1002/anie.200504022; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Mitchell JC, 2004, J AM CHEM SOC, V126, P16342, DOI 10.1021/ja043890h; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SH, 2005, NANO LETT, V5, P693, DOI 10.1021/nl050108i; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; Sharma J, 2006, ANGEW CHEM INT EDIT, V45, P730, DOI 10.1002/anie.200503208; Sharma J, 2008, ANGEW CHEM INT EDIT, V47, P5157, DOI 10.1002/anie.200801485; Sharma J, 2008, J AM CHEM SOC, V130, P7820, DOI 10.1021/ja802853r; SIMON U, 2004, NANOPARTICLES THEORY, P328; Xu XY, 2006, J AM CHEM SOC, V128, P9286, DOI 10.1021/ja061980b; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Zhang JP, 2006, NANO LETT, V6, P248, DOI 10.1021/nl052210l; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	27	590	626	8	397	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					112	116		10.1126/science.1165831	http://dx.doi.org/10.1126/science.1165831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119229	Green Accepted			2022-12-01	WOS:000262104100052
J	Chu, G; Yang, W				Chu, Gilbert; Yang, Wei			Here Comes the Sun: Recognition of UV-Damaged DNA	CELL			English	Editorial Material							UBIQUITIN LIGASE; REPAIR; PROTEIN; LESION	The first step in the repair of DNA damage is lesion detection. In this issue, Scrima et al. (2008) report the structure of the complex of DNA Damage-Binding Protein 1 (DDB1) and DDB2 bound to a DNA photodimer, providing critical insight into the repair of DNA damage caused by ultraviolet light.	[Yang, Wei] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Chu, Gilbert] Stanford Univ, Med Ctr, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Chu, Gilbert] Stanford Univ, Med Ctr, Dept Biochem, Div Oncol, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Stanford University; Stanford University	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	wei.yang@nih.gov	Yang, Wei/ABB-4785-2020; Yang, Wei/D-4926-2011	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	Intramural NIH HHS [ZIA DK036146-08, ZIA DK075037-08] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155	9	12	12	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1172	1174		10.1016/j.cell.2008.12.015	http://dx.doi.org/10.1016/j.cell.2008.12.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109889	Green Accepted, Bronze			2022-12-01	WOS:000261989800009
J	Merkwirth, C; Langer, T				Merkwirth, Carsten; Langer, Thomas			Mitofusin 2 Builds a Bridge between ER and Mitochondria	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM; DISEASE; MUTATIONS; PROTECTS	Mutations in mitofusin 2 (MFN2), a dynamin-like GTPase required for mitochondrial fusion, cause the peripheral neuropathy Charcot-Marie-Tooth type 2A. In a recent report in Nature, de Brito and Scorrano (2008) demonstrate a new function of MFN2-tethering the endoplasmic reticulum and mitochondria to control the efficiency of mitochondrial uptake of Ca(2+) ions.	[Merkwirth, Carsten; Langer, Thomas] Univ Cologne, Inst Genet, Ctr Mol Med CMMC, D-50674 Cologne, Germany; [Merkwirth, Carsten; Langer, Thomas] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany	University of Cologne; University of Cologne	Langer, T (corresponding author), Univ Cologne, Inst Genet, Ctr Mol Med CMMC, D-50674 Cologne, Germany.	thomas.langer@uni-koeln.de	Merkwirth, Carsten/H-5992-2012	Merkwirth, Carsten/0000-0001-8895-3495; Langer, Thomas/0000-0003-1250-1462				Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zuchner S, 2006, NAT CLIN PRACT NEURO, V2, P45, DOI 10.1038/ncpneuro0071	10	92	96	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 26	2008	135	7					1165	1167		10.1016/j.cell.2008.12.005	http://dx.doi.org/10.1016/j.cell.2008.12.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109886	Bronze			2022-12-01	WOS:000261989800006
J	Pisareva, VP; Pisarev, AV; Komar, AA; Hellen, CUT; Pestova, TV				Pisareva, Vera P.; Pisarev, Andrey V.; Komar, Anton A.; Hellen, Christopher U. T.; Pestova, Tatyana V.			Translation Initiation on Mammalian mRNAs with Structured 5 ' UTRs Requires DExH-Box Protein DHX29	CELL			English	Article							INTERNAL RIBOSOMAL ENTRY; SACCHAROMYCES-CEREVISIAE; HEPATITIS-C; FACTOR EIF3; BINDING; SUBUNIT; CODON; HELICASES; ROLES; SITE	Eukaryotic protein synthesis begins with assembly of 48S initiation complexes at the initiation codon of mRNA, which requires at least seven initiation factors (eIFs). First, 43S preinitiation complexes comprising 40S ribosomal subunits, eIFs 3, 2, 1, and 1A, and tRNA(i)(Met) attach to the 5'-proximal region of mRNA and then scan along the 50 untranslated region (5'UTR) to the initiation codon. Attachment of 43S complexes is mediated by three other eIFs, 4F, 4A, and 4B, which cooperatively unwind the cap-proximal region of mRNA and later also assist 43S complexes during scanning. We now report that these seven eIFs are not sufficient for efficient 48S complex formation on mRNAs with highly structured 5'UTRs, and that this process requires the DExH-box protein DHX29. DHX29 binds 40S subunits and hydrolyzes ATP, GTP, UTP, and CTP. NTP hydrolysis by DHX29 is strongly stimulated by 43S complexes and is required for DHX29's activity in promoting 48S complex formation.	[Pisareva, Vera P.; Pisarev, Andrey V.; Hellen, Christopher U. T.; Pestova, Tatyana V.] Suny Downstate Med Ctr, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA; [Komar, Anton A.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University System of Ohio; Cleveland State University	Pestova, TV (corresponding author), Suny Downstate Med Ctr, Dept Microbiol & Immunol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	tatyana.pestova@downstate.edu		Komar, Anton/0000-0003-4188-0633	NIH [GM059660, AI051340]; HFSP [RPG0055/2006-C]; National American Heart Association [0730120N]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051340, R56AI051340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059660] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSP(Human Frontier Science Program); National American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Gauss for the NCF2 vector and A. Marintchev for helpful discussions. This work was supported by NIH grant GM059660 and HFSP grant RPG0055/2006-C to T.V.P., NIH grant AI051340 to C.U.T.H., and National American Heart Association grant 0730120N to A.A.K.	Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; De Breyne S, 2008, RNA, V14, P367, DOI 10.1261/rna.696508; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; JACKSON RJ, 1991, EUR J BIOCHEM, V200, P285, DOI 10.1111/j.1432-1033.1991.tb16184.x; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; KAMINSKI A, 1990, EMBO J, V9, P3753, DOI 10.1002/j.1460-2075.1990.tb07588.x; Kolupaeva VG, 2005, RNA, V11, P470, DOI 10.1261/rna.7215305; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lee CG, 1997, EMBO J, V16, P2671, DOI 10.1093/emboj/16.10.2671; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Marsden S, 2006, J MOL BIOL, V361, P327, DOI 10.1016/j.jmb.2006.06.016; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova T. V., 2007, TRANSLATIONAL CONTRO, P87; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Svitkin YV, 2001, RNA, V7, P1743; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6	37	166	168	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1237	1250		10.1016/j.cell.2008.10.037	http://dx.doi.org/10.1016/j.cell.2008.10.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109895	Green Accepted, Bronze			2022-12-01	WOS:000261989800015
J	Preker, P; Nielsen, J; Kammler, S; Lykke-Andersen, S; Christensen, MS; Mapendano, CK; Schierup, MH; Jensen, TH				Preker, Pascal; Nielsen, Jesper; Kammler, Susanne; Lykke-Andersen, Soren; Christensen, Marianne S.; Mapendano, Christophe K.; Schierup, Mikkel H.; Jensen, Torben Heick			RNA Exosome Depletion Reveals Transcription Upstream of Active Human Promoters	SCIENCE			English	Article							HUMAN GENOME; DNA DEMETHYLATION; POLYMERASE; CHROMATIN; HISTORY; ENCODE; WIDE	Studies have shown that the bulk of eukaryotic genomes is transcribed. Transcriptome maps are frequently updated, but low- abundant transcripts have probably gone unnoticed. To eliminate RNA degradation, we depleted the exonucleolytic RNA exosome from human cells and then subjected the RNA to tiling microarray analysis. This revealed a class of short, polyadenylated and highly unstable RNAs. These promoter upstream transcripts ( PROMPTs) are produced similar to 0.5 to 2.5 kilobases upstream of active transcription start sites. PROMPT transcription occurs in both sense and antisense directions with respect to the downstream gene. In addition, it requires the presence of the gene promoter and is positively correlated with gene activity. We propose that PROMPT transcription is a common characteristic of RNA polymerase II ( RNAPII) transcribed genes with a possible regulatory potential.	[Preker, Pascal; Kammler, Susanne; Lykke-Andersen, Soren; Christensen, Marianne S.; Mapendano, Christophe K.; Jensen, Torben Heick] Univ Aarhus, Ctr mRNP Biogenesis & Metab, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Nielsen, Jesper; Schierup, Mikkel H.] Univ Aarhus, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Jensen, TH (corresponding author), Univ Aarhus, Ctr mRNP Biogenesis & Metab, Dept Mol Biol, CF Mollers Alle,Bldg 1130, DK-8000 Aarhus C, Denmark.	thj@mb.au.dk	Lykke-Andersen, Søren/B-1553-2013; Jensen, Torben H/G-2954-2017; Schierup, Mikkel H/F-1675-2010; Schierup, Mikkel Heide/AAM-4997-2020	Schierup, Mikkel H/0000-0002-5028-1790; Schierup, Mikkel Heide/0000-0002-5028-1790; Lykke-Andersen, Soren/0000-0001-9357-2910; Jensen, Torben Heick/0000-0001-5127-1239	Danish National Research Foundation; Danish Natural Science Research Council	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Natural Science Research Council(Danish Natural Science Research Council)	We thank G. Pruijn for antibodies, D. Libri, A. Sandelin, and D. Schubeler for comments on the manuscript, and D. Riishoj and K. Jorgensen for technical assistance. This work was supported by the Danish National Research Foundation and the Danish Natural Science Research Council. Microarray data have been submitted to gene expression omnibus (GEO) at the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/) under accession number GSE12431.	Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Sandelin A, 2007, NAT REV GENET, V8, P424, DOI 10.1038/nrg2026; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	13	541	565	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1851	1854		10.1126/science.1164096	http://dx.doi.org/10.1126/science.1164096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056938				2022-12-01	WOS:000261799400057
J	Lieske, B				Lieske, B.			The left handed surgical trainee	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lieske, B.] Royal Berkshire Hosp NHS Fdn Trust, Reading RG1 5AN, Berks, England	Royal Berkshire Hospital	Lieske, B (corresponding author), Royal Berkshire Hosp NHS Fdn Trust, Reading RG1 5AN, Berks, England.	Bettina_Lieske@yahoo.co.uk						Adusumilli Prasad S, 2004, Curr Surg, V61, P587, DOI 10.1016/j.cursur.2004.05.022; McManus C, 2003, RIGHT HAND LEFT HAND; SCHOTT J, 1995, BRIT MED J, V310, P739, DOI 10.1136/bmj.310.6981.739b	3	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 16	2008	337								a2883	10.1136/bmj.a2883	http://dx.doi.org/10.1136/bmj.a2883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SV	19088142				2022-12-01	WOS:000262184900005
J	Bache, S; Edenborough, F				Bache, Sarah; Edenborough, Frank			A symphony of maladies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WIND INSTRUMENT PLAYERS; EMBOUCHURE DYSTONIA; MUSICIANS DYSTONIA; BRASS MUSICIANS; FOCAL DYSTONIA; PREVALENCE; HAND; DERMATITIS; FLAUTISTS; PRESSURE		[Bache, Sarah; Edenborough, Frank] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital	Bache, S (corresponding author), No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England.	sarahbache@doctors.org.uk						Aydin P, 2000, J GLAUCOMA, V9, P322; Bejjani FJ, 1996, ARCH PHYS MED REHAB, V77, P406, DOI 10.1016/S0003-9993(96)90093-3; BRAMLEY S, 2004, STAGE NEWS      0601; Byl NN, 2003, ARCH PHYS MED REHAB, V84, P1505, DOI 10.1016/S0003-9993(03)00276-4; Chesky KS, 2000, J OCCUP ENVIRON MED, V42, P775, DOI 10.1097/00043764-200008000-00001; COUGHLAN S, 2007, BBC NEWS        0515; CURTIS P, 1974, BRIT MED J, V2, P226, DOI 10.1136/bmj.2.5912.226-a; DAHL MGC, 1978, BRIT MED J, V2, P1023, DOI 10.1136/bmj.2.6143.1023; David S, 1997, AM J EMERG MED, V15, P73, DOI 10.1016/S0735-6757(97)90054-1; Dawson WJ, 1997, MED PROBL PERFORM AR, V12, P107; Deniz O, 2006, ARCH MED RES, V37, P506, DOI 10.1016/j.arcmed.2005.09.015; Elghozi JL, 2008, CLIN AUTON RES, V18, P96, DOI 10.1007/s10286-008-0462-3; Evers S, 2000, NEUROLOGY, V55, P865, DOI 10.1212/WNL.55.6.865; EVERS S, 1998, NEUROLOGY, V104, P1203; Fetter D, 1993, Md Med J, V42, P289; Foxman Irina, 2006, AAOHN J, V54, P309; Frucht SJ, 2001, MOVEMENT DISORD, V16, P899, DOI 10.1002/mds.1167; Fry HJH, 1998, NEUROLOGY, V51, P512, DOI 10.1212/WNL.51.2.512; Gambichler T, 2008, CONTACT DERMATITIS, V58, P217, DOI 10.1111/j.1600-0536.2007.01310.x; Gambichler Thilo, 2004, BMC Dermatol, V4, P3, DOI 10.1186/1471-5945-4-3; Gilbert T B, 1998, Md Med J, V47, P23; HANSFORD R, 2007, BMJ CAREERS, V335, P159; Hirata Y, 2004, NEUROREPORT, V15, P815, DOI 10.1097/00001756-200404090-00015; Inesta C., 2008, J OCCUP MED TOXICOL, V3, P16, DOI [10.1186/1745-6673-3-16, DOI 10.1186/1745-6673-3-16]; Inoue A, 1998, CONTACT DERMATITIS, V39, P37, DOI 10.1111/j.1600-0536.1998.tb05816.x; Isaacson G, 2000, Ear Nose Throat J, V79, P272; Jabusch HC, 2005, MOVEMENT DISORD, V20, P1623, DOI 10.1002/mds.20631; Jabusch HC, 2006, ADV COGN PSYCHOL, P207, DOI DOI 10.2478/V10053-008-0056-6; Klotz DA, 2001, LARYNGOSCOPE, V111, P2157, DOI 10.1097/00005537-200112000-00015; Koppejan S, 2006, ERGONOMICS, V49, P316, DOI 10.1080/00140130500436213; Kumar G, 1998, BRIT J RADIOL, V71, P799, DOI 10.1259/bjr.71.847.9771394; Liu S, 2002, SOUTH MED J, V95, P727; Lombardi C, 2003, Eur Ann Allergy Clin Immunol, V35, P52; Lozano FJR, 2008, MED PROBL PERFORM AR, V23, P12; LUCIA R, 1994, J ASTHMA, V31, P375, DOI 10.3109/02770909409061317; Malick D, 2007, CLEFT PALATE-CRAN J, V44, P424, DOI 10.1597/06-176.1; MANDELL HN, 1962, NEW ENGL J MED, V266, P348, DOI 10.1056/NEJM196202152660708; MARSHMAN G, 1992, CONTACT DERMATITIS, V26, P134, DOI 10.1111/j.1600-0536.1992.tb00902.x; MENCIMER S, 2003, WASHINGTON POST 0325; Morais D, 2007, ACTA OTORRINOLAR ESP, V58, P401, DOI 10.1016/S0001-6519(07)74956-7; Moreno J C, 1997, Am J Contact Dermat, V8, P39, DOI 10.1016/S1046-199X(97)90035-X; MULCAHY D, 1990, BRIT HEART J, V64, P388; Murphy J, 1999, CONTACT DERMATITIS, V40, P334, DOI 10.1111/j.1600-0536.1999.tb06092.x; MURPHY JM, 1974, BMJ-BRIT MED J, V2, P335, DOI 10.1136/bmj.2.5914.335-a; Nakamura M, 1999, CONTACT DERMATITIS, V40, P219, DOI 10.1111/j.1600-0536.1999.tb06044.x; NIZET PM, 1976, J ELECTROCARDIOL, V9, P51, DOI 10.1016/S0022-0736(76)80010-6; Papsin BC, 1996, LARYNGOSCOPE, V106, P757, DOI 10.1097/00005537-199606000-00017; PETERS C, NOISE HEARING LOSS M; Rosenkranz K, 2005, BRAIN, V128, P918, DOI 10.1093/brain/awh402; Sakai N, 2002, MED PROBL PERFORM AR, V17, P178; SCHAFERCRANE G, 2006, PHYS MED REH CLIN N, V17, P827; Schuele S, 2005, NEUROLOGY, V64, P341, DOI 10.1212/01.WNL.0000149768.36634.92; Schuele S, 2004, MOVEMENT DISORD, V19, P43, DOI 10.1002/mds.10647; Schuman JS, 2001, OPHTHALMOLOGY, V108, P635, DOI 10.1016/S0161-6420(00)00559-5; SHARIPO P, 1991, J AM ACAD DERMATOL, V24, P665; SOLOMON JW, 2007, GUITAR REV, V133, P2; Stasney CR, 2003, MED PROBL PERFORM AR, V18, P153; Sternbach D, 1993, Md Med J, V42, P283; TADDEY JJ, 1992, CRANIO, V10, P241, DOI 10.1080/08869634.1992.11677916; Thayer JF, 2000, BIOMED SCI INSTRUM, V395, P301; Yeo DKL, 2002, AUST DENT J, V47, P2, DOI 10.1111/j.1834-7819.2002.tb00296.x; 1990, ART HAZARDS NEWS, V13	62	6	6	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2008	337								a2646	10.1136/bmj.a2646	http://dx.doi.org/10.1136/bmj.a2646			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CC	19074561				2022-12-01	WOS:000262777000001
J	von Braun, J				von Braun, Joachim			The food crisis isn't over	NATURE			English	Editorial Material									Int Food Policy Res Inst, Washington, DC 20036 USA	CGIAR; International Food Policy Research Institute (IFPRI)	von Braun, J (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.	j.vonbraun@cgiar.org	von Braun, Joachim/AAA-7044-2020	von Braun, Joachim/0000-0001-6571-4838				BEINTEMA NM, 2008, MEASURING AGR RES IN; Fan SG, 2008, AGR ECON-BLACKWELL, V39, P163, DOI 10.1111/j.1574-0862.2008.00328.x; *FAO, 2008, HUNG RIS SOAR PRIC A; von Braun J., 2008, FOOD FINANCIAL CRISE; VONBRAUN J, 2008, 4 IFPRI; *WORLD BANK, 2007, WORLD DEV REP 2008 A	6	44	45	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					701	701		10.1038/456701a	http://dx.doi.org/10.1038/456701a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	381TX	19079033	Bronze			2022-12-01	WOS:000261559900019
J	Hartl, TA; Smith, HF; Bosco, G				Hartl, Tom A.; Smith, Helen F.; Bosco, Giovanni			Chromosome Alignment and Transvection Are Antagonized by Condensin II	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; BITHORAX-COMPLEX; TRANS; GENE; EXPRESSION; PROTEINS; CIS	Polytene chromosome structure is a characteristic of some polyploid cells where several to thousands of chromatids are closely associated with perfect alignment of homologous DNA sequences. Here, we show that Drosophila condensin II promotes disassembly of polytene structure into chromosomal components. Condensin II also negatively regulates transvection, a process whereby certain alleles are influenced transcriptionally via interallelic physical associations. We propose that condensin II restricts trans- chromosomal interactions that affect transcription through its ability to spatially separate aligned interphase chromosomes.	[Hartl, Tom A.; Smith, Helen F.; Bosco, Giovanni] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Bosco, G (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, 1007 E Lowell St, Tucson, AZ 85721 USA.	gbosco@email.arizona.edu		Bosco, Giovanni/0000-0002-8889-9895	NIH [GM069462]; University of Arizona NSF- IGERT ( Integrative Graduate Education and Research Traineeships) Program in Genomics; Graduate Training in Biochemistry and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069462] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arizona NSF- IGERT ( Integrative Graduate Education and Research Traineeships) Program in Genomics(National Science Foundation (NSF)); Graduate Training in Biochemistry and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge T. Orr-Weaver for supporting the initial screen. We are grateful to the following individuals: C. Boswell ( microscopy), V. Lien ( UAS- Cap- H2- mCherry transgenics), M. Hart ( mitotic index), P. Jansma ( fly imaging), and J. Blumenstiel ( FISH). We thank S. Hawley, T. Orr- Weaver, M. Lilly, E. Kelleher, and the JMST student forum for critical reading of the manuscript and, especially, C.- T. Wu for exceptional guidance with transvection studies. We are grateful to J. Sedat, J. Vazquez, C. Zuker, P. O'Farrell, and C.- T. Wu for fly stocks. Support was from NIH (GM069462) grant to G. B., and T. H. was funded by the University of Arizona NSF- IGERT ( Integrative Graduate Education and Research Traineeships) Program in Genomics and NIH Grant for Graduate Training in Biochemistry and Molecular Biology.	Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; CABRERA CV, 1985, NATURE, V318, P569, DOI 10.1038/318569a0; CASTELLIGAIR JE, 1990, GENETICS, V126, P177; Dej KJ, 1999, DEVELOPMENT, V126, P293; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Gemkow MJ, 1998, DEVELOPMENT, V125, P4541; GEYER PK, 1990, EMBO J, V9, P2247, DOI 10.1002/j.1460-2075.1990.tb07395.x; Golic MM, 1996, GENETICS, V143, P385; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; LEWIS EB, 1955, AM NAT, V89, P73, DOI 10.1086/281867; Morris JR, 1998, P NATL ACAD SCI USA, V95, P10740, DOI 10.1073/pnas.95.18.10740; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Savarese F, 2006, CELL, V126, P248, DOI 10.1016/j.cell.2006.07.008; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Vazquez J, 2006, MOL BIOL CELL, V17, P2158, DOI 10.1091/mbc.E06-01-0049; WHITE RAH, 1985, NATURE, V318, P567, DOI 10.1038/318567a0; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032	20	94	96	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1384	1387		10.1126/science.1164216	http://dx.doi.org/10.1126/science.1164216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039137				2022-12-01	WOS:000261170600040
J	Murase, K; Hirano, Y; Sun, TP; Hakoshima, T				Murase, Kohji; Hirano, Yoshinori; Sun, Tai-ping; Hakoshima, Toshio			Gibberellin-induced DELLA recognition by the gibberellin receptor GID1	NATURE			English	Article							BOX PROTEIN TIR1; F-BOX; ARABIDOPSIS-THALIANA; FLORAL DEVELOPMENT; SIGNALING PATHWAY; SEED-GERMINATION; GENE ENCODES; EXPRESSION; REPRESSOR; TARGETS	Gibberellins control a range of growth and developmental processes in higher plants and have been widely used in the agricultural industry. By binding to a nuclear receptor, GIBBERELLIN INSENSITIVE DWARF1 (GID1), gibberellins regulate gene expression by promoting degradation of the transcriptional regulator DELLA proteins, including GIBBERELLIN INSENSITIVE ( GAI). The precise manner in which GID1 discriminates and becomes activated by bioactive gibberellins for specific binding to DELLA proteins remains unclear. Here we present the crystal structure of a ternary complex of Arabidopsis thaliana GID1A, a bioactive gibberellin and the amino- terminal DELLA domain of GAI. In this complex, GID1A occludes gibberellin in a deep binding pocket covered by its N- terminal helical switch region, which in turn interacts with the DELLA domain containing DELLA, VHYNP and LExLE motifs. Our results establish a structural model of a plant hormone receptor that is distinct from the mechanism of the hormone perception and effector recognition of the known auxin receptors.	[Murase, Kohji; Hirano, Yoshinori; Hakoshima, Toshio] Nara Inst Sci & Technol, Struct Biol Lab, Nara 6300192, Japan; [Sun, Tai-ping] Duke Univ, Dept Biol, Durham, NC 27708 USA	Nara Institute of Science & Technology; Duke University	Hakoshima, T (corresponding author), Nara Inst Sci & Technol, Struct Biol Lab, 8916-5 Takayama, Nara 6300192, Japan.	hakosima@bs.naist.jp	Hirano, Yoshinori/ABC-6876-2020	Hirano, Yoshinori/0000-0001-9888-1616	Mitsubishi Foundation, Japan; Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; National Science Foundation of the United States [IBN-0348814]; Young Scientists from the Japan Society for the Promotion of Science; Global COE Program in NAIST; MEXT of Japan.	Mitsubishi Foundation, Japan; Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Science Foundation of the United States(National Science Foundation (NSF)); Young Scientists from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program in NAIST(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank S. Terawaki and T. Mori for technical advice and J. Tsukamoto for technical support in performing the matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy analysis, and the beamline staff of BL41XU of SPring-8 at Harima for help with the data collection. We also acknowledge A. Isogai for advice and encouragement. This work was supported by a research grant in the natural sciences from the Mitsubishi Foundation, Japan ( to T.H.), and in part by a Grant-in-Aid for Scientific Research (A) and Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to T. H.). This work was also supported in part by grants from the National Science Foundation of the United States (IBN-0348814 to T.-p.S.). K.M. is a recipient of a postdoctoral fellowship for Young Scientists from the Japan Society for the Promotion of Science and an international research fellowship from the Global COE Program in NAIST (Frontier Biosciences: strategies for survival and adaptation in a changing global environment) from MEXT of Japan.	ALBERTS B, 2008, MOL BIOL CELL, P395; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DERKX MPM, 1994, PLANT GROWTH REGUL, V15, P223, DOI 10.1007/BF00029895; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Dill A, 2001, GENETICS, V159, P777; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu XD, 2004, PLANT CELL, V16, P1406, DOI 10.1105/tpc.021386; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; HAKOSHIMA T, 2003, NATURE ENCY HUMAN GE, V3, P679; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Ileperuma NR, 2007, BIOCHEMISTRY-US, V46, P1851, DOI 10.1021/bi062046w; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Iuchi S, 2007, PLANT J, V50, P958, DOI 10.1111/j.1365-313X.2007.03098.x; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; King KE, 2001, GENETICS, V159, P767; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; MacMillan J, 2001, J PLANT GROWTH REGUL, V20, P387, DOI 10.1007/s003440010038; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; RADLEY M, 1956, NATURE, V178, P1070, DOI 10.1038/1781070a0; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Silverstone AL, 2001, PLANT CELL, V13, P1555, DOI 10.1105/tpc.13.7.1555; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; TALON M, 1990, P NATL ACAD SCI USA, V87, P7983, DOI 10.1073/pnas.87.20.7983; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Varbanova M, 2007, PLANT CELL, V19, P32, DOI 10.1105/tpc.106.044602; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Yabuta T., 1938, J AGR CHEM SOC JAPAN, V14, P1526, DOI DOI 10.1271/NOGEIKAGAKU1924.14.12_1526; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999	49	449	510	12	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					459	U15		10.1038/nature07519	http://dx.doi.org/10.1038/nature07519			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037309				2022-12-01	WOS:000261170500029
J	Wei, CL; Wang, XH; Chen, M; Ouyang, K; Song, LS; Cheng, HP				Wei, Chaoliang; Wang, Xianhua; Chen, Min; Ouyang, Kunfu; Song, Long-Sheng; Cheng, Heping			Calcium flickers steer cell migration	NATURE			English	Article							CATION CHANNELS; CHEMOTAXIS; ACTIVATION; DICTYOSTELIUM; TRANSIENT; MOVEMENT; SIGNALS; BACK; LOOP; RAC	Directional movement is a property common to all cell types during development and is critical to tissue remodelling and regeneration after damage(1-3). In migrating cells, calcium has a multifunctional role in directional sensing, cytoskeleton redistribution, traction force generation, and relocation of focal adhesions(1,4) (-7). Here we visualize high- calcium microdomains ('calcium flickers') and their patterned activation in migrating human embryonic lung fibroblasts. Calcium flicker activity is dually coupled to membrane tension ( by means of TRPM7, a stretch-activated Ca2(+)permeant channel of the transient receptor potential superfamily(8)) and chemoattractant signal transduction ( by means of type 2 inositol-1,4,5-trisphosphate-receptors). Interestingly, calcium flickers are most active at the leading lamella of migrating cells, displaying a 4: 1 front- to- rear polarization opposite to the global calcium gradient(6). When exposed to a platelet- derived growth factor gradient perpendicular to cell movement, asymmetric calcium flicker activity develops across the lamella and promotes the turning of migrating fibroblasts. These findings show how the exquisite spatiotemporal organization of calcium microdomains can orchestrate complex cellular processes such as cell migration.	[Wei, Chaoliang; Wang, Xianhua; Chen, Min; Ouyang, Kunfu; Cheng, Heping] Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Song, Long-Sheng] Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Internal Med, Iowa City, IA 52242 USA	Peking University; University of Iowa	Cheng, HP (corresponding author), Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.	chaoliang.wei@gmail.com; chengp@pku.edu.cn	Wei, Chaoliang/A-9008-2013; Heping, Cheng/AAE-2680-2019; Song, Long-Sheng/D-5899-2012	Heping, Cheng/0000-0002-9604-6702; ouyang, kunfu/0000-0003-0292-375X; Song, Long-Sheng/0000-0002-6035-8106	Major State Basic Research Development Program of China [2007CB512100]; National Natural Science Foundation of China [30630021, 30800371]; NIH [HL090905]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090905] Funding Source: NIH RePORTER	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank I. C. Bruce, X. Zhu, J. J. Ma, H. Q. Cao, J. Liu, M. Zheng, X. D. Fu and R. P. Xiao for discussions, andM. Gorospe, Z. C. Liang, Q. Du, C. M. Cao, H. Huang, X. M. Lan, N. Lin, Y. R. Wang, R. S. Song and Y. Zhang for technical support. Special thanks to X. D. Fu for making his laboratory facility available to us. This work was supported by the Major State Basic Research Development Program of China (2007CB512100), and the National Natural Science Foundation of China (30630021 and 30800371) and an NIH grant (HL090905).	BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; HAHN K, 1992, NATURE, V359, P736, DOI 10.1038/359736a0; Hamill OP, 1996, PHARMACOL REV, V48, P231; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Numata T, 2007, AM J PHYSIOL-CELL PH, V292, pC460, DOI 10.1152/ajpcell.00367.2006; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Pettit EJ, 1998, PHYSIOL REV, V78, P949, DOI 10.1152/physrev.1998.78.4.949; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; Thomas GH, 2000, TRENDS MICROBIOL, V8, P15, DOI 10.1016/S0966-842X(99)01668-6; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Ware MF, 1998, J CELL SCI, V111, P2423; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Zou H, 2002, P NATL ACAD SCI USA, V99, P6404, DOI 10.1073/pnas.092654999	30	433	443	0	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					901	905		10.1038/nature07577	http://dx.doi.org/10.1038/nature07577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19118385	Green Accepted			2022-12-01	WOS:000263266700049
J	Kuhl, G; Briggs, DEG; Rust, J				Kuehl, Gabriele; Briggs, Derek E. G.; Rust, Jes			A Great-Appendage Arthropod with a Radial Mouth from the Lower Devonian Hunsruck Slate, Germany	SCIENCE			English	Article							BURGESS-SHALE; ANOMALOCARIS; PHYLOGENY; EVOLUTION; HEAD; MORPHOLOGY; HOMOLOGY; ORIGIN	Great- appendage arthropods, characterized by a highly modified anterior limb, were previously unknown after the Middle Cambrian. One fossil from the Lower Devonian Hunsruck Slate, Germany, extends the stratigraphic range of these arthropods by similar to 100 million years. Schinderhannes bartelsi shows an unusual combination of anomalocaridid and euarthropod characters, including a highly specialized swimming appendage. A cladistic analysis indicates that the new taxon is basal to crown- group euarthropods and that the great- appendage arthropods are paraphyletic. This new fossil shows that features of the anomalocaridids, including the multisegmented raptorial appendage and circular plated mouth, persisted long after the initial radiation of the euarthropods.	[Kuehl, Gabriele; Rust, Jes] Univ Bonn, Div Palaeontol, Steinmann Inst, D-53115 Bonn, Germany; [Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Briggs, Derek E. G.] Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA	University of Bonn; Yale University; Yale University	Kuhl, G (corresponding author), Univ Bonn, Div Palaeontol, Steinmann Inst, Nussallee 8, D-53115 Bonn, Germany.				German Science Foundation [PN RU 665/5-1]; Humboldt Foundation	German Science Foundation(German Research Foundation (DFG)); Humboldt Foundation(Alexander von Humboldt Foundation)	We thank the German Science Foundation (grant PN RU 665/5-1) and the Humboldt Foundation (Research Award to D.E.G.B.) for support; the Museum of Natural History in Mainz for access to the material; C. Bartels for information; G. Oleschinski for radiographs and photography; E. Groning for the reconstruction; and A. Maas, R. Willmann, G. D. Edgecombe, and two other reviewers for comments.	[Anonymous], 2002, METALLA; BARTELS C, 1998, FOSSILS HONSRUCK SLA; Bitsch J, 2007, ACTA ZOOL-STOCKHOLM, V88, P317, DOI 10.1111/j.1463-6395.2007.00284.x; BRIGGS DEG, 1979, PALAEONTOLOGY, V22, P77; Budd G.E., 1998, ARTHROPOD RELATIONSH, V55, P125; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; BUTTERFIELD NJ, 1995, LETHAIA, V28, P1, DOI 10.1111/j.1502-3931.1995.tb01587.x; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; Cotton TJ, 2004, T ROY SOC EDIN-EARTH, V94, P169, DOI 10.1017/S0263593300000596; Dunlop JA, 2006, ACTA ZOOLOGICA BUL S, P9; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Jager M, 2006, NATURE, V441, P506, DOI 10.1038/nature04591; Kuhl G, 2008, PALAEONTOGR ABT A, V286, P123; Maas A, 2004, PROG NAT SCI-MATER, V14, P158, DOI 10.1080/10020070412331343301; Maxmen A, 2005, NATURE, V437, P1144, DOI 10.1038/nature03984; Scholtz G, 2005, CRUSTACEAN ISS, V16, P139, DOI 10.1201/9781420037548.ch6; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Siveter DJ, 2007, P ROY SOC B-BIOL SCI, V274, P2223, DOI 10.1098/rspb.2007.0712; VAN ROY P., 2006, THESIS U GHENT GHENT; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Waloszek D, 2007, PALAEOGEOGR PALAEOCL, V254, P273, DOI 10.1016/j.palaeo.2007.03.027; Whittington H.B., 1971, Bull geol Surv Can, VNo. 209, P1; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096	26	84	89	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					771	773		10.1126/science.1166586	http://dx.doi.org/10.1126/science.1166586			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197061				2022-12-01	WOS:000263066800043
J	Das, M; Sabio, G; Jiang, F; Rincon, M; Flavell, RA; Davis, RJ				Das, Madhumita; Sabio, Guadalupe; Jiang, Feng; Rincon, Mercedes; Flavell, Richard A.; Davis, Roger J.			Induction of Hepatitis by JNK-Mediated Expression of TNF-alpha	CELL			English	Article							TUMOR-NECROSIS-FACTOR; A-INDUCED HEPATITIS; SIGNAL-TRANSDUCTION PATHWAY; NECROTIC CELL-DEATH; CONCANAVALIN-A; IN-VIVO; LIVER-INJURY; INDUCED APOPTOSIS; INDUCED ACTIVATION; CRUCIAL ROLE	The c-Jun NH2-terminal kinase (JNK) signaling pathway has been implicated in the development of tumor necrosis factor (TNF)-dependent hepatitis. JNK may play a critical role in hepatocytes during TNF-stimulated cell death in vivo. To test this hypothesis, we examined the phenotype of mice with compound disruption of the Jnk1 and Jnk2 genes. Mice with loss of JNK1/2 expression in hepatocytes exhibited no defects in the development of hepatitis compared with control mice, whereas mice with loss of JNK1/2 in the hematopoietic compartment exhibited a profound defect in hepatitis that was associated with markedly reduced expression of TNF-alpha. These data indicate that JNK is required for TNF-alpha expression but not for TNF-alpha-stimulated death of hepatocytes. Indeed, TNF-alpha induced similar hepatic damage in both mice with hepatocyte-specific JNK1/2 deficiency and control mice. These observations confirm a role for JNK in the development of hepatitis but identify hematopoietic cells as the site of the essential function of JNK.	[Das, Madhumita; Sabio, Guadalupe; Jiang, Feng; Davis, Roger J.] Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA; [Sabio, Guadalupe; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Rincon, Mercedes] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Vermont; Howard Hughes Medical Institute; Yale University; Yale University	Davis, RJ (corresponding author), Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA.	roger.davis@umassmed.edu	Sabio, Guadalupe/H-9733-2015	Sabio, Guadalupe/0000-0002-2822-0625	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA065861-14, R01 CA065861] Funding Source: Medline; NIAID NIH HHS [R01 AI051454] Funding Source: Medline; NIDDK NIH HHS [P30 DK 32520, P30 DK032520-26, P30 DK032520] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dietrich N, 2004, CELL DEATH DIFFER, V11, P301, DOI 10.1038/sj.cdd.4401353; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong ZJ, 2007, CELL MOL IMMUNOL, V4, P241; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; EISSNER G, 1995, BLOOD, V86, P4184, DOI 10.1182/blood.V86.11.4184.bloodjournal86114184; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hatada S, 2005, CELL IMMUNOL, V233, P23, DOI 10.1016/j.cellimm.2005.03.003; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kusters S, 1997, EUR J IMMUNOL, V27, P2870, DOI 10.1002/eji.1830271119; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liedtke C, 2002, HEPATOLOGY, V36, P315, DOI 10.1053/jhep.2002.34615; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Louis H, 2002, GASTROENTEROLOGY, V122, P2001, DOI 10.1053/gast.2002.33620; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Morita A, 2003, HEPATOL RES, V27, P143, DOI 10.1016/S1386-6346(03)00206-7; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Reuther-Madrid JY, 2002, MOL CELL BIOL, V22, P8175, DOI 10.1128/MCB.22.23.8175-8183.2002; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tagawa Y, 1998, EUR J IMMUNOL, V28, P4105, DOI 10.1002/(SICI)1521-4141(199812)28:12<4105::AID-IMMU4105>3.3.CO;2-#; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023	69	109	111	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					249	260		10.1016/j.cell.2008.11.017	http://dx.doi.org/10.1016/j.cell.2008.11.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167327	Bronze, Green Accepted			2022-12-01	WOS:000262648800014
J	Reddy, KC; Andersen, EC; Kruglyak, L; Kim, DH				Reddy, Kirthi C.; Andersen, Erik C.; Kruglyak, Leonid; Kim, Dennis H.			A Polymorphism in npr-1 Is a Behavioral Determinant of Pathogen Susceptibility in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; INNATE IMMUNITY; NEURONS; EXPERIENCE; HOMOLOG; PATHWAY; OXYGEN	The nematode Caenorhabditis elegans responds to pathogenic bacteria with conserved innate immune responses and pathogen avoidance behaviors. We investigated natural variation in C. elegans resistance to pathogen infection. With the use of quantitative genetic analysis, we determined that the pathogen susceptibility difference between the laboratory wild-type strain N2 and the wild isolate CB4856 is caused by a polymorphism in the npr-1 gene, which encodes a homolog of the mammalian neuropeptide Y receptor. We show that the mechanism of NPR-1-mediated pathogen resistance is through oxygen-dependent behavioral avoidance rather than direct regulation of innate immunity. For C. elegans, bacteria represent food but also a potential source of infection. Our data underscore the importance of behavioral responses to oxygen levels in finding an optimal balance between these potentially conflicting cues.	[Andersen, Erik C.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Andersen, Erik C.; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Reddy, Kirthi C.; Kim, Dennis H.] MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; Massachusetts Institute of Technology (MIT)	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu; dhkim@mit.edu		Andersen, Erik/0000-0003-0229-9651	NIH [GM084477, HG004321, GM071508]; Burroughs Wellcome Fund; Jane Coffin Childs Fund for Medical Research; James S. McDonnell Foundation; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM084477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Jane Coffin Childs Fund for Medical Research; James S. McDonnell Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center, C. Bargmann, M. de Bono, and D. Omura for strains; S. Skrovanek for technical assistance; L. Dietrich for facilitating the oxygen assay; E. Alvarez-Saavedra, J. Shapiro, and members of our laboratories for advice; and C. Bargmann for comments on the manuscript. This work was supported by grants from NIH (GM084477 to D. H. K., HG004321 to L. K., and GM071508 to the Lewis-Sigler Institute), the Burroughs Wellcome Fund (to D. H. K.), the Jane Coffin Childs Fund for Medical Research (to K. C. R.), the James S. McDonnell Foundation (to L. K.), and the Howard Hughes Medical Institute (to L. K.).	AVERY L, 1993, GENETICS, V133, P897; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Darby C., 2005, WORMBOOK; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; PUJOL N, 2007, TOLL TOLL LIKE RECEP; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; TRENT C, 1983, GENETICS, V104, P619; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	22	162	178	4	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					382	384		10.1126/science.1166527	http://dx.doi.org/10.1126/science.1166527			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150845	Green Accepted, Green Submitted			2022-12-01	WOS:000262481400039
J	Hyder, AA; Peden, M; Krug, E				Hyder, Adnan A.; Peden, Margie; Krug, Etienne			Child health must include injury prevention	LANCET			English	Editorial Material									[Hyder, Adnan A.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Injury Res Unit, Dept Int Hlth, Baltimore, MD 21205 USA; [Peden, Margie; Krug, Etienne] WHO, Dept Violence & Injury Prevent & Disabil, CH-1211 Geneva, Switzerland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization	Hyder, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Injury Res Unit, Dept Int Hlth, Baltimore, MD 21205 USA.	ahyder@jhsph.edu	Hyder, Adnan/AAT-9503-2021	Mary, Margaret/0000-0003-0872-9851; Hyder, Adnan/0000-0002-7292-577X				[Anonymous], WORLD HLTH REP 2002; Branche C., 2008, WORLD REPORT CHILD I; Hyder AA, 2003, LANCET, V362, P2034, DOI 10.1016/S0140-6736(03)15145-8; Lopez A, 2008, LANCET, V372, P1525, DOI 10.1016/S0140-6736(08)61632-3; Peden M., 2004, WORLD REPORT ROAD TR; Peden M., 2002, INJURY CHART BOOK GR; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; [No title captured]	8	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					102	103		10.1016/S0140-6736(08)61736-5	http://dx.doi.org/10.1016/S0140-6736(08)61736-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19081617				2022-12-01	WOS:000262340900007
J	Benton, R; Vannice, KS; Gomez-Diaz, C; Vosshall, LB				Benton, Richard; Vannice, Kirsten S.; Gomez-Diaz, Carolina; Vosshall, Leslie B.			Variant Ionotropic Glutamate Receptors as Chemosensory Receptors in Drosophila	CELL			English	Article							LIGAND-BINDING CORE; OLFACTORY SENSE-ORGANS; CRYSTAL-STRUCTURES; ODORANT RECEPTORS; PRONEURAL GENE; ION CHANNELS; MEMBRANE TOPOLOGY; ANTENNAL LOBE; MECHANISMS; KAINATE	Ionotropic glutamate receptors (iGluRs) mediate neuronal communication at synapses throughout vertebrate and invertebrate nervous systems. We have characterized a family of iGluR-related genes in Drosophila, which we name ionotropic receptors (IRs). These receptors do not belong to the well-described kainate, AMPA, or NMDA classes of iGluRs, and they have divergent ligand-binding domains that lack their characteristic glutamate-interacting residues. IRs are expressed in a combinatorial fashion in sensory neurons that respond to many distinct odors but do not express either insect odorant receptors (ORs) or gustatory receptors (GRs). IR proteins accumulate in sensory dendrites and not at synapses. Misexpression of IRs in different olfactory neurons is sufficient to confer ectopic odor responsiveness. Together, these results lead us to propose that the IRs comprise a novel family of chemosensory receptors. Conservation of IR/iGlu-Rrelated proteins in bacteria, plants, and animals suggests that this receptor family represents an evolutionarily ancient mechanism for sensing both internal and external chemical cues.	[Benton, Richard; Vannice, Kirsten S.; Gomez-Diaz, Carolina; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Vosshall, Leslie B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Benton, Richard] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Lausanne	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie@mail.rockefeller.edu		Gomez-Diaz, Carolina/0000-0003-2131-6074; Vosshall, Leslie/0000-0002-6060-8099	European Molecular Biology Organization Long-Term Fellowship; Maclyn McCarty Fellow of the Helen Hay Whitney Foundation; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health [RO1 DC008600]; McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008600] Funding Source: NIH RePORTER	European Molecular Biology Organization Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Maclyn McCarty Fellow of the Helen Hay Whitney Foundation; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Andrew Jarman, Hugo Bellen, the Bloomington Drosophila Stock Center, and the Developmental Studies Hybridoma Bank for Drosophila strains and antibodies, and Raphael Rytz for identifying an additional IR pseudogene. Richard Axel, Kevin Lee, Sophie Martin, Charles Zuker, and members of the Vosshall Lab provided invaluable advice, discussion, and comments on the manuscript. R. B. was supported by a European Molecular Biology Organization Long-Term Fellowship and was the Maclyn McCarty Fellow of the Helen Hay Whitney Foundation. This work was funded in part by a grant to R. Axel and L. B. V. from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative and by grants to L. B. V. from the National Institutes of Health (RO1 DC008600) and the McKnight Endowment Fund for Neuroscience. R. B. designed and carried out all the experiments in the paper, with the exception of the in situ hybridization in Figures 3C-3F, which was carried out by K.S.V.C.G.-D. performed the gene-targeting screen for IR25a and the initial characterization of the IR25a antibodies. L.B.V. and R.B. together conceived and directed the project, interpreted the results, and wrote the paper.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2008, CURR OPIN NEUROBIOL, V18, P357, DOI 10.1016/j.conb.2008.08.012; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chiu J, 1999, MOL BIOL EVOL, V16, P826, DOI 10.1093/oxfordjournals.molbev.a026167; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Dubos C, 2003, PLANT J, V35, P800, DOI 10.1046/j.1365-313X.2003.01849.x; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Jhaveri D, 2000, MECH DEVELOP, V99, P101, DOI 10.1016/S0925-4773(00)00487-1; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lage PIZ, 2003, DEVELOPMENT, V130, P4683, DOI 10.1242/dev.00680; Lam HM, 1998, NATURE, V396, P125, DOI 10.1038/24066; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Naur P, 2007, P NATL ACAD SCI USA, V104, P14116, DOI 10.1073/pnas.0703718104; Qi Z, 2006, PLANT PHYSIOL, V142, P963, DOI 10.1104/pp.106.088989; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Warr CG, 2000, CELL, V102, P145; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	53	821	876	22	206	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					149	162		10.1016/j.cell.2008.12.001	http://dx.doi.org/10.1016/j.cell.2008.12.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135896	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000262318400022
J	Fronzes, R; Schafer, E; Wang, LC; Saibil, HR; Orlova, EV; Waksman, G				Fronzes, Remi; Schafer, Eva; Wang, Luchun; Saibil, Helen R.; Orlova, Elena V.; Waksman, Gabriel			Structure of a Type IV Secretion System Core Complex	SCIENCE			English	Article							AGROBACTERIUM-TUMEFACIENS; PROTEIN SUBASSEMBLIES; ESCHERICHIA-COLI; VIRB9; DNA; BIOGENESIS; MACHINERY; SUBSTRATE; MEMBRANES; COMPONENT	Type IV secretion systems (T4SSs) are important virulence factors used by Gram- negative bacterial pathogens to inject effectors into host cells or to spread plasmids harboring antibiotic resistance genes. We report the 15 angstrom resolution cryo- electron microscopy structure of the core complex of a T4SS. The core complex is composed of three proteins, each present in 14 copies and forming a similar to 1.1- megadalton two-chambered, double membrane- spanning channel. The structure is double- walled, with each component apparently spanning a large part of the channel. The complex is open on the cytoplasmic side and constricted on the extracellular side. Overall, the T4SS core complex structure is different in both architecture and composition from the other known double membrane- spanning secretion system that has been structurally characterized.	[Fronzes, Remi; Schafer, Eva; Wang, Luchun; Saibil, Helen R.; Orlova, Elena V.; Waksman, Gabriel] Univ London Birkbeck Coll, Inst Struct & Mol Biol, Sch Crystallog, London WC1E 7HX, England; [Waksman, Gabriel] UCL, Div Biosci, London WC1E 6BT, England	University of London; Birkbeck University London; University of London; University College London	Waksman, G (corresponding author), Univ London Birkbeck Coll, Inst Struct & Mol Biol, Sch Crystallog, Malet St, London WC1E 7HX, England.	g.waksman@ucl.ac.uk	Orlova, Elena/CAF-8290-2022; Fronzes, Remi/T-2578-2019; Fronzes, Rémi/GLS-0406-2022; fronzes, Rémi/A-4311-2009	Fronzes, Remi/0000-0003-3031-9824; Orlova, Elena/0000-0003-3371-415X	Wellcome Trust; UK Biotechnology and Biological Sciences Research Council; European Union Network of Excellence in Three-Dimensional Electron Microscopy (3DEM); BBSRC [BB/F010281/1, BB/C516179/1, BB/C516144/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C516179/1, BB/C516144/1, BB/F010281/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union Network of Excellence in Three-Dimensional Electron Microscopy (3DEM)(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by research grants from the Wellcome Trust to G.W. and UK Biotechnology and Biological Sciences Research Council to H.R.S. and by an equipment grant from the Wellcome Trust to H.R.S and E.V.O. Also, H.R.S. and E.V.O. thank the European Union Network of Excellence in Three-Dimensional Electron Microscopy (3DEM) for support. EM maps have been deposited to the EM data bank under the entry codes EMD-5031 to EMD5035 for cryo-EM wild-type, negative-stain EM wild-type, negative-stain EM D1, cryo-EM D2, and negative-stain DL2 complexes, respectively.	Baron C, 1997, J BACTERIOL, V179, P1211, DOI 10.1128/jb.179.4.1211-1218.1997; Bayliss R, 2007, P NATL ACAD SCI USA, V104, P1673, DOI 10.1073/pnas.0609535104; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Das A, 2000, J BACTERIOL, V182, P758, DOI 10.1128/JB.182.3.758-763.2000; Fernandez D, 1996, J BACTERIOL, V178, P3156, DOI 10.1128/jb.178.11.3156-3167.1996; Harris RL, 2001, MOL MICROBIOL, V42, P757, DOI 10.1046/j.1365-2958.2001.02667.x; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Liu ZY, 2003, J BACTERIOL, V185, P3259, DOI 10.1128/JB.185.11.3259-3269.2003; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	17	235	240	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					266	268		10.1126/science.1166101	http://dx.doi.org/10.1126/science.1166101			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131631	Green Accepted			2022-12-01	WOS:000262290600042
J	Wang, XN; Schwarz, TL				Wang, Xinnan; Schwarz, Thomas L.			The Mechanism of Ca2+-Dependent Regulation of Kinesin-Mediated Mitochondrial Motility	CELL			English	Article							FAST AXONAL-TRANSPORT; HEAVY-CHAIN; RHO GTPASES; DROSOPHILA; NEURONS; PROTEIN; SYNAPSES; BINDING; ACTIN; ORGANIZATION	Mitochondria are mobile organelles and cells regulate mitochondrial movement in order to meet the changing energy needs of each cellular region. Ca2+ signaling, which halts both anterograde and retrograde mitochondrial motion, serves as one regulatory input. Anterograde mitochondrial movement is generated by kinesin-1, which interacts with the mitochondrial protein Miro through an adaptor protein, milton. We show that kinesin is present on all axonal mitochondria, including those that are stationary or moving retrograde. We also show that the EF-hand motifs of Miro mediate Ca2+-dependent arrest of mitochondria and elucidate the regulatory mechanism. Rather than dissociating kinesin-1 from mitochondria, Ca2+-binding permits Miro to interact directly with the motor domain of kinesin-1, preventing motor/microtubule interactions. Thus, kinesin-1 switches from an active state in which it is bound to Miro only via milton, to an inactive state in which direct binding to Miro prevents its interaction with microtubules. Disrupting Ca2+-dependent regulation diminishes neuronal resistance to excitotoxicity.	[Schwarz, Thomas L.] Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Schwarz, TL (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu	Wang, Xinnan/B-2393-2013		NIH [RO1GM069808]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069808] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Rappley, Drs. F. Sun, Z. Wills, P. Aspenstrom, K. J. Verhey, A. M. Craig, T. Pawson, G. W. Hart, and F. A. Stephenson for reagents; S. Vasquez, Drs. Z. Wills, M. Greenberg, and Z. He for assistance with hippocampal cultures, Dr. L. Bu and the Developmental Disorders Research Center Imaging Core and E. Pogoda for technical assistance; Dr. Y. Chu for assistance with Matlab script and a Labview macro. This work was supported by NIH RO1GM069808.	Adio S, 2006, J MUSCLE RES CELL M, V27, P153, DOI 10.1007/s10974-005-9054-1; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Beck M, 2002, J BIOL CHEM, V277, P30079, DOI 10.1074/jbc.M200438200; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; BRADY ST, 1984, NATURE, V310, P56, DOI 10.1038/310056a0; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Cox RT, 2006, DEVELOPMENT, V133, P3371, DOI 10.1242/dev.02514; Deavours BE, 1998, CELL MOTIL CYTOSKEL, V40, P408, DOI 10.1002/(SICI)1097-0169(1998)40:4<408::AID-CM8>3.3.CO;2-Z; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI [10.1242/jcs.02745, 10.1242/jcs.053850]; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Hurd DD, 1996, GENETICS, V144, P1075; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; MURREY HE, 2008, CHEM REV IN PRESS; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Overly CC, 1996, J CELL SCI, V109, P971; Petrozzi L, 2007, BIOSCIENCE REP, V27, P87, DOI 10.1007/s10540-007-9038-z; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Smith MJ, 2006, J BIOL CHEM, V281, P27216, DOI 10.1074/jbc.M600522200; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vinogradova MV, 2004, J BIOL CHEM, V279, P23504, DOI 10.1074/jbc.M400741200; Yang ZK, 2000, J PHYSIOL-LONDON, V523, P29, DOI 10.1111/j.1469-7793.2000.00029.x; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038	44	600	614	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					163	174		10.1016/j.cell.2008.11.046	http://dx.doi.org/10.1016/j.cell.2008.11.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135897	Bronze, Green Accepted			2022-12-01	WOS:000262318400023
J	Bashkirov, PV; Akimov, SA; Evseev, AI; Schmid, SL; Zimmerberg, J; Frolov, VA				Bashkirov, Pavel V.; Akimov, Sergey A.; Evseev, Alexey I.; Schmid, Sandra L.; Zimmerberg, Joshua; Frolov, Vadim A.			GTPase Cycle of Dynamin Is Coupled to Membrane Squeeze and Release, Leading to Spontaneous Fission	CELL			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; BIOLOGICAL-MEMBRANES; NERVE-TERMINALS; ENDOCYTOSIS; CURVATURE; VESICLES; TENSION; FUSION; DOMAIN; CELLS	The GTPase dynamin is critically involved in membrane fission during endocytosis. How does dynamin use the energy of GTP hydrolysis for membrane remodeling? By monitoring the ionic permeability through lipid nanotubes (NT), we found that dynamin was capable of squeezing NT to extremely small radii, depending on the NT lipid composition. However, long dynamin scaffolds did not produce fission: instead, fission followed GTPase-dependent cycles of assembly and disassembly of short dynamin scaffolds and involved a stochastic process dependent on the curvature stress imposed by dynamin. Fission happened spontaneously upon NT release from the scaffold, without leakage. Our calculations revealed that local narrowing of NT could induce cooperative lipid tilting, leading to self-merger of the inner monolayer of NT (hemifission), consistent with the absence of leakage. We propose that dynamin transmits GTP's energy to periodic assembling of a limited curvature scaffold that brings lipids to an unstable intermediate.	[Bashkirov, Pavel V.; Akimov, Sergey A.; Zimmerberg, Joshua; Frolov, Vadim A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, Bethesda, MD 20892 USA; [Bashkirov, Pavel V.; Akimov, Sergey A.; Evseev, Alexey I.] Russian Acad Sci, AN Frumkin Inst Phys Chem & Electrochem, Moscow 119991, Russia; [Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Russian Academy of Sciences; Frumkin Institute of Physical Chemistry & Electrochemistry; Scripps Research Institute	Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, Bethesda, MD 20892 USA.	joshz@mail.nih.gov	Bashkirov, Pavel V/Y-8464-2018; Akimov, Sergey A/L-2001-2013; Akimov, Sergey/AFV-4270-2022; Akimov, Sergey A./I-6432-2015; Frolov, Vadim/ABH-3889-2020; Bashkirov, Pavel/J-2385-2012	Akimov, Sergey/0000-0002-7916-6032; Frolov, Vadim/0000-0002-0653-5669; Schmid, Sandra/0000-0002-1690-7024; Bashkirov, Pavel/0000-0003-2250-9759	National Institutes of Health (NIH) [R01GM42455, R37MH61345]; RFBR [08-04-00085]; CRDF GAP [RUB1-1297(5)-MO-05]; Russian Federal Agency for Science and Innovations [02.512.11.0010]; Program of Molecular and Cellular Biology RAS; Leading Scientific Schools of Russian Federation [4181.2008.4]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061345, R37MH061345] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RFBR(Russian Foundation for Basic Research (RFBR)); CRDF GAP; Russian Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); Program of Molecular and Cellular Biology RAS; Leading Scientific Schools of Russian Federation(Leading Scientific Schools Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by the National Institutes of Health (NIH) intramural program (NICHD), and grants NIH R01GM42455 and R37MH61345, RFBR 08-04-00085, and CRDF GAP RUB1-1297(5)-MO-05, Russian Federal Agency for Science and Innovations 02.512.11.0010, Program of Molecular and Cellular Biology RAS, and the grant for State Support of Leading Scientific Schools of Russian Federation 4181.2008.4. The BODIPY-labeled dynamin was generously provided by Rajesh Ramachandran. We are grateful to Vladimir Lizunov and Gennady Kushnir for their technical help and Thomas Pucadyil, Anna Shnyrova, and Yuri Chizmadzhev for a careful reading of the manuscript and fruitful discussions.	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Angelova M., 1988, PROG COLL POL SCI S, V76, P59, DOI [DOI 10.1007/BFB0114157, 10.1007/bfb0114171, DOI 10.1007/BFB0114171]; BARZIV R, 1994, PHYS REV LETT, V73, P1392, DOI 10.1103/PhysRevLett.73.1392; Bashkirov PV, 2007, BIOCHEM MOSC SUPPL S, V1, P176, DOI 10.1134/S1990747807020110; Bukman DJ, 1996, PHYS REV E, V54, P5463, DOI 10.1103/PhysRevE.54.5463; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; Eliasson L, 1996, J PHYSIOL-LONDON, V493, P755, DOI 10.1113/jphysiol.1996.sp021420; EVANS E, 1994, CHEM PHYS LIPIDS, V73, P39, DOI 10.1016/0009-3084(94)90173-2; FOURCADE B, 1994, PHYS REV E, V49, P5276, DOI 10.1103/PhysRevE.49.5276; Frolov VA, 2003, P NATL ACAD SCI USA, V100, P8698, DOI 10.1073/pnas.1432962100; Frolov VA, 2003, BIOPHYS J, V85, P1725, DOI 10.1016/S0006-3495(03)74602-5; Frolov VA, 2008, CELL, V132, P727, DOI 10.1016/j.cell.2008.02.025; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Kozlov MM, 2001, TRAFFIC, V2, P51, DOI 10.1034/j.1600-0854.2001.020107.x; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Rappoport JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002416; ROSENBOOM H, 1994, P NATL ACAD SCI USA, V91, P5267, DOI 10.1073/pnas.91.12.5267; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sandre O, 1999, P NATL ACAD SCI USA, V96, P10591, DOI 10.1073/pnas.96.19.10591; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Warnock Dale E., 1996, Bioessays, V18, P885, DOI 10.1002/bies.950181107; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	42	221	223	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1276	1286		10.1016/j.cell.2008.11.028	http://dx.doi.org/10.1016/j.cell.2008.11.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19084269	Green Accepted, Bronze			2022-12-01	WOS:000261989800018
J	Boussau, B; Blanquart, S; Necsulea, A; Lartillot, N; Gouy, M				Boussau, Bastien; Blanquart, Samuel; Necsulea, Anamaria; Lartillot, Nicolas; Gouy, Manolo			Parallel adaptations to high temperatures in the Archaean eon	NATURE			English	Article							SEQUENCE ALIGNMENT; EVOLUTION; ORIGIN; BOMBARDMENT; BACTERIA; ANCESTOR; ACCURATE; PROTEIN; MODEL; TIME	Fossils of organisms dating from the origin and diversification of cellular life are scant and difficult to interpret(1), for this reason alternative means to investigate the ecology of the last universal common ancestor ( LUCA) and of the ancestors of the three domains of life are of great scientific value. It was recently recognized that the effects of temperature on ancestral organisms left 'genetic footprints' that could be uncovered in extant genomes(2-4). Accordingly, analyses of resurrected proteins predicted that the bacterial ancestor was thermophilic and that Bacteria subsequently adapted to lower temperatures(3,4). As the archaeal ancestor is also thought to have been thermophilic(5), the LUCA was parsimoniously inferred as thermophilic too. However, an analysis of ribosomal RNAs supported the hypothesis of a non- hyperthermophilic LUCA(2). Here we show that both rRNA and protein sequences analysed with advanced, realistic models of molecular evolution(6,7) provide independent support for two environmental- temperature-related phases during the evolutionary history of the tree of life. In the first period, thermotolerance increased from a mesophilic LUCA to thermophilic ancestors of Bacteria and of Archaea Eukaryota; in the second period, it decreased. Therefore, the two lineages descending from the LUCA and leading to the ancestors of Bacteria and Archaea - Eukaryota convergently adapted to high temperatures, possibly in response to a climate change of the early Earth(1,8,9), and/or aided by the transition from an RNA genome in the LUCA to organisms with more thermostable DNA genomes(10,11). This analysis unifies apparently contradictory results(2-4) into a coherent depiction of the evolution of an ecological trait over the entire tree of life.	[Boussau, Bastien; Necsulea, Anamaria; Gouy, Manolo] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Blanquart, Samuel; Lartillot, Nicolas] CNRS, LIRMM, F-34392 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier	Gouy, M (corresponding author), Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, 32 Blvd 11 Novembre, F-69622 Villeurbanne, France.	mgouy@biomserv.univ-lyon1.fr		Boussau, Bastien/0000-0003-0776-4460	Action Concertee Incitative IMPBIO-MODELPHYLO; ANR PlasmoExplore	Action Concertee Incitative IMPBIO-MODELPHYLO; ANR PlasmoExplore(French National Research Agency (ANR))	This work was supported by Action Concertee Incitative IMPBIO-MODELPHYLO and ANR PlasmoExplore. We thank C. Brochier-Armanet and A. Lazcano for help and suggestions, the LIRMM Bioinformatics platform ATGC and the computing facilities of IN2P3.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Blanquart S, 2006, MOL BIOL EVOL, V23, P2058, DOI 10.1093/molbev/msl091; Boussau B, 2006, SYSTEMATIC BIOL, V55, P756, DOI 10.1080/10635150600975218; Brooks DJ, 2004, BIOINFORMATICS, V20, P2251, DOI 10.1093/bioinformatics/bth235; Chessel D., 2004, R NEWS, DOI DOI 10.2307/3780087; Di Giulio M, 2003, J MOL EVOL, V57, P721, DOI 10.1007/s00239-003-2522-6; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Forterre P, 2002, CURR OPIN MICROBIOL, V5, P525, DOI 10.1016/S1369-5274(02)00360-0; Fournier GP, 2007, J MOL EVOL, V65, P425, DOI 10.1007/s00239-007-9024-x; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; GOGARTENBOEKELS M, 1995, ORIGINS LIFE EVOL B, V25, P251, DOI 10.1007/BF01581588; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Gowri-Shankar V, 2006, MOL BIOL EVOL, V23, P352, DOI 10.1093/molbev/msj040; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HILL MO, 1974, ROY STAT SOC C-APP, V23, P340; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Islas S, 2003, INT MICROBIOL, V6, P87, DOI 10.1007/s10123-003-0113-4; Kasting JF, 2006, PHILOS T R SOC B, V361, P917, DOI 10.1098/rstb.2006.1839; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Moreira D, 2007, MOL PHYLOGENET EVOL, V44, P255, DOI 10.1016/j.ympev.2006.11.001; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Naya H, 2002, J MOL EVOL, V55, P260, DOI 10.1007/s00239-002-2323-3; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shields GA, 2007, NATURE, V447, pE1, DOI 10.1038/nature05830; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Wolf YI, 1999, GENOME RES, V9, P689; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005; Zhaxybayeva O, 2005, PROTOPLASMA, V227, P53, DOI 10.1007/s00709-005-0135-1	45	149	153	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					942	U74		10.1038/nature07393	http://dx.doi.org/10.1038/nature07393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19037246	Green Submitted			2022-12-01	WOS:000261768300043
J	Chan, PS; Khalid, A; Longmore, LS; Berg, RA; Kosiborod, M; Spertus, JA				Chan, Paul S.; Khalid, Adnan; Longmore, Lance S.; Berg, Robert A.; Kosiborod, Mikhail; Spertus, John A.			Hospital-wide Code Rates and Mortality Before and After Implementation of a Rapid Response Team	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL EMERGENCY TEAM; CARDIAC-ARREST; CONTROLLED-TRIAL; INTENSIVE-CARE; CARDIOPULMONARY ARRESTS; HEART-FAILURE; ANTECEDENTS; REDUCTION; SURVIVAL; DEATH	Context Rapid response teams have been shown in adult inpatients to decrease cardiopulmonary arrest ( code) rates outside of the intensive care unit ( ICU). Because a primary action of rapid response teams is to transfer patients to the ICU, their ability to reduce hospital- wide code rates and mortality remains unknown. Objective To determine rates of hospital- wide codes and mortality before and after implementation of a long- term rapid response team intervention. Design, Setting, and Patients A prospective cohort design of adult inpatients admitted between January 1, 2004, and August 31, 2007, at Saint Luke's Hospital, a 404- bed tertiary care academic hospital in Kansas City, Missouri. Rapid response team education and program rollout occurred from September 1 to December 31, 2005. A total of 24 193 patient admissions were evaluated prior to the intervention ( January 1, 2004, to August 31, 2005), and 24 978 admissions were evaluated after the intervention ( January 1, 2006, to August 31, 2007). Intervention Using standard activation criteria, a 3- member rapid response team composed of experienced ICU staff and a respiratory therapist performed the evaluation, treatment, and triage of inpatients with evidence of acute physiological decline. Main Outcome Measures Hospital- wide code rates and mortality, adjusted for preintervention trends. Results There were a total of 376 rapid response team activations. After rapid response team implementation, mean hospital- wide code rates decreased from 11.2 to 7.5 per 1000 admissions. This was not associated with a reduction in the primary end point of hospital- wide code rates ( adjusted odds ratio [ AOR], 0.76 [ 95% confidence interval {CI}, 0.57- 1.01]; P=. 06), although lower rates of non- ICU codes were observed ( non- ICU AOR, 0.59 [ 95% CI, 0.40- 0.89] vs ICU AOR, 0.95 [ 95% CI, 0.641.43]; P=. 03 for interaction). Similarly, hospital- wide mortality did not differ between the preintervention and postintervention periods ( 3.22 vs 3.09 per 100 admissions; AOR, 0.95 [ 95% CI, 0.81- 1.11]; P=. 52). Secondary analyses revealed few instances of rapid response team undertreatment or underuse that may have affected the mortality findings. Conclusion In this large single- institution study, rapid response team implementation was not associated with reductions in hospital- wide code rates or mortality.	[Chan, Paul S.; Khalid, Adnan; Longmore, Lance S.; Kosiborod, Mikhail; Spertus, John A.] St Lukes Hosp, Mid Amer Heart Inst, Div Cardiol, Kansas City, MO 64111 USA; [Berg, Robert A.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Arizona	Chan, PS (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, Div Cardiol, 5th Floor,4401 Wornall Rd, Kansas City, MO 64111 USA.	pchan@cc-pc.com	Spertus, John/ABD-3075-2021					Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Brilli RJ, 2007, PEDIATR CRIT CARE ME, V8, P236, DOI 10.1097/01.PCC.0000262947.72442.EA; Bristow PJ, 2000, MED J AUSTRALIA, V173, P236, DOI 10.5694/j.1326-5377.2000.tb125627.x; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; DeVita MA, 2004, QUAL SAF HEALTH CARE, V13, P251, DOI 10.1136/qshc.2003.006585; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; Kenward G, 2004, RESUSCITATION, V61, P257, DOI 10.1016/j.resuscitation.2004.01.021; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Priestley G, 2004, INTENS CARE MED, V30, P1398, DOI 10.1007/s00134-004-2268-7; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; SCHEIN RMH, 1990, CHEST, V98, P1388, DOI 10.1378/chest.98.6.1388; Sharek PJ, 2007, JAMA-J AM MED ASSOC, V298, P2267, DOI 10.1001/jama.298.19.2267; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401	21	220	241	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2506	2513		10.1001/jama.2008.715	http://dx.doi.org/10.1001/jama.2008.715			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050194	Bronze			2022-12-01	WOS:000261286200019
J	Lenz, G; Wright, G; Dave, SS; Xiao, W; Powell, J; Zhao, H; Xu, W; Tan, B; Goldschmidt, N; Iqbal, J; Vose, J; Bast, M; Fu, K; Weisenburger, DD; Greiner, TC; Armitage, JO; Kyle, A; May, L; Gascoyne, RD; Connors, JM; Troen, G; Holte, H; Kvaloy, S; Dierickx, D; Verhoef, G; Delabie, J; Smeland, EB; Jares, P; Martinez, A; Lopez-Guillermo, A; Montserrat, E; Campo, E; Braziel, RM; Miller, TP; Rimsza, LM; Cook, JR; Pohlman, B; Sweetenham, J; Tubbs, RR; Fisher, RI; Hartmann, E; Rosenwald, A; Ott, G; Muller-Hermelink, HK; Wrench, D; Lister, TA; Jaffe, ES; Wilson, WH; Chan, WC; Staudt, LM				Lenz, G.; Wright, G.; Dave, S. S.; Xiao, W.; Powell, J.; Zhao, H.; Xu, W.; Tan, B.; Goldschmidt, N.; Iqbal, J.; Vose, J.; Bast, M.; Fu, K.; Weisenburger, D. D.; Greiner, T. C.; Armitage, J. O.; Kyle, A.; May, L.; Gascoyne, R. D.; Connors, J. M.; Troen, G.; Holte, H.; Kvaloy, S.; Dierickx, D.; Verhoef, G.; Delabie, J.; Smeland, E. B.; Jares, P.; Martinez, A.; Lopez-Guillermo, A.; Montserrat, E.; Campo, E.; Braziel, R. M.; Miller, T. P.; Rimsza, L. M.; Cook, J. R.; Pohlman, B.; Sweetenham, J.; Tubbs, R. R.; Fisher, R. I.; Hartmann, E.; Rosenwald, A.; Ott, G.; Muller-Hermelink, H. -K; Wrench, D.; Lister, T. A.; Jaffe, E. S.; Wilson, W. H.; Chan, W. C.; Staudt, L. M.		Lymphoma Leukemia Mol Profiling Pr	Stromal Gene Signatures in Large-B-Cell Lymphomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MESENCHYMAL STEM-CELLS; NON-HODGKINS-LYMPHOMA; TISSUE GROWTH-FACTOR; ANGIOGENIC SWITCH; BREAST-CANCER; TUMOR-GROWTH; MOUSE MODEL; EXPRESSION; SURVIVAL; CHEMOTHERAPY	Background: The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has significantly improved the survival of patients with diffuse large-B-cell lymphoma. Whether gene-expression signatures correlate with survival after treatment of diffuse large-B-cell lymphoma is unclear. Methods: We profiled gene expression in pretreatment biopsy specimens from 181 patients with diffuse large-B-cell lymphoma who received CHOP and 233 patients with this disease who received R-CHOP. A multivariate gene-expression-based survival-predictor model derived from a training group was tested in a validation group. Results: A multivariate model created from three gene-expression signatures - termed ``germinal-center B-cell,'' ``stromal-1,'' and ``stromal-2'' - predicted survival both in patients who received CHOP and patients who received R-CHOP. The prognostically favorable stromal-1 signature reflected extracellular-matrix deposition and histiocytic infiltration. By contrast, the prognostically unfavorable stromal-2 signature reflected tumor blood-vessel density. Conclusions: Survival after treatment of diffuse large-B-cell lymphoma is influenced by differences in immune cells, fibrosis, and angiogenesis in the tumor microenvironment.	[Lenz, G.; Dave, S. S.; Zhao, H.; Xu, W.; Tan, B.; Goldschmidt, N.; Wilson, W. H.; Staudt, L. M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wright, G.] NCI, Biometr Res Branch, Div Canc Treatment & Diagnosis, NIH, Bethesda, MD 20892 USA; [Xiao, W.; Powell, J.] NIH, Bioinformat & Mol Anal Sect, Bethesda, MD 20892 USA; [Jaffe, E. S.] NIH, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; NIH, Computat Biosci & Engn Lab, Ctr Informat Technol, Bethesda, MD 20892 USA; [Iqbal, J.; Vose, J.; Bast, M.; Fu, K.; Weisenburger, D. D.; Greiner, T. C.; Armitage, J. O.; Chan, W. C.] Univ Nebraska Med Ctr, Omaha, NE USA; [Kyle, A.; May, L.; Gascoyne, R. D.; Connors, J. M.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Troen, G.; Delabie, J.] Univ Oslo, Rikshosp Univ Hosp, Pathol Clin, N-0027 Oslo, Norway; [Holte, H.; Kvaloy, S.] Univ Oslo, Rikshosp Univ Hosp, Canc Clin, N-0027 Oslo, Norway; [Smeland, E. B.] Univ Oslo, Rikshosp Univ Hosp, Canc Res Inst, N-0027 Oslo, Norway; [Smeland, E. B.] Univ Oslo, Norwegian Radium Hosp, Ctr Canc Biomed, Fac Div, N-0027 Oslo, Norway; [Dierickx, D.; Verhoef, G.] Katholieke Univ Leuven, Dept Hematol, Louvain, Belgium; [Jares, P.; Martinez, A.; Lopez-Guillermo, A.; Montserrat, E.; Campo, E.] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Braziel, R. M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Braziel, R. M.; Miller, T. P.; Rimsza, L. M.; Cook, J. R.; Tubbs, R. R.; Fisher, R. I.] SW Oncol Grp, Tucson, AZ USA; [Miller, T. P.; Rimsza, L. M.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Pohlman, B.; Sweetenham, J.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Cook, J. R.; Tubbs, R. R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Fisher, R. I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY USA; [Hartmann, E.; Rosenwald, A.; Ott, G.; Muller-Hermelink, H. -K] Univ Wurzburg, Dept Pathol, D-8700 Wurzburg, Germany; [Ott, G.] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany; [Wrench, D.; Lister, T. A.] St Bartholomews Hosp, Canc Res UK, London, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); University of Nebraska System; University of Nebraska Medical Center; British Columbia Cancer Agency; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; KU Leuven; University of Barcelona; Hospital Clinic de Barcelona; Oregon Health & Science University; Southwest Oncology Group; University of Arizona; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Rochester; University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Cancer Research UK; University of London; Queen Mary University London	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bldg 10,Rm 4N114, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Wright, George W/M-1660-2017; Campo, Elias/AAC-5593-2019; Jaffe, Elaine/G-8981-2014; Holte, Harald/AAO-5647-2020; Martinez, Antonio/D-8188-2012; Connors, Joseph/AAF-5284-2019; Gascoyne, Randy D/A-6009-2013; Staudt, Louis/AAC-5324-2019; Lopez-Guillermo, Armando/Z-5684-2019; Jares, Pedro/T-3778-2019; Smeland, Erlend/AAO-3214-2020; Lenz, Georg/I-6844-2012	Campo, Elias/0000-0001-9850-9793; Martinez, Antonio/0000-0003-0790-9017; Connors, Joseph/0000-0002-1361-7531; Gascoyne, Randy D/0000-0002-2610-5690; Delabie, Jan/0000-0001-5023-0689; JARES, PEDRO/0000-0002-8401-579X; Iqbal, Javeed/0000-0003-3668-0629	Intramural Research Program of the National Institutes of Health; National Cancer Institute; Center for Cancer Research; NCI Strategic Partnering to Evaluate Cancer Signature [UO1-CA114778]; German Research Foundation; Genentech; Imedex Future; Ziopharm; L'Oreal; Celgene; Genitope; Biogen Idec; Roche Canada; Schering and Hoffmann-La Roche; Ventana Medical Systems; Roche Molecular Systems; Genentech BioOncology; Genentech BioOncology National Lymphocare Study; Allos Therapeutics; Millennium; Amgen; Pharmion; Roche; Seattle Genetics; Imedex; Eleos; Educational Concepts; Upside Endeavors; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIASC000550, U01CA114778, ZIABC011006] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Strategic Partnering to Evaluate Cancer Signature(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Foundation(German Research Foundation (DFG)); Genentech(Roche HoldingGenentech); Imedex Future; Ziopharm; L'Oreal(L'Oreal Group); Celgene(Bristol-Myers SquibbCelgene Corporation); Genitope; Biogen Idec(Biogen); Roche Canada(Roche Holding); Schering and Hoffmann-La Roche(Hoffmann-La Roche); Ventana Medical Systems; Roche Molecular Systems; Genentech BioOncology; Genentech BioOncology National Lymphocare Study; Allos Therapeutics; Millennium(Takeda Pharmaceutical Company Ltd); Amgen(Amgen); Pharmion; Roche(Roche Holding); Seattle Genetics; Imedex; Eleos; Educational Concepts; Upside Endeavors; CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Intramural Research Program of the National Institutes of Health, the National Cancer Institute ( NCI), and the Center for Cancer Research; an NCI Strategic Partnering to Evaluate Cancer Signature grant (UO1-CA114778); and a grant from the German Research Foundation (to Dr. Lenz).; Dr. Vose reports receiving grant support from Genentech; Dr. Greiner, lecture fees from Imedex Future; Dr. Armitage, consulting fees from Ziopharm, L'Oreal, Celgene, Genitope, and Biogen Idec and lecture fees from Genentech; Dr. Gascoyne, consulting fees from Genentech and Roche Canada and lecture fees and grant support from Roche Canada; Dr. Connors, grant support from Roche Canada; Dr. Montserrat, consulting fees from Schering and Hoffmann-La Roche; Dr. Miller, consulting fees and grant support from Genentech and Biogen Idec; Dr. Rimsza, grant support from Ventana Medical Systems; Dr. Cook, consulting fees from Roche Molecular Systems; Dr. Pohlman, consulting fees from Genentech BioOncology and grant support from Genentech BioOncology National Lymphocare Study; Dr. Fisher, consulting fees from Allos Therapeutics, Millennium, Amgen, Pharmion, Celgene, Roche, Genentech, and Seattle Genetics; Dr. Lister, consulting fees from Imedex, Eleos, Educational Concepts, Genentech, and Upside Endeavors and grant support from Millennium; and Dr. Chan, grant support from Roche Molecular Systems. No other potential conflict of interest relevant to this article was reported.; We thank Alexander Kohlmann, Mickey Williams, and Lothar Wieczorek at Roche Molecular Systems for logistical support.	Aikawa T, 2006, MOL CANCER THER, V5, P1108, DOI 10.1158/1535-7163.MCT-05-0516; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Ganjoo KN, 2006, LEUKEMIA LYMPHOMA, V47, P998, DOI 10.1080/10428190600563821; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tagawa H, 2006, BLOOD, V107, P3052; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Woodman SE, 2003, AM J PATHOL, V162, P2059, DOI 10.1016/S0002-9440(10)64337-4; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	33	1239	1274	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2313	2323		10.1056/NEJMoa0802885	http://dx.doi.org/10.1056/NEJMoa0802885			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377SG	19038878	Green Accepted, Green Submitted			2022-12-01	WOS:000261270300003
J	Boys, C; Cunningham, C; McKenna, D; Robertson, P; Weeks, DJ; Wishart, J				Boys, Carol; Cunningham, Cliff; McKenna, Down; Robertson, Penny; Weeks, Daniel J.; Wishart, Jennifer			Prenatal screening for Down's syndrome: editorial responsibilities	LANCET			English	Editorial Material							AMNIOCENTESIS		[Wishart, Jennifer] Univ Edinburgh, Moray House Sch Educ, Edinburgh EH8 8AQ, Midlothian, Scotland; [Boys, Carol] Downs Syndrome Assoc, Teddington, Middx, England; [Cunningham, Cliff] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England; [McKenna, Down] Down Syndrome Res Fdn, Vancouver, BC, Canada; [Robertson, Penny] Down Syndrome Int, Jakarta, Indonesia; [Weeks, Daniel J.] Simon Fraser Univ, Dept Psychol, Vancouver, BC, Canada	University of Edinburgh; Liverpool John Moores University; Simon Fraser University	Wishart, J (corresponding author), Univ Edinburgh, Moray House Sch Educ, Edinburgh EH8 8AQ, Midlothian, Scotland.	J.Wishart@ed.ac.uk						[Anonymous], 2007, OBSTET GYNECOL, V110, P1459; BUCKLEY F, 2008, DSRP SCREENING EDITO; Buckley Frank, 2008, Downs Syndr Res Pract, V12, P79, DOI 10.3104/editorials.2087; BUCKLEY S, 2008, PRENATAL SCREENING C; CANADY RL, 1989, FOCUS CHANGE, V1, P1; Caughey AB, 2006, OBSTET GYNECOL, V108, P612, DOI 10.1097/01.AOG.0000232512.46869.fc; *DOWN SYNDR ED INT, 2008, MOR PEOPL DOWN SYNDR; Evans MI, 2008, CURR OPIN OBSTET GYN, V20, P164, DOI 10.1097/GCO.0b013e3282f7321f; FAN HC, 2008, P NATL ACAD SCI 1016; Morris K, 2008, LANCET, V372, P791, DOI 10.1016/S0140-6736(08)61321-5; *NAT DOWN SYNDR CY, 2008, NAT DOWN SYNDR CYT R; Odibo AO, 2008, OBSTET GYNECOL, V111, P589, DOI 10.1097/AOG.0b013e318162eb53; Smith-Bindman R, 2003, AM J OBSTET GYNECOL, V189, P980, DOI 10.1067/S0002-9378(03)00721-X; TABOR A, 1986, LANCET, V1, P1287	14	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1789	1791		10.1016/S0140-6736(08)61742-0	http://dx.doi.org/10.1016/S0140-6736(08)61742-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	19027473	Green Submitted			2022-12-01	WOS:000261112000007
J	Chandra, V; Huang, PX; Hamuro, Y; Raghuram, S; Wang, YJ; Burris, TP; Rastinejad, F				Chandra, Vikas; Huang, Pengxiang; Hamuro, Yoshitomo; Raghuram, Srilatha; Wang, Yongjun; Burris, Thomas P.; Rastinejad, Fraydoon			Structure of the intact PPAR-gamma-RXR-alpha nuclear receptor complex on DNA	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; RETINOID-X-RECEPTOR; REV-ERB-ALPHA; LIGAND-BINDING; ALLOSTERIC CONTROL; DOMAIN; IDENTIFICATION; MECHANISM; POLARITY; AGONISTS	Nuclear receptors are multi- domain transcription factors that bind to DNA elements from which they regulate gene expression. The peroxisome proliferator- activated receptors ( PPARs) form heterodimers with the retinoid X receptor ( RXR), and PPAR-gamma has been intensively studied as a drug target because of its link to insulin sensitization. Previous structural studies have focused on isolated DNA or ligand- binding segments, with no demonstration of how multiple domains cooperate to modulate receptor properties. Here we present structures of intact PPAR-gamma and RXR-alpha as a heterodimer bound to DNA, ligands and coactivator peptides. PPAR-gamma and RXR-alpha form a non- symmetric complex, allowing the ligand- binding domain ( LBD) of PPAR-gamma to contact multiple domains in both proteins. Three interfaces link PPAR-gamma and RXR-alpha, including some that are DNA dependent. The PPAR-gamma LBD cooperates with both DNA- binding domains ( DBDs) to enhance response- element binding. The A/B segments are highly dynamic, lacking folded substructures despite their gene- activation properties.	[Chandra, Vikas; Huang, Pengxiang; Raghuram, Srilatha; Rastinejad, Fraydoon] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA; [Chandra, Vikas; Huang, Pengxiang; Raghuram, Srilatha; Rastinejad, Fraydoon] Univ Virginia Hlth Syst, Ctr Mol Design, Charlottesville, VA 22908 USA; [Hamuro, Yoshitomo] ExSAR Corp, Monmouth Jct, NJ 08852 USA; [Wang, Yongjun; Burris, Thomas P.] Louisiana State Univ, Pennington Biomed Res Ctr, Nucl Receptor Biol Lab, Baton Rouge, LA 70808 USA	University of Virginia; University of Virginia; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Rastinejad, F (corresponding author), Univ Virginia Hlth Syst, Dept Pharmacol, 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	fr9c@virginia.edu	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055217] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055217-11, R01 GM055217] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Berger Joel, 2002, Diabetes Technol Ther, V4, P163, DOI 10.1089/15209150260007381; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Castillo G, 1999, EMBO J, V18, P3676, DOI 10.1093/emboj/18.13.3676; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHEN F, 1993, BIOCHEM BIOPH RES CO, V196, P671, DOI 10.1006/bbrc.1993.2302; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Greschik I, 2003, CURR TOP MED CHEM, V3, P1573, DOI 10.2174/1568026033451736; Hamuro Y, 2006, PROTEIN SCI, V15, P1883, DOI 10.1110/ps.062103006; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Lazar MA, 2005, BIOCHIMIE, V87, P9, DOI 10.1016/j.biochi.2004.10.021; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Maier CS, 2005, METHOD ENZYMOL, V402, P312, DOI 10.1016/S0076-6879(05)02010-0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Schulman IG, 1997, GENE DEV, V11, P299, DOI 10.1101/gad.11.3.299; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Sierk ML, 2001, BIOCHEMISTRY-US, V40, P12833, DOI 10.1021/bi011086r; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Staels B, 2007, THERAPIE, V62, P319, DOI 10.2515/therapie:2007051; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2	49	541	557	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					350	U33		10.1038/nature07413	http://dx.doi.org/10.1038/nature07413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19043829	Green Accepted			2022-12-01	WOS:000261039600035
J	Liu, J; Ghanim, M; Xue, L; Brown, CD; Iossifov, I; Angeletti, C; Hua, SJ; Negre, N; Ludwig, M; Stricker, T; Al-Ahmadie, HA; Tretiakova, M; Camp, RL; Perera-Alberto, M; Rimm, DL; Xu, T; Rzhetsky, A; White, KP				Liu, Jiang; Ghanim, Murad; Xue, Lei; Brown, Christopher D.; Iossifov, Ivan; Angeletti, Cesar; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; Al-Ahmadie, Hikmat A.; Tretiakova, Maria; Camp, Robert L.; Perera-Alberto, Montse; Rimm, David L.; Xu, Tian; Rzhetsky, Andrey; White, Kevin P.			Analysis of Drosophila Segmentation Network Identifies a JNK Pathway Factor Overexpressed in Kidney Cancer	SCIENCE			English	Article							CARBONIC-ANHYDRASE-IX; RENAL-CELL CARCINOMA; DIFFERENTIAL-DIAGNOSIS; UBIQUITIN LIGASE; GENE-EXPRESSION; MELANOGASTER; PROTEINS; MARKERS; SYSTEM; MAP	We constructed a large-scale functional network model in Drosophila melanogaster built around two key transcription factors involved in the process of embryonic segmentation. Analysis of the model allowed the identification of a new role for the ubiquitin E3 ligase complex factor SPOP. In Drosophila, the gene encoding SPOP is a target of segmentation transcription factors. Drosophila SPOP mediates degradation of the Jun kinase phosphatase Puckered, thereby inducing tumor necrosis factor (TNF)/Eiger-dependent apoptosis. In humans, we found that SPOP plays a conserved role in TNF-mediated JNK signaling and was highly expressed in 99% of clear cell renal cell carcinomas (RCCs), the most prevalent form of kidney cancer. SPOP expression distinguished histological subtypes of RCC and facilitated identification of clear cell RCC as the primary tumor for metastatic lesions.	[Liu, Jiang; Ghanim, Murad; Brown, Christopher D.; Iossifov, Ivan; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; Rzhetsky, Andrey; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Liu, Jiang; Ghanim, Murad; Brown, Christopher D.; Iossifov, Ivan; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; Rzhetsky, Andrey; White, Kevin P.] Argonne Natl Lab, Chicago, IL 60637 USA; [Liu, Jiang; Ghanim, Murad; Brown, Christopher D.; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Xue, Lei; Xu, Tian] Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Iossifov, Ivan; Rzhetsky, Andrey] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Angeletti, Cesar; Camp, Robert L.; Rimm, David L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Ludwig, Michael; White, Kevin P.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Stricker, Thomas; Al-Ahmadie, Hikmat A.; Tretiakova, Maria] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Perera-Alberto, Montse] Univ La Laguna, Dept Anat, E-38320 Tenerife, Spain	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Howard Hughes Medical Institute; Yale University; University of Chicago; Yale University; University of Chicago; University of Chicago; Universidad de la Laguna	White, KP (corresponding author), Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA.	kpwhite@uchicago.edu	Tretiakova, Maria/U-3320-2019; rzhetsky, andrey/B-6118-2012	rzhetsky, andrey/0000-0001-6959-7405; Liu, Jiang/0000-0002-5687-5047; Brown, Christopher/0000-0002-3785-5008; Negre, Nicolas/0000-0001-9727-3416; Rimm, David/0000-0001-5820-4397	Vaadia-BARD Postdoctoral Fellowship Award; United States Israel Binational Agricultural Research and Development Fund; Lilly [Life Science Research Fellowship]; W. M. Keck Foundation; Arnold and Mabel Beckman Foundation; Searle Funds at The Chicago Community Trust from the Chicago Biomedical Consortium;  [FI-315-2001]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER	Vaadia-BARD Postdoctoral Fellowship Award(US-Israel Binational Science Foundation); United States Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Lilly(Eli Lilly); W. M. Keck Foundation(W.M. Keck Foundation); Arnold and Mabel Beckman Foundation; Searle Funds at The Chicago Community Trust from the Chicago Biomedical Consortium; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jiang, M. Van Lohuizen, C. Chung, D. McEwen for providing expression vectors. Microarray data described in this paper have been deposited in the NCBI Gene Expression Omnibus (GEO) under accession code GSE14086 (expression data) and GSE14289 (ChIP data). M.G. was supported by Vaadia-BARD Postdoctoral Fellowship Award No. FI-315-2001 from BARD, The United States Israel Binational Agricultural Research and Development Fund. C.D.B was supported by a Lilly Life Science Research Fellowship. This work was supported by grants from the W. M. Keck Foundation, the Arnold and Mabel Beckman Foundation, and the Searle Funds at The Chicago Community Trust from the Chicago Biomedical Consortium to K.P.W.	Al-Ahmadie HA, 2008, AM J SURG PATHOL, V32, P377, DOI 10.1097/PAS.0b013e3181570343; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HARDING K, 1986, SCIENCE, V233, P953, DOI 10.1126/science.3755551; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Leibovich BC, 2007, J CLIN ONCOL, V25, P4757, DOI 10.1200/JCO.2007.12.1087; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Nasiadka A., 2002, AD DEV BIOL, V12, P155; Potter C, 2004, CELL CYCLE, V3, P164; Potter CJ, 2000, TRENDS GENET, V16, P33, DOI 10.1016/S0168-9525(99)01878-8; Rosai J., 2004, ROSAI ACKERMANS SURG; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Skinnider BF, 2005, SEMIN DIAGN PATHOL, V22, P51, DOI 10.1053/j.semdp.2005.11.004; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Wang HS, 2006, EMBO J, V25, P5783, DOI 10.1038/sj.emboj.7601461; Weiss C, 2004, CELL CYCLE, V3, P111; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhou M, 2005, CLIN LAB MED, V25, P247, DOI 10.1016/j.cll.2005.01.004	29	95	104	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1218	1222		10.1126/science.1157669	http://dx.doi.org/10.1126/science.1157669			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19164706	Green Accepted, Green Submitted			2022-12-01	WOS:000263687600040
J	Ray, PS; Jia, J; Yao, P; Majumder, M; Hatzoglou, M; Fox, PL				Ray, Partho Sarothi; Jia, Jie; Yao, Peng; Majumder, Mithu; Hatzoglou, Maria; Fox, Paul L.			A stress-responsive RNA switch regulates VEGFA expression	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; TRANSLATIONAL CONTROL; BACILLUS-SUBTILIS; MESSENGER-RNAS; NONCANONICAL FUNCTION; LEADER RNA; HYPOXIA; PROTEIN; RIBOSWITCHES	Ligand binding to structural elements in the non- coding regions of messenger RNA modulates gene expression(1,2). Ligands such as free metabolites or other small molecules directly bind and induce conformational changes in regulatory RNA elements known as riboswitches(1-4). Other types of RNA switches are activated by complexed metabolites - for example, RNA- ligated metabolites such as aminoacyl- charged transfer RNA in the T- box system(5), or protein-bound metabolites in the glucose- or amino- acid- stimulated terminator-anti- terminator systems(6,7). All of these switch types are found in bacteria, fungi and plants(8-10). Here we report an RNA switch in human vascular endothelial growth factor- A ( VEGFA, also known as VEGF) mRNA 39 untranslated region ( UTR) that integrates signals from interferon ( IFN)-gamma and hypoxia to regulate VEGFA translation in myeloid cells. Analogous to riboswitches, the VEGFA 3 ' UTR undergoes a binary conformational change in response to environmental signals. However, the VEGFA 3 ' UTR switch is metabolite independent, and the conformational change is dictated by mutually exclusive, stimulus- dependent binding of proteins, namely, the IFN-gamma-activated inhibitor of translation complex(11,12) and heterogeneous	[Ray, Partho Sarothi; Jia, Jie; Yao, Peng; Fox, Paul L.] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Ray, Partho Sarothi] Indian Inst Sci Educ & Res, Dept Biol, Kolkata 700106, India; [Majumder, Mithu; Hatzoglou, Maria] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Indian Institute of Science Education & Research (IISER) - Kolkata; Case Western Reserve University	Fox, PL (corresponding author), Cleveland Clin, Dept Cell Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	foxp@ccf.org	Ray, Partho Sarothi/H-3020-2019; Yao, Peng/G-5218-2015; Yao, Peng/J-4492-2013; Yao, Peng/Y-8047-2019	Ray, Partho Sarothi/0000-0002-8795-3060; Yao, Peng/0000-0003-1022-3948; Yao, Peng/0000-0002-7029-8629; Yao, Peng/0000-0002-1145-3967; Jia, Jie/0000-0002-9583-1055	National Institutes of Health [P01 HL29582, R01 HL67725, P01 HL76491, R01 DK60596]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067725, P01HL076491, P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053307, R01DK060596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to D. Driscoll and T. M. Henkin for helpful discussions. This work was supported by National Institutes of Health grants P01 HL29582, R01 HL67725 and P01 HL76491 ( to P. L. F.), and R01 DK60596 ( to M. H.).	Bastide A, 2008, NUCLEIC ACIDS RES, V36, P2434, DOI 10.1093/nar/gkn093; Batey RT, 2006, CURR OPIN STRUC BIOL, V16, P299, DOI 10.1016/j.sbi.2006.05.001; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Grundy FJ, 2004, CURR OPIN MICROBIOL, V7, P126, DOI 10.1016/j.mib.2004.02.013; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; KNAPP G, 1989, METHOD ENZYMOL, V180, P192; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Mazumder B, 2001, MOL CELL BIOL, V21, P6440, DOI 10.1128/MCB.21.19.6440-6449.2001; MERINO E, 1995, J BACTERIOL, V177, P6362, DOI 10.1128/jb.177.22.6362-6370.1995; Merrick W C, 2001, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1109s08; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; PINOLROMA S, 1989, J CELL BIOL, V109, P2575, DOI 10.1083/jcb.109.6.2575; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Schilling O, 2004, NUCLEIC ACIDS RES, V32, P2853, DOI 10.1093/nar/gkh611; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3	31	193	197	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					915	919		10.1038/nature07598	http://dx.doi.org/10.1038/nature07598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19098893	Green Accepted			2022-12-01	WOS:000263266700052
J	Nilewski, C; Geisser, RW; Carreira, EM				Nilewski, Christian; Geisser, Roger W.; Carreira, Erick M.			Total synthesis of a chlorosulpholipid cytotoxin associated with seafood poisoning	NATURE			English	Article							COUPLING-CONSTANTS; ADRIATIC MUSSELS; CHLOROSULFOLIPIDS; TOXINS; STEREOCHEMISTRY; OCHROMONAS; OXIDATION; SHELLFISH; LIPIDS	Each year, there are many cases of seafood poisoning in humans worldwide(1). Among the various toxins isolated that contribute to these poisonings(2,3), the chlorosulpholipids are particularly intriguing because of their structural and stereochemical complexity(4-12). The mechanism of biological activity remains unknown and, although chlorosulpholipids are associated with membranes in the organisms from which they are isolated, little is understood about their role within biological membranes. The lack of availability of the natural products has impaired more in-depth biochemical studies. So far, none of the chlorosulpholipids have been obtained from total synthesis, and efficient routes to their synthesis would be desirable for the preparation ofmaterial for pharmacological characterization and proper evaluation of the risk to human health. Despite the notable advances in the science of organic synthesis, reliable methods for stereoselective construction of polychlorinated acyclic substrates are lacking, although some preliminary investigations have appeared(13-15). Here we report the synthesis of a chlorosulpholipid cytotoxin, leading to confirmation of the proposed structure and the discovery of unanticipated reactivity of polychlorinated hydrocarbons. The concise synthetic approach should enable the preparation of material in sufficient quantities to facilitate biological studies.	[Nilewski, Christian; Geisser, Roger W.; Carreira, Erick M.] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Carreira, EM (corresponding author), ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland.	carreira@org.chem.ethz.ch		Carreira, Erick/0000-0003-1472-490X	Swiss National Science Foundation; ETH Zurich; F. Hoffmann-La Roche; Eli Lilly; Boehringer Ingelheim	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); F. Hoffmann-La Roche(Hoffmann-La Roche); Eli Lilly(Eli Lilly); Boehringer Ingelheim(Boehringer Ingelheim)	We thank M.-O. Ebert for acquisition and discussion of the NMR data needed for J-based configuration analysis as well as W. B. Schweizer for the X-ray crystallographic analysis. C.N. thanks the Stiftung Stipendien-Fonds des Verbandes der Chemischen Industrie for a Kekule-Fellowship. This research was supported by the Swiss National Science Foundation and ETH Zurich. We are grateful for support for our program from F. Hoffmann-La Roche, Eli Lilly and Boehringer Ingelheim.	AHMED FE, 1991, J TOXICOL-TOXIN REV, V10, P263, DOI 10.3109/15569549109053858; CHA JK, 1984, TETRAHEDRON, V40, P2247, DOI 10.1016/0040-4020(84)80008-3; CHEN JL, 1994, J NAT PROD, V57, P524, DOI 10.1021/np50106a015; Ciminiello P, 2004, TETRAHEDRON, V60, P7093, DOI 10.1016/j.tet.2003.12.072; Ciminiello P, 2004, EUR J ORG CHEM, V2004, P2533, DOI 10.1002/ejoc.200300769; Ciminiello P, 2002, J AM CHEM SOC, V124, P13114, DOI 10.1021/ja0207347; Ciminiello P, 2001, J ORG CHEM, V66, P578, DOI 10.1021/jo001437s; ELOVSON J, 1969, P NATL ACAD SCI USA, V62, P957, DOI 10.1073/pnas.62.3.957; ELOVSON J, 1970, BIOCHEMISTRY-US, V9, P3110, DOI 10.1021/bi00818a002; HAINES TH, 1973, ANNU REV MICROBIOL, V27, P403, DOI 10.1146/annurev.mi.27.100173.002155; Hunter L, 2006, J AM CHEM SOC, V128, P16422, DOI 10.1021/ja066188p; Kang SH, 2005, CHEM REV, V105, P4537, DOI 10.1021/cr040608g; Kozminski W, 1997, J MAGN RESON, V124, P383, DOI 10.1006/jmre.1996.1016; MacCoss RN, 2003, TETRAHEDRON LETT, V44, P7779, DOI 10.1016/j.tetlet.2003.08.081; Matsumori N, 1999, J ORG CHEM, V64, P866, DOI 10.1021/jo981810k; MERCER EI, 1974, PHYTOCHEMISTRY, V13, P1607, DOI 10.1016/0031-9422(74)80337-7; MERCER EI, 1975, PHYTOCHEMISTRY, V14, P1545, DOI 10.1016/0031-9422(75)85348-9; Nakata T, 2005, CHEM REV, V105, P4314, DOI 10.1021/cr040627q; PADDONROW MN, 1982, J AM CHEM SOC, V104, P7162, DOI 10.1021/ja00389a045; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; PETERSON PE, 1967, J AM CHEM SOC, V89, P5902, DOI 10.1021/ja00999a029; PETERSON PE, 1971, TETRAHEDRON LETT, V12, P13; Schlama T, 1997, ANGEW CHEM INT EDIT, V36, P2342, DOI 10.1002/anie.199723421; Shibuya GM, 2008, J AM CHEM SOC, V130, P12514, DOI 10.1021/ja804167v; TAKAI K, 1986, J AM CHEM SOC, V108, P7408, DOI 10.1021/ja00283a046; YASUMOTO T, 1993, CHEM REV, V93, P1897, DOI 10.1021/cr00021a011; Yoshimitsu T, 2009, J ORG CHEM, V74, P696, DOI 10.1021/jo802093d	27	117	118	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					573	U76		10.1038/nature07734	http://dx.doi.org/10.1038/nature07734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	400FA	19177127				2022-12-01	WOS:000262852200039
J	Towse, A				Towse, Adrian			Should NICE's threshold range for cost per QALY be raised? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Towse, Adrian] Off Hlth Econ, London SW1A 2DY, England		Towse, A (corresponding author), Off Hlth Econ, London SW1A 2DY, England.	atowse@ohe.org	Towse, Adrian/M-3760-2014					APPLEBY J, HLTH POLICY IN PRESS; Culyer Anthony, 2007, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567; *DEP TRANSP, 2007, 12005 DEP TRANSP; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; *HOUS COMM HLTH SE, 2008, 1 REP SESS 2007 08, P103; MARTIN S, 2007, LINK HLTH CARE SPEND; MASON H, 2008, HLTH EC         1014; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; *NAT I HLTH CLIN E, 2008, NICES RESP COMM 1 RE; National Institute for Health and Clinical Excellence, 2008, GUID METH TECHN APPR; National Institute for Health and Clinical Excellence (NICE), 2009, APPR LIF EXT END LIF; WILLIAMS A, 2002, COST EFFECTIVENESS T, P85; Williams I, 2008, HEALTH TECHNOL ASSES, V12, P1	13	55	55	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2009	338								b181	10.1136/bmj.b181	http://dx.doi.org/10.1136/bmj.b181			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405EK	19171561				2022-12-01	WOS:000263205300011
J	Moffitt, JR; Chemla, YR; Aathavan, K; Grimes, S; Jardine, PJ; Anderson, DL; Bustamante, C				Moffitt, Jeffrey R.; Chemla, Yann R.; Aathavan, K.; Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.; Bustamante, Carlos			Intersubunit coordination in a homomeric ring ATPase	NATURE			English	Article							DNA PACKAGING MOTOR; REPLICATIVE HEXAMERIC HELICASE; OPTICAL TWEEZERS; PORTAL MOTOR; BACTERIOPHAGE PHI-29; TERMINATION FACTOR; INTERNAL FORCE; MECHANISM; TRANSLOCATION; MECHANOCHEMISTRY	Homomeric ring ATPases perform many vital and varied tasks in the cell, ranging from chromosome segregation to protein degradation. Here we report the direct observation of the intersubunit coordination and step size of such a ring ATPase, the double- stranded- DNA packaging motor in the bacteriophage phi 29. Using high- resolution optical tweezers, we find that packaging occurs in increments of 10 base pairs ( bp). Statistical analysis of the preceding dwell times reveals that multiple ATPs bind during each dwell, and application of high force reveals that these 10- bp increments are composed of four 2.5- bp steps. These results indicate that the hydrolysis cycles of the individual subunits are highly coordinated by means of a mechanism novel for ring ATPases. Furthermore, a step size that is a non- integer number of base pairs demands new models for motor - DNA interactions.	[Moffitt, Jeffrey R.; Chemla, Yann R.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Moffitt, Jeffrey R.; Chemla, Yann R.; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Aathavan, K.; Bustamante, Carlos] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Anderson, Dwight L.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Chemla, Yann/0000-0001-9167-0234; Bustamante, Carlos/0000-0002-2970-0073; Jardine, Paul/0000-0002-1090-0550	National Science Foundation's Graduate Research Fellowship; Burroughs Welcome Fund's Career Awards at the Scientific Interface; NIH [GM-071552, DE-003606, GM-059604]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003606, R37DE003606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059604, R01GM071552] Funding Source: NIH RePORTER	National Science Foundation's Graduate Research Fellowship(National Science Foundation (NSF)); Burroughs Welcome Fund's Career Awards at the Scientific Interface(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. L. Hetherington, M. Nollmann and G. Chistol for a critical reading of the manuscript; C. L. Hetherington, A. Politzer, M. Strycharska, M. Kopaczynska and J. Yu for critical discussions; and J. Choy, S. Grill and S. Smith for advice regarding instrumentation. J.R.M. acknowledges the National Science Foundation's Graduate Research Fellowship and Y.R.C. the Burroughs Welcome Fund's Career Awards at the Scientific Interface for funding. This research was supported in part by NIH grants GM-071552, DE-003606 and GM-059604. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; BLOCK SM, 1995, BIOPHYS J, V68, pS230; Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Bustamante C., 2008, SINGLE MOL TECHNIQUE, P297; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Chemla YR, 2008, J PHYS CHEM B, V112, P6025, DOI 10.1021/jp076153r; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chen CP, 1997, J VIROL, V71, P3864, DOI 10.1128/JVI.71.5.3864-3871.1997; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P11245, DOI 10.1073/pnas.0701323104; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Grimes S, 2002, ADV VIRUS RES, V58, P255, DOI 10.1016/S0065-3527(02)58007-6; Grimes S, 1997, J MOL BIOL, V266, P901, DOI 10.1006/jmbi.1996.0843; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1986, P NATL ACAD SCI USA, V83, P3505, DOI 10.1073/pnas.83.10.3505; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kainov DE, 2006, CELL MOL LIFE SCI, V63, P1095, DOI 10.1007/s00018-005-5450-3; Kellner L., 1937, P ROY SOC LOND A MAT, V159, P0410; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Koza Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031905; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lisal J, 2005, NAT STRUCT MOL BIOL, V12, P460, DOI 10.1038/nsmb927; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Morais MC, 2001, J STRUCT BIOL, V135, P38, DOI 10.1006/jsbi.2001.4379; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Segel I. H, 1993, ENZYME KINETICS; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; YANAGI K, 1991, J MOL BIOL, V217, P201, DOI 10.1016/0022-2836(91)90620-L	50	214	217	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					446	U2		10.1038/nature07637	http://dx.doi.org/10.1038/nature07637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19129763	Green Accepted			2022-12-01	WOS:000262519200039
J	Do, MTH; Kang, SH; Xue, T; Zhong, HN; Liao, HW; Bergles, DE; Yau, KW				Do, Michael Tri H.; Kang, Shin H.; Xue, Tian; Zhong, Haining; Liao, Hsi-Wen; Bergles, Dwight E.; Yau, King-Wai			Photon capture and signalling by melanopsin retinal ganglion cells	NATURE			English	Article							CONE PHOTORECEPTORS; LIGHT RESPONSES; MICE; PHOTOPIGMENT; REFLEX; EXPRESSION; RODS; SET	A subset of retinal ganglion cells has recently been discovered to be intrinsically photosensitive, with melanopsin as the pigment. These cells project primarily to brain centres for non- image- forming visual functions such as the pupillary light reflex and circadian photoentrainment. How well they signal intrinsic light absorption to drive behaviour remains unclear. Here we report fundamental parameters governing their intrinsic light responses and associated spike generation. The membrane density of melanopsin is 10(4)-fold lower than that of rod and cone pigments, resulting in a very low photon catch and a phototransducing role only in relatively bright light. Nonetheless, each captured photon elicits a large and extraordinarily prolonged response, with a unique shape among known photoreceptors. Notably, like rods, these cells are capable of signalling single- photon absorption. A flash causing a few hundred isomerized melanopsin molecules in a retina is sufficient for reaching threshold for the pupillary light reflex.	[Do, Michael Tri H.; Kang, Shin H.; Xue, Tian; Zhong, Haining; Liao, Hsi-Wen; Bergles, Dwight E.; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Yau, King-Wai] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Do, Michael Tri H.; Xue, Tian; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Do, MTH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	mdo@jhmi.edu; kwyau@mail.jhmi.edu	Bergles, Dwight/U-8343-2019; H, Michael Tri/A-5917-2009; Xue, Tian/G-9009-2018	Bergles, Dwight/0000-0002-7133-7378; H, Michael Tri/0000-0001-6418-0977; Zhong, Haining/0000-0002-7109-4724	NRSA; VNTP Training Grant; NIH; NATIONAL EYE INSTITUTE [R01EY014596, F32EY016959, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VNTP Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by an NRSA fellowship and a VNTP Training Grant to M. T. H. D., and NIH grants to K.-W.Y. and D. E. B. We thank Y. Koutalos, V. Bhandawat, D.-G. Luo, V. Kefalov, D. Liu, G. Maimon and C.-Y. Su for discussions, and Y. Wang, J. Hsieh and N. Nishiyama for technical assistance. We also thank J. Nathans and R. Reeves for suggestions on transgenic lines, J. Nathans and H. Cahill for the Gnat1<SUP>-/-</SUP> cl mouse line, and T. Shelley for machining. We dedicate this work to the Champalimaud Foundation, Portugal.	BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dartnell HJA, 1972, PHOTOCHEMISTRY VISIO, P122; Dorlochter M, 1997, PROG NEUROBIOL, V53, P451, DOI 10.1016/S0301-0082(97)00046-4; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Grozdanic S, 2003, CURR EYE RES, V26, P371, DOI 10.1076/ceyr.26.5.371.15439; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; HARDIE RC, 2008, COMPREHENSIVE REFERE; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; KRAFT TW, 1988, J PHYSIOL-LONDON, V404, P199, DOI 10.1113/jphysiol.1988.sp017286; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001; LISMAN JE, 1977, J GEN PHYSIOL, V70, P621, DOI 10.1085/jgp.70.5.621; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; LUO DG, 2008, SENSES COMPREHENSIVE; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Perez-Leon JA, 2006, EUR J NEUROSCI, V24, P1117, DOI 10.1111/j.1460-9568.2006.04999.x; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; QIU X, 2007, INVEST OPHTHALMOL VI, V48; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; WONG KY, 2008, INVEST OPHTHALMOL VI, V49; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	50	204	213	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					281	U2		10.1038/nature07682	http://dx.doi.org/10.1038/nature07682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19118382	Green Accepted			2022-12-01	WOS:000262440900032
J	Yarbrough, ML; Li, Y; Kinch, LN; Grishin, NV; Ball, HL; Orth, K				Yarbrough, Melanie L.; Li, Yan; Kinch, Lisa N.; Grishin, Nick V.; Ball, Haydn L.; Orth, Kim			AMPylation of Rho GTPases by Vibrio VopS Disrupts Effector Binding and Downstream Signaling	SCIENCE			English	Article							III SECRETION SYSTEM; PARAHAEMOLYTICUS; PROTEIN; ACTIVATION	The Vibrio parahaemolyticus type III effector VopS is implicated in cell rounding and the collapse of the actin cytoskeleton by inhibiting Rho guanosine triphosphatases ( GTPases). We found that VopS could act to covalently modify a conserved threonine residue on Rho, Rac, and Cdc42 with adenosine 5 '- monophosphate ( AMP). The resulting AMPylation prevented the interaction of Rho GTPases with downstream effectors, thereby inhibiting actin assembly in the infected cell. Eukaryotic proteins were also directly modified with AMP, potentially expanding the repertoire of posttranslational modifications for molecular signaling.	[Yarbrough, Melanie L.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Li, Yan; Ball, Haydn L.] Univ Texas SW Med Ctr Dallas, Prot Chem Technol Ctr, Dallas, TX 75390 USA; [Li, Yan; Ball, Haydn L.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Yarbrough, Melanie/T-4078-2019; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Kinch, Lisa/0000-0003-3041-2615; Yarbrough, Melanie/0000-0003-2166-7552	NIH-Allergy and Infectious Disease [R01-AI056404]; Welch Foundation [I-1561, I-1505]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER	NIH-Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Alto, R. Taussig, P. Sternweis, S. Mukherjee, M. Rosen, E. Olson, J. Goldstein, M. Brown, T. Iida, T. Honda, L. McCarter, and the Orth lab for insightful discussions, critical reading, and/or generous supply of reagents. K.O. and M.L.Y. are supported by grants from NIH-Allergy and Infectious Disease (R01-AI056404) and the Welch Foundation (I-1561). L.N.K. and N.G. are supported by the Welch Foundation (I-1505) and Howard Hughes Medical Institute. K.O. is a Beckman Young Investigator, Burroughs Wellcome Investigator, and W. W. Caruth Biomedical Scholar.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; BLISKA JB, 1991, P NATL ACAD SCI USA, V88, P1187, DOI 10.1073/pnas.88.4.1187; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Burdette DL, 2008, P NATL ACAD SCI USA, V105, P12497, DOI 10.1073/pnas.0802773105; Casselli T, 2008, INFECT IMMUN, V76, P2202, DOI 10.1128/IAI.01704-07; CHOCK PB, 1980, ANNU REV BIOCHEM, V49, P813, DOI 10.1146/annurev.bi.49.070180.004121; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; UTSUMI R, 1982, J BACTERIOL, V151, P807, DOI 10.1128/JB.151.2.807-812.1982	14	283	303	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					269	272		10.1126/science.1166382	http://dx.doi.org/10.1126/science.1166382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19039103				2022-12-01	WOS:000262290600043
J	Gupta, A; Khaw, FM; Stokle, EL; George, RC; Pebody, R; Stansfield, RE; Sheppard, CL; Slack, M; Gorton, R; Spencer, DA				Gupta, Atul; Khaw, F-M; Stokle, E. L.; George, R. C.; Pebody, R.; Stansfield, R. E.; Sheppard, C. L.; Slack, M.; Gorton, R.; Spencer, D. A.			Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PNEUMOCOCCAL PNEUMONIA; PARAPNEUMONIC EMPYEMA; INVASIVE DISEASE; BURKINA-FASO; MENINGITIS; INFECTION; EPIDEMIC		[Khaw, F-M; Stokle, E. L.; Gorton, R.] Hlth Protect Agcy NE, No Off, Newcastle Upon Tyne NE1 4WH, Tyne & Wear, England; [Gupta, Atul; Spencer, D. A.] Freeman Rd Hosp, Pediat Resp Unit, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [George, R. C.; Pebody, R.; Sheppard, C. L.; Slack, M.] Hlth Protect Agcy, Ctr Infect, London NW9 5EQ, England; [Stansfield, R. E.] N Tyneside Gen Hosp, Microbiol Lab Serv, Northumbria Healthcare NHS Fdn Trust, North Shields NE29 8NH, England	Newcastle Freeman Hospital; Newcastle University - UK; Health Protection Agency	Khaw, FM (corresponding author), Hlth Protect Agcy NE, No Off, Newcastle Upon Tyne NE1 4WH, Tyne & Wear, England.	Meng.khaw@hpa.org.uk		Pebody, Richard/0000-0002-9069-2885				*BIN, NOW STREPT PNEUM TES; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Byington CL, 2006, PEDIATR INFECT DIS J, V25, P250, DOI 10.1097/01.inf.0000202137.37642.ab; Byington CL, 2002, CLIN INFECT DIS, V34, P434, DOI 10.1086/338460; Cashman P, 2007, COMMUN DIS INTELL, V31, P296; Crum NF, 2003, AM J PREV MED, V25, P107, DOI 10.1016/S0749-3797(03)00114-4; Dagan R, 2000, CLIN INFECT DIS, V30, P319, DOI 10.1086/313645; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Eltringham G, 2003, J CLIN MICROBIOL, V41, P521, DOI 10.1128/JCM.41.1.521-522.2003; GRATTEN M, 1993, MED J AUSTRALIA, V158, P340, DOI 10.5694/j.1326-5377.1993.tb121794.x; Hausdorff WP, 2007, VACCINE, V25, P2406, DOI 10.1016/j.vaccine.2006.09.009; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Leeming JP, 2005, J CLIN MICROBIOL, V43, P4972, DOI 10.1128/JCM.43.10.4972-4976.2005; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; MERCAT A, 1991, CHEST, V99, P147, DOI 10.1378/chest.99.1.147; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; Proulx J F, 2002, Can Commun Dis Rep, V28, P129; Ramphul N, 2006, PEDIATR PULM, V41, P750, DOI 10.1002/ppul.20434; RAUCH AM, 1990, AM J DIS CHILD, V144, P923, DOI 10.1001/archpedi.1990.02150320087033; SHEPPARD CL, 2006, THESIS ST MARYS COLL; SHEPPARD CL, 2006, 5 INT S PNEUM PNEUM; Tan TQ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.1; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	25	15	17	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 31	2008	337								a2964	10.1136/bmj.a2964	http://dx.doi.org/10.1136/bmj.a2964			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401MZ	19118084				2022-12-01	WOS:000262946300001
J	Buehr, M; Meek, S; Blair, K; Yang, J; Ure, J; Silva, J; Mclay, R; Hall, J; Ying, QL; Smith, A				Buehr, Mia; Meek, Stephen; Blair, Kate; Yang, Jian; Ure, Janice; Silva, Jose; McLay, Renee; Hall, John; Ying, Qi-Long; Smith, Austin			Capture of Authentic Embryonic Stem Cells from Rat Blastocysts	CELL			English	Article							PRIMORDIAL GERM-CELLS; DIFFERENTIATION INHIBITING ACTIVITY; SELF-RENEWAL; X-CHROMOSOME; TRANSCRIPTIONAL NETWORK; MOUSE EPIBLAST; PLURIPOTENCY; ESTABLISHMENT; LINES; FGF	Embryonic stem (ES) cells have been available from inbred mice since 1981 but have not been validated for other rodents. Failure to establish ES cells from a range of mammals challenges the identity of cultivated stem cells and our understanding of the pluripotent state. Here we investigated derivation of ES cells from the rat. We applied molecularly defined conditions designed to shield the ground state of authentic pluripotency from inductive differentiation stimuli. Undifferentiated cell lines developed that exhibited diagnostic features of ES cells including colonization of multiple tissues in viable chimeras. Definitive ES cell status was established by transmission of the cell line genome to offspring. Derivation of germline-competent ES cells from the rat paves the way to targeted genetic manipulation in this valuable biomedical model species. Rat ES cells will also provide a refined test-bed for functional evaluation of pluripotent stem cell-derived tissue repair and regeneration.	[Blair, Kate; Yang, Jian; Silva, Jose; Hall, John; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Buehr, Mia; Meek, Stephen; Ure, Janice; McLay, Renee; Ying, Qi-Long] Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; [Buehr, Mia; Meek, Stephen] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Blair, Kate; Silva, Jose; Hall, John; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Yang, Jian] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200032, Peoples R China	University of Cambridge; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Cambridge; Fudan University	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	austin.smith@cscr.cam.ac.uk	Silva, Jose C R/X-5140-2019; Silva, Jose/G-1920-2014	Silva, Jose C R/0000-0001-5487-1117; Silva, Jose/0000-0001-5487-1117; Blair, Kate/0000-0003-0766-0952; Smith, Austin/0000-0002-3029-4682	National Institute on Drug Abuse at National Institutes of Health; Biotechnology and Biological Sciences Research Council of the United Kingdom; European Commission project EuroStemCell; Gates Cambridge Scholar; Medical Research Council; Medical Research Council [G9806702] Funding Source: researchfish; MRC [G9806702] Funding Source: UKRI	National Institute on Drug Abuse at National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission project EuroStemCell(European CommissionEuropean Commission Joint Research Centre); Gates Cambridge Scholar; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Jennifer Nichols provided advice throughout and comments on the manuscript. We thank Carolyn Manson, John Agnew, and Andrew Dyer for expert animal care and Rachel Walker for flow cytometry. We are indebted to Frances Lovell and Willem Rens at the Cambridge Resource Centre for Comparitive Genomics for FISH. We are grateful to Philip Cohen and colleagues at the Division of Signal Transduction Therapy, University of Dundee, for inhibitors and Thomas Jenuwein for H3K27me3 antibody. This research was funded by the National Institute on Drug Abuse at National Institutes of Health, the Biotechnology and Biological Sciences Research Council of the United Kingdom, and the European Commission project EuroStemCell. K. B. is a Gates Cambridge Scholar. A.S. is a Medical Research Council Professor. A.S., Q.L.Y., and M. B. conceived and planned the study. M. B. characterized ICM explants and derived cell lines; S. M. performed molecular expression profiling, transfections, and genotyping; K. B. analyzed feeder-free culture and LIF responsiveness; J.Y., J.S., and J.H. performed additional characterization experiments; J.U. and R.M. generated chimeras; and A.S. wrote the paper. A.S. and Q.-L.Y. are inventors on a patent relating to this study filed by the University of Edinburgh and licensed to Stem Cell Sciences LTD. A.S. is a remunerated scientific advisor to the Stem Cell Sciences LTD.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BATLLEMORERA L, 2008, GENESIS         1006, DOI DOI 10.1002/DVG.20442; Brenin D, 1997, TRANSPLANT P, V29, P1761, DOI 10.1016/S0041-1345(97)00046-8; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gardner RL, 1997, INT J DEV BIOL, V41, P235; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nichols J, 1998, REPROD FERT DEVELOP, V10, P517, DOI 10.1071/RD98075; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Prelle K, 1999, CELLS TISSUES ORGANS, V165, P220, DOI 10.1159/000016683; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; RATHJEN PD, 1990, GENE DEV, V4, P2308, DOI 10.1101/gad.4.12b.2308; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith A, 2001, COLD SPRING HARBOR M, P205; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Smith AG., 1991, J TISSUE CULTURE MET, V13, P89, DOI [DOI 10.1007/BF01666137, 10.1007/BF01666137, 10.1007/bf01666137]; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; YAMAMURA K, 1981, DEV GENET, V2, P131, DOI 10.1002/dvg.1020020111; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	63	583	658	0	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1287	1298		10.1016/j.cell.2008.12.007	http://dx.doi.org/10.1016/j.cell.2008.12.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109897	Bronze			2022-12-01	WOS:000261989800019
J	Blein, T; Pulido, A; Vialette-Guiraud, A; Nikovics, K; Morin, H; Hay, A; Johansen, IE; Tsiantis, M; Laufs, P				Blein, Thomas; Pulido, Amada; Vialette-Guiraud, Aurelie; Nikovics, Krisztina; Morin, Halima; Hay, Angela; Johansen, Ida Elisabeth; Tsiantis, Miltos; Laufs, Patrick			A Conserved Molecular Framework for Compound Leaf Development	SCIENCE			English	Article							RELATIVE CARDAMINE-HIRSUTA; CUP-SHAPED-COTYLEDON; ARABIDOPSIS-THALIANA; ORGAN BOUNDARIES; AUXIN TRANSPORT; APICAL MERISTEM; GENETIC-CONTROL; MORPHOGENESIS; TOMATO	Diversity in leaf shape is produced by alterations of the margin: for example, deep dissection leads to leaflet formation and less- pronounced incision results in serrations or lobes. By combining gene silencing and mutant analyses in four distantly related eudicot species, we show that reducing the function of NAM/CUC boundary genes (NO APICAL MERISTEM and CUP-SHAPED COTYLEDON) leads to a suppression of all marginal outgrowths and to fewer and fused leaflets. We propose that NAM/CUC genes promote formation of a boundary domain that delimits leaflets. This domain has a dual role promoting leaflet separation locally and leaflet formation at distance. In this manner, boundaries of compound leaves resemble boundaries functioning during animal development.	[Blein, Thomas; Pulido, Amada; Vialette-Guiraud, Aurelie; Nikovics, Krisztina; Morin, Halima; Laufs, Patrick] INRA, Biol Cellulaire Lab, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Hay, Angela; Tsiantis, Miltos] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Johansen, Ida Elisabeth] Univ Aarhus, Dept Genet & Biotechnol, DK-1871 Frederiksberg C, Denmark	INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford; Aarhus University	Laufs, P (corresponding author), INRA, Biol Cellulaire Lab, Inst Jean Pierre Bourgin, F-78026 Versailles, France.	laufs@versailles.inra.fr	Johansen, Ida E/F-7792-2014; Blein, Thomas/L-8508-2019; Pulido, Amada/B-8199-2011	Johansen, Ida E/0000-0001-8660-2018; Blein, Thomas/0000-0001-9788-5201; Pulido, Amada/0000-0003-4241-7042; Laufs, Patrick/0000-0003-4459-3445	Action Concertee Incitative "Jeunes Chercheuses et Jeunes Chercheurs" and the trilateral Genoplante GENOSOME [TRIL-046]; Ministere de l'Enseignement Superieur et de la Recherche; Fundacion Espanola para la Ciencia y la Tecnologia (Ministerio de Ciencia e Innovacion); Region Ile-de-France; UK Biotechnology and Biological	Action Concertee Incitative "Jeunes Chercheuses et Jeunes Chercheurs" and the trilateral Genoplante GENOSOME; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fundacion Espanola para la Ciencia y la Tecnologia (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Region Ile-de-France(Region Ile-de-France); UK Biotechnology and Biological	This work was partly supported by an Action Concertee Incitative "Jeunes Chercheuses et Jeunes Chercheurs" and the trilateral Genoplante GENOSOME program TRIL-046. T.B. was supported by a Ph. D. fellowship from the Ministere de l'Enseignement Superieur et de la Recherche, and A.P. was supported by the Fundacion Espanola para la Ciencia y la Tecnologia (Ministerio de Ciencia e Innovacion) and the Region Ile-de-France. M.T. is supported by the UK Biotechnology and Biological	Aida M, 2006, CURR OPIN PLANT BIOL, V9, P72, DOI 10.1016/j.pbi.2005.11.011; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Aida M, 1999, DEVELOPMENT, V126, P1563; Aida M, 2006, PLANT MOL BIOL, V60, P915, DOI 10.1007/s11103-005-2760-7; Barkoulas M, 2008, NAT GENET, V40, P1136, DOI 10.1038/ng.189; Barkoulas M, 2007, CURR OPIN PLANT BIOL, V10, P660, DOI 10.1016/j.pbi.2007.07.012; Brand A, 2007, PLANTA, V226, P941, DOI 10.1007/s00425-007-0540-0; Breuil-Broyer S, 2004, PLANT J, V38, P182, DOI 10.1111/j.1365-313X.2004.02026.x; Champagne C, 2004, DEVELOPMENT, V131, P4401, DOI 10.1242/dev.01338; Champagne CEM, 2007, PLANT CELL, V19, P3369, DOI 10.1105/tpc.107.052886; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hofer J, 1997, CURR BIOL, V7, P581, DOI 10.1016/S0960-9822(06)00257-0; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203	23	244	266	6	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1835	1839		10.1126/science.1166168	http://dx.doi.org/10.1126/science.1166168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095941				2022-12-01	WOS:000261799400052
J	Sokol, DK				Sokol, Daniel K.			Paving the way for assisted suicide	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London, Univ London St Georges Hosp, London WC1E 7HU, England	St Georges University London; University of London	Sokol, DK (corresponding author), Univ London, Univ London St Georges Hosp, London WC1E 7HU, England.	daniel.sokol@talk21.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 11	2008	337								a3010	10.1136/bmj.a3010	http://dx.doi.org/10.1136/bmj.a3010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CB	19074231				2022-12-01	WOS:000262776900018
J	Choi, H; Sell, RL; Lenert, L; Muennig, P; Goodman, RR; Gilliam, FG; Wong, JB				Choi, Hyunmi; Sell, Randall L.; Lenert, Leslie; Muennig, Peter; Goodman, Robert R.; Gilliam, Frank G.; Wong, John B.			Epilepsy Surgery for Pharmacoresistant Temporal Lobe Epilepsy A Decision Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUDDEN UNEXPECTED DEATH; MEDICALLY REFRACTORY EPILEPSY; LIFE EXPECTANCY; RISK-FACTOR; MORTALITY; LOBECTOMY; PREDICTORS; PROGNOSIS; OUTCOMES; THERAPY	Context Patients with pharmacoresistant epilepsy have increased mortality compared with the general population, but patients with pharmacoresistant temporal lobe epilepsy who meet criteria for surgery and who become seizure- free after anterior temporal lobe resection have reduced excess mortality vs those with persistent seizures. Objective To quantify the potential survival benefit of anterior temporal lobe resection for patients with pharmacoresistant temporal lobe epilepsy vs continued medical management. Design Monte Carlo simulation model that incorporates possible surgical complications and seizure status, with 10 000 runs. The model was populated with health-related quality- of- life data obtained directly from patients and data from the medical literature. Insufficient data were available to assess gamma- knife radiosurgery or vagal nerve stimulation. Main Outcome Measures Life expectancy and quality- adjusted life expectancy. Results Compared with medical management, anterior temporal lobe resection for a 35- year- old patient with an epileptogenic zone identified in the anterior temporal lobe would increase survival by 5.0 years ( 95% CI, 2.1- 9.2) with surgery preferred in 100% of the simulations. Anterior temporal lobe resection would increase qualityadjusted life expectancy by 7.5 quality- adjusted life- years ( 95%, CI, - 0.8 to 17.4) with surgery preferred in 96.5% of the simulations, primarily due to increased years spent without disabling seizures, thereby reducing seizure- related excess mortality and improving quality of life. The results were robust to sensitivity analyses. Conclusion The decision analysis model suggests that on average anterior temporal lobe resection should provide substantial gains in life expectancy and qualityadjusted life expectancy for surgically eligible patients with pharmacoresistant temporal lobe epilepsy compared with medical management.	[Choi, Hyunmi; Gilliam, Frank G.] Columbia Univ, Dept Neurol, New York, NY USA; [Goodman, Robert R.] Columbia Univ, Dept Neurol Surg, New York, NY USA; [Muennig, Peter] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA; [Sell, Randall L.] Drexel Univ, Sch Publ Hlth, Dept Community Hlth & Prevent, Philadelphia, PA 19104 USA; [Lenert, Leslie] Ctr Dis Control & Prevent, Natl Ctr Publ Hlth Informat, Atlanta, GA USA; [Wong, John B.] Tufts Univ, Sch Med, Dept Med, Div Clin Decis Making,Tufts Med Ctr, Boston, MA 02111 USA	Columbia University; Columbia University; Columbia University; Drexel University; Centers for Disease Control & Prevention - USA; Tufts Medical Center; Tufts University	Choi, H (corresponding author), Neurol Inst, Columbia Comprehens Epilepsy Ctr, 710 W 168Th St,Box 210, New York, NY 10032 USA.	hc323@columbia.edu		Muennig, Peter/0000-0002-4234-0498; Wong, John/0000-0003-4203-9010	National Center for Research Resources [KL2 RR024157]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157, K12RR017648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS047551] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This publication was made possible by grant KL2 RR024157 (Dr Choi) from the National Center for Research Resources, a component of the National Institutes of Health, and NIH Roadmap for Medical Research.	Annegers JF, 1998, EPILEPSIA, V39, P206, DOI 10.1111/j.1528-1157.1998.tb01360.x; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; BAILEY P, 1951, JAMA-J AM MED ASSOC, V145, P365, DOI 10.1001/jama.1951.02920240001001; Benbadis SR, 2003, SEIZURE-EUR J EPILEP, V12, P167, DOI 10.1016/S1059-1311(02)00320-5; Burneo JG, 2008, SEIZURE-EUR J EPILEP, V17, P314, DOI 10.1016/j.seizure.2007.10.002; Burneo JG, 2006, ARCH NEUROL-CHICAGO, V63, P1106, DOI 10.1001/archneur.63.8.1106; Choi H, 2008, EPILEPSIA, V49, P1440, DOI 10.1111/j.1528-1167.2008.01601.x; DASHEIFF RM, 1991, J CLIN NEUROPHYSIOL, V8, P216, DOI 10.1097/00004691-199104000-00010; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Gennaro G, 2004, CLIN NEUROPHYSIOL, V115, P1212, DOI 10.1016/j.clinph.2003.12.008; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DUCHOWNY MSH, 2008, EPILEPSY COMPREHENSI, V2, P1751; Elstein AS, 2002, BRIT MED J, V324, P729, DOI 10.1136/bmj.324.7339.729; Engel J, 1999, ARCH NEUROL-CHICAGO, V56, P1338, DOI 10.1001/archneur.56.11.1338; ENGEL J, 1993, NEUROLOGY, V43, P1612, DOI 10.1212/WNL.43.8.1612; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Engel J, 1998, NEUROLOGY, V51, P1243, DOI 10.1212/WNL.51.5.1243; Engel J, 2008, EPILEPSY COMPREHENSI, V2; Engel Jerome Jr., 1993, P609; Foldvary N, 2000, NEUROLOGY, V54, P630, DOI 10.1212/WNL.54.3.630; GEORGE R, 1995, NEUROLOGY, V45, P224, DOI 10.1212/wnl.45.2.224; Gilliam F, 1999, NEUROLOGY, V53, P687, DOI 10.1212/WNL.53.4.687; GOLDMAN L, 1988, NEW ENGL J MED, V319, P152, DOI 10.1056/NEJM198807213190306; Hakimi AS, 2008, EPILEPSY BEHAV, V13, P96, DOI 10.1016/j.yebeh.2008.02.003; Hennessy MJ, 1999, NEUROLOGY, V53, P1276, DOI 10.1212/WNL.53.6.1276; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Janszky J, 2005, BRAIN, V128, P395, DOI 10.1093/brain/awh358; Jeha LE, 2006, NEUROLOGY, V66, P1938, DOI 10.1212/01.wnl.0000219810.71010.9b; Jeong SW, 2005, EPILEPSIA, V46, P1273, DOI 10.1111/j.1528-1167.2005.33504.x; Kelemen A, 2006, SEIZURE-EUR J EPILEP, V15, P49, DOI 10.1016/j.seizure.2005.10.007; Kelley K, 2005, NEUROLOGY, V64, P1974, DOI 10.1212/01.WNL.0000163998.01543.CF; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Langan Y, 2005, NEUROLOGY, V64, P1131, DOI 10.1212/01.WNL.0000156352.61328.CB; Langan Y, 2000, J NEUROL NEUROSUR PS, V68, P211, DOI 10.1136/jnnp.68.2.211; LEE BI, 2004, NEUROL ASIA, V9, P47; Lhatoo SD, 2003, EPILEPSIA, V44, P673, DOI 10.1046/j.1528-1157.2003.46002.x; Markand ON, 2000, EPILEPSIA, V41, P749, DOI 10.1111/j.1528-1157.2000.tb00238.x; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Mohanraj R, 2006, EUR J NEUROL, V13, P277, DOI 10.1111/j.1468-1331.2006.01215.x; MUENNIG P, 2002, DESIGNIGN CONDUCTING; NASHEF L, 1995, J NEUROL NEUROSUR PS, V58, P462, DOI 10.1136/jnnp.58.4.462; Nikolas H, 2007, EPILEPSY BEHAV, V10, P363, DOI 10.1016/j.yebeh.2007.01.005; Nilsson L, 2003, EPILEPSIA, V44, P575, DOI 10.1046/j.1528-1157.2003.03302.x; Pasta DJ, 1999, MED DECIS MAKING, V19, P353, DOI 10.1177/0272989X9901900314; PENFIELD W, 1950, AMA ARCH NEUROL PSY, V64, P491, DOI 10.1001/archneurpsyc.1950.02310280003001; Ryvlin P, 2003, EPILEPSY RES, V56, P105, DOI 10.1016/j.eplepsyres.2003.10.001; Salanova V, 1999, EPILEPSIA, V40, P1417, DOI 10.1111/j.1528-1157.1999.tb02014.x; Salanova V, 2002, EPILEPSIA, V43, P170, DOI 10.1046/j.1528-1157.2002.33800.x; Schwartz TH, 2006, EPILEPSIA, V47, P567, DOI 10.1111/j.1528-1167.2006.00469.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Spencer SS, 2005, NEUROLOGY, V65, P912, DOI 10.1212/01.wnl.0000176055.45774.71; Spencer SS, 2003, NEUROLOGY, V61, P1680, DOI 10.1212/01.WNL.0000098937.35486.A3; Spencer SS, 2008, NEUROLOGY, V70, P1654, DOI 10.1212/01.wnl.0000311272.33720.6b; Sperling MR, 2004, CNS SPECTRUMS, V9, P98, DOI 10.1017/S1092852900008464; Sperling MR, 1999, ANN NEUROL, V46, P45, DOI 10.1002/1531-8249(199907)46:1<45::AID-ANA8>3.0.CO;2-I; Sperling MR, 2004, CNS SPECTRUMS, V9, P106, DOI DOI 10.1017/S1092852900008464; Stephen LJ, 2006, EPILEPSY BEHAV, V8, P434, DOI 10.1016/j.yebeh.2005.11.007; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; TSEVAT J, 1991, CIRCULATION, V83, P1194, DOI 10.1161/01.CIR.83.4.1194; Uijl SG, 2008, EPILEPSIA, V49, P1317, DOI 10.1111/j.1528-1167.2008.01695.x; Walczak TS, 2001, EPILEPSIA, V42, P804; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wiebe S, 2000, CAN J NEUROL SCI, V27, pS6, DOI 10.1017/S0317167100000561; Wiebe S, 2006, CAN J NEUROL SCI, V33, P365, DOI 10.1017/S031716710000531X; WONG JB, 1990, ANN INTERN MED, V113, P852, DOI 10.7326/0003-4819-113-11-852; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606	68	127	133	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2497	2505		10.1001/jama.2008.771	http://dx.doi.org/10.1001/jama.2008.771			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050193	Bronze			2022-12-01	WOS:000261286200018
J	Watts, G				Watts, Geoff			Regeneration games	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Bartunek J, 2006, EUR HEART J, V27, P1338, DOI 10.1093/eurheartj/ehi793; Lund RD, 2001, P NATL ACAD SCI USA, V98, P9942, DOI 10.1073/pnas.171266298; Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1	3	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 3	2008	337								a1321	10.1136/bmj.a1321	http://dx.doi.org/10.1136/bmj.a1321			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386NW	19052067				2022-12-01	WOS:000261890900004
J	Kara, P; Boyd, JD				Kara, Prakash; Boyd, Jamie D.			A micro-architecture for binocular disparity and ocular dominance in visual cortex	NATURE			English	Article							POSTNATAL-DEVELOPMENT; HORIZONTAL DISPARITY; DEPTH DISCRIMINATION; STRIATE CORTEX; PRIMATE V1; SENSITIVITY; NEURONS; ORGANIZATION; MECHANISMS; STEREOPSIS	In invertebrate predators such as the praying mantis and vertebrate predators such as wild cats the ability to detect small differences in inter-ocular retinal disparities is a critical means for accurately determining the depth of moving objects such as prey(1). In mammals, the first neurons along the visual pathway that encode binocular disparities are found in the visual cortex. However, a precise functional architecture for binocular disparity has never been demonstrated in any species, and coarse maps for disparity have been found in only one primate species(2,3). Moreover, the dominant approach for assaying the developmental plasticity of binocular cortical neurons used monocular tests of ocular dominance to infer binocular function(4). The few studies that examined the relationship between ocular dominance and binocular disparity of individual cells used single-unit recordings and have provided conflicting results regarding whether ocular dominance can predict the selectivity or sensitivity to binocular disparity(5-9). We used two-photon calcium imaging to sample the response to monocular and binocular visual stimuli from nearly every adjacent neuron in a small region of the cat visual cortex, area 18. Here we show that local circuits for ocular dominance always have smooth and graded transitions from one apparently monocular functional domain to an adjacent binocular region. Most unexpectedly, we discovered a new map in the cat visual cortex that had a precise functional micro-architecture for binocular disparity selectivity. At the level of single cells, ocular dominance was unrelated to binocular disparity selectivity or sensitivity. When the local maps for ocular dominance and binocular disparity both had measurable gradients at a given cortical site, the two gradient directions were orthogonal to each other. Together, these results indicate that, from the perspective of the spiking activity of individual neurons, ocular dominance cannot predict binocular disparity tuning. However, the precise local arrangement of ocular dominance and binocular disparity maps provide new clues regarding how monocular and binocular depth cues may be combined and decoded.	[Kara, Prakash; Boyd, Jamie D.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina	Kara, P (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	kara@musc.edu			NIH; Whitehall; Dana Foundations; NATIONAL EYE INSTITUTE [R01EY017925] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall; Dana Foundations; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank B. Cumming and N. Swindale for discussions. We thank B. Shi, Z. Shen, Z. Lu and J. Schnellmann for comments on the manuscript. This work was supported by grants from the NIH, Whitehall and Dana Foundations to P. K.	Anzai A, 1997, P NATL ACAD SCI USA, V94, P5438, DOI 10.1073/pnas.94.10.5438; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BONHOEFFER T, 1995, EUR J NEUROSCI, V7, P1973, DOI 10.1111/j.1460-9568.1995.tb00720.x; Chen G, 2008, NEURON, V58, P442, DOI 10.1016/j.neuron.2008.02.032; Chino YM, 1997, J NEUROSCI, V17, P296, DOI 10.1523/JNEUROSCI.17-01-00296.1997; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; FREEMAN RD, 1992, J NEUROSCI, V12, P4721; GARDNER JC, 1986, EXP BRAIN RES, V64, P505, DOI 10.1007/BF00340488; Haefner RM, 2008, NEURON, V57, P147, DOI 10.1016/j.neuron.2007.10.042; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; Maruko I, 2008, J NEUROPHYSIOL, V100, P2486, DOI 10.1152/jn.90397.2008; MITCHELL DE, 2004, VISUAL NEUROSCIENCES, P189; OBERMAYER K, 1992, PHYS REV A, V45, P7568, DOI 10.1103/PhysRevA.45.7568; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Parker A., 2003, BLINK EYE VISION SPA; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; ROSSEL S, 1983, NATURE, V302, P821, DOI 10.1038/302821a0; SHIMOJO S, 1988, NATURE, V333, P265, DOI 10.1038/333265a0; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011	30	81	81	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 2	2009	458	7238					627	U93		10.1038/nature07721	http://dx.doi.org/10.1038/nature07721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19158677	Green Accepted			2022-12-01	WOS:000264796200040
J	Fernandes-Alnemri, T; Yu, JW; Datta, P; Wu, JH; Alnemri, ES				Fernandes-Alnemri, Teresa; Yu, Je-Wook; Datta, Pinaki; Wu, Jianghong; Alnemri, Emad S.			AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA	NATURE			English	Article							INNATE IMMUNE-RESPONSE; NALP3 INFLAMMASOME; ASC PYROPTOSOME; CASPASE-1; SILICA; FAMILY; GENES; BETA	Host-and pathogen-associated cytoplasmic double-stranded DNA triggers the activation of a NALP3 (also known as cryopyrin and NLRP3)-independent inflammasome(1), which activates caspase-1 leading to maturation of pro-interleukin-1 beta and inflammation. The nature of the cytoplasmic-DNA-sensing inflammasome is currently unknown. Here we show that AIM2 (absent in melanoma 2), an interferon-inducible HIN-200 family member that contains an amino-terminal pyrin domain and a carboxy-terminal oligonucleotide/oligosaccharide-binding domain(2,3), senses cytoplasmic DNA by means of its oligonucleotide/oligosaccharide-binding domain and interacts with ASC (apoptosis-associated speck-like protein containing a CARD) through its pyrin domain to activate caspase-1. The interaction of AIM2 with ASC also leads to the formation of the ASC pyroptosome(4), which induces pyroptotic cell death in cells containing caspase-1. Knockdown of AIM2 by short interfering RNA reduced inflammasome/pyroptosome activation by cytoplasmic DNA in human and mouse macrophages, whereas stable expression of AIM2 in the non-responsive human embryonic kidney 293T cell line conferred responsiveness to cytoplasmic DNA. Our results show that cytoplasmic DNA triggers formation of the AIM2 inflammasome by inducing AIM2 oligomerization. This study identifies AIM2 as an important inflammasome component that senses potentially dangerous cytoplasmic DNA, leading to activation of the ASC pyroptosome and caspase-1.	[Fernandes-Alnemri, Teresa; Yu, Je-Wook; Datta, Pinaki; Wu, Jianghong; Alnemri, Emad S.] Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Alnemri, ES (corresponding author), Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	E_Alnemri@lac.jci.tju.edu	Alnemri, Emad S/B-4526-2010	Yu, Je-Wook/0000-0001-5943-4071	NIH [AG14357, AR055398]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AG14357 and AR055398 to E. S. A. We thank M. McCormick and D. Wang for technical assistance, X. Jiao for help with the confocal microscopy, J. Sagara for the anti-human ASC antibody, J. Yuan for the anti-mouse caspase-1 antibody, R. Johnstone for the anti-human AIM2 antibody, M.-C. Hung for the anti-human IFIX antibody, T. Ouchi for the IFI16 complementary DNA and E. Latz for the immortalized mouse bone marrow macrophages.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Albrecht M, 2005, BIOCHEM BIOPH RES CO, V327, P679, DOI 10.1016/j.bbrc.2004.12.056; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Meier O, 2005, J VIROL, V79, P2604, DOI 10.1128/JVI.79.4.2604-2613.2005; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	18	1257	1312	5	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					509	U5		10.1038/nature07710	http://dx.doi.org/10.1038/nature07710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19158676	Green Accepted			2022-12-01	WOS:000264532400045
J	Neil, H; Malabat, C; d'Aubenton-Carafa, Y; Xu, ZY; Steinmetz, LM; Jacquier, A				Neil, Helen; Malabat, Christophe; d'Aubenton-Carafa, Yves; Xu, Zhenyu; Steinmetz, Lars M.; Jacquier, Alain			Widespread bidirectional promoters are the major source of cryptic transcripts in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; UNSTABLE TRANSCRIPTS; RNA; GENOME; GENE; TERMINATION; EXPRESSION; PATHWAY; POLYMERASE; INITIATION	Pervasive and hidden transcription is widespread in eukaryotes(1-4), but its global level, the mechanisms from which it originates and its functional significance are unclear. Cryptic unstable transcripts ( CUTs) were recently described as a principal class of RNA polymerase II transcripts in Saccharomyces cerevisiae(5). These transcripts are targeted for degradation immediately after synthesis by the action of the Nrd1 - exosome - TRAMP complexes(6,7). Although CUT degradation mechanisms have been analysed in detail, the genome- wide distribution at the nucleotide resolution and the prevalence of CUTs are unknown. Here we report the first high- resolution genomic map of CUTs in yeast, revealing a class of potentially functional CUTs and the intrinsic bidirectional nature of eukaryotic promoters. An RNA fraction highly enriched in CUTs was analysed by a 3 ' Long- SAGE ( serial analysis of gene expression) approach adapted to deep sequencing. The resulting detailed genomic map of CUTs revealed that they derive from extremely widespread and very well defined transcription units and do not result from unspecific transcriptional noise. Moreover, the transcription of CUTs predominantly arises within nucleosome- free regions, most of which correspond to promoter regions of bona fide genes. Some of the CUTs start upstream from messenger RNAs and overlap their 59 end. Our study of glycolysis genes, as well as recent results from the literature(8-11), indicate that such concurrent transcription is potentially associated with regulatory mechanisms. Our data reveal numerous new CUTs with such a potential regulatory role. However, most of the identified CUTs corresponded to transcripts divergent from the promoter regions of genes, indicating that they represent by- products of divergent transcription occurring at many and possibly most promoters. Eukaryotic promoter regions are thus intrinsically bidirectional, a fundamental property that escaped previous analyses because in most cases divergent transcription generates short- lived unstable transcripts present at very low steady- state levels.	[Neil, Helen; Malabat, Christophe; Jacquier, Alain] CNRS, Inst Pasteur, Unite Genet Interact Macromol, URA2171, F-75015 Paris, France; [d'Aubenton-Carafa, Yves] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Xu, Zhenyu; Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; European Molecular Biology Laboratory (EMBL)	Jacquier, A (corresponding author), CNRS, Inst Pasteur, Unite Genet Interact Macromol, URA2171, F-75015 Paris, France.	alain.jacquier@pasteur.fr		Steinmetz, Lars/0000-0002-3962-2865; JACQUIER, ALAIN/0000-0001-5707-9184; Malabat, Christophe/0000-0003-2551-2355	Institut Pasteur; CNRS; ANR (CUT program); European Science Foundation (RNA quality program); National Institutes of Health; Deutsche Forschungsgemeinschaft	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (CUT program)(French National Research Agency (ANR)); European Science Foundation (RNA quality program)(European Science Foundation (ESF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank D. Libri for the gift of strains, D. Libri, C. Thermes, C. Saveanu and M. Fromont- Racine for discussions and for critical reading of the manuscript, staff of the Genoscope ( Evry) for sequencing, and A. Doyen, L. Decourty, S. Clauder- Muenster and T. Bahr-Ivacevic for technical assistance. This work was supported by the Institut Pasteur, the CNRS, the ANR (CUT program), the European Science Foundation (RNA quality program), and the National Institutes of Health and the Deutsche Forschungsgemeinschaft. H. N. is supported by the ANR (CUT program).	Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Ito T, 2008, IUBMB LIFE, V60, P775, DOI 10.1002/iub.121; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kuehner JN, 2008, MOL CELL, V31, P201, DOI 10.1016/j.molcel.2008.05.018; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCOTT EW, 1993, MOL CELL BIOL, V13, P543, DOI 10.1128/MCB.13.1.543; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	25	432	446	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1038	U8		10.1038/nature07747	http://dx.doi.org/10.1038/nature07747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19169244				2022-12-01	WOS:000263425400048
J	Creppe, C; Malinouskaya, L; Volvert, ML; Gillard, M; Close, P; Malaise, O; Laguesse, S; Cornez, I; Rahmouni, S; Ormenese, S; Belachew, S; Malgrange, B; Chapelle, JP; Siebenlist, U; Moonen, G; Chariot, A; Nguyen, L				Creppe, Catherine; Malinouskaya, Lina; Volvert, Marie-Laure; Gillard, Magali; Close, Pierre; Malaise, Olivier; Laguesse, Sophie; Cornez, Isabelle; Rahmouni, Souad; Ormenese, Sandra; Belachew, Shibeshih; Malgrange, Brigitte; Chapelle, Jean-Paul; Siebenlist, Ulrich; Moonen, Gustave; Chariot, Alain; Nguyen, Laurent			Elongator Controls the Migration and Differentiation of Cortical Neurons through Acetylation of alpha-Tubulin	CELL			English	Article							FAMILIAL DYSAUTONOMIA; IN-VIVO; CEREBRAL-CORTEX; CELL-MIGRATION; HISTONE ACETYLTRANSFERASE; ACTIN CYTOSKELETON; FILAMIN-A; PROTEIN; RNA; TRANSPORT	The generation of cortical projection neurons relies on the coordination of radial migration with branching. Here, we report that the multisubunit histone acetyltransferase Elongator complex, which contributes to transcript elongation, also regulates the maturation of projection neurons. Indeed, silencing of its scaffold (Elp1) or catalytic subunit (Elp3) cell-autonomously delays the migration and impairs the branching of projection neurons. Strikingly, neurons defective in Elongator show reduced levels of acetylated alpha-tubulin. Reduction of alpha-tubulin acetylation via expression of a nonacetylatable alpha-tubulin mutant leads to comparable defects in cortical neurons and suggests that alpha-tubulin is a target of Elp3. This is further supported by the demonstration that Elp3 promotes acetylation and counteracts HDAC6-mediated deacetylation of this substrate in vitro. Our results uncover alpha-tubulin as a target of the Elongator complex and suggest that a tight regulation of its acetylation underlies the maturation of cortical projection neurons.	[Creppe, Catherine; Gillard, Magali; Close, Pierre; Cornez, Isabelle; Chapelle, Jean-Paul; Chariot, Alain] Univ Liege, CHU Sart Tilman, GIGA Signal Transduct, B-4000 Liege, Belgium; [Malinouskaya, Lina; Volvert, Marie-Laure; Malaise, Olivier; Laguesse, Sophie; Belachew, Shibeshih; Malgrange, Brigitte; Moonen, Gustave; Nguyen, Laurent] Univ Liege, CHU Sart Tilman, GIGA Neurosci, B-4000 Liege, Belgium; [Rahmouni, Souad] Univ Liege, CHU Sart Tilman, GIGA Infect Immun & Inflammat, B-4000 Liege, Belgium; [Ormenese, Sandra] Univ Liege, CHU Sart Tilman, GIGA Imaging & Flow Cytometry, B-4000 Liege, Belgium; [Belachew, Shibeshih; Moonen, Gustave] Univ Liege, CHU Sart Tilman, Dept Neurol, B-4000 Liege, Belgium; [Siebenlist, Ulrich] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chariot, A (corresponding author), Univ Liege, CHU Sart Tilman, GIGA Signal Transduct, B-4000 Liege, Belgium.	alain.chariot@ulg.ac.be; lnguyen@ulg.ac.be	malgrange, brigitte/A-4887-2019; Nguyen, Laurent/E-9882-2016; Malgrange, Brigitte/F-8384-2010; Belachew, Shibeshih/V-9185-2019	malgrange, brigitte/0000-0002-8957-2528; Belachew, Shibeshih/0000-0003-3976-1950; Laguesse, Sophie/0000-0002-9217-0087; CLOSE, PIERRE/0000-0002-8844-9616; Chariot, Alain/0000-0002-1691-4347; Nguyen, Laurent/0000-0002-8560-3008	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000431] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Cau E, 1997, DEVELOPMENT, V124, P1611; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Fujita T, 2007, BIOCHEM BIOPH RES CO, V361, P605, DOI 10.1016/j.bbrc.2007.07.050; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; KOZMINSKI KG, 1993, CELL MOTIL CYTOSKEL, V25, P158, DOI 10.1002/cm.970250205; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Lom B, 1999, J NEUROSCI, V19, P9928; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mezey E, 2003, BRAIN RES, V983, P209, DOI 10.1016/S0006-8993(03)03090-7; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Petrakis TG, 2004, J BIOL CHEM, V279, P32087, DOI 10.1074/jbc.M403361200; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roy S, 2000, J NEUROSCI, V20, P6849, DOI 10.1523/JNEUROSCI.20-18-06849.2000; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Tabata H, 2003, J NEUROSCI, V23, P9996; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yokota Y, 2007, NEURON, V54, P429, DOI 10.1016/j.neuron.2007.04.016; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	50	372	381	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					551	564		10.1016/j.cell.2008.11.043	http://dx.doi.org/10.1016/j.cell.2008.11.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19185337	Bronze			2022-12-01	WOS:000263120600023
J	Gerke, J; Lorenz, K; Cohen, B				Gerke, Justin; Lorenz, Kim; Cohen, Barak			Genetic Interactions Between Transcription Factors Cause Natural Variation in Yeast	SCIENCE			English	Article							COMMON HUMAN-DISEASES; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE TRAITS; POSITIVE REGULATOR; EVOLUTION; MEIOSIS; EPISTASIS; SPORULATION; LOCUS; IME1	Our understanding of the genetic basis of phenotypic diversity is limited by the paucity of examples in which multiple, interacting loci have been identified. We show that natural variation in the efficiency of sporulation, the program in yeast that initiates the sexual phase of the life cycle, between oak tree and vineyard strains is due to allelic variation between four nucleotide changes in three transcription factors: IME1, RME1, and RSF1. Furthermore, we identified that selection has shaped quantitative variation in yeast sporulation between strains. These results illustrate how genetic interactions between transcription factors are a major source of phenotypic diversity within species.	[Gerke, Justin; Lorenz, Kim; Cohen, Barak] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA	Washington University (WUSTL)	Cohen, B (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA.	cohen@genetics.wustl.edu		Lorenz, Kim/0000-0001-8674-2942	 [NSF-MCB-0543156];  [NHGRI-T32HG000045]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Kyro for technical assistance and J. Fay, B. Engle, H.-S. Kim, and M. Johnston for sharing reagents. We also thank J. Fay, S. Doniger, C. Hittinger, and members of the Cohen laboratory for helpful advice and discussions. Funded by NSF-MCB-0543156. J.P.G. has received support from NHGRI-T32HG000045. Sequences were deposited in GenBank accessions FJ446649 to FJ446698.	Ben-Ari G, 2006, PLOS GENET, V2, P1815, DOI 10.1371/journal.pgen.0020195; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000123; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000103; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Gerke JP, 2006, GENETICS, V174, P985, DOI 10.1534/genetics.106.058453; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Heck JA, 2006, P NATL ACAD SCI USA, V103, P3256, DOI 10.1073/pnas.0510998103; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; Jambhekar A, 2008, CURR BIOL, V18, P969, DOI 10.1016/j.cub.2008.05.047; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Kim HS, 2007, P NATL ACAD SCI USA, V104, P19387, DOI 10.1073/pnas.0708194104; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; KUPIEC M, 1997, MOL CELLULAR BIOL YE, V3, P889; Lu L, 2003, CURR GENET, V43, P263, DOI 10.1007/s00294-003-0398-z; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P557, DOI 10.1128/JCM.36.2.557-562.1998; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Naumov GI, 1998, CAN J MICROBIOL, V44, P1045, DOI 10.1139/cjm-44-11-1045; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; SMITH HE, 1993, GENETICS, V133, P775; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Wagner GP, 2008, TRENDS ECOL EVOL, V23, P377, DOI 10.1016/j.tree.2008.03.006; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	42	152	152	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					498	501		10.1126/science.1166426	http://dx.doi.org/10.1126/science.1166426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164747	Green Accepted			2022-12-01	WOS:000262587900041
J	Sanchez-Garcia, I				Sanchez-Garcia, Isidro			The Crossroads of Oncogenesis and Metastasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER		[Sanchez-Garcia, Isidro] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Sanchez-Garcia, I (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain.		SANCHEZ-GARCIA, ISIDRO/A-5631-2019; 2009, Secribsal/A-1266-2012	SANCHEZ-GARCIA, ISIDRO/0000-0001-6989-9905				Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2008, NATURE, V454, P794, DOI 10.1038/nature07196	6	43	44	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					297	299		10.1056/NEJMcibr0808031	http://dx.doi.org/10.1056/NEJMcibr0808031			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394GR	19144947				2022-12-01	WOS:000262434500016
J	Grocott, MPW; Martin, DS; Levett, DZH; McMorrow, R; Windsor, J; Montgomery, HE				Grocott, Michael P. W.; Martin, Daniel S.; Levett, Denny Z. H.; McMorrow, Roger; Windsor, Jeremy; Montgomery, Hugh E.		Caudwell Xtreme Everest Res Grp	Arterial Blood Gases and Oxygen Content in Climbers on Mount Everest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALTITUDE PULMONARY-EDEMA; SIMULATED ALTITUDE; EXTREME ALTITUDE; SUPPLEMENTAL OXYGEN; MT EVEREST; SEA-LEVEL; EXERCISE; EXCHANGE; HUMANS; HYPOXIA	Background The level of environmental hypobaric hypoxia that affects climbers at the summit of Mount Everest ( 8848 m [ 29,029 ft]) is close to the limit of tolerance by humans. We performed direct field measurements of arterial blood gases in climbers breathing ambient air on Mount Everest. Methods We obtained samples of arterial blood from 10 climbers during their ascent to and descent from the summit of Mount Everest. The partial pressures of arterial oxygen ( PaO2) and carbon dioxide ( PaCO2), pH, and hemoglobin and lactate concentrations were measured. The arterial oxygen saturation ( SaO(2)), bicarbonate concentration, base excess, and alveolar - arterial oxygen difference were calculated. Results PaO2 fell with increasing altitude, whereas SaO(2) was relatively stable. The hemoglobin concentration increased such that the oxygen content of arterial blood was maintained at or above sea- level values until the climbers reached an elevation of 7100 m ( 23,294 ft). In four samples taken at 8400 m ( 27,559 ft) - at which altitude the barometric pressure was 272 mm Hg ( 36.3 kPa) - the mean PaO2 in subjects breathing ambient air was 24.6 mm Hg ( 3.28 kPa), with a range of 19.1 to 29.5 mm Hg ( 2.55 to 3.93 kPa). The mean PaCO2 was 13.3 mm Hg ( 1.77 kPa), with a range of 10.3 to 15.7 mm Hg ( 1.37 to 2.09 kPa). At 8400 m, the mean arterial oxygen content was 26% lower than it was at 7100 m ( 145.8 ml per liter as compared with 197.1 ml per liter). The mean calculated alveolar - arterial oxygen difference was 5.4 mm Hg ( 0.72 kPa). Conclusions The elevated alveolar - arterial oxygen difference that is seen in subjects who are in conditions of extreme hypoxia may represent a degree of subclinical high- altitude pulmonary edema or a functional limitation in pulmonary diffusion.	[Grocott, Michael P. W.; Martin, Daniel S.; Levett, Denny Z. H.; McMorrow, Roger; Windsor, Jeremy; Montgomery, Hugh E.] UCL, Inst Human Hlth & Performance, Ctr Altitude Space & Extreme Environm Med, London N19 5LW, England	University of London; University College London	Grocott, MPW (corresponding author), UCL, Inst Human Hlth & Performance, Ctr Altitude Space & Extreme Environm Med, 1st Fl,Charterhouse Bldg,Archway Campus,Highgate, London N19 5LW, England.	mike.grocott@ucl.ac.uk	Levett, Denny Zelda Hope/AAY-4627-2021; Mythen, Michael G/G-8682-2011; Montgomery, Hugh/L-1229-2019; Levett, Denny/D-2239-2017; Edwards, Lindsay M/B-3727-2010; Martin, Daniel S/F-7997-2010; Levett, Denny/F-4474-2011; Grocott, Michael/C-4394-2008; Cooke, Debbie/D-6605-2011; Murray, Andrew/B-3130-2010; o'dwyer, michael/D-6561-2012; Montgomery, Hugh/C-2592-2008	Levett, Denny Zelda Hope/0000-0002-8418-1675; Levett, Denny/0000-0002-8418-1675; Levett, Denny/0000-0002-8418-1675; Grocott, Michael/0000-0002-9484-7581; Murray, Andrew/0000-0002-0929-9315; Martin, Daniel/0000-0001-6220-8235; Richardson, Alan/0000-0001-8931-2518; O'Dwyer, Michael J/0000-0003-4038-5745; Montgomery, Hugh/0000-0001-8797-5019	BOC Medical (now part of Linde Gas Therapeutics); Eli Lilly; London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland; United Kingdom Intensive Care Foundation; Sir Halley Stewart Trust; Fellow of the Association of Anaesthetists of Great Britain and Ireland; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres; Siemens	BOC Medical (now part of Linde Gas Therapeutics); Eli Lilly(Eli Lilly); London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland; United Kingdom Intensive Care Foundation; Sir Halley Stewart Trust; Fellow of the Association of Anaesthetists of Great Britain and Ireland; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); Siemens(Siemens AG)	Supported by Mr. John Caudwell, BOC Medical (now part of Linde Gas Therapeutics), Eli Lilly, the London Clinic, Smiths Medical, Deltex Medical, and the Rolex Foundation (unrestricted grants), the Association of Anaesthetists of Great Britain and Ireland, the United Kingdom Intensive Care Foundation, and the Sir Halley Stewart Trust. Dr. Martin is a Critical Care Scholar of the London Clinic, and Dr. Levett is a Fellow of the Association of Anaesthetists of Great Britain and Ireland. Some of this work was undertaken at University College London Hospital-University College London Comprehensive Biomedical Research Centre, which received a proportion of funding from the United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. Caudwell Xtreme Everest is a research project coordinated by the Centre for Altitude, Space, and Extreme Environment Medicine, University College London. Membership, roles, and responsibilities of the Caudwell Xtreme Everest Research Group can be found at www. caudwell-xtreme-everest.co.uk/team.; Dr. Grocott reports receiving lecture fees from Eli Lilly and BOC Medical and grant support from BOC Medical, Eli Lilly, and Smiths Medical; Dr. Martin, lecture fees from Siemens; and Dr. McMorrow, grant support from Smiths Medical. No other potential conflict of interest relevant to this article was reported.; We thank the staff of Siemens, in particular Robert Mayall and Steve Carey, for their continual support to us in carrying out these measurements; Pasang Tenzing Sherpa for carrying the samples from the Balcony to Camp 2 in less than 2 hours; the Caudwell Xtreme Everest volunteers who trekked to the Everest base camp; and Tom Hornbein, Erik Swenson, Monty Mythen, and Mervyn Singer for their advice during the preparation of the manuscript.	BARTSCH P, 1987, J APPL PHYSIOL, V63, P752, DOI 10.1152/jappl.1987.63.2.752; Catron Thomas F, 2006, BMC Physiol, V6, P3, DOI 10.1186/1472-6793-6-3; CERRETELLI P, 1976, J APPL PHYSIOL, V40, P658, DOI 10.1152/jappl.1976.40.5.658; Cerretelli P, 2003, EUR J APPL PHYSIOL, V90, P431, DOI 10.1007/s00421-003-0928-x; EHRMEYER S, 1997, C25A NCCLS, V12; ERNSTING J, 1988, AVIATION MED, P46; GARRIDO E, 1995, EUR J APPL PHYSIOL O, V70, P477, DOI 10.1007/BF00634375; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5142; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5921; HAMMOND MD, 1986, J APPL PHYSIOL, V61, P1749, DOI 10.1152/jappl.1986.61.5.1749; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; HORNBEIN TF, 1989, NEW ENGL J MED, V321, P1714, DOI 10.1056/NEJM198912213212505; HOUSTON CS, 1987, J APPL PHYSIOL, V63, P877, DOI 10.1152/jappl.1987.63.2.877; Huey RB, 2000, JAMA-J AM MED ASSOC, V284, P181, DOI 10.1001/jama.284.2.181-a; HUEY RB, 2000, JAMA-J AM MED ASSOC, V284, P2999; JACKSON RM, 1985, CHEST, V88, P900, DOI 10.1378/chest.88.6.900; KRONENBERG RS, 1971, J CLIN INVEST, V50, P827, DOI 10.1172/JCI106554; Lindholm P, 2006, UNDERSEA HYPERBAR M, V33, P463; Messner R., 1979, EVEREST EXPEDITION U, V1st Edn; Proffitt F, 2005, SCIENCE, V308, P1541, DOI 10.1126/science.308.5728.1541; REEVES JT, 1969, J APPL PHYSIOL, V27, P658, DOI 10.1152/jappl.1969.27.5.658; REGARD M, 1989, NEUROLOGY, V39, P210, DOI 10.1212/WNL.39.2.210; Richalet JP, 1999, ADV EXP MED BIOL, V474, P297; Scherrer U, 1996, NEW ENGL J MED, V334, P624, DOI 10.1056/NEJM199603073341003; SCHOENE RB, 1984, J APPL PHYSIOL, V56, P1478, DOI 10.1152/jappl.1984.56.6.1478; SMITH CA, 2001, HIGH ALTITUDE, P139; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; TORREBUENO JR, 1985, J APPL PHYSIOL, V58, P989, DOI 10.1152/jappl.1985.58.3.989; WAGNER PD, 1986, J APPL PHYSIOL, V61, P260, DOI 10.1152/jappl.1986.61.1.260; WAGNER PD, 1987, J APPL PHYSIOL, V63, P2348, DOI 10.1152/jappl.1987.63.6.2348; WEST JB, 1983, J APPL PHYSIOL, V55, P688, DOI 10.1152/jappl.1983.55.3.688; WEST JB, 1983, J APPL PHYSIOL, V55, P678, DOI 10.1152/jappl.1983.55.3.678; WEST JB, 1983, J APPL PHYSIOL, V54, P1188, DOI 10.1152/jappl.1983.54.5.1188; Windsor JS, 2007, AVIAT SPACE ENVIR MD, V78, P426	36	286	300	0	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					140	149		10.1056/NEJMoa0801581	http://dx.doi.org/10.1056/NEJMoa0801581			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391UG	19129527	Green Published			2022-12-01	WOS:000262258300007
J	Core, LJ; Waterfall, JJ; Lis, JT				Core, Leighton J.; Waterfall, Joshua J.; Lis, John T.			Nascent RNA Sequencing Reveals Widespread Pausing and Divergent Initiation at Human Promoters	SCIENCE			English	Article							HUMAN GENOME; POLYMERASE-II; HUMAN-CELLS; TRANSCRIPTION; ARCHITECTURE; BINDING; GENES; MAPS	RNA polymerases are highly regulated molecular machines. We present a method ( global run-on sequencing, GRO-seq) that maps the position, amount, and orientation of transcriptionally engaged RNA polymerases genome- wide. In this method, nuclear run- on RNA molecules are subjected to large- scale parallel sequencing and mapped to the genome. We show that peaks of promoter- proximal polymerase reside on similar to 30% of human genes, transcription extends beyond pre-messenger RNA 3 ' cleavage, and antisense transcription is prevalent. Additionally, most promoters have an engaged polymerase upstream and in an orientation opposite to the annotated gene. This divergent polymerase is associated with active genes but does not elongate effectively beyond the promoter. These results imply that the interplay between polymerases and regulators over broad promoter regions dictates the orientation and efficiency of productive transcription.	[Core, Leighton J.; Waterfall, Joshua J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jtl10@cornell.edu		Waterfall, Joshua/0000-0002-3762-5050	NIH [GM25232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232, R37GM025232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully thank C. Haudenschild for advice on construction of our libraries and for performing the initial alignments, Q. Sun and L. Ponnala for aligning the trimmed reads, A. Siepel for computational and statistical discussion, and the members of the Lis lab for suggestions regarding this work. The work was funded by NIH grant GM25232 to J.T.L. The data discussed in this publication have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus under accession number GSE13518. The authors are filing a patent based on the work in this paper.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lian Z, 2008, GENOME RES, V18, P1224, DOI 10.1101/gr.075804.107; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wold B, 2008, NAT METHODS, V5, P19, DOI [10.1038/nmeth1157, 10.1038/NMETH1157]; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	22	1354	1388	8	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1845	1848		10.1126/science.1162228	http://dx.doi.org/10.1126/science.1162228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056941	Green Accepted			2022-12-01	WOS:000261799400055
J	Fishman, L; Saunders, A				Fishman, Lila; Saunders, Arpiar			Centromere-Associated Female Meiotic Drive Entails Male Fitness Costs in Monkeyflowers	SCIENCE			English	Article							TRANSMISSION RATIO DISTORTION; SEGREGATION; SELECTION; MEIOSIS; LOCUS	Female meiotic drive, in which paired chromosomes compete for access to the egg, is a potentially powerful but rarely documented evolutionary force. In interspecific monkeyflower ( Mimulus) hybrids, a driving M. guttatus allele ( D) exhibits a 98: 2 transmission advantage via female meiosis. We show that extreme interspecific drive is most likely caused by divergence in centromere- associated repeat domains and document cytogenetic and functional polymorphism for drive within a population of M. guttatus. In conspecific crosses, D had a 58: 42 transmission advantage over nondriving alternative alleles. However, individuals homozygous for the driving allele suffered reduced pollen viability. These fitness effects and molecular population genetic data suggest that balancing selection prevents the fixation or loss of D and that selfish chromosomal transmission may affect both individual fitness and population genetic load.	[Fishman, Lila; Saunders, Arpiar] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Fishman, L (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	lila.fishman@mso.umt.edu			NSF [DEB-0316786, BIO-0328326]	NSF(National Science Foundation (NSF))	We thank J. H. Willis, J. K. Kelly, J. Birchler, D. Charlesworth, H. Malik, C. Barr, V. Ezenwa, D. Emlen, and S. Miller for critical comments; J. H. Willis, C. Wu, T. J. Vision, E. Ganko, L. Bridges, and J. K. Kelly for materials and communicatingunpublished results; and D. Pedersen, D. Carvey, T. Huggins, E. Peters, and B. Utgaard for lab, greenhouse, and field assistance. D. Rokhsar and J. Schmutz of DOE Joint Genome Institute provided the M. guttatus draft whole-genome sequence. Supported by NSF grants DEB-0316786 (L.F.) and BIO-0328326 (J.H. Willis, L.F., et al.). Sequences have been deposited in GenBank, with the accession numbers FJ147360 to FJ147465.	Ardlie KG, 1998, TRENDS GENET, V14, P189, DOI 10.1016/S0168-9525(98)01455-3; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Birchler JA, 2003, GENETICS, V164, P835; Buckler ES, 1999, GENETICS, V153, P415; Charlesworth B, 2007, GENET RES, V89, P85, DOI 10.1017/S001667230700866X; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Daniel A, 2002, AM J MED GENET, V111, P450, DOI 10.1002/ajmg.10618; Dawe RK, 2004, CHROMOSOME RES, V12, P655, DOI 10.1023/B:CHRO.0000036607.74671.db; de Villena FPM, 2001, GENETICS, V159, P1179; de Villena FPM, 2001, MAMM GENOME, V12, P331, DOI 10.1007/s003350040003; Dyer KA, 2007, P NATL ACAD SCI USA, V104, P1587, DOI 10.1073/pnas.0605578104; Fishman L, 2005, GENETICS, V169, P347, DOI 10.1534/genetics.104.032789; Fishman L, 2001, GENETICS, V159, P1701; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Johnson T, 2005, PHILOS T R SOC B, V360, P1411, DOI 10.1098/rstb.2005.1667; Kelly JK, 2003, GENETICS, V164, P1071; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lamb JC, 2007, CURR OPIN PLANT BIOL, V10, P116, DOI 10.1016/j.pbi.2007.01.008; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Malik HS, 2005, TRENDS ECOL EVOL, V20, P151, DOI 10.1016/j.tree.2005.01.014; Mroczek RJ, 2006, GENETICS, V174, P145, DOI 10.1534/genetics.105.048322; Wu GM, 2005, GENETICS, V170, P327, DOI 10.1534/genetics.104.039479; Zwick ME, 1999, GENETICS, V152, P1605	24	183	183	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1559	1562		10.1126/science.1161406	http://dx.doi.org/10.1126/science.1161406			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056989				2022-12-01	WOS:000261377400053
J	Singh, R; Manjunatha, U; Boshoff, HIM; Ha, YH; Niyomrattanakit, P; Ledwidge, R; Dowd, CS; Lee, IY; Kim, P; Zhang, L; Kang, SH; Keller, TH; Jiricek, J; Barry, CE				Singh, Ramandeep; Manjunatha, Ujjini; Boshoff, Helena I. M.; Ha, Young Hwan; Niyomrattanakit, Pornwaratt; Ledwidge, Richard; Dowd, Cynthia S.; Lee, Ill Young; Kim, Pilho; Zhang, Liang; Kang, Sunhee; Keller, Thomas H.; Jiricek, Jan; Barry, Clifton E., III			PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release	SCIENCE			English	Article							NITRIC-OXIDE; COENZYME F-420; BOVIS BCG; METABOLISM; IDENTIFICATION; BIOSYNTHESIS; RESISTANCE	Bicyclic nitroimidazoles, including PA- 824, are exciting candidates for the treatment of tuberculosis. These prodrugs require intracellular activation for their biological function. We found that Rv3547 is a deazaflavin- dependent nitroreductase ( Ddn) that converts PA- 824 into three primary metabolites; the major one is the corresponding des- nitroimidazole ( des- nitro). When derivatives of PA- 824 were used, the amount of des- nitro metabolite formed was highly correlated with anaerobic killing of Mycobacterium tuberculosis ( Mtb). Des- nitro metabolite formation generated reactive nitrogen species, including nitric oxide ( NO), which are the major effectors of the anaerobic activity of these compounds. Furthermore, NO scavengers protected the bacilli from the lethal effects of the drug. Thus, these compounds may act as intracellular NO donors and could augment a killing mechanism intrinsic to the innate immune system.	[Singh, Ramandeep; Manjunatha, Ujjini; Boshoff, Helena I. M.; Ha, Young Hwan; Ledwidge, Richard; Dowd, Cynthia S.; Lee, Ill Young; Kim, Pilho; Zhang, Liang; Kang, Sunhee; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Manjunatha, Ujjini; Niyomrattanakit, Pornwaratt; Keller, Thomas H.; Jiricek, Jan] Novartis Inst Trop Dis, Singapore 138670, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Novartis	Barry, CE (corresponding author), NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cbarry@mail.nih.gov	kang, sunhee/AAM-9148-2020; Barry, Clifton E/ABE-7992-2020; Jiricek, Jan/AAA-4701-2021; Barry, Clifton E/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Keller, Thomas/0000-0002-7553-6235	National Institute of Allergy and Infectious Diseases; NIH; Bill and Melinda Gates Foundation; Wellcome Trust; Grand Challenges in Global Health Initiative; Korea Foundation for International Cooperation of Science and Technology; Korean Ministry of Education, Science and Technology ( MEST) [No. K20501000001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000693] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome Trust); Grand Challenges in Global Health Initiative; Korea Foundation for International Cooperation of Science and Technology; Korean Ministry of Education, Science and Technology ( MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Nathan ( Cornell University) and T. P. Begley ( Cornell University) for insightful comments, S. Ehrt ( Cornell University) for proteosome mutants, L. Daniels ( Texas A& M University) for F420 and M. Goodwin ( Tuberculosis Research Section) for analytical support. This work was funded ( in part) by the intramural research program of National Institute of Allergy and Infectious Diseases, NIH, and ( in part) by a grant from the Bill and Melinda Gates Foundation and the Wellcome Trust through the Grand Challenges in Global Health Initiative. This work was also supported by the Korea Foundation for International Cooperation of Science and Technology ( KICOS) through a grant provided by the Korean Ministry of Education, Science and Technology ( MEST) ( No. K20501000001).	Anderson RF, 2008, ORG BIOMOL CHEM, V6, P1973, DOI 10.1039/b801859f; Ballini R, 2004, TETRAHEDRON, V60, P1017, DOI 10.1016/j.tet.2003.11.016; Barry CE, 2004, CURR PHARM DESIGN, V10, P3239, DOI 10.2174/1381612043383214; BEAULIEU BB, 1981, ANTIMICROB AGENTS CH, V20, P410, DOI 10.1128/AAC.20.3.410; Boshoff H.I., 2006, DRUG DISCOV TOD DIS, V3, P237, DOI 10.1016/j.ddmec.2006.06.002; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; Choi KP, 2001, J BACTERIOL, V183, P7058, DOI 10.1128/JB.183.24.7058-7066.2001; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Fitzpatrick PF, 2005, ARCH BIOCHEM BIOPHYS, V433, P157, DOI 10.1016/j.abb.2004.08.021; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hofmann KW, 2004, APPL ENVIRON MICROB, V70, P2854, DOI 10.1128/AEM.70.5.2854-2860.2004; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Matteelli A, 2007, EXPERT REV ANTI-INFE, V5, P857, DOI 10.1586/14787210.5.5.857; Rigas B, 2008, NITRIC OXIDE-BIOL CH, V19, P199, DOI 10.1016/j.niox.2008.04.022; Smets BF, 2007, APPL MICROBIOL BIOT, V76, P267, DOI 10.1007/s00253-007-1008-7; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; WALSH C, 1986, ACCOUNTS CHEM RES, V19, P216, DOI 10.1021/ar00127a004	23	448	480	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1392	1395		10.1126/science.1164571	http://dx.doi.org/10.1126/science.1164571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039139	Green Accepted			2022-12-01	WOS:000261170600042
J	Shimada, A; Ueguchi-Tanaka, M; Nakatsu, T; Nakajima, M; Naoe, Y; Ohmiya, H; Kato, H; Matsuoka, M				Shimada, Asako; Ueguchi-Tanaka, Miyako; Nakatsu, Toru; Nakajima, Masatoshi; Naoe, Youichi; Ohmiya, Hiroko; Kato, Hiroaki; Matsuoka, Makoto			Structural basis for gibberellin recognition by its receptor GID1	NATURE			English	Article							HORMONE-SENSITIVE LIPASE; PROTEIN; MECHANISM	Gibberellins ( GAs) are phytohormones essential for many developmental processes in plants(1). A nuclear GA receptor, GIBBERELLIN INSENSITIVEDWARF1 ( GID1), has a primary structure similar to that of the hormone- sensitive lipases (HSLs)(2,3). Here we analyse the crystal structure of Oryza sativa GID1 (OsGID1) bound with GA(4) and GA(3) at 1.9 angstrom resolution. The overall structure of both complexes shows an alpha/beta-hydrolase fold similar to that of HSLs except for an amino- terminal lid. The GA- binding pocket corresponds to the substrate- binding site of HSLs. On the basis of the OsGID1 structure, we mutagenized important residues for GA binding and examined their binding activities. Almost all of them showed very little or no activity, confirming that the residues revealed by structural analysis are important for GA binding. The replacement of Ile 133 with Leu or Val - residues corresponding to those of the lycophyte Selaginella moellendorffii GID1s - caused an increase in the binding affinity for GA(34), a 2 beta-hydroxylated GA(4). These observations indicate that GID1 originated from HSL and was further modified to have higher affinity and more strict selectivity for bioactive GAs by adapting the amino acids involved in GA binding in the course of plant evolution.	[Nakatsu, Toru; Naoe, Youichi; Kato, Hiroaki] Kyoto Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shimada, Asako; Ueguchi-Tanaka, Miyako; Ohmiya, Hiroko; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Nakatsu, Toru; Kato, Hiroaki] RIKEN, Harima Inst SPring 8, Mikazuki, Hyogo 6795148, Japan; [Nakajima, Masatoshi] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Kyoto University; Nagoya University; RIKEN; University of Tokyo	Kato, H (corresponding author), Kyoto Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Sakyo Ku, 46-29 Yoshida Shimoadachi Cho, Kyoto 6068501, Japan.	katohiro@pharm.kyoto-u.ac.jp; makoto@nuagr1.agr.nagoya-u.ac.jp		Nakatsu, Toru/0000-0002-9582-4023; Kato, Hiroaki/0000-0002-5993-4532	Target Protein Research Program; Scientific Research; Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Target Protein Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Research; Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank M. Kawamura, M. Hattori, Y. Yamamoto, K. Aya and T. Matsubara for technical assistance; R. L. Ordonio and M. Tanrikulu for editing of this manuscript; and T. Shimizu, RIKEN, and N. Shimizu, JASRI at SPring- 8, for assistance with data collection. This project was funded by the Target Protein Research Program (M.M. and H.K.), Scientific Research ( M.M., and M.U.-T.), and Special Coordination Funds for Promoting Science and Technology (H.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by research fellowships from the Japan Society for the Promotion of Science (A.S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Davies PJ., 2004, PLANT HORMONES BIOSY; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; HOLM C, 1994, FEBS LETT, V344, P234, DOI 10.1016/0014-5793(94)00403-X; Ileperuma NR, 2007, BIOCHEMISTRY-US, V46, P1851, DOI 10.1021/bi062046w; Itoh H, 2008, INT REV CEL MOL BIO, V268, P191, DOI 10.1016/S1937-6448(08)00806-X; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; ROUSSEL A, 1991, SILICON GRAPHICS GEO, V81, P77; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Yasumura Y, 2007, CURR BIOL, V17, P1225, DOI 10.1016/j.cub.2007.06.037; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811	19	231	257	3	76	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					520	U44		10.1038/nature07546	http://dx.doi.org/10.1038/nature07546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037316				2022-12-01	WOS:000261170500042
J	Hearn, EM; Patel, DR; Lepore, BW; Indic, M; van den Berg, B				Hearn, Elizabeth M.; Patel, Dimki R.; Lepore, Bryan W.; Indic, Mridhu; van den Berg, Bert			Transmembrane passage of hydrophobic compounds through a protein channel wall	NATURE			English	Article							FATTY-ACID TRANSPORT; ESCHERICHIA-COLI; MULTIDRUG TRANSPORTER; MEMBRANE-PROTEIN; P-GLYCOPROTEIN; CYTOPLASMIC LEAFLET; LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; FADL GENE	Membrane proteins that transport hydrophobic compounds have important roles in multi-drug resistance(1-3) and can cause a number of diseases(4,5), underscoring the importance of protein-mediated transport of hydrophobic compounds. Hydrophobic compounds readily partition into regular membrane lipid bilayers(6), and their transport through an aqueous protein channel is energetically unfavourable(3). Alternative transport models involving acquisition from the lipid bilayer by lateral diffusion have been proposed for hydrophobic substrates(3,4,7-12). So far, all transport proteins for which a lateral diffusion mechanism has been proposed function as efflux pumps. Here we present the first example of a lateral diffusion mechanism for the uptake of hydrophobic substrates by the Escherichia coli outer membrane long-chain fatty acid transporter FadL. A FadL mutant in which a lateral opening in the barrel wall is constricted, but which is otherwise structurally identical to wild-type FadL, does not transport substrates. A crystal structure of FadL from Pseudomonas aeruginosa shows that the opening in the wall of the beta-barrel is conserved and delineates a long, hydrophobic tunnel that could mediate substrate passage from the extracellular environment, through the polar lipopolysaccharide layer and, by means of the lateral opening in the barrel wall, into the lipid bilayer from where the substrate can diffuse into the periplasm. Because FadL homologues are found in pathogenic and biodegrading bacteria, our results have implications for combating bacterial infections and bioremediating xenobiotics in the environment.	[Hearn, Elizabeth M.; Patel, Dimki R.; Lepore, Bryan W.; Indic, Mridhu; van den Berg, Bert] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	van den Berg, B (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	bert.vandenberg@umassmed.edu		van den Berg, Bert/0000-0003-1966-8804	National Insitutes of Health; NIH [1R01GM074824]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM079820, R01GM074824] Funding Source: NIH RePORTER	National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel of the National Synchrotron Light Source (NSLS) beamlines X6A and X29 for beam time and beamline support. We are grateful to P. Black and C. Petteys for the strain D10 and for their technical advice on the fatty acid transport assays. This work was supported by a training grant from the National Insitutes of Health (to E. M. H.) and by a NIH research grant (1R01GM074824 to B. v. d. B.).	Abr?moff MD., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLACK PN, 1987, J BIOL CHEM, V262, P1412; BLACK PN, 1990, BIOCHIM BIOPHYS ACTA, V1046, P97, DOI 10.1016/0005-2760(90)90099-J; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DiRusso CC, 2004, J BIOL CHEM, V279, P49563, DOI 10.1074/jbc.R400026200; Eastcott L., 1988, OIL CHEM POLLUT, V4, P191, DOI DOI 10.1016/S0269-8579(88)80020-0; EATON RW, 1994, J BACTERIOL, V176, P7757, DOI 10.1128/JB.176.24.7757-7762.1994; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GINSBURGH CL, 1984, J BIOL CHEM, V259, P8437; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hearn EM, 2008, P NATL ACAD SCI USA, V105, P8601, DOI 10.1073/pnas.0801264105; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Kahng HY, 2000, J BACTERIOL, V182, P1232, DOI 10.1128/JB.182.5.1232-1242.2000; KUMAR GB, 1991, J BIOL CHEM, V266, P1348; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NUNN WD, 1978, P NATL ACAD SCI USA, V75, P3377, DOI 10.1073/pnas.75.7.3377; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Shapiro AB, 1998, EUR J BIOCHEM, V254, P181, DOI 10.1046/j.1432-1327.1998.2540181.x; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Sun PD, 2002, ACTA CRYSTALLOGR D, V58, P1092, DOI 10.1107/S0907444902006510; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; van Veen HW, 1999, BBA-BIOMEMBRANES, V1461, P201, DOI 10.1016/S0005-2736(99)00172-8; VANBEILEN JB, 1992, MOL MICROBIOL, V6, P3121; VORUM H, 1992, BIOCHIM BIOPHYS ACTA, V1126, P135, DOI 10.1016/0005-2760(92)90283-2; WANG Y, 1995, MOL GEN GENET, V246, P570, DOI 10.1007/BF00298963; Ye JQ, 2004, EMBO J, V23, P3187, DOI 10.1038/sj.emboj.7600330	41	106	114	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					367	U134		10.1038/nature07678	http://dx.doi.org/10.1038/nature07678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19182779	Green Accepted			2022-12-01	WOS:000264285600047
J	Tang, SW; Presgraves, DC				Tang, Shanwu; Presgraves, Daven C.			Evolution of the Drosophila Nuclear Pore Complex Results in Multiple Hybrid Incompatibilities	SCIENCE			English	Article							ADAPTIVE PROTEIN EVOLUTION; DOSAGE COMPENSATION; POSITIVE SELECTION; INVIABILITY GENE; LETHAL COMPLEX; MELANOGASTER; HITCHHIKING; SPECIATION; STERILITY; PATTERNS	Speciation often involves the evolution of incompatible gene interactions that cause sterility or lethality in hybrids between populations. These so- called hybrid incompatibilities occur between two or more functionally divergent loci. We show that the nucleoporin 160kDa ( Nup160) gene of the fruitfly Drosophila simulans is incompatible with one or more factors on the D. melanogaster X chromosome, causing hybrid lethality. Nup160 encodes a nuclear pore complex protein and shows evidence of adaptive evolution. Furthermore, the protein encoded by Nup160 directly interacts with that of another hybrid lethality gene, Nup96, indicating that at least two lethal hybrid incompatibility genes have evolved as byproducts of divergent coevolution among interacting components of the Drosophila nuclear pore complex.	[Tang, Shanwu; Presgraves, Daven C.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Presgraves, Daven C.] Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA	University of Rochester; Harvard University	Tang, SW (corresponding author), Univ Rochester, Dept Biol, 601 Elmwood Ave, Rochester, NY 14627 USA.				NIH [R01GM079543]; University of Rochester; Radcliffe Institute for Advanced Study at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester; Radcliffe Institute for Advanced Study at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Drosophila Genome Resource Center for cloning vectors and the D. melanogaster Nup160 cDNA; the Bloomington Stock Center and the Exelixis Stock Collection at Harvard Medical School for fly stocks; and V. Cattani, P. Gerard, C. Meiklejohn, A. Orr, A. Sweigart, and two anonymous reviewers for comments. This work was supported by funds to D. C. P. from NIH grant R01GM079543, the University of Rochester, and the Radcliffe Institute for Advanced Study at Harvard University. Sequences have been deposited in GenBank under accession numbers FJ600378 to FJ600401.	Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Ashburner M, 2005, DROSOPHILA LAB HDB, V2nd; Bachtrog D, 2008, GENETICS, V180, P1123, DOI 10.1534/genetics.107.084244; Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Barbash DA, 2007, GENETICS, V176, P543, DOI 10.1534/genetics.107.072827; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Chakraborty P, 2008, DEV CELL, V15, P657, DOI 10.1016/j.devcel.2008.08.020; Coyne J.A., 1989, P180; Coyne J.A., 2004, SPECIATION; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.1111/j.1558-5646.1989.tb04233.x, 10.2307/2409213]; Dobzhansky T, 1937, GENETICS ORIGIN SPEC; Fay JC, 2000, GENETICS, V155, P1405; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; KAPLAN NL, 1989, GENETICS, V123, P887; Levine MT, 2007, GENETICS, V177, P1959, DOI 10.1534/genetics.107.079459; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; ORR HA, 1995, GENETICS, V139, P1805; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Presgraves DC, 2007, BIOESSAYS, V29, P386, DOI 10.1002/bies.20555; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 2003, GENETICS, V163, P955; Rodriguez MA, 2007, P NATL ACAD SCI USA, V104, P15412, DOI 10.1073/pnas.0707445104; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; TAJIMA F, 1989, GENETICS, V123, P585; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; TURELLI M, 1995, GENETICS, V140, P389; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	36	115	120	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					779	782		10.1126/science.1169123	http://dx.doi.org/10.1126/science.1169123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197064	Green Accepted			2022-12-01	WOS:000263066800046
J	Bliuc, D; Nguyen, ND; Milch, VE; Nguyen, TV; Eisman, JA; Center, JR				Bliuc, Dana; Nguyen, D. Nguyen; Milch, Vivienne E.; Nguyen, Tuan V.; Eisman, John A.; Center, Jacqueline R.			Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIP FRACTURE; OLDER WOMEN; EXCESS MORTALITY; VERTEBRAL FRACTURE; CLINICAL FRACTURES; PREDICT MORTALITY; ELDERLY-WOMEN; FOLLOW-UP; SURVIVAL; HOSPITALIZATION	Context There are few data on long- term mortality following osteoporotic fracture and fewer following subsequent fracture. Objectives To examine long- term mortality risk in women and men following all osteoporotic fractures and to assess the association of subsequent fracture with that risk. Design, Setting, and Participants Prospective cohort from the Dubbo Osteoporosis Epidemiology Study of community- dwelling women and men aged 60 years and older from Dubbo, Australia, who sustained a fracture between April 1989 and May 2007. Main Outcome Measures Age- and sex- specific standardized mortality ratios ( SMRs) compared with the overallDubbopopulation for hip, vertebral, major, and minor fractures. Results In women, there were 952 low- trauma fractures followed by 461 deaths, and in men, 343 fractures were followed by 197 deaths. Age- adjusted SMRs were increased following hip fractures ( SMRs, 2.43 [ 95% confidence interval [ CI], 2.02-2.93] and 3.51 [ 95% CI, 2.65- 4.66]), vertebral fractures ( SMRs, 1.82 [ 95% CI, 1.52-2.17] and 2.12 [ 95% CI, 1.66- 2.72]), major fractures ( SMRs, 1.65 [ 95% CI, 1.31-2.08] and 1.70 [ 95% CI, 1.23- 2.36]), and minor fractures ( SMRs, 1.42 [ 95% CI, 1.19- 1.70] and 1.33 [ 95% CI, 0.99- 1.80]) for both women and men, respectively. Mortality was increased for all ages for all fractures except minor fractures for which increased mortality was only apparent for those older than 75 years. Increased mortality risk persisted for 5 years for all fractures and up to 10 years for hip fractures. Increases in absolute mortality that were above expected, for 5 years after fracture, ranged from 1.3 to 13.2 per 100 person- years in women and from 2.7 to 22.3 per 100 person- years in men, depending on fracture type. Subsequent fracture was associated with an increased mortality hazard ratio of 1.91 ( 95% CI, 1.54- 2.37) in women and 2.99 ( 95% CI, 2.11- 4.24) in men. Mortality risk following a subsequent fracture then declined but beyond 5 years still remained higher than in the general population ( SMR, 1.41 [ 95% CI, 1.01- 1.97] and SMR, 1.78 [ 95% CI, 0.96- 3.31] for women and men, respectively). Predictors of mortality after any fragility fracture for both men and women included age, quadriceps weakness, and subsequent fracture but not comorbidities. Low bone mineral density, having smoked, and sway were also predictors for women and less physical activity for men. Conclusions In a sample of older women and men, all low- trauma fractures were associated with increased mortality risk for 5 to 10 years. Subsequent fracture was associated with increased mortality risk for an additional 5 years.	[Bliuc, Dana; Nguyen, D. Nguyen; Milch, Vivienne E.; Nguyen, Tuan V.; Eisman, John A.; Center, Jacqueline R.] St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Res Program, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney	Center, JR (corresponding author), Garvan Inst Med Res, 384 Victoria St, Sydney, NSW 2010, Australia.	j.center@garvan.org.au	Nguyen, Nguyen/D-1480-2010; Bliuc, Dana/Y-7240-2018; Nguyen, Tuan V/B-6147-2008; Eisman, John A/C-2886-2014; Center, Jacqueline/AAY-8712-2021; Nguyen, Nguyen/GVT-4511-2022; Nguyen, Thao/GWN-0419-2022	Bliuc, Dana/0000-0001-9682-2313; Nguyen, Tuan V/0000-0002-3246-6281; Center, Jacqueline/0000-0002-5278-4527; Milch, Vivienne/0000-0001-8834-0349	National Health and Medical Research Council [276413]; MBF Living Well Foundation; Ernst Heine Foundation; Amgen; Merck Sharp Dohme; Sanofi-Aventis; Servier; Novartis	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MBF Living Well Foundation; Ernst Heine Foundation; Amgen(Amgen); Merck Sharp Dohme(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Servier(Servier); Novartis(Novartis)	This study was supported in part by National Health and Medical Research Council (NHMRC) grant 276413. This study also received support from the MBF Living Well Foundation, the Ernst Heine Foundation; and untied grants from Amgen, Merck Sharp & Dohme, Sanofi-Aventis, Servier, and Novartis.	Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; BROWNER WS, 1991, LANCET, V338, P355, DOI 10.1016/0140-6736(91)90489-C; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; Cawthon PM, 2007, J AM GERIATR SOC, V55, P1216, DOI 10.1111/j.1532-5415.2007.01259.x; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Cooper Cyrus, 1997, American Journal of Medicine, V103, p12S, DOI 10.1016/S0002-9343(97)90022-X; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Empana JP, 2004, J AM GERIATR SOC, V52, P685, DOI 10.1111/j.1532-5415.2004.52203.x; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Farahmand BY, 2005, OSTEOPOROSIS INT, V16, P1583, DOI 10.1007/s00198-005-2024-z; Forsen L, 1999, OSTEOPOROSIS INT, V10, P73, DOI 10.1007/s001980050197; Haentjens P, 2004, J BONE MINER RES, V19, P1933, DOI 10.1359/JBMR.040917; Hasserius R, 2005, CALCIFIED TISSUE INT, V76, P235, DOI 10.1007/s00223-004-2222-2; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; Kado DM, 2003, OSTEOPOROSIS INT, V14, P589, DOI 10.1007/s00198-003-1412-5; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P108, DOI 10.1007/s00198-003-1516-y; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; Karagiannis A, 2006, CALCIFIED TISSUE INT, V78, P72, DOI 10.1007/s00223-005-0169-6; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Nguyen ND, 2007, J BONE MINER RES, V22, P1147, DOI 10.1359/JBMR.070412; *OST AUSTR ACC EC, 2001, BURD BRITTL BON COST; Pongchaiyakul C, 2005, J BONE MINER RES, V20, P1349, DOI 10.1359/JBMR.050317; Randell AG, 2000, OSTEOPOROSIS INT, V11, P460, DOI 10.1007/s001980070115; SIMONS LA, 1990, AUST NZ J MED, V20, P783, DOI 10.1111/j.1445-5994.1990.tb00423.x; Tosteson ANA, 2007, OSTEOPOROSIS INT, V18, P1463, DOI 10.1007/s00198-007-0429-6; Trombetti A, 2002, OSTEOPOROSIS INT, V13, P731, DOI 10.1007/s001980200100; Trone DW, 2007, AM J EPIDEMIOL, V166, P1191, DOI 10.1093/aje/kwm206; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P1583, DOI 10.1007/s00198-007-0403-3; Woodward M., 1992, STATISTICIAN, V41, P185; 2006, BASE SAS 9 1 3 PROCE	35	1005	1044	0	37	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					513	521		10.1001/jama.2009.50	http://dx.doi.org/10.1001/jama.2009.50			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402CS	19190316	Bronze			2022-12-01	WOS:000262992400021
J	Trompette, A; Divanovic, S; Visintin, A; Blanchard, C; Hegde, RS; Madan, R; Thorne, PS; Wills-Karp, M; Gioannini, TL; Weiss, JP; Karp, CL				Trompette, Aurelien; Divanovic, Senad; Visintin, Alberto; Blanchard, Carine; Hegde, Rashmi S.; Madan, Rajat; Thorne, Peter S.; Wills-Karp, Marsha; Gioannini, Theresa L.; Weiss, Jerry P.; Karp, Christopher L.			Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein	NATURE			English	Article							TLR4-MD-2 COMPLEX; CRYSTAL-STRUCTURE; ALLERGIC DISEASE; CELL ACTIVATION; ENDOTOXIN; MD-2; ASTHMA; LIPOPOLYSACCHARIDE; RESPONSES; EXPOSURE	Aeroallergy results from maladaptive immune responses to ubiquitous, otherwise innocuous environmental proteins(1). Although the proteins targeted by aeroallergic responses represent a tiny fraction of the airborne proteins humans are exposed to, allergenicity is a quite public phenomenon - the same proteins typically behave as aeroallergens across the human population. Why particular proteins tend to act as allergens in susceptible hosts is a fundamental mechanistic question that remains largely unanswered. The main house- dust- mite allergen, Der p 2, has structural homology with MD- 2 ( also known as LY96), the lipopolysaccharide ( LPS)- binding component of the Toll- like receptor ( TLR) 4 signalling complex(2-4). Here we show that Der p 2 also has functional homology, facilitating signalling through direct interactions with the TLR4 complex, and reconstituting LPS- driven TLR4 signalling in the absence of MD- 2. Mirroring this, airway sensitization and challenge with Der p 2 led to experimental allergic asthma in wild type and MD- 2- deficient, but not TLR4- deficient, mice. Our results indicate that Der p 2 tends to be targeted by adaptive immune responses because of its auto-adjuvant properties. The fact that other members of the MD- 2- like lipid- binding family are allergens, and that most defined major allergens are thought to be lipid- binding proteins(5), suggests that intrinsic adjuvant activity by such proteins and their accompanying lipid cargo may have some generality as a mechanism underlying the phenomenon of allergenicity.	[Trompette, Aurelien; Divanovic, Senad; Madan, Rajat; Karp, Christopher L.] Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA; [Blanchard, Carine] Childrens Hosp, Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Hegde, Rashmi S.] Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Wills-Karp, Marsha] Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Visintin, Alberto] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01606 USA; [Thorne, Peter S.] Univ Iowa, Dept Occupat & Environm Med, Iowa City, IA 52241 USA; [Gioannini, Theresa L.; Weiss, Jerry P.] Univ Iowa, Inflammat Program, Dept Internal Med, Iowa City, IA 52241 USA; [Gioannini, Theresa L.; Weiss, Jerry P.] Vet Affairs Med Ctr, Iowa City, IA 52247 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Worcester; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Karp, CL (corresponding author), Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA.	chris.karp@chmcc.org	Madan, Rajat/V-6168-2019	Madan, Rajat/0000-0002-9821-1257; Karp, Christopher/0000-0002-0832-2659; Thorne, Peter/0000-0002-5045-0929	Sandler Foundation for Asthma Research; National Institute of Allergy and Infectious Diseases; Veteran's Administration; NATIONAL EYE INSTITUTE [R01EY014648] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075159] Funding Source: NIH RePORTER	Sandler Foundation for Asthma Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veteran's Administration(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Vogel for re-purified LPS; E. Kurt-Jones and R. Finberg for HEK293 cells expressing TLR4 complex proteins, N.J. Gay for discussions, and L. Flick and J. Bohnert for technical assistance. This work was funded by grants from the Sandler Foundation for Asthma Research (C.L.K.), the National Institute of Allergy and Infectious Diseases (C.L.K., J.P.W.), and the Veteran's Administration (T.L.G.).	Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Gehring U, 2002, AM J RESP CRIT CARE, V166, P939, DOI 10.1164/rccm.200203-256OC; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; HEYMANN PW, 1989, J ALLERGY CLIN IMMUN, V83, P1055, DOI 10.1016/0091-6749(89)90447-8; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; MAUNSELL K, 1968, LANCET, V1, P1267; MICHEL O, 1989, J APPL PHYSIOL, V66, P1059, DOI 10.1152/jappl.1989.66.3.1059; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park GM, 2000, CLIN EXP ALLERGY, V30, P1293, DOI 10.1046/j.1365-2222.2000.00883.x; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Teghanemt A, 2007, J BIOL CHEM, V282, P36250, DOI 10.1074/jbc.M705995200; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; Tulic MK, 2000, AM J RESP CELL MOL, V22, P604; Williams LK, 2005, ANN ALLERG ASTHMA IM, V94, P323, DOI 10.1016/S1081-1206(10)60983-0; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579	30	537	548	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					585	U91		10.1038/nature07548	http://dx.doi.org/10.1038/nature07548			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19060881	Green Accepted			2022-12-01	WOS:000262852200042
J	Maximov, A; Tang, J; Yang, XF; Pang, ZPP; Sudhof, TC				Maximov, Anton; Tang, Jiong; Yang, Xiaofei; Pang, Zhiping P.; Sudhof, Thomas C.			Complexin Controls the Force Transfer from SNARE Complexes to Membranes in Fusion	SCIENCE			English	Article							SYNAPTOTAGMIN-I FUNCTIONS; NEUROTRANSMITTER RELEASE; DISTINCT DOMAINS; EXOCYTOSIS; SENSOR	Trans- SNAP receptor ( SNARE, where SNAP is defined as soluble NSF attachment protein, and NSF is defined as N- ethylmaleimide- sensitive factor) complexes catalyze synaptic vesicle fusion and bind complexin, but the function of complexin binding to SNARE complexes remains unclear. Here we show that in neuronal synapses, complexin simultaneously suppressed spontaneous fusion and activated fast calcium ion- evoked fusion. The dual function of complexin required SNARE binding and also involved distinct amino- terminal sequences of complexin that localize to the point where trans- SNARE complexes insert into the fusing membranes, suggesting that complexin controls the force that trans- SNARE complexes apply onto the fusing membranes. Consistent with this hypothesis, a mutation in the membrane insertion sequence of the v- SNARE synaptobrevin/ vesicle- associated membrane protein ( VAMP) phenocopied the complexin loss- of- function state without impairing complexin binding to SNARE complexes. Thus, complexin probably activates and clamps the force transfer from assembled trans- SNARE complexes onto fusing membranes.	[Maximov, Anton; Tang, Jiong; Yang, Xiaofei; Pang, Zhiping P.; Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Yang, Xiaofei; Pang, Zhiping P.; Sudhof, Thomas C.] Stanford Univ, Dept Cellular & Mol Physiol, Palo Alto, CA 94304 USA; [Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Sudhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	tcs1@stanford.edu	Pang, Zhiping/AAF-5757-2020	Pang, Zhiping/0000-0002-6183-1233	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. Rizo and L. Chen for advice and critical comments. This study was supported by an investigatorship to T. C. S. from the Howard Hughes Medical Institute.	Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2008, J BIOL CHEM, V283, P21211, DOI 10.1074/jbc.M803478200; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Guan R, 2008, BIOCHEMISTRY-US, V47, P1474, DOI 10.1021/bi702345m; Hu KA, 2002, J BIOL CHEM, V277, P41652, DOI 10.1074/jbc.M205044200; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Verhage M, 2007, CURR OPIN CELL BIOL, V19, P402, DOI 10.1016/j.ceb.2007.05.002; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6	22	244	251	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					516	521		10.1126/science.1166505	http://dx.doi.org/10.1126/science.1166505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164751	Green Accepted			2022-12-01	WOS:000262587900046
J	Rai, K; Huggins, IJ; James, SR; Karpf, AR; Jones, DA; Cairns, BR				Rai, Kunal; Huggins, Ian J.; James, Smitha R.; Karpf, Adam R.; Jones, David A.; Cairns, Bradley R.			DNA Demethylation in Zebrafish Involves the Coupling of a Deaminase, a Glycosylase, and Gadd45	CELL			English	Article							PATERNAL GENOME; METHYLATION; 5-METHYLCYTOSINE; ARABIDOPSIS; MBD4; ACTIVATION; PROMOTER; DEMETER	Evidence for active DNA demethylation in vertebrates is accumulating, but the mechanisms and enzymes remain unclear. Using zebrafish embryos we provide evidence for 5-methylcytosine (5-meC) removal in vivo via the coupling of a 5-meC deaminase (AID, which converts 5-meC to thymine) and a G: T mismatch-specific thymine glycosylase (Mbd4). The injection of methylated DNA into embryos induced a potent DNA demethylation activity, which was attenuated by depletion of AID or the non enzymatic factor Gadd45. Remarkably, overexpression of the deaminase/glycosylase pair AID/Mbd4 in vivo caused demethylation of the bulk genome and injected methylated DNA fragments, likely involving a G: T intermediate. Furthermore, AID or Mbd4 knockdown caused the remethylation of a set of common genes. Finally, Gadd45 promoted demethylation and enhanced functional interactions between deaminase/glycosylase pairs. Our results provide evidence for a coupled mechanism of 5-meC demethylation, whereby AID deaminates 5-meC, followed by thymine base excision by Mbd4, promoted by Gadd45.	[Rai, Kunal; Jones, David A.; Cairns, Bradley R.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Jones, David A.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Rai, Kunal; Cairns, Bradley R.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Rai, Kunal; Huggins, Ian J.; Jones, David A.; Cairns, Bradley R.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [James, Smitha R.; Karpf, Adam R.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Roswell Park Cancer Institute	Jones, DA (corresponding author), Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	david.jones@hci.utah.edu; brad.cairns@hci.utah.edu		Rai, Kunal/0000-0003-2321-6894; Karpf, Adam/0000-0002-0866-0666	Huntsman Cancer Institute; National Cancer Institute [CA24014, CA16056]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058506] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA116674, R01CA116468] Funding Source: NIH RePORTER	Huntsman Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jacqui Wittmeyer for generating antibodies for Apobec2a/b, Richard Dorsky for probes, Sung Wan Kim for plasmids, M. Ben Major for Gadd45 morpholino efficacy determinations, Bob Schackmann for oligos and Helaman Escobar for sequencing. We thank Brenda Bass, Don Ayer, and Barbara Graves for comments on the manuscript. Support has been received from: Huntsman Cancer Institute (supplies, genomics and support of K.R., I.H., and D.A.J.), the National Cancer Institute (for D.A.J, S.R.J., and A.R.K.), CA24014 and CA16056 (for core facilities), and the Howard Hughes Medical Institute (supplies, genomics, and support of B.R.C.).	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Collas P, 1998, NUCLEIC ACIDS RES, V26, P4454, DOI 10.1093/nar/26.19.4454; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mhanni AA, 2004, DEV GENES EVOL, V214, P412, DOI 10.1007/s00427-004-0418-0; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Zhu B, 2000, NUCLEIC ACIDS RES, V28, P4157, DOI 10.1093/nar/28.21.4157	33	517	538	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1201	1212		10.1016/j.cell.2008.11.042	http://dx.doi.org/10.1016/j.cell.2008.11.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109892	Bronze, Green Accepted			2022-12-01	WOS:000261989800012
J	Bindman, AB; Chattopadhyay, A; Auerback, GM				Bindman, Andrew B.; Chattopadhyay, Arpita; Auerback, Glenna M.			Interruptions in Medicaid Coverage and Risk for Hospitalization for Ambulatory Care-Sensitive Conditions	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-INSURANCE; MANAGED CARE; ENROLLMENT; CANCER	Background: Many low-income U.S. citizens experience interruptions in health insurance coverage. Objective: To determine the rate of hospitalization for ambulatory care-sensitive conditions among Medicaid beneficiaries with interruptions in coverage. Design: Retrospective cohort study. Setting: California Medicaid population. Patients: 4 735 797 adults in California age 18 to 64 years who received a minimum of 1 month of Medicaid coverage between 1998 to 2002. Measurement: Time to hospitalization for an ambulatory care sensitive condition. Results: Sixty-two percent of Medicaid beneficiaries experienced at least 1 interruption in coverage during the study period. The 3 most common ambulatory care-sensitive conditions resulting in a hospitalization were heart failure, diabetes, and chronic obstructive pulmonary disease. Interruptions in coverage were associated with a higher risk for hospitalization for an ambulatory care-sensitive condition (adjusted hazard ratio, 3.66 [95% CI, 3.59 to 3.72]; P < 0.001). In subgroup analyses, the association between interrupted coverage and hospitalization was stronger for beneficiaries eligible through the Temporary Aid to Needy Families program (adjusted hazard ratio, 8.56 [CI, 8.06 to 9.08]) than for beneficiaries eligible through the Supplemental Security Income program (adjusted hazard ratio, 1.72 [CI, 1.67 to 1.76]), who typically retain Medicare coverage even when their Medicaid coverage is interrupted. Limitation: The study lacked information on why interruptions occurred and whether beneficiaries with interruptions transitioned to other insurance coverage. Conclusion: Interruptions in Medicaid coverage are associated with a higher rate of hospitalization for ambulatory care-sensitive conditions. Policies that reduce the frequency of interruptions in Medicaid coverage might prevent some of the health events that trigger hospitalization and high-cost health care spending.	[Bindman, Andrew B.] San Francisco Gen Hosp, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Bindman, AB (corresponding author), San Francisco Gen Hosp, Bldg 10,Ward 13,1001 Potrero Ave, San Francisco, CA 94110 USA.	abindman@medsfgh.ucsf.edu	Dalla Zuanna, Teresa/G-3133-2015		The Commonwealth Fund; national, private foundation	The Commonwealth Fund; national, private foundation	By The Commonwealth Fund, a national, private foundation that supports independent research on health and social issues.	Agency for Healthcare Research and Quality, 2002, AHRQ QUAL IND GUID P; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Bindman AB, 2005, HEALTH SERV RES, V40, P19, DOI 10.1111/j.1475-6773.2005.00340.x; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Bradley CJ, 2005, CANCER-AM CANCER SOC, V103, P1712, DOI 10.1002/cncr.20954; Carrasquillo O, 1998, AM J PUBLIC HEALTH, V88, P464, DOI 10.2105/AJPH.88.3.464; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; *ER MARD ASS, 2002, US MARK RES IMPR ENR; FLEMING ST, 1995, MED CARE RES REV, V52, P88, DOI 10.1177/107755879505200106; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Harman JS, 2003, PSYCHIAT SERV, V54, P999, DOI 10.1176/appi.ps.54.7.999; *I MED, 2004, INS AM HLTH; *KAIS COMM, 2001, STAT NAT MED ENR SPE; *KAIS COMM MED UN, 2006, WHO NEEDS MED AID; KLEIN J, 2002, MED CARE STAT SECTIO; Klein K, 2005, ENTRANCES EXITS HLTH, V855, P1; Kruzikas DT, 2004, PREVENTABLE HOSPITAL; PAGE C, 1999, GUIDE MEDICAL PROGRA; Perkins CI, 2001, MED CARE, V39, P1224, DOI 10.1097/00005650-200111000-00009; RAINS J, 2001, OSHPD MEDICAL MATCH; Short PF, 2003, HEALTH AFFAIR, V22, P244, DOI 10.1377/hlthaff.22.6.244; SHORT PF, 2003, CHURN CHURN CHURN IN, V688, P1; *US GOV ACC OFF, 2007, MED STAT REP CIT DOC; YAMAGUCHI K, 1991, EVENT HIST ANAL, P182	24	73	74	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					854	+		10.7326/0003-4819-149-12-200812160-00004	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	384VI	19075204				2022-12-01	WOS:000261771900002
J	Lin, YF; Gill, ME; Koubova, J; Page, DC				Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.			Germ Cell-Intrinsic and -Extrinsic Factors Govern Meiotic Initiation in Mouse Embryos	SCIENCE			English	Article							MEIOSIS; PROTEIN; FEMALE; GENE; EXPRESSION; HOMOLOG; PATHWAY; GONADS; ARREST	Retinoic acid ( RA) is an essential extrinsic inducer of meiotic initiation in mammalian germ cells. However, RA acts too widely in mammalian development to account, by itself, for the cell- type and temporal specificity of meiotic initiation. We considered parallels to yeast, in which extrinsic and intrinsic factors combine to restrict meiotic initiation. We demonstrate that, in mouse embryos, extrinsic and intrinsic factors together regulate meiotic initiation. The mouse RNA- binding protein DAZL, which is expressed by postmigratory germ cells, is a key intrinsic factor, enabling those cells to initiate meiosis in response to RA. Within a brief developmental window, Dazl- expressing germ cells in both XX and XY embryos actively acquire the ability to interpret RA as a meiosis- inducing signal.	[Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.] MIT, Whitehead Inst, Cambridge, MA 02142 USA; [Lin, Yanfeng; Gill, Mark E.; Koubova, Jana; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lin, YF (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA.			Gill, Mark/0000-0002-2069-958X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank H. Cooke for mice carrying the Dazl<SUP>Tm1Hgu</SUP> allele; C. Heyting for SYCP3 antisera; T. Noce for MVH antisera; and A. Amon, E. Anderson, A. Baltus, A. Bortvin, M. Carmell, G. Fink, A. Hochwagen, Y. Hu, J. Lange, J. Mueller, L. Okumura, and T. Orr-Weaver for advice and comments on the manuscript. Microscopy and image capture were conducted at the W. M. Keck Foundation Biological Imaging Facility at the Whitehead Institute. This work was supported by the Howard Hughes Medical Institute.	Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bannister LA, 2004, CYTOGENET GENOME RES, V107, P191, DOI 10.1159/000080597; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; BYSKOV AG, 1976, DEV BIOL, V52, P193, DOI 10.1016/0012-1606(76)90239-6; BYSKOV AGS, 1974, NATURE, V252, P396, DOI 10.1038/252396a0; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Di Carlo A, 2000, INT J DEV BIOL, V44, P241; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; HOPPER AK, 1975, GENETICS, V80, P41; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MCLAREN A, 1983, J EXP ZOOL, V228, P167, DOI 10.1002/jez.1402280203; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Scherthan H, 2003, CYTOGENET GENOME RES, V103, P235, DOI 10.1159/000076809; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; UPADHYAY S, 1982, P NATL ACAD SCI-BIOL, V79, P6584, DOI 10.1073/pnas.79.21.6584	25	184	191	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1685	1687		10.1126/science.1166340	http://dx.doi.org/10.1126/science.1166340			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074348				2022-12-01	WOS:000261608300043
J	Tsai, AG; Lu, HH; Raghavan, SC; Muschen, M; Hsieh, CL; Lieber, MR				Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Muschen, Markus; Hsieh, Chih-Lin; Lieber, Michael R.			Human Chromosomal Translocations at CpG Sites and a Theoretical Basis for Their Lineage and Stage Specificity	CELL			English	Article							SINGLE-STRANDED-DNA; ACUTE LYMPHOBLASTIC-LEUKEMIA; CLASS SWITCH RECOMBINATION; MAJOR BREAKPOINT REGION; V(D)J RECOMBINATION; CYTOSINE DEAMINATION; TRANSGENIC MICE; EXCISION-REPAIR; RAG COMPLEX; B-CELLS	We have assembled, annotated, and analyzed a database of over 1700 breakpoints from the most common chromosomal rearrangements in human leukemias and lymphomas. Using this database, we show that although the CpG dinucleotide constitutes only 1% of the human genome, it accounts for 40%-70% of breakpoints at pro-B/pre-B stage translocation regions-specifically, those near the bcl-2, bcl-1, and E2A genes. We do not observe CpG hotspots in rearrangements involving lymphoid-myeloid progenitors, mature B cells, or T cells. The stage specificity, lineage specificity, CpG targeting, and unique breakpoint distributions at these cluster regions may be explained by a lesion-specific double-strand breakage mechanism involving the RAG complex acting at AID-deaminated methyl-CpGs.	[Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Urol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Lu, Haihui; Raghavan, Sathees C.; Hsieh, Chih-Lin; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90089 USA; [Muschen, Markus] Univ So Calif, Childrens Hosp Los Angeles, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pediat, Los Angeles, CA 90027 USA; [Muschen, Markus] Univ So Calif, Childrens Hosp Los Angeles, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90027 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California	Lieber, MR (corresponding author), Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Room 5428,1441 Eastlake Ave,MC9176, Los Angeles, CA 90089 USA.	lieber@usc.edu		Tsai, Albert/0000-0002-6607-3347; Lieber, Michael/0000-0003-3700-6345; Lieber, Michael/0000-0001-8809-0909	NCI NIH HHS [R37 CA051105, R01 CA139032-01, R37 CA051105-18, R01 CA137060, R01 CA100504-06, R37 CA051105-20, R01 CA100504, R37 CA051105-19, R01 CA139032, R21 CA152497, R37 CA051105-21] Funding Source: Medline; NIGMS NIH HHS [R01 GM056984, R01 GM043236-14, R01 GM043236, R01 GM056984-07] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA137060, R37CA051105, R01CA100504, R01CA139032, R21CA152497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056984, R01GM043236] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALT FW, 1982, NATURE, V296, P325, DOI 10.1038/296325a0; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Barreto V, 2001, EUR J IMMUNOL, V31, P3763, DOI 10.1002/1521-4141(200112)31:12<3763::AID-IMMU3763>3.0.CO;2-Y; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bassing CH, 2008, BLOOD, V111, P2163, DOI 10.1182/blood-2007-08-104760; Bertoni F, 2004, BRIT J HAEMATOL, V124, P130, DOI 10.1046/j.1365-2141.2003.04761.x; Bestor TH, 2003, ANN NY ACAD SCI, V983, P22, DOI 10.1111/j.1749-6632.2003.tb05959.x; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; BURROWS PD, 1983, NATURE, V306, P243, DOI 10.1038/306243a0; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Feldhahn N, 2007, J EXP MED, V204, P1157, DOI 10.1084/jem.20062662; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Friedberg E.C., 2006, DNA REPAIR MUTAGENES; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Hotfilder M, 2005, CANCER RES, V65, P1442, DOI 10.1158/0008-5472.CAN-04-1356; Jaffe E. S., 2001, PATHOLOGY GENETICS T; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; Jansen MWJC, 2007, LEUKEMIA, V21, P633, DOI 10.1038/sj.leu.2404578; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim N, 2007, DNA REPAIR, V6, P1285, DOI 10.1016/j.dnarep.2007.02.023; Kitagawa Y, 2002, J BIOL CHEM, V277, P46289, DOI 10.1074/jbc.M208353200; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lindahl T, 1997, CURR OPIN GENET DEV, V7, P158, DOI 10.1016/S0959-437X(97)80124-4; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; LIU YF, 1994, P NATL ACAD SCI USA, V91, P8910, DOI 10.1073/pnas.91.19.8910; LOVEC H, 1994, EMBO J, V13, P3487, DOI 10.1002/j.1460-2075.1994.tb06655.x; Mao CC, 2004, IMMUNITY, V20, P133, DOI 10.1016/S1074-7613(04)00019-6; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; MULLER JR, 1995, CANCER RES, V55, P5012; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pine SR, 2003, LEUKEMIA RES, V27, P155, DOI 10.1016/S0145-2126(02)00183-2; Raghavan SC, 2007, DNA REPAIR, V6, P751, DOI 10.1016/j.dnarep.2006.12.016; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Santagata S, 1999, MOL CELL, V4, P935, DOI 10.1016/S1097-2765(00)80223-3; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Schlissel MS, 2006, GENE DEV, V20, P1539, DOI 10.1101/gad.1446506; SCHMUTTE C, 1995, CANCER RES, V55, P3742; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Smith DP, 2005, ONCOGENE, V24, P3544, DOI 10.1038/sj.onc.1208399; Takai Daiya, 2003, In Silico Biology, V3, P235; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Unniraman S, 2006, DNA REPAIR, V5, P1259, DOI 10.1016/j.dnarep.2006.05.019; WADA M, 1993, BLOOD, V82, P3163; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; Weinberg OK, 2007, J MOL DIAGN, V9, P530, DOI 10.2353/jmoldx.2007.070038; Welzel N, 2001, CANCER RES, V61, P1629; Wiemels JL, 2002, P NATL ACAD SCI USA, V99, P15101, DOI 10.1073/pnas.222481199; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Yang AS, 1996, J MOL BIOL, V258, P240, DOI 10.1006/jmbi.1996.0246; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zhang M, 2008, J BIOL CHEM, V283, P6717, DOI 10.1074/jbc.M710301200	71	176	184	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1130	1142		10.1016/j.cell.2008.10.035	http://dx.doi.org/10.1016/j.cell.2008.10.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070581	Green Accepted, Bronze			2022-12-01	WOS:000261642800028
J	Fiscella, K; Tancredi, D				Fiscella, Kevin; Tancredi, Daniel			Socioeconomic Status and Coronary Heart Disease Risk Prediction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALL-CAUSE MORTALITY; CARDIOVASCULAR RISK; VALIDATION; PROJECT; SCORE		[Fiscella, Kevin] Univ Rochester, Dept Family Med, Rochester, NY USA; [Fiscella, Kevin] Univ Rochester, Dept Community & Prevent Med, Rochester, NY USA; [Fiscella, Kevin] Univ Rochester, Dept Oncol, Rochester, NY USA; [Tancredi, Daniel] Univ Calif Davis, Dept Pediat, Ctr Healthcare Policy & Res, Davis, CA 95616 USA	University of Rochester; University of Rochester; University of Rochester; University of California System; University of California Davis	Fiscella, K (corresponding author), 1381 South Ave, Rochester, NY 14620 USA.	Kevin_Fiscella@URMC.rochester.edu	Fiscella, Kevin Anthony/AFO-3350-2022; Tancredi, Daniel J/O-3381-2013	Fiscella, Kevin Anthony/0000-0003-3613-8012; Tancredi, Daniel J/0000-0002-3884-7907	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081066] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081066, R01 HL081066-01A2, 1R01 HL081066-01A2] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brindle PM, 2005, BRIT J GEN PRACT, V55, P838; *C BUDG OFF, 2008, GROW DSP LIF EXP; Claussen B, 2003, J EPIDEMIOL COMMUN H, V57, P40, DOI 10.1136/jech.57.1.40; Commission on Social Determinants of Health, 2008, CSDH FIN REP CLOS GA; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; Fiscella K, 2004, ANN FAM MED, V2, P469, DOI 10.1370/afm.88; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Sacks FM, 2000, CIRCULATION, V102, P1893, DOI 10.1161/01.CIR.102.16.1893; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	15	54	57	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2666	2668		10.1001/jama.2008.792	http://dx.doi.org/10.1001/jama.2008.792			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380YW	19066387	Green Accepted			2022-12-01	WOS:000261503000026
J	Driver, JA; Djousse, L; Logroscino, G; Gaziano, JM; Kurth, T				Driver, Jane A.; Djousse, Luc; Logroscino, Giancarlo; Gaziano, J. Michael; Kurth, Tobias			Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; LIFETIME RISK; PHYSICIANS HEALTH; ALZHEIMERS-DISEASE; BETA-CAROTENE; MORTALITY; BURDEN; STROKE; CHOLESTEROL; POPULATION	Objective To investigate the influence of increasing age on the incidence and remaining lifetime risk of cardiovascular disease and cancer in a cohort of older men. Design Prospective cohort study. Setting United States. Participants 22 048 male doctors aged 40- 84 who were free of major disease in 1982. Main outcome measures Incidence and remaining lifetime risk of major cardiovascular disease ( myocardial infarction, stroke, and death from cardiovascular disease) and cancer. Results 3252 major cardiovascular events and 5400 incident cancers were confirmed over 23 years of follow-up. The incidence of major cardiovascular disease continued to increase to age 100. Beginning at age 80, however, major cardiovascular disease was more likely to be diagnosed at death. The incidence of cancer peaked in those aged 80- 89 and then declined. Cancers detected by screening accounted for most of the decline, whereas most cancers for which there was no screening continued to increase to age 100. Unadjusted cumulative incidence overestimated the risk of cardiovascular disease by 16% and cancer by 8.5%. The remaining lifetime risk of cancer at age 40 was 45.1% ( 95% confidence interval 43.8% to 46.3%) and at age 90 was 9.6% ( 7.2% to 11.9%). The remaining lifetime risk of major cardiovascular disease at age 40 was 34.8% ( 33.1% to 36.5%) and at age 90 was 16.7% ( 12.9% to 20.6%). Conclusions In this prospective cohort of men, the incidence of new cardiovascular disease continued to increase after age 80 but was most often diagnosed at death. The decrease in incidence of cancer late in life seemed largely due to a decline in cancers usually detected by screening. These findings suggest that people aged 80 and older have a substantial amount of undiagnosed disease. The remaining lifetime risk of both diseases approached a plateau in the 10th decade. This may be due to decreased detection of disease and reporting of symptoms and increased resistance to disease in those who survive to old age. Accurate estimates of disease risk in an aging population require adjustment for competing risks of mortality.	[Driver, Jane A.; Djousse, Luc; Gaziano, J. Michael; Kurth, Tobias] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, Boston, MA 02215 USA; [Logroscino, Giancarlo] Univ Bari, Sch Med, Dept Neurol & Psychiat, Bari, Italy; [Gaziano, J. Michael; Kurth, Tobias] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res Informat Ctr, Boston, MA USA; [Kurth, Tobias] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universita degli Studi di Bari Aldo Moro; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health	Driver, JA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, Boston, MA 02215 USA.	jdriver@partners.org	LOGROSCINO, GIANCARLO/K-5148-2016; Kurth, Tobias/A-9243-2012; Djousse, Luc/F-5033-2017	LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Kurth, Tobias/0000-0001-7169-2620; Djousse, Luc/0000-0002-9902-3047	Hartford Foundation's Center of Excellence in Geriatric Medicine at Harvard Medical School; Eleanor and the Miles Shore 50th anniversary fellowship programme; Harvard Medical School; National Cancer Institute [CA-34944, CA-40360, CA-097193]; National Heart, Lung, and Blood Institute, Bethesda, Maryland [HL-26490, HL-34595]; NATIONAL CANCER INSTITUTE [R01CA097193, R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	Hartford Foundation's Center of Excellence in Geriatric Medicine at Harvard Medical School; Eleanor and the Miles Shore 50th anniversary fellowship programme; Harvard Medical School; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors' work was independent of the funders. JAD received support for this research from the Hartford Foundation's Center of Excellence in Geriatric Medicine at Harvard Medical School and the Eleanor and the Miles Shore 50th anniversary fellowship programme for scholars in medicine at Harvard Medical School. The Physicians' Health Study is supported by grants CA-34944, CA-40360, and CA-097193 from the National Cancer Institute, and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland.	Arias HR, 2003, INT REV NEUROBIOL, V54, P1, DOI 10.1016/S0074-7742(03)54002-8; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781; BRODY JA, 1986, J CHRON DIS, V39, P871, DOI 10.1016/0021-9681(86)90035-4; CASTELLI WP, 1989, AM J CARDIOL, V63, P12; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Cook NR, 2000, ARCH INTERN MED, V160, P921, DOI 10.1001/archinte.160.7.921; de Rijke JM, 2000, CANCER, V89, P1121, DOI 10.1002/1097-0142(20000901)89:5<1121::AID-CNCR22>3.3.CO;2-7; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Merrill RM, 2001, ANN EPIDEMIOL, V11, P547, DOI 10.1016/S1047-2797(01)00254-X; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Psaty BM, 1999, ARCH INTERN MED, V159, P1339, DOI 10.1001/archinte.159.12.1339; Rothman KJ., 2012, EPIDEMIOLOGY INTRO, V2nd; Saltzstein SL, 1998, J AM GERIATR SOC, V46, P994, DOI 10.1111/j.1532-5415.1998.tb02755.x; SCHOUTEN LJ, 1994, J EPIDEMIOL COMMUN H, V48, P596, DOI 10.1136/jech.48.6.596; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; UN Population Division, 2002, WORLD POP AG 1950 20; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; *WHO, 1971, ISCH HEART DIS REG R; World Health Organization, 2007, TOP 10 CAUS DEATH; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	30	108	112	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 9	2008	337								a2467	10.1136/bmj.a2467	http://dx.doi.org/10.1136/bmj.a2467			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399BZ	19066258	Green Published, Green Submitted			2022-12-01	WOS:000262776700003
J	Duncan, CW; Watson, DPB; Stein, A				Duncan, C. W.; Watson, D. P. B.; Stein, A.		Guideline Dev Grp	Diagnosis and management of headache in adults: summary of SIGN guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCIDENTAL FINDINGS; MIGRAINE; PREVALENCE; PHYSICIAN; BURDEN		[Stein, A.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Duncan, C. W.] Aberdeen Royal Infirm, Aberdeen, Scotland; [Watson, D. P. B.] Hamilton Med Grp, Aberdeen, Scotland	University of Aberdeen	Stein, A (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	ailsa.stein@nhs.net		Hilton Boon, Michele/0000-0002-2240-7923				Boardman HF, 2003, CEPHALALGIA, V23, P129, DOI 10.1046/j.1468-2982.2003.00468.x; *BRIT ASS STUD HEA, 2007, GUID ALL HEALTHC PRO; Diamond ML, 2002, NEUROLOGY, V58, pS3, DOI 10.1212/WNL.58.9_suppl_6.S3; Frishberg BM, 2000, EVIDENCE BASED GUIDE; *INT HEAD SOC HEAD, 2004, CEPHALALGIA S1, V24, P8; Karli N, 2007, CEPHALALGIA, V27, P41, DOI 10.1111/j.1468-2982.2006.01245.x; Katsarava Z, 2004, NEUROLOGY, V62, P788, DOI 10.1212/01.WNL.0000113747.18760.D2; Larner A., 2006, HEADACHE CARE, V3, P1; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P385, DOI 10.1136/jnnp.2005.073221; LIPTON RB, 1992, ARCH INTERN MED, V152, P1273, DOI 10.1001/archinte.152.6.1273; Lipton RB, 2002, NEUROLOGY, V58, pA100; Matharu MS, 2003, DRUGS, V63, P1637, DOI 10.2165/00003495-200363160-00002; PATTERSON VH, 1993, J NEUROL NEUROSUR PS, V56, P830, DOI 10.1136/jnnp.56.7.830; *SIGN, 2008, 107 SIGN; SMITH TR, 2004, HEADACHE CARE, V1, P195; Steiner TJ, 2003, CEPHALALGIA, V23, P519, DOI 10.1046/j.1468-2982.2003.00568.x; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tepper SJ, 2004, HEADACHE, V44, P856, DOI 10.1111/j.1526-4610.2004.04167.x; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Watson DPB, 2008, BRIT J GEN PRACT, V58, P77, DOI 10.3399/bjgp08X264009; Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016/j.jns.2005.09.008	21	19	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2008	337								a2329	10.1136/bmj.a2329	http://dx.doi.org/10.1136/bmj.a2329			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397HS	19022842				2022-12-01	WOS:000262654100005
J	Bray, GA				Bray, George A.			Is new hope on the horizon for obesity?	LANCET			English	Editorial Material							PHARMACOTHERAPY; METAANALYSIS; RIMONABANT; OVERWEIGHT; TRIALS		[Bray, George A.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Bray, GA (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	george.Bray@PBRC.edu						Astrup A, 2008, LANCET, V372, P1906, DOI 10.1016/S0140-6736(08)61525-1; Bray GA, 1999, ENDOCR REV, V20, P805, DOI 10.1210/er.20.6.805; Bray GA., 2007, BATTLE BULGE; Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; European Medicines Agency, 2008, COVID 19 EMA REC AUT; Galuska D. A., 2008, Morbidity and Mortality Weekly Report, V57, P765; Haddock CK, 2002, INT J OBESITY, V26, P262, DOI 10.1038/sj.ijo.0801889; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Simons-Morton DG, 2006, JAMA-J AM MED ASSOC, V295, P826, DOI 10.1001/jama.295.7.826; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P586, DOI 10.1038/clpt.1992.69	12	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2008	372	9653					1859	1860		10.1016/S0140-6736(08)61792-4	http://dx.doi.org/10.1016/S0140-6736(08)61792-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19041787				2022-12-01	WOS:000261388700005
J	Clemente-Blanco, A; Mayan-Santos, M; Schneider, DA; Machin, F; Jarmuz, A; Tschochner, H; Aragon, L				Clemente-Blanco, Andres; Mayan-Santos, Maria; Schneider, David A.; Machin, Felix; Jarmuz, Adam; Tschochner, Herbert; Aragon, Luis			Cdc14 inhibits transcription by RNA polymerase I during anaphase	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CHROMOSOME CONDENSATION; NUCLEOLAR SEGREGATION; RIBOSOMAL DNA; MITOTIC EXIT; CELL-CYCLE; RDNA; PHOSPHATASE; MITOSIS	Chromosome condensation and the global repression of gene transcription(1) are features of mitosis inmost eukaryotes. The logic behind this phenomenon is that chromosome condensation prevents the activity of RNA polymerases. In budding yeast, however, transcription was proposed to be continuous during mitosis(2). Here we show that Cdc14, a protein phosphatase required for nucleolar segregation(3) and mitotic exit(4), inhibits transcription of yeast ribosomal genes (rDNA) during anaphase. The phosphatase activity of Cdc14 is required for RNA polymerase I (Pol I) inhibition in vitro and in vivo. Moreover Cdc14-dependent inhibition involves nucleolar exclusion of Pol I subunits. We demonstrate that transcription inhibition is necessary for complete chromosome disjunction, because ribosomal RNA (rRNA) transcripts block condensin binding to rDNA, and show that bypassing the role of Cdc14 in nucleolar segregation requires in vivo degradation of nascent transcripts. Our results show that transcription interferes with chromosome condensation, not the reverse. We conclude that budding yeast, like most eukaryotes, inhibit Pol I transcription before segregation as a prerequisite for chromosome condensation and faithful genome separation.	[Clemente-Blanco, Andres; Mayan-Santos, Maria; Machin, Felix; Jarmuz, Adam; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Cell Cycle Grp, London W12 0NN, England; [Schneider, David A.] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Tschochner, Herbert] Univ Regensburg, Inst Biochem Mikrobiol & Genet, Munich, Germany	Imperial College London; University of Alabama System; University of Alabama Birmingham; University of Regensburg	Aragon, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Cell Cycle Grp, Du Cane Rd, London W12 0NN, England.	luis.aragon@csc.mrc.ac.uk	Mayán, María D./AAR-9227-2021; Blanco, Andrés Clemente/D-4255-2014; Mayan, Maria D./C-8813-2012; Machín, Félix/K-6569-2017	Mayán, María D./0000-0002-5809-9440; Blanco, Andrés Clemente/0000-0002-3674-0671; Mayan, Maria D./0000-0002-5809-9440; Machín, Félix/0000-0003-4559-7798; Schneider, David/0000-0003-0635-5091	Medical Research Council of the UK; UAB HSF-GEF; La Junta de Extremadura; MRC [MC_U120074328] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946] Funding Source: NIH RePORTER; Medical Research Council [MC_U120074328] Funding Source: researchfish	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UAB HSF-GEF; La Junta de Extremadura; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to A. Amon, D. Morgan, K. Kitamoto and J. Van Etten for providing reagents, and M. Nomura for advice. We thank members of the Aragon laboratory for discussions. Weacknowledge grant support from UAB HSF-GEF to D. A. S. and from 'La Junta de Extremadura' to A. C.-B. The Aragon laboratory is supported by the Medical Research Council of the UK.	Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; D'Ambrosio C, 2008, CURR BIOL, V18, P1084, DOI 10.1016/j.cub.2008.06.058; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; ELLIOTT SG, 1979, MOL GEN GENET, V169, P237, DOI 10.1007/BF00382269; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; FUJII T, 1995, BIOSCI BIOTECH BIOCH, V59, P1869, DOI 10.1271/bbb.59.1869; Gerber J, 2008, NUCLEIC ACIDS RES, V36, P793, DOI 10.1093/nar/gkm1093; GRANOT D, 1991, CELL MOTIL CYTOSKEL, V20, P47, DOI 10.1002/cm.970200106; Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Machin F, 2005, J CELL BIOL, V168, P209, DOI 10.1083/jcb.200408087; Machin F, 2006, J CELL BIOL, V173, P893, DOI 10.1083/jcb.200511129; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; TAYLOR JH, 1960, ANN NY ACAD SCI, V90, P409, DOI 10.1111/j.1749-6632.1960.tb23259.x; Tomson BN, 2006, MOL CELL BIOL, V26, P6239, DOI 10.1128/MCB.00693-06; Torres-Rosell J, 2004, CELL CYCLE, V3, P496; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Wang BD, 2004, CELL CYCLE, V3, P960; Wang BD, 2006, CELL CYCLE, V5, P2260, DOI 10.4161/cc.5.19.3292	30	94	95	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					219	U8		10.1038/nature07652	http://dx.doi.org/10.1038/nature07652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19158678	Green Accepted			2022-12-01	WOS:000264059700047
J	Leidel, S; Pedrioli, PGA; Bucher, T; Brost, R; Costanzo, M; Schmidt, A; Aebersold, R; Boone, C; Hofmann, K; Peter, M				Leidel, Sebastian; Pedrioli, Patrick G. A.; Bucher, Tamara; Brost, Renee; Costanzo, Michael; Schmidt, Alexander; Aebersold, Ruedi; Boone, Charles; Hofmann, Kay; Peter, Matthias			Ubiquitin-related modifier Urm1 acts as a sulphur carrier in thiolation of eukaryotic transfer RNA	NATURE			English	Article							PROTEIN CONJUGATION; STATISTICAL-MODEL; MASS-SPECTROMETRY; ESCHERICHIA-COLI; BIOSYNTHESIS; YEAST; IDENTIFICATION; THIAMIN; TANDEM; GENES	Ubiquitin-like proteins (UBLs) can change protein function, localization or turnover by covalent attachment to lysine residues(1). Although UBLs achieve this conjugation through an intricate enzymatic cascade, their bacterial counterparts MoaD and ThiS function as sulphur carrier proteins(2,3). Here we show that Urm1p, the most ancient UBL3, acts as a sulphur carrier in the process of eukaryotic transfer RNA ( tRNA) modification, providing a possible evolutionary link between UBL and sulphur transfer. Moreover, we identify Uba4p, Ncs2p, Ncs6p and Yor251cp as components of this conserved pathway. Using in vitro assays, we show that Ncs6p binds to tRNA, whereas Uba4p first adenylates and then directly transfers sulphur onto Urm1p. Finally, functional analysis reveals that the thiolation function of Urm1p is critical to regulate cellular responses to nutrient starvation and oxidative stress conditions, most likely by increasing translation fidelity.	[Leidel, Sebastian; Pedrioli, Patrick G. A.; Bucher, Tamara; Peter, Matthias] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Brost, Renee; Costanzo, Michael; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Brost, Renee; Costanzo, Michael; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Schmidt, Alexander; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Aebersold, Ruedi] Inst Syst Biol, Seattle, WA 98103 USA; [Schmidt, Alexander; Aebersold, Ruedi; Peter, Matthias] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Hofmann, Kay] Miltenyi Biotec GmbH, Bioinformat Grp, D-51429 Bergisch Gladbach, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Toronto; University of Toronto; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Institute for Systems Biology (ISB); Miltenyi Biotec	Peter, M (corresponding author), ETH, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	kay.hofmann@miltenyibiotec.de; matthias.peter@bc.biol.ethz.ch	Hofmann, Kay/D-6714-2011; Bucher, Tamara/AAR-9797-2020; Leidel, Sebastian/K-9507-2019; Schmidt, Alexander/D-6426-2011	Hofmann, Kay/0000-0002-2289-9083; Bucher, Tamara/0000-0003-3244-5867; Leidel, Sebastian/0000-0002-0523-6325; Schmidt, Alexander/0000-0002-3149-2381; Peter, Matthias/0000-0002-2160-6824	EuroDyna; Roche Research Foundation; ETHZ; SNF; Canadian Institutes of Health Research; Genome Canada through the Ontario Genomics Institute	EuroDyna; Roche Research Foundation; ETHZ(ETH Zurich); SNF; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada)	We thank C. Rupp for technical support, M. Sohrmann for yeast strains, G. Rabut for the gift of the pGR51 plasmid, G. L. Igloi and K.-H. Altmann for providing APM, S. Mitani for tut-1(tm1297), B. Casado-Fernandez and D. Hilvert for discussion and technical advice, and T. Kurz and J. D. Alfonzo for reading the manuscript. This work was supported by grants from EuroDyna ( to S. L.), the Roche Research Foundation ( to P. G. A. P.), ETHZ ( to S. L. and M. P.), the SNF ( to M. P.), the Canadian Institutes of Health Research ( to C. B.) and Genome Canada through the Ontario Genomics Institute ( to C. B.).	Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; BRENNER S, 1974, GENETICS, V77, P71; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.E03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; Jager G, 2004, J BACTERIOL, V186, P750, DOI 10.1128/JB.186.3.750-757.2004; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Jeong JS, 1999, BIOCHEMISTRY-US, V38, P776, DOI 10.1021/bi9817818; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Mueller EG, 1999, PROTEIN SCI, V8, P2424; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Rubio-Texeira M, 2007, FEBS LETT, V581, P541, DOI 10.1016/j.febslet.2007.01.019; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Shigi N, 2006, J BIOL CHEM, V281, P14296, DOI 10.1074/jbc.M511675200; Suzuki T, 2007, METHOD ENZYMOL, V425, P231, DOI 10.1016/S0076-6879(07)25010-4; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Tong A. H. Y., 2007, METHD MICROBIOL, V36, p[369, 706]; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Xu JJ, 2006, P NATL ACAD SCI USA, V103, P11625, DOI 10.1073/pnas.0604876103	49	196	211	4	33	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					228	U9		10.1038/nature07643	http://dx.doi.org/10.1038/nature07643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19145231				2022-12-01	WOS:000264059700049
J	Van Mooy, BAS; Fredricks, HF; Pedler, BE; Dyhrman, ST; Karl, DM; Koblizek, M; Lomas, MW; Mincer, TJ; Moore, LR; Moutin, T; Rappe, MS; Webb, EA				Van Mooy, Benjamin A. S.; Fredricks, Helen F.; Pedler, Byron E.; Dyhrman, Sonya T.; Karl, David M.; Koblizek, Michal; Lomas, Michael W.; Mincer, Tracy J.; Moore, Lisa R.; Moutin, Thierry; Rappe, Michael S.; Webb, Eric A.			Phytoplankton in the ocean use non-phosphorus lipids in response to phosphorus scarcity	NATURE			English	Article							NITROGEN-FIXATION; N-P; LIMITATION; PHOSPHATE; GROWTH; BACTERIOPLANKTON; PROCHLOROCOCCUS; TRICHODESMIUM; BIOSYNTHESIS; AVAILABILITY	Phosphorus is an obligate requirement for the growth of all organisms; major biochemical reservoirs of phosphorus in marine plankton include nucleic acids and phospholipids(1-3). However, eukaryotic phytoplankton and cyanobacteria (that is, 'phytoplankton' collectively) have the ability to decrease their cellular phosphorus content when phosphorus in their environment is scarce(1,4,5). The biochemical mechanisms that allow phytoplankton to limit their phosphorus demand and still maintain growth are largely unknown. Here we show that phytoplankton, in regions of oligotrophic ocean where phosphate is scarce, reduce their cellular phosphorus requirements by substituting non-phosphorus membrane lipids for phospholipids. In the Sargasso Sea, where phosphate concentrations were less than 10 nmol l(-1), we found that only 1.3 +/- 0.6% of phosphate uptake was used for phospholipid synthesis; in contrast, in the South Pacific subtropical gyre, where phosphate was greater than 100 nmol l(-1), plankton used 17 +/- 6% (ref. 6). Examination of the planktonic membrane lipids at these two locations showed that classes of sulphur- and nitrogen-containing membrane lipids, which are devoid of phosphorus, were more abundant in the Sargasso Sea than in the South Pacific. Furthermore, these non-phosphorus, 'substitute lipids' were dominant in phosphorus-limited cultures of all of the phytoplankton species we examined. In contrast, the marine heterotrophic bacteria we examined contained no substitute lipids and only phospholipids. Thus heterotrophic bacteria, which compete with phytoplankton for nutrients in oligotrophic regions like the Sargasso Sea, appear to have a biochemical phosphorus requirement that phytoplankton avoid by using substitute lipids. Our results suggest that phospholipid substitutions are fundamental biochemical mechanisms that allow phytoplankton to maintain growth in the face of phosphorus limitation.	[Van Mooy, Benjamin A. S.; Fredricks, Helen F.; Pedler, Byron E.; Mincer, Tracy J.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Dyhrman, Sonya T.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Karl, David M.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Koblizek, Michal] Acad Sci Czech Republ, Inst Microbiol, Trebon, Czech Republic; [Koblizek, Michal] Univ S Bohemia, Inst Phys Biol, Nove Hrady, Czech Republic; [Lomas, Michael W.] Bermuda Inst Ocean Sci, St George, Bermuda; [Moore, Lisa R.] Univ So Maine, Dept Biol Sci, Portland, ME 04103 USA; [Moutin, Thierry] Aix Marseille Univ, Ctr Oceanol Marseille, Lab Oceanog Phys & Biogeochim, Marseille, France; [Rappe, Michael S.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Webb, Eric A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; University of Hawaii System; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Bermuda Institute of Ocean Sciences; University of Maine System; University of Southern Maine; UDICE-French Research Universities; Aix-Marseille Universite; University of Hawaii System; University of Southern California	Van Mooy, BAS (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	bvanmooy@whoi.edu	Koblizek, Michal/H-2851-2014; Karl, David/AFP-3837-2022	Moore, Lisa/0000-0002-4114-1518; Lomas, Michael/0000-0003-1209-3753; Karl, David/0000-0002-6660-6721; Mincer, Tracy/0000-0002-4644-5609; Webb, Eric/0000-0003-4085-7730; Pedler Sherwood, Byron/0000-0001-9578-0481	National Science Foundation [OCE-0646944, OCE-0451419, OCE-0326616, OCE-0453023, OCE-0453019, DEB-0207085]; Office of Naval Research [N00014-06-1-0134, GAAV-1QS500200570]; Centre National de la Recherche Scientifique; Institut des Sciences de l'Univers; Gordon and Betty Moore Foundation; Center for Microbial Oceanography: Research and Education; Woods Hole Oceanographic Institution Ocean Life Institute; Woods Hole Oceanographic Institution Mary Sears Travel Fund	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut des Sciences de l'Univers; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Center for Microbial Oceanography: Research and Education; Woods Hole Oceanographic Institution Ocean Life Institute; Woods Hole Oceanographic Institution Mary Sears Travel Fund	We thank the captains and crews of the RVs L'Atalante, Atlantic Explorer, Kilo Moana and Ka'imikai-o-Kanaloa. J. Dacey, R. Johnson, N. Levine, T. Gregory, D. Sadler, H. Claustre and A. Sciandra provided access and logistical support for our cruises. K. Bjorkman and P. Rimmelin provided phosphate data. N. Trowbridge, M. Brandon, S. Haley, E. Orchard and K. Roache-Johnson assisted with cultures. D. Glover provided input on data treatment and presentation. This research was supported by grants from the National Science Foundation (OCE-0646944 to B. A. S. V. M., OCE-0451419 to S. T. D., OCE-0326616 to D. M. K., OCE-0453023 to M. W. L., OCE-0453019 to L. R. M. and DEB-0207085 to M. S. R.), the Office of Naval Research (N00014-06-1-0134 to B. A. S. V. M.) and Czech Republic research grants (GACR-206/07/0241 and GAAV-1QS500200570 to M. K.). The BIOSOPE campaign was a contribution of the French LEFE-CYBER program funded by the Centre National de la Recherche Scientifique and the Institut des Sciences de l'Univers. Funding was also provided by the Gordon and Betty Moore Foundation, the Center for Microbial Oceanography: Research and Education, the Woods Hole Oceanographic Institution Ocean Life Institute and the Woods Hole Oceanographic Institution Mary Sears Travel Fund.	Ammerman J.W., 2003, EOS T AM GEOPHYS UN, V84, P165, DOI [10.1029/2003-o180001, DOI 10.1029/2003EO180001, DOI 10.1029/2003-O180001]; BENNING C, 1993, P NATL ACAD SCI USA, V90, P1561, DOI 10.1073/pnas.90.4.1561; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bjorkman KM, 2003, LIMNOL OCEANOGR, V48, P1049; Carlson CA, 1996, DEEP-SEA RES PT II, V43, P491, DOI 10.1016/0967-0645(95)00101-8; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Guler S, 2000, J BACTERIOL, V182, P543, DOI 10.1128/JB.182.2.543-545.2000; Koblizek M, 2007, ENVIRON MICROBIOL, V9, P2401, DOI 10.1111/j.1462-2920.2007.01354.x; Krauk JM, 2006, AQUAT MICROB ECOL, V42, P243, DOI 10.3354/ame042243; Lomas MW, 2004, LIMNOL OCEANOGR, V49, P2303, DOI 10.4319/lo.2004.49.6.2303; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Mills MM, 2008, LIMNOL OCEANOGR, V53, P824, DOI 10.4319/lo.2008.53.2.0824; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Moutin T, 2008, BIOGEOSCIENCES, V5, P95, DOI 10.5194/bg-5-95-2008; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Riekhof WR, 2005, ARCH BIOCHEM BIOPHYS, V441, P96, DOI 10.1016/j.abb.2005.07.001; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; SATO N, 2000, RECENT ADV BIOCH PLA; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632; Van Mooy BAS, 2008, BIOGEOSCIENCES, V5, P133, DOI 10.5194/bg-5-133-2008; Van Mooy BAS, 2008, LIMNOL OCEANOGR, V53, P78, DOI 10.4319/lo.2008.53.1.0078; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; Webb EA, 2007, LIMNOL OCEANOGR, V52, P2221, DOI 10.4319/lo.2007.52.5.2221; Weissenmayer B, 2002, MOL MICROBIOL, V45, P721, DOI 10.1046/j.1365-2958.2002.03043.x; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zubkov MV, 2007, ENVIRON MICROBIOL, V9, P2079, DOI 10.1111/j.1462-2920.2007.01324.x	30	502	514	14	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					69	72		10.1038/nature07659	http://dx.doi.org/10.1038/nature07659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19182781				2022-12-01	WOS:000263836000034
J	Rothman, JS; Cathala, L; Steuber, V; Silver, RA				Rothman, Jason S.; Cathala, Laurence; Steuber, Volker; Silver, R. Angus			Synaptic depression enables neuronal gain control	NATURE			English	Article							SHUNTING INHIBITION; PYRAMIDAL NEURONS; NMDA RECEPTORS; SINGLE; NOISE; TRANSMISSION; INVARIANCE; SYNAPSES; CELLS; MODEL	To act as computational devices, neurons must perform mathematical operations as they transform synaptic and modulatory input into output firing rate(1). Experiments and theory indicate that neuronal firing typically represents the sum of synaptic inputs(1-3), an additive operation, but multiplication of inputs is essential for many computations(1). Multiplication by a constant produces a change in the slope, or gain, of the input - output relationship, amplifying or scaling down the sensitivity of the neuron to changes in its input. Such gain modulation occurs in vivo, during contrast invariance of orientation tuning(4), attentional scaling(5), translation- invariant object recognition(6), auditory processing(7) and coordinate transformations(8,9). Moreover, theoretical studies highlight the necessity of gain modulation in several of these tasks(9-11). Although potential cellular mechanisms for gain modulation have been identified, they often rely on membrane noise and require restrictive conditions to work(3,12-18). Because nonlinear components are used to scale signals in electronics, we examined whether synaptic nonlinearities are involved in neuronal gain modulation. We used synaptic stimulation and the dynamic- clamp technique to investigate gain modulation in granule cells in acute slices of rat cerebellum. Here we show that when excitation is mediated by synapses with short- term depression ( STD), neuronal gain is controlled by an inhibitory conductance in a noise-independent manner, allowing driving and modulatory inputs to be multiplied together. The nonlinearity introduced by STD transforms inhibition- mediated additive shifts in the input - output relationship into multiplicative gain changes. When granule cells were driven with bursts of high- frequency mossy fibre input, as observed in vivo(19,20), larger inhibition- mediated gain changes were observed, as expected with greater STD. Simulations of synaptic integration in more complex neocortical neurons suggest that STD- based gain modulation can also operate in neurons with large dendritic trees. Our results establish that neurons receiving depressing excitatory inputs can act as powerful multiplicative devices even when integration of postsynaptic conductances is linear.	[Rothman, Jason S.; Cathala, Laurence; Steuber, Volker; Silver, R. Angus] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Silver, RA (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk		Silver, Robin/0000-0002-5480-6638; Rothman, Jason/0000-0003-3036-2291; Steuber, Volker/0000-0003-0186-3580	Wellcome Trust; MRC [G0400598]; EU EUSynapse [LSHM-CT-2005-019055]; Wellcome Senior Research Fellowship; Biotechnology and Biological Sciences Research Council [BB/F005369/1] Funding Source: researchfish; Medical Research Council [G0400598] Funding Source: researchfish; BBSRC [BB/F005369/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU EUSynapse; Wellcome Senior Research Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This was supported by the Wellcome Trust, MRC (G0400598) and EU (EUSynapse, LSHM-CT-2005-019055). R.A.S. is in receipt of a Wellcome Senior Research Fellowship. We thank P. Gleeson for help with neuroConstruct, D. Ward and R. Kanichay for their experimental support, D. Digregorio and P. Kirkby for discussions, and A. Arenz, D. Attwell, G. Billings, E. Chaigneau, D. DiGregorio, M. Farrant, F. Minneci and K. Vervaeke for their comments on the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; Berends M, 2005, NEURAL COMPUT, V17, P2531, DOI 10.1162/089976605774320520; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Cathala L, 2000, J NEUROSCI, V20, P5899, DOI 10.1523/JNEUROSCI.20-16-05899.2000; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Gleeson P, 2007, NEURON, V54, P219, DOI 10.1016/j.neuron.2007.03.025; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Ingham NJ, 2005, J NEUROSCI, V25, P6187, DOI 10.1523/JNEUROSCI.0146-05.2005; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Koch Christof, 1999, P1; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Murphy BK, 2003, J NEUROSCI, V23, P10040; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; SALINAS E, 1995, J NEUROSCI, V15, P6461; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Schwindt P, 1997, J NEUROPHYSIOL, V77, P2484, DOI 10.1152/jn.1997.77.5.2484; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Tiesinga PHE, 2000, PHYS REV E, V62, P8413, DOI 10.1103/PhysRevE.62.8413; TOVEE MJ, 1994, J NEUROPHYSIOL, V72, P1049, DOI 10.1152/jn.1994.72.3.1049; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P5495; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Varela JA, 1997, J NEUROSCI, V17, P7926; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003	44	156	156	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1015	U6		10.1038/nature07604	http://dx.doi.org/10.1038/nature07604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19145233	Green Accepted			2022-12-01	WOS:000263425400043
J	Hemerly, AS; Prasanth, SG; Siddiqui, K; Stillman, B				Hemerly, Adriana S.; Prasanth, Supriya G.; Siddiqui, Khalid; Stillman, Bruce			Orc1 Controls Centriole and Centrosome Copy Number in Human Cells	SCIENCE			English	Article							ORIGIN RECOGNITION COMPLEX; CYCLIN-E; DNA-REPLICATION; DUPLICATION; AMPLIFICATION; OVERDUPLICATION; LOCALIZATION; ACCUMULATION; CDK2-CYCLIN; LICENSES	Centrosomes, each containing a pair of centrioles, organize microtubules in animal cells, particularly during mitosis. DNA and centrosomes are normally duplicated once before cell division to maintain optimal genome integrity. We report a new role for the Orc1 protein, a subunit of the origin recognition complex ( ORC) that is a key component of the DNA replication licensing machinery, in controlling centriole and centrosome copy number in human cells, independent of its role in DNA replication. Cyclin A promotes Orc1 localization to centrosomes where Orc1 prevents Cyclin E- dependent reduplication of both centrioles and centrosomes in a single cell division cycle. The data suggest that Orc1 is a regulator of centriole and centrosome reduplication as well as the initiation of DNA replication.	[Hemerly, Adriana S.; Prasanth, Supriya G.; Siddiqui, Khalid; Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hemerly, Adriana S.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil	Cold Spring Harbor Laboratory; Universidade Federal do Rio de Janeiro	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stillman@cshl.edu		Stillman, Bruce/0000-0002-9453-4091; /0000-0001-6448-0902	National Institutes of Health [CA13106]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Spector for critical reading of the manuscript, P. Wendel for technical support, and J. Salisbury and S. Doxsey for providing antibodies to centrin 2 and centriolin, respectively. This work was supported by a grant from the National Institutes of Health (CA13106), a fellowship from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) to A.S.H., and a Special Fellow award from the Leukemia and Lymphoma Society to S.G.P.	Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Duensing A, 2006, ONCOGENE, V25, P2943, DOI 10.1038/sj.onc.1209310; Ferguson RL, 2008, J CELL SCI, V121, P3224, DOI 10.1242/jcs.034702; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Gillingham AK, 2000, EMBO REP, V1, P524; Hanashiro K, 2008, ONCOGENE, V27, P5288, DOI 10.1038/onc.2008.161; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Laman H, 2001, EXP CELL RES, V271, P230, DOI 10.1006/excr.2001.5360; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Saavedra HI, 2003, CANCER CELL, V3, P333, DOI 10.1016/S1535-6108(03)00083-7; Sasaki T, 2007, CURR OPIN CELL BIOL, V19, P337, DOI 10.1016/j.ceb.2007.04.007; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Sugihara E, 2006, CANCER RES, V66, P4020, DOI 10.1158/0008-5472.CAN-05-3250; Tachibana KEK, 2005, EMBO REP, V6, P1052, DOI 10.1038/sj.embor.7400527; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993	30	114	118	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					789	793		10.1126/science.1166745	http://dx.doi.org/10.1126/science.1166745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197067	Green Accepted			2022-12-01	WOS:000263066800049
J	Friedland, JC; Lee, MH; Boettiger, D				Friedland, Julie C.; Lee, Mark H.; Boettiger, David			Mechanically Activated Integrin Switch Controls alpha(5)beta(1) Function	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; MEDIATED ADHESION; CRYSTAL-STRUCTURE; CELL-ADHESION; LIVING CELLS; CATCH BONDS; FORCE; FIBRONECTIN; ALPHA-V-BETA-3	The cytoskeleton, integrin- mediated adhesion, and substrate stiffness control a common set of cell functions required for development and homeostasis that are often deranged in cancer. The connection between these mechanical elements and chemical signaling processes is not known. Here, we show that alpha 5 beta 1 integrin switches between relaxed and tensioned states in response to myosin II- generated cytoskeletal force. Force combines with extracellular matrix stiffness to generate tension that triggers the integrin switch. This switch directly controls the alpha(5)beta(1)- fibronectin bond strength through engaging the synergy site in fibronectin and is required to generate signals through phosphorylation of focal adhesion kinase. In the context of tissues, this integrin switch connects cytoskeleton and extracellular matrix mechanics to adhesion- dependent motility and signaling pathways.	[Friedland, Julie C.; Lee, Mark H.; Boettiger, David] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Friedland, Julie C.; Lee, Mark H.; Boettiger, David] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Boettiger, David] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Boettiger, D (corresponding author), Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.	boettige@upenn.edu			National Institutes of Health [GM57388]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM57388 from the National Institutes of Health to D. B. We thank S. Akiyama (NIH) for 13G12 antibody, H. Erickson (Duke) for mutant fibronectin constructs, and Qi Shi for technical assistance.	Boettiger D, 2007, METHOD ENZYMOL, V426, P1, DOI 10.1016/S0076-6879(07)26001-X; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; WANG YL, 2007, SCI STKE, pE10; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200	24	524	534	5	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 30	2009	323	5914					642	644		10.1126/science.1168441	http://dx.doi.org/10.1126/science.1168441			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179533				2022-12-01	WOS:000262862800045
J	Roy, K; Hilliard, GM; Hamilton, DJ; Luo, JW; Ostmann, MM; Fleckenstein, JM				Roy, Koushik; Hilliard, George M.; Hamilton, David J.; Luo, Jiwen; Ostmann, Marguerite M.; Fleckenstein, James M.			Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells	NATURE			English	Article							HEAT-LABILE ENTEROTOXIN; TOLL-LIKE RECEPTOR-5; 2-PARTNER SECRETION; EPITHELIAL-CELLS; COLONIZATION; VIRULENCE; PROTEINS; IDENTIFICATION; ADHERENCE; FILAMENT	Adhesion to epithelial cells(1) and flagella- mediated motility are critical virulence traits for many Gram- negative pathogens, including enterotoxigenic Escherichia coli (ETEC)(2), a major cause of diarrhoea in travellers and children in developing countries(3,4). Many flagellated pathogens export putative adhesins belonging to the two- partner secretion ( TPS) family(5). However, the actual function of these adhesins remains largely undefined. Here we demonstrate that EtpA, a TPS exoprotein adhesin of enterotoxigenic E. coli(6), mimics and interacts with highly conserved regions of flagellin, the major subunit of flagella, and that these interactions are critical for adherence and intestinal colonization. Although conserved regions of flagellin are mostly buried in the flagellar shaft(7), our results suggest that they are at least transiently exposed at the tips of flagella where they capture EtpA adhesin molecules for presentation to eukaryotic receptors. Similarity of EtpA to molecules encoded by other motile pathogens suggests a potential common pattern for bacterial adhesion, whereas participation of conserved regions of flagellin in adherence has implications for development of vaccines for Gram- negative pathogens.	[Roy, Koushik; Luo, Jiwen; Fleckenstein, James M.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Hilliard, George M.; Fleckenstein, James M.] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; [Hamilton, David J.] Univ Tennessee, Ctr Hlth Sci, Dept Comparat Med, Memphis, TN 38163 USA; [Ostmann, Marguerite M.] Vet Adm Med Ctr, Res Serv, Memphis, TN 38104 USA; [Fleckenstein, James M.] Vet Adm Med Ctr, Med Serv, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Fleckenstein, JM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Med, 956 Court Ave, Memphis, TN 38163 USA.	jflecke1@tennessee.edu	Fleckenstein, James M./P-6242-2019	Fleckenstein, James M./0000-0002-1148-697X	National Institutes of Health (National Center for Research Resources) [RR16190-05]; Department of Veterans Affairs; University of Tennessee Microbial Pathogenesis Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016190] Funding Source: NIH RePORTER	National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Veterans Affairs(US Department of Veterans Affairs); University of Tennessee Microbial Pathogenesis Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank B. Westerlund-Wikstrom for supplying anti- flagellar antisera, K. Troughton of the Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, for her assistance with transmission electron microscopy, and L. Boykins of the Integrated Microscopy Center at the University of Memphis for her assistance with scanning electron microscopy. We thank G. Byrne, H. Courtney, J. Dale, S. Dagogo-Jack and T. Strom for reading the manuscript. This research was supported by grants from the National Institutes of Health ( National Center for Research Resources) RR16190-05, the Department of Veterans Affairs and funds from the University of Tennessee Microbial Pathogenesis Research Center.	Allen KP, 2006, INFECT IMMUN, V74, P869, DOI 10.1128/IAI.74.2.869-875.2006; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Buscher AZ, 2006, MOL MICROBIOL, V61, P470, DOI 10.1111/j.1365-2958.2006.05236.x; Cummings ED, 2007, J PROTEOME RES, V6, P1603, DOI 10.1021/pr060472y; Dorsey FC, 2006, CELL MICROBIOL, V8, P1516, DOI 10.1111/j.1462-5822.2006.00736.x; EVANS DG, 1975, INFECT IMMUN, V12, P656, DOI 10.1128/IAI.12.3.656-667.1975; Fleckenstein JM, 2006, INFECT IMMUN, V74, P2245, DOI 10.1128/IAI.74.4.2245-2258.2006; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; GOFF SP, 1991, METHOD ENZYMOL, V208, P586; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Maki-Yonekura S, 2003, P NATL ACAD SCI USA, V100, P15528, DOI 10.1073/pnas.2534343100; Mu XQ, 2008, J MOL BIOL, V376, P614, DOI 10.1016/j.jmb.2007.10.067; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Roy K, 2008, INFECT IMMUN, V76, P2106, DOI 10.1128/IAI.01304-07; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; SUDAKIN V, 2005, PROTEIN PROTEIN INTE, V1, P337; Svennerholm AM, 2008, EXPERT REV VACCINES, V7, P795, DOI 10.1586/14760584.7.6.795; Torres AG, 2005, INFECT IMMUN, V73, P18, DOI 10.1128/IAI.73.1.18-29.2005; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	29	141	153	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					594	U103		10.1038/nature07568	http://dx.doi.org/10.1038/nature07568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19060885	Green Accepted			2022-12-01	WOS:000262852200044
J	Paynter, NP; Chasman, DI; Buring, JE; Shiffman, D; Cook, NR; Ridker, PM				Paynter, Nina P.; Chasman, Daniel I.; Buring, Julie E.; Shiffman, Dov; Cook, Nancy R.; Ridker, Paul M.			Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3	ANNALS OF INTERNAL MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; MYOCARDIAL-INFARCTION; POLYMORPHISMS; REPLICATION; VALIDATION; MODELS	Background: Although genetic variation at chromosome 9p21.3 is associated with incident cardiovascular disease, it is unclear whether screening for this polymorphism improves risk prediction. Objective: To determine whether knowledge of variation at chromosome 9p21.3 provides predictive information beyond that from other readily available risk factors. Design: Prospective cohort study. Setting: United States. Patients: 22 129 female white health professionals participating in the Women's Genome Health Study, initially without any major chronic disease, who were prospectively followed over a median of 10.2 years for incident cardiovascular disease. Measurements: Polymorphism at rs10757274 in chromosome 9p21.3 and additional cardiovascular disease risk factors (blood pressure, smoking status, diabetes, blood levels of cholesterol, highsensitivity C-reactive protein, and family history of premature myocardial infarction). Results: Polymorphism at rs10757274 was associated with an adjusted hazard ratio for incident cardiovascular disease of 1.25 (95% CI, 1.04 to 1.51) for the AG genotype and 1.32 (CI, 1.07 to 1.63) for the GG genotype. However, the addition of the genotype to a prediction model based on traditional risk factors, high-sensitivity C-reactive protein, and family history of premature myocardial infarction had no effect on model discrimination as measured by the c-index (0.807 to 0.809) and did not improve the Net Reclassification Improvement score (-0.2%; P = 0.59) or the Integrated Discrimination Improvement score (0.0; P = 0.18). Limitation: Study participants were all white women. Conclusion: In this large prospective cohort of white women, genetic variation in chromosome 9p21.3 was associated with incident cardiovascular disease but did not improve on the discrimination or classification of predicted risk achieved with traditional risk factors, high-sensitivity C-reactive protein, and family history of premature myocardial infarction.	[Paynter, Nina P.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Celera, Alameda, CA USA	Harvard University; Brigham & Women's Hospital	Paynter, NP (corresponding author), Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	npaynter@partners.org			National Heart, Lung, and Blood Institute and National Cancer Institute; Donald W. Reynolds Foundation; Leducq Foundation; Celera; Roche Diagnostics; Amgen; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Foundation; Leducq Foundation; Celera(Leducq Foundation); Roche Diagnostics; Amgen(Amgen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute and National Cancer Institute; Donald W. Reynolds Foundation; Leducq Foundation; Celera; Roche Diagnostics; and Amgen.	Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	22	195	199	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					65	U16		10.7326/0003-4819-150-2-200901200-00003	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19153409	Green Accepted			2022-12-01	WOS:000262655200001
J	Lichtenstein, P; Yip, BH; Bjork, C; Pawitan, Y; Cannon, TD; Sullivan, PF; Hultman, CM				Lichtenstein, Paul; Yip, Benjamin H.; Bjork, Camilla; Pawitan, Yudi; Cannon, Tyrone D.; Sullivan, Patrick F.; Hultman, Christina M.			Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study	LANCET			English	Article							GENOME SCAN METAANALYSIS; CANDIDATE GENES; BINARY TRAITS; RISK-FACTORS; I DISORDER; TWIN; SUSCEPTIBILITY; PSYCHOSIS; RELATIVES; REGISTER	Background Whether schizophrenia and bipolar disorder are the clinical outcomes of discrete or shared causative processes is much debated in psychiatry. We aimed to assess genetic and environmental contributions to liability for schizophrenia, bipolar disorder, and their comorbidity. Methods We linked the multi-generation register, which contains information about all children and their parents in Sweden, and the hospital discharge register, which includes all public psychiatric inpatient admissions in Sweden. We identified 9 009 202 unique individuals in more than 2 million nuclear families between 1973 and 2004. Risks for schizophrenia, bipolar disorder, and their comorbidity were assessed for biological and adoptive parents, offspring, full-siblings and half-siblings of probands with one of the diseases. We used a multivariate generalised linear mixed model for analysis of genetic and environmental contributions to liability for schizophrenia, bipolar disorder, and comorbidity. Findings First-degree relatives of probands with either schizophrenia (n=35 985) or bipolar disorder (n=40 487) were at increased risk of these disorders. Half-siblings had a significantly increased risk (schizophrenia: relative risk [RR] 3.6, 95% CI 2.3-5.5 for maternal half-siblings, and 2.7, 1. 9-3 . 8 for paternal half-siblings; bipolar disorder: 4.5, 2.7-7.4 for maternal half-siblings, and 2.4, 1.4-4-1 for paternal half-siblings), but substantially lower than that of the full-siblings (schizophrenia: 9.0, 8.5-11 .6; bipolar disorder: 7.9, 7.1-8.8). When relatives of probands with bipolar disorder were analysed, increased risks for schizophrenia existed for all relationships, including adopted children to biological parents with bipolar disorder. Heritability for schizophrenia and bipolar disorder was 64% and 59%, respectively. Shared environmental effects were small but substantial (schizophrenia: 4.5%, 4.4%-7.4%; bipolar disorder: 3.4%, 2.3%-6.2%) for both disorders. The comorbidity between disorders was mainly (63%) due to additive genetic effects common to both disorders. Interpretation Similar to molecular genetic studies, we showed evidence that schizophrenia and bipolar disorder partly share a common genetic cause. These results challenge the current nosological dichotomy between schizophrenia and bipolar disorder, and are consistent with a reappraisal of these disorders as distinct diagnostic entities. Funding Swedish Council for Working Life and Social Research, and the Swedish Research Council.	[Lichtenstein, Paul; Yip, Benjamin H.; Bjork, Camilla; Pawitan, Yudi; Sullivan, Patrick F.; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Hultman, Christina M.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Cannon, Tyrone D.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Cannon, Tyrone D.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90024 USA; [Cannon, Tyrone D.] Univ Calif Los Angeles, Dept Biobehav Sci, Los Angeles, CA 90024 USA	Karolinska Institutet; Uppsala University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lichtenstein, P (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	paul.lichtenstein@ki.se	Yip, Benjamin/AAC-7845-2019; YIP, Benjamin HK/I-2336-2013	Yip, Benjamin/0000-0002-4749-7611; lichtenstein, paul/0000-0003-3037-5287	NIMH NIH HHS [R01 MH077139] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arvidsson H, 2005, NORD J PSYCHIAT, V59, P186, DOI 10.1080/08039480510023061; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Berrettini W, 2003, AM J MED GENET C, V123C, P59, DOI 10.1002/ajmg.c.20014; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; Carter CJ, 2007, SCHIZOPHRENIA BULL, V33, P1343, DOI 10.1093/schbul/sbm007; Dalman C, 2002, SOC PSYCH PSYCH EPID, V37, P527, DOI 10.1007/s00127-002-0582-3; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; GENTZ A, 1992, J COMPUTATIONAL GRAP, V1, P141; Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P952; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; McIntosh AM, 2005, BIOL PSYCHIAT, V58, P254, DOI 10.1016/j.biopsych.2005.03.044; McQueen MB, 2005, AM J HUM GENET, V77, P582, DOI 10.1086/491603; Mortensen PB, 2003, ARCH GEN PSYCHIAT, V60, P1209, DOI 10.1001/archpsyc.60.12.1209; NEALE MC, 1994, BEHAV GENET, V24, P239, DOI 10.1007/BF01067191; Owen MJ, 2007, SCHIZOPHRENIA BULL, V33, P905, DOI 10.1093/schbul/sbm053; Pawitan Y, 2004, STAT MED, V23, P449, DOI 10.1002/sim.1603; Pawitan Y., 2001, ALL LIKELIHOOD STAT; Perlis RH, 2008, ARCH GEN PSYCHIAT, V65, P53, DOI 10.1001/archgenpsychiatry.2007.15; SAS Institute Inc, 2004, SAS STAT SOFTW VERS; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; *STAT SWED, 2006, MULT REG 2005 DESCR; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P1121, DOI 10.1016/j.biopsych.2006.11.010; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tsuang MT, 2004, J PSYCHIATR RES, V38, P3, DOI 10.1016/S0022-3956(03)00096-7; World Health Organization, 1967, INT CLASS DIS; World Health Organization, 1992, INT CLASS DIS; World Health Organization, 1978, INT CLASS DIS; Yip BH, 2008, STAT MED, V27, P1086, DOI 10.1002/sim.2996	33	1392	1415	2	250	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					234	239		10.1016/S0140-6736(09)60072-6	http://dx.doi.org/10.1016/S0140-6736(09)60072-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150704	Green Accepted			2022-12-01	WOS:000262537500026
J	Schumacher, MA; Piro, KM; Xu, W; Hansen, S; Lewis, K; Brennan, RG				Schumacher, Maria A.; Piro, Kevin M.; Xu, Weijun; Hansen, Sonja; Lewis, Kim; Brennan, Richard G.			Molecular Mechanisms of HipA-Mediated Multidrug Tolerance and Its Neutralization by HipB	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; ELONGATION-FACTOR-TU; PERSISTER CELLS; AFFECTS LETHALITY; AFFECTS FREQUENCY; MUREIN SYNTHESIS; DNA-SYNTHESIS; INHIBITION; PEPTIDOGLYCAN; COMPLEX	Bacterial multidrug tolerance is largely responsible for the inability of antibiotics to eradicate infections and is caused by a small population of dormant bacteria called persisters. HipA is a critical Escherichia coli persistence factor that is normally neutralized by HipB, a transcription repressor, which also regulates hipBA expression. Here, we report multiple structures of HipA and a HipA-HipB-DNA complex. HipA has a eukaryotic serine/threonine kinase-like fold and can phosphorylate the translation factor EF-Tu, suggesting a persistence mechanism via cell stasis. The HipA-HipB-DNA structure reveals the HipB-operator binding mechanism, similar to 70 degrees DNA bending, and unexpected HipA-DNA contacts. Dimeric HipB interacts with two HipA molecules to inhibit its kinase activity through sequestration and conformational inactivation. Combined, these studies suggest mechanisms for HipA-mediated persistence and its neutralization by HipB.	[Schumacher, Maria A.; Piro, Kevin M.; Xu, Weijun; Brennan, Richard G.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, Houston, TX 77030 USA; [Hansen, Sonja; Lewis, Kim] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Hansen, Sonja; Lewis, Kim] Northeastern Univ, Antimicrobial Discovery Ctr, Boston, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Northeastern University; Northeastern University	Schumacher, MA (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, 1515 Holcombe Blvd, Houston, TX 77030 USA.	maschuma@mdanderson.org; rgbrenna@mdanderson.org		Brennan, Richard/0000-0001-7647-485X	Burroughs Wellcome [992863]; NIH [GM074815, GM061162, AI048593]; Robert A. Welch Foundation [G0040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061162, R01GM074815] Funding Source: NIH RePORTER	Burroughs Wellcome(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. R. Knudsen for her generous gift of the GST-EF-Tu expression construct. Coordinates and structure factor amplitudes for the apoHipA, HipA-ATP, HipA-HipB-DNA, and HipA(ATP)-HipB-DNA complexes have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (www.rcsb.org/) under accession codes 3DNU, 3DNT, 3DNV, and 3DNW, respectively. We acknowledge support from Burroughs Wellcome Career Development Award 992863 and NIH grant GM074815 (to M. A. S.), NIH grant GM061162 (to K. L.), and the Robert A. Welch Foundation (grant G0040) and NIH grant AI048593 (to R. G. B.).	ALEXANDER C, 1995, J BIOL CHEM, V270, P14541, DOI 10.1074/jbc.270.24.14541; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; LIPPMANN C, 1993, J BIOL CHEM, V268, P601; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Nyborg J, 1998, FEBS LETT, V430, P95, DOI 10.1016/S0014-5793(98)00624-3; Papapanagiotou I, 2007, NUCLEIC ACIDS RES, V35, P2643, DOI 10.1093/nar/gkm129; SCHERRER R, 1988, J BACTERIOL, V170, P3321, DOI 10.1128/jb.170.8.3321-3326.1988; SHAH D, 2006, BMC MICROBIOL, V12, P6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514; WOLBERGER C, 1988, NATURE, V335, P789, DOI 10.1038/335789a0	30	243	251	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					396	401		10.1126/science.1163806	http://dx.doi.org/10.1126/science.1163806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150849	Green Accepted			2022-12-01	WOS:000262481400043
J	West, JB				West, John B.			A New Approach to Very-High-Altitude Land Travel: The Train to Lhasa, Tibet	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OXYGEN ENRICHMENT; ROOM AIR	The train from Golmud in Qinghai Province, China, to Lhasa, Tibet, travels for more than 14 hours at an average altitude of 4500 m, the highest point being 5072 m (16 600 ft). Therefore, passengers are potentially exposed to very severe sustained hypoxia. The enterprising solution is to increase the oxygen concentration of the air in the train from 21% to between 24% and 25% by the use of oxygen generators in each passenger car. By increasing the oxygen concentration to 25%, the equivalent altitude is reduced by about 1200 m. The engineering challenge of oxygenating the whole train is immense but has been successfully accomplished. This is an extraordinary innovation in high-altitude transportation.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	West, JB (corresponding author), Univ Calif San Diego, Dept Med, 0623A,9500 Gilman Dr, La Jolla, CA 92093 USA.	jwest@ucsd.edu			National Heart, Lung, and Blood Institute [R01 HL 060968]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060968] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	From the National Heart, Lung, and Blood Institute, R01 HL 060968.	Barash IA, 2001, HIGH ALT MED BIOL, V2, P525, DOI 10.1089/152702901753397090; Forster P., 1986, ASPECTS HYPOXIA, P217; Gerard A B, 2000, High Alt Med Biol, V1, P51, DOI 10.1089/152702900320685; Murdoch, 1995, J Travel Med, V2, P255, DOI 10.1111/j.1708-8305.1995.tb00671.x; RAHN H, 1949, AM J PHYSIOL, V157, P445, DOI 10.1152/ajplegacy.1949.157.3.445; West JB, 2004, ANN INTERN MED, V141, P789, DOI 10.7326/0003-4819-141-10-200411160-00010; West JB, 2004, OBSERVATORY, V124, P1; WEST JB, 1995, RESP PHYSIOL, V99, P225, DOI 10.1016/0034-5687(94)00094-G; Wu TY, 2007, HIGH ALT MED BIOL, V8, P88, DOI 10.1089/ham.2007.1015; Wu TY, 2006, HIGH ALT MED BIOL, V7, P275, DOI 10.1089/ham.2006.7.275	10	11	13	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2008	149	12					898	900		10.7326/0003-4819-149-12-200812160-00009	http://dx.doi.org/10.7326/0003-4819-149-12-200812160-00009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384VI	19075209				2022-12-01	WOS:000261771900007
J	Shum, WWC; Da Silva, N; Mckee, M; Smith, PJS; Brown, D; Breton, S				Shum, Winnie Wai Chi; Da Silva, Nicolas; McKee, Mary; Smith, Peter J. S.; Brown, Dennis; Breton, Sylvie			Transepithelial Projections from Basal Cells Are Luminal Sensors in Pseudostratified Epithelia	CELL			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MALE REPRODUCTIVE-TRACT; ENDOTHELIAL NITRIC-OXIDE; TIGHT JUNCTIONS; H+-ATPASE; EPIDIDYMAL EPITHELIUM; INTERCALATED CELLS; BLOOD-PRESSURE; CLEAR CELLS; STEM-CELLS	Basal cells are by definition located on the basolateral side of several epithelia, and they have never been observed reaching the lumen. Using high-resolution 3D confocal imaging, we report that basal cells extend long and slender cytoplasmic projections that not only reach toward the lumen but can cross the tight junction barrier in some epithelia of the male reproductive and respiratory tracts. In this way, the basal cell plasma membrane is exposed to the luminal environment. In the epididymis, in which luminal acidification is crucial for sperm maturation and storage, these projections contain the angiotensin II type 2 receptor (AGTR2). Activation of AGTR2 by luminal angiotensin II, increases proton secretion by adjacent clear cells, which are devoid of AGTR2. We propose a paradigm in which basal cells scan and sense the luminal environment of pseudostratified epithelia and modulate epithelial function by a mechanism involving crosstalk with other epithelial cells.	[Shum, Winnie Wai Chi; Da Silva, Nicolas; McKee, Mary; Brown, Dennis; Breton, Sylvie] Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA; [Shum, Winnie Wai Chi; Da Silva, Nicolas; Brown, Dennis; Breton, Sylvie] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Smith, Peter J. S.] Marine Biol Lab, Mol Physiol Program, BioCurrents Res Ctr, Woods Hole, MA 02543 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Marine Biological Laboratory - Woods Hole	Breton, S (corresponding author), Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA.	sbreton@partners.org	Da Silva, Nicolas/T-3528-2019	Smith, Peter/0000-0003-4400-6853	National Institute of Health [HD40793, DK38452, DK42956]; NCRR [P41 RR001395]; Boston Area Diabetes and Endocrinology Research Center [DK57521]; Center for the Study of Inflammatory Bowel Disease [DK43341]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040793] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043341, R01DK085715, P01DK038452, P30DK057521, R37DK042956, R56DK042956, R01DK042956] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Boston Area Diabetes and Endocrinology Research Center; Center for the Study of Inflammatory Bowel Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health grants HD40793 (S. B.), DK38452 (S. B. and D. B.), DK42956 (D. B.), and NCRR P41 RR001395 grant (P.J.S. Smith). The Microscopy Core facility of the MGH Program in Membrane Biology receives support from the Boston Area Diabetes and Endocrinology Research Center (DK57521) and the Center for the Study of Inflammatory Bowel Disease (DK43341).	Beaulieu V, 2005, J BIOL CHEM, V280, P8452, DOI 10.1074/jbc.M412750200; Blomqvist SR, 2006, EMBO J, V25, P4131, DOI 10.1038/sj.emboj.7601272; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; BROWN D, 1992, AM J PHYSIOL, V263, pC913, DOI 10.1152/ajpcell.1992.263.4.C913; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Burns AR, 2000, J CELL SCI, V113, P45; Carey RM, 2005, CURR OPIN NEPHROL HY, V14, P67, DOI 10.1097/00041552-200501000-00011; Cheung KH, 2005, J GEN PHYSIOL, V125, P443, DOI 10.1085/jgp.200409205; Clermont Y, 1970, Biology Reprod., V3, P283; Da Silva N, 2007, AM J PHYSIOL-CELL PH, V293, pC199, DOI 10.1152/ajpcell.00596.2006; Esther CR, 1996, LAB INVEST, V74, P953; Evans MJ, 2001, EXP LUNG RES, V27, P401, DOI 10.1080/019021401300317125; FORD JR, 1992, EXP CELL RES, V198, P69, DOI 10.1016/0014-4827(92)90150-7; Gatti JL, 1999, BIOL REPROD, V60, P937, DOI 10.1095/biolreprod60.4.937; Gregory M, 2006, MOL REPROD DEV, V73, P580, DOI 10.1002/mrd.20467; Gregory M, 2001, ENDOCRINOLOGY, V142, P854, DOI 10.1210/en.142.2.854; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Hajj R, 2007, STEM CELLS, V25, P139, DOI 10.1634/stemcells.2006-0288; Hermo L., 2002, EPIDIDYMIS MOL CLIN, P81, DOI [10.1007/978-1-4615-0679-9_5, DOI 10.1007/978-1-4615-0679-9_5]; HINTON BT, 1995, MICROSC RES TECHNIQ, V30, P67, DOI 10.1002/jemt.1070300106; Ihrler S, 2002, VIRCHOWS ARCH, V440, P519, DOI 10.1007/s004280100537; Isnard-Bagnis C, 2003, AM J PHYSIOL-CELL PH, V284, pC220, DOI 10.1152/ajpcell.00374.2001; Jones RC, 1996, REPROD FERT DEVELOP, V8, P553, DOI 10.1071/RD9960553; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Leung GPH, 2004, MOL CELL ENDOCRINOL, V216, P5, DOI 10.1016/j.mce.2003.10.077; Leung PS, 2003, J MOL ENDOCRINOL, V30, P263, DOI 10.1677/jme.0.0300263; Leung PS, 1997, BBA-MOL CELL RES, V1357, P65, DOI 10.1016/S0167-4889(97)00015-3; Mewe M, 2006, ENDOCRINOLOGY, V147, P2051, DOI 10.1210/en.2005-1324; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Parnot C, 2004, NAT STRUCT MOL BIOL, V11, P691, DOI 10.1038/nsmb0804-691; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Pastor-Soler NM, 2008, AM J PHYSIOL-CELL PH, V294, pC488, DOI 10.1152/ajpcell.00537.2007; Pech V, 2008, J AM SOC NEPHROL, V19, P84, DOI 10.1681/ASN.2007030277; PRICE DOROTHY, 1963, NATL CANCER INST MONOGR, V12, P1; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rizzo S, 2005, CELL PROLIFERAT, V38, P363, DOI 10.1111/j.1365-2184.2005.00356.x; ROBAIRE B, 1995, BIOL REPROD, V52, P226, DOI 10.1095/biolreprod52.2.226; Rothenberger F, 2007, J AM SOC NEPHROL, V18, P2085, DOI 10.1681/ASN.2006070753; Saez F, 2004, J ANDROL, V25, P784; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Skrabanek L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-177; SMITH PJS, 2007, METHODS NEW FRONTIER, P373; STEIN B, 1997, ENDOTHELIUM CLIN PRA, P147; Takano K, 2005, J HISTOCHEM CYTOCHEM, V53, P611, DOI 10.1369/jhc.4A6539.2005; Toda N, 2007, PHARMACOL REV, V59, P54, DOI 10.1124/pr.59.1.2; van Leenders GJLH, 2003, CRIT REV ONCOL HEMAT, V46, pS3, DOI 10.1016/S1040-8428(03)00059-3; VERI JP, 1993, J ANDROL, V14, P23; Wei CW, 1997, P NATL ACAD SCI USA, V94, P6369, DOI 10.1073/pnas.94.12.6369; WONG PYD, 1978, J PHYSIOL-LONDON, V275, P13, DOI 10.1113/jphysiol.1978.sp012174; YEUNG CH, 1994, BIOL REPROD, V50, P917, DOI 10.1095/biolreprod50.4.917; Zini A, 1996, BIOL REPROD, V55, P935, DOI 10.1095/biolreprod55.5.935	57	121	128	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1108	1117		10.1016/j.cell.2008.10.020	http://dx.doi.org/10.1016/j.cell.2008.10.020			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070580	Green Accepted, Bronze			2022-12-01	WOS:000261642800026
J	Barry, MJ				Barry, Michael J.			Screening for Prostate Cancer among Men 75 Years of Age or Older.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Barry, Michael J.] Massachusetts Gen Hosp, John D Stoeckle Ctr Primary Care Innovat, Boston, MA 02114 USA; [Barry, Michael J.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Barry, MJ (corresponding author), Massachusetts Gen Hosp, John D Stoeckle Ctr Primary Care Innovat, Boston, MA 02114 USA.							Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; WOLOSHIN S, 2008, JNCI-J NATL CANCER I, V100, P1133; Woloshin S, 2008, J NATL CANCER I, V100, P845, DOI 10.1093/jnci/djn124	6	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2515	2516		10.1056/NEJMp0807209	http://dx.doi.org/10.1056/NEJMp0807209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	381KG	19073973				2022-12-01	WOS:000261534200002
J	Hall, AJ; Logan, JE; Toblin, RL; Kaplan, JA; Kraner, JC; Bixler, D; Crosby, AE; Paulozzi, LJ				Hall, Aron J.; Logan, Joseph E.; Toblin, Robin L.; Kaplan, James A.; Kraner, James C.; Bixler, Danae; Crosby, Alex E.; Paulozzi, Leonard J.			Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; OPIOID ANALGESICS; CHRONIC PAIN; DEATHS	Context Use and abuse of prescription narcotic analgesics have increased dramatically in the United States since 1990. The effect of this pharmacoepidemic has been most pronounced in rural states, including West Virginia, which experienced the nation's largest increase in drug overdose mortality rates during 1999- 2004. Objective To evaluate the risk characteristics of persons dying of unintentional pharmaceutical overdose in West Virginia, the types of drugs involved, and the role of drug abuse in the deaths. Design, Setting, and Participants Population- based, observational study using data from medical examiner, prescription drug monitoring program, and opiate treatment program records. The study population was all state residents who died of unintentional pharmaceutical overdoses in West Virginia in 2006. Main Outcome Measures Rates and rate ratios for selected demographic variables. Prevalence of specific drugs among decedents and proportion that had been prescribed to decedents. Associations between demographics and substance abuse indicators and evidence of pharmaceutical diversion, defined as a death involving a prescription drug without a documented prescription and having received prescriptions for controlled substances from 5 or more clinicians during the year prior to death ( ie, doctor shopping). Results Of 295 decedents, 198 ( 67.1%) were men and 271 ( 91.9%) were aged 18 through 54 years. Pharmaceutical diversion was associated with 186 ( 63.1%) deaths, while 63 ( 21.4%) were accompanied by evidence of doctor shopping. Prevalence of diversion was greatest among decedents aged 18 through 24 years and decreased across each successive age group. Having prescriptions for a controlled substance from 5 or more clinicians in the year prior to death was more common among women (30 [ 30.9%]) and decedents aged 35 through 44 years ( 23 [ 30.7%]) compared with men ( 33 [ 16.7%]) and other age groups ( 40 [ 18.2%]). Substance abuse indicators were identified in 279 decedents ( 94.6%), with nonmedical routes of exposure and illicit contributory drugs particularly prevalent among drug diverters. Multiple contributory substances were implicated in 234 deaths ( 79.3%). Opioid analgesics were taken by 275 decedents (93.2%), of whom only 122 ( 44.4%) had ever been prescribed these drugs. Conclusion The majority of overdose deaths in West Virginia in 2006 were associated with nonmedical use and diversion of pharmaceuticals, primarily opioid analgesics.	[Hall, Aron J.; Logan, Joseph E.; Toblin, Robin L.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Logan, Joseph E.; Toblin, Robin L.; Crosby, Alex E.; Paulozzi, Leonard J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [Hall, Aron J.; Bixler, Danae] W Virginia Dept Hlth & Human Resources, Div Surveillance & Dis Control, Charleston, WV USA; [Kaplan, James A.; Kraner, James C.] W Virginia Dept Hlth & Human Resources, Off Chief Med Examiner, Charleston, WV USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hall, AJ (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, 1600 Clifton Rd NE,Mailstop A-47, Atlanta, GA 30333 USA.	ajhall@cdc.gov						[Anonymous], MOD POL US CONTR SUB; BISHAW A, EVALUATION POVERTY E; *CDCP, 2007, CDC WONDER; *CDCP, HLTH US 2006 CHARTB; Drug Abuse Warning Network, 2005, NAT EST DRUG REL EM; *DRUG ENF ADM, 2007, DEA APP REP W VIRG 2; Drug Enforcement Administration Diversion Control Division, STAT PRESCR DRUG MON; Foley K, 2000, JAMA-J AM MED ASSOC, V283, P115, DOI 10.1001/jama.283.1.115; Gilson AM, 2007, CA-CANCER J CLIN, V57, P341, DOI 10.3322/CA.57.6.341; Haddox JD, 1997, CLIN J PAIN, V13, P6; Inciardi JA, 2007, PAIN MED, V8, P171, DOI 10.1111/j.1526-4637.2006.00255.x; *NAT DRUG INT CTR, 2008, 2008R0813001 US DEP; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; Substance Abuse and Mental Health Services Administration, DRUG AB WARN NETW DA; Substance Abuse and Mental Health Services Administration, RES 2005 NAT SURV DR; Substance Abuse and Mental Health Services Administration Office of Applied Studies, NSDUH REP PATT TREND; Sullivan MD, 2006, ARCH INTERN MED, V166, P2087, DOI 10.1001/archinte.166.19.2087; Toombs JD, 2005, AM FAM PHYSICIAN, V71, P1353; Trescot Andrea M, 2006, Pain Physician, V9, P1; TURLEY E, DRUG VIOLENT CRIME C; *US BUR CENS, POP AR HOUS UN DENS; *US BUR CENS, 2006 AM COMM SURV; *US BUR CENS, SMALL AR INC POV EST; *US BUR CENS, 2006 ANN STAT POP ES; *US DEP JUST DRUG, ARCOS AUT REP CONS O; Washington State Agency Medical Directors' Group, 2010, INT GUID OP DOS CHRO; Wilson PR, 1997, ANESTHESIOLOGY, V86, P995	29	614	620	1	44	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2008	300	22					2613	2620		10.1001/jama.2008.802	http://dx.doi.org/10.1001/jama.2008.802			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380YW	19066381	Bronze			2022-12-01	WOS:000261503000020
J	Canman, JC; Lewellyn, L; Laband, K; Smerdon, SJ; Desai, A; Bowerman, B; Oegema, K				Canman, Julie C.; Lewellyn, Lindsay; Laband, Kimberley; Smerdon, Stephen J.; Desai, Arshad; Bowerman, Bruce; Oegema, Karen			Inhibition of Rac by the GAP Activity of Centralspindlin Is Essential for Cytokinesis	SCIENCE			English	Article							GTPASE-ACTIVATING PROTEIN; CAENORHABDITIS-ELEGANS; CONTRACTILE RING; GENE-PRODUCT; COMPLEX; RHOA; MGCRACGAP; SPINDLE; ORGANIZATION; REQUIRE	During cytokinesis, the guanosine triphosphatase ( GTPase) RhoA orchestrates contractile ring assembly and constriction. RhoA signaling is controlled by the central spindle, a set of microtubule bundles that forms between the separating chromosomes. Centralspindlin, a protein complex consisting of the kinesin-6 ZEN-4 and the Rho family GTPase activating protein ( GAP) CYK- 4, is required for central spindle assembly and cytokinesis in Caenorhabditis elegans. However, the importance of the CYK- 4 GAP activity and whether it regulates RhoA remain unclear. We found that two separation- of- function mutations in the GAP domain of CYK- 4 lead to cytokinesis defects that mimic centralspindlin loss of function. These defects could be rescued by depletion of the GTPase Rac or its effectors, but not by depletion of RhoA. Thus, inactivation of Rac by centralspindlin functions in parallel with RhoA activation to drive contractile ring constriction during cytokinesis.	[Canman, Julie C.; Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Canman, Julie C.; Lewellyn, Lindsay; Laband, Kimberley; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Smerdon, Stephen J.] Natl Inst Med Res, London NW7 1AA, England	University of Oregon; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; MRC National Institute for Medical Research	Canman, JC (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	jcanman@ucsd.edu; koegema@ucsd.edu	Canman, Julie C/A-3875-2016	Canman, Julie C/0000-0001-8135-2072; Smerdon, Stephen/0000-0001-5688-8465; Lewellyn, Lindsay/0000-0001-6444-5699; Laband, Kimberley/0000-0002-8535-2050	Jane Coffin Childs Memorial Fund for Medical Research and the Leukemia and Lymphoma Society; National Institute of General Medical Sciences [T32 GM008666]; National Cancer Institute [T32 CA067754]; Ludwig Institute for Cancer Research; NIH [GM058017]; Medical Research Council [MC_U117584228] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA067754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM058017, R01GM049869, T32GM008666] Funding Source: NIH RePORTER; MRC [MC_U117584228] Funding Source: UKRI	Jane Coffin Childs Memorial Fund for Medical Research and the Leukemia and Lymphoma Society; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all members of the Oegema, Desai, and Bowerman labs; A. Maddox, J. Dumont, and R. Green for reading this manuscript; J. Dumont for making double- stranded RNAs; Y. Kohara for cDNA clones; and the Caenorhabditis Genetics Center for strains. Supported by the Jane Coffin Childs Memorial Fund for Medical Research and the Leukemia and Lymphoma Society (J.C.C.), National Institute of General Medical Sciences grant T32 GM008666 and National Cancer Institute grant T32 CA067754 (L.L.), the Ludwig Institute for Cancer Research (K.O. and A.D.), and NIH grant GM058017 (B.B.).	AHMED S, 1994, J BIOL CHEM, V269, P17642; Bement WM, 2006, BIOESSAYS, V28, P983, DOI 10.1002/bies.20477; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; D'Avino PP, 2004, J CELL BIOL, V166, P61, DOI 10.1083/jcb.200402157; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Encalada SE, 2000, DEV BIOL, V228, P225, DOI 10.1006/dbio.2000.9965; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kawashima T, 2000, BLOOD, V96, P2116; LUNDQUIST EA, WORMBOOK; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; RAPPAPORT R, 1997, CYTOKINESIS ANIMAL C; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Toure A, 1998, J BIOL CHEM, V273, P6019, DOI 10.1074/jbc.273.11.6019; Withee J, 2004, GENETICS, V167, P1165, DOI 10.1534/genetics.103.025676; Yamada T, 2006, EXP CELL RES, V312, P3517, DOI 10.1016/j.yexcr.2006.07.026; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	28	126	141	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1543	1546		10.1126/science.1163086	http://dx.doi.org/10.1126/science.1163086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056985	Green Accepted			2022-12-01	WOS:000261377400049
J	Coleman, HR; Chan, CC; Ferris, FL; Chew, EY				Coleman, Hanna R.; Chan, Chi-Chao; Ferris, Frederick L., III; Chew, Emily Y.			Age-related macular degeneration	LANCET			English	Review							COMPLEMENT FACTOR-H; VITAMIN-E SUPPLEMENTATION; 3RD NATIONAL-HEALTH; BODY-MASS INDEX; VISUAL IMPAIRMENT; RISK-FACTORS; GEOGRAPHIC ATROPHY; DIETARY-FAT; CIGARETTE-SMOKING; 5-YEAR INCIDENCE	Age-related macular degeneration is the leading cause of blindness in elderly populations of European descent. The most consistent risk factors associated with this ocular condition are increasing age and cigarette smoking. Genetic investigations have shown that complement factor H, a regulator of the alternative complement pathway, and LOC387715/HtrA1 are the most consistent genetic risk factors for age-related macular degeneration. Although the pathogenesis of this disease is unknown, oxidative stress might have an important role. Treatment with antioxidant vitamins and zinc can reduce the risk of developing advanced age-related macular degeneration by about a quarter in those at least at moderate risk. Intravitreal injections of ranibizumab, a monoclonal antibody that inhibits all forms of vascular endothelial growth factor, have been shown to stabilise loss of vision and, in some cases, improve vision in individuals with neovascular age-related macular degeneration. These findings, combined with assessments of possible environmental and genetic interactions and new approaches to modulate inflammatory pathways, will hopefully further expand our ability to understand and treat age-related macular degeneration.	[Coleman, Hanna R.; Ferris, Frederick L., III; Chew, Emily Y.] NEI, Div Epidemiol & Clin Res, NIH, Bethesda, MD 20892 USA; [Chan, Chi-Chao] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Chew, EY (corresponding author), NEI, Div Epidemiol & Clin Res, NIH, Bldg 10,CRC,Room 3-2531,10 Ctr Dr,MSC-1204, Bethesda, MD 20892 USA.	echew@nei.nih.gov		Ferris, Frederick/0000-0002-4933-0639	Intramural NIH HHS [Z01 EY000418-04, Z99 EY999999, Z01 EY000222-22] Funding Source: Medline; NATIONAL EYE INSTITUTE [ZIAEY000222, ZIAEY000418, ZICEY000461] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Albanes D, 2007, JAMA-J AM MED ASSOC, V298, P400, DOI 10.1001/jama.298.4.400-a; Allikmets R, 2008, NAT GENET, V40, P820, DOI 10.1038/ng0708-820; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2001, AM J OPHTHALMOL, V131, P767, DOI 10.1016/S0002-9394(00)00961-2; [Anonymous], 1993, Arch Ophthalmol, V111, P104; [Anonymous], 2005, ARCH OPHTHALMOL-CHIC, V123, P1570, DOI DOI 10.1001/ARCHOPHT.123.11.1570; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198; BRESSLER NM, 1994, RETINA-J RET VIT DIS, V14, P130, DOI 10.1097/00006982-199414020-00006; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; BRESSLER NM, 1989, ARCH OPHTHALMOL-CHIC, V107, P847, DOI 10.1001/archopht.1989.01070010869032; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Bunce C, 2008, EYE, V22, P905, DOI 10.1038/sj.eye.6702767; Chaine G, 1998, BRIT J OPHTHALMOL, V82, P996, DOI 10.1136/bjo.82.9.996; Chan Chi-Chao, 2007, Trans Am Ophthalmol Soc, V105, P92; Chen J, 2007, J CLIN INVEST, V117, P2758, DOI 10.1172/JCI33513; Chew EY, 2005, ARCH OPHTHALMOL-CHIC, V123, P395, DOI 10.1001/archopht.123.3.395; Cho E, 2001, AM J CLIN NUTR, V73, P209; Cho EY, 2004, ARCH OPHTHALMOL-CHIC, V122, P883, DOI 10.1001/archopht.122.6.883; Christen WG, 1996, JAMA-J AM MED ASSOC, V276, P1147, DOI 10.1001/jama.276.14.1147; Chua B, 2006, ARCH OPHTHALMOL-CHIC, V124, P981, DOI 10.1001/archopht.124.7.981; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Cruickshanks KJ, 1997, ARCH OPHTHALMOL-CHIC, V115, P242, DOI 10.1001/archopht.1997.01100150244015; Cruickshanks KJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P246; DASTGHEIB K, 1994, ARCH OPHTHALMOL-CHIC, V112, P813, DOI 10.1001/archopht.1994.01090180111045; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Delcourt C, 1998, ARCH OPHTHALMOL-CHIC, V116, P1031, DOI 10.1001/archopht.116.8.1031; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Delcourt C, 2001, ARCH OPHTHALMOL-CHIC, V119, P1463; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FINE SL, 1982, ARCH OPHTHALMOL-CHIC, V100, P912; Flood V, 2002, OPHTHALMOLOGY, V109, P2272, DOI 10.1016/S0161-6420(02)01263-0; Francis PJ, 2007, HUM HERED, V63, P212, DOI 10.1159/000100046; Fraser-Bell S, 2008, AM J OPHTHALMOL, V145, P308, DOI 10.1016/j.ajo.2007.10.007; Friberg TR, 2006, OPHTHALMOLOGY, V113, P612, DOI 10.1016/j.ophtha.2005.10.066; Friedman DS, 1999, OPHTHALMOLOGY, V106, P1049, DOI 10.1016/S0161-6420(99)90267-1; GASS JD, 1973, T AM ACAD OPHTHALMOL, V77; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; GOLDBERG J, 1988, AM J EPIDEMIOL, V128, P700, DOI 10.1093/oxfordjournals.aje.a115023; Gottfredsdottir MS, 1999, ACTA OPHTHALMOL SCAN, V77, P422, DOI 10.1034/j.1600-0420.1999.770413.x; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180; Green W R, 1999, Mol Vis, V5, P27; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HAWKINS BS, 1986, ARCH OPHTHALMOL-CHIC, V104, P694; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Heuberger RA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1833, DOI 10.1001/archopht.119.12.1833; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Huang HY, 2007, JAMA-J AM MED ASSOC, V298, P400, DOI 10.1001/jama.298.4.400-b; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; HYMAN LG, 1983, AM J EPIDEMIOL, V118, P213, DOI 10.1093/oxfordjournals.aje.a113629; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kim SY, 2002, RETINA-J RET VIT DIS, V22, P471, DOI 10.1097/00006982-200208000-00012; Kim SY, 2002, RETINA-J RET VIT DIS, V22, P464, DOI 10.1097/00006982-200208000-00011; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; KLEIN ML, 1994, ARCH OPHTHALMOL-CHIC, V112, P932, DOI 10.1001/archopht.1994.01090190080025; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Klein R, 1998, ARCH OPHTHALMOL-CHIC, V116, P506, DOI 10.1001/archopht.116.4.506; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 1999, OPHTHALMOLOGY, V106, P1056, DOI 10.1016/S0161-6420(99)90255-5; KLEIN R, 1999, AGE RELATED MACULAR, P31; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, AM J OPHTHALMOL, V143, P473, DOI 10.1016/j.ajo.2006.11.058; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Lamb LE, 2004, PHOTOCHEM PHOTOBIOL, V79, P127, DOI 10.1562/0031-8655(2004)079<0127:AACOOL>2.0.CO;2; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Lau LI, 2006, INVEST OPHTH VIS SCI, V47, P3242, DOI 10.1167/iovs.05-1532; Gluud LL, 2007, JAMA-J AM MED ASSOC, V298, P402, DOI 10.1001/jama.298.4.402; Lutty G, 1999, MOL VIS, V5; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Mares-Perlman JA, 2001, AM J EPIDEMIOL, V153, P424, DOI 10.1093/aje/153.5.424; MaresPerlman JA, 1996, ARCH OPHTHALMOL-CHIC, V114, P991, DOI 10.1001/archopht.1996.01100140199014; MARESPERLMAN JA, 1995, ARCH OPHTHALMOL-CHIC, V113, P743, DOI 10.1001/archopht.1995.01100060069034; McCarty CA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1455; McLeod DS, 2002, INVEST OPHTH VIS SCI, V43, P1986; MEYERS SM, 1995, AM J OPHTHALMOL, V120, P757, DOI 10.1016/S0002-9394(14)72729-1; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Mitchell P, 2002, OPHTHALMOLOGY, V109, P1092, DOI 10.1016/S0161-6420(02)01055-2; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Mukesh BN, 2004, OPHTHALMOLOGY, V111, P1176, DOI 10.1016/j.ophtha.2003.08.042; Mullins RF, 1997, OPHTHALMOLOGY, V104, P288, DOI 10.1016/S0161-6420(97)30322-4; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Munoz B, 2000, ARCH OPHTHALMOL-CHIC, V118, P819, DOI 10.1001/archopht.118.6.819; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Okamoto H, 2006, MOL VIS, V12, P156; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Owens SL, 2006, AM J OPHTHALMOL, V141, P276, DOI 10.1016/j.ajo.2005.08.019; Park DW, 2006, OPHTHALMOLOGY, V113, P1974, DOI 10.1016/j.ophtha.2006.08.015; PENFOLD PL, 1987, GRAEF ARCH CLIN EXP, V225, P70, DOI 10.1007/BF02155808; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Ross RJ, 2007, INVEST OPHTH VIS SCI, V48, P1128, DOI 10.1167/iovs.06-0999; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P671, DOI 10.1001/archopht.125.5.671; Sarks JP, 1997, EYE, V11, P515, DOI 10.1038/eye.1997.137; Sarks SH, 1999, BRIT J OPHTHALMOL, V83, P358, DOI 10.1136/bjo.83.3.358; Sarks S, 2007, INVEST OPHTH VIS SCI, V48, P968, DOI 10.1167/iovs.06-0443; SCHACHAT AP, 1995, ARCH OPHTHALMOL-CHIC, V113, P728, DOI 10.1001/archopht.1995.01100060054032; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Schmitz-Valckenberg S, 2006, INVEST OPHTH VIS SCI, V47, P2648, DOI 10.1167/iovs.05-0892; Scholl HPN, 2007, MOL VIS, V13, P196; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Smith W, 1996, ARCH OPHTHALMOL-CHIC, V114, P1518, DOI 10.1001/archopht.1996.01100140716016; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Smith W, 1998, AUST NZ J OPHTHALMOL, V26, P203, DOI 10.1111/j.1442-9071.1998.tb01311.x; Snellen ELM, 2002, ACTA OPHTHALMOL SCAN, V80, P368, DOI 10.1034/j.1600-0420.2002.800404.x; Souied EH, 2005, MOL VIS, V11, P1135; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Steinbrook R, 2006, NEW ENGL J MED, V355, P1409, DOI 10.1056/NEJMp068185; Tan JSL, 2007, ARCH OPHTHALMOL-CHIC, V125, P1089, DOI 10.1001/archopht.125.8.1089; Taylor HR, 2002, BMJ-BRIT MED J, V325, P11, DOI 10.1136/bmj.325.7354.11; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; VanNewkirk MR, 2000, OPHTHALMOLOGY, V107, P1593, DOI 10.1016/S0161-6420(00)00175-5; *VERT ROUNDT 2000, 2002, RETINA, V22, P6; VINDING T, 1992, ACTA OPHTHALMOL, V70, P66; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Vingerling JR, 1996, ARCH OPHTHALMOL-CHIC, V114, P1193, DOI 10.1001/archopht.1996.01100140393005; Vu HTV, 2006, BRIT J OPHTHALMOL, V90, P389, DOI 10.1136/bjo.2005.078055; Wang JJ, 2000, CLIN EXP OPHTHALMOL, V28, P268, DOI 10.1046/j.1442-9071.2000.00315.x; Weih LM, 2000, ARCH OPHTHALMOL-CHIC, V118, P264; Wong TY, 2007, OPHTHALMOLOGY, V114, P86, DOI 10.1016/j.ophtha.2006.06.039; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701; Yates YR, 2007, NEW ENGL J MED, V357, P19; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	163	405	421	1	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1835	1845		10.1016/S0140-6736(08)61759-6	http://dx.doi.org/10.1016/S0140-6736(08)61759-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	19027484	Green Accepted			2022-12-01	WOS:000261112000026
J	Chambouvet, A; Morin, P; Marie, D; Guillou, L				Chambouvet, Aurelie; Morin, Pascal; Marie, Dominique; Guillou, Laure			Control of Toxic Marine Dinoflagellate Blooms by Serial Parasitic Killers	SCIENCE			English	Article							18S RDNA SEQUENCES; CHESAPEAKE BAY; EUKARYOTIC DIVERSITY; AMOEBOPHRYA-CERATII; PICOPLANKTON; SURVIVAL; PLANKTON; STRAINS; TIME; SITE	The marine dinoflagellates commonly responsible for toxic red tides are parasitized by other dinoflagellate species. Using culture- independent environmental ribosomal RNA sequences and fluorescence markers, we identified host- specific infections among several species. Each parasitoid produces 60 to 400 offspring, leading to extraordinarily rapid control of the host's population. During 3 consecutive years of observation in a natural estuary, all dinoflagellates observed were chronically infected, and a given host species was infected by a single genetically distinct parasite year after year. Our observations in natural ecosystems suggest that although bloom- forming dinoflagellates may escape control by grazing organisms, they eventually succumb to parasite attack.	[Chambouvet, Aurelie; Morin, Pascal; Marie, Dominique; Guillou, Laure] CNRS, Biol Stn, UMR 7144, F-29682 Roscoff, France; [Chambouvet, Aurelie; Morin, Pascal; Marie, Dominique; Guillou, Laure] Univ Paris 06, Lab Adapt & Divers Milieu Marin, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Guillou, L (corresponding author), CNRS, Biol Stn, UMR 7144, Pl Georges Teissier, F-29682 Roscoff, France.	lguillou@sb-roscoff.fr	Morin, Pascal/A-1112-2016	Morin, Pascal/0000-0003-2766-1821; Chambouvet, Aurelie/0000-0003-3932-0098; Guillou, Laure/0000-0003-1032-7958	Groupement d'Interet Scientifique Genomique Marine; French Agence National de la Recherche project Aquaparadox	Groupement d'Interet Scientifique Genomique Marine; French Agence National de la Recherche project Aquaparadox(French National Research Agency (ANR))	We thank A. Carlier, D. Charruaud, A. Groisillier, and S. Maury for their earlier contributions to this work; D. Vaulot, P. von Dassow, and A. Worden for critically reading this manuscript; P. Falkowski for his help with corrections and discussions; W. Coats for cultures of Amoebophrya spp. that greatly helped us to test the oligonucleotide probes and for constructive discussions; D. Jollivet for his help with genetic population analysis; The Service Mer et Observation of the Roscoff Biological Station; and E. Mace for sample collections and nutrient acquisition parameters. This work was financially supported by the Groupement d'Interet Scientifique Genomique Marine and the French Agence National de la Recherche project Aquaparadox. We also thank Zeiss for help in the acquisition of the confocal micrographs. Sequences have been deposited in GenBank under accession numbers FJ356776 to FJ357007. The authors declare no competing financial interests.	Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; [Anonymous], [No title captured]; CHACHON J, 1964, ANN SCI NAT ZOOL, V6, P1; Chatton E., 1920, Archives de Zoologie Experimentale Paris, V59; Coats DW, 2002, J PHYCOL, V38, P520, DOI 10.1046/j.1529-8817.2002.t01-1-01200.x; COATS DW, 1994, J EUKARYOT MICROBIOL, V41, P586, DOI 10.1111/j.1550-7408.1994.tb01520.x; Coats DW, 1996, AQUAT MICROB ECOL, V11, P1, DOI 10.3354/ame011001; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Gunderson JH, 2002, J EUKARYOT MICROBIOL, V49, P469, DOI 10.1111/j.1550-7408.2002.tb00230.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Maguer JF, 2004, LIMNOL OCEANOGR, V49, P1108, DOI 10.4319/lo.2004.49.4.1108; Medlin LK, 2006, MICROB ECOL, V52, P53, DOI 10.1007/s00248-005-0062-x; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Nishitani L., 1985, P225; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Salomon PS, 2003, ENVIRON MICROBIOL, V5, P1046, DOI 10.1046/j.1462-2920.2003.00511.x; Smayda TJ, 2003, J SEA RES, V49, P95, DOI 10.1016/S1385-1101(02)00219-8; Smayda TJ, 2001, J PLANKTON RES, V23, P447, DOI 10.1093/plankt/23.5.447; TAYLOR FJR, 1968, J FISH RES BOARD CAN, V25, P2241, DOI 10.1139/f68-197; Zingone A, 2000, OCEAN COAST MANAGE, V43, P725, DOI 10.1016/S0964-5691(00)00056-9	23	209	215	4	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1254	1257		10.1126/science.1164387	http://dx.doi.org/10.1126/science.1164387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023082				2022-12-01	WOS:000261033400044
J	Holt, JW; Safaeinili, A; Plaut, JJ; Head, JW; Phillips, RJ; Seu, R; Kempf, SD; Choudhary, P; Young, DA; Putzig, NE; Biccari, D; Gim, Y				Holt, John W.; Safaeinili, Ali; Plaut, Jeffrey J.; Head, James W.; Phillips, Roger J.; Seu, Roberto; Kempf, Scott D.; Choudhary, Prateek; Young, Duncan A.; Putzig, Nathaniel E.; Biccari, Daniela; Gim, Yonggyu			Radar Sounding Evidence for Buried Glaciers in the Southern Mid-Latitudes of Mars	SCIENCE			English	Article							POLAR LAYERED DEPOSITS; LOBATE DEBRIS APRONS; CLIMATE-CHANGE; ICE; SUBSURFACE; OBLIQUITY; ACCUMULATION; REGION; FLOW	Lobate features abutting massifs and escarpments in the middle latitudes of Mars have been recognized in images for decades, but their true nature has been controversial, with hypotheses of origin such as ice- lubricated debris flows or glaciers covered by a layer of surface debris. These models imply an ice content ranging from minor and interstitial to massive and relatively pure. Soundings of these deposits in the eastern Hellas region by the Shallow Radar on the Mars Reconnaissance Orbiter reveal radar properties entirely consistent with massive water ice, supporting the debris- covered glacier hypothesis. The results imply that these glaciers formed in a previous climate conducive to glaciation at middle latitudes. Such features may collectively represent the most extensive nonpolar ice yet recognized on Mars.	[Holt, John W.; Kempf, Scott D.; Choudhary, Prateek; Young, Duncan A.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA; [Safaeinili, Ali; Plaut, Jeffrey J.; Gim, Yonggyu] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Head, James W.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Phillips, Roger J.; Putzig, Nathaniel E.] SW Res Inst, Boulder, CO 80302 USA; [Seu, Roberto; Biccari, Daniela] Univ Roma La Sapienza, INFOCOM Dept, I-00184 Rome, Italy	University of Texas System; University of Texas Austin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Brown University; Sapienza University Rome	Holt, JW (corresponding author), Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA.	jack@ig.utexas.edu	Holt, John/C-4896-2009; Young, Duncan A./G-6256-2010	Young, Duncan A./0000-0002-6866-8176; Putzig, Nathaniel/0000-0003-4485-6321	Institute for Geophysics of the Jackson School of Geosciences and NASA [NAG5-12693]	Institute for Geophysics of the Jackson School of Geosciences and NASA	We thank F. Russo, M. Cutigni, O. Fuga, and E. Giacomoni of the SHARAD Operations Center for their role in acquiring the data over these targets; F. Bernardini for his assistance in the U. S. data processing effort; and two anonymous reviewers for their comments and suggestions. Work at the University of Texas was supported by the Institute for Geophysics of the Jackson School of Geosciences and NASA grant NAG5-12693 (J.W.H.). MRO is operated for NASA by Caltech's Jet Propulsion Laboratory. SHARAD was provided to MRO by the Italian Space Agency through a contract with Thales Alenia Space Italia and is operated by the INFOCOM Department, University of Rome. This is UTIG contribution 2006.	Carr M. H., 1977, Journal of Geophysical Research, V82, P4039, DOI 10.1029/JS082i028p04039; Carr M.H, 1996, WATER MARS; Colaprete A, 1998, J GEOPHYS RES-PLANET, V103, P5897, DOI 10.1029/97JE03371; FANALE FP, 1986, ICARUS, V67, P1, DOI 10.1016/0019-1035(86)90170-3; Forget F, 2006, SCIENCE, V311, P368, DOI 10.1126/science.1120335; GUDMANDSEN P, 1971, ELECTROMAGNETIC PROB, P329; Head JW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024360; Head JW, 2006, EARTH PLANET SC LETT, V241, P663, DOI 10.1016/j.epsl.2005.11.016; Head JW, 2005, NATURE, V434, P346, DOI 10.1038/nature03359; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Heggy E., 2007, LUNAR PLANET SCI, VXXXVIII; Holt JW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002525; KRESS AM, 2008, LUNAR PLANET SCI C, V39, P1293; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; Li H, 2005, ICARUS, V176, P382, DOI 10.1016/j.icarus.2005.02.011; Lucchitta B. K., 1984, Journal of Geophysical Research, V89, P409, DOI 10.1029/JB089iS02p0B409; Mangold N, 2001, GEOPHYS RES LETT, V28, P407, DOI 10.1029/2000GL008491; Marchant DR, 2007, ICARUS, V192, P187, DOI 10.1016/j.icarus.2007.06.018; Mest SC, 2001, ICARUS, V153, P89, DOI 10.1006/icar.2001.6655; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; Phillips RJ, 2008, SCIENCE, V320, P1182, DOI 10.1126/science.1157546; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Pierce TL, 2003, ICARUS, V163, P46, DOI 10.1016/S0019-1035(03)00046-0; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; PLAUT JJ, 2008, LUNAR PLANET SCI, V39, P2290; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Seu R, 2007, SCIENCE, V317, P1715, DOI 10.1126/science.1144120; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; SQUYRES SW, 1979, J GEOPHYS RES, V84, P8087, DOI 10.1029/JB084iB14p08087	30	230	235	5	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1235	1238		10.1126/science.1164246	http://dx.doi.org/10.1126/science.1164246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023078	Green Submitted			2022-12-01	WOS:000261033400038
J	Tateishi, K; Okada, Y; Kallin, EM; Zhang, Y				Tateishi, Keisuke; Okada, Yuki; Kallin, Eric M.; Zhang, Yi			Role of Jhdm2a in regulating metabolic gene expression and obesity resistance	NATURE			English	Article							ACTIVATED RECEPTOR-ALPHA; MITOCHONDRIAL UNCOUPLING PROTEIN; ENERGY-BALANCE; BETA; THERMOGENESIS; TRANSCRIPTION; METHYLATION; ELEMENTS; MUSCLE; MICE	Recent studies indicate that the methylation state of histones can be dynamically regulated by histone methyltransferases and demethylases(1,2). The H3K9-specific demethylase Jhdm2a (also known as Jmjd1a and Kdm3a) has an important role in nuclear hormone receptor-mediated gene activation and male germ cell development(3,4). Through disruption of the Jhdm2a gene in mice, here we demonstrate that Jhdm2a is critically important in regulating the expression of metabolic genes. The loss of Jhdm2a function results in obesity and hyperlipidemia in mice. We provide evidence that the loss of Jhdm2a function disrupts beta-adrenergic-stimulated glycerol release and oxygen consumption in brown fat, and decreases fat oxidation and glycerol release in skeletal muscles. We show that Jhdm2a expression is induced by beta-adrenergic stimulation, and that Jhdm2a directly regulates peroxisome proliferator-activated receptor alpha (Ppara) and Ucp1 expression. Furthermore, we demonstrate that beta-adrenergic activation-induced binding of Jhdm2a to the PPAR responsive element (PPRE) of the Ucp1 gene not only decreases levels of H3K9me2 (dimethylation of lysine 9 of histone H3) at the PPRE, but also facilitates the recruitment of Ppar gamma and Rxr alpha and their co-activators Pgc1 alpha (also known as Ppargc1a), CBP/p300 (Crebbp) and Src1 (Ncoa1) to the PPRE. Our studies thus demonstrate an essential role for Jhdm2a in regulating metabolic gene expression and normal weight control in mice.	[Tateishi, Keisuke; Okada, Yuki; Kallin, Eric M.; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Tateishi, Keisuke; Okada, Yuki; Kallin, Eric M.; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811	UNC Clinical Nutrition Research Unit [DK56350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	UNC Clinical Nutrition Research Unit; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. M. Spiegelman for the HIB1B cells, L. Xia for construction of the targeting vector, K. E. Gardner for critical reading of the manuscript, D. Pump and K. Hua (UNC Clinical Nutrition Research Unit, DK56350) for calorimetry and MRI, and N. Takahashi for helpful comments. Y.Z. is an investigator of the Howard Hughes Medical Institute.	Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bedu E, 2007, BIOCHEM BIOPH RES CO, V357, P877, DOI 10.1016/j.bbrc.2007.04.003; CASSARDDOULCIER AM, 1993, MOL ENDOCRINOL, V7, P497, DOI 10.1210/me.7.4.497; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lomax MA, 2007, ENDOCRINOLOGY, V148, P461, DOI 10.1210/en.2006-0918; Lopez D, 2003, MOL CELL ENDOCRINOL, V205, P169, DOI 10.1016/S0303-7207(02)00300-3; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; ROSS SR, 1992, P NATL ACAD SCI USA, V89, P7561, DOI 10.1073/pnas.89.16.7561; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Wang ZY, 2006, CELL METAB, V3, P111, DOI 10.1016/j.cmet.2006.01.002; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	23	331	356	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					757	761		10.1038/nature07777	http://dx.doi.org/10.1038/nature07777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19194461	Green Published, Green Accepted			2022-12-01	WOS:000265193600040
J	Kim, JB; Sebastiano, V; Wu, GM; Arauzo-Bravo, MJ; Sasse, P; Gentile, L; Ko, K; Ruau, D; Ehrich, M; van den Boom, D; Meyer, J; Hubner, K; Bernemann, C; Ortmeier, C; Zenke, M; Fleischmann, BK; Zaehres, H; Scholer, HR				Kim, Jeong Beom; Sebastiano, Vittorio; Wu, Guangming; Arauzo-Bravo, Marcos J.; Sasse, Philipp; Gentile, Luca; Ko, Kinarm; Ruau, David; Ehrich, Mathias; van den Boom, Dirk; Meyer, Johann; Huebner, Karin; Bernemann, Christof; Ortmeier, Claudia; Zenke, Martin; Fleischmann, Bernd K.; Zaehres, Holm; Schoeler, Hans R.			Oct4-Induced Pluripotency in Adult Neural Stem Cells	CELL			English	Article							PRIMORDIAL GERM-CELLS; HUMAN FIBROBLASTS; SELF-RENEWAL; MOUSE; GENERATION; EXPRESSION; DERIVATION; INDUCTION; OCT4; MYC	The four transcription factors Oct4, Sox2, Klf4, and c-Myc can induce pluripotency in mouse and human fibroblasts. We previously described direct reprogramming of adult mouse neural stem cells (NSCs) by Oct4 and either Klf4 or c-Myc. NSCs endogenously express Sox2, c-Myc, and Klf4 as well as several intermediate reprogramming markers. Here we report that exogenous expression of the germline-specific transcription factor Oct4 is sufficient to generate pluripotent stem cells from adult mouse NSCs. These one-factor induced pluripotent stem cells (1F iPS) are similar to embryonic stem cells in vitro and in vivo. Not only can these cells can be efficiently differentiated into NSCs, cardiomyocytes, and germ cells in vitro, but they are also capable of teratoma formation and germline transmission in vivo. Our results demonstrate that Oct4 is required and sufficient to directly reprogram NSCs to pluripotency.	[Kim, Jeong Beom; Sebastiano, Vittorio; Wu, Guangming; Arauzo-Bravo, Marcos J.; Gentile, Luca; Ko, Kinarm; Huebner, Karin; Bernemann, Christof; Ortmeier, Claudia; Zaehres, Holm; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, NRW, Germany; [Sasse, Philipp; Fleischmann, Bernd K.] Univ Bonn, Inst Physiol 1, Life & Brain Ctr, D-53105 Bonn, NRW, Germany; [Ruau, David; Zenke, Martin] RWTH Aachen Univ Med Sch, Inst Biomed Engn, Dept Cell Biol, D-52074 Aachen, NRW, Germany; [Ehrich, Mathias; van den Boom, Dirk] SEQUENOM Inc, San Diego, CA 92121 USA; [Meyer, Johann] Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany	Max Planck Society; University of Bonn; RWTH Aachen University; Sequenom; Hannover Medical School	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, NRW, Germany.	office@mpi-muenster.mpg.de	Sasse, Philipp/G-9866-2013; Gentile, Luca/L-4473-2014; , HS/AAB-4434-2019; Marcos, Arauzo-Bravo/A-1706-2011; Gentile, Luca/E-4908-2019	Sasse, Philipp/0000-0002-8502-9472; , HS/0000-0003-2643-5136; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Gentile, Luca/0000-0002-7393-7502; Wu, Guangming/0000-0003-1923-7609; Ehrich, Mathias/0000-0001-8415-0310; Kim, Jeong Beom/0000-0001-6230-8826	Deutsche Forschungsgemeinschaft DFG [SPP1356, SPP1109]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	We thank J. Muller-Keuker and S. Kolsch for critically reviewing the manuscript, M. Stehling for FACS analysis, B. Schafer for histology, C. Becker, B. Kratz, and B. Denecke for probe processing and array hybridization, F. Holst for technical help, and Dr. Toshio Kitamura for the pMX retroviral vector. The project was funded in part by a grant from the Deutsche Forschungsgemeinschaft DFG within the Priority Programme SPP 1356 "Pluripotency and Cellular Reprogramming.'' The microarray analyses were funded in part by a grant from the Deutsche Forschungsgemeinschaft DFG SPP1109. M. E. and D. v. d. B. are employees of SEQUENOM, Inc.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fu LJ, 2008, STEM CELLS DEV, V17, P1109, DOI 10.1089/scd.2008.0068; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Hubner K, 2006, METHOD ENZYMOL, V418, P284, DOI 10.1016/S0076-6879(06)18017-9; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kolossov E, 1998, J CELL BIOL, V143, P2045, DOI 10.1083/jcb.143.7.2045; Lee J, 2003, CANCER RES, V63, P8877; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McLaren A., 1981, GERM CELLS SOMA NEW; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Weismann A., 1892, KEIMPLASMA THEORIE V; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2006, METHOD ENZYMOL, V420, P49, DOI 10.1016/S0076-6879(06)20004-1	41	737	896	2	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					411	419		10.1016/j.cell.2009.01.023	http://dx.doi.org/10.1016/j.cell.2009.01.023			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203577	Bronze			2022-12-01	WOS:000263120600012
J	Bach, PB				Bach, Peter B.			Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHEMOTHERAPY; CARE; PRESCRIPTION; PAYMENT; REIMBURSEMENT; INTERFERON; HEALTH; COSTS; PRICE		[Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, 1275 York Ave, New York, NY 10021 USA.							Bach PB, 2006, NEW ENGL J MED, V354, P2312, DOI 10.1056/NEJMp068108; Bach PB, 2005, NEW ENGL J MED, V353, P2733, DOI 10.1056/NEJMp058249; Bach PB, 2005, J CLIN ONCOL, V23, P9041, DOI 10.1200/JCO.2005.03.6111; Bach PB, 2007, J CLIN ONCOL, V25, P187, DOI 10.1200/JCO.2006.08.6116; Berenson Alex, 2006, N Y Times Web, pC2; Berenson Robert A., 2006, MEDICARE PROSPECTIVE; Bowman J, 2006, HEALTH AFFAIR, V25, P1240, DOI 10.1377/hlthaff.25.5.1240; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; *CTR MED MED SERV, 2007, PROP DEC MEM ER STIM; Culliton BJ, 2008, HEALTH AFFAIR, V27, pW41, DOI 10.1377/hlthaff.27.1.w41; *DEP HHS, 2004, MED REIMB LUPR; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; FLAHERTY T, 2007, HME NEWS        0625; Garber AM, 2007, NEW ENGL J MED, V357, P1575, DOI 10.1056/NEJMp078204; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; *HOUS REPR, 2008, MED COMP BIDD MED EQ; Jacobson M, 2006, HEALTH AFFAIR, V25, P437, DOI 10.1377/hlthaff.25.2.437; Kanavos P, 2003, HEALTH AFFAIR, V22, P16, DOI 10.1377/hlthaff.22.3.16; Lee TH, 2008, NEW ENGL J MED, V359, P333, DOI 10.1056/NEJMp0804261; LICHTENBERG FR, 2004, EXPANDING PHARM ARSE; LOHR KN, 1986, MED CARE, V24, pUS1; Meropol NJ, 2007, J CLIN ONCOL, V25, P180, DOI 10.1200/JCO.2006.09.6081; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; RUSSELL LB, 1989, NEW ENGL J MED, V320, P439, DOI 10.1056/NEJM198902163200706; Schneeweiss S, 2002, J AM GERIATR SOC, V50, P521, DOI 10.1046/j.1532-5415.2002.50120.x; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Schrag D, 2004, NEW ENGL J MED, V351, P317, DOI 10.1056/NEJMp048143; Schrag D, 2007, J CLIN ONCOL, V25, P233, DOI 10.1200/JCO.2006.09.2437; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; Weight CJ, 2008, CANCER-AM CANCER SOC, V112, P2195, DOI 10.1002/cncr.23421; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572; WITTES RE, 2004, WASHINGTON POST 0615, pA23	34	295	299	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					626	633		10.1056/NEJMhpr0807774	http://dx.doi.org/10.1056/NEJMhpr0807774			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402QS	19176475				2022-12-01	WOS:000263028800012
J	Bannard, O; Kraman, M; Fearon, DT				Bannard, Oliver; Kraman, Matthew; Fearon, Douglas T.			Secondary Replicative Function of CD8(+) T Cells That Had Developed an Effector Phenotype	SCIENCE			English	Article							MEMORY; DIFFERENTIATION; LYMPHOCYTES; EXPRESSION	Models of the differentiation of memory CD8+ T cells that replicate during secondary infections differ over whether such cells had acquired effector function during primary infections. We created a transgenic mouse line that permits mapping of the fate of granzyme B (gzmB)- expressing CD8(+) T cells and their progeny by indelibly marking them with enhanced yellow fluorescent protein ( EYFP). Virus- specific CD8(+) T cells express gzmB within the first 2 days of a primary response to infection with influenza, without impairment of continued primary clonal expansion. On secondary infection, virus- specific CD8(+) T cells that became EYFP+ during a primary infection clonally expand as well as all virus- specific CD8(+) T cells. Thus, CD8(+) T cells that have acquired an effector phenotype during primary infection may function as memory cells with replicative function.	[Bannard, Oliver; Kraman, Matthew; Fearon, Douglas T.] Univ Cambridge, Ctr Mrc, Wellcome Trust Immunol Unit, Dept Med, Cambridge CB2 2QH, England	University of Cambridge	Fearon, DT (corresponding author), Univ Cambridge, Ctr Mrc, Wellcome Trust Immunol Unit, Dept Med, Hills Rd, Cambridge CB2 2QH, England.	dtf1000@cam.ac.uk		Kraman, Matthew/0000-0002-5040-0067	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank D. Winton for ROSA26EYFP mice, B. Crombrugghe for the CreER<SUP>12</SUP> construct, G. Eberl for the recombineering shuttle vector, and P. Digard and E. Hutchinson for help with viruses. This work was funded by the Wellcome Trust.	Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; HANSON RD, 1991, J BIOL CHEM, V266, P24433; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jenkins MR, 2008, J IMMUNOL, V181, P3818, DOI 10.4049/jimmunol.181.6.3818; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	13	125	127	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					505	509		10.1126/science.1166831	http://dx.doi.org/10.1126/science.1166831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164749	Green Accepted			2022-12-01	WOS:000262587900043
J	Cameron, A; Ewen, M; Ross-Degnan, D; Ball, D; Laing, R				Cameron, A.; Ewen, M.; Ross-Degnan, D.; Ball, D.; Laing, R.			Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis	LANCET			English	Article							DRUGS	Background WHO and Health Action International (HAI) have developed a standardised method for surveying medicine prices, availability, affordability, and price components in low-income and middle-income countries. Here, we present a secondary analysis of medicine availability in 45 national and subnational surveys done using the WHO/HAI methodology. Methods Data from 45 WHO/HAI surveys in 36 countries were adjusted for inflation or deflation and purchasing power parity. international reference prices from open international procurements for generic products were used as comparators. Results are presented for 15 medicines included in at least 80% of surveys and four individual medicines. Findings Average public sector availability of generic medicines ranged from 29.4% to 54.4% across WHO regions. Median government procurement prices for 15 generic medicines were 1.11 times corresponding international reference prices, although purchasing efficiency ranged from 0 . 09 to 5 . 37 times international reference prices. Low procurement prices did not always translate into low patient prices. Private sector patients paid 9-25 times international reference prices for lowest-priced generic products and over 20 times international reference prices for originator products across WHO regions. Treatments for acute and chronic illness were largely unaffordable in many countries. In the private sector, wholesale mark-ups ranged from 2% to 380%, whereas retail mark-ups ranged from 10% to 552%. In countries where value added tax was applied to medicines, the amount charged varied from 4% to 15%. Interpretation Overall, public and private sector prices for originator and generic medicines were substantially higher than would be expected if purchasing and distribution were efficient and mark-ups were reasonable. Policy options such as promoting generic medicines and alternative financing mechanisms are needed to increase availability reduce prices, and improve affordability. Funding None.	[Cameron, A.; Laing, R.] WHO, CH-1211 Geneva 27, Switzerland; [Ewen, M.] Hlth Act Int, Amsterdam, Netherlands; [Ross-Degnan, D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ross-Degnan, D.] Harvard Pilgrim Hlth Care, Boston, MA USA	World Health Organization; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Cameron, A (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	camerona@who.int			Ministry of Foreign Affairs, the Netherlands; The Rockefeller Foundation; Swedish International Development Cooperation Agency; Department for International Development, UK; European Union DG Development; Open Society Institute; Finnish International Development Agency	Ministry of Foreign Affairs, the Netherlands; The Rockefeller Foundation; Swedish International Development Cooperation Agency; Department for International Development, UK; European Union DG Development(European Commission); Open Society Institute; Finnish International Development Agency	We thank Jean-Marc Guimier, Edson Meza, and Peter Stephens for providing information and data used in the paper, and Kirsten Myhr for providing input into an early draft. We also thank the country teams who undertook surveys of medicine prices and availability, as well as the consultants who provided technical support for data collection, analysis, and interpretation. We also appreciate the support of the WHO Regional Office for Africa and the WHO Department of Technical Cooperation for Essential Drugs and Traditional Medicine for surveys done in Africa. Financial support for the WHO/HAI Project on Medicine Prices and Availability has been provided by: Ministry of Foreign Affairs, the Netherlands; The Rockefeller Foundation; Swedish International Development Cooperation Agency; Department for International Development, UK; European Union DG Development; Open Society Institute; and Finnish International Development Agency.	ANDERSSON F, 1993, PHARMACOECONOMICS, V4, P247, DOI 10.2165/00019053-199304040-00003; [Anonymous], 2004, WORLD MED SIT; Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; BALA K, 1998, HAINEWS          APR, V100, P2; BALA K, 1998, HAINEWS          APR, V100, P13; BALA K, 2000, HAINEWS          APR, V112, P1; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Danzon PM, 1998, PHARMACOECONOMICS, V14, P115, DOI 10.2165/00019053-199814001-00014; Gelders S, 2006, PRICE AVAILABILITY A; *HLTH ACT INT, 2007, HLTH ACT INT MED PRI; *HLTH ACT INT, 2006, COMP PRIC DAT DIFF S; *INT FED PHARM MAN, ACC ACC IN AAI; International Monetary Fund, 2007, WORLD EC OUTL DAT; Laing R., 2005, PHARM TARIFFS WHAT I; MADDEN J, 2003, ESSENTIAL DRUGS MONI, V33, P19; Management Sciences for Health, INT DRUG PRIC IND GU, V2014; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; MYHR K, COMP PRICES ESSENTIA; *NOV, COART AFR GAIN MOM G; *NOV NORD, SUST REP 2003 WHAT D; Organisation for Economic Co-operation and Development, DRUG SPEND OECD COUN; Ridley DB, 2005, PHARMACOECONOMICS, V23, P651, DOI 10.2165/00019053-200523070-00002; SAGOO K, 2000, HAINEWS          DEC, V110, P1; Vasan A, 2006, B WORLD HEALTH ORGAN, V84, P393, DOI 10.2471/BLT.05.025684; *WHO, 1997, PUBL PRIV ROL PHARM; *WHO, 2001, 54 WORLD HLTH ASS GE, V1; *WHO, 2007, REP REG COMM E MED 5; WHO, 2004, WORLD HLTH REP 2004, P126; *WHO HLTH ACT INT, 2003, MED PRIC NE IN PRESS; *WHO HLTH ACT INT, 2008, SYR AR REP MED PRIC; *WORLD BANK, 2007, COUNTR CLASS; World Health Organization, 2004, EQ ACC ESS MED FRAM; World Health Organization and Health Action International, MEAS MED PRIC AV AFF	33	484	500	6	75	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					240	249		10.1016/S0140-6736(08)61762-6	http://dx.doi.org/10.1016/S0140-6736(08)61762-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QB	19042012				2022-12-01	WOS:000262537500027
J	de Ruijter, W; Westendorp, RGJ; Assendelft, WJJ; den Elzen, WPJ; de Craen, AJM; le Cessie, S; Gussekloo, J				de Ruijter, Wouter; Westendorp, Rudi G. J.; Assendelft, Willem J. J.; den Elzen, Wendy P. J.; de Craen, Anton J. M.; le Cessie, Saskia; Gussekloo, Jacobijn			Use of Framinghamrisk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; RISK-FACTORS; INFLAMMATORY MARKERS; PLASMA HOMOCYSTEINE; NATRIURETIC PEPTIDE; MULTIPLE BIOMARKERS; PRIMARY PREVENTION	Objectives To investigate the performance of classic risk factors, and of some new biomarkers, in predicting cardiovascular mortality in very old people from the general population with no history of cardiovascular disease. Design The Leiden 85-plus Study (1997-2004) is an observational prospective cohort study with 5 years of follow-up. Setting General population of the city of Leiden, the Netherlands. Participants Population based sample of participants aged 85 years (215 women and 87 men) with no history of cardiovascular disease; no other exclusion criteria. Main measurements Cause specific mortality was registered during follow-up. All classic risk factors included in the Framingham risk score (sex, systolic blood pressure, total and high density lipoprotein cholesterol, diabetes mellitus, smoking and electrocardiogram based left ventricular hypertrophy), as well as plasma concentrations of the new biomarkers homocysteine, folic acid, C reactive protein, and interleukin 6, were assessed at baseline. Results During follow-up, 108 of the 302 participants died; 32% (35/108) of deaths were from cardiovascular causes. Classic risk factors did not predict cardiovascular mortality when used in the Framingham risk score (area under receiver operating characteristic curve 0.53, 95% confidence interval 0.42 to 0.63) or in a newly calibrated model (0.53, 0.43 to 0.64). Of the new biomarkers studied, homocysteine had most predictive power (0.65, 0.55 to 0.75). Entering any additional risk factor or combination of factors into the homocysteine prediction model did not increase its discriminative power. Conclusions In very old people from the general population with no history of cardiovascular disease, concentrations of homocysteine alone can accurately identify those at high risk of cardiovascular mortality, whereas classic risk factors included in the Framingham risk score do not. These preliminary findings warrant validation in a separate cohort.	[Assendelft, Willem J. J.; den Elzen, Wendy P. J.; Gussekloo, Jacobijn] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, NL-2300 RA Leiden, Netherlands; [Westendorp, Rudi G. J.; de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriat, NL-2300 RA Leiden, Netherlands; [le Cessie, Saskia] Leiden Univ, Dept Med Stat, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	de Ruijter, W (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, PO Box 9600, NL-2300 RA Leiden, Netherlands.	w.de_ruijter@lumc.nl	assendelft, willem/AAW-1854-2021; de Ruijter, Wouter/GRF-3867-2022; Assendelft, W.J.J./H-8008-2014; Gussekloo, Jacobijn/ABE-3879-2021	assendelft, willem/0000-0002-2966-3778; Assendelft, W.J.J./0000-0002-2966-3778; Gussekloo, Jacobijn/0000-0001-7186-8278; den Elzen, Wendy/0000-0002-6774-4077; le Cessie, Saskia/0000-0003-2154-4923	Dutch Ministry of Health, Welfare and Sports	Dutch Ministry of Health, Welfare and Sports	The Leiden 85-plus Study was partly funded by an unrestricted grant from the Dutch Ministry of Health, Welfare and Sports. The funder played no role in study design, collection, analysis and interpretation of data, writing of the report, nor in the decision to submit the article for publication. Independence of researchers: All researchers were independent from the funder.	Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; Afilalo J, 2008, J AM COLL CARDIOL, V51, P37, DOI 10.1016/j.jacc.2007.06.063; Ali Robin, 2007, Am J Geriatr Pharmacother, V5, P52, DOI 10.1016/j.amjopharm.2007.03.008; Ammar KA, 2004, AM HEART J, V148, P277, DOI 10.1016/j.ahj.2004.03.019; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Andrawes WF, 2005, DRUG AGING, V22, P859, DOI 10.2165/00002512-200522100-00005; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; BEMMEL T, 2006, J HYPERTENS, V24, P287; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Boshuizen HC, 1998, BMJ-BRIT MED J, V316, P1780, DOI 10.1136/bmj.316.7147.1780; Bots ML, 1999, ARCH INTERN MED, V159, P38, DOI 10.1001/archinte.159.1.38; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Chobanian AV, 2007, NEW ENGL J MED, V357, P789, DOI 10.1056/NEJMcp071137; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; De Ruijter W, 2008, SCAND J PRIM HEALTH, V26, P147, DOI 10.1080/02813430802095812; de Ruijter W, 2007, J AM GERIATR SOC, V55, P872, DOI 10.1111/j.1532-5415.2007.01180.x; Dornbrook-Lavender KA, 2003, ANN PHARMACOTHER, V37, P1654, DOI 10.1345/aph.1D025; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; KAGAN A, 1962, FED PROC, V21, P52; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kannel William B., 1995, Am J Geriatr Cardiol, V4, P10; Kannel WB, 2006, AM J GERIATR CARDIOL, V15, P382, DOI 10.1111/j.1076-7460.2006.04397.x; Kannel William B, 2002, Am J Geriatr Cardiol, V11, P101, DOI 10.1111/j.1076-7460.2002.00995.x; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Kritchevsky SB, 2005, CARDIOVASC RES, V66, P265, DOI 10.1016/j.cardiores.2004.12.026; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; MCCULLY KS, 1969, AM J PATHOL, V56, P111; McDermott MM, 2007, JAMA-J AM MED ASSOC, V297, P1253, DOI 10.1001/jama.297.11.1253; MULROW CD, 1994, JAMA-J AM MED ASSOC, V272, P1932, DOI 10.1001/jama.272.24.1932; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Oates DJ, 2007, J AM GERIATR SOC, V55, P383, DOI 10.1111/j.1532-5415.2007.01069.x; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PRINEAS RJ, 1982, MINNESOTA CODE MAN; Raggi P, 2008, J AM COLL CARDIOL, V52, P17, DOI 10.1016/j.jacc.2008.04.004; Rastas S, 2006, J AM GERIATR SOC, V54, P912, DOI 10.1111/j.1532-5415.2006.00742.x; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rothenbacher D, 2006, ARCH INTERN MED, V166, P2455, DOI 10.1001/archinte.166.22.2455; Sattar N, 2006, CIRCULATION, V114, P143; Schmitt J, 2005, EUR CARDIOL REV, DOI 10.15420/ecr.2005.1w; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Strandberg TE, 2000, ARTERIOSCL THROM VAS, V20, P1057, DOI 10.1161/01.ATV.20.4.1057; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; van der Steeg WA, 2007, ANN INTERN MED, V146, P640, DOI 10.7326/0003-4819-146-9-200705010-00007; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; *WHO, 2006, INT CLASS DIS; Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	64	236	240	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2009	338								a3083	10.1136/bmj.a3083	http://dx.doi.org/10.1136/bmj.a3083			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AA	19131384	Green Published, hybrid			2022-12-01	WOS:000263193100021
J	Saksena, S; Wahlman, J; Teis, D; Johnson, AE; Emr, SD				Saksena, Suraj; Wahlman, Judit; Teis, David; Johnson, Arthur E.; Emr, Scott D.			Functional Reconstitution of ESCRT-III Assembly and Disassembly	CELL			English	Article							STRUCTURAL BASIS; VPS4; RECOGNITION; FILAMENTS; PROTEINS; DOMAIN	Receptor downregulation in the MVB pathway is mediated by the ESCRT complexes. ESCRT-III is composed of four protein subunits that are monomeric in the cytosol and oligomerize into a protein lattice only upon membrane binding. Recent studies have shown that the ESCRT-III protein Snf7 can form a filament by undergoing homo-oligomerization. To examine the role of membrane binding and of interactions with other ESCRT components in initiating Snf7 oligomerization, we used fluorescence spectroscopy to directly detect and characterize the assembly of the Snf7 oligomer on liposomes using purified ESCRT components. The observed fluorescence changes reveal an obligatory sequence of membrane-protein and protein-protein interactions that generate the active conformation of Snf7. Also, we demonstrate that ESCRT-III assembly drives membrane deformation. Furthermore, usingan in vitro disassembly assay, we directly demonstrate that Vps24 and Vps2 function as adaptors in the ATP-dependent membrane disassembly of the ESCRT-III complex by recruiting the AAA ATPase Vps4.	[Wahlman, Judit; Johnson, Arthur E.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Saksena, Suraj; Teis, David; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Saksena, Suraj; Teis, David; Emr, Scott D.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Cornell University; Cornell University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Johnson, AE (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	ajohnson@medicine.tamhsc.edu; sde26@cornell.edu	Johnson, Arthur E/G-3457-2012	Teis, David/0000-0002-8181-0253	American Heart Association (AHA) [0826060D]; HFSP [LT00634/2006-L]; National Institutes of Health [GM26494]; Robert A. Welch Foundation [BE-0017]; Weill Institute for Cell and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007273, R01GM026494] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); HFSP(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Weill Institute for Cell and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Y. Miao, Y. Shao, and S. Weys for technical assistance; B. Judson for EM expertise; and E. V. MacGurn for assistance with graphics. S.S. and D.T. were supported by fellowships from American Heart Association (AHA 0826060D) and HFSP (LT00634/2006-L), respectively. This work was supported by National Institutes of Health grant GM26494 and the Robert A. Welch Foundation (Chair Grant BE-0017) (A.E.J.) and funds from the Weill Institute for Cell and Molecular Biology (S.D.E.).	Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	13	216	216	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					97	109		10.1016/j.cell.2008.11.013	http://dx.doi.org/10.1016/j.cell.2008.11.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135892	Green Accepted, Bronze			2022-12-01	WOS:000262318400018
J	Turanov, AA; Lobanov, AV; Fomenko, DE; Morrison, HG; Sogin, ML; Klobutcher, LA; Hatfield, DL; Gladyshev, VN				Turanov, Anton A.; Lobanov, Alexey V.; Fomenko, Dmitri E.; Morrison, Hilary G.; Sogin, Mitchell L.; Klobutcher, Lawrence A.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Genetic Code Supports Targeted Insertion of Two Amino Acids by One Codon	SCIENCE			English	Article							SEQUENCE ELEMENT; TRANSFER-RNA; EXPRESSION	Strict one- to- one correspondence between codons and amino acids is thought to be an essential feature of the genetic code. However, we report that one codon can code for two different amino acids with the choice of the inserted amino acid determined by a specific 3 ' untranslated region structure and location of the dual- function codon within the messenger RNA ( mRNA). We found that the codon UGA specifies insertion of selenocysteine and cysteine in the ciliate Euplotes crassus, that the dual use of this codon can occur even within the same gene, and that the structural arrangements of Euplotes mRNA preserve location- dependent dual function of UGA when expressed in mammalian cells. Thus, the genetic code supports the use of one codon to code for multiple amino acids.	[Turanov, Anton A.; Lobanov, Alexey V.; Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Turanov, Anton A.; Lobanov, Alexey V.; Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Morrison, Hilary G.; Sogin, Mitchell L.] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA; [Klobutcher, Lawrence A.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06032 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Marine Biological Laboratory - Woods Hole; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Sogin, Mitchell/AAE-7186-2019; Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Klobutcher, Lawrence/0000-0001-9485-3482; Morrison, Hilary/0000-0003-0281-326X; Gladyshev, Vadim/0000-0002-0372-7016	NIH [GM061603, GM065204, AI058054]; NSF [0343813]; Intramural Research Program; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM061603, R01GM065204] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Intramural Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Hammar for constructing the EST library and I. Sorokina (Midwest Bio Services) for protein sequencing. This work was supported by NIH GM061603 and GM065204 to V.N.G., AI058054 to M.L.S., NSF 0343813 to L.A.K., and the Intramural Research Program, National Cancer Institute, NIH, to D.L.H. Sequences for tRNA and selenoprotein genes have been deposited in the GenBank database under accession numbers FJ440148 to FJ440159.	Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Atkins JF, 2007, NATURE, V448, P1004, DOI 10.1038/4481004a; Berry MJ, 2002, METHOD ENZYMOL, V347, P17; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; MEYER F, 1991, P NATL ACAD SCI USA, V88, P3758, DOI 10.1073/pnas.88.9.3758; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Suzuki T, 1997, EMBO J, V16, P1122, DOI 10.1093/emboj/16.5.1122	10	83	93	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					259	261		10.1126/science.1164748	http://dx.doi.org/10.1126/science.1164748			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131629	Green Submitted, Green Accepted			2022-12-01	WOS:000262290600040
J	Vasconcelos, C; McKenzie, JA				Vasconcelos, Crisogono; McKenzie, Judith A.			GEOCHEMISTRY The Descent of Minerals	SCIENCE			English	Editorial Material							MICROBIAL MATS		[Vasconcelos, Crisogono; McKenzie, Judith A.] ETH, Inst Geol, Geomicrobiol Lab, CH-8092 Zurich, Switzerland	ETH Zurich	Vasconcelos, C (corresponding author), ETH, Inst Geol, Geomicrobiol Lab, CH-8092 Zurich, Switzerland.	cris.vasconcelos@erdw.ethz.ch						Hazen RM, 2008, AM MINERAL, V93, P1693, DOI 10.2138/am.2008.2955; Konhauser KO, 2005, GEOBIOLOGY, V3, P167, DOI 10.1111/j.1472-4669.2005.00055.x; SEMIKHATOV MA, 1979, CAN J EARTH SCI, V16, P992, DOI 10.1139/e79-088; Vasconcelos C, 2006, SEDIMENT GEOL, V185, P175, DOI 10.1016/j.sedgeo.2005.12.022; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016	5	6	6	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					218	219		10.1126/science.1168807	http://dx.doi.org/10.1126/science.1168807			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131619				2022-12-01	WOS:000262290600025
J	Boztug, K; Appaswamy, G; Ashikov, A; Schaffer, AA; Salzer, U; Diestelhorst, J; Germeshausen, M; Brandes, G; Lee-Gossler, J; Noyan, F; Gatzke, AK; Minkov, M; Greil, J; Kratz, C; Petropoulou, T; Pellier, I; Bellanne-Chantelot, C; Rezaei, N; Monkemoller, K; Irani-Hakimeh, N; Bakker, H; Gerardy-Schahn, R; Zeidler, C; Grimbacher, B; Welte, K; Klein, C				Boztug, Kaan; Appaswamy, Giridharan; Ashikov, Angel; Schaffer, Alejandro A.; Salzer, Ulrich; Diestelhorst, Jana; Germeshausen, Manuela; Brandes, Gudrun; Lee-Gossler, Jacqueline; Noyan, Fatih; Gatzke, Anna-Katherina; Minkov, Milen; Greil, Johann; Kratz, Christian; Petropoulou, Theoni; Pellier, Isabelle; Bellanne-Chantelot, Christine; Rezaei, Nima; Moenkemoeller, Kirsten; Irani-Hakimeh, Noha; Bakker, Hans; Gerardy-Schahn, Rita; Zeidler, Cornelia; Grimbacher, Bodo; Welte, Karl; Klein, Christoph			A Syndrome with Congenital Neutropenia and Mutations in G6PC3	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNFOLDED PROTEIN RESPONSE; GLYCOGEN-STORAGE-DISEASE; SUBUNIT-RELATED PROTEIN; GLUCOSE-LEVELS; GENE; ELASTASE; APOPTOSIS; MCL-1; IDENTIFICATION; DEFICIENCY	Background The main features of severe congenital neutropenia are the onset of severe bacterial infections early in life, a paucity of mature neutrophils, and an increased risk of leukemia. In many patients, the genetic causes of severe congenital neutropenia are unknown. Methods We performed genomewide genotyping and linkage analysis on two consanguineous pedigrees with a total of five children affected with severe congenital neutropenia. Candidate genes from the linkage interval were sequenced. Functional assays and reconstitution experiments were carried out. Results All index patients were susceptible to bacterial infections and had very few mature neutrophils in the bone marrow; structural heart defects, urogenital abnormalities, and venous angiectasia on the trunk and extremities were additional features. Linkage analysis of the two index families yielded a combined multipoint lod score of 5.74 on a linkage interval on chromosome 17q21. Sequencing of G6PC3, the candidate gene encoding glucose- 6- phosphatase, catalytic subunit 3, revealed a homozygous missense mutation in exon 6 that abolished the enzymatic activity of glucose- 6- phosphatase in all affected children in the two families. The patients' neutrophils and fibroblasts had increased susceptibility to apoptosis. The myeloid cells showed evidence of increased endoplasmic reticulum stress and increased activity of glycogen synthase kinase 3 beta (GSK-3 beta). We identified seven additional, unrelated patients who had severe congenital neutropenia with syndromic features and distinct biallelic mutations in G6PC3. Conclusions Defective function of glucose- 6- phosphatase, catalytic subunit 3, underlies a severe congenital neutropenia syndrome associated with cardiac and urogenital malformations.	[Boztug, Kaan; Appaswamy, Giridharan; Ashikov, Angel; Diestelhorst, Jana; Germeshausen, Manuela; Brandes, Gudrun; Lee-Gossler, Jacqueline; Noyan, Fatih; Gatzke, Anna-Katherina; Bakker, Hans; Gerardy-Schahn, Rita; Zeidler, Cornelia; Welte, Karl; Klein, Christoph] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-30625 Hannover, Germany; [Schaffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Salzer, Ulrich] Univ Med Ctr Freiburg, Freiburg, Germany; [Minkov, Milen] St Anna Childrens Hosp, A-1090 Vienna, Austria; [Greil, Johann] Univ Heidelberg, Childrens Hosp, D-6900 Heidelberg, Germany; [Kratz, Christian] Univ Freiburg, Freiburg, Germany; [Petropoulou, Theoni] Univ Athens, Aghia Sophia Childrens Hosp, Athens, Greece; [Pellier, Isabelle] CHU Angers, Angers, France; [Bellanne-Chantelot, Christine] Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Paris, France; [Rezaei, Nima] Univ Tehran Med Sci, Immunol Asthma & Allergy Res Inst, Tehran, Iran; [Moenkemoeller, Kirsten] Childrens Hosp Amsterdamer Str, Cologne, Germany; [Irani-Hakimeh, Noha] St Georges Univ Hosp, Beirut, Lebanon; [Grimbacher, Bodo] Royal Free & Univ Coll Med Sch, London WC1E 6BT, England	Hannover Medical School; National Institutes of Health (NIH) - USA; University of Freiburg; Saint Anna Children's Hospital; Ruprecht Karls University Heidelberg; University of Freiburg; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Immunology Asthma & Allergy Research Institute - Iran; Tehran University of Medical Sciences; University of Cologne; University of London; University College London	Klein, C (corresponding author), Hannover Med Sch, Dept Pediat Hematol & Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	klein.christoph@mh-hannover.de	Rezaei, Nima/B-4245-2008; Boztug, Kaan/AAM-4161-2021; isabelle, pellier/L-5683-2015; Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019; Kratz, Christian/AAC-9726-2021; Bakker, Hans/AAA-1623-2020; Noyan, Fatih/B-9449-2018; Ashikov, Angel/N-7714-2015; Bakker, Hans/A-1787-2017	Rezaei, Nima/0000-0002-3836-1827; Boztug, Kaan/0000-0001-8387-9185; Bakker, Hans/0000-0002-1364-9154; Ashikov, Angel/0000-0001-9679-7955; Bakker, Hans/0000-0002-1364-9154; Minkov, Milen/0000-0001-6471-8423; Salzer, Ulrich/0000-0002-1769-1157	Deutsche Forschungsgemeinschaft [KliFo 110-2]; Junior Research Group "Glycomics"; Bundesministerium fur Bildung und Forschung Bone Marrow Failure Syndromes; European Union [MEXT-CT-2006-042316]; Intramural Research Program of the National Institutes of Health; National Library of Medicine; Else Kroner Memorial Fellowship; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Junior Research Group "Glycomics"; Bundesministerium fur Bildung und Forschung Bone Marrow Failure Syndromes(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Else Kroner Memorial Fellowship; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Supported by grants from the Deutsche Forschungsgemeinschaft (DFG KliFo 110-2, to Dr. Klein), the Junior Research Group "Glycomics" (to Dr. Gerardy-Schahn), the Bundesministerium fur Bildung und Forschung Bone Marrow Failure Syndromes (to Drs. Welte and Klein), and the European Union (MEXT-CT-2006-042316, to Dr. Grimbacher); and by the Intramural Research Program of the National Institutes of Health, National Library of Medicine (for Dr. Schaffer). Dr. Boztug is a recipient of an Else Kroner Memorial Fellowship. Drs. Klein and Gerardy-Schahn are members of REBIRTH, a Deutsche Forschungsgemeinschaft Cluster of Excellence.; Dr. Welte reports owning equity in Amgen and receiving royalties on a patent for rhG-CSF. No other potential conflict of interest relevant to this article was reported.; We thank the patients and their families for supporting our study; all colleagues referring and registering patients at the Severe Chronic Neutropenia International Registry; Francois-Loic Cosset for the kind gift of the RD114 plasmid; Edelgard Odenwald for analysis of bone marrow smears; Thomas Jack for his help with echocardiography; Jessica Pfannstiel, Maren Sievers, Marie Bohm, Marly Dalton, Martina Wackerhahn, Tanja Reinke, and Gwendoline Leroy for technical assistance; and Dr. Jean Donadieu at the Pediatric Hematology Oncology Service, Hopital Trousseau, Paris, and Dr. Roula Farah at the Department of Pediatrics, Saint Georges Hospital, Balamand University, Beirut, Lebanon, for excellent collaboration.	Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; BEAUDET AL, 1980, J PEDIATR-US, V97, P906, DOI 10.1016/S0022-3476(80)80418-5; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; BONILLA MA, 1989, NEW ENGL J MED, V320, P1574, DOI 10.1056/NEJM198906153202402; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Boxer LA, 2007, PEDIATR BLOOD CANCER, V49, P609, DOI 10.1002/pbc.21282; Boztug K, 2008, IMMUNOL ALLERGY CLIN, V28, P259, DOI 10.1016/j.iac.2008.01.007; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Carlsson G, 2004, BLOOD, V103, P3355, DOI 10.1182/blood-2003-04-1011; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Cheung YY, 2007, J CLIN INVEST, V117, P784, DOI 10.1172/JCI30443; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Fishelson M, 2004, J COMPUT BIOL, V11, P263, DOI 10.1089/1066527041410409; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Glembotski CC, 2008, J MOL CELL CARDIOL, V44, P453, DOI 10.1016/j.yjmcc.2007.10.017; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Guionie O, 2003, FEBS LETT, V551, P159, DOI 10.1016/S0014-5793(03)00903-7; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; KOSTMANN R, 1950, SVENSKA LAKARTIDNING, V47, P2861; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Martin CC, 2002, J MOL ENDOCRINOL, V29, P205, DOI 10.1677/jme.0.0290205; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Melis D, 2005, EUR J PEDIATR, V164, P501, DOI 10.1007/s00431-005-1657-4; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Petrolonis AJ, 2004, J BIOL CHEM, V279, P13976, DOI 10.1074/jbc.M307756200; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosenberg PS, 2006, BLOOD, V107, P4628, DOI 10.1182/blood-2005-11-4370; Schaffer AA, 2007, CURR OPIN ALLERGY CL, V7, P481, DOI 10.1097/ACI.0b013e3282f1d690; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Wang YD, 2006, J BIOL CHEM, V281, P39982, DOI 10.1074/jbc.M605858200; Welte K, 2006, SEMIN HEMATOL, V43, P189, DOI 10.1053/j.seminhematol.2006.04.004; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	47	249	251	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					32	43		10.1056/NEJMoa0805051	http://dx.doi.org/10.1056/NEJMoa0805051			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118303	Green Accepted, Bronze			2022-12-01	WOS:000262096800005
J	Goodman, AA; Rosolowsky, EW; Borkin, MA; Foster, JB; Halle, M; Kauffmann, J; Pineda, JE				Goodman, Alyssa A.; Rosolowsky, Erik W.; Borkin, Michelle A.; Foster, Jonathan B.; Halle, Michael; Kauffmann, Jens; Pineda, Jaime E.			A role for self-gravity at multiple length scales in the process of star formation	NATURE			English	Article							TURBULENCE; CLOUDS	Self-gravity plays a decisive role in the final stages of star formation, where dense cores (size similar to 0.1 parsecs) inside molecular clouds collapse to form star- plus- disk systems(1). But self- gravity's role at earlier times ( and on larger length scales, such as similar to 1 parsec) is unclear; some molecular cloud simulations that do not include self- gravity suggest that 'turbulent fragmentation' alone is sufficient to create a mass distribution of dense cores that resembles, and sets, the stellar initial mass function(2). Here we report a 'dendrogram' (hierarchical tree- diagram) analysis that reveals that self- gravity plays a significant role over the full range of possible scales traced by (CO)-C-13 observations in the L1448 molecular cloud, but not everywhere in the observed region. In particular, more than 90 per cent of the compact 'pre- stellar cores' traced by peaks of dust emission(3) are projected on the sky within one of the dendrogram's self- gravitating 'leaves'. As these peaks mark the locations of already- forming stars, or of those probably about to form, a self- gravitating cocoon seems a critical condition for their existence. Turbulent fragmentation simulations without self- gravity even of unmagnetized isothermal material - can yield mass and velocity power spectra very similar to what is observed in clouds like L1448. But a dendrogram of such a simulation(4) shows that nearly all the gas in it ( much more than in the observations) appears to be self- gravitating. A potentially significant role for gravity in ` non- self- gravitating' simulations suggests inconsistency in simulation assumptions and output, and that it is necessary to include self- gravity in any realistic simulation of the star- formation process on subparsec scales.	[Goodman, Alyssa A.; Borkin, Michelle A.; Halle, Michael; Kauffmann, Jens] Harvard Univ, Initiat Innovat Comp, Cambridge, MA 02138 USA; [Goodman, Alyssa A.; Rosolowsky, Erik W.; Foster, Jonathan B.; Kauffmann, Jens; Pineda, Jaime E.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Rosolowsky, Erik W.] Univ British Columbia, Dept Phys, Kelowna, BC V1V 1V7, Canada; [Halle, Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Surg Planning Lab, Boston, MA 02115 USA; [Halle, Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of British Columbia; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Goodman, AA (corresponding author), Harvard Univ, Initiat Innovat Comp, Cambridge, MA 02138 USA.	agoodman@cfa.harvard.edu	Rosolowsky, Erik/ABI-3078-2020; Goodman, Alyssa A/A-6007-2010; Pineda, Jaime/AAX-3157-2021; Pineda, Jaime/J-7405-2013	Goodman, Alyssa A/0000-0003-1312-0477; Pineda, Jaime/0000-0002-3972-1978; Pineda, Jaime/0000-0002-3972-1978; Kauffmann, Jens/0000-0002-5094-6393; Borkin, Michelle/0000-0002-8016-355X	National Institutes of Health [U54-EB005149]; National Science Foundation [AST-0502605]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank A. Munshi for putting us in touch with M. Thomas and colleagues at Right Hemisphere, whose software and assistance enabled the interactive PDF in this paper; P. Padoan for providing the simulated data cube; R. Shetty for comments on the paper; F. Shu for suggesting we extend our analysis to measure boundedness of p-p-v 'bound' objects in p-p-p space using simulations; and S. Hyman, Provost of Harvard University, for supporting the start- up of the Initiative in Innovative Computing at Harvard, which substantially enabled the creation of this work. 3D Slicer is developed by the National Alliance for Medical Image Computing and funded by the National Institutes of Health grant U54-EB005149. The COMPLETE group is supported in part by the National Science Foundation. E.W.R. is supported by the NSF AST-0502605.	BERTOLDI F, 1992, ASTROPHYS J, V395, P140, DOI 10.1086/171638; di Francesco J., 2007, PROTOSTARS PLANETS, P17; Enoch ML, 2006, ASTROPHYS J, V638, P293, DOI 10.1086/498678; Foster JB, 2006, ASTROPHYS J, V636, pL105, DOI 10.1086/500131; GOODMAN A, 2008, ASTROPHYS J IN PRESS; Heine C, 2006, IEEE T VIS COMPUT GR, V12, P781, DOI 10.1109/TVCG.2006.196; HOULAHAN P, 1992, ASTROPHYS J, V393, P172, DOI 10.1086/171495; Jorgensen JK, 2008, ASTROPHYS J, V683, P822, DOI 10.1086/589956; KAUFFMANN G, 1993, MON NOT R ASTRON SOC, V261, P921, DOI 10.1093/mnras/261.4.921; KAUFFMANN J, ASTROPHYS J UNPUB; LARSON RB, 1981, MON NOT R ASTRON SOC, V194, P809, DOI 10.1093/mnras/194.4.809; Ostriker EC, 2001, ASTROPHYS J, V546, P980, DOI 10.1086/318290; Padoan P, 2002, ASTROPHYS J, V576, P870, DOI 10.1086/341790; Padoan P, 2006, ASTROPHYS J, V653, pL125, DOI 10.1086/510620; Pineda JE, 2008, ASTROPHYS J, V679, P481, DOI 10.1086/586883; Ridge NA, 2006, ASTRON J, V131, P2921, DOI 10.1086/503704; Rosolowsky EW, 2008, ASTROPHYS J, V679, P1338, DOI 10.1086/587685; Rosolowsky EW, 2008, ASTROPHYS J SUPPL S, V175, P509, DOI 10.1086/524299; STUTZKI J, 1990, ASTROPHYS J, V356, P513, DOI 10.1086/168859; Vliegen R, 2006, IEEE T VIS COMPUT GR, V12, P789, DOI 10.1109/TVCG.2006.200; WILLIAMS JP, 1994, ASTROPHYS J, V428, P693, DOI 10.1086/174279	21	102	103	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					63	66		10.1038/nature07609	http://dx.doi.org/10.1038/nature07609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122636	Green Accepted			2022-12-01	WOS:000262104900030
J	Marraffini, LA; Sontheimer, EJ				Marraffini, Luciano A.; Sontheimer, Erik J.			CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA	SCIENCE			English	Article							PROVIDES ACQUIRED-RESISTANCE; EPIDERMIDIS STRAIN; PLASMID; AUREUS; GENOME; IDENTIFICATION; PROKARYOTES; INFECTIONS; RNAS; REPLICATION	Horizontal gene transfer (HGT) in bacteria and archaea occurs through phage transduction, transformation, or conjugation, and the latter is particularly important for the spread of antibiotic resistance. Clustered, regularly interspaced, short palindromic repeat (CRISPR) loci confer sequence- directed immunity against phages. A clinical isolate of Staphylococcus epidermidis harbors a CRISPR spacer that matches the nickase gene present in nearly all staphylococcal conjugative plasmids. Here we show that CRISPR interference prevents conjugation and plasmid transformation in S. epidermidis. Insertion of a self- splicing intron into nickase blocks interference despite the reconstitution of the target sequence in the spliced mRNA, which indicates that the interference machinery targets DNA directly. We conclude that CRISPR loci counteract multiple routes of HGT and can limit the spread of antibiotic resistance in pathogenic bacteria.	[Marraffini, Luciano A.; Sontheimer, Erik J.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Sontheimer, EJ (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	erik@northwestern.edu		Sontheimer, Erik/0000-0002-0881-0310	The Jane Coffin Childs Memorial Fund for Medical Research; NIH [GM072830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072830] Funding Source: NIH RePORTER	The Jane Coffin Childs Memorial Fund for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to O. Schneewind (University of Chicago) for reagents and experimental assistance, B. Golden (Purdue University) for orf142-2 intron constructs and advice, and members of our laboratory for discussions and comments on the manuscript. Results described here are being used in support of a patent filing by Northwestern University. L.A.M. is a fellow of The Jane Coffin Childs Memorial Fund for Medical Research. This work was supported by a grant (GM072830) from NIH to E. J. S.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BYEON WH, 1984, J BACTERIOL, V158, P543, DOI 10.1128/JB.158.2.543-550.1984; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Climo MW, 1996, J BACTERIOL, V178, P4975, DOI 10.1128/jb.178.16.4975-4983.1996; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Furuya EY, 2006, NAT REV MICROBIOL, V4, P36, DOI 10.1038/nrmicro1325; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; GROS MF, 1987, EMBO J, V6, P3863, DOI 10.1002/j.1460-2075.1987.tb02724.x; GROS MF, 1989, EMBO J, V8, P2711, DOI 10.1002/j.1460-2075.1989.tb08412.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Landthaler M, 1999, P NATL ACAD SCI USA, V96, P7005, DOI 10.1073/pnas.96.12.7005; Lim SM, 2005, ANAESTHESIA, V60, P887, DOI 10.1111/j.1365-2044.2005.04220.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; MORTON TM, 1995, ANTIMICROB AGENTS CH, V39, P1272, DOI 10.1128/AAC.39.6.1272; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	28	1088	1282	22	359	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1843	1845		10.1126/science.1165771	http://dx.doi.org/10.1126/science.1165771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095942	Green Accepted			2022-12-01	WOS:000261799400054
J	Stotland, NE				Stotland, Naomi E.			Obesity and pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL WEIGHT-GAIN; BODY-MASS INDEX; CESAREAN DELIVERY; MATERNAL OBESITY; BARIATRIC SURGERY; VAGINAL BIRTH; FETAL; OUTCOMES; WOMEN; VISUALIZATION		[Stotland, Naomi E.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94110 USA	University of California System; University of California San Francisco	Stotland, NE (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 1001 Potrero Ave 6D-1, San Francisco, CA 94110 USA.	stotlandn@obgyn.ucsf.edu						Abodeely A, 2008, SURG OBES RELAT DIS, V4, P464, DOI 10.1016/j.soard.2007.08.018; American College of Obstetricians and Gynecologists (ACOG), 2005, OBSTET GYNECOL, V106, P671, DOI [10.1097/00006250-200509000-00054, DOI 10.1097/00006250-200509000-00054]; Artal R, 2007, APPL PHYSIOL NUTR ME, V32, P596, DOI 10.1139/H07-024; Boulvain M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000451.pub2; Carroll CS, 2003, AM J OBSTET GYNECOL, V188, P1516, DOI 10.1067/mob.2003.472; Catalano PM, 2007, OBSTET GYNECOL, V109, P419, DOI 10.1097/01.AOG.0000253311.44696.85; Chelmow D, 2004, OBSTET GYNECOL, V103, P974, DOI 10.1097/01.AOG.0000124807.76451.47; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Dietz PM, 2006, EPIDEMIOLOGY, V17, P170, DOI 10.1097/01.ede.0000198470.26932.9a; Durnwald CP, 2004, AM J OBSTET GYNECOL, V191, P954, DOI 10.1016/j.ajog.2004.05.051; Goffman D, 2007, J PERINATOL, V27, P597, DOI 10.1038/sj.jp.7211810; Grimes DA, 2005, CONTRACEPTION, V72, P1, DOI 10.1016/j.contraception.2005.04.002; Gunderson EP, 2001, INT J OBESITY, V25, P853, DOI 10.1038/sj.ijo.0801631; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Hendler I, 2005, J ULTRAS MED, V24, P1205, DOI 10.7863/jum.2005.24.9.1205; Hendler I, 2004, AM J OBSTET GYNECOL, V190, P1616, DOI 10.1016/j.ajog.2004.03.064; Hendler I, 2004, INT J OBESITY, V28, P1607, DOI 10.1038/sj.ijo.0802759; Huber LRB, 2007, AM J EPIDEMIOL, V166, P1306, DOI 10.1093/aje/kwm221; Huber LRB, 2005, MATERN CHILD HLTH J, V9, P413, DOI 10.1007/s10995-005-0015-5; Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Oddy WH, 2006, J PEDIATR-US, V149, P185, DOI 10.1016/j.jpeds.2006.04.005; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Patel JA, 2008, SURG OBES RELAT DIS, V4, P39, DOI 10.1016/j.soard.2007.10.008; Smaill Fiona M, 2019, Cochrane Database Syst Rev, V2019, DOI 10.1002/14651858.CD000490.pub4; Soens MA, 2008, ACTA ANAESTH SCAND, V52, P6, DOI 10.1111/j.1399-6576.2007.01483.x; Stotland NE, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.048; Stotland NE, 2005, OBSTET GYNECOL, V105, P633, DOI 10.1097/01.AOG.0000152349.84025.35; Stuebe AM, 2005, JAMA-J AM MED ASSOC, V294, P2601, DOI 10.1001/jama.294.20.2601; Wax JR, 2007, OBSTET GYNECOL SURV, V62, P595, DOI 10.1097/01.ogx.0000279291.86611.46; Wing RR, 2003, PRIMARY CARE, V30, P375, DOI 10.1016/S0095-4543(03)00009-5; World Health Organization, 2006, OB OV	32	9	9	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2008	337								a2450	10.1136/bmj.a2450	http://dx.doi.org/10.1136/bmj.a2450			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SS	19074938				2022-12-01	WOS:000262184600004
J	Kwiatkowski, D				Kwiatkowski, Dominic		Malaria Genomic Epidemiology	A global network for investigating the genomic epidemiology of malaria	NATURE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; WIDE ASSOCIATION; INSECTICIDE RESISTANCE; GENETIC-ASSOCIATION; ANOPHELES-GAMBIAE; AFRICAN CHILDREN; SEQUENCE; COLLABORATION; POPULATION; DIVERSITY	Large-scale studies of genomic variation could assist efforts to eliminate malaria. But there are scientific, ethical and practical challenges to carrying out such studies in developing countries, where the burden of disease is greatest. The Malaria Genomic Epidemiology Network (MalariaGEN) is now working to overcome these obstacles, using a consortial approach that brings together researchers from 21 countries.				dominic@sanger.ac.uk	Troye-Blomberg, Marita/B-9210-2016; Mead, Daniel/AAE-6629-2019; Makani, Julie/N-9370-2013; Makani, Julie/E-8525-2017; Clark, Taane G./AAM-2570-2020; Dunstan, Sarah/AAO-9597-2020; Deloukas, Panos/B-2922-2013; mangano, valentina/I-2456-2012	Troye-Blomberg, Marita/0000-0002-2804-0325; Mead, Daniel/0000-0001-7717-4330; Makani, Julie/0000-0002-4801-6250; Makani, Julie/0000-0002-4801-6250; Clark, Taane G./0000-0001-8985-9265; Deloukas, Panos/0000-0001-9251-070X; Kwiatkowski, Dominic/0000-0002-5023-0176; Karunaweera, Nadira/0000-0003-3985-1817; Small, Kerrin/0000-0003-4566-0005; Reeder, John/0000-0003-1395-1289; Moyes, Catherine/0000-0002-8028-4079; Bojang, Kalifa/0000-0001-7506-0938; Farrar, Jeremy/0000-0002-2700-623X; Oluoch, Tom/0000-0001-9621-5900; Ishengoma, Deus/0000-0003-2040-3416; Maslen, Gareth/0000-0001-7318-3678; Bull, Susan/0000-0002-9730-091X; Mangano, Valentina D/0000-0002-2021-6162; Singhasivanon, Pratap/0000-0002-9759-1702; Manske, Magnus/0000-0001-5916-0947; Conway, David/0000-0002-8711-3037; Apinjoh, Tobias/0000-0001-9889-7271; Kivinen, Katja/0000-0002-1135-7625; Ragoussis, Ioannis/0000-0002-8515-0934; Hart, Lee/0000-0002-6473-0964; Thera, Mahamadou A/0000-0002-2679-035X; Amodu, Olukemi/0000-0003-1477-4229; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Lin, Enmoore/0000-0002-8584-7627; Allen, Stephen/0000-0001-6675-249X; Dunstan, Sarah/0000-0001-7873-933X	Medical Research Council [G19/9, G0600718, G0200454(62635), G0600230, G0600230(77610), G0200454] Funding Source: Medline; Wellcome Trust [076934, 077383/Z/05/Z, 077383] Funding Source: Medline; MRC [G0200454, G19/9, G0600718, G0600230] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chokshi DA, 2005, GENOMICS SOC POLICY, V1, P1; Chokshi DA, 2007, PLOS MED, V4, P636, DOI 10.1371/journal.pmed.0040095; Chokshi DA, 2006, B WORLD HEALTH ORGAN, V84, P382, DOI 10.2471/BLT.06.029843; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Nuffield Council on Bioethics, 2002, ETH RES REL HEALTHC; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Teo YY, 2008, NAT METHODS, V5, P279, DOI 10.1038/nmeth0408-279; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	34	112	115	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					732	U39		10.1038/nature07632	http://dx.doi.org/10.1038/nature07632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	381TX	19079050	Bronze, Green Accepted			2022-12-01	WOS:000261559900037
J	Mastepanov, M; Sigsgaard, C; Dlugokencky, EJ; Houweling, S; Strom, L; Tamstorf, MP; Christensen, TR				Mastepanov, Mikhail; Sigsgaard, Charlotte; Dlugokencky, Edward J.; Houweling, Sander; Strom, Lena; Tamstorf, Mikkel P.; Christensen, Torben R.			Large tundra methane burst during onset of freezing	NATURE			English	Article							TRACE GAS-EXCHANGE; ATMOSPHERIC METHANE; NORTHEAST GREENLAND; ARCTIC TUNDRA; CH4; EMISSION; CLIMATE; THAW; CO2	Terrestrial wetland emissions are the largest single source of the greenhouse gas methane(1). Northern high- latitude wetlands contribute significantly to the overall methane emissions from wetlands, but the relative source distribution between tropical and high- latitude wetlands remains uncertain(2,3). As a result, not all the observed spatial and seasonal patterns of atmospheric methane concentrations can be satisfactorily explained, particularly for high northern latitudes. For example, a late- autumn shoulder is consistently observed in the seasonal cycles of atmospheric methane at high- latitude sites(4), but the sources responsible for these increased methane concentrations remain uncertain. Here we report a data set that extends hourly methane flux measurements from a high Arctic setting into the late autumn and early winter, during the onset of soil freezing. We find that emissions fall to a low steady level after the growing season but then increase significantly during the freeze- in period. The integral of emissions during the freeze- in period is approximately equal to the amount of methane emitted during the entire summer season. Three- dimensional atmospheric chemistry and transport model simulations of global atmospheric methane concentrations indicate that the observed early winter emission burst improves the agreement between the simulated seasonal cycle and atmospheric data from latitudes north of 60 degrees N. Our findings suggest that permafrost- associated freeze- in bursts of methane emissions from tundra regions could be an important and so far unrecognized component of the seasonal distribution of methane emissions from high latitudes.	[Mastepanov, Mikhail; Strom, Lena; Christensen, Torben R.] Lund Univ, Geobiosphere Sci Ctr, S-22362 Lund, Sweden; [Sigsgaard, Charlotte] Univ Copenhagen, Inst Geog & Geol, DK-1350 Copenhagen, Denmark; [Dlugokencky, Edward J.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Houweling, Sander] SRON, Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Houweling, Sander] Univ Utrecht, Inst Marine & Atmospher Res Utrecht IMAU, NL-3584 CC Utrecht, Netherlands; [Tamstorf, Mikkel P.] Univ Aarhus, Natl Environm Res Inst, DK-4000 Roskilde, Denmark	Lund University; University of Copenhagen; National Oceanic Atmospheric Admin (NOAA) - USA; Utrecht University; Aarhus University	Christensen, TR (corresponding author), Lund Univ, Geobiosphere Sci Ctr, Solvegatan 12, S-22362 Lund, Sweden.	Torben.Christensen@nateko.lu.se	Dlugokencky, Edward/AAN-8746-2020; Tamstorf, Mikkel/ACU-7592-2022; Mastepanov, Mikhail/G-1235-2016; Tamstorf, Mikkel/AAB-6627-2020; Tamstorf, Mikkel/I-7101-2013	Dlugokencky, Edward/0000-0003-0612-6985; Mastepanov, Mikhail/0000-0002-5543-0302; Tamstorf, Mikkel/0000-0002-2811-331X; Tamstorf, Mikkel/0000-0002-2811-331X	Danish Ministry of the Environment; Commission for Scientific Research in Greenland (KVUG); Swedish Research Councils VR; FORMAS	Danish Ministry of the Environment; Commission for Scientific Research in Greenland (KVUG); Swedish Research Councils VR(Swedish Research Council); FORMAS(Swedish Research Council Formas)	This work was carried out under the auspices of the GeoBasis programme and part of the Zackenberg Ecological Research Operations funded by the Danish Ministry of the Environment and the ISICaB project funded by the Commission for Scientific Research in Greenland (KVUG). ASIAQ-Greenland Survey provided climate data. The work was also supported by the Swedish Research Councils VR and FORMAS. We thank P. Bergamachi (JRC) and J.-F. Meirink (KNMI) for providing the TM5 model setup. T. Tagesson helped with the field work in Zackenberg. We are grateful for comments on earlier versions of this manuscript from A. Lindroth and B. Christensen.	Bergamaschi P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007268; Bliss L C, 1992, ARCTIC ECOSYSTEMS CH, P59, DOI DOI 10.1016/B978-0-12-168250-7.50010-9; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Christensen TR, 2000, GLOBAL BIOGEOCHEM CY, V14, P701, DOI 10.1029/1999GB001134; CHRISTENSEN TR, 1993, BIOGEOCHEMISTRY, V21, P117, DOI 10.1007/BF00000874; Christiansen HH, 2002, J QUATERNARY SCI, V17, P145, DOI 10.1002/jqs.665; Corradi C, 2005, GLOBAL CHANGE BIOL, V11, P1910, DOI 10.1111/j.1365-2486.2005.01023.x; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; DLUGOKENCKY EJ, 1994, J GEOPHYS RES-ATMOS, V99, P17021, DOI 10.1029/94JD01245; FAN SM, 1992, J GEOPHYS RES-ATMOS, V97, P16627, DOI 10.1029/91JD02531; Fletcher SEM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002223; Friborg T, 2000, GLOBAL BIOGEOCHEM CY, V14, P715, DOI 10.1029/1999GB001136; Gedney N, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020919; Hargreaves KJ, 2001, THEOR APPL CLIMATOL, V70, P203, DOI 10.1007/s007040170015; Krol M, 2005, ATMOS CHEM PHYS, V5, P417, DOI 10.5194/acp-5-417-2005; Meltofte H, 2008, ADV ECOL RES, V40, P1, DOI 10.1016/S0065-2504(07)00001-3; Miller JB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029213; Reeburgh WS, 1998, J GEOPHYS RES-ATMOS, V103, P29005, DOI 10.1029/98JD00993; Tokida T, 2007, CHEMOSPHERE, V70, P165, DOI 10.1016/j.chemosphere.2007.06.042; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34207, DOI 10.1029/2001JD900164; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040; Whalen SC, 1988, GLOBAL BIOGEOCHEM CY, V2, P399, DOI 10.1029/GB002i004p00399	22	218	246	3	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					628	U58		10.1038/nature07464	http://dx.doi.org/10.1038/nature07464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052625	Green Published			2022-12-01	WOS:000261340000038
J	Gardner, MK; Bouck, DC; Paliulis, LV; Meehl, JB; O'Toole, ET; Haase, J; Soubry, A; Joglekar, AP; Winey, M; Salmon, ED; Bloom, K; Odde, DJ				Gardner, Melissa K.; Bouck, David C.; Paliulis, Leocadia V.; Meehl, Janet B.; O'Toole, Eileen T.; Haase, Julian; Soubry, Adelheid; Joglekar, Ajit P.; Winey, Mark; Salmon, Edward D.; Bloom, Kerry; Odde, David J.			Chromosome Congression by Kinesin-5 Motor-Mediated Disassembly of Longer Kinetochore Microtubules	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; NUCLEAR MIGRATION; YEAST; DYNAMICS; PROTEINS; ORIENTATION; REQUIRES; MITOSIS; KIF18A	During mitosis, sister chromatids congress to the spindle equator and are subsequently segregated via attachment to dynamic kinetochore microtubule (kMT) plus ends. A major question is how kMT plus-end assembly is spatially regulated to achieve chromosome congression. Here we find in budding yeast that the widely conserved kinesin-5 sliding motor proteins, Cin8p and Kip1p, mediate chromosome congression by suppressing kMT plus-end assembly of longer kMTs. Of the two, Cin8p is the major effector and its activity requires a functional motor domain. In contrast, the depolymerizing kinesin-8 motor Kip3p plays a minor role in spatial regulation of yeast kMT assembly. Our analysis identified a model where kinesin-5 motors bind to kMTs, move to kMT plus ends, and upon arrival at a growing plus end promote net kMT plus-end disassembly. In conclusion, we find that length-dependent control of net kMT assembly by kinesin-5 motors yields a simple and stable self-organizing mechanism for chromosome congression.	[Gardner, Melissa K.; Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Bouck, David C.; Paliulis, Leocadia V.; Haase, Julian; Soubry, Adelheid; Joglekar, Ajit P.; Salmon, Edward D.; Bloom, Kerry] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Meehl, Janet B.; O'Toole, Eileen T.; Winey, Mark] Univ Colorado, MCD Biol, Boulder, CO 80301 USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Boulder	Odde, DJ (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	oddex002@umn.edu	Odde, David/AAY-1720-2020; Odde, David/H-4925-2011; Bloom, Kerry/AAE-5336-2019	Odde, David/0000-0001-7731-2799; Bloom, Kerry/0000-0002-3457-004X; Joglekar, Ajit/0000-0002-0607-5332; Haase, Julian/0000-0001-5891-4241; Bouck, David/0000-0002-6281-2544	NIH [GM071522, GM32238]; NIH NRSA [EB005568]; SPIRE [GM00678]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F31EB005568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032238, R01GM071522, R37GM024364, R01GM032238, K12GM000678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPIRE; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dominique Seetapun for providing matlab kymograph code, Drs. Tom Hays and Leah Gheber for helpful discussions, Dr. Jeff Molk for comments on the manuscript, and Marybeth Anderson for assistance with bim1 Delta images. Plasmids and strains were kindly provided by Drs. S. Reed, B. Errede, M. A. Hoyt, L. Gheber, and D. Pellman. This work was supported by NIH grant GM071522 to D. J. O. K. B. is supported by NIH grant GM32238 and M. K. G. is supported by NIH NRSA grant EB005568. E. T. O. is supported in part by grant RR-00592 from the National Center for Research Resources of the NIH to A. Hoenger. L. V. P. is supported by a SPIRE fellowship (GM00678).	Bouck DC, 2007, CURR BIOL, V17, P741, DOI 10.1016/j.cub.2007.03.033; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; de Gramont A, 2007, CELL CYCLE, V6, P1231, DOI 10.4161/cc.6.10.4181; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Gardner MK, 2008, TRENDS CELL BIOL, V18, P307, DOI 10.1016/j.tcb.2008.05.003; Gardner MK, 2007, METHODS, V41, P232, DOI 10.1016/j.ymeth.2006.08.002; Gardner MK, 2005, MOL BIOL CELL, V16, P3764, DOI 10.1091/mbc.E05-04-0275; Geiser JR, 1997, MOL BIOL CELL, V8, P1035, DOI 10.1091/mbc.8.6.1035; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; Gupta ML, 2002, MOL BIOL CELL, V13, P2919, DOI 10.1091/mbc.E02-01-0003; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Huang BY, 2006, J CELL BIOL, V175, P17, DOI 10.1083/jcb.200606021; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; Mayr MI, 2007, CURR BIOL, V17, P488, DOI 10.1016/j.cub.2007.02.036; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; O'Toole ET, 2002, METHOD ENZYMOL, V351, P81; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.E03-03-0180; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Pearson CG, 2006, MOL BIOL CELL, V17, P4069, DOI 10.1091/mbc.E06-04-0312; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; Sprague BL, 2003, BIOPHYS J, V84, P3529, DOI 10.1016/S0006-3495(03)75087-5; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Sudakin V, 2007, BIODRUGS, V21, P225, DOI 10.2165/00063030-200721040-00003; Tao L, 2006, CURR BIOL, V16, P2293, DOI 10.1016/j.cub.2006.09.064; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	43	131	131	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					894	906		10.1016/j.cell.2008.09.046	http://dx.doi.org/10.1016/j.cell.2008.09.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041752	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000261183900020
J	Zhan, LX; Rosenberg, A; Bergami, KC; Yu, M; Xuan, ZY; Jaffe, AB; Allred, C; Muthuswamy, SK				Zhan, Lixing; Rosenberg, Avi; Bergami, Kenneth C.; Yu, Min; Xuan, Zhenyu; Jaffe, Aron B.; Allred, Craig; Muthuswamy, Senthil K.			Deregulation of Scribble Promotes Mammary Tumorigenesis and Reveals a Role for Cell Polarity in Carcinoma	CELL			English	Article							PAPILLOMAVIRUS E6 PROTEINS; TUMOR-SUPPRESSOR SCRIBBLE; MYC-INDUCED TUMORIGENESIS; GROWTH-FACTOR-ALPHA; C-MYC; TRANSGENIC MICE; MOUSE MAMMARY; EPITHELIAL-CELLS; BREAST-CANCER; PROLIFERATION CONTROL	Loss of cell polarity proteins such as Scribble induces neoplasia in Drosophila by promoting uncontrolled proliferation. In mammals, the role that polarity proteins play during tumorigenesis is not well understood. Here, we demonstrate that depletion of Scribble in mammary epithelia disrupts cell polarity, blocks three-dimensional morphogenesis, inhibits apoptosis, and induces dysplasia in vivo that progress to tumors after long latency. Loss of Scribble cooperates with oncogenes such as c-myc to transform epithelial cells and induce tumors in vivo by blocking activation of an apoptosis pathway. Like depletion, mislocalization of Scribble from cell-cell junction was sufficient to promote cell transformation. Interestingly, spontaneous mammary tumors in mice and humans possess both downregulated and mislocalized Scribble. Thus, we demonstrate that scribble inhibits breast cancer formation and that deregulation of polarity pathways promotes dysplastic and neoplastic growth in mammals by disrupting morphogenesis and inhibiting cell death.	[Zhan, Lixing; Rosenberg, Avi; Bergami, Kenneth C.; Yu, Min; Xuan, Zhenyu; Muthuswamy, Senthil K.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Rosenberg, Avi] SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; [Jaffe, Aron B.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Allred, Craig] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center; Washington University (WUSTL)	Muthuswamy, SK (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	muthuswa@cshl.edu	Muthuswamy, Senthil K/AGY-2834-2022	Muthuswamy, Senthil K/0000-0001-6564-9634; Zhan, Lixing/0000-0003-4949-4358; Jaffe, Aron/0000-0002-6220-0476; Rosenberg, Avi/0000-0003-2356-950X; Xuan, Zhenyu/0000-0001-9344-8493; Yu, Min/0000-0002-3969-8720	NCI [CA098830, DOD BC075024, CA105388]; Rita Allen Foundation; FACT foundation; Glen Cove Cares; Long Islanders Against Breast Cancer; NATIONAL CANCER INSTITUTE [R01CA098830, R56CA098830, U01CA105388] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rita Allen Foundation; FACT foundation; Glen Cove Cares; Long Islanders Against Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Dan Medina (Baylor College of Medicine) for the COMMA-1D cells and for his continued support and guidance during the course of the experiments. We thank Lewis Chodosh for providing tumor samples from MMTV-Myc transgenics and Patrick Humbert for the Scribble cDNA. We also wish to thank Alan Hall and members of the Muthuswamy laboratory for their critical discussions and comments regarding the manuscript, Jim Duffy for his assistance with art work, and Bill Tansey for the reagents and helpful discussions. This work was supported by CA098830, DOD BC075024, and CA105388 grants from NCI, Rita Allen Foundation, FACT foundation, Glen Cove Cares, and Long Islanders Against Breast Cancer.	AGUILARCORDOVA E, 1991, ONCOGENE, V6, P1601; ALLRED CA, 2004, DIS BREAST, P507; Allred DC, 2001, ENDOCR-RELAT CANCER, V8, P47, DOI 10.1677/erc.0.0080047; AMUNDADOTTIR LT, 1995, CELL GROWTH DIFFER, V6, P737; Amundadottir LT, 1996, ONCOGENE, V13, P757; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Bryant PJ, 1997, DEV GENET, V20, P75, DOI 10.1002/(SICI)1520-6408(1997)20:2<75::AID-DVG1>3.3.CO;2-G; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Deugnier MA, 2006, DEV BIOL, V293, P414, DOI 10.1016/j.ydbio.2006.02.007; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Edwards P A, 1996, Cancer Treat Res, V83, P23; EHMANN UK, 1987, JNCI-J NATL CANCER I, V78, P751; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Jager R, 1997, ONCOGENE, V15, P1787, DOI 10.1038/sj.onc.1201353; Jamerson MH, 2004, BRIT J CANCER, V91, P1372, DOI 10.1038/sj.bjc.6602137; JERRY DJ, 1994, IN VITRO CELL DEV-AN, V30A, P87; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Lane MA, 1999, ONCOL REP, V6, P507; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; LORENZO C, 1999, CANC METASTASIS REV, V18, P295; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Murtagh J, 2004, J CELL BIOL, V166, P133, DOI 10.1083/jcb.200403020; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nass SJ, 1997, BREAST CANCER RES TR, V44, P1, DOI 10.1023/A:1005858611585; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Ramljak D, 2003, EXP CELL RES, V287, P397, DOI 10.1016/S0014-4827(03)00135-6; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; SANDGREN EP, 1995, CANCER RES, V55, P3915; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; SPANDIDOS DA, 1987, ANTICANCER RES, V7, P1299; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tilli Maddalena T, 2003, Breast Cancer Res, V5, P202, DOI 10.1186/bcr614; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X; Yu K, 1997, CELL GROWTH DIFFER, V8, P731; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158	64	308	322	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					865	878		10.1016/j.cell.2008.09.045	http://dx.doi.org/10.1016/j.cell.2008.09.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041750	Green Accepted, Bronze			2022-12-01	WOS:000261183900018
J	Serganov, A; Huang, LL; Patel, DJ				Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.			Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch	NATURE			English	Article							MESSENGER-RNA; STRUCTURAL BASIS; BINDING; EXPRESSION; TRANSCRIPTION; RIBOSOME	The biosynthesis of several protein cofactors is subject to feedback regulation by riboswitches(1-3). Flavin mononucleotide (FMN)specific riboswitches(4,5), also known as RFN elements(6), direct expression of bacterial genes involved in the biosynthesis and transport of riboflavin (vitamin B-2) and related compounds. Here we present the crystal structures of the Fusobacterium nucleatum riboswitch bound to FMN, riboflavin and antibiotic roseoflavin(7). The FMN riboswitch structure, centred on an FMN-bound six-stem junction, does not fold by collinear stacking of adjacent helices, typical for folding of large RNAs. Rather, it adopts a butterfly-like scaffold, stapled together by opposingly directed but nearly identically folded peripheral domains. FMN is positioned asymmetrically within the junctional site and is specifically bound to RNA through interactions with the isoalloxazine ring chromophore and direct and Mg2+-mediated contacts with the phosphate moiety. Our structural data, complemented by binding and footprinting experiments, imply a largely pre-folded tertiary RNA architecture and FMN recognition mediated by conformational transitions within the junctional binding pocket. The inherent plasticity of the FMN-binding pocket and the availability of large openings make the riboswitch an attractive target for structure-based design of FMN-like antimicrobial compounds. Our studies also explain the effects of spontaneous and antibiotic-induced deregulatory mutations and provided molecular insights into FMN-based control of gene expression in normal and riboflavin-overproducing bacterial strains.	[Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Serganov, A (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	serganoa@mskcc.org; pateld@mskcc.org		Serganov, Alexander/0000-0001-8328-9310	the US Department of Energy; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073618] Funding Source: NIH RePORTER	the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel of beamline X29 at the Brookhaven National Laboratory and beamline 24-ID-C at the Advanced Photon Source, Argonne National Laboratory, funded by the US Department of Energy. We thank L. Jaeger (University of California, Santa Barbara) for discussions and O. Ouerfelli (Memorial Sloan-Kettering Cancer Center, New York) for the synthesis of iridium hexamine. D. J. P. was supported by funds from the National Institutes of Health.	Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Burgess C, 2004, APPL ENVIRON MICROB, V70, P5769, DOI 10.1128/AEM.70.10.5769-5777.2004; Burgess Catherine M, 2006, Microb Cell Fact, V5, P24, DOI 10.1186/1475-2859-5-24; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Fan P, 1996, J MOL BIOL, V258, P480, DOI 10.1006/jmbi.1996.0263; Feig A. L., 1999, RNA WORLD, P287; Garst AD, 2008, J BIOL CHEM, V283, P22347, DOI 10.1074/jbc.C800120200; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Jaeger L, 2009, NUCLEIC ACIDS RES, V37, P215, DOI 10.1093/nar/gkn911; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Serganov A, 1997, EUR J BIOCHEM, V246, P291, DOI 10.1111/j.1432-1033.1997.00291.x; Serganov A, 2003, EMBO J, V22, P1898, DOI 10.1093/emboj/cdg170; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899	35	180	197	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					233	U10		10.1038/nature07642	http://dx.doi.org/10.1038/nature07642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19169240	Green Accepted			2022-12-01	WOS:000264059700050
J	Velu, V; Titanji, K; Zhu, BG; Husain, S; Pladevega, A; Lai, LL; Vanderford, TH; Chennareddi, L; Silvestri, G; Freeman, GJ; Ahmed, R; Amara, RR				Velu, Vijayakumar; Titanji, Kehmia; Zhu, Baogong; Husain, Sajid; Pladevega, Annette; Lai, Lilin; Vanderford, Thomas H.; Chennareddi, Lakshmi; Silvestri, Guido; Freeman, Gordon J.; Ahmed, Rafi; Amara, Rama Rao			Enhancing SIV-specific immunity in vivo by PD-1 blockade	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD8 T-CELLS; CHRONIC VIRAL-INFECTION; PROGRAMMED DEATH-1; EFFECTOR FUNCTION; EXPRESSION; LYMPHOCYTES; PERSISTENCE; EXHAUSTION; MECHANISMS	Chronic immunodeficiency virus infections are characterized by dysfunctional cellular and humoral antiviral immune responses(1-3). As such, immune modulatory therapies that enhance and/or restore the function of virus-specific immunity may protect from disease progression. Here we investigate the safety and immune restoration potential of blockade of the co-inhibitory receptor programmed death 1 (PD-1) 4,5 during chronic simian immunodeficiency virus (SIV) infection in macaques. We demonstrate that PD-1 blockade using an antibody to PD-1 is well tolerated and results in rapid expansion of virus-specific CD8 T cells with improved functional quality. This enhanced T-cell immunity was seen in the blood and also in the gut, a major reservoir of SIV infection. PD-1 blockade also resulted in proliferation of memory B cells and increases in SIV envelope-specific antibody. These improved immune responses were associated with significant reductions in plasma viral load and also prolonged the survival of SIV-infected macaques. Blockade was effective during the early (week 10) as well as late (similar to week 90) phases of chronic infection even under conditions of severe lymphopenia. These results demonstrate enhancement of both cellular and humoral immune responses during a pathogenic immunodeficiency virus infection by blocking a single inhibitory pathway and identify a novel therapeutic approach for control of human immunodeficiency virus infections.	[Velu, Vijayakumar; Titanji, Kehmia; Husain, Sajid; Pladevega, Annette; Lai, Lilin; Chennareddi, Lakshmi; Ahmed, Rafi; Amara, Rama Rao] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Velu, Vijayakumar; Titanji, Kehmia; Husain, Sajid; Pladevega, Annette; Lai, Lilin; Chennareddi, Lakshmi; Amara, Rama Rao] Emory Univ, Div Microbiol & Immunol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Zhu, Baogong; Freeman, Gordon J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Zhu, Baogong; Freeman, Gordon J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Vanderford, Thomas H.; Silvestri, Guido] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Emory University; Emory University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Pennsylvania	Amara, RR (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	ramara@emory.edu	Amara, Rama/AAO-8136-2021; Velu, Vijayakumar/I-7585-2019; Freeman, Gordon/AAC-5380-2019	Velu, Vijayakumar/0000-0003-4238-1924; Freeman, Gordon/0000-0002-7210-5616; Lai, Lilin/0000-0002-9528-6990	NCRR NIH HHS [P51 RR00165, P51 RR000165, R24 RR016038, R24 RR16038] Funding Source: Medline; NIAID NIH HHS [R01 AI074417, R01 AI057029-04, R01 AI057029-05, P30 AI050409, R01 AI057029, R01 AI074417-02, R01 AI071852, R01 AI057029-01, R01 AI057029-02, R01 AI074417-01A1, R01 AI057029-03] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016038, P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074417, R01AI071852, R01AI057029, P30AI050409] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 1998, J IMMUNOL, V160, P6062; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Cecchinato V, 2008, J IMMUNOL, V180, P5439, DOI 10.4049/jimmunol.180.8.5439; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dorfman DM, 2006, AM J SURG PATHOL, V30, P802, DOI 10.1097/01.pas.0000209855.28282.ce; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lai L, 2007, VIROLOGY, V369, P153, DOI 10.1016/j.virol.2007.07.017; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Malley R, 1998, J INFECT DIS, V178, P1555, DOI 10.1086/314523; Moir S, 2008, J ALLERGY CLIN IMMUN, V122, P12, DOI 10.1016/j.jaci.2008.04.034; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	30	575	617	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					206	U5		10.1038/nature07662	http://dx.doi.org/10.1038/nature07662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19078956	Green Accepted			2022-12-01	WOS:000264059700044
J	Lincoln, TA; Joyce, GF				Lincoln, Tracey A.; Joyce, Gerald F.			Self-Sustained Replication of an RNA Enzyme	SCIENCE			English	Article							LIGASE RIBOZYME; ORIGIN	An RNA enzyme that catalyzes the RNA-templated joining of RNA was converted to a format whereby two enzymes catalyze each other's synthesis from a total of four oligonucleotide substrates. These cross-replicating RNA enzymes undergo self-sustained exponential amplification in the absence of proteins or other biological materials. Amplification occurs with a doubling time of about 1 hour and can be continued indefinitely. Populations of various cross-replicating enzymes were constructed and allowed to compete for a common pool of substrates, during which recombinant replicators arose and grew to dominate the population. These replicating RNA enzymes can serve as an experimental model of a genetic system. Many such model systems could be constructed, allowing different selective outcomes to be related to the underlying properties of the genetic system.	[Lincoln, Tracey A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	gjoyce@scripps.edu			NASA [NNX07AJ23G]; NIH [R01GM065130]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065130] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Orgel for many stimulating discussions. This research was supported by grants from NASA (NNX07AJ23G) and NIH (R01GM065130) and by the Skaggs Institute for Chemical Biology.	CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kim DE, 2004, CHEM BIOL, V11, P1505, DOI 10.1016/j.chembiol.2004.08.021; Kim KS, 2008, FEBS LETT, V582, P2745, DOI 10.1016/j.febslet.2008.07.013; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Paul N, 2002, P NATL ACAD SCI USA, V99, P12733, DOI 10.1073/pnas.202471099; Rogers J, 2001, RNA, V7, P395, DOI 10.1017/S135583820100228X; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176	8	411	429	16	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1229	1232		10.1126/science.1167856	http://dx.doi.org/10.1126/science.1167856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19131595	Green Accepted			2022-12-01	WOS:000263687600043
J	Brown, SP; Hestrin, S				Brown, Solange P.; Hestrin, Shaul			Intracortical circuits of pyramidal neurons reflect their long-range axonal targets	NATURE			English	Article							VISUAL-CORTEX; LAYER-V; CORTICOSTRIATAL NEURONS; SYNAPTIC CONNECTIONS; PROJECTION NEURONS; MORPHOLOGY; CELLS; CORTICOPONTINE; ORGANIZATION; PATTERNS	Cortical columns generate separate streams of information that are distributed to numerous cortical and subcortical brain regions(1). We asked whether local intracortical circuits reflect these different processing streams by testing whether the intracortical connectivity among pyramidal neurons reflects their long-range axonal targets. We recorded simultaneously from up to four retrogradely labelled pyramidal neurons that projected to the superior colliculus, the contralateral striatum or the contralateral cortex to assess their synaptic connectivity. Here we show that the probability of synaptic connection depends on the functional identities of both the presynaptic and postsynaptic neurons. We first found that the frequency of monosynaptic connections among corticostriatal pyramidal neurons is significantly higher than among corticocortical or corticotectal pyramidal neurons. We then show that the probability of feed-forward connections from corticocortical neurons to corticotectal neurons is approximately three- to four-fold higher than the probability of monosynaptic connections among corticocortical or corticotectal cells. Moreover, we found that the average axodendritic overlap of the presynaptic and postsynaptic pyramidal neurons could not fully explain the differences in connection probability that we observed. The selective synaptic interactions we describe demonstrate that the organization of local networks of pyramidal cells reflects the long-range targets of both the presynaptic and postsynaptic neurons.	[Brown, Solange P.; Hestrin, Shaul] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA	Stanford University	Hestrin, S (corresponding author), Stanford Univ, Sch Med, Dept Comparat Med, 300 Pasteur Dr,Edwards Bldg,R314, Stanford, CA 94305 USA.	shaul.hestrin@stanford.edu	Brown, Solange/H-1615-2012; Hestrin, Shaul/F-4410-2010		National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY012114, R01EY009120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Li and S. Pak for technical assistance. This work was supported by National Institutes of Health grants to S. P. B and to S. H.	Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg VB, 1998, CORTEX STAT GEOMETRY, DOI 10.1007/978-3-662-03733-1; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frick A, 2008, CEREB CORTEX, V18, P397, DOI 10.1093/cercor/bhm074; HALLMAN LE, 1988, J COMP NEUROL, V272, P149, DOI 10.1002/cne.902720111; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; HUBENER M, 1988, NEUROSCI LETT, V94, P76, DOI 10.1016/0304-3940(88)90273-X; Jones E. G., 1984, CELLULAR COMPONENTS, P521; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; KASPER EM, 1994, J COMP NEUROL, V339, P459, DOI 10.1002/cne.903390402; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; KISVARDAY ZF, 1986, EXP BRAIN RES, V64, P541, DOI 10.1007/BF00340492; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Larsen DD, 2008, FRONT NEURAL CIRCUIT, V1, DOI 10.3389/neuro.04.005.2007; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MCGUIRE BA, 1984, J NEUROSCI, V4, P3021; Mercer A, 2005, CEREB CORTEX, V15, P1485, DOI 10.1093/cercor/bhi027; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; SINGER W, 1975, J NEUROPHYSIOL, V38, P1080, DOI 10.1152/jn.1975.38.5.1080; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; SWADLOW HA, 1988, J NEUROPHYSIOL, V59, P1162, DOI 10.1152/jn.1988.59.4.1162; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WANG Z, 1993, J NEUROSCI, V13, P2199; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	36	239	242	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1133	U89		10.1038/nature07658	http://dx.doi.org/10.1038/nature07658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19151698	Green Accepted			2022-12-01	WOS:000263680100041
J	Petreanu, L; Mao, TY; Sternson, SM; Svoboda, K				Petreanu, Leopoldo; Mao, Tianyi; Sternson, Scott M.; Svoboda, Karel			The subcellular organization of neocortical excitatory connections	NATURE			English	Article							RAT BARREL CORTEX; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; PYRAMIDAL NEURONS; SYNAPTIC CONNECTIVITY; VISUAL-CORTEX; MOTOR CORTEX; DENDRITES; CIRCUIT; CHANNELRHODOPSIN-2; PROJECTIONS	Understanding cortical circuits will require mapping the connections between specific populations of neurons(1), as well as determining the dendritic locations where the synapses occur(2). The dendrites of individual cortical neurons overlap with numerous types of local and long-range excitatory axons, but axodendritic overlap is not always a good predictor of actual connection strength(3-5). Here we developed an efficient channelrhodopsin-2 (ChR2)-assisted method(6-8) to map the spatial distribution of synaptic inputs, defined by presynaptic ChR2 expression, within the dendritic arborizations of recorded neurons. We expressed ChR2 in two thalamic nuclei, the whisker motor cortex and local excitatory neurons and mapped their synapses with pyramidal neurons in layers 3, 5A and 5B (L3, L5A and L5B) in the mouse barrel cortex. Within the dendritic arborizations of L3 cells, individual inputs impinged onto distinct single domains. These domains were arrayed in an orderly, monotonic pattern along the apical axis: axons from more central origins targeted progressively higher regions of the apical dendrites. In L5 arborizations, different inputs targeted separate basal and apical domains. Input to L3 and L5 dendrites in L1 was related to whisker movement and position, suggesting that these signals have a role in controlling the gain of their target neurons(9). Our experiments reveal high specificity in the subcellular organization of excitatory circuits.	[Petreanu, Leopoldo; Mao, Tianyi; Sternson, Scott M.; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org		Petreanu, Leopoldo/0000-0003-1434-4691; Mao, Tianyi/0000-0002-3532-8319	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Liao GY, 2008, GENESIS, V46, P289, DOI 10.1002/dvg.20393; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; White EL, 2002, J NEUROCYTOL, V31, P195, DOI 10.1023/A:1024109606722; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	34	668	672	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1142	U100		10.1038/nature07709	http://dx.doi.org/10.1038/nature07709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19151697	Green Accepted			2022-12-01	WOS:000263680100043
J	Krug, AZ; Jablonski, D; Valentine, JW				Krug, Andrew Z.; Jablonski, David; Valentine, James W.			Signature of the End-Cretaceous Mass Extinction in the Modern Biota	SCIENCE			English	Article							LATITUDINAL DIVERSITY GRADIENT; RECENT BIVALVE FAUNAS; INDO-WEST PACIFIC; FOSSIL RECORD; MARINE REALM; DIVERSIFICATION; ORIGINATION; SPECIATION; EVOLUTION; PATTERNS	The long- term effects of mass extinctions on spatial and evolutionary dynamics have been poorly studied. Here we show that the evolutionary consequences of the end- Cretaceous [ Cretaceous/ Paleogene ( K/ Pg)] mass extinction persist in present- day biogeography. The geologic ages of genera of living marine bivalves show a significant break from a smooth exponential distribution, corresponding to the K/ Pg boundary. The break reflects a permanent increase in origination rates, intermediate between the Mesozoic rate and the post- extinction recovery pulse. This global rate shift is most clearly seen today in tropical bioprovinces and weakens toward the poles. Coupled with the modern geographic distributions of taxa originating before and after the K/ Pg boundary, this spatial pattern indicates that tropical origination rates after the K/ Pg event have left a permanent mark on the taxonomic and biogeographic structure of the modern biota, despite the complex Cenozoic history of marine environments.	[Krug, Andrew Z.; Jablonski, David] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Valentine, James W.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Valentine, James W.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	University of Chicago; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Krug, AZ (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.				NASA	NASA(National Aeronautics & Space Administration (NASA))	We thank M. Foote, S. M. Kidwell, T. D. Price, K. Roy, and three anonymous reviewers for comments and M. Foote for programming assistance. This research was supported by NASA.	Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Behrensmeyer AK, 2005, PALEOBIOLOGY, V31, P607, DOI 10.1666/0094-8373(2005)031[0607:ATMDST]2.0.CO;2; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Crame JA, 2002, PALEOBIOLOGY, V28, P184; Foote M, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P245; Foote M, 2003, J GEOL, V111, P125, DOI 10.1086/345841; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; MILLER AI, 1988, PALEOBIOLOGY, V14, P364, DOI 10.1017/S0094837300012100; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Nee S, 2001, EVOLUTION, V55, P661, DOI 10.1554/0014-3820(2001)055[0661:ISRFP]2.0.CO;2; Nee S, 2004, PALEOBIOLOGY, V30, P172, DOI 10.1666/0094-8373(2004)030<0172:EMESMI>2.0.CO;2; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; PEASE CM, 1987, PALEOBIOLOGY, V13, P484; RAUP D M, 1975, Paleobiology, V1, P333; RAUP DM, 1978, PALEOBIOLOGY, V4, P1; RAUP DM, 1993, SCIENCE, V260, P971, DOI 10.1126/science.11537491; Reaka ML, 2008, P NATL ACAD SCI USA, V105, P11474, DOI 10.1073/pnas.0802594105; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Roy K, 2007, AM NAT, V170, pS71, DOI 10.1086/519403; Sepkoski, 2002, B AM PALEONTOL, V363, P1; Sepkoski J. J., 1996, GLOBAL EVENTS EVENT, DOI DOI 10.1007/978-3-642-79634-0_4; Stanley SM, 2008, PALEOBIOLOGY, V34, P1, DOI 10.1666/07026.1; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Vermeij G.J, 1987, EVOLUTION ESCALATION; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x	31	54	54	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					767	771		10.1126/science.1164905	http://dx.doi.org/10.1126/science.1164905			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197060				2022-12-01	WOS:000263066800042
J	Moses, M				Moses, Melanie			Being Human: Engineering: Worldwide ebb	NATURE			English	Editorial Material									[Moses, Melanie] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA	University of New Mexico	Moses, M (corresponding author), Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA.	melaniem@unm.edu							0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 5	2009	457	7230					660	661		10.1038/457660a	http://dx.doi.org/10.1038/457660a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	403EA	19194432	Bronze			2022-12-01	WOS:000263064700021
J	van Mameren, J; Modesti, M; Kanaar, R; Wyman, C; Peterman, EJG; Wuite, GJL				van Mameren, Joost; Modesti, Mauro; Kanaar, Roland; Wyman, Claire; Peterman, Erwin J. G.; Wuite, Gijs J. L.			Counting RAD51 proteins disassembling from nucleoprotein filaments under tension	NATURE			English	Article							DNA STRAND-EXCHANGE; ATP HYDROLYSIS; BIOCHEMICAL-CHARACTERIZATION; HOMOLOGOUS RECOMBINATION; RAD51-DSDNA FILAMENT; RECA FILAMENTS; MOLECULES; DYNAMICS; BINDING; RESOLUTION	The central catalyst in eukaryotic ATP- dependent homologous recombination consists of RAD51 proteins, polymerized around single- stranded DNA. This nucleoprotein filament recognizes and invades a homologous duplex DNA segment(1,2). After strand exchange, the nucleoprotein filament should disassemble so that the recombination process can be completed(3). The molecular mechanism of RAD51 filament disassembly is poorly understood. Here we show, by combining optical tweezers with single- molecule fluorescence microscopy and microfluidics(4,5), that disassembly of human RAD51 nucleoprotein filaments results from the interplay between ATP hydrolysis and the release of the tension stored in the filament. By applying external tension to the DNA, we found that disassembly slows down and can even be stalled. We quantified the fluorescence of RAD51 patches and found that disassembly occurs in bursts interspersed by long pauses. After relaxation of a stalled complex, pauses were suppressed resulting in a large burst. These results indicate that tension- dependent disassembly takes place only from filament ends, after tension- independent ATP hydrolysis. This integrative single-molecule approach allowed us to dissect the mechanism of this principal homologous recombination reaction step, which in turn clarifies how disassembly can be influenced by accessory proteins.	[van Mameren, Joost; Peterman, Erwin J. G.; Wuite, Gijs J. L.] Vrije Univ Amsterdam, Ctr Laser, NL-1081 HV Amsterdam, Netherlands; [van Mameren, Joost; Peterman, Erwin J. G.; Wuite, Gijs J. L.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Modesti, Mauro; Kanaar, Roland; Wyman, Claire] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands; [Modesti, Mauro] Univ Aix Marseille 2, CNRS, Unite Propre Rech 3081, F-13402 Marseille 20, France; [Kanaar, Roland; Wyman, Claire] Erasmus MC, Dept Radiat Oncol, NL-3000 CA Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Erasmus University Rotterdam; Erasmus MC	Peterman, EJG (corresponding author), Vrije Univ Amsterdam, Ctr Laser, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	erwinp@few.vu.nl; gwuite@few.vu.nl	Modesti, Mauro/D-6258-2017; Classen, Scott/AAY-8176-2020; Peterman, Erwin/G-5529-2010	Modesti, Mauro/0000-0002-4964-331X; Peterman, Erwin/0000-0003-1058-249X; van Mameren, Joost/0000-0002-0582-6173; wuite, gijs/0000-0002-5706-043X	Biomolecular Physics; Dutch organization for Fundamental Research of Matter (FOM); Dutch Cancer Society; Netherlands Organization for Scientific Research; Netherlands Genomics Initiative/NWO; Association for International Cancer Research; European Commission Integrated Projects Molecular Imaging; DNA Repair; National Cancer Institute-National Institutes of Health USA; NWO Vidi; NWO Vici; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER	Biomolecular Physics; Dutch organization for Fundamental Research of Matter (FOM)(FOM (The Netherlands)); Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative/NWO(Netherlands Organization for Scientific Research (NWO)); Association for International Cancer Research; European Commission Integrated Projects Molecular Imaging(European CommissionEuropean Commission Joint Research Centre); DNA Repair; National Cancer Institute-National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NWO Vidi(Netherlands Organization for Scientific Research (NWO)); NWO Vici(Netherlands Organization for Scientific Research (NWO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. van den Broek and R. T. Dame for discussions and a critical reading of the manuscript and J. Kerssemakers for kindly providing his step fitting algorithm. This work was supported by the Biomolecular Physics program of the Dutch organization for Fundamental Research of Matter (FOM) ( to R.K., C.W., E.J. G.P. and G.J.L.W.), and grants from the Dutch Cancer Society (KWF), the Netherlands Organization for Scientific Research (NWO), the Netherlands Genomics Initiative/NWO, the Association for International Cancer Research and the European Commission Integrated Projects Molecular Imaging and DNA Repair and a National Cancer Institute-National Institutes of Health USA program project (to C.W. and R.K.). E.J.G.P. and G.J.L.W. are recipients of NWO Vidi grants; C.W. of an NWO Vici grant.	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bianco P R, 1998, Front Biosci, V3, pD570; Brau RR, 2006, BIOPHYS J, V91, P1069, DOI 10.1529/biophysj.106.082602; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kiianitsa K, 2006, P NATL ACAD SCI USA, V103, P9767, DOI 10.1073/pnas.0604240103; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.bi.63.070194.005015; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; Noom MC, 2007, NAT METHODS, V4, P1031, DOI 10.1038/nmeth1126; Ristic D, 2005, NUCLEIC ACIDS RES, V33, P3292, DOI 10.1093/nar/gki640; Shim KS, 2006, DNA REPAIR, V5, P704, DOI 10.1016/j.dnarep.2006.03.004; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Symington LS, 2006, GENE DEV, V20, P2479, DOI 10.1101/gad.1477106; Tombline G, 2002, J BIOL CHEM, V277, P14426, DOI 10.1074/jbc.M109916200; Tombline G, 2002, J BIOL CHEM, V277, P14417, DOI 10.1074/jbc.M109915200; van den Broek B, 2005, NUCLEIC ACIDS RES, V33, P2676, DOI 10.1093/nar/gki565; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629; van Mameren J, 2006, BIOPHYS J, V91, pL78, DOI 10.1529/biophysj.106.089466; Wyman C, 2006, STRUCTURE, V14, P949, DOI 10.1016/j.str.2006.05.008; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	30	125	126	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					745	748		10.1038/nature07581	http://dx.doi.org/10.1038/nature07581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19060884	Green Accepted			2022-12-01	WOS:000263064700046
J	Koppel, DA				Koppel, David A.			Medicine and the Media Serious documentary or freak show?	BRITISH MEDICAL JOURNAL			English	Editorial Material									So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow	Koppel, DA (corresponding author), So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland.	David.Koppel@ggc.scot.nhs.uk							0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 4	2009	338								b71	10.1136/bmj.b71	http://dx.doi.org/10.1136/bmj.b71			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OY	19193688				2022-12-01	WOS:000263876300013
J	Paterson, AH; Bowers, JE; Bruggmann, R; Dubchak, I; Grimwood, J; Gundlach, H; Haberer, G; Hellsten, U; Mitros, T; Poliakov, A; Schmutz, J; Spannagl, M; Tang, HB; Wang, XY; Wicker, T; Bharti, AK; Chapman, J; Feltus, FA; Gowik, U; Grigoriev, IV; Lyons, E; Maher, CA; Martis, M; Narechania, A; Otillar, RP; Penning, BW; Salamov, AA; Wang, Y; Zhang, LF; Carpita, NC; Freeling, M; Gingle, AR; Hash, CT; Keller, B; Klein, P; Kresovich, S; McCann, MC; Ming, R; Peterson, DG; Mehboob-ur-Rahman; Ware, D; Westhoff, P; Mayer, KFX; Messing, J; Rokhsar, DS				Paterson, Andrew H.; Bowers, John E.; Bruggmann, Remy; Dubchak, Inna; Grimwood, Jane; Gundlach, Heidrun; Haberer, Georg; Hellsten, Uffe; Mitros, Therese; Poliakov, Alexander; Schmutz, Jeremy; Spannagl, Manuel; Tang, Haibao; Wang, Xiyin; Wicker, Thomas; Bharti, Arvind K.; Chapman, Jarrod; Feltus, F. Alex; Gowik, Udo; Grigoriev, Igor V.; Lyons, Eric; Maher, Christopher A.; Martis, Mihaela; Narechania, Apurva; Otillar, Robert P.; Penning, Bryan W.; Salamov, Asaf A.; Wang, Yu; Zhang, Lifang; Carpita, Nicholas C.; Freeling, Michael; Gingle, Alan R.; Hash, C. Thomas; Keller, Beat; Klein, Patricia; Kresovich, Stephen; McCann, Maureen C.; Ming, Ray; Peterson, Daniel G.; Mehboob-ur-Rahman; Ware, Doreen; Westhoff, Peter; Mayer, Klaus F. X.; Messing, Joachim; Rokhsar, Daniel S.			The Sorghum bicolor genome and the diversification of grasses	NATURE			English	Article							RICE GENOME; WIDE ANALYSIS; MAIZE GENOME; CELL-WALLS; EVOLUTION; SEQUENCE; IDENTIFICATION; RECOMBINATION; DUPLICATION; REVEALS	Sorghum, an African grass related to sugar cane and maize, is grown for food, feed, fibre and fuel. We present an initial analysis of the similar to 730- megabase Sorghumbicolor ( L.) Moench genome, placing, 98% of genes in their chromosomal context using whole- genome shotgun sequence validated by genetic, physical and syntenic information. Genetic recombination is largely confined to about one- third of the sorghum genome with gene order and density similar to those of rice. Retrotransposon accumulation in recombinationally recalcitrant heterochromatin explains the similar to 75% larger genome size of sorghum compared with rice. Although gene and repetitive DNA distributions have been preserved since palaeopolyploidization similar to 70 million years ago, most duplicated gene sets lost one member before the sorghum - rice divergence. Concerted evolution makes one duplicated chromosomal segment appear to be only a few million years old. About 24% of genes are grass- specific and 7% are sorghum- specific. Recent gene and microRNA duplications may contribute to sorghum's drought tolerance.	[Paterson, Andrew H.; Bowers, John E.; Tang, Haibao; Wang, Xiyin; Feltus, F. Alex; Gingle, Alan R.; Peterson, Daniel G.; Mehboob-ur-Rahman] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Bruggmann, Remy; Bharti, Arvind K.; Messing, Joachim] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Dubchak, Inna; Hellsten, Uffe; Poliakov, Alexander; Chapman, Jarrod; Grigoriev, Igor V.; Otillar, Robert P.; Salamov, Asaf A.; Rokhsar, Daniel S.] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Grimwood, Jane; Schmutz, Jeremy; Rokhsar, Daniel S.] Stanford Univ, Stanford Human Genome Ctr, Palo Alto, CA 94304 USA; [Gundlach, Heidrun; Haberer, Georg; Spannagl, Manuel; Martis, Mihaela; Wang, Yu; Mayer, Klaus F. X.] Helmholtz Zentrum Munchen, MIPS IBIS, D-85764 Neuherberg, Germany; [Mitros, Therese] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Wang, Xiyin] Hebei Polytech Univ, Coll Sci, Tangshan 063000, Hebei, Peoples R China; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Feltus, F. Alex] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29631 USA; [Gowik, Udo; Westhoff, Peter] Univ Dusseldorf, Inst Entwicklungs & Mol Biol Pflanzen, D-40225 Dusseldorf, Germany; [Lyons, Eric; Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA; [Maher, Christopher A.; Narechania, Apurva; Zhang, Lifang] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Penning, Bryan W.; McCann, Maureen C.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Carpita, Nicholas C.] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Hash, C. Thomas] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Andhra Pradesh, India; [Klein, Patricia] Texas A&M Univ, Dept Hort, College Stn, TX 77843 USA; [Klein, Patricia] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; [Kresovich, Stephen] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Ming, Ray] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Peterson, Daniel G.] Mississippi State Univ, Mississippi Genome Explorat Lab, Starkville, MS 39762 USA; [Mehboob-ur-Rahman] NIBGE, Faisalabad, Pakistan; [Ware, Doreen] USDA, NAA Robert Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	University System of Georgia; University of Georgia; Rutgers State University New Brunswick; United States Department of Energy (DOE); Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California Berkeley; North China University of Science & Technology; University of Zurich; Clemson University; Heinrich Heine University Dusseldorf; University of California System; University of California Berkeley; Cold Spring Harbor Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Cornell University; University of Illinois System; University of Illinois Urbana-Champaign; Mississippi State University; Pakistan Institute of Engineering & Applied Science; United States Department of Agriculture (USDA)	Paterson, AH (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@uga.edu	Wicker, Thomas/Z-1978-2019; Tang, Haibao/A-6715-2011; Schmutz, Jeremy/N-3173-2013; Grimwood, Jane/ABD-5737-2021; McCann, Maureen C/T-9258-2017; Keller, Beat/K-3093-2019; Rahman, Mehboob-ur-/I-7983-2015; Mayer, Klaus FX/M-7941-2015; Bowers, John/B-9245-2009; Bowers, John/AAD-7601-2019	Tang, Haibao/0000-0002-3460-8570; Schmutz, Jeremy/0000-0001-8062-9172; McCann, Maureen C/0000-0001-6956-4216; Keller, Beat/0000-0003-2379-9225; Mayer, Klaus FX/0000-0001-6484-1077; Bowers, John/0000-0001-8984-9796; Spannagl, Manuel/0000-0003-0701-7035; Penning, Bryan/0000-0002-0374-8693; Gowik, Udo/0000-0002-8986-7318; Lyons, Eric/0000-0002-3348-8845; Martis, Mihaela-Maria/0000-0001-7509-2446; Bowers, John/0000-0001-5693-2796; Bruggmann, Remy/0000-0001-5629-6363; Feltus, Frank/0000-0002-2123-6114; Messing, Joachim/0000-0001-8260-2643; Rokhsar, Daniel/0000-0002-8704-2224; Grigoriev, Igor/0000-0002-3136-8903; Haberer, Georg/0000-0002-6612-6939; Peterson, Daniel/0000-0002-0274-5968; , Thomas/0000-0002-6777-7135; Gundlach, Heidrun/0000-0002-6757-0943	US National Science Foundation [DBI-9872649, DBI-0115903, MCB-0450260, DBI-0321467]; International Consortium for Sugarcane Biotechnology; National Sorghum Producers; John Simon Guggenheim Foundation; US Department of Energy [DE-FG05-95ER20194]; German Federal Ministry of Education GABI initiative [0313117, 0314000C]; US Department of Agriculture-Agricultural Research Service	US National Science Foundation(National Science Foundation (NSF)); International Consortium for Sugarcane Biotechnology; National Sorghum Producers; John Simon Guggenheim Foundation; US Department of Energy(United States Department of Energy (DOE)); German Federal Ministry of Education GABI initiative; US Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	We thank the US Department of Energy Joint Genome Institute Community Sequencing Program, J. Bristow, S. Lucas and the JGI production sequencing team for sequencing sorghum; and L. Lin for contributions to Fig. 1. We appreciate funding from the US National Science Foundation (NSF DBI-9872649, 0115903; MCB-0450260), International Consortium for Sugarcane Biotechnology, National Sorghum Producers, and a John Simon Guggenheim Foundation fellowship to A.H.P.; US Department of Energy (DE-FG05-95ER20194) to J.M.; German Federal Ministry of Education GABI initiative to MIPS (0313117 and 0314000C); NSF DBI-0321467 to A.N.; and US Department of Agriculture-Agricultural Research Service to C.A.M., L.Z. and D.W.	Bowers JE, 2005, P NATL ACAD SCI USA, V102, P13206, DOI 10.1073/pnas.0502365102; Bowers JE, 2003, GENETICS, V165, P367; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Choisne N, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-20; Devos KM, 2000, THEOR APPL GENET, V100, P190, DOI 10.1007/s001220050026; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; GARDNER RC, 1981, NUCLEIC ACIDS RES, V9, P2871, DOI 10.1093/nar/9.12.2871; Haas B, 2002, GENOME BIOL, V3; Haberer G, 2005, PLANT PHYSIOL, V139, P1612, DOI 10.1104/pp.105.068718; Hamblin MT, 2005, GENETICS, V171, P1247, DOI 10.1534/genetics.105.041566; HATCH MD, 1966, BIOCHEM J, V101, P103, DOI 10.1042/bj1010103; Hazen SP, 2003, PLANT PHYSIOL, V132, P263, DOI 10.1104/pp.103.020016; HUO N, 2007, GENOMICS, V8, P135; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kim JS, 2005, GENETICS, V169, P1169, DOI 10.1534/genetics.104.035980; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Lohithaswa HC, 2007, THEOR APPL GENET, V115, P237, DOI 10.1007/s00122-007-0559-4; Lu C, 2008, P NATL ACAD SCI USA, V105, P4951, DOI 10.1073/pnas.0708743105; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCann MC, 1991, CYTOSKELETAL BASIS P, P109; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Miller JT, 1998, THEOR APPL GENET, V96, P832, DOI 10.1007/s001220050809; Ming R, 2006, PL BRED RE, V27, P15; Morrell PL, 2005, MOL ECOL, V14, P2143, DOI 10.1111/j.1365-294X.2005.02579.x; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; PATERSON AH, 1995, P NATL ACAD SCI USA, V92, P6127, DOI 10.1073/pnas.92.13.6127; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Singh NK, 2007, FUNCT INTEGR GENOMIC, V7, P17, DOI 10.1007/s10142-006-0033-4; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Swigonova Z, 2005, GENETICS, V169, P891, DOI 10.1534/genetics.104.034629; Swigonova Z, 2004, COMP FUNCT GENOM, V5, P281, DOI 10.1002/cfg.395; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Wang XY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-447; Wang XY, 2007, GENETICS, V177, P1753, DOI 10.1534/genetics.107.073197; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Xu JH, 2008, P NATL ACAD SCI USA, V105, P14330, DOI 10.1073/pnas.0807026105; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022	50	1960	2248	8	378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					551	556		10.1038/nature07723	http://dx.doi.org/10.1038/nature07723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19189423	Green Accepted, Green Submitted, hybrid			2022-12-01	WOS:000262852200034
J	Oda, T; Iwasa, M; Aihara, T; Maeda, Y; Narita, A				Oda, Toshiro; Iwasa, Mitsusada; Aihara, Tomoki; Maeda, Yuichiro; Narita, Akihiro			The nature of the globular-to fibrous-actin transition	NATURE			English	Article							FIBER DIFFRACTION DATA; F-ACTIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MONOMERIC ACTIN; ARP2/3 COMPLEX; ELECTRON CRYOMICROSCOPY; MOLECULAR-DYNAMICS; NORMAL-MODES; YEAST ACTIN	Actin plays crucial parts in cell motility through a dynamic process driven by polymerization and depolymerization, that is, the globular ( G) to fibrous ( F) actin transition. Although our knowledge about the actin- based cellular functions and the molecules that regulate the G- to F- actin transition is growing, the structural aspects of the transition remain enigmatic. We created a model of F- actin using X- ray fibre diffraction intensities obtained from well oriented sols of rabbit skeletal muscle F- actin to 3.3 A in the radial direction and 5.6 A along the equator. Here we show that the G- to F- actin conformational transition is a simple relative rotation of the two major domains by about 20 degrees. As a result of the domain rotation, the actin molecule in the filament is flat. The flat form is essential for the formation of stable, helical F- actin. Our F- actin structure model provides the basis for understanding actin polymerization as well as its molecular interactions with actin- binding proteins.	[Oda, Toshiro; Aihara, Tomoki] RIKEN, Harima Inst, Xray Struct Anal Res Team, SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Oda, Toshiro; Iwasa, Mitsusada; Maeda, Yuichiro] Japan Sci & Technol Agcy, ERATO Project Actin Filament Dynam, Mikazuki, Hyogo 6795148, Japan; [Maeda, Yuichiro; Narita, Akihiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Nagoya, Aichi 4648601, Japan; [Maeda, Yuichiro; Narita, Akihiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan	Japan Synchrotron Radiation Research Institute; RIKEN; Japan Science & Technology Agency (JST); Nagoya University; Nagoya University	Oda, T (corresponding author), RIKEN, Harima Inst, Xray Struct Anal Res Team, SPring 8 Ctr, 1-1-1 Kouto, Mikazuki, Hyogo 6795148, Japan.	toda@spring8.or.jp	Oda, Toshiro/F-6151-2011		Kazato Research Foundation	Kazato Research Foundation(Kazato Research Foundation)	We thank K. C. Holmes for continuous encouragement and D. Hanein for the gift of the atomic coordinates of the Volkmann et al. model ( ref. 24). We thank K. Namba, K. Makino and K. Hasegwa for comments on the manuscript, the gift of software package for the fibre analysis and help with recording the diffraction patterns. We also thank S. Fujiwara and K. Mihashi for comments on the manuscript. We finally thank beam- line staffs at SPring-8 BL40B2, BL41XU and BL45XU-SAX, especially M. Kawamoto and K. Ito. The electron microscopy section of this study is partially supported by the Kazato Research Foundation (A.N.).	Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; Allingham JS, 2005, P NATL ACAD SCI USA, V102, P14527, DOI 10.1073/pnas.0502089102; Asakura S., 1975, THERMODYNAMICS POLYM; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; Dalhaimer P, 2008, J MOL BIOL, V376, P166, DOI 10.1016/j.jmb.2007.11.068; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FURUHASHI K, 1992, J BIOL CHEM, V267, P9326; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO;2-I; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; Joel PB, 2004, BIOCHEMISTRY-US, V43, P11554, DOI 10.1021/bi048899a; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kudryashov DS, 2005, P NATL ACAD SCI USA, V102, P13105, DOI 10.1073/pnas.0506429102; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Narita A, 2006, EMBO J, V25, P5626, DOI 10.1038/sj.emboj.7601395; Narita A, 2007, J MOL BIOL, V365, P480, DOI 10.1016/j.jmb.2006.06.056; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; Oda T, 1998, BIOPHYS J, V75, P2672, DOI 10.1016/S0006-3495(98)77712-4; Oda T, 2007, ADV EXP MED BIOL, V592, P385; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rizvi SA, 2006, J AM CHEM SOC, V128, P3882, DOI 10.1021/ja058319c; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Straub FB, 1942, STUD I MED CHEM U SZ, V2, P3; TIRION MM, 1995, BIOPHYS J, V68, P5, DOI 10.1016/S0006-3495(95)80156-6; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; WANG H, 1993, ACTA CRYSTALLOGR A, V49, P504, DOI 10.1107/S0108767392011255; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; WERTMAN KF, 1992, GENETICS, V132, P337; Wu YH, 2004, BIOPHYS J, V86, P116, DOI 10.1016/S0006-3495(04)74089-8; Yao XY, 2002, J BIOL CHEM, V277, P22875, DOI 10.1074/jbc.M201685200	50	446	448	5	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					441	445		10.1038/nature07685	http://dx.doi.org/10.1038/nature07685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158791				2022-12-01	WOS:000262519200038
J	Young, LJ				Young, Larry J.			Being Human: Love: Neuroscience reveals all	NATURE			English	Editorial Material									[Young, Larry J.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University	Young, LJ (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30322 USA.	lyoun03@emory.edu							0	51	55	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					148	148		10.1038/457148a	http://dx.doi.org/10.1038/457148a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19129828				2022-12-01	WOS:000262360200017
J	De'ath, G; Lough, JM; Fabricius, KE				De'ath, Glenn; Lough, Janice M.; Fabricius, Katharina E.			Declining Coral Calcification on the Great Barrier Reef	SCIENCE			English	Article							MASSIVE PORITES; OCEAN ACIDIFICATION; CLIMATE-CHANGE; TEMPERATURE; GROWTH; VARIABILITY; CENTURIES; SEAWATER; CARBON	Reef- building corals are under increasing physiological stress from a changing climate and ocean absorption of increasing atmospheric carbon dioxide. We investigated 328 colonies of massive Porites corals from 69 reefs of the Great Barrier Reef ( GBR) in Australia. Their skeletal records show that throughout the GBR, calcification has declined by 14.2% since 1990, predominantly because extension ( linear growth) has declined by 13.3%. The data suggest that such a severe and sudden decline in calcification is unprecedented in at least the past 400 years. Calcification increases linearly with increasing large- scale sea surface temperature but responds nonlinearly to annual temperature anomalies. The causes of the decline remain unknown; however, this study suggests that increasing temperature stress and a declining saturation state of seawater aragonite may be diminishing the ability of GBR corals to deposit calcium carbonate.	[De'ath, Glenn; Lough, Janice M.; Fabricius, Katharina E.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	De'ath, G (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	g.death@aims.gov.au	Gates, Audrey/AAD-2165-2019; Lough, Janice M/L-1682-2013; Fabricius, Katharina E/F-1759-2010	Lough, Janice M/0000-0002-3789-1009; Fabricius, Katharina E/0000-0001-7671-4358	Australian Institute of Marine Science	Australian Institute of Marine Science	We thank M. Devereux, E. Matson, D. Thomson, T. Cooper, and R. Berkelmans for collecting and preparing coral samples. This study was funded by the Australian Institute of Marine Science. The long coral core growth data are lodged with the National Oceanographic and Atmospheric Administration Paleoclimatology Data Center (www.ncdc.noaa.gov/paleo/).	Bessat F, 2001, PALAEOGEOGR PALAEOCL, V175, P381, DOI 10.1016/S0031-0182(01)00381-9; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CHALKER BE, 1990, CORAL REEFS, V9, P11, DOI 10.1007/BF00686717; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; Gagan MK, 2000, QUATERNARY SCI REV, V19, P45, DOI 10.1016/S0277-3791(99)00054-2; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; Lough JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034634; Lough JM, 2008, J ENVIRON MONITOR, V10, P21, DOI 10.1039/B714627M; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Lough JM, 1997, J EXP MAR BIOL ECOL, V211, P29, DOI 10.1016/S0022-0981(96)02710-4; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Ohde S, 2004, GEOCHEM J, V38, P613, DOI 10.2343/geochemj.38.613; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pelejero C, 2005, SCIENCE, V309, P2204, DOI 10.1126/science.1113692; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Veron J.E.N., 2008, REEF TIME GREAT BARR; WAHBA G, 1983, J ROY STAT SOC B MET, V45, P133	28	461	467	4	534	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					116	119		10.1126/science.1165283	http://dx.doi.org/10.1126/science.1165283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119230				2022-12-01	WOS:000262104100053
J	Yu, Y; Maroney, PA; Denker, JA; Zhang, XHF; Dybkov, O; Luhrmann, R; Jankowsky, E; Chasin, LA; Nilsen, TW				Yu, Yang; Maroney, Patricia A.; Denker, John A.; Zhang, Xiang H. -F.; Dybkov, Olexandr; Luehrmann, Reinhard; Jankowsky, Eckhard; Chasin, Lawrence A.; Nilsen, Timothy W.			Dynamic Regulation of Alternative Splicing by Silencers that Modulate 5 ' Splice Site Competition	CELL			English	Article							PRE-MESSENGER-RNA; SEX-LETHAL; U1 SNRNP; PREMESSENGER RNA; EXON RECOGNITION; GENE-EXPRESSION; SR PROTEINS; HNRNP A1; IN-VIVO; COMPLEX	Alternative splicing makes a major contribution to proteomic diversity in higher eukaryotes with similar to 70% of genes encoding two or more isoforms. In most cases, the molecular mechanisms responsible for splice site choice remain poorly understood. Here, we used a randomization-selection approach in vitro to identify sequence elements that could silence a proximal strong 5' splice site located downstream of a weakened 5' splice site. We recovered two exonic and four intronic motifs that effectively silenced the proximal 5' splice site both in vitro and in vivo. Surprisingly, silencing was only observed in the presence of the competing upstream 5' splice site. Biochemical evidence strongly suggests that the silencing motifs function by altering the U1 snRNP/5' splice site complex in a manner that impairs commitment to specific splice site pairing. The data indicate that perturbations of non-ratelimiting step(s) in splicing can lead to dramatic shifts in splice site choice.	[Yu, Yang; Maroney, Patricia A.; Denker, John A.; Jankowsky, Eckhard; Nilsen, Timothy W.] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Yu, Yang; Jankowsky, Eckhard; Nilsen, Timothy W.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Zhang, Xiang H. -F.; Chasin, Lawrence A.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Dybkov, Olexandr; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Abt Zellulare Biochem, D-37077 Gottingen, Germany	Case Western Reserve University; Case Western Reserve University; Columbia University; Max Planck Society	Nilsen, TW (corresponding author), Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA.	twn@case.edu	Yu, Yang/E-8245-2010	Yu, Yang/0000-0003-0536-2783; Zhang, Xiang/0000-0002-5674-8670; Jankowsky, Eckhard/0000-0001-7677-7412	Sixth Framework Program of the European Union; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R01GM031528] Funding Source: NIH RePORTER	Sixth Framework Program of the European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bruzik, B. Chabot, and P. Grabowski for providing constructs, and S. Gunderson and I. Mattai for anti-U1A antiserum. We also thank D. Black, C. Burge, M. Caprara, X.D. Fu, B. Graveley, K. Hertel, B. Konforti, A. Krainer, K. Lynch, J. Manley, D. Rio, and J. Steitz as well as the anonymous reviewers for constructive comments, and A. M. Micenmacher for preparing the manuscript. The research was supported by a grant from the Sixth Framework Program of the European Union via The Network of Excellence "EURASNET'' to R.L. and NIH grants to E.J., L.A.C., and T.W.N.	AGRIS CH, 1989, MOL CELL BIOL, V9, P259, DOI 10.1128/MCB.9.1.259; BARABINO SML, 1990, CELL, V63, P293, DOI 10.1016/0092-8674(90)90162-8; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Black DL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-317; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Chen CD, 1999, RNA, V5, P290, DOI 10.1017/S1355838299980743; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donmez G, 2007, MOL CELL, V25, P399, DOI 10.1016/j.molcel.2006.12.019; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fu XD, 2004, CELL, V119, P736, DOI 10.1016/j.cell.2004.11.039; Giles KE, 2005, MOL CELL BIOL, V25, P4397, DOI 10.1128/MCB.25.11.4397-4405.2005; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hochleitner EO, 2005, J BIOL CHEM, V280, P2536, DOI 10.1074/jbc.M409587200; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; JAMISON SF, 1992, MOL CELL BIOL, V12, P4279, DOI 10.1128/MCB.12.10.4279; KAMBACH C, 1992, J CELL BIOL, V118, P11, DOI 10.1083/jcb.118.1.11; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kanopka A, 1996, NATURE, V381, P535, DOI 10.1038/381535a0; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kheli AH, 2008, FEBS J, V275, P1150, DOI 10.1111/j.1742-4658.2008.06276.x; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Labourier E, 2001, MOL CELL, V8, P363, DOI 10.1016/S1097-2765(01)00311-2; Lam BJ, 2003, J BIOL CHEM, V278, P22740, DOI 10.1074/jbc.M301036200; Lim SR, 2004, MOL CELL, V15, P477, DOI 10.1016/j.molcel.2004.06.025; Manabe T, 2007, GENES CELLS, V12, P1179, DOI 10.1111/j.1365-2443.2007.01123.x; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Maroney PA, 2000, RNA, V6, P1905, DOI 10.1017/S1355838200001308; Maroney PA, 2000, MOL CELL, V6, P317, DOI 10.1016/S1097-2765(00)00032-0; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAYEDA A, 1988, MOL CELL BIOL, V8, P4484, DOI 10.1128/MCB.8.10.4484; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; MOUNT SM, 1983, CELL, V33, P509, DOI 10.1016/0092-8674(83)90432-4; Nagengast AA, 2003, DEVELOPMENT, V130, P463, DOI 10.1242/dev.00274; NELSON KK, 1988, GENE DEV, V2, P319, DOI 10.1101/gad.2.3.319; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; Olson S, 2007, NAT STRUCT MOL BIOL, V14, P1134, DOI 10.1038/nsmb1339; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; RUSKIN B, 1985, CELL, V43, P131, DOI 10.1016/0092-8674(85)90018-2; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; Shin C, 2004, NATURE, V427, P553, DOI 10.1038/nature02288; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; TAKACS AM, 1988, P NATL ACAD SCI USA, V85, P7932, DOI 10.1073/pnas.85.21.7932; TIAN M, 1994, GENE DEV, V8, P1703, DOI 10.1101/gad.8.14.1703; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhang XHF, 2003, GENOME RES, V13, P2637, DOI 10.1101/gr.1679003; Zheng ZM, 1998, P NATL ACAD SCI USA, V95, P14088, DOI 10.1073/pnas.95.24.14088; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	70	102	104	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1224	1236		10.1016/j.cell.2008.10.046	http://dx.doi.org/10.1016/j.cell.2008.10.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109894	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000261989800014
J	Qato, DM; Alexander, GC; Conti, RM; Johnson, M; Schumm, P; Lindau, ST				Qato, Dima M.; Alexander, G. Caleb; Conti, Rena M.; Johnson, Michael; Schumm, Phil; Lindau, Stacy Tessler			Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; NATIONAL-HEALTH	Context Despite concerns about drug safety, current information on older adults' use of prescription and over- the- counter medications and dietary supplements is limited. Objective To estimate the prevalence and patterns of medication use among older adults ( including concurrent use), and potential major drug- drug interactions. Design, Setting, and Participants Three thousand five community- residing individuals, aged 57 through 85 years, were drawn from a cross- sectional, nationally representative probability sample of the United States. In- home interviews, including medication logs, were administered between June 2005 and March 2006. Medication use was defined as prescription, over- the- counter, and dietary supplements used "on a regular schedule, like every day or every week." Concurrent use was defined as the regular use of at least 2 medications. Main Outcome Measure Population estimates of the prevalence of medication use, concurrent use, and potential major drug- drug interactions, stratified by age group and gender. Results The unweighted survey response rate was 74.8% ( weighted response rate, 75.5%). Eighty- one percent ( 95% confidence interval [ CI], 79.4%- 83.5%) used at least 1 prescription medication, 42% ( 95% CI, 39.7%- 44.8%) used at least 1 over- the-counter medication, and 49%( 95% CI, 46.2%- 52.7%) used a dietary supplement. Twenty-nine percent ( 95% CI, 26.6%- 30.6%) used at least 5 prescription medications concurrently; this was highest among men ( 37.1%; 95% CI, 31.7%- 42.4%) and women( 36.0%; 95% CI, 30.2%- 41.9%) aged 75 to 85 years. Among prescription medication users, concurrent use of over- the- counter medications was 46%( 95% CI, 43.4%- 49.1%) and concurrent use of dietary supplements was 52% ( 95% CI, 48.8%- 55.5%). Overall, 4% of individuals were potentially at risk of having a major drug- drug interaction; half of these involved the use of nonprescription medications. These regimens were most prevalent among men in the oldest age group ( 10%; 95% CI, 6.4%- 13.7%) and nearly half involved anticoagulants. No contraindicated concurrent drug use was identified. Conclusions In this sample of community- dwelling older adults, prescription and nonprescription medications were commonly used together, with nearly 1 in 25 individuals potentially at risk for a major drug- drug interaction.	[Qato, Dima M.; Lindau, Stacy Tessler] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Alexander, G. Caleb; Conti, Rena M.] Univ Chicago, Gen Internal Med Sect, Dept Med, Chicago, IL 60637 USA; [Alexander, G. Caleb; Lindau, Stacy Tessler] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; [Alexander, G. Caleb; Conti, Rena M.] Univ Chicago, Ctr Hlth & Social Sci, Chicago, IL 60637 USA; [Conti, Rena M.] Univ Chicago, Sect Pediat Hematol Oncol, Chicago, IL 60637 USA; [Johnson, Michael; Schumm, Phil] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Lindau, Stacy Tessler] Univ Chicago, Sect Geriatr, Dept Med, Chicago, IL 60637 USA; [Qato, Dima M.; Lindau, Stacy Tessler] Univ Chicago, Ctr Demog & Econ Aging, Chicago, IL 60637 USA; [Qato, Dima M.; Lindau, Stacy Tessler] Univ Chicago, NORC, Chicago Core Biomarkers Populat Based Res, Chicago, IL 60637 USA; [Qato, Dima M.] Univ Illinois, Dept Hlth Policy & Adm, Sch Publ Hlth, Chicago, IL USA; [Alexander, G. Caleb] Univ Illinois, Dept Pharm Practice, Sch Pharm, Chicago, IL USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Qato, DM (corresponding author), Univ Chicago, Dept Obstet & Gynecol, 5841 S Maryland Ave,MC 2050, Chicago, IL 60637 USA.	dqato@babies.bsd.uchicago.edu		Qato, Dima/0000-0001-5411-6998; Schumm, Phil/0000-0002-3050-2429; Conti, Rena/0000-0002-4190-1839	National Institutes of Health; National Institute on Aging; Office of Research on Women's Health; Office of AIDS Research; Office of Behavioral and Social Sciences Research [5R01AG021487]; NORC; Merck Foundation; Agency for Healthcare Research and Quality [K08 HS1569901A1]; Robert Wood Johnson Physician Faculty Scholars Program; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS015699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021487, P30AG012857, K23AG032870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Behavioral and Social Sciences Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC; Merck Foundation(Merck & Company); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Robert Wood Johnson Physician Faculty Scholars Program(Robert Wood Johnson Foundation (RWJF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The National Social Life, Health and Aging Project ( NSHAP) is supported by the National Institutes of Health, including the National Institute on Aging, the Office of Research on Women's Health, the Office of AIDS Research, and the Office of Behavioral and Social Sciences Research (5R01AG021487). NSHAP is also supported by NORC, whose staff was responsible for the data collection. The National Institutes of Health, National Institute on Aging University of Chicago - NORC Center on Demography and Economics of Aging Core on Biomarkers in Population-Based Health and Aging Research ( 5 P30 AG 012857) and the University of Chicago Program in Pharmaceutical Policy ( David Meltzer, principal investigator) also supported the effort of Dr Qato and Mssrs Schumm and Johnson on this article with a pilot grant ( Dr Lindau, principal investigator). The University of Chicago Program in Pharmaceutical Policy is supported by the Merck Foundation. Dr Alexander has career development awards from the Agency for Healthcare Research and Quality (K08 HS1569901A1) and the Robert Wood Johnson Physician Faculty Scholars Program. Supplies were donated to the NSHAP study by OraSure, Sunbeam, A&D Medical/LifeSource, Wilmer Eye Institute at the Johns Hopkins Bloomberg School of Public Health, Schleicher & Schuell Bioscience, BioMerieux, Roche Diagnostics, Digene, and Richard Williams.	Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Catlin A, 2008, HEALTH AFFAIR, V27, P14, DOI 10.1377/hlthaff.27.1.14; *CERN MULT INC, LEX PLUS DAT; CHRISCHILLES EA, 1992, J GERONTOL, V47, pM137, DOI 10.1093/geronj/47.5.M137; Curtis LH, 2007, JAMA-J AM MED ASSOC, V298, P1517, DOI 10.1001/jama.298.13.1517; Elmer GW, 2007, ANN PHARMACOTHER, V41, P1617, DOI 10.1345/aph.1K221; FILLENBAUM GG, 1993, AM J PUBLIC HEALTH, V83, P1577, DOI 10.2105/AJPH.83.11.1577; Gardiner P, 2006, ARCH INTERN MED, V166, P1968, DOI 10.1001/archinte.166.18.1968; Gaskin Darrell J, 2006, Am J Geriatr Pharmacother, V4, P96, DOI 10.1016/j.amjopharm.2006.06.008; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hanlon JT, 2001, DRUG AGING, V18, P123, DOI 10.2165/00002512-200118020-00005; Hensrud DD, 1999, MAYO CLIN PROC, V74, P443; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; *IMS, COMM REQ THER CLASS; *IMS, GEN MARK EXP SOAR 80; *IOM, 2006, FUT DRUG SAF PROM PR; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kris-Etherton, 2003, CIRCULATION, V107, P512, DOI 10.1161/01.CIR.0000054601.17182.B0; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; *NACDA, NAT SOC LIF HLTH AG; QATO D, NATL SOCIAL LIFE HLT; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; STAGNITTI MN, 2004, STAT BRIEF 180 TOP 5; *STATACORP, 2007, STAT COMP PROGR VERS; *THOMS REUT HEALTH, MICR HEALTHC SER; *US BUR CENS, POV THRESH 2006; *US FDA, CDER DRUG BIOL APPR; *US FDA, SENT IN NAT STRAT MO	33	629	663	4	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2867	2878						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109115	Bronze, Green Accepted			2022-12-01	WOS:000261920900020
J	Sharkey, N				Sharkey, Noel			COMPUTER SCIENCE The Ethical Frontiers of Robotics	SCIENCE			English	Editorial Material									[Sharkey, Noel] Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England	University of Sheffield	Sharkey, N (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England.	noel@dcs.shef.ac.uk						Blum, 2003, LOVE GOON PARK H HAR; Breazeal C, 2003, ROBOT AUTON SYST, V42, P167, DOI 10.1016/S0921-8890(02)00373-1; BROOKS RA, 1986, IEEE T ROBOTIC AUTOM, V2, P14, DOI 10.1109/JRA.1986.1087032; Fong T, 2003, ROBOT AUTON SYST, V42, P143, DOI 10.1016/S0921-8890(02)00372-X; Forlizzi J, 2004, HUM-COMPUT INTERACT, V19, P25, DOI 10.1207/s15327051hci1901&2_3; *IFR STAT DEP, WORLD ROB REP 2008; *NAT RES COUNC COM, 2005, AUT VEH SUPP NAV OP; Sharkey N, 2008, IEEE INTELL SYST, V23, P14, DOI 10.1109/MIS.2008.60; Sharkey N, 2006, ARTIF INTELL REV, V25, P9, DOI 10.1007/s10462-007-9048-z; Sparrow R., 2002, Ethics and Information Technology, V4, P305, DOI 10.1023/A:1021386708994; SPARROW R, 2004, MIND MACH, V16, P141; TANAKA F, 2007, P NATL ACAD SCI USA, V194, P46; *UN PRESS INT, 2008, BAE SYST TECH BOOSTS; *US DEP DEF, 2005, LSD AT L DEF SYST WA; US Department of Defense, 2007, UNM SYST ROADM 2007	15	82	84	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1800	1801		10.1126/science.1164582	http://dx.doi.org/10.1126/science.1164582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	385FF	19095930				2022-12-01	WOS:000261799400041
J	Blossom, DB; Kallen, AJ; Patel, PR; Elward, A; Robinson, L; Gao, GP; Langer, R; Perkins, KM; Jaeger, JL; Kurkjian, KM; Jones, M; Schillie, SF; Shehab, N; Ketterer, D; Venkataraman, G; Kishimoto, TK; Shriver, Z; McMahon, AW; Austen, KF; Kozlowski, S; Srinivasan, A; Turabelidze, G; Gould, CV; Arduino, MJ; Sasisekharan, R				Blossom, David B.; Kallen, Alexander J.; Patel, Priti R.; Elward, Alexis; Robinson, Luke; Gao, Ganpan; Langer, Robert; Perkins, Kiran M.; Jaeger, Jennifer L.; Kurkjian, Katie M.; Jones, Marilyn; Schillie, Sarah F.; Shehab, Nadine; Ketterer, Daniel; Venkataraman, Ganesh; Kishimoto, Takashi Kei; Shriver, Zachary; McMahon, Ann W.; Austen, K. Frank; Kozlowski, Steven; Srinivasan, Arjun; Turabelidze, George; Gould, Carolyn V.; Arduino, Matthew J.; Sasisekharan, Ram			Outbreak of Adverse Reactions Associated with Contaminated Heparin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANAPHYLACTOID REACTIONS; CLINICAL EVENTS; HEMODIALYSIS	Background: In January 2008, the Centers for Disease Control and Prevention began a nationwide investigation of severe adverse reactions that were first detected in a single hemodialysis facility. Preliminary findings suggested that heparin was a possible cause of the reactions. Methods: Information on clinical manifestations and on exposure was collected for patients who had signs and symptoms that were consistent with an allergic-type reaction after November 1, 2007. Twenty-one dialysis facilities that reported reactions and 23 facilities that reported no reactions were included in a case-control study to identify facility-level risk factors. Unopened heparin vials from facilities that reported reactions were tested for contaminants. Results: A total of 152 adverse reactions associated with heparin were identified in 113 patients from 13 states from November 19, 2007, through January 31, 2008. The use of heparin manufactured by Baxter Healthcare was the factor most strongly associated with reactions (present in 100.0% of case facilities vs. 4.3% of control facilities, P<0.001). Vials of heparin manufactured by Baxter from facilities that reported reactions contained a contaminant identified as oversulfated chondroitin sulfate (OSCS). Adverse reactions to the OSCS-contaminated heparin were often characterized by hypotension, nausea, and shortness of breath occurring within 30 minutes after administration. Of 130 reactions for which information on the heparin lot was available, 128 (98.5%) occurred in a facility that had OSCS-contaminated heparin on the premises. Of 54 reactions for which the lot number of administered heparin was known, 52 (96.3%) occurred after the administration of OSCS-contaminated heparin. Conclusions: Heparin contaminated with OSCS was epidemiologically linked to adverse reactions in this nationwide outbreak. The reported clinical features of many of the cases further support the conclusion that contamination of heparin with OSCS was the cause of the outbreak.	[Blossom, David B.; Kallen, Alexander J.; Patel, Priti R.; Schillie, Sarah F.; Shehab, Nadine; Srinivasan, Arjun; Gould, Carolyn V.; Arduino, Matthew J.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Blossom, David B.; Kallen, Alexander J.; Jaeger, Jennifer L.; Kurkjian, Katie M.; Schillie, Sarah F.] Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Atlanta, GA 30333 USA; [Blossom, David B.; Kallen, Alexander J.; Perkins, Kiran M.; Jaeger, Jennifer L.; Kurkjian, Katie M.; Schillie, Sarah F.; Ketterer, Daniel] Ctr Dis Control & Prevent, Off Workforce & Career Dev, Atlanta, GA 30333 USA; [Elward, Alexis] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Jones, Marilyn] BJC Healthcare, St Louis, MO USA; [Turabelidze, George] Missouri Dept Hlth & Senior Serv, St Louis, MO USA; [Robinson, Luke; Gao, Ganpan; Langer, Robert; Sasisekharan, Ram] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Langer, Robert; Sasisekharan, Ram] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Robinson, Luke; Gao, Ganpan; Langer, Robert; Sasisekharan, Ram] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Venkataraman, Ganesh; Kishimoto, Takashi Kei; Shriver, Zachary] Momenta Pharmaceut, Cambridge, MA USA; [McMahon, Ann W.; Kozlowski, Steven] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Austen, K. Frank] Brigham & Womens Hosp, Boston, MA 02115 USA; [Austen, K. Frank] Harvard Univ, Sch Med, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; St. Louis Children's Hospital; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); US Food & Drug Administration (FDA); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Patel, PR (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,MS-A31, Atlanta, GA 30333 USA.	ppatel@cdc.gov	Arduino, Matthew/C-1461-2012; Moore, Jeff/W-5653-2019	Arduino, Matthew/0000-0001-7072-538X; Shehab, Nadine/0000-0001-8700-8539	National Institutes of Health [GM57073, HL080279]; Momenta Pharmaceuticals and Scientific Protein; Momenta Pharmaceuticals; SAGE Products; Pfizer; Lilly; Monsanto; Walgreens; General Electric; Abbott; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, R01GM057073, T32GM008334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Momenta Pharmaceuticals and Scientific Protein; Momenta Pharmaceuticals; SAGE Products(General Electric); Pfizer(Pfizer); Lilly(Eli Lilly); Monsanto; Walgreens; General Electric(General Electric); Abbott(Abbott Laboratories); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The CDC investigation had no external funding. The laboratory analysis was supported in part by grants from the National Institutes of Health (GM57073 and HL080279, to Dr. Sasisekharan).; Dr. Venkataraman reports being an employee of Momenta Pharmaceuticals and holding equity in the company, which performs the analysis and characterization of complex mixtures, including heparin, and being an inventor on patent applications for Momenta Pharmaceuticals; Dr. Kishimoto, being an employee of, holding equity in, and being an inventor on patent applications for Momenta Pharmaceuticals; Dr. Langer, receiving consulting fees from Momenta Pharmaceuticals and Scientific Protein, having equity in Momenta Pharmaceuticals, and serving on a paid board of Momenta Pharmaceuticals; Dr. Shriver, being an employee of Momenta Pharmaceuticals and holding equity in the company; Dr. Sasisekharan, holding equity in Momenta Pharmaceuticals and receiving consulting fees or serving on a paid board of Momenta Pharmaceuticals and Scientific Protein Labs; Dr. Austen, receiving consulting fees from Momenta Pharmaceuticals; Dr. Elward, receiving consulting fees or serving on a paid advisory board for Trinity and receiving grant support from SAGE Products; and Dr. Schillie, holding equity in Pfizer, Lilly, Monsanto, Walgreens, General Electric, and Abbott. No other potential conflict of interest relevant to this article was reported.; The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U. S. Department of Health and Human Services.; We thank the many health care professionals at facilities at which adverse events occurred for reporting to public health authorities and for sending heparin vials for laboratory testing; the state epidemiologists and representatives of the End Stage Renal Disease Network for their assistance in facilitating contact between facilities with adverse events and the CDC; Laura Governale ( IMS Health), Gary Warns ( Gambro), and Bill Singley ( Minntech) for the timely information they provided; and representatives of the FDA for their close collaboration, especially in the early stages of this outbreak investigation, in particular, Karen Deasy and Tarun Mallick, who served as important links between the FDA and the CDC and furthered our collective efforts.	Arduino MJ, 2000, SEMIN DIALYSIS, V13, P86, DOI 10.1046/j.1525-139x.2000.00025.x; Berkun Y, 2004, CLIN EXP ALLERGY, V34, P1916, DOI 10.1111/j.1365-2222.2004.02129.x; Bircher AJ, 2006, ALLERGY, V61, P1432, DOI 10.1111/j.1398-9995.2006.01227.x; Bishu K, 2006, CLIN J AM SOC NEPHRO, V1, P820, DOI 10.2215/CJN.00060106; Bottio T, 2003, J THORAC CARDIOV SUR, V126, P1194, DOI 10.1016/S0022-5223(03)00813-4; *CTR MED MED SERV, 2008, INF DIAL FAC COMP; Dias MBS, 2008, INFECT CONT HOSP EP, V29, P125, DOI 10.1086/526440; Ebo DG, 2006, ALLERGY, V61, P211, DOI 10.1111/j.1398-9995.2006.00982.x; *FDA, 2008, INF ADV EV REP HEP; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Leypoldt JK, 2002, KIDNEY INT, V61, P266, DOI 10.1046/j.1523-1755.2002.00099.x; Ludwig RJ, 2006, MINI-REV MED CHEM, V6, P1009, DOI 10.2174/138955706778195180; Maharaj Chris, 2004, Curr Opin Anaesthesiol, V17, P35, DOI 10.1097/00001503-200402000-00007; PEGUES DA, 1992, KIDNEY INT, V42, P1232, DOI 10.1038/ki.1992.409; Schwartz LB, 2008, NEW ENGL J MED, V358, P2505, DOI 10.1056/NEJMe0803599; Vonberg RP, 2007, J HOSP INFECT, V65, P15, DOI 10.1016/j.jhin.2006.09.018; Walenga Jeanine M, 2007, Clin Adv Hematol Oncol, V5, P759; Wan S, 1999, ANN THORAC SURG, V68, P1230, DOI 10.1016/S0003-4975(99)00701-8; ZAKKAR M, 2007, CARDIOPULMONARY BYPA, P321; 2008, MMWR MORB MORTAL WKL, V57, P124; 2005, MMWR MORB MORTAL WKL, V54, P269	22	187	195	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2008	359	25					2674	2684		10.1056/NEJMoa0806450	http://dx.doi.org/10.1056/NEJMoa0806450			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384PS	19052120	Green Accepted			2022-12-01	WOS:000261757300007
J	Gormley, GJ; Dempster, M; Best, R				Gormley, Gerard J.; Dempster, Martin; Best, Rachael			Right-left discrimination among medical students: questionnaire and psychometric study	BRITISH MEDICAL JOURNAL			English	Article							SPATIAL ABILITY; MENTAL ROTATION; SEX-DIFFERENCES; HANDEDNESS; SITE	Objective To determine medical students' self awareness and ability to discriminate right from left; to identify characteristics associated with this ability; and to identify any techniques used to aid discrimination. Design Questionnaire and psychometric study. Setting Undergraduate medical school, Northern Ireland. Participants 290 first year undergraduate students. Main outcome measure Medical students' ability to discriminate right from left using the Bergen right- left discrimination test. Results Test scores ranged from 31 to 143 on a scale of 0144 ( mean 112 ( standard deviation 22.2)). Male students significantly outperformed female students ( 117.18 ( 26.96) v 110.80 ( 28.94)). Students who wanted to be surgeons performed significantly better than those who wanted to be general practitioners or medical doctors ( 119.87 ( 25.15) v 110.55 ( 27.36) v 112.50 ( 26.88)). The interaction effect for sex and career wishes was not significant ( P= 0.370). Students who used learnt techniques to help them discriminate scored significantly less than those who did not ( P< 0.001). Students had greater difficulty in discriminating right from left when looking at the forward view rather than the back view ( P< 0.001). Conclusions Male students were better than female students at distinguishing right from left, and aspiring surgeons were better than aspiring general practitioners or medical doctors. Students had more difficulty with the forward view than the back view. The ability to discriminate right from left calls on several higher functions including memory, visuospatial processing, language, integration of sensory information, and sometimes mental rotation.(1) Some people have difficulty in distinguishing right from left in themselves and in others.(23) Correctly discriminating right from left is important in the practice of medicine. Confusing a patient's right side from their left can result in surgery, procedures, and investigations being carried out on the wrong side.(4) Such mistakes may occur more frequently than is reported,(4) and prevention should start at undergraduate level.(5) Medical students perform better than psychology or law students in right- left discrimination tests, but data are limited.(6) We aimed to assess medical students' perceived and actual right- left discriminatory ability; to identify characteristics associated with this ability; and to identify any techniques used to aid discrimination.	[Gormley, Gerard J.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Med Educ, Belfast, Antrim, North Ireland; [Dempster, Martin; Best, Rachael] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Gormley, GJ (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Med Educ, Belfast, Antrim, North Ireland.	g.gormley@qub.ac.uk	Dempster, Martin/D-7188-2013	Dempster, Martin/0000-0001-9499-3186	Association for the Study of Medical Education	Association for the Study of Medical Education	Association for the Study of Medical Education (small project grant).	Auer T, 2008, LATERALITY, V13, P427, DOI 10.1080/13576500802114120; Benton AL, 1979, CLIN NEUROPSYCHOLOGY; *GEN MED COUNC, 1993, TOM DOCT REC CHANG U; Gibbs VC, 2005, SURG CLIN N AM, V85, P1307, DOI 10.1016/j.suc.2005.09.007; Gibson J B, 1973, Nature, V243, P482, DOI 10.1038/243482b0; GOLDSTEIN D, 1990, MEM COGNITION, V18, P546, DOI 10.3758/BF03198487; HANNAY HJ, 1990, PERCEPT MOTOR SKILL, V70, P451, DOI 10.2466/PMS.70.2.451-457; Johnson BW, 2002, NEUROREPORT, V13, P1929, DOI 10.1097/00001756-200210280-00020; KOHN L, 2000, TO ERR IS HUMAN BUIL; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; MARTINO G, 1995, BRAIN COGNITION, V29, P66, DOI 10.1006/brcg.1995.1268; MCKEEVER WF, 1986, CORTEX, V22, P521, DOI 10.1016/S0010-9452(86)80013-2; Ofte SH, 2002, J CLIN EXP NEUROPSYC, V24, P82, DOI 10.1076/jcen.24.1.82.966; Ofte SH, 2002, SCAND J PSYCHOL, V43, P213, DOI 10.1111/1467-9450.00289; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Seiden SC, 2006, ARCH SURG-CHICAGO, V141, P931, DOI 10.1001/archsurg.141.9.931; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; SILVERMAN AJ, 1966, J PSYCHOSOM RES, V10, P151, DOI 10.1016/0022-3999(66)90058-4; SNYDER TJ, 1991, DEV NEUROPSYCHOL, V7, P219, DOI 10.1080/87565649109540489	19	16	16	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 16	2008	337								a2826	10.1136/bmj.a2826	http://dx.doi.org/10.1136/bmj.a2826			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SV	19088140	Green Submitted, hybrid, Green Published			2022-12-01	WOS:000262184900002
J	Agogue, H; Brink, M; Dinasquet, J; Herndl, GJ				Agogue, Helene; Brink, Maaike; Dinasquet, Julie; Herndl, Gerhard J.			Major gradients in putatively nitrifying and non-nitrifying Archaea in the deep North Atlantic	NATURE			English	Article							AMMONIA-OXIDIZING BACTERIA; WATER MASSES; PLANKTONIC ARCHAEA; AMINO-ACIDS; OCEAN; SEA; NITRIFICATION; CRENARCHAEOTA; OXIDATION; ABUNDANCE	Aerobic nitrification of ammonia to nitrite and nitrate is a key process in the oceanic nitrogen cycling mediated by prokaryotes(1). Apart from Bacteria belonging to the beta- and gamma-Proteobacteria involved in the first nitrification step, Crenarchaeota have recently been recognized as main drivers of the oxidation of ammonia to nitrite in soil as well as in the ocean, as indicated by the dominance of archaeal ammonia monooxygenase (amoA) genes over bacterial amoA(2,3). Evidence is accumulating that archaeal amoA genes are common in a wide range of marine systems(3-6). Essentially, all these reports focused on surface and mesopelagic (200-1,000 m depth) waters, where ammonia concentrations are higher than in waters below 1,000 m depth. However, Crenarchaeota are also abundant in the water column below 1,000 m, where ammonia concentrations are extremely low. Here we show that, throughout the NorthAtlantic Ocean, the abundance of archaeal amoA genes decreases markedly from subsurface waters to 4,000 m depth, and from subpolar to equatorial deep waters, leading to pronounced vertical and latitudinal gradients in the ratio of archaeal amoA to crenarchaeal 16S ribosomal RNA ( rRNA) genes. The lack of significant copy numbers of amoA genes and the very low fixation rates of dark carbon dioxide in the bathypelagic North Atlantic suggest that most bathypelagic Crenarchaeota are not autotrophic ammonia oxidizers: most likely, they utilize organic matter and hence live heterotrophically.	[Agogue, Helene; Brink, Maaike; Dinasquet, Julie; Herndl, Gerhard J.] Royal Netherlands Inst Sea Res, Dept Biol Oceanog, NL-1790 AB Den Burg, Texel, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Herndl, GJ (corresponding author), Univ Vienna, Vienna Ecol Ctr, Dept Marine Biol, Waehringer Guertel 18, A-1090 Vienna, Austria.	herndl@nioz.nl	Herndl, Gerhard J./B-1513-2013; chen, qi/C-8585-2011; Herndl, Gerhard J./S-3011-2019; Agogué, Hélène/O-4122-2014	Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852; Agogué, Hélène/0000-0002-1078-0130	Marie Curie Fellowship of the European Community; Earth and Life Science Division of the Dutch Science Foundation (ALW-NWO) (TRANSAT and ARCHIMEDES projects); 6th Framework Program of the European Union	Marie Curie Fellowship of the European Community(European Commission); Earth and Life Science Division of the Dutch Science Foundation (ALW-NWO) (TRANSAT and ARCHIMEDES projects)(Netherlands Organization for Scientific Research (NWO)); 6th Framework Program of the European Union(European Commission)	We thank the captain and crew of the RV Pelagia for their help during work at sea. We thank H. M. van Aken for the characterization of the water masses, J.M. Arrieta for collecting the samples during the TRANSAT-1 cruise, B. Abbas, J. van Bleijswijk and H. Witte for technical discussions about the qPCR and phylogenetic analyses, and T. Reinthaler for discussions. We also thank A. Hunting, A. M. Schmitz and W. D. Lienhart for help with data processing. This research was supported by a Marie Curie Fellowship of the European Community to H. A. Shiptimewas provided through grants of the Earth and Life Science Division of the Dutch Science Foundation (ALW-NWO) (TRANSAT and ARCHIMEDES projects) to G. J. H. The work was performed within the frame of the 'Networks of Excellence' MarBef and EurOceans supported by the 6th Framework Program of the European Union.	Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Caffrey JM, 2007, ISME J, V1, P660, DOI 10.1038/ismej.2007.79; Church MJ, 2003, LIMNOL OCEANOGR, V48, P1893, DOI 10.4319/lo.2003.48.5.1893; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Hollibaugh JT, 2002, APPL ENVIRON MICROB, V68, P1478, DOI 10.1128/AEM.68.3.1478-1484.2002; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kirchman DL, 2007, LIMNOL OCEANOGR, V52, P495, DOI 10.4319/lo.2007.52.2.0495; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Martin-Cuadrado AB, 2008, ISME J, V2, P865, DOI 10.1038/ismej.2008.40; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Nakagawa T, 2007, MICROBES ENVIRON, V22, P365, DOI 10.1264/jsme2.22.365; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Rhein M, 2002, J PHYS OCEANOGR, V32, P648, DOI 10.1175/1520-0485(2002)032<0648:LSWPCI>2.0.CO;2; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Smethie WM, 2001, DEEP-SEA RES PT I, V48, P189, DOI 10.1016/S0967-0637(00)00048-0; Teira E, 2006, LIMNOL OCEANOGR, V51, P60, DOI 10.4319/lo.2006.51.1.0060; Teira E, 2006, LIMNOL OCEANOGR, V51, P2131, DOI 10.4319/lo.2006.51.5.2131; van Aken HM, 2000, DEEP-SEA RES PT I, V47, P757, DOI 10.1016/S0967-0637(99)00092-8; Varela MM, 2008, ENVIRON MICROBIOL, V10, P110, DOI 10.1111/j.1462-2920.2007.01437.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward BB, 2007, OCEANOGRAPHY, V20, P101, DOI 10.5670/oceanog.2007.53; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	29	205	217	3	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					788	U72		10.1038/nature07535	http://dx.doi.org/10.1038/nature07535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19037244	Green Submitted			2022-12-01	WOS:000261559900048
J	Blow, N				Blow, Nathan			Cell imaging: New ways to see a smaller world	NATURE			English	Editorial Material							MICROSCOPY											Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Lord SJ, 2008, J AM CHEM SOC, V130, P9204, DOI 10.1021/ja802883k; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929	6	20	22	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					825	830		10.1038/456825a	http://dx.doi.org/10.1038/456825a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079061	Bronze			2022-12-01	WOS:000261559900058
J	Thomson, G; Wilson, N; Edwards, R; Woodward, A				Thomson, George; Wilson, Nick; Edwards, Richard; Woodward, Alistair			Should smoking in outside public spaces be banned? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SCHOOL; HOME		[Thomson, George; Wilson, Nick; Edwards, Richard] Univ Otago, Wellington, New Zealand; [Woodward, Alistair] Univ Auckland, Auckland 1, New Zealand	University of Otago; University of Auckland	Thomson, G (corresponding author), Univ Otago, Box 7343, Wellington, New Zealand.	george.thomson@otago.ac.nz	Edwards, Richard/O-4771-2017	Edwards, Richard/0000-0003-2264-9823; Woodward, Alistair/0000-0001-5425-6018				Alesci NL, 2003, PREV MED, V36, P272, DOI 10.1016/S0091-7435(02)00029-4; *DEP ED, 1995, DRUG PREV SCH ANN 8; Fong GT, 2004, NICOTINE TOB RES, V6, P341, DOI 10.1080/14622200412331320743; Gilpin EA, 2004, TOB CONTROL, V13, P96, DOI 10.1136/tc.2003.007054; Griffiths J, 2005, SMOKE FREE SCOTLAND; *HLTH SPONS COUNC, 2008, ACC SMOK OUTD PUBL P; Klein EG, 2007, NICOTINE TOB RES, V9, pS49, DOI 10.1080/14622200601083467; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Levy DT, 2004, TOB CONTROL, V13, P258, DOI 10.1136/tc.2003.006056; Mackay J, 2006, TOBACCO ATLAS; McCaul KD, 2006, ADDICT BEHAV, V31, P42, DOI 10.1016/j.addbeh.2005.04.004; Milton B, 2004, PUBLIC HEALTH, V118, P247, DOI 10.1016/j.puhe.2003.10.006; *NAT CHILDC ACCR C, 2006, SMOK FREE ENV POL; New Zealand Government, 2003, SMOK FREE ENV AM ACT; Nuffield Council on Bioethics, 2007, PUBL HLTH ETH ISS; *POP, 2007, BBC DAIL POL SHOW PO; *QUIT VICT, 2007, QUIT GETS SMOK PLAYG; Repace JL, 2008, W MITCHELL LAW, V34, P1621; Stewart-Knox BJ, 2005, BRIT J SOC PSYCHOL, V44, P397, DOI 10.1348/014466604X18073; Tyas SL, 1998, TOB CONTROL, V7, P409, DOI 10.1136/tc.7.4.409; United Nations Office of the High Commissioner, 1990, CONV RIGHTS CHILD; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; Wilson Nick, 2007, N Z Med J, V120, pU2624	23	41	41	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2008	337								a2806	10.1136/bmj.a2806	http://dx.doi.org/10.1136/bmj.a2806			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CB	19074220				2022-12-01	WOS:000262776900007
J	Lewis, KW; Aharonson, O; Grotzinger, JP; Kirk, RL; McEwen, AS; Suer, TA				Lewis, Kevin W.; Aharonson, Oded; Grotzinger, John P.; Kirk, Randolph L.; McEwen, Alfred S.; Suer, Terry-Ann			Quasi-Periodic Bedding in the Sedimentary Rock Record of Mars	SCIENCE			English	Article							ARABIA TERRA; ATMOSPHERE; EVOLUTION; CRATERS; CYCLES	Widespread sedimentary rocks on Mars preserve evidence of surface conditions different from the modern cold and dry environment, although it is unknown how long conditions favorable to deposition persisted. We used 1- meter stereo topographic maps to demonstrate the presence of rhythmic bedding at several outcrops in the Arabia Terra region. Repeating beds are similar to 10 meters thick, and one site contains hundreds of meters of strata bundled into larger units at a similar to 10: 1 thickness ratio. This repetition likely points to cyclicity in environmental conditions, possibly as a result of astronomical forcing. If deposition were forced by orbital variation, the rocks may have been deposited over tens of millions of years.	[Lewis, Kevin W.; Aharonson, Oded; Grotzinger, John P.; Suer, Terry-Ann] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Kirk, Randolph L.] US Geol Survey, Flagstaff, AZ 86004 USA; [McEwen, Alfred S.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	California Institute of Technology; United States Department of the Interior; United States Geological Survey; University of Arizona	Lewis, KW (corresponding author), CALTECH, Div Geol & Planetary Sci, 150-21, Pasadena, CA 91125 USA.	klewis@gps.caltech.edu	Lewis, Kevin/E-5557-2012	Aharonson, Oded/0000-0001-9930-2495	NASA's Mars Data Analysis Program; NASA Earth and Space Science Fellowship	NASA's Mars Data Analysis Program(National Aeronautics & Space Administration (NASA)); NASA Earth and Space Science Fellowship	Supported by NASA's Mars Data Analysis Program and by the NASA Earth and Space Science Fellowship program. We thank two anonymous reviewers for helpful comments and suggestions.	Carlson J, 2001, SEDIMENTOLOGY, V48, P1331, DOI 10.1046/j.1365-3091.2001.00426.x; Carr MH, 1997, J GEOPHYS RES-PLANET, V102, P9145, DOI 10.1029/97JE00113; Christensen P., 1992, MARS SPACE SCI SERIE, P686; CUTTS JA, 1982, ICARUS, V50, P216, DOI 10.1016/0019-1035(82)90124-5; Edgett KS, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001587; Edgett KS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016515; FANALE FP, 1994, ICARUS, V111, P305, DOI 10.1006/icar.1994.1147; FISCHER AG, 1986, ANNU REV EARTH PL SC, V14, P351; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Hinnov LA, 2000, ANNU REV EARTH PL SC, V28, P419, DOI 10.1146/annurev.earth.28.1.419; HOUSE MR, 1995, GEOL SOC SP, P1, DOI 10.1144/GSL.SP.1995.085.01.01; Hynek BM, 2003, GEOLOGY, V31, P757, DOI 10.1130/G19607.1; Kahn R. A., 1992, MARS, P1017; Kieffer H. H., 1992, MARS, P1180; Kirk RL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003000; Landis GA, 2000, J GEOPHYS RES-PLANET, V105, P1855, DOI 10.1029/1999JE001029; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; Malamud BD, 2006, J HYDROL, V322, P168, DOI 10.1016/j.jhydrol.2005.02.032; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; McEwen A. S., 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; Milkovich SM, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002349; Schwarzacher W, 2000, EARTH-SCI REV, V50, P51, DOI 10.1016/S0012-8252(99)00070-7; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; WAITT RB, 1980, J GEOL, V88, P653, DOI 10.1086/628553; Ward W. R., 1992, MARS, P298; WARD WR, 1974, J GEOPHYS RES, V79, P3387, DOI 10.1029/JC079i024p03387; WEEDOM GP, 2003, TIME SERIES ANAL CYC; Wilkinson BH, 1998, GEOL SOC AM BULL, V110, P1075, DOI 10.1130/0016-7606(1998)110<1075:MHMPAR>2.3.CO;2	30	100	101	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1532	1535		10.1126/science.1161870	http://dx.doi.org/10.1126/science.1161870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056983				2022-12-01	WOS:000261377400046
J	McMahon, A; Supatto, W; Fraser, SE; Stathopoulos, A				McMahon, Amy; Supatto, Willy; Fraser, Scott E.; Stathopoulos, Angelike			Dynamic Analyses of Drosophila Gastrulation Provide Insights into Collective Cell Migration	SCIENCE			English	Article							MORPHOGENESIS; FGF; HEARTLESS; MOVEMENTS; MESODERM; INTERCALATION; ZEBRAFISH; BEHAVIOR; EMBRYOS	The concerted movement of cells from different germ layers contributes to morphogenesis during early embryonic development. Using an optimized imaging approach and quantitative methods, we analyzed the trajectories of hundreds of ectodermal cells and internalized mesodermal cells within Drosophila embryos over 2 hours during gastrulation. We found a high level of cellular organization, with mesoderm cell movements correlating with some but not all ectoderm movements. During migration, the mesoderm population underwent two ordered waves of cell division and synchronous cell intercalation, and cells at the leading edge stably maintained position. Fibroblast growth factor ( FGF) signaling guides mesodermal cell migration; however, we found some directed dorsal migration in an FGF receptor mutant, which suggests that additional signals are involved. Thus, decomposing complex cellular movements can provide detailed insights into collective cell migration.	[McMahon, Amy; Stathopoulos, Angelike] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Supatto, Willy; Fraser, Scott E.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Stathopoulos, A (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	angelike@caltech.edu	Fraser, Scott/Y-3406-2019; Supatto, Willy/B-3720-2013	Fraser, Scott/0000-0002-5377-0223; Supatto, Willy/0000-0002-4562-9166	NIH [R01 GM078542]; Searle Scholars Program; March of Dimes; Basil O'Conner Starter Scholar Award [5-FY06-12]; Caltech Beckman Institute; NIH Center for Excellence in Genomic Science [P50 HG004071]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; March of Dimes(March of Dimes); Basil O'Conner Starter Scholar Award(March of Dimes); Caltech Beckman Institute; NIH Center for Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Levine and E. Meyerowiz for comments on the manuscript, M. Liebling for advice on Imaris and Matlab, and the Caltech Biological Imaging Center for sharing equipment. This work was supported by grants to A. S. from NIH (R01 GM078542), the Searle Scholars Program, and the March of Dimes (Basil O'Conner Starter Scholar Award, 5-FY06-12), and grants to S. F. from the Caltech Beckman Institute and NIH (Center for Excellence in Genomic Science grant P50 HG004071).	Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lecaudey V, 2006, CURR OPIN CELL BIOL, V18, P102, DOI 10.1016/j.ceb.2005.12.001; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; Montell DJ, 2006, CURR OPIN GENET DEV, V16, P374, DOI 10.1016/j.gde.2006.06.010; Murray MJ, 2007, DEVELOPMENT, V134, P3975, DOI 10.1242/dev.005389; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Schumacher S, 2004, DEVELOPMENT, V131, P2631, DOI 10.1242/dev.01149; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Stern C.D., 2004, GASTRULATION CELLS E; Supatto W, 2005, P NATL ACAD SCI USA, V102, P1047, DOI 10.1073/pnas.0405316102; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Wilson R, 2005, DEVELOPMENT, V132, P491, DOI 10.1242/dev.01603; Wilson R, 2000, PHILOS T ROY SOC B, V355, P891, DOI 10.1098/rstb.2000.0625; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Zallen JA, 2008, SEMIN CELL DEV BIOL, V19, P263, DOI 10.1016/j.semcdb.2008.01.005	22	115	118	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1546	1550		10.1126/science.1167094	http://dx.doi.org/10.1126/science.1167094			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056986	Green Accepted			2022-12-01	WOS:000261377400050
J	Monne, M; Han, L; Schwend, T; Burendahl, S; Jovine, L				Monne, Magnus; Han, Ling; Schwend, Thomas; Burendahl, Sofia; Jovine, Luca			Crystal structure of the ZP-N domain of ZP3 reveals the core fold of animal egg coats	NATURE			English	Article							ZONA-PELLUCIDA PROTEINS; STRUCTURE ALIGNMENT; SPERM RECEPTORS; BINDING; PREDICTION; FERTILIZATION; GLYCOPROTEIN; MODEL; TOOL; CRYSTALLOGRAPHY	Species- specific recognition between the egg extracellular matrix ( zona pellucida) and sperm is the first, crucial step of mammalian fertilization(1). Zona pellucida filament components ZP3 and ZP2 act as sperm receptors, and mice lacking either of the corresponding genes produce oocytes without a zona pellucida and are completely infertile(2). Like their counterparts in the vitelline envelope of non- mammalian eggs and many other secreted eukaryotic proteins, zona pellucida subunits polymerize using a 'zona pellucida ( ZP) domain' module(3-5), whose conserved amino- terminal part (ZP-N) was suggested to constitute a domain of its own(6). No atomic structure has been reported for ZP domain proteins, and there is no structural information on any conserved vertebrate protein that is essential for fertilization and directly involved in egg - sperm binding. Here we describe the 2.3 angstrom (angstrom) resolution structure of the ZP-N fragment of mouse primary sperm receptor ZP3. The ZP- N fold defines a new immunoglobulin superfamily subtype with a beta-sheet extension characterized by an E' strand and an invariant tyrosine residue implicated in polymerization. The structure strongly supports the presence of ZP- N repeats within the N- terminal region of ZP2 and other vertebrate zona pellucida/ vitelline envelope proteins, with implications for overall egg coat architecture, the post- fertilization block to polyspermy and speciation. Moreover, it provides an important framework for understanding human diseases caused by mutations in ZP domain proteins and developing new methods of non- hormonal contraception.	[Monne, Magnus; Han, Ling; Schwend, Thomas; Burendahl, Sofia; Jovine, Luca] Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden	Karolinska Institutet	Jovine, L (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Halsovagen 7, SE-14157 Huddinge, Sweden.	luca.jovine@ki.se	Jovine, Luca/J-3563-2019; Jovine, Luca/E-8170-2010; Monné, Magnus/D-5642-2012	Jovine, Luca/0000-0002-2679-6946; Jovine, Luca/0000-0002-2679-6946; Monné, Magnus/0000-0003-2344-3878	Karolinska Institutet; Swedish Research Council [2005-5102]; European Community [Marie Curie ERG 31055]; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Karolinska Institutet, the Swedish Research Council (grant 2005-5102) and European Community (Marie Curie ERG 31055). We thank P. Nordlund and G. Schneider for access to the Stockholm SGC robotic crystallization facility and beamtime; H. Belrhali, J. McCarthy, R. Ravelli and M. Walsh for assistance at ESRF; P. Afonine, R. Grosse- Kunstleve and P. Zwart for help with phenix. refine; G. Murshudov for help with REFMAC; C. Chothia, F. Cotelli, J.- A. Gustafsson, R. Herbst-Irmer, A. Kohl, R. Ladenstein, M. Letarte, E. Litscher, E. Morgunova, A. Murzin, K. Nagai, L. Nilsson, D. Rhodes, R. Toftga rd and P. Wassarman for discussions and comments.	Afonine P., 2005, CCP4 NEWSLETTER, V42; Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; BORK P, 2005, NUCLEIC ACIDS RES, V33, pW299; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burendahl S, 2008, BIOCHEMISTRY-US, V47, P5205, DOI 10.1021/bi7025084; Callebaut I, 2007, BIOINFORMATICS, V23, P1871, DOI 10.1093/bioinformatics/btm265; Center RJ, 1998, PROTEIN SCI, V7, P1612, DOI 10.1002/pro.5560070715; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis IW, 2006, STRUCTURE, V14, P265, DOI 10.1016/j.str.2005.10.007; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Doren S, 1999, DEV GENES EVOL, V209, P330, DOI 10.1007/s004270050261; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G, 2001, J APPL CRYSTALLOGR, V34, P82, DOI 10.1107/S0021889800014655; Familiari G, 2008, FRONT BIOSCI-LANDMRK, V13, P6730, DOI 10.2741/3185; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Galindo BE, 2003, P NATL ACAD SCI USA, V100, P4639, DOI 10.1073/pnas.0830022100; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hasegawa A, 2002, J REPROD IMMUNOL, V53, P91, DOI 10.1016/S0165-0378(01)00084-5; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Jovine Luca, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091/7/11; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanai S, 2008, MOL REPROD DEV, V75, P847, DOI 10.1002/mrd.20836; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P935, DOI 10.1107/S090744490703315X; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Lindsay LL, 2004, BIOCHEM BIOPH RES CO, V324, P648, DOI 10.1016/j.bbrc.2004.09.099; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negi SS, 2007, J MOL MODEL, V13, P1157, DOI 10.1007/s00894-007-0237-0; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Nixon B, 2007, CELL MOL LIFE SCI, V64, P1805, DOI 10.1007/s00018-007-6552-x; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Rankin TL, 2003, DEV CELL, V5, P33, DOI 10.1016/S1534-5807(03)00195-3; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; SOMOZA JR, 1995, ACTA CRYSTALLOGR A, V51, P691, DOI 10.1107/S0108767395002315; Stebbings LA, 2004, NUCLEIC ACIDS RES, V32, pD203, DOI 10.1093/nar/gkh027; Sun W, 1999, BIOL REPROD, V60, P900, DOI 10.1095/biolreprod60.4.900; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Tian JD, 1999, P NATL ACAD SCI USA, V96, P829, DOI 10.1073/pnas.96.3.829; Tsubamoto H, 1999, BIOL REPROD, V61, P1649, DOI 10.1095/biolreprod61.6.1649; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; van den Bedem H, 2005, ACTA CRYSTALLOGR D, V61, P2, DOI 10.1107/S0907444904025697; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; WASSARMAN PM, 1991, INT REV CYTOL, V130, P85, DOI 10.1016/S0074-7696(08)61502-8; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7	68	100	103	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					653	U82		10.1038/nature07599	http://dx.doi.org/10.1038/nature07599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052627	Green Published			2022-12-01	WOS:000261340000044
J	Guttman, M; Amit, I; Garber, M; French, C; Lin, MF; Feldser, D; Huarte, M; Zuk, O; Carey, BW; Cassady, JP; Cabili, MN; Jaenisch, R; Mikkelsen, TS; Jacks, T; Hacohen, N; Bernstein, BE; Kellis, M; Regev, A; Rinn, JL; Lander, ES				Guttman, Mitchell; Amit, Ido; Garber, Manuel; French, Courtney; Lin, Michael F.; Feldser, David; Huarte, Maite; Zuk, Or; Carey, Bryce W.; Cassady, John P.; Cabili, Moran N.; Jaenisch, Rudolf; Mikkelsen, Tarjei S.; Jacks, Tyler; Hacohen, Nir; Bernstein, Bradley E.; Kellis, Manolis; Regev, Aviv; Rinn, John L.; Lander, Eric S.			Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals	NATURE			English	Article							X-INACTIVATION CENTER; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; MOUSE OOCYTES; STEM-CELLS; GENOME; CHROMOSOME; INTERFERENCE; SEQUENCES; NOISE	There is growing recognition that mammalian cells produce many thousands of large intergenic transcripts(1-4). However, the functional significance of these transcripts has been particularly controversial. Although there are some well-characterized examples, most (>95%) show little evidence of evolutionary conservation and have been suggested to represent transcriptional noise(5,6). Here we report a new approach to identifying large non-coding RNAs using chromatin-state maps to discover discrete transcriptional units intervening known protein-coding loci. Our approach identified similar to 1,600 large multi-exonic RNAs across four mouse cell types. In sharp contrast to previous collections, these large intervening non-coding RNAs (lincRNAs) show strong purifying selection in their genomic loci, exonic sequences and promoter regions, with greater than 95% showing clear evolutionary conservation. We also developed a functional genomics approach that assigns putative functions to each lincRNA, demonstrating a diverse range of roles for lincRNAs in processes from embryonic stem cell pluripotency to cell proliferation. We obtained independent functional validation for the predictions for over 100 lincRNAs, using cell-based assays. In particular, we demonstrate that specific lincRNAs are transcriptionally regulated by key transcription factors in these processes such as p53, NF kappa B, Sox2, Oct4 (also known as Pou5f1) and Nanog. Together, these results define a unique collection of functional lincRNAs that are highly conserved and implicated in diverse biological processes.	[Guttman, Mitchell; Amit, Ido; Garber, Manuel; French, Courtney; Lin, Michael F.; Huarte, Maite; Zuk, Or; Mikkelsen, Tarjei S.; Hacohen, Nir; Bernstein, Bradley E.; Kellis, Manolis; Regev, Aviv; Rinn, John L.; Lander, Eric S.] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Guttman, Mitchell; Carey, Bryce W.; Cassady, John P.; Jaenisch, Rudolf; Jacks, Tyler; Regev, Aviv; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Feldser, David; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Mikkelsen, Tarjei S.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Huarte, Maite; Rinn, John L.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Cabili, Moran N.; Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Carey, Bryce W.; Cassady, John P.; Jaenisch, Rudolf; Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Bernstein, Bradley E.; Rinn, John L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rinn, JL (corresponding author), MIT & Harvard, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	jrinn@broad.mit.edu	Mikkelsen, Tarjei S/A-1306-2007; Huarte, Maite/J-6903-2014; Kellis, Manolis/ABE-7385-2020	Mikkelsen, Tarjei S/0000-0002-8133-3135; Huarte, Maite/0000-0003-3753-6493; Kellis, Manolis/0000-0001-7113-9630; Rinn, John/0000-0002-7231-7539	Human Frontier Science Program Organization; Beth Israel Deaconess Medical Center; National Human Genome Research Institute; Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	Human Frontier Science Program Organization(Human Frontier Science Program); Beth Israel Deaconess Medical Center; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank our colleagues at the Broad Institute, especially J. P. Mesirov for discussions and statistical insights, X. Xie for statistical help with conservation analyses, J. Robinson for visualization help, M. Ku, E. Mendenhall and X. Zhang for help generating ChIP samples, and N. Novershtern and A. Levy for providing transcription factor lists. M. Guttman is a Vertex scholar, I. A. acknowledges the support of the Human Frontier Science Program Organization. This work was funded by Beth Israel Deaconess Medical Center, National Human Genome Research Institute, and the Broad Institute of MIT and Harvard.	Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sotomaru Y, 2002, J BIOL CHEM, V277, P12474, DOI 10.1074/jbc.M109212200; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	30	3052	3278	11	391	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					223	227		10.1038/nature07672	http://dx.doi.org/10.1038/nature07672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19182780	Green Accepted, Green Submitted			2022-12-01	WOS:000264059700048
J	Mandel, MJ; Wollenberg, MS; Stabb, EV; Visick, KL; Ruby, EG				Mandel, Mark J.; Wollenberg, Michael S.; Stabb, Eric V.; Visick, Karen L.; Ruby, Edward G.			A single regulatory gene is sufficient to alter bacterial host range	NATURE			English	Article							VIBRIO-FISCHERI; SYMBIOTIC COLONIZATION; BIOFILM FORMATION; COMPARATIVE GENOMICS; EUPRYMNA-SCOLOPES; SEQUENCE; INTERFACE; EVOLUTION; ALIGNMENT; ISLANDS	Microbial symbioses are essential for the normal development and growth of animals(1-3). Often, symbionts must be acquired from the environment during each generation, and identification of the relevant symbiotic partner against a myriad of unwanted relationships is a formidable task(4). Although examples of this specificity are well-documented, the genetic mechanisms governing it are poorly characterized(5). Here we show that the two-component sensor kinase RscS is necessary and sufficient for conferring efficient colonization of Euprymna scolopes squid by bioluminescent Vibrio fischeri from the North Pacific Ocean. In the squid symbiont V. fischeri ES114, RscS controls light-organ colonization by inducing the Syp exopolysaccharide, a mediator of biofilm formation during initial infection. A genome-level comparison revealed that rscS, although present in squid symbionts, is absent from the fish symbiont V. fischeri MJ11. We found that heterologous expression of RscS in strain MJ11 conferred the ability to colonize E. scolopes in a manner comparable to that of natural squid isolates. Furthermore, phylogenetic analyses support an important role for rscS in the evolution of the squid symbiosis. Our results demonstrate that a regulatory gene can alter the host range of animal-associated bacteria. We show that, by encoding a regulator and not an effector that interacts directly with the host, a single gene can contribute to the evolution of host specificity by switching 'on' pre-existing capabilities for interaction with animal tissue.	[Mandel, Mark J.; Wollenberg, Michael S.; Ruby, Edward G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Stabb, Eric V.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Visick, Karen L.] Loyola Univ Chicago, Dept Microbiol & Immunol, Maywood, IL 60153 USA	University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; University of Georgia; Loyola University Chicago	Mandel, MJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, 1550 Linden Dr, Madison, WI 53706 USA.	mmandel@wisc.edu		Visick, Karen/0000-0002-2400-2591; Mandel, Mark/0000-0001-6506-6711	Gordon and Betty Moore Foundation Marine Microbial Genome Sequencing Project; National Institutes of Health - National Center for Research Resources; National Science Foundation Division of Integrative Organismal Systems; National Science Foundation CAREER Award; National Institute of General Medical Sciences; National Institute of General Medical Sciences National Research Service Award Postdoctoral Fellowship; National Science Foundation Predoctoral Fellowship and a National Institutes of Health Molecular Biosciences Training; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR012294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, F32GM078760, R01GM059690] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation Marine Microbial Genome Sequencing Project; National Institutes of Health - National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation Division of Integrative Organismal Systems(National Science Foundation (NSF)); National Science Foundation CAREER Award(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Predoctoral Fellowship and a National Institutes of Health Molecular Biosciences Training; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank: P. Dunlap for sharing bacterial strains; N. Perna, J. Glasner, K. Geszvain, D. Baum, J. Johnson, M. Sarmiento and S. Ferriera for technical assistance; A. Wier, N. Bekiares, R. Gates and the Hawaii Institute of Marine Biology for animal facilities and care; J. McCosker and the Steinhart Aquarium for access to fish specimens; M. McFall- Ngai, H. Goodrich- Blair, C. Brennan and J. Troll for discussions; and L. Proctor for project support. MJ11 genome sequencing was funded by the Gordon and Betty Moore Foundation Marine Microbial Genome Sequencing Project; E. G. R. and co- workers are funded by the National Institutes of Health - National Center for Research Resources and the National Science Foundation Division of Integrative Organismal Systems; E. V. S. is funded by a National Science Foundation CAREER Award; K. L. V. is funded by the National Institute of General Medical Sciences; M. J. M. is funded by a National Institute of General Medical Sciences National Research Service Award Postdoctoral Fellowship; M. S. W. is funded by a National Science Foundation Predoctoral Fellowship and a National Institutes of Health Molecular Biosciences Training Grant to the University of Wisconsin.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bose JL, 2008, ARCH MICROBIOL, V190, P169, DOI 10.1007/s00203-008-0387-1; Brinig MM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r81; Cowles CE, 2008, J BACTERIOL, V190, P4121, DOI 10.1128/JB.00123-08; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Foster JS, 2002, B MAR SCI, V70, P141; Geszvain K, 2008, FEMS MICROBIOL LETT, V285, P33, DOI 10.1111/j.1574-6968.2008.01209.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Groisman EA, 2005, MOL MICROBIOL, V56, P1, DOI 10.1111/j.1365-2958.2005.04564.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HAYGOOD MG, 1993, CRIT REV MICROBIOL, V19, P191, DOI 10.3109/10408419309113529; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hussa EA, 2008, J BACTERIOL, V190, P4576, DOI 10.1128/JB.00130-08; Hussa EA, 2007, J BACTERIOL, V189, P5825, DOI 10.1128/JB.00242-07; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; Long SR, 2001, PLANT PHYSIOL, V125, P69, DOI 10.1104/pp.125.1.69; Mandel MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-138; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rajashekara G, 2004, J BACTERIOL, V186, P5040, DOI 10.1128/jb.186.15.5040-5051.2004; RUBY EG, 1977, APPL ENVIRON MICROB, V34, P164, DOI 10.1128/AEM.34.2.164-169.1977; Ruby EG, 2005, P NATL ACAD SCI USA, V102, P3004, DOI 10.1073/pnas.0409900102; RUBY EG, 1976, BIOL BULL, V151, P574, DOI 10.2307/1540507; Silhavy T.J., 1984, EXPT GENE FUSIONS; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stabb EV, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P233; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; STABB EV, 2001, RECENT ADV MARINE SC, P269; Swofford D.L., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Hijum SAFT, 2005, NUCLEIC ACIDS RES, V33, pW560, DOI 10.1093/nar/gki356; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Visick KL, 2001, J BACTERIOL, V183, P835, DOI 10.1128/JB.183.3.835-842.2001; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yip ES, 2006, MOL MICROBIOL, V62, P1586, DOI 10.1111/j.1365-2958.2006.05475.x; Yip ES, 2005, MOL MICROBIOL, V57, P1485, DOI 10.1111/j.1365-2958.2005.04784.x; Zwickl D.J., 2006, GENETIC ALGORITHM AP	45	151	151	0	63	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					215	U7		10.1038/nature07660	http://dx.doi.org/10.1038/nature07660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19182778	Green Accepted			2022-12-01	WOS:000264059700046
J	Sena, G; Wang, XN; Liu, HY; Hofhuis, H; Birnbaum, KD				Sena, Giovanni; Wang, Xiaoning; Liu, Hsiao-Yun; Hofhuis, Hugo; Birnbaum, Kenneth D.			Organ regeneration does not require a functional stem cell niche in plants	NATURE			English	Article							ROOT; EXPRESSION; SCARECROW; POLARITY	Plants rely on the maintenance of stem cell niches at their apices for the continuous growth of roots and shoots. However, although the developmental plasticity of plant cells has been demonstrated(1), it is not known whether the stem cell niche is required for organogenesis. Here we explore the capacity of a broad range of differentiating cells to regenerate an organ without the activity of a stem cell niche. Using a root-tip regeneration system in Arabidopsis thaliana to track the molecular and functional recovery of cell fates, we show that respecification of lost cell identities begins within hours of excision and that the function of specialized cells is restored within one day. Critically, regeneration proceeds in plants with mutations that fail to maintain the stem cell niche. These results show that stem-cell-like properties that mediate complete organ regeneration are dispersed in plant meristems and are not restricted to niches, which nonetheless seem to be necessary for indeterminate growth. This regenerative reprogramming of an entire organ without transition to a stereotypical stem cell environment has intriguing parallels to recent reports of induced transdifferentiation of specific cell types in the adult organs of animals(2,3).	[Sena, Giovanni; Wang, Xiaoning; Liu, Hsiao-Yun; Birnbaum, Kenneth D.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Hofhuis, Hugo] Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands	New York University; Utrecht University	Birnbaum, KD (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, Silver Bldg,100 Washington Sq E, New York, NY 10003 USA.	ken.birnbaum@nyu.edu	Sena, Giovanni/C-3297-2012	Sena, Giovanni/0000-0003-3626-5038; hofhuis, hugo/0000-0001-7882-7380	National Institutes of Health [5R01GM078279]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Scheres and R. Heidstra for mutant and reporter lines and for comments. We thank P. Doerner for the CYCB1;1::GFP reporter, J. Friml for the PINFORMED (PIN) reporter lines, and C. Desplan, T. Nawy, B. Bargmann and M. Gifford for comments. This work was supported by the National Institutes of Health grant 5R01GM078279 (K. D. B.)	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Beemster GTS, 2006, J PLANT RES, V119, P43, DOI 10.1007/s10265-005-0234-2; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blancaflor EB, 1998, PLANT PHYSIOL, V116, P213, DOI 10.1104/pp.116.1.213; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; FELDMAN LJ, 1976, PLANTA, V128, P207, DOI 10.1007/BF00393230; FIGDOR W, 1907, JB WISS BOT, V44, P41; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; ROST TL, 1988, ANN BOT-LONDON, V61, P513, DOI 10.1093/oxfordjournals.aob.a087583; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sack FD, 1997, PLANTA, V203, pS63, DOI 10.1007/PL00008116; STEWARD FC, 1970, ANN BOT-LONDON, V34, P761, DOI 10.1093/oxfordjournals.aob.a084408; Thowfeequ S, 2007, DEV DYNAM, V236, P3208, DOI 10.1002/dvdy.21336; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	25	168	176	0	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1150	U110		10.1038/nature07597	http://dx.doi.org/10.1038/nature07597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19182776	Green Accepted, Green Submitted			2022-12-01	WOS:000263680100045
J	Cator, LJ; Arthur, BJ; Harrington, LC; Hoy, RR				Cator, Lauren J.; Arthur, Ben J.; Harrington, Laura C.; Hoy, Ronald R.			Harmonic Convergence in the Love Songs of the Dengue Vector Mosquito	SCIENCE			English	Article							STERILE INSECT TECHNIQUE; FEMALE AEDES-AEGYPTI; ATTRACTION; DIPTERA; FLIGHT; SOUND; ORGAN	The familiar buzz of flying mosquitoes is an important mating signal, with the fundamental frequency of the female's flight tone signaling her presence. In the yellow fever and dengue vector Aedes aegypti, both sexes interact acoustically by shifting their flight tones to match, resulting in a courtship duet. Matching is made not at the fundamental frequency of 400 hertz ( female) or 600 hertz ( male) but at a shared harmonic of 1200 hertz, which exceeds the previously known upper limit of hearing in mosquitoes. Physiological recordings from Johnston's organ ( the mosquito's "ear") reveal sensitivity up to 2000 hertz, consistent with our observed courtship behavior. These findings revise widely accepted limits of acoustic behavior in mosquitoes.	[Arthur, Ben J.; Hoy, Ronald R.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Cator, Lauren J.; Harrington, Laura C.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Hoy, RR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	rrh3@cornell.edu			Foundation for the National Institutes of Health; Grand Challenges in Global Health Initiative and Hatch Project [NTC-139432]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000103] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health; Grand Challenges in Global Health Initiative and Hatch Project; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Wyttenbach for the suggestion to look for sustained deflections in the neural response and are grateful to L. Ristroph and I. Cohen for high-speed video of males and females in free flight. Support was provided ( to L. C. H.) from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative and Hatch Project NYC-139432.	BELTON P, 1979, ENTOMOL EXP APPL, V26, P105, DOI 10.1111/j.1570-7458.1979.tb02904.x; BELTON P, 1989, CAN J ZOOL, V67, P2625, DOI 10.1139/z89-371; BELTON P, 1994, J AM MOSQUITO CONTR, V10, P297; Belton P., 1986, P60; BELTON P, 1974, P139; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BOO KS, 1975, J INSECT PHYSIOL, V21, P1129, DOI 10.1016/0022-1910(75)90126-2; Borkent A, 2006, CAN ENTOMOL, V138, P91; BUSHLAND RC, 1955, SCIENCE, V122, P287, DOI 10.1126/science.122.3163.287; CLEMENTS AN, 1999, BIOL MOSQUITOES SENS, P740; DOWNES JA, 1969, ANNU REV ENTOMOL, V14, P271, DOI 10.1146/annurev.en.14.010169.001415; Gibson G, 2006, CURR BIOL, V16, P1311, DOI 10.1016/j.cub.2006.05.053; Gopfert MC, 2001, P ROY SOC B-BIOL SCI, V268, P333, DOI 10.1098/rspb.2000.1376; Gopfert MC, 1999, J EXP BIOL, V202, P2727; Gopfert MC, 2000, P ROY SOC B-BIOL SCI, V267, P453, DOI 10.1098/rspb.2000.1021; Haskell P. T., 1974, PHYSL INSECTA, VII, P353; Johnston C., 1855, Q J MICROSC SCI, V3, P97; KAHN MC, 1949, AM J TROP MED, V29, P811; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Mayer AM, 1874, AM NAT, V8, P577; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; ROTH LM, 1948, AM MIDL NAT, V40, P265, DOI 10.2307/2421604; SCHWARTZKOFF J, 1974, PHYSIOL INSECT, V2, P273; Scott TW, 2008, ADV EXP MED BIOL, V627, P151, DOI 10.1007/978-0-387-78225-6_13; Vreysen M.J.B., 2007, AREA WIDE CONTROL IN, P792; WILLIAMS RW, 1980, MOSQ NEWS, V40, P597; WISHART G., 1959, CANADIAN ENT, V91, P181; YOUNG ADM, 1982, PHYSIOL ENTOMOL, V7, P467, DOI 10.1111/j.1365-3032.1982.tb00323.x	28	187	197	7	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1077	1079		10.1126/science.1166541	http://dx.doi.org/10.1126/science.1166541			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19131593	Green Accepted			2022-12-01	WOS:000263478400047
J	Myong, S; Cui, S; Cornish, PV; Kirchhofer, A; Gack, MU; Jung, JU; Hopfner, KP; Ha, T				Myong, Sua; Cui, Sheng; Cornish, Peter V.; Kirchhofer, Axel; Gack, Michaela U.; Jung, Jae U.; Hopfner, Karl-Peter; Ha, Taekjip			Cytosolic Viral Sensor RIG-I Is a 5 '-Triphosphate-Dependent Translocase on Double-Stranded RNA	SCIENCE			English	Article							HEPATITIS-C VIRUS; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; DNA; MECHANISM; HELICASE; RECOGNITION; DOMAIN; ROLES	Retinoic acid inducible- gene I ( RIG- I) is a cytosolic multidomain protein that detects viral RNA and elicits an antiviral immune response. Two N- terminal caspase activation and recruitment domains ( CARDs) transmit the signal, and the regulatory domain prevents signaling in the absence of viral RNA. 5 '- triphosphate and double- stranded RNA ( dsRNA) are two molecular patterns that enable RIG- I to discriminate pathogenic from self- RNA. However, the function of the DExH box helicase domain that is also required for activity is less clear. Using single- molecule protein- induced fluorescence enhancement, we discovered a robust adenosine 5 ' - triphosphate- powered dsRNA translocation activity of RIG- I. The CARDs dramatically suppress translocation in the absence of 5 '- triphosphate, and the activation by 5 '- triphosphate triggers RIG- I to translocate preferentially on dsRNA in cis. This functional integration of two RNA molecular patterns may provide a means to specifically sense and counteract replicating viruses.	[Myong, Sua; Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cui, Sheng; Kirchhofer, Axel; Hopfner, Karl-Peter] Univ Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Cui, Sheng; Kirchhofer, Axel; Hopfner, Karl-Peter] Univ Munich, Munich Ctr Adv Photon, Gene Ctr, D-81377 Munich, Germany; [Cornish, Peter V.; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Cornish, Peter V.; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Cornish, Peter V.; Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL USA; [Gack, Michaela U.; Jung, Jae U.] Univ So Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90033 USA; [Gack, Michaela U.; Jung, Jae U.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Gack, Michaela U.; Jung, Jae U.] Harvard Univ, Sch Med, Div Tumor Virol, New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Gack, Michaela U.] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany	University of Illinois System; University of Illinois Urbana-Champaign; University of Munich; University of Munich; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Southern California; Harvard University; Harvard University; University of Erlangen Nuremberg	Myong, S (corresponding author), Univ Illinois, Inst Genom Biol, 1206 W Gregory Dr, Urbana, IL 61801 USA.	smyong@uiuc.edu; hopfner@lmb.uni-muenchen.de; tjha@uiuc.edu	Hopfner, Karl-Peter/B-6864-2014; Ha, Taekjip/B-9506-2009; Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020	Hopfner, Karl-Peter/0000-0002-4528-8357; Ha, Taekjip/0000-0003-2195-6258; Sheng, CUI/0000-0001-6329-3582; 	NIH [R01-GM065367, CA82057]; NSF Physics Frontiers Center [0822613]; Human Frontiers of Science; German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG) program project 455; DFG graduate school 1202; Institute for Genomic Biology; NATIONAL CANCER INSTITUTE [R01CA082057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Physics Frontiers Center(National Science Foundation (NSF)); Human Frontiers of Science; German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG) program project 455(German Research Foundation (DFG)); DFG graduate school 1202(German Research Foundation (DFG)); Institute for Genomic Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Joo and K. Ragunathan for careful review of the manuscript. This work was supported by NIH grant R01-GM065367 and NSF Physics Frontiers Center grant 0822613 to T.H., NIH grant CA82057 to J. U. J., and a Human Frontiers of Science grant to T.H. and K.-P. H.K.-P.H. acknowledges support from the German Excellence Initiative. S. C. is supported by Deutsche Forschungsgemeinschaft (DFG) program project 455 to K.- P. H. A. K. acknowledges support from the DFG graduate school 1202. T. H. is an investigator with Howard Hughes Medical Institute. S. M. is a fellow at the Institute for Genomic Biology.	Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; SINGH R, 1989, P NATL ACAD SCI USA, V86, P8280, DOI 10.1073/pnas.86.21.8280; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	29	284	288	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1070	1074		10.1126/science.1168352	http://dx.doi.org/10.1126/science.1168352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19119185	Green Accepted			2022-12-01	WOS:000263478400045
J	Hall, CB; Weinberg, GA; Iwane, MK; Blumkin, AK; Edwards, KM; Staat, MA; Auinger, P; Griffin, MR; Poehling, KA; Erdman, D; Grijalva, CG; Zhu, YW; Szilagyi, P				Hall, Caroline Breese; Weinberg, Geoffrey A.; Iwane, Marika K.; Blumkin, Aaron K.; Edwards, Kathryn M.; Staat, Mary A.; Auinger, Peggy; Griffin, Marie R.; Poehling, Katherine A.; Erdman, Dean; Grijalva, Carlos G.; Zhu, Yuwei; Szilagyi, Peter			The Burden of Respiratory Syncytial Virus Infection in Young Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; HUMAN METAPNEUMOVIRUS; TRACT INFECTIONS; 1ST YEAR; INFLUENZA; HOSPITALIZATION; INFANTS; DISEASE; RATES; RSV	Background The primary role of respiratory syncytial virus ( RSV) in causing infant hospitalizations is well recognized, but the total burden of RSV infection among young children remains poorly defined. Methods We conducted prospective, population- based surveillance of acute respiratory infections among children under 5 years of age in three U. S. counties. We enrolled hospitalized children from 2000 through 2004 and children presenting as outpatients in emergency departments and pediatric offices from 2002 through 2004. RSV was detected by culture and reverse- transcriptase polymerase chain reaction. Clinical information was obtained from parents and medical records. We calculated population- based rates of hospitalization associated with RSV infection and estimated the rates of RSV- associated outpatient visits. Results Among 5067 children enrolled in the study, 919 ( 18%) had RSV infections. Overall, RSV was associated with 20% of hospitalizations, 18% of emergency department visits, and 15% of office visits for acute respiratory infections from November through April. Average annual hospitalization rates were 17 per 1000 children under 6 months of age and 3 per 1000 children under 5 years of age. Most of the children had no coexisting illnesses. Only prematurity and a young age were independent risk factors for hospitalization. Estimated rates of RSV- associated office visits among children under 5 years of age were three times those in emergency departments. Outpatients had moderately severe RSV- associated illness, but few of the illnesses ( 3%) were diagnosed as being caused by RSV. Conclusions RSV infection is associated with substantial morbidity in U. S. children in both inpatient and outpatient settings. Most children with RSV infection were previously healthy, suggesting that control strategies targeting only high- risk children will have a limited effect on the total disease burden of RSV infection.	[Hall, Caroline Breese; Weinberg, Geoffrey A.; Blumkin, Aaron K.; Auinger, Peggy; Szilagyi, Peter] Univ Rochester, Sch Med & Dent, Div Infect Dis, Dept Pediat, Rochester, NY 14642 USA; [Hall, Caroline Breese] Univ Rochester, Sch Med & Dent, Div Infect Dis, Dept Med, Rochester, NY 14642 USA; [Iwane, Marika K.; Erdman, Dean] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Edwards, Kathryn M.; Poehling, Katherine A.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Griffin, Marie R.; Grijalva, Carlos G.] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37232 USA; [Zhu, Yuwei] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Staat, Mary A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	University of Rochester; University of Rochester; Centers for Disease Control & Prevention - USA; Vanderbilt University; Vanderbilt University; Vanderbilt University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hall, CB (corresponding author), Univ Rochester, Sch Med & Dent, Div Infect Dis, Dept Pediat, 601 Elmwood Ave,Box 689, Rochester, NY 14642 USA.	caroline_hall@urmc.rochester.edu	Weinberg, Geoffrey A./W-7510-2019	Weinberg, Geoffrey A./0000-0002-3900-379X; Grijalva, Carlos/0000-0002-2329-7797	MedImmune; Astellas; GlaxoSmithKline; Merck; Pfizer; Wyeth; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [K01IP000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI065805] Funding Source: NIH RePORTER	MedImmune(AstraZenecaMedimmune); Astellas(Astellas Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Wyeth(Wyeth); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported through cooperative agreements with the CDC.; Dr. Hall reports receiving grant support and consulting fees from MedImmune; Dr. Weinberg, research support from Astellas and MedImmune and consulting fees from MedImmune; Dr. Staat, consulting fees or fees for serving on paid advisory boards from GlaxoSmithKline, Merck, and MedImmune, lecture fees from Merck, and research support from MedImmune; Dr. Griffin, grant support from MedImmune and Pfizer; and Dr. Grijalva, lecture fees from Wyeth. No other potential conflict of interest relevant to this article was reported.; The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the CDC.; We thank the children and their parents who participated in this study; all the members of the New Vaccine Surveillance Network, including Geraldine Lofthus, Kenneth Schnabel, Andrea Marino, Lynne Shelley, Jennifer Carnahan, Linda Anderson, Gladys Lathan, Charlene Freundlich, Christina Albertin, and Rebecca Martinez at the University of Rochester; John Williams, Diane Kent, Ann Clay, Ayesha Khan, Yi Wei Tang, Haijing Li, Jennifer Doersam, Amondrea Blackman, Nayleen Whitehead, Erin Keckley, and Jody Peters at Vanderbilt University; Linda Jamison, David Witte, David Bernstein, Emilie Grube, Vanessa Florian, Pamela Groen, and Joel Mortensen at the Cincinnati Children's Medical Center; and Ranee Seither, Aaron Curns, Larry Anderson, Carolyn B. Bridges, Benjamin Schwartz, Frances Walker, John Copeland, Alicia Fry, Jennifer Reuer, and John Zhang at the CDC.	Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Bradley JP, 2005, PEDIATRICS, V115, pE7, DOI 10.1542/peds.2004-0059; Carbonell-Estrany Xavier, 2004, Pediatr Infect Dis J, V23, pS193, DOI 10.1097/01.inf.0000144664.31888.53; Casella G, 2002, STAT INFERENCE, P240; Collins Peter L, 2005, Proc Am Thorac Soc, V2, P166, DOI 10.1513/pats.200501-011AW; Comperat E, 2007, PROG UROL, V17, P5, DOI 10.1016/S1166-7087(07)92218-6; Englund J, 2005, J INFECT DIS, V191, P1036, DOI 10.1086/427998; Erdman DD, 2003, J CLIN MICROBIOL, V41, P4298, DOI 10.1128/JCM.41.9.4298-4303.2003; Griffin Marie R, 2004, Pediatr Infect Dis J, V23, pS188, DOI 10.1097/01.inf.0000144660.53024.64; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; HOLBERG CJ, 1991, AM J EPIDEMIOL, V133, P1135, DOI 10.1093/oxfordjournals.aje.a115826; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Law BJ, 2004, PEDIATR INFECT DIS J, V23, P806, DOI 10.1097/01.inf.0000137568.71589.bd; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; Meissner HC, 2004, PEDIATR INFECT DIS J, V23, P284, DOI 10.1097/01.inf.0000121203.33560.f9; Miller EK, 2008, PEDIATRICS, V121, P1, DOI 10.1542/peds.2007-1053; Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; *NAT I ALL INF DIS, 2002, JORD REP ACC DEV VAC; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Nielsen HE, 2003, ACTA PAEDIATR, V92, P1314, DOI 10.1080/08035250310006304; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Peck AJ, 2005, PEDIATR INFECT DIS J, V24, P342, DOI 10.1097/01.inf.0000157250.95880.91; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Reeve CA, 2006, J PAEDIATR CHILD H, V42, P248, DOI 10.1111/j.1440-1754.2006.00849.x; Romero JR, 2003, PEDIATR INFECT DIS J, V22, pS46, DOI 10.1097/00006454-200302001-00007; Rossi GA, 2007, EUR J PEDIATR, V166, P1267, DOI 10.1007/s00431-007-0418-y; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; StataCorp, 2007, STAT STAT SOFTW REL; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; von Linstow ML, 2008, EUR J PEDIATR, V167, P1125, DOI 10.1007/s00431-007-0643-4; Weinberg GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456; WEINBERG GA, J PEDIAT IN PRESS; WELLIVER RC, 2004, PAEDIATR RESPIR REV, pS127	38	1357	1410	0	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					588	598		10.1056/NEJMoa0804877	http://dx.doi.org/10.1056/NEJMoa0804877			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402QS	19196675	Green Accepted			2022-12-01	WOS:000263028800005
J	Ndrepepa, G; Kastrati, A; Mehilli, J; Antoniucci, D; Schomig, A				Ndrepepa, Gjin; Kastrati, Adnan; Mehilli, Julinda; Antoniucci, David; Schoemig, Albert			Mechanical Reperfusion and Long-term Mortality in Patients With Acute Myocardial Infarction Presenting 12 to 48 Hours From Onset of Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ndrepepa, Gjin; Kastrati, Adnan; Mehilli, Julinda; Schoemig, Albert] Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany; [Antoniucci, David] Azienda Osped Careggi, Florence, Italy	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; University of Florence; Azienda Ospedaliero Universitaria Careggi	Ndrepepa, G (corresponding author), Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany.	kastrati@dhm.mhn.de	, Kastrati/Y-2389-2019; Mehilli, Julinda/F-2629-2016					Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Parodi G, 2006, AM HEART J, V152, P1133, DOI 10.1016/j.ahj.2006.08.007; Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865	4	39	46	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					487	488		10.1001/jama.2009.32	http://dx.doi.org/10.1001/jama.2009.32			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402CS	19190313	Bronze			2022-12-01	WOS:000262992400017
J	El Harchaoui, K; Arsenault, BJ; Franssen, R; Despres, JP; Hovingh, K; Stroes, ESG; Otvos, JD; Wareham, NJ; Kastelein, JJP; Khaw, KT; Boekholdt, SM				El Harchaoui, Karim; Arsenault, Benoit J.; Franssen, Remco; Despres, Jean-Pierre; Hovingh, Kees; Stroes, Erik S. G.; Otvos, James D.; Wareham, Nicholas J.; Kastelein, John J. P.; Khaw, Kay-Tee; Boekholdt, S. Matthijs			High-Density Lipoprotein Particle Size and Concentration and Coronary Risk	ANNALS OF INTERNAL MEDICINE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; APOLIPOPROTEIN-A-I; INTIMA-MEDIA THICKNESS; ARTERY-DISEASE; EPIC-NORFOLK; INSULIN-RESISTANCE; NONFASTING TRIGLYCERIDES; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; HEART-DISEASE	Background: High-density lipoprotein (HDL) cholesterol levels are inversely related to risk for coronary artery disease (CAD). Because HDL particles are heterogeneous in size and composition, they may be differentially associated with other cardiovascular risk factors and with cardiovascular risk. Objective: To study the independent relationships of HDL size and particle concentration to risk for future CAD. Design: Nested case-control study within the EPIC (European Prospective Investigation into Cancer and Nutrition)-Norfolk cohort; baseline survey between 1993 and 1997, follow-up until November 2003. Setting: Norfolk, United Kingdom. Participants: Case patients were 822 apparently healthy men and women who developed CAD during follow-up. Control participants were 1401 participants who remained without CAD and were matched to case patients by sex, age, and enrollment time. Measurements: First CAD event leading to either hospitalization or death. Results: Nuclear magnetic resonance spectroscopy-measured HDL particle concentration (mean, 33.9 mu mol/L [SD, 5] vs. 32.9 mu mol/L [SD, 6]; P < 0.001) and HDL size (mean, 8.9 nm [SD, 0.5] vs. 8.8 nm [SD, 0.5]; P < 0.001), as well as gradient gel electrophoresis measured HDL size (mean, 8.9 nm [SD, 0.4] vs. 8.8 nm [SD, 0.4]; P = 0.005) were lower in case patients than in control participants. High-density lipoprotein size and HDL particle concentration were only weakly correlated (r = 0.08, for those measured with nuclear magnetic resonance spectroscopy; r = 0.10, for those measured with gradient gel electrophoresis). High-density lipoprotein size was strongly associated with risk factors characteristic of the metabolic syndrome, including waist-to-hip ratio, triglyceride level, and apolipoprotein B level, whereas HDL particle concentration was not. Both HDL size and HDL particle concentration were independently associated with CAD risk. The association between HDL size and CAD risk was abolished on adjustment for apolipoprotein B and triglyceride levels (adjusted odds ratio, 1.00 [95% CI, 0.71 to 1.39] for top vs. bottom quartile), whereas HDL particle concentration remained independently associated with CAD risk (adjusted odds ratio, 0.50 [CI, 0.37 to 0.66]). Limitation: Measurements were performed in nonfasting blood samples, and residual confounding cannot be excluded. Conclusion: Both HDL size and HDL particle concentration were independently associated with other cardiovascular risk factors and with the risk for CAD. The relationship between HDL size and CAD risk was explained by markers associated with the metabolic syndrome, indicating that part of the relationship between HDL cholesterol and CAD risk is merely a reflection of this metabolic risk.	[Boekholdt, S. Matthijs] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands; Hop Laval, Res Ctr, Quebec Heart Inst, Quebec City, PQ, Canada; LipoSci, Raleigh, NC USA; Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; Univ Cambridge, Inst Publ Hlth & Primary Care, Cambridge, England	University of Amsterdam; Academic Medical Center Amsterdam; Laval University; LipoScience, Inc; University of Cambridge; University of Cambridge	Boekholdt, SM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, F4-159-2,POB 22660, NL-1100 DD Amsterdam, Netherlands.	s.m.boekholdt@amc.uva.nl	Khaw, Kay-Tee/AAZ-3209-2021; Kastelein, John/AAF-7950-2020; Boekholdt, Matthijs S.M./G-7562-2014	Boekholdt, Matthijs/0000-0002-0861-0765	The Medical Research Council and Cancer Research UK; European Union; Stroke Association; British Heart Foundation; United Kingdom Department of Health; Food Standards Agency; Wellcome Trust; Future Forum	The Medical Research Council and Cancer Research UK; European Union(European Commission); Stroke Association; British Heart Foundation(British Heart Foundation); United Kingdom Department of Health; Food Standards Agency; Wellcome Trust(Wellcome TrustEuropean Commission); Future Forum	The Medical Research Council and Cancer Research UK, European Union, Stroke Association, British Heart Foundation, United Kingdom Department of Health, Food Standards Agency, the Wellcome Trust, and the Future Forum.	ALBERS JJ, 1992, CLIN CHEM, V38, P658; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Bruins P, 1997, CIRCULATION, V96, P3542; CHEUNG MC, 1991, J LIPID RES, V32, P383; Colhoun HM, 2002, DIABETES, V51, P1949, DOI 10.2337/diabetes.51.6.1949; Day N, 1999, BRIT J CANCER, V80, P95; Festa A, 2005, CIRCULATION, V111, P3465, DOI 10.1161/CIRCULATIONAHA.104.512079; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; Freedman DS, 1998, ARTERIOSCL THROM VAS, V18, P1046, DOI 10.1161/01.ATV.18.7.1046; Garvey WT, 2003, DIABETES, V52, P453, DOI 10.2337/diabetes.52.2.453; Grundy SM, 1999, J LIPID RES, V40, P229; Jeyarajah EJ, 2006, CLIN LAB MED, V26, P847, DOI 10.1016/j.cll.2006.07.006; JOHANSSON J, 1991, ARTERIOSCLER THROMB, V11, P174, DOI 10.1161/01.ATV.11.1.174; Josse D, 2002, J BIOL CHEM, V277, P33386, DOI 10.1074/jbc.M200108200; Kontush A, 2003, ARTERIOSCL THROM VAS, V23, P1881, DOI 10.1161/01.ATV.0000091338.93223.E8; Lyons TJ, 2006, DIABETIC MED, V23, P955, DOI 10.1111/j.1464-5491.2006.01905.x; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; MacLean PS, 2000, METABOLISM, V49, P285, DOI 10.1016/S0026-0495(00)80002-5; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Mora S, 2008, CIRCULATION, V118, P993, DOI 10.1161/CIRCULATIONAHA.108.777334; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P2416, DOI 10.1161/01.ATV.0000184760.95957.d6; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; Pascot A, 2001, J LIPID RES, V42, P2007; Perusse M, 2001, J LIPID RES, V42, P1331; Pussinen PJ, 2004, J LIPID RES, V45, P139, DOI 10.1194/jlr.M300250-JLR200; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Shah PK, 2001, CIRCULATION, V103, P3047, DOI 10.1161/hc2501.092494; Syvanne M, 1998, CIRCULATION, V98, P1993, DOI 10.1161/01.CIR.98.19.1993; SYVANNE M, 1995, J LIPID RES, V36, P573; Thuahnai ST, 2004, J BIOL CHEM, V279, P12448, DOI 10.1074/jbc.M311718200; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van der Steeg WA, 2008, J AM COLL CARDIOL, V51, P634, DOI 10.1016/j.jacc.2007.09.060; VANDERPOLL T, 1995, INFECT IMMUN, V63, P3396, DOI 10.1128/IAI.63.9.3396-3400.1995; Wang L, 2006, J AM COLL CARDIOL, V48, P1459, DOI 10.1016/j.jacc.2006.07.040; Watanabe H, 2006, ARTERIOSCL THROM VAS, V26, P897, DOI 10.1161/01.ATV.0000209577.04246.c0; WILSON PW, 1980, AM J CARDIOL, V46, P649, DOI 10.1016/0002-9149(80)90516-0; Yancey PG, 2004, J LIPID RES, V45, P337, DOI 10.1194/jlr.M300231-JLR200	42	186	190	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					84	U43		10.7326/0003-4819-150-2-200901200-00006	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19153411				2022-12-01	WOS:000262655200003
J	Bettencourt-Dias, M; Glover, DM				Bettencourt-Dias, Monica; Glover, David M.			SnapShot: Centriole Biogenesis	CELL			English	Editorial Material							CENTROSOME; DUPLICATION; CELLS		[Bettencourt-Dias, Monica] Gulbenkian Inst Sci, Oeiras, Portugal; [Glover, David M.] Univ Cambridge, Cambridge, England	University of Cambridge	Bettencourt-Dias, M (corresponding author), Gulbenkian Inst Sci, Oeiras, Portugal.		Bettencourt-Dias, Monica/B-5176-2015	Bettencourt-Dias, Monica/0000-0003-1987-5598; Glover, David/0000-0003-0956-0103				Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985	9	11	11	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 9	2009	136	1					188	U1		10.1016/j.cell.2008.12.035	http://dx.doi.org/10.1016/j.cell.2008.12.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135899	Bronze			2022-12-01	WOS:000262318400025
J	Cochran, JC; Sindelar, CV; Mulko, NK; Collins, KA; Kong, SE; Hawley, RS; Kull, FJ				Cochran, Jared C.; Sindelar, Charles V.; Mulko, Natasha K.; Collins, Kimberly A.; Kong, Stephanie E.; Hawley, R. Scott; Kull, F. Jon			ATPase Cycle of the Nonmotile Kinesin NOD Allows Microtubule End Tracking and Drives Chromosome Movement	CELL			English	Article							DROSOPHILA-MELANOGASTER; MONASTROL INHIBITION; MOTOR PROTEINS; EG5; SEGREGATION; MECHANISM; PATHWAY; BINDING; MYOSIN; MODEL	Segregation of nonexchange chromosomes during Drosophila melanogaster meiosis requires the proper function of NOD, a nonmotile kinesin-10. We have determined the X-ray crystal structure of the NOD catalytic domain in the ADP- and AMPPNP-bound states. These structures reveal an alternate conformation of the microtubule binding region as well as a nucleotide-sensitive relay of hydrogen bonds at the active site. Additionally, a cryo-electron microscopy reconstruction of the nucleotide-free microtubule-NOD complex shows an atypical binding orientation. Thermodynamic studies show that NOD binds tightly to microtubules in the nucleotide-free state, yet other nucleotide states, including AMPPNP, are weakened. Our pre-steady-state kinetic analysis demonstrates that NOD interaction with microtubules occurs slowly with weak activation of ADP product release. Upon rapid substrate binding, NOD detaches from the microtubule prior to the rate-limiting step of ATP hydrolysis, which is also atypical for a kinesin. We propose a model for NOD's microtubule plus-end tracking that drives chromosome movement.	[Cochran, Jared C.; Mulko, Natasha K.; Kull, F. Jon] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA; [Sindelar, Charles V.] Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Collins, Kimberly A.; Kong, Stephanie E.; Hawley, R. Scott] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Hawley, R. Scott] Univ Kansas, Med Ctr, Dept Physiol, Kansas City, KS 66160 USA	Dartmouth College; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Kull, FJ (corresponding author), Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA.	f.jon.kull@dartmouth.edu		Hawley, R. Scott/0000-0002-6478-0494	National Institutes of Health (NIH) [F32AR054653 from the]; NIH [GM46033, GM51487, F32GM082104, GM-0080]; American Heart Association Scientist Development [0330345N]; U. S. Department of Energy [DE-AC02-98CH10886, DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR054653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM051487, R01GM046033, F32GM082104] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of National Synchrotron Light Source (NSLS) beamline X6A, particularly Vivian Stojanoff and Jean Jakoncic, for beam time and help with data collection. We also thank Susan P. Gilbert (Rensselaer Polytechnic Institute) and Heinrich J. Matthies (Vanderbilt University) for their insightful comments on this manuscript and our colleagues in the Kull lab for their intellectual discussions. The project described was supported by F32AR054653 from the National Institutes of Health (NIH) (National Institute of Arthritis and Musculoskeletal and Skin Diseases) to J.C.C., GM46033 and GM51487 from the NIH to C. V. S., F32GM082104 from the NIH (National Institute of General Medical Sciences [NIGMS]) to K. A. C., and also by American Heart Association Scientist Development Grant 0330345N to F.J.K. Research carried out at X6A beam line was funded by the NIH (NIGMS) under agreement GM-0080. The NSLS, Brookhaven National Laboratory is supported by the U. S. Department of Energy under contract DE-AC02-98CH10886. Lawrence Berkeley National Laboratory is supported by the U. S. DOE under contract DE-AC02-05CH11231.	AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARPENTER AT, 1973, GENETICS, V73, P393; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Cui W, 2005, GENETICS, V171, P1823, DOI 10.1534/genetics.105.047464; Cui W, 2005, MOL BIOL CELL, V16, P5400, DOI 10.1091/mbc.E05-06-0582; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; DeBonis S, 2003, BIOCHEMISTRY-US, V42, P338, DOI 10.1021/bi026716j; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; JOHNSON KA, 1983, J BIOL CHEM, V258, P3825; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Klumpp LM, 2004, BIOCHEMISTRY-US, V43, P2792, DOI 10.1021/bi035830e; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Kull FJ, 2004, TRENDS BIOCHEM SCI, V29, P103, DOI 10.1016/j.tibs.2004.01.001; Kull FJ, 2002, J CELL SCI, V115, P15; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Matthies HJG, 2001, MOL BIOL CELL, V12, P4000, DOI 10.1091/mbc.12.12.4000; Matthies HJG, 1999, J CELL BIOL, V147, P1137, DOI 10.1083/jcb.147.6.1137; Meneely PM, 2002, GENETICS, V162, P1169; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; RASOOLY RS, 1994, MOL GEN GENET, V242, P145, DOI 10.1007/BF00391007; Shipley K, 2004, EMBO J, V23, P1422, DOI 10.1038/sj.emboj.7600165; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tan DY, 2006, J CELL BIOL, V175, P25, DOI 10.1083/jcb.200605194; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P	49	48	48	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					110	122		10.1016/j.cell.2008.11.048	http://dx.doi.org/10.1016/j.cell.2008.11.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135893	Bronze, Green Accepted			2022-12-01	WOS:000262318400019
J	Kawahara, TLA; Michishita, E; Adler, AS; Damian, M; Berber, E; Lin, M; McCord, RA; Ongaigui, KCL; Boxer, LD; Chang, HY; Chua, KF				Kawahara, Tiara L. A.; Michishita, Eriko; Adler, Adam S.; Damian, Mara; Berber, Elisabeth; Lin, Meihong; McCord, Ron A.; Ongaigui, Kristine C. L.; Boxer, Lisa D.; Chang, Howard Y.; Chua, Katrin F.			SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-kappa B-Dependent Gene Expression and Organismal Life Span	CELL			English	Article							CHROMATIN MODIFICATIONS; CELLULAR SENESCENCE; CALORIE RESTRICTION; TRANSCRIPTION; CELLS; REVEALS; MODULE	Members of the sirtuin (SIRT) family of NAD-dependent deacetylases promote longevity in multiple organisms. Deficiency of mammalian SIRT6 leads to shortened life span and an aging-like phenotype in mice, but the underlying molecular mechanisms are unclear. Here we show that SIRT6 functions at chromatin to attenuate NF-kappa B signaling. SIRT6 interacts with the NF-kappa B RELA subunit and deacetylates histone H3 lysine 9 (H3K9) at NF-kappa B target gene promoters. In SIRT6-deficient cells, hyperacetylation of H3K9 at these target promoters is associated with increased RELA promoter occupancy and enhanced NF-kappa B-dependent modulation of gene expression, apoptosis, and cellular senescence. Computational genomics analyses revealed increased activity of NF-kappa B-driven gene expression programs in multiple Sirt6-deficient tissues in vivo. Moreover, haploinsufficiency of RelA rescues the early lethality and degenerative syndrome of Sirt6-deficient mice. We propose that SIRT6 attenuates NF-kappa B signaling via H3K9 deacetylation at chromatin, and hyperactive NF-kappa B signaling may contribute to premature and normal aging.	[Kawahara, Tiara L. A.; Adler, Adam S.; Lin, Meihong; Ongaigui, Kristine C. L.; Chang, Howard Y.] Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Program Epithelial Biol, Stanford, CA 94305 USA; [Kawahara, Tiara L. A.; Adler, Adam S.; McCord, Ron A.; Chang, Howard Y.; Chua, Katrin F.] Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Canc Biol Program, Stanford, CA 94305 USA; [Michishita, Eriko; Damian, Mara; Berber, Elisabeth; McCord, Ron A.; Boxer, Lisa D.; Chua, Katrin F.] Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Dept Med, Stanford, CA 94305 USA; [Michishita, Eriko; Damian, Mara; Berber, Elisabeth; McCord, Ron A.; Boxer, Lisa D.; Chua, Katrin F.] VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Chang, HY (corresponding author), Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu; kfchua@stanford.edu		Adler, Adam/0000-0001-9301-0037; Boxer, Lisa/0000-0002-4402-1060	NIH; Department of Veterans Affairs Merit Review; Stanford Graduate Fellowship; California Breast Cancer Research Program; American Cancer Society; Damon Runyon Cancer Research Foundation; Paul B. Beeson Aging Research Program; NATIONAL CANCER INSTITUTE [R01CA118750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG028961, R01AG028867] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); Stanford Graduate Fellowship(Stanford University); California Breast Cancer Research Program; American Cancer Society(American Cancer Society); Damon Runyon Cancer Research Foundation; Paul B. Beeson Aging Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank O. Gozani, P. Khavari, R. Mostoslavsky, and T. Rando for comments or advice, T. Hong for assistance with primer design, Regeneron Pharmaceuticals for generation of the Sirt6 gene-targeted mouse embryonic stem cell line, and R. Mostoslavsky and F. W. Alt for generation of the Sirt6 mutant mice. This work was supported by the NIH (K.F.C., T.L.A.K., R.A.M.), Department of Veterans Affairs Merit Review (K.F.C.), Stanford Graduate Fellowship (T.L.A.K.), California Breast Cancer Research Program (A.S.A.), and American Cancer Society (H.Y.C.). H.Y.C. is the Kenneth G. and Elaine A. Langone Scholar of the Damon Runyon Cancer Research Foundation. K. F. C. is a Scholar of the Paul B. Beeson Aging Research Program.	Adler AS, 2008, CELL CYCLE, V7, P556, DOI 10.4161/cc.7.5.5490; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chi JT, 2003, P NATL ACAD SCI USA, V100, P6343, DOI 10.1073/pnas.1037853100; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.E04-05-0392; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	38	782	840	2	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					62	74		10.1016/j.cell.2008.10.052	http://dx.doi.org/10.1016/j.cell.2008.10.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135889	Green Accepted, Bronze			2022-12-01	WOS:000262318400015
J	Wright, CW; Duckett, CS				Wright, Casey W.; Duckett, Colin S.			The Aryl Hydrocarbon Nuclear Translocator Alters CD30-Mediated NF-kappa B-Dependent Transcription	SCIENCE			English	Article							ACTIVATION; CD30; RECEPTOR; FAMILY; RELB; CELL; EXPRESSION; INDUCTION; TRAF2; MICE	Expression and signaling of CD30, a tumor necrosis factor receptor family member, is up- regulated in numerous lymphoid- derived neoplasias, most notably anaplastic large- cell lymphoma ( ALCL) and Hodgkin's lymphoma. To gain insight into the mechanism of CD30 signaling, we used an affinity purification strategy that led to the identification of the aryl hydrocarbon receptor nuclear translocator ( ARNT) as a CD30- interacting protein that modulated the activity of the RelB subunit of the transcription factor nuclear factor kappa B (NF-kappa B). ALCL cells that were deficient in ARNT exhibited defects in RelB recruitment to NF-kappa B-responsive promoters, whereas RelA recruitment to the same sites was potentiated, resulting in the augmented expression of these NF-kappa B-responsive genes. These findings indicate that ARNT functions in concert with RelB in a CD30- induced negative feedback mechanism.	[Wright, Casey W.; Duckett, Colin S.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Duckett, Colin S.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Duckett, CS (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	colind@umich.edu		Duckett, Colin/0000-0001-9413-2263; Wright, Casey/0000-0002-9512-1264	NIH [R01 GM067827]; Cancer Research Fund of the University of Michigan Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067827] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Fund of the University of Michigan Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Burstein and members of the Duckett laboratory for helpful discussions, C. Duvauchelle for assistance with statistical analyses, and A. Savory for assistance with the manuscript. This work was supported by NIH grant R01 GM067827 and an award from the Cancer Research Fund of the University of Michigan Comprehensive Cancer Center to C. S. D.	Aizawa S, 1997, J BIOL CHEM, V272, P2042; Boucher LM, 1997, BIOCHEM BIOPH RES CO, V233, P592, DOI 10.1006/bbrc.1997.6509; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Chandel NS, 2008, CELL DEATH DIFFER, V15, P619, DOI 10.1038/cdd.2008.11; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chiarle R, 1999, CLIN IMMUNOL, V90, P157, DOI 10.1006/clim.1998.4636; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Horie R, 2004, CANCER CELL, V5, P353, DOI 10.1016/S1535-6108(04)00084-4; Horie R, 2002, ONCOGENE, V21, P2493, DOI 10.1038/sj.onc.1205337; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sutherland MSK, 2006, J BIOL CHEM, V281, P10540, DOI 10.1074/jbc.M510026200; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wolke C, 2006, INT J MOL MED, V17, P275; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Younes A, 2003, CANCER-AM CANCER SOC, V98, P458, DOI 10.1002/cncr.11524; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080	27	41	42	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					251	255		10.1126/science.1162818	http://dx.doi.org/10.1126/science.1162818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131627	Green Accepted			2022-12-01	WOS:000262290600038
J	McDonald-Madden, E; Gordon, A; Wintle, BA; Walker, S; Grantham, H; Carvalho, S; Bottrill, M; Joseph, L; Ponce, R; Stewart, R; Possingham, HP				McDonald-Madden, Eve; Gordon, Ascelin; Wintle, Brendan A.; Walker, Susan; Grantham, Hedley; Carvalho, Silvia; Bottrill, Madeleine; Joseph, Liana; Ponce, Rocio; Stewart, Romola; Possingham, Hugh P.			ENVIRONMENT "True" Conservation Progress	SCIENCE			English	Editorial Material							PROTECTED AREAS; BIODIVERSITY; TRENDS		[McDonald-Madden, Eve; Grantham, Hedley; Carvalho, Silvia; Bottrill, Madeleine; Joseph, Liana; Ponce, Rocio; Stewart, Romola; Possingham, Hugh P.] Univ Queensland, Ctr Appl Environm Decis Anal, Sch Integrat Biol, St Lucia, Qld 4075, Australia; [Gordon, Ascelin] RMIT Univ, Melbourne, Vic 3001, Australia; [Wintle, Brendan A.] Univ Melbourne, Ctr Appl Environm Decis Anal, Sch Bot, Melbourne, Vic 3010, Australia; [Walker, Susan] Landcare Res, Dunedin, New Zealand; [Carvalho, Silvia] Univ Lisbon, Dept Anim Biol, Fac Ciencias, P-1749016 Lisbon, Portugal; [Carvalho, Silvia] Univ Porto, Inst Ciencias Agr Vairao, CIBIO, Ctr Invest Biodivers & Recursos Genet, P-4485661 Vairao, Portugal; Univ Nacl Autonoma Mexico, Colecc Nacl Anfibios & Reptiles Inst Biol, Mexico City 04510, DF, Mexico	University of Queensland; Royal Melbourne Institute of Technology (RMIT); University of Melbourne; Landcare Research - New Zealand; Universidade de Lisboa; Universidade do Porto; Universidad Nacional Autonoma de Mexico	McDonald-Madden, E (corresponding author), Univ Queensland, Ctr Appl Environm Decis Anal, Sch Integrat Biol, St Lucia, Qld 4075, Australia.	e.mcdonaldmadden@uq.edu.au	Carvalho, Silvia/AAE-9566-2020; Bottrill, Madeleine/A-4687-2011; Ponce-Reyes, Rocio/V-5178-2019; Ponce-Reyes, Rocio/K-1553-2013; McDonald-Madden, Eve/A-5186-2012; Carvalho, Silvia B/J-3343-2013; POSSINGHAM, HUGH/R-8310-2019; Possingham, Hugh/B-1337-2008; Gordon, Ascelin/I-9184-2012	Carvalho, Silvia/0000-0003-4368-4708; Ponce-Reyes, Rocio/0000-0002-3680-8736; Ponce-Reyes, Rocio/0000-0002-3680-8736; McDonald-Madden, Eve/0000-0001-7755-2338; Carvalho, Silvia B/0000-0003-4368-4708; POSSINGHAM, HUGH/0000-0001-7755-996X; Possingham, Hugh/0000-0001-7755-996X; Gordon, Ascelin/0000-0002-0648-0346; wintle, brendan/0000-0002-4234-5950; STEWART, Romola/0000-0002-4280-8951				BALLANCE A, 1999, STATE ENV S AFRICA O; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; *COMM ENV COOP, 2001, N AM MOS STAT ENV RE; *DETR, 2000, CAS STUD BUS BIOD; Economic and Social Commission for Asia and the Pacific, 2005, STAT ENV AS PAC; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; HIGGINS J, 2007, ECOREGIONAL STATUS M; *HJ HEINZ III CTR, 2002, STAT NAT EC MEAS LAN, P1; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Niehus, 2006, REMNANT VEGETATION Q; POSSINGHAM HP, 2001, TELA, V9, P1; Pressey RL, 2002, BIOL CONSERV, V106, P57, DOI 10.1016/S0006-3207(01)00229-4; Salafsky N, 2002, CONSERV BIOL, V16, P1469, DOI 10.1046/j.1523-1739.2002.01232.x; State of the Environment Advisory Council, 1996, AUSTR STAT ENV 1996; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; Truscott M, 2006, AUSTR STAT ENV COMM; UNEP, 2007, GLOB ENV OUTL 4 ENV; Walker S, 2008, CONSERV BIOL, V22, P48, DOI 10.1111/j.1523-1739.2007.00844.x	18	30	32	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					43	44		10.1126/science.1164342	http://dx.doi.org/10.1126/science.1164342			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119202				2022-12-01	WOS:000262104100026
J	Rouach, N; Koulakoff, A; Abudara, V; Willecke, K; Giaume, C				Rouach, Nathalie; Koulakoff, Annette; Abudara, Veronica; Willecke, Klaus; Giaume, Christian			Astroglial Metabolic Networks Sustain Hippocampal Synaptic Transmission	SCIENCE			English	Article							GAP-JUNCTIONS; ASTROCYTES; EXPRESSION	Astrocytes provide metabolic substrates to neurons in an activity- dependent manner. However, the molecular mechanisms involved in this function, as well as its role in synaptic transmission, remain unclear. Here, we show that the gap- junction subunit proteins connexin 43 and 30 allow intercellular trafficking of glucose and its metabolites through astroglial networks. This trafficking is regulated by glutamatergic synaptic activity mediated by AMPA receptors. In the absence of extracellular glucose, the delivery of glucose or lactate to astrocytes sustains glutamatergic synaptic transmission and epileptiform activity only when they are connected by gap junctions. These results indicate that astroglial gap junctions provide an activity- dependent intercellular pathway for the delivery of energetic metabolites from blood vessels to distal neurons.	[Rouach, Nathalie; Koulakoff, Annette; Abudara, Veronica; Giaume, Christian] Coll France, INSERM, U840, F-75005 Paris, France; [Abudara, Veronica] Univ Republica, Fac Med, Montevideo, Uruguay; [Willecke, Klaus] Univ Bonn, Inst Genet, D-53117 Bonn, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universidad de la Republica, Uruguay; University of Bonn	Rouach, N (corresponding author), Coll France, INSERM, U840, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	nathalie.rouach@college-de-france.fr	Rouach, Nathalie/L-4767-2017	Rouach, Nathalie/0000-0002-5574-888X; KOULAKOFF, Annette/0000-0002-3143-2215	Human Frontier Science Program Organization (Career Development Award); Agence Nationale de la Recherche (Programme Jeunes chercheurs); INSERM; German Research Association [SFB 615, B3]; International Brain Research Organization	Human Frontier Science Program Organization (Career Development Award)(Human Frontier Science Program); Agence Nationale de la Recherche (Programme Jeunes chercheurs)(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); German Research Association(German Research Foundation (DFG)); International Brain Research Organization	We thank P. Ezan for technical assistance and R. Nicoll, G. Bonvento, J. Deitmer, and P. Magistretti for helpful discussions. This work was supported by grants from the Human Frontier Science Program Organization (Career Development Award) and Agence Nationale de la Recherche ( Programme Jeunes chercheurs) to N.R.; from INSERM to N.R., A.K., and C.G.; from the German Research Association (SFB 615, B3) to K.W.; and from International Brain Research Organization to V. A. N. R. dedicates this work to her daughter Angela.	Clarke Donald D., 1994, P645; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; Kacem K, 1998, GLIA, V23, P1; Matthias K, 2003, J NEUROSCI, V23, P1750; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Simard M, 2003, J NEUROSCI, V23, P9254; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Wallraff A, 2004, GLIA, V48, P36, DOI 10.1002/glia.20040	14	601	625	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1551	1555		10.1126/science.1164022	http://dx.doi.org/10.1126/science.1164022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056987				2022-12-01	WOS:000261377400051
J	Mullighan, CG; Phillips, LA; Su, XP; Ma, J; Miller, CB; Shurtleff, SA; Downing, JR				Mullighan, Charles G.; Phillips, Letha A.; Su, Xiaoping; Ma, Jing; Miller, Christopher B.; Shurtleff, Sheila A.; Downing, James R.			Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia	SCIENCE			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; MINIMAL RESIDUAL DISEASE; GENE REARRANGEMENTS; YOUNG-CHILDREN; IMMUNOGENOTYPE; EVOLUTION; DIAGNOSIS; SELECTION; DELETION; SUBCLONE	Most children with acute lymphoblastic leukemia ( ALL) can be cured, but the prognosis is dismal for the minority of patients who relapse after treatment. To explore the genetic basis of relapse, we performed genome- wide DNA copy number analyses on matched diagnosis and relapse samples from 61 pediatric patients with ALL. The diagnosis and relapse samples typically showed different patterns of genomic copy number abnormalities ( CNAs), with the CNAs acquired at relapse preferentially affecting genes implicated in cell cycle regulation and B cell development. Most relapse samples lacked some of the CNAs present at diagnosis, which suggests that the cells responsible for relapse are ancestral to the primary leukemia cells. Backtracking studies revealed that cells corresponding to the relapse clone were often present as minor subpopulations at diagnosis. These data suggest that genomic abnormalities contributing to ALL relapse are selected for during treatment, and they point to new targets for therapeutic intervention.	[Mullighan, Charles G.; Phillips, Letha A.; Su, Xiaoping; Miller, Christopher B.; Shurtleff, Sheila A.; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Downing, JR (corresponding author), St Jude Childrens Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.downing@stjude.org	Mullighan, Charles/H-3253-2011	Mullighan, Charles/0000-0002-1871-1850	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Ashmun and the St. Jude Flow Cytometry and Cell Sorting Shared Resource for flow sorting of leukemia samples, the St. Jude Clinical Applications Core Technology Laboratory for performing SNP arrays, L. Kiedrowski for lesion mapping and backtracking assays, and J. Stokes for assistance with artwork. Supported by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital and by the National Health and Medical Research Council of Australia (C.G.M.). Primary SNP array data are available from the authors upon request. J.R.D. has participated in gene expression profiling research sponsored by Roche. C.G.M. and J.R.D. have filed a patent application related to this work.	BEISHUIZEN A, 1994, BLOOD, V83, P2238, DOI 10.1182/blood.V83.8.2238.bloodjournal8382238; Choi S, 2007, BLOOD, V110, P632, DOI 10.1182/blood-2007-01-067785; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Davi F, 1996, BLOOD, V88, P609, DOI 10.1182/blood.V88.2.609.bloodjournal882609; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Ford AM, 2001, BLOOD, V98, P558, DOI 10.1182/blood.V98.3.558; Germano G, 2003, LEUKEMIA, V17, P1573, DOI 10.1038/sj.leu.2403008; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Irving JAE, 2005, CANCER RES, V65, P3053, DOI 10.1158/0008-5472.CAN-04-2604; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; Konrad M, 2003, BLOOD, V101, P3635, DOI 10.1182/blood-2002-10-3252; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Maloney KW, 1999, BLOOD, V93, P2380, DOI 10.1182/blood.V93.7.2380.407k27_2380_2385; MARSHALL GM, 1995, LEUKEMIA, V9, P1847; Moorman AV, 2007, BLOOD, V109, P2327, DOI 10.1182/blood-2006-08-040436; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Panzer-Grumayer ER, 2005, CLIN CANCER RES, V11, P7720, DOI 10.1158/1078-0432.CCR-05-1239; Peham M, 2004, GENE CHROMOSOME CANC, V39, P156, DOI 10.1002/gcc.10305; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; RAIMONDI SC, 1993, BLOOD, V82, P576; Rivera GK, 2005, CANCER-AM CANCER SOC, V103, P368, DOI 10.1002/cncr.20743; Rosenquist R, 1999, EUR J HAEMATOL, V63, P171; Takeuchi S, 2003, ONCOGENE, V22, P6970, DOI 10.1038/sj.onc.1206974; TAYLOR JJ, 1994, LEUKEMIA, V8, P60; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zuna J, 2004, CLIN CANCER RES, V10, P5355, DOI 10.1158/1078-0432.CCR-04-0584	27	611	633	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1377	1380		10.1126/science.1164266	http://dx.doi.org/10.1126/science.1164266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039135	Green Accepted			2022-12-01	WOS:000261170600038
J	Puthanveettil, SV; Monje, FJ; Miniaci, MC; Choi, YB; Karl, KA; Khandros, E; Gawinowicz, MA; Sheetz, MP; Kandel, ER				Puthanveettil, Sathyanarayanan V.; Monje, Francisco J.; Miniaci, Maria Concetta; Choi, Yun-Beom; Karl, Kevin A.; Khandros, Eugene; Gawinowicz, Mary Ann; Sheetz, Michael P.; Kandel, Eric R.			A New Component in Synaptic Plasticity: Upregulation of Kinesin in the Neurons of the Gill-Withdrawal Reflex	CELL			English	Article							LONG-TERM FACILITATION; LOCAL PROTEIN-SYNTHESIS; APLYSIA SENSORY NEURONS; AXONAL-TRANSPORT; HETEROSYNAPTIC FACILITATION; NERVOUS-SYSTEM; MEMORY STORAGE; MOTOR; EXPRESSION; SYNAPSES	To explore how gene products, required for the initiation of synaptic growth, move from the cell body of the sensory neuron to its presynaptic terminals, and from the cell body of the motor neuron to its postsynaptic dendritic spines, we have investigated the anterograde transport machinery in both the sensory and motor neurons of the gill-withdrawal reflex of Aplysia. We found that the induction of long-term facilitation (LTF) by repeated applications of serotonin, a modulatory transmitter released during learning in Aplysia, requires upregulation of kinesin heavy chain (KHC) in both pre- and postsynaptic neurons. Indeed, upregulation of KHC in the presynaptic neurons alone is sufficient for the induction of LTF. However, KHC is not required for the persistence of LTF. Thus, in addition to transcriptional activation in the nucleus and local protein synthesis at the synapse, our studies have identified a third component critical for long-term learning-related plasticity: the coordinated upregulation of kinesin-mediated transport.	[Puthanveettil, Sathyanarayanan V.; Monje, Francisco J.; Miniaci, Maria Concetta; Choi, Yun-Beom; Khandros, Eugene; Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Karl, Kevin A.; Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Gawinowicz, Mary Ann] Columbia Univ Coll Phys & Surg, Prot Chem Core Facil, New York, NY 10032 USA; [Sheetz, Michael P.] Columbia Univ Coll Phys & Surg, Dept Biol Sci, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Kavli Inst Brain Sci, New York, NY 10032 USA; [Choi, Yun-Beom] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Miniaci, Maria Concetta] Univ Naples Federico II, Dept Expt Pharmacol, I-80131 Naples, Italy	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University; University of Naples Federico II	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu		Miniaci, Maria/0000-0003-3844-0581	HHMI; NIH [P50 HG002806, R01 MH075026]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060762] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	members Joseph Rayman and Ilias Pavlopoulos for their critical comments on an earlier version of this manuscript. We are grateful to Peter Schieffele for the gift of anti-neurexin antibody. We thank Joun-Hun Kim for help with Piccolo antisense microinjection experiments, Aviva Olsavsky for help with the RTPCR experiments, and John Edwards of Columbia's Genome Center for help with kinesin ESTs. Special thanks to Vivian Zhu for help with cell cultures, Hannah Cho for technical help, and Charles Lam for help with graphics. This work is supported by HHMI, and NIH grants P50 HG002806 and R01 MH075026.	BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Giustetto M, 2003, P NATL ACAD SCI USA, V100, P13680, DOI 10.1073/pnas.1835674100; GLANZMAN DL, 1989, J NEUROSCI, V9, P4200; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Grigoriev I S, 1999, Membr Cell Biol, V13, P23; Gyoeva FK, 2000, J CELL SCI, V113, P2047; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHNAPP BJ, 1985, CELL, V40, P455, DOI 10.1016/0092-8674(85)90160-6; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Terada S, 2000, CELL, V103, P141, DOI 10.1016/S0092-8674(00)00094-5; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026	44	67	67	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					960	973		10.1016/j.cell.2008.11.003	http://dx.doi.org/10.1016/j.cell.2008.11.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041756	Bronze, Green Accepted			2022-12-01	WOS:000261183900025
J	Onwude, JL				Onwude, Joseph L.			What is the most effective treatment of interstitial cystitis?	BRITISH MEDICAL JOURNAL			English	Editorial Material							BACILLUS-CALMETTE-GUERIN; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PENTOSAN POLYSULFATE; DIMETHYL-SULFOXIDE; L-ARGININE; EFFICACY		[Onwude, Joseph L.] Community Gynaecol Ltd, Chelmsford CM1 3RW, Essex, England		Onwude, JL (corresponding author), Community Gynaecol Ltd, Chelmsford CM1 3RW, Essex, England.	jlonwude@btconnect.com	ONWUDE, JOSEPH LOZE/ABA-4929-2021; ONWUDE, JOSEPH Loze/AFM-0527-2022; ONWUDE, JOSEPH Loze/AAH-2903-2022; ONWUDE, JOSEPH LOZE/ABF-7876-2021					Bade JJ, 1997, BRIT J UROL, V79, P168, DOI 10.1046/j.1464-410X.1997.03384.x; Cartledge JJ, 2000, BJU INT, V85, P421, DOI 10.1046/j.1464-410x.2000.00490.x; Hwang P, 1997, UROLOGY, V50, P39, DOI 10.1016/S0090-4295(97)00110-6; *INT CYST CLIN RES, 2007, EFF AM PAINF BLADD S; Korting GE, 1999, J UROLOGY, V161, P558, DOI 10.1016/S0022-5347(01)61950-5; Mayer R, 2005, J UROLOGY, V173, P1186, DOI 10.1097/01.ju.0000152337.82806.e8; Payne CK, 2005, J UROLOGY, V173, P1590, DOI 10.1097/01.ju.0000154631.92150.ef; Peeker R, 2000, J UROLOGY, V164, P1912, DOI 10.1016/S0022-5347(05)66916-9; PEREZMARRERO R, 1988, J UROLOGY, V140, P36, DOI 10.1016/S0022-5347(17)41478-9; Peters K, 1997, J UROLOGY, V157, P2090, DOI 10.1016/S0022-5347(01)64682-2; Sairanen J, 2005, J UROLOGY, V174, P2235, DOI 10.1097/01.ju.0000181808.45786.84; Sant GR, 2003, J UROLOGY, V170, P810, DOI 10.1097/01.ju.0000083020.06212.3d; Thilagarajah R, 2001, BJU INT, V87, P207, DOI 10.1046/j.1464-410x.2001.02031.x; van Ophoven A, 2004, J UROLOGY, V172, P533, DOI 10.1097/01.ju.0000132388.54703.4d; Warren JW, 2000, J UROLOGY, V163, P1685, DOI 10.1016/S0022-5347(05)67520-9	15	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 27	2008	337								a2325	10.1136/bmj.a2325	http://dx.doi.org/10.1136/bmj.a2325			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QC	19039011				2022-12-01	WOS:000261827700003
J	Briffa, T; Hickling, S; Knuiman, M; Hobbs, M; Hung, J; Sanfilippo, FM; Jamrozik, K; Thompson, PL				Briffa, Tom; Hickling, S.; Knuiman, M.; Hobbs, M.; Hung, J.; Sanfilippo, F. M.; Jamrozik, K.; Thompson, P. L.			Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; CASE-FATALITY RATES; WESTERN-AUSTRALIA; UNSTABLE ANGINA; MEDICAL-CARE; EVENT RATES; TRENDS; MORTALITY; MORBIDITY; PROGNOSIS	Objective To examine trends in long term survival in patients alive 28 days after myocardial infarction and the impact of evidence based medical treatments and coronary revascularisation during or near the event. Design Population based cohort with 12 year follow- up. Setting Perth, Australia. Participants 4451 consecutive patients with a definite acute myocardial infarction according to the World Health Organization MONICA ( monitoring trends and determinants in cardiovascular disease) criteria admitted to hospital during 1984- 7, 1988- 90, and 1991- 3. Main outcome measures All cause mortality identified from official mortality records and the hospital morbidity data, with death from cardiovascular disease as a secondary end point. Results In the 1991- 3 cohort, 28 day survivors of acute myocardial infarction had a 7.6% absolute event reduction ( 95% confidence interval 4% to 11%) or a 28% lower relative risk reduction ( 16% to 38%), unadjusted for risk of death, over 12 years after the incident admission compared with the 1984- 7 cohort, similar to the survival of the 1988- 90 cohort. The improved survival for the 1991- 3 cohort persisted after adjustment for demographic factors, coronary risk factors, severity of disease, and event complications with an adjusted relative risk reduction of 26%( 14% to 37%), but this was not apparent after further adjustment for medical treatments in hospital and coronary revascularisation procedures within 12 months of the incident myocardial infarction. Conclusion The improving trends in 12 year survival after a definite acute myocardial infarction are associated with progressive use of evidence based treatments during the initial admission to hospital and in the 12 months after the event. These changes in the management of acute myocardial infarction are probably contributing to the continuing decline in mortality from coronary heart disease in Australia.	[Briffa, Tom; Hickling, S.; Knuiman, M.; Hobbs, M.; Sanfilippo, F. M.] Univ Western Australia, Sch Populat Hlth M431, Crawley, WA 6009, Australia; [Hung, J.; Thompson, P. L.] Univ Western Australia, Sch Med & Pharmacol M503, Crawley, WA 6009, Australia; [Jamrozik, K.] Univ Adelaide, Sch Populat Hlth & Clin Sci NG45, Adelaide, SA 5005, Australia	University of Western Australia; University of Western Australia; University of Adelaide	Briffa, T (corresponding author), Univ Western Australia, Sch Populat Hlth M431, Crawley, WA 6009, Australia.	tom.briffa@uwa.edu.au	Sanfilippo, Frank M/H-9334-2013; Thompson, Peter L/P-1071-2014; Knuiman, Matthew W/I-5549-2013	Sanfilippo, Frank M/0000-0003-3639-0787; Knuiman, Matthew/0000-0001-8874-2305; Hickling, Siobhan/0000-0001-8337-2894	University of Western Australia; WHO MONICA	University of Western Australia; WHO MONICA	The study was supported by the University of Western Australia and the WHO MONICA project.	[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1988, BRIT MED J, V296, P320; Beaglehole R, 1997, AM J EPIDEMIOL, V145, P707, DOI 10.1093/aje/145.8.707; Botkin NF, 2006, AM HEART J, V151, P199, DOI 10.1016/j.ahj.2005.03.016; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; CZARN AOS, 1992, MED J AUSTRALIA, V157, P302, DOI 10.5694/j.1326-5377.1992.tb137179.x; Department of Health, 2000, NAT SERV FRAM NSF CO; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Glesby MJ, 1996, ANN INTERN MED, V124, P999, DOI 10.7326/0003-4819-124-11-199606010-00008; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Herlitz J, 1996, CARDIOVASC DRUG THER, V10, P485, DOI 10.1007/BF00051115; Hobbs MS, 2008, EUR J CARDIOV PREV R, V15, P319, DOI 10.1097/HJR.0b013e3282f3c76b; Hobbs MST, 2004, HEART, V90, P1036, DOI 10.1136/hrt.2003.022160; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; JAMROZIK K, 2001, CARDIOVASCULAR DIS S, V17; Kattainen A, 2006, EUR HEART J, V27, P296, DOI 10.1093/eurheartj/ehi630; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; MARTIN CA, 1987, J CHRON DIS, V40, P661, DOI 10.1016/0021-9681(87)90102-0; MARTIN CA, 1989, AM J EPIDEMIOL, V129, P655, DOI 10.1093/oxfordjournals.aje.a115182; MARTIN CA, 1986, J CHRON DIS, V39, P683, DOI 10.1016/0021-9681(86)90151-7; MCELDUFF P, 2000, 11 AIHW; MCGOVERN PG, 1992, CIRCULATION, V85, P172, DOI 10.1161/01.CIR.85.1.172; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; Norman PE, 1998, BMJ-BRIT MED J, V317, P852, DOI 10.1136/bmj.317.7162.852; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; SALA J, 1995, EUR HEART J, V16, P779, DOI 10.1093/oxfordjournals.eurheartj.a060996; Setoguchi S, 2008, J AM COLL CARDIOL, V51, P1247, DOI 10.1016/j.jacc.2007.10.063; Taylor R, 2006, EUR J CARDIOV PREV R, V13, P760, DOI 10.1097/01.hjr.0000220581.42387.d4; THOMPSON PL, 1991, J HYPERTENS, V9, pS35, DOI 10.1097/00004872-199112007-00009; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088	34	62	64	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2009	338								b36	10.1136/bmj.b36	http://dx.doi.org/10.1136/bmj.b36			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EK	19171564	Green Published, hybrid			2022-12-01	WOS:000263205300001
J	Teixeiro, E; Daniels, MA; Hamilton, SE; Schrum, AG; Bragado, R; Jameson, SC; Palmer, E				Teixeiro, Emma; Daniels, Mark A.; Hamilton, Sara E.; Schrum, Adam G.; Bragado, Rafael; Jameson, Stephen C.; Palmer, Ed			Different T Cell Receptor Signals Determine CD8(+) Memory Versus Effector Development	SCIENCE			English	Article							TRANSCRIPTION; LYMPHOCYTE; GENERATION; RESPONSES; SELECTION; DIVISION	Following infection, naive CD8(+) T cells bearing pathogen- specific T cell receptors ( TCRs) differentiate into a mixed population of short- lived effector and long- lived memory T cells to mediate an adaptive immune response. How the TCR regulates memory T cell development has remained elusive. Using a mutant TCR transgenic model, we found that point mutations in the TCR beta transmembrane domain (beta TMD) impair the development and function of CD8(+) memory T cells without affecting primary effector T cell responses. Mutant T cells are deficient in polarizing the TCR and in organizing the nuclear factor kappa B signal at the immunological synapse. Thus, effector and memory states of CD8(+) T cells are separable fates, determined by differential TCR signaling.	[Teixeiro, Emma; Daniels, Mark A.; Schrum, Adam G.; Palmer, Ed] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Teixeiro, Emma; Daniels, Mark A.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Sch Med,Ctr Cellular & Mol Immunol, Columbia, MO 65212 USA; [Hamilton, Sara E.; Jameson, Stephen C.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55454 USA; [Hamilton, Sara E.; Jameson, Stephen C.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA; [Bragado, Rafael] Fdn Jimenez Diaz, Dept Immunol, E-28040 Madrid, Spain; [Schrum, Adam G.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA	University of Basel; University of Missouri System; University of Missouri Columbia; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Teixeiro, E (corresponding author), Univ Basel Hosp, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland.	teixeiropernase@missouri.edu; ed.palmer@unibas.ch	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Schrum, Adam/0000-0001-9276-1859; Daniels, Mark/0000-0002-5175-9901	Mission Enhancement Program, University of Missouri; Fundacion Ramon Areces, Spain; American Cancer Society; Cancer Research Institute; Spanish Ministry of Science and Education (MEC) [BFU 2005-02807]; Novartis; Roche; Sybilla (EUFP7); Swiss National Science Foundation	Mission Enhancement Program, University of Missouri; Fundacion Ramon Areces, Spain; American Cancer Society(American Cancer Society); Cancer Research Institute; Spanish Ministry of Science and Education (MEC)(Spanish Government); Novartis(Novartis); Roche(Roche Holding); Sybilla (EUFP7)(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank D. Roubaty, B. Hausmann, V. Jaggin, G. E. Fernandez, H. Karauzum, M. Schmaler, and Z. Rajacic for technical assistance; R. Landmann-Suter for technical advice; and C. Pernas Pernas for helpful discussion. This work was supported by Mission Enhancement Program, University of Missouri (E.T. and M.A.D.) fellowships from the Fundacion Ramon Areces, Spain (E.T.), the American Cancer Society (S.E.H.), the Cancer Research Institute (M.A.D.), the Spanish Ministry of Science and Education (MEC) (BFU 2005-02807) (R.B.), Novartis, Roche, Sybilla (EUFP7) and the Swiss National Science Foundation (E.P.).	Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Campbell K S, 1994, Semin Immunol, V6, P393, DOI 10.1006/smim.1994.1049; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hettmann T, 2003, IMMUNOL LETT, V85, P297, DOI 10.1016/S0165-2478(02)00260-2; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kersh EN, 2006, J IMMUNOL, V177, P3821, DOI 10.4049/jimmunol.177.6.3821; Krieg C, 2007, NAT IMMUNOL, V8, P162, DOI 10.1038/ni1418; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Teixeiro E, 1999, EUR J IMMUNOL, V29, P745, DOI 10.1002/(SICI)1521-4141(199903)29:03<745::AID-IMMU745>3.0.CO;2-0; Teixeiro E, 2004, IMMUNITY, V21, P515, DOI 10.1016/j.immuni.2004.08.014; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548	23	149	152	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					502	505		10.1126/science.1163612	http://dx.doi.org/10.1126/science.1163612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164748				2022-12-01	WOS:000262587900042
J	Chakravarti, A				Chakravarti, Aravinda			Kinship: Race relations	NATURE			English	Editorial Material									[Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Geriatr Med, Baltimore, MD 21205 USA	Johns Hopkins University	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Geriatr Med, Broadway Res Bldg,Room 579,733 N Broadway, Baltimore, MD 21205 USA.	aravinda@jhmi.edu							0	16	16	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					380	381		10.1038/457380a	http://dx.doi.org/10.1038/457380a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158772				2022-12-01	WOS:000262519200019
J	Saavedra, S; Reed-Tsochas, F; Uzzi, B				Saavedra, Serguei; Reed-Tsochas, Felix; Uzzi, Brian			A simple model of bipartite cooperation for ecological and organizational networks	NATURE			English	Article							FOOD; EMBEDDEDNESS; EXPLOITATION; PATTERNS; RULES	In theoretical ecology, simple stochastic models that satisfy two basic conditions about the distribution of niche values and feeding ranges have proved successful in reproducing the overall structural properties of real food webs, using species richness and connectance as the only input parameters(1-4). Recently, more detailed models have incorporated higher levels of constraint in order to reproduce the actual links observed in real food webs(5,6). Here, building on previous stochastic models of consumer - resource interactions between species(1-3), we propose a highly parsimonious model that can reproduce the overall bipartite structure of cooperative partner - partner interactions, as exemplified by plant - animal mutualistic networks(7). Our stochastic model of bipartite cooperation uses simple specialization and interaction rules, and only requires three empirical input parameters. We test the bipartite cooperation model on ten large pollination data sets that have been compiled in the literature, and find that it successfully replicates the degree distribution, nestedness and modularity of the empirical networks. These properties are regarded as key to understanding cooperation in mutualistic networks(8-10). We also apply our model to an extensive data set of two classes of company engaged in joint production in the garment industry. Using the same metrics, we find that the network of manufacturer - contractor interactions exhibits similar structural patterns to plant - animal pollination networks. This surprising correspondence between ecological and organizational networks suggests that the simple rules of cooperation that generate bipartite networks may be generic, and could prove relevant in many different domains, ranging from biological systems to human society(11-14).	[Saavedra, Serguei; Reed-Tsochas, Felix] Univ Oxford, CABDyN Complex Ctr, Oxford OX1 1HP, England; [Saavedra, Serguei] Univ Oxford, Corp Reputat Ctr, Oxford OX1 1HP, England; [Reed-Tsochas, Felix] Univ Oxford, James Martin Inst, Said Business Sch, Oxford OX1 1HP, England; [Saavedra, Serguei] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Uzzi, Brian] Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA; [Uzzi, Brian] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA; [Uzzi, Brian] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Northwestern University; Northwestern University; University of California System; University of California Berkeley	Reed-Tsochas, F (corresponding author), Univ Oxford, CABDyN Complex Ctr, Oxford OX1 1HP, England.	felix.reed-tsochas@sbs.ox.ac.uk			European Commission; MMCOMNET; CONACYT; Oxford University Corporate Reputation Centre; CABDyN Complexity Centre	European Commission(European CommissionEuropean Commission Joint Research Centre); MMCOMNET; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Oxford University Corporate Reputation Centre; CABDyN Complexity Centre	We thank J. Dunne, R. Guimera, J. Kertesz, M. Sales-Pardo, D. Stouffer and R. Williams for comments and suggestions. F.R.-T. acknowledges funding from the European Commission under the FP6 NEST Pathfinder Initiative 'Tackling Complexity in Science' (MMCOMNET project, contract no. 012999). S.S. held a Doctoral Research Studentship funded by MMCOMNET and CONACYT, and currently is supported by a Postdoctoral Fellowship at the Oxford University Corporate Reputation Centre in conjunction with the CABDyN Complexity Centre.	Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2006, SFI S SCI C, P143; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Carroll G. R., 2004, DEMOGRAPHY CORPORATI; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimaraes PR, 2007, J THEOR BIOL, V249, P181, DOI 10.1016/j.jtbi.2007.08.004; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hammerstein P, 2003, GENETIC CULTURAL EVO; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Moody J, 2003, AM SOCIOL REV, V68, P103, DOI 10.2307/3088904; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.2307/3071803; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; Podolny J., 2005, STATUS SIGNALS SOCIO; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	30	115	115	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					463	466		10.1038/nature07532	http://dx.doi.org/10.1038/nature07532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19052545				2022-12-01	WOS:000262519200043
J	Moran, NA; McLaughlin, HJ; Sorek, R				Moran, Nancy A.; McLaughlin, Heather J.; Sorek, Rotem			The Dynamics and Time Scale of Ongoing Genomic Erosion in Symbiotic Bacteria	SCIENCE			English	Article							EVOLUTION; SEQUENCE	Among cellular organisms, symbiotic bacteria provide the extreme examples of genome degradation and reduction. However, only isolated snapshots of eroding symbiont genomes have previously been available. We documented the dynamics of symbiont genome evolution by sequencing seven strains of Buchnera aphidicola from pea aphid hosts. We estimated a spontaneous mutation rate of at least 4 x 10(-9) substitutions per site per replication, which is more than 10 times as high as the rates previously estimated for any bacteria. We observed a high rate of small insertions and deletions associated with abundant DNA homopolymers, and occasional larger deletions. Although purifying selection eliminates many mutations, some persist, resulting in ongoing loss of genes and DNA from this already tiny genome. Our results provide a general model for the stepwise process leading to genome reduction.	[Moran, Nancy A.; McLaughlin, Heather J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	University of Arizona; Weizmann Institute of Science	Moran, NA (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	nmoran@email.arizona.edu	Moran, Nancy A/G-1591-2010		NSF [0723472]; Y. Leon Benoziyo Institute for Molecular Medicine; U. S. Department of Energy	NSF(National Science Foundation (NSF)); Y. Leon Benoziyo Institute for Molecular Medicine; U. S. Department of Energy(United States Department of Energy (DOE))	We thank staff at the Joint Genome Institute for the Solexa sequencing runs, E. Rubin for support and facilities, and H. Ochman for comments on the manuscript. Aphid samples were donated by G. Powell and J. C. Simon. K. Hammond maintained insect cultures, and B. Nankivell prepared figures. Funding was provided by NSF award 0723472 (to N.A.M.), the Y. Leon Benoziyo Institute for Molecular Medicine (to R. S.), and the U. S. Department of Energy (to the Joint Genome Institute supporting the sequencing). GenBank accession numbers are CP00158 and CP00161 for the genomic sequences and FJ357501 to FJ357538 for sequences used for the phylogeny of fig. S2.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Coenye T, 2005, DNA RES, V12, P221, DOI 10.1093/dnares/dsi009; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; HARPER AM, 1978, SPECIAL PUBLICATION, V50, P1; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; PARKER BO, 1992, P NATL ACAD SCI USA, V89, P1730, DOI 10.1073/pnas.89.5.1730; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Tamas I, 2008, P NATL ACAD SCI USA, V105, P14934, DOI 10.1073/pnas.0806554105; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	19	224	724	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					379	382		10.1126/science.1167140	http://dx.doi.org/10.1126/science.1167140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150844				2022-12-01	WOS:000262481400038
J	Ebert, AD; Yu, JY; Rose, FF; Mattis, VB; Lorson, CL; Thomson, JA; Svendsen, CN				Ebert, Allison D.; Yu, Junying; Rose, Ferrill F., Jr.; Mattis, Virginia B.; Lorson, Christian L.; Thomson, James A.; Svendsen, Clive N.			Induced pluripotent stem cells from a spinal muscular atrophy patient	NATURE			English	Article							MOTOR-NEURON GENE; VALPROIC ACID INCREASES; PROTEIN-LEVEL; SMN; SURVIVAL; COMPLEX; MOUSE; NORMALIZATION; SPECIFICATION; PRODUCT	Spinal muscular atrophy is one of the most common inherited forms of neurological disease leading to infant mortality. Patients have selective loss of lower motor neurons resulting in muscle weakness, paralysis and often death. Although patient fibroblasts have been used extensively to study spinal muscular atrophy, motor neurons have a unique anatomy and physiology which may underlie their vulnerability to the disease process. Here we report the generation of induced pluripotent stem cells from skin fibroblast samples taken from a child with spinal muscular atrophy. These cells expanded robustly in culture, maintained the disease genotype and generated motor neurons that showed selective deficits compared to those derived from the child's unaffected mother. This is the first study to show that human induced pluripotent stem cells can be used to model the specific pathology seen in a genetically inherited disease. As such, it represents a promising resource to study disease mechanisms, screen new drug compounds and develop new therapies.	[Ebert, Allison D.; Svendsen, Clive N.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Ebert, Allison D.; Thomson, James A.; Svendsen, Clive N.] Univ Wisconsin, Stem Cell & Regenerat Med Ctr, Madison, WI 53705 USA; [Yu, Junying; Thomson, James A.] Univ Wisconsin, Genome Ctr, Madison, WI 53706 USA; [Yu, Junying; Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Rose, Ferrill F., Jr.; Mattis, Virginia B.; Lorson, Christian L.] Univ Missouri, Dept Vet Pathobiol, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Thomson, James A.; Svendsen, Clive N.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; [Svendsen, Clive N.] Univ Wisconsin, Dept Neurol, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ebert, AD (corresponding author), Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA.	ebert@waisman.wisc.edu; cnsvendsen@wisc.edu			Amyotrophic Lateral Sclerosis Association; National Institutes of Neurological Disorders and Stroke [P01NS057778, R01NS41584]; National Institutes of Child Health and Human Development [R01HD054413]; National Institutes of General Medical Sciences [T32GM008396]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS057778, R01NS041584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG027566] Funding Source: NIH RePORTER	Amyotrophic Lateral Sclerosis Association; National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Meyer for helpful discussions and B. Shelley, B. Heins and E. McMillan for technical assistance. We also thank WiCell Research Institute for karyotypeanalysis, Cell LineGenetics for DNA fingerprinting, R. Stewart, S. Tian and V. Ruotti at the Morgridge Institute for Research for microarray analysis, and Promega Corp. for qRT-PCR analysis (all at Madison, Wisconsin). The MNR2/HB9 (81.5C10) and the ISLET1 (40.2D6) monoclonal antibodies (both developed by T. Jessell) were obtained from the Developmental Studies HybridomaBank. Funding support was provided by the Amyotrophic Lateral Sclerosis Association (to C.N.S.), the National Institutes of Neurological Disorders and Stroke (P01NS057778 to C.N.S. and R01NS41584 to C.L.L.), National Institutes of Child Health and Human Development (R01HD054413 to C.L.L.), and National Institutes of General Medical Sciences (T32GM008396 for F.F.R.).	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Carriedo SG, 1996, J NEUROSCI, V16, P4069; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; DiDonato CJ, 1997, GENOME RES, V7, P339, DOI 10.1101/gr.7.4.339; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fox V, 2008, STEM CELLS, V26, P715, DOI 10.1634/stemcells.2007-0368; Gavrilov DK, 1998, NAT GENET, V20, P230, DOI 10.1038/3030; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Schmid A, 2007, J CHILD NEUROL, V22, P1004, DOI 10.1177/0883073807305667; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Sumner CJ, 2006, NEUROLOGY, V66, P1067, DOI 10.1212/01.wnl.0000201929.56928.13; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	41	1074	1207	3	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					277	U1		10.1038/nature07677	http://dx.doi.org/10.1038/nature07677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19098894	Green Accepted			2022-12-01	WOS:000262440900031
J	He, YP; Vogelstein, B; Velculescu, VE; Papadopoulos, N; Kinzler, KW				He, Yiping; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.			The Antisense Transcriptomes of Human Cells	SCIENCE			English	Article							GENOME; RNA	Transcription in mammalian cells can be assessed at a genome- wide level, but it has been difficult to reliably determine whether individual transcripts are derived from the plus or minus strands of chromosomes. This distinction can be critical for understanding the relationship between known transcripts ( sense) and the complementary antisense transcripts that may regulate them. Here, we describe a technique that can be used to (i) identify the DNA strand of origin for any particular RNA transcript, and (ii) quantify the number of sense and antisense transcripts from expressed genes at a global level. We examined five different human cell types and in each case found evidence for antisense transcripts in 2900 to 6400 human genes. The distribution of antisense transcripts was distinct from that of sense transcripts, was nonrandom across the genome, and differed among cell types. Antisense transcripts thus appear to be a pervasive feature of human cells, which suggests that they are a fundamental component of gene regulation.	[He, Yiping; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [He, Yiping; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Papadopoulos, N (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	npapado1@jhmi.edu	Velculescu, Victor/ABF-4846-2020; Papadopoulos, Nickolas/K-7272-2012	Velculescu, Victor/0000-0003-1195-438X; 	Virginia and D. K. Ludwig Fund for Cancer Research; NIH [CA57345, CA43460, CA62924, CA121113]; NATIONAL CANCER INSTITUTE [R01CA121113, P50CA062924, R37CA057345, R01CA057345, R37CA043460, R01CA043460] Funding Source: NIH RePORTER	Virginia and D. K. Ludwig Fund for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Yu for assistance with microarrays. Supported by the Virginia and D. K. Ludwig Fund for Cancer Research and NIH grants CA57345, CA43460, CA62924, and CA121113. Under a licensing agreement between Johns Hopkins University and Genzyme, technologies related to SAGE were licensed to Genzyme for commercial purposes, and B.V., V.E.V., and K.W.K. are entitled to a share of the royalties received by the university from the sales of the licensed technologies. The university and researchers (B.V. and K.W.K.) own Genzyme stock, which is subject to certain restrictions under university policy. The terms of these arrangements are being managed by the university in accordance with its conflict-of-interest policies. There are existing patents for SAGE that have been licensed as disclosed above, and similar patents are likely to be filed for ASSAGE.	Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Carmichael GG, 2003, NAT BIOTECHNOL, V21, P371, DOI 10.1038/nbt0403-371; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Fahey ME, 2002, COMP FUNCT GENOM, V3, P244, DOI 10.1002/cfg.173; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Peters BA, 2007, GENOME RES, V17, P287, DOI 10.1101/gr.5486607; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; Shendure J, 2002, GENOME BIOL, V3; Simpson AJG, 2001, COMP FUNCT GENOM, V2, P169, DOI 10.1002/cfg.81; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Timmons JA, 2006, BIOCHEM SOC T, V34, P1148, DOI 10.1042/BST0341148; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Yazgan O, 2007, BIOCHEM CELL BIOL, V85, P484, DOI 10.1139/O07-061; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	25	394	432	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1855	1857		10.1126/science.1163853	http://dx.doi.org/10.1126/science.1163853			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19056939	Green Accepted			2022-12-01	WOS:000261799400058
J	Thum, T; Gross, C; Fiedler, J; Fischer, T; Kissler, S; Bussen, M; Galuppo, P; Just, S; Rottbauer, W; Frantz, S; Castoldi, M; Soutschek, J; Koteliansky, V; Rosenwald, A; Basson, MA; Licht, JD; Pena, JTR; Rouhanifard, SH; Muckenthaler, MU; Tuschl, T; Martin, GR; Bauersachs, J; Engelhardt, S				Thum, Thomas; Gross, Carina; Fiedler, Jan; Fischer, Thomas; Kissler, Stephan; Bussen, Markus; Galuppo, Paolo; Just, Steffen; Rottbauer, Wolfgang; Frantz, Stefan; Castoldi, Mirco; Soutschek, Jurgen; Koteliansky, Victor; Rosenwald, Andreas; Basson, M. Albert; Licht, Jonathan D.; Pena, John T. R.; Rouhanifard, Sara H.; Muckenthaler, Martina U.; Tuschl, Thomas; Martin, Gail R.; Bauersachs, Johann; Engelhardt, Stefan			MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts	NATURE			English	Article							CARDIAC-HYPERTROPHY; HEART-FAILURE; IN-VIVO; EXPRESSION; REGULATOR; MECHANISM; SPROUTY2; MICE; PLAY	MicroRNAs comprise a broad class of small non- coding RNAs that control expression of complementary target messenger RNAs(1,2). Dysregulation of microRNAs by several mechanisms has been described in various disease states(3-5) including cardiac disease(6-10). Whereas previous studies of cardiac disease have focused on microRNAs that are primarily expressed in cardiomyocytes, the role of microRNAs expressed in other cell types of the heart is unclear. Here we show that microRNA-21 (miR-21, also known as Mirn21) regulates the ERK - MAP kinase signalling pathway in cardiac fibroblasts, which has impacts on global cardiac structure and function. miR-21 levels are increased selectively in fibroblasts of the failing heart, augmenting ERK - MAP kinase activity through inhibition of sprouty homologue 1 ( Spry1). This mechanism regulates fibroblast survival and growth factor secretion, apparently controlling the extent of interstitial fibrosis and cardiac hypertrophy. In vivo silencing of miR- 21 by a specific antagomir in a mouse pressure- overload- induced disease model reduces cardiac ERK - MAP kinase activity, inhibits interstitial fibrosis and attenuates cardiac dysfunction. These findings reveal that microRNAs can contribute to myocardial disease by an effect in cardiac fibroblasts. Our results validate miR- 21 as a disease target in heart failure and establish the therapeutic efficacy of microRNA therapeutic intervention in a cardiovascular disease setting.	[Thum, Thomas; Fiedler, Jan; Galuppo, Paolo; Frantz, Stefan; Bauersachs, Johann] Univ Wurzburg, Dept Med 1, D-97080 Wurzburg, Germany; [Thum, Thomas; Fiedler, Jan] Univ Wurzburg, Jr Res Grp, IZKF, D-97080 Wurzburg, Germany; [Gross, Carina; Fischer, Thomas; Kissler, Stephan; Engelhardt, Stefan] Univ Wurzburg, Rudolf Virchow Ctr, DFG, Res Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany; [Bussen, Markus] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Just, Steffen; Rottbauer, Wolfgang] Univ Heidelberg, Dept Internal Med 3, D-69120 Heidelberg, Germany; [Castoldi, Mirco; Muckenthaler, Martina U.] Univ Heidelberg, Dept Pediat Hematol Oncol & Immunol, D-69120 Heidelberg, Germany; [Castoldi, Mirco; Muckenthaler, Martina U.] Univ Heidelberg, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Soutschek, Jurgen] Regulus Therapeut, Carlsbad, CA 92008 USA; [Koteliansky, Victor] Alnylam Pharmaceut, Cambridge, MA 02142 USA; [Basson, M. Albert] Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England; [Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Pena, John T. R.; Rouhanifard, Sara H.; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10065 USA; [Engelhardt, Stefan] Tech Univ Munich, Inst Pharmacol & Toxicol, D-80802 Munich, Germany	University of Wurzburg; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; University of Wurzburg; University of California System; University of California San Francisco; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Isis Pharmaceuticals Inc; University of London; King's College London; Northwestern University; Feinberg School of Medicine; Rockefeller University; Technical University of Munich	Bauersachs, J (corresponding author), Univ Wurzburg, Dept Med 1, D-97080 Wurzburg, Germany.	j.bauersachs@medizin.uni-wuerzburg.de; stefan.engelhardt@tum.de	Engelhardt, Stefan/AAA-9329-2019; Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020; Basson, M. Albert/C-5565-2009; Frantz, Stefan/G-1723-2012	Engelhardt, Stefan/0000-0001-5378-8661; Licht, Jonathan/0000-0002-3942-1369; Thum, Thomas/0000-0003-4360-1511; /0000-0003-3062-7800; Basson, M. Albert/0000-0001-9834-7528; Muckenthaler, Martina/0000-0002-3778-510X; Rouhanifard, Sara/0000-0002-6991-4877	IZKF [E-31]; Deutsche Forschungsgemeinschaft [DFG TH903/7-1]; Rudolf Virchow Center/DFG Research Center for Experimental Biomedicine; Bavarian Ministry of Technology; ProCorde; Sanofi-Aventis; US NIH [R01 CA78711]; The Medical Faculty of the University of Heidelberg; Cancer Research Net [BMBF (NGFN) 201GS0450]; Leopoldina Academy [BMBF-LPD 9901/8-141]; NATIONAL CANCER INSTITUTE [R01CA059998, R01CA078711] Funding Source: NIH RePORTER	IZKF; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rudolf Virchow Center/DFG Research Center for Experimental Biomedicine; Bavarian Ministry of Technology; ProCorde; Sanofi-Aventis(Sanofi-Aventis); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Medical Faculty of the University of Heidelberg; Cancer Research Net; Leopoldina Academy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Hemmrich, U. Keller, J. Schittl, C. Dienesch, S. Thum, A. Leupold, M. Kummel, S. Schraut, A. Lauer, S. Marquart, E. Leich and A. Horn for technical assistance. Weacknowledge the contribution of V. Benes and S. Schmidt (miChip microarray Platform, EMBL), D. Fraccarollo and K. Hu (in vivo studies), S. Leierseder and X. Loyer (primary fibroblast preparation), C. Sohn- Lee (in situ hybridization experiments) and M. Manoharan, R. Braich and B. Bhat (antagomir oligonucleotides). We also thank L. Field, T. Brand and M. Gessler for discussions. This work was supported in part by grants from the IZKF (E-31 to T. Thum), the Deutsche Forschungsgemeinschaft (DFG TH903/7-1 to T. Thum and J. B.), the Rudolf Virchow Center/ DFG Research Center for Experimental Biomedicine (S.E., S.K.), the Bavarian Ministry of Technology, ProCorde and Sanofi-Aventis (S.E.), and the US NIH (R01 CA78711 to G. R. M.). M. C. is supported by an Excellence Fellowship of The Medical Faculty of the University of Heidelberg, M.U.M. by a Cancer Research Net grant (BMBF (NGFN) 201GS0450), and M. B. by the Leopoldina Academy (BMBF-LPD 9901/ 8- 141).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kudej RK, 1997, J MOL CELL CARDIOL, V29, P2735, DOI 10.1006/jmcc.1997.0508; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li X, 1997, BIOTECHNIQUES, V23, P874, DOI 10.2144/97235st03; Merkle S, 2007, CIRC RES, V100, P645, DOI 10.1161/01.RES.0000260203.55077.61; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; THURN T, 2004, CIRC RES, V94, pE1; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zhao CM, 2007, ADV INTEL SYS RES, V2, P317	30	1828	1974	4	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					980	U83		10.1038/nature07511	http://dx.doi.org/10.1038/nature07511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19043405				2022-12-01	WOS:000261768300052
J	Prucca, CG; Slavin, I; Quiroga, R; Elias, EV; Rivero, FD; Saura, A; Carranza, PG; Lujan, HD				Prucca, Cesar G.; Slavin, Ileana; Quiroga, Rodrigo; Elias, Eliana V.; Rivero, Fernando D.; Saura, Alicia; Carranza, Pedro G.; Lujan, Hugo D.			Antigenic variation in Giardia lamblia is regulated by RNA interference	NATURE			English	Article							GENE; PROTEIN; IDENTIFICATION; MECHANISMS; TRANSCRIPTS; EXPRESSION; EUKARYOTE; PLANTS; FUNGI; SENSE	Giardia lamblia ( also called Giardia intestinalis) is one of the most common intestinal parasites of humans. To evade the host's immune response, Giardia undergoes antigenic variation - a process that allows the parasite to develop chronic and recurrent infections. From a repertoire of similar to 190 variant- specific surface protein ( VSP)- coding genes, Giardia expresses only one VSP on the surface of each parasite at a particular time, but spontaneously switches to a different VSP by unknown mechanisms. Here we show that regulation of VSP expression involves a system comprising RNA- dependent RNA polymerase, Dicer and Argonaute, known components of the RNA interference machinery. Clones expressing a single surface antigen efficiently transcribe several VSP genes but only accumulate transcripts encoding the VSP to be expressed. Detection of antisense RNAs corresponding to the silenced VSP genes and small RNAs from the silenced but not for the expressed vsp implicate the RNA interference pathway in antigenic variation. Remarkably, silencing of Dicer and RNA- dependent RNA polymerase leads to a change from single to multiple VSP expression in individual parasites.	[Prucca, Cesar G.; Slavin, Ileana; Quiroga, Rodrigo; Elias, Eliana V.; Rivero, Fernando D.; Saura, Alicia; Carranza, Pedro G.; Lujan, Hugo D.] Univ Catolica Cordoba, Fac Med, Lab Bioquim & Biol Mol, Cordoba, Argentina	Catholic University of Cordoba	Lujan, HD (corresponding author), Univ Catolica Cordoba, Fac Med, Lab Bioquim & Biol Mol, X5004ASK, Cordoba, Argentina.	hlujan@ucc.edu.ar	RIVERO, Fernando/AFV-5689-2022; Prucca, César Germán/AAC-4630-2021; Elias, Eliana Vanina/AAF-1997-2021; Prucca, César/AAQ-4401-2020; Quiroga, Rodrigo/GLT-7145-2022	Prucca, César Germán/0000-0003-4165-4660; Quiroga, Rodrigo/0000-0001-5015-0531	Agencia Nacional para la Promocion de la Ciencia y la Tecnologia; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad Catolica de Cordoba; Howard Hughes Medical Institute; European Union CONTENT	Agencia Nacional para la Promocion de la Ciencia y la Tecnologia; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Catolica de Cordoba; Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Union CONTENT(European Commission)	We thank N. Gottig and M. E. Alvarez for technical support. This work was supported by grants from the Agencia Nacional para la Promocion de la Ciencia y la Tecnologia (ANPCYT), the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Universidad Catolica de Cordoba (UCC), the Howard Hughes Medical Institute (HHMI), and the European Union CONTENT project. H. D. L. is an HHMI International Research Scholar and a Member of the Scientific Investigator's Career of the CONICET.	ADAM RD, 1988, J EXP MED, V167, P109, DOI 10.1084/jem.167.1.109; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cogoni C, 1999, CURR OPIN MICROBIOL, V2, P657, DOI 10.1016/S1369-5274(99)00041-7; Deitsch KW, 1997, MICROBIOL MOL BIOL R, V61, P281, DOI 10.1128/.61.3.281-293.1997; DOUGHERTY WG, 1995, CURR OPIN CELL BIOL, V7, P399, DOI 10.1016/0955-0674(95)80096-4; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Elmendorf HG, 2001, NUCLEIC ACIDS RES, V29, P4674, DOI 10.1093/nar/29.22.4674; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Green-Willms NS, 1998, MOL CELL BIOL, V18, P1826, DOI 10.1128/MCB.18.4.1826; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hutvagner G, 2000, RNA, V6, P1445, DOI 10.1017/S1355838200001096; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Kloc M, 2001, INT REV CYTOL, V203, P63; Kulakova L, 2006, MOL MICROBIOL, V61, P1533, DOI 10.1111/j.1365-2958.2006.05345.x; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; NASH TE, 1990, EXP PARASITOL, V71, P415, DOI 10.1016/0014-4894(90)90067-M; Nash TE, 1997, PHILOS T R SOC B, V352, P1369, DOI 10.1098/rstb.1997.0122; NASH TE, 1988, J IMMUNOL, V141, P636; Nash TE, 2001, INFECT IMMUN, V69, P1922, DOI 10.1128/IAI.69.3.1922-1923.2001; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Touz MC, 2002, J BIOL CHEM, V277, P50557, DOI 10.1074/jbc.M202558200; Ullu E, 2005, EUKARYOT CELL, V4, P1155, DOI 10.1128/EC.4.6.1155-1157.2005; von Allmen N, 2005, PARASITOLOGY, V130, P389, DOI 10.1017/S0031182004006742; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; WHITE TC, 1990, NUCLEIC ACIDS RES, V18, P553, DOI 10.1093/nar/18.3.553; YEE J, 1995, P NATL ACAD SCI USA, V92, P5615, DOI 10.1073/pnas.92.12.5615; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	38	153	168	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					750	754		10.1038/nature07585	http://dx.doi.org/10.1038/nature07585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079052				2022-12-01	WOS:000261559900040
J	Dello Ioio, R; Nakamura, K; Moubayidin, L; Perilli, S; Taniguchi, M; Morita, MT; Aoyama, T; Costantino, P; Sabatini, S				Dello Ioio, Raffaele; Nakamura, Kinu; Moubayidin, Laila; Perilli, Serena; Taniguchi, Masatoshi; Morita, Miyo T.; Aoyama, Takashi; Costantino, Paolo; Sabatini, Sabrina			A Genetic Framework for the Control of Cell Division and Differentiation in the Root Meristem	SCIENCE			English	Article							ARABIDOPSIS ROOTS; AUXIN RESPONSE; CYTOKININ; EXPRESSION; PROTEINS; SPECIFICITY; REGULATORS; GROWTH; ARR1	Plant growth and development are sustained by meristems. Meristem activity is controlled by auxin and cytokinin, two hormones whose interactions in determining a specific developmental output are still poorly understood. By means of a comprehensive genetic and molecular analysis in Arabidopsis, we show that a primary cytokinin- response transcription factor, ARR1, activates the gene SHY2/IAA3 (SHY2), a repressor of auxin signaling that negatively regulates the PIN auxin transport facilitator genes: thereby, cytokinin causes auxin redistribution, prompting cell differentiation. Conversely, auxin mediates degradation of the SHY2 protein, sustaining PIN activities and cell division. Thus, the cell differentiation and division balance necessary for controlling root meristem size and root growth is the result of the interaction between cytokinin and auxin through a simple regulatory circuit converging on the SHY2 gene.	[Dello Ioio, Raffaele; Moubayidin, Laila; Perilli, Serena; Costantino, Paolo; Sabatini, Sabrina] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Lab Genom & Proteom Funzionale Sistem Mod FGPL, I-00185 Rome, Italy; [Nakamura, Kinu; Taniguchi, Masatoshi; Aoyama, Takashi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Morita, Miyo T.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan	Sapienza University Rome; Kyoto University; Nara Institute of Science & Technology	Sabatini, S (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Lab Genom & Proteom Funzionale Sistem Mod FGPL, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	sabrina.sabatini@uniroma1.it	Costantino, Paolo/K-4753-2015; dello ioio, raffaele/P-6254-2015	Costantino, Paolo/0000-0002-9166-2194; dello ioio, raffaele/0000-0001-8679-9412; Morita, Miyo/0000-0002-6176-5758; SABATINI, Sabrina/0000-0002-9691-6595	Giovanni Armenise-Harvard Foundation; Istituto Pasteur- Fondazione Cenci Bolognetti; Ministero dell'Istruzione; dell'Universita e della Ricerca ( MIUR); Ricerca di Interesse Nazionale; MIUR Fondo per gli Investimenti della Ricerca di Base European Research Area-Plant Genomics	Giovanni Armenise-Harvard Foundation; Istituto Pasteur- Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca ( MIUR)(Ministry of Education, Universities and Research (MIUR)); Ricerca di Interesse Nazionale; MIUR Fondo per gli Investimenti della Ricerca di Base European Research Area-Plant Genomics(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	We thank B. Scheres, O. Leyser, J. Reed, and G. Jurgens for providing material and all members of the FGPL for indispensable and helpful technical support. This work was supported by a Giovanni Armenise-Harvard Foundation career development grant (to S. S.) and by Istituto Pasteur- Fondazione Cenci Bolognetti, Ministero dell'Istruzione, dell'Universita e della Ricerca ( MIUR) progetti di Ricerca di Interesse Nazionale, and MIUR Fondo per gli Investimenti della Ricerca di Base European Research Area- Plant Genomics ( to P. C.).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dello Loio R, 2008, CURR OPIN PLANT BIOL, V11, P23, DOI 10.1016/j.pbi.2007.10.006; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Klee Harry J., 1995, P340; Knox K, 2003, DEVELOPMENT, V130, P5769, DOI 10.1242/dev.00659; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; MOCKAITIS K, 2008, ANNU REV CELL DEV BI, V10, P453; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Taniguchi M, 2007, PLANT CELL PHYSIOL, V48, P263, DOI 10.1093/pcp/pcl063; Tian Q, 2003, PLANT J, V36, P643, DOI 10.1046/j.1365-313X.2003.01909.x; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Tian Q, 1999, DEVELOPMENT, V126, P711; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659	23	635	655	13	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1380	1384		10.1126/science.1164147	http://dx.doi.org/10.1126/science.1164147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039136				2022-12-01	WOS:000261170600039
J	Oberdoerffer, P; Michan, S; Mcvay, M; Mostoslavsky, R; Vann, J; Park, SK; Hartlerode, A; Stegmuller, J; Hafner, A; Loerch, P; Wright, SM; Mills, KD; Bonni, A; Yankner, BA; Scully, R; Prolla, TA; Alt, FW; Sinclair, DA				Oberdoerffer, Philipp; Michan, Shaday; Mcvay, Michael; Mostoslavsky, Raul; Vann, James; Park, Sang-Kyu; Hartlerode, Andrea; Stegmuller, Judith; Hafner, Angela; Loerch, Patrick; Wright, Sarah M.; Mills, Kevin D.; Bonni, Azad; Yankner, Bruce A.; Scully, Ralph; Prolla, Tomas A.; Alt, Frederick W.; Sinclair, David A.			SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging	CELL			English	Article							DOUBLE-STRAND BREAKS; EMBRYONIC STEM-CELLS; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; DNA-DAMAGE; HISTONE H2AX; HETEROCHROMATIN FORMATION; CELLULAR SENESCENCE; GENOTOXIC STRESS; MATING-TYPE	Genomic instability and alterations in gene expression are hallmarks of eukaryotic aging. The yeast histone deacetylase Sir2 silences transcription and stabilizes repetitive DNA, but during aging or in response to a DNA break, the Sir complex relocalizes to sites of genomic instability, resulting in the desilencing of genes that cause sterility, a characteristic of yeast aging. Using embryonic stem cells, we show that mammalian Sir2, SIRT1, represses repetitive DNA and a functionally diverse set of genes across the mouse genome. In response to DNA damage, SIRT1 dissociates from these loci and relocalizes to DNA breaks to promote repair, resulting in transcriptional changes that parallel those in the aging mouse brain. Increased SIRT1 expression promotes survival in a mouse model of genomic instability and suppresses age-dependent transcriptional changes. Thus, DNA damage-induced redistribution of SIRT1 and other chromatin-modifying proteins may be a conserved mechanism of aging in eukaryotes.	[Oberdoerffer, Philipp; Michan, Shaday; Mcvay, Michael; Stegmuller, Judith; Hafner, Angela; Loerch, Patrick; Bonni, Azad; Yankner, Bruce A.; Sinclair, David A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Oberdoerffer, Philipp; Michan, Shaday; Mcvay, Michael; Stegmuller, Judith; Hafner, Angela; Loerch, Patrick; Bonni, Azad; Yankner, Bruce A.; Sinclair, David A.] Harvard Univ, Sch Med, Glenn Labs Aging Res, Boston, MA 02115 USA; [Mostoslavsky, Raul] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Vann, James; Park, Sang-Kyu; Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; [Hartlerode, Andrea; Scully, Ralph] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Hartlerode, Andrea; Scully, Ralph] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Wright, Sarah M.; Mills, Kevin D.] Jackson Lab, Bar Harbor, ME 04609 USA; [Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Immune Dis Inst, Boston, MA 02115 USA; [Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Jackson Laboratory; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	david_sinclair@hms.harvard.edu	Scully, Ralph/F-5008-2013	Sinclair, David/0000-0002-9936-436X	National Space Biomedical Research Institute [PF00903]; National Institutes of Health [NIH] [RO1GM068072, R01AG19719, NS047188, GM 073894, R01AG 020681]; Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072, R01GM073894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027916, R01AG020681, R01AG028730, R01AG019719] Funding Source: NIH RePORTER	National Space Biomedical Research Institute; National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	D. A. S. wishes to thank B. Stillman and C. Westphal for advice and scientific discussions. We are also grateful to K. Rajewsky, D. Reinberg, D. Lamming, L. Guarente, A. Vaquero, and M. Jasin for advice and reagents. We thank E. Vollmann, J. Campbell, and D. Zimmerman for technical assistance and R. Bronson for mouse necropsy. We are especially grateful to P. Glenn, M. Collins, and L. Ellison for their support of aging research. P. O. was supported by a fellowship from the National Space Biomedical Research Institute (grant PF00903), the Sinclair Lab by grants RO1GM068072 and R01AG19719 (National Institutes of Health [NIH]), and the Glenn Foundation for Medical Research. D. A. S. and F. W. A. are Ellison Medical Foundation Senior Scholars. R. M. is a V and Kimmel Foundation Scholar. A. B. supported by NIH grant NS047188; R. S. by GM 073894; and J. V., S. P., and T. A. P. by R01AG 020681. F. W. A. is an Investigator of the Howard Hughes Medical Institute. D. A. S. is a consultant to Shaklee, Genocea, and Sirtris (a GSK company developing sirtuin-based drugs) and an inventor on Harvard patents licensed to GSK.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Binda O, 2008, ONCOGENE, V27, P3384, DOI 10.1038/sj.onc.1211014; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; CUTLER RG, 1995, MCBU, P15; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Imai S, 1998, EXP GERONTOL, V33, P555; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; KLAR AJS, 1979, GENETICS, V93, P37; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lim CS, 2006, MED HYPOTHESES, V67, P341, DOI 10.1016/j.mehy.2006.01.050; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; McAinsh AD, 1999, CURR BIOL, V9, P963, DOI 10.1016/S0960-9822(99)80424-2; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; NICHOLS NR, 1995, NEUROBIOL AGING, V16, P105, DOI 10.1016/0197-4580(95)80013-H; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Park PU, 1999, MOL CELL BIOL, V19, P3848; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; RINE J, 1979, GENETICS, V93, P877; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vijg J, 2004, MECH AGEING DEV, V125, P747, DOI 10.1016/j.mad.2004.07.004; Villeponteau B, 1997, EXP GERONTOL, V32, P383, DOI 10.1016/S0531-5565(96)00155-6; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Wu JF, 2008, J MOL NEUROSCI, V34, P1, DOI 10.1007/s12031-007-0009-4; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhu P, 2004, CELL CYCLE, V3, P1240, DOI 10.4161/cc.3.10.1195	70	579	605	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					907	918		10.1016/j.cell.2008.10.025	http://dx.doi.org/10.1016/j.cell.2008.10.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041753	Green Accepted, Bronze			2022-12-01	WOS:000261183900021
J	Whooley, MA; de Jonge, P; Vittinghoff, E; Otte, C; Moos, R; Carney, RM; Ali, S; Dowray, S; Na, B; Feldman, MD; Schiller, NB; Browner, WS				Whooley, Mary A.; de Jonge, Peter; Vittinghoff, Eric; Otte, Christian; Moos, Rudolf; Carney, Robert M.; Ali, Sadia; Dowray, Sunaina; Na, Beeya; Feldman, Mitchell D.; Schiller, Nelson B.; Browner, Warren S.			Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPORTED PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; MAJOR DEPRESSION; MEDICATION ADHERENCE; ENHANCING RECOVERY; CONSTRUCT-VALIDITY; EXERCISE TREATMENT; RATE-VARIABILITY; NATIONAL-HEART; OLDER PERSONS	Context Depressive symptoms predict adverse cardiovascular outcomes in patients with coronary heart disease, but the mechanisms responsible for this association are unknown. Objective To determine why depressive symptoms are associated with an increased risk of cardiovascular events. Design and Participants The Heart and Soul Study is a prospective cohort study of 1017 outpatients with stable coronary heart disease followed up for a mean ( SD) of 4.8 ( 1.4) years. Setting Participants were recruited between September 11, 2000, and December 20, 2002, from 12 outpatient clinics in the San Francisco Bay Area and were followed up to January 12, 2008. Main Outcome Measures Baseline depressive symptoms were assessed using the Patient Health Questionnaire ( PHQ). We used proportional hazards models to evaluate the extent to which the association of depressive symptoms with subsequent cardiovascular events ( heart failure, myocardial infarction, stroke, transient ischemic attack, or death) was explained by baseline disease severity and potential biological or behavioral mediators. Results A total of 341 cardiovascular events occurred during 4876 person- years of follow-up. The age- adjusted annual rate of cardiovascular events was 10.0% among the 199 participants with depressive symptoms ( PHQ score >= 10) and 6.7% among the 818 participants without depressive symptoms ( hazard ratio [ HR], 1.50; 95% confidence interval, [ CI], 1.16- 1.95; P=. 002). After adjustment for comorbid conditions and disease severity, depressive symptoms were associated with a 31% higher rate of cardiovascular events ( HR, 1.31; 95% CI, 1.00- 1.71; P=. 04). Additional adjustment for potential biological mediators attenuated this association ( HR, 1.24; 95% CI, 0.94- 1.63; P=. 12). After further adjustment for potential behavioral mediators, including physical inactivity, there was no significant association ( HR, 1.05; 95% CI, 0.79- 1.40; P=. 75). Conclusion In this sample of outpatients with coronary heart disease, the association between depressive symptoms and adverse cardiovascular events was largely explained by behavioral factors, particularly physical inactivity.	[Whooley, Mary A.; Ali, Sadia; Dowray, Sunaina; Na, Beeya; Schiller, Nelson B.] VA Med Ctr, San Francisco, CA USA; [Whooley, Mary A.; Vittinghoff, Eric; Feldman, Mitchell D.; Schiller, Nelson B.; Browner, Warren S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [de Jonge, Peter] Univ Groningen, Groningen, Netherlands; [de Jonge, Peter] Tilburg Univ, NL-5000 LE Tilburg, Netherlands; [Otte, Christian] Univ Hosp Hamburg Eppendorf, Hamburg, Germany; [Moos, Rudolf] Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Moos, Rudolf] Stanford Univ, Palo Alto, CA 94304 USA; [Carney, Robert M.] Washington Univ, St Louis, MO USA; [Browner, Warren S.] Calif Pacific Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of Groningen; Tilburg University; University of Hamburg; University Medical Center Hamburg-Eppendorf; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Washington University (WUSTL); California Pacific Medical Center	Whooley, MA (corresponding author), 4150 Clement St 111A1, San Francisco, CA 94121 USA.	mary.whooley@ucsf.edu	de Jonge, peter/L-6395-2013	de Jonge, peter/0000-0002-0866-6929; Otte, Christian/0000-0002-4051-997X	VA Epidemiology (Merit Review) Program; VA Health Research and Development Service Career Development Program; National Heart, Lung, and Blood Institute [R01 HL079235]; American Federation for Aging Research (Paul Beeson Scholars Program); Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program); Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	VA Epidemiology (Merit Review) Program(US Department of Veterans Affairs); VA Health Research and Development Service Career Development Program; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Federation for Aging Research (Paul Beeson Scholars Program); Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program)(Robert Wood Johnson Foundation (RWJF)); Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the VA Epidemiology (Merit Review) Program; the VA Health Research and Development Service Career Development Program; the National Heart, Lung, and Blood Institute (R01 HL079235); the American Federation for Aging Research (Paul Beeson Scholars Program); the Robert Wood Johnson Foundation ( Generalist Physician Faculty Scholars Program); the Ischemia Research and Education Foundation; and the Nancy Kirwan Heart Research Fund.	Aadahl M, 2007, EUR J CARDIOV PREV R, V14, P422, DOI 10.1097/HJR.0b013e3280128d00; Abramson J, 2001, ARCH INTERN MED, V161, P1725, DOI 10.1001/archinte.161.14.1725; Ades PA, 2002, AM HEART J, V143, P151, DOI 10.1067/mhj.2002.119379; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ALI S, IN PRESS PSYCHOTHER; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Bijnen FCH, 1998, ARCH INTERN MED, V158, P1499, DOI 10.1001/archinte.158.14.1499; BLOUIN AG, 1988, PSYCHIAT RES, V23, P335, DOI 10.1016/0165-1781(88)90024-8; Blumberg EJ, 2005, J CLIN EPIDEMIOL, V58, P645, DOI 10.1016/j.jclinepi.2004.11.022; Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Blumenthal JA, 2007, CLIN TRIALS, V4, P548, DOI 10.1177/1740774507083388; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Borowicz L, 2002, PSYCHOSOMATICS, V43, P464, DOI 10.1176/appi.psy.43.6.464; Bowles HR, 2004, AM J EPIDEMIOL, V160, P279, DOI 10.1093/aje/kwh209; Brunner EJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub2; Carney RM, 2004, PSYCHOSOM MED, V66, P466, DOI 10.1097/01.psy.0000133362.75075.a6; Carney RM, 2005, ARCH INTERN MED, V165, P1486, DOI 10.1001/archinte.165.13.1486; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; Craft LL, 1998, J SPORT EXERCISE PSY, V20, P339, DOI 10.1123/jsep.20.4.339; de Jonge P, 2007, AM J PSYCHIAT, V164, P1371, DOI 10.1176/appi.ajp.2007.06091492; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355; Frasure-Smith N, 2004, BIOL PSYCHIAT, V55, P891, DOI 10.1016/j.biopsych.2004.01.021; Frasure-Smith N, 2007, BIOL PSYCHIAT, V62, P302, DOI 10.1016/j.biopsych.2006.09.029; Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508; Gehi A, 2005, ARCH GEN PSYCHIAT, V62, P661, DOI 10.1001/archpsyc.62.6.661; Gehi AK, 2007, ARCH INTERN MED, V167, P1798, DOI 10.1001/archinte.167.16.1798; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; GREIST JH, 1987, HOSP COMMUNITY PSYCH, V38, P1304; Harris AHS, 2006, J AFFECT DISORDERS, V93, P79, DOI 10.1016/j.jad.2006.02.013; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HAYNES SG, 1980, AM J EPIDEMIOL, V111, P37, DOI 10.1093/oxfordjournals.aje.a112873; Ho PM, 2006, ARCH INTERN MED, V166, P1842, DOI 10.1001/archinte.166.17.1842; Jackson AW, 2007, RES Q EXERCISE SPORT, V78, P24; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Kaleta Dorota, 2004, Int J Occup Med Environ Health, V17, P457; KNAPIK J, 1993, AM J PREV MED, V9, P203, DOI 10.1016/S0749-3797(18)30716-5; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Lett H, 2008, PSYCHOSOM MED, V70, P444, DOI 10.1097/PSY.0b013e31816c3c5c; Lett HS, 2004, PSYCHOSOM MED, V66, P305, DOI 10.1097/01.psy.0000126207.43307.c0; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; MATSUI D, 1994, J CLIN PHARMACOL, V34, P944, DOI 10.1002/j.1552-4604.1994.tb04009.x; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; North T C, 1990, Exerc Sport Sci Rev, V18, P379; Otte C, 2005, AM J PSYCHIAT, V162, P2139, DOI 10.1176/appi.ajp.162.11.2139; Otte C, 2004, BIOL PSYCHIAT, V56, P241, DOI 10.1016/j.biopsych.2004.06.003; Penninx BWJH, 2002, J GERONTOL B-PSYCHOL, V57, pP124, DOI 10.1093/geronb/57.2.P124; Penninx BWJH, 1999, AM J PUBLIC HEALTH, V89, P1346, DOI 10.2105/AJPH.89.9.1346; Ren XS, 2007, AM J CARDIOL, V99, P1643, DOI 10.1016/j.amjcard.2007.01.041; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Ruo B, 2004, AM J CARDIOL, V94, P96, DOI 10.1016/j.amjcard.2004.03.035; Schins A, 2004, LIFE SCI, V76, P637, DOI 10.1016/j.lfs.2004.04.060; Schmoor C, 2000, STAT MED, V19, P441, DOI 10.1002/(SICI)1097-0258(20000229)19:4<441::AID-SIM349>3.0.CO;2-N; Sherwood A, 2007, ARCH INTERN MED, V167, P367, DOI 10.1001/archinte.167.4.367; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Vaccarino V, 2001, J AM COLL CARDIOL, V38, P199, DOI 10.1016/S0735-1097(01)01334-1; Vaccarino V, 2007, J AM COLL CARDIOL, V50, P2044, DOI 10.1016/j.jacc.2007.07.069; Van Melle JP, 2007, BRIT J PSYCHIAT, V190, P460, DOI 10.1192/bjp.bp.106.028647; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Wellenius GA, 2008, CIRCULATION, V117, P2313, DOI 10.1161/CIRCULATIONAHA.107.741058; WHO, 2007, WORLD HLTH STAT; Whooley MA, 2007, BIOL PSYCHIAT, V62, P314, DOI 10.1016/j.biopsych.2006.10.016; Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874; Williams SA, 2002, PSYCHOSOM MED, V64, P6, DOI 10.1097/00006842-200201000-00002; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	80	566	581	5	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2379	2388		10.1001/jama.2008.711	http://dx.doi.org/10.1001/jama.2008.711			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	375YX	19033588	Green Accepted			2022-12-01	WOS:000261150800020
J	Hornung, V; Ablasser, A; Charrel-Dennis, M; Bauernfeind, F; Horvath, G; Caffrey, DR; Latz, E; Fitzgerald, KA				Hornung, Veit; Ablasser, Andrea; Charrel-Dennis, Marie; Bauernfeind, Franz; Horvath, Gabor; Caffrey, Daniel. R.; Latz, Eicke; Fitzgerald, Katherine A.			AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC	NATURE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; CONTAINING APAF1-LIKE PROTEIN; REGULATES ACTIVATION; INDUCIBLE GENES; HIN-200 FAMILY; DNA; CASPASE-1; EXPRESSION; INFECTION	The innate immune system senses nucleic acids by germline-encoded pattern recognition receptors. RNA is sensed by Toll-like receptor members TLR3, TLR7 and TLR8, or by the RNA helicases RIG-I (also known as DDX58) and MDA-5 (IFIH1)(1). Little is known about sensors for cytoplasmic DNA that trigger antiviral and/or inflammatory responses(2-6). The best characterized of these responses involves activation of the TANK-binding kinase (TBK1)-interferon regulatory factor 3 (IRF3) signalling axis to trigger transcriptional induction of type I interferon genes(2,3). A second, less well-defined pathway leads to the activation of an 'inflammasome' that, via caspase-1, controls the catalytic cleavage of the pro-forms of the cytokines IL1 beta and IL18 (refs 6, 7). Using mouse and human cells, here we identify the PYHIN (pyrin and HIN domain-containing protein)(8) family member absent in melanoma 2 (AIM2) as a receptor for cytosolic DNA, which regulates caspase-1. The HIN200 domain of AIM2 binds to DNA, whereas the pyrin domain (but not that of the other PYHIN family members) associates with the adaptor molecule ASC (apoptosis-associated speck-like protein containing a caspase activation and recruitment domain) to activate both NF-kappa B and caspase-1. Knockdown of Aim2 abrogates caspase-1 activation in response to cytoplasmic double-stranded DNA and the double-stranded DNA vaccinia virus. Collectively, these observations identify AIM2 as a new receptor for cytoplasmic DNA, which forms an inflammasome with the ligand and ASC to activate caspase-1.	[Hornung, Veit; Ablasser, Andrea; Charrel-Dennis, Marie; Bauernfeind, Franz; Horvath, Gabor; Latz, Eicke; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Caffrey, Daniel. R.] Pfizer, Cambridge, MA 02139 USA; [Hornung, Veit; Ablasser, Andrea; Bauernfeind, Franz] Univ Klinikum Bonn, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany	University of Massachusetts System; University of Massachusetts Worcester; Pfizer; University of Bonn	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	veit.hornung@uni-bonn.de; kate.fitzgerald@umassmed.edu	Hornung, Veit/C-3565-2012; Horvath, Gabor L/J-3917-2014; Bauernfeind, Franz-Georg/ABF-1148-2020; Latz, Eicke/H-3951-2014; Fitzgerald, Katherine/ABE-6317-2020	Hornung, Veit/0000-0002-4150-194X; Horvath, Gabor L/0000-0003-0309-595X; Latz, Eicke/0000-0003-1488-5666; Fitzgerald, Kate/0000-0003-3175-609X	Deutsche Forschungsgemeinschaft [Ho2783/2-1]; National Institutes of Health [AI-065483, AI-067497]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI067497, R56AI067497, R01AI065483, R01AI067497] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank A. Cerny for animal husbandry and genotyping and R. Johnstone for the anti-AIM2 antibody. V. H. is supported by a fellowship from the Deutsche Forschungsgemeinschaft (German Research Foundation; Ho2783/2-1), E. L. and K. A. F. are supported by grants from the National Institutes of Health (AI-065483 (to E. L.) and AI-067497 (to K. A. F.)).	Albrecht M, 2005, BIOCHEM BIOPH RES CO, V327, P679, DOI 10.1016/j.bbrc.2004.12.056; BURRUS GR, 1992, J CELL BIOCHEM, V48, P190, DOI 10.1002/jcb.240480210; Caffrey DR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-381; Cresswell KS, 2005, BIOCHEM BIOPH RES CO, V326, P417, DOI 10.1016/j.bbrc.2004.11.048; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Ding Y, 2004, ONCOGENE, V23, P4556, DOI 10.1038/sj.onc.1207592; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn R., 2003, CURR PROTOC BIOINFOR; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Landolfo S, 1998, BIOCHIMIE, V80, P721, DOI 10.1016/S0300-9084(99)80025-X; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; SCHACHMAN HK, 1960, J BIOL CHEM, V235, P3242; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun KH, 2000, IMMUNOLOGY, V99, P352, DOI 10.1046/j.1365-2567.2000.00970.x; Szentesi G, 2004, COMPUT METH PROG BIO, V75, P201, DOI 10.1016/j.cmpb.2004.02.004; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; TRAPANI JA, 1992, IMMUNOGENETICS, V36, P369; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	29	1679	1759	3	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					514	U6		10.1038/nature07725	http://dx.doi.org/10.1038/nature07725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19158675	Green Accepted, Green Submitted			2022-12-01	WOS:000264532400046
J	Maher, CA; Kumar-Sinha, C; Cao, XH; Kalyana-Sundaram, S; Han, B; Jing, XJ; Sam, L; Barrette, T; Palanisamy, N; Chinnaiyan, AM				Maher, Christopher A.; Kumar-Sinha, Chandan; Cao, Xuhong; Kalyana-Sundaram, Shanker; Han, Bo; Jing, Xiaojun; Sam, Lee; Barrette, Terrence; Palanisamy, Nallasivam; Chinnaiyan, Arul M.			Transcriptome sequencing to detect gene fusions in cancer	NATURE			English	Article							SOMATIC MUTATIONS; HUMAN BREAST; LUNG-CANCER; IDENTIFICATION; ABERRATIONS; INHIBITOR; PATTERNS; EFFICACY; IMATINIB; PROTEIN	Recurrent gene fusions, typically associated with haematological malignancies and rare bone and soft-tissue tumours(1), have recently been described in common solid tumours(2-9). Here we use an integrative analysis of high-throughput long- and short-read transcriptome sequencing of cancer cells to discover novel gene fusions. As a proof of concept, we successfully used integrative transcriptome sequencing to 're-discover' the BCR-ABL1 (ref. 10) gene fusion in a chronic myelogenous leukaemia cell line and the TMPRSS2-ERG(2,3) gene fusion in a prostate cancer cell line and tissues. Additionally, we nominated, and experimentally validated, novel gene fusions resulting in chimaeric transcripts in cancer cell lines and tumours. Taken together, this study establishes a robust pipeline for the discovery of novel gene chimaeras using high-throughput sequencing, opening up an important class of cancer-related mutations for comprehensive characterization.	[Maher, Christopher A.; Kumar-Sinha, Chandan; Cao, Xuhong; Kalyana-Sundaram, Shanker; Han, Bo; Jing, Xiaojun; Sam, Lee; Barrette, Terrence; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Maher, Christopher A.; Kumar-Sinha, Chandan; Kalyana-Sundaram, Shanker; Han, Bo; Jing, Xiaojun; Sam, Lee; Barrette, Terrence; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Palanisamy, Nallasivam/ABC-8844-2020; Kalyana-Sundaram, Shanker/F-6860-2012	Palanisamy, Nallasivam/0000-0002-0633-9772; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Kumar, Chandan/0000-0002-8696-3400	National Institutes of Health; Department of Defense; Early Detection Research Network; NCIBI [U54 DA 021519]; American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research; Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA132874, U01CA111275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Early Detection Research Network; NCIBI; American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research(Amgen); Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Illumina and 454 for technical support, R. Mehra and J. Siddiqui for providing tissue samples, Y. Gong, S. Shankar, X. Wang and A. Menon for technical assistance, J. Yu for help with the Illumina Genome Analyzer, and R. J. Lonigro for discussions. C. A. M. was supported by a National Institutes of Health Ruth L. Kirschstein post-doctoral training grant, and currently derives support from the American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research, the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship. This work was supported in part by the National Institutes of Health ( to A. M. C.), the Department of Defense ( to A. M. C.), the Early Detection Research Network ( to A. M. C.), and NCIBI (grant number U54 DA 021519).	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Barber TD, 2004, NEW ENGL J MED, V351, P2883, DOI 10.1056/NEJM200412303512724; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Communi D, 2001, J BIOL CHEM, V276, P16561, DOI 10.1074/jbc.M009609200; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gleave M, 2006, PROSTATE, V66, P1674, DOI 10.1002/pros.20499; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han B, 2008, CANCER RES, V68, P7629, DOI 10.1158/0008-5472.CAN-08-2014; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Korenchuk S, 2001, IN VIVO, V15, P163; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Strausberg RL, 2000, TRENDS GENET, V16, P103, DOI 10.1016/S0168-9525(99)01937-X; Takahara T, 2005, MOL CELL, V18, P245, DOI 10.1016/j.molcel.2005.03.018; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	33	623	688	4	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					97	U9		10.1038/nature07638	http://dx.doi.org/10.1038/nature07638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19136943	Green Accepted			2022-12-01	WOS:000263836000040
J	Shank, SS; Margoliash, D				Shank, Sylvan S.; Margoliash, Daniel			Sleep and sensorimotor integration during early vocal learning in a songbird	NATURE			English	Article							SLOW-WAVE SLEEP; ZEBRA FINCHES; HUMAN HIPPOCAMPUS; MEMORY; SPARROWS; REPLAY; CONSOLIDATION; SEQUENCES; BIRDSONG; BEHAVIOR	Behavioural studies widely implicate sleep in memory consolidation in the learning of a broad range of behaviours(1-4). During sleep, brain regions are reactivated(5,6), and specific patterns of neural activity are replayed(7-10), consistent with patterns observed in previous waking behaviour. Birdsong learning is a paradigmatic model system for skill learning(11-14). Song development in juvenile zebra finches (Taeniopygia guttata) is characterized by sleep-dependent circadian fluctuations in singing behaviour, with immediate post-sleep deterioration in song structure followed by recovery later in the day(15). In sleeping adult birds, spontaneous bursting activity of forebrain premotor neurons in the robust nucleus of the arcopallium (RA) carries information about daytime singing(16). Here we show that, in juvenile zebra finches, playback during the day of an adult 'tutor' song induced profound and tutor-song-specific changes in bursting activity of RA neurons during the following night of sleep. The night-time neuronal changes preceded tutor-song-induced changes in singing, first observed the following day. Interruption of auditory feedback greatly reduced sleep bursting and prevented the tutor-song-specific neuronal remodelling. Thus, night-time neuronal activity is shaped by the interaction of the song model (sensory template) and auditory feedback, with changes in night-time activity preceding the onset of practice associated with vocal learning. We hypothesize that night-time bursting induces adaptive changes in premotor networks during sleep as part of vocal learning. By this hypothesis, adaptive changes driven by replay of sensory information at night and by evaluation of sensory feedback during the day interact to produce the complex circadian patterns seen early in vocal development.	[Shank, Sylvan S.; Margoliash, Daniel] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Margoliash, Daniel] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Margoliash, D (corresponding author), Univ Chicago, Dept Psychol, Chicago, IL 60637 USA.	dan@bigbird.uchicago.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059831] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH059831-09, R01 MH059831] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adret P, 2002, J COMP NEUROL, V454, P409, DOI 10.1002/cne.10459; Crandall SR, 2007, J NEUROPHYSIOL, V98, P232, DOI 10.1152/jn.00128.2007; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; EVARTS EV, 1962, SCIENCE, V135, P727, DOI 10.1126/science.135.3505.726; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Funabiki Y, 2003, J NEUROSCI, V23, P6928; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Hennevin E, 2007, NEUROBIOL LEARN MEM, V87, P416, DOI 10.1016/j.nlm.2006.10.006; HULTSCH H, 1989, J COMP PHYSIOL A, V165, P197, DOI 10.1007/BF00619194; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Konishi M., 1978, PERCEPTION EXPERIENC, P105; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; Low PS, 2008, P NATL ACAD SCI USA, V105, P9081, DOI 10.1073/pnas.0703452105; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nick TA, 2005, J NEUROBIOL, V62, P231, DOI 10.1002/neu.20087; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Pytte CL, 1999, NEUROREPORT, V10, P1773, DOI 10.1097/00001756-199906030-00027; Qin YL, 1997, PHILOS T R SOC B, V352, P1525, DOI 10.1098/rstb.1997.0139; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rattenborg NC, 2004, PLOS BIOL, V2, P924, DOI 10.1371/journal.pbio.0020212; Roper A, 2006, ETHOLOGY, V112, P458, DOI 10.1111/j.1439-0310.2005.01169.x; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; ZEIGLER HP, 2004, BEHAV NEUROBIOLOGY B	34	122	123	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					73	U4		10.1038/nature07615	http://dx.doi.org/10.1038/nature07615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19079238	Green Accepted			2022-12-01	WOS:000263836000035
J	Anstey, ML; Rogers, SM; Ott, SR; Burrows, M; Simpson, SJ				Anstey, Michael L.; Rogers, Stephen M.; Ott, Swidbert R.; Burrows, Malcolm; Simpson, Stephen J.			Serotonin Mediates Behavioral Gregarization Underlying Swarm Formation in Desert Locusts	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; PHASE-CHANGE; CRUSTACEANS; AGGRESSION; PHYSIOLOGY; RECEPTOR; FIGHT	Desert locusts, Schistocerca gregaria, show extreme phenotypic plasticity, transforming between a little- seen solitarious phase and the notorious swarming gregarious phase depending on population density. An essential tipping point in the process of swarm formation is the initial switch from strong mutual aversion in solitarious locusts to coherent group formation and greater activity in gregarious locusts. We show here that serotonin, an evolutionarily conserved mediator of neuronal plasticity, is responsible for this behavioral transformation, being both necessary if behavioral gregarization is to occur and sufficient to induce it. Our data demonstrate a neurochemical mechanism linking interactions between individuals to large- scale changes in population structure and the onset of mass migration.	[Anstey, Michael L.; Rogers, Stephen M.; Simpson, Stephen J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Rogers, Stephen M.; Ott, Swidbert R.; Burrows, Malcolm] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Simpson, Stephen J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Oxford; University of Cambridge; University of Sydney	Rogers, SM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	smr34@cam.ac.uk		Simpson, Stephen J./0000-0003-0256-7687; Ott, Swidbert/0000-0003-4278-2613	Biotechnology and Biological Sciences Research Council, UK; University Research Fellowship from the Royal Society, UK; Natural Sciences and Engineering Research Council of Canada; Hope Studentship in Entomology from Jesus College; University of Oxford, UK; Australian Research Council Federation Fellowship	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University Research Fellowship from the Royal Society, UK(Royal Society of London); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Hope Studentship in Entomology from Jesus College; University of Oxford, UK; Australian Research Council Federation Fellowship(Australian Research Council)	We thank J. Niven, G. Sutton, and G. Sword for reading and commenting upon the manuscript; C. de la Riva at the Babraham Institute (UK) for technical support with the HPLC and K. Kendrick for permission to use the facility; T. Dodgson and E. Miller for locust rearing and technical support; and M. Ungless for advice and support to M. A. This work is supported by grants from the Biotechnology and Biological Sciences Research Council, UK (to M.B, S.S., and S.O.), and a University Research Fellowship from the Royal Society, UK, to S.O.M.A. was supported by the Natural Sciences and Engineering Research Council of Canada, an Overseas Research Student Award, UK, and the Hope Studentship in Entomology from Jesus College and the University of Oxford, UK. S.S. is supported by an Australian Research Council Federation Fellowship.	Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Enserink M, 2004, SCIENCE, V306, P1880, DOI 10.1126/science.306.5703.1880; Gatellier L, 2004, J EXP BIOL, V207, P2487, DOI 10.1242/jeb.01035; Hoeffer CA, 2003, J NEUROSCI, V23, P6362; Hofmann HA, 2000, NATURE, V403, P613, DOI 10.1038/35001137; Huber R, 1997, P NATL ACAD SCI USA, V94, P5939, DOI 10.1073/pnas.94.11.5939; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Molaei G, 2003, J INSECT PHYSIOL, V49, P1073, DOI 10.1016/j.jinsphys.2003.08.004; OSBORNE NN, 1974, BRAIN RES, V74, P366, DOI 10.1016/0006-8993(74)90593-9; PARKER D, 1995, J NEUROPHYSIOL, V73, P923, DOI 10.1152/jn.1995.73.3.923; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; ROESSINGH P, 1993, P ROY SOC B-BIOL SCI, V252, P43, DOI 10.1098/rspb.1993.0044; Roessingh P, 1998, J INSECT PHYSIOL, V44, P883, DOI 10.1016/S0022-1910(98)00070-5; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; SLOLEY BD, 1988, J NEUROCHEM, V51, P535, DOI 10.1111/j.1471-4159.1988.tb01071.x; Spitzer N, 2008, J EXP BIOL, V211, P92, DOI 10.1242/jeb.012450; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; TYRER NM, 1984, J COMP NEUROL, V227, P313, DOI 10.1002/cne.902270303; Ureshi M, 2002, J COMP PHYSIOL A, V188, P767, DOI 10.1007/s00359-002-0364-0; Uvarov B., 1966, GRASSHOPPER LOCUSTS, V1; West-Eberhard Mary Jane, 2003, pi	30	251	259	4	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					627	630		10.1126/science.1165939	http://dx.doi.org/10.1126/science.1165939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179529				2022-12-01	WOS:000262862800041
J	Slutsky, AS; Hudson, LD; Dubler, NN; Weijer, C; Tonelli, MR				Slutsky, Arthur S.; Hudson, Leonard D.; Dubler, Nancy N.; Weijer, Charles; Tonelli, Mark R.			Care of an Unresponsive Patient with a Poor Prognosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SURVIVAL		[Slutsky, Arthur S.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Slutsky, Arthur S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Hudson, Leonard D.] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Hudson, Leonard D.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Dubler, Nancy N.] Montefiore Med Ctr, Montefiore Einstein Ctr Bioeth, Bronx, NY 10467 USA; [Weijer, Charles] Univ Western Ontario, Dept Philosophy, London, ON, Canada; [Weijer, Charles] Univ Western Ontario, Dept Med, London, ON, Canada; [Tonelli, Mark R.] Univ Washington, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Tonelli, Mark R.] Univ Washington, Med Ctr, Dept Bioeth & Humanities, Seattle, WA 98195 USA	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Slutsky, AS (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Slutsky, Arthur/M-3325-2019					Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643; Berger JT, 2008, ANN INTERN MED, V149, P48, DOI 10.7326/0003-4819-149-1-200807010-00010; Buchanan A, 1990, DECIDING OTHERS ETHI; Dubler N.N., 2004, BIOETHICS MEDIATION; DUBLER NN, 1995, KENNEDY INST ETHIC J, V5, P289; Helft PR, 2000, NEW ENGL J MED, V343, P293, DOI 10.1056/NEJM200007273430411; Kapp M B, 1997, Univ Toledo Law Rev, V28, P521; LUCE JM, 1995, CRIT CARE MED, V23, P760, DOI 10.1097/00003246-199504000-00027; *PC, 1983, DEC FOR LIF SUST TRE; Reisfield GM, 2006, RESUSCITATION, V71, P152, DOI 10.1016/j.resuscitation.2006.02.022; Tonelli MR, 1997, J LAW MED ETHICS, V25, P22, DOI 10.1111/j.1748-720X.1997.tb01392.x; Toussaint LG, 2005, NEUROSURGERY, V57, P25, DOI 10.1227/01.NEU.0000163086.23124.70; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; Weijer C, 1998, CAN MED ASSOC J, V159, P817	14	13	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					527	531		10.1056/NEJMclde0808330	http://dx.doi.org/10.1056/NEJMclde0808330			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179322				2022-12-01	WOS:000262812400017
J	Salje, J; Zuber, B; Lowe, J				Salje, Jeanne; Zuber, Benoit; Lowe, Jan			Electron Cryomicroscopy of E-coli Reveals Filament Bundles Involved in Plasmid DNA Segregation	SCIENCE			English	Article							PROKARYOTIC ACTIN HOMOLOG; DYNAMIC INSTABILITY; PARM; R1; INCOMPATIBILITY; MECHANISM; MICROSCOPY; DRIVEN	Bipolar elongation of filaments of the bacterial actin homolog ParM drives movement of newly replicated plasmid DNA to opposite poles of a bacterial cell. We used a combination of vitreous sectioning and electron cryotomography to study this DNA partitioning system directly in native, frozen cells. The diffraction patterns from overexpressed ParM bundles in electron cryotomographic reconstructions were used to unambiguously identify ParM filaments in Escherichia coli cells. Using a low- copy number plasmid encoding components required for partitioning, we observed small bundles of three to five intracellular ParM filaments that were situated close to the edge of the nucleoid. We propose that this may indicate the capture of plasmid DNA within the periphery of this loosely defined, chromosome- containing region.	[Salje, Jeanne; Zuber, Benoit; Lowe, Jan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Salje, J (corresponding author), Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	jsalje@mrc-lmb.cam.ac.uk	Löwe, Jan/X-6998-2019; Löwe, Jan/B-3882-2011; Zuber, Benoît/U-1952-2019	Zuber, Benoît/0000-0001-7725-5579; Lowe, Jan/0000-0002-5218-6615	European Molecular Biology Organization; MRC [MC_U105184294, MC_U105184326] Funding Source: UKRI; Medical Research Council [MC_U105184326, MC_U105184294] Funding Source: researchfish	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank K. Gerdes (Newcastle, UK) and J. Moller-Jensen (Odense, Denmark) for kindly supplying plasmids and strains and W. Kuhlbrandt and D. Mills (Frankfurt, Germany) for generously allowing us the use of their microscope. J.S. is supported by MRC and Leverhulme Trust studentships, and B.Z. is supported by a European Molecular Biology Organization long-term fellowship. J.S. performed all experiments and their analysis except the initial cryo-sectioning that was done with B.Z.	Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Choi CL, 2008, J BIOL CHEM, V283, P28081, DOI 10.1074/jbc.M803833200; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; Ebersbach G, 2005, MOL MICROBIOL, V56, P1430, DOI 10.1111/j.1365-2958.2005.04643.x; Eltsov M, 2006, J STRUCT BIOL, V156, P246, DOI 10.1016/j.jsb.2006.07.007; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Jensen RB, 1998, P NATL ACAD SCI USA, V95, P8550, DOI 10.1073/pnas.95.15.8550; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; NORDSTROM K, 1980, PLASMID, V4, P332, DOI 10.1016/0147-619X(80)90071-2; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Tao WT, 2000, MOL MICROBIOL, V38, P392, DOI 10.1046/j.1365-2958.2000.02138.x; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672	19	79	79	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					509	512		10.1126/science.1164346	http://dx.doi.org/10.1126/science.1164346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19095899				2022-12-01	WOS:000262587900044
J	Chan, CKF; Chen, CC; Luppen, CA; Kim, JB; DeBoer, AT; Wei, K; Helms, JA; Kuo, CJ; Kraft, DL; Weissman, IL				Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; Kim, Jae-Beom; DeBoer, Anthony T.; Wei, Kevin; Helms, Jill A.; Kuo, Calvin J.; Kraft, Daniel L.; Weissman, Irving L.			Endochondral ossification is required for haematopoietic stem-cell niche formation	NATURE			English	Article							BONE-FORMATION; ENDOTHELIAL-CELLS; C-KIT; EXPRESS; ANGIOGENESIS; OSTERIX; MICE	Little is known about the formation of niches, local micro- environments required for stem- cell maintenance. Here we develop an in vivo assay for adult haematopoietic stem- cell ( HSC) niche formation(1,2). With this assay, we identified a population of progenitor cells with surface markers CD45(-)Tie2(-)alpha(+)(V)CD105(+)Thy1.1(-) (CD105(+)Thy1(-)) that, when sorted from 15.5 days post- coitum fetal bones and transplanted under the adult mouse kidney capsule, could recruit host- derived blood vessels, produce donor- derived ectopic bones through a cartilage intermediate and generate a marrow cavity populated by host- derived long- term reconstituting HSC (LT-HSC). In contrast, CD45(-)Tie2(-)alpha(+)(V)CD105(+)Thy1(+) (CD105(+)Thy1(+)) fetal bone progenitors form bone that does not contain a marrow cavity. Suppressing expression of factors involved in endochondral ossification, such as osterix and vascular endothelial growth factor ( VEGF), inhibited niche generation. CD105(+)Thy1(-) progenitor populations derived from regions of the fetal mandible or calvaria that do not undergo endochondral ossification formed only bone without marrow in our assay. Collectively, our data implicate endochondral ossification, bone formation that proceeds through a cartilage intermediate, as a requirement for adult HSC niche formation.	[Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; DeBoer, Anthony T.; Kraft, Daniel L.; Weissman, Irving L.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; DeBoer, Anthony T.; Kraft, Daniel L.; Weissman, Irving L.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Chan, Charles K. F.; Chen, Ching-Cheng; Luppen, Cynthia A.; DeBoer, Anthony T.; Kraft, Daniel L.; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Kim, Jae-Beom; Helms, Jill A.] Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; [Wei, Kevin; Kuo, Calvin J.] Stanford Univ, Dept Hematol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Chan, CKF (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	chazchan@stanford.edu; c3chen@stanford.edu	Chen, Ching-Cheng/C-1259-2009	Helms, Jill/0000-0002-0463-396X; Kuo, Calvin/0000-0002-7427-5985; Chen, Ching-Cheng/0000-0003-4499-0889	USPHS National Institutes of Health [2R01HL058770-08, 5R01CA086065-09, 1R01HL074267-01, 1R01NS052830-01]; NIH Pathway to Independence [5K99HL087936-02]; NIH Career Development [K08-HL076335]; Hope Street Kids; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074267, R00HL087936, K99HL087936, K08HL076335, R01HL058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052830] Funding Source: NIH RePORTER	USPHS National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NIH Pathway to Independence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Career Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Street Kids; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Peault for suggestions; L. Jerabek for laboratory management; C. Muscat for antibody production and conjugation; Y. Park, J. K. Lee and A. K. Bershad for technical support; and T. Serwold and L. Richie for advice and reading the manuscript. This study was supported in part by a USPHS National Institutes of Health ( NIH) grant (2R01HL058770-08) and in part by a NIH grant (5R01CA086065-09), terminated by NIH Study Section, and in part by the Virginia and Daniel K. Ludwig Professorship to I.L.W. C.K.F.C. and C.A.L. are supported by an NIH Regenerative Medicine training grant. C.-C.C. is supported by an NIH Pathway to Independence award (5K99HL087936-02). D.L.K. is supported by an NIH Career Development award (K08-HL076335) and a Hope Street Kids research award, K.W. and C.J.K. are supported by NIH grants (1R01HL074267-01 and 1R01NS052830-01).	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; AYE MT, 1992, EXP HEMATOL, V20, P523; Blair HC, 1999, BIOCHEM BIOPH RES CO, V255, P778, DOI 10.1006/bbrc.1999.0260; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; FLEISCHMAN RA, 1979, P NATL ACAD SCI USA, V76, P5736, DOI 10.1073/pnas.76.11.5736; GARVEY W, 1986, STAIN TECHNOL, V61, P60, DOI 10.3109/10520298609110708; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Jacobi J, 2004, CIRCULATION, V110, P2424, DOI 10.1161/01.CIR.0000145142.85645.EA; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; WEISS B, 2005, CONTEMP OBSTET GYNEC, V50, P34; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	29	313	321	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					490	U9		10.1038/nature07547	http://dx.doi.org/10.1038/nature07547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19078959	Green Accepted			2022-12-01	WOS:000262519200049
J	Carmona-Fontaine, C; Matthews, HK; Kuriyama, S; Moreno, M; Dunn, GA; Parsons, M; Stern, CD; Mayor, R				Carmona-Fontaine, Carlos; Matthews, Helen K.; Kuriyama, Sei; Moreno, Mauricio; Dunn, Graham A.; Parsons, Maddy; Stern, Claudio D.; Mayor, Roberto			Contact inhibition of locomotion in vivo controls neural crest directional migration	NATURE			English	Article							PLANAR CELL-POLARITY; GASTRULATION; XENOPUS; MORPHOGENESIS; CHEMOTAXIS; ZEBRAFISH; MOVEMENTS; BEHAVIOR; WNT11	Contact inhibition of locomotion was discovered by Abercrombie more than 50 years ago and describes the behaviour of fibroblast cells confronting each other in vitro, where they retract their protrusions and change direction on contact(1,2). Its failure was suggested to contribute to malignant invasion(3-6). However, the molecular basis of contact inhibition of locomotion and whether it also occurs in vivo are still unknown. Here we show that neural crest cells, a highly migratory and multipotent embryonic cell population, whose behaviour has been likened to malignant invasion(6-8), demonstrate contact inhibition of locomotion both in vivo and in vitro, and that this accounts for their directional migration. When two migrating neural crest cells meet, they stop, collapse their protrusions and change direction. In contrast, when a neural crest cell meets another cell type, it fails to display contact inhibition of locomotion; instead, it invades the other tissue, in the same manner as metastatic cancer cells(3,5,9). We show that inhibition of non-canonical Wnt signalling abolishes both contact inhibition of locomotion and the directionality of neural crest migration. Wnt- signalling members localize at the site of cell contact, leading to activation of RhoA in this region. These results provide the first example of contact inhibition of locomotion in vivo, provide an explanation for coherent directional migration of groups of cells and establish a previously unknown role for noncanonical Wnt signalling.	[Carmona-Fontaine, Carlos; Matthews, Helen K.; Kuriyama, Sei; Moreno, Mauricio; Stern, Claudio D.; Mayor, Roberto] UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; [Dunn, Graham A.; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; University College London; University of London; King's College London	Mayor, R (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.	r.mayor@ucl.ac.uk	Zebrafish, UCL/A-3125-2009; Parsons, Maddy/B-2203-2013; Matthews, Helen/A-3204-2009; Kuriyama, Sei/AAV-2368-2020; Ladoux, Benoit/A-9879-2013; Stern, Claudio D/C-6265-2008; Carmona-Fontaine, Carlos/D-1581-2009; Mayor, Roberto/C-6688-2008; Stern, Claudio/AAZ-7381-2021	Parsons, Maddy/0000-0002-2021-8379; Kuriyama, Sei/0000-0002-5502-7177; Stern, Claudio D/0000-0002-9907-889X; Stern, Claudio/0000-0002-9907-889X; Matthews, Helen/0000-0001-6660-9685; Mayor, Roberto/0000-0001-9053-9613	Medical Research Council; Biotechnology and Biological Sciences Research Council; MRC; Boehringer Ingelheim Fonds; Biotechnology and Biological Sciences Research Council [BB/D017521/1] Funding Source: researchfish; Medical Research Council [G0401026, G0400559, G0100152, G117/506] Funding Source: researchfish; BBSRC [BB/D017521/1] Funding Source: UKRI; MRC [G117/506, G0401026, G0400559, G0100152] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Tada, M. Tawk, J. Clarke, C.- P. Heisenberg, R. Kelsh, L. Dale and S. Fraser for reagents, constructs and fish lines; C. F. Riaz for scanning electron microscopy images; and M. Bronner- Fraser, M. Raff, J. Green and A. Ridley for comments on the manuscript. This study was supported by grants to R.M. from the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council. H. K. M. and C.C.-F. are MRC and Boehringer Ingelheim Fonds PhD scholarship holders, respectively, and M.M. is an EMBO postdoctoral fellow.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; ABERCROMBIE M, 1954, NATURE, V174, P697, DOI 10.1038/174697a0; ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7; Alfandari D, 2003, DEV BIOL, V260, P449, DOI 10.1016/S0012-1606(03)00277-X; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; DAVIS EM, 1981, J EMBRYOL EXP MORPH, V63, P29; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cellbio.4.1.649; DUNN GA, 1982, PHILOS T ROY SOC B, V299, P147, DOI 10.1098/rstb.1982.0121; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; HEAYSMAN JE, 1970, EXPERIENTIA, V26, P1344, DOI 10.1007/BF02113020; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Lecaudey V, 2006, CURR OPIN CELL BIOL, V18, P102, DOI 10.1016/j.ceb.2005.12.001; Matthews HK, 2008, DEV DYNAM, V237, P3404, DOI 10.1002/dvdy.21758; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; PADDOCK SW, 1986, J CELL SCI, V81, P163; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Tada M, 2000, DEVELOPMENT, V127, P2227; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017	29	406	409	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					957	961		10.1038/nature07441	http://dx.doi.org/10.1038/nature07441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19078960	Green Accepted			2022-12-01	WOS:000261768300047
J	Sytina, OA; Heyes, DJ; Hunter, CN; Alexandre, MT; van Stokkum, IHM; van Grondelle, R; Groot, ML				Sytina, Olga A.; Heyes, Derren J.; Hunter, C. Neil; Alexandre, Maxime T.; van Stokkum, Ivo H. M.; van Grondelle, Rienk; Groot, Marie Louise			Conformational changes in an ultrafast light-driven enzyme determine catalytic activity	NATURE			English	Article							PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; DIHYDROFOLATE-REDUCTASE; DYNAMICS; SPECTROSCOPY; CHLOROPHYLLIDE; IDENTIFICATION; MUTAGENESIS; COMPLEX; PROTEIN; NADPH	The role of conformational changes in explaining the huge catalytic power of enzymes is currently one of the most challenging questions in biology(1-7). Although it is now widely regarded that enzymes modulate reaction rates by means of short- and long- range protein motions(3-7), it is almost impossible to distinguish between conformational changes and catalysis. We have solved this problem using the chlorophyll biosynthetic enzyme NADPH: protochlorophyllide ( Pchlide) oxidoreductase, which catalyses a unique light- driven reaction involving hydride and proton transfers(8). Here we report that prior excitation of the enzyme- substrate complex with a laser pulse induces a more favourable conformation of the active site, enabling the coupled hydride and proton transfer reactions to occur. This effect, which is triggered during the Pchlide excited-state lifetime and persists on a long timescale, switches the enzyme into an active state characterized by a high rate and quantum yield of formation of a catalytic intermediate. The corresponding spectral changes in the mid- infrared following the absorption of one photon reveal significant conformational changes in the enzyme, illustrating the importance of flexibility and dynamics in the structure of enzymes for their function.	[Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Sytina, Olga A.; Alexandre, Maxime T.; van Stokkum, Ivo H. M.; van Grondelle, Rienk; Groot, Marie Louise] Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands; [Heyes, Derren J.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Sheffield; Vrije Universiteit Amsterdam; University of Manchester	Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Firth Court, Sheffield S10 2TN, S Yorkshire, England.	c.n.hunter@sheffield.ac.uk	Groot, Marie Louise/E-8954-2010; van Stokkum, Ivo HM/E-7175-2015	van Stokkum, Ivo HM/0000-0002-6143-2021; Groot, Marie Louise/0000-0001-5360-6987; Heyes, Derren/0000-0002-7453-1571	The Netherlands Organization for Scientific Research; Dutch Foundation for Earth and Life Sciences [834.01.002]; NWO-ALW [831.00.004]; NWO-CW [700.53.307]; Biotechnology and Biological Sciences Research Council, UK	The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Foundation for Earth and Life Sciences; NWO-ALW(Netherlands Organization for Scientific Research (NWO)); NWO-CW(Netherlands Organization for Scientific Research (NWO)); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by The Netherlands Organization for Scientific Research through the Dutch Foundation for Earth and Life Sciences ( Investment Grant no. 834.01.002). M. L. G. is grateful to NWO-ALW for providing financial support with a long-term fellowship (Grant no. 831.00.004) and O. S. received support from NWO-CW ( Grant no. 700.53.307). D.J.H. and C.N.H. gratefully acknowledge support from the Biotechnology and Biological Sciences Research Council, UK. We thank H. Fidder and F. van Mourik for reading the manuscript.	Agarwal PK, 2005, J AM CHEM SOC, V127, P15248, DOI 10.1021/ja055251s; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; BEGLEY TP, 1989, J AM CHEM SOC, V111, P3095, DOI 10.1021/ja00190a071; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Flomenbom O, 2005, P NATL ACAD SCI USA, V102, P2368, DOI 10.1073/pnas.0409039102; GRIFFITHS WT, 1978, BIOCHEM J, V174, P681, DOI 10.1042/bj1740681; Groot ML, 2004, J PHYS CHEM B, V108, P8001, DOI 10.1021/jp037966s; HARTWICH G, 1995, J AM CHEM SOC, V117, P7784, DOI 10.1021/ja00134a025; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Iwaki M, 2006, J AM CHEM SOC, V128, P2621, DOI 10.1021/ja0556272; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MANTELE WG, 1988, P NATL ACAD SCI USA, V85, P8468, DOI 10.1073/pnas.85.22.8468; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; NABEDRYK E, 1990, BIOCHEMISTRY-US, V29, P3242, DOI 10.1021/bi00465a015; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; VALERA V, 1987, BIOCHEM BIOPH RES CO, V148, P515, DOI 10.1016/0006-291X(87)91141-7; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; Wang L, 2006, P NATL ACAD SCI USA, V103, P15753, DOI 10.1073/pnas.0606976103; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; Zhao GJ, 2008, BIOPHYS J, V94, P38, DOI 10.1529/biophysj.107.113738	31	108	110	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					1001	U89		10.1038/nature07354	http://dx.doi.org/10.1038/nature07354			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092933				2022-12-01	WOS:000261768300057
J	Ballestar, E; Esteller, M				Ballestar, Esteban; Esteller, Manel			SnapShot: The Human DNA Methylome in Health and Disease	CELL			English	Editorial Material							METHYLATION; CANCER; EPIGENOMICS; CELLS		[Ballestar, Esteban; Esteller, Manel] Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Grp, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Ballestar, E (corresponding author), Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Grp, Madrid 28029, Spain.		Esteller, Manel/L-5956-2014; Ballestar, Esteban/ABG-8561-2020	Esteller, Manel/0000-0003-4490-6093; Ballestar, Esteban/0000-0002-1400-2440				Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	10	6	8	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 12	2008	135	6					1144	U25	1144.e1	10.1016/j.cell.2008.11.040	http://dx.doi.org/10.1016/j.cell.2008.11.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070582	Bronze			2022-12-01	WOS:000261642800029
J	Hameed, S				Hameed, Salman			Science and religion Bracing for Islamic Creationism	SCIENCE			English	Editorial Material									[Hameed, Salman] Hampshire Coll, Sch Cognit Sci, Amherst, MA 01002 USA; [Hameed, Salman] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA		Hameed, S (corresponding author), Hampshire Coll, Sch Cognit Sci, Amherst, MA 01002 USA.	shameed@hampshire.edu						Asghar A., 2007, P NAT ASS RES SCI TE; Bucaille Maurice, 1989, WHAT IS ORIGIN MAN; Edis Taner, 2007, ILLUSION HARMONY SCI; Hassan R, 2007, MUSLIM WORLD, V97, P437, DOI 10.1111/j.1478-1913.2007.00190.x; IAP, 2006, IAP STAT TEACH EV; IQBAL M, 2006, ISLAM SCI, V4, P89; Iqbal Mohammad., 1930, RECONSTRUCTION RELIG; Koning D., 2006, ISIM NEWSLETTER, V18, P48; Miller JD, 2006, SCIENCE, V313, P765, DOI 10.1126/science.1126746; Nasr SeyyedHossein., 2006, ISLAM SCI, V4, P181; Nisbet MC, 2007, SCIENCE, V316, P56, DOI 10.1126/science.1142030; Numbers RL., 2006, CREATIONISTS SCI CRE; *PUNJ TXB BOARD, 2003, BIOLOGY, V12, P222	13	58	59	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1637	1638		10.1126/science.1163672	http://dx.doi.org/10.1126/science.1163672			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	382LU	19074331				2022-12-01	WOS:000261608300025
J	Bhutta, MF				Bhutta, Mahmood F.			Fair and ethical trade in health procurement	LANCET			English	Editorial Material									[Bhutta, Mahmood F.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Bhutta, Mahmood F.] Int Grp, Med Fair & Eth Trade Grp, London WC1H 9JP, England	University of Oxford	Bhutta, MF (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England.	fairtrade@bma.org.uk		Bhutta, Mahmood/0000-0002-4688-1670				Bhutta MF, 2006, BMJ-BRIT MED J, V333, P297, DOI 10.1136/bmj.38901.619074.55; BJURLING K, 2007, DARK SIDE HEALTHCARE; Fairtrade Foundation, 2008, ANN REV 2007 2008; KJELLSTROM T, 2007, SCAND J PUBLIC HEALT, V35, P2; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-6; *NHS PURCH SUPPL A, 2008, FRAM ETH PROC STRAT; *NHS SUPPL CHAIN, 2008, SUPPL COD COND; Ram R, 2006, SOC SCI MED, V62, P779, DOI 10.1016/j.socscimed.2005.06.034; *STOCKH COUNT COUN, 2008, SUST PROC; [No title captured]	10	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1935	1937		10.1016/S0140-6736(08)61826-7	http://dx.doi.org/10.1016/S0140-6736(08)61826-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	380NE	19059038				2022-12-01	WOS:000261471600008
J	Mathieson, PW				Mathieson, Peter W.			Proteinuria and Immunity - An Overstated Relationship?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PODOCYTES; CYTOSKELETON		[Mathieson, Peter W.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Mathieson, Peter W.] Southmead Hosp, Bristol, Avon, England	University of Bristol; Southmead Hospital	Mathieson, PW (corresponding author), Univ Bristol, Acad Renal Unit, Bristol, Avon, England.							Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Grimbert P, 2003, J EXP MED, V198, P797, DOI 10.1084/jem.20030566; Guigonis V, 2008, PEDIATR NEPHROL, V23, P1269, DOI 10.1007/s00467-008-0814-1; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Xing CY, 2006, KIDNEY INT, V70, P1038, DOI 10.1038/sj.ki.5001655	5	53	60	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2492	2494		10.1056/NEJMcibr0806881	http://dx.doi.org/10.1056/NEJMcibr0806881			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378MT	19052132				2022-12-01	WOS:000261325900014
J	Chopra, AR; Louet, JF; Saha, P; An, J; DeMayo, F; Xu, JM; York, B; Karpen, S; Finegold, M; Moore, D; Chan, L; Newgard, CB; O'Malley, BW				Chopra, Atul R.; Louet, Jean-Francois; Saha, Pradip; An, Jie; DeMayo, Franco; Xu, Jianming; York, Brian; Karpen, Saul; Finegold, Milton; Moore, David; Chan, Lawrence; Newgard, Christopher B.; O'Malley, Bert W.			Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease	SCIENCE			English	Article							STEROID-RECEPTOR COACTIVATOR-2; STORAGE-DISEASE; LIVER-REGENERATION; MOUSE; GLUCOSE-6-PHOSPHATASE; GENE; SUPPRESSION; DELETION; GLUCOSE; PGC-1	Hepatic glucose production is critical for basal brain function and survival when dietary glucose is unavailable. Glucose- 6- phosphatase (G6Pase) is an essential, rate- limiting enzyme that serves as a terminal gatekeeper for hepatic glucose release into the plasma. Mutations in G6Pase result in Von Gierke's disease ( glycogen storage disease-1a), a potentially fatal genetic disorder. We have identified the transcriptional coactivator SRC-2 as a regulator of fasting hepatic glucose release, a function that SRC- 2 performs by controlling the expression of hepatic G6Pase. SRC- 2 modulates G6Pase expression directly by acting as a coactivator with the orphan nuclear receptor ROR alpha. In addition, SRC- 2 ablation, in both a whole- body and liver- specific manner, resulted in a Von Gierke's disease phenotype in mice. Our results position SRC- 2 as a critical regulator of mammalian glucose production.	[Chopra, Atul R.; Louet, Jean-Francois; Saha, Pradip; DeMayo, Franco; Xu, Jianming; York, Brian; Karpen, Saul; Moore, David; Chan, Lawrence; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Karpen, Saul] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Finegold, Milton] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [An, Jie; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Duke University	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	berto@bcm.tmc.edu	; DeMayo, Francesco/C-6255-2019	Louet, Jean-Francois/0000-0002-1626-7098; DeMayo, Francesco/0000-0002-9480-7336; Chopra, Atul/0000-0002-1304-3777	National Institute of Diabetes and Digestive and Kidney Diseases [PO1 DK59820]; NIH [HL51586, DK58242, PO1 DK58398]; Nuclear Receptor Signaling Atlas ( NURSA) [U19 DK062434]; Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056239, P01DK058398, R01DK058242, P01DK059820, U19DK062434] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nuclear Receptor Signaling Atlas ( NURSA); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank O. McGuinness for help with assessment of liver glycogen and triglyceride content; D. White for help with primary hepatocyte isolation; S. Zhou and J. Song for help with animal breeding; J. Barish for performing the electron microscopy; J. Lin for the RORa adenovirus; J. Lydon for the SRC- 2 F/ F mice and M. Stallcup for the SRC- 2 activation domain mutants; R. Lanz for help with QPCR setup and analysis; M. Muehlbauer for help with plasma analysis of various metabolites; H. Klein and S. Greene for help with figure and model construction; and J. Sagen and C. Foulds for helpful discussion and critical reading of the manuscript. F. D. is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (grant PO1 DK59820). L.C. is supported by the NIH (grant HL51586). J.X. is supported by the NIH (DK58242). C.B.N. is supported by the NIH (grant PO1 DK58398). B.W.O. is supported by the NIDDK (grant PO1 DK59820), Nuclear Receptor Signaling Atlas (NURSA) (U19 DK062434), and a grant from the Welch Foundation.	Atkins GB, 1999, MOL ENDOCRINOL, V13, P1550, DOI 10.1210/me.13.9.1550; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gogus S, 2002, PEDIATR DEVEL PATHOL, V5, P299, DOI 10.1007/s10024-001-0139-6; Jeong JW, 2007, ENDOCRINOLOGY, V148, P4238, DOI 10.1210/en.2007-0122; Koeberl DD, 2007, MOL THER, V15, P1253, DOI 10.1038/sj.mt.6300188; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Li F, 2006, CANCER RES, V66, P5608, DOI 10.1158/0008-5472.CAN-05-4242; Liedtke AJ, 1997, J MOL CELL CARDIOL, V29, P1073, DOI 10.1006/jmcc.1996.0341; Mukherjee Atish, 2007, Nucl Recept Signal, V5, pe011, DOI 10.1621/nrs.05011; Mukherjee A, 2006, MOL CELL BIOL, V26, P6571, DOI 10.1128/MCB.00654-06; Nordlie R C, 1974, Curr Top Cell Regul, V8, P33; NORDLIE RC, 1979, LIFE SCI, V24, P2397, DOI 10.1016/0024-3205(79)90447-8; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Phaneuf D, 2004, DNA CELL BIOL, V23, P592, DOI 10.1089/1044549041939250; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stec DE, 1999, J BIOL CHEM, V274, P21285, DOI 10.1074/jbc.274.30.21285; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025	20	127	131	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1395	1399		10.1126/science.1164847	http://dx.doi.org/10.1126/science.1164847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19039140	Green Accepted			2022-12-01	WOS:000261170600043
J	Dias, A; Bouvier, D; Crepin, T; McCarthy, AA; Hart, DJ; Baudin, F; Cusack, S; Ruigrok, RWH				Dias, Alexandre; Bouvier, Denis; Crepin, Thibaut; McCarthy, Andrew A.; Hart, Darren J.; Baudin, Florence; Cusack, Stephen; Ruigrok, Rob W. H.			The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit	NATURE			English	Article							RNA-POLYMERASE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; MESSENGER-RNA; CLEAVAGE; BINDING; SITES; PB2; TRANSCRIPTION; RECOGNITION	The influenza virus polymerase, a heterotrimer composed of three subunits, PA, PB1 and PB2, is responsible for replication and transcription of the eight separate segments of the viral RNA genome in the nuclei of infected cells. The polymerase synthesizes viral messenger RNAs using short capped primers derived from cellular transcripts by a unique 'cap-snatching' mechanism(1). The PB2 subunit binds the 59 cap of host pre-mRNAs(2-4), which are subsequently cleaved after 10-13 nucleotides by the viral endonuclease, hitherto thought to reside in the PB2 (ref. 5) or PB1 (ref. 2) subunits. Here we describe biochemical and structural studies showing that the amino-terminal 209 residues of the PA subunit contain the endonuclease active site. We show that this domain has intrinsic RNA and DNA endonuclease activity that is strongly activated by manganese ions, matching observations reported for the endonuclease activity of the intact trimeric polymerase(6,7). Furthermore, this activity is inhibited by 2,4-dioxo-4-phenylbutanoic acid, a known inhibitor of the influenza endonuclease(8). The crystal structure of the domain reveals a structural core closely resembling resolvases and type II restriction endonucleases. The active site comprises a histidine and a cluster of three acidic residues, conserved in all influenza viruses, which bind two manganese ions in a configuration similar to other two-metal-dependent endonucleases. Two active site residues have previously been shown to specifically eliminate the polymerase endonuclease activity when mutated(9). These results will facilitate the optimisation of endonuclease inhibitors(10-12) as potential new anti-influenza drugs.	[Dias, Alexandre; Bouvier, Denis; Crepin, Thibaut; McCarthy, Andrew A.; Hart, Darren J.; Baudin, Florence; Cusack, Stephen; Ruigrok, Rob W. H.] UJF, EMBL, CNRS, Unit Virus Host Cell Interact,UMR 5233, F-38042 Grenoble 9, France; [McCarthy, Andrew A.; Hart, Darren J.; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL)	Cusack, S (corresponding author), UJF, EMBL, CNRS, Unit Virus Host Cell Interact,UMR 5233, 6 Rue Jules Horowitz,BP181, F-38042 Grenoble 9, France.	cusack@embl.fr	McCarthy, Andrew A/A-5926-2013; Hart, Darren/C-4858-2015	McCarthy, Andrew A/0000-0003-4478-0136; Baudin, Florence/0000-0003-0816-0861; CREPIN, Thibaut/0000-0003-2663-1794; Cusack, Stephen/0000-0002-9324-0796; Hart, Darren/0000-0002-3502-2002	EU FLUPOL [SP5B-CT-2007-044263]; ANR FLU INTERPOL [ANR-06-MIME-014-02]; MENRT	EU FLUPOL; ANR FLU INTERPOL(French National Research Agency (ANR)); MENRT	We thank the ESRF, EMBL and MRC-France for access to synchrotron facilities and the Partnership for Structural Biology for an integrated structural biology environment. The work was partially funded by the EU FLUPOL contract (SP5B-CT-2007-044263) and the ANR FLU INTERPOL contract (ANR-06-MIME-014-02). A. D. has a PhD fellowship from the MENRT. We thank J.-L. Decout for advice about the inhibitor, E. Kowalinski and C. Swale for RNA transcripts, and C. Petosa and J. Perona for a critical reading of the manuscript.	BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Doan L, 1999, BIOCHEMISTRY-US, V38, P5612, DOI 10.1021/bi9828932; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; HAGEN M, 1994, J VIROL, V68, P1509, DOI 10.1128/JVI.68.3.1509-1515.1994; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hastings JC, 1996, ANTIMICROB AGENTS CH, V40, P1304, DOI 10.1128/AAC.40.5.1304; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Horton NC, 2004, BIOCHEMISTRY-US, V43, P6841, DOI 10.1021/bi0499056; Klumpp K, 2000, J BIOL CHEM, V275, P6181, DOI 10.1074/jbc.275.9.6181; Knizewski L, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-40; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Nishino T, 2001, STRUCTURE, V9, P197, DOI 10.1016/S0969-2126(01)00576-7; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Parkes KEB, 2003, J MED CHEM, V46, P1153, DOI 10.1021/jm020334u; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; SHI LC, 1995, VIROLOGY, V208, P38, DOI 10.1006/viro.1995.1127; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; TOMASSINI J, 1994, ANTIMICROB AGENTS CH, V38, P2827, DOI 10.1128/AAC.38.12.2827; Tomassini JE, 1996, ANTIMICROB AGENTS CH, V40, P1189, DOI 10.1128/AAC.40.5.1189; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352	30	542	584	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					914	918		10.1038/nature07745	http://dx.doi.org/10.1038/nature07745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19194459				2022-12-01	WOS:000265182500048
J	Jovanovic-Talisman, T; Tetenbaum-Novatt, J; McKenney, AS; Zilman, A; Peters, R; Rout, MP; Chait, BT				Jovanovic-Talisman, Tijana; Tetenbaum-Novatt, Jaclyn; McKenney, Anna Sophia; Zilman, Anton; Peters, Reiner; Rout, Michael P.; Chait, Brian T.			Artificial nanopores that mimic the transport selectivity of the nuclear pore complex	NATURE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; IMPORTIN-BETA; NUCLEOPORINS; PERMEABILITY; ARCHITECTURE; MECHANISM; MEMBRANES; REVEALS; REGIONS; SITES	Nuclear pore complexes ( NPCs) act as effective and robust gateways between the nucleus and the cytoplasm, selecting for the passage of particular macromolecules across the nuclear envelope. NPCs comprise an elaborate scaffold that defines a similar to 30 nm diameter passageway connecting the nucleus and the cytoplasm. This scaffold anchors proteins termed 'phenylalanine- glycine' ( FG)- nucleoporins, the natively disordered domains of which line the passageway and extend into its lumen(1). Passive diffusion through this lined passageway is hindered in a size- dependent manner. However, transport factors and their cargo- bound complexes overcome this restriction by transient binding to the FG-nucleoporins(2-10). To test whether a simple passageway and a lining of transport- factor- binding FG- nucleoporins are sufficient for selective transport, we designed a functionalized membrane that incorporates just these two elements. Here we demonstrate that this membrane functions as a nanoselective filter, efficiently passing transport factors and transport- factor - cargo complexes that specifically bind FG- nucleoporins, while significantly inhibiting the passage of proteins that do not. This inhibition is greatly enhanced when transport factor is present. Determinants of selectivity include the passageway diameter, the length of the nanopore region coated with FG- nucleoporins, the binding strength to FG-nucleoporins, and the antagonistic effect of transport factors on the passage of proteins that do not specifically bind FG- nucleoporins. We show that this artificial system faithfully reproduces key features of trafficking through the NPC, including transport-factor-mediated cargo import.	[Jovanovic-Talisman, Tijana; Chait, Brian T.] Rockefeller Univ, Lab Mass Spect & Gaseous Ion Chem, New York, NY 10065 USA; [Tetenbaum-Novatt, Jaclyn; McKenney, Anna Sophia; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; [Zilman, Anton] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Zilman, Anton] Los Alamos Natl Lab, Div Theoret, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Peters, Reiner] Univ Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany; [Peters, Reiner] Univ Munster, Ctr Nanotechnol CeNTech, D-48149 Munster, Germany	Rockefeller University; Rockefeller University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Munster; University of Munster	Chait, BT (corresponding author), Rockefeller Univ, Lab Mass Spect & Gaseous Ion Chem, 1230 York Ave, New York, NY 10065 USA.	chait@rockefeller.edu	Novatt, Jaclyn/H-3459-2013	Novatt, Jaclyn/0000-0002-3906-3469; Jovanovic-Talisman, Tijana/0000-0003-1928-4763; Rout, Michael/0000-0003-2010-706X; McKenney, Anna Sophia/0000-0003-4464-6869	NIH; DoE; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071329, R01GM062427, T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Coutavas, S. Darst, G. Belfort and C. Martin for suggestions and comments, G. Blobel for use of his confocal microscope, D. Phillips for use of his sputtering device, P. Nahirney and A. Labissiere for electron microscopy work, J. M. Crawford for amino acid analysis, D. Gadsby and A. Gulyas Kovacs for providing Xenopus oocytes, J. Aitchison for Kap95-GST and Kap121-GST plasmids, K. Zerf and M. Kahms for providing RanGDP, K. Zerf for NTF2-YFP cloning assistance, R. Mironska for help in preparing measuring chambers, and other members of the Peters, Rout and Chait laboratories for their assistance. We gratefully acknowledge support from the NIH and DoE. J.T.-N. is a HHMI pre-doctoral fellow.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Caspi Y, 2008, NANO LETT, V8, P3728, DOI 10.1021/nl801975q; Clarkson WD, 1997, J MOL BIOL, V272, P716, DOI 10.1006/jmbi.1997.1255; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dutta AK, 2007, LANGMUIR, V23, P3088, DOI 10.1021/la0624743; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; Iqbal SM, 2007, NAT NANOTECHNOL, V2, P243, DOI 10.1038/nnano.2007.78; Jirage KB, 1999, ANAL CHEM, V71, P4913, DOI 10.1021/ac990615i; Koerner C, 2003, J BIOL CHEM, V278, P16216, DOI 10.1074/jbc.M301137200; Krishnan VV, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000145; Lakshmi BB, 1997, NATURE, V388, P758, DOI 10.1038/41978; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Peters R, 2003, ANNU REV BIOPH BIOM, V32, P47, DOI 10.1146/annurev.biophys.32.110601.142429; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Strawn LA, 2001, J BIOL CHEM, V276, P6445, DOI 10.1074/jbc.M008311200; Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125	29	219	220	8	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1023	1027		10.1038/nature07600	http://dx.doi.org/10.1038/nature07600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19098896	Green Accepted			2022-12-01	WOS:000263425400045
J	Pope, CA; Ezzati, M; Dockery, DW				Pope, C. Arden, III; Ezzati, Majid; Dockery, Douglas W.			Fine-Particulate Air Pollution and Life Expectancy in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM EXPOSURE; MORTALITY; HEALTH; MATTER; ASSOCIATION; CANCER; RATES	Background: Exposure to fine-particulate air pollution has been associated with increased morbidity and mortality, suggesting that sustained reductions in pollution exposure should result in improved life expectancy. This study directly evaluated the changes in life expectancy associated with differential changes in fine particulate air pollution that occurred in the United States during the 1980s and 1990s. Methods: We compiled data on life expectancy, socioeconomic status, and demographic characteristics for 211 county units in the 51 U.S. metropolitan areas with matching data on fine-particulate air pollution for the late 1970s and early 1980s and the late 1990s and early 2000s. Regression models were used to estimate the association between reductions in pollution and changes in life expectancy, with adjustment for changes in socioeconomic and demographic variables and in proxy indicators for the prevalence of cigarette smoking. Results: A decrease of 10 microg per cubic meter in the concentration of fine particulate matter was associated with an estimated increase in mean (+/-SE) life expectancy of 0.61+/-0.20 year (P=0.004). The estimated effect of reduced exposure to pollution on life expectancy was not highly sensitive to adjustment for changes in socioeconomic, demographic, or proxy variables for the prevalence of smoking or to the restriction of observations to relatively large counties. Reductions in air pollution accounted for as much as 15% of the overall increase in life expectancy in the study areas. Conclusions: A reduction in exposure to ambient fine-particulate air pollution contributed to significant and measurable improvements in life expectancy in the United States. N Engl J Med 2009;360:376-86.	[Pope, C. Arden, III] Brigham Young Univ, Dept Econ, Provo, UT 84602 USA; [Ezzati, Majid; Dockery, Douglas W.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Initiat Global Hlth, Cambridge, MA USA	Brigham Young University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Pope, CA (corresponding author), Brigham Young Univ, Dept Econ, 142 FOB, Provo, UT 84602 USA.	cap3@byu.edu	, dwdockery/AAO-7272-2021; Pope, C. Arden/ABD-5522-2021	Dockery, Douglas/0000-0002-6052-4880	Association of Schools of Public Health [U36/CCU300430-23)]; Harvard Environmental Protection Agency (EPA) Particulate Matter Center [EPA RD832416]; National Institute of Environmental Health Sciences [ES0002]; Mary Lou Fulton Professorship; Brigham Young University; Health Effects Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	Association of Schools of Public Health; Harvard Environmental Protection Agency (EPA) Particulate Matter Center(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Mary Lou Fulton Professorship; Brigham Young University; Health Effects Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by a cooperative agreement with the Centers for Disease Control and Prevention; by grants from the Association of Schools of Public Health (U36/CCU300430-23), the Harvard Environmental Protection Agency (EPA) Particulate Matter Center (EPA RD832416), and the National Institute of Environmental Health Sciences (ES0002); and funds from the Mary Lou Fulton Professorship, Brigham Young University.; Dr. Dockery reports receiving grant support from the Health Effects Institute. No other potential conflict of interest relevant to this article was reported.; The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Association of Schools of Public Health. Although funded in part by the EPA, this study has not been subjected to the agency's peer- and policy- review process and therefore does not necessarily reflect the views of the agency, and no official endorsement should be inferred.	Anderson HR, 2005, EPIDEMIOLOGY, V16, P155, DOI 10.1097/01.ede.0000152528.22746.0f; Brunekreef B, 1997, OCCUP ENVIRON MED, V54, P781, DOI 10.1136/oem.54.11.781; BURNETT RT, 2003, REVISED ANAL TIME SE, P85; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Eftim SE, 2008, EPIDEMIOLOGY, V19, P209, DOI 10.1097/EDE.0b013e3181632c09; EVANS JS, 1984, ENVIRON INT, V10, P55, DOI 10.1016/0160-4120(84)90233-2; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Krewski D., 2000, REANALYSIS HARVARD 6; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; LAVE LB, 1970, SCIENCE, V169, P723, DOI 10.1126/science.169.3947.723; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; OZKAYNAK H, 1987, RISK ANAL, V7, P449, DOI 10.1111/j.1539-6924.1987.tb00482.x; Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pope CA, 2007, ENVIRON HEALTH PERSP, V115, P679, DOI 10.1289/ehp.9762; Pope C. Arden III, 2000, Environmental Health Perspectives, V108, P713, DOI 10.2307/3454408; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Preston, 2001, DEMOGRAPHY; Schwartz J, 2008, ENVIRON HEALTH PERSP, V116, P64, DOI 10.1289/ehp.9955; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wooldridge J.M., 2002, DATA; 1997, FED REG, V62, P5725	28	1473	1518	9	444	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					376	386		10.1056/NEJMsa0805646	http://dx.doi.org/10.1056/NEJMsa0805646			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395JH	19164188	Green Accepted			2022-12-01	WOS:000262519900009
J	Mihola, O; Trachtulec, Z; Vlcek, C; Schimenti, JC; Forejt, J				Mihola, Ondrej; Trachtulec, Zdenek; Vlcek, Cestmir; Schimenti, John C.; Forejt, Jiri			A Mouse Speciation Gene Encodes a Meiotic Histone H3 Methyltransferase	SCIENCE			English	Article							HYBRID STERILITY; CHROMOSOME 17; WILD MOUSE; DROSOPHILA; MUSCULUS; STRAINS; REGION; MICE	Speciation genes restrict gene flow between the incipient species and related taxa. Three decades ago, we mapped a mammalian speciation gene, hybrid sterility 1 (Hst1), in the intersubspecific hybrids of house mouse. Here, we identify this gene as Prdm9, encoding a histone H3 lysine 4 trimethyltransferase. We rescued infertility in male hybrids with bacterial artificial chromosomes carrying Prdm9 from a strain with the "fertility" Hst1(f) allele. Sterile hybrids display down-regulated microrchidia 2B (Morc2b) and fail to compartmentalize gamma H2AX into the pachynema sex (XY) body. These defects, seen also in Prdm9-null mutants, are rescued by the Prdm9 transgene. Identification of a vertebrate hybrid sterility gene reveals a role for epigenetics in speciation and opens a window to a hybrid sterility gene network.	[Mihola, Ondrej; Trachtulec, Zdenek; Vlcek, Cestmir; Forejt, Jiri] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic; [Schimenti, John C.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ctr Vertebrate Genom, Ithaca, NY 14853 USA	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Cornell University	Forejt, J (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CR-14220 Prague, Czech Republic.	jforejt@img.cas.cz	Vlcek, Cestmir/I-8820-2014; Forejt, Jiri/G-7719-2012; Mihola, Ondrej/G-6362-2014; Trachtulec, Zdenek/G-3449-2014; Forejt, Jiri/AAF-5276-2019; Mihola, Ondrej/AAM-7009-2020	Forejt, Jiri/0000-0002-2793-3623; Trachtulec, Zdenek/0000-0001-5772-9394; Forejt, Jiri/0000-0002-2793-3623; Mihola, Ondrej/0000-0003-3243-0825	Czech Science Foundation; Grant Agency of the Academy of Sciences of the Czech Republic; Ministry of Education, Youth and Sports of the Czech Republic; NIH	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Nachman (University of Arizona), K. Paigen (The Jackson Laboratory), and D. Barbash (Cornell University) for valuable comments. We are grateful to P. Jansa for advice with the immunofluorescence and P. Flachs for assistance. This work was funded by the Czech Science Foundation, the Grant Agency of the Academy of Sciences of the Czech Republic and the Ministry of Education, Youth and Sports of the Czech Republic (J. F. and Z. T.), and a grant from NIH (J. C. S.). J. F. was an International Fellow of the Howard Hughes Medical Institute.	Bannister LA, 2007, PLOS BIOL, V5, P1016, DOI 10.1371/journal.pbio.0050105; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Dobzhansky T., 1951, A MONTAGU PAPERS, V3rd; FOREJT J, 1974, GENET RES, V24, P189, DOI 10.1017/S0016672300015214; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; FOREJT J, 1981, CURRENT TRENDS HISTO, V1, P103; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Gregorova S, 1996, MAMM GENOME, V7, P107, DOI 10.1007/s003359900029; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mihola O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-20; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Orr HA, 2005, P NATL ACAD SCI USA, V102, P6522, DOI 10.1073/pnas.0501893102; Osoegawa K, 2000, GENOME RES, V10, P116; Storchova R, 2004, MAMM GENOME, V15, P515, DOI 10.1007/s00335-004-2386-0; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Trachtulec Z, 2005, BIOL J LINN SOC, V84, P637, DOI 10.1111/j.1095-8312.2005.00460.x; Trachtulec Z, 1997, MAMM GENOME, V8, P312, DOI 10.1007/s003359900430; Trachtulec Z, 2008, GENETICS, V178, P1777, DOI 10.1534/genetics.107.082404; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; YOSHIKI A, 1993, DEV GROWTH DIFFER, V35, P271, DOI 10.1111/j.1440-169X.1993.00271.x	25	309	317	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					373	375		10.1126/science.1163601	http://dx.doi.org/10.1126/science.1163601			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19074312				2022-12-01	WOS:000262481400036
J	Wilson, RW; Millero, FJ; Taylor, JR; Walsh, PJ; Christensen, V; Jennings, S; Grosell, M				Wilson, R. W.; Millero, F. J.; Taylor, J. R.; Walsh, P. J.; Christensen, V.; Jennings, S.; Grosell, M.			Contribution of Fish to the Marine Inorganic Carbon Cycle	SCIENCE			English	Article							INTESTINAL BICARBONATE SECRETION; CALCIUM-CARBONATE; ACID-BASE; OCEAN; DISSOLUTION; ARAGONITE; IMPACT; CO2; SEDIMENTATION; CHEMISTRY	Oceanic production of calcium carbonate is conventionally attributed to marine plankton (coccolithophores and foraminifera). Here we report that marine fish produce precipitated carbonates within their intestines and excrete these at high rates. When combined with estimates of global fish biomass, this suggests that marine fish contribute 3 to 15% of total oceanic carbonate production. Fish carbonates have a higher magnesium content and solubility than traditional sources, yielding faster dissolution with depth. This may explain up to a quarter of the increase in titratable alkalinity within 1000 meters of the ocean surface, a controversial phenomenon that has puzzled oceanographers for decades. We also predict that fish carbonate production may rise in response to future environmental changes in carbon dioxide, and thus become an increasingly important component of the inorganic carbon cycle.	[Wilson, R. W.] Univ Exeter, Sch Biosci, Exeter EX4 4PS, Devon, England; [Millero, F. J.; Taylor, J. R.; Walsh, P. J.; Grosell, M.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Walsh, P. J.] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Christensen, V.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada; [Jennings, S.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Jennings, S.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of Exeter; University of Miami; University of Ottawa; University of British Columbia; Centre for Environment Fisheries & Aquaculture Science; University of East Anglia	Wilson, RW (corresponding author), Univ Exeter, Sch Biosci, Exeter EX4 4PS, Devon, England.	r.w.wilson@ex.ac.uk; fmillero@rsmas.miami.edu; mgrosell@rsmas.miami.edu	Jennings, Simon/F-5085-2012; Christensen, Villy/C-3945-2009	Jennings, Simon/0000-0002-2390-7225; Christensen, Villy/0000-0003-0688-2633	UK Biotechnology and Biological Sciences Research Council [BB/D005108/1, BB/F009364/1, ISIS 1766]; The Royal Society [RSRG 24241]; Oceanographic Section of the U.S. National Science Foundation; Natural Sciences and Engineering Research Council; Canada and the Canada Research Chair; NSERC; Global Environment Facility's UNEP/UNESCO/IOC (Intergovernmental Oceanographic Commission); LME; The Pew Charitable Trusts; European Commission; UK Department of Environment, Food, and Rural Affairs; NSF [0416440, 0714024, 0743903]; Directorate For Geosciences [0752972] Funding Source: National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/D005108/1, BB/F009364/1] Funding Source: researchfish; BBSRC [BB/F009364/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The Royal Society(Royal Society of London); Oceanographic Section of the U.S. National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada and the Canada Research Chair; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Global Environment Facility's UNEP/UNESCO/IOC (Intergovernmental Oceanographic Commission); LME; The Pew Charitable Trusts; European Commission(European CommissionEuropean Commission Joint Research Centre); UK Department of Environment, Food, and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	R.W.W. acknowledges support from the UK Biotechnology and Biological Sciences Research Council (awards BB/D005108/1 , BB/F009364/1, and ISIS 1766) and The Royal Society (award RSRG 24241). F.J.M. acknowledges the Oceanographic Section of the U.S. National Science Foundation (NSF). P.J.W. is supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada and the Canada Research Chair program. V. C. acknowledges support from NSERC, the Global Environment Facility's UNEP/UNESCO/IOC (Intergovernmental Oceanographic Commission) LME (Large Marine Ecosystem) activities, and from the Sea Around Us Project, initiated and funded by The Pew Charitable Trusts. S.J. thanks the European Commission and the UK Department of Environment, Food, and Rural Affairs for funding support, and A. Clarke (British Antarctic Survey, Cambridge) for providing a compilation of fish oxygen consumption data. M.G. and S.J. are supported by the NSF (awards 0416440, 0714024, and 0743903). We also thank referees for their insightful comments; K. Knapp (School of Physics, University of Exeter) for the fish x-ray images (Fig. 2); R. Walton (University of Warwick, UK) for the powder x-ray diffraction analysis (fig. S1); H. Stoll (Department of Geoscience, Williams College, Williamstown, MA) and A. Pritchard (University of Exeter, Biosciences) for the scanning electron micrographs of sediment trap samples and fish carbonates, respectively (fig. S3); R. Forster (Centre for Environment, Fisheries and Aquaculture Science, Lowestoft) for plotting fig. S4; FishBase (www.fishbase.org) for providing fish species' information; J. Whittamore for preparation of flounder for x-ray imaging; J. Corcoran and C. Cooper for the sheepshead minnow experiments in the Supporting Online Material; and R. van Aerle for assistance with graphical illustrations.	BISHOP JKB, 1986, PROG OCEANOGR, V17, P1, DOI 10.1016/0079-6611(86)90024-8; BROECKER WS, 1977, FATE FOSSIL CO2 OCEA, P207; BYRNE RH, 1984, NATURE, V312, P321, DOI 10.1038/312321a0; Christensen V, 2008, IOC TECHNICAL SERIES, V80; Chung SN, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002001; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; FABRY VJ, 1991, DEEP-SEA RES, V38, P713, DOI 10.1016/0198-0149(91)90008-4; FEELY RA, 1988, MAR CHEM, V25, P227, DOI 10.1016/0304-4203(88)90052-7; Feely RA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001866; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Genz J, 2008, J EXP BIOL, V211, P2327, DOI 10.1242/jeb.016832; Grosell M, 2005, AM J PHYSIOL-REG I, V288, pR936, DOI 10.1152/ajpregu.00684.2003; Grosell M, 2006, J EXP BIOL, V209, P2813, DOI 10.1242/jeb.02345; HARRIS RP, 1994, MAR BIOL, V119, P431, DOI 10.1007/BF00347540; Iglesias-Rodriguez MD., 2002, EOS T AM GEOPHYS UN, V83, P365, DOI [10.1029/2002EO000267, DOI 10.1029/2002EO000267]; Jansen H, 2001, MAR ECOL PROG SER, V221, P199, DOI 10.3354/meps221199; Jennings S, 2008, P ROY SOC B-BIOL SCI, V275, P1375, DOI 10.1098/rspb.2008.0192; Lee K, 2001, LIMNOL OCEANOGR, V46, P1287, DOI 10.4319/lo.2001.46.6.1287; Millero F. J., 2006, CHEM OCEANOGR; Milliman JD, 1999, DEEP-SEA RES PT I, V46, P1653, DOI 10.1016/S0967-0637(99)00034-5; Milliman JD, 1996, GEOL RUNDSCH, V85, P496, DOI 10.1007/BF02369004; Morse J.W., 1990, GEOCHEMISTRY SEDIMEN; Morse JW, 2003, GEOCHIM COSMOCHIM AC, V67, P2819, DOI 10.1016/S0016-7037(03)00103-0; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; POND DW, 1995, MAR BIOL, V123, P75, DOI 10.1007/BF00350325; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Sabine CL, 2004, SCOPE SER, V62, P17; Sabine CL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001869; Schiebel R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001459; Seibel BA, 2001, SCIENCE, V294, P319, DOI 10.1126/science.1065301; TAKAHASHI T, 1975, Cushman Foundation for Foraminiferal Research Special Publication, V13, P11; VANDERWAL P, 1995, MAR ECOL PROG SER, V126, P247, DOI 10.3354/meps126247; WALSH PJ, 1991, LIMNOL OCEANOGR, V36, P1227, DOI 10.4319/lo.1991.36.6.1227; Wilson RW, 2003, BBA-BIOMEMBRANES, V1618, P163, DOI 10.1016/j.bbamem.2003.09.014; Wilson RW, 2002, BBA-BIOMEMBRANES, V1566, P182, DOI 10.1016/S0005-2736(02)00600-4; Wilson RW, 1996, J EXP BIOL, V199, P2331	37	174	181	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					359	362		10.1126/science.1157972	http://dx.doi.org/10.1126/science.1157972			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150840				2022-12-01	WOS:000262481400032
J	Chandler, RK; Fletcher, BW; Volkow, ND				Chandler, Redonna K.; Fletcher, Bennett W.; Volkow, Nora D.			Treating Drug Abuse and Addiction in the Criminal Justice System Improving Public Health and Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CLINICAL-TRIAL; HIV-INFECTED PRISONERS; METHADONE-MAINTENANCE; COCAINE ADDICTION; HEPATITIS-C; CORRECTIONAL POPULATIONS; COOCCURRING DISORDERS; ORBITOFRONTAL CORTEX; NEURAL SYSTEMS; SELF-CONTROL	Despite increasing evidence that addiction is a treatable disease of the brain, most individuals do not receive treatment. Involvement in the criminal justice system often results from illegal drug- seeking behavior and participation in illegal activities that reflect, in part, disrupted behavior ensuing from brain changes triggered by repeated drug use. Treating drug- involved offenders provides a unique opportunity to decrease substance abuse and reduce associated criminal behavior. Emerging neuroscience has the potential to transform traditional sanction- oriented public safety approaches by providing new therapeutic strategies against addiction that could be used in the criminal justice system. We summarize relevant neuroscientific findings and evidence- based principles of addiction treatment that, if implemented in the criminal justice system, could help improve public heath and reduce criminal behavior.	[Chandler, Redonna K.; Fletcher, Bennett W.; Volkow, Nora D.] Natl Inst Drug Abuse, Serv Res Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Volkow, ND (corresponding author), Natl Inst Drug Abuse, Serv Res Branch, 6001 Execut Blvd,Room 5274, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 DA999999] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ABRAM KM, 1991, AM PSYCHOL, V46, P1036, DOI 10.1037/0003-066X.46.10.1036; Allen SA, 2003, ANN INTERN MED, V138, P187, DOI 10.7326/0003-4819-138-3-200302040-00010; [Anonymous], 1999, PRISON J, DOI DOI 10.1177/0032885599079004003; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bickel WK, 2007, DRUG ALCOHOL DEPEN, V90, pS85, DOI 10.1016/j.drugalcdep.2006.09.016; Binswanger IA, 2007, NEW ENGL J MED, V356, P536; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Boutwell AE, 2005, CLIN INFECT DIS, V40, pS367, DOI 10.1086/427455; Butzin CA, 2006, J CRIM JUST, V34, P557, DOI 10.1016/j.jcrimjus.2006.09.010; Chandler RK, 2004, BEHAV SCI LAW, V22, P431, DOI 10.1002/bsl.598; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; Comer SD, 2002, PSYCHOPHARMACOLOGY, V159, P351, DOI 10.1007/s002130100909; Cropsey KL, 2005, SUBST USE MISUSE, V40, P1983, DOI 10.1080/10826080500294866; Dackis C, 2005, NAT NEUROSCI, V8, P1431, DOI 10.1038/nn1105-1431; Daley M., 2004, J OFFENDER REHABILIT, V39, P69, DOI DOI 10.1300/J076V39N03_04; DELEON G, 1997, COMMUNITY METHOD THE, P3; Desai AA, 2002, AIDS EDUC PREV, V14, P45, DOI 10.1521/aeap.14.7.45.23867; Ersche KD, 2007, NEUROPSYCHOL REV, V17, P317, DOI 10.1007/s11065-007-9033-y; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fellows LK, 2007, ANN NY ACAD SCI, V1121, P421, DOI 10.1196/annals.1401.023; FIELD G, 2004, TREATING ADDICTED OF; FLETCHER BW, 2006, NIH PUBLICATION; Flynn PM, 1999, DRUG ALCOHOL DEPEN, V57, P167, DOI 10.1016/S0376-8716(99)00083-6; Freudenberg N, 2001, J URBAN HEALTH, V78, P214, DOI 10.1093/jurban/78.2.214; GLAZE LE, 2006, DEP JUSTICE PUBLICAT; Gordon MS, 2008, ADDICTION, V103, P1333, DOI 10.1111/j.1360-0443.2008.002238.x; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P737, DOI 10.1001/jama.297.7.737; Gray MA, 2007, NEURON, V54, P183, DOI 10.1016/j.neuron.2007.03.024; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Hammett TM, 2001, CRIME DELINQUENCY, V47, P390, DOI 10.1177/0011128701047003006; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Humphreys K, 2004, J SUBST ABUSE TREAT, V26, P151, DOI 10.1016/S0740-5472(03)00212-5; Inciardi JA, 1997, J DRUG ISSUES, V27, P261, DOI 10.1177/002204269702700206; Jensen EL., 2004, CRIMINAL JUSTICE POL, V15, P100, DOI [10.1177/0887403403255315, DOI 10.1177/0887403403255315]; Johnson BA, 2007, JAMA-J AM MED ASSOC, V298, P1641, DOI 10.1001/jama.298.14.1641; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Karberg J. C., 2005, DEP JUSTICE PUBLICAT, VNCJ209588; Kinlock TW, 2008, CRIM JUSTICE BEHAV, V35, P34, DOI 10.1177/0093854807309111; Kinlock TW, 2007, DRUG ALCOHOL DEPEN, V91, P220, DOI 10.1016/j.drugalcdep.2007.05.022; Knight K, 2004, TREATING ADDICTED OF; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kosten TR, 1998, AM J PSYCHIAT, V155, P711; Kosten TR, 1998, J NERV MENT DIS, V186, P737, DOI 10.1097/00005053-199812000-00001; LANGAN PA, 2002, DEP JUSTICE PUBLICAT; LEUKEFELD CG, 2002, TREATMENT DRUG OFFEN; Logan TK, 2004, EVAL PROGRAM PLANN, V27, P381, DOI 10.1016/j.evalprogplan.2004.04.012; Lurigio AJ, 2000, CRIM JUSTICE BEHAV, V27, P495, DOI 10.1177/0093854800027004005; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; Martin S., 1999, PRISON J, V79, P294, DOI [10.1177/0032885599079003002, DOI 10.1177/0032885599079003002]; McCollister KE, 2004, JUSTICE Q, V21, P659, DOI 10.1080/07418820400095941; MITCHELL O, 2007, J EXPT CRIMINOLOGY, V0003; Mumola CJ, 2006, DEP JUSTICE PUBLICAT; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Peters RH, 2000, CRIM JUSTICE BEHAV, V27, P72, DOI 10.1177/0093854800027001005; Prendergast ML, 2002, DRUG ALCOHOL DEPEN, V67, P53, DOI 10.1016/S0376-8716(02)00014-5; Rich JD, 2005, J ADDICT DIS, V24, P49, DOI 10.1300/J069v24n03_04; Rich JD, 2005, J URBAN HEALTH, V82, P411, DOI 10.1093/jurban/jti072; Rich JD, 2001, J URBAN HEALTH, V78, P279, DOI 10.1093/jurban/78.2.279; Sabin KM, 2001, J URBAN HEALTH, V78, P241, DOI 10.1093/jurban/78.2.241; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Shivy VA, 2007, J COUNS PSYCHOL, V54, P466, DOI 10.1037/0022-0167.54.4.466; Simpler AH, 2005, ADDICT RES THEORY, V13, P503, DOI 10.1080/16066350500151739; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; STEPHAN JJ, 2004, DEP JUSTICE PUBLICAT; Taxman FS, 2007, J SUBST ABUSE TREAT, V32, P239, DOI 10.1016/j.jsat.2006.12.019; Uhl GR, 2004, NEUROPHARMACOLOGY, V47, P140, DOI 10.1016/j.neuropharm.2004.07.029; Uhl GR, 2004, ARCH GEN PSYCHIAT, V61, P223, DOI 10.1001/archpsyc.61.3.223; Vallabhaneni S, 2006, EPIDEMIOL INFECT, V134, P243, DOI 10.1017/S0950268805004991; Volkow N, 2005, NAT NEUROSCI, V8, P1429, DOI 10.1038/nn1105-1429; Volkow ND, 2005, PHARMACOL THERAPEUT, V108, P3, DOI 10.1016/j.pharmthera.2005.06.021; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Weinbaum CA, 2005, AIDS, V19, pS41, DOI 10.1097/01.aids.0000192069.95819.aa; Wexler HK, 2007, PRISON J, V87, P9, DOI 10.1177/0032885506299036; Wilson DB, 2005, CRIM JUSTICE BEHAV, V32, P172, DOI 10.1177/0093854804272889; Winstanley CA, 2007, ANN NY ACAD SCI, V1121, P639, DOI 10.1196/annals.1401.024; Wormith JS, 2007, CRIM JUSTICE BEHAV, V34, P879, DOI 10.1177/0093854807301552; Yucel M, 2007, AUST NZ J PSYCHIAT, V41, P957, DOI 10.1080/00048670701689444; Zaller N, 2007, PUBLIC HEALTH REP, V122, P49, DOI 10.1177/003335490712200107; Zarkin GA, 2005, HEALTH ECON, V14, P1133, DOI 10.1002/hec.999	82	355	357	2	52	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					183	190		10.1001/jama.2008.976	http://dx.doi.org/10.1001/jama.2008.976			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	393VV	19141766	Green Accepted			2022-12-01	WOS:000262405500020
J	Chi, AS; Bernstein, BE				Chi, Andrew S.; Bernstein, Bradley E.			DEVELOPMENTAL BIOLOGY Pluripotent Chromatin State	SCIENCE			English	Editorial Material							EMBRYONIC STEM-CELLS; POLYCOMB; TRANSCRIPTION; REGULATORS		[Chi, Andrew S.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Chi, Andrew S.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Canc Res Ctr, Charlestown, MA 02129 USA; [Chi, Andrew S.; Bernstein, Bradley E.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02139 USA; [Chi, Andrew S.] Massachusetts Gen Hosp, Stephen E & Catherine Pappas Ctr Neurooncol, Dept Neurol, Boston, MA 02114 USA; [Bernstein, Bradley E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Chi, AS (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	bernstein.bradley@mgh.harvard.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG004570-01, U54 HG004570] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	17	43	43	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					220	221		10.1126/science.1166261	http://dx.doi.org/10.1126/science.1166261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131621	Green Accepted			2022-12-01	WOS:000262290600027
J	Han, J; Pedersen, JS; Kwon, SC; Belair, CD; Kim, YK; Yeom, KH; Yang, WY; Haussler, D; Blelloch, R; Kim, VN				Han, Jinju; Pedersen, Jakob S.; Kwon, S. Chul; Belair, Cassandra D.; Kim, Young-Kook; Yeom, Kyu-Hyeon; Yang, Woo-Young; Haussler, David; Blelloch, Robert; Kim, V. Narry			Posttranscriptional Crossregulation between Drosha and DGCR8	CELL			English	Article							MICROPROCESSOR COMPLEX; MICRORNA BIOGENESIS; ALZHEIMERS-DISEASE; RNA INTERFERENCE; EXPRESSION; PROLIFERATION; DROSOPHILA; MIR-222; PATHWAY; CELLS	The Drosha-DGCR8 complex, also known as Microprocessor, is essential for microRNA (miRNA) maturation. Drosha functions as the catalytic subunit, while DGCR8 (also known as Pasha) recognizes the RNA substrate. Although the action mechanism of this complex has been intensively studied, it remains unclear how Drosha and DGCR8 are regulated and if these proteins have any additional role(s) apart from miRNA processing. Here, we report that Drosha and DGCR8 regulate each other posttranscriptionally. The Drosha-DGCR8 complex cleaves the hairpin structures embedded in the DGCR8 mRNA and thereby destabilizes the mRNA. We further find that DGCR8 stabilizes the Drosha protein via protein-protein interaction. This crossregulation between Drosha and DGCR8 may contribute to the homeostatic control of miRNA biogenesis. Furthermore, microarray analyses suggest that a number of mRNAs may be downregulated in a Microprocessor-dependent, miRNA-independent manner. Our study reveals a previously unsuspected function of Microprocessor in mRNA stability control.	[Han, Jinju; Kwon, S. Chul; Kim, Young-Kook; Yeom, Kyu-Hyeon; Yang, Woo-Young; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Pedersen, Jakob S.] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Belair, Cassandra D.; Blelloch, Robert] Univ Calif San Francisco, Inst Regenerat Med, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Belair, Cassandra D.; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA	Seoul National University (SNU); University of Copenhagen; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Kim, VN (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Pedersen, Jakob/C-4985-2009; Kim, Young-Kook/AAE-8306-2020; Kwon, S. Chul/ABG-9415-2020; Pedersen, Jakob/G-3382-2012; Kwon, S. Chul/K-2515-2017; Han, Jinju/D-9091-2017	Kim, Young-Kook/0000-0001-6434-2235; Pedersen, Jakob/0000-0002-7236-4001; Kwon, S. Chul/0000-0002-9519-5132; Kim, Young Kook/0000-0002-6037-8449; HAN, Jinju/0000-0003-1844-2301	Creative Research Initiatives Program [R16-2007-073-01000-0]; BK21 Research Fellowships; Ministry of Education, Science, and Technology of Korea; Danish Medical Research Council [271-06-0711]; University of California, San Francisco, Urology Developmental Award; Prostate Cancer Foundation; National Institutes of Health [K08 NS48118, RO1 NS057221]; Stem Cell Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057221, K08NS048118] Funding Source: NIH RePORTER	Creative Research Initiatives Program; BK21 Research Fellowships(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of California, San Francisco, Urology Developmental Award(University of California System); Prostate Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stem Cell Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Dr. Seogang Hyun for help with S2 transfection, to Dr. Chirlmin Joo for critical reading of this manuscript, and to members of our laboratory for helpful discussion. We also thank Dr. Young-Joon Kim for kindly providing S2 cell. This work was supported by the Creative Research Initiatives Program (R16-2007-073-01000-0) (V.N.K.) and the BK21 Research Fellowships (J.H. and S.C.K.) from the Ministry of Education, Science, and Technology of Korea. J.S.P. was supported by the Danish Medical Research Council (271-06-0711). C.B. was supported through a University of California, San Francisco, Urology Developmental Award and the Prostate Cancer Foundation. R.B. is a Pew Scholar and was supported by National Institutes of Health grants (K08 NS48118, RO1 NS057221), the Prostate Cancer Foundation, and Stem Cell Research Foundation. J.H., S.C.K., Y.K.K., K.H.Y., and W.Y.Y. performed the experiments and analyzed the data. C.B. and R.B. carried out experiments with Dgcr8 KO mES cells, generated Dgcr8 KO MEF, and helped with manuscript preparation. J.S.P. performed bioinformatics analyses with D.H. and helped with editing of paper. J.H. and V.N.K. designed the study and wrote the paper.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2008, BRAIN PATHOL, V18, P113, DOI 10.1111/j.1750-3639.2007.00121.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zeng Y, 2002, RNA, V8, P855, DOI 10.1017/S1355838202020071	41	308	324	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					75	84		10.1016/j.cell.2008.10.053	http://dx.doi.org/10.1016/j.cell.2008.10.053			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135890	Green Accepted, Bronze			2022-12-01	WOS:000262318400016
J	Pandey, S; Nelson, DC; Assmann, SM				Pandey, Sona; Nelson, David C.; Assmann, Sarah M.			Two Novel GPCR-Type G Proteins Are Abscisic Acid Receptors in Arabidopsis	CELL			English	Article							EARLY SEEDLING DEVELOPMENT; COUPLED RECEPTORS; BINDING PROTEIN; GUARD-CELLS; ABA CONTROL; SUBUNIT; GERMINATION; EXPRESSION; GCR2; RICE	In plants, G proteins modulate signaling by the stress hormone, abscisic acid (ABA). We identify and characterize two novel Arabidopsis proteins that show homology to an orphan vertebrate GPCR (GPR89) and interact with the sole Arabidopsis G protein a subunit, GPA1, but also have intrinsic GTP-binding and GTPase activity. We have named these proteins GPCR-type G proteins (GTG1 and GTG2). Arabidopsis mutants lacking both GTG1 and GTG2 exhibit ABA hyposensitivity. GTG1 and GTG2 bind ABA specifically. The GDP-bound form of the GTGs exhibits greater ABA binding than the GTP-bound form, the GTPase activity of the GTGs is inhibited by GPA1, and gpa1 null mutants exhibit ABA-hypersensitive phenotypes. These results predict that, unusually, it is the GDP-bound, not the GTP-ound, form of the GTGs that actively relays the signal. We propose that GTG proteins function both as a new type of G protein and as a class of membrane-localized ABA receptors.	[Pandey, Sona; Assmann, Sarah M.] Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; [Pandey, Sona] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Nelson, David C.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA; [Nelson, David C.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Donald Danforth Plant Science Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Assmann, SM (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	sma3@psu.edu	Pandey, Sona/M-2847-2013	Pandey, Sona/0000-0002-5570-3120; Nelson, David/0000-0001-9792-5015	UW College of Agricultural and Life Sciences, the Morgridge family; NSF [0209694]	UW College of Agricultural and Life Sciences, the Morgridge family; NSF(National Science Foundation (NSF))	Single gtg1-1 and gtg2-1 mutants were isolated and the gtg1 gtg2 mutant created by D.C.N. in the laboratory of Professor Michael R. Sussman at the University of Wisconsin-Madison, under the support of funds from the UW College of Agricultural and Life Sciences, the Morgridge family, and an NIH Graduate Fellowship Training Grant administered through the Department of Genetics. Other research was performed at Penn State and supported by NSF grant 0209694 and the Penn State Waller Professorship to S. M. A. Technical assistance from Ms. Liza A. Wilson, Ms. Anne Gibson, and Ms. Heather Burch, the pGW series of binary vectors from Dr. Tsuyoshi Nakagawa, modified pEarleyGate 102 vector from Dr. Gabriele Monshausen, advice on phylogenetic analysis from Professor Claude dePamphilis, and access to the FLx800 from Professor Doug Cavener are gratefully acknowledged. D.C.N. isolated the single gtg1-1 and gtg2-1mutants and created the gtg1 gtg2 double mutant. S.P. and D.C.N. performed initial phenotypic analyses. S. P. and S. M. A. designed, performed, and interpreted all other experiments. S. P. and S. M. A. wrote the paper, with input from all authors.	ASSMANN SM, 1994, PLANT CELL, V6, P1187, DOI 10.1105/tpc.6.9.1187; ASSMANN SM, 2004, SCI STKE, V264, pRE20; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chow B, 2006, GENE DEV, V20, P1998, DOI 10.1101/gad.1432806; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ding L, 2008, PLANT J, V53, P248, DOI 10.1111/j.1365-313X.2007.03335.x; FAIRLEYGRENOT K, 1991, PLANT CELL, V3, P1037; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Gookin TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r120; Guo JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002982; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Illingworth CJR, 2008, BIOPHYS CHEM, V133, P28, DOI 10.1016/j.bpc.2007.11.004; Jang YH, 2008, PLANT CELL PHYSIOL, V49, P1898, DOI 10.1093/pcp/pcn151; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Mancia F, 2007, MOL BIOSYST, V3, P723, DOI 10.1039/B713558K; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Mhaouty-Kodja S, 2004, BIOL CELL, V96, P363, DOI 10.1016/j.biolcel.2004.03.003; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Razem FA, 2004, J BIOL CHEM, V279, P9922, DOI 10.1074/jbc.M311064200; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seo HS, 1997, BIOCHEM J, V324, P273, DOI 10.1042/bj3240273; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Sussman MR, 2000, PLANT PHYSIOL, V124, P1465, DOI 10.1104/pp.124.4.1465; Sutton F, 2000, PLANT PHYSIOL, V124, P223, DOI 10.1104/pp.124.1.223; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Tsugeki R, 1999, P NATL ACAD SCI USA, V96, P12941, DOI 10.1073/pnas.96.22.12941; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; Willard FS, 2005, ANAL BIOCHEM, V340, P341, DOI 10.1016/j.ab.2005.02.015; Zhang DP, 2002, PLANT PHYSIOL, V128, P714, DOI 10.1104/pp.010531	46	323	368	4	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					136	148		10.1016/j.cell.2008.12.026	http://dx.doi.org/10.1016/j.cell.2008.12.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135895	Bronze			2022-12-01	WOS:000262318400021
J	Muscat, M; Bang, H; Wohlfahrt, J; Glismann, S; Molbak, K				Muscat, Mark; Bang, Henrik; Wohlfahrt, Jan; Glismann, Steffen; Molbak, Kare		EUVAC NET Grp	Measles in Europe: an epidemiological assessment	LANCET			English	Article							DEATH CERTIFICATION; ELIMINATION	Background Measles persists in Europe despite the incorporation of the measles vaccine into routine childhood vaccination programmes more than 20 years ago. Our aim was therefore to review the epidemiology of measles in relation to the goal of elimination by 2010. Methods National surveillance institutions from 32 European countries submitted data for 2006-07. Data for age-group, diagnosis confirmation, vaccination, hospital treatment, the presence of acute encephalitis as a complication of disease, and death were obtained. 30 countries also supplied data about importation of disease. Clinical, laboratory-confirmed, and epidemiologically linked cases that met the requirements for national surveillance were analysed. Cases were separated by age: younger than 1 year, 1-4 years, 5-9 years, 10-14 years, 15-19 years, and older than 20 years. Countries with indigenous measles incidence per 100000 inhabitants per year of 0, less than 0.1, 0 . 1-1, and more than 1 were grouped into categories of zero, low, moderate, and high incidence, respectively. Findings For the 2 years of the study, 12132 cases of measles were recorded with most cases (n=10329; 85%) from five countries: Romania, Germany, UK, Switzerland, and Italy. Most cases were unvaccinated or incompletely vaccinated children; however, almost a fifth were aged 20 years or older. For the same 2 years, seven measles-related deaths were recorded. High measles incidence in some European countries revealed suboptimum vaccination coverage. Of the 210 cases that were reported as being imported, 117 (56%) came from another country within Europe and 43 (20%) from Asia. Interpretation The suboptimum vaccination coverage raises serious doubts that the goal of elimination by 2010 can be attained. Achievement and maintenance of optimum vaccination coverage and improved surveillance are the cornerstones of the measles elimination plan for Europe. Funding European Commission and the Statens Serum Institut, Denmark.	[Muscat, Mark; Bang, Henrik; Glismann, Steffen; Molbak, Kare] Statens Serum Inst, Dept Epidemiol, EUVAC NET Hub, DK-2300 Copenhagen S, Denmark; [Wohlfahrt, Jan] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut; Statens Serum Institut	Muscat, M (corresponding author), Statens Serum Inst, Dept Epidemiol, EUVAC NET Hub, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	mmc@ssi.dk		Molbak, Kare/0000-0002-3100-4990	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank the following collaborators within various public health and surveillance institutions: Vanya Mehandzhieva (Bulgaria); Jitka Castkova and Marcela SmelhausovA (Czech Republic); Ulpu Elonsalo (Finland); Theano Georgakopoulou and Elem Kalamara (Greece); Massimo De Crescenzo, Corrado Cenci, and Lucia Virtuani, (Italy); leleria Curikova (Latvia); Andrew Amato Gauci (Malta), and Miroslaw P Czarkowski (Poland); Judite Catarino (Portugal); Mateja Blasko Markic (Slovenia); Eva Miderovd and Alexandra Zampachova (Slovakia); Solveig Olsson (Sweden); and Kevin Brown, Claire Cameron, and Mary Ramsay (UK). We also thank Paolo Guglielmetti (SANCO C3, European Commission) for contributing valuable suggestions and Hannah Lewis (Statens Serum Insfitut) for proof-reading the first submitted version and adding useful comments. EUVAC.NET is jointly funded by the European Commission under the public health programme 2003-08 (DG SANCO) under grant agreement number 2004205 and the Statens Serum Institut, Denmark. The network is co-ordinated by the EUVAC.NET hub within the Department of Epidemiology, Statens Serum Instimt, and is composed ofpublic health and surveillance institutions from the 27 EU member states together with Croatia, Iceland, Norway, Switzerland, and Turkey.	Andrews N, 2008, B WORLD HEALTH ORGAN, V86, P197, DOI 10.2471/BLT.07.041129; Armour A, 1997, ULSTER MED J, V66, P13; Atti MLC, 2004, VACCINE, V22, P4351, DOI 10.1016/j.vaccine.2004.04.026; Bernard H, 2008, Euro Surveill, V13; COLNUET S, 2007, EURO SURVEILL, V12; *COMM DIS CTR I PU, ANN REP COV 1999 200; Filia A, 2006, EUROSURVEILLANCE, V11; Filia Antonietta, 2008, Euro Surveill, V13; Garg RK, 2002, POSTGRAD MED J, V78, P63, DOI 10.1136/pmj.78.916.63; GEORGAKOPOULOU T, 2006, EUROSURVEILLANCE, V11; *HLTH PROT AG, CONF MEASL MUMPS RUB; *HLTH PROT AG UK, CONF MEASL CAS ENGL; *HLTH PROT AG UK, ANN COV VACC EV RAP; *HLTH PROT AG UK, INCR MEASL CAS 2006; *HLTH PROT SURV CT, ANN REP 2006; *HUNG CENTR STAT O, YB HLTH STAT 2000 20; Hutchins SS, 2004, J INFECT DIS, V189, pS153, DOI 10.1086/379652; IOVOLL O, 2007, EURO SURVEILL, V12; Kalies H, 2006, EUR J PEDIATR, V165, P30, DOI 10.1007/s00431-005-1758-0; Kremer JR, 2008, EMERG INFECT DIS, V14, P107, DOI 10.3201/eid1401.070778; LERNOUT T, 2007, EUROSURVEILLANCE, V12; *MIN HLTH, 2007, DGPREVV10606P14CA9 P; *MIN HLTH IT, VACC COV; Mulders MN, 2001, VACCINE, V19, P2245, DOI 10.1016/S0264-410X(00)00453-9; Muscat M, 2007, VACCINE, V25, P6232, DOI 10.1016/j.vaccine.2007.05.063; *NAT PUBL HLTH I F, VACC COV; Pritt BS, 2005, ARCH PATHOL LAB MED, V129, P1476; *PUBL HLTH AUTH SL, EV ADM INSP VACC SLO; Richard J l, 2008, Euro Surveill, V13; RICHARD JL, 2007, EUROSURVEILLANCE, V12; Rota PA, 2003, J INFECT DIS, V187, pS270, DOI 10.1086/368042; Schmid D., 2008, Eurosurveillance, V13, P18838; TORNER N, 2007, EUROSURVEILLANCE, V12; *WHO, 2005, EL MEASL RUB PREV CO; World Health Organization, 2003, SURV GUID MEASL CONG	35	158	164	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					383	389		10.1016/S0140-6736(08)61849-8	http://dx.doi.org/10.1016/S0140-6736(08)61849-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401BC	19131097				2022-12-01	WOS:000262912100029
J	Branzei, D; Vanoli, F; Foiani, M				Branzei, Dana; Vanoli, Fabio; Foiani, Marco			SUMOylation regulates Rad18-mediated template switch	NATURE			English	Article							DEFECTIVE POSTREPLICATION REPAIR; UV-DAMAGED DNA; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; GENOMIC INSTABILITY; GROUP GENES; UBIQUITIN; REPLICATION; HELICASE; RAD18	Replication by template switch is thought to mediate DNA damage- bypass and fillings of gaps. Gap- filling repair requires homologous recombination as well as Rad18- and Rad5- mediated proliferating cell nuclear antigen ( PCNA) polyubiquitylation. However, it is unclear whether these processes are coordinated, and the physical evidence for Rad18 - Rad5- dependent template switch at replication forks is still elusive. Here we show, using genetic and physical approaches, that in budding yeast ( Saccharomyces cerevisiae) Rad18 is required for the formation of X- shaped sister chromatid junctions ( SCJs) at damaged replication forks through a process involving PCNA polyubiquitylation and the ubiquitin- conjugating enzymes Mms2 and Ubc13. The Rad18 - Mms2- mediated damage- bypass through SCJs requires the small ubiquitin- like modifier ( SUMO)- conjugating enzyme Ubc9 and SUMOylated PCNA, and is coordinated with Rad51- dependent recombination events. We propose that the Rad18 - Rad5 - Mms2- dependent SCJs represent template switch events. Altogether, our results unmask a role for PCNA ubiquitylation and SUMOylation pathways in promoting transient damage- induced replication- coupled recombination events involving sister chromatids at replication forks.	[Branzei, Dana; Vanoli, Fabio; Foiani, Marco] IFOM IEO, FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; [Foiani, Marco] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Branzei, D (corresponding author), IFOM IEO, FIRC Inst Mol Oncol Fdn, Via Adamello 16, I-20139 Milan, Italy.	dana.branzei@ifom-ieo-campus.it	Branzei, Dana/A-2806-2015; Foiani, Marco/M-8234-2014; Branzei, Dana/GOG-9093-2022	Branzei, Dana/0000-0002-0544-4888; Foiani, Marco/0000-0003-4795-834X; Branzei, Dana/0000-0002-0544-4888	Associazione Italiana per la Ricerca sul Cancro; Association for International Cancer Research; European Community GENICA; European Community DNA Repair; Telethon; MIUR; Ministry of Health; Buzzati-Traverso foundation	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Association for International Cancer Research; European Community GENICA(European Commission); European Community DNA Repair; Telethon(Fondazione Telethon); MIUR(Ministry of Education, Universities and Research (MIUR)); Ministry of Health; Buzzati-Traverso foundation	We thank S. Jentsch and H. Ulrich for yeast strains, T. Enomoto for critical reading, and all members of our laboratories for helpful discussions. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro to D. B., Association for International Cancer Research and European Community GENICA grant to M. F. and D. B., and partly by European Community DNA Repair grant, Telethon, MIUR, and Ministry of Health to M. F. D. B. was partly supported by the Buzzati-Traverso foundation.	ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Branzei D, 2004, GENES CELLS, V9, P1031, DOI 10.1111/j.1365-2443.2004.00787.x; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2007, CELL, V131, P1228, DOI 10.1016/j.cell.2007.12.007; Branzei D, 2007, DNA REPAIR, V6, P994, DOI 10.1016/j.dnarep.2007.02.018; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Daee DL, 2007, MOL CELL BIOL, V27, P102, DOI 10.1128/MCB.01167-06; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gangavarapu V, 2007, MOL CELL BIOL, V27, P7758, DOI 10.1128/MCB.01331-07; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Goldfless SJ, 2006, MOL CELL, V21, P595, DOI 10.1016/j.molcel.2006.01.025; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Lehmann AR, 2006, DNA REPAIR, V5, P1495, DOI 10.1016/j.dnarep.2006.07.002; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Motegi A, 2006, MOL CELL BIOL, V26, P1424, DOI 10.1128/MCB.26.4.1424-1433.2006; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Onoda F, 2001, MOL GEN GENET, V264, P702, DOI 10.1007/s004380000358; Otsuki M, 2007, J CELL BIOL, V179, P53, DOI 10.1083/jcb.200702183; PALLADINO F, 1992, GENETICS, V132, P23; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; SCHIESTL RH, 1990, GENETICS, V124, P817; Shekhar MPV, 2002, CANCER RES, V62, P2115; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Szuts D, 2006, MOL CELL BIOL, V26, P8032, DOI 10.1128/MCB.01291-06; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	50	207	210	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					915	920		10.1038/nature07587	http://dx.doi.org/10.1038/nature07587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092928				2022-12-01	WOS:000261768300037
J	Hamant, O; Heisler, MG; Jonsson, H; Krupinski, P; Uyttewaal, M; Bokov, P; Corson, F; Sahlin, P; Boudaoud, A; Meyerowitz, EM; Couder, Y; Traas, J				Hamant, Olivier; Heisler, Marcus G.; Jonsson, Henrik; Krupinski, Pawel; Uyttewaal, Magalie; Bokov, Plamen; Corson, Francis; Sahlin, Patrik; Boudaoud, Arezki; Meyerowitz, Elliot M.; Couder, Yves; Traas, Jan			Developmental Patterning by Mechanical Signals in Arabidopsis	SCIENCE			English	Article							SHOOT APICAL MERISTEM; CORTICAL MICROTUBULES; EPIDERMAL-CELLS; AUXIN TRANSPORT; GROWTH; MORPHOGENESIS; APEX; WALL; PHYLLOTAXIS; MODEL	A central question in developmental biology is whether and how mechanical forces serve as cues for cellular behavior and thereby regulate morphogenesis. We found that morphogenesis at the Arabidopsis shoot apex depends on the microtubule cytoskeleton, which in turn is regulated by mechanical stress. A combination of experiments and modeling shows that a feedback loop encompassing tissue morphology, stress patterns, and microtubule- mediated cellular properties is sufficient to account for the coordinated patterns of microtubule arrays observed in epidermal cells, as well as for patterns of apical morphogenesis.	[Heisler, Marcus G.; Meyerowitz, Elliot M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jonsson, Henrik; Krupinski, Pawel; Sahlin, Patrik] Lund Univ, Computat Biol & Biol Phys Grp, Dept Theoret Phys, S-22100 Lund, Sweden; [Bokov, Plamen; Corson, Francis; Boudaoud, Arezki] Ecole Normale Super, Phys Stat Lab, F-75231 Paris 05, France; [Bokov, Plamen; Couder, Yves] Univ Paris Diderot, F-75025 Paris 13, France; [Hamant, Olivier; Uyttewaal, Magalie; Traas, Jan] INRA, Lab Reprod & Dev Plantes, F-69364 Lyon 07, France; [Hamant, Olivier; Uyttewaal, Magalie; Traas, Jan] Univ Lyon 1, CNRS, ENS, F-69364 Lyon 07, France	California Institute of Technology; Lund University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Meyerowitz, EM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	meyerow@caltech.edu; couder@lps.ens.fr; jan.traas@ens-lyon.fr	Boudaoud, Arezki/Q-7436-2016; Meyerowitz, Elliot M/A-7118-2009; Traas, Jan/AAZ-7004-2020; heisler, marcus G/B-9738-2015	Boudaoud, Arezki/0000-0002-2780-4717; Traas, Jan/0000-0001-5107-1472; heisler, marcus G/0000-0001-5644-8398; Hamant, Olivier/0000-0001-6906-6620	International Human Frontier Science Program Organization; U. S. Department of Energy [FG02-88ER13873]; Balzan Foundation; Swedish Research Council	International Human Frontier Science Program Organization(Human Frontier Science Program); U. S. Department of Energy(United States Department of Energy (DOE)); Balzan Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank A. Roeder for critical reading of the manuscript, and P. Barbier de Reuille and IFR128 Platim for help with imaging. Supported by the International Human Frontier Science Program Organization, by U. S. Department of Energy grant FG02-88ER13873 (E.M.M.), by the Balzan Foundation (E.M.M.), and by the Swedish Research Council (H.J.).	BEENAKKER CWJ, 1986, PHYS REV LETT, V57, P2454, DOI 10.1103/PhysRevLett.57.2454; Castle ES, 1937, J CELL COMPAR PHYSL, V10, P113, DOI 10.1002/jcp.1030100110; Chan J, 2007, NAT CELL BIOL, V9, P171, DOI 10.1038/ncb1533; CLEARY AL, 1993, PLANT CELL PHYSIOL, V34, P1003; Cosgrove DJ, 2000, PLANT PHYSIOL BIOCH, V38, P109, DOI 10.1016/S0981-9428(00)00164-9; CYR RJ, 1994, ANNU REV CELL BIOL, V10, P153, DOI 10.1146/annurev.cb.10.110194.001101; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Dumais J, 2006, INT J DEV BIOL, V50, P209, DOI 10.1387/ijdb.052066jd; Dumais J, 2000, J PLANT GROWTH REGUL, V19, P7, DOI 10.1007/s003440000003; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Flugge W., 1973, STRESSES SHELLS, V2, DOI [10.1007/978-3-642-88291-3, DOI 10.1007/978-3-642-88291-3]; GLAZIER JA, 1987, PHYS REV A, V36, P306, DOI 10.1103/PhysRevA.36.306; GOODBODY KC, 1990, PROTOPLASMA, V157, P92, DOI 10.1007/BF01322641; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; GREEN PB, 1966, AUST J BIOL SCI, V19, P421, DOI 10.1071/BI9660421; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hejnowicz Z, 2005, PROTOPLASMA, V225, P243, DOI 10.1007/s00709-005-0091-9; Hejnowicz Z, 2000, PATTERN FORMATION BI, P240; HERNANDEZ LF, 1993, PLANT CELL, V5, P1725, DOI 10.1105/tpc.5.12.1725; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; HUSH JM, 1991, CELL BIOL INT REP, V15, P551, DOI 10.1016/0309-1651(91)90002-Z; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lintilhac P. M., 1984, Positional controls in plant development, P83; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Peters WS, 1996, ANN BOT-LONDON, V77, P657, DOI 10.1006/anbo.1996.0082; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; SAKAGUCHI S, 1988, BOT MAG TOKYO, V101, P497, DOI 10.1007/BF02488091; Savaldi-Goldstein S, 2008, CURR OPIN PLANT BIOL, V11, P42, DOI 10.1016/j.pbi.2007.10.009; Schopfer P, 2006, AM J BOT, V93, P1415, DOI 10.3732/ajb.93.10.1415; SELKER JML, 1992, DEV BIOL, V153, P29, DOI 10.1016/0012-1606(92)90089-Y; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Traas J, 2001, INT REV CYTOL, V208, P161; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Wei CF, 2001, PLANT PHYSIOL, V126, P1129, DOI 10.1104/pp.126.3.1129; WILLIAMSON RE, 1990, AUST J PLANT PHYSIOL, V17, P601, DOI 10.1071/PP9900601; WILLIAMSON RE, 1991, INT REV CYTOL, V129, P135; Wymer CL, 1996, PLANT PHYSIOL, V110, P425, DOI 10.1104/pp.110.2.425	40	607	621	3	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1650	1655		10.1126/science.1165594	http://dx.doi.org/10.1126/science.1165594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074340				2022-12-01	WOS:000261608300034
J	Pollin, TI; Damcott, CM; Shen, HQ; Ott, SH; Shelton, J; Horenstein, RB; Post, W; McLenithan, JC; Bielak, LF; Peyser, PA; Mitchell, BD; Miller, M; O'Connell, JR; Shuldiner, AR				Pollin, Toni I.; Damcott, Coleen M.; Shen, Haiqing; Ott, Sandra H.; Shelton, John; Horenstein, Richard B.; Post, Wendy; McLenithan, John C.; Bielak, Lawrence F.; Peyser, Patricia A.; Mitchell, Braxton D.; Miller, Michael; O'Connell, Jeffrey R.; Shuldiner, Alan R.			A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection	SCIENCE			English	Article							APOLIPOPROTEIN-C-III; CORONARY-HEART-DISEASE; TRIGLYCERIDE-RICH LIPOPROTEINS; A-I; NONFASTING TRIGLYCERIDES; RISK; ARTERY; GENE; CIII; ATHEROSCLEROSIS	Apolipoprotein C-III ( apoC-III) inhibits triglyceride hydrolysis and has been implicated in coronary artery disease. Through a genome- wide association study, we have found that about 5% of the Lancaster Amish are heterozygous carriers of a null mutation ( R19X) in the gene encoding apoC- III ( APOC3) and, as a result, express half the amount of apoC- III present in noncarriers. Mutation carriers compared with noncarriers had lower fasting and postprandial serum triglycerides, higher levels of HDL- cholesterol and lower levels of LDL- cholesterol. Subclinical atherosclerosis, as measured by coronary artery calcification, was less common in carriers than noncarriers, which suggests that lifelong deficiency of apoC- III has a cardioprotective effect.	[Pollin, Toni I.; Damcott, Coleen M.; Shen, Haiqing; Ott, Sandra H.; Shelton, John; Horenstein, Richard B.; McLenithan, John C.; Mitchell, Braxton D.; Miller, Michael; O'Connell, Jeffrey R.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Post, Wendy] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; [McLenithan, John C.; Shuldiner, Alan R.] Baltimore Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Bielak, Lawrence F.; Peyser, Patricia A.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Geriatric Research Education & Clinical Center; University of Michigan System; University of Michigan	Pollin, TI (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	tpollin@medicine.umaryland.edu	Mitchell, Braxton/CAF-0876-2022; Humphries, Stephen E/C-5075-2008; Talmud, Philippa J/C-4402-2008; Miller, Michael/AGX-6773-2022	Miller, Michael/0000-0002-1679-2095; Mitchell, Braxton/0000-0003-4920-4744; Shuldiner, Alan/0000-0001-9921-4305	NIH [R01 HL088119, R01 AR046838, U01 HL72515, R01 AG18728, U01 HL084756]; General Clinical Research Centers Program; National Center for Research Resources; University of Maryland General Clinical Research Center [M01 RR 16500]; University of Maryland Clinical Nutrition Research Unit [P30 DK072488]; Johns Hopkins University General Clinical Research Center [M01 RR 000052]; Baltimore Veterans Administration Geriatric Research and Education Clinical Center; Paul Beeson Faculty Scholars in Aging Program; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, M01RR016500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088119, U01HL072515, U01HL084756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018728] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Maryland General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Maryland Clinical Nutrition Research Unit; Johns Hopkins University General Clinical Research Center(Johns Hopkins UniversityUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Baltimore Veterans Administration Geriatric Research and Education Clinical Center; Paul Beeson Faculty Scholars in Aging Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge our Amish liaisons, field workers, and clinic staff and the extraordinary cooperation and support of the Amish community, without which these studies would not have been possible. We thank R. Agarwala and A. Schaffer for assistance in pedigree construction and K. Ryan for data management. This work was supported by NIH grants R01 HL088119, R01 AR046838, U01 HL72515, R01 AG18728, and U01 HL084756; General Clinical Research Centers Program, National Center for Research Resources (NCRR), NIH; the University of Maryland General Clinical Research Center, grant M01 RR 16500; University of Maryland Clinical Nutrition Research Unit grant P30 DK072488; the Johns Hopkins University General Clinical Research Center, grant M01 RR 000052; the Baltimore Veterans Administration Geriatric Research and Education Clinical Center (GRECC); and the Paul Beeson Faculty Scholars in Aging Program.	Auwerx J, 1996, ATHEROSCLEROSIS, V124, pS29, DOI 10.1016/0021-9150(96)05854-6; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Chan DC, 2008, J CLIN ENDOCR METAB, V93, P557, DOI 10.1210/jc.2006-2676; CLAVEY V, 1995, ARTERIOSCL THROM VAS, V15, P963, DOI 10.1161/01.ATV.15.7.963; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; HOSPATTANKAR AV, 1986, FEBS LETT, V197, P67, DOI 10.1016/0014-5793(86)80300-3; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; KANE JP, 2001, ONLINE METABOLIC MOL, pCH114; KARATHANASIS SK, 1983, NATURE, V301, P718, DOI 10.1038/301718a0; KARATHANASIS SK, 1987, P NATL ACAD SCI USA, V84, P7198, DOI 10.1073/pnas.84.20.7198; Kawakami A, 2006, CIRCULATION, V113, P691, DOI 10.1161/CIRCULATIONAHA.105.591743; Libby P, 2007, CIRC RES, V100, P299, DOI 10.1161/01.RES.0000259393.89870.58; Liu HQ, 2000, J LIPID RES, V41, P1760; MAEDA N, 1994, J BIOL CHEM, V269, P23610; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; ORDOVAS JM, 1989, J BIOL CHEM, V264, P16339; Post W, 2007, CIRCULATION, V115, P717, DOI 10.1161/CIRCULATIONAHA.106.637512; Sacks FM, 2000, CIRCULATION, V102, P1886, DOI 10.1161/01.CIR.102.16.1886; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; VONECKARDSTEIN A, 1991, J CLIN INVEST, V87, P1724, DOI 10.1172/JCI115190; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	32	504	563	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1702	1705		10.1126/science.1161524	http://dx.doi.org/10.1126/science.1161524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19074352	Green Accepted			2022-12-01	WOS:000261608300048
J	Cecil, JE; Tavendale, R; Watt, P; Hetherington, MM; Palmer, CNA				Cecil, Joanne E.; Tavendale, Roger; Watt, Peter; Hetherington, Marion M.; Palmer, Colin N. A.			An Obesity-Associated FTO Gene Variant and Increased Energy Intake in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; INSULIN-RESISTANCE; METABOLIC SYNDROME; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; ADULT OBESITY; RISK-FACTORS; HUMANS; EXPENDITURE	Background: Variation in the fat mass and obesity-associated (FTO) gene has provided the most robust associations with common obesity to date. However, the role of FTO variants in modulating specific components of energy balance is unknown. Methods: We studied 2726 Scottish children, 4 to 10 years of age, who underwent genotyping for FTO variant rs9939609 and were measured for height and weight. A subsample of 97 children was examined for possible association of the FTO variant with adiposity, energy expenditure, and food intake. Results: In the total study group and the subsample, the A allele of rs9939609 was associated with increased weight (P=0.003 and P=0.049, respectively) and body-mass index (P=0.003 and P=0.03, respectively). In the intensively phenotyped subsample, the A allele was also associated with increased fat mass (P=0.01) but not with lean mass. Although total and resting energy expenditures were increased in children with the A allele (P=0.009 and P=0.03, respectively), resting energy expenditure was identical to that predicted for the age and weight of the child, indicating that there is no defect in metabolic adaptation to obesity in persons bearing the risk-associated allele. The A allele was associated with increased energy intake (P=0.006) independently of body weight. In contrast, the weight of food ingested by children who had the allele was similar to that in children who did not have the allele (P=0.82). Conclusions: The FTO variant that confers a predisposition to obesity does not appear to be involved in the regulation of energy expenditure but may have a role in the control of food intake and food choice, suggesting a link to a hyperphagic phenotype or a preference for energy-dense foods.	[Tavendale, Roger; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Cecil, Joanne E.] Univ St Andrews, Bute Med Sch, St Andrews, Fife, Scotland; [Watt, Peter] Univ Brighton, Chelsea Sch, Brighton, E Sussex, England; [Hetherington, Marion M.] Glasgow Caledonian Univ, Dept Psychol, Glasgow G4 0BA, Lanark, Scotland	University of Dundee; University of St Andrews; University of Brighton; Glasgow Caledonian University	Palmer, CNA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland.	nuclear-receptor@dundee.ac.uk	Cecil, Joanne E/A-3071-2010; Hetherington, Marion/A-4397-2013; Palmer, Colin NA/C-7053-2008	Palmer, Colin NA/0000-0002-6415-6560; Hetherington, Marion/0000-0001-8677-5234; Cecil, Joanne/0000-0003-4779-6037	U.K. Biotechnology and Biological Sciences Research Council [D13460]	U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a grant from the U.K. Biotechnology and Biological Sciences Research Council (D13460). No potential conflict of interest relevant to this article was reported. We thank the children, parents, and schoolteachers for their enthusiastic participation in this study; Dr. Wendy Wrieden, Dr. Deborah Wallis, and Inez Murrie for their support; and Dr. Lydia Martinez, Dr. Andy Coward, and Antony Wright for their technical assistance and helpful discussions.	Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Ball EJ, 2001, AM J CLIN NUTR, V74, P524; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Burgert Tania S, 2006, Pediatr Endocrinol Rev, V3 Suppl 4, P555; Cecil JE, 2005, INT J OBESITY, V29, P1199, DOI 10.1038/sj.ijo.0803055; Cecil JE, 2005, AM J CLIN NUTR, V82, P302, DOI 10.1093/ajcn/82.2.302; Cecil JE, 2007, AM J CLIN NUTR, V86, P167, DOI 10.1093/ajcn/86.1.167; Cecil JE, 2006, PHYSIOL BEHAV, V88, P227, DOI 10.1016/j.physbeh.2006.05.028; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Ferreira AP, 2007, J PEDIAT-BRAZIL, V83, P21, DOI [10.2223/JPED.1562, 10.1590/S0021-75572007000100005]; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Freedman DS, 2002, J PEDIATR ENDOCR MET, V15, P1099; Garcia AL, 2005, OBES RES, V13, P626, DOI 10.1038/oby.2005.67; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Lohman T.G., 1989, PEDIATR EXERC SCI, V1, P19, DOI [DOI 10.1123/PES.1.1.19, 10.1123/pes.1.1.19]; LOHMAN TG, 1986, EXERCISE SPORT SCI R, V14, P325; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Reilly JJ, 2004, LANCET, V363, P211, DOI 10.1016/S0140-6736(03)15331-7; SCHOELLER DA, 1983, AM J CLIN NUTR, V38, P999, DOI 10.1093/ajcn/38.6.999; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; TSCHRITTER O, 2008, DIABETOLOGIA, V51, P1558; VanKreel BK, 1996, J MASS SPECTROM, V31, P108; Wiegand S, 2005, INT J OBESITY, V29, pS136, DOI 10.1038/sj.ijo.0803081; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	31	487	519	1	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2008	359	24					2558	2566		10.1056/NEJMoa0803839	http://dx.doi.org/10.1056/NEJMoa0803839			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	381KG	19073975	Bronze			2022-12-01	WOS:000261534200007
J	Munch, E; Launey, ME; Alsem, DH; Saiz, E; Tomsia, AP; Ritchie, RO				Munch, E.; Launey, M. E.; Alsem, D. H.; Saiz, E.; Tomsia, A. P.; Ritchie, R. O.			Tough, Bio-Inspired Hybrid Materials	SCIENCE			English	Article							FRACTURE-RESISTANCE MECHANISM; HUMAN CORTICAL BONE; CRACK-PROPAGATION; LAYERED CERAMICS; POROUS CERAMICS; SILICON-CARBIDE; PORE STRUCTURE; NACRE; COMPOSITES; ALUMINA	The notion of mimicking natural structures in the synthesis of new structural materials has generated enormous interest but has yielded few practical advances. Natural composites achieve strength and toughness through complex hierarchical designs that are extremely difficult to replicate synthetically. We emulate nature's toughening mechanisms by combining two ordinary compounds, aluminum oxide and polymethyl methacrylate, into ice- templated structures whose toughness can be more than 300 times ( in energy terms) that of their constituents. The final product is a bulk hybrid ceramic- based material whose high yield strength and fracture toughness [similar to 200 megapascals (MPa) and similar to 30 MPa.m(1/2)] represent specific properties comparable to those of aluminum alloys. These model materials can be used to identify the key microstructural features that should guide the synthesis of bio- inspired ceramic- based composites with unique strength and toughness.	[Munch, E.; Launey, M. E.; Alsem, D. H.; Saiz, E.; Tomsia, A. P.; Ritchie, R. O.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Alsem, D. H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; [Ritchie, R. O.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ritchie, RO (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	roritchie@lbl.gov	Ritchie, Robert O/A-8066-2008	Ritchie, Robert O/0000-0002-0501-6998	Office of Science; Office of Basic Energy Sciences; Division of Materials Sciences and Engineering; U.S. Department of Energy [DE-AC02-05CH11231]	Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the Director, Office of Science, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, of the U. S. Department of Energy under Contract No. DE-AC02-05CH11231	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Araki K, 2004, J AM CERAM SOC, V87, P1859; Barthelat F, 2007, EXP MECH, V47, P311, DOI 10.1007/s11340-007-9040-1; Becher PF, 1998, J AM CERAM SOC, V81, P2821, DOI 10.1111/j.1151-2916.1998.tb02702.x; Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726; Cao JJ, 1996, J AM CERAM SOC, V79, P461, DOI 10.1111/j.1151-2916.1996.tb08145.x; Chan HM, 1997, ANNU REV MATER SCI, V27, P249, DOI 10.1146/annurev.matsci.27.1.249; COOK J, 1964, PROC R SOC LON SER-A, V282, P508, DOI 10.1098/rspa.1964.0248; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003; Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339; Fukasawa T, 2001, J AM CERAM SOC, V84, P230, DOI 10.1111/j.1151-2916.2001.tb00638.x; Fukasawa T, 2001, J MATER SCI, V36, P2523, DOI 10.1023/A:1017946518955; JOHNSON DR, 1995, INTERMETALLICS, V3, P99, DOI 10.1016/0966-9795(95)92674-O; Jones RM., 1999, MECH COMPOS MATER, V2nd, DOI DOI 10.1201/9781498711067; Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221; Kruzic JJ, 2005, J AM CERAM SOC, V88, P2236, DOI 10.1111/j.1551-2916.2005.00434.x; Kruzic JJ, 2004, J AM CERAM SOC, V87, P93, DOI 10.1111/j.1551-2916.2004.00093.x; LANGE FF, 1973, J AM CERAM SOC, V56, P518, DOI 10.1111/j.1151-2916.1973.tb12401.x; Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k; Lin AYM, 2008, ACTA BIOMATER, V4, P131, DOI 10.1016/j.actbio.2007.05.005; MAI YW, 1987, J AM CERAM SOC, V70, P289, DOI 10.1111/j.1151-2916.1987.tb04983.x; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; MOYA JS, 1995, ADV MATER, V7, P185, DOI 10.1002/adma.19950070219; Nalla RK, 2005, BIOMATERIALS, V26, P217, DOI 10.1016/j.biomaterials.2004.02.017; Nalla RK, 2003, BIOMATERIALS, V24, P3955, DOI 10.1016/S0142-9612(03)00278-3; Ortiz C, 2008, SCIENCE, V319, P1053, DOI 10.1126/science.1154295; PADTURE NP, 1994, J AM CERAM SOC, V77, P2518, DOI 10.1111/j.1151-2916.1994.tb04637.x; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; RITCHIE RO, 1988, MAT SCI ENG A-STRUCT, V103, P15, DOI 10.1016/0025-5416(88)90547-2; Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354; SHANG JK, 1989, METALL TRANS A, V20, P897, DOI 10.1007/BF02651656; SIGL LS, 1988, ACTA METALL MATER, V36, P945, DOI 10.1016/0001-6160(88)90149-6; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Song F, 2003, BIOMATERIALS, V24, P3623, DOI 10.1016/S0142-9612(03)00215-1; SWANSON PL, 1987, J AM CERAM SOC, V70, P279, DOI 10.1111/j.1151-2916.1987.tb04982.x; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Tasdemirci A, 2004, J COMPOS MATER, V38, P995, DOI 10.1177/0021998304040564; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340; Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935	41	1287	1310	77	1547	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1516	1520		10.1126/science.1164865	http://dx.doi.org/10.1126/science.1164865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056979	Green Submitted			2022-12-01	WOS:000261377400042
J	Chandran, S				Chandran, Siddharthan			What are the prospects of stem cell therapy for neurology?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; TRANSPLANTATION; NEURONS		[Chandran, Siddharthan] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England; [Chandran, Siddharthan] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge CB2 0SZ, England	University of Cambridge; University of Cambridge	Chandran, S (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England.	sc222@cam.ac.uk			MRC [G0502107] Funding Source: UKRI; Medical Research Council [G0502107] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Chandran S, 2008, PHILOS T R SOC B, V363, P171, DOI 10.1098/rstb.2006.2019; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Compston A, 2006, ACTA NEUROL SCAND, V113, P41, DOI 10.1111/j.1600-0404.2006.00614.x; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; Lindvall O, 2008, EXP NEUROL, V209, P82, DOI 10.1016/j.expneurol.2007.08.019; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Rosser AE, 2007, CURR OPIN NEUROL, V20, P688, DOI 10.1097/WCO.0b013e3282f132fc; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Suzuki M, 2008, TRENDS NEUROSCI, V31, P192, DOI 10.1016/j.tins.2008.01.006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Wasiak J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005489.pub2; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	21	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2008	337								a1934	10.1136/bmj.a1934	http://dx.doi.org/10.1136/bmj.a1934			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QD	19042937				2022-12-01	WOS:000261827800006
J	Bataille, V; de Vries, E				Bataille, Veronique; de Vries, Esther			Melanoma - Part 1: epidemiology, risk factors, and prevention	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CUTANEOUS MELANOMA; MELANOCORTIN-1 RECEPTOR; MALIGNANT-MELANOMA; EXPOSURE; TRENDS; SITE; METAANALYSIS; AUSTRALIA; MORTALITY; SURVIVAL		[Bataille, Veronique] W Hertfordshire Hosp NHS Trust, Hemel Hempstead HP2 4AD, England; [Bataille, Veronique] Kings Coll London, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England; [de Vries, Esther] Erasmus MC Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [de Vries, Esther] Erasmus MC Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands	University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Bataille, V (corresponding author), W Hertfordshire Hosp NHS Trust, Hemel Hempstead HP2 4AD, England.	bataille@doctors.org.uk	de Vries, Esther/A-6603-2009	de Vries, Esther/0000-0002-5560-2258				*AUSTR I HLTH WELF, 2007, AUSTR CANC INC MORT; Autier P, 2005, EXPERT REV ANTICANC, V5, P821, DOI 10.1586/14737140.5.5.821; Bataille V, 2004, EUR J CANCER, V40, P429, DOI 10.1016/j.ejca.2003.09.030; Bataille W, 2005, EUR J CANCER, V41, P2141, DOI 10.1016/j.ejca.2005.04.038; Bishop JAN, 2007, SEMIN ONCOL, V34, P452, DOI 10.1053/j.seminoncol.2007.09.006; BLISS JM, 1995, INT J CANCER, V62, P367, DOI 10.1002/ijc.2910620402; Bulliard JL, 1997, INT J CANCER, V72, P231, DOI 10.1002/(SICI)1097-0215(19970717)72:2<231::AID-IJC5>3.3.CO;2-K; *CANC RES UK, MEL SKIN CANC; Cho EY, 2005, CANCER EPIDEM BIOMAR, V14, P1241, DOI 10.1158/1055-9965.EPI-04-0632; Coory M, 2006, CANCER CAUSE CONTROL, V17, P21, DOI 10.1007/s10552-005-3637-4; Cress RD, 1997, CANCER CAUSE CONTROL, V8, P246, DOI 10.1023/A:1018432632528; De Vries E, 2008, ANN ONCOL, V19, P583, DOI 10.1093/annonc/mdm498; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; Giles GG, 1996, BMJ-BRIT MED J, V312, P1121; Harrison SL, 2000, J NATL CANCER I, V92, P1436, DOI 10.1093/jnci/92.17.1436; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; *MEL MOL MAP PROJ, TNM STAG; Mossner R, 2007, ARCH DERMATOL RES, V298, P371, DOI 10.1007/s00403-006-0708-7; *NCI, SURV EP END RES FAST; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; WESTERDAHL J, 1994, AM J EPIDEMIOL, V140, P691, DOI 10.1093/oxfordjournals.aje.a117317; WHITEMAN DC, 2008, J CANC PREV, V17, P243	24	67	69	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2008	337								a2249	10.1136/bmj.a2249	http://dx.doi.org/10.1136/bmj.a2249			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397HS	19022841	Green Submitted			2022-12-01	WOS:000262654100003
J	Kaplan, N; Moore, IK; Fondufe-Mittendorf, Y; Gossett, AJ; Tillo, D; Field, Y; LeProust, EM; Hughes, TR; Lieb, JD; Widom, J; Segal, E				Kaplan, Noam; Moore, Irene K.; Fondufe-Mittendorf, Yvonne; Gossett, Andrea J.; Tillo, Desiree; Field, Yair; LeProust, Emily M.; Hughes, Timothy R.; Lieb, Jason D.; Widom, Jonathan; Segal, Eran			The DNA-encoded nucleosome organization of a eukaryotic genome	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HIGH-RESOLUTION; MULTIPLE ALIGNMENT; PROMOTER ELEMENT; YEAST GENOME; SEQUENCE; HISTONE; TRANSCRIPTION; SITES; CORE	Nucleosome organization is critical for gene regulation(1). In living cells this organization is determined by multiple factors, including the action of chromatin remodellers(2), competition with site-specific DNA-binding proteins(3), and the DNA sequence preferences of the nucleosomes themselves(4-8). However, it has been difficult to estimate the relative importance of each of these mechanisms in vivo(7,9-11), because in vivo nucleosome maps reflect the combined action of all influencing factors. Here we determine the importance of nucleosome DNA sequence preferences experimentally by measuring the genome-wide occupancy of nucleosomes assembled on purified yeast genomic DNA. The resulting map, in which nucleosome occupancy is governed only by the intrinsic sequence preferences of nucleosomes, is similar to in vivo nucleosome maps generated in three different growth conditions. In vitro, nucleosome depletion is evident at many transcription factor binding sites and around gene start and end sites, indicating that nucleosome depletion at these sites in vivo is partly encoded in the genome. We confirm these results with a micrococcal nuclease-independent experiment that measures the relative affinity of nucleosomes for similar to 40,000 double-stranded 150-base-pair oligonucleotides. Using our in vitro data, we devise a computational model of nucleosome sequence preferences that is significantly correlated with in vivo nucleosome occupancy in Caenorhabditis elegans. Our results indicate that the intrinsic DNA sequence preferences of nucleosomes have a central role in determining the organization of nucleosomes in vivo.	[Moore, Irene K.; Fondufe-Mittendorf, Yvonne; Widom, Jonathan] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Kaplan, Noam; Field, Yair; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Gossett, Andrea J.; Lieb, Jason D.] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Gossett, Andrea J.; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tillo, Desiree; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [LeProust, Emily M.] Genom LSSU, Agilent Technol Inc, Santa Clara, CA 95051 USA; [Hughes, Timothy R.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Hughes, Timothy R.] Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	Northwestern University; Weizmann Institute of Science; Weizmann Institute of Science; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; Agilent Technologies; University of Toronto; University of Toronto	Widom, J (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	j-widom@northwestern.edu; eran.segal@weizmann.ac.il	Kaplan, Noam/A-3544-2011; Segal, Eran/AAF-4855-2019; Kaplan, Noam/K-4383-2019	Kaplan, Noam/0000-0001-9940-1987; Kaplan, Noam/0000-0001-9940-1987; Segal, Eran/0000-0002-6859-1164; Gossett, Andrea/0000-0002-9471-3970; Lieb, Jason/0000-0001-7601-8061	CIHR; NIH; European Research Council (ERC); NSERC; Lineberger Comprehensive Cancer Center; University Cancer Research Funds; NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054692, R01GM072518, R01GM058617] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC)(European Research Council (ERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Lineberger Comprehensive Cancer Center; University Cancer Research Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Kelkar for bioinformatics support in handling the sequencing files, P. Mieczkowski and J. McPherson for Illumina sequencing ( library preparation and instrument operation), and the members of our respective laboratories for technical assistance, discussions and comments on the manuscript. The UNC sequencing facility is funded by the Lineberger Comprehensive Cancer Center and University Cancer Research Funds. J. W. acknowledges the use of instruments at Northwestern University's Keck Biophysics Facility. This work was supported by a grant from CIHR to T. R. H. and C. Nislow, a grant from the NIH to J. D. L., a grant from the NIH to J. W., and grants from the European Research Council (ERC) and NIH to E. S. D. T. holds an NSERC postgraduate scholarship. N.K. is a Clore scholar. E. S. is the incumbent of the Soretta and Henry Shapiro career development chair.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Bolshoy A, 1996, COMPUT APPL BIOSCI, V12, P383; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; FENG HP, 1993, BIOCHEMISTRY-US, V32, P7824, DOI 10.1021/bi00081a030; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Graber JH, 1999, NUCLEIC ACIDS RES, V27, P888, DOI 10.1093/nar/27.3.888; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Ioshikhes I, 1996, J MOL BIOL, V262, P129, DOI 10.1006/jmbi.1996.0503; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Korber P, 2004, MOL CELL BIOL, V24, P10965, DOI 10.1128/MCB.24.24.10965-10974.2004; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Lascaris RF, 2000, NUCLEIC ACIDS RES, V28, P1390, DOI 10.1093/nar/28.6.1390; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	37	882	899	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					362	U129		10.1038/nature07667	http://dx.doi.org/10.1038/nature07667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19092803	Green Accepted, hybrid, Green Submitted			2022-12-01	WOS:000264285600046
J	Fejes-Toth, K; Sotirova, V; Sachidanandam, R; Assaf, G; Hannon, GJ; Kapranov, P; Foissac, S; Willingham, AT; Duttagupta, R; Dumais, E; Gingeras, TR				Fejes-Toth, Katalin; Sotirova, Vihra; Sachidanandam, Ravi; Assaf, Gordon; Hannon, Gregory J.; Kapranov, Philipp; Foissac, Sylvain; Willingham, Aarron T.; Duttagupta, Radha; Dumais, Erica; Gingeras, Thomas R.		Affymetrix Cold Spring Harbor Lab	Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs	NATURE			English	Article							GENE-EXPRESSION; HUMAN GENOME; CELLS; IDENTIFICATION; TRANSCRIPTION; REVEAL; MAPS	The transcriptomes of eukaryotic cells are incredibly complex. Individual non- coding RNAs dwarf the number of protein- coding genes, and include classes that are well understood as well as classes for which the nature, extent and functional roles are obscure(1). Deep sequencing of small RNAs (, 200 nucleotides) from human HeLa and HepG2 cells revealed a remarkable breadth of species. These arose both from within annotated genes and from unannotated intergenic regions. Overall, small RNAs tended to align with CAGE ( cap- analysis of gene expression) tags(2), which mark the 5 ' ends of capped, long RNA transcripts. Many small RNAs, including the previously described promoter- associated small RNAs3, appeared to possess cap structures. Members of an extensive class of both small RNAs and CAGE tags were distributed across internal exons of annotated protein coding and noncoding genes, sometimes crossing exon - exon junctions. Here we show that processing of mature mRNAs through an as yet unknown mechanism may generate complex populations of both long and short RNAs whose apparently capped 5 ' ends coincide. Supplying synthetic promoter- associated small RNAs corresponding to the c-MYC transcriptional start site reduced MYC messenger RNA abundance. The studies presented here expand the catalogue of cellular small RNAs and demonstrate a biological impact for at least one class of non- canonical small RNAs.	[Fejes-Toth, Katalin; Sotirova, Vihra; Sachidanandam, Ravi; Assaf, Gordon; Gingeras, Thomas R.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Fejes-Toth, Katalin; Sotirova, Vihra; Assaf, Gordon; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Kapranov, Philipp; Foissac, Sylvain; Willingham, Aarron T.; Duttagupta, Radha; Dumais, Erica; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA 95051 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Affymetrix	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu; gingeras@cshl.edu	Hannon, Gregory/AAB-3568-2019; sachidanandam, ravi/Q-6916-2019	sachidanandam, ravi/0000-0001-9844-4459; Gingeras, Thomas/0000-0001-9106-3573; Foissac, Sylvain/0000-0002-2631-5356	Schering Foundation; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004557] Funding Source: NIH RePORTER	Schering Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank L. Cardone, D. Rebolini, M. Kramer, and W. R. McCombie for Illumina sequencing. We wish to thank J. Brosius, J. Schmitz and T. Rozhdestvensky for their help with the small RNA cloning protocol and J. Dumais for technical assistance. K.F.-T. was in part supported by the Schering Foundation. This work was supported in part by grants from the NIH and was performed as part of the ENCODE consortium (G.J.H. and T.R.G.). G.J.H is an investigator of the Howard Hughes Medical Institute.	BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOCHNIG P, 1987, EUR J BIOCHEM, V168, P461, DOI 10.1111/j.1432-1033.1987.tb13439.x; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; EDDY S, 2006, UCSC GENOME BROWSER; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672	20	302	330	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1028	1032		10.1038/nature07759	http://dx.doi.org/10.1038/nature07759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19169241	Green Accepted, Green Published			2022-12-01	WOS:000263425400046
J	Carnaval, AC; Hickerson, MJ; Haddad, CFB; Rodrigues, MT; Moritz, C				Carnaval, Ana Carolina; Hickerson, Michael J.; Haddad, Celio F. B.; Rodrigues, Miguel T.; Moritz, Craig			Stability Predicts Genetic Diversity in the Brazilian Atlantic Forest Hotspot	SCIENCE			English	Article							RAIN-FOREST; CLIMATE DYNAMICS; LATE QUATERNARY; PHYLOGEOGRAPHY; CONSERVATION; BIODIVERSITY; SELECTION; AMAZONIA; ENDEMISM; REPTILES	Biodiversity hotspots, representing regions with high species endemism and conservation threat, have been mapped globally. Yet, biodiversity distribution data from within hotspots are too sparse for effective conservation in the face of rapid environmental change. Using frogs as indicators, ecological niche models under paleoclimates, and simultaneous Bayesian analyses of multispecies molecular data, we compare alternative hypotheses of assemblage- scale response to late Quaternary climate change. This reveals a hotspot within the Brazilian Atlantic forest hotspot. We show that the southern Atlantic forest was climatically unstable relative to the central region, which served as a large climatic refugium for neotropical species in the late Pleistocene. This sets new priorities for conservation in Brazil and establishes a validated approach to biodiversity prediction in other understudied, species- rich regions.	[Carnaval, Ana Carolina; Moritz, Craig] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Hickerson, Michael J.] CUNY Queens Coll, Dept Biol, Flushing, NY 11367 USA; [Haddad, Celio F. B.] UNESP, Dept Zool, Inst Biociencias, BR-35264100 Rio Claro, SP, Brazil; [Rodrigues, Miguel T.] Univ Fed Sao Paulo, Dept Zool, Inst Biociencias, BR-05508090 Sao Paulo, SP, Brazil	University of California System; University of California Berkeley; City University of New York (CUNY) System; Queens College NY (CUNY); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Carnaval, AC (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	carnaval@berkeley.edu	Rodrigues, Miguel T./F-8174-2012; Haddad, Célio F. B./C-4267-2012; Moritz, Craig/A-7755-2012	Rodrigues, Miguel T./0000-0003-3958-9919; Haddad, Célio F. B./0000-0002-7044-5764; Moritz, Craig/0000-0001-5313-7279; Carnaval, Ana/0000-0002-4399-1313	NSF [DBI 0512013, DEB 0743648, DEB 416250, DEB 0817035]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	NSF(National Science Foundation (NSF)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank U. Caramaschi and H. Zaher for providing access to collections MNRJ and MZUSP; O. Peixoto, M. Gomes, A. Muri, R. Kautskyi, S. Lima, E. Santos, J. S. Filho, J. V. Filho, G. Barros, J. Queiroz, R. Araljo, L. Japp, H. Japp, J. Giovanelli, J. Alexandrino, L. Toledo, O. Araljo, G. Egito, J. Zina, D. Loebmann, D. Pavan, R. Amaro, V. Verdade, F. Curcio, M. Dixo, and J. Cassimiro for field work assistance; W. Monahan and R. Hijmans for discussions about the modeling work; L. Smith and D. Turong for DNA- sequencing assistance; R. Pereira, R. Damasceno, S. Rovito, J. Kolbe, S. Singhal, R. Puschendorf, and A. Pounds for discussions about earlier versions of the manuscript. Funding was provided by the NSF (awards DBI 0512013 to A.C.C., DEB 0743648 to M.J.H., DEB 416250 and DEB 0817035 to C.M.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grants to C.F.B.H. and M.T.R.). Sequences are deposited in GenBank (FJ502639-FJ502822). A.C.C. and C. M. designed the study; A.C.C., C.F.B.H., and M.T.R. collected the data; A.C.C., C.M. and M.J.H. analyzed the data; A.C.C. wrote the paper. All authors discussed the results and commented on earlier versions of the manuscript.	Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; BALLARD JWO, 1994, GENETICS, V138, P757; Behling H, 2002, PALAEOGEOGR PALAEOCL, V179, P227, DOI 10.1016/S0031-0182(01)00435-7; Behling H, 2001, QUATERNARY RES, V56, P383, DOI 10.1006/qres.2001.2264; Cabanne GS, 2008, MOL PHYLOGENET EVOL, V49, P760, DOI 10.1016/j.ympev.2008.09.013; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Fay JC, 2000, GENETICS, V155, P1405; FROST DR, 2008, AMPHIBIAN SPECIES WO; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; HADDAD C. F. B., 2008, ANFIBIOS MATA ATLANT; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hickerson MJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-322; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Ledru MP, 2007, DIVERS DISTRIB, V13, P761, DOI 10.1111/j.1472-4642.2007.00389.x; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1646/0006-3606(2000)032[0786:ITBAF]2.0.CO;2; Nei M., 1987, MOL EVOLUTIONARY GEN; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Rodrigues MT, 2005, CONSERV BIOL, V19, P659, DOI 10.1111/j.1523-1739.2005.00690.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Tajima F, 1996, GENETICS, V143, P1457; TAMURA K, 1992, MOL BIOL EVOL, V9, P678	30	756	778	1	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					785	789		10.1126/science.1166955	http://dx.doi.org/10.1126/science.1166955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197066				2022-12-01	WOS:000263066800048
J	Parker, C				Parker, Charles			Eculizumab for paroxysmal nocturnal haemoglobinuria	LANCET			English	Article							COMPLEMENT INHIBITOR ECULIZUMAB; TERMINAL COMPLEMENT; NATURAL-HISTORY; COMPONENT; ANTIBODY; MENINGITIS; DEFICIENCY; DIAGNOSIS; DRUGS	The complement system plays a central part in both innate and acquired immunity, but the contribution of complement activation to pathobiology is largely ancillary. An exception to the non-dominant role of complement in disease is the haemolytic anaemia of paroxysmal nocturnal haemoglobinuria (PNH). The intravascular haemolysis that is the clinical hallmark of PNH is a consequence of deficiency of the complement inhibitory proteins decay accelerating factor (DAF, CD55) and membrane inhibitor of reactive lysis (MIRL, CD59). Eculizumab is a humanised monoclonal antibody that binds and prevents activation of complement C5 and the subsequent formation of the cytolytic membrane attack complex of complement. Eculizumab inhibits the intravascular haemolysis of PNH, reduces transfusion requirements, stabilises haemoglobin concentration, and improves quality of life. Although chronic treatment with eculizumab increases the risk of infections with Neisseria meningitides, the drug is generally safe and well tolerated. But as is the case with other drugs developed for treatment of ultra-orphan diseases, eculizumab is expensive, and treatment must continue indefinitely because C5 inhibition does not affect the process (ie, clonal proliferation of haemopoietic stem cells with a mutant phosphatidylinositol glycan complementation class A [PIGA] gene) that underlies PNH. Moreover, due to the heterogeneous nature of the disease, treatment with eculizumab is not appropriate for all patients with PNH.	Univ Utah, Sch Med, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Parker, C (corresponding author), Univ Utah, Sch Med, 30 N 1900 E, Salt Lake City, UT 84132 USA.	Charles.Parker@hsc.utah.edu						Bao L, 2007, SEMIN NEPHROL, V27, P69, DOI 10.1016/j.semnephrol.2006.09.009; Brodsky RA, 2008, ANN INTERN MED, V148, P587, DOI 10.7326/0003-4819-148-8-200804150-00003; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; DACIE J V, 1972, Series Haematologica, V5, P3; de Latour RP, 2008, BLOOD, V112, P3099, DOI 10.1182/blood-2008-01-133918; Ferreira VP, 2007, BLOOD, V110, P2190, DOI 10.1182/blood-2007-04-083170; HAENEY MR, 1980, CLIN EXP IMMUNOL, V40, P16; Hall C, 2003, BLOOD, V102, P3587, DOI 10.1182/blood-2003-01-0009; Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316; HARRIMAN GR, 1981, J IMMUNOL, V127, P2386; Hill A, 2005, BLOOD, V106, P2559, DOI 10.1182/blood-2005-02-0564; Hill Anita, 2008, Clin Adv Hematol Oncol, V6, P499; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Hillmen P, 2007, BLOOD, V110, P4123, DOI 10.1182/blood-2007-06-095646; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Hughes DA, 2005, QJM-INT J MED, V98, P829, DOI 10.1093/qjmed/hci128; Kinoshita T, 1995, ADV IMMUNOL, V60, P57, DOI 10.1016/S0065-2776(08)60584-2; Luzzatto L, 2006, INT J HEMATOL, V84, P104, DOI 10.1532/IJH97.06117; MATIS LA, 1995, NAT MED, V1, P839, DOI 10.1038/nm0895-839; McCabe C, 2005, BRIT MED J, V331, P1016, DOI 10.1136/bmj.331.7523.1016; Moyo VM, 2004, BRIT J HAEMATOL, V126, P133, DOI 10.1111/j.1365-2141.2004.04992.x; Nishimura JI, 2004, MEDICINE, V83, P193, DOI 10.1097/01.md.0000126763.68170.46; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Parker CJ, 2007, NAT REV DRUG DISCOV, V6, P515, DOI 10.1038/nrd2369; Parker CJ, 2007, EXP HEMATOL, V35, P523, DOI 10.1016/j.exphem.2007.01.046; Parker CJ, 2003, PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND RELATED DISORDERS, P11; PETER G, 1981, PEDIATRICS, V67, P882; Platonov AE, 2003, VACCINE, V21, P4437, DOI 10.1016/S0264-410X(03)00440-7; Richards SJ, 2000, CYTOMETRY, V42, P223, DOI 10.1002/1097-0320(20000815)42:4<223::AID-CYTO2>3.3.CO;2-4; Rother RP, 2004, LUPUS, V13, P328, DOI 10.1191/0961203303lu1021oa; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Ruggenenti P, 2007, EXPERT OPIN PHARMACO, V8, P3159, DOI 10.1517/14656566.8.18.3159; Socie G, 1996, LANCET, V348, P573, DOI 10.1016/S0140-6736(95)12360-1; Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; Wang Y, 1996, P NATL ACAD SCI USA, V93, P8563, DOI 10.1073/pnas.93.16.8563; YONEMURA Y, 1990, BRIT J HAEMATOL, V74, P108, DOI 10.1111/j.1365-2141.1990.tb02546.x	39	118	122	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					759	767		10.1016/S0140-6736(09)60001-5	http://dx.doi.org/10.1016/S0140-6736(09)60001-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19144399				2022-12-01	WOS:000263725400035
J	Ibrahim, HN; Foley, R; Tan, LP; Rogers, T; Bailey, RF; Guo, HF; Gross, CR; Matas, AJ				Ibrahim, Hassan N.; Foley, Robert; Tan, LiPing; Rogers, Tyson; Bailey, Robert F.; Guo, Hongfei; Gross, Cynthia R.; Matas, Arthur J.			Long-Term Consequences of Kidney Donation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-FUNCTION; FOLLOW-UP; UNILATERAL NEPHRECTOMY; BLOOD-PRESSURE; DONORS; TRANSPLANTATION; METAANALYSIS; HYPERTENSION; FILTRATION; RISK	Background: The long-term renal consequences of kidney donation by a living donor are attracting increased appropriate interest. The overall evidence suggests that living kidney donors have survival similar to that of nondonors and that their risk of end-stage renal disease (ESRD) is not increased. Previous studies have included relatively small numbers of donors and a brief follow-up period. Methods: We ascertained the vital status and lifetime risk of ESRD in 3698 kidney donors who donated kidneys during the period from 1963 through 2007; from 2003 through 2007, we also measured the glomerular filtration rate (GFR) and urinary albumin excretion and assessed the prevalence of hypertension, general health status, and quality of life in 255 donors. Results: The survival of kidney donors was similar to that of controls who were matched for age, sex, and race or ethnic group. ESRD developed in 11 donors, a rate of 180 cases per million persons per year, as compared with a rate of 268 per million per year in the general population. At a mean (+/-SD) of 12.2+/-9.2 years after donation, 85.5% of the subgroup of 255 donors had a GFR of 60 ml per minute per 1.73 m(sup 2) of body-surface area or higher, 32.1% had hypertension, and 12.7% had albuminuria. Older age and higher body-mass index, but not a longer time since donation, were associated with both a GFR that was lower than 60 ml per minute per 1.73 m(sup 2) and hypertension. A longer time since donation, however, was independently associated with albuminuria. Most donors had quality-of-life scores that were better than population norms, and the prevalence of coexisting conditions was similar to that among controls from the National Health and Nutrition Examination Survey (NHANES) who were matched for age, sex, race or ethnic group, and body-mass index. Conclusions: Survival and the risk of ESRD in carefully screened kidney donors appear to be similar to those in the general population. Most donors who were studied had a preserved GFR, normal albumin excretion, and an excellent quality of life. N Engl J Med 2009;360:459-69.	[Ibrahim, Hassan N.; Tan, LiPing; Rogers, Tyson] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Bailey, Robert F.; Matas, Arthur J.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Guo, Hongfei] Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA; [Guo, Hongfei] Univ Minnesota, Off Clin Res, Minneapolis, MN 55455 USA; [Gross, Cynthia R.] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA; [Gross, Cynthia R.] Univ Minnesota, Sch Nursing, Minneapolis, MN 55455 USA; [Foley, Robert] Chron Dis Res Grp, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ibrahim, HN (corresponding author), Univ Minnesota, Div Renal Dis & Hypertens, Suite 353,717 Delaware St SE, Minneapolis, MN 55414 USA.	ibrah007@umn.edu	matas, arthur/ABE-1018-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK013083] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00400, M01 RR000400] Funding Source: Medline; NIDDK NIH HHS [P01 DK013083, P01DK13083] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2007, US REN DAT SYST USRD; BAUDOIN P, 1993, AM J KIDNEY DIS, V21, P603, DOI 10.1016/S0272-6386(12)80032-1; BAY WH, 1987, ANN INTERN MED, V106, P719, DOI 10.7326/0003-4819-106-5-719; BOHANNON LL, 1988, J UROLOGY, V140, P810, DOI 10.1016/S0022-5347(17)41822-2; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; BOURGOIGNIE JJ, 1989, KIDNEY INT, V36, pS86; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; DUNN JF, 1986, ANN SURG, V203, P637, DOI 10.1097/00000658-198606000-00008; Ellison MD, 2002, TRANSPLANTATION, V74, P1349, DOI 10.1097/00007890-200211150-00025; Fehrman-Ekholm I, 2006, TRANSPLANTATION, V82, P1646, DOI 10.1097/01.tp.0000250728.73268.e3; FehrmanEkholm I, 1997, TRANSPLANTATION, V64, P976, DOI 10.1097/00007890-199710150-00007; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; GASPARI F, 1995, J AM SOC NEPHROL, V6, P257; Gibney EM, 2007, TRANSPLANTATION, V84, P647, DOI 10.1097/01.tp.0000277288.78771.c2; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Ibrahim HN, 2006, AM J TRANSPLANT, V6, P1479, DOI 10.1111/j.1600-6143.2006.01335.x; KAPLAN C, 1975, AM J PATHOL, V80, P227; KROHN AG, 1966, J AMER MED ASSOC, V196, P322, DOI 10.1001/jama.196.4.322; NAJARIAN JS, 1992, LANCET, V340, P807, DOI 10.1016/0140-6736(92)92683-7; NARKUNBURGESS DM, 1993, KIDNEY INT, V43, P1110, DOI 10.1038/ki.1993.156; Ramcharan T, 2002, AM J TRANSPLANT, V2, P959, DOI 10.1034/j.1600-6143.2002.21013.x; ROBERTSON JL, 1986, KIDNEY INT, V29, P511, DOI 10.1038/ki.1986.29; SOBH M, 1989, International Urology and Nephrology, V21, P547, DOI 10.1007/BF02549594; THORNER PS, 1984, PEDIATRICS, V73, P806; TORRES VE, 1987, KIDNEY INT, V31, P1383, DOI 10.1038/ki.1987.153; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Ware J.E., 2002, SF 12V2TM SCORE VERS, V1st; Ware JE., 1994, SF 36 PHYS MENTAL HL; WATNICK TJ, 1988, TRANSPLANTATION, V45, P59	29	749	770	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					459	469		10.1056/NEJMoa0804883	http://dx.doi.org/10.1056/NEJMoa0804883			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179315	Green Accepted			2022-12-01	WOS:000262812400005
J	Pollard, RT; Salter, I; Sanders, RJ; Lucas, MI; Moore, CM; Mills, RA; Statham, PJ; Allen, JT; Baker, AR; Bakker, DCE; Charette, MA; Fielding, S; Fones, GR; French, M; Hickman, AE; Holland, RJ; Hughes, JA; Jickells, TD; Lampitt, RS; Morris, PJ; Nedelec, FH; Nielsdottir, M; Planquette, H; Popova, EE; Poulton, AJ; Read, JF; Seeyave, S; Smith, T; Stinchcombe, M; Taylor, S; Thomalla, S; Venables, HJ; Williamson, R; Zubkov, MV				Pollard, Raymond T.; Salter, Ian; Sanders, Richard J.; Lucas, Mike I.; Moore, C. Mark; Mills, Rachel A.; Statham, Peter J.; Allen, John T.; Baker, Alex R.; Bakker, Dorothee C. E.; Charette, Matthew A.; Fielding, Sophie; Fones, Gary R.; French, Megan; Hickman, Anna E.; Holland, Ross J.; Hughes, J. Alan; Jickells, Timothy D.; Lampitt, Richard S.; Morris, Paul J.; Nedelec, Florence H.; Nielsdottir, Maria; Planquette, Helene; Popova, Ekaterina E.; Poulton, Alex J.; Read, Jane F.; Seeyave, Sophie; Smith, Tania; Stinchcombe, Mark; Taylor, Sarah; Thomalla, Sandy; Venables, Hugh J.; Williamson, Robert; Zubkov, Mike V.			Southern Ocean deep-water carbon export enhanced by natural iron fertilization	NATURE			English	Article							PHYTOPLANKTON BLOOM; CROZET PLATEAU; RADIUM ISOTOPES; CO2; SEQUESTRATION; RESPONSES; NORTH; SCALE; SI	The addition of iron to high- nutrient, low- chlorophyll regions induces phytoplankton blooms that take up carbon(1-3). Carbon export from the surface layer and, in particular, the ability of the ocean and sediments to sequester carbon for many years remains, however, poorly quantified(3). Here we report data from the CROZEX experiment(4) in the Southern Ocean, which was conducted to test the hypothesis that the observed north - south gradient in phytoplankton concentrations in the vicinity of the Crozet Islands is induced by natural iron fertilization that results in enhanced organic carbon flux to the deep ocean. We report annual particulate carbon fluxes out of the surface layer, at three kilometres below the ocean surface and to the ocean floor. We find that carbon fluxes from a highly productive, naturally iron-fertilized region of the sub- Antarctic Southern Ocean are two to three times larger than the carbon fluxes from an adjacent high-nutrient, low- chlorophyll area not fertilized by iron. Our findings support the hypothesis that increased iron supply to the glacial sub- Antarctic may have directly enhanced carbon export to the deep ocean(5). The CROZEX sequestration efficiency(6) ( the amount of carbon sequestered below the depth of winter mixing for a given iron supply) of 8,600 mol mol(-1) was 18 times greater than that of a phytoplankton bloom induced artificially by adding iron(7), but 77 times smaller than that of another bloom(8) initiated, like CROZEX, by a natural supply of iron. Large losses of purposefully added iron can explain the lower efficiency of the induced bloom(6). The discrepancy between the blooms naturally supplied with iron may result in part from an underestimate of horizontal iron supply.	[Pollard, Raymond T.; Salter, Ian; Sanders, Richard J.; Moore, C. Mark; Mills, Rachel A.; Statham, Peter J.; Allen, John T.; Holland, Ross J.; Hughes, J. Alan; Lampitt, Richard S.; Morris, Paul J.; Nielsdottir, Maria; Popova, Ekaterina E.; Poulton, Alex J.; Read, Jane F.; Seeyave, Sophie; Smith, Tania; Stinchcombe, Mark; Taylor, Sarah; Zubkov, Mike V.] Natl Environm Res Council, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Pollard, Raymond T.; Salter, Ian; Sanders, Richard J.; Moore, C. Mark; Mills, Rachel A.; Statham, Peter J.; Allen, John T.; Holland, Ross J.; Hughes, J. Alan; Lampitt, Richard S.; Morris, Paul J.; Nielsdottir, Maria; Popova, Ekaterina E.; Poulton, Alex J.; Read, Jane F.; Seeyave, Sophie; Smith, Tania; Stinchcombe, Mark; Taylor, Sarah; Zubkov, Mike V.] Univ Southampton, Southampton SO14 3ZH, Hants, England; [Salter, Ian] Observ Oceanol, BP44, F-66651 Banyuls Sur Mer, France; [Lucas, Mike I.] Univ Cape Town, Dept Zool, ZA-7701 Rondebosch, South Africa; [Baker, Alex R.; Bakker, Dorothee C. E.; French, Megan; Jickells, Timothy D.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Charette, Matthew A.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem MS25, Woods Hole, MA 02543 USA; [Fielding, Sophie; Venables, Hugh J.] British Antarctic Survey, Cambridge CB3 0ET, England; [Fones, Gary R.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth PO1 3QL, Hants, England; [Hickman, Anna E.] Univ Liverpool, Dept Earth & Ocean Sci, Liverpool L69 3GP, Merseyside, England; [Nedelec, Florence H.] IFREMER, Lab Environm & Resources Normandie, F-14520 Port En Bessen, France; [Planquette, Helene] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Thomalla, Sandy; Williamson, Robert] Univ Cape Town, Dept Oceanog, ZA-7701 Rondebosch, South Africa	NERC National Oceanography Centre; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Southampton; University of Southampton; UDICE-French Research Universities; Sorbonne Universite; University of Cape Town; University of East Anglia; Woods Hole Oceanographic Institution; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Portsmouth; University of Liverpool; Ifremer; Rutgers State University New Brunswick; University of Cape Town	Sanders, RJ (corresponding author), Natl Environm Res Council, Natl Oceanog Ctr Southampton, European Way, Southampton SO14 3ZH, Hants, England.	rics@noc.soton.ac.uk	Salter, Ian/A-7404-2011; Sanders, Richard J/B-8717-2012; Hickman, Anna E/A-9351-2011; Popova, Ekaterina E/B-4520-2012; Baker, Alex R/D-1233-2011; Fielding, Sophie/E-5137-2012; Bakker, Dorothee C E/E-4951-2015; Mills, Rachel A/A-1150-2011; Zubkov, Mikhail/AAW-9674-2020; Poulton, Alex J/A-9859-2012; Salter, Ian/AAI-1015-2021; Thomalla, Sandy/AAS-4133-2021; Charette, Matthew/I-9495-2012; Allen, John Taylor/AHB-3419-2022; Seas, Deep/J-9245-2014; Menet-Nedelec, Florence H. A./K-2262-2015; Fones, Gary/G-2489-2010; Planquette, Helene/B-4990-2013	Sanders, Richard J/0000-0002-6884-7131; Popova, Ekaterina E/0000-0002-2012-708X; Baker, Alex R/0000-0002-8365-8953; Fielding, Sophie/0000-0002-3152-4742; Bakker, Dorothee C E/0000-0001-9234-5337; Mills, Rachel A/0000-0002-9811-246X; Zubkov, Mikhail/0000-0001-7723-6810; Poulton, Alex J/0000-0002-5149-6961; Allen, John Taylor/0000-0001-7357-6623; Menet-Nedelec, Florence H. A./0000-0002-0933-2509; Moore, Mark/0000-0002-9541-6046; Hickman, Anna/0000-0002-2774-3934; Salter, Ian/0000-0002-4513-0314; Fones, Gary/0000-0002-1999-0716; Williamson, Robert/0000-0002-7288-1762; Planquette, Helene/0000-0002-2235-5158; French, Megan Anne/0000-0002-5837-1360; Seeyave, Sophie/0000-0002-4583-2869	Natural Environment Research Council; NERC [bas010017, soc010008, NE/F017359/1] Funding Source: UKRI; Natural Environment Research Council [NE/B502844/1, NE/C507353/1, NE/F017359/1, bas010017, soc010008] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the operators, master and crew of RRS Discovery for their support. CROZEX was a component of Biophysical Interactions and Controls on Export Production, a five-year project at the National Oceanography Centre, Southampton, supported by the Natural Environment Research Council (NERC).	Bakker DCE, 2007, DEEP-SEA RES PT II, V54, P2174, DOI 10.1016/j.dsr2.2007.06.009; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2004, NATURE, V428, P549, DOI 10.1038/nature02437; Brown L, 2003, LIMNOL OCEANOGR, V48, P1831, DOI 10.4319/lo.2003.48.5.1831; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Buesseler KO, 2003, SCIENCE, V300, P67, DOI 10.1126/science.1082959; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Charette MA, 2007, DEEP-SEA RES PT II, V54, P1989, DOI 10.1016/j.dsr2.2007.06.003; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Franck VM, 2000, DEEP-SEA RES PT II, V47, P3315; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI [10.1126/science.1105375, 10.1126/science.11053 75]; Lucas M, 2007, DEEP-SEA RES PT II, V54, P2138, DOI 10.1016/j.dsr2.2007.06.017; Marsh R, 2007, DEEP-SEA RES PT II, V54, P2260, DOI 10.1016/j.dsr2.2007.06.004; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Mongin M, 2008, DEEP-SEA RES PT II, V55, P880, DOI 10.1016/j.dsr2.2007.12.039; Moore CM, 2007, DEEP-SEA RES PT II, V54, P2066, DOI 10.1016/j.dsr2.2007.06.015; Morris PJ, 2007, DEEP-SEA RES PT II, V54, P2208, DOI 10.1016/j.dsr2.2007.06.002; Planquette H, 2007, DEEP-SEA RES PT II, V54, P1999, DOI 10.1016/j.dsr2.2007.06.019; PLANQUETTE HF, 2008, THESIS SOUTHAMPTON U; Pollard RT, 2007, DEEP-SEA RES PT II, V54, P1915, DOI 10.1016/j.dsr2.2007.06.012; Pollard R, 2007, DEEP-SEA RES PT II, V54, P1905, DOI 10.1016/j.dsr2.2007.07.023; Poulton AJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002712; Poulton AJ, 2007, DEEP-SEA RES PT II, V54, P2085, DOI 10.1016/j.dsr2.2007.06.005; Sanders R, 2007, DEEP-SEA RES PT II, V54, P2191, DOI 10.1016/j.dsr2.2007.06.007; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; van Beek P, 2008, DEEP-SEA RES PT II, V55, P622, DOI 10.1016/j.dsr2.2007.12.025; Venables HJ, 2007, DEEP-SEA RES PT II, V54, P1949, DOI 10.1016/j.dsr2.2007.06.014; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Zhang Y, 2008, DEEP-SEA RES PT II, V55, P638, DOI 10.1016/j.dsr2.2007.12.029	32	248	252	0	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					577	U81		10.1038/nature07716	http://dx.doi.org/10.1038/nature07716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177128				2022-12-01	WOS:000262852200040
J	Zhu, LQ; Gibson, P; Currle, DS; Tong, Y; Richardson, RJ; Bayazitov, IT; Poppleton, H; Zakharenko, S; Ellison, DW; Gilbertson, RJ				Zhu, Liqin; Gibson, Paul; Currle, D. Spencer; Tong, Yiai; Richardson, Robert J.; Bayazitov, Ildar T.; Poppleton, Helen; Zakharenko, Stanislav; Ellison, David W.; Gilbertson, Richard J.			Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation	NATURE			English	Article							HEMATOPOIETIC STEM; PERIVASCULAR NICHE; COLORECTAL-CANCER; TUMOR-GROWTH; MOUSE; IDENTIFICATION; MUTATION; GENE; TUMORIGENESIS; POLYPOSIS	Cancer stem cells are remarkably similar to normal stem cells: both self- renew, are multipotent and express common surface markers, for example, prominin 1 ( PROM1, also called CD133)(1). What remains unclear is whether cancer stem cells are the direct progeny of mutated stem cells or more mature cells that reacquire stem cell properties during tumour formation. Answering this question will require knowledge of whether normal stem cells are susceptible to cancer- causing mutations; however, this has proved difficult to test because the identity of most adult tissue stem cells is not known. Here, using an inducible Cre, nuclear LacZ reporter allele knocked into the Prom1 locus (Prom1(C-L)), we show that Prom1 is expressed in a variety of developing and adult tissues. Lineage- tracing studies of adult Prom1(+/C-L) mice containing the Rosa26-YFP reporter allele showed that Prom1(+) cells are located at the base of crypts in the small intestine, co- express Lgr5 ( ref. 2), generate the entire intestinal epithelium, and are therefore the small intestinal stem cell. Prom1 was reported recently to mark cancer stem cells of human intestinal tumours that arise frequently as a consequence of aberrant wingless ( Wnt) signalling(3-5). Activation of endogenous Wnt signalling in Prom1(+/C-L) mice containing a Cre- dependent mutant allele of beta-catenin (Ctnnb1(lox(ex3))) resulted in a gross disruption of crypt architecture and a disproportionate expansion of Prom1(+) cells at the crypt base. Lineage tracing demonstrated that the progeny of these cells replaced the mucosa of the entire small intestine with neoplastic tissue that was characterized by focal high- grade intraepithelial neoplasia and crypt adenoma formation. Although all neoplastic cells arose from Prom1(+) cells in these mice, only 7% of tumour cells retained Prom1 expression. Our data indicate that Prom1 marks stem cells in the adult small intestine that are susceptible to transformation into tumours retaining a fraction of mutant Prom1(+) tumour cells.	[Zhu, Liqin; Gibson, Paul; Currle, D. Spencer; Tong, Yiai; Richardson, Robert J.; Bayazitov, Ildar T.; Poppleton, Helen; Zakharenko, Stanislav; Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Ellison, David W.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Gilbertson, RJ (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Richard.Gilbertson@stjude.org	Zakharenko, Stanislav/D-3287-2013; Ellison, David/N-4806-2018; Gilbertson, Richard James/ABE-1346-2021	Zakharenko, Stanislav/0000-0001-8115-202X; Gilbertson, Richard James/0000-0001-7539-9472	National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P01CA096832, P30CA021765, R01CA129541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	R.J.G. holds the Sydney Schlobohm Leadership Chair of Research from the Brain Tumor Society and the Howard C. Schott Research Chair from the Malia's Cord Foundation, and is supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765), the Collaborative Ependymoma Research Network (CERN) and by the American Lebanese Syrian Associated Charities (ALSAC). We are grateful to the staff of the ARC for technical assistance.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; SHMELKOV SV, 2008, J CLIN INVEST, V22, P22; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sparks AB, 1998, CANCER RES, V58, P1130; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Taketo MM, 2006, ONCOGENE, V25, P7522, DOI 10.1038/sj.onc.1210058; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318	30	493	518	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					603	U114		10.1038/nature07589	http://dx.doi.org/10.1038/nature07589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19092805	Green Accepted			2022-12-01	WOS:000262852200046
J	Vetter, ML; Cardillo, S; Rickels, MR; Iqbal, N				Vetter, Marion L.; Cardillo, Serena; Rickels, Michael R.; Iqbal, Nayyar			Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Review							GASTRIC BYPASS-SURGERY; GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; WEIGHT-LOSS; PLASMA GHRELIN; INHIBITORY POLYPEPTIDE; GUT HORMONE; BILIOPANCREATIC DIVERSION; INSULIN SENSITIVITY; GLUCOSE-METABOLISM	Bariatric surgery leads to substantial and durable weight reduction. Nearly 30% of patients who undergo bariatric surgery have type 2 diabetes, and for many of them, diabetes resolves after surgery (84% to 98% for bypass procedures and 48% to 68% for restrictive procedures). Glycemic control improves in part because of caloric restriction but also because gut peptide secretion changes. Gut peptides, which mediate the enteroinsular axis, include the incretins glucagon-like peptide-1 and glucose-dependent insulinotropic peptide, as well as ghrelin and peptide YY. Bariatric surgery (particularly bypass procedures) alters secretion of these gut hormones, which results in enhanced insulin secretion and sensitivity. This review discusses the various bariatric procedures and how they alter the enteroinsular axis. Familiarity with these effects can help physicians decide among the different surgical procedures and avoid postoperative hypoglycemia.	[Vetter, Marion L.] Hosp Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Vetter, ML (corresponding author), Hosp Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, 1 Maloney Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	marion.vetter@uphs.upenn.edu	Rickels, Michael/D-1380-2009	Rickels, Michael/0000-0002-9253-838X				Ballantyne GH, 2006, OBES SURG, V16, P651, DOI 10.1381/096089206776944959; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Bult MJF, 2008, EUR J ENDOCRINOL, V158, P135, DOI 10.1530/EJE-07-0145; Clements RH, 2004, AM SURGEON, V70, P1; Cohen RV, 2007, SURG OBES RELAT DIS, V3, P195, DOI 10.1016/j.soard.2007.01.009; Colquitt J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub2; Creutzfeldt W, 2005, REGUL PEPTIDES, V128, P87, DOI 10.1016/j.regpep.2004.08.004; CREUTZFELDT W, 1979, DIABETOLOGIA, V16, P75, DOI 10.1007/BF01225454; CROCKETT SE, 1976, DIABETES, V25, P931, DOI 10.2337/diabetes.25.10.931; Cummings DE, 2007, SURG OBES RELAT DIS, V3, P109, DOI 10.1016/j.soard.2007.02.003; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Cummings DE, 2003, J CLIN ENDOCR METAB, V88, P2999, DOI 10.1210/jc.2003-030705; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Deacon CF, 2005, REGUL PEPTIDES, V128, P117, DOI 10.1016/j.regpep.2004.06.007; Dixon JB, 2003, DIABETIC MED, V20, P127, DOI 10.1046/j.1464-5491.2003.00889.x; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Dunn JP., 2007, CLIN DIABETES, V25, P112, DOI [10.2337/diaclin.25.3.112, DOI 10.2337/DIACLIN.25.3.112]; Faraj M, 2003, J CLIN ENDOCR METAB, V88, P1594, DOI 10.1210/jc.2002-021309; Ferchak CV, 2004, DIABETES-METAB RES, V20, P438, DOI 10.1002/dmrr.507; Fetner R, 2005, SURG OBES RELAT DIS, V1, P597; Fetner Rachel, 2005, Surg Obes Relat Dis, V1, P589, DOI 10.1016/j.soard.2005.09.001; Flint A, 2001, INT J OBESITY, V25, P781, DOI 10.1038/sj.ijo.0801627; Folli F, 2007, MED CLIN N AM, V91, P393, DOI 10.1016/j.mcna.2007.01.005; Fruhbeck G, 2004, OBES SURG, V14, P606, DOI 10.1381/096089204323093363; Geloneze B, 2003, OBES SURG, V13, P17, DOI 10.1381/096089203321136539; Goldfine AB, 2007, J CLIN ENDOCR METAB, V92, P4678, DOI 10.1210/jc.2007-0918; Gould J, 2005, J GASTROINTEST SURG, V9, P1117; GREY N, 1971, NEW ENGL J MED, V285, P827, DOI 10.1056/NEJM197110072851504; Gumbs AA, 2005, OBES SURG, V15, P462, DOI 10.1381/0960892053723367; Gutzwiller JP, 1999, GUT, V44, P81, DOI 10.1136/gut.44.1.81; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Higgins JPT, 2008, COCHRANE HDB SYSTEMA; Holdstock C, 2003, J CLIN ENDOCR METAB, V88, P3177, DOI 10.1210/jc.2002-021734; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 1997, DIABETOLOGIA, V40, P984, DOI 10.1007/s001250050779; HOROWITZ M, 1984, BRIT J SURG, V71, P435, DOI 10.1002/bjs.1800710610; Kageyama H, 2005, REGUL PEPTIDES, V126, P67, DOI 10.1016/j.regpep.2004.08.031; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; KELLEY DE, 1993, J CLIN ENDOCR METAB, V77, P1287, DOI 10.1210/jc.77.5.1287; Korner J, 2005, J CLIN ENDOCR METAB, V90, P359, DOI 10.1210/jc.2004-1076; Korner J, 2007, SURG OBES RELAT DIS, V3, P597, DOI 10.1016/j.soard.2007.08.004; Korner J, 2006, OBESITY, V14, P1553, DOI 10.1038/oby.2006.179; LAFERRERE B, 2007, OBESITY, V15, P7; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Laferrere B, 2007, DIABETES CARE, V30, P1709, DOI 10.2337/dc06-1549; le Roux CW, 2007, ANN SURG, V246, P780, DOI 10.1097/SLA.0b013e3180caa3e3; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Levy P, 2007, OBES SURG, V17, P1248, DOI 10.1007/s11695-007-9214-z; Luque MA, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730465; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Marceau P, 1998, WORLD J SURG, V22, P947, DOI 10.1007/s002689900498; Meier JJ, 2002, REGUL PEPTIDES, V107, P1, DOI 10.1016/S0167-0115(02)00039-3; Morinigo R, 2006, J CLIN ENDOCR METAB, V91, P1735, DOI 10.1210/jc.2005-0904; Morinigo R, 2008, ANN SURG, V247, P270, DOI 10.1097/SLA.0b013e31815f6e77; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Naslund E, 1998, DIGEST DIS SCI, V43, P945, DOI 10.1023/A:1018806129102; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Nijhuis J, 2004, OBES SURG, V14, P783, DOI 10.1381/0960892041590980; Patriti A, 2004, OBES SURG, V14, P840, DOI 10.1381/0960892041590818; Patriti A, 2007, SURGERY, V142, P74, DOI 10.1016/j.surg.2007.03.001; Patti ME, 2005, DIABETOLOGIA, V48, P2236, DOI 10.1007/s00125-005-1933-x; PERLEY MJ, 1967, J CLIN INVEST, V46, P1954, DOI 10.1172/JCI105685; Ponce J, 2004, OBES SURG, V14, P1335, DOI 10.1381/0960892042583932; Pontiroli AE, 2002, J CLIN ENDOCR METAB, V87, P3555, DOI 10.1210/jc.87.8.3555; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Poykko SM, 2003, DIABETES, V52, P2546, DOI 10.2337/diabetes.52.10.2546; Rodieux F, 2008, OBESITY, V16, P298, DOI 10.1038/oby.2007.83; ROSS SA, 1977, DIABETES, V26, P525, DOI 10.2337/diabetes.26.6.525; Rubino F, 2004, ANN SURG, V240, P236, DOI 10.1097/01.sla.0000133117.12646.48; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Rubino F, 2006, CURR OPIN CLIN NUTR, V9, P497, DOI 10.1097/01.mco.0000232914.14978.c5; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Schneider BE, 2005, DIABETES CARE, V28, P475, DOI 10.2337/diacare.28.2.475; Scopinaro N, 2005, DIABETES CARE, V28, P2406, DOI 10.2337/diacare.28.10.2406; Shah M, 2006, J CLIN ENDOCR METAB, V91, P4223, DOI 10.1210/jc.2006-0557; Shak JR, 2008, OBES SURG, V18, P1089, DOI 10.1007/s11695-008-9454-6; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sugerman HJ, 2003, ANN SURG, V237, P751, DOI 10.1097/00000658-200306000-00002; Toft-Nielsen MB, 1999, DIABETES CARE, V22, P1137, DOI 10.2337/diacare.22.7.1137; Torquati A, 2005, J GASTROINTEST SURG, V9, P1112, DOI 10.1016/j.gassur.2005.07.016; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tseng CC, 1996, AM J PHYSIOL-ENDOC M, V270, pE661, DOI 10.1152/ajpendo.1996.270.4.E661; UNGER RH, 1969, ARCH INTERN MED, V123, P261, DOI 10.1001/archinte.123.3.261; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Whitson BA, 2007, J SURG RES, V141, P31, DOI 10.1016/j.jss.2007.02.022	89	127	140	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					94	U54		10.7326/0003-4819-150-2-200901200-00007	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19153412				2022-12-01	WOS:000262655200004
J	Zhao, R; Follows, GA; Beer, PA; Scott, LM; Huntly, BJP; Green, AR; Alexander, DR				Zhao, Rui; Follows, George A.; Beer, Philip A.; Scott, Linda M.; Huntly, Brian J. P.; Green, Anthony R.; Alexander, Denis R.			Inhibition of the Bcl-x(L) Deamidation Pathway in Myeloproliferative Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; X-L DEAMIDATION; TYROSINE KINASE JAK2; BCL-X; POLYCYTHEMIA-VERA; V617F MUTATION; DNA-DAMAGE; STEM-CELLS; RESISTANCE; APOPTOSIS	Background: The myeloproliferative disorders are clonal disorders with frequent somatic gain-of-function alterations affecting tyrosine kinases. In these diseases, there is an increase in DNA damage and a risk of progression to acute leukemia. The molecular mechanisms in myeloproliferative disorders that prevent apoptosis induced by damaged DNA are obscure. Methods: We searched for abnormalities of the proapoptotic Bcl-x(L) deamidation pathway in primary cells from patients with chronic myeloid leukemia (CML) or polycythemia vera, myeloproliferative disorders associated with the BCR-ABL fusion kinase and the Janus tyrosine kinase 2 (JAK2) V617F mutation, respectively. Results: The Bcl-x(L) deamidation pathway was inhibited in myeloid cells, but not T cells, in patients with CML or polycythemia vera. DNA damage did not increase levels of the amiloride-sensitive sodium-hydrogen exchanger isoform 1 (NHE-1), intracellular pH, Bcl-x(L) deamidation, and apoptosis. Inhibition of the pathway was reversed by enforced alkalinization or overexpression of NHE-1, leading to a restoration of apoptosis. In patients with CML, the pathway was blocked in CD34+ progenitor cells and mature myeloid cells. Imatinib or JAK2 inhibitors reversed inhibition of the pathway in cells from patients with CML and polycythemia vera, respectively, but not in cells from a patient with resistance to imatinib because of a mutation in the BCR-ABL kinase domain. Conclusions: BCR-ABL and mutant JAK2 inhibit the Bcl-x(L) deamidation pathway and the apoptotic response to DNA damage in primary cells from patients with CML or polycythemia vera.	[Zhao, Rui; Alexander, Denis R.] Univ Cambridge, Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England; [Follows, George A.; Beer, Philip A.; Scott, Linda M.; Huntly, Brian J. P.; Green, Anthony R.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Zhao, R (corresponding author), Univ Cambridge, Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England.	rui.zhao@bbsrc.ac.uk; arg1000@cam.ac.uk	huntly, brian JP/E-6725-2014; Scott, Linda/D-9777-2012	huntly, brian JP/0000-0003-0312-161X; Scott, Linda/0000-0003-0334-1479; Green, Anthony/0000-0002-9795-0218; Beer, Philip/0000-0003-3056-5419	Association for International Cancer Research; Biotechnology and Biological Sciences Research Council; U.K. Leukaemia Research Fund; Wellcome Trust; U.K. Medical Research Council; Cancer Research UK; National Institute for Health Research Cambridge Biomedical Research Center; U.S. Leukemia and Lymphoma Society; MRC [G116/187] Funding Source: UKRI; Cancer Research UK [8961] Funding Source: researchfish; Medical Research Council [G116/187, G0300723B] Funding Source: researchfish	Association for International Cancer Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.K. Leukaemia Research Fund; Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research Cambridge Biomedical Research Center(National Institute for Health Research (NIHR)); U.S. Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Association for International Cancer Research, the Biotechnology and Biological Sciences Research Council, the U.K. Leukaemia Research Fund, the Wellcome Trust, the U.K. Medical Research Council, Cancer Research UK, the National Institute for Health Research Cambridge Biomedical Research Center, and the U.S. Leukemia and Lymphoma Society.	Aichberger KJ, 2005, CANCER RES, V65, P9436, DOI 10.1158/0008-5472.CAN-05-0972; Amarante-Mendes GP, 1998, BLOOD, V91, P1700, DOI 10.1182/blood.V91.5.1700.1700_1700_1705; Amarante-Mendes GP, 1998, ONCOGENE, V16, P1383, DOI 10.1038/sj.onc.1201664; Amundson SA, 2000, CANCER RES, V60, P6101; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; BEDI A, 1995, BLOOD, V86, P1148, DOI 10.1182/blood.V86.3.1148.bloodjournal8631148; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Chang CY, 2006, ONCOGENE, V25, P2656, DOI 10.1038/sj.onc.1209294; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Fang GF, 2000, BLOOD, V96, P2246, DOI 10.1182/blood.V96.6.2246.h8002246_2246_2253; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Hoffmann C, 2004, J BIOL CHEM, V279, P16026, DOI 10.1074/jbc.M313556200; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kano Y, 2001, BLOOD, V97, P1999, DOI 10.1182/blood.V97.7.1999; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kuroda J, 2007, CELL DEATH DIFFER, V14, P1667, DOI 10.1038/sj.cdd.4402168; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Moss CX, 2005, J BIOL CHEM, V280, P18498, DOI 10.1074/jbc.M501241200; Nishii K, 1996, ONCOGENE, V13, P2225; Oetzel C, 2000, CLIN CANCER RES, V6, P1958; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Robinson N. E., 2004, MOL CLOCKS DEAMIDATI; Schiffer CA, 2007, NEW ENGL J MED, V357, P258, DOI 10.1056/NEJMct071828; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Skorski T, 2002, ONCOGENE, V21, P8591, DOI 10.1038/sj.onc.1206087; Slupianek A, 2002, MOL CELL BIOL, V22, P4189, DOI 10.1128/MCB.22.12.4189-4201.2002; Topaly J, 2001, LEUKEMIA, V15, P342, DOI 10.1038/sj.leu.2402041; Zhao R, 2004, CANCER CELL, V5, P37, DOI 10.1016/S1535-6108(03)00333-7; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001	44	71	74	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2778	2789		10.1056/NEJMoa0804953	http://dx.doi.org/10.1056/NEJMoa0804953			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109573	Bronze			2022-12-01	WOS:000261950800005
J	Wang, YL; Juranek, S; Li, HT; Sheng, G; Tuschl, T; Patel, DJ				Wang, Yanli; Juranek, Stefan; Li, Haitao; Sheng, Gang; Tuschl, Thomas; Patel, Dinshaw J.			Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex	NATURE			English	Article							CRYSTAL-STRUCTURE; RECOGNITION; RISC; SIRNAS; SLICER; INTERFERENCE; CLEAVAGE; INSIGHTS; DISEASE	Here we report on a 3.0 angstrom crystal structure of a ternary complex of wild- type Thermus thermophilus argonaute bound to a 5 '- phosphorylated 21- nucleotide guide DNA and a 20- nucleotide target RNA containing cleavage- preventing mismatches at the 10 - 11 step. The seed segment ( positions 2 to 8) adopts an A- helical- like Watson - Crick paired duplex, with both ends of the guide strand anchored in the complex. An arginine, inserted between guide- strand bases 10 and 11 in the binary complex, locking it in an inactive conformation, is released on ternary complex formation. The nucleic- acid- binding channel between the PAZ- and PIWI- containing lobes of argonaute widens on formation of a more open ternary complex. The relationship of structure to function was established by determining cleavage activity of ternary complexes containing position- dependent base mismatch, bulge and 2 '- O- methyl modifications. Consistent with the geometry of the ternary complex, bulges residing in the seed segments of the target, but not the guide strand, were better accommodated and their complexes were catalytically active.	[Wang, Yanli; Li, Haitao; Sheng, Gang; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Juranek, Stefan; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Rockefeller University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	ttuschl@mail.rockefeller.edu; pateld@mskcc.org	Li, Haitao/B-2668-2012; wang, yanli/G-3306-2010	Li, Haitao/0000-0001-6741-293X; Wang, Yanli/0000-0002-5969-1745	National Institutes of Health; Starr Foundation; US Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by funds from the National Institutes of Health and the Starr Foundation to D.J.P. and T.T. We would like to thank the staff of NE-CAT beam line at the Advanced Photon Source, Argonne National Laboratory, supported by the US Department of Energy, for assistance with data collection.	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hall TMT, 2005, STRUCTURE, V13, P1403, DOI 10.1016/j.str.2005.08.005; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Patel DJ, 2006, COLD SPRING HARB SYM, V71, P81, DOI 10.1101/sqb.2006.71.053; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	41	412	440	7	83	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					921	U72		10.1038/nature07666	http://dx.doi.org/10.1038/nature07666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19092929	Green Accepted			2022-12-01	WOS:000261768300038
J	Anderson, DJ				Anderson, Deborah J.			Coca-Cola douches and contraception	BRITISH MEDICAL JOURNAL			English	Editorial Material							SPERMATOZOA; INFECTION		[Anderson, Deborah J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Anderson, Deborah J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Boston University; Harvard University; Harvard Medical School	Anderson, DJ (corresponding author), Boston Univ, Sch Med, 670 Albany St,Suite 516, Boston, MA 02118 USA.	Deborah.Anderson@BMC.org		Anderson, Deborah/0000-0002-2848-7290	NIAID NIH HHS [R56 AI071909] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1966, FUGS; Ayehunie S, 2006, TOXICOL IN VITRO, V20, P689, DOI 10.1016/j.tiv.2005.10.002; Cooper TG, 2006, FERTIL STERIL, V85, P220, DOI 10.1016/j.fertnstert.2005.07.1286; Douglas RJ, 2007, BMJ-BRIT MED J, V335, P1281, DOI 10.1136/bmj.39419.449942.AD; HONG CY, 1987, HUM TOXICOL, V6, P395, DOI 10.1177/096032718700600508; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Ness RB, 2005, AM J EPIDEMIOL, V161, P186, DOI 10.1093/aje/kwi025; NWOHA PU, 1992, CONTRACEPTION, V46, P537, DOI 10.1016/0010-7824(92)90118-D; Tanne JH, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1992; TIETZE C, 1959, AM J OBSTET GYNECOL, V78, P650, DOI 10.1016/0002-9378(59)90541-1; Trussell J, 1999, FAM PLANN PERSPECT, V31, P64, DOI 10.2307/2991641; UMPIERRE SA, 1985, NEW ENGL J MED, V313, P1351; Zhang J, 1997, AM J PUBLIC HEALTH, V87, P1207, DOI 10.2105/AJPH.87.7.1207	13	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2008	337								a2873	10.1136/bmj.a2873	http://dx.doi.org/10.1136/bmj.a2873			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SW	19091763				2022-12-01	WOS:000262185000009
J	Zheng, Y; Chaudhry, A; Kas, A; deRoos, P; Kim, JM; Chu, TT; Corcoran, L; Treuting, P; Klein, U; Rudensky, AY				Zheng, Ye; Chaudhry, Ashutosh; Kas, Arnold; deRoos, Paul; Kim, Jeong M.; Chu, Tin-Tin; Corcoran, Lynn; Treuting, Piper; Klein, Ulf; Rudensky, Alexander Y.			Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses	NATURE			English	Article							SELF-TOLERANCE; TARGET GENES; DIFFERENTIATION; FOXP3; LINEAGE; TH2; INTERLEUKIN-10; ADENOSINE; DISEASE; ABSENCE	In the course of infection or autoimmunity, particular transcription factors orchestrate the differentiation of T(H)1, T(H)2 or T(H)17 effector cells, the responses of which are limited by a distinct lineage of suppressive regulatory T cells (T-reg). T-reg cell differentiation and function are guided by the transcription factor Foxp3, and their deficiency due to mutations in Foxp3 results in aggressive fatal autoimmune disease associated with sharply augmented T(H)1 and T(H)2 cytokine production(1-3). Recent studies suggested that Foxp3 regulates the bulk of the Foxp3-dependent transcriptional program indirectly through a set of transcriptional regulators serving as direct Foxp3 targets(4,5). Here we show that in mouse T-reg cells, high amounts of interferon regulatory factor-4 (IRF4), a transcription factor essential for T(H)2 effector cell differentiation, is dependent on Foxp3 expression. We proposed that IRF4 expression endows T-reg cells with the ability to suppress T(H)2 responses. Indeed, ablation of a conditional Irf4 allele in T-reg cells resulted in selective dysregulation of T(H)2 responses, IL4-dependent immunoglobulin isotype production, and tissue lesions with pronounced plasma cell infiltration, in contrast to the mononuclear-cell-dominated pathology typical of mice lacking T-reg cells. Our results indicate that T-reg cells use components of the transcriptional machinery, promoting a particular type of effector CD4(+) T cell differentiation, to efficiently restrain the corresponding type of the immune response.	[Zheng, Ye; Chaudhry, Ashutosh; Kas, Arnold; deRoos, Paul; Kim, Jeong M.; Chu, Tin-Tin; Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Zheng, Ye; Chaudhry, Ashutosh; Kas, Arnold; deRoos, Paul; Kim, Jeong M.; Chu, Tin-Tin; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Treuting, Piper] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Corcoran, Lynn] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia; [Klein, Ulf] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Klein, Ulf] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Columbia University; Columbia University	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA.	rudenska@mskcc.org	Zheng, Ye/G-4866-2015; Treuting, Piper M./AAB-2721-2019; Corcoran, Lynn M/C-9316-2013	Zheng, Ye/0000-0001-5012-4309; Treuting, Piper M./0000-0002-1812-1519; Chaudhry, Ashutosh/0000-0003-3379-5236	CRI-Irvington Institute; Howard Hughes Medical Institute; National Institutes of Health	CRI-Irvington Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Acknowledgements We thank K. Hilgner and K. Murphy for providing TH1, TH2 and TH0 gene expression data sets, B. Sullivan, R. Locksley, S. Quezada and J. Allison for critical reagents, K. Forbush and L. Karpik for expert technical assistance and mouse colony management, and R. Dalla- Favera for discussions. This work was supported by grants from the National Institutes of Health (A.Y.R.). Y. Z. and J. M. K. were supported by the CRI-Irvington Institute postdoctoral fellowship. A. Y. R. is an investigator with the Howard Hughes Medical Institute.	Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	30	686	704	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 19	2009	458	7236					351	U116		10.1038/nature07674	http://dx.doi.org/10.1038/nature07674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19182775	Green Accepted			2022-12-01	WOS:000264285600044
J	Worth, A; Irshad, T; Bhopal, R; Brown, D; Lawton, J; Grant, E; Murray, S; Kendall, M; Adam, J; Gardee, R; Sheikh, A				Worth, Allison; Irshad, Tasneem; Bhopal, Raj; Brown, Duncan; Lawton, Julia; Grant, Elizabeth; Murray, Scott; Kendall, Marilyn; Adam, James; Gardee, Rafik; Sheikh, Aziz			Vulnerability and access to care for South Asian Sikh and Muslim patients with life limiting illness in Scotland: prospective longitudinal qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SPECIALIST PALLIATIVE CARE; HEALTH-CARE; ETHNIC DIVERSITY; SERVICES; CANCER; COMMUNITY; VIEWS; END; UK; PROFESSIONALS	Objectives To examine the care experiences of South Asian Sikh and Muslim patients in Scotland with life limiting illness and their families and to understand the reasons for any difficulties with access to services and how these might be overcome. Design Prospective, longitudinal, qualitative design using in-depth interviews. Setting Central Scotland. Participants 25 purposively selected South Asian Sikh and Muslim patients, 18 family carers, and 20 key health professionals. Results 92 interviews took place. Most services struggled to deliver responsive, culturally appropriate care. Barriers to accessing effective end of life care included resource constrained services; institutional and, occasionally, personal racial and religious discrimination; limited awareness and understanding among South Asian people of the role of hospices; and difficulty discussing death. The most vulnerable patients, including recent migrants and those with poor English language skills, with no family advocate, and dying of non-malignant diseases were at particularly high risk of inadequate care. Conclusions Despite a robust Scottish diversity policy, services for South Asian Sikh and Muslim patients with life limiting illness were wanting in many key areas. Active case management of the most vulnerable patients and carers, and "real time" support, from where professionals can obtain advice specific to an individual patient and family, are the approaches most likely to instigate noticeable improvements in access to high quality end of life care. Improving access to palliative care for all, particularly those with non-malignant illnesses, as well as focusing on the specific needs of ethnic minority groups, is required.	[Bhopal, Raj; Murray, Scott; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland; [Brown, Duncan] St Columbas Hosp, Edinburgh, Midlothian, Scotland; [Adam, James] Marie Curie Hosp, Glasgow, Lanark, Scotland; [Gardee, Rafik] Natl Resource Ctr Ethn Minor Hlth, Glasgow, Lanark, Scotland	University of Edinburgh; University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland.	Aziz.Sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056	Chief Scientist Office, Scottish Government Health Department	Chief Scientist Office, Scottish Government Health Department	Chief Scientist Office, Scottish Government Health Department. The research team is independent of the funders and the views expressed are those of the researchers, not the funding body.	Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; Bhopal R, 2007, ETHNICITY RACE HLTH; Boyd KJ, 2004, EUR J HEART FAIL, V6, P585, DOI 10.1016/j.ejheart.2003.11.018; Carstairs V., 1991, DEPRIVATION HLTH SCO; Clark J, 2003, BRIT MED J, V327, P174, DOI 10.1136/bmj.327.7408.174; CONILL C, 1990, CANCER, V65, P1864, DOI 10.1002/1097-0142(19900415)65:8<1864::AID-CNCR2820650832>3.0.CO;2-U; Darzi A., 2008, HIGH QUALITY CARE AL; DAVIES E, 2004, PALLIATIVE CARE SOLI; Davies E., 2004, BETTER PALLIATIVE CA; Elkan R, 2007, EUR J CANCER CARE, V16, P109, DOI 10.1111/j.1365-2354.2006.00726.x; Equalities Review, 2007, FAIRN FREED FIN REP; Exley C, 2005, PALLIATIVE MED, V19, P76, DOI 10.1191/0269216305pm973oa; Firth S, 2001, WIDER HORIZONS CARE; Gatrad AR, 2003, BRIT MED J, V327, P176, DOI 10.1136/bmj.327.7408.176; GATRAD R, 2007, PALLIATIVE CARE S AS; *GEN REG OFF SCOTL, 2008, SCOTL CENS 2001; Grande GE, 2006, AGE AGEING, V35, P267, DOI 10.1093/ageing/afj071; Gunaratnam Y., 2007, IMPROVING QUALITY PA; Higginson IJ, 1999, J PUBLIC HEALTH MED, V21, P22, DOI 10.1093/pubmed/21.1.22; HILL D, 1995, OPENING DOORS IMPROV; Jones K, 2005, J RES NURS, V10, P431, DOI 10.1177/174498710501000406; Kai J, 2001, MED EDUC, V35, P262, DOI 10.1046/j.1365-2923.2001.00880.x; Kai J, 2006, VALUING DIVERSITY RE; Kai J, 2007, PLOS MED, V4, P1766, DOI 10.1371/journal.pmed.0040323; Karim K, 2000, PALLIATIVE MED, V14, P471, DOI 10.1191/026921600701536390; Kendall M, 2007, BMJ-BRIT MED J, V334, P521, DOI 10.1136/bmj.39097.582639.55; Kessler D, 2005, PALLIATIVE MED, V19, P105, DOI 10.1191/0269216305pm980oa; Koffman J, 2007, PALLIATIVE MED, V21, P145, DOI 10.1177/0269216306074639; Krakauer EL, 2002, J AM GERIATR SOC, V50, P182, DOI 10.1046/j.1532-5415.2002.50027.x; Lingard L, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39602.690162.47; Merrell J, 2006, HEALTH SOC CARE COMM, V14, P197, DOI 10.1111/j.1365-2524.2006.00610.x; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2008, BRIT MED J, V336, P958, DOI 10.1136/bmj.39535.491238.94; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; Nazroo JY, 1998, SOCIOL HEALTH ILL, V20, P710, DOI 10.1111/1467-9566.00126; NBCWN, 2008, WE CAR TOO PUTT BLAC; Netuveli G, 2005, LANCET, V365, P312, DOI 10.1016/S0140-6736(05)17785-X; Owens A, 2004, HEALTH SOC CARE COMM, V12, P414, DOI 10.1111/j.1365-2524.2004.00511.x; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Richardson A, 2006, EUR J ONCOL NURS, V10, P93, DOI 10.1016/j.ejon.2005.05.002; ROBINSON LA, 1995, BRIT MED J, V311, P315, DOI 10.1136/bmj.311.7000.315; Salway S., 2007, LONG TERM ILL HLTH P; *SCOTT EX, 2002, 200251 NHS HDL SCOTT; Seamark DA, 2007, J ROY SOC MED, V100, P225, DOI 10.1258/jrsm.100.5.225; Sheikh A, 2006, PLOS MED, V3, P166, DOI 10.1371/journal.pmed.0030049; Sheikh A., 2008, CARING MUSLIM PATIEN; Sheikh A, 2007, BRIT MED J, V334, P74, DOI 10.1136/bmj.39072.347720.68; Shi LY, 2005, J GEN INTERN MED, V20, P148, DOI 10.1111/j.1525-1497.2005.40136.x; Shipman C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1720; Sultana K, 2008, J ROY SOC MED, V101, P463, DOI 10.1258/jrsm.2008.080007; Szczepura A, 2005, POSTGRAD MED J, V81, P141, DOI 10.1136/pgmj.2004.026237; WEBB E, 2005, ARCH DIS CHILDHOOD-E, V90, P11; Wild SH, 2006, BRIT J CANCER, V94, P1079, DOI 10.1038/sj.bjc.6603031	53	76	76	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2009	338								b183	10.1136/bmj.b183	http://dx.doi.org/10.1136/bmj.b183			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OX	19190015	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000263876200003
J	del Rio, A; Perez-Jimenez, R; Liu, RC; Roca-Cusachs, P; Fernandez, JM; Sheetz, MP				del Rio, Armando; Perez-Jimenez, Raul; Liu, Ruchuan; Roca-Cusachs, Pere; Fernandez, Julio M.; Sheetz, Michael P.			Stretching Single Talin Rod Molecules Activates Vinculin Binding	SCIENCE			English	Article							FORCE; PROTEIN; SITES; STABILITY; UBIQUITIN; COMPLEX; BUNDLE	The molecular mechanism by which a mechanical stimulus is translated into a chemical response in biological systems is still unclear. We show that mechanical stretching of single cytoplasmic proteins can activate binding of other molecules. We used magnetic tweezers, total internal reflection fluorescence, and atomic force microscopy to investigate the effect of force on the interaction between talin, a protein that links liganded membrane integrins to the cytoskeleton, and vinculin, a focal adhesion protein that is activated by talin binding, leading to reorganization of the cytoskeleton. Application of physiologically relevant forces caused stretching of single talin rods that exposed cryptic binding sites for vinculin. Thus in the talin- vinculin system, molecular mechanotransduction can occur by protein binding after exposure of buried binding sites in the talin-vinculin system. Such protein stretching may be a more general mechanism for force transduction.	[del Rio, Armando; Perez-Jimenez, Raul; Roca-Cusachs, Pere; Fernandez, Julio M.; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Liu, Ruchuan] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore	Columbia University; National University of Singapore	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ms2001@columbia.edu	Perez-Jimenez, Raul/C-3085-2017; Liu, Ruchuan/K-8376-2019; del Río Hernández, Armando E/D-3555-2012; Liu, Ruchuan/G-2279-2012; Roca-Cusachs, Pere/D-4309-2009; del rio hernandez, armando e/N-4262-2013	Perez-Jimenez, Raul/0000-0001-7094-6799; del Río Hernández, Armando E/0000-0001-5062-8910; Roca-Cusachs, Pere/0000-0001-6947-961X; del rio hernandez, armando e/0000-0001-5062-8910	NIH; Spanish Ministry of Science and Education; Marie Curie international fellowship; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001480] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Education(Spanish Government); Marie Curie international fellowship(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank D. Critchley and N. Bate for Vh and TR monomer constructs, C. Badilla-Fernandez for advisement with constructs, and V. Hytonen for contribution to Fig. 1. This work was supported by NIH grants to J.M.F. and M.P.S., an NIH award to A.d.R., a grant from the Spanish Ministry of Science and Education to R.P.-J.,and a Marie Curie international fellowship to P.R.-C.	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Critchley DR, 2005, BIOCHEM SOC T, V33, P1308, DOI 10.1042/BST0331308; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Tanase M, 2007, METHOD CELL BIOL, V83, P473, DOI 10.1016/S0091-679X(07)83020-2; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890	25	1016	1024	7	262	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					638	641		10.1126/science.1162912	http://dx.doi.org/10.1126/science.1162912			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179532	Green Accepted			2022-12-01	WOS:000262862800044
J	Jinnah, S; Jungcurt, S				Jinnah, Sikina; Jungcurt, Stefan			GLOBAL BIOLOGICAL RESOURCES Could Access Requirements Stifle Your Research?	SCIENCE			English	Editorial Material							GENETIC-RESOURCES; SCIENCE; PREDICAMENT		[Jinnah, Sikina] Brown Univ, Watson Inst Int Studies, Providence, RI 02912 USA; [Jungcurt, Stefan] Int Inst Sustainable Dev, Winnipeg, MB R3B 0Y4, Canada	Brown University	Jinnah, S (corresponding author), Brown Univ, Watson Inst Int Studies, Providence, RI 02912 USA.	sikina_jinnah@brown.edu; stefan@iisd.org	Jungcurt, Stefan/AAI-9864-2020; Jinnah, Sikina/AAI-9231-2020	Jungcurt, Stefan/0000-0001-9520-613X; Jinnah, Sikina/0000-0003-4528-3000				Bawa KS, 2006, CURR SCI INDIA, V91, P1005; Check E, 2007, NATURE, V448, P634, DOI 10.1038/448634a; Cooper H.D., 2002, REV EUROPEAN COMMUNI, V11, P1, DOI [https://doi.org/10.1111/1467-9388.00298, DOI 10.1111/1467-9388.00298]; Fowler C, 2004, GENET RESOUR CROP EV, V51, P609, DOI 10.1023/B:GRES.0000024646.81612.1f; Fowler C, 2002, SCIENCE, V297, P157, DOI 10.1126/science.297.5579.157; Gaillard J., 1994, KNOWL TECH POL, V7, P31, DOI DOI 10.1007/BF02692761; *INT I SUST DEV, 2007, EARTH NEG B, V398; *INT I SUST DEV, 2008, EARTH NEG B, V452; *INT I SUST DEV, 2008, EARTH NEG B, V416; Jayaraman KS, 2008, NATURE, V452, P7, DOI 10.1038/452007a; Jungcurt S., 2008, I INTERPLAY INT ENV; Madhusudan MD, 2006, CURR SCI INDIA, V91, P1015; MASOOD E, 2004, SCIDEVNET NEWS  0415; Pethiyagoda R, 2007, CURR SCI INDIA, V92, P426; Prathapan KD, 2008, CURR SCI INDIA, V94, P170; REVKIN A, 2002, NY TIMES        1203, pF1; Sauve R, 2003, AGR SYST, V78, P307, DOI 10.1016/S0308-521X(03)00131-8; ten Kate K, 2002, SCIENCE, V295, P2371, DOI 10.1126/science.1070725	18	33	35	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					464	465		10.1126/science.1167234	http://dx.doi.org/10.1126/science.1167234			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396JL	19164733				2022-12-01	WOS:000262587900026
J	Kafsack, BFC; Pena, JDO; Coppens, I; Ravindran, S; Boothroyd, JC; Carruthers, VB				Kafsack, Bjorn F. C.; Pena, Janethe D. O.; Coppens, Isabelle; Ravindran, Sandeep; Boothroyd, John C.; Carruthers, Vern B.			Rapid Membrane Disruption by a Perforin-Like Protein Facilitates Parasite Exit from Host Cells	SCIENCE			English	Article							PORE-FORMING TOXINS; TOXOPLASMA-GONDII; ATTACK; MECHANISM; DOMAIN; FAMILY; SPOROZOITES; INFECTION; DEFENSE; DEATH	Perforin-like proteins are expressed by many bacterial and protozoan pathogens, yet little is known about their function or mode of action. Here, we describe Toxoplasma perforin- like protein 1 ( TgPLP1), a secreted perforin- like protein of the intracellular protozoan pathogen Toxoplasma gondii that displays structural features necessary for pore formation. After intracellular growth, TgPLP1- deficient parasites failed to exit normally, resulting in entrapment within host cells. We show that this defect is due to an inability to rapidly permeabilize the parasitophorous vacuole membrane and host plasma membrane during exit. TgPLP1 ablation had little effect on growth in culture but resulted in a reduction greater than five orders of magnitude of acute virulence in mice. Perforin- like proteins from other intracellular pathogens may play a similar role in microbial egress and virulence.	[Kafsack, Bjorn F. C.; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Kafsack, Bjorn F. C.; Coppens, Isabelle] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Pena, Janethe D. O.] Univ Fed Uberlandia, Dept Immunol, BR-38400 Uberlandia, MG, Brazil; [Ravindran, Sandeep; Boothroyd, John C.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Uberlandia; Stanford University	Carruthers, VB (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu		Kafsack, Bjorn F.C./0000-0003-0089-1096; Carruthers, Vern/0000-0001-6859-8895; Boothroyd, John C./0000-0001-9719-745X	NIH [RO1 AI46675]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046675, R01AI021423] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Schultz, S. Meshinchi, A. Silva, E. Mastrantonio, and C. Pereira for technical assistance; D. Roos and F. Dzierszinski for reagents; G. Zeiner for help with the HA-tagging; and M.-H. Huynh, L.D. Sibley, J. Swanson, and M. O'Riordan for valuable discussion and input. This work was supported by NIH grant RO1 AI46675 and a predoctoral fellowship by the American Heart Association. TgPLP1 GenBank accession number is EF102772.	Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Ecker A, 2007, EXP PARASITOL, V116, P504, DOI 10.1016/j.exppara.2007.01.015; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Kaiser K, 2004, MOL BIOCHEM PARASIT, V133, P15, DOI 10.1016/j.molbiopara.2003.08.009; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Ponting CP, 1999, CURR BIOL, V9, pR911, DOI 10.1016/S0960-9822(00)80102-5; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983	20	207	215	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					530	533		10.1126/science.1165740	http://dx.doi.org/10.1126/science.1165740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19095897	Green Accepted			2022-12-01	WOS:000262587900050
J	Piddini, E; Vincent, JP				Piddini, Eugenia; Vincent, Jean-Paul			Interpretation of the Wingless Gradient Requires Signaling-Induced Self-Inhibition	CELL			English	Article							LONG-RANGE ACTION; MORPHOGEN GRADIENT; POSITIONAL INFORMATION; DISC DEVELOPMENT; SONIC HEDGEHOG; BETA-CATENIN; DROSOPHILA; ENCODES; AXIN; PROTEINS	In a classical view of development, a cell can acquire positional information by reading the local concentration of a morphogen independently of its neighbors. Accordingly, in Drosophila, the morphogen Wingless produced in the wing's prospective distal region activates target genes in a dose-dependent fashion to organize the proximodistal pattern. Here, we show that, in parallel, Wingless triggers two nonautonomous inhibitory programs that play an important role in the establishment of positional information. Cells flanking the source of Wingless produce a negative signal (encoded by notum) that inhibits Wingless signaling in nearby cells. Additionally, in response to Wingless, all prospective wing cells produce an unidentified signal that dampens target gene expression in surrounding cells. Thus, cells influence each other's response to Wingless through at least two modes of lateral inhibition. Without lateral inhibition, some cells acquire ectopic fates. Lateral inhibition may be a general mechanism behind the interpretation of morphogen gradients.	[Piddini, Eugenia; Vincent, Jean-Paul] Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Vincent, JP (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jvincen@nimr.mrc.ac.uk		Piddini, Eugenia/0000-0003-3901-076X	MRC [MC_U117584268] Funding Source: UKRI; Medical Research Council [MC_U117584268] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Arias AM, 2003, NAT REV MOL CELL BIO, V4, P321, DOI 10.1038/nrm1078; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Chen CM, 1999, DEVELOPMENT, V126, P5441; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Day SJ, 2000, DEVELOPMENT, V127, P2977; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Feldman B, 2002, CURR BIOL, V12, P2129, DOI 10.1016/S0960-9822(02)01361-1; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Gurdon JB, 1999, DEVELOPMENT, V126, P5309; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hoffmans R, 2005, CURR BIOL, V15, P1207, DOI 10.1016/j.cub.2005.05.054; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jaeger J, 2008, DEVELOPMENT, V135, P3175, DOI 10.1242/dev.018697; Jaiswal M, 2006, DEVELOPMENT, V133, P925, DOI 10.1242/dev.02243; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Klein T, 1999, DEVELOPMENT, V126, P913; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Lawrence PA, 2001, NAT CELL BIOL, V3, pE151, DOI 10.1038/35083096; Liem KF, 2000, DEVELOPMENT, V127, P4855; Masland RH, 2005, CURR BIOL, V15, pR808, DOI 10.1016/j.cub.2005.09.023; McHale P, 2006, PHYS BIOL, V3, P107, DOI 10.1088/1478-3975/3/2/003; Meinhardt H, 2001, INT J DEV BIOL, V45, P177; MORATA G, 1977, DEV BIOL, V56, P227, DOI 10.1016/0012-1606(77)90266-4; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Ng M, 1996, NATURE, V381, P316, DOI 10.1038/381316a0; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Patten I, 2002, CURR BIOL, V12, P47, DOI 10.1016/S0960-9822(01)00631-5; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Sato A, 1999, DEVELOPMENT, V126, P4421; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; SHARMA RP, 1976, DEV BIOL, V48, P461, DOI 10.1016/0012-1606(76)90108-1; Sivasankaran R, 2000, MECH DEVELOP, V91, P427, DOI 10.1016/S0925-4773(99)00313-5; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vincent JP, 2001, CURR BIOL, V11, pR851, DOI 10.1016/S0960-9822(01)00514-0; Wang SH, 2000, GENE DEV, V14, P2271, DOI 10.1101/gad.827000; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wu J, 2002, DEVELOPMENT, V129, P2411; XU T, 1993, DEVELOPMENT, V117, P1223; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zecca M, 2007, DEVELOPMENT, V134, P3001, DOI 10.1242/dev.006411; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	59	47	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					296	307		10.1016/j.cell.2008.11.036	http://dx.doi.org/10.1016/j.cell.2008.11.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167331	Bronze			2022-12-01	WOS:000262648800018
J	Zhang, YX; Yan, LB; Zhou, Z; Yang, PG; Tian, E; Zhang, K; Zhao, Y; Li, ZP; Song, B; Han, JH; Miao, L; Zhang, H				Zhang, Yuxia; Yan, Libo; Zhou, Zhi; Yang, Peiguo; Tian, E.; Zhang, Kai; Zhao, Yu; Li, Zhipeng; Song, Bing; Han, Jinghua; Miao, Long; Zhang, Hong			SEPA-1 Mediates the Specific Recognition and Degradation of P Granule Components by Autophagy in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; GERM GRANULES; MOLECULAR MACHINERY; SELF-DIGESTION; MECHANISMS; MICE; NEURODEGENERATION; PROTEINS; DISEASE; P62	How autophagy, an evolutionarily conserved intracellular catabolic system for bulk degradation, selectively degrades protein aggregates is poorly understood. Here, we show that several maternally derived germ P granule components are selectively eliminated by autophagy in somatic cells during C. elegans embryogenesis. The activity of sepa-1 is required for the degradation of these P granule components and for their accumulation into aggregates, termed PGL granules, in autophagy mutants. SEPA-1 forms protein aggregates and is also a preferential target of autophagy. SEPA-1 directly binds to the P granule component PGL-3 and also to the autophagy protein LGG-1/Atg8. SEPA-1 aggregates consistently colocalize with PGL granules and with LGG-1 puncta. Thus, SEPA-1 functions as a bridging molecule in mediating the specific recognition and degradation of P granule components by autophagy. Our study reveals a mechanism for preferential degradation of protein aggregates by autophagy and emphasizes the physiological significance of selective autophagy during animal development.	[Zhang, Yuxia; Yan, Libo; Zhou, Zhi; Yang, Peiguo; Tian, E.; Zhao, Yu; Li, Zhipeng; Song, Bing; Han, Jinghua; Zhang, Hong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yan, Libo] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Yan, Libo] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Kai; Miao, Long] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, H (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	zhanghong@nibs.ac.cn	Yan, Libo/H-2328-2012; Zhang, Kai/M-9831-2017; Zhang, Yuxia/J-3449-2013; yan, libo/H-9533-2013	Yan, Libo/0000-0002-4204-3397; Zhang, Kai/0000-0003-2962-3976; Zhang, Hong/0000-0002-3342-5377; YANG, PEIGUO/0000-0002-2334-5664; Li, Zhipeng/0000-0001-8806-9667; Miao, Long/0000-0002-0562-6681	National High Technology Projects 863 [2005AA210910]	National High Technology Projects 863	We thank Drs. Susan Strome and Xiaodong Wang for their helpful comments on the manuscript, Dr. David Hall for his advice on immuno EM, and Dr. Isabel Hanson for editing the manuscript. This work was supported by the National High Technology Projects 863 (2005AA210910).	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hird SN, 1996, DEVELOPMENT, V122, P1303; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kawasaki L, 2004, GENETICS, V167, P645, DOI 10.1534/genetics.103.023093; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rowland AM, 2006, J NEUROSCI, V26, P1711, DOI 10.1523/JNEUROSCI.2279-05.2006; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; van der Vaart A, 2008, TRAFFIC, V9, P281, DOI 10.1111/j.1600-0854.2007.00674.x	20	168	186	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					308	321		10.1016/j.cell.2008.12.022	http://dx.doi.org/10.1016/j.cell.2008.12.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167332	Bronze			2022-12-01	WOS:000262648800019
J	Morrow, TJ; Li, MW; Kim, J; Mayer, TS; Keating, CD				Morrow, Thomas J.; Li, Mingwei; Kim, Jaekyun; Mayer, Theresa S.; Keating, Christine D.			Programmed Assembly of DNA-Coated Nanowire Devices	SCIENCE			English	Article							ARRAYS; BOTTOM		[Li, Mingwei; Kim, Jaekyun; Mayer, Theresa S.] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA; [Morrow, Thomas J.; Keating, Christine D.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mayer, TS (corresponding author), Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.	tsm2@psu.edu; keating@chem.psu.edu		Keating, Christine/0000-0001-6039-1961	NIH; NSF; Semiconductor Research Corporation-Nanoelectronics Research Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000268] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Semiconductor Research Corporation-Nanoelectronics Research Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Supported by NIH, NSF, and Semiconductor Research Corporation-Nanoelectronics Research Initiative.	Ahn JH, 2006, SCIENCE, V314, P1754, DOI 10.1126/science.1132394; Ho TT, 2008, NANO LETT, V8, P4359, DOI 10.1021/nl8022059; Ito T, 2000, NATURE, V406, P1027, DOI 10.1038/35023233; Li MW, 2008, NAT NANOTECHNOL, V3, P88, DOI 10.1038/nnano.2008.26; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640	6	99	105	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					352	352		10.1126/science.1165921	http://dx.doi.org/10.1126/science.1165921			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150837	Green Accepted			2022-12-01	WOS:000262481400029
J	Zaher, HS; Green, R				Zaher, Hani S.; Green, Rachel			Quality control by the ribosome following peptide bond formation	NATURE			English	Article							AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; CODON RECOGNITION; RELEASE FACTORS; E-SITE; TRANSLATION; ACCURACY; DISCRIMINATION; TERMINATION; ERRORS	The overall fidelity of protein synthesis has been thought to rely on the combined accuracy of two basic processes: the aminoacylation of transfer RNAs with their cognate amino acid by the aminoacyl- tRNA synthetases, and the selection of cognate aminoacyl- tRNAs by the ribosome in cooperation with the GTPase elongation factor EF- Tu. These two processes, which together ensure the specific acceptance of a correctly charged cognate tRNA into the aminoacyl ( A) site, operate before peptide bond formation. Here we report the identification of an additional mechanism that contributes to high fidelity protein synthesis after peptidyl transfer, using a well- defined in vitro bacterial translation system. In this retrospective quality control step, the incorporation of an amino acid from a non- cognate tRNA into the growing polypeptide chain leads to a general loss of specificity in the A site of the ribosome, and thus to a propagation of errors that results in abortive termination of protein synthesis.	[Zaher, Hani S.; Green, Rachel] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			National Institutes of Health; Howard Hughes Medical Institute.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute.(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Cormack, A. Nahvi, A. Buskirk and R. Reed for helpful comments on the manuscript and members of the laboratory for useful discussions. This work was supported by the National Institutes of Health with salary support from Howard Hughes Medical Institute.	Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; BARTETZKO A, 1988, METHOD ENZYMOL, V164, P650; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; BROWN CM, 1993, NUCLEIC ACIDS RES, V21, P2109, DOI 10.1093/nar/21.9.2109; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Brunelle JL, 2008, RNA, V14, P1526, DOI 10.1261/rna.1057908; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; DONG HJ, 1995, J MOL BIOL, V248, P551, DOI 10.1006/jmbi.1995.0242; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; EDELMANN P, 1977, CELL, V10, P131, DOI 10.1016/0092-8674(77)90147-7; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; GEIGENMULLER U, 1990, EMBO J, V9, P4527, DOI 10.1002/j.1460-2075.1990.tb07904.x; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; MANLEY JL, 1978, J MOL BIOL, V125, P407, DOI 10.1016/0022-2836(78)90308-X; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; PRECUP J, 1987, J BIOL CHEM, V262, P11351; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Shaw JJ, 2007, MOL CELL, V28, P458, DOI 10.1016/j.molcel.2007.09.007; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SOLL D, 1990, EXPERIENTIA, V46, P1089; Sundararajan A, 1999, MOL CELL, V4, P1005, DOI 10.1016/S1097-2765(00)80229-4; Szaflarski W, 2008, J MOL BIOL, V380, P193, DOI 10.1016/j.jmb.2008.04.060; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zaher HS, 2004, BIOCHEMISTRY-US, V43, P7873, DOI 10.1021/bi0497300	39	155	162	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					161	U51		10.1038/nature07582	http://dx.doi.org/10.1038/nature07582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19092806	Green Accepted			2022-12-01	WOS:000262360200025
J	Viale, A; De Franco, F; Orleth, A; Cambiaghi, V; Giuliani, V; Bossi, D; Ronchini, C; Ronzoni, S; Muradore, I; Monestiroli, S; Gobbi, A; Alcalay, M; Minucci, S; Pelicci, PG				Viale, Andrea; De Franco, Francesca; Orleth, Annette; Cambiaghi, Valeria; Giuliani, Virginia; Bossi, Daniela; Ronchini, Chiara; Ronzoni, Simona; Muradore, Ivan; Monestiroli, Silvia; Gobbi, Alberto; Alcalay, Myriam; Minucci, Saverio; Pelicci, Pier Giuseppe			Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; ONCOGENE-INDUCED SENESCENCE; HEMATOPOIETIC STEM; REPOPULATING ABILITY; PROGENITOR CELLS; GENE-TRANSFER; REPAIR; REPLICATION; EXPRESSION; BREAKS	Rare cells with the properties of stem cells are integral to the development and perpetuation of leukaemias. A defining characteristic of stem cells is their capacity to self- renew, which is markedly extended in leukaemia stem cells. The underlying molecular mechanisms, however, are largely unknown. Here we demonstrate that expression of the cell- cycle inhibitor p21 is indispensable for maintaining self- renewal of leukaemia stem cells. Expression of leukaemia- associated oncogenes in mouse haematopoietic stem cells ( HSCs) induces DNA damage and activates a p21- dependent cellular response, which leads to reversible cell- cycle arrest and DNA repair. Activated p21 is critical in preventing excess DNA- damage accumulation and functional exhaustion of leukaemic stem cells. These data unravel the oncogenic potential of p21 and suggest that inhibition of DNA repair mechanisms might function as potent strategy for the eradication of the slowly proliferating leukaemia stem cells.	[Viale, Andrea; De Franco, Francesca; Orleth, Annette; Cambiaghi, Valeria; Giuliani, Virginia; Bossi, Daniela; Ronchini, Chiara; Ronzoni, Simona; Muradore, Ivan; Monestiroli, Silvia; Gobbi, Alberto; Alcalay, Myriam; Minucci, Saverio; Pelicci, Pier Giuseppe] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; [De Franco, Francesca; Orleth, Annette] Univ Perugia, Dipartimento Med Clin & Sperimentale, Monteluce Policlin, I-06100 Perugia, Italy; [Minucci, Saverio] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20100 Milan, Italy; [Alcalay, Myriam; Pelicci, Pier Giuseppe] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20100 Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Perugia; University of Milan; University of Milan	Viale, A (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus, I-20141 Milan, Italy.	andrea.viale@ifom-ieo-campus.it; piergiuseppe.pelicci@ifom-ieo-campus.it	Minucci, Saverio/J-9669-2012; Ronzoni, Simona/AAQ-1669-2020; Alcalay, Myriam/B-3182-2016; Bossi, Daniela/G-2401-2015; Alcalay, Myriam/AAB-4300-2019; Pelicci, Pier Giuseppe/AAL-6572-2020; Ronchini, Chiara/K-3935-2013	Alcalay, Myriam/0000-0002-5558-4272; Bossi, Daniela/0000-0002-8507-6754; Alcalay, Myriam/0000-0002-5558-4272; Ronchini, Chiara/0000-0003-3908-4021	Italian Association on Cancer Research; Ministero Italiano della Salute, Cariplo; European Community (FP6: EPITRON and GENICA); Vollaro Foundation	Italian Association on Cancer Research(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano della Salute, Cariplo(Fondazione Cariplo); European Community (FP6: EPITRON and GENICA)(European Commission); Vollaro Foundation	We thank L. Luzi, D. Shing and M. Faretta for discussions and suggestions; M. Capillo, M. Stendardo and D. Sardella for assistance in maintenance of mouse colonies and for mouse genotyping; B. Amati, G. McVie, P. P. Di Fiore and C. Basilico for reviewing the manuscript; and P. Dalton for editing the manuscript. This study was supported by grants from the Italian Association on Cancer Research (AIRC), Ministero Italiano della Salute, Cariplo and the European Community (FP6: EPITRON and GENICA) to P. G.P.A.V. is a fellow of the Vollaro Foundation.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cheng T, 2004, ONCOGENE, V23, P7256, DOI 10.1038/sj.onc.1207945; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Furuta T, 2006, ONCOGENE, V25, P2839, DOI 10.1038/sj.onc.1209313; Grignani F, 1998, CANCER RES, V58, P14; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; HARRISON DE, 1983, J EXP MED, V157, P1496, DOI 10.1084/jem.157.5.1496; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; HEYTING C, 1980, CARCINOGENESIS, V1, P769, DOI 10.1093/carcin/1.9.769; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Insinga A, 2004, EMBO J, V23, P1144, DOI 10.1038/sj.emboj.7600109; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ishikawa K, 2006, DNA CELL BIOL, V25, P406, DOI 10.1089/dna.2006.25.406; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Livneh Z, 2001, J BIOL CHEM, V276, P25639, DOI 10.1074/jbc.R100019200; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Minucci S, 2002, BLOOD, V100, P2989, DOI 10.1182/blood-2001-11-0089; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Paulson QX, 2008, ONCOGENE, V27, P4954, DOI 10.1038/onc.2008.138; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Shepherd BE, 2007, BLOOD, V110, P1806, DOI 10.1182/blood-2007-02-075382; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; SZILVASSY SJ, 1989, BLOOD, V74, P930; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhou CX, 2006, MUTAT RES-GEN TOX EN, V604, P8, DOI 10.1016/j.mrgentox.2005.12.004	46	236	250	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 1	2009	457	7225					51	U52		10.1038/nature07618	http://dx.doi.org/10.1038/nature07618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122635				2022-12-01	WOS:000262104900028
J	Schwaber, MJ; Carmeli, Y				Schwaber, Mitchell J.; Carmeli, Yehuda			Carbapenem-Resistant Enterobacteriaceae A Potential Threat	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; BETA-LACTAMASES; STAPHYLOCOCCUS-AUREUS; NEW-YORK; INFECTIONS; MORTALITY; SPREAD		[Schwaber, Mitchell J.] Minist Hlth, Natl Ctr Infect Control, IL-64239 Tel Aviv, Israel; [Carmeli, Yehuda] Tel Aviv Med Ctr & Sch Med, Div Epidemiol & Prevent Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Schwaber, MJ (corresponding author), Minist Hlth, Natl Ctr Infect Control, 6 Weizmann St, IL-64239 Tel Aviv, Israel.	mitchells@tasmc.health.gov.il	Schwaber, Mitchell/AAI-2486-2019					Appelbaum PC, 2007, CLIN INFECT DIS, V45, pS165, DOI 10.1086/519474; Bratu S, 2005, ARCH INTERN MED, V165, P1430, DOI 10.1001/archinte.165.12.1430; Bratu S, 2007, CLIN INFECT DIS, V44, P972, DOI 10.1086/512370; Daikos GL, 2007, INT J ANTIMICROB AG, V29, P471, DOI 10.1016/j.ijantimicag.2006.11.006; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rodriguez-Bano J, 2008, ARCH INTERN MED, V168, P1897, DOI 10.1001/archinte.168.17.1897; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; SCHWABER MJ, 2008, 48 ANN INT C ANT AG; Urban C, 2008, CLIN INFECT DIS, V46, pE127, DOI 10.1086/588048; Vatopoulos A, 2008, Euro Surveill, V13	14	201	210	1	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2911	2913						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109119	Green Accepted			2022-12-01	WOS:000261920900024
J	[Anonymous]				[Anonymous]			Cell imaging: LIGHT ACTIVATED	NATURE			English	Editorial Material																			0	2	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					826	827		10.1038/456826a	http://dx.doi.org/10.1038/456826a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19079062	Bronze			2022-12-01	WOS:000261559900059
J	Garner, EC				Garner, Ethan Clark			GE PRIZE ESSAY Understanding a Minimal DNA-Segregating Machine	SCIENCE			English	Editorial Material							PROKARYOTIC ACTIN HOMOLOG; DYNAMIC INSTABILITY; PARTITION; PLASMID; GROWTH		[Garner, Ethan Clark] Univ Calif San Francisco, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Garner, EC (corresponding author), Univ Calif San Francisco, San Francisco, CA 94158 USA.	egarner@mullinslab2.ucsf.edu	Garner, Ethan/J-4025-2014	Garner, Ethan/0000-0003-0141-3555				AUSTIN S, 1983, J MOL BIOL, V169, P353, DOI 10.1016/S0022-2836(83)80055-2; Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3	9	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1486	1487		10.1126/science.1168506	http://dx.doi.org/10.1126/science.1168506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056970				2022-12-01	WOS:000261377400033
J	Vandenbroucke, JP; Psaty, BM				Vandenbroucke, Jan P.; Psaty, Bruce M.			Benefits and Risks of Drug Treatments How to Combine the Best Evidence on Benefits With the Best Data About Adverse Effects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEMATIC REVIEWS; RANDOMIZED-TRIALS; HARMS		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Vandenbroucke, Jan P.] Leiden Univ, Med Ctr, Dept Epidemiol, Leiden, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu	Vandenbroucke, Jan/AAM-3928-2020	Vandenbroucke, Jan/0000-0001-5668-6716	NHLBI NIH HHS [HL085251, HL080295, HL74745, HL087652] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087652, R01HL080295, R01HL074745, U01HL080295, R01HL085251] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agency for Healthcare Research and Quality, 2007, METH REF GUID EFF CO; BACIU A, 2006, FUTURE DRUG SAFETY P; Chou R, 2005, ANN INTERN MED, V142, P1090, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00009; Higgins JPT, 2008, COCHRANE HDB SYSTEMA; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; JICK H, 1978, AM J EPIDEMIOL, V107, P1; Loke YK, 2008, ALIMENT PHARM THERAP, V27, P31, DOI 10.1111/j.1365-2036.2007.03541.x; Loke YK, 2004, BRIT J CLIN PHARMACO, V57, P616, DOI 10.1111/j.0306-5251.2003.02055.x; Mallett S, 2002, INT J TECHNOL ASSESS, V18, P820, DOI 10.1017/S0266462302000624; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Vandenbroucke JP, 2006, CAN MED ASSOC J, V174, P645, DOI 10.1503/cmaj.051484; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2	15	103	104	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2417	2419		10.1001/jama.2008.723	http://dx.doi.org/10.1001/jama.2008.723			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033592				2022-12-01	WOS:000261150800024
J	Schuckit, MA				Schuckit, Marc A.			Alcohol-use disorders	LANCET			English	Review							SUBSTANCE-USE DISORDERS; RECEPTOR GENE OPRM1; AT-RISK DRINKING; UNITED-STATES; DSM-IV; IDENTIFICATION TEST; BRIEF INTERVENTIONS; RELAPSE PREVENTION; LABORATORY MARKERS; DEPENDENT PATIENTS	Alcohol dependence and alcohol abuse or harmful use cause substantial morbidity and mortality. Alcohol-use disorders are associated with depressive episodes, severe anxiety, insomnia, suicide, and abuse of other drugs. Continued heavy alcohol use also shortens the onset of heart disease, stroke, cancers, and liver cirrhosis, by affecting the cardiovascular, gastrointestinal, and immune systems. Heavy drinking can also cause mild anterograde amnesias, temporary cognitive deficits, sleep problems, and peripheral neuropathy; cause gastroinestinal problems; decrease bone density and production of blood cells; and cause fetal alcohol syndrome. Alcohol-use disorders complicate assessment and treatment of other medical and psychiatric problems. Standard criteria for alcohol dependence-the more severe disorder-can be used to reliably identify people for whom drinking causes major physiological consequences and persistent impairment of quality of life and ability to function. Clinicians should routinely screen for alcohol disorders, using clinical interviews, questionnaires, blood tests, or a combination of these methods. Causes include environmental factors and specific genes that affect the risk of alcohol-use disorders, including genes for enzymes that metabolise alcohol, such as alcohol dehydrogenase and aldehyde dehydrogenase; those associated with disinhibition; and those that confer a low sensitivity to alcohol. Treatment can include motivational interviewing to help people to evaluate their situations, brief interventions to facilitate more healthy behaviours, detoxification to address withdrawal symptoms, cognitive-behavioural therapies to avoid relapses, and judicious use of drugs to diminish cravings or discourage relapses.	[Schuckit, Marc A.] VA San Diego Healthcare Syst, La Jolla, CA 92161 USA; [Schuckit, Marc A.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Schuckit, MA (corresponding author), VA San Diego Healthcare Syst, 3350 Jolla Village Dr, La Jolla, CA 92161 USA.	mschuckit@ucsd.edu			Veterans Affairs Research Service [NIAAA 2R01, NIAAA AA05526, NIAAA U10, NIAAA AA08401, NIAAA 5R01AA15760]; State of California; University of California, San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015760, R01AA005526, U10AA008401] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); State of California; University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Veterans Affairs Research Service (NIAAA grants 2R01 AA05526, U10 AA08401, and 5ROIAA5760), and by funds provided by the, State of California for medical research oil alcohol and substance abuse through the University of California, San Francisco.	Alati R, 2006, ARCH GEN PSYCHIAT, V63, P1009, DOI 10.1001/archpsyc.63.9.1009; Alte D, 2003, J STUD ALCOHOL, V64, P75, DOI 10.15288/jsa.2003.64.75; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890423349; Anton RF, 2006, ALCOHOL CLIN EXP RES, V30, P1878, DOI 10.1111/j.1530-0277.2006.00225.x; BABOR TF, 1992, ARCH GEN PSYCHIAT, V49, P599; Babor TF, 2006, ALCOHOL ALCOHOLISM, V41, P624, DOI 10.1093/alcalc/agl078; BARR C, 2005, ALCOHOL CLIN EXP RES, V27, P812; Bartsch AJ, 2007, BRAIN, V130, P36, DOI 10.1093/brain/awl303; Berner MM, 2007, J STUD ALCOHOL DRUGS, V68, P461, DOI 10.15288/jsad.2007.68.461; Blednov YA, 2007, NEUROPSYCHOPHARMACOL, V32, P1570, DOI 10.1038/sj.npp.1301274; Bodin MC, 2006, J STUD ALCOHOL, V67, P139, DOI 10.15288/jsa.2006.67.139; Borghese CM, 2002, ALCOHOL CLIN EXP RES, V26, P1764, DOI 10.1097/01.ALC.0000042012.58231.D9; Bottlender M, 2005, DRUG ALCOHOL DEPEN, V80, P83, DOI 10.1016/j.drugalcdep.2005.03.011; Carroll KM, 2006, DRUG ALCOHOL DEPEN, V81, P301, DOI 10.1016/j.drugalcdep.2005.08.002; Clark DB, 2004, ADDICTION, V99, P5, DOI 10.1111/j.1360-0443.2004.00851.x; Conigrave KM, 2002, ALCOHOL CLIN EXP RES, V26, P332, DOI 10.1097/00000374-200203000-00005; Conroy DA, 2006, ALCOHOL CLIN EXP RES, V30, P1992, DOI 10.1111/j.1530-0277.2006.00245.x; Cook TAR, 2005, J STUD ALCOHOL, V66, P196, DOI 10.15288/jsa.2005.66.196; Cox WM, 2004, ALCOHOL ALCOHOLISM, V39, P130, DOI 10.1093/alcalc/agh035; Crawford M, 2004, LANCET, V364, P1334, DOI 10.1016/S0140-6736(04)17190-0; Dawson DA, 2005, ADDICTION, V100, P281, DOI 10.1111/j.1360-0443.2004.00964.x; Dick DM, 2006, BEHAV GENET, V36, P577, DOI 10.1007/s10519-005-9041-8; Dickson PA, 2006, ALCOHOL CLIN EXP RES, V30, P1093, DOI 10.1111/j.1530-0277.2006.00128.x; Duranceaux NCE, 2006, ALCOHOL CLIN EXP RES, V30, P1470, DOI 10.1111/j.1530-0277.2006.00178.x; Enoch MA, 2006, AM J MED GENET B, V141B, P599, DOI 10.1002/ajmg.b.30336; Fatjo F, 2007, ALCOHOL CLIN EXP RES, V31, P1099, DOI 10.1111/j.1530-0277.2007.00404.x; Feeney GFX, 2006, ALCOHOL ALCOHOLISM, V41, P321, DOI 10.1093/alcalc/agl007; Fuller RK, 2004, ADDICTION, V99, P21, DOI 10.1111/j.1360-0443.2004.00597.x; Gelernter J, 2007, ALCOHOL CLIN EXP RES, V31, P555, DOI 10.1111/j.1530-0277.2007.00339.x; Hamilton SP, 2004, NEUROPSYCHOPHARMACOL, V29, P558, DOI 10.1038/sj.npp.1300311; Harford TC, 2006, J STUD ALCOHOL, V67, P803, DOI 10.15288/jsa.2006.67.803; Hasin D, 1997, DRUG ALCOHOL DEPEN, V47, P217, DOI 10.1016/S0376-8716(97)00092-6; Hasin D, 1996, ADDICTION, V91, P1517; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Heather N, 2000, J STUD ALCOHOL, V61, P561, DOI 10.15288/jsa.2000.61.561; Hietala J, 2006, ALCOHOL ALCOHOLISM, V41, P528, DOI 10.1093/alcalc/agl050; Hinckers AS, 2006, BIOL PSYCHIAT, V60, P282, DOI 10.1016/j.biopsych.2005.12.009; Ho MP, 2007, AM J MED SCI, V333, P53, DOI 10.1097/00000441-200701000-00007; Hughes JR, 2006, DRUG ALCOHOL DEPEN, V82, P91, DOI 10.1016/j.drugalcdep.2005.08.018; Humphreys K, 2007, ALCOHOL CLIN EXP RES, V31, P64, DOI 10.1111/j.1530-0277.2006.00273.x; IRWIN M, 1988, AM J PSYCHIAT, V145, P595; Johnson BA, 2006, ALCOHOL CLIN EXP RES, V30, P567, DOI 10.1111/j.1530-0277.2005.00066.x; Johnson BA, 2007, JAMA-J AM MED ASSOC, V298, P1641, DOI 10.1001/jama.298.14.1641; Johnston L. D., 2007, NIH PUBLICATION, VI; Jones KA, 2006, BEHAV GENET, V36, P627, DOI 10.1007/s10519-006-9075-6; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kaukonen JP, 2006, ALCOHOL ALCOHOLISM, V41, P345, DOI 10.1093/alcalc/agh259; Kendler KS, 2006, ALCOHOL CLIN EXP RES, V30, P1972, DOI 10.1111/j.1530-0277.2006.00243.x; Kiefer F, 2003, ARCH GEN PSYCHIAT, V60, P92, DOI 10.1001/archpsyc.60.1.92; Kodituwakku PW, 2006, J STUD ALCOHOL, V67, P502, DOI 10.15288/jsa.2006.67.502; Krampe H, 2006, ALCOHOL CLIN EXP RES, V30, P86, DOI 10.1111/j.1530-0277.2006.00013.x; Kranzler HR, 2006, ALCOHOL CLIN EXP RES, V30, P272, DOI 10.1111/j.1530-0277.2006.00022.x; Krishnan-Sarin S, 2007, BIOL PSYCHIAT, V62, P694, DOI 10.1016/j.biopsych.2006.11.018; Krystal JH, 2006, ARCH GEN PSYCHIAT, V63, P957, DOI 10.1001/archpsyc.63.9.957; Kuperman S, 2005, ALCOHOL CLIN EXP RES, V29, P1869, DOI 10.1097/01.alc.0000183190.32692.c7; Laucht M, 2007, BIOL PSYCHIAT, V61, P87, DOI 10.1016/j.biopsych.2006.05.025; Lemke S, 2005, J STUD ALCOHOL, V66, P756, DOI 10.15288/jsa.2005.66.756; Li TK, 2007, BIOL PSYCHIAT, V61, P1, DOI 10.1016/j.biopsych.2006.11.004; Lingford-Hughes AR, 2004, J PSYCHOPHARMACOL, V18, P293, DOI 10.1177/026988110401800321; Maddrey W C, 2000, Clin Liver Dis, V4, P115, DOI 10.1016/S1089-3261(05)70099-4; Maisto SA, 2006, J STUD ALCOHOL, V67, P823, DOI 10.15288/jsa.2006.67.823; Mann K, 2004, ALCOHOL CLIN EXP RES, V28, P51, DOI 10.1097/01.ALC.0000108656.81563.05; Mann K, 2005, ADDICTION, V100, P797, DOI 10.1111/j.1360-0443.2005.01065.x; Mason BJ, 2006, J PSYCHIATR RES, V40, P383, DOI 10.1016/j.jpsychires.2006.02.002; McKellar JD, 2006, J STUD ALCOHOL, V67, P685, DOI 10.15288/jsa.2006.67.685; Mertens JR, 2005, ALCOHOL CLIN EXP RES, V29, P989, DOI 10.1097/01.ALC.0000167958.68586.3D; Moos RH, 2006, ADDICTION, V101, P212, DOI 10.1111/j.1360-0443.2006.01310.x; Moos RH, 2000, ADDICTION, V95, P833, DOI 10.1046/j.1360-0443.2000.9568332.x; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; Mundt MP, 2005, J STUD ALCOHOL, V66, P389, DOI 10.15288/jsa.2005.66.389; Nelson EC, 2004, ARCH GEN PSYCHIAT, V61, P257, DOI 10.1001/archpsyc.61.3.257; Niemela O, 2007, CLIN CHIM ACTA, V377, P39, DOI 10.1016/j.cca.2006.08.035; Norstrom T, 2004, ADDICTION, V99, P1274, DOI [10.1111/j.1360-0443.2004.00849.x, 10.1111/j.1360-0443.2004.00894.x]; Nurnberger JI, 2007, SCI AM, V296, P46, DOI 10.1038/scientificamerican0407-46; O'Malley SS, 2007, J CLIN PSYCHOPHARM, V27, P507, DOI 10.1097/jcp.0b013e31814ce50d; Palmieri VO, 2006, ADV EXP MED BIOL, V578, P125; Parker AJR, 2008, BMJ-BRIT MED J, V336, P496, DOI 10.1136/bmj.39483.457708.80; Pastor R, 2006, NEUROPSYCHOPHARMACOL, V31, P1489, DOI 10.1038/sj.npp.1300928; Peters TJ, 2006, ALCOHOL ALCOHOLISM, V41, P636, DOI 10.1093/alcalc/agl058; Pitel AL, 2007, ALCOHOL CLIN EXP RES, V31, P1169, DOI 10.1111/j.1530-0277.2007.00418.x; Polednak AP, 2005, ALCOHOL ALCOHOLISM, V40, P234, DOI 10.1093/alcalc/agh150; Ramstedt M, 2004, ADDICTION, V99, P1255, DOI 10.1111/j.1360-0443.2004.00798.x; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Reoux JP, 2000, AM J ADDICTION, V9, P135; Rivara FP, 2004, J STUD ALCOHOL, V65, P530, DOI 10.15288/jsa.2004.65.530; ROMEROGOMEZ M, 2002, ALCOHOL RES, V7, P66; Rosenbloom MJ, 2007, J STUD ALCOHOL DRUGS, V68, P115, DOI 10.15288/jsad.2007.68.115; Rumpf HJ, 2006, ALCOHOL ALCOHOLISM, V41, P311, DOI 10.1093/alcalc/agl008; Rush A.J., 2000, HDB PSYCHIAT MEASURE; Sannibale C, 2005, DRUG ALCOHOL REV, V24, P475, DOI 10.1080/09595230500292912; Saremi A, 2001, J STUD ALCOHOL, V62, P294, DOI 10.15288/jsa.2001.62.294; Saxena S, 1997, ADDICTION, V92, pS43, DOI 10.1111/j.1360-0443.1997.tb03394.x; Schellenberg F, 2005, ALCOHOL ALCOHOLISM, V40, P531, DOI 10.1093/alcalc/agh194; Schuckit M.A., 2002, NEUROPSYCHOPHARMACOL, P1399; Schuckit MA, 2006, J STUD ALCOHOL, V67, P215, DOI 10.15288/jsa.2006.67.215; Schuckit MA, 2005, AM J PSYCHIAT, V162, P350, DOI 10.1176/appi.ajp.162.2.350; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; Schuckit MA, 2006, DRUG ALCOHOL ABUSE C; Schuckit MA, 2008, J PSYCHIATR RES, V42, P644, DOI 10.1016/j.jpsychires.2007.07.013; Schuckit MA, 2006, ADDICTION, V101, P76, DOI 10.1111/j.1360-0443.2006.01592.x; Schumann G, 2005, NERVENARZT, V76, P1355, DOI 10.1007/s00115-005-1917-6; Smith TL, 1999, ALCOHOL CLIN EXP RES, V23, P1772, DOI 10.1111/j.1530-0277.1999.tb04072.x; Srisurapanont M, 2005, INT J NEUROPSYCHOPH, V8, P267, DOI 10.1017/S1461145704004997; Stahlbrandt H, 2007, ALCOHOL CLIN EXP RES, V31, P458, DOI 10.1111/j.1530-0277.2006.00327.x; Stecker T, 2007, J STUD ALCOHOL DRUGS, V68, P510, DOI 10.15288/jsad.2007.68.510; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Suh JJ, 2006, J CLIN PSYCHOPHARM, V26, P290, DOI 10.1097/01.jcp.0000222512.25649.08; Szucs S, 2005, ADDICTION, V100, P536, DOI 10.1111/j.1360-0443.2005.01009.x; Teesson M, 2006, DRUG ALCOHOL DEPEN, V81, P149, DOI 10.1016/j.drugalcdep.2005.06.007; Thomson AD, 2006, ALCOHOL ALCOHOLISM, V41, P151, DOI 10.1093/alcalc/agh249; Timberlake DS, 2007, ALCOHOL CLIN EXP RES, V31, P1020, DOI 10.1111/j.1530-0277.2007.00383.x; Uyarel H, 2005, J STUD ALCOHOL, V66, P555, DOI 10.15288/jsa.2005.66.555; van den Wildenberg E, 2007, ALCOHOL CLIN EXP RES, V31, P1, DOI 10.1111/j.1530-0277.2006.00258.x; Van Reen E, 2006, ALCOHOL CLIN EXP RES, V30, P974, DOI 10.1111/j.1530-0277.2006.00111.x; Vasilaki EI, 2006, ALCOHOL ALCOHOLISM, V41, P328, DOI 10.1093/alcalc/agl016; Verge C, 2006, WORLD J GASTROENTERO, V12, P5078, DOI 10.3748/wjg.v12.i31.5078; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Weinshenker D, 2007, NEUROPSYCHOPHARMACOL, V32, P1433, DOI 10.1038/sj.npp.1301263; Witkiewitz K, 2004, AM PSYCHOL, V59, P224, DOI 10.1037/0003-066X.59.4.224; Witkiewitz K, 2008, J STUD ALCOHOL DRUGS, V69, P594, DOI 10.15288/jsad.2008.69.594; World Health Organization, 1992, ICD 10 CLASS MENT BE	121	405	420	4	131	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					492	501		10.1016/S0140-6736(09)60009-X	http://dx.doi.org/10.1016/S0140-6736(09)60009-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19168210				2022-12-01	WOS:000263132800032
J	McMorran, BJ; Marshall, VM; de Graaf, C; Drysdale, KE; Shabbar, M; Smyth, GK; Corbin, JE; Alexander, WS; Foote, SJ				McMorran, Brendan J.; Marshall, Vikki M.; de Graaf, Carolyn; Drysdale, Karen E.; Shabbar, Meriam; Smyth, Gordon K.; Corbin, Jason E.; Alexander, Warren S.; Foote, Simon J.			Platelets Kill Intraerythrocytic Malarial Parasites and Mediate Survival to Infection	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; VIVAX MALARIA; BLOOD-CELLS; THROMBOCYTOPENIA; CHILDREN; PATHOLOGY; ANEMIA	Platelets play a critical role in the pathogenesis of malarial infections by encouraging the sequestration of infected red blood cells within the cerebral vasculature. But platelets also have well- established roles in innate protection against microbial infections. We found that purified human platelets killed Plasmodium falciparum parasites cultured in red blood cells. Inhibition of platelet function by aspirin and other platelet inhibitors abrogated the lethal effect human platelets exert on P. falciparum parasites. Likewise, platelet- deficient and aspirin- treated mice were more susceptible to death during erythrocytic infection with Plasmodium chabaudi. Both mouse and human platelets bind malarial- infected red cells and kill the parasite within. These results indicate a protective function for platelets in the early stages of erythrocytic infection distinct from their role in cerebral malaria.	[McMorran, Brendan J.; Drysdale, Karen E.; Shabbar, Meriam; Foote, Simon J.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Marshall, Vikki M.; de Graaf, Carolyn; Smyth, Gordon K.; Corbin, Jason E.; Alexander, Warren S.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [de Graaf, Carolyn] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	University of Tasmania; Menzies Institute for Medical Research; Walter & Eliza Hall Institute; University of Melbourne	McMorran, BJ (corresponding author), Univ Tasmania, Menzies Res Inst, Private Bag 23, Hobart, Tas 7000, Australia.	brendan.mcmorran@utas.edu.au	Foote, Simon J/F-2802-2013; Smyth, Gordon/B-5276-2008	Smyth, Gordon/0000-0001-9221-2892; Foote, Simon/0000-0002-9142-2107; McMorran, Brendan/0000-0003-1845-8872	National Health and Medical Research Council of Australia [490037, 461219]; Australian Cancer Research Foundation; Howard Hughes Medical Institute; Human Research Ethics Committee (Tasmania) Network [H0009004]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Research Ethics Committee (Tasmania) Network	We thank M. Cozens for flow cytometry support; D. Senyschen, G. Panoschi, and F. Rodda for technical support; the Australian Red Cross Blood Service for providing purified red blood cells; S. Jackson for advice; R. Anders for providing the P. falciparum parasites; and C. Flowers for manuscript preparation. Funding support was from the National Health and Medical Research Council of Australia ( Program Grants 490037 and 461219), Australian Cancer Research Foundation, and Howard Hughes Medical Institute. Statistical Analysis. P values were calculated by means of two-tailed t tests, except where specifically mentioned. Ethics approval for animal experiments was received from the Royal Melbourne Hospital, Melbourne, Australia (2002.053), and University of Tasmania ( 0008702). Ethics approval for the platelet donations was received from Human Research Ethics Committee (Tasmania) Network (H0009004).	Adedapo Aduragbenro D., 2007, Journal of Vector Borne Diseases, V44, P266; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Brass LF, 2007, PLATELETS, 2ND EDITION, P319, DOI 10.1016/B978-012369367-9/50778-3; Cattaneo M, 2007, PLATELETS, 2ND EDITION, P201, DOI 10.1016/B978-012369367-9/50772-2; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; DEGRAVES FJ, 1983, J PARASITOL, V69, P262, DOI 10.2307/3281215; English M, 1996, LANCET, V347, P1736, DOI 10.1016/S0140-6736(96)90809-0; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1993, EUR CYTOKINE NETW, V4, P415; HELLGREN U, 1989, B WORLD HEALTH ORGAN, V67, P197; HORSTMANN RD, 1981, BLUT, V42, P157, DOI 10.1007/BF01026385; Jeremiah ZA, 2007, PLATELETS, V18, P469, DOI 10.1080/09537100701194871; Kakar A, 1999, DIAGN MICR INFEC DIS, V35, P243, DOI 10.1016/S0732-8893(99)00069-3; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Lou JN, 1997, AM J PATHOL, V151, P1397; Min-Oo G, 2005, CELL MICROBIOL, V7, P753, DOI 10.1111/j.1462-5822.2005.00524.x; Oh MD, 2001, AM J TROP MED HYG, V65, P143, DOI 10.4269/ajtmh.2001.65.143; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; PEYRON F, 1989, PARASITOLOGY, V99, P317, DOI 10.1017/S0031182000059011; Polack B, 1997, HAEMOSTASIS, V27, P278; Rex S, 2007, PLATELETS, 2ND EDITION, P251, DOI 10.1016/B978-012369367-9/50775-8; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; WEISS HJ, 1968, J CLIN INVEST, V47, P2169, DOI 10.1172/JCI105903; Yeaman MR, 2007, PLATELETS, 2ND EDITION, P727, DOI 10.1016/B978-012369367-9/50802-8	25	184	191	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					797	800		10.1126/science.1166296	http://dx.doi.org/10.1126/science.1166296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197068				2022-12-01	WOS:000263066800051
J	Korennykh, AV; Egea, PF; Korostelev, AA; Finer-Moore, J; Zhang, C; Shokat, KM; Stroud, RM; Walter, P				Korennykh, Alexei V.; Egea, Pascal F.; Korostelev, Andrei A.; Finer-Moore, Janet; Zhang, Chao; Shokat, Kevan M.; Stroud, Robert M.; Walter, Peter			The unfolded protein response signals through high-order assembly of Ire1	NATURE			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; ER-STRESS; KINASE; MECHANISM; AUTOPHOSPHORYLATION; ACTIVATION; SOFTWARE	Aberrant folding of proteins in the endoplasmic reticulum activates the bifunctional transmembrane kinase/ endoribonuclease Ire1. Ire1 excises an intron from HAC1 messenger RNA in yeasts and Xbp1 messenger RNA in metozoans encoding homologous transcription factors. This non- conventional mRNA splicing event initiates the unfolded protein response, a transcriptional program that relieves the endoplasmic reticulum stress. Here we show that oligomerization is central to Ire1 function and is an intrinsic attribute of its cytosolic domains. We obtained the 3.2- A crystal structure of the oligomer of the Ire1 cytosolic domains in complex with a kinase inhibitor that acts as a potent activator of the Ire1 RNase. The structure reveals a rod- shaped assembly that has no known precedence among kinases. This assembly positions the kinase domain for trans- autophosphorylation, orders the RNase domain, and creates an interaction surface for binding of the mRNA substrate. Activation of Ire1 through oligomerization expands the mechanistic repertoire of kinase- based signalling receptors.	[Korennykh, Alexei V.; Egea, Pascal F.; Finer-Moore, Janet; Stroud, Robert M.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Korennykh, Alexei V.; Zhang, Chao; Shokat, Kevan M.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Korostelev, Andrei A.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Korennykh, AV (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	alexei.korennykh@ucsf.edu	Longo, Kenneth A/A-5631-2010; egea, pascal/V-7662-2019; Egea, Pascal Francois/AAI-2759-2020	egea, pascal/0000-0003-4432-8625; Korostelev, Andrei/0000-0003-1588-717X	Jane Coffin Childs; National Parkinson Foundation; NIH [RO1 GM60641]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060641] Funding Source: NIH RePORTER	Jane Coffin Childs; National Parkinson Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Krutchinsky for the help with MALDI instruments and for the tryptic digest analysis of Ire1KR32, F. Gruswitz for useful discussions, C. Waddling for managing the protein crystallization facility of the molecular structure group (MSG) at UCSF, and to the staff of the beamline 8.3.1 at the Advanced Light Source (Berkeley). We thank members of the Walter laboratory for critical review of the manuscript. A.V.K. is a recipient of Jane Coffin Childs fellowship. C.Z. was supported by a grant from the National Parkinson Foundation. R.M.S., J.F.-M. and P.F.E. were supported by an NIH grant RO1 GM60641. P. W. and K.M.S. are Investigators of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fabiola F, 2006, ACTA CRYSTALLOGR D, V62, P227, DOI 10.1107/S0907444905040680; Goffin L, 2006, MOL BIOL CELL, V17, P5309, DOI 10.1091/mbc.E06-04-0292; Gonzalez TN, 2000, METH MOL B, V160, P25; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Korostelev A, 2002, ACTA CRYSTALLOGR D, V58, P761, DOI 10.1107/S0907444902003402; Kudo T, 2002, ANN NY ACAD SCI, V977, P349, DOI 10.1111/j.1749-6632.2002.tb04837.x; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Naidoo N, 2005, J NEUROCHEM, V92, P1150, DOI 10.1111/j.1471-4159.2004.02952.x; Nock S, 2001, METHOD ENZYMOL, V342, P3, DOI 10.1016/S0076-6879(01)42530-4; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Yonemoto W, 1997, PROTEIN ENG, V10, P915, DOI 10.1093/protein/10.8.915; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zheng Y, 2005, J MICROBIOL, V43, P529	35	444	463	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					687	U2		10.1038/nature07661	http://dx.doi.org/10.1038/nature07661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19079236	Green Accepted			2022-12-01	WOS:000263064700033
J	Ruth, T				Ruth, Thomas			Accelerating production of medical isotopes	NATURE			English	Editorial Material									[Ruth, Thomas] TRIUMF, Vancouver, BC V6T 2A3, Canada; [Ruth, Thomas] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; British Columbia Cancer Agency	Ruth, T (corresponding author), TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.	truth@triumf.ca							0	72	72	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 29	2009	457	7229					536	537		10.1038/457536a	http://dx.doi.org/10.1038/457536a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177112	Bronze			2022-12-01	WOS:000262852200023
J	Broadfield, E; Doshi, N; Alexander, PDG; Greaves, M; Woodcock, A				Broadfield, Emma; Doshi, Neelam; Alexander, Peter D. G.; Greaves, Melanie; Woodcock, Ashley			Cunning and community-acquired pneumonia	LANCET			English	Editorial Material							ASSOCIATION; MRSA		[Broadfield, Emma; Alexander, Peter D. G.] Univ S Manchester Hosp, Dept Intens Care Med, Manchester M20 8LR, Lancs, England; [Doshi, Neelam] Univ S Manchester Hosp, Dept Med Microbiol, Manchester M20 8LR, Lancs, England; [Greaves, Melanie] Univ S Manchester Hosp, Dept Radiol, Manchester M20 8LR, Lancs, England; [Woodcock, Ashley] Univ S Manchester Hosp, Dept Resp Med, Manchester M20 8LR, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Broadfield, E (corresponding author), Wythenshawe Hosp, Univ S Manchester Hosp, Southmoor Rd, Manchester M23 9LT, Lancs, England.	emma@ejcbroad.fsnet.co.uk		Woodcock, Ashley/0000-0002-5428-8578				Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Nathwani D, 2008, J ANTIMICROB CHEMOTH, V61, P976, DOI 10.1093/jac/dkn096; Yamaoka Toshimori, 2007, Journal of Infection and Chemotherapy, V13, P141, DOI 10.1007/s10156-007-0521-z	4	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					270	270		10.1016/S0140-6736(09)60074-X	http://dx.doi.org/10.1016/S0140-6736(09)60074-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150706				2022-12-01	WOS:000262537500030
J	Ren, H; Sigman, DM; Meckler, AN; Plessen, B; Robinson, RS; Rosenthal, Y; Haug, GH				Ren, H.; Sigman, D. M.; Meckler, A. N.; Plessen, B.; Robinson, R. S.; Rosenthal, Y.; Haug, G. H.			Foraminiferal Isotope Evidence of Reduced Nitrogen Fixation in the Ice Age Atlantic Ocean	SCIENCE			English	Article							PLANKTONIC-FORAMINIFERA; SEDIMENT N-15/N-14; PARTICLE DYNAMICS; ATMOSPHERIC CO2; NORTH-ATLANTIC; ARABIAN SEA; DENITRIFICATION; PACIFIC; CARBON; FRACTIONATION	Fixed nitrogen ( N) is a limiting nutrient for algae in the low- latitude ocean, and its oceanic inventory may have been higher during ice ages, thus helping to lower atmospheric CO(2) during those intervals. In organic matter within planktonic foraminifera shells in Caribbean Sea sediments, we found that the (15)N/(14)N ratio from the last ice age is higher than that from the current interglacial, indicating a higher nitrate (15)N/(14)N ratio in the Caribbean thermocline. This change and other species- specific differences are best explained by less N fixation in the Atlantic during the last ice age. The fixation decrease was most likely a response to a known ice age reduction in ocean N loss, and it would have worked to balance the ocean N budget and to curb ice age- interglacial change in the N inventory.	[Ren, H.; Sigman, D. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Meckler, A. N.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Plessen, B.] Deutsch Geoforschungszentrum, Helmholtz Zentrum Potsdam, D-14473 Potsdam, Germany; [Robinson, R. S.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Rosenthal, Y.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Rosenthal, Y.] Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA; [Haug, G. H.] ETH, Dept Earth Sci, Inst Geol, CH-8092 Zurich, Switzerland; [Haug, G. H.] Univ Potsdam, DFG Leibniz Ctr Earth Surface Proc & Climate Stud, Inst Geosci, D-14476 Potsdam, Germany	Princeton University; California Institute of Technology; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Rhode Island; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Potsdam	Ren, H (corresponding author), Princeton Univ, Dept Geosci, Guyot Hall, Princeton, NJ 08544 USA.	hren@princeton.edu	Meckler, Anna Nele/AAC-2490-2020; Sigman, Daniel M/A-2649-2008	Meckler, Anna Nele/0000-0002-7225-8276; Sigman, Daniel M/0000-0002-7923-1973; Robinson, Rebecca/0000-0002-8072-1603; REN, HAO-JIA/0000-0002-1769-4243	NSF [ANT-0453680, OCE- 9981479, OCE- 0447570, OCE-0220776, OCE-0341412, OCE-0502504, OCE-0437366, OCE-0350794]; Schlanger Ocean Drilling Fellowship; Princeton Carbon Mitigation Initiative; Deutsche Forschungsgemeinschaft	NSF(National Science Foundation (NSF)); Schlanger Ocean Drilling Fellowship; Princeton Carbon Mitigation Initiative; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. Bernhard and D. McCorkle for supplying surface sediment samples; Y. Wang, M. Coray, and S. Bishop for technical assistance; B. Brunelle for advice; and two anonymous reviewers for comments. Supported by NSF grants ANT-0453680, OCE- 9981479, and OCE- 0447570 (D.M.S.), OCE-0220776, OCE-0341412, and OCE-0502504 (Y.R.), and OCE-0437366 and OCE-0350794 (J. Bernhard), a Schlanger Ocean Drilling Fellowship (H.R.), BP through the Princeton Carbon Mitigation Initiative, and Deutsche Forschungsgemeinschaft grants (G.H.H.). This research used samples provided by the ODP, which is sponsored by NSF and participating countries under the management of Joint Oceanographic Institutions.	ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; ALTABET MA, 1988, DEEP-SEA RES, V35, P535, DOI 10.1016/0198-0149(88)90130-6; ALTABET MA, 1989, LIMNOL OCEANOGR, V34, P1185, DOI 10.4319/lo.1989.34.7.1185; Altabet MA, 1989, GLOBAL BIOGEOCHEM CY, V3, P107, DOI 10.1029/GB003i002p00107; Barford CC, 1999, APPL ENVIRON MICROB, V65, P989; Brandes JA, 1997, GEOCHIM COSMOCHIM AC, V61, P1793, DOI 10.1016/S0016-7037(97)00041-0; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; CHECKLEY DM, 1989, DEEP-SEA RES, V36, P1449, DOI 10.1016/0198-0149(89)90050-2; CHRISTENSEN JP, 1994, CONT SHELF RES, V14, P547, DOI 10.1016/0278-4343(94)90103-1; De Pol-Holz R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024477; Deutsch C, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002189; DiFiore PJ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003216; Emmer E, 2000, PALEOCEANOGRAPHY, V15, P377, DOI 10.1029/1999PA000417; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Hastings MG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003789; Haug GH, 1998, PALEOCEANOGRAPHY, V13, P427, DOI 10.1029/98PA01976; JASPER JP, 1990, NATURE, V347, P462, DOI 10.1038/347462a0; KAO SJ, 2008, ATMOS CHEM PHYS DISC, V5, P1017; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; KING K JR, 1972, Micropaleontology (New York), V18, P285, DOI 10.2307/1485009; Knapp AN, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002320; Knapp AN, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003107; MCELROY MB, 1983, NATURE, V302, P328, DOI 10.1038/302328a0; Meckler AN, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002893; Mintenbeck K, 2007, DEEP-SEA RES PT I, V54, P1015, DOI 10.1016/j.dsr.2007.03.005; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; Mora G, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001132; NAKATSUKA T, 1995, GEOPHYS RES LETT, V22, P2525, DOI 10.1029/95GL02544; Ravelo AC, 1992, PALEOCEANOGRAPHY, V7, P815, DOI 10.1029/92PA02092; REDFIELD AC, 1958, AM SCI, V46, P205; ROBBINS LL, 1990, GEOCHIM COSMOCHIM AC, V54, P2285, DOI 10.1016/0016-7037(90)90052-M; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; SWEENEY RE, 1980, MAR CHEM, V9, P145, DOI 10.1016/0304-4203(80)90064-X; Thunell RC, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI [10.1029/2002GB002028, 10.1029/2003GB002185]; Uhle ME, 1997, ORG GEOCHEM, V27, P103, DOI 10.1016/S0146-6380(97)00075-2; UHLE ME, 1990, LIMNOL OCEANOGR, V44, P1968; WADA E, 1976, GEOCHIM COSMOCHIM AC, V40, P249, DOI 10.1016/0016-7037(76)90183-6	41	109	112	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					244	248		10.1126/science.1165787	http://dx.doi.org/10.1126/science.1165787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19095896				2022-12-01	WOS:000262290600036
J	Ghosh, D; Griswold, J; Erman, M; Pangborn, W				Ghosh, Debashis; Griswold, Jennifer; Erman, Mary; Pangborn, Walter			Structural basis for androgen specificity and oestrogen synthesis in human aromatase	NATURE			English	Article							HUMAN PLACENTAL AROMATASE; CYTOCHROME-P450 AROMATASE; KINETIC-PROPERTIES; CRYSTAL-STRUCTURES; DIOXYGEN COMPLEX; WILD-TYPE; PURIFICATION; INHIBITORS; MODEL; MECHANISM	Aromatase cytochrome P450 is the only enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens(1-3). Aromatase inhibitors therefore constitute a front-line therapy for oestrogen- dependent breast cancer(3,4). In a three-step process, each step requiring 1 mol of O-2, 1 mol of NADPH, and coupling with its redox partner cytochrome P450 reductase, aromatase converts androstenedione, testosterone and 16 alpha-hydroxytestosterone to oestrone, 17 beta-oestradiol and 17 beta, 16 alpha-oestriol, respectively(1-3). The first two steps are C19- methyl hydroxylation steps, and the third involves the aromatization of the steroid A- ring, unique to aromatase. Whereas most P450s are not highly substrate selective, it is the hallmark androgenic specificity that sets aromatase apart. The structure of this enzyme of the endoplasmic reticulum membrane has remained unknown for decades, hindering elucidation of the biochemical mechanism. Here we present the crystal structure of human placental aromatase, the only natural mammalian, full- length P450 and P450 in hormone biosynthetic pathways to be crystallized so far. Unlike the active sites of many microsomal P450s that metabolize drugs and xenobiotics, aromatase has an androgen- specific cleft that binds the androstenedione molecule snugly. Hydrophobic and polar residues exquisitely complement the steroid backbone. The locations of catalytically important residues shed light on the reaction mechanism. The relative juxtaposition of the hydrophobic amino- terminal region and the opening to the catalytic cleft shows why membrane anchoring is necessary for the lipophilic substrates to gain access to the active site. The molecular basis for the enzyme's androgenic specificity and unique catalytic mechanism can be used for developing next- generation aromatase inhibitors.	[Ghosh, Debashis; Griswold, Jennifer; Erman, Mary; Pangborn, Walter] Hauptman Woodward Res Inst, Buffalo, NY 14203 USA; [Ghosh, Debashis] Roswell Pk Canc Inst, Buffalo, NY 14263 USA	Hauptman Woodward Medical Research Institute; Roswell Park Cancer Institute	Ghosh, D (corresponding author), Hauptman Woodward Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	ghosh@hwi.buffalo.edu			National Institutes of Health [GM62794, GM59450]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062794, R01GM086893, R21GM059450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Osawa, who pioneered aromatase research and its purification from human placenta at the institute, for many discussions and encouragement; past graduate students, postdoctoral scientists and research associates for contributions to the initial purification and crystallization efforts; H. Davies for discussions; D. Gewirth, V. Cody, G. DeTitta and J. Griffin for critically reading the manuscript; staff at the Women's and Children's Hospital of Buffalo for providing the placenta used in this work; and staffs of the Cornell High Energy Synchrotron Source and the Advanced Photon Source, Argonne National Laboratory, for helping with the synchrotron X- ray data collection. The research is supported in part by grants GM62794 and GM59450 (to D.G.) from the National Institutes of Health.	AKHTAR M, 1993, J STEROID BIOCHEM, V44, P375, DOI 10.1016/0960-0760(93)90241-N; AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; AMARNEH B, 1995, MOL CELL ENDOCRINOL, V109, pR1, DOI 10.1016/0303-7207(95)03524-B; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen SA, 2003, J STEROID BIOCHEM, V86, P231, DOI 10.1016/S0960-0760(03)00361-3; CHEN SU, 1993, J STEROID BIOCHEM, V44, P347, DOI 10.1016/0960-0760(93)90238-R; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Eisen A, 2008, CANCER TREAT REV, V34, P157, DOI 10.1016/j.ctrv.2007.11.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GRAHAMLORENCE S, 1995, PROTEIN SCI, V4, P1065, DOI 10.1002/pro.5560040605; Guallar V, 2003, P NATL ACAD SCI USA, V100, P6998, DOI 10.1073/pnas.0732000100; Hackett JC, 2005, J AM CHEM SOC, V127, P5224, DOI 10.1021/ja044716w; Hong Y, 2008, BIOCHEM PHARMACOL, V75, P1161, DOI 10.1016/j.bcp.2007.11.010; Johnston JO, 1998, CRIT REV BIOCHEM MOL, V33, P375; KADOHAMA N, 1992, J STEROID BIOCHEM, V43, P693, DOI 10.1016/0960-0760(92)90295-T; Kao YC, 2001, EUR J BIOCHEM, V268, P243, DOI 10.1046/j.1432-1033.2001.01886.x; KELLIS JT, 1987, J BIOL CHEM, V262, P4413; Lala P, 2004, J STEROID BIOCHEM, V88, P235, DOI 10.1016/j.jsbmb.2003.12.010; LAUGHTON CA, 1993, J STEROID BIOCHEM, V44, P399, DOI 10.1016/0960-0760(93)90243-P; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; NAKAJIN S, 1986, BIOCHEM BIOPH RES CO, V134, P704, DOI 10.1016/S0006-291X(86)80477-6; OH SS, 1993, J STEROID BIOCHEM, V44, P389, DOI 10.1016/0960-0760(93)90242-O; Omura T, 1978, CYTOCHROME P 450; OTNINOWSKI Z, 1995, HKL MANUAL; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Sansen S, 2007, ARCH BIOCHEM BIOPHYS, V464, P197, DOI 10.1016/j.abb.2007.04.028; SHIMOZAWA O, 1993, J BIOL CHEM, V268, P21399; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; THOMPSON EA, 1974, J BIOL CHEM, V249, P5364; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; YOSHIDA N, 1991, BIOCHEMISTRY-US, V30, P3003, DOI 10.1021/bi00226a004; ZHOU DJ, 1991, P NATL ACAD SCI USA, V88, P410, DOI 10.1073/pnas.88.2.410	36	388	397	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					219	U119		10.1038/nature07614	http://dx.doi.org/10.1038/nature07614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19129847	Green Accepted			2022-12-01	WOS:000262360200038
J	Eid, J; Fehr, A; Gray, J; Luong, K; Lyle, J; Otto, G; Peluso, P; Rank, D; Baybayan, P; Bettman, B; Bibillo, A; Bjornson, K; Chaudhuri, B; Christians, F; Cicero, R; Clark, S; Dalal, R; Dewinter, A; Dixon, J; Foquet, M; Gaertner, A; Hardenbol, P; Heiner, C; Hester, K; Holden, D; Kearns, G; Kong, XX; Kuse, R; Lacroix, Y; Lin, S; Lundquist, P; Ma, CC; Marks, P; Maxham, M; Murphy, D; Park, I; Pham, T; Phillips, M; Roy, J; Sebra, R; Shen, G; Sorenson, J; Tomaney, A; Travers, K; Trulson, M; Vieceli, J; Wegener, J; Wu, D; Yang, A; Zaccarin, D; Zhao, P; Zhong, F; Korlach, J; Turner, S				Eid, John; Fehr, Adrian; Gray, Jeremy; Luong, Khai; Lyle, John; Otto, Geoff; Peluso, Paul; Rank, David; Baybayan, Primo; Bettman, Brad; Bibillo, Arkadiusz; Bjornson, Keith; Chaudhuri, Bidhan; Christians, Frederick; Cicero, Ronald; Clark, Sonya; Dalal, Ravindra; deWinter, Alex; Dixon, John; Foquet, Mathieu; Gaertner, Alfred; Hardenbol, Paul; Heiner, Cheryl; Hester, Kevin; Holden, David; Kearns, Gregory; Kong, Xiangxu; Kuse, Ronald; Lacroix, Yves; Lin, Steven; Lundquist, Paul; Ma, Congcong; Marks, Patrick; Maxham, Mark; Murphy, Devon; Park, Insil; Pham, Thang; Phillips, Michael; Roy, Joy; Sebra, Robert; Shen, Gene; Sorenson, Jon; Tomaney, Austin; Travers, Kevin; Trulson, Mark; Vieceli, John; Wegener, Jeffrey; Wu, Dawn; Yang, Alicia; Zaccarin, Denis; Zhao, Peter; Zhong, Frank; Korlach, Jonas; Turner, Stephen			Real-Time DNA Sequencing from Single Polymerase Molecules	SCIENCE			English	Article							PHOSPHATE-LABELED NUCLEOTIDES; HUMAN GENOME; MODE; FLUORESCENCE; SPECTROSCOPY; RESOLUTION; ALGORITHM; SUBSTRATE	We present single- molecule, real- time sequencing data obtained from a DNA polymerase performing uninterrupted template- directed synthesis using four distinguishable fluorescently labeled deoxyribonucleoside triphosphates (dNTPs). We detected the temporal order of their enzymatic incorporation into a growing DNA strand with zero- mode waveguide nanostructure arrays, which provide optical observation volume confinement and enable parallel, simultaneous detection of thousands of single- molecule sequencing reactions. Conjugation of fluorophores to the terminal phosphate moiety of the dNTPs allows continuous observation of DNA synthesis over thousands of bases without steric hindrance. The data report directly on polymerase dynamics, revealing distinct polymerization states and pause sites corresponding to DNA secondary structure. Sequence data were aligned with the known reference sequence to assay biophysical parameters of polymerization for each template position. Consensus sequences were generated from the single- molecule reads at 15- fold coverage, showing a median accuracy of 99.3%, with no systematic error beyond fluorophore- dependent error rates.	[Eid, John; Fehr, Adrian; Gray, Jeremy; Luong, Khai; Lyle, John; Otto, Geoff; Peluso, Paul; Rank, David; Baybayan, Primo; Bettman, Brad; Bibillo, Arkadiusz; Bjornson, Keith; Chaudhuri, Bidhan; Christians, Frederick; Cicero, Ronald; Clark, Sonya; Dalal, Ravindra; deWinter, Alex; Dixon, John; Foquet, Mathieu; Gaertner, Alfred; Hardenbol, Paul; Heiner, Cheryl; Hester, Kevin; Holden, David; Kearns, Gregory; Kong, Xiangxu; Kuse, Ronald; Lacroix, Yves; Lin, Steven; Lundquist, Paul; Ma, Congcong; Marks, Patrick; Maxham, Mark; Murphy, Devon; Park, Insil; Pham, Thang; Phillips, Michael; Roy, Joy; Sebra, Robert; Shen, Gene; Sorenson, Jon; Tomaney, Austin; Travers, Kevin; Trulson, Mark; Vieceli, John; Wegener, Jeffrey; Wu, Dawn; Yang, Alicia; Zaccarin, Denis; Zhao, Peter; Zhong, Frank; Korlach, Jonas; Turner, Stephen] Pacific Biosci, Menlo Pk, CA 94025 USA		Korlach, J (corresponding author), Pacific Biosci, 1505 Adams Dr, Menlo Pk, CA 94025 USA.	jkorlach@pacificbiosciences.com; sturner@pacificbiosciences.com	Turner, Stephen/GXM-4654-2022; chen, qi/C-8585-2011	Sorenson, Jon/0000-0002-5301-8306; Eid, John/0000-0002-2099-8344; Marks, Patrick/0000-0002-3231-7163; Rank, David/0000-0001-9213-6965	National Human Genome Research Institute [R01HG003710]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003710] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the entire staff at Pacific Biosciences, and J. Puglisi, M. Hunkapiller, R. Kornberg, K. Johnson, D. Haussler, W. Webb, and H. Craighead for many helpful discussions. Supported by National Human Genome Research Institute grant R01HG003710.	BALASUBRAMANIAN S, 2001, Patent No. 01057248; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Bosiers JT, 2008, PROC SPIE, V6996, DOI 10.1117/12.785847; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; CHAN EY, 2001, Patent No. 6210896; Cockroft SL, 2008, J AM CHEM SOC, V130, P818, DOI 10.1021/ja077082c; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Foquet M, 2008, J APPL PHYS, V103, DOI 10.1063/1.2831366; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Gusfield D., 1997, ALGORITHMS STRINGS T, P287; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; HORNE K, 1986, PUBL ASTRON SOC PAC, V98, P609, DOI 10.1086/131801; Ju JY, 2006, P NATL ACAD SCI USA, V103, P19635, DOI 10.1073/pnas.0609513103; KAO CC, 2002, Patent No. 6399335; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Kornberg A., 1992, DNA REPLICATION; KORTACH J, 2008, NUCLEOS NUCLEOT, V27, P1072; Kumar S, 2005, NUCLEOS NUCLEOT NUCL, V24, P401, DOI 10.1081/NCN-200059823; Lang MJ, 2004, NAT METHODS, V1, P133, DOI 10.1038/NMETH714; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lieto AM, 2003, BIOPHYS J, V85, P3294, DOI 10.1016/S0006-3495(03)74748-1; Lundquist PM, 2008, OPT LETT, V33, P1026, DOI 10.1364/OL.33.001026; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2005, GENOME RES, V15, P1767, DOI 10.1101/gr.3770505; Mitra RD, 2003, ANAL BIOCHEM, V320, P55, DOI 10.1016/S0003-2697(03)00291-4; Mulder BA, 2005, NUCLEIC ACIDS RES, V33, P4865, DOI 10.1093/nar/gki779; Reynolds B, 2008, NUCLEOS NUCLEOT NUCL, V27, P18, DOI 10.1080/15257770701571768; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sood A, 2005, J AM CHEM SOC, V127, P2394, DOI 10.1021/ja043595x; TABOR S, 1987, J BIOL CHEM, V262, P16212; Themissen AJP, 2008, SOLID STATE ELECTRON, V52, P1401, DOI 10.1016/j.sse.2008.04.012; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108	40	2272	2719	28	695	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					133	138		10.1126/science.1162986	http://dx.doi.org/10.1126/science.1162986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19023044				2022-12-01	WOS:000262104100059
J	Kennett, DJ; Kennett, JP; West, A; Mercer, C; Hee, SSQ; Bement, L; Bunch, TE; Sellers, M; Wolbach, WS				Kennett, D. J.; Kennett, J. P.; West, A.; Mercer, C.; Hee, S. S. Que; Bement, L.; Bunch, T. E.; Sellers, M.; Wolbach, W. S.			Nanodiamonds in the Younger Dryas Boundary Sediment Layer	SCIENCE			English	Article							DIAMOND		[Kennett, D. J.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Kennett, J. P.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [West, A.] GeoSci Consulting, Dewey, AZ 86327 USA; [Mercer, C.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Hee, S. S. Que] Univ Calif Los Angeles, Dept Environm Hlth Sci, Ctr Occupat & Environm Hlth, Los Angeles, CA 90095 USA; [Bement, L.] Univ Oklahoma, Oklahoma Archeol Survey, Norman, OK 73019 USA; [Bunch, T. E.; Sellers, M.] No Arizona Univ, Dept Geol, Flagstaff, AZ 86011 USA; [Bunch, T. E.; Sellers, M.] No Arizona Univ, Dept Sci Biol, Flagstaff, AZ 86011 USA; [Wolbach, W. S.] De Paul Univ, Dept Chem, Chicago, IL 60614 USA	University of Oregon; University of California System; University of California Santa Barbara; National Institute for Materials Science; University of California System; University of California Los Angeles; University of Oklahoma System; University of Oklahoma - Norman; Northern Arizona University; Northern Arizona University; DePaul University	Kennett, DJ (corresponding author), Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA.	dkennett@uoregon.edu	Kennett, Douglas J/I-7613-2015; MERCER, Christopher/H-2654-2011	Kennett, Douglas J/0000-0001-5133-9010; Wolbach, Wendy/0000-0003-4398-8269	NSF [ATM-0713769]	NSF(National Science Foundation (NSF))	This research was funded by the NSF (grant ATM-0713769). We thank three anonymous reviewers and V. Haynes for assistance.	CHYBA CF, 1993, NATURE, V361, P40, DOI 10.1038/361040a0; Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104; Grady MM, 1995, EARTH PLANET SC LETT, V136, P677, DOI 10.1016/0012-821X(95)00162-6; Haynes CV, 2008, P NATL ACAD SCI USA, V105, P6520, DOI 10.1073/pnas.0800560105; Hough RM, 1997, GEOLOGY, V25, P1019, DOI 10.1130/0091-7613(1997)025<1019:DFTIRK>2.3.CO;2; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606; Wen B, 2007, INT MATER REV, V52, P131, DOI 10.1179/174328007X160236	7	117	123	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					94	94		10.1126/science.1162819	http://dx.doi.org/10.1126/science.1162819			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119227				2022-12-01	WOS:000262104100047
J	Lo Celso, C; Fleming, HE; Wu, JWW; Zhao, CX; Miake-Lye, S; Fujisaki, J; Cote, D; Rowe, DW; Lin, CP; Scadden, DT				Lo Celso, Cristina; Fleming, Heather E.; Wu, Juwell W.; Zhao, Cher X.; Miake-Lye, Sam; Fujisaki, Joji; Cote, Daniel; Rowe, David W.; Lin, Charles P.; Scadden, David T.			Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche	NATURE			English	Article							STEM-CELL; IDENTIFICATION; OSTEOPONTIN; EXPRESSION; COMPONENT	Stem cells reside in a specialized, regulatory environment termed the niche that dictates how they generate, maintain and repair tissues(1,2). We have previously documented that transplanted haematopoietic stem and progenitor cell populations localize to subdomains of bone- marrow microvessels where the chemokine CXCL12 is particularly abundant(3). Using a combination of high-resolution confocal microscopy and two- photon video imaging of individual haematopoietic cells in the calvarium bone marrow of living mice over time, we examine the relationship of haematopoietic stem and progenitor cells to blood vessels, osteoblasts and endosteal surface as they home and engraft in irradiated and c-Kit-receptor-deficient recipient mice. Osteoblasts were enmeshed in microvessels and relative positioning of stem/ progenitor cells within this complex tissue was nonrandom and dynamic. Both cell autonomous and non- autonomous factors influenced primitive cell localization. Different haematopoietic cell subsets localized to distinct locations according to the stage of differentiation. When physiological challenges drove either engraftment or expansion, bone- marrow stem/ progenitor cells assumed positions in close proximity to bone and osteoblasts. Our analysis permits observing in real time, at a single cell level, processes that previously have been studied only by their long- term outcome at the organismal level.	[Lo Celso, Cristina; Fleming, Heather E.; Zhao, Cher X.; Miake-Lye, Sam; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Wu, Juwell W.; Fujisaki, Joji; Cote, Daniel; Lin, Charles P.] Massachusetts Gen Hosp, Adv Microscopy Program, Ctr Syst Biol, Boston, MA 02114 USA; [Wu, Juwell W.; Fujisaki, Joji; Cote, Daniel; Lin, Charles P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Lo Celso, Cristina; Fleming, Heather E.; Wu, Juwell W.; Zhao, Cher X.; Fujisaki, Joji; Lin, Charles P.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Rowe, David W.] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA; [Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Connecticut; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	lin@helix.mgh.harvard.edu; dscadden@mgh.harvard.edu	Fang, Zhijun/L-9620-2013; Côté, Daniel/D-5185-2011	Lo Celso, Cristina/0000-0002-1163-4207	EMBO; HFSP; National Institutes of Health; Harvard Stem Cell Institute; NATIONAL EYE INSTITUTE [R01EY014106] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Schipani for providing the PPR mice. We are grateful for help and advice from A. Catic, L. Purton, V. Janzen, G. Adams, J. Spencer, J. Runnels and P. O'Donovan. We thank Y. Tang for the mice husbandry care; D. Dombkowski, L. Prickett and K. Folz-Donahue for cell sorting expertise; R. Klein and K. Chomsky-Higgins for technical assistance; and C. Pasker, V. Shannon, M. Indico Miklosik and D. Machon for administrative assistance. C. L. C. was funded by EMBO and HFSP. The project was funded by the National Institutes of Health (to D.T.S. and C.P.L.), the Harvard Stem Cell Institute (to C.P.L.) and philanthropic sources (to D.T.S. and C.L.C.).	Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CROCK HW, 1967, BLOOD SUPPLY LOWER L; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; LORD BI, 1975, BLOOD, V46, P65; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Migliaccio AR, 1999, EXP HEMATOL, V27, P1655, DOI 10.1016/S0301-472X(99)00110-1; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 1997, BLOOD, V90, P4646; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Suzuki N, 2006, P NATL ACAD SCI USA, V103, P2202, DOI 10.1073/pnas.0508928103; Taichman RUSSELL S., 2000, Hematology, V4, P421; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhong JF, 2002, BLOOD, V100, P3521, DOI 10.1182/blood-2002-04-1256; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	33	654	662	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					92	U96		10.1038/nature07434	http://dx.doi.org/10.1038/nature07434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19052546	Green Accepted			2022-12-01	WOS:000262104900037
J	Patton, D; McIntosh, A				Patton, Declan; McIntosh, Andrew			Head and neck injury risks in heavy metal: head bangers stuck between rock and a hard bass	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To investigate the risks of mild traumatic brain injury and neck injury associated with head banging, a popular dance form accompanying heavy metal music. Design Observational studies, focus group, and biomechanical analysis. Participants Head bangers. Main outcome measures Head Injury Criterion and Neck Injury Criterion were derived for head banging styles and both popular heavy metal songs and easy listening music controls. Results An average head banging song has a tempo of about 146 beats per minute, which is predicted to cause mild head injury when the range of motion is greater than 75 degrees. At higher tempos and greater ranges of motion there is a risk of neck injury. Conclusion To minimise the risk of head and neck injury, head bangers should decrease their range of head and neck motion, head bang to slower tempo songs by replacing heavy metal with adult oriented rock, only head bang to every second beat, or use personal protective equipment.	[Patton, Declan; McIntosh, Andrew] Univ New S Wales, Sch Risk & Safety Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	McIntosh, A (corresponding author), Univ New S Wales, Sch Risk & Safety Sci, Sydney, NSW 2052, Australia.	a.mcintosh@unsw.edu.au						BALSAMO T, 2006, EVANESCENCE GUITARIS; BASHAM D, 2001, BASSIST J NEWSTED LE; BENNETT J, 2008, SKY NEWS; BOSTROM O, 1996, INT RES COUNC BIOM I; BRANDLE L, 2003, BILLBOARD B; Brault JR, 1998, ARCH PHYS MED REHAB, V79, P72, DOI 10.1016/S0003-9993(98)90212-X; Clauser C. E., 1969, WEIGHT VOLUME CTR MA, P1; DANENBERG MA, 1987, LANG SPEECH HEAR SER, V8, P267; EGNOR M R, 1991, Pediatric Neurosurgery, V17, P135, DOI 10.1159/000120583; Ferrario VF, 2002, J ORTHOPAED RES, V20, P122, DOI 10.1016/S0736-0266(01)00079-1; FINE M, 2008, NIELSEN SOUNDSCAN; JAKOBSSON L, 1999, INT RES COUNC BIOM I; KIMPTON P, 2008, OBSERVER; Kunin M, 2007, J NEUROPHYSIOL, V98, P3095, DOI 10.1152/jn.00764.2007; LEWIS D, 1997, L ZEPPELIN CONCERT F; McConville J. T., 1980, ANTHROPOMETRIC RELAT; Neyaz Z, 2006, NEUROL INDIA, V54, P319; Panjabi MM, 2005, J BIOMECH, V38, P1694, DOI 10.1016/j.jbiomech.2004.07.015; Spheeris P., 1988, DECLINE W CIVILIZA 2; Spheeris Penelope, 1992, WAYNES WORLD; THOMPSON B, 2008, DAILY TELEGRAPH; TYRELL D, 1998, CRASHWORTHINESS PASS	22	8	8	0	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2008	337								a2825	10.1136/bmj.a2825	http://dx.doi.org/10.1136/bmj.a2825			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SW	19091761	hybrid, Green Published			2022-12-01	WOS:000262185000007
J	Hori, T; Amano, M; Suzuki, A; Backer, CB; Welburn, JP; Dong, YM; McEwen, BF; Shang, WH; Suzuki, E; Okawa, K; Cheeseman, IM; Fukagawa, T				Hori, Tetsuya; Amano, Miho; Suzuki, Aussie; Backer, Chelsea B.; Welburn, Julie P.; Dong, Yimin; McEwen, Bruce F.; Shang, Wei-Hao; Suzuki, Emiko; Okawa, Katsuya; Cheeseman, Iain M.; Fukagawa, Tatsuo			CCAN Makes Multiple Contacts with Centromeric DNA to Provide Distinct Pathways to the Outer Kinetochore	CELL			English	Article							CENP-A CHROMATIN; CHROMOSOME SEGREGATION; MOLECULAR ARCHITECTURE; MITOTIC CHECKPOINT; HUMAN-CELLS; COMPLEX; COMPONENT; ORGANIZATION; INTERPHASE; PROTEINS	Kinetochore specification and assembly requires the targeted deposition of specialized nucleosomes containing the histone H3 variant CENP-A at centromeres. However, CENP-A is not sufficient to drive full-kinetochore assembly, and it is not clear how centromeric chromatin is established. Here, we identify CENP-W as a component of the DNA-proximal constitutive centromere-associated network (CCAN) of proteins. We demonstrate that CENP-W forms a DNA-binding complex together with the CCAN component CENP-T. This complex directly associates with nucleosomal DNA and with canonical histone H3, but not with CENP-A, in centromeric regions. CENP-T/CENP-W functions upstream of other CCAN components with the exception of CENP-C, an additional putative DNA-binding protein. Our analysis indicates that CENP-T/CENP-W and CENP-C provide distinct pathways to connect the centromere with outer kinetochore assembly. In total, our results suggest that the CENP-T/CENP-W complex is directly involved in establishment of centromere chromatin structure coordinately with CENP-A.	[Hori, Tetsuya; Amano, Miho; Suzuki, Aussie; Shang, Wei-Hao; Fukagawa, Tatsuo] Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; [Suzuki, Emiko] Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, SOKENDAI, Mishima, Shizuoka 4118540, Japan; [Backer, Chelsea B.; Welburn, Julie P.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Backer, Chelsea B.; Welburn, Julie P.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Dept Biol, Cambridge, MA 02142 USA; [Dong, Yimin; McEwen, Bruce F.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); State University of New York (SUNY) System; Wadsworth Center; Kyoto University	Fukagawa, T (corresponding author), Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan.	tfukagaw@lab.nig.ac.jp	Fukagawa, Tatsuo/AAK-3922-2021; Suzuki, Aussie/ABF-4170-2021	Suzuki, Aussie/0000-0001-7390-5116; Welburn, Julie/0000-0002-5440-6060; Cheeseman, Iain/0000-0002-3829-5612; Suzuki, Emiko/0000-0002-4005-0542	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Smith Family Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smith Family Foundation	The authors are very grateful to K. Suzuki, M. Takahashi, and K. Kita for technical assistance. We also thank H. Kimura and V. Regnier for reagents. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to T. F. and a Smith Family Foundation New Investigator Award and Thomas D. and Virginia W. Cabot Career Development Professorship to I. M. C.	Alonso A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r148; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Krasikova A, 2006, CHROMOSOME RES, V14, P777, DOI 10.1007/s10577-006-1085-y; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Lee S, 2007, BIOCHEM BIOPH RES CO, V360, P633, DOI 10.1016/j.bbrc.2007.06.102; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Yang CH, 1996, MOL CELL BIOL, V16, P3576	41	292	300	2	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 12	2008	135	6					1039	1052		10.1016/j.cell.2008.10.019	http://dx.doi.org/10.1016/j.cell.2008.10.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070575	Bronze			2022-12-01	WOS:000261642800020
J	Shubeita, GT; Tran, SL; Xu, J; Vershinin, M; Cermelli, S; Cotton, SL; Welte, MA; Gross, SP				Shubeita, George T.; Tran, Susan L.; Xu, Jing; Vershinin, Michael; Cermelli, Silvia; Cotton, Sean L.; Welte, Michael A.; Gross, Steven P.			Consequences of Motor Copy Number on the Intracellular Transport of Kinesin-1-Driven Lipid Droplets	CELL			English	Article							KINESIN-HEAVY-CHAIN; TUG-OF-WAR; CARGO TRANSPORT; IN-VIVO; ORGANELLE TRANSPORT; DROSOPHILA EMBRYOS; CYTOPLASMIC DYNEIN; VESICLE TRANSPORT; MOLECULAR MOTORS; PROTEIN	The microtubule motor kinesin-1 plays central roles in intracellular transport. It has been widely assumed that many cellular cargos are moved by multiple kinesins and that cargos with more motors move faster and for longer distances; concrete evidence, however, is sparse. Here we rigorously test these notions using lipid droplets in Drosophila embryos. We first employ antibody inhibition, genetics, biochemistry, and particle tracking to demonstrate that kinesin-1 mediates plus-end droplet motion. We then measure how variation in kinesin-1 expression affects the forces driving individual droplets and estimate the number of kinesins actively engaged per droplet. Unlike in vitro, increased motor number results in neither longer travel distances nor higher velocities. Our data suggest that cargos in vivo can simultaneously engage multiple kinesins and that transport properties are largely unaffected by variation in motor number. Apparently, higher-order regulatory mechanisms rather than motor number per se dominate cargo transport in vivo.	[Shubeita, George T.; Xu, Jing; Vershinin, Michael; Cermelli, Silvia; Gross, Steven P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Tran, Susan L.; Welte, Michael A.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Tran, Susan L.; Cotton, Sean L.; Welte, Michael A.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Tran, Susan L.; Cotton, Sean L.; Welte, Michael A.] Brandeis Univ, Rosenstiel Med Res Ctr, Waltham, MA 02454 USA	University of California System; University of California Irvine; University of Rochester; Brandeis University; Brandeis University	Welte, MA (corresponding author), Univ Rochester, Dept Biol, 601 Elmwood Ave, Rochester, NY 14627 USA.	michael.welte@rochester.edu; sgross@uci.edu	Welte, Michael/AAH-5589-2019	Welte, Michael/0000-0001-5741-4720; Shubeita, George/0000-0003-4889-7542; Vershinin, Michael/0000-0002-8207-1376	NIGMS [GM64624, GM64687]; University of Rochester; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064687, T32GM007122, R01GM064624] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Rochester; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bloomington Stock Center, B. Saxton, and I. Palacios for fly stocks, B. Theurkauf and B. Cha for advice on antibody microinjections, N. Rizzo for help with western analysis, and A. Mu r ller and D. Lambert for comments on the manuscript. This work was supported by NIGMS grantGM64624 ( to S. P. G.) and NIGMS grant GM64687 and start- up support from the University of Rochester ( to M. A. W). G. T. S. was a Paul Sigler/Agouron Fellow of the Helen Hay Whitney Foundation.	Brendza KM, 1999, J BIOL CHEM, V274, P31506, DOI 10.1074/jbc.274.44.31506; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Carter BC, 2005, PHYS BIOL, V2, P60, DOI 10.1088/1478-3967/2/1/008; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Foe Victoria E., 1993, P149; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Guo Y, 2005, MOL BIOL CELL, V16, P1406, DOI 10.1091/mbc.E04-10-0920; Hill DB, 2004, EUR BIOPHYS J BIOPHY, V33, P623, DOI 10.1007/s00249-004-0403-6; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Snider J, 2004, P NATL ACAD SCI USA, V101, P13204, DOI 10.1073/pnas.0403092101; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045	33	270	272	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2008	135	6					1098	1107		10.1016/j.cell.2008.10.021	http://dx.doi.org/10.1016/j.cell.2008.10.021			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382ZB	19070579	Green Accepted, Bronze			2022-12-01	WOS:000261642800025
J	Greely, H; Sahakian, B; Harris, J; Kessler, RC; Gazzaniga, M; Campbell, P; Farah, MJ				Greely, Henry; Sahakian, Barbara; Harris, John; Kessler, Ronald C.; Gazzaniga, Michael; Campbell, Philip; Farah, Martha J.			Towards responsible use of cognitive-enhancing drugs by the healthy	NATURE			English	Editorial Material							BRAIN; MODAFINIL; SLEEP		[Greely, Henry] Stanford Univ, Sch Law, Stanford, CA 94305 USA; [Sahakian, Barbara] Univ Cambridge, Dept Psychiat, Cambridge, England; [Sahakian, Barbara] MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England; [Harris, John] Univ Manchester, Inst Sci Eth & Innovat, Manchester M13 9PL, Lancs, England; [Harris, John] Univ Manchester, Wellcome Strateg Programme Human Body Its Scope L, Manchester M13 9PL, Lancs, England; [Kessler, Ronald C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Gazzaniga, Michael] Univ Calif Santa Barbara, Sage Ctr Study Mind, Santa Barbara, CA 93106 USA; [Campbell, Philip] Nature, London N1 9XW, England; [Farah, Martha J.] Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	Stanford University; University of Cambridge; University of Cambridge; University of Manchester; University of Manchester; Harvard University; Harvard Medical School; University of California System; University of California Santa Barbara; University of Pennsylvania; Pennsylvania Medicine	Greely, H (corresponding author), Stanford Univ, Sch Law, Crown Quadrangle,559 Nathan Abbott Way, Stanford, CA 94305 USA.	hgreely@stanford.edu; jenny.hall@cpft.nhs.uk; john.harris@manchester.ac.uk; kessler@hcp.med.harvard.edu; m.gazzaniga@psych.ucsb.edu; nature@nature.com; mfarah@psych.upenn.edu	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745	Medical Research Council [G0001354] Funding Source: Medline; Medical Research Council [G0001354B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Almeida SS, 2002, NUTR NEUROSCI, V5, P311, DOI 10.1080/1028415021000033776; Beddington J, 2008, NATURE, V455, P1057, DOI 10.1038/4551057a; Boonstra TW, 2007, CELL MOL LIFE SCI, V64, P934, DOI 10.1007/s00018-007-6457-8; Chatterjee A, 2004, NEUROLOGY, V63, P968, DOI 10.1212/01.WNL.0000138438.88589.7C; Diller LD, 1996, HASTINGS CENT REP, V26, P12, DOI 10.2307/3528571; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Fukuyama F., 2002, OUR POSTHUMAN FUTURE; Gron G, 2005, PSYCHOPHARMACOLOGY, V182, P170, DOI 10.1007/s00213-005-0043-2; Harris J., 2007, ENHANCING EVOLUTION; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Kass Leon, 2003, THERAPY BIOTECHNOLOG; Lynch G, 2006, TRENDS NEUROSCI, V29, P554, DOI 10.1016/j.tins.2006.07.007; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Moreno J. D., 2006, MIND WARS BRAIN RES; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Schacter D., 2002, 7 SINS MEMORY; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8; Vastag B, 2004, JAMA-J AM MED ASSOC, V291, P167, DOI 10.1001/jama.291.2.167; Weyandt Lisa L, 2006, J Atten Disord, V10, P9	23	469	482	1	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					702	705		10.1038/456702a	http://dx.doi.org/10.1038/456702a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19060880	Green Submitted			2022-12-01	WOS:000261559900020
J	Rozema, J; Flowers, T				Rozema, Jelte; Flowers, Timothy			ECOLOGY Crops for a Salinized World	SCIENCE			English	Editorial Material							SALT TOLERANCE; WATER RELATIONS; HALOPHYTES; IRRIGATION; GROWTH		[Rozema, Jelte] Vrije Univ Amsterdam, Dept Syst Ecol, Amsterdam, Netherlands; [Flowers, Timothy] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Flowers, Timothy] Univ Western Australia, Sch Plant Biol, Fac Nat & Agr Sci, Crawley, WA 6009, Australia	Vrije Universiteit Amsterdam; University of Sussex; University of Western Australia	Rozema, J (corresponding author), Vrije Univ Amsterdam, Dept Syst Ecol, Amsterdam, Netherlands.	jelte.rozema@falw.vu.nl	Flowers, Timothy/AAI-7078-2020	Flowers, Timothy/0000-0002-2712-9504				AHMAD R, 2002, PROSPECTS SALINE AGR; Brown JJ, 1999, AQUACULTURE, V175, P255, DOI 10.1016/S0044-8486(99)00084-8; FAO, GLOB NETW INT SOIL M; FAO, TERR DAT; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Glenn EP, 1999, CRIT REV PLANT SCI, V18, P227, DOI 10.1016/S0735-2689(99)00388-3; GLENN EP, 1991, SCIENCE, V251, P1065, DOI 10.1126/science.251.4997.1065; Koyro HW, 2006, ENVIRON EXP BOT, V56, P136, DOI 10.1016/j.envexpbot.2005.02.001; Malash NM, 2008, IRRIGATION SCI, V26, P313, DOI 10.1007/s00271-007-0095-7; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Niazi BH, 2000, J AGRON CROP SCI, V184, P101, DOI 10.1046/j.1439-037x.2000.00353.x; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Rozema J, 1996, HALOPHYTES AND BIOSALINE AGRICULTURE, P17; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; *UN POP DIV, CHART PROGR POP; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002	17	417	479	8	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2008	322	5907					1478	1480		10.1126/science.1168572	http://dx.doi.org/10.1126/science.1168572			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19056965	Green Submitted			2022-12-01	WOS:000261377400028
J	Quintana, E; Shackleton, M; Sabel, MS; Fullen, DR; Johnson, TM; Morrison, SJ				Quintana, Elsa; Shackleton, Mark; Sabel, Michael S.; Fullen, Douglas R.; Johnson, Timothy M.; Morrison, Sean J.			Efficient tumour formation by single human melanoma cells	NATURE			English	Article							CANCER STEM-CELLS; ACUTE MYELOID-LEUKEMIA; NOD/SCID MICE; LYMPHOBLASTIC-LEUKEMIA; MALIGNANT-MELANOMA; BASEMENT-MEMBRANE; INITIATING CELLS; LIVER METASTASIS; PROGENITOR CELLS; CD122(+) CELLS	A fundamental question in cancer biology is whether cells with tumorigenic potential are common or rare within human cancers. Studies on diverse cancers, including melanoma, have indicated that only rare human cancer cells ( 0.1 - 0.0001%) form tumours when transplanted into non- obese diabetic/ severe combined immunodeficiency ( NOD/ SCID) mice. However, the extent to which NOD/ SCID mice underestimate the frequency of tumorigenic human cancer cells has been uncertain. Here we show that modified xenotransplantation assay conditions, including the use of more highly immunocompromised NOD/ SCID interleukin- 2 receptor gamma chain null (Il2rg(-/-)) mice, can increase the detection of tumorigenic melanoma cells by several orders of magnitude. In limiting dilution assays, approximately 25% of unselected melanoma cells from 12 different patients, including cells from primary and metastatic melanomas obtained directly from patients, formed tumours under these more permissive conditions. In single- cell transplants, an average of 27% of unselected melanoma cells from four different patients formed tumours. Modifications to xenotransplantation assays can therefore dramatically increase the detectable frequency of tumorigenic cells, demonstrating that they are common in some human cancers.	[Quintana, Elsa; Shackleton, Mark; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; [Quintana, Elsa; Shackleton, Mark; Morrison, Sean J.] Univ Michigan, Ctr Cell Biol, Ann Arbor, MI 48109 USA; [Sabel, Michael S.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Fullen, Douglas R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Johnson, Timothy M.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Sabel, Michael S/A-7521-2009; Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; Allen H. Blondy Research Fellowship; Lewis and Lillian Becker; University of Michigan Comprehensive Cancer Center; National Institutes of Health [CA46592]; University of Michigan Flow Cytometry Core Facility; N. McAnsh and the University of Michigan Cancer Centre Histology Core; National Institute of Diabetes, Digestive, and Kidney Diseases [NIH5P60- DK20572]; Michigan Diabetes Research and Training Center; Spanish Ministry of Education; Marie Curie Outgoing International Fellowship from the European Commission; Australian National Health and Medical Research Council; Human Frontiers Science Program and Australia Post; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Allen H. Blondy Research Fellowship; Lewis and Lillian Becker; University of Michigan Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Flow Cytometry Core Facility(University of Michigan System); N. McAnsh and the University of Michigan Cancer Centre Histology Core; National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Michigan Diabetes Research and Training Center; Spanish Ministry of Education(Spanish Government); Marie Curie Outgoing International Fellowship from the European Commission(European Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Human Frontiers Science Program and Australia Post(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Howard Hughes Medical Institute and by the Allen H. Blondy Research Fellowship. The University of Michigan Melanoma Bank was supported by a gift from Lewis and Lillian Becker. Flow cytometry was partly supported by the University of Michigan Comprehensive Cancer Center grant from the National Institutes of Health CA46592. We thank: D. Adams, M. White and the University of Michigan Flow Cytometry Core Facility for support; N. McAnsh and the University of Michigan Cancer Centre Histology Core for histological studies; G. K. Smyth for assistance with statistics; and Z. Azizan for support with tissue collection. Antibody production was supported in part by the National Institute of Diabetes, Digestive, and Kidney Diseases, grant NIH5P60- DK20572 to the Michigan Diabetes Research and Training Center. Some antibodies were provided by Caltag or by eBioscience to screen for cancer stem- cell markers. Human primary melanocyte cultures were provided by M. Soengas. Human mesenchymal stem cells were provided by Z. Wang and P. Krebsbach. E. Q. was supported by the Spanish Ministry of Education and the Marie Curie Outgoing International Fellowship from the European Commission. M. S. was supported by the Australian National Health and Medical Research Council, the Human Frontiers Science Program and Australia Post.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bancroft JD, 1990, THEORY PRACTICE HIST; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Cox CV, 2004, BLOOD, V104, P2919, DOI 10.1182/blood-2004-03-0901; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; FRIDMAN R, 1991, JNCI-J NATL CANCER I, V83, P769, DOI 10.1093/jnci/83.11.769; Hamada K, 2008, INT J ONCOL, V32, P153; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; NAKAJIMA T, 1982, CANCER, V50, P912, DOI 10.1002/1097-0142(19820901)50:5<912::AID-CNCR2820500519>3.0.CO;2-U; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; PRETLOW TG, 1991, CANCER RES, V51, P3814; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2003, EXP HEMATOL, V31, P551, DOI 10.1016/S0301-472X(03)00076-6; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Suemizu H, 2007, INT J ONCOL, V31, P741; SWEENEY TM, 1991, CANCER METAST REV, V10, P245, DOI 10.1007/BF00050795; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang JCY, 1998, BLOOD, V91, P2406, DOI 10.1182/blood.V91.7.2406.2406_2406_2414; Wang Z, 2006, STEM CELLS, V24, P1573, DOI 10.1634/stemcells.2005-0399; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	43	1345	1399	5	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					593	U33		10.1038/nature07567	http://dx.doi.org/10.1038/nature07567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19052619	Green Accepted, Green Published			2022-12-01	WOS:000261340000031
J	Conen, D; Tedrow, UB; Cook, NR; Moorthy, MV; Buring, JE; Albert, CM				Conen, David; Tedrow, Usha B.; Cook, Nancy R.; Moorthy, M. V.; Buring, Julie E.; Albert, Christine M.			Alcohol Consumption and Risk of Incident Atrial Fibrillation in Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; ADRENERGIC ACTIVITY; PRIMARY PREVENTION; CARDIAC-RHYTHM; HEART-FAILURE; OLDER-ADULTS; FOLLOW-UP; HEALTH; MEN; DRINKING		[Conen, David] Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland; [Conen, David; Tedrow, Usha B.; Moorthy, M. V.; Albert, Christine M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Ctr Arrhythmia Prevent, Boston, MA USA; [Conen, David; Cook, Nancy R.; Moorthy, M. V.; Buring, Julie E.; Albert, Christine M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA USA; [Tedrow, Usha B.; Albert, Christine M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Boston, MA USA; [Buring, Julie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Aging, Boston, MA USA; [Cook, Nancy R.; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA	University of Basel; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Conen, D (corresponding author), Univ Basel Hosp, Div Cardiol, Petersgraben 4, CH-4031 Basel, Switzerland.	conend@uhbs.ch	Tedrow, Usha/AFV-2528-2022	Albert, Christine/0000-0002-2081-1121	Swiss National Science Foundation [PASMA 118586/1]; National Heart, Lung, and Blood Institute [HL-043851, HL-080467]; National Cancer Institute [CA-047988]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, R01HL080467] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Conen was supported by grant PASMA 118586/1 from the Swiss National Science Foundation. The Women's Health Study was supported by grants HL-043851 and HL-080467 from the National Heart, Lung, and Blood Institute and CA-047988 from the National Cancer Institute.	BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; COX DR, 1972, J R STAT SOC B, V34, P187; DENISON H, 1994, BRIT HEART J, V72, P554; Djousse L, 2004, AM J CARDIOL, V93, P710, DOI 10.1016/j.amjcard.2003.12.004; Djousse L, 2007, CIRCULATION, V115, P34, DOI 10.1161/CIRCULATIONAHA.106.661868; ETTINGER PO, 1978, AM HEART J, V95, P555, DOI 10.1016/0002-8703(78)90296-X; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Gavazzi A, 2000, AM J CARDIOL, V85, P1114, DOI 10.1016/S0002-9149(00)00706-2; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; HANSAGI H, 1995, STROKE, V26, P1768, DOI 10.1161/01.STR.26.10.1768; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; KOSKINEN P, 1987, BRIT HEART J, V57, P468, DOI 10.1136/hrt.57.5.468; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lazarevic AM, 2000, J AM COLL CARDIOL, V35, P1599, DOI 10.1016/S0735-1097(00)00565-9; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Maki T, 1998, AM J CARDIOL, V82, P317, DOI 10.1016/S0002-9149(98)00299-9; Marcus GM, 2008, PACE, V31, P266, DOI 10.1111/j.1540-8159.2008.00985.x; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; Meagher EA, 1999, J CLIN INVEST, V104, P805, DOI 10.1172/JCI5584; Mukamal KJ, 2007, AM HEART J, V153, P260, DOI 10.1016/j.ahj.2006.10.039; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Psaty BM, 1997, CIRCULATION, V96, P2455; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; THORNTON JR, 1984, LANCET, V2, P1013; Tolstrup J, 2006, BMJ-BRIT MED J, V332, P1244, DOI 10.1136/bmj.38831.503113.7C; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; Walsh CR, 2002, ANN INTERN MED, V136, P181, DOI 10.7326/0003-4819-136-3-200202050-00005; Zhang SMM, 2007, AM J EPIDEMIOL, V165, P667, DOI 10.1093/aje/kwk054	32	143	142	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2489	2496		10.1001/jama.2008.755	http://dx.doi.org/10.1001/jama.2008.755			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	19050192	Green Accepted, Bronze			2022-12-01	WOS:000261286200017
J	Venkatachalam, K; Long, AA; Elsaesser, R; Nikolaeva, D; Broadie, K; Montell, C				Venkatachalam, Kartik; Long, A. Ashleigh; Elsaesser, Rebecca; Nikolaeva, Daria; Broadie, Kendal; Montell, Craig			Motor Deficit in a Drosophila Model of Mucolipidosis Type IV due to Defective Clearance of Apoptotic Cells	CELL			English	Article							RETINAL DEGENERATION; MEMBRANE-PROTEIN; DEATH; NEURODEGENERATION; MUTATIONS; AUTOPHAGY; IDENTIFICATION; SUPPRESSION; ENDOCYTOSIS; CROQUEMORT	Disruption of the Transient Receptor Potential (TRP) mucolipin 1 (TRPML1) channel results in the neurodegenerative disorder mucolipidosis type IV (MLIV), a lysosomal storage disease with severe motor impairments. The mechanisms underlying MLIV are poorly understood and there is no treatment. Here, we report a Drosophila MLIV model, which recapitulates the key disease features, including abnormal intracellular accumulation of macromolecules, motor defects, and neurodegeneration. The basis for the buildup of macromolecules was defective autophagy, which resulted in oxidative stress and impaired synaptic transmission. Late-apoptotic cells accumulated in trpml mutant brains, suggesting diminished cell clearance. The accumulation of late-apoptotic cells and motor deficits were suppressed by expression of trpml(+) in neurons, glia, or hematopoietic cells. We conclude that the neurodegeneration and motor defects result primarily from decreased clearance of apoptotic cells. Since hematopoietic cells in humans are involved in clearance of apoptotic cells, our results raise the possibility that bone marrow transplantation may limit the progression of MLIV.	[Venkatachalam, Kartik; Elsaesser, Rebecca; Nikolaeva, Daria; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA; [Venkatachalam, Kartik; Elsaesser, Rebecca; Nikolaeva, Daria; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Neurosci, Baltimore, MD 21205 USA; [Long, A. Ashleigh; Broadie, Kendal] Vanderbilt Univ, Vanderbilt Brain Inst, Kennedy Ctr Res Human Dev, Dept Biol Sci, Nashville, TN 37232 USA	Johns Hopkins University; Johns Hopkins University; Vanderbilt University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Long, Ashleigh/AAE-7365-2022; Montell, Craig/AAH-3357-2021	Long, Ashleigh/0000-0002-0190-6707; Montell, Craig/0000-0001-5637-1482	MLIV Foundation; National Institute of Neurological Disorders and Stroke [NS41740]; March of Dimes; National Eye Institute [EY08117]; NATIONAL EYE INSTITUTE [R01EY008117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041740] Funding Source: NIH RePORTER	MLIV Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); March of Dimes(March of Dimes); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Bloomington Stock Center for fly stocks, T. Neufeld for the hsGFP-ATG8 flies, N. Franc for the UAS-crq flies, J. Corden, J. Lorsch, R. Rao, and S. Muend for use of equipment, and M. Sepanski for preparing sections of fly heads. We thank S. J. Moon, Y. Jiao, and X. Wang for technical advice, and M. Kottgen, Y. Kwon, and D. Wasserman for helpful discussions. We also thank the Microscopy Facility at the Cell Biology Department, the Johns Hopkins University School of Medicine, for use of their equipment. K. V. was supported in part by an MLIV Foundation postdoctoral fellowship. The work in the K. B. laboratory was supported by the National Institute of Neurological Disorders and Stroke (NS41740), and that in the C. M. laboratory was supported by grants from the March of Dimes and the National Eye Institute (EY08117). The authors declare no conflicts of interest.	Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bach G, 2005, PFLUG ARCH EUR J PHY, V451, P313, DOI 10.1007/s00424-004-1361-7; Badre NH, 2005, COMP BIOCHEM PHYS A, V140, P363, DOI 10.1016/j.cbpb.2005.01.019; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Brignull HR, 2007, ADV EXP MED BIOL, V594, P167; Brunell AB, 2007, J SOC CLIN PSYCHOL, V26, P92, DOI 10.1521/jscp.2007.26.1.92; Cooper JD, 2003, CURR OPIN NEUROL, V16, P121, DOI 10.1097/00019052-200304000-00001; Dermaut B, 2005, J CELL BIOL, V170, P127, DOI 10.1083/jcb.200412001; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/88281; Fergestad T, 2001, J NEUROSCI, V21, P1218; FLETCHER BL, 1973, ANAL BIOCHEM, V52, P1, DOI 10.1016/0003-2697(73)90327-8; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1298, DOI 10.2741/franc; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; GOLDIN E, 1995, PEDIATR RES, V37, P687, DOI 10.1203/00006450-199506000-00003; Hersh BM, 2002, P NATL ACAD SCI USA, V99, P4355, DOI 10.1073/pnas.062065399; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Lee CY, 2001, DEVELOPMENT, V128, P1443; Li J, 2000, CELL BIOL INT, V24, P9, DOI 10.1006/cbir.1999.0438; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Menoret A, 2002, INT J HYPERTHER, V18, P490, DOI 10.1080/02656730210146926; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nakano Y, 2001, MOL CELL BIOL, V21, P3775, DOI 10.1128/MCB.21.11.3775-3788.2001; Pang Z, 1997, J NEUROSCI, V17, P3064; Phillips SE, 2008, J NEUROSCI, V28, P6569, DOI 10.1523/JNEUROSCI.5529-07.2008; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Trotta N, 2004, J NEUROBIOL, V60, P328, DOI 10.1002/neu.20017; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112	52	168	170	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					838	851		10.1016/j.cell.2008.09.041	http://dx.doi.org/10.1016/j.cell.2008.09.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19041749	Bronze, Green Accepted			2022-12-01	WOS:000261183900016
